PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Moshe, SL; Perucca, E; Ryvlin, P; Tomson, T				Moshe, Solomon L.; Perucca, Emilio; Ryvlin, Philippe; Tomson, Torbjoern			Epilepsy: new advances	LANCET			English	Article							SUDDEN UNEXPECTED DEATH; TEMPORAL-LOBE EPILEPSY; CONTROLLED-RELEASE CARBAMAZEPINE; PULSE ELECTRICAL-STIMULATION; FEBRILE STATUS EPILEPTICUS; VAGUS NERVE-STIMULATION; ANTIEPILEPTIC DRUGS; PSYCHIATRIC COMORBIDITY; INTERNATIONAL-LEAGUE; PREMATURE MORTALITY	Epilepsy affects 65 million people worldwide and entails a major burden in seizure-related disability, mortality, comorbidities, stigma, and costs. In the past decade, important advances have been made in the understanding of the pathophysiological mechanisms of the disease and factors affecting its prognosis. These advances have translated into new conceptual and operational definitions of epilepsy in addition to revised criteria and terminology for its diagnosis and classification. Although the number of available antiepileptic drugs has increased substantially during the past 20 years, about a third of patients remain resistant to medical treatment. Despite improved effectiveness of surgical procedures, with more than half of operated patients achieving long-term freedom from seizures, epilepsy surgery is still done in a small subset of drug-resistant patients. The lives of most people with epilepsy continue to be adversely affected by gaps in knowledge, diagnosis, treatment, advocacy, education, legislation, and research. Concerted actions to address these challenges are urgently needed.	[Moshe, Solomon L.] Albert Einstein Coll Med, Montefiore Einstein Epilepsy Management Ctr, Lab Dev Epilepsy, Saul R Korey Dept Neurol, New York, NY USA; [Moshe, Solomon L.] Albert Einstein Coll Med, Montefiore Einstein Epilepsy Management Ctr, Lab Dev Epilepsy, Dominick P Purpura Dept Neurosci, New York, NY USA; [Moshe, Solomon L.] Albert Einstein Coll Med, Montefiore Einstein Epilepsy Management Ctr, Lab Dev Epilepsy, Dept Pediat, New York, NY USA; [Moshe, Solomon L.] Montefiore Med Ctr, New York, NY USA; [Perucca, Emilio] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy; [Perucca, Emilio] C Mondino Natl Neurol Inst, Pavia, Italy; [Tomson, Torbjoern] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ryvlin, Philippe] CNRS 5292, Hosp Civils Lyon, Lyons Neurosci Res Ctr, Dept Funct Neurol & Epileptol,INSERM,U1028, Lyon, France; [Ryvlin, Philippe] CNRS 5292, Hosp Civils Lyon, Lyons Neurosci Res Ctr, IDEE,INSERM,U1028, Lyon, France; [Ryvlin, Philippe] CHU Vaudois, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland	Yeshiva University; Yeshiva University; Yeshiva University; Montefiore Medical Center; University of Pavia; IRCCS Fondazione Casimiro Mondino; Karolinska Institutet; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Perucca, E (corresponding author), Univ Pavia, Dept Internal Med & Therapeut, Div Clin & Expt Pharmacol, Via Ferrata 9, I-27100 Pavia, Italy.	perucca@unipv.it	Ryvlin, Philippe/K-7402-2019; Perucca, Emilio/Q-7308-2019; Ryvlin, Philippe/O-5214-2016	Ryvlin, Philippe/0000-0001-7775-6576; Ryvlin, Philippe/0000-0001-7775-6576; Perucca, Emilio/0000-0001-8703-223X; Moshe, Solomon/0000-0001-9427-9476	US National Institutes of Neurological Diseases and Stroke (NINDS) [NS-20253, NS-43209, NS-45911, NS-78333]; US Department of Defense; CURE Foundation; UCB Pharma; Heffer Family Medical Foundation; Segal Family Foundation; Lundbeck; European Union; Italian Medicines Agency; Italian Ministry of Health; Italian Ministry for Education, University and Research; C Mondino National Neurological Institute; GW Pharma; Upsher-Smith; Eisai; GSK; Medichem; Sun Pharma; Supernus; Vertex; Viropharma; French Ministry of Health (PHRC); French Agency for Research (ANR); Cyberonics; Medtronic; Stockholm County Council; AFA Insurance; CURE; UCB; Sanofi-Aventis; Novartis; Bial	US National Institutes of Neurological Diseases and Stroke (NINDS); US Department of Defense(United States Department of Defense); CURE Foundation; UCB Pharma(UCB Pharma SA); Heffer Family Medical Foundation; Segal Family Foundation; Lundbeck(Lundbeck Corporation); European Union(European Commission); Italian Medicines Agency; Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); C Mondino National Neurological Institute; GW Pharma; Upsher-Smith; Eisai(Eisai Co Ltd); GSK(GlaxoSmithKline); Medichem; Sun Pharma; Supernus; Vertex(Vertex Pharmaceuticals); Viropharma; French Ministry of Health (PHRC); French Agency for Research (ANR)(French National Research Agency (ANR)); Cyberonics; Medtronic(Medtronic); Stockholm County Council(Stockholm County Council); AFA Insurance; CURE; UCB(UCB Pharma SA); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Bial(Bial Group)	SLM is an employee of the Einstein College of Medicine and Charles Frost Chair in Neurosurgery and Neurology. He received grants from the US National Institutes of Neurological Diseases and Stroke (NINDS: NS-20253, NS-43209, NS-45911, NS-78333) and from the US Department of Defense, CURE Foundation, UCB Pharma, the Heffer Family Medical Foundation and the Segal Family Foundation. He received consultancy fees from Lundbeck and UCB Pharma. EP is an employee of the University of Pavia and received grants from the European Union, the Italian Medicines Agency, the Italian Ministry of Health, the Italian Ministry for Education, University and Research and the C Mondino National Neurological Institute. He also received speaker's or consultancy fees from GW Pharma, Upsher-Smith, Eisai, GSK, Lundbeck, Medichem, Sun Pharma, Supernus, UCB Pharma, Vertex, and Viropharma. PR is an employee of the University Claude Bernard Lyon-1 and Hospices Civils de Lyon, and received grants from the European Union, the French Ministry of Health (PHRC), and the French Agency for Research (ANR). He also received speaker's or consultancy fees from Eisai, GSK, UCB Pharma, Cyberonics, and Medtronic. TT is an employee of Karolinska Institutet and received grants from Stockholm County Council, AFA Insurance, CURE, GSK, Eisai, UCB, Sanofi-Aventis, Novartis, and Bial. He has received speaker's or consultancy fees from Eisai, GSK, UCB, and Sun Pharma.	Ackermann RF, 2010, ATLAS OF EPILEPSIES, VOL 1-3, P177, DOI 10.1007/978-1-84882-128-6_24; Adelow C, 2012, NEUROLOGY, V78, P396, DOI 10.1212/WNL.0b013e318245f461; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Avanzini G, 2012, EPILEPSIA, V53, P771, DOI 10.1111/j.1528-1167.2012.03462.x; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Barba C, 2007, BRAIN, V130, P1957, DOI 10.1093/brain/awm108; Barbaro NM, 2009, ANN NEUROL, V65, P167, DOI 10.1002/ana.21558; Baulac M, 2012, LANCET NEUROL, V11, P579, DOI 10.1016/S1474-4422(12)70105-9; Beghi E, 2003, EPILEPSY RES, V57, P1, DOI 10.1016/j.eplepsyres.2003.09.007; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bertram EH, 2013, EXP NEUROL, V244, P67, DOI 10.1016/j.expneurol.2012.01.028; Bonelli SB, 2010, BRAIN, V133, P1186, DOI 10.1093/brain/awq006; Boshuisen K, 2012, LANCET NEUROL, V11, P784, DOI 10.1016/S1474-4422(12)70165-5; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Brodie MJ, 2007, NEUROLOGY, V68, P402, DOI 10.1212/01.wnl.0000252941.50833.4a; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Brodie MJ, 2011, EPILEPSY BEHAV, V21, P331, DOI 10.1016/j.yebeh.2011.05.025; Brodie MJ, 1997, EPILEPSY RES, V26, P423, DOI 10.1016/S0920-1211(96)01007-8; Callaghan B, 2011, EPILEPSIA, V52, P619, DOI 10.1111/j.1528-1167.2010.02929.x; Cameron A, 2012, EPILEPSIA, V53, P962, DOI 10.1111/j.1528-1167.2012.03446.x; Camfield CS, 2002, LANCET, V359, P1891, DOI 10.1016/S0140-6736(02)08779-2; Canevini MP, 2010, EPILEPSIA, V51, P797, DOI 10.1111/j.1528-1167.2010.02520.x; Catenoix H, 2008, NEUROLOGY, V71, P1719, DOI 10.1212/01.wnl.0000335166.20451.88; Chassoux F, 2010, NEUROLOGY, V75, P2168, DOI 10.1212/WNL.0b013e31820203a9; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Coppola Antonietta, 2012, Handb Clin Neurol, V107, P63, DOI 10.1016/B978-0-444-52898-8.00004-5; Cossu M, 2014, J NEUROL NEUROSUR PS, V85, P611, DOI 10.1136/jnnp-2013-305514; Crossley J, 2013, EPILEPSY BEHAV, V26, P175, DOI 10.1016/j.yebeh.2012.11.046; D'Ambrosio R, 2013, EXPERT REV NEUROTHER, V13, P615, DOI [10.1586/ERN.13.54, 10.1586/ern.13.54]; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; de Boer HM, 2013, CURR OPIN NEUROL, V26, P219, DOI 10.1097/WCO.0b013e32835f2037; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; DeGiorgio CM, 2013, NEUROLOGY, V80, P786, DOI 10.1212/WNL.0b013e318285c11a; Ding D, 2013, EPILEPSIA, V54, P512, DOI 10.1111/epi.12048; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Englot DJ, 2012, NEUROLOGY, V78, P1200, DOI 10.1212/WNL.0b013e318250d7ea; Englot DJ, 2011, J NEUROSURG, V115, P1248, DOI 10.3171/2011.7.JNS11977; Erba G, 2012, EPILEPSIA, V53, P35, DOI 10.1111/j.1528-1167.2011.03282.x; Fallah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053565; Fattore C, 2011, DRUGS, V71, P2151, DOI 10.2165/11594640-000000000-00000; Fauser S, 2009, BRAIN, V132, P2079, DOI 10.1093/brain/awp145; Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gaitatzis A, 2004, BRAIN, V127, P2427, DOI 10.1093/brain/awh267; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Galanopoulou AS, 2007, EPILEPSIA, V48, P14, DOI 10.1111/j.1528-1167.2007.01284.x; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Galanopoulou AS, 2012, EPILEPSIA, V53, P571, DOI 10.1111/j.1528-1167.2011.03391.x; Galanopoulou AS, 2011, BIOMARK MED, V5, P615, DOI [10.2217/BMM.11.71, 10.2217/bmm.11.71]; Galanopoulou AS, 2010, PFLUG ARCH EUR J PHY, V460, P505, DOI 10.1007/s00424-010-0816-2; Galanopoulou AS, 2013, NEURONAL NETWORKS BR; Gazzola DM, 2007, EPILEPSIA, V48, P1303, DOI 10.1111/j.1528-1167.2007.01136.x; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Glauser TA, 2013, EPILEPSIA, V54, P141, DOI 10.1111/epi.12028; Glauser TA, 2010, NEW ENGL J MED, V362, P790, DOI 10.1056/NEJMoa0902014; Gonzalez-Martinez J, 2013, EPILEPSIA, V54, P323, DOI 10.1111/j.1528-1167.2012.03672.x; Grouiller F, 2011, BRAIN, V134, P2867, DOI 10.1093/brain/awr156; Guerrini R, 2006, LANCET, V367, P499, DOI 10.1016/S0140-6736(06)68182-8; Haneef Z, 2010, NEUROLOGY, V75, P699, DOI 10.1212/WNL.0b013e3181eee457; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Hesdorffer DC, 2012, EPILEPSIA, V53, P249, DOI 10.1111/j.1528-1167.2011.03354.x; Hildebrand MS, 2013, J MED GENET, V50, P271, DOI 10.1136/jmedgenet-2012-101448; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Holst AG, 2013, EPILEPSIA, V54, P1613, DOI 10.1111/epi.12328; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Jacobs J, 2010, ANN NEUROL, V67, P209, DOI 10.1002/ana.21847; Jette N, 2012, NEUROLOGY, V79, P1084, DOI 10.1212/WNL.0b013e3182698c4c; Jung J, 2013, BRAIN, V136, P3176, DOI 10.1093/brain/awt213; Kanner AM, 2013, CURR OPIN NEUROL, V26, P208, DOI 10.1097/WCO.0b013e32835ee579; Knowlton RC, 2008, ANN NEUROL, V64, P35, DOI 10.1002/ana.21419; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2006, DRUGS, V66, P1817, DOI 10.2165/00003495-200666140-00004; Kwan P, 2011, LANCET NEUROL, V10, P881, DOI 10.1016/S1474-4422(11)70154-5; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Liu Y, 2013, ANN NEUROL, V74, P128, DOI 10.1002/ana.23897; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; McGonigal A, 2007, BRAIN, V130, P3169, DOI 10.1093/brain/awm218; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Meyer AC, 2010, B WORLD HEALTH ORGAN, V88, P260, DOI 10.2471/BLT.09.064147; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Mpimbaza A, 2008, PEDIATRICS, V121, pE58, DOI 10.1542/peds.2007-0930; Nashef L, 2012, EPILEPSIA, V53, P227, DOI 10.1111/j.1528-1167.2011.03358.x; Neligan A, 2010, EPILEPSIA, V51, P2241, DOI 10.1111/j.1528-1167.2010.02711.x; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Nice Guideline 137, 2012, NIC GUID; Nordli DR, 2012, NEUROLOGY, V79, P2180, DOI 10.1212/WNL.0b013e3182759766; Ono T, 2012, ADV EXP MED BIOL, V724, P99, DOI 10.1007/978-1-4614-0653-2_8; Park KI, 2010, ANN NEUROL, V67, P230, DOI 10.1002/ana.21884; Perucca E, 1998, CNS DRUGS, V10, P171, DOI 10.2165/00023210-199810030-00002; Perucca E., 2009, TREATMENT EPILEPSY, V3, P121; Perucca E, 2011, CNS DRUGS, V25, P907, DOI 10.2165/11587900-000000000-00000; Perucca E, 2011, LANCET NEUROL, V10, P446, DOI 10.1016/S1474-4422(11)70047-3; Petkar S, 2012, EUROPACE, V14, P1653, DOI 10.1093/europace/eus185; Pisani F, 1999, EPILEPSIA, V40, P1141, DOI 10.1111/j.1528-1157.1999.tb00832.x; Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x; Plosker GL, 2012, CNS DRUGS, V26, P1085, DOI 10.1007/s40263-012-0021-2; Prunetti P, 2011, CURR OPIN NEUROL, V24, P159, DOI 10.1097/WCO.0b013e32834479a7; Quintas R, 2012, EPILEPSY BEHAV, V25, P60, DOI 10.1016/j.yebeh.2012.05.016; Rai D, 2012, EPILEPSIA, V53, P1095, DOI 10.1111/j.1528-1167.2012.03500.x; Rheims S, 2011, EPILEPSIA, V52, P219, DOI 10.1111/j.1528-1167.2010.02915.x; Ryvlin P, 2005, CURR OPIN NEUROL, V18, P125, DOI 10.1097/01.wco.0000162852.22026.6f; Ryvlin P, 2013, LANCET NEUROL, V12, P966, DOI 10.1016/S1474-4422(13)70214-X; Ryvlin P, 2011, LANCET NEUROL, V10, P961, DOI 10.1016/S1474-4422(11)70193-4; Sake JK, 2010, CNS DRUGS, V24, P1055, DOI 10.2165/11587550-000000000-00000; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sarkis RA, 2012, EPILEPSIA, V53, P44, DOI 10.1111/j.1528-1167.2011.03274.x; Scheffer IE, ORG EPILEPSIES REPOR; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Schiller Y, 2008, NEUROLOGY, V70, P54, DOI 10.1212/01.wnl.0000286959.22040.6e; Seiam AHR, 2011, EPILEPSY BEHAV, V21, P441, DOI 10.1016/j.yebeh.2011.05.005; Shinnar S, 2012, NEUROLOGY, V79, P871, DOI 10.1212/WNL.0b013e318266fcc5; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494; Sillanpaa M, 2010, NEW ENGL J MED, V363, P2522, DOI 10.1056/NEJMoa0911610; Simasathien T, 2013, ANN NEUROL, V73, P646, DOI 10.1002/ana.23862; Stefan H, 2012, EPILEPSIA, V53, pe115, DOI 10.1111/j.1528-1167.2012.03492.x; Talukdar B, 2009, BRAIN DEV-JPN, V31, P744, DOI 10.1016/j.braindev.2008.11.006; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Toyoda I, 2013, J NEUROSCI, V33, P11100, DOI 10.1523/JNEUROSCI.0472-13.2013; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Trinka E, 2011, EPILEPSIA, V52, P35, DOI 10.1111/j.1528-1167.2011.03232.x; Valentin A, 2005, LANCET NEUROL, V4, P718, DOI 10.1016/S1474-4422(05)70200-3; van 't Klooster MA, 2011, BRAIN, V134, P2855, DOI 10.1093/brain/awr211; Vaudano AE, 2012, NEUROLOGY, V79, P249, DOI 10.1212/WNL.0b013e31825fdf3a; Wagner J, 2011, BRAIN, V134, P2844, DOI 10.1093/brain/awr204; Wellmer J, 2012, EPILEPSIA, V53, P1322, DOI 10.1111/j.1528-1167.2012.03545.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Winston GP, 2012, ANN NEUROL, V71, P334, DOI 10.1002/ana.22619; World Health Organization, 2012, MAN EP WOM CHILD BEA	143	504	533	15	240	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					884	898		10.1016/S0140-6736(14)60456-6	http://dx.doi.org/10.1016/S0140-6736(14)60456-6			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25260236				2022-12-28	WOS:000350451100037
J	Victora, CG				Victora, Cesar G.			Causes of child deaths: looking to the future	LANCET			English	Editorial Material							GLOBAL BURDEN		Univ Fed Pelotas, BR-96020220 Pelotas, Brazil	Universidade Federal de Pelotas	Victora, CG (corresponding author), Univ Fed Pelotas, BR-96020220 Pelotas, Brazil.	cvictora@gmail.com	Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180	Wellcome Trust [101815] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alkema L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101112; [Anonymous], 2014, COUNTD 2015 FULF HLT; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Horton R, 2013, LANCET, V381, ps1, DOI DOI 10.1016/S0140-6736(13)61256-8; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Liu L, 2014, LANCET; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Open Working Group on Sustainable Development Goals, OUTC DOC; Requejo JH, 2014, LANCET; Stein CE, 2003, J INFECT DIS, V187, pS8, DOI 10.1086/368114; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8	12	4	4	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					398	399		10.1016/S0140-6736(14)61695-0	http://dx.doi.org/10.1016/S0140-6736(14)61695-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ9CT	25282518				2022-12-28	WOS:000348509900006
J	Keall, MD; Pierse, N; Howden-Chapman, P; Cunningham, C; Cunningham, M; Guria, J; Baker, MG				Keall, Michael D.; Pierse, Nevil; Howden-Chapman, Philippa; Cunningham, Chris; Cunningham, Malcolm; Guria, Jagadish; Baker, Michael G.			Home modifications to reduce injuries from falls in the Home Injury Prevention Intervention (HIPI) study: a cluster-randomised controlled trial	LANCET			English	Article							NEW-ZEALAND; OUTCOMES; HAZARDS	Background Despite the considerable injury burden attributable to falls at home among the general population, few effective safety interventions have been identified. We tested the safety benefits of home modifications, including handrails for outside steps and internal stairs, grab rails for bathrooms, outside lighting, edging for outside steps, and slip-resistant surfacing for outside areas such as decks and porches. Methods We did a single-blind, cluster-randomised controlled trial of households from the Taranaki region of New Zealand. To be eligible, participants had to live in an owner-occupied dwelling constructed before 1980 and at least one member of every household had to be in receipt of state benefits or subsidies. We randomly assigned households by electronic coin toss to either immediate home modifications (treatment group) or a 3-year wait before modifications (control group). Household members in the treatment group could not be masked to their assigned status because modifications were made to their homes. The primary outcome was the rate of falls at home per person per year that needed medical treatment, which we derived from administrative data for insurance claims. Coders who were unaware of the random allocation analysed text descriptions of injuries and coded injuries as all falls and injuries most likely to be affected by the home modifications tested. To account for clustering at the household level, we analysed all injuries from falls at home per person-year with a negative binomial generalised linear model with generalised estimating equations. Analysis was by intention to treat. Findings Of 842 households recruited, 436 (n=950 individual occupants) were randomly assigned to the treatment group and 406 (n=898 occupants) were allocated to the control group. After a median observation period of 1148 days (IQR 1085-1263), the crude rate of fall injuries per person per year was 0.061 in the treatment group and 0.072 in the control group (relative rate 0.86, 95% CI 0.66-1.12). The crude rate of injuries specific to the intervention per person per year was 0.018 in the treatment group and 0.028 in the control group (0.66, 0.43-1.00). A 26% reduction in the rate of injuries caused by falls at home per year exposed to the intervention was estimated in people allocated to the treatment group compared with those assigned to the control group, after adjustment for age, previous falls, sex, and ethnic origin (relative rate 0.74, 95% CI 0.58-0.94). Injuries specific to the home-modification intervention were cut by 39% per year exposed (0.61, 0.41-0.91). Interpretation Our findings suggest that low-cost home modifications and repairs can be a means to reduce injury in the general population. Further research is needed to identify the effectiveness of particular modifications from the package tested.	[Keall, Michael D.; Pierse, Nevil; Howden-Chapman, Philippa; Baker, Michael G.] Univ Otago, Wellington 6242, New Zealand; [Cunningham, Chris] Massey Univ, Wellington, New Zealand; [Guria, Jagadish] Newlands, Wellington, New Zealand; [Cunningham, Malcolm] Bldg Res Assoc New Zealand, Porirua City, New Zealand	University of Otago; Massey University	Keall, MD (corresponding author), Univ Otago, Wellington 6242, New Zealand.	michael.keall@otago.ac.nz			Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	Health Research Council of New Zealand.	Accident Compensation Corporation, 2013, ACC CLAIMS STAT SUMM; [Anonymous], 2013, GBD COMP; [Anonymous], 2005, 142 NZ 2005 HOUS CON; [Anonymous], 2007, INJURIES EUROPEAN UN; Baker MG, 2012, LANCET, V379, P1112, DOI 10.1016/S0140-6736(11)61780-7; Bergen G, 2008, INJURY US 2007 CHART; Chapman R, 2009, J EPIDEMIOL COMMUN H, V63, P271, DOI 10.1136/jech.2007.070037; Chen LH, 2009, INJURY EPISODES CIRC; CUMMINGS P, 1995, ANNU REV PUBL HEALTH, V16, P381; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Howden-Chapman P, 2007, BMJ-BRIT MED J, V334, P460, DOI 10.1136/bmj.39070.573032.80; Howden-Chapman P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1411; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Keall MD, 2008, ACCIDENT ANAL PREV, V40, P887, DOI 10.1016/j.aap.2007.10.003; Keall MD, 2013, ACCIDENT ANAL PREV, V57, P124, DOI 10.1016/j.aap.2013.04.011; Keall MD, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-98; Lyons Ronan A, 2005, Int J Inj Contr Saf Promot, V12, P207, DOI 10.1080/17457300500172776; Statistics New Zealand, 2013, GROSS DOM PROD MARCH; Statistics New Zealand, 2013, 2013 CENS RES; Statistics New Zealand, 2014, DWELL HOUS EST; Stevens M, 2001, J AM GERIATR SOC, V49, P1448, DOI 10.1046/j.1532-5415.2001.4911236.x; Turner S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003600.pub3; WHO, 2002, RED RISKS PROM HLTH; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 2001, MACR HLTH INV HLTH E; Wyeth EH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-120; Young B, 2013, ACCIDENT ANAL PREV, V60, P158, DOI 10.1016/j.aap.2013.08.001	27	125	128	1	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					231	238		10.1016/S0140-6736(14)61006-0	http://dx.doi.org/10.1016/S0140-6736(14)61006-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25255696				2022-12-28	WOS:000348044800027
J	Edwards, PM; Brown, SS; Roberts, JM; Ahmadov, R; Banta, RM; deGouw, JA; Dube, WP; Field, RA; Flynn, JH; Gilman, JB; Graus, M; Helmig, D; Koss, A; Langford, AO; Lefer, BL; Lerner, BM; Li, R; Li, SM; McKeen, SA; Murphy, SM; Parrish, DD; Senff, CJ; Soltis, J; Stutz, J; Sweeney, C; Thompson, CR; Trainer, MK; Tsai, C; Veres, PR; Washenfelder, RA; Warneke, C; Wild, RJ; Young, CJ; Yuan, B; Zamora, R				Edwards, Peter M.; Brown, Steven S.; Roberts, James M.; Ahmadov, Ravan; Banta, Robert M.; deGouw, Joost A.; Dube, William P.; Field, Robert A.; Flynn, James H.; Gilman, Jessica B.; Graus, Martin; Helmig, Detlev; Koss, Abigail; Langford, Andrew O.; Lefer, Barry L.; Lerner, Brian M.; Li, Rui; Li, Shao-Meng; McKeen, Stuart A.; Murphy, Shane M.; Parrish, David D.; Senff, Christoph J.; Soltis, Jeffrey; Stutz, Jochen; Sweeney, Colm; Thompson, Chelsea R.; Trainer, Michael K.; Tsai, Catalina; Veres, Patrick R.; Washenfelder, Rebecca A.; Warneke, Carsten; Wild, Robert J.; Young, Cora J.; Yuan, Bin; Zamora, Robert			High winter ozone pollution from carbonyl photolysis in an oil and gas basin	NATURE			English	Article							VOLATILE ORGANIC-COMPOUNDS; GREEN RIVER-BASIN; NITROUS-ACID HONO; NATURAL-GAS; SHALE GAS; TROPOSPHERIC DEGRADATION; PHOTOCHEMICAL PRODUCTION; VERTICAL PROFILES; BOUNDARY-LAYER; UINTAH BASIN	The United States is now experiencing the most rapid expansion in oil and gas production in four decades, owing in large part to implementation of new extraction technologies such as horizontal drilling combined with hydraulic fracturing. The environmental impacts of this development, from its effect on water quality(1) to the influence of increased methane leakage on climate(2), have been a matter of intense debate. Air quality impacts are associated with emissions of nitrogen oxides(3,4) (NOx = NO + NO2) and volatile organic compounds(5-7) (VOCs), whose photochemistry leads to production of ozone, a secondary pollutant with negative health effects(8). Recent observations in oil-and gas-producing basins in the western United States have identified ozone mixing ratios well in excess of present air quality standards, but only during winter(9-13). Understanding winter ozone production in these regions is scientifically challenging. It occurs during cold periods of snow cover when meteorological inversions concentrate air pollutants from oil and gas activities, but when solar irradiance and absolute humidity, which are both required to initiate conventional photochemistry essential for ozone production, are at a minimum. Here, using data from a remote location in the oil and gas basin of northeastern Utah and a box model, we provide a quantitative assessment of the photochemistry that leads to these extreme winter ozone pollution events, and identify key factors that control ozone production in this unique environment. We find that ozone production occurs at lower NOx and much larger VOC concentrations than does its summertime urban counterpart, leading to carbonyl (oxygenated VOCs with a C=O moiety) photolysis as a dominant oxidant source. Extreme VOC concentrations optimize the ozone production efficiency of NOx. There is considerable potential for global growth in oil and gas extraction from shale. This analysis could help inform strategies to monitor and mitigate air quality impacts and provide broader insight into the response of winter ozone to primary pollutants.	[Edwards, Peter M.; Brown, Steven S.; Roberts, James M.; Ahmadov, Ravan; Banta, Robert M.; deGouw, Joost A.; Dube, William P.; Gilman, Jessica B.; Graus, Martin; Koss, Abigail; Langford, Andrew O.; Lerner, Brian M.; Li, Rui; McKeen, Stuart A.; Parrish, David D.; Senff, Christoph J.; Sweeney, Colm; Trainer, Michael K.; Veres, Patrick R.; Washenfelder, Rebecca A.; Warneke, Carsten; Wild, Robert J.; Young, Cora J.; Yuan, Bin; Zamora, Robert] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Edwards, Peter M.; Ahmadov, Ravan; deGouw, Joost A.; Dube, William P.; Gilman, Jessica B.; Graus, Martin; Koss, Abigail; Lerner, Brian M.; Li, Rui; McKeen, Stuart A.; Senff, Christoph J.; Sweeney, Colm; Veres, Patrick R.; Washenfelder, Rebecca A.; Warneke, Carsten; Wild, Robert J.; Yuan, Bin] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Field, Robert A.; Murphy, Shane M.; Soltis, Jeffrey] Univ Wyoming, Dept Atmospher Sci, Larmie, WY 82070 USA; [Flynn, James H.; Lefer, Barry L.] Univ Houston, Dept Earth & Atmospher Sci, Houston, TX 77204 USA; [Helmig, Detlev; Thompson, Chelsea R.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Li, Shao-Meng] Environm Canada, Air Qual Res Div, Toronto, ON M3H 5T4, Canada; [Stutz, Jochen; Tsai, Catalina] Univ Calif Los Angeles, Dept Ocean & Atmospher Sci, Los Angeles, CA 90095 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Wyoming; University of Houston System; University of Houston; University of Colorado System; University of Colorado Boulder; Environment & Climate Change Canada; University of California System; University of California Los Angeles	Brown, SS (corresponding author), NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA.	steven.s.brown@noaa.gov	Trainer, Michael/H-5168-2013; Roberts, James/AAI-3283-2020; Young, Cora/AAX-8089-2020; Ahmadov, Ravan/F-2036-2011; Brown, Steven S/I-1762-2013; Banta, Robert M/B-8361-2008; Lefer, Barry/X-9091-2019; Washenfelder, Rebecca Ann/E-7169-2010; Graus, Martin G/E-7546-2010; Senff, Christoph J/I-2592-2013; Roberts, James M./A-1082-2009; Parrish, David/E-8957-2010; Lerner, Brian M/H-6556-2013; Koss, Abigail R/B-5421-2015; Wild, Robert/I-1963-2013; Langford, Andrew O/D-2323-2009; Yuan, Bin/A-1223-2012; de Gouw, Joost/A-9675-2008; Warneke, Carsten/E-7174-2010; Thompson, Chelsea/L-2302-2015; Stutz, Jochen/K-7159-2014; Edwards, Peter/H-5236-2013; Young, Cora/A-4551-2010; FIELD, ROBERT A/L-7974-2018; Sweeney, Colm/AAE-9291-2019; Gilman, Jessica B/E-7751-2010; Veres, Patrick R/E-7441-2010	Trainer, Michael/0000-0002-1668-2961; Roberts, James/0000-0002-2671-3207; Young, Cora/0000-0002-6908-5829; Ahmadov, Ravan/0000-0002-6996-7071; Banta, Robert M/0000-0002-0009-5340; Lefer, Barry/0000-0001-9520-5495; Washenfelder, Rebecca Ann/0000-0002-8106-3702; Graus, Martin G/0000-0002-2025-9242; Roberts, James M./0000-0002-8485-8172; Parrish, David/0000-0001-6312-2724; Lerner, Brian M/0000-0001-8721-8165; Koss, Abigail R/0000-0002-2415-1730; Wild, Robert/0000-0002-4800-5172; Langford, Andrew O/0000-0002-2932-7061; Yuan, Bin/0000-0003-3041-0329; de Gouw, Joost/0000-0002-0385-1826; Thompson, Chelsea/0000-0002-7332-9945; Edwards, Peter/0000-0002-1076-6793; Young, Cora/0000-0002-6908-5829; FIELD, ROBERT A/0000-0003-0228-1419; Gilman, Jessica B/0000-0002-7899-9948; Veres, Patrick R/0000-0001-7539-353X; Sweeney, Colm/0000-0002-4517-0797; Li, Shao-Meng/0000-0002-7628-6581	Uintah Impact Mitigation Special Service District (UIMSSD); Bureau of Land Management (BLM); Environmental Protection Agency (EPA); Utah State University; Western Energy Alliance; NOAA's Atmospheric Chemistry, Climate and Carbon Cycle programme; Questar Energy Products; National Science Foundation [1212666, 1215926]	Uintah Impact Mitigation Special Service District (UIMSSD); Bureau of Land Management (BLM); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Utah State University; Western Energy Alliance; NOAA's Atmospheric Chemistry, Climate and Carbon Cycle programme; Questar Energy Products; National Science Foundation(National Science Foundation (NSF))	The Uintah Basin Winter Ozone Studies were a joint project led and coordinated by the Utah Department of Environmental Quality (UDEQ) and supported by the Uintah Impact Mitigation Special Service District (UIMSSD), the Bureau of Land Management (BLM), the Environmental Protection Agency (EPA) and Utah State University. This work was funded in part by the Western Energy Alliance, and NOAA's Atmospheric Chemistry, Climate and Carbon Cycle programme. We thank Questar Energy Products for site preparation and support. Funding for the 2012 LP-DOAS HNO<INF>2</INF> measurements was provided by the National Science Foundation (award no. 1212666). S.M.M. acknowledges the National Science Foundation for award no. 1215926. We would like to thank L. Lee and R. Cohen of UC Berkley for their contributions and discussions relating to the representation of alkyl nitrate chemistry in this study.	Anderson PS, 2008, ATMOS CHEM PHYS, V8, P3563, DOI 10.5194/acp-8-3563-2008; Beine H, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045005; Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045; Carbajo PG, 2008, J PHYS CHEM A, V112, P12437, DOI 10.1021/jp8070508; Carlton AG, 2014, ENVIRON SCI TECHNOL, V48, P893, DOI 10.1021/es405672t; Carter WPL, 2012, ATMOS ENVIRON, V50, P255, DOI 10.1016/j.atmosenv.2011.12.025; CARTER WPL, 1989, J ATMOS CHEM, V8, P165, DOI 10.1007/BF00053721; Chang YH, 2012, ENVIRON SCI TECHNOL, V46, P12281, DOI 10.1021/es3040939; de Gouw JA, 2014, EARTHS FUTURE, V2, P75, DOI 10.1002/2013EF000196; de Gouw JA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003863; Dube WP, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2176058; Edwards PM, 2013, ATMOS CHEM PHYS, V13, P8955, DOI 10.5194/acp-13-8955-2013; Edwards PA, 2011, HANDBOOK ON FAMILY AND COMMUNITY ENGAGEMENT, P116; Emmerson KM, 2009, ATMOS CHEM PHYS, V9, P1831, DOI 10.5194/acp-9-1831-2009; Fuchs H, 2009, ENVIRON SCI TECHNOL, V43, P7831, DOI 10.1021/es902067h; Gilman JB, 2013, ENVIRON SCI TECHNOL, V47, P1297, DOI 10.1021/es304119a; Heard DE, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020544; Helmig D, 2014, ENVIRON SCI TECHNOL, V48, P4707, DOI 10.1021/es405046r; Helmig D., 2007, ATMOS CHEM PHYS, V7, P15, DOI [DOI 10.5194/ACP-7-15-2007, 10.5194/acp-7-15-2007]; Honrath RE, 2002, ATMOS ENVIRON, V36, P2629, DOI 10.1016/S1352-2310(02)00132-2; Jacobi HW, 2002, ATMOS ENVIRON, V36, P2619, DOI 10.1016/S1352-2310(02)00106-1; Jenkin ME, 1997, ATMOS ENVIRON, V31, P81, DOI 10.1016/S1352-2310(96)00105-7; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Jordan A, 2009, INT J MASS SPECTROM, V286, P122, DOI 10.1016/j.ijms.2009.07.005; Karion A, 2013, GEOPHYS RES LETT, V40, P4393, DOI 10.1002/grl.50811; Katzenstein AS, 2003, P NATL ACAD SCI USA, V100, P11975, DOI 10.1073/pnas.1635258100; Kleinman LI, 2005, ATMOS ENVIRON, V39, P575, DOI 10.1016/j.atmosenv.2004.08.047; Kuster WC, 2004, ENVIRON SCI TECHNOL, V38, P221, DOI 10.1021/es034710r; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; Li HS, 2014, ENVIRON SCI TECHNOL, V48, P1484, DOI 10.1021/es404668b; Li X, 2012, ATMOS CHEM PHYS, V12, P1497, DOI 10.5194/acp-12-1497-2012; Li X, 2014, SCIENCE, V344, P292, DOI 10.1126/science.1248999; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Martin R., 2011, EDL11039 UT STAT U; McLinden CA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050273; Michoud V, 2014, ATMOS CHEM PHYS, V14, P2805, DOI 10.5194/acp-14-2805-2014; Ohmura A, 1998, B AM METEOROL SOC, V79, P2115, DOI 10.1175/1520-0477(1998)079<2115:BSRNBW>2.0.CO;2; Oltmans Samuel, 2014, Elementa-Science of the Anthropocene, V2, P000024, DOI 10.12952/journal.elementa.000024; Oswald R, 2013, SCIENCE, V341, P1233, DOI 10.1126/science.1242266; Paulson SE, 1996, GEOPHYS RES LETT, V23, P3727, DOI 10.1029/96GL03477; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Phillips GJ, 2013, ATMOS CHEM PHYS, V13, P1129, DOI 10.5194/acp-13-1129-2013; Rappengluck B, 2014, ATMOS CHEM PHYS, V14, P4909, DOI 10.5194/acp-14-4909-2014; Roberts JM, 2010, ATMOS MEAS TECH, V3, P981, DOI 10.5194/amt-3-981-2010; RUSSELL A, 1995, SCIENCE, V269, P491, DOI 10.1126/science.269.5223.491; Russell AR, 2012, ATMOS CHEM PHYS, V12, P12197, DOI 10.5194/acp-12-12197-2012; Saunders SM, 2003, ATMOS CHEM PHYS, V3, P161, DOI 10.5194/acp-3-161-2003; Schnell RC, 2009, NAT GEOSCI, V2, P120, DOI 10.1038/NGEO415; SEINFELD JH, 1989, SCIENCE, V243, P745, DOI 10.1126/science.243.4892.745; Selley RC, 2012, MAR PETROL GEOL, V31, P100, DOI 10.1016/j.marpetgeo.2011.08.017; Slusher DL, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004670; Stone D, 2010, ATMOS CHEM PHYS, V10, P9415, DOI 10.5194/acp-10-9415-2010; Thornton JA, 2010, NATURE, V464, P271, DOI 10.1038/nature08905; US Energy Information Administration, 2013, AN PROJ; VandenBoer TC, 2013, J GEOPHYS RES-ATMOS, V118, P10155, DOI 10.1002/jgrd.50721; Volkamer R, 2010, ATMOS CHEM PHYS, V10, P6969, DOI 10.5194/acp-10-6969-2010; Wang SS, 2013, ATMOS ENVIRON, V77, P718, DOI 10.1016/j.atmosenv.2013.05.071; Warneke C, 2011, ATMOS MEAS TECH, V4, P2345, DOI 10.5194/amt-4-2345-2011; Washenfelder RA, 2011, ENVIRON SCI TECHNOL, V45, P2938, DOI 10.1021/es103340u; Weijermars R, 2013, APPL ENERG, V106, P100, DOI 10.1016/j.apenergy.2013.01.025; Wong KW, 2012, ATMOS CHEM PHYS, V12, P635, DOI 10.5194/acp-12-635-2012; Wong KW, 2011, ATMOS CHEM PHYS, V11, P3595, DOI 10.5194/acp-11-3595-2011; Young CJ, 2012, ENVIRON SCI TECHNOL, V46, P10965, DOI 10.1021/es302206a; Zhou XL, 2011, NAT GEOSCI, V4, P440, DOI [10.1038/ngeo1164, 10.1038/NGEO1164]; Zhou XL, 2001, GEOPHYS RES LETT, V28, P4087, DOI 10.1029/2001GL013531	65	189	194	19	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					351	+		10.1038/nature13767	http://dx.doi.org/10.1038/nature13767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25274311				2022-12-28	WOS:000342988600048
J	Ffrench-Constant, RH				Ffrench-Constant, Richard H.			GENOMICS Of monarchs and migration	NATURE			English	Editorial Material							BUTTERFLY WING SCALES; MYOSIN-VA; EVOLUTION; REVEALS; TAIL; MICE		Univ Exeter, Ctr Ecol & Conservat, Falmouth TR10 9EZ, England	University of Exeter	Ffrench-Constant, RH (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Falmouth TR10 9EZ, England.	rf222@exeter.ac.uk		ffrench-Constant, Richard/0000-0001-5385-9888	Biotechnology and Biological Sciences Research Council [BB/E006191/1, BB/H014268/1] Funding Source: Medline; BBSRC [BB/H014268/1, BB/E006191/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dinwiddie A, 2014, DEV BIOL, V392, P404, DOI 10.1016/j.ydbio.2014.06.005; Evans RD, 2014, CURR BIOL, V24, P1743, DOI 10.1016/j.cub.2014.06.019; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Galant R, 1998, CURR BIOL, V8, P807, DOI 10.1016/S0960-9822(98)70322-7; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; KAYSERWEGMANN I, 1976, CELL TISSUE RES, V171, P513; Li QG, 2014, NATURE, V507, P350, DOI 10.1038/nature12973; Salewski V, 2007, NATURWISSENSCHAFTEN, V94, P268, DOI 10.1007/s00114-006-0186-y; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	14	1	1	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					314	315		10.1038/nature13757	http://dx.doi.org/10.1038/nature13757			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25274308				2022-12-28	WOS:000342988600040
J	Oostdijk, EAN; Kesecioglu, J; Schultz, MJ; Visser, CE; de Jonge, E; van Essen, EHR; Bernards, AT; Purmer, I; Brimicombe, R; Bergmans, D; van Tiel, F; Bosch, FH; Mascini, E; van Griethuysen, A; Bindels, A; Jansz, A; van Steveninck, FL; Van der Zwet, WC; Fijen, JW; Thijsen, S; de Jong, R; Oudbier, J; Raben, A; Van der Vorm, E; Koeman, M; Rothbarth, P; Rijkeboer, A; Gruteke, P; Hart-Sweet, H; Peerbooms, P; Winsser, LJ; van Elsacker-Niele, AMW; Demmendaal, K; Brandenburg, A; de Smet, AMGA; Bonten, MJM				Oostdijk, Evelien A. N.; Kesecioglu, Jozef; Schultz, Marcus J.; Visser, Caroline E.; de Jonge, Evert; van Essen, Einar H. R.; Bernards, Alexandra T.; Purmer, Ilse; Brimicombe, Roland; Bergmans, Dennis; van Tiel, Frank; Bosch, Frank H.; Mascini, Ellen; van Griethuysen, Arjanne; Bindels, Alexander; Jansz, Arjan; van Steveninck, Fred (A. ) L.; Van der Zwet, Wil C.; Fijen, Jan Willem; Thijsen, Steven; de Jong, Remko; Oudbier, Joke; Raben, Adrienne; Van der Vorm, Eric; Koeman, Mirelle; Rothbarth, Philip; Rijkeboer, Annemieke; Gruteke, Paul; Hart-Sweet, Helga; Peerbooms, Paul; Winsser, Lex J.; van Elsacker-Niele, Anne-Marie W.; Demmendaal, Kees; Brandenburg, Afke; de Smet, Anne Marie G. A.; Bonten, Marc J. M.			Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELECTIVE DIGESTIVE DECONTAMINATION; INTENSIVE-CARE UNITS; GRAM-NEGATIVE BACTERIA; ANTIMICROBIAL RESISTANCE; COLISTIN RESISTANCE; METAANALYSIS; EMERGENCE	IMPORTANCE Selective decontamination of the digestive tract (SDD) and selective oropharyngeal decontamination (SOD) are prophylactic antibiotic regimens used in intensive care units (ICUs) and associated with improved patient outcome. Controversy exists regarding the relative effects of both measures on patient outcome and antibiotic resistance. OBJECTIVE To compare the effects of SDD and SOD, applied as unit-wide interventions, on antibiotic resistance and patient outcome. DESIGN, SETTING, AND PARTICIPANTS Pragmatic, cluster randomized crossover trial comparing 12 months of SOD with 12 months of SDD in 16 Dutch ICUs between August 1, 2009, and February 1, 2013. Patients with an expected length of ICU stay longer than 48 hours were eligible to receive the regimens, and 5881 and 6116 patients were included in the clinical outcome analysis for SOD and SDD, respectively. INTERVENTIONS Intensive care units were randomized to administer either SDD or SOD. MAIN OUTCOMES AND MEASURES Unit-wide prevalence of antibiotic-resistant gram-negative bacteria. Secondary outcomes were day-28 mortality, ICU-acquired bacteremia, and length of ICU stay. RESULTS In point-prevalence surveys, prevalences of antibiotic-resistant gram-negative bacteria in perianal swabs were significantly lower during SDD compared with SOD; for aminoglycoside resistance, average prevalence was 5.6%(95% CI, 4.6%-6.7%) during SDD and 11.8%(95% CI, 10.3%-13.2%) during SOD (P < .001). During both interventions the prevalence of rectal carriage of aminoglycoside-resistant gram-negative bacteria increased 7% per month (95% CI, 1%-13%) during SDD (P = .02) and 4% per month (95% CI, 0%-8%) during SOD (P = .046; P = .40 for difference). Day 28-mortality was 25.4% and 24.1% during SOD and SDD, respectively (adjusted odds ratio, 0.96 [95% CI, 0.88-1.06]; P = .42), and there were no statistically significant differences in other outcome parameters or between surgical and nonsurgical patients. Intensive care unit-acquired bacteremia occurred in 5.9% and 4.6% of the patients during SOD and SDD, respectively (odds ratio, 0.77 [95% CI, 0.65-0.91]; P = .002; number needed to treat, 77). CONCLUSIONS AND RELEVANCE Unit-wide application of SDD and SOD was associated with low levels of antibiotic resistance and no differences in day-28 mortality. Compared with SOD, SDD was associated with lower rectal carriage of antibiotic-resistant gram-negative bacteria and ICU-acquired bacteremia but a more pronounced gradual increase in aminoglycoside-resistant gram-negative bacteria.	[Oostdijk, Evelien A. N.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3508 GA Utrecht, Netherlands; [Oostdijk, Evelien A. N.; Kesecioglu, Jozef] Univ Med Ctr Utrecht, Dept Intens Care Med, NL-3508 GA Utrecht, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [Visser, Caroline E.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [de Jonge, Evert; van Essen, Einar H. R.] Leiden Univ, Med Ctr, Dept Intens Care Med, Leiden, Netherlands; [Bernards, Alexandra T.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Purmer, Ilse; Koeman, Mirelle] HagaZiekenhuis, Dept Intens Care, The Hague, Netherlands; [Brimicombe, Roland] HagaZiekenhuis, Dept Med Microbiol, The Hague, Netherlands; [Bergmans, Dennis] Maastricht Univ, Dept Intens Care, Med Ctr, Maastricht, Netherlands; [van Tiel, Frank] Maastricht Univ, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands; [Bosch, Frank H.] Rijnstate Hosp, Dept Intens Care, Arnhem, Netherlands; [Mascini, Ellen; van Griethuysen, Arjanne] Rijnstate Hosp, Lab Med Microbiol & Immunol, Arnhem, Netherlands; [Bindels, Alexander] Catharina Hosp, Dept Intens Care Med, Eindhoven, Netherlands; [Jansz, Arjan] Catharina Hosp, Labs Pathol & Med Microbiol, Lab Med Microbiol, Eindhoven, Netherlands; [van Steveninck, Fred (A. ) L.] Deventer Hosp, Dept Intens Care, Deventer, Netherlands; [Van der Zwet, Wil C.] Deventer Hosp, Dept Med Microbiol, Deventer, Netherlands; [Fijen, Jan Willem] Diakonessenhuis Utrecht, Dept Intens Care, Utrecht, Netherlands; [Thijsen, Steven] Diakonessenhuis Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [de Jong, Remko] BovenIJ Hosp, Dept Intens Care, Amsterdam, Netherlands; [Oudbier, Joke] Zaans Med Ctr, Dept Med Microbiol, Zaandam, Netherlands; [Raben, Adrienne] Groene Hart Hosp, Dept Intens Care, Gouda, Netherlands; [Van der Vorm, Eric] Groene Hart Hosp, Dept Med Microbiol, Gouda, Netherlands; [Rothbarth, Philip] Rijnland Hosp, Dept Med Microbiol, Leiderdorp, Netherlands; [Rijkeboer, Annemieke] Flevo Hosp, Dept Intens Care, Almere, Netherlands; [Gruteke, Paul] Flevo Hosp, Dept Med Microbiol, Almere, Netherlands; [Hart-Sweet, Helga] Sint Lucas Andreas Hosp, Dept Intens Care, Amsterdam, Netherlands; [Peerbooms, Paul] Sint Lucas Andreas Hosp, Dept Med Microbiol, Amsterdam, Netherlands; [Winsser, Lex J.] Antonius Hosp, Dept Intens Care, Sneek, Netherlands; [van Elsacker-Niele, Anne-Marie W.; Brandenburg, Afke] Izore, Ctr Infect Dis Friesland, Leeuwarden, Netherlands; [Demmendaal, Kees] Nij Smellinghe Hosp, Drachten, Netherlands; [de Smet, Anne Marie G. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; Haga Hospital; Maastricht University; Maastricht University; Rijnstate Hospital; Rijnstate Hospital; Catharina Hospital; Catharina Hospital; Deventer Hospital; Deventer Hospital; Diakonessenhuis; Diakonessenhuis; Rijnland Hospital; Sint Lucas Andreas Hospital; Sint Lucas Andreas Hospital; University of Groningen; Utrecht University; Utrecht University Medical Center	Oostdijk, EAN (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, G04-517,POB 85500, NL-3508 GA Utrecht, Netherlands.	e.a.n.oostdijk@umcutrecht.nl	van der Zwet, Wil/CAI-0427-2022; Bosch, Frank/AAW-6704-2020; van Steveninck, Fred/AAL-6417-2020; Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792; Gruteke, Paul/0000-0003-1788-5960; de Smet, Anne Marie G.A./0000-0002-4421-4890	Netherlands Organization for Scientific Research [NWO-VICI 918.76.611]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Dr Bonten was supported by the Netherlands Organization for Scientific Research (NWO-VICI 918.76.611).	Al Naiemi N, 2006, J ANTIMICROB CHEMOTH, V58, P853, DOI 10.1093/jac/dkl316; Bergmans DCJJ, 2001, AM J RESP CRIT CARE, V164, P382, DOI 10.1164/ajrccm.164.3.2005003; Buelow E, 2014, J ANTIMICROB CHEMOTH, V69, P2215, DOI 10.1093/jac/dku092; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Halaby T, 2013, ANTIMICROB AGENTS CH, V57, P3224, DOI 10.1128/AAC.02634-12; Heininger A, 2006, INTENS CARE MED, V32, P1569, DOI 10.1007/s00134-006-0304-5; Higgins JPT, 2008, CLIN TRIALS, V5, P225, DOI 10.1177/1740774508091600; Houben AJM, 2014, J ANTIMICROB CHEMOTH, V69, P797, DOI 10.1093/jac/dkt416; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kluytmans-VandenBergh MFQ, 2005, INFECTION, V33, P309, DOI 10.1007/s15010-005-5079-z; Leone M, 2003, CRIT CARE MED, V31, P2090, DOI 10.1097/01.CCM.0000079606.16776.C5; Oostdijk EAN, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002529; Oostdijk EAN, 2013, INTENS CARE MED, V39, P653, DOI 10.1007/s00134-012-2761-3; Oostdijk EAN, 2011, CRIT CARE MED, V39, P961, DOI 10.1097/CCM.0b013e318208ee26; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950	19	113	116	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1429	1437		10.1001/jama.2014.7247	http://dx.doi.org/10.1001/jama.2014.7247			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25271544	Bronze			2022-12-28	WOS:000342630200019
J	Giacomet, V; Trabattoni, D; Zanchetta, N; Biasin, M; Gismondo, M; Clerici, M; Zuccotti, G				Giacomet, Vania; Trabattoni, Daria; Zanchetta, Nadia; Biasin, Mara; Gismondo, Mariarita; Clerici, Mario; Zuccotti, Gianvincenzo			No cure of HIV infection in a child despite early treatment and apparent viral clearance	LANCET			English	Editorial Material							IMMUNE ACTIVATION		[Giacomet, Vania; Zuccotti, Gianvincenzo] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci, Paediat Unit, I-20122 Milan, Italy; [Trabattoni, Daria; Biasin, Mara] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci, Immunol Unit, I-20122 Milan, Italy; [Zanchetta, Nadia; Gismondo, Mariarita] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci, Clin Microbiol Virol & Bioemergency Unit, I-20122 Milan, Italy; [Clerici, Mario] Univ Milan, Dept Physiopathol & Transplantat, I-20122 Milan, Italy; [Clerici, Mario] IRCCS, Don C Gnocchi Fdn, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Clerici, M (corresponding author), Univ Milan, Dept Physiopathol & Transplantat, Chair Immunol, Via F Sforza 35, I-20122 Milan, Italy.	mario.clerici@unimi.it	giacomet, vania/M-5350-2017; biasin, mara/G-7426-2012; Trabattoni, Daria/G-7424-2012; Giacomet, Vania/AAM-1411-2020; Zuccotti, Gianvincenzo/H-8572-2017; Gismondo, Maria Rita/I-3965-2017	giacomet, vania/0000-0002-0892-9039; biasin, mara/0000-0003-3671-4235; Trabattoni, Daria/0000-0001-9535-3359; Giacomet, Vania/0000-0002-0892-9039; Clerici, Mario/0000-0001-5920-6191; Zuccotti, Gianvincenzo/0000-0002-2795-9874; Gismondo, Maria Rita/0000-0001-6926-8660				Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347	5	41	43	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1320	1320		10.1016/S0140-6736(14)61405-7	http://dx.doi.org/10.1016/S0140-6736(14)61405-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	25283573				2022-12-28	WOS:000343003400036
J	Stoop, D; Cobo, A; Silber, S				Stoop, Dominic; Cobo, Ana; Silber, Sherman			Fertility preservation for age-related fertility decline	LANCET			English	Article							CRYOPRESERVED OVARIAN TISSUE; MONOZYGOTIC TWINS DISCORDANT; ASSISTED REPRODUCTIVE TECHNOLOGIES; OOCYTE CRYOPRESERVATION; LIVE BIRTH; EUROPEAN REGISTERS; EMBRYO DEVELOPMENT; CORTICAL STRIPS; LIFE-SPAN; TRANSPLANTATION	Cryopreservation of eggs or ovarian tissue to preserve fertility for patients with cancer has been studied since 1994 with R G Gosden's paper describing restoration of fertility in oophorectomised sheep, and for decades previously by others in smaller mammals. Clinically this approach has shown great success. Many healthy children have been born from eggs cryopreserved with the Kuwayama egg vitrification technique for non-medical (social) indications, but until now very few patients with cancer have achieved pregnancy with cryopreserved eggs. Often, oncologists do not wish to delay cancer treatment while the patient goes through multiple ovarian stimulation cycles to retrieve eggs, and the patient can only start using the oocytes after full recovery from cancer. Ovarian stimulation and egg retrieval is not a barrier for patients without cancer who wish to delay childbearing, which makes oocyte cryopreservation increasingly popular to overcome an age-related decline in fertility. Cryopreservation of ovarian tissue is an option if egg cryopreservation is ruled out. More than 35 babies have been born so far with cryopreserved ovarian tissue in patients with cancer who have had a complete return of hormonal function, and fertility to baseline. Both egg and ovarian tissue cryopreservation might be ready for application to the preservation of fertility not only in patients with cancer but also in countering the increasing incidence of age-related decline in female fertility.	[Stoop, Dominic] UZ Brussel, Ctr Reprod Med, B-1090 Brussels, Belgium; [Cobo, Ana] IVI Valencia, Valencia, Spain; [Silber, Sherman] St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO USA	University Hospital Brussels; University of Valencia; Saint Luke's Hospital - Missouri	Stoop, D (corresponding author), UZ Brussel, Ctr Reprod Med, Laarbeeklaan 101, B-1090 Brussels, Belgium.	dominic.stoop@gmail.com	Stoop, Dominic/AAG-6206-2020	Stoop, Dominic/0000-0001-7831-1085				Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028; Andersen AN, 2009, HUM REPROD, V24, P1267, DOI 10.1093/humrep/dep035; Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244; Andersen CY, 2012, REPROD BIOMED ONLINE, V25, P128, DOI 10.1016/j.rbmo.2012.03.014; Aubard Y, 1999, HUM REPROD, V14, P2149, DOI 10.1093/humrep/14.8.2149; Aydin Y, 2010, SYST BIOL REPROD MEC, V56, P311, DOI 10.3109/19396368.2010.496033; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Borini A, 2006, HUM REPROD, V21, P512, DOI 10.1093/humrep/dei346; Bukulmez O, 2010, FERTIL STERIL, V94, P905, DOI 10.1016/j.fertnstert.2009.05.017; Burmeister L, 2013, MED J AUSTRALIA, V198, P158, DOI 10.5694/mja12.11768; Candy CJ, 2000, HUM REPROD, V15, P1300, DOI 10.1093/humrep/15.6.1300; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Cil AP, 2013, FERTIL STERIL, V100, P492, DOI 10.1016/j.fertnstert.2013.04.023; Cobo A, 2008, FERTIL STERIL, V89, P1657, DOI 10.1016/j.fertnstert.2007.05.050; Cobo A, 2013, FERTIL STERIL, V99, P1485, DOI 10.1016/j.fertnstert.2013.02.050; Cobo A, 2011, FERTIL STERIL, V96, P277, DOI 10.1016/j.fertnstert.2011.06.030; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; DEANESLY R, 1954, J ENDOCRINOL, V11, P197, DOI 10.1677/joe.0.0110197; Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437; Dittrich R, 2012, FERTIL STERIL, V97, P387, DOI 10.1016/j.fertnstert.2011.11.047; Dondorp W, 2012, HUM REPROD, V27, P1231, DOI 10.1093/humrep/des029; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Donnez J, 2013, NAT REV ENDOCRINOL, V9, P735, DOI 10.1038/nrendo.2013.205; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Donnez J, 2011, ANN MED, V43, P437, DOI 10.3109/07853890.2010.546807; Edgar DH, 2012, HUM REPROD UPDATE, V18, P536, DOI 10.1093/humupd/dms016; Engmann L, 2008, FERTIL STERIL, V89, P84, DOI 10.1016/j.fertnstert.2007.02.002; Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5; FADDY MJ, 1995, HUM REPROD, V10, P770, DOI 10.1093/oxfordjournals.humrep.a136036; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Ferraretti AP, 2013, HUM REPROD, V28, P2318, DOI 10.1093/humrep/det278; Garcia-Velasco JA, 2013, FERTIL STERIL, V99, P1994, DOI 10.1016/j.fertnstert.2013.02.004; Gold E, 2006, FERTIL STERIL, V86, pS201, DOI 10.1016/j.fertnstert.2006.07.537; Gook DA, 1999, HUM REPROD, V14, P2061, DOI 10.1093/humrep/14.8.2061; Gook DA, 2000, MOL CELL ENDOCRINOL, V169, P99, DOI 10.1016/S0303-7207(00)00360-9; Gook DA, 2007, HUM REPROD UPDATE, V13, P591, DOI 10.1093/humupd/dmm028; Gosden R, 1996, TRANSPLANTATION OVAR; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; GOSDEN RG, 1994, J REPROD FERTIL, V101, P619, DOI 10.1530/jrf.0.1010619; GOSDEN RG, 1989, J REPROD FERTIL, V87, P257, DOI 10.1530/jrf.0.0870257; Gunasena KT, 1997, HUM REPROD, V12, P101, DOI 10.1093/humrep/12.1.101; Hilders CG, 2004, CANCER-AM CANCER SOC, V101, P2771, DOI 10.1002/cncr.20715; Hirshfeld-Cytron J, 2012, FERTIL STERIL, V97, P665, DOI 10.1016/j.fertnstert.2011.12.029; Hoorens S, 2007, HUM REPROD, V22, P2471, DOI 10.1093/humrep/dem181; Kaaijk EM, 1999, HUM REPROD, V14, P889, DOI 10.1093/humrep/14.4.889; Kagawa N, 2009, REPROD BIOMED ONLINE, V18, P568, DOI 10.1016/S1472-6483(10)60136-8; Keros V, 2009, HUM REPROD, V24, P1670, DOI 10.1093/humrep/dep079; Kim SS, 2004, FERTIL STERIL, V82, P930, DOI 10.1016/j.fertnstert.2004.02.137; Kim SS, 2003, HUM REPROD, V18, P1759, DOI 10.1093/humrep/deg381; Koskas M, 2011, HUM REPROD, V26, P808, DOI 10.1093/humrep/deq399; Lee DM, 2004, NATURE, V428, P137, DOI 10.1038/428137a; Leridon H, 2004, HUM REPROD, V19, P1548, DOI 10.1093/humrep/deh304; Liat LG, 2012, GYNECOL ENDOCRINOL, V28, P809, DOI 10.3109/09513590.2012.671391; Lockwood GM, 2011, REPROD BIOMED ONLINE, V23, P334, DOI 10.1016/j.rbmo.2011.05.010; MAZUR P, 1990, CELL BIOPHYS, V17, P53, DOI 10.1007/BF02989804; Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237; MENKEN J, 1986, SCIENCE, V233, P1389, DOI 10.1126/science.3755843; MEREDITH S, 1992, BIOL REPROD, V47, P162, DOI 10.1095/biolreprod47.2.162; Morris RT., 1935, 50 YEARS SURG; Nekkebroeck J, 2010, HUM REPROD, V25, pI15; Nelson SM, 2013, HUM REPROD UPDATE, V19, P67, DOI 10.1093/humupd/dms043; Nugent D, 1997, HUM REPROD UPDATE, V3, P267, DOI 10.1093/humupd/3.3.267; Oktay K, 2000, NEW ENGL J MED, V342, P1919, DOI 10.1056/NEJM200006223422516; Oktay K, 2004, LANCET, V363, P837, DOI 10.1016/S0140-6736(04)15728-0; Oktay K, 2001, JAMA-J AM MED ASSOC, V286, P1490, DOI 10.1001/jama.286.12.1490; Oktay K, 2004, LANCET, V364, P2091, DOI 10.1016/S0140-6736(04)17541-7; Oktay K, 2006, FERTIL STERIL, V86, P70, DOI 10.1016/j.fertnstert.2006.03.017; Parmegiani L, 2010, FERTIL STERIL, V94, P1525, DOI 10.1016/j.fertnstert.2009.05.089; PARROTT DMV, 1960, J REPROD FERTIL, V1, P230, DOI 10.1530/jrf.0.0010230; Porcu E, 2008, REPROD BIOMED ONLINE, V17, P265, DOI 10.1016/S1472-6483(10)60204-0; Radford JA, 2001, LANCET, V357, P1172, DOI 10.1016/S0140-6736(00)04335-X; Revel A, 2011, HUM REPROD, V26, P1097, DOI 10.1093/humrep/der063; Revelli A, 2013, FERTIL STERIL, V99, P227, DOI 10.1016/j.fertnstert.2012.09.029; Rienzi L, 2012, HUM REPROD, V27, P1606, DOI 10.1093/humrep/des088; Rienzi L, 2010, HUM REPROD, V25, P66, DOI 10.1093/humrep/dep346; Rosendahl M, 2006, HUM REPROD, V21, P2006, DOI 10.1093/humrep/del140; Saiduddin S, 1970, Biol Reprod, V2, P408, DOI 10.1095/biolreprod2.3.408; Salle B, 2002, FERTIL STERIL, V77, P403, DOI 10.1016/S0015-0282(01)02960-0; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Setti PEL, 2006, HUM REPROD, V21, P370, DOI 10.1093/humrep/dei347; Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032; Silber SJ, 2012, BBA-MOL BASIS DIS, V1822, P1981, DOI 10.1016/j.bbadis.2012.10.004; Silber SJ, 2012, MOL HUM REPROD, V18, P59, DOI 10.1093/molehr/gar082; Silber SJ, 2012, MIDDLE EAST FERTIL S, V17, P215, DOI 10.1016/j.mefs.2012.09.008; Silber S, 2010, FERTIL STERIL, V94, P2191, DOI 10.1016/j.fertnstert.2009.12.073; Silber SJ, 2007, NEW ENGL J MED, V356, P1382, DOI 10.1056/NEJMc066574; Silber SJ, 2008, NEW ENGL J MED, V359, P2617, DOI 10.1056/NEJMc0804321; Silber SJ, 2005, NEW ENGL J MED, V353, P58, DOI 10.1056/NEJMoa043157; Smith GD, 2010, FERTIL STERIL, V94, P2088, DOI 10.1016/j.fertnstert.2009.12.065; Sonmezer M, 2004, HUM REPROD UPDATE, V10, P251, DOI 10.1093/humupd/dmh021; Stern CJ, 2013, HUM REPROD, V28, P2996, DOI 10.1093/humrep/det360; Stoop D, 2011, HUM REPROD, V26, P655, DOI 10.1093/humrep/deq367; Stoop D, 2014, REPROD BIOMED ONLINE, V28, P548, DOI 10.1016/j.rbmo.2014.01.007; Stoop D, 2012, FERTIL STERIL, V97, P1328, DOI 10.1016/j.fertnstert.2012.03.012; Thomas-Teinturier C, 2013, HUM REPROD, V28, P488, DOI 10.1093/humrep/des391; Ting AY, 2011, HUM REPROD, V26, P2461, DOI 10.1093/humrep/der196; Vajta G, 2009, REPROD BIOMED ONLINE, V19, P1, DOI 10.1016/S1472-6483(10)60278-7; van Loendersloot LL, 2011, HUM REPROD, V26, P3054, DOI 10.1093/humrep/der284; Wallace WH, 2012, REPROD BIOMED ONLINE, V25, P93, DOI 10.1016/j.rbmo.2012.06.008; Yang DS, 2007, FERTIL STERIL, V87, DOI 10.1016/j.fertnstert.2006.07.1546; Yasui T, 2012, MATURITAS, V72, P249, DOI 10.1016/j.maturitas.2012.04.002; Zhai A, 2012, J PEDIATR SURG, V47, P1272, DOI 10.1016/j.jpedsurg.2012.03.038; Ziebe S, 2008, HUM REPROD UPDATE, V14, P583, DOI 10.1093/humupd/dmn038	103	141	147	3	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1311	1319		10.1016/S0140-6736(14)61261-7	http://dx.doi.org/10.1016/S0140-6736(14)61261-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	25283572				2022-12-28	WOS:000343003400035
J	Tournaye, H; Dohle, GR; Barratt, CLR				Tournaye, Herman; Dohle, Gert R.; Barratt, Christopher L. R.			Fertility preservation in men with cancer	LANCET			English	Article							TESTICULAR SPERM EXTRACTION; STEM-CELL TRANSPLANTATION; GERM-CELLS; SEMEN PARAMETERS; CRYOPRESERVATION; CHEMOTHERAPY; SPERMATOGENESIS; CHILDHOOD; SURVIVORS; TISSUE	During the past decade, advances in cancer treatment have increased survival rates of both boys and men. However, cancer treatment itself can compromise fertility, especially exposure to alkylating agents and whole body irradiation, which cause substantial germ cell loss. Children and adolescents with testicular cancer, leukaemia, and Ewing sarcomas are at the highest risk of developing permanent sterility from cancer treatment. Consequently, various strategies to preserve fertility are necessary. Sperm cryopreservation is an effective but underused method to safeguard spermatozoa. In the past few years, large advances have been made in prepubertal germ cell storage aimed at subsequent transplantation of testicular tissue and associated stem cells. Although still experimental, these approaches off er hope to many men in whom germ cell loss is associated with sterility. The derivation of male gametes from stem cells also holds much promise; however, data are only available in animals, and the use of this method in human beings is probably many years away.	[Tournaye, Herman] Free Univ Brussels, Univ Hosp, Ctr Reprod Med, Brussels, Belgium; [Dohle, Gert R.] Erasmus MC, Dept Urol, Androl Unit, Rotterdam, Netherlands; [Barratt, Christopher L. R.] Univ Dundee, Ninewells Hosp, Sch Med, Reprod & Dev Biol, Dundee, Scotland	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Erasmus University Rotterdam; Erasmus MC; University of Dundee	Tournaye, H (corresponding author), UZ Brussel, Ctr Reprod Med, B-1090 Brussels, Belgium.	tournaye@uzbrussel.be		Barratt, christopher/0000-0003-0062-9979; Tournaye, Herman/0000-0002-9863-9309	Research Fund of Flanders; Research Fund Willy Gepts; Ferring; NHS Scotland; MRC	Research Fund of Flanders; Research Fund Willy Gepts; Ferring(Ferring Pharmaceuticals); NHS Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HT's institution receives research grants from the Research Fund of Flanders, the Research Fund Willy Gepts, and an unconditional grant from Ferring for research on testicular stem cells. CLRB receives funding from NHS Scotland and MRC. GRD declares no competing interests.	Agarwal A, 2004, FERTIL STERIL, V81, P342, DOI 10.1016/j.fertnstert.2003.07.021; Aksglaede L, 2013, EUR J ENDOCRINOL, V168, pR67, DOI 10.1530/EJE-12-0934; Baert Y, 2013, HUM REPROD, V28, P1816, DOI 10.1093/humrep/det100; Baert Y, 2012, FERTIL STERIL, V97, P1152, DOI 10.1016/j.fertnstert.2012.02.010; Bahadur G, 2004, HUM REPROD, V19, P2702, DOI 10.1093/humrep/deh538; BARR RD, 1993, MED HYPOTHESES, V40, P165, DOI 10.1016/0306-9877(93)90205-5; Behringer K, 2013, J CLIN ONCOL, V31, P231, DOI 10.1200/JCO.2012.44.3721; Berookhim BM, 2014, FERTIL STERIL, V101, P805, DOI 10.1016/j.fertnstert.2013.11.122; Bizet P, 2012, REPROD BIOMED ONLINE, V24, P321, DOI 10.1016/j.rbmo.2011.11.015; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BUNGE RG, 1953, NATURE, V172, P767, DOI 10.1038/172767b0; Byrne J, 1998, AM J HUM GENET, V62, P45, DOI 10.1086/301677; Calogero AE, 2001, HUM REPROD, V16, P1845, DOI 10.1093/humrep/16.9.1845; Chemes HE, 2001, INT J ANDROL, V24, P2, DOI 10.1046/j.1365-2605.2001.00260.x; Chow EJ, 2009, ARCH PEDIAT ADOL MED, V163, P887, DOI 10.1001/archpediatrics.2009.111; Choy JT, 2013, FERTIL STERIL, V100, P1187, DOI 10.1016/j.fertnstert.2013.07.1974; Eiser C, 2011, HUM REPROD, V26, P2791, DOI 10.1093/humrep/der243; Geens M, 2011, FERTIL STERIL, V95, P787, DOI 10.1016/j.fertnstert.2010.09.054; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gilbert E, 2011, ANN ONCOL, V22, P1209, DOI 10.1093/annonc/mdq579; Goossens E, 2013, HUM REPROD, V28, P897, DOI 10.1093/humrep/det039; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hermann BP, 2012, CELL STEM CELL, V11, P715, DOI 10.1016/j.stem.2012.07.017; Horne G, 2004, HUM REPROD, V19, P1448, DOI 10.1093/humrep/deh249; Hotaling JM, 2013, FERTIL STERIL, V99, P464, DOI 10.1016/j.fertnstert.2012.09.031; Hourvitz A, 2008, FERTIL STERIL, V90, P557, DOI 10.1016/j.fertnstert.2007.03.002; Hovav Y, 2001, FERTIL STERIL, V75, P811, DOI 10.1016/S0015-0282(01)01680-6; Hsiao W, 2011, J CLIN ONCOL, V29, P1607, DOI 10.1200/JCO.2010.33.7808; Kelleher S, 2001, HUM REPROD, V16, P2632, DOI 10.1093/humrep/16.12.2632; Li YF, 2014, STEM CELL RES, V12, P517, DOI 10.1016/j.scr.2013.12.007; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; McCook A, 2013, NAT MED, V19, P958, DOI 10.1038/nm0813-958; Meistrich ML, 2013, FERTIL STERIL, V100, P1180, DOI 10.1016/j.fertnstert.2013.08.010; MEISTRICH ML, 1992, CANCER, V70, P2703, DOI 10.1002/1097-0142(19921201)70:11<2703::AID-CNCR2820701123>3.0.CO;2-X; MULLER J, 1983, INT J ANDROL, V6, P143, DOI 10.1111/j.1365-2605.1983.tb00333.x; Ning L, 2012, FERTIL STERIL, V98, P1443, DOI 10.1016/j.fertnstert.2012.08.023; NYSOM K, 1994, ACTA PAEDIATR, V83, P520, DOI 10.1111/j.1651-2227.1994.tb13071.x; O'Flaherty C, 2008, HUM REPROD, V23, P1044, DOI 10.1093/humrep/den081; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Pacey AA, 2012, HUM REPROD, V27, P3132, DOI 10.1093/humrep/des300; Pacey AA, 2014, EXPERT REV ANTICANC, V14, P487, DOI 10.1586/14737140.2014.883283; Paul C, 2013, NAT REV UROL, V10, P227, DOI 10.1038/nrurol.2013.18; PEDERSEN JL, 1993, ARCH DIS CHILD, V69, P384, DOI 10.1136/adc.69.3.384; Poels J, 2013, HUM REPROD, V28, P578, DOI 10.1093/humrep/des455; Quinn GP, 2009, J CLIN ONCOL, V27, P5952, DOI 10.1200/JCO.2009.23.0250; Reuter K, 2014, TISSUE CELL, V46, P86, DOI 10.1016/j.tice.2013.12.001; Ribas-Maynou J, 2014, ANDROLOGY-US, V2, P83, DOI 10.1111/j.2047-2927.2013.00158.x; Rives N, 2012, J ANDROL, V33, P1394, DOI 10.2164/jandrol.112.016592; Romerius P, 2011, INT J ANDROL, V34, P69, DOI 10.1111/j.1365-2605.2010.01058.x; Ruutiainen T, 2013, AM J BIOETHICS, V13, P28, DOI 10.1080/15265161.2012.760672; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Sartorius GA, 2010, HUM REPROD UPDATE, V16, P65, DOI 10.1093/humupd/dmp027; Schrader M, 2003, UROLOGY, V61, P421, DOI 10.1016/S0090-4295(02)02264-1; Sheth KR, 2012, J UROLOGY, V187, P979, DOI 10.1016/j.juro.2011.10.154; Shetty G, 2013, ANDROLOGY-US, V1, P886, DOI 10.1111/j.2047-2927.2013.00126.x; Smit M, 2010, HUM REPROD, V25, P1877, DOI 10.1093/humrep/deq104; Stahl O, 2011, JNCI-J NATL CANCER I, V103, P398, DOI 10.1093/jnci/djq550; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Stukenborg JB, 2009, MOL HUM REPROD, V15, P521, DOI 10.1093/molehr/gap052; van Casteren NJ, 2010, INT J ANDROL, V33, P73, DOI 10.1111/j.1365-2605.2009.00956.x; van Casteren NJ, 2009, PEDIATR BLOOD CANCER, V52, P108, DOI 10.1002/pbc.21780; van den Berg H, 2007, HUM REPROD, V22, P594, DOI 10.1093/humrep/del375; van der Kaaij MAE, 2010, HEMATOL ONCOL, V28, P168, DOI 10.1002/hon.939; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Wikstrom AM, 2008, HORM RES, V69, P317, DOI 10.1159/000117387; Williams DH, 2009, J UROLOGY, V181, P736, DOI 10.1016/j.juro.2008.10.023	66	85	90	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1295	1301		10.1016/S0140-6736(14)60495-5	http://dx.doi.org/10.1016/S0140-6736(14)60495-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	25283570				2022-12-28	WOS:000343003400033
J	Clevers, H; Loh, KM; Nusse, R				Clevers, Hans; Loh, Kyle M.; Nusse, Roel			An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control	SCIENCE			English	Review							POSTNATAL MAMMARY-GLAND; LONG-TERM EXPANSION; IN-VITRO EXPANSION; WNT/BETA-CATENIN; SELF-RENEWAL; SMALL-INTESTINE; TUMOR-SUPPRESSOR; PLANARIAN REGENERATION; STEM/PROGENITOR CELLS; KIDNEY DEVELOPMENT	Stem cells fuel tissue development, renewal, and regeneration, and these activities are controlled by the local stem cell microenvironment, the "niche." Wnt signals emanating from the niche can act as self-renewal factors for stem cells in multiple mammalian tissues. Wnt proteins are lipid-modified, which constrains them to act as short-range cellular signals. The locality of Wnt signaling dictates that stem cells exiting the Wnt signaling domain differentiate, spatially delimiting the niche in certain tissues. In some instances, stem cells may act as or generate their own niche, enabling the self-organization of patterned tissues. In this Review, we discuss the various ways by which Wnt operates in stem cell control and, in doing so, identify an integral program for tissue renewal and regeneration.	[Clevers, Hans] Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] CancerGenomics Nl, NL-3584 CT Utrecht, Netherlands; [Loh, Kyle M.; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Stanford Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, Stanford, CA 94305 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, 265 Campus Dr, Stanford, CA 94305 USA.	rnusse@stanford.edu		Loh, Kyle/0000-0002-8042-0149	Howard Hughes Medical Institute; California Institute for Regenerative Medicine; Fannie and John Hertz Foundation; U.S. National Science Foundation; Davidson Institute for Talent Development; European Union; CancerGenomics.nl program	Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Fannie and John Hertz Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); Davidson Institute for Talent Development; European Union(European Commission); CancerGenomics.nl program	We thank R. van Amerongen for insightful comments. The authors are supported by the Howard Hughes Medical Institute and the California Institute for Regenerative Medicine (R.N.), the Fannie and John Hertz Foundation (K. M. L.), the U.S. National Science Foundation (K. M. L.), the Davidson Institute for Talent Development (K. M. L.), the European Union (H. C.), and the CancerGenomics.nl program (H. C.). H. C. is an inventor on several patent applications that cover culturing methods for Wnt-dependent stem cells, filed by the Royal Netherlands Academy of Arts and Sciences.	Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Bowman AN, 2013, P NATL ACAD SCI USA, V110, P7324, DOI 10.1073/pnas.1305411110; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Holstein TW, 2011, CURR TOP DEV BIOL, V97, P137, DOI 10.1016/B978-0-12-385975-4.00012-7; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jan TA, 2013, DEVELOPMENT, V140, P1196, DOI 10.1242/dev.087528; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; LEBLOND CP, 1956, PHYSIOL REV, V36, P255, DOI 10.1152/physrev.1956.36.2.255; LEBLOND CP, 1948, ANAT REC, V100, P357, DOI 10.1002/ar.1091000306; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Leushacke M, 2013, CELL REP, V5, P349, DOI 10.1016/j.celrep.2013.09.025; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Paneth J., 1887, ARCH MIKROSK ANAT, V31, P113, DOI [10.1007/BF02955706, DOI 10.1007/BF02955706]; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rinkevich Y, 2014, CELL REP, V7, P1270, DOI 10.1016/j.celrep.2014.04.018; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Roman AKS, 2014, STEM CELL REP, V2, P127, DOI 10.1016/j.stemcr.2013.12.012; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Stamos JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01998; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Takeda N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066314; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhu AJ, 1996, J CELL SCI, V109, P3013	105	811	840	30	330	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					54	+	1248012	10.1126/science.1248012	http://dx.doi.org/10.1126/science.1248012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278615				2022-12-28	WOS:000342446900046
J	Friedland, JS				Friedland, Jon S.			Targeting the Inflammatory Response in Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England	Imperial College London	Friedland, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England.			Friedland, Jonathan S/0000-0001-7789-9649				Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489	1	11	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1354	1356		10.1056/NEJMcibr1408663	http://dx.doi.org/10.1056/NEJMcibr1408663			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25271609				2022-12-28	WOS:000342429800015
J	Secura, GM; Madden, T; McNicholas, C; Mullersman, J; Buckel, CM; Zhao, QH; Peipert, JF				Secura, Gina M.; Madden, Tessa; McNicholas, Colleen; Mullersman, Jennifer; Buckel, Christina M.; Zhao, Qiuhong; Peipert, Jeffrey F.			Provision of No-Cost, Long-Acting Contraception and Teenage Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSIBLE CONTRACEPTION; CONTINUATION	BACKGROUND The rate of teenage pregnancy in the United States is higher than in other developed nations. Teenage births result in substantial costs, including public assistance, health care costs, and income losses due to lower educational attainment and reduced earning potential. METHODS The Contraceptive CHOICE Project was a large prospective cohort study designed to promote the use of long-acting, reversible contraceptive (LARC) methods to reduce unintended pregnancy in the St. Louis region. Participants were educated about reversible contraception, with an emphasis on the benefits of LARC methods, were provided with their choice of reversible contraception at no cost, and were followed for 2 to 3 years. We analyzed pregnancy, birth, and induced-abortion rates among teenage girls and women 15 to 19 years of age in this cohort and compared them with those observed nationally among U. S. teens in the same age group. RESULTS Of the 1404 teenage girls and women enrolled in CHOICE, 72% chose an intrauterine device or implant (LARC methods); the remaining 28% chose another method. During the 2008-2013 period, the mean annual rates of pregnancy, birth, and abortion among CHOICE participants were 34.0, 19.4, and 9.7 per 1000 teens, respectively. In comparison, rates of pregnancy, birth, and abortion among sexually experienced U. S. teens in 2008 were 158.5, 94.0, and 41.5 per 1000, respectively. CONCLUSIONS Teenage girls and women who were provided contraception at no cost and educated about reversible contraception and the benefits of LARC methods had rates of pregnancy, birth, and abortion that were much lower than the national rates for sexually experienced teens. (Funded by the Susan Thompson Buffett Foundation and others.)	[Secura, Gina M.; Madden, Tessa; McNicholas, Colleen; Mullersman, Jennifer; Buckel, Christina M.; Zhao, Qiuhong; Peipert, Jeffrey F.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Clin Res, St Louis, MO 63110 USA	Washington University (WUSTL)	Peipert, JF (corresponding author), Washington Univ, Sch Med, 4533 Clayton Ave,Campus Box 8219, St Louis, MO 63110 USA.	peipertj@wudosis.wustl.edu		Madden, Tessa/0000-0001-9455-1943	Susan Thompson Buffett Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD070979] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER	Susan Thompson Buffett Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by the Susan Thompson Buffett Foundation and others.	[Anonymous], WINN BATTL FACT SHEE; Boonstra H., 2010, GUTTMACHER POLICY RE, V13; Curtis KM, 2013, MMWR RECOMM REP, V62, P1; Finer LB, 2012, FERTIL STERIL, V98, P893, DOI 10.1016/j.fertnstert.2012.06.027; Harper C, 2004, PERSPECT SEX REPRO H, V36, P20, DOI 10.1111/j.1931-2393.2004.tb00004.x; Kavanaugh ML, 2013, J PEDIATR ADOL GYNEC, V26, P86, DOI 10.1016/j.jpag.2012.10.006; Kavanaugh ML, 2013, J ADOLESCENT HEALTH, V52, P284, DOI 10.1016/j.jadohealth.2012.10.276; Kost K, 2014, US TEENAGE PREGNANCI; Kost K, 2008, US TEENAGE PREGNANCI; Madden T, 2013, CONTRACEPTION, V88, P243, DOI 10.1016/j.contraception.2012.07.015; Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1; Martinez Gladys, 2011, Vital Health Stat 23, P1; National Campaign to Prevent Teen and Unplanned Pregnancy, 2013, COUNT IT PUBL COSTS; National Campaign to Prevent Teen Pregnancy, 2013, FAST FACTS TEEN PREG; O'Neil-Callahan M, 2013, OBSTET GYNECOL, V122, P1083, DOI 10.1097/AOG.0b013e3182a91f45; Rosenstock JR, 2012, OBSTET GYNECOL, V120, P1298, DOI [10.1097/AOG.0b013e31827499bd, http://10.1097/AOG.0b013e31827499bd]; Secura G, 2013, EXPERT REV OBSTET GY, V8, P297, DOI DOI 10.1586/17474108.2013.811942; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; The National Campaign to Prevent Teen and Unplanned Pregnancy, 2011, FAST FACTS IS 3 10 S; Tocce KM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.04.015; WHO, 2004, MED EL CRIT CONTR US, V3; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	22	252	256	0	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1316	1323		10.1056/NEJMoa1400506	http://dx.doi.org/10.1056/NEJMoa1400506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25271604	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000342429800008
J	Varis, O				Varis, Olli			Curb vast water use in central Asia	NATURE			English	Editorial Material									Aalto Univ, Espoo, Finland	Aalto University	Varis, O (corresponding author), Aalto Univ, Espoo, Finland.	olli.varis@aalto.fi						[Anonymous], 2013, AFR DEV IND 2012 201; Dukhovny V. A., 2011, WATER CENTRAL ASIA P; Falkenmark M, 1997, PHILOS T ROY SOC B, V352, P929, DOI 10.1098/rstb.1997.0072; Granit J., 2010, REGIONAL WATER INTEL; Porkka M, 2012, INT J WATER RESOUR D, V28, P453, DOI 10.1080/07900627.2012.684310; Stone R, 2008, SCIENCE, V320, P1002, DOI 10.1126/science.320.5879.1002; United Nations Economic Commission for Europe, 2011, STRENGTH WAT MAN TRA; United Nations Environmental Programme, 2011, ENV SEC AM DAR BAS; Varis O, 2009, INT J WATER RESOUR D, V25, P507, DOI 10.1080/07900620902972679; Zonn I.S., 2013, TURKMEN LAKE ALTYN A	10	68	69	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					27	29		10.1038/514027a	http://dx.doi.org/10.1038/514027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP9SS	25279902	Bronze			2022-12-28	WOS:000342420800017
J	Lankester, F; Hampson, K; Lembo, T; Palmer, G; Taylor, L; Cleaveland, S				Lankester, Felix; Hampson, Katie; Lembo, Tiziana; Palmer, Guy; Taylor, Louise; Cleaveland, Sarah			Implementing Pasteur's vision for rabies elimination	SCIENCE			English	Editorial Material							CANINE RABIES; TRANSMISSION DYNAMICS; AFRICA; VACCINATION; INDONESIA; DEATHS; BALI		[Lankester, Felix; Palmer, Guy] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Lankester, Felix; Palmer, Guy; Cleaveland, Sarah] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Arusha, Tanzania; [Lankester, Felix; Hampson, Katie; Lembo, Tiziana; Cleaveland, Sarah] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Taylor, Louise] Global Alliance Rabies Control, Manhattan, KS 66502 USA	Washington State University; Nelson Mandela African Institution of Science & Technology; University of Glasgow	Lankester, F (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	lankesterf@vetmed.wsu.edu	Taylor, Louise/H-9765-2019	Taylor, Louise/0000-0001-8141-2346; Lankester, Felix/0000-0002-0802-0693; Hampson, Katie/0000-0001-5392-6884; Cleaveland, Sarah/0000-0002-0456-0959	Medical Research Council [G0901135] Funding Source: Medline; Wellcome Trust [095787/Z/11/Z, 095787] Funding Source: Medline; MRC [G0901135] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Davlin SL, 2012, VACCINE, V30, P3492, DOI 10.1016/j.vaccine.2012.03.069; Fitzpatrick MC, 2014, ANN INTERN MED, V160, P91, DOI 10.7326/M13-0542; Geison GL., 1995, PRIVATE SCI L PASTEU; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lembo T, 2006, EMERG INFECT DIS, V12, P310; Lembo T., 2013, ZOONOSES PUBLIC HLTH, P205; Lembo T, 2008, J APPL ECOL, V45, P1246, DOI 10.1111/j.1365-2664.2008.01468.x; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Mallewa M, 2007, EMERG INFECT DIS, V13, P136, DOI 10.3201/eid1301.060810; Morters MK, 2013, J ANIM ECOL, V82, P6, DOI 10.1111/j.1365-2656.2012.02033.x; Vigilato MAN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0143; Putra AAG, 2013, EMERG INFECT DIS, V19, P648, DOI 10.3201/eid1904.120380; Shwiff S, 2013, ANTIVIR RES, V98, P352, DOI 10.1016/j.antiviral.2013.03.004; Suraweera W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001847; Townsend SE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002372; Zinsstag J, 2009, P NATL ACAD SCI USA, V106, P14996, DOI 10.1073/pnas.0904740106	18	47	49	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1562	1564		10.1126/science.1256306	http://dx.doi.org/10.1126/science.1256306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP6CG	25258065	Green Accepted			2022-12-28	WOS:000342164500021
J	Sewell, MD; Eastwood, DM; Wimalasundera, N				Sewell, Mathew D.; Eastwood, Deborah M.; Wimalasundera, Neil			Managing common symptoms of cerebral palsy in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BOTULINUM TOXIN ASSESSMENT; SELECTIVE DORSAL RHIZOTOMY; BIRTH-WEIGHT INFANTS; QUALITY-OF-LIFE; YOUNG-PEOPLE; CLASSIFICATION-SYSTEM; LESS-THAN-32 WEEKS; HIP SURVEILLANCE; FOLLOW-UP; POPULATION		[Sewell, Mathew D.; Eastwood, Deborah M.] Royal Natl Orthopaed Hosp, Catterall Unit, Stanmore HA7 4LP, Middx, England; [Wimalasundera, Neil] Wolfson Neurodisabil Serv, London, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Sewell, MD (corresponding author), Royal Natl Orthopaed Hosp, Catterall Unit, Stanmore HA7 4LP, Middx, England.	matbuzz1@hotmail.com		Sewell, Mathew/0000-0003-0948-2985				Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; [Anonymous], 2013, REPORT AUSTR CEREBRA; Anttila H, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-14; Arrowsmith F, 2010, DEV MED CHILD NEUROL, V52, P1043, DOI 10.1111/j.1469-8749.2010.03702.x; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Bache CE, 2003, CURR ORTHOPAED, V17, P88, DOI 10.1054/cuor.2003.0328; Benigni I, 2011, CLIN NUTR, V30, P769, DOI 10.1016/j.clnu.2011.06.008; BUNDEY S, 1977, DEV MED CHILD NEUROL, V19, P179; Calis EAC, 2008, DEV MED CHILD NEUROL, V50, P625, DOI 10.1111/j.1469-8749.2008.03047.x; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Castle K, 2007, DEV MED CHILD NEUROL, V49, P445, DOI 10.1111/j.1469-8749.2007.00445.x; Darrah J., 1997, PEDIAT PHYSICAL THER, V9, P12; Dickinson HO, 2007, LANCET, V369, P2171, DOI 10.1016/S0140-6736(07)61013-7; Dobson F, 2002, J BONE JOINT SURG BR, V84B, P720, DOI 10.1302/0301-620X.84B5.12398; Dodd KJ, 2002, ARCH PHYS MED REHAB, V83, P1157, DOI 10.1053/apmr.2002.34286; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; ESCOBAR GJ, 1991, ARCH DIS CHILD, V66, P204, DOI 10.1136/adc.66.2.204; Fauconnier J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1458; Fehlings D, 2010, EUR J NEUROL, V17, P38, DOI 10.1111/j.1468-1331.2010.03127.x; Fung EB, 2002, J AM DIET ASSOC, V102, P361, DOI 10.1016/S0002-8223(02)90084-2; Gorter JW, 2004, DEV MED CHILD NEUROL, V46, P461, DOI 10.1017/S0012162204000763; Grunt S, 2011, DEV MED CHILD NEUROL, V53, P490, DOI 10.1111/j.1469-8749.2011.03912.x; Hagglund G, 2005, J BONE JOINT SURG BR, V87B, P95, DOI 10.1302/0301-620X.87B1; Hetzel BS, 2000, J NUTR, V130, p493S, DOI 10.1093/jn/130.2.493S; Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x; HUGHES I, 1992, DEV MED CHILD NEUROL, V34, P80; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Krageloh-Mann I, 2007, DEV MED CHILD NEUROL, V49, P144; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Leonard JM, 2011, DEV MED CHILD NEUROL, V53, P226, DOI 10.1111/j.1469-8749.2010.03810.x; Love SC, 2010, EUR J NEUROL, V17, P9, DOI 10.1111/j.1468-1331.2010.03126.x; Martinez-Biarge M, 2010, EARLY HUM DEV, V86, P675, DOI 10.1016/j.earlhumdev.2010.08.013; Morris C, 2002, DEV MED CHILD NEUROL, V44, P205, DOI 10.1017/S0012162201001943; Mugglestone MA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4845; National Institute for Health and Care Excellence, 2012, SPAST CHILDR YOUNG P; Nolan J, 2000, ANAESTHESIA, V55, P32, DOI 10.1046/j.1365-2044.2000.01065.x; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; O'Flaherty SJ, 2011, DEV MED CHILD NEUROL, V53, P125, DOI 10.1111/j.1469-8749.2010.03814.x; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Parkinson KN, 2010, ACTA PAEDIATR, V99, P446, DOI 10.1111/j.1651-2227.2009.01626.x; Parkinson KN, 2013, ARCH DIS CHILD, V98, P434, DOI 10.1136/archdischild-2012-303482; Pennington L, 2004, COCHRANE DB SYST REV, V2; Persson-Bunke M, 2012, SPINE, V37, pE708, DOI 10.1097/BRS.0b013e318246a962; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3; Reddihough D, 2010, EUR J NEUROL, V17, P109, DOI 10.1111/j.1468-1331.2010.03131.x; Reilly S, 1996, J PEDIATR-US, V129, P877, DOI 10.1016/S0022-3476(96)70032-X; Roebroeck ME, 2009, DEV MED CHILD NEUROL, V51, P670, DOI 10.1111/j.1469-8749.2009.03322.x; Rosenbaum P, 2003, BRIT MED J, V326, P970, DOI 10.1136/bmj.326.7396.970; Rosenbaum P., 1998, FAMILY CENTRED SERVI, V18, P1, DOI [10.1080/J006v18n01, DOI 10.1080/J006V18N01, DOI 10.1080/J006v18n01_01]; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Russman Barry S, 2004, Semin Pediatr Neurol, V11, P47, DOI 10.1016/j.spen.2004.01.007; Scheinberg A, 2006, J PAEDIATR CHILD H, V42, P715, DOI 10.1111/j.1440-1754.2006.00957.x; Sleigh G, 2004, COCHRANE DB SYST REV, V2; Snider L, 2011, PHYS OCCUP THER PEDI, V31, P58, DOI 10.3109/01942638.2010.523397; Soo B, 2006, J BONE JOINT SURG AM, V88A, P121, DOI 10.2106/JBJS.E.00071; Spittle AJ, 2009, PEDIATRICS, V123, P512, DOI 10.1542/peds.2008-0590; Strauss D, 2008, DEV MED CHILD NEUROL, V50, P487, DOI 10.1111/j.1469-8749.2008.03000.x; Sullivan PB, 2004, DEV MED CHILD NEUROL, V46, P796, DOI 10.1017/S0012162204001392; Surman G, 2006, J PUBLIC HEALTH, V28, P148, DOI 10.1093/pubmed/fdi087; Tedroff K, 2011, DEV MED CHILD NEUROL, V53, P724, DOI 10.1111/j.1469-8749.2011.03969.x; Tollanes MC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4294; Vernon-Roberts A, 2010, DEV MED CHILD NEUROL, V52, P1099, DOI 10.1111/j.1469-8749.2010.03789.x; Verschuren O, 2008, AM J PHYS MED REHAB, V87, P404, DOI 10.1097/PHM.0b013e31815b2675; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Ward A, 2009, J PAEDIATR CHILD H, V45, P720, DOI 10.1111/j.1440-1754.2009.01601.x; Weir KA, 2013, ARCH PHYS MED REHAB, V94, P495, DOI 10.1016/j.apmr.2012.10.007; WHO, 2001, WHO INT CLASS FUNCT; Wu YW, 2006, PEDIATRICS, V118, P690, DOI 10.1542/peds.2006-0278; Wynter M, 2011, J PEDIATR REHAB MED, V4, P183, DOI 10.3233/PRM-2011-0174; Zafeiriou DI, 1999, J CHILD NEUROL, V14, P289, DOI 10.1177/088307389901400504	75	29	29	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2014	349								g5474	10.1136/bmj.g5474	http://dx.doi.org/10.1136/bmj.g5474			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UR	25255910				2022-12-28	WOS:000342426400004
J	Tana, C; Tchernev, G				Tana, Claudio; Tchernev, Georgi			Familial Multiple Lipomatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tana, Claudio] Univ G DAnnunzio, Chieti, Italy; [Tchernev, Georgi] Lozenetz Univ Hosp, Sofia, Bulgaria	G d'Annunzio University of Chieti-Pescara; University of Sofia	Tana, C (corresponding author), Univ G DAnnunzio, Chieti, Italy.	claudio.tana@yahoo.it	Tchernev, Georgi/AAG-9403-2019; Tana, Claudio/L-5576-2019; Scuderi, Nicolò/J-2711-2018; Borroni, Giovanni/E-7642-2012	Scuderi, Nicolò/0000-0002-2458-0498; Tana, Claudio/0000-0002-9162-7866					0	2	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1237	1237		10.1056/NEJMicm1316241	http://dx.doi.org/10.1056/NEJMicm1316241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4WH	25251618				2022-12-28	WOS:000342079700011
J	Geiss, LS; Wang, J; Cheng, YLJ; Thompson, TJ; Barker, L; Li, YF; Albright, AL; Gregg, EW				Geiss, Linda S.; Wang, Jing; Cheng, Yiling J.; Thompson, Theodore J.; Barker, Lawrence; Li, Yanfeng; Albright, Ann L.; Gregg, Edward W.			Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; AMERICAN-INDIANS; NATIONAL-HEALTH; US POPULATION; OBESITY; GLUCOSE; PERFORMANCE; MELLITUS; RISK	IMPORTANCE Although the prevalence and incidence of diabetes have increased in the United States in recent decades, no studies have systematically examined long-term, national trends in the prevalence and incidence of diagnosed diabetes. OBJECTIVE To examine long-term trends in the prevalence and incidence of diagnosed diabetes to determine whether there have been periods of acceleration or deceleration in rates. DESIGN, SETTING, AND PARTICIPANTS We analyzed 1980-2012 data for 664 969 adults aged 20 to 79 years from the National Health Interview Survey (NHIS) to estimate incidence and prevalence rates for the overall civilian, noninstitutionalized, US population and by demographic subgroups (age group, sex, race/ethnicity, and educational level). MAIN OUTCOMES AND MEASURES The annual percentage change (APC) in rates of the prevalence and incidence of diagnosed diabetes (type 1 and type 2 combined). RESULTS The APC for age-adjusted prevalence and incidence of diagnosed diabetes did not change significantly during the 1980s, but each increased sharply each year during 1990-2008 before leveling off with no significant change during 2008-2012. The prevalence per 100 persons was 3.5 (95% CI, 3.2 to 3.9) in 1990, 7.9 (95% CI, 7.4 to 8.3) in 2008, and 8.3 (95% CI, 7.9 to 8.7) in 2012. The incidence per 1000 persons was 3.2 (95% CI, 2.2 to 4.1) in 1990, 8.8 (95% CI, 7.4 to 10.3) in 2008, and 7.1 (95% CI, 6.1 to 8.2) in 2012. [GRAPHICS] Trends in many demographic subpopulations were similar to these overall trends. However, incidence rates among non-Hispanic black and Hispanic adults continued to increase (for interaction, P = .03 for non-Hispanic black adults and P =.01 for Hispanic adults) at rates significantly greater than for non-Hispanic white adults. In addition, the rate of increase in prevalence was higher for adults who had a high school education or less compared with those who had more than a high school education (for interaction, P = .006 for < high school and P < .001 for high school). CONCLUSIONS AND RELEVANCE Analyses of nationally representative data from 1980 to 2012 suggest a doubling of the incidence and prevalence of diabetes during 1990-2008, and a plateauing between 2008 and 2012. However, there appear to be continued increases in the prevalence or incidence of diabetes among subgroups, including non-Hispanic black and Hispanic subpopulations and those with a high school education or less.	[Geiss, Linda S.; Wang, Jing; Cheng, Yiling J.; Thompson, Theodore J.; Barker, Lawrence; Li, Yanfeng; Albright, Ann L.; Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Geiss, LS (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, 4770 Buford Hwy NE,MS F73, Atlanta, GA 30341 USA.	lgeiss@cdc.gov	Cheng, Yiling J/A-6547-2009; li, yan/GTI-4638-2022	Cheng, Yiling J/0000-0002-5053-0814; Gregg, Edward/0000-0003-2381-6822				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2000, Vital Health Stat 2, P1; [Anonymous], 1985, Vital Health Stat 1, P1; [Anonymous], 2011, DIABETES PUBLIC HLTH; Barker LE, 2013, DATA SCI, V11, P249; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; Burke JP, 2002, AM J EPIDEMIOL, V155, P859, DOI 10.1093/aje/155.9.859; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Centers for Disease Control, 2020, NATL DIABETES STAT R; Centers for Disease Control and Prevention, 2012, DAT FIL DOC NAT HLTH; Centers for Disease Control and Prevention, NAT HLTH INT SURV ME; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Gavin JR, 1997, DIABETES CARE, V20, P1183; Geiss Linda S., 2012, Morbidity and Mortality Weekly Report, V61, P918; Geiss LS, 2006, AM J PREV MED, V30, P371, DOI 10.1016/j.amepre.2005.12.009; Hattori A, 2013, OBESITY, V21, P856, DOI 10.1002/oby.20313; Health United States, 2013, HLTH US 2013 SPEC FE; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; [Internet] Centers for Disease Control and Prevention, NAT HLTH INT SURV; Jackson JM, 2014, MENOPAUSE, V21, P861, DOI [10.1097/GME.0000000000000189, 10.1097/gme.0000000000000189]; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lee ET, 2002, DIABETES CARE, V25, P49, DOI 10.2337/diacare.25.1.49; Lorenzo C, 2010, DIABETES CARE, V33, P335, DOI 10.2337/dc09-1357; Massey JT, DESIGN ESTIMATION NA; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2001, DIABETES CARE, V24, P1508, DOI 10.2337/diacare.24.8.1508-a; National Center for Health Statistics, 1981, CURR EST NAT HLTH 10; Ng SW, 2014, AM J CLIN NUTR, V99, P609, DOI 10.3945/ajcn.113.072892; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008	39	444	449	1	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1218	1226		10.1001/jama.2014.11494	http://dx.doi.org/10.1001/jama.2014.11494			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25247518	Bronze			2022-12-28	WOS:000341990600022
J	Hurley, R				Hurley, Richard			The BMJ Awards India: And the winners are ... robotic spinal surgery, hospital stewardship of antibiotics, and primary care for hill tribes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						Bhargava A, 2014, NATL MED J INDIA, V27, P128; D'Silva J., 2014, BMJ-BRIT MED J, V349, pg5454; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5662; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4540; Perappadan BS, 2014, THE HINDU	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2014	349								g5803	10.1136/bmj.g5803	http://dx.doi.org/10.1136/bmj.g5803			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UP	25253775	Green Published, Bronze			2022-12-28	WOS:000342426100009
J	Gaydos, LJ; Wang, WC; Strome, S				Gaydos, Laura J.; Wang, Wenchao; Strome, Susan			H3K27me and PRC2 transmit a memory of repression across generations and during development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HISTONE METHYLATION; CHROMATIN-STRUCTURE; NONCODING RNAS; X-CHROMOSOME; GERM-CELLS; C-ELEGANS; POLYCOMB; GENES; MARKS	For proper development, cells must retain patterns of gene expression and repression through cell division. Repression via methylation of histone H3 on Lys27 (H3K27me) by Polycomb repressive complex 2 (PRC2) is conserved, but its transmission is not well understood. Our studies suggest that PRC2 represses the X chromosomes in Caenorhabditis elegans germ cells, and this repression is transmitted to embryos by both sperm and oocytes. By generating embryos containing some chromosomes with and some without H3K27me, we show that, without PRC2, H3K27me is transmitted to daughter chromatids through several rounds of cell division. In embryos with PRC2, a mosaic H3K27me pattern persists through embryogenesis. These results demonstrate that H3K27me and PRC2 each contribute to epigenetically transmitting the memory of repression across generations and during development.	[Gaydos, Laura J.; Strome, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Wang, Wenchao; Strome, Susan] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington	Strome, S (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	sstrome@ucsc.edu			UCSC Dissertation-Year Fellowship; Achievement Rewards for College Scientists Foundation Award;  [NIH-ORIP-P40OD010440];  [NIH-T32GM008646];  [NIH-R01GM034059]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646, R01GM034059] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	UCSC Dissertation-Year Fellowship; Achievement Rewards for College Scientists Foundation Award; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Strome laboratory members, N. Bhalla, and J. Tamkun for helpful discussions; H. Kimura for antibodies; and the Caenorhabditis Genetics Center for some strains ( funded by NIH-ORIP-P40OD010440). This work was supported by NIH-T32GM008646, UCSC Dissertation-Year Fellowship, and Achievement Rewards for College Scientists Foundation Award to L.J.G. and NIH-R01GM034059 to S.S.	Arico JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001391; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Chu DS, 2006, NATURE, V443, P101, DOI 10.1038/nature05050; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Garvin C, 1998, GENETICS, V148, P167; Gaydos LJ, 2012, CELL REP, V2, P1169, DOI 10.1016/j.celrep.2012.09.019; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Iovino N, 2013, DEV CELL, V26, P431, DOI 10.1016/j.devcel.2013.06.021; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lanzuolo C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002370; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mochizuki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046036; Ohno K, 2008, MECH DEVELOP, V125, P527, DOI 10.1016/j.mod.2008.01.002; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Saitou M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008375; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Strome S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018366; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051	32	184	193	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1515	1518		10.1126/science.1255023	http://dx.doi.org/10.1126/science.1255023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237104	Green Accepted, Green Published			2022-12-28	WOS:000341752900045
J	Terry, RF; Salm, JF; Nannei, C; Dye, C				Terry, Robert F.; Salm, Jose F., Jr.; Nannei, Claudia; Dye, Christopher			Creating a global observatory for health R&D	SCIENCE			English	Editorial Material							NEGLECTED DISEASES; DRUG	A global map of health R&D activity would improve the coordination of research and help to match limited resources with public health priorities, such as combating antimicrobial resistance. The challenges of R&D mapping are large because there are few standards for research classification and governance and limited capacity to report on R&D data, especially in low-income countries. Nevertheless, based on developments in semantic classification, and with better reporting of funded research though the Internet, it is now becoming feasible to create a global observatory for health R&D.	[Terry, Robert F.] World Hlth Org, Special Programme Res & Training Trop Dis, Geneva, Switzerland; [Salm, Jose F., Jr.] Santa Catarina State Univ, Stela Inst, Ctr Management & Socioecon Sci ESAG, Florianopolis, SC, Brazil; [Nannei, Claudia] World Hlth Org, Dept Essential Med & Hlth Prod Publ Hlth Innovat, Geneva, Switzerland; [Dye, Christopher] World Hlth Org, Off Director Gen, Geneva, Switzerland	World Health Organization; Universidade do Estado de Santa Catarina; World Health Organization; World Health Organization	Terry, RF (corresponding author), World Hlth Org, Special Programme Res & Training Trop Dis, Geneva, Switzerland.	terryr@who.int	Dye, Christopher/AIC-4659-2022	Terry, Robert/0000-0003-3849-7705; Dye, Christopher/0000-0002-2957-1793	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2014, G FINDER SURV OP POL; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Lane J. I., 2011, ROCK MOUNT ID ACC MA; Pedrique B, 2013, LANCET GLOB HEALTH, V1, pE371, DOI 10.1016/S2214-109X(13)70078-0; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Terry RF, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-28; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; WHO, 2012, RES DEV MEET HLTH NE; World Health Organization, 2014, FEAS STUD G FIND GLO; World Health Organization, 2016, ANTIMICROBIAL RESIST	10	31	31	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1302	1304		10.1126/science.1258737	http://dx.doi.org/10.1126/science.1258737			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214621				2022-12-28	WOS:000341483800053
J	Mehta, N; Croudace, T; Davies, SC				Mehta, Nisha; Croudace, Tim; Davies, Sally C.			Public mental health: evidenced-based priorities	LANCET			English	Editorial Material							BEING SCALE WEMWBS; DISORDERS		[Mehta, Nisha; Davies, Sally C.] Dept Hlth, Off Chief Med Officer, London SW1A 2NS, England; [Croudace, Tim] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Croudace, Tim] Univ York, Dept Hlth Sci, Mental Hlth & Addict Res Grp, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK	Davies, SC (corresponding author), Dept Hlth, Off Chief Med Officer, London SW1A 2NS, England.	sally.davies@dh.gsi.gov.uk	Croudace, Tim/ABC-9681-2021	Croudace, Tim/0000-0001-8346-7463	National Institute for Health Research [PHCS/C4/4/002] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: Medline; Department of Health [PHCS/C4/4/002] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		[Anonymous], 2013, MENT HLTH ACT PLAN 2; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Clarke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-487; Davies S, 2014, PUBLIC ENTAL HLTH EV; Dodge R., 2012, INT J WELLBEING, V2, P222, DOI [DOI 10.5502/IJW.V2I3.4, 10.5502/ijw.v2i3.4, 10.5502/ijw10.5502/ijw.v2i310.5502/ijw.v2i3.4]; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Forgeard M.C., 2011, INT J WELLBEING, V1, P79; Forsman AK, 2014, EUR J PUBLIC HEALTH, V24, P955, DOI 10.1093/eurpub/cku055; Goldberg DP, 1972, THE DETECTION OF PSY; Huppert FA, 2009, PERSPECT PSYCHOL SCI, V4, P108, DOI 10.1111/j.1745-6924.2009.01100.x; Layard R, WORLD HAPPINESS REPO; Local Government Improvement and Development New Economics Foundation (NEF) National Mental Health Development Unit, 2010, ROL LOC GOV PROM WEL; NHS, 2013, WELL SELF ASS HAPP A; Office for National Statistics, 2011, AN EXP SOBJ WELL BEI; Oguz S, 2013, MEASURING NATL WELL; Organization WH, 2004, PREVENTION MENTAL DI; Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107; Rose G., 2008, ROSES STRATEGY PREVE; Stewart-Brown S., 2013, PUBLIC MENTAL HLTH G, P33; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; The Government Office for Science, 2008, FOR MIGR GLOB ENV CH; Whittington JE, 1996, PSYCHOL MED, V26, P1253, DOI 10.1017/S0033291700035972; WHO Regional Office for Europe, 2009, MENTAL HLTH RESILIEN; World Health Organization, 2005, PROM MENT HLTH SUMM	24	23	23	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1472	1475		10.1016/S0140-6736(14)61400-8	http://dx.doi.org/10.1016/S0140-6736(14)61400-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF7EU	25217115				2022-12-28	WOS:000352719800035
J	Frayling, TM				Frayling, Timothy M.			Statins and type 2 diabetes: genetic studies on target	LANCET			English	Editorial Material							CORONARY-ARTERY-DISEASE; RISK; METAANALYSIS; THERAPY; LOCI		Univ Exeter, Royal Devon & Exeter NHS Fdn Trust, Sch Med, Exeter EX2 5DW, Devon, England	University of Exeter	Frayling, TM (corresponding author), Univ Exeter, Royal Devon & Exeter NHS Fdn Trust, Sch Med, Exeter EX2 5DW, Devon, England.	t.m.frayling@exeter.ac.uk		Frayling, Timothy/0000-0001-8362-2603	Diabetes UK [12/0004470] Funding Source: Medline	Diabetes UK(Diabetes UK)		Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Swerdlow DI, 2014, LANCET; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	14	19	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					310	312		10.1016/S0140-6736(14)61639-1	http://dx.doi.org/10.1016/S0140-6736(14)61639-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25262342	Green Submitted			2022-12-28	WOS:000348509000006
J	Iliodromiti, S; Mackay, DF; Smith, GCS; Pell, JP; Nelson, SM				Iliodromiti, Stamatina; Mackay, Daniel F.; Smith, Gordon C. S.; Pell, Jill P.; Nelson, Scott M.			Apgar score and the risk of cause-specific infant mortality: a population-based cohort study	LANCET			English	Article							UPDATED SYSTEMATIC ANALYSIS; CEREBRAL-PALSY; DEATH-SYNDROME; CHILD-MORTALITY; TERM; DELIVERY	Background The Apgar score has been used worldwide as an index of early neonatal condition for more than 60 years. With advances in health-care service provision, neonatal resuscitation, and infant care, its present relevance is unclear. The aim of the study was to establish the strength of the relation between Apgar score at 5 min and the risk of neonatal and infant mortality, subdivided by specific causes. Methods We linked routine discharge and mortality data for all births in Scotland, UK between 1992 and 2010. We restricted our analyses to singleton livebirths, in women aged over 10 years, with a gestational age at delivery between 22 and 44 weeks, and excluded deaths due to congenital anomalies or isoimmunisation. We calculated the relative risks (RRs) of neonatal and infant death of neonates with low (0-3) and intermediate (4-6) Apgar scores at 5 min referent to neonates with normal Apgar score (7-10) using binomial log-linear modelling with adjustment for confounders. Analyses were stratified by gestational age at birth because it was a significant effect modifier. Missing covariate data were imputed. Findings Complete data were available for 1 029 207 eligible livebirths. Across all gestational strata, low Apgar score at 5 min was associated with an increased risk of neonatal and infant death. However, the strength of the association (adjusted RR, 95% CI referent to Apgar 7-10) was strongest at term (p<0.0001). A low Apgar (0-3) was associated with an adjusted RR of 359.4 (95% CI 277.3-465.9) for early neonatal death, 30.5 (18.0-51.6) for late neonatal death, and 50.2 (42.8-59.0) for infant death. We noted similar associations of a lower magnitude for intermediate Apgar (4-6). The strongest associations were for deaths attributed to anoxia and low Apgar (0-3) for term infants (RR 961.7, 95% CI 681.3-1357.5) and preterm infants (141.7, 90.1-222.8). No association between Apgar score at 5 min and the risk of sudden infant death syndrome was noted at any gestational age (RR 0.6, 95% CI 0.1-4.6 at term; 1.2, 0.3-4.8 at preterm). Interpretation Low Apgar score at 5 min was strongly associated with the risk of neonatal and infant death. Our findings support its continued usefulness in contemporary practice.	[Iliodromiti, Stamatina; Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow Royal Infirm, Glasgow G31 2ER, Lanark, Scotland; [Mackay, Daniel F.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G31 2ER, Lanark, Scotland; [Smith, Gordon C. S.] Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge, England; [Smith, Gordon C. S.] NIHR Cambridge Biomed Res Ctr, Cambridge, England	University of Glasgow; University of Glasgow; University of Cambridge; University of Cambridge	Nelson, SM (corresponding author), Univ Glasgow, Sch Med, Glasgow Royal Infirm, New Lister Bldg, Glasgow G31 2ER, Lanark, Scotland.	scott.nelson@glasgow.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Nelson, Scott/0000-0002-9099-3047; Pell, Jill/0000-0002-8898-7035; Iliodromiti, Stamatina/0000-0001-6453-6654	Chief Scientist Office [SCPH/11] Funding Source: researchfish	Chief Scientist Office		APGAR V, 1953, Curr Res Anesth Analg, V32, P260; APGAR V, 1962, AM J DIS CHILD, V104, P419, DOI 10.1001/archpedi.1962.02080030421015; Brooke Hazel, 1997, BMJ, V314, P1516; BUCK GM, 1991, AM J EPIDEMIOL, V133, P900, DOI 10.1093/oxfordjournals.aje.a115969; Campbell S., 1993, ULTRASOUND OBSTET GY, P1432; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; CATLIN EA, 1986, J PEDIATR-US, V109, P865, DOI 10.1016/S0022-3476(86)80715-6; Chong DSY, 2004, ACTA PAEDIATR, V93, P471, DOI 10.1080/08035250310023495; DRAGE JS, 1964, OBSTET GYNECOL, V24, P222; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Hegyi T, 1998, PEDIATRICS, V101, P77, DOI 10.1542/peds.101.1.77; Information and Statistics Division NHS Scotland, 2008, SCOTT PER INF MORT M; Information Services Division, 2010, DAT QUAL ASS MAT DAT; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069072; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Malloy Michael H, 2004, J Perinatol, V24, P181, DOI 10.1038/sj.jp.7211051; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; NAEYE RL, 1979, NEW ENGL J MED, V301, P1198, DOI 10.1056/NEJM197911293012202; NELSON KB, 1981, PEDIATRICS, V68, P36; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Stark AR, 2006, PEDIATRICS, V117, P1444, DOI 10.1542/peds.2006-0325; SYKES GS, 1982, LANCET, V1, P494; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; Weinberger B, 2000, ARCH PEDIAT ADOL MED, V154, P294, DOI 10.1001/archpedi.154.3.294; WHO, 2013, COUNTD 2015 MAT NEWB	28	150	158	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1749	1755		10.1016/S0140-6736(14)61135-1	http://dx.doi.org/10.1016/S0140-6736(14)61135-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25236409	Green Accepted			2022-12-28	WOS:000345116400025
J	Rakoff-Nahoum, S; Comstock, LE				Rakoff-Nahoum, Seth; Comstock, Laurie E.			IMMUNOLOGY Starve a fever, feed the microbiota	NATURE			English	Editorial Material							TOLERANCE		[Rakoff-Nahoum, Seth; Comstock, Laurie E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rakoff-Nahoum, Seth; Comstock, Laurie E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rakoff-Nahoum, Seth] Boston Childrens Hosp, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Rakoff-Nahoum, S (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	lcomstock@rics.bwh.harvard.edu						Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; UMESAKI Y, 1981, J BIOCHEM-TOKYO, V90, P559, DOI 10.1093/oxfordjournals.jbchem.a133506	9	2	2	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					576	577		10.1038/nature13756	http://dx.doi.org/10.1038/nature13756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25274298				2022-12-28	WOS:000343801500037
J	Linksvayer, T				Linksvayer, Timothy			EVOLUTIONARY BIOLOGY Survival of the fittest group	NATURE			English	Editorial Material							GROUP SELECTION; KIN SELECTION; COLONIES		Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Linksvayer, T (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	tlinks@sas.upenn.edu		Linksvayer, Timothy/0000-0001-7034-1546				Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; Gordon DM, 2013, NATURE, V498, P91, DOI 10.1038/nature12137; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Holldobler B., 2009, SUPERORGANISM; Lehmann L, 2007, P NATL ACAD SCI USA, V104, P6736, DOI 10.1073/pnas.0700662104; Linksvayer TA, 2009, AM NAT, V173, pE99, DOI 10.1086/596527; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Pruitt JN, 2014, NATURE, V514, P359, DOI 10.1038/nature13811; Seeley TD, 1997, AM NAT, V150, pS22, DOI 10.1086/286048; Wade MJ, 2010, EVOL APPL, V3, P453, DOI 10.1111/j.1752-4571.2010.00147.x; WADE MJ, 1980, SCIENCE, V210, P665, DOI 10.1126/science.210.4470.665	11	1	2	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					308	309		10.1038/nature13755	http://dx.doi.org/10.1038/nature13755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25274299				2022-12-28	WOS:000342988600035
J	Amrein, K; Schnedl, C; Holl, A; Riedl, R; Christopher, KB; Pachler, C; Purkart, TU; Waltensdorfer, A; Munch, A; Warnkross, H; Stojakovic, T; Bisping, E; Toller, W; Smolle, KH; Berghold, A; Pieber, TR; Dobnig, H				Amrein, Karin; Schnedl, Christian; Holl, Alexander; Riedl, Regina; Christopher, Kenneth B.; Pachler, Christoph; Purkart, Tadeja Urbanic; Waltensdorfer, Andreas; Muench, Andreas; Warnkross, Helga; Stojakovic, Tatjana; Bisping, Egbert; Toller, Wolfgang; Smolle, Karl-Heinz; Berghold, Andrea; Pieber, Thomas R.; Dobnig, Harald			Effect of High-Dose Vitamin D-3 on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency The VITdAL-ICU Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; D SUPPLEMENTATION; RISK; METAANALYSIS; ASSOCIATION; OUTCOMES; HEALTH	IMPORTANCE Low vitamin D status is linked to increased mortality and morbidity in patients who are critically ill. It is unknown if this association is causal. OBJECTIVE To investigate whether a vitamin D-3 treatment regimen intended to restore and maintain normal vitamin D status over 6 months is of health benefit for patients in ICUs. DESIGN, SETTING, AND PARTICIPANTS A randomized double-blind, placebo-controlled, single-center trial, conducted from May 2010 through September 2012 at 5 ICUs that included a medical and surgical population of 492 critically ill adult white patients with vitamin D deficiency (<= 20 ng/mL) assigned to receive either vitamin D-3 (n = 249) or a placebo (n = 243). INTERVENTIONS Vitamin D-3 or placebo was given orally or via nasogastric tube once at a dose of 540 000 IU followed by monthly maintenance doses of 90 000 IU for 5 months. MAIN OUTCOMES AND MEASURES The primary outcome was hospital length of stay. Secondary outcomes included, among others, length of ICU stay, the percentage of patients with 25-hydroxyvitamin D levels higher than 30 ng/mL at day 7, hospital mortality, and 6-month mortality. A predefined severe vitamin D deficiency (<= 12 ng/mL) subgroup analysis was specified before data unblinding and analysis. RESULTS A total of 475 patients were included in the final analysis (237 in the vitamin D-3 group and 238 in the placebo group). The median (IQR) length of hospital stay was not significantly different between groups (20.1 days [IQR, 11.1-33.3] for vitamin D-3 vs 19.3 days [IQR, 11.1-34.9] for placebo; P = .98). Hospital mortality and 6-month mortality were also not significantly different (hospital mortality: 28.3%[95% CI, 22.6%-34.5%] for vitamin D-3 vs 35.3%[95% CI, 29.2%-41.7%] for placebo; hazard ratio [HR], 0.81 [95% CI, 0.58-1.11]; P = .18; 6-month mortality: 35.0%[95% CI, 29.0%-41.5%] for vitamin D-3 vs 42.9%[95% CI, 36.5%-49.4%] for placebo; HR, 0.78 [95% CI, 0.58-1.04]; P = .09). For the severe vitamin D deficiency subgroup analysis (n = 200), length of hospital stay was not significantly different between the 2 study groups: 20.1 days (IQR, 12.9-39.1) for vitamin D-3 vs 19.0 days (IQR, 11.6-33.8) for placebo. Hospital mortality was significantly lower with 28 deaths among 98 patients (28.6%[95% CI, 19.9%-38.6%]) for vitamin D-3 compared with 47 deaths among 102 patients (46.1% [95% CI, 36.2%-56.2%]) for placebo (HR, 0.56 [95% CI, 0.35-0.90], P for interaction = .04), but not 6-month mortality (34.7%[95% CI, 25.4%-45.0%] for vitamin D-3 vs 50.0%[95% CI, 39.9%-60.1%] for placebo; HR, 0.60 [95% CI, 0.39-0.93], P for interaction = .12). CONCLUSIONS AND RELEVANCE Among critically ill patients with vitamin D deficiency, administration of high-dose vitamin D-3 compared with placebo did not reduce hospital length of stay, hospital mortality, or 6-month mortality. Lower hospital mortality was observed in the severe vitamin D deficiency subgroup, but this finding should be considered hypothesis generating and requires further study. Copyright 2014 American Medical Association. All rights reserved.	[Amrein, Karin; Schnedl, Christian; Warnkross, Helga; Pieber, Thomas R.; Dobnig, Harald] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, A-8036 Graz, Austria; [Holl, Alexander] Med Univ Graz, Div Neurogeriatr, Dept Neurol, A-8036 Graz, Austria; [Riedl, Regina; Berghold, Andrea] Med Univ Graz, Inst Med Informat Stat & Documentat, A-8036 Graz, Austria; [Christopher, Kenneth B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA; [Pachler, Christoph; Waltensdorfer, Andreas; Muench, Andreas; Toller, Wolfgang] Med Univ Graz, Dept Anesthesiol & Intens Care Med, A-8036 Graz, Austria; [Purkart, Tadeja Urbanic] Med Univ Graz, Div Gen Neurol, Dept Neurol, A-8036 Graz, Austria; [Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Bisping, Egbert] Med Univ Graz, Dept Internal Med, Div Cardiol, A-8036 Graz, Austria; [Smolle, Karl-Heinz] Med Univ Graz, Med Intens Care Unit, Dept Internal Med, A-8036 Graz, Austria; [Dobnig, Harald] Schilddrusen Endokrinol Osteoporose Inst Dobnig, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Amrein, K (corresponding author), Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Auenbruggerpl 15, A-8036 Graz, Austria.	karin.amrein@medunigraz.at	Christopher, Kenneth/AAD-6801-2021; Christopher, Kenneth B./C-5243-2012	Christopher, Kenneth/0000-0001-6067-972X; Christopher, Kenneth B./0000-0001-6067-972X; Amrein, Karin/0000-0003-0915-085X; Pieber, Thomas/0000-0003-3554-0405	European Society for Clinical Nutrition and Metabolism (ESPEN); Fresenius Kabi (Germany); Austrian National Bank (Jubilaumsfonds) [14143]	European Society for Clinical Nutrition and Metabolism (ESPEN); Fresenius Kabi (Germany); Austrian National Bank (Jubilaumsfonds)	The study was supported by the European Society for Clinical Nutrition and Metabolism (ESPEN), a research grant including provision of study medication from Fresenius Kabi (Germany), and the Austrian National Bank (Jubilaumsfonds, Project Nr. 14143).	Amrein K, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-27; Amrein K, 2011, CRIT CARE, V15, DOI 10.1186/cc10120; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bacon CJ, 2009, OSTEOPOROSIS INT, V20, P1407, DOI 10.1007/s00198-008-0814-9; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Braun AB, 2012, CRIT CARE MED, V40, P3170, DOI 10.1097/CCM.0b013e318260c928; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Cluse ZN, 2012, ANN CLIN BIOCHEM, V49, P159, DOI 10.1258/acb.2011.011018; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Institute of Medicine, 2011, DIETARY REFERENCE IN; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Knox S, 2009, ANN CLIN BIOCHEM, V46, P226, DOI 10.1258/acb.2009.008206; Lee P, 2009, NEW ENGL J MED, V360, P1912, DOI 10.1056/NEJMc0809996; McNally JD, 2014, J PEDIAT-BRAZIL, V90, P99, DOI 10.1016/j.jped.2013.12.002; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; Michaud J, 2010, J AM SOC NEPHROL, V21, P1488, DOI 10.1681/ASN.2009080815; Moromizato T, 2014, CRIT CARE MED, V42, P97, DOI 10.1097/CCM.0b013e31829eb7af; Perron Rachel M., 2013, Inflammation & Allergy Drug Targets, V12, P273; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Spriet I, 2009, INTENS CARE MED, V35, P603, DOI 10.1007/s00134-008-1383-2; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Vieth R, 2006, J NUTR, V136, P1117, DOI 10.1093/jn/136.4.1117; von Restorff C, 2009, BONE, V45, P747, DOI 10.1016/j.bone.2009.06.012; World Medical Association, DECL HELS ETH PRINC; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779	29	291	302	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1520	1530		10.1001/jama.2014.13204	http://dx.doi.org/10.1001/jama.2014.13204			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25268295	Bronze			2022-12-28	WOS:000342983200016
J	Moskvitch, K				Moskvitch, Katia			TO CATCH A COSMIC RAY	NATURE			English	News Item														Waldrop, M Mitchell/0000-0002-8063-1472				Abraham J, 2007, SCIENCE, V318, P938, DOI 10.1126/science.1151124; Abreu P, 2010, ASTROPART PHYS, V34, P314, DOI 10.1016/j.astropartphys.2010.08.010; BIRD DJ, 1994, ASTROPHYS J, V424, P491, DOI 10.1086/173906; The Pierre Auger Collaboration, 2010, PHYS REV LETT, V104; 2007, NATURE, V448, P8	5	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					20	22		10.1038/514020a	http://dx.doi.org/10.1038/514020a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279900	hybrid			2022-12-28	WOS:000342420800015
J	Oh, J; Byrd, AL; Deming, C; Conlan, S; Kong, HH; Segre, JA				Oh, Julia; Byrd, Allyson L.; Deming, Clay; Conlan, Sean; Kong, Heidi H.; Segre, Julia A.		NISC Comparative Sequencing Progra	Biogeography and individuality shape function in the human skin metagenome	NATURE			English	Article							MAXIMUM-LIKELIHOOD; DIVERSITY; IDENTIFICATION; ALGORITHMS; ALIGNMENT; GENES	The varied topography of human skin offers a unique opportunity to study how the body's microenvironments influence the functional and taxonomic composition of microbial communities. Phylogenetic marker gene-based studies have identified many bacteria and fungi that colonize distinct skin niches. Here metagenomic analyses of diverse body sites in healthy humans demonstrate that local biogeography and strong individuality define the skin microbiome. We developed a relational analysis of bacterial, fungal and viral communities, which showed not only site specificity but also individual signatures. We further identified strain-level variation of dominant species as heterogeneous and multiphyletic. Reference-free analyses captured the uncharacterized metagenome through the development of a multi-kingdom gene catalogue, which was used to uncover genetic signatures of species lacking reference genomes. This work is foundational for human disease studies investigating inter-kingdom interactions, metabolic changes and strain tracking, and defines the dual influence of biogeography and individuality on microbial composition and function.	[Oh, Julia; Byrd, Allyson L.; Deming, Clay; Conlan, Sean; Segre, Julia A.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Kong, Heidi H.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kong, HH (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	konghe@mail.nih.gov; jsegre@mail.nih.gov	Kong, Heidi H/L-4856-2018; Conlan, Sean/B-4401-2008	Kong, Heidi H/0000-0003-4424-064X; Conlan, Sean/0000-0001-6848-3465	National Institutes of Health (NIH) NHGRI; National Institutes of Health (NIH) NCI; National Institutes of Health [1UH2AR057504-01, 4UH3AR057504-02];  [1K99AR059222]; NATIONAL CANCER INSTITUTE [ZIABC010938] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180, ZIBHG000196] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH) NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Schoenfeld, A. Pradhan, M. Park and G. Bouffard for their efforts. We also thank members of the Segre laboratory and M. C. Udey for their discussions. This work was supported by National Institutes of Health (NIH) NHGRI and NCI Intramural Research Programs and in part by 1K99AR059222 (H. H. K.). This study used the high-performance computational capabilities of the NIH Biowulf Linux cluster. Sequencing was funded by grants from the National Institutes of Health (1UH2AR057504-01 and 4UH3AR057504-02).	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Francis OE, 2013, GENOME RES, V23, P1721, DOI 10.1101/gr.150151.112; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Peters BM, 2013, INFECT IMMUN, V81, P2178, DOI 10.1128/IAI.00265-13; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	40	571	601	15	261	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					59	+		10.1038/nature13786	http://dx.doi.org/10.1038/nature13786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279917	Green Accepted			2022-12-28	WOS:000342420800034
J	Gopal, S; Fedoriw, Y; Montgomery, ND; Kampani, C; Krysiak, R; Sanders, MK; Dittmer, DP; Liomba, NG				Gopal, Satish; Fedoriw, Yuri; Montgomery, Nathan D.; Kampani, Coxcilly; Krysiak, Robert; Sanders, Marcia K.; Dittmer, Dirk P.; Liomba, N. George			Multicentric Castleman's disease in Malawi	LANCET			English	Editorial Material							HERPESVIRUS		[Gopal, Satish; Kampani, Coxcilly; Krysiak, Robert; Liomba, N. George] UNC Project Malawi, Lilongwe, Malawi; [Gopal, Satish; Sanders, Marcia K.; Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Program Global Oncol, Chapel Hill, NC 27599 USA; [Fedoriw, Yuri; Montgomery, Nathan D.] Univ N Carolina, Div Hematopathol, Chapel Hill, NC USA; [Dittmer, Dirk P.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gopal, S (corresponding author), UNC Project Malawi, Private Bag A 104, Lilongwe, Malawi.	gopal@med.unc.edu	Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022	Dittmer, Dirk/0000-0003-4968-5656; Montgomery, Nathan/0000-0003-1765-6623	FOGARTY INTERNATIONAL CENTER [K01TW009488] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA190152, R21CA180815, R21CA177315, P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW009488] Funding Source: Medline; NCI NIH HHS [U54 CA190152, R21 CA180815, P01 CA019014] Funding Source: Medline; NIAID NIH HHS [P30 AI050410] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adesina A, 2013, LANCET ONCOL, V14, pE152, DOI 10.1016/S1470-2045(12)70598-3; Engels EA, 2007, HUM PATHOL, V38, P308, DOI 10.1016/j.humpath.2006.08.009; Naresh KN, 2011, BRIT J HAEMATOL, V154, P696, DOI 10.1111/j.1365-2141.2011.08772.x; Uldrick TS, 2012, CURR OPIN ONCOL, V24, P495, DOI 10.1097/CCO.0b013e328355e0f3; Wiggill TM, 2011, JAIDS-J ACQ IMM DEF, V56, P460, DOI 10.1097/QAI.0b013e31820bb06a	5	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1158	1158		10.1016/S0140-6736(14)61366-0	http://dx.doi.org/10.1016/S0140-6736(14)61366-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PU	25241721	Green Accepted			2022-12-28	WOS:000342630600036
J	Seth, AC; van den Bosch, R; Mieske, S; Baumgardt, H; den Brok, M; Strader, J; Neumayer, N; Chilingarian, I; Hilker, M; McDermid, R; Spitler, L; Brodie, J; Frank, MJ; Walsh, JL				Seth, Anil C.; van den Bosch, Remco; Mieske, Steffen; Baumgardt, Holger; den Brok, Mark; Strader, Jay; Neumayer, Nadine; Chilingarian, Igor; Hilker, Michael; McDermid, Richard; Spitler, Lee; Brodie, Jean; Frank, Matthias J.; Walsh, Jonelle L.			A supermassive black hole in an ultra-compact dwarf galaxy	NATURE			English	Article							INITIAL MASS FUNCTION; MULTI-GAUSSIAN EXPANSION; GLOBULAR-CLUSTER G1; ACS FORNAX CLUSTER; STAR-CLUSTERS; STELLAR-SYSTEMS; HOST GALAXIES; ACCRETION; SPECTRA; MODELS	Ultra-compact dwarf galaxies are among the densest stellar systems in the Universe. These systems have masses of up to 2 x 10(8) solar masses, but half-light radii of just 3-50 parsecs(1). Dynamicalmass estimates show that many such dwarfs are more massive than expected from their luminosity(2). It remains unclear whether these high dynamical mass estimates arise because of the presence of supermassive black holes or result from a non-standard stellar initial mass function that causes the average stellar mass to be higher than expected(3,4). Here we report adaptive optics kinematic data of the ultra-compact dwarf galaxy M60-UCD1 that show a central velocity dispersion peak exceeding 100 kilometres per second and modest rotation. Dynamical modelling of these data reveals the presence of a supermassive black hole with amass of 2.1 x 10(7) solarmasses. This is 15 per cent of the object's total mass. The high black hole mass and mass fraction suggest that M60-UCD1 is the stripped nucleus of a galaxy. Our analysis also shows that M60-UCD1's stellar mass is consistent with its luminosity, implying a large population of previously unrecognized supermassive black holes in other ultra-compact dwarf galaxies(2).	[Seth, Anil C.; den Brok, Mark] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [van den Bosch, Remco; Neumayer, Nadine] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Mieske, Steffen] European So Observ, Santiago 7630355, Chile; [Baumgardt, Holger] Univ Queensland, Sch Math & Phys, St Lucia, Qld 4072, Australia; [Strader, Jay] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Neumayer, Nadine; Hilker, Michael] European So Observ, D-85748 Garching, Germany; [Chilingarian, Igor] Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; [Chilingarian, Igor] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow 119992, Russia; [McDermid, Richard; Spitler, Lee] Australian Astron Observ, Sydney, NSW 2113, Australia; [McDermid, Richard; Spitler, Lee] Macquarie Univ, Dept Phys & Astron, Sydney, NSW 2109, Australia; [Brodie, Jean] Univ Calif Observ, Santa Cruz, CA 95064 USA; [Brodie, Jean] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Frank, Matthias J.] Heidelberg Univ, Zentrum Astron, Landessternwarte, D-69117 Heidelberg, Germany; [Walsh, Jonelle L.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA	Utah System of Higher Education; University of Utah; Max Planck Society; European Southern Observatory; University of Queensland; Michigan State University; European Southern Observatory; Harvard University; Smithsonian Institution; Lomonosov Moscow State University; Macquarie University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Ruprecht Karls University Heidelberg; University of Texas System; University of Texas Austin	Seth, AC (corresponding author), Univ Utah, Dept Phys & Astron, 115 South 1400 East, Salt Lake City, UT 84112 USA.	aseth@astro.utah.edu	McDermid, Richard/AAY-1946-2021; Baumgardt, Holger/A-5444-2012; Neumayer, Nadine/AAY-6290-2021; Chilingarian, Igor/N-5117-2016	McDermid, Richard/0000-0002-8175-7229; Neumayer, Nadine/0000-0002-6922-2598; van den Bosch, Remco/0000-0002-0420-6159; Hilker, Michael/0000-0002-2363-5522; Spitler, Lee/0000-0001-5185-9876; Chilingarian, Igor/0000-0002-7924-3253; Seth, Anil/0000-0003-0248-5470	NSF [AST-1350389, 1102845, AST-1109878]; German Research Foundation [Ko4161/1]; Russian Science Foundation [14-22-00041]; Division Of Astronomical Sciences [1350389, 1109878] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Russian Science Foundation(Russian Science Foundation (RSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was based on observations obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy under a cooperative agreement with the NSF on behalf of the Gemini partnership: the National Science Foundation (United States), the National Research Council (Canada), CONICYT (Chile), the Australian Research Council (Australia), Ministerio da Ciencia, Tecnologia e Inovacao (Brazil) and Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina). Work on this paper by A.C.S. was supported by NSF CAREER grant AST-1350389. J.L.W. is supported by an NSF Astronomy and Astrophysics Postdoctoral Fellowship under award number 1102845. J.B. is supported by NSF grant AST-1109878. M.J.F. is supported by German Research Foundation grant Ko4161/1. I.C. acknowledges support from the Russian Science Foundation grant 14-22-00041.	Bastian N, 2010, ANNU REV ASTRON ASTR, V48, P339, DOI 10.1146/annurev-astro-082708-101642; Binney J., 2008, GALACTIC DYNAMICS; Blakeslee JP, 2009, ASTROPHYS J, V694, P556, DOI 10.1088/0004-637X/694/1/556; Brodie JP, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/6/199; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Cappellari M, 2003, MON NOT R ASTRON SOC, V342, P345, DOI 10.1046/j.1365-8711.2003.06541.x; Cappellari M, 2002, MON NOT R ASTRON SOC, V333, P400, DOI 10.1046/j.1365-8711.2002.05412.x; Cappellari M., 2010, PREPRINT; Cappellari M, 2008, MON NOT R ASTRON SOC, V390, P71, DOI 10.1111/j.1365-2966.2008.13754.x; Cappellari M, 2012, NATURE, V484, P485, DOI 10.1038/nature10972; Cote P, 2006, ASTROPHYS J SUPPL S, V165, P57, DOI 10.1086/504042; Dabringhausen J, 2009, MON NOT R ASTRON SOC, V394, P1529, DOI 10.1111/j.1365-2966.2009.14425.x; Dabringhausen J, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/72; Drinkwater MJ, 2003, NATURE, V423, P519, DOI 10.1038/nature01666; EMSELLEM E, 1994, ASTRON ASTROPHYS, V285, P723; Ferrarese L., 2006, Astrophysical Journal, Letters, V644, pL21, DOI 10.1086/505388; Frank MJ, 2011, MON NOT R ASTRON SOC, V414, pL70, DOI 10.1111/j.1745-3933.2011.01058.x; Gallo E, 2010, ASTROPHYS J, V714, P25, DOI 10.1088/0004-637X/714/1/25; Gebhardt K, 2005, ASTROPHYS J, V634, P1093, DOI 10.1086/497023; Graham AW, 2009, MON NOT R ASTRON SOC, V397, P2148, DOI 10.1111/j.1365-2966.2009.15118.x; Gultekin K, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L22; Ho LC, 2008, ANNU REV ASTRON ASTR, V46, P475, DOI 10.1146/annurev.astro.45.051806.110546; Husser TO, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201219058; Jalali B, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201116923; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; McGregor P, 2003, P SOC PHOTO-OPT INS, V4841, P1581, DOI 10.1117/12.459448; Merritt D., 2013, DYNAMICS EVOLUTION G; Mieske S, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322167; Mieske S, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117634; Miller MC, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/116; Miller-Jones JCA, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/1/L1; Pfeffer J, 2013, MON NOT R ASTRON SOC, V433, P1997, DOI 10.1093/mnras/stt867; Reines AE, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/116; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Schodel R, 2009, ASTRON ASTROPHYS, V502, P91, DOI 10.1051/0004-6361/200810922; SCHWARZSCHILD M, 1979, ASTROPHYS J, V232, P236, DOI 10.1086/157282; Seth AC, 2010, ASTROPHYS J, V725, P670, DOI 10.1088/0004-637X/725/1/670; Seth AC, 2010, ASTROPHYS J, V714, P713, DOI 10.1088/0004-637X/714/1/713; Strader J, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L6; Strader J, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/8; Tollerud EJ, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/108; Turner ML, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/5; van de Ven G, 2008, MON NOT R ASTRON SOC, V385, P614, DOI 10.1111/j.1365-2966.2008.12873.x; van den Bosch RCE, 2008, MON NOT R ASTRON SOC, V385, P647, DOI 10.1111/j.1365-2966.2008.12874.x; van den Bosch RCE, 2012, NATURE, V491, P729, DOI 10.1038/nature11592; van den Bosch RCE, 2010, MON NOT R ASTRON SOC, V401, P1770, DOI 10.1111/j.1365-2966.2009.15832.x; van den Bosch RCE, 2009, MON NOT R ASTRON SOC, V398, P1117, DOI 10.1111/j.1365-2966.2009.15177.x; van der Marel RP, 2010, ASTROPHYS J, V710, P1063, DOI 10.1088/0004-637X/710/2/1063; Wallace L, 1996, ASTROPHYS J SUPPL S, V107, P312, DOI 10.1086/192367; Zwart SFP, 2004, NATURE, V428, P724, DOI 10.1038/nature02448	50	179	179	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					398	+		10.1038/nature13762	http://dx.doi.org/10.1038/nature13762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230660	Green Submitted			2022-12-28	WOS:000341814900055
J	Qaseem, A; Dallas, P; Forciea, MA; Starkey, M; Denberg, TD; Shekelle, P				Qaseem, Amir; Dallas, Paul; Forciea, Mary Ann; Starkey, Melissa; Denberg, Thomas D.; Shekelle, Paul		Amer Coll Phys	Nonsurgical Management of Urinary Incontinence in Women: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; EXTENDED-RELEASE TOLTERODINE; OVERACTIVE BLADDER SYMPTOMS; PELVIC FLOOR EXERCISES; SELECTIVE RECEPTOR ANTAGONIST; QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; PHASE-III TRIAL; ANTIMUSCARINIC AGENT SOLIFENACIN	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the nonsurgical management of urinary incontinence (UI) in women. Methods: This guideline is based on published English-language literature on nonsurgical management of UI in women from 1990 through December 2013 that was identified using MEDLINE, the Cochrane Library, Scirus, and Google Scholar. The outcomes evaluated for this guideline include continence, improvement in UI, quality of life, adverse effects, and discontinuation due to adverse effects. It grades the evidence and recommendations by using ACP's guideline grading system. The target audience is all clinicians, and the target patient population is all women with UI. Recommendation 1: ACP recommends first-line treatment with pelvic floor muscle training in women with stress UI. (Grade: strong recommendation, high-quality evidence) Recommendation 2: ACP recommends bladder training in women with urgency UI. (Grade: weak recommendation, low-quality evidence) Recommendation 3: ACP recommends pelvic floor muscle training with bladder training in women with mixed UI. (Grade: strong recommendation, high-quality evidence) Recommendation 4: ACP recommends against treatment with systemic pharmacologic therapy for stress UI. (Grade: strong recommendation, low-quality evidence) Recommendation 5: ACP recommends pharmacologic treatment in women with urgency UI if bladder training was unsuccessful. Clinicians should base the choice of pharmacologic agents on tolerability, adverse effect profile, ease of use, and cost of medication. (Grade: strong recommendation, high-quality evidence) Recommendation 6: ACP recommends weight loss and exercise for obese women with UI. (Grade: strong recommendation, moderate-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn Hlth Syst, Philadelphia, PA 19104 USA; Virginia Tech, Caril Sch Med, Roanoke, VA 24014 USA; Caril Clin, Roanoke, VA 24036 USA; West Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; University of Pennsylvania; Virginia Polytechnic Institute & State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265; Chou, Roger/0000-0001-9889-8610	ACP; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [RC1EB010649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK080227] Funding Source: NIH RePORTER	ACP; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Abrams P, 1998, BRIT J UROL, V81, P801; Agency for Healthcare Research and Quality, 2007, METH GUID COMP EFF R; Aksac B, 2003, GYNECOL OBSTET INVES, V56, P23, DOI 10.1159/000072327; [Anonymous], 2005, P 20 C EUR ASS UR IS; [Anonymous], FES FLEX DOS STUD; Appell RA, 2001, MAYO CLIN PROC, V76, P358; Armstrong RB, 2007, INT UROL NEPHROL, V39, P1069, DOI 10.1007/s11255-006-9157-7; Armstrong Robert B., 2005, International Urology and Nephrology, V37, P247, DOI 10.1007/s11255-004-4703-7; Berghmans LCM, 1996, NEUROUROL URODYNAM, V15, P37, DOI 10.1002/(SICI)1520-6777(1996)15:1<37::AID-NAU4>3.0.CO;2-G; Bo K, 1999, BMJ-BRIT MED J, V318, P487, DOI 10.1136/bmj.318.7182.487; Bo K, 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P36; Burgio KL, 2002, JAMA-J AM MED ASSOC, V288, P2293, DOI 10.1001/jama.288.18.2293; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; BURNS PA, 1993, J GERONTOL, V48, pM167; BURNS PA, 1990, J AM GERIATR SOC, V38, P341, DOI 10.1111/j.1532-5415.1990.tb03517.x; Camargo FD, 2009, INT UROGYNECOL J, V20, P1455, DOI 10.1007/s00192-009-0971-1; Capobianco G, 2012, ARCH GYNECOL OBSTET, V285, P397, DOI 10.1007/s00404-011-1955-1; Cardozo L, 2004, OBSTET GYNECOL, V104, P511, DOI 10.1097/01.AOG.0000134525.86480.0f; Cardozo L, 2008, BJU INT, V102, P1120, DOI 10.1111/j.1464-410X.2008.07939.x; Cardozo L, 2006, INT UROGYNECOL J, V17, P512, DOI 10.1007/s00192-005-0058-6; Cardozo L, 2013, BJU INT, V111, P804, DOI 10.1111/j.1464-410X.2012.11654.x; Cardozo L, 2010, BJU INT, V106, P816, DOI 10.1111/j.1464-410X.2010.09202.x; Cardozo L, 2010, CURR MED RES OPIN, V26, P253, DOI 10.1185/03007990903438295; Carls Carrie, 2007, Urol Nurs, V27, P21; Castro RA, 2008, CLINICS, V63, P465, DOI 10.1590/S1807-59322008000400009; Castro-Diaz D, 2007, INT UROGYNECOL J, V18, P919, DOI 10.1007/s00192-006-0256-x; Chancellor MB, 2010, NEUROUROL URODYNAM, V29, P551, DOI 10.1002/nau.20787; Chapple C, 2007, CURR MED RES OPIN, V23, P2347, DOI 10.1185/03007X226294; Chapple C, 2004, 2004 C INT CONT SOC; Chapple C, 2007, EUR UROL, V52, P1204, DOI 10.1016/j.eururo.2007.07.009; Chapple CR, 2007, EUR UROL, V52, P1195, DOI 10.1016/j.eururo.2007.05.027; Chapple CR, 2013, NEUROUROL URODYNAM, V32, P1116, DOI 10.1002/nau.22373; Chapple CR, 2004, EXPERT OPIN INV DRUG, V13, P1493, DOI 10.1517/13543784.13.11.1493; Chapple CR, 2004, BJU INT, V93, P303, DOI 10.1111/j.1464-410X.2004.04606.x; Chapple CR, 2004, BJU INT, V93, P71, DOI 10.1111/j.1464-410X.2004.04561.x; Choo MS, 2008, INT J CLIN PRACT, V62, P1675, DOI 10.1111/j.1742-1241.2008.01898.x; Chu F, 2009, CURR THER RES CLIN E, V70, P405, DOI 10.1016/j.curtheres.2009.11.001; Dede H, 2013, ARCH GYNECOL OBSTET, V287, P511, DOI 10.1007/s00404-012-2596-8; Dessole S, 2004, MENOPAUSE, V11, P49, DOI 10.1097/01.GME.0000077620.13164.62; Zanetti MRD, 2007, SAO PAULO MED J, V125, P265, DOI 10.1590/S1516-31802007000500003; Diokno AC, 2004, J UROLOGY, V171, P1165, DOI 10.1097/01.ju.0000111503.73803.c2; Diokno AC, 2003, MAYO CLIN PROC, V78, P687, DOI 10.4065/78.6.687; Dmochowski RR, 2008, UROLOGY, V71, P449, DOI 10.1016/j.urology.2007.11.008; Dmochowski RR, 2010, UROLOGY, V75, P62, DOI 10.1016/j.urology.2009.09.018; Dmochowski RR, 2003, UROLOGY, V62, P237, DOI 10.1016/S0090-4295(03)00356-X; Dmochowski RR, 2003, J UROLOGY, V170, P1259, DOI 10.1097/01.ju.0000080708.87092.cc; Dorschner W, 2000, EUR UROL, V37, P702, DOI 10.1159/000020221; Drutz H P, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P283, DOI 10.1007/s001929970003; DuBeau CE, 2005, NEUROUROL URODYNAM, V24, P13, DOI 10.1002/nau.20083; Duckett JRA, 2007, BJOG-INT J OBSTET GY, V114, P543, DOI 10.1111/j.1471-0528.2007.01288.x; Elser DM, 1999, NEUROUROL URODYNAM, V18, P427, DOI 10.1002/(SICI)1520-6777(1999)18:5<427::AID-NAU3>3.0.CO;2-0; FANTL JA, 1991, JAMA-J AM MED ASSOC, V265, P609, DOI 10.1001/jama.265.5.609; Felicissimo MF, 2010, INT UROGYNECOL J, V21, P835, DOI 10.1007/s00192-010-1125-1; Freeman R, 2003, OBSTET GYNECOL, V102, P605, DOI 10.1016/S0029-7844(03)00623-9; Gameiro MO, 2010, INT UROGYNECOL J, V21, P395, DOI 10.1007/s00192-009-1059-7; Ginsberg D, 2013, BJU INT, V112, P373, DOI 10.1111/bju.12174; Glavind K, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P339, DOI 10.1007/BF01901111; Goode PS, 2004, UROLOGY, V63, P58, DOI 10.1016/j.urology.2003.10.032; Goode PS, 2003, JAMA-J AM MED ASSOC, V290, P345, DOI 10.1001/jama.290.3.345; Goode PS, 2002, J AM GERIATR SOC, V50, P808, DOI 10.1046/j.1532-5415.2002.50204.x; Griffiths A N, 2006, J Obstet Gynaecol, V26, P442, DOI 10.1080/01443610600747272; Halaska M, 2002, WORLD J UROL, V20, P392, DOI 10.1007/s00345-003-0321-8; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Herschorn Sender, 2006, Can J Urol, V13 Suppl 1, P5; Herschorn S, 2010, BJU INT, V105, P58, DOI 10.1111/j.1464-410X.2009.09086.x; Herschorn S, 2008, CURR MED RES OPIN, V24, P3513, DOI 10.1185/03007990802537122 ; Hill S, 2006, INT UROGYNECOL J, V17, P239, DOI 10.1007/s00192-005-1340-3; Holtedahl K, 1998, ACTA OBSTET GYN SCAN, V77, P671, DOI 10.1034/j.1600-0412.1998.770616.x; Homma Y, 2004, WORLD J UROL, V22, P251, DOI 10.1007/s00345-004-0455-3; Homma Y, 2003, BJU INT, V92, P741, DOI 10.1046/j.1464-410X.2003.04468.x; Huang AJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.03.002; Hung HC, 2010, MANUAL THER, V15, P273, DOI 10.1016/j.math.2010.01.008; Jacquetin B, 2001, EUR J OBSTET GYN R B, V98, P97, DOI 10.1016/S0301-2115(00)00561-3; Johnson TM, 2005, J AM GERIATR SOC, V53, P846, DOI 10.1111/j.1532-5415.2005.53260.x; Jonas U, 1997, WORLD J UROL, V15, P144, DOI 10.1007/BF02201987; Junemann KP, 2006, UROL INT, V77, P334, DOI 10.1159/000096338; Kafri R, 2013, INT UROGYNECOL J, V24, P1181, DOI 10.1007/s00192-012-1992-8; Kaplan SA, 2010, JOINT M INT CONT SOC; Karram MM, 2009, UROLOGY, V73, P14, DOI 10.1016/j.urology.2008.08.485; Kelleher CJ, 2002, AM J MANAG CARE, V8, pS608; Khullar V, 2004, UROLOGY, V64, P269, DOI 10.1016/j.urology.2004.02.029; Kim H, 2009, 39 ANN M INT CONT SO; Kim H, 2007, J AM GERIATR SOC, V55, P1932, DOI 10.1111/j.1532-5415.2007.01447.x; Kim JI, 2001, PUBLIC HEALTH NURS, V18, P64, DOI 10.1046/j.1525-1446.2001.00064.x; Kinchen KS, 2007, J WOMENS HEALTH, V16, P415, DOI 10.1089/jwh.2006.0122; Konstantinidou E, 2007, NEUROUROL URODYNAM, V26, P486, DOI 10.1002/nau.20380; Kumari S, 2008, INT J GYNECOL OBSTET, V103, P125, DOI 10.1016/j.ijgo.2008.06.019; LAGROJANSSEN ALM, 1992, FAM PRACT, V9, P284, DOI 10.1093/fampra/9.3.284; LAGROJANSSEN TLM, 1991, BRIT J GEN PRACT, V41, P445; Layton D, 2001, DRUG SAFETY, V24, P703, DOI 10.2165/00002018-200124090-00005; Lee JG, 2002, INT J UROL, V9, P247, DOI 10.1046/j.1442-2042.2002.00460.x; Lee KS, 2010, BJU INT, V105, P1565, DOI 10.1111/j.1464-410X.2009.09050.x; Lehtoranta K, 2002, SCAND J UROL NEPHROL, V36, P18, DOI 10.1080/003655902317259319; Lin Alex Tong-Long, 2008, BMC Urol, V8, P2, DOI 10.1186/1471-2490-8-2; Madersbacher H, 1999, BJU INT, V84, P646; Malone-Lee J, 2003, BJU INT, V92, P415, DOI 10.1046/j.1464-410X.2003.04351.x; Malone-Lee JG, 2009, BJU INT, V103, P931, DOI 10.1111/j.1464-410X.2009.08361.x; Malone-Lee JG, 2001, J AM GERIATR SOC, V49, P700, DOI 10.1046/j.1532-5415.2001.49144.x; MC2 Therapeutics, 2017, DIFF 85 COMP MC2 01; McFall SL, 2000, J AGING HEALTH, V12, P250, DOI 10.1177/089826430001200206; Millard RJ, 2004, BJU INT, V93, P311, DOI 10.1111/j.1464-410X.2004.04607.x; MOORE KH, 1990, BRIT J UROL, V66, P479, DOI 10.1111/j.1464-410X.1990.tb14992.x; Moore KH, 2003, BJOG-INT J OBSTET GY, V110, P649, DOI 10.1046/j.1471-0528.2003.02264.x; Morkved S, 2002, OBSTET GYNECOL, V100, P730, DOI 10.1016/S0029-7844(02)02160-9; Morrison A, 2006, VALUE HEALTH, V9, P272, DOI 10.1111/j.1524-4733.2006.00109.x; Ng SC, 2008, INT UROGYNECOL J, V19, P637, DOI 10.1007/s00192-007-0492-8; Nitti VW, 2013, INT J CLIN PRACT, V67, P619, DOI 10.1111/ijcp.12194; Nitti VW, 2007, J UROLOGY, V178, P2488, DOI 10.1016/j.juro.2007.08.033; Norton PA, 2002, AM J OBSTET GYNECOL, V187, P40, DOI 10.1067/mob.2002.124840; O'Brien J, 1996, Nurs Stand, V10, P40; OBRIEN J, 1991, BRIT MED J, V303, P1308, DOI 10.1136/bmj.303.6813.1308; Ohlstein EH, 2012, EUR UROL, V62, P834, DOI 10.1016/j.eururo.2012.05.053; Qaseem A, 2014, ANN INTERN MED, V161, P429, DOI 10.7326/M13-2410; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Rentzhog L, 1998, BRIT J UROL, V81, P42; Rogers R, 2008, INT UROGYNECOL J, V19, P1551, DOI 10.1007/s00192-008-0688-6; Rogers RG, 2009, CURR MED RES OPIN, V25, P2159, DOI 10.1185/03007990903103279; Rudy D, 2006, UROLOGY, V67, P275, DOI 10.1016/j.urology.2005.08.017; Rufford J, 2003, INT UROGYNECOL J, V14, P78, DOI 10.1007/s00192-003-1054-3; Sampselle CM, 2002, OBSTET GYNECOL, V100, P1230, DOI 10.1016/S0029-7844(02)02241-X; Sand PK, 2011, DRUG AGING, V28, P151, DOI 10.2165/11586740-000000000-00000; Sand PK, 2009, INT UROGYNECOL J, V20, P1431, DOI 10.1007/s00192-009-0969-8; Sand PK, 2009, INT UROGYNECOL J, V20, P827, DOI 10.1007/s00192-009-0857-2; Sand PK, 2004, INT UROGYNECOL J, V15, P243, DOI 10.1007/s00192-004-1161-9; Scheepe J, 2000, NEUROUROL URODYNAM, V19, P714; Seo JT, 2004, YONSEI MED J, V45, P879; Shamliyan T, 2012, AHRQ PUBLICATION; Shamliyan T, 2012, ANN INTERN MED, V156, P861, DOI 10.7326/0003-4819-156-12-201206190-00436; Shamliyan Tatyana, 2007, Evid Rep Technol Assess (Full Rep), P1; Staskin D, 2007, J UROLOGY, V178, P978, DOI 10.1016/j.juro.2007.05.058; Staskin DR, 2006, BJU INT, V97, P1256, DOI 10.1111/j.1464-410X.2006.06150.x; Staskin David R, 2004, Curr Urol Rep, V5, P423, DOI 10.1007/s11934-004-0064-0; Staskin DR, 2009, J UROLOGY, V181, P1764, DOI 10.1016/j.juro.2008.11.125; Steers W, 2005, BJU INT, V95, P580, DOI 10.1111/j.1464-410X.2005.05343.x; Steers WD, 2007, BJU INT, V100, P337, DOI 10.1111/j.1464-410X.2007.06980.x; Subak LL, 2009, NEW ENGL J MED, V360, P481, DOI 10.1056/NEJMoa0806375; Subak LL, 2005, J UROLOGY, V174, P190, DOI 10.1097/01.ju.0000162056.30326.83; Subak LL, 2002, OBSTET GYNECOL, V100, P72, DOI 10.1016/S0029-7844(02)01993-2; SZONYI G, 1995, AGE AGEING, V24, P287, DOI 10.1093/ageing/24.4.287; THUROFF JW, 1991, J UROLOGY, V145, P813, DOI 10.1016/S0022-5347(17)38459-8; Toglia MR, 2009, POSTGRAD MED, V121, P151, DOI 10.3810/pgm.2009.09.2062; Tsai YC, 2009, INT J NURS STUD, V46, P1181, DOI 10.1016/j.ijnurstu.2009.03.003; U.S. Department of Health and Human Services; U.S. Food and Drug Administration; Center for Devices and Radiological Health, 2008, GUID IND FD IN PRESS; U.S. Food and Drug Administration, 2004, DRUG APPR PACK EN DA; U.S. Food and Drug Administration, 2007, DRUG APPR SANCT XR T; van Kerrebroeck P, 2004, BJOG-INT J OBSTET GY, V111, P249, DOI 10.1111/j.1471-0528.2004.00067.x; van Leeuwen JHS, 2008, MATURITAS, V60, P138, DOI 10.1016/j.maturitas.2008.04.012; Vardy MD, 2009, INT J CLIN PRACT, V63, P1702, DOI 10.1111/j.1742-1241.2009.02209.x; Waetjen LE, 2005, OBSTET GYNECOL, V106, P946, DOI 10.1097/01.AOG.0000182576.48290.6d; Wang AC, 2004, UROLOGY, V63, P61, DOI 10.1016/j.urology.2003.08.047; Wang AC, 2006, UROLOGY, V68, P999, DOI 10.1016/j.urology.2006.05.038; Wein AJ, 2007, BJU INT, V99, P360, DOI 10.1111/j.1464-410X.2006.06621.x; Wenger NS, 2009, J AM GERIATR SOC, V57, P547, DOI 10.1111/j.1532-5415.2008.02128.x; Williams KS, 2006, BJU INT, V98, P1043, DOI 10.1111/j.1464-410X.2006.06484.x; Williams KS, 2005, BRIT J GEN PRACT, V55, P696; Wyman JF, 1998, AM J OBSTET GYNECOL, V179, P999, DOI 10.1016/S0002-9378(98)70206-6; Yalcin I, 2006, UROLOGY, V67, P1304, DOI 10.1016/j.urology.2005.12.006; Yalcin I, 2010, NEUROUROL URODYNAM, V29, P344, DOI 10.1002/nau.20744; Yamaguchi O, 2007, BJU INT, V100, P579, DOI 10.1111/j.1464-410X.2007.07031.x; Zellner M, 2009, CLIN THER, V31, P2519, DOI 10.1016/j.clinthera.2009.11.005; Zinner N, 2006, INT J CLIN PRACT, V60, P119, DOI 10.1111/j.1368-5031.2005.00770.x; Zinner N, 2004, J UROLOGY, V171, P2311, DOI 10.1097/01.ju.0000127742.73136.0c; Zinner N, 2005, WORLD J UROL, V23, P248, DOI 10.1007/s00345-005-0507-3; [No title captured], DOI DOI 10.1111/J.1471-0528.2008.01751.X	164	90	104	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					429	U98		10.7326/M13-2410	http://dx.doi.org/10.7326/M13-2410			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222388				2022-12-28	WOS:000343894400018
J	Meza, LR; Das, S; Greer, JR				Meza, Lucas R.; Das, Satyajit; Greer, Julia R.			Strong, lightweight, and recoverable three-dimensional ceramic nanolattices	SCIENCE			English	Article							HIGH-TOUGHNESS; FABRICATION; NANOSTRUCTURES; DEFORMATION; COMPOSITES; ULTRALIGHT; DUCTILITY; STRENGTH; DESIGN; SHELLS	Ceramics have some of the highest strength- and stiffness-to-weight ratios of any material but are suboptimal for use as structural materials because of their brittleness and sensitivity to flaws. We demonstrate the creation of structural metamaterials composed of nanoscale ceramics that are simultaneously ultralight, strong, and energy-absorbing and can recover their original shape after compressions in excess of 50% strain. Hollow-tube alumina nanolattices were fabricated using two-photon lithography, atomic layer deposition, and oxygen plasma etching. Structures were made with wall thicknesses of 5 to 60 nanometers and densities of 6.3 to 258 kilograms per cubic meter. Compression experiments revealed that optimizing the wall thickness-to-radius ratio of the tubes can suppress brittle fracture in the constituent solid in favor of elastic shell buckling, resulting in ductile-like deformation and recoverability.	[Meza, Lucas R.; Das, Satyajit; Greer, Julia R.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Greer, Julia R.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Greer, JR (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	jrgreer@caltech.edu		Meza, Lucas/0000-0003-0250-2621	Defense Advanced Research Projects Agency [W91CRB-10-0305]; U.S. Army Research Office [W911NF-09-0001]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Army Research Office	The authors gratefully acknowledge the financial support from the Defense Advanced Research Projects Agency under the Materials with Controlled Microstructure and Architecture program managed by J. Goldwasser (contract no. W91CRB-10-0305) and to the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred. The authors are grateful to the Kavli Nanoscience Institute at Caltech for the availability of critical cleanroom facilities, and to R. Liontas and C. Garland for TEM assistance. Part of this work was carried out in the Lewis Group facilities at Caltech.	Akimov YK, 2003, INSTRUM EXP TECH+, V46, P287, DOI 10.1023/A:1024401803057; Allen H. G. B., 1980, BACKGROUND BUCKLING; Bauer J, 2014, P NATL ACAD SCI USA, V111, P2453, DOI 10.1073/pnas.1315147111; BECHER PF, 1991, J AM CERAM SOC, V74, P255, DOI 10.1111/j.1151-2916.1991.tb06872.x; Berdova M, 2014, ACTA MATER, V66, P370, DOI 10.1016/j.actamat.2013.11.024; Chen DZ, 2013, NANO LETT, V13, P4462, DOI 10.1021/nl402384r; CHEN IW, 1990, J AM CERAM SOC, V73, P2585, DOI 10.1111/j.1151-2916.1990.tb06734.x; Deshpande VS, 2001, J MECH PHYS SOLIDS, V49, P1747, DOI 10.1016/S0022-5096(01)00010-2; Deshpande VS, 2001, ACTA MATER, V49, P1035, DOI 10.1016/S1359-6454(00)00379-7; EVANS AG, 1990, J AM CERAM SOC, V73, P187, DOI 10.1111/j.1151-2916.1990.tb06493.x; Gibson L.J., 1988, CELLULAR SOLIDS STRU, DOI [10.1017/CBO9781139878326, DOI 10.1017/CBO9781139878326]; Greer JR, 2011, PROG MATER SCI, V56, P654, DOI 10.1016/j.pmatsci.2011.01.005; Groner MD, 2004, CHEM MATER, V16, P639, DOI 10.1021/cm0304546; Gu XW, 2013, NANO LETT, V13, P5703, DOI 10.1021/nl403453h; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hofmann DC, 2008, NATURE, V451, P1085, DOI 10.1038/nature06598; Jang DC, 2013, NAT MATER, V12, P893, DOI [10.1038/NMAT3738, 10.1038/nmat3738]; JU GT, 1992, INT J SOLIDS STRUCT, V29, P1143, DOI 10.1016/0020-7683(92)90140-O; Maloney KJ, 2013, APL MATER, V1, DOI 10.1063/1.4818168; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Meza LR, 2014, J MATER SCI, V49, P2496, DOI 10.1007/s10853-013-7945-x; Montemayor LC, 2014, ADV ENG MATER, V16, P184, DOI 10.1002/adem.201300254; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; PELLEGRINO S, 1986, INT J SOLIDS STRUCT, V22, P409, DOI 10.1016/0020-7683(86)90014-4; Rys J, 2014, ADV ENG MATER, V16, P889, DOI 10.1002/adem.201300454; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Torrents A, 2012, ACTA MATER, V60, P3511, DOI 10.1016/j.actamat.2012.03.007; Valdevit L, 2013, J MATER RES, V28, P2461, DOI 10.1557/jmr.2013.160; Valdevit L, 2011, J AM CERAM SOC, V94, P1, DOI 10.1111/j.1551-2916.2011.04599.x; Weaver JC, 2007, J STRUCT BIOL, V158, P93, DOI 10.1016/j.jsb.2006.10.027; Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291	31	828	848	62	984	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1322	1326		10.1126/science.1255908	http://dx.doi.org/10.1126/science.1255908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214624				2022-12-28	WOS:000341483800058
J	Takashima, Y; Guo, G; Loos, R; Nichols, J; Ficz, G; Krueger, F; Oxley, D; Santos, F; Clarke, J; Mansfield, W; Reik, W; Bertone, P; Smith, A				Takashima, Yasuhiro; Guo, Ge; Loos, Remco; Nichols, Jennifer; Ficz, Gabriella; Krueger, Felix; Oxley, David; Santos, Fatima; Clarke, James; Mansfield, William; Reik, Wolf; Bertone, Paul; Smith, Austin			Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human	CELL			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME INACTIVATION; SELF-RENEWAL; DNA METHYLATION; NAIVE PLURIPOTENCY; PRIMITIVE STREAK; IN-VIVO; EPIBLAST; INHIBITION; LINES	Current human pluripotent stem cells lack the transcription factor circuitry that governs the ground state of mouse embryonic stem cells (ESC). Here, we report that short-term expression of two components, NANOG and KLF2, is sufficient to ignite other elements of the network and reset the human pluripotent state. Inhibition of ERK and protein kinase C sustains a transgene-independent rewired state. Reset cells self-renew continuously without ERK signaling, are phenotypically stable, and are karyo-typically intact. They differentiate in vitro and form teratomas in vivo. Metabolism is reprogrammed with activation of mitochondrial respiration as in ESC. DNA methylation is dramatically reduced and transcriptome state is globally realigned across multiple cell lines. Depletion of ground-state transcription factors, TFCP2L1 or KLF4, has marginal impact on conventional human pluripotent stem cells but collapses the reset state. These findings demonstrate feasibility of installing and propagating functional control circuitry for ground-state pluripotency in human cells.	[Takashima, Yasuhiro; Guo, Ge; Loos, Remco; Nichols, Jennifer; Clarke, James; Mansfield, William; Bertone, Paul; Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Takashima, Yasuhiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Loos, Remco; Bertone, Paul] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SD, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Ficz, Gabriella] Univ London, Ctr Haematooncol, Barts Canc Inst, London EC1M 6BQ, England; [Krueger, Felix; Oxley, David; Santos, Fatima; Reik, Wolf] Babraham Inst, Babraham CB22 3AT, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Bertone, Paul] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Bertone, Paul] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; Japan Science & Technology Agency (JST); European Molecular Biology Laboratory (EMBL); University of Cambridge; University of London; Queen Mary University London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Cambridge	Bertone, P (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	bertone@ebi.ac.uk; austin.smith@cscr.cam.ac.uk	Ficz, Gabriella/HCH-3771-2022; Bertone, Paul/Z-3734-2019; Reik, Wolf/I-6794-2012; Bertone, Paul/A-6600-2013; Krueger, Felix/J-3340-2019	Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Loos, Remco/0000-0002-9850-6821; Ficz, Gabriella/0000-0001-9313-9578; Santos, Fatima/0000-0002-3854-4084; Krueger, Felix/0000-0002-5513-3324; Takashima, Yasuhiro/0000-0003-0126-7260; Smith, Austin/0000-0002-3029-4682; Nichols, Jennifer/0000-0002-8650-1388; Reik, Wolf/0000-0003-0216-9881	UK Medical Research Council; Japan Science and Technology agency (JST, PRESTO); Genome Biology Unit of the European Molecular Biology Laboratory; European Commission; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H334, BBS/E/B/000C0402, BBS/E/B/0000S266] Funding Source: researchfish; Medical Research Council [G1001028, MC_PC_12009, G1100526] Funding Source: researchfish; BBSRC [BBS/E/B/0000S266, BBS/E/B/000C0402, BBS/E/B/0000H334] Funding Source: UKRI; MRC [G1001028] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Japan Science and Technology agency (JST, PRESTO)(Japan Science & Technology Agency (JST)); Genome Biology Unit of the European Molecular Biology Laboratory; European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Hitoshi Niwa for DOX-regulatable PB vector, Noemi Fusaki for Sendai virus reprogramming constructs, and Ivan Damjanov for teratoma assessment. We also thank Sally Marchant (Barts Hospital) and couples who donated embryos. Illumina sequencing and microarray hybridization were carried out by Bettina Haase and Jelena Pistolic at the EMBL Genomics Core Facility. CytoScan HD array analysis was performed by Rehannah Borup at the Center for Genomic Medicine, Copenhagen University Hospital. Sam Myers and Masayo Fujiwara provided technical assistance, and Peter Humphreys performed confocal imaging. This research was supported by the UK Medical Research Council, the Japan Science and Technology agency (JST, PRESTO), the Genome Biology Unit of the European Molecular Biology Laboratory, European Commission projects PluriMes, BetaCellTherapy, EpiGeneSys, and Blueprint, and the Wellcome Trust. Y.T. was a University of Cambridge Herchel Smith Fellow. A.S. is a Medical Research Council Professor.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Anders S, 2014, HTSEQ PYTHON FRAMEWO, DOI [10.1101/ 002824, DOI 10.1101/002824, 10.1101/002824]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Meek S, 2013, STEM CELLS, V31, P2104, DOI 10.1002/stem.1466; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen T.W., 2014, CELL STEM CELL; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	57	569	595	2	122	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1254	1269		10.1016/j.cell.2014.08.029	http://dx.doi.org/10.1016/j.cell.2014.08.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215486	Green Published, hybrid			2022-12-28	WOS:000343094200009
J	Wang, G; Han, T; Nijhawan, D; Theodoropoulos, P; Naidoo, J; Yadavalli, S; Mirzaei, H; Pieper, AA; Ready, JM; McKnight, SL				Wang, Gelin; Han, Ting; Nijhawan, Deepak; Theodoropoulos, Pano; Naidoo, Jacinth; Yadavalli, Sivaramakrishnan; Mirzaei, Hamid; Pieper, Andrew A.; Ready, Joseph M.; McKnight, Steven L.			P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage	CELL			English	Article							DEGENERATION WLD(S) MOUSE; PROGRAMMED CELL-DEATH; WALLERIAN DEGENERATION; AMINOPROPYL CARBAZOLES; HIPPOCAMPAL-NEURONS; DENTATE GYRUS; STEM-CELLS; NEUROGENESIS; STATE; BIOSYNTHESIS	The P7C3 class of aminopropyl carbazole chemicals fosters the survival of neurons in a variety of rodent models of neurodegeneration or nerve cell injury. To uncover its mechanism of action, an active derivative of P7C3 was modified to contain both a benzophenone for photocrosslinking and an alkyne for CLICK chemistry. This derivative was found to bind nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme involved in the conversion of nicotinamide into nicotinamide adenine dinucleotide (NAD). Administration of active P7C3 chemicals to cells treated with doxorubicin, which induces NAD depletion, led to a rebound in intracellular levels of NAD and concomitant protection from doxorubicin-mediated toxicity. Active P7C3 variants likewise enhanced the activity of the purified NAMPT enzyme, providing further evidence that they act by increasing NAD levels through its NAMPT-mediated salvage.	[Wang, Gelin; Han, Ting; Nijhawan, Deepak; Theodoropoulos, Pano; Naidoo, Jacinth; Yadavalli, Sivaramakrishnan; Mirzaei, Hamid; Ready, Joseph M.; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Nijhawan, Deepak] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Nijhawan, Deepak] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Psychiat, Dept Neurol, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Vet Affairs, Iowa City, IA 52242 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Ready, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joseph.ready@utsouthwestern.edu; steven.mcknight@utsouthwestern.edu	Pieper, Andrew A/R-5552-2016; Sivaramakrishna, Yadavalli/P-8642-2019	Pieper, Andrew/0000-0001-6299-6577	NIMH [5-RO1-MH087986]; Welch Foundation [I-1612]; Edward N. and Della C. Thome Memorial Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087986] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Welch Foundation(The Welch Foundation); Edward N. and Della C. Thome Memorial Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Leeju Wu and Masato Kato for help in the expression and purification of NAMPT; Paula Huntington, Ruth Starwalt, Sandi Terpack, Stephanie Tran, and Jeremiah Britt for help with neurogenesis assays on hundreds of chemical derivatives of P7C3; Mike Brown for advice and encouragement; Bruce Posner in the UTSWMC high-throughput screening core for assistance in numerous screening assays; and Noelle Williams for help with pharmacological studies. This work was funded by a grant awarded to A.A.P. and S.L.M. from the NIMH (5-RO1-MH087986), grants awards from the Welch Foundation (I-1612) and the Edward N. and Della C. Thome Memorial Foundation to J.M.R., and unrestricted funds provided to S.L.M. by an anonymous donor.	Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bandyopadhyay S, 2011, EUR J ORG CHEM, V2011, P751, DOI 10.1002/ejoc.201001264; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kim WR, 2009, EUR J NEUROSCI, V29, P1408, DOI 10.1111/j.1460-9568.2009.06693.x; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Naidoo J, 2014, J MED CHEM, V57, P3746, DOI 10.1021/jm401919s; Pacher P, 2002, J PHARMACOL EXP THER, V300, P862, DOI 10.1124/jpet.300.3.862; Pieper AA, 2014, CHEM SOC REV, V43, P6716, DOI 10.1039/c3cs60448a; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; PREISS J, 1958, J BIOL CHEM, V233, P488; Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	33	155	167	3	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1324	1334		10.1016/j.cell.2014.07.040	http://dx.doi.org/10.1016/j.cell.2014.07.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215490	Green Accepted, Bronze			2022-12-28	WOS:000343094200014
J	Raal, FJ; Stein, EA; Dufour, R; Turner, T; Civeira, F; Burgess, L; Langslet, G; Scott, R; Olsson, AG; Sullivan, D; Hovingh, GK; Cariou, B; Gouni-Berthold, I; Somaratne, R; Bridges, I; Scott, R; Wasserman, SM; Gaudet, D				Raal, Frederick J.; Stein, Evan A.; Dufour, Robert; Turner, Traci; Civeira, Fernando; Burgess, Lesley; Langslet, Gisle; Scott, Russell; Olsson, Anders G.; Sullivan, David; Hovingh, G. Kees; Cariou, Bertrand; Gouni-Berthold, Ioanna; Somaratne, Ransi; Bridges, Ian; Scott, Rob; Wasserman, Scott M.; Gaudet, Daniel		RUTHERFORD-2 Investigators	PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; SUBTILISIN/KEXIN TYPE 9; MONOCLONAL-ANTIBODY; RECEPTOR GENE; LDL-C; EFFICACY; REDUCTION; GUIDANCE; DISEASE; UPDATE	Background Heterozygous familial hypercholesterolaemia is characterised by low cellular uptake of LDL cholesterol, increased plasma LDL cholesterol concentrations, and premature cardiovascular disease. Despite intensive statin therapy, with or without ezetimibe, many patients are unable to achieve recommended target levels of LDL cholesterol. We investigated the effect of PCSK9 inhibition with evolocumab (AMG 145) on LDL cholesterol in patients with this disorder. Methods This multicentre, randomised, double-blind, placebo-controlled trial was undertaken at 39 sites (most of which were specialised lipid clinics, mainly attached to academic institutions) in Australia, Asia, Europe, New Zealand, North America, and South Africa between Feb 7 and Dec 19,2013.331 eligible patients (18-80 years of age), who met clinical criteria for heterozygous familial hypercholesterolaemia and were on stable lipid-lowering therapy for at least 4 weeks, with a fasting LDL cholesterol concentration of 2.6 mmol/L or higher, were randomly allocated in a 2:2:1:1 ratio to receive subcutaneous evolocumab 140 mg every 2 weeks, evolocumab 420 mg monthly, or subcutaneous placebo every 2 weeks or monthly for 12 weeks. Randomisation was computer generated by the study sponsor, implemented by a computerised voice interactive system, and stratified by LDL cholesterol concentration at screening (higher or lower than 4.1 mmol/L) and by baseline ezetimibe use (yes/no). Patients, study personnel, investigators, and Amgen study staff were masked to treatment assignments within dosing frequency groups. The coprimary endpoints were percentage change from baseline in LDL cholesterol at week 12 and at the mean of weeks 10 and 12, analysed by intention-to-treat. This trial is registered with ClinicalTrials.gov, number NCT01763918. Findings Of 415 screened patients, 331 were eligible and were randomly assigned to the four treatment groups: evolocumab 140 mg every 2 weeks (n=111), evolocumab 420 mg monthly (n=110), placebo every 2 weeks (n=55), or placebo monthly (n=55). 329 patients received at least one dose of study drug. Compared with placebo, evolocumab at both dosing schedules led to a significant reduction in mean LDL cholesterol at week 12 (every-2-weeks dose: 59.2% reduction [95% CI 53.4-65.1], monthly dose: 61.3% reduction [53.6-69.0]; both p<0.0001) and at the mean of weeks 10 and 12 (60.2% reduction [95% CI 54.5-65.8] and 65.6% reduction [59.8-71.3]; both p<0.0001). Evolocumab was well tolerated, with rates of adverse events similar to placebo. The most common adverse events occurring more frequently in the evolocumab-treated patients than in the placebo groups were nasopharyngitis (in 19 patients [9%] vs five [5%] in the placebo group) and muscle-related adverse events (ten patients [5%] vs 1 [1%]). Interpretation In patients with heterozygous familial hypercholesterolaemia, evolocumab administered either 140 mg every 2 weeks or 420 mg monthly was well tolerated and yielded similar and rapid 60% reductions in LDL cholesterol compared with placebo.	[Raal, Frederick J.] Univ Witwatersrand, Fac Hlth Sci, Carbohydrate & Lipid Metab Res Unit, ZA-2193 Johannesburg, South Africa; [Stein, Evan A.; Turner, Traci] Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA; [Dufour, Robert] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Gaudet, Daniel] Univ Montreal, ECOGENE 21, Dyslipidemia Diabet & Atherosclerosis Res Grp, Dept Med, Montreal, PQ, Canada; [Civeira, Fernando] Univ Hosp Miguel Servet, Zaragoza, Spain; [Burgess, Lesley] Tygerberg Hosp, Dept Internal Med, TREAD Res, Cape Town, South Africa; [Langslet, Gisle] Oslo Univ Hosp, Lipid Clin, Oslo, Norway; [Scott, Russell] Univ Otago, Lipid & Diabet Res Grp, Christchurch, New Zealand; [Olsson, Anders G.] Linkoping Univ, Stockholm, Sweden; [Olsson, Anders G.] Stockholm Heart Ctr, Stockholm, Sweden; [Sullivan, David] Royal Prince Alfred Hosp, Dept Clin Biochem, Camperdown, NSW 2050, Australia; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Cariou, Bertrand] Nantes Univ Hosp, Inst Thorax, F-44035 Nantes, France; [Gouni-Berthold, Ioanna] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany; [Somaratne, Ransi; Scott, Rob; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Bridges, Ian] Amgen Ltd, Milton, MA USA	University of Witwatersrand; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Miguel Servet University Hospital; Tygerberg Hospital; University of Oslo; University of Otago; Linkoping University; University of Sydney; University of Amsterdam; Academic Medical Center Amsterdam; Nantes Universite; CHU de Nantes; University of Cologne; Amgen	Raal, FJ (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Med, 7 York Rd, ZA-2193 Johannesburg, South Africa.	frederick.raal@wits.ac.za	Raal, FJ/ABD-5111-2021; Scott, Russell/ABC-8328-2020; Carmen, Team2/Y-7383-2019	Raal, FJ/0000-0002-9170-7938; Scott, Russell/0000-0002-2107-6480; Carmen, Team2/0000-0001-9867-5724; Khan, Michael/0000-0002-8591-384X; Lab, Carmen/0000-0002-5935-3236; Cariou, Bertrand/0000-0002-1580-8040; Scott, Robert/0000-0001-8266-1061; Eriksson, Mats/0000-0001-6481-5549; Bruckert, Eric/0000-0002-4527-9629				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Besseling J, 2014, ATHEROSCLEROSIS, V233, P219, DOI 10.1016/j.atherosclerosis.2013.12.020; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; Koren MJ, 2014, CIRCULATION, V129, P234, DOI 10.1161/CIRCULATIONAHA.113.007012; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Pijlman AH, 2010, ATHEROSCLEROSIS, V209, P189, DOI 10.1016/j.atherosclerosis.2009.09.014; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Raal FJ, 2014, LANCET; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Sjouke B, 2015, EUR HEART J, V36, P560, DOI 10.1093/eurheartj/ehu058; Stein EA, 2007, J CLIN LIPIDOL, V1, P280, DOI 10.1016/j.jacl.2007.07.003; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Talmud PJ, 2013, LANCET, V381, P1293, DOI 10.1016/S0140-6736(12)62127-8; THOROGOOD M, 1991, BRIT MED J, V303, P893; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Vandrovcova J, 2013, GENET MED, V15, P948, DOI 10.1038/gim.2013.55; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Watts GF, 2014, INT J CARDIOL, V171, P309, DOI 10.1016/j.ijcard.2013.11.025	28	494	533	4	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					331	340		10.1016/S0140-6736(14)61399-4	http://dx.doi.org/10.1016/S0140-6736(14)61399-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25282519				2022-12-28	WOS:000348509000026
J	Eng, C; Kramer, CK; Zinman, B; Retnakaran, R				Eng, Conrad; Kramer, Caroline K.; Zinman, Bernard; Retnakaran, Ravi			Glucagon-like peptide-1 receptor agonist and basal insulin combination tre atment for the management of type 2 diabetes: a systematic review and meta-analysis	LANCET			English	Article							ONCE-DAILY LIXISENATIDE; LIRAGLUTIDE; PLACEBO; EXENATIDE; THERAPY; TRIAL; METFORMIN; GLARGINE; BENEFITS; EFFICACY	Background Combination treatment with a glucagon-like peptide-1 (GLP-1) agonist and basal insulin has been proposed as a treatment strategy for type 2 diabetes that could provide robust glucose-lowering capability with low risk of hypoglycaemia or weight gain. We thus did a systematic review and meta-analysis of randomised controlled trials to assess the effect of this combination treatment on glycaemic control, hypoglycaemia, and weight gain in patients with type 2 diabetes. Methods We systematically searched PubMed, Embase, Cochrane, Web of Knowledge, FDA.gov, and ClinicalTrials.gov for randomised controlled trials (published between Jan 1, 1950, and July 29, 2014; no language restrictions) comparing GLP-1 agonist and basal insulin combination treatment to other anti-diabetic treatments. Our main endpoints were glycaemic control, hypoglycaemia, and change in weight. We assessed pooled data by use of a random-effects model. Findings Of 2905 identified studies, 15 were eligible and were included in our analysis (N=4348 participants). Compared with other anti-diabetic treatments, GLP-1 agonist and basal insulin combination treatment yielded an improved mean reduction in glycated haemoglobin (HbA(1c)) of -0.44% (95% CI -0.60 to -0.29), an improved likelihood of achieving the target HbA(1c) of 7.0% or lower (relative risk [RR] 1.92; 95% CI 1.43 to 2.56), no increased relative risk of hypoglycaemia (0.99; 0.76 to 1.29), and a mean reduction in weight of -3.22 kg (-4.90 to -1.54). Furthermore, compared with basal-bolus insulin regimens, the combination treatment yielded a mean reduction in HbA(1c) of -0.1% (-0.17 to -0.02), with lower relative risk of hypoglycaemia (0.67, 0.56 to 0.80), and reduction in mean weight (-5.66 kg; -9.8 to -1.51). Interpretation GLP-1 agonist and basal insulin combination treatment can enable achievement of the ideal trifecta in diabetic treatment: robust glycaemic control with no increased hypoglycaemia or weight gain. This combination is thus a potential therapeutic strategy that could improve the management of patients with type 2 diabetes.	[Eng, Conrad; Kramer, Caroline K.; Zinman, Bernard; Retnakaran, Ravi] Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Toronto, ON M5T 3L9, Canada; [Zinman, Bernard; Retnakaran, Ravi] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5T 3L9, Canada; [Kramer, Caroline K.; Zinman, Bernard] Univ Toronto, Div Endocrinol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Retnakaran, R (corresponding author), Mt Sinai Hosp, Leadership Sinai Ctr Diabet, 60 Murray St,Suite L5-025,Mailbox 21, Toronto, ON M5T 3L9, Canada.	rretnakaran@mtsinai.on.ca	Retnakaran, Ravi/P-2002-2015; Zinman, Bernard/E-7266-2013; Kramer, Caroline K/L-9093-2018	Retnakaran, Ravi/0000-0003-1989-027X; 	Canadian Diabetes Association (CDA); Heart and Stroke Foundation of Ontario Mid-Career Investigator Award; Ontario Ministry of Research and Innovation Early Researcher Award	Canadian Diabetes Association (CDA); Heart and Stroke Foundation of Ontario Mid-Career Investigator Award; Ontario Ministry of Research and Innovation Early Researcher Award(Ministry of Research and Innovation, Ontario)	CKK holds a Canadian Diabetes Association (CDA) Postdoctoral Fellowship Award. BZ holds the Sam and Judy Pencer Family Chair in Diabetes Research at Mount Sinai Hospital and University of Toronto. RR is supported by a Heart and Stroke Foundation of Ontario Mid-Career Investigator Award and his research programme is supported by an Ontario Ministry of Research and Innovation Early Researcher Award.	Ahmann AJ, 2014, DIABETES, V63, pA87; Balena R, 2013, DIABETES OBES METAB, V15, P485, DOI 10.1111/dom.12025; Buse JB, 2011, ANN INTERN MED, V154, P103, DOI 10.7326/0003-4819-154-2-201101180-00300; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; de Wit HM, 2014, DIABETOLOGIA, V57, P1812, DOI 10.1007/s00125-014-3302-0; DeVries JH, 2012, DIABETES CARE, V35, P1446, DOI 10.2337/dc11-1928; Diamant M, 2014, DIABETES CARE, V37, P2763, DOI 10.2337/dc14-0876; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holst JJ, 2013, DIABETES OBES METAB, V15, P3, DOI 10.1111/j.1463-1326.2012.01628.x; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Kahn SE, 2009, DIABETOLOGIA, V52, P1003, DOI 10.1007/s00125-009-1321-z; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Lane W, 2014, DIABETES OBES METAB, V16, P827, DOI 10.1111/dom.12286; Li CJ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-142; Mathieu C, 2014, DIABETES OBES METAB, V16, P636, DOI 10.1111/dom.12262; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Riddle MC, 2013, DIABETES CARE, V36, P2497, DOI 10.2337/dc12-2462; Rosenstock J, 2014, DIABETES CARE, DOI [10.1111/dom.12286, DOI 10.1111/DOM.12286]; Rosenstock J, 2014, DIABETES, V63, pA87; Seino Y, 2012, DIABETES OBES METAB, V14, P910, DOI 10.1111/j.1463-1326.2012.01618.x; Seino Y, 2014, DIABETES, V63, pA253; Shao N, 2014, DIABETES-METAB RES, V30, P521, DOI 10.1002/dmrr.2561; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038	31	259	272	17	151	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2228	2234		10.1016/S0140-6736(14)61335-0	http://dx.doi.org/10.1016/S0140-6736(14)61335-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25220191				2022-12-28	WOS:000346655700025
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							AFRICAN-AMERICAN WOMEN; RANDOMIZED-TRIAL; HIV-RISK; PATIENT EDUCATION; ADOLESCENT GIRLS; PRIMARY-CARE; STD; EFFICACY; DISEASE; PREGNANCY	Description: Update of the U.S. Preventive Services Task Force (USPSTF) 2008 recommendation on behavioral counseling interventions to prevent sexually transmitted infections (STIs). Methods: The USPSTF reviewed the evidence on behavioral counseling for sexual risk reduction in primary care, including interventions targeting risky sexual behaviors to prevent STIs (alone or in combination with other behaviors) in persons of any sexual orientation or level of reported sexual activity. Population: This recommendation applies to all sexually active adolescents and to adults who are at increased risk for acquiring or transmitting STIs. Recommendation: The USPSTF recommends intensive behavioral counseling for all sexually active adolescents and for adults who are at increased risk for STIs. (B recommendation)	[LeFevre, Michael L.] US Prevent Serv Task Force, Rockville, MD 20850 USA		LeFevre, ML (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.							ACOG Committee on Health Care for Underserved Women, 2012, Obstet Gynecol, V119, P1077, DOI 10.1097/AOG.0b013e3182564991; American Academy of Family Physicians, 2014, REC TYP CLIN PREV SE; [Anonymous], 2009, Obstet Gynecol, V113, P243, DOI 10.1097/AOG.0b013e3181964254; [Anonymous], 2010, Obstet Gynecol, V116, P240, DOI 10.1097/AOG.0b013e3181e8b0a9; Berenson AB, 2012, CONTRACEPTION, V86, P716, DOI 10.1016/j.contraception.2012.06.007; Boekeloo BO, 1999, PEDIATRICS, V103, P107, DOI 10.1542/peds.103.1.107; Boyer CB, 1997, AIDS, V11, P359, DOI 10.1097/00002030-199703110-00014; Carey MP, 2010, AIDS BEHAV, V14, P504, DOI 10.1007/s10461-009-9587-1; Carey MP, 2004, J CONSULT CLIN PSYCH, V72, P252, DOI 10.1037/0022-006X.72.2.252; Centers for Disease Control and Prevention, 2013, CDC FACT SHEET INC P; Centers for Disease Control and Prevention, 2011, SEX TRANSM DIS SURV; Champion JD, 2012, INT J NURS STUD, V49, P138, DOI 10.1016/j.ijnurstu.2011.08.010; Chesson HW, 2011, SEX TRANSM DIS, V38, P889, DOI 10.1097/OLQ.0b013e318223be77; Cianelli R, 2012, HEALTH CARE WOMEN IN, V33, P321, DOI 10.1080/07399332.2012.655388; Committee on Adolescent Health Care, 2013, Obstet Gynecol, V122, P1378, DOI 10.1097/01.AOG.0000438963.23732.80; Committee on Gynecologic Practice, 2012, Obstet Gynecol, V120, P421, DOI 10.1097/AOG.0b013e3182680517; Committee on Health Care for Underserved Women The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P735, DOI 10.1097/AOG.0b013e31826dc477; Crosby R, 2009, AM J PUBLIC HEALTH, V99, pS96, DOI 10.2105/AJPH.2007.123893; DANIELSON R, 1990, FAM PLANN PERSPECT, V22, P115, DOI 10.2307/2135642; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Forhan SE, 2009, PEDIATRICS, V124, P1505, DOI 10.1542/peds.2009-0674; Guilamo-Ramos V, 2011, J ADOLESCENT HEALTH, V48, P159, DOI 10.1016/j.jadohealth.2010.06.007; Jemmott JB, 2005, ARCH PEDIAT ADOL MED, V159, P440, DOI 10.1001/archpedi.159.5.440; Jemmott LS, 2007, AM J PUBLIC HEALTH, V97, P1034, DOI 10.2105/AJPH.2003.020271; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kershaw TS, 2009, AM J PUBLIC HEALTH, V99, P2079, DOI 10.2105/AJPH.2008.154476; Marion LN, 2009, RES NURS HEALTH, V32, P274, DOI 10.1002/nur.20326; Marrazzo JM, 2011, SEX TRANSM INFECT, V87, P399, DOI 10.1136/sti.2011.049213; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Miles IJ, 2013, MMWR-MORBID MORTAL W, V62, P183; Neumann MS, 2011, SEX TRANSM DIS, V38, P133, DOI 10.1097/OLQ.0b013e3181f0c051; O'Connor EA, 2014, AHRQ PUBLICATION; O'Connor EA, 2014, ANN INTERN MED, V161, P874, DOI 10.7326/M14-0475; O'Donnell CR, 1998, SEX TRANSM DIS, V25, P161, DOI 10.1097/00007435-199803000-00010; ODONNELL LN, 1995, AM J PUBLIC HEALTH, V85, P817, DOI 10.2105/AJPH.85.6.817; Peipert JF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.038; Petersen R, 2007, PERSPECT SEX REPRO H, V39, P21, DOI 10.1363/3902107; Proude EM, 2004, FAM PRACT, V21, P537, DOI 10.1093/fampra/cmh510; Robinson B., 2019, MANUAL BEST PRACTICE; Scholes D, 2003, AIDS, V17, P1547, DOI 10.1097/00002030-200307040-00016; Shain RN, 1999, NEW ENGL J MED, V340, P93, DOI 10.1056/NEJM199901143400203; Shain RN, 2004, SEX TRANSM DIS, V31, P401, DOI 10.1097/01.olq.0000135301.97350.84; Warner L, 2008, PLOS MED, V5, P919, DOI 10.1371/journal.pmed.0050135; WENGER NS, 1992, ANN INTERN MED, V117, P905, DOI 10.7326/0003-4819-117-11-905; Whitmore Suzanne K., 2012, Morbidity and Mortality Weekly Report, V61, P971; Wilkinson J., 2013, PREVENTIVE SERVICES; Wingood GM, 2013, JAIDS-J ACQ IMM DEF, V63, pS36, DOI 10.1097/QAI.0b013e3182920031; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	48	37	37	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					894	U90		10.7326/M14-1965	http://dx.doi.org/10.7326/M14-1965			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UW	25244227				2022-12-28	WOS:000347248400031
J	Page, ZA; Liu, Y; Duzhko, VV; Russell, TP; Emrick, T				Page, Zachariah A.; Liu, Yao; Duzhko, Volodimyr V.; Russell, Thomas P.; Emrick, Todd			Fulleropyrrolidine interlayers: Tailoring electrodes to raise organic solar cell efficiency	SCIENCE			English	Article							POWER CONVERSION EFFICIENCY; POLYMER PHOTOVOLTAIC CELLS; BUFFER LAYERS; PERFORMANCE; TRANSPARENT; ZWITTERIONS; ENHANCE; C-60	A major challenge in organic solar cell design is the trade-off between oxidative stability and work function of the metal cathode. We found that in single-junction polymer solar cells, this problem can be surmounted by solution-based incorporation of fulleropyrrolidines with amine (C-60-N) or zwitterionic (C-60-SB) substituents as cathode-independent buffer layers. Specifically, a thin layer of C-60-N reduced the effective work function of Ag, Cu, and Au electrodes to 3.65 electron volts. Power conversion efficiency values exceeding 8.5% were obtained for organic photovoltaics independent of the cathode selection (Al, Ag, Cu, or Au). Such high efficiencies did not require precise control over interlayer thickness, as devices prepared with C-60-N and C-60-SB layers ranging from 5 to 55 nanometers performed with high efficiency.	[Page, Zachariah A.; Liu, Yao; Duzhko, Volodimyr V.; Russell, Thomas P.; Emrick, Todd] Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Duzhko, VV (corresponding author), Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA.	duzhko@mail.pse.umass.edu; russell@mail.pse.umass.edu; tsemrick@mail.pse.umass.edu	liu, yao/H-2534-2016; Russell, Thomas Paul/ADL-3689-2022; Duzhko, Volodimyr V./E-7016-2011; Page, Zachariah A/P-8400-2018	Russell, Thomas Paul/0000-0001-6384-5826; Duzhko, Volodimyr V./0000-0001-9951-2599; Page, Zachariah A/0000-0002-1013-5422	Polymer-Based Materials for Harvesting Solar Energy (PHaSE), an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Basic Energy Sciences [DE-SC0001087]; DOE Office of Science Graduate Fellowship Program (DOE SCGF); DOE [DE-AC05-06OR23100]	Polymer-Based Materials for Harvesting Solar Energy (PHaSE), an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Science Graduate Fellowship Program (DOE SCGF)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	Supported by the Polymer-Based Materials for Harvesting Solar Energy (PHaSE), an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, under award DE-SC0001087, and an award from the DOE Office of Science Graduate Fellowship Program (DOE SCGF) (Z.A.P.). The DOE SCGF Program was made possible in part by the American Recovery and Reinvestment Act of 2009. The DOE SCGF program is administered by the Oak Ridge Institute for Science and Education (ORISE) for the DOE. ORISE is managed by Oak Ridge Associated Universities (ORAU) under DOE contract number DE-AC05-06OR23100. All opinions expressed in this paper are those of the authors and do not necessarily reflect the policies and views of DOE, ORAU, or ORISE. We thank PHaSE and the NSF-MRSEC on Polymers at UMass (DMR-0820506) for facilities support. A provisional U.S. patent, including some of the contents of this work, has been filed (no. 61/990,305).	Betancur R, 2013, NAT PHOTONICS, V7, P995, DOI [10.1038/NPHOTON.2013.276, 10.1038/nphoton.2013.276]; Braun S, 2009, ADV MATER, V21, P1450, DOI 10.1002/adma.200802893; Broker B, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3049616; Chueh CC, 2013, ADV ENERGY MATER, V3, P417, DOI 10.1002/aenm.201200679; Duan CH, 2013, CHEM SOC REV, V42, P9071, DOI 10.1039/c3cs60200a; Duan CH, 2012, CHEM MATER, V24, P1682, DOI 10.1021/cm300824h; Gu C, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301771; Guo F, 2013, ADV ENERGY MATER, V3, P1062, DOI 10.1002/aenm.201300100; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI [10.1038/nphoton.2012.190, 10.1038/NPHOTON.2012.190]; HUMMELEN JC, 1995, J ORG CHEM, V60, P532, DOI 10.1021/jo00108a012; Kim JY, 2006, ADV MATER, V18, P572, DOI 10.1002/adma.200501825; Krebs FC, 2009, J MATER CHEM, V19, P5442, DOI 10.1039/b823001c; Krebs FC, 2009, SOL ENERG MAT SOL C, V93, P465, DOI 10.1016/j.solmat.2008.12.012; Lai YY, 2013, ACS APPL MATER INTER, V5, P5122, DOI 10.1021/am400962e; Li SS, 2013, ADV ENERGY MATER, V3, P1569, DOI 10.1002/aenm.201300425; Li XD, 2013, J MATER CHEM A, V1, P12413, DOI 10.1039/c3ta12875j; Liang YY, 2010, ADV MATER, V22, pE135, DOI 10.1002/adma.200903528; Lindell L, 2006, CHEM MATER, V18, P4246, DOI 10.1021/cm061081m; Lindell L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912818; Liu F, 2013, ADV MATER, V25, P6868, DOI 10.1002/adma.201302477; Liu YS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03356; MAGGINI M, 1993, J AM CHEM SOC, V115, P9798, DOI 10.1021/ja00074a056; Martinez-Otero A, 2013, ADV OPT MATER, V1, P37, DOI 10.1002/adom.201200027; Mei Q, 2013, ACS APPL MATER INTER, V5, P8076, DOI 10.1021/am402157b; MITSUNOBU O, 1967, B CHEM SOC JPN, V40, P2380, DOI 10.1246/bcsj.40.2380; O'Malley KM, 2012, ADV ENERGY MATER, V2, P82, DOI 10.1002/aenm.201100522; Page ZA, 2014, CHEM SCI, V5, P2368, DOI 10.1039/c4sc00475b; Page ZA, 2013, MACROMOLECULES, V46, P344, DOI 10.1021/ma302232q; Prato M, 1998, ACCOUNTS CHEM RES, V31, P519, DOI 10.1021/ar970210p; Sze S. M., 2021, PHYS SEMICONDUCTOR D, DOI DOI 10.1002/0470068329; Wei QS, 2008, ADV MATER, V20, P2211, DOI 10.1002/adma.200792876; Woo S, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301692; Worfolk BJ, 2012, ADV ENERGY MATER, V2, P361, DOI 10.1002/aenm.201100714; Yang X, 2013, ADV ENERGY MATER, V3, P666, DOI 10.1002/aenm.201200726; Yao K, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400206; Yip HL, 2012, ENERG ENVIRON SCI, V5, P5994, DOI 10.1039/c2ee02806a; You JB, 2013, ADV MATER, V25, P3973, DOI 10.1002/adma.201300964; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411; Zhang ZG, 2013, J MATER CHEM A, V1, P9624, DOI 10.1039/c3ta12478a; Zhou YH, 2012, SCIENCE, V336, P327, DOI 10.1126/science.1218829	40	226	232	13	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					441	444		10.1126/science.1255826	http://dx.doi.org/10.1126/science.1255826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25236470				2022-12-28	WOS:000343822900035
J	Seedorf, H; Griffin, NW; Ridaura, VK; Reyes, A; Cheng, JY; Rey, FE; Smith, MI; Simon, GM; Scheffrahn, RH; Woebken, D; Spormann, AM; Van Treuren, W; Ursell, LK; Pirrung, M; Robbins-Pianka, A; Cantarel, BL; Lombard, V; Henrissat, B; Knight, R; Gordon, JI				Seedorf, Henning; Griffin, Nicholas W.; Ridaura, Vanessa K.; Reyes, Alejandro; Cheng, Jiye; Rey, Federico E.; Smith, Michelle I.; Simon, Gabriel M.; Scheffrahn, Rudolf H.; Woebken, Dagmar; Spormann, Alfred M.; Van Treuren, William; Ursell, Luke K.; Pirrung, Megan; Robbins-Pianka, Adam; Cantarel, Brandi L.; Lombard, Vincent; Henrissat, Bernard; Knight, Rob; Gordon, Jeffrey I.			Bacteria from Diverse Habitats Colonize and Compete in the Mouse Gut	CELL			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; ROBINSONIELLA-PEORIENSIS; INTESTINAL MICROBIOTA; CETOBACTERIUM-SOMERAE; SP-NOV; TRANSPLANTATION; MAMMALS; MICE	To study how microbes establish themselves in a mammalian gut environment, we colonized germfree mice with microbial communities from human, zebrafish, and termite guts, human skin and tongue, soil, and estuarine microbial mats. Bacteria from these foreign environments colonized and persisted in the mouse gut; their capacity to metabolize dietary and host carbohydrates and bile acids correlated with colonization success. Cohousing mice harboring these xenomicrobiota or a mouse cecal microbiota, along with germ-free "bystanders," revealed the success of particular bacterial taxa in invading guts with established communities and empty gut habitats. Unanticipated patterns of ecological succession were observed; for example, a soil-derived bacterium dominated even in the presence of bacteria from other gut communities (zebrafish and termite), and human-derived bacteria colonized germ-free bystander mice before mouse-derived organisms. This approach can be generalized to address a variety of mechanistic questions about succession, including succession in the context of microbiota-directed therapeutics.	[Seedorf, Henning; Griffin, Nicholas W.; Ridaura, Vanessa K.; Reyes, Alejandro; Cheng, Jiye; Rey, Federico E.; Smith, Michelle I.; Simon, Gabriel M.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Scheffrahn, Rudolf H.] Univ Florida, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA; [Woebken, Dagmar; Spormann, Alfred M.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Woebken, Dagmar; Spormann, Alfred M.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Van Treuren, William; Ursell, Luke K.; Pirrung, Megan; Robbins-Pianka, Adam; Knight, Rob] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Cantarel, Brandi L.; Lombard, Vincent; Henrissat, Bernard] CNRS, UMR 7257, F-13288 Marseille, France; [Lombard, Vincent; Henrissat, Bernard] Aix Marseille Univ, UMR 7257, F-13288 Marseille, France; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Washington University (WUSTL); State University System of Florida; University of Florida; Stanford University; Stanford University; University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Woebken, Dagmar/A-4447-2013; Reyes, Alejandro/AAD-8445-2022; Seedorf, Henning/AAW-6023-2020; Cantarel, Brandi/ABF-5756-2020; Knight, Rob/D-1299-2010; Henrissat, Bernard/J-2475-2012	Woebken, Dagmar/0000-0002-1314-9926; Reyes, Alejandro/0000-0003-2907-3265; Seedorf, Henning/0000-0002-5763-0236; Cantarel, Brandi/0000-0003-4126-4478; Henrissat, Bernard/0000-0002-3434-8588; Lombard, Vincent/0000-0002-9684-7067; Knight, Rob/0000-0002-0975-9019; Spormann, Alfred/0000-0001-5103-9704	NIH [DK30292, DK70977, DK78669, DK58529, DK007120]; Crohn's and Colitis Foundation of America; Signaling and Cellular Recognition Training grant [T32 GM08759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, T32DK007120, R01DK058529, R37DK030292, R01DK070977, R01DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Signaling and Cellular Recognition Training grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank David O'Donnell, Maria Karlsson, Sabrina Wagoner, Janaki Guruge, Marty Meier, Jill Manchester, and Su Deng for superb technical assistance. This work was supported in part by grants from the NIH (DK30292, DK70977, DK78669, and DK58529) and the Crohn's and Colitis Foundation of America. N.W.G. was supported by an NIH T32 postdoctoral fellowship training grant (DK007120), and L.K.U. was supported by a Signaling and Cellular Recognition Training grant (T32 GM08759). J.I.G. is cofounder of Matatu, Inc., a company that is characterizing the role of diet-by-microbiota interactions in defining health.	BOHNHOFF M, 1964, J EXP MED, V120, P817, DOI 10.1084/jem.120.5.817; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Chen W, 2012, INT J SYST EVOL MICR, V62, P78, DOI 10.1099/ijs.0.026567-0; Cotta MA, 2009, INT J SYST EVOL MICR, V59, P150, DOI 10.1099/ijs.0.65676-0; Finegold SM, 2003, SYST APPL MICROBIOL, V26, P177, DOI 10.1078/072320203322346010; FOSTER G, 1995, LETT APPL MICROBIOL, V21, P202, DOI 10.1111/j.1472-765X.1995.tb01041.x; Gomez E, 2011, J CLIN MICROBIOL, V49, P458, DOI 10.1128/JCM.01305-10; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; He DN, 2003, J LIPID RES, V44, P2242, DOI 10.1194/jlr.M300128-JLR200; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hofmann AF, 2010, J LIPID RES, V51, P226, DOI 10.1194/jlr.R000042; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Khoruts A, 2011, MUCOSAL IMMUNOL, V4, P4, DOI 10.1038/mi.2010.79; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; POTRIKUS CJ, 1977, APPL ENVIRON MICROB, V33, P392, DOI 10.1128/AEM.33.2.392-399.1977; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reyes A, 2013, P NATL ACAD SCI USA, V110, P20236, DOI 10.1073/pnas.1319470110; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; VESSEY DA, 1978, BIOCHEM J, V174, P621, DOI 10.1042/bj1740621; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	28	224	236	4	138	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					253	266		10.1016/j.cell.2014.09.008	http://dx.doi.org/10.1016/j.cell.2014.09.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25284151	Bronze, Green Accepted			2022-12-28	WOS:000343095600009
J	Alamaro, M				Alamaro, Moshe			Water politics must adapt to a warming world	NATURE			English	Editorial Material									[Alamaro, Moshe] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Alamaro, Moshe] More Aqua, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Alamaro, M (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	alamaro@mit.edu							0	9	9	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					7	7		10.1038/514007a	http://dx.doi.org/10.1038/514007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP9SS	25279881	Bronze			2022-12-28	WOS:000342420800008
J	Colla, CH				Colla, Carrie H.			Swimming against the Current - What Might Work to Reduce Low-Value Care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Colla, Carrie H.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Colla, Carrie H.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Colla, CH (corresponding author), Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA.				NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001086, KL2TR001088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR062799] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001086, KL2 TR001088] Funding Source: Medline; NIAMS NIH HHS [P60 AR062799] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABIM Foundation, 2014, UNN TESTS PROC HLTH; Neubauer MA, 2010, J ONCOL PRACT, V6, P12, DOI 10.1200/JOP.091058; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Tannenbaum C, 2014, JAMA INTERN MED, V174, P890, DOI 10.1001/jamainternmed.2014.949	5	75	76	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1280	1283		10.1056/NEJMp1404503	http://dx.doi.org/10.1056/NEJMp1404503			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP9VS	25271601	Green Accepted, Bronze			2022-12-28	WOS:000342429800004
J	Djulbegovic, B; Guyatt, GH				Djulbegovic, Benjamin; Guyatt, Gordon H.			Evidence-Based Practice Is Not Synonymous With Delivery of Uniform Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Djulbegovic, Benjamin] Univ S Florida, Dept Internal Med, Div Evidence Based Med, Morsani Coll Med, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; McMaster University	Djulbegovic, B (corresponding author), Univ S Florida, Dept Internal Med, Div Evidence Based Med, 3515 E Fletcher Ave,MDT 1201,MDC 27, Tampa, FL 33612 USA.	bdjulbeg@health.usf.edu	Djulbegovic, Benjamin/I-3661-2012	Djulbegovic, Benjamin/0000-0003-0671-1447				Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Gliwa C, 2014, JAMA-J AM MED ASSOC, V311, P1443, DOI 10.1001/jama.2013.285362; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3863; James BC, 2000, ARCH PATHOL LAB MED, V124, P1001; Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110; Wennberg J. E., 2010, TRACKING MED RESEARC	9	35	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1293	1294		10.1001/jama.2014.10713	http://dx.doi.org/10.1001/jama.2014.10713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268433				2022-12-28	WOS:000342345400010
J	Yoshioka, K; Murakami, G; Yamazaki, A; Tsuchiya, F; Kimura, T; Kagitani, M; Sakanoi, T; Uemizu, K; Kasaba, Y; Yoshikawa, I; Fujimoto, M				Yoshioka, K.; Murakami, G.; Yamazaki, A.; Tsuchiya, F.; Kimura, T.; Kagitani, M.; Sakanoi, T.; Uemizu, K.; Kasaba, Y.; Yoshikawa, I.; Fujimoto, M.			Evidence for global electron transportation into the jovian inner magnetosphere	SCIENCE			English	Article							IO PLASMA TORUS; RADIAL VARIATIONS; ATOMIC DATABASE; INTERCHANGE; EMISSION; ASYMMETRY; VOYAGER-1; SPECTRUM; JUPITER; CHIANTI	Jupiter's magnetosphere is a strong particle accelerator that contains ultrarelativistic electrons in its inner part. They are thought to be accelerated by whistler-mode waves excited by anisotropic hot electrons (>10 kiloelectron volts) injected from the outer magnetosphere. However, electron transportation in the inner magnetosphere is not well understood. By analyzing the extreme ultraviolet line emission from the inner magnetosphere, we show evidence for global inward transport of flux tubes containing hot plasma. High-spectral-resolution scanning observations of the Io plasma torus in the inner magnetosphere enable us to generate radial profiles of the hot electron fraction. It gradually decreases with decreasing radial distance, despite the short collisional time scale that should thermalize them rapidly. This indicates a fast and continuous resupply of hot electrons responsible for exciting the whistler-mode waves.	[Yoshioka, K.; Murakami, G.; Yamazaki, A.; Kimura, T.; Uemizu, K.; Fujimoto, M.] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa, Japan; [Tsuchiya, F.; Kagitani, M.; Sakanoi, T.] Tohoku Univ, Planetary Plasma & Atmospher Res Ctr, Sendai, Miyagi 980, Japan; [Uemizu, K.] Natl Astron Observ, Mitaka, Tokyo 181, Japan; [Kasaba, Y.] Tohoku Univ, Dept Geophys, Sendai, Miyagi 980, Japan; [Yoshikawa, I.] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan; [Fujimoto, M.] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Tohoku University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Tohoku University; University of Tokyo; Tokyo Institute of Technology	Yoshioka, K (corresponding author), Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa, Japan.	kazuo@stp.isas.jaxa.jp	Sakanoi, Takeshi/C-5593-2018; Kimura, Tomoki/T-4768-2019; Tsuchiya, Fuminori/T-1957-2019; Kasaba, Yasumasa/ABB-4167-2020	Sakanoi, Takeshi/0000-0002-7146-9020; Kimura, Tomoki/0000-0002-0636-4687; Tsuchiya, Fuminori/0000-0003-3386-6794; Kasaba, Yasumasa/0000-0002-8160-3553; Murakami, Go/0000-0002-2759-7682	Grants-in-Aid for Scientific Research [26302005, 26400476, 24403007] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BAGENAL F, 1994, J GEOPHYS RES-SPACE, V99, P11043, DOI 10.1029/93JA02908; BARBOSA DD, 1985, ASTROPHYS J, V289, P392, DOI 10.1086/162899; BARBOSA DD, 1983, GEOPHYS RES LETT, V10, P210, DOI 10.1029/GL010i003p00210; BARBOSA DD, 1994, ASTROPHYS J, V430, P376, DOI 10.1086/174413; Bolton S., 2004, JUPITER PLANET SATEL; Crary FJ, 1997, J GEOPHYS RES-SPACE, V102, P37, DOI 10.1029/96JA02409; Delamere PA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011251; Delamere PA, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010354; Delamere PA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009706; Dere KP, 1997, ASTRON ASTROPHYS SUP, V125, P149, DOI 10.1051/aas:1997368; Feldman PD, 2004, ASTROPHYS J, V601, P583, DOI 10.1086/380302; Frank LA, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA009150; Frank LA, 2000, J GEOPHYS RES-SPACE, V105, P16017, DOI 10.1029/1999JA000250; HALL DT, 1994, ASTROPHYS J, V426, pL51, DOI 10.1086/187337; Hess SLG, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014928; Horne RB, 2008, NAT PHYS, V4, P301, DOI 10.1038/nphys897; Huba J. D., 2009, NRLPU679009523, P71; IP WH, 1983, NATURE, V302, P232, DOI 10.1038/302232a0; Kivelson MG, 1997, GEOPHYS RES LETT, V24, P2127, DOI 10.1029/97GL02202; Landi E, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/86; Mauk BH, 1997, GEOPHYS RES LETT, V24, P2949, DOI 10.1029/97GL03026; Moncuquet M, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA900124; Nakaya K., 2011, P 28 ISTS; Schreier R, 1998, J GEOPHYS RES-PLANET, V103, P19901, DOI 10.1029/98JE00697; SHEMANSKY DE, 1981, J GEOPHYS RES-SPACE, V86, P9179, DOI 10.1029/JA086iA11p09179; SISCOE GL, 1981, J GEOPHYS RES-SPACE, V86, P8471, DOI 10.1029/JA086iA10p08471; SITTLER EC, 1987, J GEOPHYS RES, V92, P5741, DOI 10.1029/JA092iA06p05741; Steffl AJ, 2004, ICARUS, V172, P91, DOI 10.1016/j.icarus.2004.04.016; Thorne RM, 1997, GEOPHYS RES LETT, V24, P2131, DOI 10.1029/97GL01788; Xiao F, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017123; Yoshioka K, 2013, PLANET SPACE SCI, V85, P250, DOI 10.1016/j.pss.2013.06.021; Yoshioka K, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016583	32	28	28	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1581	1584		10.1126/science.1256259	http://dx.doi.org/10.1126/science.1256259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258073				2022-12-28	WOS:000342164500036
J	O'Dowd, A				O'Dowd, Adrian			BRIEFING What next for tobacco's legal war against regulation?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com						American Cancer Society, 2012, TOBACCO ATLAS; Australian Department of Health, COMMONWEALTH TREASUR; Christie B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8490; Department of Health, 2014, CONSULTATION ON THE; Kmietowicz Z, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4689; Kmietowicz Z, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2596; Morris Philip, 2014, RESPONSE TO THE CONS; O'Dowd A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5172	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2014	349								g5770	10.1136/bmj.g5770	http://dx.doi.org/10.1136/bmj.g5770			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UP	25248332				2022-12-28	WOS:000342426100007
J	Loveland, W				Loveland, Walter			Superheavy carbonyls	SCIENCE			English	Editorial Material							ELEMENT 114		Oregon State Univ, Corvallis, OR 97331 USA	Oregon State University	Loveland, W (corresponding author), Oregon State Univ, Corvallis, OR 97331 USA.	lovelanw@onid.orst.edu	Loveland, Walter/A-2955-2008					Eichler R, 2007, NATURE, V447, P72, DOI 10.1038/nature05761; Eichler R, 2010, RADIOCHIM ACTA, V98, P133, DOI 10.1524/ract.2010.1705; Even J, 2014, SCIENCE, V345, P1491, DOI 10.1126/science.1255720; Nash CS, 1999, J AM CHEM SOC, V121, P10830, DOI 10.1021/ja9928273; Pershina V, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4802765; Schadel M, 2012, RADIOCHIM ACTA, V100, P579, DOI 10.1524/ract.2012.1965; Yakushev A, 2014, INORG CHEM, V53, P1624, DOI 10.1021/ic4026766	7	5	5	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1451	1452		10.1126/science.1259349	http://dx.doi.org/10.1126/science.1259349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237088				2022-12-28	WOS:000341752900022
J	Kumar, B; Hosn, NA				Kumar, Bharat; Hosn, Nael Aboul			Superior Vena Cava Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kumar, Bharat; Hosn, Nael Aboul] Univ Kentucky, Lexington, KY 40506 USA	University of Kentucky	Kumar, B (corresponding author), Univ Kentucky, Lexington, KY 40506 USA.	bharat.kumar@uky.edu		Kumar, Bharat/0000-0002-4245-521X					0	1	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1142	1142		10.1056/NEJMicm1311911	http://dx.doi.org/10.1056/NEJMicm1311911			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25229918				2022-12-28	WOS:000341687300009
J	Silk, JB				Silk, Joan B.			ANIMAL BEHAVIOUR The evolutionary roots of lethal conflict	NATURE			English	Editorial Material							WAR	A comprehensive analysis of lethal coalitionary aggression in chimpanzees convincingly demonstrates that such aggression is an adaptive behaviour, not one that has emerged in response to human impacts. See Letter p. 414	Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Silk, JB (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	joan.silk@asu.edu						Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Crofoot MC, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P171, DOI 10.1007/978-3-642-02725-3_8; Ferguson RB, 2011, DEV PRIMATOL-PROG PR, P249, DOI 10.1007/978-1-4419-9520-9_14; Fry DP, 2013, SCIENCE, V341, P270, DOI 10.1126/science.1235675; Goodall J., 1979, GREAT APES, P13; Power Margaret, 2005, EGALITARIANS HUMAN C; Themner L, 2014, J PEACE RES, V51, P541, DOI 10.1177/0022343314542076; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727	8	1	1	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					321	322		10.1038/513321a	http://dx.doi.org/10.1038/513321a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230649				2022-12-28	WOS:000341814900041
J	Gostin, LO; Phelan, A; Stoto, MA; Kraemer, JD; Reddy, KS				Gostin, Lawrence O.; Phelan, Alexandra; Stoto, Michael A.; Kraemer, John D.; Reddy, K. Srinath			Virus sharing, genetic sequencing, and global health security	SCIENCE			English	Editorial Material								This Perspective focuses on the future of the Pandemic Influenza Preparedness (PIP) Framework, which was initially established to promote the fair sharing of public health-related pandemic influenza samples between countries. We examine the changes that need to be made to address the growing likelihood that genetic sequence data might be shared instead of physical virus samples, as well as the need to expand the PIP framework's scope and to improve its fairness.	[Gostin, Lawrence O.; Phelan, Alexandra; Kraemer, John D.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Stoto, Michael A.; Kraemer, John D.] Georgetown Univ, Dept Hlth Syst Adm, Washington, DC 20057 USA; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi 110070, India	Georgetown University; Georgetown University; Public Health Foundation of India	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Reddy, K Srinath/0000-0003-3416-3548; Phelan, Alexandra/0000-0002-3084-9158; Gostin, Lawrence/0000-0001-5286-4044				Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; Enserink M., 2013, SCI INSIDER     0925; Fidler David, 2013, FOREIGN AFF; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Gostin L.O., 2014, GLOBAL HLTH LAW; Kraemer JD, 2012, SCIENCE, V335, P1047, DOI 10.1126/science.1219215; Sedyaningsih ER, 2008, ANN ACAD MED SINGAP, V37, P482; Technical Expert Working Group on Genetic Sequence Data, 2014, FIN REP TECHN EXP WO; WHO, 2011, A648 WHO; World Intellectual Property Organization, 2007, WORK PAP PAT ISS REL	10	21	25	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1295	1296		10.1126/science.1257622	http://dx.doi.org/10.1126/science.1257622			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214618	Green Submitted			2022-12-28	WOS:000341483800050
J	Bonney, HE				Bonney, Heather E.			Richard III: skeletal evidence of perimortem trauma	LANCET			English	Editorial Material									Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Natural History Museum London	Bonney, HE (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England.	h.bonney@nhm.ac.uk	Bonney, Heather/AAQ-7116-2021	Bonney, Heather/0000-0003-0441-7877				Appleby I, 2014, LANCET; Biasotti A, 1997, MODERN SCI EVIDENCE, V3, P144; Iscan M.Y., 2013, HUMAN SKELETON FOREN, V3rd, P493; Nakhaeizadeh S, 2014, J FORENSIC SCI	4	2	2	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					210	210		10.1016/S0140-6736(14)61253-8	http://dx.doi.org/10.1016/S0140-6736(14)61253-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25238932				2022-12-28	WOS:000348044800008
J	Zakher, B; Cantor, AG; Pappas, M; Daeges, M; Nelson, HD				Zakher, Bernadette; Cantor, Amy G.; Pappas, Miranda; Daeges, Monica; Nelson, Heidi D.			Screening for Gonorrhea and Chlamydia: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							SEXUALLY-TRANSMITTED-DISEASES; PELVIC-INFLAMMATORY-DISEASE; NEISSERIA-GONORRHOEAE; PSYCHOSOCIAL IMPACT; CONTROLLED-TRIAL; CT/NG TEST; TRACHOMATIS; INFECTION; SEX; MEN	Background: Previous research has supported screening for gonorrhea and chlamydia in asymptomatic, sexually active women (including pregnant women) who are younger than 25 years or at increased risk but not in other patient populations. Purpose: To update the 2005 and 2007 systematic reviews for the U.S. Preventive Services Task Force on screening for gonorrhea and chlamydia in men and women, including pregnant women and adolescents. Data Sources: MEDLINE (1 January 2004 to 13 June 2014), Cochrane databases (May 2014), ClinicalTrials.gov, and reference lists. Study Selection: English-language trials and observational studies about screening effectiveness, test accuracy, and screening harms. Data Extraction: Extracted study data were confirmed by a second investigator, and study quality and applicability were dual-rated using prespecified criteria. Data Synthesis: Screening a subset of asymptomatic young women for chlamydia in a good-quality trial did not significantly reduce the incidence of pelvic inflammatory disease over the following year (relative risk, 0.39 [95% CI, 0.14 to 1.08]); however, 1 previous trial reported a reduction. An observational study evaluating a risk prediction tool to identify persons with chlamydia in high-risk populations had low predictive ability and applicability. In 10 new studies of asymptomatic patients, nucleic acid amplification tests demonstrated sensitivity of 86% or greater and specificity of 97% or greater for diagnosing gonorrhea and chlamydia, regardless of specimen type or test. Limitations: There were few relevant studies of screening benefits and harms. Only screening tests and methods cleared by the U.S. Food and Drug Administration for current clinical practice were included to determine diagnostic accuracy. Conclusion: Chlamydia screening in young women may reduce the incidence of pelvic inflammatory disease. Nucleic acid amplification tests are accurate for diagnosing gonorrhea and chlamydia in asymptomatic persons.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Providence Canc Ctr, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Mailcode BICC,3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu		Cantor, Amy/0000-0002-4467-8484	AHRQ [HSSA 290-2007-10057-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By AHRQ (contract HSSA 290-2007-10057-I).	Alexander S, 2008, SEX TRANSM INFECT, V84, P488, DOI 10.1136/sti.2008.031443; Andersen B, 2011, SEX TRANSM INFECT, V87, P156, DOI 10.1136/sti.2010.042192; Baeten JM, 2003, CURR HIV RES, V1, P69, DOI 10.2174/1570162033352110; Bias MM, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022665; Bissessor M, 2011, J CLIN MICROBIOL, V49, P4304, DOI 10.1128/JCM.05341-11; Calonge N, 2005, ANN FAM MED, V3, P263, DOI 10.1370/afm.337; Campbell R, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-106; Centers for Disease Control and Prevention, 2012 SEX TRANSM DIS; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P709; Chernesky MA, 2005, J CLIN MICROBIOL, V43, P127, DOI 10.1128/JCM.43.1.127-131.2005; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; Gaydos CA, 2013, INT J STD AIDS, V24, P736, DOI 10.1177/0956462413483252; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Glass N., 2005, SCREENING GONORRHEA; Gottlieb SL, 2011, SEX TRANSM DIS, V38, P1004, DOI 10.1097/OLQ.0b013e31822b0bed; Gotz HM, 2006, SEX TRANSM DIS, V33, P374, DOI [10.1097/01.olq.0000194585., 10.1097/01.olq.0000194585.82456.51]; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hood Ellie E, 2010, W V Med J, V106, P10; Kangas I, 2006, BRIT J GEN PRACT, V56, P587; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; Low N., 2007, HEALTH TECHNOL ASSES, V11, pix; Marcus JL, 2011, SEX TRANSM DIS, V38, P922, DOI 10.1097/OLQ.0b013e31822a2b2e; Meyers DS, 2007, ANN INTERN MED, V147, P135, DOI 10.7326/0003-4819-147-2-200707170-00173; Miller JM, 2005, J MATERN-FETAL NEO M, V18, P231, DOI 10.1080/14767050500223630; Miller WC, 2000, AM J PREV MED, V18, P115, DOI 10.1016/S0749-3797(99)00146-4; Nelson HD, 2001, AM J PREV MED, V20, P95, DOI 10.1016/S0749-3797(01)00253-7; Nelson HD., 2014, AHRQ PUBLICATION; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Pimenta JM, 2003, SEX TRANSM INFECT, V79, P22, DOI 10.1136/sti.79.1.22; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Satterwhite C. L., 2011, Morbidity and Mortality Weekly Report, V60, P370; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Schachter J, 2008, SEX TRANSM DIS, V35, P637, DOI 10.1097/OLQ.0b013e31817bdd7e; Schoeman SA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8013; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Scholes D, 2012, SEX TRANSM DIS, V39, P81, DOI 10.1097/OLQ.0b013e31823e3009; Shrier LA, 2004, AM J OBSTET GYNECOL, V190, P654, DOI 10.1016/j.ajog.2003.09.063; Stewart CMW, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8107; Taylor SN, 2012, SEX TRANSM DIS, V39, P543, DOI 10.1097/OLQ.0b013e31824e26ff; Taylor SN, 2011, SEX TRANSM DIS, V38, P603, DOI 10.1097/OLQ.0b013e31820a94d2; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; US Preventive Services Task Force, PROC MAN; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; Van Der Pol B, 2012, J CLIN MICROBIOL, V50, P2244, DOI 10.1128/JCM.06481-11; Van Der Pol B, 2012, SEX TRANSM DIS, V39, P147, DOI 10.1097/OLQ.0b013e3182372fd8; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	51	37	37	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					884	U81		10.7326/M14-1022	http://dx.doi.org/10.7326/M14-1022			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25244000				2022-12-28	WOS:000347248400030
J	Stasevich, TJ; Hayashi-Takanaka, Y; Sato, Y; Maehara, K; Ohkawa, Y; Sakata-Sogawa, K; Tokunaga, M; Nagase, T; Nozaki, N; McNally, JG; Kimura, H				Stasevich, Timothy J.; Hayashi-Takanaka, Yoko; Sato, Yuko; Maehara, Kazumitsu; Ohkawa, Yasuyuki; Sakata-Sogawa, Kumiko; Tokunaga, Makio; Nagase, Takahiro; Nozaki, Naohito; McNally, James G.; Kimura, Hiroshi			Regulation of RNA polymerase II activation by histone acetylation in single living cells	NATURE			English	Article							GLUCOCORTICOID-RECEPTOR; FRAP ANALYSIS; IN-VIVO; TRANSCRIPTION; PHOSPHORYLATION; CHROMATIN; DYNAMICS; REVEALS; ORGANIZATION; DEACETYLASES	In eukaryotic cells, post-translational histone modifications have an important role in gene regulation. Starting with early work on histone acetylation 1, a variety of residue-specific modifications have now been linked to RNA polymerase II (RNAP2) activity(2,3), but it remains unclear if these markers are active regulators of transcription or just passive byproducts(4,5). This is because studies have traditionally relied on fixed cell populations, meaning temporal resolution is limited to minutes at best, and correlated factors may not actually be present in the same cell at the same time. Complementary approaches are therefore needed to probe the dynamic interplay of histone modifications and RNAP2 with higher temporal resolution in single living cells(2,5,6). Here we address this problem by developing a system to track residue-specific histone modifications and RNAP2 phosphorylation in living cells by fluorescence microscopy. This increases temporal resolution to the tens-of-seconds range. Our single-cell analysis reveals histone H3 lysine-27 acetylation at a gene locus can alter downstream transcription kinetics by as much as 50%, affecting two temporally separate events. First acetylation enhances the search kinetics of transcriptional activators, and later the acetylation accelerates the transition of RNAP2 from initiation to elongation. Signatures of the latter can be found genome-wide using chromatin immunoprecipitation followed by sequencing. We argue that this regulation leads to a robust and potentially tunable transcriptional response.	[Stasevich, Timothy J.; Hayashi-Takanaka, Yoko; Sato, Yuko; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan; [Stasevich, Timothy J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Stasevich, Timothy J.] Howard Hughes Med Inst, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Hayashi-Takanaka, Yoko; Ohkawa, Yasuyuki; Kimura, Hiroshi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan; [Hayashi-Takanaka, Yoko; Sato, Yuko; Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; [Maehara, Kazumitsu; Ohkawa, Yasuyuki] Kyushu Univ, Dept Adv Med Initiat, Fac Med, Fukuoka 8128582, Japan; [Sakata-Sogawa, Kumiko; Tokunaga, Makio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Yokohama, Kanagawa 2268501, Japan; [Sakata-Sogawa, Kumiko; Tokunaga, Makio] RIKEN Ctr Integrat Med Sci IMS, Yokohama, Kanagawa 2300045, Japan; [Nagase, Takahiro] Kazusa DNA Res Inst, Dept Biotechnol Res, Chiba 2920818, Japan; [Nozaki, Naohito] Mab Inst Inc, Sapporo, Hokkaido 00002, Japan; [McNally, James G.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [McNally, James G.] Helmholtz Zentrum Berlin, Inst Soft Matter & Funct Mat, D-14109 Berlin, Germany	Osaka University; Colorado State University; Howard Hughes Medical Institute; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Kyushu University; Tokyo Institute of Technology; RIKEN; Kazusa DNA Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Stasevich, TJ (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan.	tim.stasevich@colostate.edu; hkimura@bio.titech.ac.jp	Hayashi, Yoko/GPT-4159-2022; Ohkawa, Yasuyuki/C-4087-2016; 優子, 佐藤/GOH-1956-2022; Ohkawa, Yasuyuki/ABG-1839-2021; Kimura, Hiroshi/B-9524-2015	Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954; Kimura, Hiroshi/0000-0003-0854-083X; Maehara, Kazumitsu/0000-0002-2933-5176; Tokunaga, Makio/0000-0003-4586-8922; HAYASHI, Yoko/0000-0002-0556-6738; Sato, Yuko/0000-0002-7805-9171	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS; Grants-in-Aid for Scientific Research [25118714] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology of Japan. T.J.S. and Y.H.-T. were supported by JSPS fellowships. We thank T. Kanda, A. Kitamura and T. Morisaki for the mCh-H2B construct, D. Stavreva and G. Hager for the mCherry-NF1A1.1 construct, and F. Mueller and D. Mazza for comments on the manuscript.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Byun JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1652; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Jee J, 2011, BIOINFORMATICS, V27, P1152, DOI 10.1093/bioinformatics/btr092; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kimura H, 1999, MOL CELL BIOL, V19, P5383; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kimura H, 2010, CURR OPIN CELL BIOL, V22, P412, DOI 10.1016/j.ceb.2010.02.004; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; MCNEIL PL, 1987, J CELL SCI, V88, P669; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2012, BIOPHYS J, V102, P1656, DOI 10.1016/j.bpj.2012.02.029; Odawara J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-516; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rafalska-Metcalf IU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010272; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sugaya K, 2000, J CELL SCI, V113, P2679; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	44	164	166	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					272	+		10.1038/nature13714	http://dx.doi.org/10.1038/nature13714			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25252976				2022-12-28	WOS:000346383500051
J	Platt, RJ; Chen, SD; Zhou, Y; Yim, MJ; Swiech, L; Kempton, HR; Dahlman, JE; Parnas, O; Eisenhaure, TM; Jovanovic, M; Graham, DB; Jhunjhunwala, S; Heidenreich, M; Xavier, RJ; Langer, R; Anderson, DG; Hacohen, N; Regev, A; Feng, GP; Sharp, PA; Zhang, F				Platt, Randall J.; Chen, Sidi; Zhou, Yang; Yim, Michael J.; Swiech, Lukasz; Kempton, Hannah R.; Dahlman, James E.; Parnas, Oren; Eisenhaure, Thomas M.; Jovanovic, Marko; Graham, Daniel B.; Jhunjhunwala, Siddharth; Heidenreich, Matthias; Xavier, Ramnik J.; Langer, Robert; Anderson, Daniel G.; Hacohen, Nir; Regev, Aviv; Feng, Guoping; Sharp, Phillip A.; Zhang, Feng			CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling	CELL			English	Article							ZINC-FINGER NUCLEASES; GENE-EXPRESSION; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; CRE RECOMBINASE; LUNG-CANCER; VECTORS; SYSTEM; RNA; DNA	CRISPR-Cas9 is a versatile genome editing technology for studying the functions of genetic elements. To broadly enable the application of Cas9 in vivo, we established a Cre-dependent Cas9 knockin mouse. We demonstrated in vivo as well as ex vivo genome editing using adeno-associated virus (AAV)-, lentivirus-, or particle-mediated delivery of guide RNA in neurons, immune cells, and endothelial cells. Using these mice, we simultaneously modeled the dynamics of KRAS, p53, and LKB1, the top three significantly mutated genes in lung adenocarcinoma. Delivery of a single AAV vector in the lung generated loss-of-function mutations in p53 and Lkb1, as well as homology-directed repair-mediated Kras(G12D) mutations, leading to macroscopic tumors of adenocarcinoma pathology. Together, these results suggest that Cas9 mice empower a wide range of biological and disease modeling applications.	[Platt, Randall J.; Yim, Michael J.; Swiech, Lukasz; Kempton, Hannah R.; Parnas, Oren; Eisenhaure, Thomas M.; Jovanovic, Marko; Graham, Daniel B.; Heidenreich, Matthias; Xavier, Ramnik J.; Hacohen, Nir; Regev, Aviv; Feng, Guoping; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Platt, Randall J.; Zhou, Yang; Yim, Michael J.; Swiech, Lukasz; Kempton, Hannah R.; Heidenreich, Matthias; Feng, Guoping; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Platt, Randall J.; Zhou, Yang; Yim, Michael J.; Swiech, Lukasz; Heidenreich, Matthias; Feng, Guoping; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Platt, Randall J.; Yim, Michael J.; Swiech, Lukasz; Kempton, Hannah R.; Heidenreich, Matthias; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chen, Sidi; Dahlman, James E.; Jhunjhunwala, Siddharth; Langer, Robert; Anderson, Daniel G.; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Sidi; Regev, Aviv; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Dahlman, James E.; Langer, Robert; Anderson, Daniel G.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Dahlman, James E.; Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Eisenhaure, Thomas M.; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Feng, Guoping; Zhang, Feng] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu; zhang@broadinstitute.org	CHEN, SIDI/D-8284-2016; Jhunjhunwala, Siddharth/K-1526-2013; Macrae, Rhiannon/AAX-1536-2020; Feng, Guoping/Y-2827-2019	CHEN, SIDI/0000-0002-3819-5005; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Platt, Randall/0000-0002-2914-7052	Swanson Biotechnology Center; National Science Foundation Graduate Research Fellowship [1122374]; Simons Center for the Social Brain at MIT; NDSEG; NSF; MIT; Swiss National Science Foundation (SNF); Marie Sklodowska-Curie IOF; Helmsley CharitableTrust; Human Frontiers Science Program; NHGRI CEGS [P50 HG006193]; HHMI; Klarman Cell Observatory; NIH Centers of Cancer Nanotechnology Excellence grant [U54CA151884]; NIH Controlled Release grant [EB000244]; National Heart, Lung, and Blood Institute, National Institutes of Health [HHSN268201000045C]; McGovern Internal Funding Poitras Gift [1631119]; Stanley Center; SFARI/Simons Foundation [6927482]; Nancy Lurie Marks Family Foundation [6928117]; United States Public Health Service from the National Institutes of Health [R01-CA133404]; MIT-Harvard Center for Cancer Nanotechnology Excellence Grant from the National Cancer Institute [U54 CA151884]; Marie D. and Pierre Casimir-Lambert Fund; SkTech/MIT Initiative Grant from the Skolkovo Foundation; Koch Institute Support (core) grant from the National Cancer Institute [P30-CA14051]; NIMH through NIH [DP1-MH100706]; NINDS through NIH [R01-NS 07312401]; NSF Waterman Award; Keck Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Vallee Foundation; Merkin Foundation; Simons Foundation; Bob Metcalfe;  [DK43351]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA133404, U54CA151884] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	Swanson Biotechnology Center; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Simons Center for the Social Brain at MIT; NDSEG; NSF(National Science Foundation (NSF)); MIT; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Marie Sklodowska-Curie IOF; Helmsley CharitableTrust; Human Frontiers Science Program(Human Frontier Science Program); NHGRI CEGS; HHMI(Howard Hughes Medical Institute); Klarman Cell Observatory; NIH Centers of Cancer Nanotechnology Excellence grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Controlled Release grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); McGovern Internal Funding Poitras Gift; Stanley Center; SFARI/Simons Foundation; Nancy Lurie Marks Family Foundation; United States Public Health Service from the National Institutes of Health; MIT-Harvard Center for Cancer Nanotechnology Excellence Grant from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie D. and Pierre Casimir-Lambert Fund; SkTech/MIT Initiative Grant from the Skolkovo Foundation; Koch Institute Support (core) grant from the National Cancer Institute; NIMH through NIH; NINDS through NIH; NSF Waterman Award; Keck Foundation(W.M. Keck Foundation); Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Vallee Foundation; Merkin Foundation; Simons Foundation; Bob Metcalfe; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the entire Zhang laboratory and Sharp laboratory. We thank J.T. Ting, I. Tirosh, N. Sanjana, S. Jones, Y. Li, and colleagues in the Broad and Koch Institutes for technical assistance and discussions. We thank the Swanson Biotechnology Center for their support (Applied Therapeutics and Whole Animal Imaging, Bioinformatics and Computing, ES Cell and Transgenics, Microscopy, Flow Cytometry, and Histology, in particular). R.J.P. is supported by a National Science Foundation Graduate Research Fellowship under grant number 1122374. S. C. is a Damon Runyon Cancer Research Fellow (DRG-2117-12). Y.Z. is supported by the Simons Center for the Social Brain at MIT, postdoctoral fellowship. L. S. is a European Molecular Biology Organization (EMBO) and Foundation for Polish Science (FNP) Fellow. J.E.D. is supported by the NDSEG, NSF, and MIT Presidential Graduate Fellowships. M.J. is supported by fellowships of the Swiss National Science Foundation for advanced researchers (SNF) and the Marie Sklodowska-Curie IOF. R.J.X. and D. G. are supported by the Helmsley CharitableTrust and DK43351. M. H. is supported by a postdoctoral fellowship from the Human Frontiers Science Program. A. R. is supported by NHGRI CEGS P50 HG006193, HHMI and the Klarman Cell Observatory. N. H. is supported by NHGRI CEGS P50 HG006193. R. L. and D. A. G. are supported by the NIH Centers of Cancer Nanotechnology Excellence grant U54CA151884, the Controlled Release grant EB000244, and the National Heart, Lung, and Blood Institute, National Institutes of Health, as a Program of Excellence in Nanotechnology (PEN) Award, contract HHSN268201000045C. G. F. is supported by the McGovern Internal Funding Poitras Gift 1631119, the Stanley Center, the SFARI/Simons Foundation 6927482, and the Nancy Lurie Marks Family Foundation 6928117. P. A. S. is supported by United States Public Health Service R01-CA133404 from the National Institutes of Health; by an MIT-Harvard Center for Cancer Nanotechnology Excellence Grant U54 CA151884 from the National Cancer Institute; by a generous gift from the Marie D. and Pierre Casimir-Lambert Fund; by an SkTech/MIT Initiative Grant from the Skolkovo Foundation; and partially by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. F.Z. is supported by the NIMH through a NIH Director's Pioneer Award (DP1-MH100706), the NINDS through a NIH Transformative R01 grant (R01-NS 07312401), NSF Waterman Award, the Keck, Damon Runyon, Searle Scholars, Klingenstein, Vallee, Merkin, and Simons Foundations, and Bob Metcalfe. CRISPR reagents are available to the academic community through Addgene, and associated protocols, support forum, and computational tools are available via the Zhang lab website (http://www.genome-engineering.org). The Cre-dependent Cas9 (JAX Stock Number: 024857) and constitutive Cas9-expressing (JAX Stock Number: 024858) mice are available via the Jackson Laboratory.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Chen SD, 2014, GENE DEV, V28, P1054, DOI 10.1101/gad.239681.114; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Griffiths A. J. F., 2012, INTRO GENETIC ANAL; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Heyer MP, 2010, GENOMICS ESSENTIAL M, P211; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; JASIN M, 1985, CELL, V43, P695, DOI 10.1016/0092-8674(85)90242-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Limberis MP, 2006, P NATL ACAD SCI USA, V103, P12993, DOI 10.1073/pnas.0601433103; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mitzner W, 2001, PHYSIOL GENOMICS, V4, P215, DOI 10.1152/physiolgenomics.2001.4.3.215; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okada S, 2011, J CELL PHYSIOL, V226, P552, DOI 10.1002/jcp.22365; Park WY, 2012, MODERN PATHOL, V25, P1265, DOI 10.1038/modpathol.2012.76; RUDIN N, 1989, GENETICS, V122, P519; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Varble A, 2013, CELL HOST MICROBE, V14, P346, DOI 10.1016/j.chom.2013.08.007; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weinberg RA, 2007, BIOL CANC; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xue W., 2014, NATURE; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	62	1071	1254	16	577	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					440	455		10.1016/j.cell.2014.09.014	http://dx.doi.org/10.1016/j.cell.2014.09.014			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25263330	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000343095600023
J	Scantlebury, DM; Mills, MGL; Wilson, RP; Wilson, JW; Mills, MEJ; Durant, SM; Bennett, NC; Bradford, P; Marks, NJ; Speakman, JR				Scantlebury, David M.; Mills, Michael G. L.; Wilson, Rory P.; Wilson, John W.; Mills, Margaret E. J.; Durant, Sarah M.; Bennett, Nigel C.; Bradford, Peter; Marks, Nikki J.; Speakman, John R.			Flexible energetics of cheetah hunting strategies provide resistance against kleptoparasitism	SCIENCE			English	Article							FIELD METABOLIC-RATE; AFRICAN WILD DOGS; LARGE CARNIVORES; AVOIDANCE; SERENGETI; COMPETITION; PREDATION; ECOLOGY; MAMMALS; LIONS	Population viability is driven by individual survival, which in turn depends on individuals balancing energy budgets. As carnivores may function close to maximum sustained power outputs, decreased food availability or increased activity may render some populations energetically vulnerable. Prey theft may compromise energetic budgets of mesopredators, such as cheetahs and wild dogs, which are susceptible to competition from larger carnivores. We show that daily energy expenditure (DEE) of cheetahs was similar to size-based predictions and positively related to distance traveled. Theft at 25% only requires cheetahs to hunt for an extra 1.1 hour per day, increasing DEE by just 12%. Therefore, not all mesopredators are energetically constrained by direct competition. Other factors that increase DEE, such as those that increase travel, may be more important for population viability.	[Scantlebury, David M.; Marks, Nikki J.] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Mills, Michael G. L.; Mills, Margaret E. J.] Lewis Fdn, ZA-2024 Craighall, South Africa; [Mills, Michael G. L.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Wilson, Rory P.] Swansea Univ, Coll Sci, Swansea Lab Anim Movement, Swansea SA2 8PP, W Glam, Wales; [Wilson, John W.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Wilson, John W.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Durant, Sarah M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Bennett, Nigel C.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Bradford, Peter] Global Vision Int, South African Wildlife Res Expedit, ZA-1380 Hoedspruit, South Africa; [Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China	Queens University Belfast; University of Oxford; Swansea University; University of North Carolina; North Carolina State University; University System of Ohio; Ohio State University; Zoological Society of London; University of Pretoria; University of Aberdeen; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Scantlebury, DM (corresponding author), Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland.	m.scantlebury@qub.ac.uk	Durant, Sarah M/AAB-9659-2019; Mills, Gus/GWV-2639-2022; Speakman, John R./A-9494-2008; Wilson, John W./E-9601-2011; Bennett, Nigel/E-4238-2010	Durant, Sarah M/0000-0003-0724-0878; Speakman, John R./0000-0002-2457-1823; Wilson, John W./0000-0002-7230-1449; Bennett, Nigel/0000-0001-9748-2947	Royal Society [2009/R3 JP090604]; Natural Environment Research Council [NE/I002030/1]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13030000]; 1000 Talents professorship; Lewis Foundation, South Africa; Howard G. Buffet Foundation; National Geographic; Kanabo Conservation Link; Comanis Foundation; Panthera; Kruger Park Marathon Club; NASA [NNX11AP61G, NNX11AL49H]; NERC [NE/I002030/1] Funding Source: UKRI	Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 1000 Talents professorship; Lewis Foundation, South Africa; Howard G. Buffet Foundation; National Geographic(National Geographic Society); Kanabo Conservation Link; Comanis Foundation; Panthera; Kruger Park Marathon Club; NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The data reported in this paper are presented in the supplementary materials (table S1). This study was supported by the Royal Society (2009/R3 JP090604) and Natural Environment Research Council (NE/I002030/1) to D. M. S. J.R.S. was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB13030000) and a 1000 Talents professorship. We thank SANParks and the Department of Wildlife and National Parks, Botswana, for allowing our research in the Kgalagadi Transfrontier Park (Permit Number 2006-05-01 to M. G. L. M.) and the Lewis Foundation, South Africa; The Howard G. Buffet Foundation; National Geographic; Kanabo Conservation Link; Comanis Foundation; Panthera; and the Kruger Park Marathon Club for financial support to M. G. L. M. J.W.W. was funded by NASA grants NNX11AP61G and NNX11AL49H. We thank the management and land owners of Karongwe Game Reserve, as well as the directors of Karongwe Game Association, for supporting this research on their land. We are also grateful to the many Global Vision International field staff and volunteers who conducted the Karongwe fieldwork. We thank I. Capellini for providing additional information on DEE allometry and C. Hambly and P. Thomson for technical assistance with the isotope analysis. Author contributions: D. M. S., M. G. L. M., J.W.W., M.E.J.M., P. B., and N.J.M. collected data; J.R.S. analyzed isotopes; D. M. S., M. G. L. M., R. P. W., and J.W.W. analyzed data; and D. M. S., M. G. L. M., R. P. W., J.W.W., M.E.J.M., S. M. D., N.C.B., P. B., N.J.M., and J.R.S. wrote the manuscript.	BOTHMA JD, 1990, J ARID ENVIRON, V18, P79, DOI 10.1016/S0140-1963(18)30873-5; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Carbone C, 2011, BIOL LETTERS, V7, P312, DOI 10.1098/rsbl.2010.0996; Caro T., 1994, CHEETAHS SERENGETI P; Caro T. M., 2013, MAMMALS AFRICA, VV, P186; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S., 2002, AFRICAN WILD DOG BEH; DEGEN AA, 1995, ECOSCIENCE, V2, P48, DOI 10.1080/11956860.1995.11682268; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Durant SM, 2000, BEHAV ECOL, V11, P624, DOI 10.1093/beheco/11.6.624; Gorman ML, 1998, NATURE, V391, P479, DOI 10.1038/35131; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Hilborn A, 2012, ANIM BEHAV, V84, P701, DOI 10.1016/j.anbehav.2012.06.027; Hudson LN, 2013, J ANIM ECOL, V82, P1009, DOI 10.1111/1365-2656.12086; Humphries MM, 2014, J ANIM ECOL, V83, P7, DOI 10.1111/1365-2656.12124; Hunter JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1033, DOI 10.1007/s00265-006-0336-4; Mills MGL, 2014, J ZOOL, V292, P136, DOI 10.1111/jzo.12087; Mills M.G.L., 1990, KALAHARI HYENAS COMP; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; MILLS MGL, 1993, SYM ZOOL S, P253; PETERSON CC, 1990, P NATL ACAD SCI USA, V87, P2324, DOI 10.1073/pnas.87.6.2324; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Schaller G. B., 1972, SERENGETI LION STUDY; Speakman J.R., 1997, DOUBLY LABELLED WATE; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Swanson A, 2014, J ANIM ECOL, V83, P1418, DOI 10.1111/1365-2656.12231; Tomlinson S, 2014, TRENDS ECOL EVOL, V29, P280, DOI 10.1016/j.tree.2014.03.003; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson JW, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0620	34	65	66	1	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					79	81		10.1126/science.1256424	http://dx.doi.org/10.1126/science.1256424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278609	Green Submitted			2022-12-28	WOS:000342446900054
J	Mayosi, BM; Benatar, SR				Mayosi, Bongani M.; Benatar, Solomon R.			Health and Health Care in South Africa-20 Years after Mandela	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHALLENGES; HIV; DISPARITIES; TRANSITION; COST		[Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Mayosi, BM (corresponding author), Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa.							Alexander Neville., 2013, THOUGHTS NEW S AFRIC; Bateman Chris, 2013, SAMJ, S. Afr. med. j., V103, P603; [Anonymous], 2011, GREEN PAP NAT HLTH I; [Anonymous], 2011, BMJ-BRIT MED J, DOI DOI 10.1136/bmj.d7031; [Anonymous], 2013, DEATH DYING E CAPE I; [Anonymous], 2011, HUM RES HLT IN PRESS; [Anonymous], DEM PROJ S AFR PALSA; [Anonymous], 2011, 2020 FUT HEALTHC W C; [Anonymous], 2013, GUARDIAN NEWS   1210; [Anonymous], 2011, STOP MAK EXC ACC MAT; Awases M., 2004, MIGRATION HLTH PROFE; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Benatar S, 2013, SAMJ S AFR MED J, V103, P154, DOI [10.7196/SAMJ.6622, 10.7196/samj.6622]; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Benatar SR, 1998, AM J PUBLIC HEALTH, V88, P295, DOI 10.2105/AJPH.88.2.295; BENATAR SR, 1986, NEW ENGL J MED, V315, P527, DOI 10.1056/NEJM198608213150829; Benatar SR, 2001, INT AFF, V77, P347, DOI 10.1111/1468-2346.00196; Benatar SR, 2011, GLOBAL CRISIS CRISIS, P127; Birn AE, 2011, GLOBAL HEALTH AND GLOBAL HEALTH ETHICS, P37; Cameron Edwin, 2005, WITNESS AIDS; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Dorrington RE, 2012, RAPID MORTALITY SURV; Doyal Lesley, 2013, LIVING HIV DYING AID; Engelbrecht MC, 2012, HLTH HLTH CARE S AFR, P483; Erasmus N, 2012, SAMJ S AFR MED J, V102, P655, DOI 10.7196/SAMJ.5987; Feinstein Andrew, 2007, PARTY PERSONAL POLIT; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gauld Z, 2012, DOCTOR IS EXPLORATIO; Gill S, 2011, GLOBAL HEALTH AND GLOBAL HEALTH ETHICS, P221; Global Burden of Disease (GBD), 2014, GBD DAT VIS; Habib A., 2013, S AFRICAS SUSPENDED; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Johnson R. W., 2010, S AFRICAS BRAVE NEW; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Karim SSA, 2004, LANCET, V363, P1395, DOI 10.1016/S0140-6736(04)16056-X; Katz AA, 2014, SAMJ S AFR MED J, V104, P111, DOI 10.7196/SAMJ.7639; Katz IT, 2013, NEW ENGL J MED, V369, P1385, DOI 10.1056/NEJMp1310982; Kevany S, 2013, GLOB PUBLIC HEALTH, V8, P570, DOI 10.1080/17441692.2013.790461; Labonte R, 2011, GLOBAL HEALTH AND GLOBAL HEALTH ETHICS, P24; Leibbrandt M, OECD NPC TRENDS PHAR; Mayosi BM, 2012, STRENGTHENING RES HL; Mayosi BM, 2009, REVITALISING CLIN RE; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McIntyre D, 2012, SAMJ S AFR MED J, V102, P489, DOI 10.7196/SAMJ.5611; McKinley DT, 2014, REAL STORY S AFRICAS; Mjamba-Matshoba NB, 2013, NUMBERS MED STUDENTS; Nabukalu D, 2013, GLOBAL HLTH ACT 1219; Oreskes N, 2013, DAEDALUS-US, V142, P40, DOI 10.1162/DAED_a_00184; Phalime M., 2014, POSTMORTEM DOCTOR WH; Poverty trends in South Africa, 2014, POV TRENDS S AFR EX; Rotberg RI, 2014, ANN AM ACAD POLIT SS, V652, P8, DOI 10.1177/0002716213513542; Senkubuge F, 2013, S AFRICAN HLTH REV 2, P141; Simelela NP, 2014, SAMJ S AFR MED J, V104, P249, DOI [10.7196/SAMJ.7700, 10.7196/samj.7700]; South African National Health and Nutrition Examination Survey, 2012, SANHANES 1; South African Nursing Council, 2014, GROWTH REG GROWTH ST; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Von Holdt K, 2006, PUBLIC HOSP S AFRICA; Whiteside A, 2014, ANN AM ACAD POLIT SS, V652, P166, DOI 10.1177/0002716213508067; Wilkinson Richard, 2009, SPIRIT LEVEL WHY EQU; World Health Organization, 2013, GLOB HLTH WORKF STAT; World Health Organization (WHO), 2019, TUBERCULOSIS	64	259	267	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1344	1353		10.1056/NEJMsr1405012	http://dx.doi.org/10.1056/NEJMsr1405012			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP9VS	25265493				2022-12-28	WOS:000342429800014
J	Prieto-Gonzalez, S				Prieto-Gonzalez, Sergio			Chronic Obstructive Pyelonephritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Clin Barcelona, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona	Prieto-Gonzalez, S (corresponding author), Hosp Clin Barcelona, Barcelona, Spain.	sprieto@clinic.ub.es							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1332	1332		10.1056/NEJMicm1314520	http://dx.doi.org/10.1056/NEJMicm1314520			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25271606				2022-12-28	WOS:000342429800010
J	Hoffmann, TC; Montori, VM; Del Mar, C				Hoffmann, Tammy C.; Montori, Victor M.; Del Mar, Chris			The Connection Between Evidence-Based Medicine and Shared Decision Making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hoffmann, Tammy C.; Del Mar, Chris] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Hoffmann, Tammy C.] Univ Queensland, Brisbane, Qld, Australia; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res KER Unit, Rochester, MN 55905 USA	Bond University; University of Queensland; Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, 200 First St SW,Plummer 3-35, Rochester, MN 55905 USA.	montori.victor@mayo.edu	Hoffmann, Tammy/E-8029-2010; Del Mar, Chris/B-1136-2008	Hoffmann, Tammy/0000-0001-5210-8548; Del Mar, Chris/0000-0003-3821-8163; Montori, Victor/0000-0003-0595-2898				Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Hoffmann TC, 2014, J GEN INTERN MED, V29, P844, DOI 10.1007/s11606-014-2765-5; Meats E, 2009, MED TEACH, V31, P369, DOI 10.1080/01421590802572791; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Montori VM, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S5; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Straus SE, 2004, BMJ-BRIT MED J, V329, P987, DOI 10.1136/bmj.329.7473.987; van der Weijden T, 2013, BMJ QUAL SAF, V22, P855, DOI 10.1136/bmjqs-2012-001502	9	226	241	4	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1295	1296		10.1001/jama.2014.10186	http://dx.doi.org/10.1001/jama.2014.10186			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268434				2022-12-28	WOS:000342345400011
J	Luo, JS; Im, JH; Mayer, MT; Schreier, M; Nazeeruddin, MK; Park, NG; Tilley, SD; Fan, HJ; Gratzel, M				Luo, Jingshan; Im, Jeong-Hyeok; Mayer, Matthew T.; Schreier, Marcel; Nazeeruddin, Mohammad Khaja; Park, Nam-Gyu; Tilley, S. David; Fan, Hong Jin; Graetzel, Michael			Water photolysis at 12.3% efficiency via perovskite photovoltaics and Earth-abundant catalysts	SCIENCE			English	Article							SOLAR-CELLS; HYDROGEN-PRODUCTION; ARTIFICIAL PHOTOSYNTHESIS; EVOLUTION; HYDROXIDE; FILM; DEVICE; ROUTE	Although sunlight-driven water splitting is a promising route to sustainable hydrogen fuel production, widespread implementation is hampered by the expense of the necessary photovoltaic and photoelectrochemical apparatus. Here, we describe a highly efficient and low-cost water-splitting cell combining a state-of-the-art solution-processed perovskite tandem solar cell and a bifunctional Earth-abundant catalyst. The catalyst electrode, a NiFe layered double hydroxide, exhibits high activity toward both the oxygen and hydrogen evolution reactions in alkaline electrolyte. The combination of the two yields a water-splitting photocurrent density of around 10 milliamperes per square centimeter, corresponding to a solar-to-hydrogen efficiency of 12.3%. Currently, the perovskite instability limits the cell lifetime.	[Luo, Jingshan; Im, Jeong-Hyeok; Mayer, Matthew T.; Schreier, Marcel; Nazeeruddin, Mohammad Khaja; Tilley, S. David; Graetzel, Michael] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, Lab Photon & Interfaces, CH-1015 Lausanne, Switzerland; [Luo, Jingshan; Fan, Hong Jin] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore 637371, Singapore; [Park, Nam-Gyu] Sungkyunkwan Univ SKKU, Sch Chem Engn, Suwon 440746, South Korea; [Park, Nam-Gyu] Sungkyunkwan Univ SKKU, Dept Energy Sci, Suwon 440746, South Korea	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Gratzel, M (corresponding author), Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, Lab Photon & Interfaces, CH-1015 Lausanne, Switzerland.	michael.graetzel@epfl.ch	Schreier, Marcel/AAL-5408-2021; Luo, Jingshan/Q-1293-2016; Nazeeruddin, Mohammad K/B-1323-2008; Mayer, Matthew T./C-8062-2011; Park, Nam-Gyu/F-2477-2014; Fan, Hong Jin/A-2662-2010; Tilley, David/B-3023-2018	Schreier, Marcel/0000-0002-3674-5667; Luo, Jingshan/0000-0002-1770-7681; Nazeeruddin, Mohammad K/0000-0001-5955-4786; Mayer, Matthew T./0000-0001-5379-2775; Park, Nam-Gyu/0000-0003-2368-6300; Fan, Hong Jin/0000-0003-1237-4555; Tilley, David/0000-0002-7542-1147	Swiss Federal Office for Energy (PECHouse Competence Center) [SI/500090-02]; Europe's Fuel Cell and Hydrogen Joint Undertaking [621252]; European Union [308997, 577490]; Swiss National Science Foundation; Swiss National Center of Competence in Research Molecular Ultrafast Science and Technology; European Research Council [ARG 247404]; Singapore-Berkeley Research Initiative for Sustainable Energy (SinBeRISE) program; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning (MSIP) of Korea [NRF-2012M1A2A2671721, NRF-2012M3A6A7054861]	Swiss Federal Office for Energy (PECHouse Competence Center); Europe's Fuel Cell and Hydrogen Joint Undertaking; European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center of Competence in Research Molecular Ultrafast Science and Technology(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Singapore-Berkeley Research Initiative for Sustainable Energy (SinBeRISE) program; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning (MSIP) of Korea	The authors thank the Swiss Federal Office for Energy (PECHouse Competence Center, contract SI/500090-02), Nano-Tera NTF project TANDEM, the PECDEMO project, cofunded by Europe's Fuel Cell and Hydrogen Joint Undertaking under Grant Agreement 621252, the European Union for supporting the following projects: NANOMATCELL, under grant agreement 308997, MESO, and GLOBASOL, under the grant agreement 577490. In addition, we are grateful to the Swiss National Science Foundation and Swiss National Center of Competence in Research Molecular Ultrafast Science and Technology for financial support. M. G. thanks the European Research Council for financial support under the Advanced Research Grant (ARG 247404) "Mesolight" and acknowledges his affiliation as a visiting faculty member with Nanyang Technological University Singapore; the King Abdulaziz University Jeddah, Saudi Arabia; and the Advanced Institute for Nanotechnology at SKKU, Suwon, Korea. M.K.N. acknowledges his affiliation as a visiting faculty member to the King Abdulaziz University Jeddah, Saudi Arabia. H.J.F is thankful for the support from Singapore-Berkeley Research Initiative for Sustainable Energy (SinBeRISE) program. J.-H.I and N.-G. P are grateful to the National Research Foundation of Korea grants funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea under contracts NRF-2012M1A2A2671721 and NRF-2012M3A6A7054861 (Global Frontier R&D Program on Center for Multiscale Energy System).	BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; Brillet J, 2012, NAT PHOTONICS, V6, P823, DOI [10.1038/nphoton.2012.265, 10.1038/NPHOTON.2012.265]; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Danilovic N, 2012, ANGEW CHEM INT EDIT, V51, P12495, DOI 10.1002/anie.201204842; Edri E, 2014, J PHYS CHEM LETT, V5, P429, DOI 10.1021/jz402706q; Edri E, 2013, J PHYS CHEM LETT, V4, P897, DOI 10.1021/jz400348q; Etgar L, 2012, J AM CHEM SOC, V134, P17396, DOI 10.1021/ja307789s; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Gao MR, 2014, J AM CHEM SOC, V136, P7077, DOI 10.1021/ja502128j; Gong M, 2013, J AM CHEM SOC, V135, P8452, DOI 10.1021/ja4027715; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Greeley J, 2006, NAT MATER, V5, P909, DOI 10.1038/nmat1752; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Hernandez-Pagan EA, 2012, ENERG ENVIRON SCI, V5, P7582, DOI 10.1039/c2ee03422k; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Jacobsson TJ, 2013, ENERG ENVIRON SCI, V6, P3676, DOI 10.1039/c3ee42519c; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kim TW, 2014, SCIENCE, V343, P990, DOI 10.1126/science.1246913; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Lin FD, 2014, NAT MATER, V13, P81, DOI [10.1038/NMAT3811, 10.1038/nmat3811]; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Lu ZY, 2014, CHEM COMMUN, V50, P6479, DOI 10.1039/c4cc01625d; Luo JS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00451; McKone JR, 2013, ACS CATAL, V3, P166, DOI 10.1021/cs300691m; Merki D, 2011, CHEM SCI, V2, P1262, DOI 10.1039/c1sc00117e; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Pinaud BA, 2013, ENERG ENVIRON SCI, V6, P1983, DOI 10.1039/c3ee40831k; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816; Rocheleau RE, 1998, ENERG FUEL, V12, P3, DOI 10.1021/ef9701347; Ryu S, 2014, ENERG ENVIRON SCI, V7, P2614, DOI 10.1039/c4ee00762j; Smith RDL, 2013, SCIENCE, V340, P60, DOI 10.1126/science.1233638; Subbaraman R, 2012, NAT MATER, V11, P550, DOI [10.1038/NMAT3313, 10.1038/nmat3313]; Tachibana Y, 2012, NAT PHOTONICS, V6, P511, DOI 10.1038/nphoton.2012.175; Trotochaud L, 2014, J AM CHEM SOC, V136, P6744, DOI 10.1021/ja502379c; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Xia XH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00981; Zeng K, 2010, PROG ENERG COMBUST, V36, P307, DOI 10.1016/j.pecs.2009.11.002	41	1920	1944	89	2645	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1593	1596		10.1126/science.1258307	http://dx.doi.org/10.1126/science.1258307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258076				2022-12-28	WOS:000342164500040
J	Olsen, BR				Olsen, Bjorn R.			Statins give bone growth a boost	NATURE			English	Editorial Material							SKELETAL DYSPLASIA; ACHONDROPLASIA; CNP		Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Olsen, BR (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	bjorn_olsen@hms.harvard.edu						Braamskamp MJ, 2013, CIRCULATION, V128; COLLIPP PJ, 1972, AM J DIS CHILD, V124, P682, DOI 10.1001/archpedi.1972.02110170060008; Eiland Lea S, 2010, J Pediatr Pharmacol Ther, V15, P160; Hatano Hiroshi, 2003, J Orthop Sci, V8, P842, DOI 10.1007/s00776-003-0724-9; Hunter AGW, 1996, AM J MED GENET, V62, P255, DOI 10.1002/(SICI)1096-8628(19960329)62:3<255::AID-AJMG10>3.0.CO;2-J; Koyama N, 2013, STEM CELLS DEV, V22, P102, DOI 10.1089/scd.2012.0127; Laederich MB, 2010, CURR OPIN PEDIATR, V22, P516, DOI 10.1097/MOP.0b013e32833b7a69; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Simopoulou T, 2010, J ORTHOP RES, V28, P110, DOI 10.1002/jor.20953; Tavormina PL, 1999, AM J HUM GENET, V64, P722, DOI 10.1086/302275; Wynn J, 2007, AM J MED GENET A, V143A, P2502, DOI 10.1002/ajmg.a.31919; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971	15	0	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					494	495		10.1038/nature13750	http://dx.doi.org/10.1038/nature13750			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25231860				2022-12-28	WOS:000342075800026
J	Beatson, SA; Walker, MJ				Beatson, Scott A.; Walker, Mark J.			Tracking antibiotic resistance	SCIENCE			English	Editorial Material									[Beatson, Scott A.; Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Beatson, Scott A.; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	Beatson, SA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.	mark.walker@uq.edu.au	Beatson, Scott/B-6985-2013	Beatson, Scott/0000-0002-1806-3283; Walker, Mark/0000-0001-7423-2769				Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST	7	20	20	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1454	1455		10.1126/science.1260471	http://dx.doi.org/10.1126/science.1260471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237090				2022-12-28	WOS:000341752900024
J	Patek, SN				Patek, S. N.			Biomimetics and evolution	SCIENCE			English	Editorial Material							ADHESIVES		Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Patek, SN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	snp2@duke.edu		Patek, S. N./0000-0001-9738-882X	Direct For Biological Sciences [1439850] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.124; Bartlett MD, 2014, ADV MATER, V26, P3405, DOI 10.1002/adma.201305593; Bartlett MD, 2012, ADV FUNCT MATER, V22, P4985, DOI 10.1002/adfm.201201344; Bartlett MD, 2012, ADV MATER, V24, P1078, DOI 10.1002/adma.201104191; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039429, 10.1371/journal.pone.0035982]; Ge L, 2007, P NATL ACAD SCI USA, V104, P10792, DOI 10.1073/pnas.0703505104; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; King DR, 2014, ADV MATER, V26, P4345, DOI 10.1002/adma.201306259; Malik FT, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/031002; Nunn C. L., 2011, COMP APPROACH EVOLUT; Parness A, 2009, J R SOC INTERFACE, V6, P1223, DOI [10.1098/rsif.2009.0048, 10.1098/rsif.2008.0048]; Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104; Taylor GK, 2014, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780198566373.001.0001; Tokic G, 2012, P ROY SOC B-BIOL SCI, V279, P3065, DOI 10.1098/rspb.2012.0057	15	19	20	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1448	1449		10.1126/science.1256617	http://dx.doi.org/10.1126/science.1256617			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237086				2022-12-28	WOS:000341752900020
J	Sedgwick, P				Sedgwick, Philip			Randomised controlled trials: balance in baseline characteristics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOCATION		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5310; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2409; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1742; Sedgwick P, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3345; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f822; van Wijk RM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2741	7	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2014	349								g5721	10.1136/bmj.g5721	http://dx.doi.org/10.1136/bmj.g5721			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4PK	25238747				2022-12-28	WOS:000342060000013
J	Ruiz-Casares, M				Ruiz-Casares, Monica			Tailor informed-consent processes	NATURE			English	Editorial Material							RESEARCH PARTICIPATION; PERSPECTIVES		McGill Univ, Div Social & Transcultural Psychiat, Montreal, PQ, Canada	McGill University	Ruiz-Casares, M (corresponding author), McGill Univ, Div Social & Transcultural Psychiat, Montreal, PQ, Canada.	monica.ruizcasares@mcgill.ca						Barata PC, 2006, SOC SCI MED, V62, P479, DOI 10.1016/j.socscimed.2005.06.012; Osamor PE, 2012, DEV WORLD BIOETH, V12, P87, DOI 10.1111/j.1471-8847.2012.00326.x; Ruiz-Casares M., 2014, TRANSCULT PSYCHIAT; Ruiz-Casares M., CHILD GEOGR IN PRESS; Vreeman R, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-23	5	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					304	304		10.1038/513304a	http://dx.doi.org/10.1038/513304a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1GD	25230633	Bronze			2022-12-28	WOS:000341814900020
J	Sage, L				Sage, Leslie			Exoplanets	NATURE			English	Editorial Material																			0	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					327	327		10.1038/513327a	http://dx.doi.org/10.1038/513327a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230653	Bronze			2022-12-28	WOS:000341814900070
J	Budenholzer, B				Budenholzer, Brian			Review: In high-risk patients, fatty acid supplementation does not prevent coronary events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Eastern Virginia Med Sch, Norfolk, VA 23501 USA	Eastern Virginia Medical School	Budenholzer, B (corresponding author), Eastern Virginia Med Sch, Norfolk, VA 23501 USA.							Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC7	10.7326/0003-4819-161-6-201409160-02007	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222419				2022-12-28	WOS:000343894400006
J	Gates, MF				Gates, Melinda French			Putting women and girls at the center of development	SCIENCE			English	Editorial Material								The development field needs to be more serious about gender inequities and women's empowerment. By ignoring gender inequities, many development projects fail to achieve their objective. And when development organizations do not focus on women's empowerment, they neglect the fact that empowered women have the potential to transform their societies. I also review the Gates Foundation's record on gender and propose some approaches to improve it.	Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Gates, MF (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.							Alderman, 1997, INTRAHOUSEHOLD RESOU; Blackden C. M., 2006, WORKING PAPER; BLUMBERG RL, 1995, ENGENDERING WEALTH W; Corroon M, 2014, MATERN CHILD HLTH J, V18, P307, DOI 10.1007/s10995-013-1266-1; Duflo Esther, 2011, 17702 NAT BUR EC RES; Food and Agriculture Organization of the United Nations ( FAO), 2011, STAT FOOD AGR 2010 2; Grameen Foundation, 2012, WOM MOB PHON SAV GRA; Herz Barbara, 2004, WHAT WORKS GIRLS ED; Levine R., 2009, GIRLS COUNT GLOBAL I; O'Sullivan M., 2014, 86039 WORLD BANK; Shroff MR, 2011, SOC SCI MED, V73, P447, DOI 10.1016/j.socscimed.2011.05.040; Smith LC KF, 2011, ADMISSIBLE EVIDENCE; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2014, VOIC AG EMP WOM GIRL	14	49	49	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1273	1275		10.1126/science.1258882	http://dx.doi.org/10.1126/science.1258882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214610				2022-12-28	WOS:000341483800042
J	Stein, A; Ruggiano, A; Carvalho, P; Rapoport, TA				Stein, Alexander; Ruggiano, Annamaria; Carvalho, Pedro; Rapoport, Tom A.			Key Steps in ERAD of Luminal ER Proteins Reconstituted with Purified Components	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; RETRO-TRANSLOCATION; MEMBRANE; DISLOCATION; COMPLEX; CDC48	Misfolded proteins of the endoplasmic reticulum (ER) are retrotranslocated into the cytosol, polyubiquitinated, and degraded by the proteasome, a process called ER-associated protein degradation (ERAD). Here, we use purified components from Saccharomyces cerevisiae to analyze the mechanism of retrotranslocation of luminal substrates (ERAD-L), recapitulating key steps in a basic process in which the ubiquitin ligase Hrd1p is the only required membrane protein. We show that Hrd1p interacts with substrate through its membrane-spanning domain and discriminates misfolded from folded polypeptides. Both Hrd1p and substrate are polyubiquitinated, resulting in the binding of Cdc48p ATPase complex. Subsequently, ATP hydrolysis by Cdc48p releases substrate from Hrd1p. Finally, ubiquitin chains are trimmed by the deubiquitinating enzyme Otu1p, which is recruited and activated by the Cdc48p complex. Cdc48p-dependent membrane extraction of polyubiquitinated proteins can be reproduced with reconstituted proteoliposomes. Our results suggest a model for retrotranslocation in which Hrd1p forms a membrane conduit for misfolded proteins.	[Stein, Alexander; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Stein, Alexander; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ruggiano, Annamaria; Carvalho, Pedro] CRG, Dept Cell & Dev Biol, Barcelona 08003, Spain	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Stein, A (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	alexander_stein@hms.harvard.edu; tom_rapoport@hms.harvard.edu	Ruggiano, Annamaria/ABF-4337-2021; Carvalho, Pedro/HHN-1424-2022; Stein, Alexander/I-4950-2012	Ruggiano, Annamaria/0000-0003-4514-7922; Stein, Alexander/0000-0002-2696-0611; Carvalho, Pedro/0000-0002-9691-5277	Otto Hahn Fellowship of the Max Planck Society; "La Caixa'' graduate fellowship; NIH [GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	Otto Hahn Fellowship of the Max Planck Society; "La Caixa'' graduate fellowship(La Caixa Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Robert Oliete for preliminary experiments, Ryan Baldridge, Alexandra Boye-Doe, Angelyn Larkin, Nicholas Bodnar, and Stefan Schoebel for help with some in vitro experiments, and Randy King, Ryan Baldridge, and Adrian Salic for their critical reading of the manuscript. A.S. is supported by an Otto Hahn Fellowship of the Max Planck Society; A.R. is supported by a "La Caixa'' graduate fellowship; and T.A.R. is supported by an NIH grant (GM052586). T.A.R. is a Howard Hughes Medical Institute Investigator.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bernardi KM, 2013, MOL BIOL CELL, V24, P3545, DOI 10.1091/mbc.E13-06-0332; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bordallo J, 1999, FEBS LETT, V448, P244, DOI 10.1016/S0014-5793(99)00362-2; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Mehnert M, 2014, NAT CELL BIOL, V16, P77, DOI 10.1038/ncb2882; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Plemper RK, 1999, J CELL SCI, V112, P4123; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang XL, 2013, J BIOL CHEM, V288, P23295, DOI 10.1074/jbc.M113.482018; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	38	132	132	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1375	1388		10.1016/j.cell.2014.07.050	http://dx.doi.org/10.1016/j.cell.2014.07.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215493	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000343094200018
J	Isakov, A; Jamison, A; Miles, W; Ribner, B				Isakov, Alexander; Jamison, Aaron; Miles, Wade; Ribner, Bruce			Safe Management of Patients With Serious Communicable Diseases: Recent Experience With Ebola Virus	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMBULANCES		Emory Univ, Sch Med, Emory Healthcare, Atlanta, GA 30322 USA; Grady Hlth Syst, Atlanta, GA USA	Emory University	Isakov, A (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Sect Prehosp & Disaster Med, 1599 Clifton Rd,Suite 2-113, Atlanta, GA 30322 USA.	aisakov@emory.edu						Alves DW, 2008, PREHOSP EMERG CARE, V12, P218, DOI 10.1080/10903120801906721; Bledsoe BE, 2014, PREHOSP EMERG CARE, V18, P290, DOI 10.3109/10903127.2013.851311; Brown R, 2010, PREHOSP EMERG CARE, V14, P176, DOI 10.3109/10903120903564480; Centers for Disease Control and Prevention, 2014, INF PREV CONTR REC H; World Health Organization, 2005, WHO GUID HAND HYG HL	5	14	15	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					829	U121		10.7326/M14-2084	http://dx.doi.org/10.7326/M14-2084			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UJ	25244492				2022-12-28	WOS:000347247200013
J	Tittensor, DP; Walpole, M; Hill, SLL; Boyce, DG; Britten, GL; Burgess, ND; Butchart, SHM; Leadley, PW; Regan, EC; Alkemade, R; Baumung, R; Bellard, C; Bouwman, L; Bowles-Newark, NJ; Chenery, AM; Cheung, WWL; Christensen, V; Cooper, HD; Crowther, AR; Dixon, MJR; Galli, A; Gaveau, V; Gregory, RD; Gutierrez, NL; Hirsch, TL; Hoft, R; Januchowski-Hartley, SR; Karmann, M; Krug, CB; Leverington, FJ; Loh, J; Lojenga, RK; Malsch, K; Marques, A; Morgan, DHW; Mumby, PJ; Newbold, T; Noonan-Mooney, K; Pagad, SN; Parks, BC; Pereira, HM; Robertson, T; Rondinini, C; Santini, L; Scharlemann, JPW; Schindler, S; Sumaila, UR; Teh, LSL; van Kolck, J; Visconti, P; Ye, YM				Tittensor, Derek P.; Walpole, Matt; Hill, Samantha L. L.; Boyce, Daniel G.; Britten, Gregory L.; Burgess, Neil D.; Butchart, Stuart H. M.; Leadley, Paul W.; Regan, Eugenie C.; Alkemade, Rob; Baumung, Roswitha; Bellard, Celine; Bouwman, Lex; Bowles-Newark, Nadine J.; Chenery, Anna M.; Cheung, William W. L.; Christensen, Villy; Cooper, H. David; Crowther, Annabel R.; Dixon, Matthew J. R.; Galli, Alessandro; Gaveau, Valerie; Gregory, Richard D.; Gutierrez, Nicolas L.; Hirsch, Tim L.; Hoeft, Robert; Januchowski-Hartley, Stephanie R.; Karmann, Marion; Krug, Cornelia B.; Leverington, Fiona J.; Loh, Jonathan; Lojenga, Rik Kutsch; Malsch, Kelly; Marques, Alexandra; Morgan, David H. W.; Mumby, Peter J.; Newbold, Tim; Noonan-Mooney, Kieran; Pagad, Shyama N.; Parks, Bradley C.; Pereira, Henrique M.; Robertson, Tim; Rondinini, Carlo; Santini, Luca; Scharlemann, Joern P. W.; Schindler, Stefan; Sumaila, U. Rashid; Teh, Louise S. L.; van Kolck, Jennifer; Visconti, Piero; Ye, Yimin			A mid-term analysis of progress toward international biodiversity targets	SCIENCE			English	Article							CONSERVATION; IMPACT	In 2010, the international community, under the auspices of the Convention on Biological Diversity, agreed on 20 biodiversity-related "Aichi Targets" to be achieved within a decade. We provide a comprehensive mid-term assessment of progress toward these global targets using 55 indicator data sets. We projected indicator trends to 2020 using an adaptive statistical framework that incorporated the specific properties of individual time series. On current trajectories, results suggest that despite accelerating policy and management responses to the biodiversity crisis, the impacts of these efforts are unlikely to be reflected in improved trends in the state of biodiversity by 2020. We highlight areas of societal endeavor requiring additional efforts to achieve the Aichi Targets, and provide a baseline against which to assess future progress.	[Tittensor, Derek P.; Walpole, Matt; Hill, Samantha L. L.; Burgess, Neil D.; Regan, Eugenie C.; Bowles-Newark, Nadine J.; Chenery, Anna M.; Crowther, Annabel R.; Dixon, Matthew J. R.; Malsch, Kelly; Newbold, Tim; Scharlemann, Joern P. W.] UNEP WCMC, 219 Huntingdon Rd, Cambridge CB3 0DL, England; [Tittensor, Derek P.; Britten, Gregory L.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Boyce, Daniel G.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Boyce, Daniel G.] Bedford Inst Oceanog, Ocean Sci Div, Dartmouth, NS B2Y 4A2, Canada; [Burgess, Neil D.] Nat Hist Museum, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Butchart, Stuart H. M.] BirdLife Int, Cambridge CB3 0NA, England; [Leadley, Paul W.; Bellard, Celine; Krug, Cornelia B.] Univ Paris Sud, CNRS, UMR 8079, ESE Lab, F-91405 Orsay, France; [Alkemade, Rob; Bouwman, Lex; van Kolck, Jennifer] PBL Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands; [Baumung, Roswitha; Ye, Yimin] UN, Food & Agr Org, I-00153 Rome, Italy; [Bouwman, Lex] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, NL-3508 TA Utrecht, Netherlands; [Cheung, William W. L.; Christensen, Villy; Sumaila, U. Rashid; Teh, Louise S. L.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Cooper, H. David; Hoeft, Robert; Noonan-Mooney, Kieran] Secretariat Convent Biol Divers, Montreal, PQ H2Y 1N9, Canada; [Galli, Alessandro] Global Footprint Network, CH-1219 Geneva, Switzerland; [Gaveau, Valerie] Org Econ Cooperat & Dev, F-75775 Paris 16, France; [Gregory, Richard D.] RSPB Ctr Conservat Sci Lodge, Sandy SG19 2DL, Beds, England; [Gutierrez, Nicolas L.] Marine Stewardship Council, London EC1A 2DH, England; [Hirsch, Tim L.; Robertson, Tim] Global Biodivers Informat Facil GBIF Secretariat, DK-2100 Copenhagen, Denmark; [Januchowski-Hartley, Stephanie R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Karmann, Marion] Forest Stewardship Council FSC Int, D-53113 Bonn, Germany; [Krug, Cornelia B.] DIVERSITAS, F-75231 Paris 05, France; [Leverington, Fiona J.] Univ Queensland, Middleton, Qld 4735, Australia; [Loh, Jonathan] Zool Soc London, London NW1 4RY, England; [Lojenga, Rik Kutsch] Union Eth BioTrade, NL-1013 AA Amsterdam, Netherlands; [Marques, Alexandra; Pereira, Henrique M.] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Pereira, Henrique M.] Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Saale, Germany; [Morgan, David H. W.] Convent Int Trade Endangered Species Secretariat, CH-1219 Geneva, Switzerland; [Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia Brisbane, Qld 4072, Australia; [Pagad, Shyama N.] Univ Auckland, Invas Species Specialist Grp, IUCN SSC, Auckland 1, New Zealand; [Parks, Bradley C.] Coll William & Mary, Williamsburg, VA 23187 USA; [Rondinini, Carlo; Santini, Luca] Univ Roma La Sapienza, Dept Biol & Biotechnol, I-00185 Rome, Italy; [Scharlemann, Joern P. W.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Schindler, Stefan] Environm Agcy Austria, Dept Biodivers & Nat Conservat, A-1090 Vienna, Austria; [Schindler, Stefan] Univ Vienna, Dept Bot & Biodivers Res, Div Conservat Biol Vegetat Ecol & Landscape Ecol, A-1030 Vienna, Austria; [Visconti, Piero] Microsoft Res, Sci Computat Lab, Cambridge CB1 2FB, England	United Nations Environment Programme; Dalhousie University; Queens University - Canada; Bedford Institute of Oceanography; Fisheries & Oceans Canada; BirdLife International; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Food & Agriculture Organization of the United Nations (FAO); Utrecht University; University of British Columbia; Organisation for Economic Co-operation & Development (OECD); Royal Society for Protection of Birds; University of Wisconsin System; University of Wisconsin Madison; University of Queensland; Zoological Society of London; Martin Luther University Halle Wittenberg; University of Queensland; University of Auckland; William & Mary; Sapienza University Rome; University of Sussex; University of Vienna; Microsoft	Tittensor, DP (corresponding author), UNEP WCMC, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	derek.tittensor@unep-wcmc.org	Bouwman, Lex F/B-7053-2012; Mumby, Peter/F-9914-2010; Newbold, Tim/D-1524-2012; Rondinini, Carlo/E-9027-2011; Butchart, Stuart HM/Y-2711-2018; Bellard, Céline/J-8157-2014; Schindler, Stefan/A-1695-2011; Galli, Alessandro/AAV-5906-2020; Marques, Alexandra/A-9689-2013; Santini, Luca/M-8492-2018; Scharlemann, Jorn/A-4737-2008; Newbold, Tim/R-8958-2019; Tittensor, Derek P./AAV-1117-2021; Sumaila, U. Rashid/ABE-6475-2020; Visconti, Piero/A-3253-2009; Lobo, Diele/I-9106-2012; Krug, Cornelia/B-5680-2013; Pereira, Henrique/B-3975-2009; Butchart, Stuart/AAJ-1852-2021; Bouwman, Lex/F-1444-2015; Alkemade, Rob/U-3663-2017; Christensen, Villy/C-3945-2009; , William/F-5104-2013	Mumby, Peter/0000-0002-6297-9053; Newbold, Tim/0000-0001-7361-0051; Bellard, Céline/0000-0003-2012-1160; Schindler, Stefan/0000-0002-1755-4304; Marques, Alexandra/0000-0001-6669-1201; Santini, Luca/0000-0002-5418-3688; Scharlemann, Jorn/0000-0002-2834-6367; Newbold, Tim/0000-0001-7361-0051; Tittensor, Derek P./0000-0002-9550-3123; Visconti, Piero/0000-0001-6823-2826; Pereira, Henrique/0000-0003-1043-1675; Butchart, Stuart/0000-0002-1140-4049; Gregory, Richard/0000-0002-7419-5053; Krug, Cornelia/0000-0002-2470-1229; Bouwman, Lex/0000-0002-2045-1859; Alkemade, Rob/0000-0001-8761-1768; Christensen, Villy/0000-0003-0688-2633; Hirsch, Tim/0000-0002-5015-5807; Rondinini, Carlo/0000-0002-6617-018X; Dixon, Matthew/0000-0001-5020-7171; Marion, Karmann/0000-0001-8119-5062; Cooper, David/0000-0003-4538-205X; Galli, Alessandro/0000-0001-9503-4104; , William/0000-0003-3626-1045	NSERC; Natural Sciences and Engineering Research Council of Canada; NF-UBC Nereus Program; National Science Foundation [DEB-1115025]; DIVERSITAS; European Union; NERC [NE/J011193/2, NE/J011193/1] Funding Source: UKRI; Natural Environment Research Council [NE/J011193/2, NE/J011193/1] Funding Source: researchfish	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NF-UBC Nereus Program; National Science Foundation(National Science Foundation (NSF)); DIVERSITAS; European Union(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank I. Arto, A. H. W. Beusen, C. Brown, L. Coad, L. Collette, R. de Groot, F. Essl, J. Geldmann, P. Genovesi, M. Harfoot, M. Hockings, I. Hoffmann, M. Hoffman, L. Joppa, D. Juffe-Bignoli, N. Kingston, F. Krausmann, V. Lam, B. MacSharry, M. McGeoch, L. McRae, H. Meng, B. O'Connor, D. Pritchard, W. Rabitsch, B. Russell, C. Smith, S. Stewart, P. Stoett, M van Oorschot, H. Visser, M. Wackernagel, A. Watkins, M. Wieczorek, B. Worm, and M. Zemp. A. G. acknowledges Global Footprint Network's Research team and MAVA Fondation pour la Nature. D. B. acknowledges support from NSERC Discovery grant to W. C. Leggett & K. T. Franmk. V. C. acknowledges support from the Natural Sciences and Engineering Research Council of Canada. W. C. acknowledges support from NF-UBC Nereus Program. S. R. J. H. acknowledges support from the National Science Foundation (DEB-1115025) and DIVERSITAS. S.C.B.D. and UNEP-WCMC acknowledge funding support from Canada, the European Union, Germany, Japan, Netherlands, the Republic of Korea, Switzerland, and the UK. All scripts and data used to conduct analyses are available at https://github.com/derekt/Aichi-2020-analysis.	Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Di Marco M, 2014, CONSERV BIOL, V28, P1109, DOI 10.1111/cobi.12249; Durbin James, 2001, TIME SERIES ANAL STA, Vsecond; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; SCBD, 2010, GLOB BIOD OUTL 3; *SCBD, 2003, HDB CONV BIOL DIV; Sparks TH, 2011, ORYX, V45, P411, DOI 10.1017/S003060531100024X; UNEP CBD, 2010, 2010 UNEPCBDCOPDECX2; UNEP CBD, 2012, 2012 UNEPCBDCOPDECX1; United Nations, 1992, CONV BIOL DIV; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	20	745	774	25	559	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					241	244		10.1126/science.1257484	http://dx.doi.org/10.1126/science.1257484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25278504				2022-12-28	WOS:000342721500049
J	Laundre, JW				Laundre, John W.			How large predators manage the cost of hunting	SCIENCE			English	Editorial Material							ENERGETICS; SUCCESS; FEAR		Univ Calif Riverside, James San Jacinto Mt Nat Reserve, Idyllwild, CA 92549 USA	University of California System; University of California Riverside	Laundre, JW (corresponding author), Univ Calif Riverside, James San Jacinto Mt Nat Reserve, POB 1775, Idyllwild, CA 92549 USA.	john.laundre@ucr.edu						ALDAMA JJ, 1991, J WILDLIFE MANAGE, V55, P635, DOI 10.2307/3809512; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; CORTS KE, 1984, J WILDLIFE MANAGE, V48, P1456, DOI 10.2307/3801820; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Iribarren C, 2012, WILDLIFE BIOL, V18, P194, DOI 10.2981/11-041; Laundre J.W., 2010, OPEN ECOL J, V3, P1, DOI [DOI 10.2174/1874213001003030001, 10.2174/1874213001003030001]; Laundre JW, 2005, J WILDLIFE MANAGE, V69, P723, DOI 10.2193/0022-541X(2005)069[0723:PEAR]2.0.CO;2; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; Scantlebury DM, 2014, SCIENCE, V346, P79, DOI 10.1126/science.1256424; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885	12	8	8	1	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					33	34		10.1126/science.1260170	http://dx.doi.org/10.1126/science.1260170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278597				2022-12-28	WOS:000342446900022
J	Jarvies, D; Coombes, R; Stahl-Timmins, W				Jarvies, Duncan; Coombes, Rebecca; Stahl-Timmins, Will			Open Payments goes live with pharma to doctor fee data: first analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jarvies, Duncan; Coombes, Rebecca; Stahl-Timmins, Will] BMJ, London, England		Jarvies, D (corresponding author), BMJ, London, England.	djarvies@bmj.com						McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5693; Morain SR, 2014, ANN INTERN MED; Ornstein C, 2014, PROPUBLICA      0929; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327	4	14	14	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2014	349								g6003	10.1136/bmj.g6003	http://dx.doi.org/10.1136/bmj.g6003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CF	25273350				2022-12-28	WOS:000342665600012
J	Smith, R; Peedell, C				Smith, Richard; Peedell, Clive			Is the private sector a good thing for the NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE		[Smith, Richard] Patients Know Best, Cambridge, England; [Peedell, Clive] South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England		Smith, R (corresponding author), Patients Know Best, Cambridge, England.	richardswsmith@yahoo.co.uk; clive.peedell@btinternet.com						Al-Ubaydli M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5575; Alliance for Lobbying Transparency, REV DOOR IS UNH; [Anonymous], 2011, IMPR QUAL PRIM CAR; Arora A, 2013, PUBLIC PAYMENT PRIVA; Arrow Kenneth J, 1963, AM EC REV; BLENDON RJ, 1988, JAMA-J AM MED ASSOC, V259, P3587, DOI 10.1001/jama.259.24.3587; Chard J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6404; Davies P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2912; Davis K, 2014, MIRROR MIRROR WALL 2; Dowler C., 2010, HSJ             1217; Ham C., 2014, REFORMING NHS HIERAR; Health Select Committee, 4 HLTH SEL COMM; Manis K, 2013, GP              0211; Muschell J, 1995, TECHNICAL BRIEFING N; National Audit Office, 2012, DEL PUBL SERV MARK P; Paton C., 2014, WHAT COST PAYING PRI; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2688; Smith R., 2012, ALJAZEERA       0520; Soterious M, 2013, GP              0820; Stevens S, 2005, PROSPECT; Watt N., 2014, GUARDIAN; Williams H, 2004, ENVIRON PLANN A, V36, P701, DOI 10.1068/a3616; Woolhandler S, 2007, BRIT MED J, V335, P1126, DOI 10.1136/bmj.39400.549502.94	23	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2014	349								g5865	10.1136/bmj.g5865	http://dx.doi.org/10.1136/bmj.g5865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CA	25270310				2022-12-28	WOS:000342665100009
J	Kay, M				Kay, Meera			Coding a million deaths in India, one interview at a time	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VERBAL AUTOPSY; PERFORMANCE; COUNTRIES; CRITERIA					meerakay@ymail.com						Aleksandrowicz L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-21; BANG AT, 1992, B WORLD HEALTH ORGAN, V70, P499; Dhar A., 2013, HINDU; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-19; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-50; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 26	2014	349								g5800	10.1136/bmj.g5800	http://dx.doi.org/10.1136/bmj.g5800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UT	25261334				2022-12-28	WOS:000342426600006
J	Brittenden, J; Cotton, SC; Elders, A; Ramsay, CR; Norrie, J; Burr, J; Campbell, B; Bachoo, P; Chetter, I; Gough, M; Earnshaw, J; Lees, T; Scott, J; Baker, SA; Francis, J; Tassie, E; Scotland, G; Wileman, S; Campbell, MK				Brittenden, Julie; Cotton, Seonaidh C.; Elders, Andrew; Ramsay, Craig R.; Norrie, John; Burr, Jennifer; Campbell, Bruce; Bachoo, Paul; Chetter, Ian; Gough, Michael; Earnshaw, Jonothan; Lees, Tim; Scott, Julian; Baker, Sara A.; Francis, Jill; Tassie, Emma; Scotland, Graham; Wileman, Samantha; Campbell, Marion K.			A Randomized Trial Comparing Treatments for Varicose Veins	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOVENOUS LASER-ABLATION; CLINICAL-TRIAL; FOAM SCLEROTHERAPY; CONVENTIONAL SURGERY; HIGH LIGATION; THERAPY; SOCIETY; HEALTH; COST	BACKGROUND Ultrasound-guided foam sclerotherapy and endovenous laser ablation are widely used alternatives to surgery for the treatment of varicose veins, but their comparative effectiveness and safety remain uncertain. METHODS In a randomized trial involving 798 participants with primary varicose veins at 11 centers in the United Kingdom, we compared the outcomes of foam, laser, and surgical treatments. Primary outcomes at 6 months were disease-specific quality of life and generic quality of life, as measured on several scales. Secondary outcomes included complications and measures of clinical success. RESULTS After adjustment for baseline scores and other covariates, the mean disease-specific quality of life was slightly worse after treatment with foam than after surgery (P = 0.006) but was similar in the laser and surgery groups. There were no significant differences between the surgery group and the foam or the laser group in measures of generic quality of life. The frequency of procedural complications was similar in the foam group (6%) and the surgery group (7%) but was lower in the laser group (1%) than in the surgery group (P<0.001); the frequency of serious adverse events (approximately 3%) was similar among the groups. Measures of clinical success were similar among the groups, but successful ablation of the main trunks of the saphenous vein was less common in the foam group than in the surgery group (P<0.001). CONCLUSIONS Quality-of-life measures were generally similar among the study groups, with the exception of a slightly worse disease-specific quality of life in the foam group than in the surgery group. All treatments had similar clinical efficacy, but complications were less frequent after laser treatment and ablation rates were lower after foam treatment.	[Brittenden, Julie] Univ Aberdeen, Div Appl Med, Aberdeen AB25 2ZN, Scotland; [Cotton, Seonaidh C.; Elders, Andrew; Ramsay, Craig R.; Norrie, John; Scotland, Graham; Wileman, Samantha; Campbell, Marion K.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZN, Scotland; [Tassie, Emma; Scotland, Graham] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB25 2ZN, Scotland; [Bachoo, Paul] Aberdeen Royal Infirm, NHS Grampian, Dept Vasc Surg, Aberdeen, Scotland; [Burr, Jennifer] Univ St Andrews, Sch Med Med & Biol Sci, St Andrews KY16 9AJ, Fife, Scotland; [Campbell, Bruce] Royal Devon & Exeter Hosp, Dept Vasc Surg, Exeter EX2 5DW, Devon, England; [Chetter, Ian] Hull Royal Infirm, Dept Vasc Surg, Kingston Upon Hull, N Humberside, England; [Gough, Michael] Univ Leeds, Sch Surg, Leeds LS2 9JT, W Yorkshire, England; [Scott, Julian] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Earnshaw, Jonothan] Gloucestershire Royal Hosp, Gloucester, England; [Lees, Tim] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Baker, Sara A.] Royal Bournemouth Hosp, Vasc Surg Unit, Bournemouth, Dorset, England; [Francis, Jill] City Univ London, Sch Hlth Sci, London EC1V 0HB, England	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of St Andrews; University of Exeter; University of Hull; University of Leeds; Saint James's University Hospital; Gloucestershire Royal Hospital; Newcastle Freeman Hospital; Newcastle University - UK; City University London	Brittenden, J (corresponding author), Univ Aberdeen, Div Appl Med, Polwarth Bldg,Foresterhill, Aberdeen AB25 2ZN, Scotland.	j.brittenden@abdn.ac.uk	Campbell, Marion/ABB-7063-2020; Ramsay, Craig/AAD-8249-2021; Elders, Andrew/N-4195-2015; Francis, Jill/AHE-6998-2022	Ramsay, Craig/0000-0003-4043-7349; Elders, Andrew/0000-0003-4172-4702; chetter, ian/0000-0002-2566-6859; Burr, Jennifer/0000-0002-9478-738X; Francis, Jill/0000-0001-5784-8895; Campbell, Marion/0000-0001-5386-4097	Health Technology Assessment Programme of the National Institute for Health Research; Chief Scientist Office [HERU1, NMAHP2, HSRU1] Funding Source: researchfish	Health Technology Assessment Programme of the National Institute for Health Research; Chief Scientist Office	Funded by the Health Technology Assessment Programme of the National Institute for Health Research; Current Controlled Trials number, ISRCTN51995477.	Biemans AAM, 2013, J VASC SURG, V58, P727, DOI 10.1016/j.jvs.2012.12.074; Carradice D, 2011, BRIT J SURG, V98, P501, DOI 10.1002/bjs.7394; Carradice D, 2009, BRIT J SURG, V96, P369, DOI 10.1002/bjs.6556; Christenson JT, 2010, J VASC SURG, V52, P1234, DOI 10.1016/j.jvs.2010.06.104; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Darwood RJ, 2008, BRIT J SURG, V95, P294, DOI 10.1002/bjs.6101; Figueiredo M, 2009, EUR J VASC ENDOVASC, V38, P758, DOI 10.1016/j.ejvs.2009.07.015; Flessenkamper I, 2013, PHLEBOLOGY, V28, P16, DOI 10.1258/phleb.2011.011147; Garratt A M, 1993, Qual Health Care, V2, P5, DOI 10.1136/qshc.2.1.5; Garratt AM, 1996, QUAL LIFE RES, V5, P223, DOI 10.1007/BF00434744; Gloviczki P, 2011, J VASC SURG, V53, p2S, DOI 10.1016/j.jvs.2011.01.079; Klem TMAL, 2009, EUR J VASC ENDOVASC, V37, P232, DOI 10.1016/j.ejvs.2008.08.025; Kundu S, 2007, J VASC SURG, V46, P582, DOI 10.1016/j.jvs.2007.05.025; Lattimer CR, 2012, EUR J VASC ENDOVASC, V43, P594, DOI 10.1016/j.ejvs.2012.01.032; Luebke T, 2008, J CARDIOVASC SURG, V49, P213; Nesbitt C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005624.pub2; Pronk P, 2010, EUR J VASC ENDOVASC, V40, P649, DOI 10.1016/j.ejvs.2010.08.007; Rasmussen LH, 2011, BRIT J SURG, V98, P1079, DOI 10.1002/bjs.7555; Rasmussen LH, 2010, EUR J VASC ENDOVASC, V39, P630, DOI 10.1016/j.ejvs.2009.11.040; Rass K, 2012, ARCH DERMATOL, V148, P49, DOI 10.1001/archdermatol.2011.272; Ratcliffe J, 2006, BRIT J SURG, V93, P182, DOI 10.1002/bjs.5263; Samuel N, 2013, ANN SURG, V257, P419, DOI 10.1097/SLA.0b013e318275f4e4; Shadid N, 2012, BRIT J SURG, V99, P1062, DOI 10.1002/bjs.8781; Smith JJ, 1999, J VASC SURG, V30, P710, DOI 10.1016/S0741-5214(99)70110-2; The CLASS Study, 2010, LANCET; van den Bos R, 2009, J VASC SURG, V49, P230, DOI 10.1016/j.jvs.2008.06.030; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; Wright D, 2006, PHLEBOLOGY, V21, P180, DOI 10.1258/026835506779115807	28	127	136	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1218	1227		10.1056/NEJMoa1400781	http://dx.doi.org/10.1056/NEJMoa1400781			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4WH	25251616	Green Published, Green Accepted			2022-12-28	WOS:000342079700009
J	Denig, P; Schuling, J; Haaijer-Ruskamp, F; Voorham, J				Denig, Petra; Schuling, Jan; Haaijer-Ruskamp, Flora; Voorham, Jaco			Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTOR MANAGEMENT; MEDICATION ADHERENCE; CARE; MELLITUS; QUALITY; DISEASE; INTERVENTIONS; PERCEPTIONS; MEDICINES; SUPPORT	Objective To assess the effects of a patient oriented decision aid for prioritising treatment goals in diabetes compared with usual care on patient empowerment and treatment decisions. Design Pragmatic randomised controlled trial. Setting 18 general practices in the north of the Netherlands. Participants 344 patients with type 2 diabetes aged <= 65 years at the time of diagnosis and managed in primary care between April 2011 and August 2012: 225 were allocated to the intervention group and 119 to the usual care group. Intervention The intervention comprised a decision aid for people with diabetes, with individually tailored risk information and treatment options for multiple risk factors. The aid was intended to empower patients to prioritise between clinical domains and to support treatment decisions. It was offered to participants before a regular diabetes check-up and to their healthcare provider during the consultation. Four different formats of the decision aid were included for additional explorative analyses. Main outcome measures The primary outcome was the effects on patient empowerment for setting and achieving goals. The secondary outcomes were changes in the prescribing of drugs to regulate glucose, blood pressure, lipids, and albuminuria. Data were collected through structured questionnaires and automated data extraction from electronic health records during six months before and after the intervention. Results Of all intervention participants, 103 (46%) reported to have received the basic elements of the intervention. For the primary outcome analysis, 199 intervention and 107 control patients with sufficient baseline and follow-up data could be included. The mean empowerment score increased 0.1 on a 5 point scale in the overall intervention group, which was not significantly different from that of the control group (mean difference after adjusting for baseline 0.039, 95% confidence interval -0.056 to 0.134). Lipid regulating drug treatment was intensified in 25% of intervention and 12% of control participants with increased cholesterol levels, which did not reach significance when the intervention was compared with the usual care group (odds ratio 2.54, 95% confidence interval 0.89 to 7.23). Prespecified explorative analyses showed that this effect was significant for the printed version of the decision aid in comparison to usual care (3.90, 1.29 to 11.80). No relevant or significant changes were seen for other treatments. Conclusion We found no evidence that the patient oriented treatment decision aid improves patient empowerment by an important amount. The aid was not used to its full extent in a substantial number of participants.	[Denig, Petra; Schuling, Jan; Haaijer-Ruskamp, Flora; Voorham, Jaco] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	University of Groningen	Denig, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, POB 30-001, NL-9713 AV Groningen, Netherlands.	p.denig@umcg.nl	Denig, Petra/L-9865-2014	Denig, Petra/0000-0002-7929-4739; Voorham, Jaco/0000-0001-9002-1865	ZonMW-the Netherlands Organisation for Health Research and Development	ZonMW-the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This study has been funded by ZonMW-the Netherlands Organisation for Health Research and Development.	Ali Mohammed K, 2011, J Diabetes Sci Technol, V5, P553; Anderson R, 2000, NAT HIST, V109, P23; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Branda ME, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-301; Breslin M, 2008, PATIENT EDUC COUNS, V73, P465, DOI 10.1016/j.pec.2008.07.024; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Cegala DJ, 2001, J AM GERIATR SOC, V49, P1505, DOI 10.1046/j.1532-5415.2001.4911244.x; Cox K, 2007, BRIT J GEN PRACT, V57, P777; Denig P, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-219; Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x; Elissen A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-117; Frost J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003396; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Hajos TRS, 2011, PATIENT EDUC COUNS, V85, P258, DOI 10.1016/j.pec.2010.08.019; Handelsman Y, 2011, J CLIN HYPERTENS, V13, P613, DOI 10.1111/j.1751-7176.2011.00490.x; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Jones JB, 2011, AM J PREV MED, V40, pS179, DOI 10.1016/j.amepre.2011.01.017; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Linn AJ, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1738; Meddings J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-270; Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; Naik AD, 2008, CIRCULATION, V117, P1361, DOI 10.1161/CIRCULATIONAHA.107.724005; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; O'Connor PJ, 2013, CURR DIABETES REP, V13, P172, DOI 10.1007/s11892-012-0350-z; Pouwer F, 2002, QUAL SAF HEALTH CARE, V11, P131, DOI 10.1136/qhc.11.2.131; Rachmani R, 2005, J AM SOC NEPHROL, V16, pS22, DOI 10.1681/ASN.2004110965; Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220; Ramadas A, 2011, INT J MED INFORM, V80, P389, DOI 10.1016/j.ijmedinf.2011.02.002; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5; Sheehan J, 2012, PATIENT EDUC COUNS, V88, P69, DOI 10.1016/j.pec.2011.11.006; Sidorenkov G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024278; Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Tang PC, 2013, J AM MED INFORM ASSN, V20, P526, DOI 10.1136/amiajnl-2012-001263; van Hateren KJJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001387; Vink NM, 2009, PHARMACOEPIDEM DR S, V18, P159, DOI 10.1002/pds.1698; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Voorham J, 2008, DIABETES CARE, V31, P501, DOI 10.2337/dc07-1043; Voorham J, 2007, J AM MED INFORM ASSN, V14, P349, DOI 10.1197/jamia.M2128; Voorham J, 2011, CLIN THER, V33, P121, DOI 10.1016/j.clinthera.2011.01.024; Voorham J, 2010, PHARMACOEPIDEM DR S, V19, P1078, DOI 10.1002/pds.2023; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	45	43	43	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2014	349								g5651	10.1136/bmj.g5651	http://dx.doi.org/10.1136/bmj.g5651			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP9UR	25255799	hybrid, Green Published			2022-12-28	WOS:000342426400005
J	Gold, KJ; Goldman, EB; Kamil, LH; Walton, S; Burdette, TG; Moseley, KL				Gold, Katherine J.; Goldman, Edward B.; Kamil, Leslie H.; Walton, Sarah; Burdette, Tommy G.; Moseley, Kathryn L.			No Appointment Necessary? Ethical Challenges in Treating Friends and Family	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROFESSIONAL COURTESY; PHYSICIANS; CARE; CHILDREN		[Gold, Katherine J.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Gold, Katherine J.; Goldman, Edward B.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Kamil, Leslie H.] Univ Michigan, Dept Compliance, Ann Arbor, MI 48109 USA; [Walton, Sarah] Univ Michigan, Dept Anesthesia, Ann Arbor, MI 48109 USA; [Burdette, Tommy G.] Univ Michigan, Dept Spiritual Care, Ann Arbor, MI 48109 USA; [Moseley, Kathryn L.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Goldman, Edward B.; Moseley, Kathryn L.] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Goldman, Edward B.] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gold, KJ (corresponding author), Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA.							Aboff BM, 2002, JAMA-J AM MED ASSOC, V288, P381, DOI 10.1001/jama.288.3.381; [Anonymous], 2012, VIRTUAL MENTOR, V14, P396; [Anonymous], 2013, MEDICARE BENEFIT POL; Diekema DS, 2009, PEDIATRICS, V124, P1685, DOI 10.1542/peds.2009-2147; DUSDIEKER LB, 1993, AM J DIS CHILD, V147, P146, DOI 10.1001/archpedi.1993.02160260036018; Gendel MH, 2012, J MED ETHICS, V38, P294, DOI 10.1136/medethics-2011-100167; Jones JW, 2004, J VASC SURG, V39, P1140, DOI 10.1016/j.jvs.2004.01.035; Kreichelt Ray, 2008, J Healthc Risk Manag, V28, P27, DOI 10.1002/jhrm.5600280105; LAPUMA J, 1991, NEW ENGL J MED, V325, P1290, DOI 10.1056/NEJM199110313251806; LEVY MA, 1993, NEW ENGL J MED, V329, P1627, DOI 10.1056/NEJM199311253292207; Reagan B, 1994, Arch Fam Med, V3, P599, DOI 10.1001/archfami.3.7.599; Sansome R A, 1995, Arch Fam Med, V4, P686, DOI 10.1001/archfami.4.8.686; Schneider M, 2007, SWISS MED WKLY, V137, P121; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Strong Carson, 2013, J Clin Ethics, V24, P41; WASSERMAN RC, 1989, PEDIATRICS, V83, P319	16	16	16	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1254	1258		10.1056/NEJMsb1402963	http://dx.doi.org/10.1056/NEJMsb1402963			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25251620				2022-12-28	WOS:000342079700015
J	Kempton, EMR				Kempton, Eliza M. R.			Window on a watery world	NATURE			English	Editorial Material									Grinnell Coll, Grinnell, IA 50112 USA		Kempton, EMR (corresponding author), Grinnell Coll, Grinnell, IA 50112 USA.	kemptone@grinnell.edu		Kempton, Eliza/0000-0002-1337-9051				Florensky C. P., 1977, P LUNAR PLANET SCI C, P2655; Fraine J, 2014, NATURE, V513, P526, DOI 10.1038/nature13785; Knutson HA, 2014, NATURE, V505, P66, DOI 10.1038/nature12887; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888	4	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					493	494		10.1038/513493a	http://dx.doi.org/10.1038/513493a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254470				2022-12-28	WOS:000342075800025
J	Orhon, D				Orhon, Derin			Istanbul canal needs environmental study	NATURE			English	Editorial Material									Istanbul Tech Univ, Istanbul, Turkey	Istanbul Technical University	Orhon, D (corresponding author), Istanbul Tech Univ, Istanbul, Turkey.	orhon@itu.edu.tr							0	4	4	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					461	461		10.1038/513461a	http://dx.doi.org/10.1038/513461a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254439	Bronze			2022-12-28	WOS:000342075800006
J	Ramos, JA; Festic, E				Ramos, Juan A.; Festic, Emir			Catastrophic Gastroduodenal Pneumatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ramos, Juan A.; Festic, Emir] Mayo Clin, Jacksonville, FL 32224 USA	Mayo Clinic	Ramos, JA (corresponding author), Mayo Clin, Jacksonville, FL 32224 USA.	juan_ramos66@hotmail.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					E19	E19		10.1056/NEJMicm1313058	http://dx.doi.org/10.1056/NEJMicm1313058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4WH	25251633				2022-12-28	WOS:000342079700001
J	Kannu, P; Howard, A				Kannu, Peter; Howard, Andrew			Perthes' disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN; AGE; HIP		[Kannu, Peter; Howard, Andrew] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Howard, A (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.howard@sickkids.ca		Howard, Andrew/0000-0001-7226-6471				Bahmanyar S, 2008, PEDIATRICS, V122, pE459, DOI 10.1542/peds.2008-0307; CHUNG SMK, 1976, J BONE JOINT SURG AM, V58, P961, DOI 10.2106/00004623-197658070-00011; De Inocencio J, 2004, ARCH DIS CHILD, V89, P431, DOI 10.1136/adc.2003.028860; HALL AJ, 1983, BRIT MED J, V287, P1757, DOI 10.1136/bmj.287.6407.1757; Herring John Anthony, 2011, J Pediatr Orthop, V31, pS137, DOI 10.1097/BPO.0b013e318223b52d; Jandial S, 2009, J PEDIATR-US, V154, P267, DOI 10.1016/j.jpeds.2008.08.013; Joseph B, 2003, J PEDIATR ORTHOPED, V23, P590, DOI 10.1097/01241398-200309000-00005; Kim Harry K W, 2011, J Pediatr Orthop, V31, pS141, DOI 10.1097/BPO.0b013e318223b4bd; Lee ST, 2007, J PEDIATR ORTHOPED, V27, P198, DOI 10.1097/01.bpb.0000242381.89510.e5; Nguyen NAT, 2012, J PEDIATR ORTHOPED, V32, P697, DOI 10.1097/BPO.0b013e318269c55d; Perry DC, 2012, AM J EPIDEMIOL, V175, P159, DOI 10.1093/aje/kwr293; Rich MM, 2013, J PEDIATR ORTHOPED, V33, P112, DOI 10.1097/BPO.0b013e318281ab44; Wiig O, 2008, J BONE JOINT SURG BR, V90B, P1364, DOI 10.1302/0301-620X.90B10.20649	13	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2014	349								g5584	10.1136/bmj.g5584	http://dx.doi.org/10.1136/bmj.g5584			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UL	25248443				2022-12-28	WOS:000342425700003
J	Hurley, R				Hurley, Richard			Which doctors have been shortlisted for the BMJ Awards India 2014?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE					rhurley@bmj.com						D'Silva J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5454; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4540	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2014	349								g5662	10.1136/bmj.g5662	http://dx.doi.org/10.1136/bmj.g5662			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OW	25230917	Bronze, Green Published			2022-12-28	WOS:000342058300016
J	Martyn, C				Martyn, Christopher			Risky business: doctors' understanding of statistics As medicine becomes increasingly preventive, doctors need a good grasp of risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												christopher.martyn@gmail.com						CASSCELLS W, 1978, NEW ENGL J MED, V299, P999, DOI 10.1056/NEJM197811022991808; Goldacre B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4745; Manrai AK, 2014, JAMA INTERN MED, V174, P991, DOI 10.1001/jamainternmed.2014.1059	3	8	8	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2014	349								g5619	10.1136/bmj.g5619	http://dx.doi.org/10.1136/bmj.g5619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OW	25230984				2022-12-28	WOS:000342058300009
J	Gagne, JJ; Choudhry, NK; Kesselheim, AS; Polinski, JM; Hutchins, D; Matlin, OS; Brennan, TA; Avorn, J; Shrank, WH				Gagne, Joshua J.; Choudhry, Niteesh K.; Kesselheim, Aaron S.; Polinski, Jennifer M.; Hutchins, David; Matlin, Olga S.; Brennan, Troyen A.; Avorn, Jerry; Shrank, William H.			Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							POSITIVE PREDICTIVE-VALUE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; MEDICATION ADHERENCE; CHOLESTEROL LEVELS; PROPENSITY SCORE; HEART-DISEASE; CANCER-RISK; METAANALYSIS; THERAPY	Background: Statins are effective in preventing cardiovascular events, but patients do not fully adhere to them. Objective: To determine whether patients are more adherent to generic statins versus brand-name statins (lovastatin, pravastatin, or simvastatin) and whether greater adherence improves health outcomes. Design: Observational, propensity score-matched, new-user cohort study. Setting: Linked electronic data from medical and pharmacy claims. Participants: Medicare beneficiaries aged 65 years or older with prescription drug coverage between 2006 and 2008. Intervention: Initiation of a generic or brand-name statin. Measurements: Adherence to statin therapy (measured as the proportion of days covered [PDC] up to 1 year) and a composite outcome comprising hospitalization for an acute coronary syndrome or stroke and all-cause mortality. Hazard ratios (HRs) and absolute rate differences were estimated. Results: A total of 90 111 patients who initiated a statin during the study was identified; 83 731 (93%) initiated a generic drug, and 6380 (7%) initiated a brand-name drug. The mean age of patients was 75.6 years, and most (61%) were female. The average PDC was 77% for patients in the generic group and 71% for those in the brand-name group (P < 0.001). An 8% reduction in the rate of the clinical outcome was observed among patients in the generic group versus those in the brand-name group (HR, 0.92 [95% CI, 0.86 to 0.99]). The absolute difference was -1.53 events per 100 person-years (CI, -2.69 to -0.19 events per 100 person-years). Limitation: Results may not be generalizable to other populations with different incomes or drug benefit structures. Conclusion: Compared with those initiating brand-name statins, patients initiating generic statins were more likely to adhere and had a lower rate of a composite clinical outcome.	[Gagne, Joshua J.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Gagne, Joshua J.] Harvard Univ, Sch Med, Boston, MA 02120 USA; CVS Caremark, Woonsocket, RI 02895 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gagne, JJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	jgagne1@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Teva Pharmaceuticals [2010A057139]	Teva Pharmaceuticals(Teva Pharmaceutical Industries)	By Teva Pharmaceuticals (2010A057139).	[Anonymous], 1998, N ENGL J MED, V339, P1349; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Boudreau DM, 2010, EXPERT OPIN DRUG SAF, V9, P603, DOI 10.1517/14740331003662620; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Choudhry NK, 2008, J GEN INTERN MED, V23, P216, DOI 10.1007/s11606-007-0478-8; Choudhry NK, 2012, J AM COLL CARDIOL, V60, P1817, DOI 10.1016/j.jacc.2012.06.050; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Claxton G, 2012, EMPLOYER HLTH BENEFI; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Desai NR, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0322-6; Federman AD, 2007, MED CARE, V45, P109, DOI 10.1097/01.mlr.0000250293.24939.2e; Federman AD, 2006, AM J MANAG CARE, V12, P611; Gagne JJ, 2011, JAMA-J AM MED ASSOC, V305, P711, DOI 10.1001/jama.2011.152; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Glynn RJ, 2001, EPIDEMIOLOGY, V12, P682, DOI 10.1097/00001648-200111000-00017; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Green JB, 2013, JAMA INTERN MED, V173, P229, DOI 10.1001/jamainternmed.2013.1529; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; IMS Institute for Healthcare Informatics, 2011, US MED US RE 2010; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kesselheim AS, 2010, DRUGS, V70, P605, DOI 10.2165/10898530-000000000-00000; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Setoguchi S, 2007, CIRCULATION, V115, P27, DOI 10.1161/CIRCULATIONAHA.106.650176; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shrank WH, 2007, J GEN INTERN MED, V22, P1298, DOI 10.1007/s11606-007-0284-3; Shrank WH, 2011, AM J MED, V124, P309, DOI 10.1016/j.amjmed.2010.11.020; Shrank WH, 2011, J GEN INTERN MED, V26, P546, DOI 10.1007/s11606-010-1609-1; Shroufi A, 2010, J EPIDEMIOL COMMUN H, V64, P109, DOI 10.1136/jech.2009.091033; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Taira DA, 2006, AM J MANAG CARE, V12, P678; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; United States Food and Drug Administration, 2012, OR BOOK APPR DRUG PR; Varas-Lorenzo C, 2008, PHARMACOEPIDEM DR S, V17, P842, DOI 10.1002/pds.1619	42	126	127	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					400	U56		10.7326/M13-2942	http://dx.doi.org/10.7326/M13-2942			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222387	Green Published			2022-12-28	WOS:000343894400015
J	Granwehr, B				Granwehr, Bruno			Review: Influenza vaccine reduces influenza-like illness in healthy adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Granwehr, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.		Granwehr, Bruno/S-3997-2019	Granwehr, Bruno/0000-0002-5143-6416				Chu HY, 2014, CLIN INFECT DIS, V59, P560, DOI 10.1093/cid/ciu327; Cooksley CD, 2005, CANCER-AM CANCER SOC, V104, P618, DOI 10.1002/cncr.21203; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Pollyea DA, 2010, J CLIN ONCOL, V28, P2481, DOI 10.1200/JCO.2009.26.6908	4	1	1	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC6	10.7326/0003-4819-161-6-201409160-02006	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222418				2022-12-28	WOS:000343894400005
J	de Glas, NA; de Craen, AJM; Bastiaannet, E; 't Land, EGO; Kiderlen, M; van de Water, W; Siesling, S; Portielje, JEA; Schuttevaer, HM; de Bock, GH; van de Velde, CJH; Liefers, GJ				de Glas, Nienke A.; de Craen, Anton J. M.; Bastiaannet, Esther; 't Land, Ester G. Op; Kiderlen, Mandy; van de Water, Willemien; Siesling, Sabine; Portielje, Johanneke E. A.; Schuttevaer, Herman M.; de Bock, Geertruida (Truuske) H.; van de Velde, Cornelis J. H.; Liefers, Gerrit-Jan			Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAMMOGRAPHY; MORTALITY; SURVIVAL; BIAS	Objective To assess the incidence of early stage and advanced stage breast cancer before and after the implementation of mass screening in women aged 70-75 years in the Netherlands in 1998. Design Prospective nationwide population based study. Setting National cancer registry, the Netherlands. Participants Patients aged 70-75 years with a diagnosis of invasive or ductal carcinoma in situ breast cancer between 1995 and 2011 (n=25 414). Incidence rates were calculated using population data from Statistics Netherlands. Main outcome measure Incidence rates of early stage (I, II, or ductal carcinoma in situ) and advanced stage (III and IV) breast cancer before and after implementation of screening. Hypotheses were formulated before data collection. Results The incidence of early stage tumours significantly increased after the extension for implementation of screening (248.7 cases per 100 000 women before screening up to 362.9 cases per 100 000 women after implementation of screening, incidence rate ratio 1.46, 95% confidence interval 1.40 to 1.52, P<0.001). However, the incidence of advanced stage breast cancers decreased to a far lesser extent (58.6 cases per 100 000 women before screening to 51.8 cases per 100 000 women after implementation of screening, incidence rate ratio 0.88, 0.81 to 0.97, P<0.001). Conclusions The extension of the upper age limit to 75 years has only led to a small decrease in incidence of advanced stage breast cancer, while that of early stage tumours has strongly increased.	[de Glas, Nienke A.; de Craen, Anton J. M.; Bastiaannet, Esther; 't Land, Ester G. Op; Kiderlen, Mandy; van de Velde, Cornelis J. H.; Liefers, Gerrit-Jan] Leiden Univ, Med Ctr, Dept Surg, NL-2300 RC Leiden, Netherlands; [de Glas, Nienke A.; de Craen, Anton J. M.; Bastiaannet, Esther; Kiderlen, Mandy; van de Water, Willemien] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Siesling, Sabine] Ctr Comprehens Canc, Dept Res, Utrecht, Netherlands; [Portielje, Johanneke E. A.] Haga Hosp, Dept Med Oncol, The Hague, Netherlands; [Schuttevaer, Herman M.] Rijnland Hosp Leiderdorp, Dept Radiol, Leiderdorp, Netherlands; [de Bock, Geertruida (Truuske) H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; Rijnland Hospital; University of Groningen	Liefers, GJ (corresponding author), Leiden Univ, Med Ctr, Dept Surg, POB 9600,Postzone K6-R, NL-2300 RC Leiden, Netherlands.	G.J.Liefers@lumc.nl	van de Velde, Cornelis/AAY-8360-2020; de Glas, Nienke A/AAL-3546-2021; de Bock, Geertruida H./F-6529-2014	de Glas, Nienke/0000-0001-8350-4252; de Bock, Geertruida H./0000-0003-3104-4471; portielje, johanna/0000-0002-5169-6306	Alpe d'Huzes Foundation [UL-2011-5263]	Alpe d'Huzes Foundation	This study was funded by the Alpe d'Huzes Foundation (UL-2011-5263). The funding source was not involved in any part of the study design, data collection, analyses or drafting of the manuscript. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Aarts MJ, 2011, BREAST CANCER RES TR, V128, P517, DOI 10.1007/s10549-011-1363-z; [Anonymous], 2009, Ann Intern Med, V151, pI, DOI 10.7326/0003-4819-151-9-200911030-00002; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Autier P, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-163; Badgwell BD, 2008, J CLIN ONCOL, V26, P2482, DOI 10.1200/JCO.2007.12.8058; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Braithwaite D, 2010, JNCI-J NATL CANCER I, V102, P1468, DOI 10.1093/jnci/djq344; Broeders MJM, 2002, J MED SCREEN, V9, P163, DOI 10.1136/jms.9.4.163; Cox B, 2013, BREAST, V22, P1041, DOI 10.1016/j.breast.2013.07.046; de Glas NA, 2013, BREAST CANCER RES TR, V138, P561, DOI 10.1007/s10549-013-2462-9; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Esserman LJ, 2011, BREAST CANCER RES TR, V130, P725, DOI 10.1007/s10549-011-1748-z; Fracheboud J, 2006, INT J CANCER, V118, P2020, DOI 10.1002/ijc.21560; Fracheboud J, 2009, NATL EVALUATION BREA, P1; Galit W, 2007, MATURITAS, V57, P109, DOI 10.1016/j.maturitas.2007.01.010; Helvie MA, 2014, CANCER-AM CANCER SOC, V120, P2649, DOI 10.1002/cncr.28784; Hurria A, 2005, BREAST CANCER RES TR, V92, P151, DOI 10.1007/s10549-005-1410-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lousdal ML, 2014, EUR J PUBLIC HLTH; NABON, 2012, RICHTL MAMM VERS 2 0; Nederend J, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3091; NHS Breast Screening Programme, 2012, EV AG EXT NHS BREAST; Otto SJ, 2003, LANCET, V361, P1411, DOI 10.1016/S0140-6736(03)13132-7; Otto SJ, 2012, CANCER EPIDEM BIOMAR, V21, P66, DOI 10.1158/1055-9965.EPI-11-0476; Paesmans M, 2010, MATURITAS, V66, P263, DOI 10.1016/j.maturitas.2010.03.016; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; PELIKAN S, 1993, CANCER, V71, P1998, DOI 10.1002/1097-0142(19930315)71:6<1998::AID-CNCR2820710613>3.0.CO;2-P; Van de Water W, 2012, ASS AGE DIAGNOSIS DI, V307, P590; van de Water W, 2012, ONCOLOGIST, V17, P55, DOI 10.1634/theoncologist.2011-0037; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Walter LC, 2014, JAMA-J AM MED ASSOC, V311, P1336, DOI 10.1001/jama.2014.2834; Zackrisson S, 2007, SCAND J PUBLIC HEALT, V35, P548, DOI 10.1080/14034940701291716	33	27	27	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2014	349								g5410	10.1136/bmj.g5410	http://dx.doi.org/10.1136/bmj.g5410			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ5KC	25224469	Green Published, hybrid			2022-12-28	WOS:000367140300001
J	Chen, L; Xiao, S; Pang, K; Zhou, CM; Yuan, XL				Chen, Lei; Xiao, Shuhai; Pang, Ke; Zhou, Chuanming; Yuan, Xunlai			Cell differentiation and germ-soma separation in Ediacaran animal embryo-like fossils	NATURE			English	Article							NEOPROTEROZOIC DOUSHANTUO FORMATION; ORIGIN; WENGAN; ALGAE; MICROFOSSILS; EVOLUTION; GUIZHOU; CHINA	Phosphorites of the Ediacaran Doushantuo Formation (similar to 600 million years old) yield spheroidal microfossils with a palintomic cell cleavage pattern(1,2). These fossils have been variously interpreted as sulphur-oxidizing bacteria(3), unicellular protists(4), mesomycetozoean-like holozoans(5), green algae akin to Volvox(6,7), and blastula embryos of early metazoans(1,2,8-10) or bilaterian animals(11,12). However, their complete life cycle is unknown and it is uncertain whether they had a cellularly differentiated ontogenetic stage, making it difficult to test their various phylogenetic interpretations. Here we describe new spheroidal fossils from black phosphorites of the Doushantuo Formation that have been overlooked in previous studies. These fossils represent later developmental stages of previously published blastula-like fossils, and they show evidence for cell differentiation, germ-soma separation, and programmed cell death. Their complex multicellularity is inconsistent with a phylogenetic affinity with bacteria, unicellular protists, or mesomycetozoean-like holozoans. Available evidence also indicates that the Doushantuo fossils are unlikely crown-group animals or volvocine green algae. We conclude that an affinity with cellularly differentiated multicellular eukaryotes, including stem-group animals or algae, is likely but more data are needed to constrain further the exact phylogenetic affinity of the Doushantuo fossils.	[Chen, Lei; Pang, Ke; Zhou, Chuanming; Yuan, Xunlai] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Lei; Pang, Ke; Zhou, Chuanming; Yuan, Xunlai] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Key Lab Econ Stratig & Palaeogeog, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Lei; Pang, Ke] Univ Chinese Acad Sci, Coll Earth Sci, Beijing 100049, Peoples R China; [Xiao, Shuhai] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA; [Yuan, Xunlai] NW Univ Xian, Dept Geol, Xian 710069, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Virginia Polytechnic Institute & State University; Northwest University Xi'an	Xiao, S (corresponding author), Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA.	xiao@vt.edu; xlyuan@nigpas.ac.cn	Zhou, Chuanming/E-5313-2010; Xiao, Shuhai/A-2190-2009	Xiao, Shuhai/0000-0003-4655-2663; Pang, Ke/0000-0001-9995-7627	Ministry of Science and Technology of China; National Natural Science Foundation of China; Chinese Academy of Sciences; US National Science Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); US National Science Foundation(National Science Foundation (NSF))	This work was supported by the Ministry of Science and Technology of China, National Natural Science Foundation of China, Chinese Academy of Sciences, and the US National Science Foundation. We thank Q. Fu, S. Golubic, F. Meng, and D. Wang for discussion.	Bailey JV, 2007, NATURE, V445, P198, DOI 10.1038/nature05457; Bengtson S, 2004, SCIENCE, V306; Bengtson S, 2012, EVOL DEV, V14, P421, DOI 10.1111/j.1525-142X.2012.00562.x; Boyle RA, 2007, GEOBIOLOGY, V5, P337, DOI 10.1111/j.1472-4669.2007.00115.x; Butterfield NJ, 2011, SCIENCE, V334, P1655, DOI 10.1126/science.1216125; Chen JY, 2009, P NATL ACAD SCI USA, V106, P19056, DOI 10.1073/pnas.0904805106; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Cunningham JA, 2012, P ROY SOC B-BIOL SCI, V279, P2369, DOI 10.1098/rspb.2011.2280; GREEN KJ, 1981, J CELL BIOL, V91, P743, DOI 10.1083/jcb.91.3.743; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Herron MD, 2013, BIOL REV, V88, P844, DOI 10.1111/brv.12031; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Huldtgren T, 2011, SCIENCE, V334, P1696, DOI 10.1126/science.1209537; Kirk DL., 1998, VOLVOX MOL GENETIC O; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Li SX, 2010, CHINESE SCI BULL, V55, P114, DOI 10.1007/s11434-009-0650-0; Liu Peng-ju, 2009, Acta Geoscientia Sinica, V30, P457; Marshall WL, 2010, MOL BIOL EVOL, V27, P2014, DOI 10.1093/molbev/msq078; Mikhailov KV, 2009, BIOESSAYS, V31, P758, DOI 10.1002/bies.200800214; Raff EC, 2006, P NATL ACAD SCI USA, V103, P5846, DOI 10.1073/pnas.0601536103; Schiffbauer JD, 2012, GEOLOGY, V40, P223, DOI 10.1130/G32546.1; Umen JG, 2012, ADV BOT RES, V64, P185, DOI 10.1016/B978-0-12-391499-6.00006-2; Xiao S., 2012, SCIENCE, V335, p1169c; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2004, AM J BOT, V91, P214, DOI 10.3732/ajb.91.2.214; Xiao SH, 2002, PALEOBIOLOGY, V28, P244, DOI 10.1666/0094-8373(2002)028<0244:MTAMON>2.0.CO;2; Xiao SH, 2007, NATURE, V446, pE9, DOI 10.1038/nature05753; Xiao SH, 2014, J PALEONTOL, V88, P1, DOI 10.1666/12-157R; Xue Yao-song, 1995, Acta Palaeontologica Sinica, V34, P688; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682; Yin Zong-jun, 2008, Acta Palaeontologica Sinica, V47, P477; Yin ZJ, 2014, GONDWANA RES, V25, P1019, DOI 10.1016/j.gr.2013.01.008; Yin ZJ, 2013, PRECAMBRIAN RES, V225, P44, DOI 10.1016/j.precamres.2011.08.011; Zhou CM, 2002, CHINESE SCI BULL, V47, P1918, DOI 10.1360/02tb9419	36	64	73	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					238	+		10.1038/nature13766	http://dx.doi.org/10.1038/nature13766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25252979				2022-12-28	WOS:000346383500043
J	Laptook, AR				Laptook, Abbot R.			Neonatal and infant death: the Apgar score reassessed	LANCET			English	Editorial Material							CHILDHOOD OUTCOMES; CEREBRAL-PALSY; HYPOTHERMIA; ENCEPHALOPATHY		Women & Infants Hosp Rhode Isl, Providence, RI 02903 USA	Women & Infants Hospital Rhode Island	Laptook, AR (corresponding author), Women & Infants Hosp Rhode Isl, Providence, RI 02903 USA.	alaptook@wihri.org						American Academy of Pediatrics American Heart Association, 2011, NEON RES TXB; American College of Obstetricians and Gynecologists American Academy of Pediatrics, 2014, NEON ENC NEUR OUTC; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; APGAR V, 1958, JAMA-J AM MED ASSOC, V168, P1985, DOI 10.1001/jama.1958.03000150027007; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Bharti B, 2005, J CLIN EPIDEMIOL, V58, P121, DOI 10.1016/j.jclinepi.2004.04.012; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; DRAGE JS, 1964, OBSTET GYNECOL, V24, P222; Iliodromiti S, 2014, LANCET; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069072; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Stark AR, 2006, PEDIATRICS, V117, P1444, DOI 10.1542/peds.2006-0325	15	2	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1727	1728		10.1016/S0140-6736(14)61305-2	http://dx.doi.org/10.1016/S0140-6736(14)61305-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25236410				2022-12-28	WOS:000345116400007
J	Long, GV; Stroyakovskiy, D; Gogas, H; Levchenko, E; de Braud, F; Larkin, J; Garbe, C; Jouary, T; Hauschild, A; Grob, JJ; Sileni, VC; Lebbe, C; Mandala, M; Millward, M; Arance, A; Bondarenko, I; Haanen, JBAG; Hansson, J; Utikal, J; Ferraresi, V; Kovalenko, N; Mohr, P; Probachai, V; Schadendorf, D; Nathan, P; Robert, C; Ribas, A; DeMarini, DJ; Irani, JG; Casey, M; Ouellet, D; Martin, AM; Le, N; Patel, K; Flaherty, K				Long, G. V.; Stroyakovskiy, D.; Gogas, H.; Levchenko, E.; de Braud, F.; Larkin, J.; Garbe, C.; Jouary, T.; Hauschild, A.; Grob, J. J.; Sileni, V. Chiarion; Lebbe, C.; Mandala, M.; Millward, M.; Arance, A.; Bondarenko, I.; Haanen, J. B. A. G.; Hansson, J.; Utikal, J.; Ferraresi, V.; Kovalenko, N.; Mohr, P.; Probachai, V.; Schadendorf, D.; Nathan, P.; Robert, C.; Ribas, A.; DeMarini, D. J.; Irani, J. G.; Casey, M.; Ouellet, D.; Martin, A. -M.; Le, N.; Patel, K.; Flaherty, K.			Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC MELANOMA; RAF INHIBITORS; ACQUIRED-RESISTANCE; IMPROVED SURVIVAL; SOLID TUMORS; DABRAFENIB; MUTATIONS; TRIAL; VEMURAFENIB; PROGRESSION	BACKGROUND Combined BRAF and MEK inhibition, as compared with BRAF inhibition alone, delays the emergence of resistance and reduces toxic effects in patients who have melanoma with BRAF V600E or V600K mutations. METHODS In this phase 3 trial, we randomly assigned 423 previously untreated patients who had unresectable stage IIIC or stage IV melanoma with a BRAF V600E or V600K mutation to receive a combination of dabrafenib (150 mg orally twice daily) and trametinib (2 mg orally once daily) or dabrafenib and placebo. The primary end point was progression-free survival. Secondary end points included overall survival, response rate, response duration, and safety. A preplanned interim overall survival analysis was conducted. RESULTS The median progression-free survival was 9.3 months in the dabrafenib-trametinib group and 8.8 months in the dabrafenib-only group (hazard ratio for progression or death in the dabrafenib-trametinib group, 0.75; 95% confidence interval [CI], 0.57 to 0.99; P = 0.03). The overall response rate was 67% in the dabrafenib-trametinib group and 51% in the dabrafenib-only group (P = 0.002). At 6 months, the interim overall survival rate was 93% with dabrafenib-trametinib and 85% with dabrafenib alone (hazard ratio for death, 0.63; 95% CI, 0.42 to 0.94; P = 0.02). However, a specified efficacy-stopping boundary (two-sided P = 0.00028) was not crossed. Rates of adverse events were similar in the two groups, although more dose modifications occurred in the dabrafenib-trametinib group. The rate of cutaneous squamous-cell carcinoma was lower in the dabrafenib-trametinib group than in the dabrafenib-only group (2% vs. 9%), whereas pyrexia occurred in more patients (51% vs. 28%) and was more often severe (grade 3, 6% vs. 2%) in the dabrafenib-trametinib group. CONCLUSIONS A combination of dabrafenib and trametinib, as compared with dabrafenib alone, improved the rate of progression-free survival in previously untreated patients who had metastatic melanoma with BRAF V600E or V600K mutations.	[Long, G. V.] Univ Sydney, Melanoma Inst Australia, Mater Hosp, Sydney, NSW 2006, Australia; [Millward, M.] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Stroyakovskiy, D.] Moscow City Oncol Hosp 62, Moscow, Russia; [Levchenko, E.] Petrov Res Inst Oncol, St Petersburg, Russia; [Kovalenko, N.] Volograd Reg Oncol Dispensary 3, Volzhsky, Russia; [Gogas, H.] Univ Athens, GR-10679 Athens, Greece; [de Braud, F.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Sileni, V. Chiarion] Veneto Oncol Inst IRCCS, Padua, Italy; [Mandala, M.] Papa Giovanni XXIII Hosp, Bergamo, Italy; [Ferraresi, V.] Regina Elena Inst Canc Res, Rome, Italy; [Larkin, J.] Royal Marsden NHS Fdn Trust, London, England; [Nathan, P.] Mt Vernon Canc Ctr, Northwood, Middx, England; [Garbe, C.] Univ Tubingen, Tubingen, Germany; [Hauschild, A.] Univ Hosp Schleswig Holstein, Kiel, Germany; [Utikal, J.] Heidelberg Univ, German Canc Res Ctr DKFZ, Mannheim, Germany; [Utikal, J.] Heidelberg Univ, Univ Med Ctr Mannheim, Mannheim, Germany; [Utikal, J.] Heidelberg Univ, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Utikal, J.] Heidelberg Univ, Univ Med Ctr Mannheim, Heidelberg, Germany; [Mohr, P.] Elbe Kliniken Stade Buxtehude, Buxtehude, Germany; [Stroyakovskiy, D.] Univ Hosp Essen, Essen, Germany; [Jouary, T.] Hop Francois Mitterrand, Pau, France; [Grob, J. J.] Hop Enfants La Timone, Marseille, France; [Lebbe, C.] Hop St Louis, Paris, France; [Robert, C.] Inst Gustave Roussy, Villejuif, France; [Arance, A.] Hosp Clin Barcelona, Barcelona, Spain; [Bondarenko, I.] Dnipropetrovsk Med Acad, Clin Hosp 4, Dnepropetrovsk, Ukraine; [Probachai, V.] Dnipropetrovsk State Council, Dnipropetrovsk Clin Oncol Ctr, Dnepropetrovsk, Ukraine; [Haanen, J. B. A. G.] Netherlands Canc Inst, Amsterdam, Netherlands; [Hansson, J.] Karolinska Inst, Stockholm, Sweden; [Ribas, A.] Univ Calif Los Angeles, Los Angeles, CA USA; [DeMarini, D. J.; Irani, J. G.; Casey, M.; Martin, A. -M.; Le, N.; Patel, K.] GlaxoSmithKline, Collegeville, PA USA; [Ouellet, D.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Flaherty, K.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Melanoma Institute Australia; University of Sydney; University of Western Australia; N.N. Petrov Research Institute of Oncology; National & Kapodistrian University of Athens; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Istituto Oncologico Veneto (IOV); ASST Papa Giovanni XXIII; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Royal Marsden NHS Foundation Trust; Mount Vernon Cancer Centre; Eberhard Karls University of Tubingen; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Duisburg Essen; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; University of Barcelona; Hospital Clinic de Barcelona; Dnipro State Medical University; Netherlands Cancer Institute; Karolinska Institutet; University of California System; University of California Los Angeles; GlaxoSmithKline; GlaxoSmithKline; Harvard University; Massachusetts General Hospital	Long, GV (corresponding author), Univ Sydney, Melanoma Inst Australia, 40 Rocklands Rd, Sydney, NSW 2060, Australia.	georgina.long@sydney.edu.au	ferraresi, virginia/ABH-7898-2020; Haanen, John/AAD-8534-2022; sileni, vanna chiarion/B-9042-2018; Haanen, John/AAD-8578-2022; Robert, Caroline/G-6157-2018; Schadendorf, Dirk/AAE-8206-2019; Ferraresi, Virginia/A-2075-2019; de Braud, Filippo/B-9997-2017; Bondarenko, Igor N/GQP-1497-2022; Levchenko, Evgeny/X-8697-2018; Bondarenko, Igor/W-9412-2019; Bondarenko, Igor/U-5156-2017; mandala, mario/AAB-8637-2022; Mandala', Mario/AAA-4258-2019; Long, Georgina V/C-1771-2013; Kovalenko, Nadezhda/AAG-6298-2021; Garbe, Claus/ABH-2128-2021	ferraresi, virginia/0000-0001-6419-1668; Haanen, John/0000-0001-5884-7704; sileni, vanna chiarion/0000-0001-9191-9124; Robert, Caroline/0000-0002-9493-0238; de Braud, Filippo/0000-0003-0103-730X; Bondarenko, Igor N/0000-0002-7071-2471; Levchenko, Evgeny/0000-0003-3837-2515; Bondarenko, Igor/0000-0002-7071-2471; Bondarenko, Igor/0000-0002-7071-2471; Long, Georgina V/0000-0001-8894-3545; Garbe, Claus/0000-0001-8530-780X; Nathan, Paul/0000-0002-2327-3250; Utikal, Jochen/0000-0001-5316-0241; Larkin, James/0000-0001-5569-9523; Stroyakovskiy, Daniil/0000-0003-1973-1092; Grob, Jean-Jacques/0000-0002-0667-153X; Arance, Ana/0000-0003-2896-1957	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Supported by GlaxoSmithKline.	Ascierto PA, 2013, J CLIN ONCOL, V31, P3205, DOI 10.1200/JCO.2013.49.8691; Callahan MK, 2012, NEW ENGL J MED, V367, P2316, DOI 10.1056/NEJMoa1208958; Chapman PB, 2012, J CLIN ONCOL, V30; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2013, J CLIN ONCOL, V31; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Infante J.R., 2011, J CLIN ONCOL, V29, P8503; Lee CI, 2014, MELANOMA RES, V24, P468, DOI 10.1097/CMR.0000000000000110; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312	30	1189	1209	2	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1877	1888		10.1056/NEJMoa1406037	http://dx.doi.org/10.1056/NEJMoa1406037			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25265492	Green Published			2022-12-28	WOS:000344709800005
J	Wang, KL; Jiang, K; Chung, B; Ouchi, T; Burke, PJ; Boysen, DA; Bradwell, DJ; Kim, H; Muecke, U; Sadoway, DR				Wang, Kangli; Jiang, Kai; Chung, Brice; Ouchi, Takanari; Burke, Paul J.; Boysen, Dane A.; Bradwell, David J.; Kim, Hojong; Muecke, Ulrich; Sadoway, Donald R.			Lithium-antimony-lead liquid metal battery for grid-level energy storage	NATURE			English	Article							ALLOYS; MAGNESIUM; SYSTEMS	The ability to store energy on the electric grid would greatly improve its efficiency and reliability while enabling the integration of intermittent renewable energy technologies (such as wind and solar) into baseload supply(1-4). Batteries have long been considered strong candidate solutions owing to their small spatial footprint, mechanical simplicity and flexibility in siting. However, the barrier to widespread adoption of batteries is their high cost. Here we describe a lithium-antimony-lead liquid metal battery that potentially meets the performance specifications for stationary energy storage applications. This Li parallel to Sb-Pb battery comprises a liquid lithium negative electrode, a molten salt electrolyte, and a liquid antimony-lead alloy positive electrode, which self-segregate by density into three distinct layers owing to the immiscibility of the contiguous salt and metal phases. The all-liquid construction confers the advantages of higher current density, longer cycle life and simpler manufacturing of large-scale storage systems (because no membranes or separators are involved) relative to those of conventional batteries(5,6). At charge-discharge current densities of 275 milliamperes per square centimetre, the cells cycled at 450 degrees Celsius with 98 per cent Coulombic efficiency and 73 per cent round-trip energy efficiency. To provide evidence of their high power capability, the cells were discharged and charged at current densities as high as 1,000 milliamperes per square centimetre. Measured capacity loss after operation for 1,800 hours (more than 450 charge-discharge cycles at 100 per cent depth of discharge) projects retention of over 85 per cent of initial capacity after ten years of daily cycling. Our results demonstrate that alloying a high-melting-point, high-voltage metal (antimony) with a low-melting-point, low-cost metal (lead) advantageously decreases the operating temperature while maintaining a high cell voltage. Apart from the fact that this finding puts us on a desirable cost trajectory, this approach may well be more broadly applicable to other battery chemistries.	[Wang, Kangli; Jiang, Kai; Chung, Brice; Ouchi, Takanari; Burke, Paul J.; Boysen, Dane A.; Bradwell, David J.; Kim, Hojong; Muecke, Ulrich; Sadoway, Donald R.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sadoway, DR (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dsadoway@mit.edu	Sadoway, Donald/AAE-7708-2019; Wang, kangli/E-2789-2013	Sadoway, Donald/0000-0003-1978-8654; Wang, Kangli/0000-0002-4481-6082; Kim, Hojong/0000-0002-6247-3474	Advanced Research Projects Agency-Energy (US Department of Energy); Total SA	Advanced Research Projects Agency-Energy (US Department of Energy)(United States Department of Energy (DOE)); Total SA(Total SA)	We acknowledge financial support from the Advanced Research Projects Agency-Energy (US Department of Energy) and Total SA.	Barnhart CJ, 2013, ENERG ENVIRON SCI, V6, P1083, DOI 10.1039/c3ee24040a; Bradwell DJ, 2012, J AM CHEM SOC, V134, P1895, DOI 10.1021/ja209759s; Cairns E. J., 1967, ANL7316; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; DWORKIN AS, 1962, J PHYS CHEM-US, V66, P572, DOI 10.1021/j100809a517; ECKERT CA, 1983, METALL TRANS B, V14, P451, DOI 10.1007/BF02654364; Gasior W, 2001, J NUCL MATER, V294, P77, DOI 10.1016/S0022-3115(01)00440-8; Kanevskii L. S., 2005, ELEKTROKHIMIYA, V41, P3; Kanevskii LS, 2005, RUSS J ELECTROCHEM+, V41, P1; Kim H, 2013, CHEM REV, V113, P2075, DOI 10.1021/cr300205k; Morachevskii A. G., 2011, ZH PRIKL KHIM, V73, P1620; Morachevskii AG, 2002, RUSS J APPL CHEM+, V75, P367, DOI 10.1023/A:1016170016271; Ohtani H, 1995, J PHASE EQUILIB, V16, P416, DOI 10.1007/BF02645349; Soloveichik GL, 2011, ANNU REV CHEM BIOMOL, V2, P503, DOI 10.1146/annurev-chembioeng-061010-114116; WEPPNER W, 1978, J ELECTROCHEM SOC, V125, P7, DOI 10.1149/1.2131401; Yang ZG, 2011, CHEM REV, V111, P3577, DOI 10.1021/cr100290v	16	253	283	28	637	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					348	+		10.1038/nature13700	http://dx.doi.org/10.1038/nature13700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25252975	Green Submitted			2022-12-28	WOS:000342988600047
J	Gray, G; Lane, R				Gray, Glenda; Lane, Richard			Glenda Gray: leading South Africa's future in medical research	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1255	1255		10.1016/S0140-6736(14)61758-X	http://dx.doi.org/10.1016/S0140-6736(14)61758-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	25283564	Bronze			2022-12-28	WOS:000343003400016
J	Qiao, J; Li, R				Qiao, Jie; Li, Rong			Fertility preservation: challenges and opportunities	LANCET			English	Editorial Material							WOMEN		[Qiao, Jie] Peking Univ, Hosp 3, Ctr Reprod Med, Dept Obstet & Gynecol, Beijing 100191, Peoples R China; Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China; Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China	Peking University	Qiao, J (corresponding author), Peking Univ, Hosp 3, Ctr Reprod Med, Dept Obstet & Gynecol, Beijing 100191, Peoples R China.	jie.qiao@263.net		Qiao, Jie/0000-0003-2126-1376				De Vos M, 2014, LANCET, V384, P1302, DOI 10.1016/S0140-6736(14)60834-5; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Hyman JH, 2013, CLIN MED INSIGHTS-RE, V7, P61, DOI 10.4137/CMRH.S10848; Johnson JA, 2012, J OBSTET GYNAECOL CA, V34, P80, DOI 10.1016/S1701-2163(16)35138-6; Le Ray C, 2012, HUM REPROD, V27, P896, DOI 10.1093/humrep/der469; National Bureau of Statistic of the People's Republic of China, 2010, 6 NAT POP CENS 6 NAT POP CENS; National Bureau of Statistics of the People's Republic of China, 2000, 5 NAT POP CENS; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stoop D, 2014, LANCET, V384, P1311, DOI 10.1016/S0140-6736(14)61261-7; Tournaye H, 2014, LANCET, V384, P1295, DOI 10.1016/S0140-6736(14)60495-5	10	14	22	2	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1246	1247		10.1016/S0140-6736(14)61749-9	http://dx.doi.org/10.1016/S0140-6736(14)61749-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	25283562				2022-12-28	WOS:000343003400010
J	Cheng, C; Kao, KC				Cheng, Clint; Kao, Katy C.			How to survive being hot and inebriated	SCIENCE			English	Editorial Material							MEMBRANE		[Cheng, Clint; Kao, Katy C.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Cheng, C (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	kao.katy@mail.che.tamu.edu						dos Santos JRA, 2010, QUIM NOVA, V33, P904, DOI 10.1590/S0100-40422010000400027; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Lam FH, 2014, SCIENCE, V346, P71, DOI 10.1126/science.1257859; Liu YQ, 2014, BIORESOURCE TECHNOL, V170, P38, DOI 10.1016/j.biortech.2014.07.063; Madeira A, 2010, FEMS YEAST RES, V10, P252, DOI 10.1111/j.1567-1364.2010.00607.x; PIPER PW, 1993, FEMS MICROBIOL REV, V11, P339, DOI 10.1016/0168-6445(93)90005-T; Sharma SC, 2006, FEMS YEAST RES, V6, P1047, DOI 10.1111/j.1567-1364.2006.00149.x	8	3	5	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					35	36		10.1126/science.1260127	http://dx.doi.org/10.1126/science.1260127			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278598				2022-12-28	WOS:000342446900023
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The private sector providers letting down the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Centre for Health and the Public Interest, 2014, PAT SAF PRIV HOSP KN; Iacobucci G., 2011, PULSE           0418; Mahony C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4955; Matthews-King A., 2014, PULSE           0818; Morris S., 2014, GUARDIAN; Payne D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3277; Plimmer G., 2014, FINANCIAL TIMES; Public Accounts Committee, 2013, REP OUT OF HOURS GP; Royal College of Ophthalmologists, COMPL CAT SURG; Wise J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7549	10	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2014	349								g5726	10.1136/bmj.g5726	http://dx.doi.org/10.1136/bmj.g5726			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3BT	25266334	Green Published, Bronze			2022-12-28	WOS:000342664400001
J	Kendall, T; Morriss, R; Mayo-Wilson, E; Marcus, E				Kendall, Tim; Morriss, Richard; Mayo-Wilson, Evan; Marcus, Elena		Guideline Dev Grp	Assessment and management of bipolar disorder: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOUBLE-BLIND; CHILDREN; ADOLESCENTS; EFFICACY; TRENDS		[Kendall, Tim] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Morriss, Richard] Univ Nottingham, Fac Med & Hlth Sci, Nottingham NG7 2RD, England; [Mayo-Wilson, Evan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Marcus, Elena] UCL, Natl Collaborating Ctr Mental Hlth, London, England; [Marcus, Elena] UCL, Ctr Outcomes Res & Effectiveness, London, England	University of London; University College London; University of Nottingham; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; University College London; University of London; University College London	Kendall, T (corresponding author), Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England.	tim2.kendall@virgin.net	Mayo-Wilson, Evan/J-6289-2019; Cipriani, Andrea/P-6944-2015; Whittington, Craig/B-1380-2008; MAVRANEZOULI, IFIGENEIA/C-2430-2008; Marcus, Elena/AAC-4693-2022	Mayo-Wilson, Evan/0000-0001-6126-2459; Cipriani, Andrea/0000-0001-5179-8321; Whittington, Craig/0000-0002-1950-0334; MAVRANEZOULI, IFIGENEIA/0000-0001-9095-3566; Marcus, Elena/0000-0003-0900-8976; Jones, Steven/0000-0002-8801-5113; Morriss, Richard/0000-0003-2910-4121; Byng, Richard/0000-0001-7411-9467; Geddes, John/0000-0002-5281-5960	National Institute for Health Research [NF-SI-0611-10150] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Blanco C, 2002, AM J PSYCHIAT, V159, P1005, DOI 10.1176/appi.ajp.159.6.1005; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Crump C, 2013, JAMA PSYCHIAT, V70, P931, DOI 10.1001/jamapsychiatry.2013.1394; Findling RL, 2012, J CLIN PSYCHIAT, V73, P57, DOI 10.4088/JCP.11m07104; HARROW M, 1990, ARCH GEN PSYCHIAT, V47, P665; Howard L, 2011, J PSYCHIATR MENT HLT, V18, P105, DOI 10.1111/j.1365-2850.2010.01642.x; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; National Institute for Health and Care Excellence, 2014, BIP DIS UPD MAN BIP; National Institute for Health and Care Excellence, 2013, AR TREAT MOD SEV MAN, V292; National Institute for Health and Care Excellence, 2014, PSYCH SCH AD TREATM; National Institute for Health and Care Excellence (NICE), 2011, SERV US EXP AD MENT; National Institute for Health and Clinical Excellence, 2006, BIP DIS MAN BIP DIS; National Institute for Health and Clinical Excellence, 2009, DEPR AD TREATM MAN D; National Institute for Health and Clinical Excellence, 2014, BIP DIS UPD MAN BIP; Olfson M, 2010, J AM ACAD CHILD PSY, V49, P13, DOI 10.1016/j.jaac.2009.09.003; Paediatric Formulary Committee, 2013, BNF FOR CHILDR; Tijssen MJA, 2010, BRIT J PSYCHIAT, V196, P102, DOI 10.1192/bjp.bp.109.065763; Wagner KD, 2009, J AM ACAD CHILD PSY, V48, P519, DOI 10.1097/CHI.0b013e31819c55ec; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	20	70	70	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2014	349								g5673	10.1136/bmj.g5673	http://dx.doi.org/10.1136/bmj.g5673			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UR	25258392	Green Accepted			2022-12-28	WOS:000342426400006
J	Herrero, R; Parsonnet, J; Greenberg, ER				Herrero, Rolando; Parsonnet, Julie; Greenberg, Edwin Robert			Prevention of Gastric Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HELICOBACTER-PYLORI ERADICATION; METAANALYSIS; THERAPY		[Herrero, Rolando] Int Agcy Res Canc, Sect Early Detect & Prevent, F-69372 Lyon, France; [Parsonnet, Julie] Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA; [Greenberg, Edwin Robert] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	World Health Organization; International Agency for Research on Cancer (IARC); Stanford University; Fred Hutchinson Cancer Center	Herrero, R (corresponding author), Int Agcy Res Canc, Sect Early Detect & Prevent, 150 Cours Albert Thomas, F-69372 Lyon, France.	herreror@iarc.fr		Parsonnet, Julie/0000-0001-7342-5366				Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Gatta L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4587; International Agency for Research on Cancer, STOMACH CANCER ESTIM; International Agency for Research on Cancer, IARC WORKING GROUP R; Lane JA, 2006, BMJ-BRIT MED J, V332, P199, DOI 10.1136/bmj.38702.662546.55; Lansdorp-Vogelaar I, 2013, BEST PRACT RES CL GA, V27, P933, DOI 10.1016/j.bpg.2013.09.005; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; National Cancer Institute at the National Institutes of Health, SNAPSH STOM CANC; Plummer M, 2015, INT J CANCER, V136, P487, DOI 10.1002/ijc.28999	10	66	71	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1197	1198		10.1001/jama.2014.10498	http://dx.doi.org/10.1001/jama.2014.10498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25247512				2022-12-28	WOS:000341990600015
J	Black, BA; Sydeman, WJ; Frank, DC; Griffin, D; Stahle, DW; Garcia-Reyes, M; Rykaczewski, RR; Bograd, SJ; Peterson, WT				Black, Bryan A.; Sydeman, William J.; Frank, David C.; Griffin, Daniel; Stahle, David W.; Garcia-Reyes, Marisol; Rykaczewski, Ryan R.; Bograd, Steven J.; Peterson, William T.			Six centuries of variability and extremes in a coupled marine-terrestrial ecosystem	SCIENCE			English	Article							TROPICAL PACIFIC; CLIMATE-CHANGE; OSCILLATION; TREE	Reported trends in the mean and variability of coastal upwelling in eastern boundary currents have raised concerns about the future of these highly productive and biodiverse marine ecosystems. However, the instrumental records on which these estimates are based are insufficiently long to determine whether such trends exceed preindustrial limits. In the California Current, a 576-year reconstruction of climate variables associated with winter upwelling indicates that variability increased over the latter 20th century to levels equaled only twice during the past 600 years. This modern trend in variance may be unique, because it appears to be driven by an unprecedented succession of extreme, downwelling-favorable, winter climate conditions that profoundly reduce productivity for marine predators of commercial and conservation interest.	[Black, Bryan A.] Univ Texas Marine Sci Inst, Port Aransas, TX 78373 USA; [Sydeman, William J.; Garcia-Reyes, Marisol] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA; [Frank, David C.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Frank, David C.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Griffin, Daniel] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Stahle, David W.] Univ Arkansas, Dept Geosci, Fayetteville, AR 72701 USA; [Rykaczewski, Ryan R.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Rykaczewski, Ryan R.] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; [Bograd, Steven J.] NOAA, Environm Res Div, Southwest Fisheries Sci Ctr, Pacific Grove, CA 93950 USA; [Peterson, William T.] NOAA, Northwest Fisheries Sci Ctr, Hatfield Marine Sci Ctr, Newport, OR 97365 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Woods Hole Oceanographic Institution; University of Arkansas System; University of Arkansas Fayetteville; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Black, BA (corresponding author), Univ Texas Marine Sci Inst, 750 Channel View Dr, Port Aransas, TX 78373 USA.	bryan.black@utexas.edu	Griffin, Daniel/AAE-8381-2021; Rykaczewski, Ryan/A-8625-2016; Bograd, Steven/AAA-4824-2021; Black, Bryan/A-7057-2009; Frank, David/C-7764-2013	Rykaczewski, Ryan/0000-0001-8893-872X; Black, Bryan/0000-0001-6851-257X; Griffin, Daniel/0000-0002-1547-3615; Frank, David/0000-0001-5463-5640	NSF [1130125]; NOAA Fisheries and the Environment (FATE) program; California Department of Fish and Wildlife Ecosystem Restoration Program [ERP02-P30]; Nippon Foundation-University of British Columbia Nereus Program; NOAA Climate and Global Change Postdoctoral Fellowship; Direct For Biological Sciences [0823380] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NOAA Fisheries and the Environment (FATE) program; California Department of Fish and Wildlife Ecosystem Restoration Program; Nippon Foundation-University of British Columbia Nereus Program; NOAA Climate and Global Change Postdoctoral Fellowship(National Oceanic Atmospheric Admin (NOAA) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF (grant no. 1130125), the NOAA Fisheries and the Environment (FATE) program, the California Department of Fish and Wildlife Ecosystem Restoration Program (grant no. ERP02-P30), and the Nippon Foundation-University of British Columbia Nereus Program. D. G. was supported by a NOAA Climate and Global Change Postdoctoral Fellowship. Seabird data were obtained from Point Blue Conservation Science/Farallon National Wildlife Refuge. We are grateful to contributors to the International Tree-Ring Databank and thank M. O'Connor for assistance with Fig. 1. Finally, we thank the reviewers for their comments and insights, which greatly improved the paper. All data used in this work, or the sources from which they are available, are included in the supplementary materials.	Black BA, 2011, GLOBAL CHANGE BIOL, V17, P2536, DOI 10.1111/j.1365-2486.2011.02422.x; Black BA, 2009, MAR ECOL PROG SER, V378, P37, DOI 10.3354/meps07854; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Fowler AM, 2012, NAT CLIM CHANGE, V2, P172, DOI [10.1038/NCLIMATE1374, 10.1038/nclimate1374]; Garcia-Reyes M, 2013, ECOSYSTEMS, V16, P722, DOI 10.1007/s10021-013-9643-6; Graham NE, 2007, CLIMATIC CHANGE, V83, P241, DOI [10.1007/s10584-007-9239-2, 10.1007/s 10584-007-9239-2]; Hamlet AF, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005099; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Keister JE, 2011, GLOBAL CHANGE BIOL, V17, P2498, DOI 10.1111/j.1365-2486.2010.02383.x; Kipfmueller KF, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050645; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Li JB, 2011, NAT CLIM CHANGE, V1, P114, DOI [10.1038/nclimate1086, 10.1038/NCLIMATE1086]; Malamud-Roam FP, 2006, QUATERNARY SCI REV, V25, P1570, DOI 10.1016/j.quascirev.2005.11.012; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Schroder ID, 2013, GEOPHYS RES LETT, V40, P1; Schwing FB, 2002, PROG OCEANOGR, V53, P115, DOI 10.1016/S0079-6611(02)00027-7; Schwing FB, 1997, J GEOPHYS RES-OCEANS, V102, P3421, DOI 10.1029/96JC03591; Schwing FB, 1996, NOAA TECH MEMO NMFS; SMITH R L, 1968, Oceanography and Marine Biology an Annual Review, V6, P11; St George S, 2010, HOLOCENE, V20, P983, DOI 10.1177/0959683610365937; Stahle DW, 2013, EARTH INTERACT, V17, DOI 10.1175/2013EI000518.1; Stahle DW, 1998, B AM METEOROL SOC, V79, P2137, DOI 10.1175/1520-0477(1998)079<2137:EDROTS>2.0.CO;2; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Sydeman WJ, 2013, GLOBAL CHANGE BIOL, V19, P1662, DOI 10.1111/gcb.12165; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X	27	55	57	0	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1498	1502		10.1126/science.1253209	http://dx.doi.org/10.1126/science.1253209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237100				2022-12-28	WOS:000341752900040
J	Hofmann, W; Wisneski, DC; Brandt, MJ; Skitka, LJ				Hofmann, Wilhelm; Wisneski, Daniel C.; Brandt, Mark J.; Skitka, Linda J.			Morality in everyday life	SCIENCE			English	Article							GOSSIP	The science of morality has drawn heavily on well-controlled but artificial laboratory settings. To study everyday morality, we repeatedly assessed moral or immoral acts and experiences in a large (N = 1252) sample using ecological momentary assessment. Moral experiences were surprisingly frequent and manifold. Liberals and conservatives emphasized somewhat different moral dimensions. Religious and nonreligious participants did not differ in the likelihood or quality of committed moral and immoral acts. Being the target of moral or immoral deeds had the strongest impact on happiness, whereas committing moral or immoral deeds had the strongest impact on sense of purpose. Analyses of daily dynamics revealed evidence for both moral contagion and moral licensing. In sum, morality science may benefit from a closer look at the antecedents, dynamics, and consequences of everyday moral experience.	[Hofmann, Wilhelm] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Wisneski, Daniel C.; Skitka, Linda J.] Univ Illinois, Dept Psychol, Chicago, IL 60607 USA; [Brandt, Mark J.] Tilburg Univ, Dept Social Psychol, NL-5000 Tilburg, Netherlands	University of Cologne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tilburg University	Hofmann, W (corresponding author), Univ Cologne, Dept Psychol, D-50931 Cologne, Germany.	wilhelm.hofmann@uni-koeln.de	Skitka, Linda/P-4085-2019	Skitka, Linda/0000-0002-7078-0650; Brandt, Mark/0000-0002-7185-7031	SAGE Award from the Foundation for Personality and Social Psychology; University of Chicago Booth School of Business	SAGE Award from the Foundation for Personality and Social Psychology; University of Chicago Booth School of Business(University of Chicago)	Supported by a SAGE Award from the Foundation for Personality and Social Psychology and a research grant from the University of Chicago Booth School of Business (W.H.), where portions of this work were completed. The study was approved by the institutional review board of the University of Chicago. W.H. is a co-founder of SurveySignal, a University spin-off of the Web-based experience-sampling software used for this project, and has been advising the development of SurveySignal on an unpaid basis. The replication data are available at the Harvard Dataverse Network (doi:10.7910/DVN/26910).	Aquino K, 2002, J PERS SOC PSYCHOL, V83, P1423, DOI 10.1037//0022-3514.83.6.1423; Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111; Dawkins R., 2008, GOD DELUSION; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; HAIDT J, 1993, J PERS SOC PSYCHOL, V65, P613, DOI 10.1037/0022-3514.65.4.613; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Harris Sam, 2004, END FAITH RELIG TERR; Kohlberg L., 1976, MORAL DEV BEHAV THEO, P31; Miller DT, 2010, ADV EXP SOC PSYCHOL, V43, P115, DOI 10.1016/S0065-2601(10)43003-8; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Skitka LJ, 2005, J PERS SOC PSYCHOL, V88, P895, DOI 10.1037/0022-3514.88.6.895; Turiel E., 2002, CULTURE MORALITY SOC; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448	20	245	253	13	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1340	1343		10.1126/science.1251560	http://dx.doi.org/10.1126/science.1251560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214626				2022-12-28	WOS:000341483800063
J	Rausch, B; Symes, MD; Chisholm, G; Cronin, L				Rausch, Benjamin; Symes, Mark D.; Chisholm, Greig; Cronin, Leroy			Decoupled catalytic hydrogen evolution from a molecular metal oxide redox mediator in water splitting	SCIENCE			English	Article							OXYGEN EVOLUTION; ELECTRON; OXIDATION; H-2	The electrolysis of water using renewable energy inputs is being actively pursued as a route to sustainable hydrogen production. Here we introduce a recyclable redox mediator (silicotungstic acid) that enables the coupling of low-pressure production of oxygen via water oxidation to a separate, catalytic hydrogen production step outside the electrolyzer that requires no post-electrolysis energy input. This approach sidesteps the production of high-pressure gases inside the electrolytic cell (a major cause of membrane degradation) and essentially eliminates the hazardous issue of product gas crossover at the low current densities that characterize renewables-driven water-splitting devices. We demonstrated that a platinum-catalyzed system can produce pure hydrogen over 30 times faster than state-of-the-art proton exchange membrane electrolyzers at equivalent platinum loading.	[Rausch, Benjamin; Symes, Mark D.; Chisholm, Greig; Cronin, Leroy] Univ Glasgow, Sch Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Cronin, L (corresponding author), Univ Glasgow, Sch Chem, WestCHEM, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	lee.cronin@glasgow.ac.uk	Chisholm, Greig/AAD-4682-2021; Cronin, Leroy/AAW-8067-2020; Symes, Mark/L-9810-2015; Cronin, Leroy/B-7752-2008	Cronin, Leroy/0000-0001-8035-5757; Symes, Mark/0000-0001-8067-5240; Cronin, Leroy/0000-0001-8035-5757; Chisholm, Greig/0000-0002-4003-346X	Engineeering and Physical Sciences Research Council (UK); Royal Society/Wolfson Foundation; University of Glasgow; Engineering and Physical Sciences Research Council [EP/J00135X/1, EP/J015156/1, EP/K023004/1] Funding Source: researchfish; EPSRC [EP/J015156/1, EP/J00135X/1, EP/K023004/1] Funding Source: UKRI	Engineeering and Physical Sciences Research Council (UK); Royal Society/Wolfson Foundation(Royal Society of London); University of Glasgow; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineeering and Physical Sciences Research Council (UK). L.C. thanks the Royal Society/Wolfson Foundation for a Merit Award. M.D.S. thanks the University of Glasgow for a Lord Kelvin Adam Smith Research Fellowship. We are grateful to J. Liddell (University of Glasgow) for production of the H cells used in this work. Supplementary materials are available, which include full experimental details for electrochemical procedures, GCHA, and catalytic H<INF>2</INF> evolution, as well as a movie showing the H<INF>2</INF> evolution step (movie S1). The advances presented in the work form part of a patent filing.	[Anonymous], 2012, 1468722012 ISO; Arico AS, 2013, J APPL ELECTROCHEM, V43, P107, DOI 10.1007/s10800-012-0490-5; Armaroli N, 2011, CHEMSUSCHEM, V4, P21, DOI 10.1002/cssc.201000182; Barbir F, 2005, SOL ENERGY, V78, P661, DOI 10.1016/j.solener.2004.09.003; Berger A, 2014, ENERG ENVIRON SCI, V7, P1468, DOI 10.1039/c3ee43807d; Carmo M, 2013, INT J HYDROGEN ENERG, V38, P4901, DOI 10.1016/j.ijhydene.2013.01.151; Ghassemzadeh L, 2010, J PHYS CHEM C, V114, P14635, DOI 10.1021/jp102533v; Grigoriev SA, 2009, INT J HYDROGEN ENERG, V34, P5986, DOI 10.1016/j.ijhydene.2009.01.047; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Han ZJ, 2012, SCIENCE, V338, P1321, DOI 10.1126/science.1227775; HISKIA A, 1992, INORG CHEM, V31, P163, DOI 10.1021/ic00028a007; Holladay JD, 2009, CATAL TODAY, V139, P244, DOI 10.1016/j.cattod.2008.08.039; Joya KS, 2013, ANGEW CHEM INT EDIT, V52, P10426, DOI 10.1002/anie.201300136; Karunadasa HI, 2012, SCIENCE, V335, P698, DOI 10.1126/science.1215868; KEITA B, 1987, J ELECTROANAL CHEM, V217, P287, DOI 10.1016/0022-0728(87)80225-5; Kim TW, 2014, SCIENCE, V343, P990, DOI 10.1126/science.1246913; LaConti A.B., 2006, ECS T, V1, P199, DOI [DOI 10.1149/1.2214554, 10.1149/1.2214554]; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Mamaca N, 2012, APPL CATAL B-ENVIRON, V111, P376, DOI 10.1016/j.apcatb.2011.10.020; Merki D, 2011, CHEM SCI, V2, P1262, DOI 10.1039/c1sc00117e; Millet P, 2010, INT J HYDROGEN ENERG, V35, P5043, DOI 10.1016/j.ijhydene.2009.09.015; Popczun EJ, 2013, J AM CHEM SOC, V135, P9267, DOI 10.1021/ja403440e; Prabhakaran V, 2012, P NATL ACAD SCI USA, V109, P1029, DOI 10.1073/pnas.1114672109; Rausch B, 2013, J AM CHEM SOC, V135, P13656, DOI 10.1021/ja4071893; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816; Siracusano S, 2012, INT J HYDROGEN ENERG, V37, P1939, DOI 10.1016/j.ijhydene.2011.06.019; Symes MD, 2013, NAT CHEM, V5, P403, DOI 10.1038/nchem.1621; Tachibana Y, 2012, NAT PHOTONICS, V6, P511, DOI 10.1038/nphoton.2012.175; Toma FM, 2010, NAT CHEM, V2, P826, DOI [10.1038/nchem.761, 10.1038/NCHEM.761]; U.S. Department of Energy Hydrogen Analysis Resource Center, 2012, HYDR PROD WORLDW REF; Wiberg N., 2001, INORGANIC CHEM, V1; Xu CB, 2012, INT J HYDROGEN ENERG, V37, P2985, DOI 10.1016/j.ijhydene.2011.04.031; Xu JY, 2012, ELECTROCHIM ACTA, V59, P105, DOI 10.1016/j.electacta.2011.10.044	33	435	451	33	792	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1326	1330		10.1126/science.1257443	http://dx.doi.org/10.1126/science.1257443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214625				2022-12-28	WOS:000341483800059
J	Storch, NI; Anderson, KR; Lai, D				Storch, Natalia I.; Anderson, Kassandra R.; Lai, Dong			Chaotic dynamics of stellar spin in binaries and the production of misaligned hot Jupiters	SCIENCE			English	Article							TIDAL EVOLUTION; PLANET SCATTERING; SECULAR CHAOS; GIANT PLANETS; ORBIT; ECCENTRICITY; ROTATION; MIGRATION; STARS; AXES	Many exoplanetary systems containing hot Jupiters are observed to have highly misaligned orbital axes relative to the stellar spin axes. Kozai-Lidov oscillations of orbital eccentricity and inclination induced by a binary companion, in conjunction with tidal dissipation, constitute a major channel for the production of hot Jupiters. We demonstrate that gravitational interaction between the planet and its oblate host star can lead to chaotic evolution of the stellar spin axis during Kozai cycles. As parameters such as the planet mass and stellar rotation period are varied, periodic islands can appear in an ocean of chaos, in a manner reminiscent of other dynamical systems. In the presence of tidal dissipation, the complex spin evolution can leave an imprint on the final spin-orbit misalignment angles.	[Storch, Natalia I.; Anderson, Kassandra R.; Lai, Dong] Cornell Univ, Dept Astron, Ctr Space Res, Ithaca, NY 14853 USA	Cornell University	Lai, D (corresponding author), Cornell Univ, Dept Astron, Ctr Space Res, Ithaca, NY 14853 USA.	dong@astro.cornell.edu			NSF Graduate Research Fellowship Program grant [DGE-1144153]; NSF grants [AST-1008245, AST-1211061]; NASA grants [NNX12AF85G, NNX14AG94G]	NSF Graduate Research Fellowship Program grant; NSF grants(National Science Foundation (NSF)); NASA grants	We thank K. Batygin, D. Fabrycky, M. Holman, and D. Munoz for useful discussions. Supported by NSF Graduate Research Fellowship Program grant DGE-1144153 (K.R.A.), NSF grants AST-1008245 and AST-1211061, and NASA grants NNX12AF85G and NNX14AG94G.	Albrecht S, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/83; Albrecht S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/18; Albrecht S, 2009, NATURE, V461, P373, DOI 10.1038/nature08408; Bate MR, 2010, MON NOT R ASTRON SOC, V401, P1505, DOI 10.1111/j.1365-2966.2009.15773.x; Batygin K, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/169; Batygin K, 2012, NATURE, V491, P418, DOI 10.1038/nature11560; CHIRIKOV BV, 1979, PHYS REP, V52, P263, DOI 10.1016/0370-1573(79)90023-1; CLARET A, 1992, ASTRON ASTROPHYS SUP, V96, P255; Correia ACM, 2011, CELEST MECH DYN ASTR, V111, P105, DOI 10.1007/s10569-011-9368-9; Dawson RI, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/2/L24; Dong SB, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/1/L5; Eggleton PP, 2001, ASTROPHYS J, V562, P1012, DOI 10.1086/323843; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Ford EB, 2000, ASTROPHYS J, V535, P385, DOI 10.1086/308815; Ford EB, 2008, ASTROPHYS J, V686, P621, DOI 10.1086/590926; Gallet F, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321302; Hebrard G, 2008, ASTRON ASTROPHYS, V488, P763, DOI 10.1051/0004-6361:200810056; Hebrard G, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/201014327; Holman M, 1997, NATURE, V386, P254, DOI 10.1038/386254a0; HUT P, 1981, ASTRON ASTROPHYS, V99, P126; Katz B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.181101; Knutson HA, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/126; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; Lai D, 2014, MON NOT R ASTRON SOC, V440, P3532, DOI 10.1093/mnras/stu485; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; Lichtenberg A. J., 1992, REGUL CHAOTIC DYN; LIDOV ML, 1962, PLANET SPACE SCI, V9, P719, DOI 10.1016/0032-0633(62)90129-0; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lithwick Y, 2014, P NATL ACAD SCI USA, V111, P12610, DOI 10.1073/pnas.1308261110; Nagasawa M, 2008, ASTROPHYS J, V678, P498, DOI 10.1086/529369; Naoz S, 2013, MON NOT R ASTRON SOC, V431, P2155, DOI 10.1093/mnras/stt302; Naoz S, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L36; Naoz S, 2011, NATURE, V473, P187, DOI 10.1038/nature10076; Narita N, 2009, PUBL ASTRON SOC JPN, V61, pL35, DOI 10.1093/pasj/61.5.L35; SKUMANICH A, 1972, ASTROPHYS J, V171, P565, DOI 10.1086/151310; Storch NI, 2014, MON NOT R ASTRON SOC, V438, P1526, DOI 10.1093/mnras/stt2292; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; Triaud AHMJ, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201219643; Triaud AHMJ, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014525; Winn JN, 2009, ASTROPHYS J LETT, V703, pL99, DOI 10.1088/0004-637X/703/2/L99; WISDOM J, 1984, ICARUS, V58, P137, DOI 10.1016/0019-1035(84)90032-0; Wu Y, 2003, ASTROPHYS J, V589, P605, DOI 10.1086/374598; Wu YQ, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/109	49	68	69	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1317	1321		10.1126/science.1254358	http://dx.doi.org/10.1126/science.1254358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214623	Green Submitted			2022-12-28	WOS:000341483800057
J	Worby, CA; Dixon, JE				Worby, Carolyn A.; Dixon, Jack E.			Unpacking the Unfolded Protein Response	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; MESSENGER-RNA; KINASE-ACTIVITY; IDENTIFICATION; INDUCTION; ELEMENT; NUCLEUS		[Worby, Carolyn A.; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Worby, Carolyn A.; Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Worby, Carolyn A.; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	jedixon@ucsd.edu						Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	13	5	6	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1221	1224		10.1016/j.cell.2014.08.025	http://dx.doi.org/10.1016/j.cell.2014.08.025			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215479	Bronze			2022-12-28	WOS:000343094200001
J	Goyal, P; Krasteva, PV; Van Genven, N; Gubellini, F; Van den Broeck, I; Troupiotis-Tsailaki, A; Jonckheere, W; Pehau-Arnaudet, G; Pinkner, JS; Chapman, MR; Hultgren, SJ; Howorka, S; Fronzes, R; Remaut, H				Goyal, Parveen; Krasteva, Petya V.; Van Genven, Nani; Gubellini, Francesca; Van den Broeck, Imke; Troupiotis-Tsailaki, Anastassia; Jonckheere, Wim; Pehau-Arnaudet, Gerard; Pinkner, Jerome S.; Chapman, Matthew R.; Hultgren, Scott J.; Howorka, Stefan; Fronzes, Remi; Remaut, Han			Structural and mechanistic insights into the bacterial amyloid secretion channel CsgG	NATURE			English	Article							ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; PHENYLALANINE CLAMP; SURFACE ORGANELLES; BINDING CURLI; SYSTEM; REFINEMENT; BIOGENESIS; SIMULATION; MEMBRANE	Curli are functional amyloid fibres that constitute the major protein component of the extracellular matrix in pellicle biofilms formed by Bacteroidetes and Proteobacteria (predominantly of the alpha and gamma classes)(1-3). They provide a fitness advantage in pathogenic strains and induce a strong pro-inflammatory response during bacteraemia(1,4,5). Curli formation requires a dedicated protein secretion machinery comprising the outer membrane lipoprotein CsgG and two soluble accessory proteins, CsgE and CsgF(6,7). Here we report the X-ray structure of Escherichia coli CsgGin a non-lipidated, soluble form as well as in its native membrane-extracted conformation. CsgG forms an oligomeric transport complex composed of nine anticodon-binding-domain-like units that give rise to a 36-stranded beta-barrel that traverses the bilayer and is connected to a cage-like vestibule in the periplasm. The transmembrane and periplasmic domains are separated by a 0.9-nm channel constriction composed of three stacked concentric phenylalanine, asparagine and tyrosine rings that may guide the extended polypeptide substrate through the secretion pore. The specificity factor CsgE forms a nonameric adaptor that binds and closes off the periplasmic face of the secretion channel, creating a 24,000 angstrom(3) pre-constriction chamber. Our structural, functional and electrophysiological analyses imply that CsgG is an ungated, non-selective protein secretion channel that is expected to employ a diffusion-based, entropy-driven transport mechanism.	[Goyal, Parveen; Van Genven, Nani; Van den Broeck, Imke; Jonckheere, Wim; Remaut, Han] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Goyal, Parveen; Van Genven, Nani; Van den Broeck, Imke; Jonckheere, Wim; Remaut, Han] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Krasteva, Petya V.; Gubellini, Francesca; Fronzes, Remi] Inst Pasteur, Unite Biol Struct Secret Bacterienne G5, F-75015 Paris, France; [Krasteva, Petya V.; Gubellini, Francesca; Pehau-Arnaudet, Gerard; Fronzes, Remi] Inst Pasteur, CNRS, UMR 3528, F-75015 Paris, France; [Troupiotis-Tsailaki, Anastassia] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Pinkner, Jerome S.; Hultgren, Scott J.] Washington Univ, Dept Mol Microbiol & Microbial Pathogenesis, Sch Med, St Louis, MO 63110 USA; [Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Howorka, Stefan] UCL, Inst Struct & Mol Biol, Dept Chem, London WC1H 0AJ, England	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite Libre de Bruxelles; Washington University (WUSTL); University of Michigan System; University of Michigan; University of London; Birkbeck University London; University College London	Remaut, H (corresponding author), VIB, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium.	remi.fronzes@pasteur.fr; han.remaut@vib-vub.be	Krasteva, Petya Violinova/ABF-2168-2020; Fronzes, Rémi/GLS-0406-2022; Krasteva, Petya/E-4132-2014; goyal, parveen/J-8435-2014; goyal, parveen/W-6345-2019; Fronzes, Remi/T-2578-2019	Krasteva, Petya Violinova/0000-0002-1858-8127; Krasteva, Petya/0000-0002-1858-8127; goyal, parveen/0000-0002-7808-8298; Van Gerven, Nani/0000-0002-4269-3904; Chapman, Matthew/0000-0002-2645-1294; pehau-arnaudet, gerard/0000-0001-6479-9470; Gubellini, Francesca/0000-0002-2155-9765; Howorka, Stefan/0000-0002-6527-2846; Remaut, Han/0000-0002-9775-4102; Pinkner, Jerome/0000-0002-7389-7440; Fronzes, Remi/0000-0003-3031-9824	VIB [PRJ9]; Hercules Foundation [UABR/09/005]; National Institutes of Health [AI099099, AI048689, A1073847]; Institut Pasteur; Centre national de la recherche scientifique; Engineering and Physical Sciences Research Council; National Physical Laboratory; University College London Chemistry; 'Bourse Roux' from Institut Pasteur; European Research Council (ERC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048689, R01AI099099, R56AI073847, R01AI073847] Funding Source: NIH RePORTER	VIB; Hercules Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur(European Commission); Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Physical Laboratory; University College London Chemistry; 'Bourse Roux' from Institut Pasteur; European Research Council (ERC)(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by VIB through project grant PRJ9 (P.G., N.V.G. and H.R.), by Hercules Foundation through equipment grant UABR/09/005, by National Institutes of Health RO1 grants AI099099 and AI048689 (J.P. and S.J.H.) and A1073847 (M.R.C.), and by Institut Pasteur and Centre national de la recherche scientifique (F.G., G.P.A. and R.F.). S.H. is funded by the Engineering and Physical Sciences Research Council (Institutional Sponsorship Award), the National Physical Laboratory and University College London Chemistry. F.G. is the recipient of a 'Bourse Roux' from Institut Pasteur. P.V.K. was supported by the European Research Council (ERC). We acknowledge Diamond Light Source for time on beamlines I02, I03, I04 and I24 under proposal mx7351, and the Soleil synchrotron for access to Proxima-1 and Proxima-2a under proposals 20100734, 20110924 and 20121253.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bian Z, 1997, EMBO J, V16, P5827, DOI 10.1093/emboj/16.19.5827; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen AY, 2014, NAT MATER, V13, P515, DOI [10.1038/nmat3912, 10.1038/NMAT3912]; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Del Rio Martinez J. M., 2014, SMALL; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goyal P, 2013, ACTA CRYSTALLOGR F, V69, P1349, DOI 10.1107/S1744309113028054; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; Janowiak BE, 2010, J BIOL CHEM, V285, P8130, DOI 10.1074/jbc.M109.093195; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Movileanu L, 2000, NAT BIOTECHNOL, V18, P1091, DOI 10.1038/80295; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sivanathan V, 2013, NAT PROTOC, V8, P1381, DOI 10.1038/nprot.2013.081; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Swamy Mahima, 2006, Sci STKE, V2006, ppl4, DOI 10.1126/stke.3452006pl4; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Van Gerven N, 2014, MOL MICROBIOL, V91, P1022, DOI 10.1111/mmi.12515; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013	56	181	206	7	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					250	+		10.1038/nature13768	http://dx.doi.org/10.1038/nature13768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25219853	Green Submitted, Green Accepted			2022-12-28	WOS:000346383500046
J	Bach, PB				Bach, Peter B.			Indication-Specific Pricing for Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER		Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 1275 York Ave,POB 44, New York, NY 10021 USA.	bachp@mskcc.org						Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Chen W, 2009, VALUE HEALTH, V12, pS82, DOI 10.1111/j.1524-4733.2009.00634.x; Dranitsaris George, 2009, J Oncol Pharm Pract, V15, P67, DOI 10.1177/1078155208098584; IMS Institute for Healthcare Informatics, MED US SHIFT COSTS H; Kupferschmidt K, 2011, CMAJ, V183, P77; National Institute for Health and Care Excellence (NICE), CET TREATM LOC ADV S; Whiting S, 2014, J CLIN ONCOL S, V32, P353	7	89	89	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1629	1630		10.1001/jama.2014.13235	http://dx.doi.org/10.1001/jama.2014.13235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25279433				2022-12-28	WOS:000343301400014
J	Nienow, P				Nienow, Peter			GEOSCIENCE The plumbing of Greenland's ice	NATURE			English	Editorial Material							SUBGLACIAL DRAINAGE SYSTEM; HAUT GLACIER DAROLLA; SWITZERLAND; EVOLUTION; BENEATH		Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland	University of Edinburgh	Nienow, P (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland.	peter.nienow@ed.ac.uk						ALLEY RB, 1987, J GEOPHYS RES-SOLID, V92, P8921, DOI 10.1029/JB092iB09p08921; Andrews LC, 2014, NATURE, V514, P80, DOI 10.1038/nature13796; Bartholomew I, 2010, NAT GEOSCI, V3, P408, DOI 10.1038/NGEO863; Catania GA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041108; Chandler DM, 2013, NAT GEOSCI, V6, P195, DOI 10.1038/ngeo1737; Fountain AG, 1998, REV GEOPHYS, V36, P299, DOI 10.1029/97RG03579; Gordon S, 1998, HYDROL PROCESS, V12, P105, DOI 10.1002/(SICI)1099-1085(199801)12:1<105::AID-HYP566>3.3.CO;2-R; HUBBARD BP, 1995, J GLACIOL, V41, P572, DOI 10.3189/S0022143000034894; IKEN A, 1986, J GLACIOL, V32, P101, DOI 10.3189/S0022143000006936; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Mair D, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000514; MURRAY T, 1995, J GEOPHYS RES-SOL EA, V100, P10231, DOI 10.1029/95JB00671; Nienow P, 1998, EARTH SURF PROC LAND, V23, P825, DOI 10.1002/(SICI)1096-9837(199809)23:9<825::AID-ESP893>3.0.CO;2-2	13	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					38	39		10.1038/514038a	http://dx.doi.org/10.1038/514038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279912				2022-12-28	WOS:000342420800026
J	Jensen, KM; Bulova, PD				Jensen, Kristin M.; Bulova, Peter D.			Managing the care of adults with Down's syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OBSTRUCTIVE SLEEP-APNEA; CERVICAL-SPINE ABNORMALITIES; CONGENITAL HEART-DISEASE; MITRAL-VALVE PROLAPSE; BONE-MINERAL DENSITY; ALZHEIMERS-DISEASE; YOUNG-ADULTS; HEALTH-CARE; CELIAC-DISEASE; INSTITUTIONALIZED ADULTS		[Jensen, Kristin M.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Jensen, Kristin M.] Univ Colorado, Sch Med, Dept Internal Med, Aurora, CO 80045 USA; [Bulova, Peter D.] Univ Pittsburgh, Dept Internal Med, Med Ctr, UPMC Montefiore Hosp, Pittsburgh, PA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian	Jensen, KM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	kristin.jensen@ucdenver.edu	Jensen, Kristin/D-3478-2014	Jensen, Kristin/0000-0003-1352-0518				Adams D, 2010, J INTELL DISABIL RES, V54, P393, DOI 10.1111/j.1365-2788.2010.01271.x; AKIN K, 1988, JAMA-J AM MED ASSOC, V259, P842, DOI 10.1001/jama.1988.03720060014018; Ali FE, 2006, INT ORTHOP, V30, P284, DOI 10.1007/s00264-005-0070-y; ALLISON DB, 1995, INT J OBESITY, V19, P858; American College of Obstetrics and Gynecology, 2014, ACOG MED SCREEN SERV; [Anonymous], 2010, PREV HLTH CAR SCREEN; [Anonymous], 2014, HLTH CAR AD INT DEV; [Anonymous], 2006, J DEV DISABILITIES; Baum Rebecca A, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P241, DOI 10.1016/j.cppeds.2008.07.001; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; Bosch Joni Jacobsen, 2003, J Am Acad Nurse Pract, V15, P5, DOI 10.1111/j.1745-7599.2003.tb00248.x; BOVICELLI L, 1982, OBSTET GYNECOL, V59, pS13; Bull MJ, 2011, PEDIATRICS, V128, P393, DOI 10.1542/peds.2011-1605; Busciglio J, 2013, CYTOGENET GENOME RES, V141, P260, DOI 10.1159/000354306; Capone G, 2006, AM J MED GENET C, V142C, P158, DOI 10.1002/ajmg.c.30097; Capone GT, 2013, AM J MED GENET A, V161, P2188, DOI 10.1002/ajmg.a.36052; Carnicer J, 2001, EUR J GASTROEN HEPAT, V13, P263, DOI 10.1097/00042737-200103000-00008; Carnicer J, 1997, CYTOGENET CELL GENET, V77, P19; Centers for Disease Control and Prevention, 2014, REC AD IMM SCHED US; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P463; Cerqueira RM, 2010, EUR J GASTROEN HEPAT, V22, P868, DOI 10.1097/MEG.0b013e3283328341; Cohen W. I., 1999, DOWN SYNDROME Q, V4, P1, DOI DOI 10.1002/0471227579.CH17; COOLEY WC, 1991, CLIN PEDIATR, V30, P233, DOI 10.1177/000992289103000407; Couwenhoven T., 2007, TEACHING CHILDREN DO; Cunniff C, 2001, PEDIATRICS, V107, P442; Curtin C, 2013, J PEDIATR-US, V163, P1402, DOI 10.1016/j.jpeds.2013.06.081; Davidson MA, 2008, PEDIATR CLIN N AM, V55, P1099, DOI 10.1016/j.pcl.2008.07.001; de Miguel-Diaz J, 2003, SLEEP, V26, P1006, DOI 10.1093/sleep/26.8.1006; de Winter CF, 2012, RES DEV DISABIL, V33, P398, DOI 10.1016/j.ridd.2011.09.022; Devenny D, 2011, INT REV RES DEV DISA, V41, P233, DOI 10.1016/B978-0-12-386495-6.00007-2; Dixon N, 2006, AM J MED GENET C, V142C, P149, DOI 10.1002/ajmg.c.30096; Dreyfus D, 2014, J AM BOARD FAM MED, V27, P104, DOI 10.3122/jabfm.2014.01.130114; Dykens EM, 2007, MENT RETARD DEV D R, V13, P272, DOI 10.1002/mrdd.20159; Edgin JO, 2010, J INTELL DISABIL RES, V54, P406, DOI 10.1111/j.1365-2788.2010.01278.x; EDWARDS J, 1988, YOUNG PERSON DOWN SY, P187; Englund A, 2013, AM J MED GENET A, V161A, P642, DOI 10.1002/ajmg.a.35706; Esbensen AJ, 2010, INT REV RES MENT RET, V39, P107, DOI 10.1016/S0074-7750(10)39004-5; Faulks D, 2008, J ORAL REHABIL, V35, P854, DOI 10.1111/j.1365-2842.2008.01877.x; Feldman MA, 2012, J INTELL DISABIL RES, V56, P1110, DOI 10.1111/j.1365-2788.2012.01626.x; Fergeson MA, 2009, GENET MED, V11, P548, DOI 10.1097/GIM.0b013e3181a9c250; Fujiura GT, 1997, RES DEV DISABIL, V18, P261, DOI 10.1016/S0891-4222(97)00008-5; GEGGEL RL, 1993, J PEDIATR-US, V122, P821, DOI 10.1016/S0022-3476(06)80036-3; Geijer JR, 2014, AJIDD-AM J INTELLECT, V119, P107, DOI 10.1352/1944-7558-119.2.107; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; Goday-Arno A, 2009, CLIN ENDOCRINOL, V71, P110, DOI 10.1111/j.1365-2265.2008.03419.x; GOLDHABER SZ, 1987, JAMA-J AM MED ASSOC, V258, P1793, DOI 10.1001/jama.258.13.1793; GOLDHABER SZ, 1986, AM J CARDIOL, V57, P278, DOI 10.1016/0002-9149(86)90905-7; Hasle H, 2003, LEUKEMIA, V17, P277, DOI 10.1038/sj.leu.2402765; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Hayes C, 1997, INT J EPIDEMIOL, V26, P822, DOI 10.1093/ije/26.4.822; Henderson A, 2007, BRIT J GEN PRACT, V57, P50; Hsieh K, 2014, J INTELL DISABIL RES, V58, P851, DOI 10.1111/jir.12100; Hwang SW, 2013, CLIN PEDIATR, V52, P845, DOI 10.1177/0009922813491311; Jasien J, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/469235; Jensen KM, 2013, J INTELL DISABIL RES, V57, P409, DOI 10.1111/j.1365-2788.2012.01545.x; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Kerins Gerard, 2008, Downs Syndr Res Pract, V12, P141, DOI 10.3104/reports.2009; Kozma C, 2008, TOP GERIATR REHABIL, V24, P41; Lazenby T, 2008, DYSPHAGIA, V23, P88, DOI 10.1007/s00455-007-9096-1; Levy DJ, 2013, PEDIATR CARDIOL, V34, P670, DOI 10.1007/s00246-012-0526-y; Li CX, 2013, INT J REHABIL RES, V36, P187, DOI 10.1097/MRR.0b013e3283634e9c; Lin AE, 2008, GENET MED, V10, P469, DOI [10.1097/GIM.0b013e3181772111, 10.1097GIM.0b013e3181772111]; Livingston G, 2012, LANCET, V379, P498, DOI 10.1016/S0140-6736(11)61929-6; Lose EJ, 2007, CURR OPIN PEDIATR, V19, P611, DOI 10.1097/MOP.0b013e3282f18a01; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; Maatta T, 2011, J INTELLECT DEV DIS, V36, P118, DOI 10.1080/13668250.2011.570253; MACLACHLAN RA, 1993, J INTELL DISABIL RES, V37, P277; Majdalany DS, 2010, CONGENIT HEART DIS, V5, P38, DOI 10.1111/j.1747-0803.2009.00349.x; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; Mantry D, 2008, J INTELL DISABIL RES, V52, P141, DOI 10.1111/j.1365-2788.2007.00985.x; MARCUS CL, 1991, PEDIATRICS, V88, P132; McDowell KM, 2011, J PEDIATR-US, V158, P319, DOI 10.1016/j.jpeds.2010.07.023; McGuire D, 2014, GROOVE; McGuire DE, 2002, DOWN SYNDROME VISION, P221; McKelvey KD, 2013, OSTEOPOROSIS INT, V24, P1333, DOI 10.1007/s00198-012-2109-4; Menendez M, 2005, BRAIN DEV-JPN, V27, P246, DOI 10.1016/j.braindev.2004.07.008; Miodrag N, 2013, J APPL RES INTELLECT, V26, P207, DOI 10.1111/jar.12023; Mohan M, 2009, COCHRANE DB SYST REV, V1; Mohan M, 2009, COCHRANE DB SYST REV, V1; Mohan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007657; Mohan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007178.pub2; Mooney PD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1561; Morris J. K., 2014, NATL DOWN SYNDROME C; MURDOCH JC, 1977, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.6081.226; Murphy J, 2005, Ir Med J, V98, P48; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; National Institutes of Health, 2014, DS CONN DOWN SYNDR R; Natoli JL, 2012, PRENATAL DIAG, V32, P142, DOI 10.1002/pd.2910; Nieuwenhuis-Mark RE, 2009, RES DEV DISABIL, V30, P827, DOI 10.1016/j.ridd.2009.01.010; Nisihara Renato M., 2005, J. Pediatr. (Rio J.), V81, P373, DOI 10.1590/S0021-75572005000600006; Nizetic D, 2012, NAT REV CANCER, V12, P721, DOI 10.1038/nrc3355; OLIVE PM, 1988, SPINE, V13, P781, DOI 10.1097/00007632-198807000-00012; Oster-Granite ML, 2011, MOL GENET METAB, V104, P13, DOI 10.1016/j.ymgme.2011.07.005; Palmer JB, 2000, AM FAM PHYSICIAN, V61, P2453; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Pandit C, 2012, J PAEDIATR CHILD H, V48, pE147, DOI 10.1111/j.1440-1754.2011.02077.x; Pradhan M, 2006, FERTIL STERIL, V86, DOI 10.1016/j.fertnstert.2006.03.071; Prasher V, 2007, J INTELL DISABIL RES, V51, P312, DOI 10.1111/j.1365-2788.2006.00879.x; Prasher V, 2004, RES DEV DISABIL, V25, P385, DOI 10.1016/j.ridd.2003.12.002; Prasher Vee, 2002, Irish Journal of Psychological Medicine, V19, P101, DOI 10.1017/S0790966700007205; Presson AP, 2013, J PEDIATR-US, V163, P1163, DOI 10.1016/j.jpeds.2013.06.013; Pueschel S, 2002, DOWN SYNDROME VISION, P149; PUESCHEL SM, 1987, PEDIATRICS, V80, P555; PUESCHEL SM, 1995, ACTA PAEDIATR, V84, P823, DOI 10.1111/j.1651-2227.1995.tb13768.x; Puri BK, 2001, INT J CLIN PRACT, V55, P442; Radcliff K, 2012, CLIN ORTHOP RELAT R, V470, P1602, DOI 10.1007/s11999-011-2151-0; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; Rodrigues AN, 2011, VASC HEALTH RISK MAN, V7, P375, DOI 10.2147/VHRM.S21273; Roizen Nancy J, 2002, Adolesc Med, V13, P345; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Roizen NJ, 2002, ADOLESC MED, V13, pvii; Rosen A, 2014, PEDIATRICS, V133, P211, DOI 10.1542/peds.2012-3765; Rosen D, 2011, CURR OPIN PULM MED, V17, P431, DOI 10.1097/MCP.0b013e32834ba9c0; Saenz RB, 1999, AM FAM PHYSICIAN, V59, P381; Saenz RB, 1999, AM FAM PHYSICIAN, V59, P95; Saenz RB, 1999, AM FAM PHYSICIAN, V59, P92; Satge D, 1997, CANCER, V80, P929; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; SEASHORE MR, 1994, PEDIATRICS, V93, P855; Seewald L, 2012, MOL GENET METAB, V107, P25, DOI 10.1016/j.ymgme.2012.07.011; Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Shott SR, 2006, AM J MED GENET C, V142C, P131, DOI 10.1002/ajmg.c.30095; Smith CH, 2014, DYSPHAGIA, V29, P52, DOI 10.1007/s00455-013-9479-4; Smith DS, 2001, AM FAM PHYSICIAN, V64, P1031; Steingass KJ, 2011, J DEV BEHAV PEDIATR, V32, P548, DOI 10.1097/DBP.0b013e31822182e0; Stevenson GS, 2009, INT J LAW PSYCHIAT, V32, P120, DOI 10.1016/j.ijlp.2009.01.008; Swigonski NL, 2006, PEDIATRICS, V118, P594, DOI 10.1542/peds.2005-2123; Taggard DA, 2000, J NEUROSURG, V93, P205, DOI 10.3171/spi.2000.93.2.0205; Tan JOA, 2004, J MED ETHICS, V30, P427, DOI 10.1136/jme.2003.003822; Tan M, 2013, J PAEDIATR CHILD H, V49, P223, DOI 10.1111/jpc.12129; Tenenbaum A, 2012, RES DEV DISABIL, V33, P435, DOI 10.1016/j.ridd.2011.09.026; Trois MS, 2009, J CLIN SLEEP MED, V5, P317; Tyler C, 2004, PRIMARY CARE, V31, P627, DOI 10.1016/j.pop.2004.04.006; Uibo O, 2006, WORLD J GASTROENTERO, V12, P1430, DOI 10.3748/wjg.v12.i9.1430; Van Allen MI, 1999, AM J MED GENET, V89, P100, DOI 10.1002/(SICI)1096-8628(19990625)89:2<100::AID-AJMG8>3.3.CO;2-E; Van Riper M, 2001, J Pediatr Health Care, V15, P123, DOI 10.1067/mph.2001.110627; Verma I. C., 1996, Indian Journal of Pediatrics, V63, P121, DOI 10.1007/BF02823883; Naznin B, 2007, PAED CHILD HEALT-CAN, V12, P179, DOI 10.1093/pch/12.3.179; Visser FE, 1997, AM J MENT RETARD, V101, P400; Walker JC, 2011, RES DEV DISABIL, V32, P1432, DOI 10.1016/j.ridd.2011.02.010; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; White SM, 2009, ANAEST INTENS CARE M, V10, P111, DOI 10.1016/j.mpaic.2009.01.004; WHO, 2012, GEN HUM DIS; Wilson GN, 2006, PREVENTIVE HLTH CARE, P175; Wu JH, 2013, EUR J HUM GENET, V21, P1016, DOI 10.1038/ejhg.2012.294; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Zeilinger EL, 2013, RES DEV DISABIL, V34, P3962, DOI 10.1016/j.ridd.2013.08.013; Zhu JL, 2013, GENET MED, V15, P64, DOI 10.1038/gim.2012.93; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163; Zigman WB, 2008, INT REV RES MENT RET, V36, P103, DOI 10.1016/S0074-7750(08)00004-9	153	31	31	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2014	349								g5596	10.1136/bmj.g5596	http://dx.doi.org/10.1136/bmj.g5596			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ3CA	25269800				2022-12-28	WOS:000342665100004
J	Stan, R				Stan, Rodica			The borders I crossed	SCIENCE			English	Editorial Material									City Hopes Beckman Res Inst, Dept Virol, Duarte, CA 91010 USA		Stan, R (corresponding author), City Hopes Beckman Res Inst, Dept Virol, Duarte, CA 91010 USA.								0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1650	1650		10.1126/science.345.6204.1650	http://dx.doi.org/10.1126/science.345.6204.1650			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP6CG	25258082	Bronze			2022-12-28	WOS:000342164500050
J	Yamey, G				Yamey, Gavin			Commentary: False dichotomy hinders global health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Yamey, G (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94105 USA.	yameyg@globalhealth.ucsf.edu						[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Evidence to Policy Initiative, PRIC SUBS SCHEM ART; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hutt P, 2004, CONFRONTING ILL SOC; JAMISON D, 2004, WHY HAS INFANT MORTA; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Lee K, 2010, BMJ-BRIT MED J, V340, pc2004; Mills A, 2005, B WORLD HEALTH ORGAN, V83, P315; Murray CJ, 2014, LANCET; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Sabot O, 2011, HEALTH POLICY PLANN, V26, P441, DOI 10.1093/heapol/czr067; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; World Health Organization, 2001, MACR HLTH INV HLTH E	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2014	349								g5458	10.1136/bmj.g5458	http://dx.doi.org/10.1136/bmj.g5458			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UR	25258372				2022-12-28	WOS:000342426400003
J	Botstein, D				Botstein, David			Lasker similar to Koshland to Genetics Pioneer	CELL			English	Editorial Material							BREAST-CANCER; LINKAGE		Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University	Botstein, D (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	botstein@calicolabs.com						BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044	5	0	0	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1230	1232		10.1016/j.cell.2014.08.020	http://dx.doi.org/10.1016/j.cell.2014.08.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215481	Bronze			2022-12-28	WOS:000343094200003
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; NEISSERIA-GONORRHOEAE; CT/NG TEST; TRACHOMATIS; INFECTION; WOMEN; PERFORMANCE; PREGNANCY; ASSAYS; SWABS	Description: Update of previous U.S. Preventive Services Task Force (USPSTF) recommendations on screening for chlamydia (2007) and gonorrhea (2005). Methods: The USPSTF reviewed the evidence on screening for chlamydial and gonococcal infections in asymptomatic patients from studies published since its last reviews. The USPSTF also considered evidence from its previous recommendations and reviews. Population: This recommendation applies to all sexually active adolescents and adults, including pregnant women. Recommendations: The USPSTF recommends screening for chlamydia in sexually active females aged 24 years or younger and in older women who are at increased risk for infection. (B recommendation) The USPSTF recommends screening for gonorrhea in sexually active females aged 24 years or younger and in older women who are at increased risk for infection. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men. (I statement)							USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2014, CLIN PREV SERV; Baeten JM, 2003, CURR HIV RES, V1, P69, DOI 10.2174/1570162033352110; Burstein G, 2010, CHANGES 2010 STD TRE; Calonge N, 2005, ANN FAM MED, V3, P263, DOI 10.1370/afm.337; *CDCP, 1991, SEX TRANSM DIS CLIN; Centers for Disease Control and Prevention, 2012, 2012 SEX TRANSM DIS; Centers for Disease Control and Prevention, 2014, GON CDC FACT SHEET D; Centers for Disease Control and Prevention, 2014, REP STDS US 2012 NAT; Chernesky MA, 2005, J CLIN MICROBIOL, V43, P127, DOI 10.1128/JCM.43.1.127-131.2005; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Glass N, 2005, AHRQ PUBLICATION; HOOK EW, 1990, SEXUALLY TRANSMITTED; Meyers DS, 2007, AHRQ PUBLICATION; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Murray PJ, 2014, PEDIATRICS, V134, pE302, DOI 10.1542/peds.2014-1024; Nelson HD, 2001, AM J PREV MED, V20, P95, DOI 10.1016/S0749-3797(01)00253-7; Nelson HD., 2014, AHRQ PUBLICATION; Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Public Health Agency of Canada, 2008, CAN GUID SEX TRANSM; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; RYAN GM, 1990, AM J OBSTET GYNECOL, V162, P34, DOI 10.1016/0002-9378(90)90815-O; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Schoeman SA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8013; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Shrier LA, 2004, AM J OBSTET GYNECOL, V190, P654, DOI 10.1016/j.ajog.2003.09.063; SMITH JR, 1993, BAILLIERE CLIN OB GY, V7, P237, DOI 10.1016/S0950-3552(05)80154-3; Stewart CMW, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8107; Tao G, 2008, SEX TRANSM DIS, V35, P167, DOI 10.1097/OLQ.0b013e3181585be5; Taylor SN, 2012, SEX TRANSM DIS, V39, P543, DOI 10.1097/OLQ.0b013e31824e26ff; Taylor SN, 2011, SEX TRANSM DIS, V38, P603, DOI 10.1097/OLQ.0b013e31820a94d2; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Van Der Pol B, 2012, J CLIN MICROBIOL, V50, P2244, DOI 10.1128/JCM.06481-11; Van Der Pol B, 2012, SEX TRANSM DIS, V39, P147, DOI 10.1097/OLQ.0b013e3182372fd8; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Zakher B, 2014, ANN INTERN MED, V161, P884, DOI 10.7326/M14-1022	39	179	184	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					902	U101		10.7326/M14-1981	http://dx.doi.org/10.7326/M14-1981			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25243785				2022-12-28	WOS:000347248400032
J	Parker, HJ; Bronner, ME; Krumlauf, R				Parker, Hugo J.; Bronner, Marianne E.; Krumlauf, Robb			A Hox regulatory network of hindbrain segmentation is conserved to the base of vertebrates	NATURE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; EVOLUTION; LAMPREY; INSIGHTS; ELEMENTS; CLUSTER; ORIGINS; GENOME; KROX20	A defining feature governing head patterning of jawed vertebrates is a highly conserved gene regulatory network that integrates hindbrain segmentation with segmentally restricted domains of Hox gene expression. Although non-vertebrate chordates display nested domains of axial Hox expression, they lack hindbrain segmentation. The sea lamprey, a jawless fish, can provide unique insights into vertebrate origins owing to its phylogenetic position at the base of the vertebrate tree(1-3). It has been suggested that lamprey may represent an intermediate state where nested Hox expression has not been coupled to the process of hindbrain segmentation(4-6). However, little is known about the regulatory network underlying Hox expression in lamprey or its relationship to hindbrain segmentation. Here, using a novel tool that allows cross-species comparisons of regulatory elements between jawed and jawless vertebrates, we report deep conservation of both upstream regulators and segmental activity of enhancer elements across these distant species. Regulatory regions from diverse gnathostomes drive segmental reporter expression in the lamprey hindbrain and require the same transcriptional inputs (for example, Kreisler (also known as Mafba), Krox20 (also known as Egr2a)) in both lamprey and zebrafish. We find that lamprey hox genes display dynamic segmentally restricted domains of expression; we also isolated a conserved exonic hox2 enhancer from lamprey that drives segmental expression in rhombomeres 2 and 4. Our results show that coupling of Hox gene expression to segmentation of the hindbrain is an ancient trait with origin at the base of vertebrates that probably led to the formation of rhombomeric compartments with an underlying Hox code.	[Parker, Hugo J.; Krumlauf, Robb] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Bronner, Marianne E.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Krumlauf, Robb] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; California Institute of Technology; University of Kansas; University of Kansas Medical Center	Krumlauf, R (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	rek@Stowers.org	Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927; Bronner, Marianne/0000-0003-4274-1862; Parker, Hugo/0000-0001-7646-2007	Stowers Institute [2013-1001];  [R01N5086907];  [R01DE017911]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086907] Funding Source: NIH RePORTER	Stowers Institute; ; ; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Green for sharing expertise, methods and managing the lamprey facility; T. Sauka-Spengler for in situ hybridization advice; M. Simoes-Costa and B. Uy for help with reporter constructs; J. McEllin, C. Nolte, C. Scott and L. Wiedemann for discussions and assistance with lamprey hox genes; M. Distel and R. Koster for the r3/r5-mCherry zebrafish line; M. Miller for graphic design; A. Ikmi for manuscript comments and the Stowers Institute aquatics facility for zebrafish care. H.J.P. and R.K. were supported by the Stowers Institute (RK grant #2013-1001). M.E.B. was supported by grants R01N5086907 and R01DE017911.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Lumsden A, 2004, MECH DEVELOP, V121, P1081, DOI 10.1016/j.mod.2004.04.018; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; Manzanares M, 1997, NATURE, V387, P191, DOI 10.1038/387191a0; Manzanares M, 2002, EMBO J, V21, P365, DOI 10.1093/emboj/21.3.365; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Murakami Y, 2004, DEVELOPMENT, V131, P983, DOI 10.1242/dev.00986; Natale A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-330; Nolte C, 2013, DEV BIOL, V383, P158, DOI 10.1016/j.ydbio.2013.09.016; Nonchev S, 1996, P NATL ACAD SCI USA, V93, P9339, DOI 10.1073/pnas.93.18.9339; Nonchev S, 1996, DEVELOPMENT, V122, P543; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Parker HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085492; Parker HJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-637; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; TAHARA Y, 1988, ZOOL SCI, V5, P109; Takio Y, 2004, NATURE, V429, DOI 10.1038/nature02616; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; Theil T, 1998, DEVELOPMENT, V125, P443; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Tumpel S, 2006, P NATL ACAD SCI USA, V103, P5419, DOI 10.1073/pnas.0600993103; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Tumpel S, 2008, P NATL ACAD SCI USA, V105, P20077, DOI 10.1073/pnas.0806360105; Wada H, 1999, DEV BIOL, V213, P131, DOI 10.1006/dbio.1999.9369; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; Zhang F, 2000, MECH DEVELOP, V96, P79, DOI 10.1016/S0925-4773(00)00377-4	39	71	71	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					490	+		10.1038/nature13723	http://dx.doi.org/10.1038/nature13723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25219855	Green Accepted			2022-12-28	WOS:000343775900040
J	Carbone, FR; Gebhardt, T				Carbone, Francis R.; Gebhardt, Thomas			A neighborhood watch upholds local immune protection	SCIENCE			English	Editorial Material							CD8(+) T-CELLS; MEMORY; TISSUE; SKIN; INFECTION; TRIGGER; HERPES		[Carbone, Francis R.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia	University of Melbourne	Carbone, FR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia.	f.carbone@microbiology.unimelb.edu.au	Carbone, Francis/ABF-2141-2020	Gebhardt, Thomas/0000-0002-3768-9468				Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745	14	7	8	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					40	41		10.1126/science.1259925	http://dx.doi.org/10.1126/science.1259925			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0BR	25278601				2022-12-28	WOS:000342446900026
J	Cannavo, E; Cejka, P				Cannavo, Elda; Cejka, Petr			Sae2 promotes dsDNA endonuclease activity within Mre11-Rad50-Xrs2 to resect DNA breaks	NATURE			English	Article							DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; END RESECTION; NUCLEASE ACTIVITIES; TOPOISOMERASE-I; MRE11 NUCLEASE; REPAIR; EXO1; COMPLEX; RAD50	To repair double-strand DNA breaks by homologous recombination, the 5'-terminated DNA strand must first be resected, which generates 3' single-stranded DNA overhangs. Genetic evidence suggests that this process is initiated by the Mre11-Rad50-Xrs2 (MRX) complex(1-3). However, its involvement was puzzling, as the complex possesses exonuclease activity with the opposite (3' to 5') polarity from that required for homologous recombination(4,5). Consequently, a bidirectional model has been proposed(6-8) whereby dsDNA is first incised endonucleolytically and MRX then proceeds back to the dsDNA end using its 3' to 5' exonuclease. The endonuclease creates entry sites for Sgs1-Dna2 and/or Exo1, which then carry out long-range resection in the 5' to 3' direction. However, the identity of the endonuclease remained unclear. Using purified Saccharomyces cerevisiae proteins, we show that Sae2 promotes dsDNA-specific endonuclease activity by the Mre11 subunit within the MRX complex. The endonuclease preferentially cleaves the 5'-terminated dsDNA strand, which explains the polarity paradox. The dsDNA end clipping is strongly stimulated by protein blocks at the DNA end, and requires the ATPase activity ofRad50 and physical interactions between MRX and Sae2. Our results suggest that MRX initiates dsDNA break processing by dsDNA endonuclease rather than exonuclease activity, and that Sae2 is the key regulator of this process. These findings demonstrate a probable mechanism for the initiation of dsDNA break processing in both vegetative and meiotic cells.	[Cannavo, Elda; Cejka, Petr] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	University of Zurich	Cejka, P (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	cejka@imcr.uzh.ch		Cejka, Petr/0000-0002-9087-032X	Swiss National Science Foundation [PP00P3 133636]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank L. Ranjha, R. Anand, L. Mlejnkova and M. Levikova for assistance and comments on the manuscript. This work was supported by Swiss National Science Foundation Grant PP00P3 133636 to P.C.	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Bressan DA, 1998, GENETICS, V150, P591; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Chen L, 2005, J BIOL CHEM, V280, P2620, DOI 10.1074/jbc.M410192200; Deshpande RA, 2014, EMBO J, V33, P482, DOI 10.1002/embj.201386100; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Levikova M, 2013, P NATL ACAD SCI USA, V110, pE1992, DOI 10.1073/pnas.1300390110; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Rattray AJ, 2001, GENETICS, V158, P109; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	34	275	277	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					122	+		10.1038/nature13771	http://dx.doi.org/10.1038/nature13771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25231868				2022-12-28	WOS:000342420800048
J	Hawkes, N				Hawkes, Nigel			How to tackle the NHS funding crisis? Levy charges	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5396; Le Grand J., 2014, HLTH SERV J; O'Dowd A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5864	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2014	349								g5907	10.1136/bmj.g5907	http://dx.doi.org/10.1136/bmj.g5907			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CF	25274612				2022-12-28	WOS:000342665600004
J	Belloche, A; Garrod, RT; Muller, HSP; Menten, KM				Belloche, Arnaud; Garrod, Robin T.; Mueller, Holger S. P.; Menten, Karl M.			Detection of a branched alkyl molecule in the interstellar medium: iso-propyl cyanide	SCIENCE			English	Article							SAGITTARIUS B2(N)	The largest noncyclic molecules detected in the interstellar medium (ISM) are organic with a straight-chain carbon backbone. We report an interstellar detection of a branched alkyl molecule, iso-propyl cyanide (i-C3H7CN), with an abundance 0.4 times that of its straight-chain structural isomer. This detection suggests that branched carbon-chain molecules may be generally abundant in the ISM. Our astrochemical model indicates that both isomers are produced within or upon dust grain ice mantles through the addition of molecular radicals, albeit via differing reaction pathways. The production of iso-propyl cyanide appears to require the addition of a functional group to a nonterminal carbon in the chain. Its detection therefore bodes well for the presence in the ISM of amino acids, for which such side-chain structure is a key characteristic.	[Belloche, Arnaud; Menten, Karl M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Garrod, Robin T.] Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; [Mueller, Holger S. P.] Univ Cologne, Inst Phys 1, D-50937 Cologne, Germany	Max Planck Society; Cornell University; University of Cologne	Belloche, A (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	belloche@mpifr-bonn.mpg.de		Mueller, Holger/0000-0002-0183-8927	Deutsche Forschungsgemeinschaft [SFB 956]; Bundesministerium fur Bildung und Forschung [FKZ 50OF0901, 05A11PK3]; NASA [NNX11AC38G]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NASA(National Aeronautics & Space Administration (NASA))	We thank D. Petry and E. Humphreys at the European ALMA Regional Center (ARC), F. Gueth at the IRAM ARC node, and D. Muders at the MPIfR for their help with the reduction of the ALMA data; S. Bardeau, S. Maret, J. Pety, M. Lonjaret, and P. Hily-Blant for the new developments implemented in the Weeds software; and M. Koerber for help with preparing Fig. 1. This work made use of the National Institute of Standards and Technology Chemical Kinetics Database. This work has been supported in part by the Deutsche Forschungsgemeinschaft through the collaborative research grant SFB 956 "Conditions and Impact of Star Formation," project area B3. H. S. P. M. is very grateful to the Bundesministerium fur Bildung und Forschung for support through projects FKZ 50OF0901 (ICC HIFI Herschel) and 05A11PK3 (ALMA ARC Node). R. T. G. acknowledges support from the NASA Astrophysics Theory Program through grant NNX11AC38G. This paper makes use of the following ALMA data: ADS/JAO. ALMA#2011.0.00017. S. ALMA is a partnership of the European Southern Observatory (ESO) (representing its member states), NSF (USA), and National Institutes of Natural Sciences (Japan), together with National Research Council (Canada) and National Science Council and Academia Sinica Institute of Astronomy and Astrophysics (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, Associated Universities Incorporated/National Radio Astronomy Observatory, and National Astronomical Observatory of Japan. The interferometric data are available in the ALMA archive at https://almascience.eso.org/aq/. The chemical model input files are located at www.astro.cornell.edu/similar to rgarrod/resources.	Bell MB, 1997, ASTROPHYS J, V483, pL61, DOI 10.1086/310732; Belloche A, 2008, ASTRON ASTROPHYS, V482, P179, DOI 10.1051/0004-6361:20079203; Belloche A, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201321096; Belloche A, 2009, ASTRON ASTROPHYS, V499, P215, DOI 10.1051/0004-6361/200811550; Botta O, 2002, SURV GEOPHYS, V23, P411, DOI 10.1023/A:1020139302770; Cronin J R, 1983, Adv Space Res, V3, P5, DOI 10.1016/0273-1177(83)90036-4; Curran HJ, 2006, INT J CHEM KINET, V38, P250, DOI 10.1002/kin.20153; Garrod RT, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/60; Goldsmith PF, 1999, ASTROPHYS J, V517, P209, DOI 10.1086/307195; MILLAR TJ, 1988, ASTRON ASTROPHYS, V205, pL5; Muller HSP, 2011, J MOL SPECTROSC, V267, P100, DOI 10.1016/j.jms.2011.02.011; Muller HSP, 2005, J MOL STRUCT, V742, P215, DOI 10.1016/j.molstruc.2005.01.027; Reid MJ, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/130	14	145	145	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1584	1587		10.1126/science.1256678	http://dx.doi.org/10.1126/science.1256678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258074	Green Submitted			2022-12-28	WOS:000342164500037
J	Chen, L; Kostadima, M; Martens, JHA; Canu, G; Garcia, SP; Turro, E; Downes, K; Macaulay, IC; Bielczyk-Maczynska, E; Coe, S; Farrow, S; Poudel, P; Burden, F; Jansen, SBG; Astle, WJ; Attwood, A; Bariana, T; de Bono, B; Breschi, A; Chambers, JC; Choudry, FA; Clarke, L; Coupland, P; van der Ent, M; Erber, WN; Jansen, JH; Favier, R; Fenech, ME; Foad, N; Freson, K; van Geet, C; Gomez, K; Guigo, R; Hampshire, D; Kelly, AM; Kerstens, HHD; Kooner, JS; Laffan, M; Lentaigne, C; Labalette, C; Martin, T; Meacham, S; Mumford, A; Nurnberg, S; Palumbo, E; van der Reijden, BA; Richardson, D; Sammut, SJ; Slodkowicz, G; Tamuri, AU; Vasquez, L; Voss, K; Watt, S; Westbury, S; Flicek, P; Loos, R; Goldman, N; Bertone, P; Read, RJ; Richardson, S; Cvejic, A; Soranzo, N; Ouwehand, WH; Stunnenberg, HG; Frontini, M; Rendon, A				Chen, Lu; Kostadima, Myrto; Martens, Joost H. A.; Canu, Giovanni; Garcia, Sara P.; Turro, Ernest; Downes, Kate; Macaulay, Iain C.; Bielczyk-Maczynska, Ewa; Coe, Sophia; Farrow, Samantha; Poudel, Pawan; Burden, Frances; Jansen, Sjoert B. G.; Astle, William J.; Attwood, Antony; Bariana, Tadbir; de Bono, Bernard; Breschi, Alessandra; Chambers, John C.; Choudry, Fizzah A.; Clarke, Laura; Coupland, Paul; van der Ent, Martijn; Erber, Wendy N.; Jansen, Joop H.; Favier, Remi; Fenech, Matthew E.; Foad, Nicola; Freson, Kathleen; van Geet, Chris; Gomez, Keith; Guigo, Roderic; Hampshire, Daniel; Kelly, Anne M.; Kerstens, Hindrik H. D.; Kooner, Jaspal S.; Laffan, Michael; Lentaigne, Claire; Labalette, Charlotte; Martin, Tiphaine; Meacham, Stuart; Mumford, Andrew; Nuernberg, Sylvia; Palumbo, Emilio; van der Reijden, Bert A.; Richardson, David; Sammut, Stephen J.; Slodkowicz, Greg; Tamuri, Asif U.; Vasquez, Louella; Voss, Katrin; Watt, Stephen; Westbury, Sarah; Flicek, Paul; Loos, Remco; Goldman, Nick; Bertone, Paul; Read, Randy J.; Richardson, Sylvia; Cvejic, Ana; Soranzo, Nicole; Ouwehand, Willem H.; Stunnenberg, Hendrik G.; Frontini, Mattia; Rendon, Augusto		BRIDGE Consortium	Transcriptional diversity during lineage commitment of human blood progenitors	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; NUCLEAR FACTOR-I; RNA-SEQ; GENE; DIFFERENTIATION; EXPRESSION; BINDING; GENOME; MEGAKARYOPOIESIS; MYELODYSPLASIA	Blood cells derive from hematopoietic stem cells through stepwise fating events. To characterize gene expression programs driving lineage choice, we sequenced RNA from eight primary human hematopoietic progenitor populations representing the major myeloid commitment stages and the main lymphoid stage. We identified extensive cell type-specific expression changes: 6711 genes and 10,724 transcripts, enriched in non-protein-coding elements at early stages of differentiation. In addition, we found 7881 novel splice junctions and 2301 differentially used alternative splicing events, enriched in genes involved in regulatory processes. We demonstrated experimentally cell-specific isoform usage, identifying nuclear factor I/B (NFIB) as a regulator of megakaryocyte maturation-the platelet precursor. Our data highlight the complexity of fating events in closely related progenitor populations, the understanding of which is essential for the advancement of transplantation and regenerative medicine.	[Chen, Lu; Coupland, Paul; Flicek, Paul; Cvejic, Ana; Soranzo, Nicole; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Chen, Lu; Kostadima, Myrto; Canu, Giovanni; Garcia, Sara P.; Turro, Ernest; Downes, Kate; Bielczyk-Maczynska, Ewa; Coe, Sophia; Farrow, Samantha; Poudel, Pawan; Burden, Frances; Jansen, Sjoert B. G.; Astle, William J.; Attwood, Antony; Choudry, Fizzah A.; Foad, Nicola; Hampshire, Daniel; Kelly, Anne M.; Labalette, Charlotte; Martin, Tiphaine; Meacham, Stuart; Nuernberg, Sylvia; Voss, Katrin; Cvejic, Ana; Soranzo, Nicole; Ouwehand, Willem H.; Frontini, Mattia; Rendon, Augusto] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Chen, Lu; Kostadima, Myrto; Canu, Giovanni; Garcia, Sara P.; Turro, Ernest; Downes, Kate; Bielczyk-Maczynska, Ewa; Coe, Sophia; Farrow, Samantha; Poudel, Pawan; Burden, Frances; Jansen, Sjoert B. G.; Astle, William J.; Attwood, Antony; Choudry, Fizzah A.; Foad, Nicola; Hampshire, Daniel; Kelly, Anne M.; Labalette, Charlotte; Martin, Tiphaine; Meacham, Stuart; Nuernberg, Sylvia; Vasquez, Louella; Voss, Katrin; Watt, Stephen; Ouwehand, Willem H.; Frontini, Mattia; Rendon, Augusto] Natl Hlth Serv NHS Blood & Transplant, Cambridge CB2 0PT, England; [Kostadima, Myrto; Clarke, Laura; Richardson, David; Slodkowicz, Greg; Tamuri, Asif U.; Flicek, Paul; Loos, Remco; Goldman, Nick; Bertone, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Martens, Joost H. A.; van der Ent, Martijn; Kerstens, Hindrik H. D.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Macaulay, Iain C.] Wellcome Trust Sanger Inst, EBI Single Cell Genom Ctr, Sanger Inst, Cambridge CB10 1SA, England; [Astle, William J.; Richardson, Sylvia; Rendon, Augusto] MRC, Biostat Unit, Cambridge CB2 0SR, England; [Bariana, Tadbir] UCL, Inst Canc, Dept Haematol, London WC1E 6DD, England; [Bariana, Tadbir; Gomez, Keith] Royal Free NHS Trust, Katharine Dormandy Haemophilia Ctr, London NW3 2QG, England; [Bariana, Tadbir; Gomez, Keith] Royal Free NHS Trust, Thrombosis Unit, London NW3 2QG, England; [de Bono, Bernard] UCL, CHIME Inst, London NW1 2DA, England; [de Bono, Bernard] Univ Auckland, Auckland Bioengn Inst, Auckland 1010, New Zealand; [Breschi, Alessandra; Guigo, Roderic; Palumbo, Emilio] Ctr Genom Regulat, Barcelona 08002, Spain; [Breschi, Alessandra; Guigo, Roderic; Palumbo, Emilio] Univ Pompeu Fabra, Barcelona 08002, Spain; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London W12 0HS, England; [Chambers, John C.; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Southall UB1 3HW, Middx, England; [Erber, Wendy N.] Univ Western Australia, Crawley, WA 6009, Australia; [Jansen, Joop H.; van der Reijden, Bert A.] Radboud Univ Nijmegen, Med Ctr, Hematol Lab, Dept Lab Med, NL-6525 GA Nijmegen, Netherlands; [Favier, Remi] AP HP, INSERM U1009, F-94805 Villejuif, France; [Fenech, Matthew E.] Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Freson, Kathleen; van Geet, Chris] Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Leuven, Belgium; [Kelly, Anne M.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge B2 0QQ, England; [Laffan, Michael; Lentaigne, Claire] Univ London Imperial Coll Sci Technol & Med, Acad Hlth Sci Ctr, Dept Haematol, London W12 0HS, England; [Martin, Tiphaine] Kings Coll London, St Thomas Hosp, Genet & Mol Med Div, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Mumford, Andrew] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Sammut, Stephen J.] Addenbrookes Cambridge Univ Hosp NHS Trust, Dept Oncol, Cambridge CB2 0RE, England; [Sammut, Stephen J.] Canc Res UK, Cambridge Inst, Cambridge CB2 0RE, England; [Westbury, Sarah] Univ Bristol, Sch Clin Sci, Bristol BS2 8DZ, Avon, England; [Bertone, Paul] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Bertone, Paul] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Bertone, Paul] Univ Cambridge, Wellcome Trust, MRC, Stem Cell Inst, Cambridge CB2 1QR, England; [Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England	Wellcome Trust Sanger Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL); Radboud University Nijmegen; Wellcome Trust Sanger Institute; MRC Biostatistics Unit; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Auckland; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Imperial College London; University of Western Australia; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of East Anglia; KU Leuven; University of Cambridge; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Bristol; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Bristol; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge	Frontini, M (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge CB2 0PT, England.	mf471@cam.ac.uk; ar506@cam.ac.uk	Canu, Giovanni/AAN-8515-2021; van der Reijden, Bert A/A-3543-2014; Martens, Joost/D-4966-2012; Heemskerk, Johan/AAM-8323-2021; Read, Randy J/L-1418-2013; Jansen, J.H./H-8054-2014; Richardson, Sylvia T/G-4691-2015; Bertone, Paul/Z-3734-2019; Stunnenberg, Hendrik G./D-6875-2012; Guigo, Roderic/D-1303-2010; Bertone, Paul/A-6600-2013; Loos, Ruth/Q-2862-2016	Canu, Giovanni/0000-0002-3349-4479; Martens, Joost/0000-0003-2008-6537; Heemskerk, Johan/0000-0002-2848-5121; Read, Randy J/0000-0001-8273-0047; Jansen, J.H./0000-0001-9459-568X; Richardson, Sylvia T/0000-0003-1998-492X; Bertone, Paul/0000-0001-5059-4829; Stunnenberg, Hendrik G./0000-0002-0066-1576; Guigo, Roderic/0000-0002-5738-4477; Bertone, Paul/0000-0001-5059-4829; Turro, Ernest/0000-0002-1820-6563; Loos, Remco/0000-0002-9850-6821; Slodkowicz, Grzegorz/0000-0001-6918-0386; de Bono, Bernard/0000-0003-0638-5274; Sammut, Stephen John/0000-0003-4472-904X; Goldman, Nick/0000-0001-8486-2211; mumford, andrew/0000-0002-5523-511X; Ouwehand, Willem/0000-0002-7744-1790; Clarke, Laura/0000-0002-5989-6898; Meacham, Stuart/0000-0002-3667-6059; Tamuri, Asif/0000-0001-6633-3789; Soranzo, Nicole/0000-0003-1095-3852; Garcia, Sara/0000-0003-3312-6454; Palumbo, Emilio/0000-0003-4599-8161; Astle, William John/0000-0001-8866-6672; Fenech, Matthew/0000-0001-9970-0215; Flicek, Paul/0000-0002-3897-7955; Coupland, Paul/0000-0002-2871-3374; Macaulay, Iain/0000-0002-6761-757X; Erber, Wendy/0000-0002-1028-9376; Loos, Ruth/0000-0002-8532-5087; Gomez, Keith/0000-0002-8934-0700; Martin, Tiphaine/0000-0001-9990-1455; schulman, sol/0000-0002-5229-3592; Jansen, Sjoert/0000-0002-3728-644X; Vasquez, Louella Judy/0000-0002-5758-6036; Cvejic, Ana/0000-0003-3204-9311; Kostadima, Myrto Areti/0000-0002-1818-4050; Bielczyk-Maczynska, Ewa/0000-0002-0558-1188; Westbury, Sarah/0000-0002-0950-8148; Rendon, Augusto/0000-0001-8994-0039; Richardson, David/0000-0003-0247-9118; freson, kathleen/0000-0002-4381-2442; Laffan, Michael/0000-0002-8268-3268	European Commission [HEALTH-F5-2011-282510]; National Institute for Health Research (NIHR); British Heart Foundation [RP-PG-0310-1002, RG/09/12/28096]; NETSIM FP7 program - European Commission; NHS Blood and Transplant; NIHR; NIHR BioResource-Rare Diseases; Wellcome Trust [WT098051, WT091310, 084183/Z/07/Z, 082961/Z/07/Z, 095908]; EU FP7 EPIGENESYS initiative [257082]; Cancer Research UK [C45041/A14953]; British Heart Foundation Clinical Research Training Fellowship [FS/12/27/29405]; Imperial College BRC; Medical Research Council; British Society of Haematology/NHS Blood and Transplant; EMBL; FWO-Vlaanderen [G.0B17.13N]; British Heart Foundation [FS/12/27/29405, RG/09/012/28096] Funding Source: researchfish; Cancer Research UK [14953] Funding Source: researchfish; Medical Research Council [MR/J011711/1, MR/K006584/1, MR/K024043/1, MR/K023489/1, MC_UP_0801/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10151, RP-PG-0310-1002, ACF-2012-14-006, NF-SI-0510-10214] Funding Source: researchfish; MRC [MR/K023489/1, MR/J011711/1, MR/K024043/1, MC_UP_0801/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); NETSIM FP7 program - European Commission; NHS Blood and Transplant; NIHR(National Institute for Health Research (NIHR)); NIHR BioResource-Rare Diseases; Wellcome Trust(Wellcome Trust); EU FP7 EPIGENESYS initiative; Cancer Research UK(Cancer Research UK); British Heart Foundation Clinical Research Training Fellowship; Imperial College BRC; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Society of Haematology/NHS Blood and Transplant; EMBL; FWO-Vlaanderen(FWO); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work described in this article was primarily supported by the European Commission Seventh Framework Program through the BLUEPRINT grant with code HEALTH-F5-2011-282510 (D. H., F. B., G. C., J.H.A.M., K. D., L. C., M. F., S. C., S. F., and S. P. G.). Research in the Ouwehand laboratory is further supported by program grants from the National Institute for Health Research (NIHR, www.nihr.ac.uk; to A. A., M. K., P. P., S.B.G.J., S.N., and W.H.O.) and the British Heart Foundation under nos. RP-PG-0310-1002 and RG/09/12/28096 (www.bhf.org.uk; to A. R. and W.J.A.). K. F. and M. K. were supported by Marie Curie funding from the NETSIM FP7 program funded by the European Commission. The laboratory receives funding from the NHS Blood and Transplant for facilities. The Cambridge BioResource (www.cambridgebioresource.org.uk), the Cell Phenotyping Hub, and the Cambridge Translational GenOmics laboratory (www.catgo.org.uk) are supported by an NIHR grant to the Cambridge NIHR Biomedical Research Centre (BRC). The BRIDGE-Bleeding and Platelet Disorders Consortium is supported by the NIHR BioResource-Rare Diseases (http://bioresource.nihr.ac.uk/; to E. T., N.F., and Whole Exome Sequencing effort). Research in the Soranzo laboratory (L. V., N.S., and S. Watt) is further supported by the Wellcome Trust (Grant Codes WT098051 and WT091310) and the EU FP7 EPIGENESYS initiative (Grant Code 257082). Research in the Cvejic laboratory (A. Cvejic and C. L.) is funded by the Cancer Research UK under grant no. C45041/A14953. S.J.S. is funded by NIHR. M. E. F. is supported by a British Heart Foundation Clinical Research Training Fellowship, no. FS/12/27/29405. E. B.-M. is supported by a Wellcome Trust grant, no. 084183/Z/07/Z. Research in the Laffan laboratory is supported by Imperial College BRC. F. A. C., C. L., and S. Westbury are supported by Medical Research Council Clinical Training Fellowships, and T. B. by a British Society of Haematology/NHS Blood and Transplant grant. R.J.R. is a Principal Research Fellow of the Wellcome Trust, grant no. 082961/Z/07/Z. Research in the Flicek laboratory is also supported by the Wellcome Trust (grant no. 095908) and EMBL. Research in the Bertone laboratory is supported by EMBL. K. F. and C. v. G. are supported by FWO-Vlaanderen through grant G.0B17.13N. P. F. is a compensated member of the Omicia Inc. Scientific Advisory Board. This study made use of data generated by the UK10K Consortium, derived from samples from the Cohorts arm of the project. A full list of the investigators who contributed to the generation of the data is available from www.UK10K.org. We wish to acknowledge the following facilities and people: Cambridge BRC Cell Phenotyping Hub, Cambridge BRC Translational Genomics Laboratory, Cambridge BRC Blood and Stem Cell Biobank, NHS Blood and Transplant donation clinic, Sanger Institute-EBI Single-Cell Genomics Centre, J. Garwood, D. Fletcher, L. Guglielmi, team of the Ouwehand laboratory, and M. Bussemakers from the University of Nijmegen. The critical comments from J.-P. Allain and D. Rico are greatly appreciated. The data are available from the Blueprint Consortium Web site www.blueprint-epigenome.eu/and the European Genome-phenome Archive with accession no. EGAD00001000745. Visualization tools are also accessible from http://blueprint.haem.cam.ac.uk/.	APT D, 1993, J VIROL, V67, P4455, DOI 10.1128/JVI.67.8.4455-4463.1993; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bluteau O, 2013, J THROMB HAEMOST, V11, P1730, DOI 10.1111/jth.12326; Bryder D, 2010, CURR OPIN IMMUNOL, V22, P148, DOI 10.1016/j.coi.2010.02.001; Cazzola M, 2013, BLOOD, V122, P4021, DOI 10.1182/blood-2013-09-381665; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Dekker J, 1996, MOL CELL BIOL, V16, P4073; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Giebel B, 2008, CURR STEM CELL RES T, V3, P9, DOI 10.2174/157488808783489444; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoggatt J, 2013, STEM CELLS, V31, P2599, DOI 10.1002/stem.1574; Holmfeldt P, 2013, BLOOD, V122, P2987, DOI 10.1182/blood-2013-04-493973; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Lambert MP, 2013, BLOOD, V121, P3319, DOI 10.1182/blood-2012-09-455428; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paul DS, 2013, GENOME RES, V23, P1130, DOI 10.1101/gr.155127.113; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Slukvin II, 2013, BLOOD, V122, P4035, DOI 10.1182/blood-2013-07-474825; Starnes LM, 2010, LEUKEMIA, V24, P1220, DOI 10.1038/leu.2010.78; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Turro E, 2014, BIOINFORMATICS, V30, P180, DOI 10.1093/bioinformatics/btt624; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Wan YZ, 2013, BLOOD, V121, P4627, DOI 10.1182/blood-2013-02-427641; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wilkinson AC, 2013, ADV EXP MED BIOL, V786, P187, DOI 10.1007/978-94-007-6621-1_11; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	60	172	179	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1580	+	1251033	10.1126/science.1251033	http://dx.doi.org/10.1126/science.1251033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258084	Green Accepted, Green Submitted			2022-12-28	WOS:000342164500035
J	Venditti, JG; Rennie, CD; Bomhof, J; Bradley, RW; Little, M; Church, M				Venditti, Jeremy G.; Rennie, Colin D.; Bomhof, James; Bradley, Ryan W.; Little, Malcolm; Church, Michael			Flow in bedrock canyons	NATURE			English	Article							RIVER INCISION; EVOLUTION; MODEL	Bedrock erosion in rivers sets the pace of landscape evolution, influences the evolution of orogens and determines the size, shape and relief of mountains(1,2). A variety of models link fluid flow and sediment transport processes to bedrock incision in canyons. The model components that represent sediment transport processes are increasingly well developed(3-5). In contrast, the model components being used to represent fluid flow are largely untested because there are no observations of the flow structure in bedrock canyons. Here we present a 524-kilometre, continuous centreline, acoustic Doppler current profiler survey of the Fraser Canyon in western Canada, which includes 42 individual bedrock canyons. Our observations of three-dimensional flow structure reveal that, as water enters the canyons, a high-velocity core follows the bed surface, causing a velocity inversion (high velocities near the bed and low velocities at the surface). The plunging water then upwells along the canyon walls, resulting in counter-rotating, along-stream coherent flow structures that diverge near the bed. The resulting flow structure promotes deep scour in the bedrock channel floor and undercutting of the canyon walls. This provides a mechanism for channel widening and ensures that the base of the walls is swept clear of the debris that is often deposited there, keeping the walls nearly vertical. These observations reveal that the flow structure in bedrock canyons is more complex than assumed in the models presently used. Fluid flow models that capture the essence of the three-dimensional flow field, using simple phenomenological rules that are computationally tractable, are required to capture the dynamic coupling between flow, bedrock erosion and solid-Earth dynamics.	[Venditti, Jeremy G.; Bradley, Ryan W.; Little, Malcolm] Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada; [Rennie, Colin D.; Bomhof, James] Univ Ottawa, Dept Civil Engn, Ottawa, ON K1N 6N5, Canada; [Church, Michael] Univ British Columbia, Dept Geog, Vancouver, BC V6T 1Z2, Canada	Simon Fraser University; University of Ottawa; University of British Columbia	Venditti, JG (corresponding author), Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada.	jeremy_venditti@sfu.ca	Rennie, Colin D/D-1852-2015	Rennie, Colin D/0000-0003-0683-1932	Natural Science and Engineering Research Council	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Science and Engineering Research Council grants to M. C., J.G.V. and C. D. R. We thank D. Baerg and his crew at Fraser River Raft Expeditions for undertaking the logistics of the river traverse, R. DiBiase for reviewing an early draft of the manuscript, and M. Lin and C. Adderley for assistance with data processing.	Barbour JR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035786; BATHURST JC, 1977, NATURE, V269, P504, DOI 10.1038/269504a0; Chatanantavet P, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001044; DiBiase RA, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002095; Ferrier KL, 2013, NATURE, V496, P206, DOI 10.1038/nature11982; Finnegan NJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000569; Finnegan NJ, 2014, NATURE, V505, P391, DOI 10.1038/nature12913; Fuller T. K., 2013, THESIS U MINNESOTA; Howard A., 1983, GEOL SOC AM BULL, V94, P739, DOI DOI 10.1130/0016-7606(1983)94<739:CCIB>2.0.C0;2; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; Jamieson EC, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010043; Kean JW, 2004, WATER SCI APPL, V8, P237; Kironoto BA, 1995, P I CIVIL ENG-WATER, V112, P336, DOI 10.1680/iwtme.1995.28114; Lamb MP, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000915; Leopold L.B., 1992, FLUVIAL PROCESSES GE; MacVicar B. J., 2013, COHERENT FLOW STRUCT, P243; MacVicar BJ, 2012, WATER RESOUR RES, V48, DOI 10.1029/2010WR009374; Nelson PA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048628; Nezu I., 1993, TURBULENCE OPEN CHAN, P96; Rennie CD, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001556; Seidl M.A., 1992, CATENA S, V23, P101, DOI DOI 10.1029/2007WR006219; SEIDL MA, 1994, J GEOL, V102, P457, DOI 10.1086/629686; Sklar LS, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002496; Stark CP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL023193; Tucker GE, 2010, EARTH SURF PROC LAND, V35, P28, DOI 10.1002/esp.1952; Turowski JM, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001133; Venditti J.G., 2013, COHERENT FLOW STRUCT, P1, DOI [10.1002/9781118527221.ch1, DOI 10.1002/9781118527221.CH1]; Whipple K.X., 2013, TREATISE GEOMORPHOLO, P550, DOI DOI 10.1016/B978-0-12-374739-6.00254-2; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Willett SD, 2014, SCIENCE, V343, P1117, DOI 10.1126/science.1248765; Wobus CW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027182; Yang SQ, 2009, J HYDRAUL RES, V47, P177, DOI 10.3826/jhr.2009.3254	33	47	48	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					534	+		10.1038/nature13779	http://dx.doi.org/10.1038/nature13779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254474				2022-12-28	WOS:000342075800037
J	Checchi, KD; Huybrechts, KF; Avorn, J; Kesselheim, AS				Checchi, Kyle D.; Huybrechts, Krista F.; Avorn, Jerry; Kesselheim, Aaron S.			Electronic Medication Packaging Devices and Medication Adherence A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; VISUAL-FEEDBACK THERAPY; HIV-INFECTED PATIENTS; CLINICAL-TRIAL; INTERVENTION; IMPACT; NONADHERENCE; HYPERTENSION; PEOPLE	IMPORTANCE Medication nonadherence, which has been estimated to affect 28% to 31% of US patients with hypertension, hyperlipidemia, and diabetes, may be improved by electronic medication packaging (EMP) devices (adherence-monitoring devices incorporated into the packaging of a prescription medication). OBJECTIVES To investigate whether EMP devices are associated with improved adherence and to identify and describe common features of EMP devices. EVIDENCE REVIEW Systematic review of peer-reviewed studies testing the effectiveness of EMP systems in the MEDLINE, EMBASE, PsycINFO, CINAHL, International Pharmaceutical Abstracts, and Sociological Abstracts databases from searches conducted to June 13, 2014, with extraction of associations between the interventions and adherence, as well as other key findings. Each study was assessed for bias using the Cochrane Handbook for Systematic Reviews of Interventions; features of EMP devices and interventions were qualitatively assessed. FINDINGS Thirty-seven studies (32 randomized and 5 nonrandomized) including 4326 patients met inclusion criteria (10 patient interface-only "simple" interventions and 29 "complex" interventions integrated into the health care system [2 qualified for both categories]). Overall, the effect estimates for differences in mean adherence ranged from a decrease of 2.9% to an increase of 34.0%, and the those for differences in the proportion of patients defined as adherent ranged from a decrease of 8.0% to an increase of 49.5%. We identified 5 common EMP characteristics: recorded dosing events and stored records of adherence, audiovisual reminders to cue dosing, digital displays, real-time monitoring, and feedback on adherence performance. CONCLUSIONS AND RELEVANCE Many varieties of EMP devices exist. However, data supporting their use are limited, with variability in the quality of studies testing EMP devices. Devices integrated into the care delivery system and designed to record dosing events are most frequently associated with improved adherence, compared with other devices. Higher-quality evidence is needed to determine the effect, if any, of these low-cost interventions on medication nonadherence and to identify their most useful components.	Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Agency for Healthcare Research and Quality [K08HS18465-01]; Greenwall Faculty Scholars in Bioethics, an Ignition Award from the Harvard Program in Therapeutic Science; Robert Wood Johnson Foundation Investigator Award in Health Policy Research; National Institute of Mental Health [K01MH099141]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Greenwall Faculty Scholars in Bioethics, an Ignition Award from the Harvard Program in Therapeutic Science; Robert Wood Johnson Foundation Investigator Award in Health Policy Research(Robert Wood Johnson Foundation (RWJF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr Kesselheim's work is supported by a career development award from the Agency for Healthcare Research and Quality (K08HS18465-01), the Greenwall Faculty Scholars in Bioethics, an Ignition Award from the Harvard Program in Therapeutic Science, and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research. Dr Huybrechts' work is supported by a career development grant (K01MH099141) from the National Institute of Mental Health.	[Anonymous], ADHERENCE LONG TERM; BARRIOS V, 2007, THERAPY, V4, P433; Bowry ADK, 2011, J GEN INTERN MED, V26, P1479, DOI 10.1007/s11606-011-1825-3; Charles T, 2007, J ALLERGY CLIN IMMUN, V119, P811, DOI 10.1016/j.jaci.2006.11.700; Christensen A, 2010, J HYPERTENS, V28, P194, DOI 10.1097/HJH.0b013e328331b718; Cramer JA, 1999, J NERV MENT DIS, V187, P53, DOI 10.1097/00005053-199901000-00009; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Davies S, 2010, J INT AIDS SOC S4, V13, P120, DOI DOI 10.1186/1758-2652-13-S4-P120; De Bruin M, 2005, AIDS PATIENT CARE ST, V19, P384; de Bruin M., 2010, J INT ASS PHYS AIDS, V9, P255; de Bruin M, 2010, HEALTH PSYCHOL, V29, P421, DOI 10.1037/a0020335; ELIXHAUSER A, 1990, MED CARE, V28, P882, DOI 10.1097/00005650-199010000-00003; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Fitzgerald AA, 2011, J CARD FAIL, V17, P664, DOI 10.1016/j.cardfail.2011.04.011; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Granger BB, 2011, CURR OPIN CARDIOL, V26, P279, DOI 10.1097/HCO.0b013e328347c150; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, COCHRANE HDB SYSTEMA, P4; HOLLO G, 2008, PHARM MED, V22, P175; Holstad MM, 2011, AIDS PATIENT CARE ST, V25, P431, DOI 10.1089/apc.2010.0331; Kooy MJ, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00069; Kozuki Y, 2006, INT CLIN PSYCHOPHARM, V21, P57, DOI 10.1097/01.yic.0000177016.59484.ce; Kozuki Y, 2005, ARCH PSYCHIAT NURS, V19, P70, DOI 10.1016/j.apnu.2005.02.008; KRUSE W, 1994, INT J CLIN PHARM TH, V32, P452; Laster S F, 1996, J Am Optom Assoc, V67, P654; MATSUYAMA JR, 1993, ANN PHARMACOTHER, V27, P851, DOI 10.1177/106002809302700705; Matteson M, 2011, THESIS U MISSOURI CO; Mazor KM, 2013, PSYCHO-ONCOLOGY, V22, P2487, DOI 10.1002/pon.3317; MCKENNEY JM, 1992, J CLIN PHARMACOL, V32, P277, DOI 10.1002/j.1552-4604.1992.tb03837.x; Mengden Thomas, 2006, BMC Cardiovasc Disord, V6, P36, DOI 10.1186/1471-2261-6-36; Misono AS, 2010, AM J MANAG CARE, V16, pSP82; Mooney ME, 2007, ADDICT BEHAV, V32, P875, DOI 10.1016/j.addbeh.2006.06.022; Muntner P, 2011, J CLIN HYPERTENS, V13, P479, DOI 10.1111/j.1751-7176.2011.00464.x; Murray MD, 2007, ANN INTERN MED, V146, P714, DOI 10.7326/0003-4819-146-10-200705150-00005; Murray Michael D, 2004, Am J Geriatr Pharmacother, V2, P53, DOI 10.1016/S1543-5946(04)90007-4; Naditz A, 2008, TELEMED J E-HEALTH, V14, P875, DOI 10.1089/tmj.2008.8476; NIDES MA, 1993, CHEST, V104, P501, DOI 10.1378/chest.104.2.501; Ogna VF, 2012, CIRCULATION, V126; Ogna VF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/104892; Okeke CO, 2009, OPHTHALMOLOGY, V116, P2286, DOI 10.1016/j.ophtha.2009.05.026; Onyirimba F, 2003, ANN ALLERG ASTHMA IM, V90, P411, DOI 10.1016/S1081-1206(10)61825-X; Rigsby MO, 2000, J GEN INTERN MED, V15, P841, DOI 10.1046/j.1525-1497.2000.00127.x; Rosen MI, 2004, BEHAV RES THER, V42, P409, DOI 10.1016/S0005-7967(03)00149-9; Ruppar TM., 2010, EUR J CARDIOVASC S1, V9, pS26; Ruppar TM, 2010, J CARDIOVASC NURS, V25, P470, DOI 10.1097/JCN.0b013e3181d5f9c5; Russell C, 2011, CLIN TRANSPLANT, V25, P864, DOI 10.1111/j.1399-0012.2010.01358.x; Russell CL, 2010, AM J TRANSPLANT, V10, P376; Sabin LL, 2010, AIDS BEHAV, V14, P580, DOI 10.1007/s10461-009-9615-1; Santschi V, 2007, EUR J CLIN PHARMACOL, V63, P1179, DOI 10.1007/s00228-007-0364-7; Schmitz JM, 2005, J BEHAV MED, V28, P139, DOI 10.1007/s10865-005-3663-4; TASHKIN DP, 1991, AM J MED, V91, pS33, DOI 10.1016/0002-9343(91)90260-5; van Onzenoort HAW, 2012, AM J HYPERTENS, V25, P54, DOI 10.1038/ajh.2011.153; Vervloet M, 2014, DIABETIC MED, V31, P821, DOI 10.1111/dme.12439; Vervloet M, OPLETTEND MEDICIJNDO; Vervloet M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-5; Waeber B, 1999, INT J CLIN PRACT, V53, P37; Wagner Glenn J, 2002, HIV Clin Trials, V3, P45, DOI 10.1310/XGXU-FUDK-A9QT-MPTF; Wu JR, 2012, J CARD FAIL, V18, P1, DOI 10.1016/j.cardfail.2011.09.006; Zullig LL, 2013, JAMA-J AM MED ASSOC, V310, P2611, DOI 10.1001/jama.2013.282818	60	114	117	3	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1237	1247		10.1001/jama.2014.10059	http://dx.doi.org/10.1001/jama.2014.10059			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP3QA	25247520	Green Accepted			2022-12-28	WOS:000341990600024
J	Bobbert, PA				Bobbert, Peter A.			Manipulating spin in organic spintronics	SCIENCE			English	Editorial Material							ROOM-TEMPERATURE; MAGNETIC COMPASS; MAGNETORESISTANCE		Tech Univ Eindhoven, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology	Bobbert, PA (corresponding author), Tech Univ Eindhoven, Dept Appl Phys, POB 513, NL-5600 MB Eindhoven, Netherlands.	p.a.bobbert@tue.nl	Bobbert, Peter A/L-4959-2013	Bobbert, Peter A/0000-0001-7780-7062				Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; Francis TL, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/185; Mahato RN, 2013, SCIENCE, V341, P257, DOI 10.1126/science.1237242; Malissa H, 2014, SCIENCE, V345, P1487, DOI 10.1126/science.1255624; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Wohlgenannt M, 2014, MRS BULL, V39, P590, DOI 10.1557/mrs.2014.132	6	6	7	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1450	1451		10.1126/science.1259655	http://dx.doi.org/10.1126/science.1259655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237087				2022-12-28	WOS:000341752900021
J	Graham, UM; Magorrian, M; Burns, P; Lindsay, JR				Graham, Una M.; Magorrian, Mark; Burns, Paul; Lindsay, John R.			An unusual headache	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPOGLOSSAL NERVE PALSY; INTERNAL CAROTID-ARTERY; SPONTANEOUS DISSECTION; STROKE; MANAGEMENT; GUIDELINE; TONGUE; RISK; MR		[Graham, Una M.; Lindsay, John R.] Mater Hosp, Dept Diabet & Endocrinol, Belfast BT14 6AB, Antrim, North Ireland; [Magorrian, Mark] Mater Hosp, Dept Stroke & Elderly Care Med, Belfast BT14 6AB, Antrim, North Ireland; [Burns, Paul] Royal Victoria Hosp, Dept Neuroradiol, Belfast BT12 6BA, Antrim, North Ireland		Graham, UM (corresponding author), Mater Hosp, Dept Diabet & Endocrinol, Belfast BT14 6AB, Antrim, North Ireland.	qublbc8@hotmail.com						Brott TG, 2011, J AM COLL CARDIOL, V57, P1002, DOI 10.1016/j.jacc.2010.11.005; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Hershey LA, 2013, CURR TREAT OPTION NE, V15, P56, DOI 10.1007/s11940-012-0205-6; Holle D, 2009, J NEUROL NEUROSUR PS, V80, P1393, DOI 10.1136/jnnp.2008.169938; Kaushik S, 2009, J GEN INTERN MED, V24, P126, DOI 10.1007/s11606-008-0813-8; Kennedy F, 2012, NEUROLOGY, V79, P686, DOI 10.1212/WNL.0b013e318264e36b; Learned KO, 2012, J COMPUT ASSIST TOMO, V36, P718, DOI 10.1097/RCT.0b013e318268ec18; Mokri B, 1996, NEUROLOGY, V46, P356, DOI 10.1212/WNL.46.2.356; Murakami R, 1998, AM J NEURORADIOL, V19, P515; Provenzale JM, 2009, AM J ROENTGENOL, V193, P1167, DOI 10.2214/AJR.08.1688; Rao AS, 2011, J VASC SURG, V54, P370, DOI 10.1016/j.jvs.2011.02.059; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; THOMPSON EO, 1994, RADIOGRAPHICS, V14, P939, DOI 10.1148/radiographics.14.5.7991825; Tietjen GE, 2005, CNS DRUGS, V19, P683, DOI 10.2165/00023210-200519080-00004; Touze E, 2003, NEUROLOGY, V61, P1347, DOI 10.1212/01.WNL.0000094325.95097.86	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2014	349								g5602	10.1136/bmj.g5602	http://dx.doi.org/10.1136/bmj.g5602			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OP	25228308				2022-12-28	WOS:000342057500009
J	Hinrichsen, GA; Leipzig, RM				Hinrichsen, Gregory A.; Leipzig, Rosanne M.			Review: Supervised withdrawal plus other interventions reduces benzodiazepine use in older persons	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hinrichsen, Gregory A.; Leipzig, Rosanne M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Hinrichsen, GA (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Ayers CR, 2007, PSYCHOL AGING, V22, P8, DOI 10.1037/0882-7974.22.1.8; Belanger L, 2012, COGN BEHAV PRACT, V19, P101, DOI 10.1016/j.cbpra.2010.10.003; Tannenbaum C, 2014, JAMA INTERN MED, V174, P890, DOI 10.1001/jamainternmed.2014.949	3	0	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC2	10.7326/0003-4819-161-6-201409160-02002	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9LF	25222414				2022-12-28	WOS:000343894400001
J	Kottilil, S; Wright, M; Polis, MA; Masur, H				Kottilil, Shyam; Wright, Mary; Polis, Michael A.; Masur, Henry			Treatment of Hepatitis C Virus Infection: Is It Time for the Internist to Take the Reins?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SOFOSBUVIR		NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA; NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Masur, H (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, 10 Ctr Dr,Room 2C145, Bethesda, MD 20892 USA.		Kottilil, Shyam/ABF-7605-2021		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alavi M, 2014, LIVER INT, V34, P1198, DOI 10.1111/liv.12370; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Kohli A, 2014, LANCET IN PRESS; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; McGowan CE, 2013, HEPATOLOGY, V57, P1325, DOI 10.1002/hep.26246; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184	10	16	16	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					443	U104		10.7326/M14-0741	http://dx.doi.org/10.7326/M14-0741			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222390				2022-12-28	WOS:000343894400020
J	Ray, JG				Ray, Joel G.			Preconception-initiated, low-dose aspirin did not increase live birth after 1 or 2 pregnancy losses	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ray, Joel G.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Ray, JG (corresponding author), Univ Toronto, St Michaels Hosp, Toronto, ON, Canada.							Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC13	10.7326/0003-4819-161-6-201409160-02013	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222413				2022-12-28	WOS:000343894400012
J	Pham, JC; Pronovost, PJ				Pham, Julius Cuong; Pronovost, Peter J.			California's Proposition 46: A Wolf in Sheep's Wool	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICIANS		Johns Hopkins Univ, Sch Med, Baltimore, MD 21202 USA; Armstrong Inst Patient Safety & Qual, Baltimore, MD 21202 USA	Johns Hopkins University	Pham, JC (corresponding author), Johns Hopkins Univ, Sch Med, Armstrong Inst Patient Safety & Qual, Dept Anesthesia Crit Care Med,Dept Emergency Med, 750 East Pratt St,15th Floor, Baltimore, MD 21202 USA.	jpham3@jhmi.edu						Bowen D, 2014, OFFICIAL VOTER INFOR; DesRoches CM, 2010, JAMA-J AM MED ASSOC, V304, P187, DOI 10.1001/jama.2010.921; Federation of State Medical Boards, 2011, POL PHYS IMP; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; Pham JC, 2013, JAMA-J AM MED ASSOC, V309, P2101, DOI 10.1001/jama.2013.4635; Pronovost PJ, 2014, AM J MED QUAL, V29, P165, DOI 10.1177/1062860613495554; SHORE JH, 1987, JAMA-J AM MED ASSOC, V257, P2931	9	1	1	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					913	U107		10.7326/M14-2167	http://dx.doi.org/10.7326/M14-2167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25265344				2022-12-28	WOS:000347248400034
J	Jacobs, FMJ; Greenberg, D; Nguyen, N; Haeussler, M; Ewing, AD; Katzman, S; Paten, B; Salama, SR; Haussler, D				Jacobs, Frank M. J.; Greenberg, David; Ngan Nguyen; Haeussler, Maximilian; Ewing, Adam D.; Katzman, Sol; Paten, Benedict; Salama, Sofie R.; Haussler, David			An evolutionary arms race between KRAB zinc-finger genes ZNF91/93 and SVA/L1 retrotransposons	NATURE			English	Article							EMBRYONIC STEM-CELLS; TRANSPOSABLE ELEMENTS; SEQUENCE ALIGNMENT; INSERTIONS; FAMILY	Throughout evolution primate genomes have been modified by waves of retrotransposon insertions(1-3). For each wave, the host eventually finds a way to repress retrotransposon transcription and prevent further insertions. In mouse embryonic stem cells, transcriptional silencing of retrotransposons requires KAP1 (also known as TRIM28) and its repressive complex, which can be recruited to target sites by KRAB zinc-finger(KZNF) proteins such as murine-specific ZFP809 which binds to integrated murine leukaemia virus DNA elements and recruits KAP1 to repress them(4,5). KZNF genes are one of the fastest growing gene families in primates and this expansion is hypothesized to enable primates to respond to newly emerged retrotransposons(6,7). However, the identity of KZNF genes battling retrotransposons currently active in the human genome, such as SINE-VNTR-Alu (SVA)(8) and long interspersed nuclear element 1 (L1)(9), is unknown. Here we show that two primate-specific KZNF genes rapidly evolved to repress these two distinct retrotransposon families shortly after they began to spread in our ancestral genome. ZNF91 underwent a series of structural changes 8-12 million years ago that enabled it to repress SVA elements. ZNF93 evolved earlier to repress the primate L1 lineage until similar to 12.5 million years ago when the L1PA3-subfamily of retrotransposons escaped ZNF93's restriction through the removal of the ZNF93-binding site. Our data support a model where KZNF gene expansion limits the activity of newly emerged retrotransposon classes, and this is followed by mutations in these retrotransposons to evade repression, a cycle of events that could explain the rapid expansion of lineage-specific KZNF genes.	[Jacobs, Frank M. J.; Greenberg, David; Ngan Nguyen; Haeussler, Maximilian; Ewing, Adam D.; Katzman, Sol; Paten, Benedict; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Greenberg, David; Ngan Nguyen] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Haussler, D (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu	Haeussler, Maximilian/AAY-1649-2021; Jacobs, Frank/GSD-3616-2022; Salama, Sofie/K-6412-2019; Ewing, Adam D/M-3164-2014; Jacobs, Frank/O-1809-2014	Ewing, Adam D/0000-0002-4544-994X; Jacobs, Frank/0000-0003-4423-1479; Salama, Sofie/0000-0001-6999-7193	California Institute of Regenerative Medicine (CIRM) [FA1-00617, CL1-00506-1.2, TG2-01157]; Human Frontier Science Program Postdoctoral fellowship [LT000689]; California Institute for Quantitative Biosciences; TCGA [U24 24010-443720]; EMBO ALTF [292-2011]; ENCODE [U41HG004568]; NATIONAL CANCER INSTITUTE [U24CA143858] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Human Frontier Science Program Postdoctoral fellowship(Human Frontier Science Program); California Institute for Quantitative Biosciences; TCGA; EMBO ALTF; ENCODE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by California Institute of Regenerative Medicine (CIRM) facility awards (FA1-00617, CL1-00506-1.2) and scholar awards (TG2-01157) to F.M.J.J. and D.G. and F.M.J.J. also received a Human Frontier Science Program Postdoctoral fellowship (LT000689). D.H. is an Investigator of the Howard Hughes Medical Institute. S.K. is supported by the California Institute for Quantitative Biosciences, A.D.E. was supported by TCGA U24 24010-443720, M.H. by EMBO ALTF 292-2011, and B.P. and N.N. by ENCODE U41HG004568. We thank F. Wianny and C. Dehay (Lyon University) for the LYON-ES1 macaque embryonic stem cells; M. Oshimura and T. Inoue (Tottori University) for the E14(hChr11) trans-chromosomic embryonic stem cells, N. Pourmand and the UCSC genome sequencing center; B. Nazario (UCSC Institute for the Biology of Stem Cells) for flow cytometry assistance; M. Batzer (LSU) and K. Han (Dankook University) for L1CER sequences; L. Carbone (OHSU) for gibbon genomic DNA; A. Smit (ISB, Seattle) for discussions on L1PA evolution; D. Segal (UC Davis) for advice on ZNF mutations; H. Kazazian, D. Hancks and J. Goodier (JHMI) for retrotransposition plasmids and advice; K. Tygi, C. Vizenor, J. Rosenkrantz, W. Novey, S. Kyane and B. Mylenek for technical assistance and the entire Haussler laboratory for discussions and support.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; BELLEFROID EJ, 1995, P NATL ACAD SCI USA, V92, P10757, DOI 10.1073/pnas.92.23.10757; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Hancks DC, 2012, MOL CELL BIOL, V32, P4718, DOI 10.1128/MCB.00860-12; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Kai Y, 2009, CELL RES, V19, P247, DOI 10.1038/cr.2008.305; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Moore M, 2001, P NATL ACAD SCI USA, V98, P1432, DOI 10.1073/pnas.98.4.1432; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Onodera CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043511; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Turelli P, 2014, GENOME RES, V24, P1260, DOI 10.1101/gr.172833.114; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Ward MC, 2013, MOL CELL, V49, P262, DOI 10.1016/j.molcel.2012.11.013; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	260	267	4	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					242	+		10.1038/nature13760	http://dx.doi.org/10.1038/nature13760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25274305	Green Accepted, Green Submitted			2022-12-28	WOS:000346383500044
J	Crevillen, P; Yang, HC; Cui, X; Greeff, C; Trick, M; Qiu, Q; Cao, XF; Dean, C				Crevillen, Pedro; Yang, Hongchun; Cui, Xia; Greeff, Christiaan; Trick, Martin; Qiu, Qi; Cao, Xiaofeng; Dean, Caroline			Epigenetic reprogramming that prevents transgenerational inheritance of the vernalized state	NATURE			English	Article							FLOWERING-LOCUS-C; GENE; FLC; EXPRESSION; METHYLATION; RNA; REPRESSION; FRIGIDA; PLANT	The reprogramming of epigenetic states in gametes and embryos is essential for correct development in plants and mammals(1). In plants, the germ line arises from somatic tissues of the flower, necessitating the erasure of chromatin modifications that have accumulated at specific loci during development or in response to external stimuli. If this process occurs inefficiently, it can lead to epigenetic states being inherited from one generation to the next(2-4). However, inmost cases, accumulated epigenetic modifications are efficiently erased before the next generation. An important example of epigenetic reprogramming in plants is the resetting of the expression of the floral repressor locus FLC in Arabidopsis thaliana. FLC is epigenetically silenced by prolonged cold in a process called vernalization. However, the locus is reactivated before the completion of seed development, ensuring the requirement for vernalization in every generation. In contrast to our detailed understanding of the polycomb-mediated epigenetic silencing induced by vernalization, little is known about the mechanism involved in the reactivation of FLC. Here we show that a hypomorphic mutation in the jumonji-domain-containing protein ELF6 impaired the reactivation of FLC in reproductive tissues, leading to the inheritance of a partially vernalized state. ELF6 has H3K27 me3 demethylase activity, and the mutation reduced this enzymatic activity in planta. Consistent with this, in the next generation of mutant plants, H3K27me3 levels at the FLC locus stayed higher, and FLC expression remained lower, than in the wild type. Our data reveal an ancient role for H3K27 demethylation in the reprogramming of epigenetic states in plant and mammalian embryos(5-7).	[Crevillen, Pedro; Yang, Hongchun; Greeff, Christiaan; Trick, Martin; Dean, Caroline] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Cui, Xia; Qiu, Qi; Cao, Xiaofeng] Chinese Acad Sci, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Cui, Xia; Qiu, Qi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Crevillén, Pedro/G-7113-2012	Crevillén, Pedro/0000-0003-1276-9792; Yang, Hongchun/0000-0002-8265-3958; Dean, Caroline/0000-0002-6555-3525	UK Biotechnology and Biological Sciences Research Council [BB/G009562/1, BB/C517633/1]; European Research Council [233039 ENVGENE]; National Basic Research Program of China [2013CB967300, 2011CB915400]; National Natural Science Foundation of China [31271363]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA447, BBS/E/J/000CA369, BB/G009562/1, BBS/E/J/00000581, BB/C517633/1] Funding Source: researchfish; BBSRC [BB/G009562/1, BBS/E/J/000CA447, BBS/E/J/000CA369] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Dean laboratory members and A. Surani for discussions. The Dean laboratory is supported by the UK Biotechnology and Biological Sciences Research Council grants BB/G009562/1 and BB/C517633/1 and by a European Research Council Advanced Investigator grant (233039 ENVGENE). The Cao laboratory is supported by National Basic Research Program of China grants 2013CB967300 and 2011CB915400 and by the National Natural Science Foundation of China grant 31271363.	Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Canovas S, 2012, P NATL ACAD SCI USA, V109, P2400, DOI 10.1073/pnas.1119112109; Choi J, 2009, PLANT J, V57, P918, DOI 10.1111/j.1365-313X.2008.03776.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crevillen P, 2013, EMBO J, V32, P140, DOI 10.1038/emboj.2012.324; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gu XF, 2009, PLANT J, V57, P522, DOI 10.1111/j.1365-313X.2008.03709.x; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Jiang DH, 2009, PLANT CELL, V21, P1733, DOI 10.1105/tpc.109.067967; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kim DH, 2013, PLANT CELL, V25, P454, DOI 10.1105/tpc.112.104760; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Mylne J, 2004, COLD SPRING HARB SYM, V69, P457, DOI 10.1101/sqb.2004.69.457; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Sheldon CC, 2008, P NATL ACAD SCI USA, V105, P2214, DOI 10.1073/pnas.0711453105; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006	36	159	168	3	139	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					587	+		10.1038/nature13722	http://dx.doi.org/10.1038/nature13722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25219852	Green Accepted			2022-12-28	WOS:000346247600003
J	Patz, JA; Frumkin, H; Holloway, T; Vimont, DJ; Haines, A				Patz, Jonathan A.; Frumkin, Howard; Holloway, Tracey; Vimont, Daniel J.; Haines, Andrew			Climate Change Challenges and Opportunities for Global Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GREENHOUSE-GAS EMISSIONS; HEAT-RELATED DEATHS; MENTAL-HEALTH; PHYSICAL-ACTIVITY; AIR-QUALITY; UNITED-STATES; CO-BENEFITS; AMBIENT-TEMPERATURE; CARDIOVASCULAR RISK; ATMOSPHERIC CO2	IMPORTANCE Health is inextricably linked to climate change. It is important for clinicians to understand this relationship in order to discuss associated health risks with their patients and to inform public policy. OBJECTIVES To provide new US-based temperature projections from downscaled climate modeling and to review recent studies on health risks related to climate change and the cobenefits of efforts to mitigate greenhouse gas emissions. DATA SOURCES, STUDY SELECTION, AND DATA SYNTHESIS We searched PubMed and Google Scholar from 2009 to 2014 for articles related to climate change and health, focused on governmental reports, predictive models, and empirical epidemiological studies. Of the more than 250 abstracts reviewed, 56 articles were selected. In addition, we analyzed climate data averaged over 13 climate models and based future projections on downscaled probability distributions of the daily maximum temperature for 2046-2065. We also compared maximum daily 8-hour average ozone with air temperature data taken from the National Oceanic and Atmospheric Administration, National Climate Data Center. RESULTS By 2050, many US cities may experience more frequent extreme heat days. For example, New York and Milwaukee may have 3 times their current average number of days hotter than 32 degrees C (90 degrees F). High temperatures are also strongly associated with ozone exceedance days, for example, in Chicago, Illinois. The adverse health aspects related to climate change may include heat-related disorders, such as heat stress and economic consequences of reduced work capacity; respiratory disorders, including those exacerbated by air pollution and aeroallergens, such as asthma; infectious diseases, including vectorborne diseases and waterborne diseases, such as childhood gastrointestinal diseases; food insecurity, including reduced crop yields and an increase in plant diseases; and mental health disorders, such as posttraumatic stress disorder and depression, that are associated with natural disasters. Substantial health and economic cobenefits could be associated with reductions in fossil fuel combustion. For example, greenhouse gas emission policies may yield net economic benefit, with health benefits from air quality improvements potentially offsetting the cost of US and international carbon policies. CONCLUSIONS AND RELEVANCE Evidence over the past 20 years indicates that climate change can be associated with adverse health outcomes. Health care professionals have an important role in understanding and communicating the related potential health concerns and the cobenefits from policies to reduce greenhouse gas emissions. Copyright 2014 American Medical Association. All rights reserved.	[Patz, Jonathan A.] Global Hlth Inst, Madison, WI USA; [Patz, Jonathan A.; Holloway, Tracey] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53726 USA; [Patz, Jonathan A.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53726 USA; [Frumkin, Howard] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Holloway, Tracey; Vimont, Daniel J.] Univ Wisconsin, Dept Atmospher Ocean Sci, Madison, WI 53726 USA; [Vimont, Daniel J.] Univ Wisconsin, Nelson Inst, Ctr Climat Res, Madison, WI 53726 USA; [Haines, Andrew] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Haines, Andrew] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Patz, JA (corresponding author), Univ Wisconsin, Global Hlth Inst, 1710 Univ Ave, Madison, WI 53726 USA.	patz@wisc.edu		Haines, Andy/0000-0002-8053-4605; Vimont, Daniel/0000-0001-9733-9032; Frumkin, Howard/0000-0001-7079-3534	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047873] Funding Source: NIH RePORTER; NICHD NIH HHS [P2C HD047873] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abroms LC, 2008, ANNU REV PUBL HEALTH, V29, P219, DOI 10.1146/annurev.publhealth.29.020907.090824; Adger WN, 2005, GLOBAL ENVIRON CHANG, V15, P77, DOI [10.1016/j.gloenvcha.2004.12.005, 10.1016/j.gloenvcha.2005.03.001]; Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Akerlof K, 2013, GLOBAL ENVIRON CHANG, V23, P81, DOI 10.1016/j.gloenvcha.2012.07.006; Akerlof K, 2010, INT J ENV RES PUB HE, V7, P2559, DOI 10.3390/ijerph7062559; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; American Society of Civil Engineers, AM SOC CIV ENG 2013; Anderegg WRL, 2010, P NATL ACAD SCI USA, V107, P12107, DOI 10.1073/pnas.1003187107; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; [Anonymous], 2012, MAN RISKS EXTR EV DI; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; [Anonymous], 2011, ANN DISASTER STAT RE; [Anonymous], 2014, CLIM CHANG 2014 IMP; Aspinall P, 2015, BRIT J SPORT MED, V49, P272, DOI 10.1136/bjsports-2012-091877; Bailey R., 2011, Growing a better future: food justice in a resource-constrained world; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Bell ML, 2007, CLIMATIC CHANGE, V82, P61, DOI 10.1007/s10584-006-9166-7; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Berry HL, 2011, ASIA-PAC J PUBLIC HE, V23, p119S, DOI 10.1177/1010539510392556; Berry HL, 2010, INT J PUBLIC HEALTH, V55, P123, DOI 10.1007/s00038-009-0112-0; Beyer KMM, 2014, INT J ENV RES PUB HE, V11, P3453, DOI 10.3390/ijerph110303453; Bobb JF, 2014, ENV HLTH PERSPECT; Bostrom A, 2013, WIRES CLIM CHANGE, V4, P447, DOI 10.1002/wcc.234; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Boykoff M. T., 2011, MAKING SENSE MEDIA R; Boykoff MT, 2007, GEOFORUM, V38, P1190, DOI 10.1016/j.geoforum.2007.01.008; Boykoff MT, 2007, EMBO REP, V8, P207, DOI 10.1038/sj.embor.7400924; Boykoff MT, 2004, GLOBAL ENVIRON CHANG, V14, P125, DOI 10.1016/j.gloenvcha.2003.10.001; Bradley R. S., 2011, GLOBAL WARMING POLIT; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Brubaker M, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8445; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Brulle RJ, 2014, CLIMATIC CHANGE, V122, P681, DOI 10.1007/s10584-013-1018-7; Bulbena A, 2006, PSYCHIAT SERV, V57, P1519, DOI 10.1176/appi.ps.57.10.1519; Bush KF, 2014, ENVIRON HEALTH PERSP, V122, P249, DOI 10.1289/ehp.1306807; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Center for Naval Analysis, 2014, NAT SEC ACC RISKS CL; Centers for Disease Control and Prevention, 2010, NAT HLTH INT SURV DA; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Chang HH, 2010, INT J ENV RES PUB HE, V7, P2866, DOI 10.3390/ijerph7072866; CHEW KSY, 1995, SOC SCI MED, V40, P223, DOI 10.1016/0277-9536(94)E0070-9; Chong TW, 2004, SCHIZOPHR RES, V69, P149, DOI 10.1016/S0920-9964(03)00222-6; Climate Change Impacts in the United States, 2014, 3 NAT CLIM ASS, P841; Cohen G., 2006, C SPONS ROB WOOD JOH; Connecticut Department of Energy and Environmental Protection, OZ AIR QUAL LEV CONN; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Corner A, 2014, WIRES CLIM CHANGE, V5, P411, DOI 10.1002/wcc.269; Cusack L, 2011, J ADV NURS, V67, P915, DOI 10.1111/j.1365-2648.2010.05551.x; Davidson JRT, 2006, J CLIN PSYCHIAT, V67, P9; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; de Man H, 2014, WATER RES, V48, P90, DOI 10.1016/j.watres.2013.09.022; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Deisenhammer EA, 2003, ACTA PSYCHIAT SCAND, V108, P402, DOI 10.1046/j.0001-690X.2003.00209.x; Diamond-Smith N, 2011, INT PERSPECT SEX R H, V37, P155, DOI 10.1363/3715511; Doherty TJ, 2011, AM PSYCHOL, V66, P265, DOI 10.1037/a0023141; Donner SD, 2013, CLIMATIC CHANGE, V118, P537, DOI 10.1007/s10584-012-0690-3; Donoghue ER, 1997, AM J FOREN MED PATH, V18, P11, DOI 10.1097/00000433-199703000-00002; Doocy Shannon, 2013, PLoS Curr, V5, DOI [10.1371/currents.dis.67bd14fe457f1db0b5433a8ee20fb833, 10.1371/currents.dis.f4deb457904936b07c09daa98ee8171a]; Drewniak BA, 2014, ENVIRON RES LETT, V9, P14; Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Ebi KL, 2013, WIRES CLIM CHANGE, V4, P203, DOI 10.1002/wcc.211; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; Epstein Y, 1997, ANN NY ACAD SCI, V813, P553, DOI 10.1111/j.1749-6632.1997.tb51746.x; Eyer F, 2007, CRIT CARE, V11, DOI 10.1186/cc6177; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Fewtrell L, 2008, PUBLIC HEALTH, V122, P446, DOI 10.1016/j.puhe.2007.09.010; Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51; Food and Agriculture Organization of the United Nations, 2013, STAT FOOD INS WORLD; Forrest KYZ, 2001, MED SCI SPORT EXER, V33, P1598, DOI 10.1097/00005768-200109000-00025; Fowler DR, 2013, MMWR-MORBID MORTAL W, V62, P433; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Fritze Jessica G, 2008, Int J Ment Health Syst, V2, P13, DOI 10.1186/1752-4458-2-13; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Garcia-Mozo H, 2006, ANN AGR ENV MED, V13, P209; Garvin EC, 2013, INJURY PREV, V19, P198, DOI 10.1136/injuryprev-2012-040439; Gifford R, 2011, AM PSYCHOL, V66, P290, DOI 10.1037/a0023566; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Goodess CM, 2013, ENVIRON SCI POLICY, V27, pS4, DOI 10.1016/j.envsci.2012.04.001; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Grace K, 2012, APPL GEOGR, V35, P405, DOI 10.1016/j.apgeog.2012.06.017; GREEN BL, 1994, J AM ACAD CHILD PSY, V33, P71, DOI 10.1097/00004583-199401000-00011; Haines A, 2004, JAMA-J AM MED ASSOC, V291, P99, DOI 10.1001/jama.291.1.99; Haines A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1018; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hajat S, 2014, J EPIDEMIOL COMMUN H, V68, P641, DOI 10.1136/jech-2013-202449; Halpern J., 2019, DISASTER MENTAL HLTH; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Handmer J, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P231; Hankey S, 2012, ENVIRON HEALTH PERSP, V120, P247, DOI 10.1289/ehp.1103806; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Hart CR, 2011, AUST J RURAL HEALTH, V19, P231, DOI 10.1111/j.1440-1584.2011.01225.x; Hermesh H, 2000, AM J PSYCHIAT, V157, P1327, DOI 10.1176/appi.ajp.157.8.1327; Hmielowski J., 2013, PUBLIC UNDERST SCI; Hochman G, 2012, AGRICULTURE-BASEL, V2, P272, DOI 10.3390/agriculture2030272; Holloway T, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009775; Hou L, 2004, AM J EPIDEMIOL, V160, P860, DOI 10.1093/aje/kwh301; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hu G, 2007, AM J HYPERTENS, V20, P1242, DOI 10.1016/j.amjhyper.2007.07.015; Huq S., 2004, ADAPTATION POLICY FR; International Federation of Red Cross and Red Crescent Societies, 1998, WORLD DIS REP 1997; IPCC, P AR6 SCOP M ADD AB; Jacob B, 2008, PUBLIC HEALTH REP, V123, P555, DOI 10.1177/003335490812300505; Jacob DJ, 2009, ATMOS ENVIRON, V43, P51, DOI 10.1016/j.atmosenv.2008.09.051; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Jensen HT, 2013, CLIMATIC CHANGE, V121, P223, DOI 10.1007/s10584-013-0881-6; Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422; Jones Jeffrey M., 2014, GALLUP POLITICS; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kinney PL, 2008, ENVIRON SCI POLICY, V11, P87, DOI 10.1016/j.envsci.2007.08.001; Kirchmeier MC, 2014, J APPL METEOROL CLIM, V53, P660, DOI 10.1175/JAMC-D-13-0230.1; Kjellstrom T., 2011, Asian-Pacific Newsletter on Occupational Health and Safety, V18, P6; Kjellstrom T, 2009, GLOBAL HEALTH ACTION, V2, DOI [10.3402/gha.v2i0.1958, 10.3402/gha.v2i0.2047]; Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Leiserowitz A., 2014, PUBLIC SUPPORT CLIMA; Leiserowitz A, 2012, GLOBAL WARMINGS 6 AM; Leiserowitz A, 2014, CLIMATE CHANGE AM MI; Leiserowitz A, 2007, CREATING A CLIMATE FOR CHANGE: COMMUNICATING CLIMATE CHANGE AND FACILITATING SOCIAL CHANGE, P44, DOI 10.1017/CBO9780511535871.005; Levy BS, 2014, HEALTH HUM RIGHTS, V16, P32; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Li B, 2012, CLIMATIC CHANGE, V110, P959, DOI [10.1007/s10584-011-0120-y, 10.1007/s10584-011-0120-v]; Liao H, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006852; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lindsay G, 2011, AUST NZ J PUBL HEAL, V35, P54, DOI 10.1111/j.1753-6405.2010.00621.x; Lloyd SJ, 2011, ENVIRON HEALTH PERSP, V119, P1817, DOI 10.1289/ehp.1003311; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Maas J, 2009, HEALTH PLACE, V15, P586, DOI 10.1016/j.healthplace.2008.09.006; MacDonald JM, 2010, AM J PREV MED, V39, P105, DOI 10.1016/j.amepre.2010.03.016; Macmillan A, 2014, ENVIRON HEALTH PERSP, V122, P335, DOI 10.1289/ehp.1307250; MAES M, 1994, ACTA PSYCHIAT SCAND, V90, P391, DOI 10.1111/j.1600-0447.1994.tb01612.x; Maibach E., 2011, CONVEYING HUMAN IMPL; Maibach E, 2014, EARTHS FUTURE, V2, P295, DOI 10.1002/2013EF000226; Maibach EW, 2008, AM J PREV MED, V35, P488, DOI 10.1016/j.amepre.2008.08.016; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; Maizlish N, 2013, AM J PUBLIC HEALTH, V103, P703, DOI 10.2105/AJPH.2012.300939; Martin-Latry K, 2007, EUR PSYCHIAT, V22, P335, DOI 10.1016/j.eurpsy.2007.03.007; Martinez M, 2002, SOUTHERN MED J, V95, P799; Matsueda M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046557; McAdam J, 2010, CLIMAGE CHANGE DISPL; McCright AM, 2011, CLIMATIC CHANGE, V104, P243, DOI 10.1007/s10584-010-9946-y; McFarlane AC, 2009, BRIT J PSYCHIAT, V195, P142, DOI 10.1192/bjp.bp.108.054270; McMichael AJ, 2010, CLIMATE CHANGE POPUL; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Molina M., 2014, WHAT WE KNOW REALITY; Moser SC, 2007, CREATING A CLIMATE FOR CHANGE: COMMUNICATING CLIMATE CHANGE AND FACILITATING SOCIAL CHANGE, P1, DOI 10.1017/CBO9780511535871; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; Naucler T., 2009, PATHWAYS LOW CARBON; Nelson GC, 2009, CLIMAGE CHANGE IMPAC; Nemet GF, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014007; Nordhaus WD, 2011, REV ENV ECON POLICY, V5, P240, DOI 10.1093/reep/rer004; Norgaard KM., 2011, LIVING DENIAL CLIMAT; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; North CS, 2013, JAMA-J AM MED ASSOC, V310, P507, DOI 10.1001/jama.2013.107799; Notaro M, 2011, INT J CLIMATOL, V31, P1615, DOI 10.1002/joc.2179; O'Neill BC, 2012, LANCET, V380, P157, DOI 10.1016/S0140-6736(12)60958-1; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Oldham RL, 2013, SOUTH MED J, V106, P115, DOI 10.1097/SMJ.0b013e31827cd091; Oreskes N., 2010, MERCHANTS DOUBT; Page LA, 2007, BRIT J PSYCHIAT, V191, P106, DOI 10.1192/bjp.bp.106.031948; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Patz JA, 2000, ENVIRON HEALTH PERSP, V108, P367, DOI 10.2307/3454357; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Patz JA, 2008, AM J PREV MED, V35, P451, DOI 10.1016/j.amepre.2008.08.026; Patz JA, 2013, CURR TOP MICROBIOL, V366, P141, DOI 10.1007/82_2012_274; Paxson C, 2012, SOC SCI MED, V74, P150, DOI 10.1016/j.socscimed.2011.10.004; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Pew Research Center, 2014, CLIM CHANG KEY DAT P; Pew Research Center Global Attitudes Project, GLOB WARM SEEN MAJ P; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Plachinski SD, 2014, ATMOS ENVIRON, V94, P180, DOI 10.1016/j.atmosenv.2014.03.028; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Posner R., 2004, CATASTROPHE RISK RES; Powell JL, 2011, INQUISTION CLIMATE S; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Pugliese A., 2009, J HARVARD INT REV, V31, P64; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Reser JP, 2011, AM PSYCHOL, V66, P277, DOI 10.1037/a0023412; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Roe JJ, 2013, INT J ENV RES PUB HE, V10, P4086, DOI 10.3390/ijerph10094086; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Rojas-Rueda D, 2012, ENVIRON INT, V49, P100, DOI 10.1016/j.envint.2012.08.009; Rudman LA, 2013, PSYCHOL SCI, V24, P2290, DOI 10.1177/0956797613492775; Salamanca F, 2014, J GEOPHYS RES-ATMOS, V119, P5949, DOI 10.1002/2013JD021225; Sarfaty M, 2009, FAM MED, V41, P358; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Shiloh R, 2001, EUR NEUROPSYCHOPHARM, V11, P285, DOI 10.1016/S0924-977X(01)00096-7; Shiloh R, 2009, WORLD J BIOL PSYCHIA, V10, P163, DOI 10.1080/15622970701413833; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Singer BD, 2005, FUNCT PLANT BIOL, V32, P667, DOI 10.1071/FP05039; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Stollberger C, 2009, EUR J NEUROL, V16, P879, DOI 10.1111/j.1468-1331.2009.02581.x; Stone B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100852; Sukhdev P, 2010, EC ECOSYSTEMS BIODIV; Sunstein C.R., 2007, WORST CASE SCENARIOS; Tasian GE, 2014, DAILY MEAN TEMPERATU; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; Thompson TM, 2014, SYSTEMS APPROACH EVA; Trail M, 2014, ATMOS ENVIRON, V94, P552, DOI 10.1016/j.atmosenv.2014.05.079; Trumbo C., 1996, PUBLIC UNDERST SCI, V5, P269, DOI [10.1088/0963-6625/5/3/006, DOI 10.1088/0963-6625/5/3/006]; U. S. Environmental Protection Agency, 2011, BEN COSTS CLEAN AIR; Uejio CK, 2014, AM J PUBLIC HEALTH, V104, P639, DOI 10.2105/AJPH.2013.301659; UN High Commissioner for Refugees, 2009, CLIM CHANG NAT DIS H; United Nations Population Fund, 2007, UNFPA STAT WORLD POP; US Environmental Protection Agency, 2014, SUMM NONATT AR POP E; Vinck P., 2013, WORLD DISASER REPORT; Washington H, 2011, CLIMATE CHANGE DENIAL: HEADS IN THE SAND, P1; Weisskopf MG, 2002, AM J PUBLIC HEALTH, V92, P830, DOI 10.2105/AJPH.92.5.830; West JJ, 2013, NAT CLIM CHANGE, V3, P885, DOI [10.1038/NCLIMATE2009, 10.1038/nclimate2009]; Westhoek H, 2014, GLOBAL ENVIRON CHANG, V26, P196, DOI 10.1016/j.gloenvcha.2014.02.004; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Whitmarsh L, 2011, ENGAGING PUBLIC CLIM; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Wolf J, 2011, WIRES CLIM CHANGE, V2, P547, DOI 10.1002/wcc.120; Woodcock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051462; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; Zaval L, 2014, NAT CLIM CHANGE, V4, P143, DOI 10.1038/NCLIMATE2093; Zia A, 2010, PUBLIC UNDERST SCI, V19, P743, DOI 10.1177/0963662509357871; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108	234	242	253	20	393	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1565	1580		10.1001/jama.2014.13186	http://dx.doi.org/10.1001/jama.2014.13186			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7HL	25244362	Green Accepted			2022-12-28	WOS:000342983200021
J	Ali, MN; Xiong, J; Flynn, S; Tao, J; Gibson, QD; Schoop, LM; Liang, T; Haldolaarachchige, N; Hirschberger, M; Ong, NP; Cava, RJ				Ali, Mazhar N.; Xiong, Jun; Flynn, Steven; Tao, Jing; Gibson, Quinn D.; Schoop, Leslie M.; Liang, Tian; Haldolaarachchige, Neel; Hirschberger, Max; Ong, N. P.; Cava, R. J.			Large, non-saturating magnetoresistance in WTe2	NATURE			English	Article							COLOSSAL MAGNETORESISTANCE; GIANT MAGNETORESISTANCE; ELECTRICAL-PROPERTIES; NANOPARTICLES; TRANSITION; WS2	Magnetoresistance is the change in a material's electrical resistance in response to an applied magnetic field. Materials with large magnetoresistance have found use as magnetic sensors(1), in magnetic memory(2), and in hard drives(3) at room temperature, and their rarity has motivated many fundamental studies in materials physics at low temperatures(4). Here we report the observation of an extremely large positive magnetoresistance at low temperatures in the non-magnetic layered transition-metal dichalcogenide WTe2: 452,700 per cent at 4.5 kelvins in a magnetic field of 14.7 teslas, and 13 million per cent at 0.53 kelvins in a magnetic field of 60 teslas. In contrast with other materials, there is no saturation of the magnetoresistance value even at very high applied fields. Determination of the origin and consequences of this effect, and the fabrication of thin films, nanostructures and devices based on the extremely large positive magnetoresistance of WTe2, will represent a significant new direction in the study of magnetoresistivity.	[Ali, Mazhar N.; Flynn, Steven; Gibson, Quinn D.; Schoop, Leslie M.; Haldolaarachchige, Neel; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Xiong, Jun; Liang, Tian; Hirschberger, Max; Ong, N. P.] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Xiong, Jun; Liang, Tian; Hirschberger, Max; Ong, N. P.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Tao, Jing] Brookhaven Natl Lab, Dept Condensed Matter Phys & Mat Sci, Upton, NY 11973 USA	Princeton University; Princeton University; Princeton University; United States Department of Energy (DOE); Brookhaven National Laboratory	Ali, MN (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	mnali@princeton.edu	Hirschberger, Max/AAE-8003-2019; Schoop, Leslie M/A-4627-2013; Haldolaarachchige, Neel/L-8217-2019; Ong, N. Phuan/Z-1626-2019; Haldolaarachchige, Neel/AAW-3428-2021; Liang, Tian/AAE-6777-2022; Ali, Mazhar/C-6473-2013	Hirschberger, Max/0000-0002-1780-1619; Schoop, Leslie M/0000-0003-3459-4241; Haldolaarachchige, Neel/0000-0002-4681-4144; Liang, Tian/0000-0002-4332-2814; Ali, Mazhar/0000-0002-1129-6105; Ong, N. Phuan/0000-0001-7166-1058; Flynn, Steven/0000-0001-8262-6987	Army Research Office [W911NF-12-1-0461, W911NF-11-1-0379]; NSF MRSEC Program Grant [DMR-0819860]; National Science Foundation [DMR-1157490]; State of Florida; US Department of Energy; US Department of Energy's Basic Energy Sciences (DOE BES) project 'Science at 100 Tesla'; DOE BES, by the Materials Sciences and Engineering Division [DE-AC02-98CH10886]	Army Research Office; NSF MRSEC Program Grant; National Science Foundation(National Science Foundation (NSF)); State of Florida; US Department of Energy(United States Department of Energy (DOE)); US Department of Energy's Basic Energy Sciences (DOE BES) project 'Science at 100 Tesla'(United States Department of Energy (DOE)); DOE BES, by the Materials Sciences and Engineering Division(United States Department of Energy (DOE))	We thank T. Valla, I. Pletikosic, F. Balakirev, R. McDonald and J. Betts for discussions, and E. Tutuc for inquiring about WTe<INF>2</INF>. This research was supported by the Army Research Office, grants W911NF-12-1-0461 and W911NF-11-1-0379, and the NSF MRSEC Program Grant DMR-0819860. The National Magnet Laboratory is supported by the National Science Foundation Cooperative Agreement no. DMR-1157490, the State of Florida, and the US Department of Energy; this work was supported by the US Department of Energy's Basic Energy Sciences (DOE BES) project 'Science at 100 Tesla'. The electron microscopy study at Brookhaven National Laboratory was supported by the DOE BES, by the Materials Sciences and Engineering Division under contract DE-AC02-98CH10886, and through the use of the Center for Functional Nanomaterials.	ALERS PB, 1953, PHYS REV, V91, P1060, DOI 10.1103/PhysRev.91.1060; Augustin J, 2000, PHYS REV B, V62, P10812, DOI 10.1103/PhysRevB.62.10812; Ayari A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2407388; BATES JB, 1994, SOLID STATE IONICS, V70, P619, DOI 10.1016/0167-2738(94)90383-2; Blaha P., 2001, WIEN2K; BROWN BE, 1966, ACTA CRYSTALLOGR, V20, P268, DOI 10.1107/S0365110X66000513; Daughton JM, 1999, J MAGN MAGN MATER, V192, P334, DOI 10.1016/S0304-8853(98)00376-X; DISALVO FJ, 1976, PHYS REV B, V14, P4321, DOI 10.1103/PhysRevB.14.4321; Du X, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.166601; EGELHOFF WF, 1995, J APPL PHYS, V78, P273, DOI 10.1063/1.360692; Ekin J. W, 2006, EXPT TECHNIQUES LOW, DOI DOI 10.1093/ACPROF:OSO/9780198570547.001.0001; Fauque B, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113012; Ishiwata S, 2013, NAT MATER, V12, P512, DOI [10.1038/NMAT3621, 10.1038/nmat3621]; Jankowski J, 2011, SENSORS-BASEL, V11, P876, DOI 10.3390/s110100876; JIN S, 1994, J APPL PHYS, V76, P6929, DOI 10.1063/1.358119; KABASHIMA S, 1966, J PHYS SOC JPN, V21, P945, DOI 10.1143/JPSJ.21.945; Kopelevich Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.156402; LENZ JE, 1990, P IEEE, V78, P973, DOI 10.1109/5.56910; Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b; MONCTON DE, 1977, PHYS REV B, V16, P801, DOI 10.1103/PhysRevB.16.801; Moritomo Y, 1996, NATURE, V380, P141, DOI 10.1038/380141a0; MORRIS RC, 1972, PHYS REV B, V5, P895, DOI 10.1103/PhysRevB.5.895; Mun E, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.035135; Pillo T, 2000, PHYS REV B, V61, P16213, DOI 10.1103/PhysRevB.61.16213; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Ramirez AP, 1997, NATURE, V386, P156, DOI 10.1038/386156a0; Rapoport L, 2005, J MATER CHEM, V15, P1782, DOI 10.1039/b417488g; Rapoport L, 1997, NATURE, V387, P791, DOI 10.1038/42910; REVOLINSKY E, 1964, J APPL PHYS, V35, P2086, DOI 10.1063/1.1702795; Singh D. J., 2006, PLANEWAVES PSEUDOPOT, V2nd, DOI DOI 10.1007/978-1-4757-2312-0; Solin SA, 2000, SCIENCE, V289, P1530, DOI 10.1126/science.289.5484.1530; URUSHIBARA A, 1995, PHYS REV B, V51, P14103, DOI 10.1103/PhysRevB.51.14103; Yang FY, 1999, SCIENCE, V284, P1335, DOI 10.1126/science.284.5418.1335	33	1117	1130	47	1250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					205	+		10.1038/nature13763	http://dx.doi.org/10.1038/nature13763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25219849	Green Submitted			2022-12-28	WOS:000342663100037
J	Andrews-Hanna, JC; Besserer, J; Head, JW; Howett, CJA; Kiefer, WS; Lucey, PJ; McGovern, PJ; Melosh, HJ; Neumann, GA; Phillips, RJ; Schenk, PM; Smith, DE; Solomon, SC; Zuber, MT				Andrews-Hanna, Jeffrey C.; Besserer, Jonathan; Head, James W., III; Howett, Carly J. A.; Kiefer, Walter S.; Lucey, Paul J.; McGovern, Patrick J.; Melosh, H. Jay; Neumann, Gregory A.; Phillips, Roger J.; Schenk, Paul M.; Smith, David E.; Solomon, Sean C.; Zuber, Maria T.			Structure and evolution of the lunar Procellarum region as revealed by GRAIL gravity data	NATURE			English	Article							SOUTH-POLE; MARE BASALTS; ORIGIN; MOON; ENCELADUS; INTERIOR; MODEL; CONSTRAINTS; TECTONICS; VOLCANISM	The Procellarum region is a broad area on the nearside of the Moon that is characterized by low elevations(1), thin crust(2), and high surface concentrations of the heat-producing elements uranium, thorium, and potassium(3,4). The region has been interpreted as an ancient impact basin approximately 3,200 kilometres in diameter(5-7), although supporting evidence at the surface would have been largely obscured as a result of the great antiquity and poor preservation of any diagnostic features. Here we use data from the Gravity Recovery and Interior Laboratory (GRAIL) mission(8) to examine the subsurface structure of Procellarum. The Bouguer gravity anomalies and gravity gradients reveal a pattern of narrow linear anomalies that border Procellarum and are interpreted to be the frozen remnants of lava-filled rifts and the underlying feeder dykes that served as the magma plumbing system for much of the nearside mare volcanism. The discontinuous surface structures that were earlier interpreted as remnants of an impact basin rim are shown in GRAIL data to be a part of this continuous set of border structures in a quasi-rectangular pattern with angular intersections, contrary to the expected circular or elliptical shape of an impact basin(9). The spatial pattern of magmatic-tectonic structures bounding Procellarum is consistent with their formation in response to thermal stresses produced by the differential cooling of the province relative to its surroundings, coupled with magmatic activity driven by the greater-than-average heat flux in the region.	[Andrews-Hanna, Jeffrey C.] Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA; [Andrews-Hanna, Jeffrey C.] Colorado Sch Mines, Ctr Space Resources, Golden, CO 80401 USA; [Besserer, Jonathan] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Head, James W., III] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Howett, Carly J. A.; Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Kiefer, Walter S.; McGovern, Patrick J.; Schenk, Paul M.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Lucey, Paul J.] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Melosh, H. Jay] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Neumann, Gregory A.] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Smith, David E.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Colorado School of Mines; Colorado School of Mines; University of California System; University of California Santa Cruz; Brown University; University of Hawaii System; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; Columbia University	Andrews-Hanna, JC (corresponding author), Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA.	jcahanna@mines.edu	Neumann, Gregory A/I-5591-2013; Kiefer, Walter/F-2759-2016	Neumann, Gregory A/0000-0003-0644-9944; Kiefer, Walter/0000-0001-6741-5460; McGovern, Patrick/0000-0001-9647-3096	NASA's GRAIL Guest Scientist Program [NNX12AL20G]	NASA's GRAIL Guest Scientist Program	The GRAIL mission is a component of the NASA Discovery Program and is performed under contract to the Massachusetts Institute of Technology and the Jet Propulsion Laboratory, California Institute of Technology. J.C.A.-H. was supported by grant NNX12AL20G from NASA's GRAIL Guest Scientist Program.	Andrews-Hanna JC, 2008, NATURE, V453, P1212, DOI 10.1038/nature07011; Andrews-Hanna JC, 2013, SCIENCE, V339, P675, DOI 10.1126/science.1231753; Andrews-Hanna JC, 2010, GEOL SOC AM SPEC PAP, V465, P1, DOI 10.1130/2010.2465(01); [Anonymous], 2001, GEODYNAMICS; Barr AC, 2010, ICARUS, V208, P499, DOI 10.1016/j.icarus.2010.03.038; Barr AC, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003114; Bassis J. N., 2012, J GEOPHYS RES, V117, DOI DOI 10.1029/2012JE004084; Behounkova M, 2012, ICARUS, V219, P655, DOI 10.1016/j.icarus.2012.03.024; Besserer J, 2013, J GEOPHYS RES-PLANET, V118, P908, DOI 10.1002/jgre.20079; Besserer J, 2013, LUNAR PLANET SCI, V44; Blakely R. J., 1995, POTENTIAL THEORY GRA; Bland MT, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052736; BUCK WR, 1991, J GEOPHYS RES-SOL EA, V96, P20161, DOI 10.1029/91JB01485; CADOGAN PH, 1974, NATURE, V250, P315, DOI 10.1038/250315a0; Collins GC, 2007, ICARUS, V189, P72, DOI 10.1016/j.icarus.2007.01.010; Crow-Willard E., 2011, EPSC ABSTR, V6; DeHon R. A., 1978, P LUNAR PLANET SCI C, V9, P229; Elkins-Tanton LT, 2011, EARTH PLANET SC LETT, V304, P326, DOI 10.1016/j.epsl.2011.02.004; Elkins-Tanton LT, 2002, EARTH PLANET SC LETT, V196, P239, DOI 10.1016/S0012-821X(01)00613-6; Giese B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036149; Gioia G, 2007, P NATL ACAD SCI USA, V104, P13578, DOI 10.1073/pnas.0706018104; Grimm RE, 2013, J GEOPHYS RES-PLANET, V118, DOI 10.1029/2012JE004114; Head JW, 2011, SCIENCE, V333, P1853, DOI 10.1126/science.1211997; HESS PC, 1995, EARTH PLANET SC LETT, V134, P501, DOI 10.1016/0012-821X(95)00138-3; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P11999, DOI 10.1029/1999JE001193; Hiesinger H, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001985; Hiesinger H, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003380; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P29239, DOI 10.1029/2000JE001244; Howett CJA, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003718; Hurford TA, 2007, NATURE, V447, P292, DOI 10.1038/nature05821; Iess L, 2014, SCIENCE, V344, P78, DOI 10.1126/science.1250551; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Kiefer WS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051319; Lachenbruch A. H., 1962, GEOL SOC AM SPEC PAP, V70, P1, DOI DOI 10.1130/SPE70-P1; Lainey V, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/14; Laneuville M, 2013, J GEOPHYS RES-PLANET, V118, P1435, DOI 10.1002/jgre.20103; Lawrence DJ, 1998, SCIENCE, V281, P1484, DOI 10.1126/science.281.5382.1484; Lemoine FG, 2014, GEOPHYS RES LETT, V41, P3382, DOI 10.1002/2014GL060027; McGovern P. J., 2013, LUNAR PLANET SCI, V44; McGovern PJ, 2013, J GEOPHYS RES-PLANET, V118, P2423, DOI 10.1002/2013JE004455; MELOSH HJ, 1980, GEOPHYS J ROY ASTR S, V60, P333, DOI 10.1111/j.1365-246X.1980.tb04812.x; Meyer J, 2007, ICARUS, V188, P535, DOI 10.1016/j.icarus.2007.03.001; Nakamura R, 2012, NAT GEOSCI, V5, P775, DOI [10.1038/NGEO1614, 10.1038/ngeo1614]; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; O'Neill C, 2010, NAT GEOSCI, V3, P88, DOI 10.1038/NGEO731; Parmentier EM, 2002, EARTH PLANET SC LETT, V201, P473, DOI 10.1016/S0012-821X(02)00726-4; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Presley MA, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003482; Pritchard M.E., 2000, ORIGIN EARTH MOON, P179, DOI [10.2307/j.ctv1v7zdrp.16, DOI 10.2307/J.CTV1V7ZDRP.16]; Reed GB, 1973, OHIO STATE U REPORT; Roberts JH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033725; Schenk PM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039916; Scott D. H., 1974, P LUNAR PLANET SCI C, P3025; Smith DE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043751; SOLOMON SC, 1977, PHYS EARTH PLANET IN, V15, P135, DOI 10.1016/0031-9201(77)90026-7; Spencer J. R., 2013, EPSC ABSTR, V8; Spencer JR, 2009, SATURN FROM CASSINI-HUYGENS, P683, DOI 10.1007/978-1-4020-9217-6_21; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Thomas PC, 2007, ICARUS, V190, P573, DOI 10.1016/j.icarus.2007.03.012; Tobie G, 2008, ICARUS, V196, P642, DOI 10.1016/j.icarus.2008.03.008; TOKSOZ MN, 1974, REV GEOPHYS, V12, P539, DOI 10.1029/RG012i004p00539; Watters T. R., 2010, PLANETARY TECTONICS, P121; Whitaker E. A., 1981, LUNAR PLANET SCI A, P105; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; Wieczorek MA, 1998, J GEOPHYS RES-PLANET, V103, P1715, DOI 10.1029/97JE03136; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Wilhelms D. E., 1987, US GEOL SURV PROF PA, V1348, P1; WILSON L, 1981, J GEOPHYS RES, V86, P2971, DOI 10.1029/JB086iB04p02971; Yin A., 2013, LUNAR PLANET SCI, V44; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507; Zuber MT, 2012, SCIENCE, V336, P217, DOI 10.1126/science.1218805	72	58	58	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					68	+		10.1038/nature13697	http://dx.doi.org/10.1038/nature13697			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279919				2022-12-28	WOS:000342420800036
J	Lionetti, E; Castellaneta, S; Francavilla, R; Pulvirenti, A; Tonutti, E; Amarri, S; Barbato, M; Barbera, C; Barera, G; Bellantoni, A; Castellano, E; Guariso, G; Limongelli, MG; Pellegrino, S; Polloni, C; Ughi, C; Zuin, G; Fasano, A; Catassi, C				Lionetti, Elena; Castellaneta, Stefania; Francavilla, Ruggiero; Pulvirenti, Alfredo; Tonutti, Elio; Amarri, Sergio; Barbato, Maria; Barbera, Cristiana; Barera, Graziano; Bellantoni, Antonella; Castellano, Emanuela; Guariso, Graziella; Limongelli, Maria Giovanna; Pellegrino, Salvatore; Polloni, Carlo; Ughi, Claudio; Zuin, Giovanna; Fasano, Alessio; Catassi, Carlo		SIGENP Italian Soc Pediat Gastroen	Introduction of Gluten, HLA Status, and the Risk of Celiac Disease in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATURAL-HISTORY; PEDIATRIC-GASTROENTEROLOGY; ISLET AUTOIMMUNITY; FAMILY-RISK; FOLLOW-UP; PREVALENCE; NUTRITION; INFANTS; INTERVENTION; POPULATION	BACKGROUND The relationship between the risk of celiac disease and both the age at which gluten is introduced to a child's diet and a child's early dietary pattern is unclear. METHODS We randomly assigned 832 newborns who had a first-degree relative with celiac disease to the introduction of dietary gluten at 6 months (group A) or 12 months (group B). The HLA genotype was determined at 15 months of age, and serologic screening for celiac disease was evaluated at 15, 24, and 36 months and at 5, 8, and 10 years. Patients with positive serologic findings underwent intestinal biopsies. The primary outcome was the prevalence of celiac disease autoimmunity and of overt celiac disease among the children at 5 years of age. RESULTS Of the 707 participants who remained in the trial at 36 months, 553 had a standard-risk or high-risk HLA genotype and completed the study. At 2 years of age, significantly higher proportions of children in group A than in group B had celiac disease autoimmunity (16% vs. 7%, P = 0.002) and overt celiac disease (12% vs. 5%, P = 0.01). At 5 years of age, the between-group differences were no longer significant for autoimmunity (21% in group A and 20% in group B, P = 0.59) or overt disease (16% and 16%, P = 0.78 by the log-rank test). At 10 years, the risk of celiac disease autoimmunity was far higher among children with high-risk HLA than among those with standard-risk HLA (38% vs. 19%, P = 0.001), as was the risk of overt celiac disease (26% vs. 16%, P = 0.05). Other variables, including breast-feeding, were not associated with the development of celiac disease. CONCLUSIONS Neither the delayed introduction of gluten nor breast-feeding modified the risk of celiac disease among at-risk infants, although the later introduction of gluten was associated with a delayed onset of disease. A high-risk HLA genotype was an important predictor of disease. (Funded by the Fondazione Celiachia of the Italian Society for Celiac Disease; CELIPREV ClinicalTrials.gov number, NCT00639444.)	[Lionetti, Elena] Univ Catania, Dept Pediat, I-95124 Catania, Italy; [Pulvirenti, Alfredo] Univ Catania, Dept Clin & Mol Biomed, I-95124 Catania, Italy; [Castellaneta, Stefania] San Paolo Hosp, Dept Pediat, Milan, Italy; [Francavilla, Ruggiero] Univ Bari, Dept Dev Biomed, Bari, Italy; [Tonutti, Elio] Udine Hosp, Dept Immunopathol & Allergol, Udine, Italy; [Amarri, Sergio] Azienda Osped IRCCS Santa Maria Nuova Hosp, Dept Pediat, Reggio Emilia, Italy; [Barbato, Maria] Univ Roma La Sapienza, Dept Pediat, I-00185 Rome, Italy; [Barbera, Cristiana] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Barera, Graziano] Hosp San Raffaele, Dept Pediat, Milan, Italy; [Zuin, Giovanna] Vittore Buzzi Childrens Hosp, Dept Pediat, Milan, Italy; [Bellantoni, Antonella] Bianchi Melacrino Morelli Hosp, Dept Pediat, Reggio Di Calabria, Italy; [Castellano, Emanuela] Ist Giannina Gaslini, Pediat Gastroenterol Unit, I-16148 Genoa, Italy; [Guariso, Graziella] Univ Padua, Dept Pediat, Padua, Italy; [Limongelli, Maria Giovanna] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Polloni, Carlo] Rovereto Hosp, Dept Pediat, Rovereto, Trento, Italy; [Ughi, Claudio] Univ Pisa, Dept Pediat, Pisa, Italy; [Catassi, Carlo] Marche Polytech Univ, Dept Pediat, I-60123 Ancona, Italy; [Fasano, Alessio] MassGen Hosp Children, Div Pediat Gastroenterol & Nutr, Boston, MA USA; [Fasano, Alessio] MassGen Hosp Children, Ctr Celiac Res, Boston, MA USA; [Fasano, Alessio; Catassi, Carlo] Harvard Univ, Sch Med, Celiac Program, Boston, MA USA	University of Catania; University of Catania; San Paolo-Polo Universitaria Hospital; Universita degli Studi di Bari Aldo Moro; University of Udine; IRCCS Arcispedale S. Maria Nuova; Sapienza University Rome; University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Padua; University of Naples Federico II; University of Pisa; Marche Polytechnic University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Catassi, C (corresponding author), Marche Polytech Univ, Dept Pediat, Via F Corridoni 1, I-60123 Ancona, Italy.	catassi@univpm.it	Pulvirenti, Alfredo/I-7272-2018; barera, graziano/AAN-5041-2020; Fasano, Alessio/K-5486-2016; FRANCAVILLA, RUGGIERO/S-1391-2019	Pulvirenti, Alfredo/0000-0002-9764-0295; Fasano, Alessio/0000-0002-2134-0261; FRANCAVILLA, RUGGIERO/0000-0002-4603-974X; Pellegrino, Salvatore/0000-0003-1163-0748	Fondazione Celiachia of the Italian Society for Celiac Disease	Fondazione Celiachia of the Italian Society for Celiac Disease	Funded by the Fondazione Celiachia of the Italian Society for Celiac Disease; CELIPREV ClinicalTrials.gov number, NCT00639444.)	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Akobeng AK, 2006, ARCH DIS CHILD, V91, P39, DOI 10.1136/adc.2005.082016; Anderson RP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-188; AURICCHIO S, 1983, J PEDIATR GASTR NUTR, V2, P428, DOI 10.1097/00005176-198302030-00006; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; GRECO L, 1988, J PEDIATR GASTR NUTR, V7, P395, DOI 10.1097/00005176-198805000-00013; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Hogberg L, 2003, SCAND J GASTROENTERO, V38, P61, DOI 10.1080/00365520310000456; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hummel S, 2011, DIABETES CARE, V34, P1301, DOI 10.2337/dc10-2456; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Ivarsson A, 2013, PEDIATRICS, V131, pE687, DOI 10.1542/peds.2012-1015; Latronico N., 1977, HIST PEDIAT; Lionetti E, 2012, J PEDIATR-US, V161, P908, DOI 10.1016/j.jpeds.2012.05.008; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Peters U, 2001, ANN NUTR METAB, V45, P135, DOI 10.1159/000046720; Prescott SL, 2008, PEDIAT ALLERG IMM-UK, V19, P375, DOI 10.1111/j.1399-3038.2008.00718.x; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040; Rubio-Tapia A, 2008, CLIN GASTROENTEROL H, V6, P983, DOI 10.1016/j.cgh.2008.04.008; Stordal K, 2013, PEDIATRICS, V132, pE1202, DOI 10.1542/peds.2013-1752; Szajewska H, 2012, ALIMENT PHARM THER, V36, P607, DOI 10.1111/apt.12023; Tosco A, 2011, CLIN GASTROENTEROL H, V9, P320, DOI 10.1016/j.cgh.2010.09.006; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; vanOverbeek FM, 1997, EUR J GASTROEN HEPAT, V9, P1097, DOI 10.1097/00042737-199711000-00013; Vriezinga SL, 2014, NEW ENGL J MED, V371, P1304, DOI 10.1056/NEJMoa1404172; ZEIGER RS, 1995, J ALLERGY CLIN IMMUN, V95, P1179, DOI 10.1016/S0091-6749(95)70074-9; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	36	289	302	1	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1295	1303		10.1056/NEJMoa1400697	http://dx.doi.org/10.1056/NEJMoa1400697			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25271602	Green Published			2022-12-28	WOS:000342429800006
J	Dhalla, IA; O'Brien, T; Morra, D; Thorpe, KE; Wong, BM; Mehta, R; Frost, DW; Abrams, H; Ko, F; Van Rooyen, P; Bell, CM; Gruneir, A; Lewis, GH; Daub, S; Anderson, GM; Hawker, GA; Rochon, PA; Laupacis, A				Dhalla, Irfan A.; O'Brien, Tara; Morra, Dante; Thorpe, Kevin E.; Wong, Brian M.; Mehta, Rajin; Frost, David W.; Abrams, Howard; Ko, Francoise; Van Rooyen, Patrick; Bell, Chaim M.; Gruneir, Andrea; Lewis, Geraint H.; Daub, Stacey; Anderson, Geoff M.; Hawker, Gillian A.; Rochon, Paula A.; Laupacis, Andreas			Effect of a Postdischarge Virtual Ward on Readmission or Death for High-Risk Patients A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BOOST; CARE; REHOSPITALIZATION; INTERVENTIONS; ASSOCIATION; PROGRAM; SIZE	IMPORTANCE Hospital readmissions are common and costly, and no single intervention or bundle of interventions has reliably reduced readmissions. Virtual wards, which use elements of hospital care in the community, have the potential to reduce readmissions, but have not yet been rigorously evaluated. OBJECTIVE To determine whether a virtual ward-a model of care that uses some of the systems of a hospital ward to provide interprofessional care for community-dwelling patients-can reduce the risk of readmission in patients at high risk of readmission or death when being discharged from hospital. DESIGN, SETTING, AND PATIENTS High-risk adult hospital discharge patients in Toronto were randomly assigned to either the virtual ward or usual care. A total of 1923 patients were randomized during the course of the study: 960 to the usual care group and 963 to the virtual ward group. The first patient was enrolled on June 29, 2010, and follow-up was completed on June 2, 2014. INTERVENTIONS Patients assigned to the virtual ward received care coordination plus direct care provision (via a combination of telephone, home visits, or clinic visits) from an interprofessional team for several weeks after hospital discharge. The interprofessional team met daily at a central site to design and implement individualized management plans. Patients assigned to usual care typically received a typed, structured discharge summary, prescription for new medications if indicated, counseling from the resident physician, arrangements for home care as needed, and recommendations, appointments, or both for follow-up care with physicians as indicated. MAIN OUTCOMES AND MEASURES The primary outcome was a composite of hospital readmission or death within 30 days of discharge. Secondary outcomes included nursing home admission and emergency department visits, each of the components of the primary outcome at 30 days, as well as each of the outcomes (including the composite primary outcome) at 90 days, 6 months, and 1 year. RESULTS There were no statistically significant between-group differences in the primary or secondary outcomes at 30 or 90 days, 6 months, or 1 year. The primary outcome occurred in 203 of 959 (21.2%) of the virtual ward patients and 235 of 956 (24.6%) of the usual care patients (absolute difference, 3.4%; 95% CI, -0.3% to 7.2%; P = .09). There were no statistically significant interactions to indicate that the virtual ward model of care was more or less effective in any of the prespecified subgroups. CONCLUSIONS AND RELEVANCE In a diverse group of high-risk patients being discharged from the hospital, we found no statistically significant effect of a virtual ward model of care on readmissions or death at either 30 days or 90 days, 6 months, or 1 year after hospital discharge. Copyright 2014 American Medical Association. All rights reserved.	[Dhalla, Irfan A.; O'Brien, Tara; Morra, Dante; Wong, Brian M.; Mehta, Rajin; Frost, David W.; Abrams, Howard; Bell, Chaim M.; Hawker, Gillian A.; Rochon, Paula A.; Laupacis, Andreas] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Gruneir, Andrea; Anderson, Geoff M.; Rochon, Paula A.; Laupacis, Andreas] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Thorpe, Kevin E.; Van Rooyen, Patrick; Laupacis, Andreas] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Bell, Chaim M.; Gruneir, Andrea; Hawker, Gillian A.; Rochon, Paula A.; Laupacis, Andreas] Inst Clin Evaluat Sci, Toronto, ON, Canada; [O'Brien, Tara; Hawker, Gillian A.; Rochon, Paula A.] Womens Coll Hosp, Dept Med, Toronto, ON, Canada; [Morra, Dante] Trillium Hlth Partners, Mississauga, ON, Canada; [Thorpe, Kevin E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada; [Wong, Brian M.; Mehta, Rajin] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Wong, Brian M.] Univ Toronto, Ctr Qual Improvement & Patient Safety, Toronto, ON M5B 1W8, Canada; [Frost, David W.; Abrams, Howard] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Ko, Francoise] Taddle Creek Family Hlth Team, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Gruneir, Andrea; Rochon, Paula A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Lewis, Geraint H.] NHS England, London, England; [Daub, Stacey] Toronto Cent Community Care Access Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Trillium Health Partners; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Centre for Quality Improvement & Patient Safety; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Womens College Hospital	Dhalla, IA (corresponding author), Univ Toronto, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	dhallai@smh.ca	Bell, Chaim/C-4611-2015; Rochon, Paula A/J-2918-2016	Bell, Chaim/0000-0002-3778-9469; Rochon, Paula A/0000-0002-5973-4151; Thorpe, Kevin/0000-0002-7586-3893; Frost, David William/0000-0002-4313-3802; Abrams, Howard/0000-0002-4869-3913	Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Green Shield Canada Foundation; University of Toronto Department of Medicine; Academic Funding Plan Innovation Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Green Shield Canada Foundation; University of Toronto Department of Medicine(University of Toronto); Academic Funding Plan Innovation Fund	This research was funded by the Canadian Institutes of Health Research, the Ontario Ministry of Health and Long-Term Care, the Green Shield Canada Foundation, the University of Toronto Department of Medicine, and the Academic Funding Plan Innovation Fund.	Auerbach A, 2013, J HOSP MED, V8, P468, DOI 10.1002/jhm.2065; Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Chen YHJ, 2004, STAT MED, V23, P1023, DOI 10.1002/sim.1688; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Detsky AS, 2014, JAMA-J AM MED ASSOC, V311, P2169, DOI 10.1001/jama.2014.3695; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Gruneir Andrea, 2011, Open Med, V5, pe104; Hansen LO, 2013, J HOSP MED, V8, P421, DOI 10.1002/jhm.2054; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2013, J HOSP MED, V8, P470, DOI 10.1002/jhm.2069; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Larson EB, 2010, JAMA-J AM MED ASSOC, V303, P1644, DOI 10.1001/jama.2010.524; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; Lewis G, 2013, INT J INTEGR CARE, V13; Lewis G, 2012, POPUL HEALTH MANAG, V15, P315, DOI 10.1089/pop.2011.0086; McAlister FA, 2013, CMAJ, V185, P681; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Reuben DB, 2014, NEW ENGL J MED, V370, P694, DOI 10.1056/NEJMp1315568; Schachter ME, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-33; Schwenk TL, 2014, JAMA-J AM MED ASSOC, V311, P802, DOI 10.1001/jama.2014.352; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; vanWalraven C, 2011, CMAJ, V183, P1067	28	83	83	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1305	1312		10.1001/jama.2014.11492	http://dx.doi.org/10.1001/jama.2014.11492			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268437				2022-12-28	WOS:000342345400016
J	Arie, S; Mahony, C				Arie, Sophie; Mahony, Chris			COMPETING INTERESTS Should patient groups be more transparent about their funding?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						[Anonymous], 2014, HERALD          0615; Association of the British Pharmaceutical Industry, 2014, COD PRACT; Bayer, 2012, PAT GROUP DON 2012; Bayer, 2013, PAT GROUP DON 2013; BBC, 2014, BBC; Biogen Idec, PAT ORG SUPP; Department of Health NHS Confederation. ABPI, 2012, JOINT WORK QUICK STA; Mitchell M, 2014, TELEGRAPH; MS Society, OUR CORP SUPP; MS Society, ANN REP ACC 2013; MS Society, VIS MISS; MS Trust, 2013, TRUST REP FIN STAT Y; MS Trust, POL WORK PHARM BIOT	13	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2014	349								g5892	10.1136/bmj.g5892	http://dx.doi.org/10.1136/bmj.g5892			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3BT	25266116				2022-12-28	WOS:000342664400005
J	Kneebone, R				Kneebone, Roger			The art of medicine Escaping Babel: the surgical voice	LANCET			English	Editorial Material									[Kneebone, Roger] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Div Surg, London SW7 2AZ, England; [Kneebone, Roger] St Marys Hosp, Clin Skills Ctr, London W2 1NY, England	Imperial College London; Imperial College London	Kneebone, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Div Surg, London SW7 2AZ, England.	r.kneebone@imperial.ac.uk			Arts and Humanities Research Council [AH/J002267/1] Funding Source: researchfish; AHRC [AH/J002267/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))			0	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1179	1180		10.1016/S0140-6736(14)61715-3	http://dx.doi.org/10.1016/S0140-6736(14)61715-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	25268029				2022-12-28	WOS:000343002600014
J	Cheng, SC; Quintin, J; Cramer, RA; Shepardson, KM; Saeed, S; Kumar, V; Giamarellos-Bourboulis, EJ; Martens, JHA; Rao, NA; Aghajanirefah, A; Manjeri, GR; Li, Y; Ifrim, DC; Arts, RJW; van der Meer, BMJW; Deen, PMT; Logie, C; O'Neill, LA; Willems, P; van de Veerdonk, FL; van der Meer, JWM; Ng, A; Joosten, LAB; Wijmenga, C; Stunnenberg, HG; Xavier, RJ; Netea, MG				Cheng, Shih-Chin; Quintin, Jessica; Cramer, Robert A.; Shepardson, Kelly M.; Saeed, Sadia; Kumar, Vinod; Giamarellos-Bourboulis, Evangelos J.; Martens, Joost H. A.; Rao, Nagesha Appukudige; Aghajanirefah, Ali; Manjeri, Ganesh R.; Li, Yang; Ifrim, Daniela C.; Arts, Rob J. W.; van der Meer, Brian M. J. W.; Deen, Peter M. T.; Logie, Colin; O'Neill, Luke A.; Willems, Peter; van de Veerdonk, Frank L.; van der Meer, Jos W. M.; Ng, Aylwin; Joosten, Leo A. B.; Wijmenga, Cisca; Stunnenberg, Hendrik G.; Xavier, Ramnik J.; Netea, Mihai G.			mTOR- and HIF-1 alpha-mediated aerobic glycolysis as metabolic basis for trained immunity	SCIENCE			English	Article							INNATE IMMUNITY; BETA-GLUCAN; CELLS; MACROPHAGES; ACTIVATION; INFECTION; INFLAMMATION; REINFECTION; EXPRESSION; PROTECTION	Epigenetic reprogramming of myeloid cells, also known as trained immunity, confers nonspecific protection from secondary infections. Using histone modification profiles of human monocytes trained with the Candida albicans cell wall constituent beta-glucan, together with a genome-wide transcriptome, we identified the induced expression of genes involved in glucose metabolism. Trained monocytes display high glucose consumption, high lactate production, and a high ratio of nicotinamide adenine dinucleotide (NAD+) to its reduced form (NADH), reflecting a shift in metabolism with an increase in glycolysis dependent on the activation of mammalian target of rapamycin (mTOR) through a dectin-1-Akt-HIF-1 alpha (hypoxia-inducible factor-1 alpha) pathway. Inhibition of Akt, mTOR, or HIF-1 alpha blocked monocyte induction of trained immunity, whereas the adenosine monophosphate-activated protein kinase activator metformin inhibited the innate immune response to fungal infection. Mice with a myeloid cell-specific defect in HIF-1 alpha were unable to mount trained immunity against bacterial sepsis. Our results indicate that induction of aerobic glycolysis through an Akt-mTOR-HIF-1 alpha pathway represents the metabolic basis of trained immunity.	[Cheng, Shih-Chin; Quintin, Jessica; Ifrim, Daniela C.; Arts, Rob J. W.; van de Veerdonk, Frank L.; van der Meer, Jos W. M.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Cramer, Robert A.; Shepardson, Kelly M.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Saeed, Sadia; Martens, Joost H. A.; Rao, Nagesha Appukudige; Aghajanirefah, Ali; Logie, Colin] Radboud Univ Nijmegen, Fac Sci, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands; [Saeed, Sadia; Martens, Joost H. A.; Rao, Nagesha Appukudige; Aghajanirefah, Ali; Logie, Colin] Radboud Univ Nijmegen, Fac Med, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands; [Kumar, Vinod; Li, Yang; van der Meer, Brian M. J. W.; Wijmenga, Cisca; Stunnenberg, Hendrik G.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Giamarellos-Bourboulis, Evangelos J.] Univ Athens, Sch Med, Dept Internal Med 4, Athens 12462, Greece; [Manjeri, Ganesh R.; Willems, Peter] Radboud Univ Nijmegen, Fac Sci, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Manjeri, Ganesh R.; Willems, Peter] Radboud Univ Nijmegen, Fac Med, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Deen, Peter M. T.] Radboud Univ Nijmegen, Dept Physiol, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [O'Neill, Luke A.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Radboud University Nijmegen; Dartmouth College; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Athens Medical School; National & Kapodistrian University of Athens; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Trinity College Dublin; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Netea, MG (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 GA Nijmegen, Netherlands.	mihal.netea@radboudumc.nl	CHENG, SHIH-CHIN/M-3773-2019; Arts, Rob JW/P-8678-2015; Ng, Aylwin/AAQ-6478-2020; Deen, P.M.T./H-8023-2014; van der Meer, Jos W.M./C-8521-2013; Martens, Joost/D-4966-2012; Wijmenga, Cisca/AAE-7719-2019; Deen, Peter MT/B-9854-2013; Joosten, Leo AB/H-3138-2015; Stunnenberg, Hendrik G./D-6875-2012; Netea, Mihai/N-5155-2014; Logie, Colin/A-1528-2010; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; Logie, Colin/L-9833-2019; Cheng, Shih-Chin/H-4567-2015; Kumar, Vinod/ABC-4866-2020; Manjeri, Ganesh/AAB-7551-2020; van de Veerdonk, Frank L/C-7256-2008; van der Veer, Brian/AAE-8588-2022; Li, Yang/HGT-8446-2022; Wijmenga, Cisca/D-2173-2009; Willems, P.H.G.M./L-4759-2015	CHENG, SHIH-CHIN/0000-0003-1251-8774; Arts, Rob JW/0000-0002-6649-7190; Deen, P.M.T./0000-0002-7868-4655; van der Meer, Jos W.M./0000-0001-5120-3690; Martens, Joost/0000-0003-2008-6537; Wijmenga, Cisca/0000-0002-5635-1614; Deen, Peter MT/0000-0002-7868-4655; Joosten, Leo AB/0000-0001-6166-9830; Stunnenberg, Hendrik G./0000-0002-0066-1576; Logie, Colin/0000-0002-8534-6582; Logie, Colin/0000-0002-8534-6582; Cheng, Shih-Chin/0000-0003-1251-8774; Kumar, Vinod/0000-0002-2775-6049; van de Veerdonk, Frank L/0000-0002-1121-4894; van der Veer, Brian/0000-0001-8837-8283; Li, Yang/0000-0003-4022-7341; Willems, P.H.G.M./0000-0002-0915-1599; Cramer, Robert/0000-0001-5503-5006; Shepardson, Kelly/0000-0003-3631-2594; O'Neill, Luke/0000-0002-4333-2748; Saeed, Sadia/0000-0002-6587-6543; Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911	Netherlands Organization of Scientific Research [863.13.011]; ERC [310372]; European Research Council under European Union [2012-322698]; National Institute of General Medical Sciences [5P30GM103415-03, 1P30GM106394-01]; National Institute of Allergy and Infectious Diseases [R01AI81838]; Helmsley Trust; JDRF;  [DK43351];  [DK097485]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK097485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394, P30GM103415] Funding Source: NIH RePORTER	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); European Research Council under European Union(European Research Council (ERC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Helmsley Trust; JDRF(Juvenile Diabetes Research Foundation); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.-C. C., J.Q., and M.G.N. were supported by a Vici grant of the Netherlands Organization of Scientific Research and ERC Consolidator grant 310372 (both to M.G.N). C. W. is supported by funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement 2012-322698). Y.L. is supported by Veni grant 863.13.011 of the Netherlands Organization for Scientific Research. R. A. C. and K. M. S. were supported by National Institute of General Medical Sciences grant 5P30GM103415-03 (William Green, PI) and 1P30GM106394-01 (Bruce Stanton, PI), and National Institute of Allergy and Infectious Diseases grant R01AI81838 (R. A. C., PI). R.A.C./K.M.S. thank B. Berwin for the S. aureus. R.J.X funded by DK43351, DK097485, Helmsley Trust, and JDRF. The detailed data have been deposited in the GEO database with accession number GSE57206.	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; [Anonymous], 2011, GUIDE FOR THE CARE A, V8; Bekkering S, 2013, CURR OPIN LIPIDOL, V24, P487, DOI 10.1097/MOL.0000000000000023; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Bosi E, 2009, DIABETES OBES METAB, V11, P3, DOI 10.1111/j.1463-1326.2008.01031.x; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hamilton JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045853; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jang SY, 2012, J BIOL CHEM, V287, P19304, DOI 10.1074/jbc.M112.363747; Jaskiewicz M, 2011, EMBO REP, V12, P50, DOI 10.1038/embor.2010.186; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Marakalala MJ, 2013, MICROBES INFECT, V15, P511, DOI 10.1016/j.micinf.2013.03.002; Masuda Y, 2012, J LEUKOCYTE BIOL, V91, P547, DOI 10.1189/jlb.0711386; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; OREN R, 1963, J CELL BIOL, V17, P487, DOI 10.1083/jcb.17.3.487; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; Warburg O, 1923, BIOCHEM Z, V142, P317; Yanez A, 2013, EUR J IMMUNOL, V43, P2114, DOI 10.1002/eji.201343403; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zinkernagel AS, 2008, J INFECT DIS, V197, P214, DOI 10.1086/524843	46	1074	1114	27	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1579	+	1250684	10.1126/science.1250684	http://dx.doi.org/10.1126/science.1250684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258083	Green Accepted			2022-12-28	WOS:000342164500034
J	Schwartz, S; Bernstein, DA; Mumbach, MR; Jovanovic, M; Herbst, RH; Leon-Ricardo, BX; Engreitz, JM; Guttman, M; Satija, R; Lander, ES; Fink, G; Regev, A				Schwartz, Schraga; Bernstein, Douglas A.; Mumbach, Maxwell R.; Jovanovic, Marko; Herbst, Rebecca H.; Leon-Ricardo, Brian X.; Engreitz, Jesse M.; Guttman, Mitchell; Satija, Rahul; Lander, Eric S.; Fink, Gerald; Regev, Aviv			Transcriptome-wide Mapping Reveals Widespread Dynamic-Regulated Pseudouridylation of ncRNA and mRNA	CELL			English	Article							ACID SECONDARY STRUCTURE; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; DYSKERATOSIS-CONGENITA; TELOMERASE RNA; PEPTIDYLTRANSFERASE CENTER; CHEMICAL-MODIFICATION; CARBODIIMIDE REAGENT; U2 SNRNA; YEAST	Pseudouridine is the most abundant RNA modification, yet except for a few well-studied cases, little is known about the modified positions and their function(s). Here, we develop Psi-seq for transcriptome-wide quantitative mapping of pseudouridine. We validate Psi-seq with spike-ins and de novo identification of previously reported positions and discover hundreds of unique sites in human and yeast mRNAs and snoRNAs. Perturbing pseudouridine synthases (PUS) uncovers which pseudouridine synthase modifies each site and their target sequence features. mRNA pseudouridinylation depends on both site-specific and snoRNA-guided pseudouridine synthases. Upon heat shock in yeast, Pus7p-mediated pseudouridylation is induced at >200 sites, and PUS7 deletion decreases the levels of otherwise pseudouridylated mRNA, suggesting a role in enhancing transcript stability. rRNA pseudouridine stoichiometries are conserved but reduced in cells from dyskeratosis congenita patients, where the PUS DKC1 is mutated. Our work identifies an enhanced, transcriptome-wide scope for pseudouridine and methods to dissect its underlying mechanisms and function.	[Schwartz, Schraga; Mumbach, Maxwell R.; Jovanovic, Marko; Herbst, Rebecca H.; Leon-Ricardo, Brian X.; Engreitz, Jesse M.; Satija, Rahul; Lander, Eric S.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bernstein, Douglas A.; Fink, Gerald] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Herbst, Rebecca H.; Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Leon-Ricardo, Brian X.] Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA; [Engreitz, Jesse M.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Lander, Eric S.; Fink, Gerald; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Massachusetts Institute of Technology (MIT); California Institute of Technology; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Fink, G (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; aregev@broad.mit.edu	Satija, Rahul/AAF-9564-2019	Schwartz, Schraga/0000-0002-3671-9709; Mumbach, Maxwell/0000-0002-5570-6663	NHGRI [P50HG006193]; Pioneer Award; HHMI; NHGRI Broad Institute Funds [U54 HG003067]; NIH [GM035010, 1F32HD075541-01]; HFSP fellowship; Swiss National Science Foundation; Marie Curie IOF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193, U54HG003067, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035010, R01GM035010] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Pioneer Award; HHMI(Howard Hughes Medical Institute); NHGRI Broad Institute Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie IOF(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by NHGRI P50HG006193, Pioneer Award, HHMI (A.R.), NHGRI U54 HG003067 (E.S.L.) Broad Institute Funds, NIH GM035010 (G.F.), HFSP fellowship (S.S.), NIH 1F32HD075541-01 (R.S.), and fellowships of the Swiss National Science Foundation and the Marie Curie IOF (M.J.).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Ansmant I, 2000, NUCLEIC ACIDS RES, V28, P1941, DOI 10.1093/nar/28.9.1941; Ashbridge B, 2009, BIOCHEMISTRY-US, V48, P10858, DOI 10.1021/bi901373e; BAKIN A, 1995, NUCLEIC ACIDS RES, V23, P3290, DOI 10.1093/nar/23.16.3290; BAKIN A, 1994, BIOCHEMISTRY-US, V33, P13475, DOI 10.1021/bi00249a036; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Bakin AV, 1998, METH MOL B, V77, P297; Becker HF, 1997, J MOL BIOL, V274, P505, DOI 10.1006/jmbi.1997.1417; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; Bellodi C, 2013, CELL REP, V3, P1493, DOI 10.1016/j.celrep.2013.04.030; Charette M, 2000, IUBMB LIFE, V49, P341; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Courtes FC, 2014, J BIOTECHNOL, V174, P16, DOI 10.1016/j.jbiotec.2014.01.024; Decatur WA, 2008, MOL CELL BIOL, V28, P3089, DOI 10.1128/MCB.01574-07; Durant P C, 1997, Nucleic Acids Symp Ser, P56; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Esakova O, 2013, NUCLEIC ACIDS RES, V41, P7084, DOI 10.1093/nar/gkt432; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Fujiwara T, 2013, PEDIATR INT, V55, P675, DOI 10.1111/ped.12217; Grosshans H, 2001, J BIOL CHEM, V276, P46333, DOI 10.1074/jbc.M107141200; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gu BW, 2009, FEBS LETT, V583, P3086, DOI 10.1016/j.febslet.2009.08.038; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HO NWY, 1971, BIOCHEMISTRY-US, V10, P3651; Hoareau-Aveilla C, 2008, M S-MED SCI, V24, P390, DOI 10.1051/medsci/2008244390; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; JIANG WD, 1993, MOL CELL BIOL, V13, P4884, DOI 10.1128/MCB.13.8.4884; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Kierzek E, 2014, NUCLEIC ACIDS RES, V42, P3492, DOI 10.1093/nar/gkt1330; Kim NK, 2010, NUCLEIC ACIDS RES, V38, P6746, DOI 10.1093/nar/gkq525; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; LANE BG, 1992, FEBS LETT, V302, P1, DOI 10.1016/0014-5793(92)80269-M; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Massenet S, 1999, MOL CELL BIOL, V19, P2142; METZ DH, 1969, BIOCHEMISTRY-US, V8, P2329, DOI 10.1021/bi00834a013; METZ DH, 1969, BIOCHEMISTRY-US, V8, P2312, DOI 10.1021/bi00834a012; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Reilly TH, 1996, MOL BIOL REP, V22, P87, DOI 10.1007/BF00988711; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Toh SM, 2008, J MOL BIOL, V380, P593, DOI 10.1016/j.jmb.2008.05.027; Trahan C, 2009, RNA, V15, P235, DOI 10.1261/rna.1354009; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Yu AT, 2011, PROTEIN CELL, V2, P712, DOI 10.1007/s13238-011-1087-1; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zhang Q, 2011, P NATL ACAD SCI USA, V108, P20325, DOI 10.1073/pnas.1100279108; Zucchini C, 2003, INT J MOL MED, V11, P697	56	551	577	10	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					148	162		10.1016/j.cell.2014.08.028	http://dx.doi.org/10.1016/j.cell.2014.08.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25219674	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000343095000016
J	Wellbery, C				Wellbery, Caroline			Code Green	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA	Georgetown University	Wellbery, C (corresponding author), Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA.	wellberc@georgetown.edu						El Dib RP, 2007, J EVAL CLIN PRACT, V13, P689, DOI 10.1111/j.1365-2753.2007.00886.x; Fraser S., 2013, BMJ GROUP BLOGS 0603; Gallup, HON ETH PROF SURV RE; IPCC, 2018, SUMMARY POLICYMAKERS; McMichael AJ, 2013, NEW ENGL J MED, V368, P1335, DOI 10.1056/NEJMra1109341; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783	6	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1201	1202		10.1001/jama.2014.5242	http://dx.doi.org/10.1001/jama.2014.5242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25247513				2022-12-28	WOS:000341990600017
J	Lazaridis, I; Patterson, N; Mittnik, A; Renaud, G; Mallick, S; Kirsanow, K; Sudmant, PH; Schraiber, JG; Castellano, S; Lipson, M; Berger, B; Economou, C; Bollongino, R; Fu, QM; Bos, KI; Nordenfelt, S; Li, H; de Filippo, C; Prufer, K; Sawyer, S; Posth, C; Haak, W; Hallgren, F; Fornander, E; Rohland, N; Delsate, D; Francken, M; Guinet, JM; Wahl, J; Ayodo, G; Babiker, HA; Bailliet, G; Balanovska, E; Balanovsky, O; Barrantes, R; Bedoya, G; Ben-Ami, H; Bene, J; Berrada, F; Bravi, CM; Brisighelli, F; Busby, GBJ; Cali, F; Churnosov, M; Cole, DEC; Corach, D; Damba, L; van Driem, G; Dryomov, S; Dugoujon, JM; Fedorova, SA; Romero, IG; Gubina, M; Hammer, M; Henn, BM; Hervig, T; Hodoglugil, U; Jha, AR; Karachanak-Yankova, S; Khusainova, R; Khusnutdinova, E; Kittles, R; Kivisild, T; Klitz, W; Kucinskas, V; Kushniarevich, A; Laredj, L; Litvinov, S; Loukidis, T; Mahley, RW; Melegh, B; Metspalu, E; Molina, J; Mountain, J; Nakkalajarvi, K; Nesheva, D; Nyambo, T; Osipova, L; Parik, J; Platonov, F; Posukh, O; Romano, V; Rothhammer, F; Rudan, I; Ruizbakiev, R; Sahakyan, H; Sajantila, A; Salas, A; Starikovskaya, EB; Tarekegn, A; Toncheva, D; Turdikulova, S; Uktveryte, I; Utevska, O; Vasquez, R; Villena, M; Voevoda, M; Winkler, CA; Yepiskoposyan, L; Zalloua, P; Zemunik, T; Cooper, A; Capelli, C; Thomas, MG; Ruiz-Linares, A; Tishkoff, SA; Singh, L; Thangaraj, K; Villems, R; Comas, D; Sukernik, R; Metspalu, M; Meyer, M; Eichler, EE; Burger, J; Slatkin, M; Paabo, S; Kelso, J; Reich, D; Krause, J				Lazaridis, Iosif; Patterson, Nick; Mittnik, Alissa; Renaud, Gabriel; Mallick, Swapan; Kirsanow, Karola; Sudmant, Peter H.; Schraiber, Joshua G.; Castellano, Sergi; Lipson, Mark; Berger, Bonnie; Economou, Christos; Bollongino, Ruth; Fu, Qiaomei; Bos, Kirsten I.; Nordenfelt, Susanne; Li, Heng; de Filippo, Cesare; Pruefer, Kay; Sawyer, Susanna; Posth, Cosimo; Haak, Wolfgang; Hallgren, Fredrik; Fornander, Elin; Rohland, Nadin; Delsate, Dominique; Francken, Michael; Guinet, Jean-Michel; Wahl, Joachim; Ayodo, George; Babiker, Hamza A.; Bailliet, Graciela; Balanovska, Elena; Balanovsky, Oleg; Barrantes, Ramiro; Bedoya, Gabriel; Ben-Ami, Haim; Bene, Judit; Berrada, Fouad; Bravi, Claudio M.; Brisighelli, Francesca; Busby, George B. J.; Cali, Francesco; Churnosov, Mikhail; Cole, David E. C.; Corach, Daniel; Damba, Larissa; van Driem, George; Dryomov, Stanislav; Dugoujon, Jean-Michel; Fedorova, Sardana A.; Romero, Irene Gallego; Gubina, Marina; Hammer, Michael; Henn, Brenna M.; Hervig, Tor; Hodoglugil, Ugur; Jha, Aashish R.; Karachanak-Yankova, Sena; Khusainova, Rita; Khusnutdinova, Elza; Kittles, Rick; Kivisild, Toomas; Klitz, William; Kucinskas, Vaidutis; Kushniarevich, Alena; Laredj, Leila; Litvinov, Sergey; Loukidis, Theologos; Mahley, Robert W.; Melegh, Bela; Metspalu, Ene; Molina, Julio; Mountain, Joanna; Nakkalajarvi, Klemetti; Nesheva, Desislava; Nyambo, Thomas; Osipova, Ludmila; Parik, Jueri; Platonov, Fedor; Posukh, Olga; Romano, Valentino; Rothhammer, Francisco; Rudan, Igor; Ruizbakiev, Ruslan; Sahakyan, Hovhannes; Sajantila, Antti; Salas, Antonio; Starikovskaya, Elena B.; Tarekegn, Ayele; Toncheva, Draga; Turdikulova, Shahlo; Uktveryte, Ingrida; Utevska, Olga; Vasquez, Rene; Villena, Mercedes; Voevoda, Mikhail; Winkler, Cheryl A.; Yepiskoposyan, Levon; Zalloua, Pierre; Zemunik, Tatijana; Cooper, Alan; Capelli, Cristian; Thomas, Mark G.; Ruiz-Linares, Andres; Tishkoff, Sarah A.; Singh, Lalji; Thangaraj, Kumarasamy; Villems, Richard; Comas, David; Sukernik, Rem; Metspalu, Mait; Meyer, Matthias; Eichler, Evan E.; Burger, Joachim; Slatkin, Montgomery; Paeaebo, Svante; Kelso, Janet; Reich, David; Krause, Johannes			Ancient human genomes suggest three ancestral populations for present-day Europeans	NATURE			English	Article							HUNTER-GATHERERS; DNA EXTRACTION; SEQUENCE; ADMIXTURE; NEANDERTHAL; AFRICA; STRATIFICATION; ALGORITHM; EVOLUTION; INFERENCE	We sequenced the genomes of a similar to 7,000-year-old farmer from Germany and eight similar to 8,000-year-old hunter-gatherers from Luxembourg and Sweden. We analysed these and other ancient genomes(1-4) with 2,345 contemporary humans to show that most present-day Europeans derive from at least three highly differentiated populations: west European hunter-gatherers, who contributed ancestry to all Europeans but not to Near Easterners; ancient north Eurasians related to Upper Palaeolithic Siberians(3), who contributed to both Europeans and Near Easterners; and early European farmers, who were mainly of Near Eastern origin but also harboured west European hunter-gatherer related ancestry. We model these populations' deep relationships and show that early European farmers had similar to 44% ancestry from a 'basal Eurasian' population that split before the diversification of other non-African lineages.	[Lazaridis, Iosif; Mallick, Swapan; Fu, Qiaomei; Nordenfelt, Susanne; Li, Heng; Rohland, Nadin; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lazaridis, Iosif; Patterson, Nick; Mallick, Swapan; Berger, Bonnie; Nordenfelt, Susanne; Li, Heng; Rohland, Nadin; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Mittnik, Alissa; Bos, Kirsten I.; Posth, Cosimo; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, D-72074 Tubingen, Germany; [Renaud, Gabriel; Castellano, Sergi; Fu, Qiaomei; de Filippo, Cesare; Pruefer, Kay; Sawyer, Susanna; Meyer, Matthias; Paeaebo, Svante; Kelso, Janet] Max Planck Inst Evolutionare Anthropol, D-04103 Leipzig, Germany; [Kirsanow, Karola; Bollongino, Ruth; Burger, Joachim] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55128 Mainz, Germany; [Sudmant, Peter H.; Schraiber, Joshua G.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schraiber, Joshua G.; Klitz, William; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Lipson, Mark; Berger, Bonnie] MIT, Dept Math & Comp Sci, Cambridge, MA 02139 USA; [Lipson, Mark; Berger, Bonnie] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Economou, Christos] Stockholm Univ, Archaeol Res Lab, S-11418 Stockholm, Sweden; [Fu, Qiaomei] Chinese Acad Sci, IVPP, Key Lab Vertebrate Evolut & Human Origins, Beijing 100049, Peoples R China; [Haak, Wolfgang; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA & Environm Inst, Adelaide, SA 5005, Australia; [Hallgren, Fredrik; Fornander, Elin] Cultural Heritage Fdn, S-72212 Vasteras, Sweden; [Delsate, Dominique; Guinet, Jean-Michel] Natl Museum Nat Hist, L-2160 Luxembourg, Luxembourg; [Delsate, Dominique] Natl Museum Nat Hist, Natl Ctr Archaeol Res, L-2160 Luxembourg, Luxembourg; [Francken, Michael] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Dept Paleoanthropol, D-72070 Tubingen, Germany; [Wahl, Joachim] State Off Cultural Heritage Management Baden Wurt, D-78467 Constance, Germany; [Ayodo, George] Ctr Global Hlth & Child Dev, Kisumu 40100, Kenya; [Babiker, Hamza A.] Univ Edinburgh, Sch Biol Sci, Inst Evolut Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Babiker, Hamza A.] Univ Edinburgh, Sch Biol Sci, Inst Immunol Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Babiker, Hamza A.] Univ Edinburgh, Sch Biol Sci, Inst Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Babiker, Hamza A.] Sultan Qaboos Univ, Fac Med, Dept Biochem, Muscat 123, Oman; [Bailliet, Graciela; Bravi, Claudio M.] Consejo Nacl Invest Cient & Tecn, CCT, Inst Multidisciplinario Biol Celular IMBICE, Lab Genet Mol Poblac, La Plata, Buenos Aires, Argentina; [Bailliet, Graciela; Bravi, Claudio M.] CICPBA, La Plata, Buenos Aires, Argentina; [Balanovska, Elena; Balanovsky, Oleg] Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; [Balanovsky, Oleg] NI Vavilov Gen Genet Res Inst, Moscow 119991, Russia; [Barrantes, Ramiro] Univ Costa Rica, Escuela Biol, San Jose 2060, Costa Rica; [Bedoya, Gabriel] Univ Antioquia, Res Grp GENMOL, Inst Biol, Medellin, Colombia; [Ben-Ami, Haim] Rambam Hlth Care Campus, IL-31096 Haifa, Israel; [Bene, Judit; Melegh, Bela] Univ Pecs, Dept Med Genet, H-7624 Pecs, Hungary; [Bene, Judit; Melegh, Bela] Univ Pecs, Szentagothai Res Ctr, H-7624 Pecs, Hungary; [Berrada, Fouad] Al Akhawayn Univ Ifrane AUI, Sch Sci & Engn, Ifrane 53000, Morocco; [Brisighelli, Francesca] Univ Cattolica Sacro Cuore, Inst Legal Med, Forens Genet Lab, I-00168 Rome, Italy; [Busby, George B. J.; Capelli, Cristian] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Busby, George B. J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Cali, Francesco] IRCCS Assoc Oasi Maria SS, Genet Mol Lab, I-94018 Troina, Italy; [Churnosov, Mikhail] Belgorod State Univ, Belgorod 308015, Russia; [Cole, David E. C.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; [Corach, Daniel] Univ Buenos Aires, Sch Pharm & Biochem, Serv Huellas Digitales Genet, RA-1113 Caba, Argentina; [Damba, Larissa; Gubina, Marina; Osipova, Ludmila; Posukh, Olga; Voevoda, Mikhail] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [van Driem, George] Univ Bern, Inst Linguist, CH-3012 Bern, Switzerland; [Dryomov, Stanislav; Starikovskaya, Elena B.; Sukernik, Rem] Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Lab Human Mol Genet, Novosibirsk 630090, Russia; [Dugoujon, Jean-Michel] Univ Toulouse 3, CNRS UMR 5288, F-31000 Toulouse, France; [Fedorova, Sardana A.] North Eastern Fed Univ, Yakutsk 677013, Russia; [Fedorova, Sardana A.] Yakut Res Ctr Complex Med Problems, Yakutsk 677013, Russia; [Romero, Irene Gallego; Jha, Aashish R.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Hammer, Michael] Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA; [Henn, Brenna M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Hervig, Tor] Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway; [Hodoglugil, Ugur] Illumina, NextBio, Santa Clara, CA 95050 USA; [Karachanak-Yankova, Sena; Nesheva, Desislava; Toncheva, Draga] Med Univ Sofia, Natl Human Genome Ctr, Dept Med Genet, Sofia 1431, Bulgaria; [Khusainova, Rita; Khusnutdinova, Elza; Litvinov, Sergey] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Khusainova, Rita; Khusnutdinova, Elza; Litvinov, Sergey] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Russia; [Kittles, Rick] Univ Arizona, Coll Med, Tucson, AZ 85724 USA; [Kivisild, Toomas] Univ Cambridge, Div Biol Anthropol, Cambridge CB2 1QH, England; [Kucinskas, Vaidutis; Uktveryte, Ingrida] Vilnius State Univ, Dept Human & Med Genet, LT-08661 Vilnius, Lithuania; [Kushniarevich, Alena; Litvinov, Sergey; Sahakyan, Hovhannes; Villems, Richard; Metspalu, Mait] Estonian Bioctr, Evolutionary Biol Grp, EE-51010 Tartu, Estonia; [Laredj, Leila] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Loukidis, Theologos; Thomas, Mark G.; Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Mahley, Robert W.] Gladstone Inst, San Francisco, CA 94158 USA; [Metspalu, Ene; Parik, Jueri; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Molina, Julio] Ctr Invest Biomed Guatemala, Guatemala City, Guatemala; [Mountain, Joanna] 23andMe, Res Dept, Mountain View, CA 94043 USA; [Nakkalajarvi, Klemetti] Univ Oulu, Cultural Anthropol Program, Oulu 90014, Finland; [Nyambo, Thomas] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam 65001, Tanzania; [Platonov, Fedor] North Eastern Fed Univ, Res Inst Hlth, Yakutsk 677000, Russia; [Romano, Valentino] Univ Palermo, Dipartimento Fis & Chim, I-90128 Palermo, Italy; [Rothhammer, Francisco] Univ Tarapaca, Inst Alta Invest, Arica 1000000, Chile; [Rothhammer, Francisco] Univ Chile, Fac Med, Programa Genet Humana, ICBM, Santiago 8320000, Chile; [Rothhammer, Francisco] Ctr Invest Hombre Desierto, Arica 1000000, Chile; [Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Ruizbakiev, Ruslan] Uzbek Acad Sci, Inst Immunol, Tashkent 70000, Uzbekistan; [Sahakyan, Hovhannes; Yepiskoposyan, Levon] Natl Acad Sci Armenia, Inst Mol Biol, Lab Ethnogenom, Yerevan 0014, Armenia; [Sajantila, Antti] Univ Helsinki, Dept Forens Med, Hjelt Inst, Helsinki 00014, Finland; [Sajantila, Antti] Univ North Texas Hlth Sci Ctr, Dept Mol & Med Genet, Inst Appl Genet, Ft Worth, TX 76107 USA; [Salas, Antonio] Univ Santiago de Compostela, Fac Med, GMX, Dept Anat Patol & Ciencias Forenses,Unidade Xenet, Galcia 15872, Spain; [Salas, Antonio] Univ Santiago de Compostela, Fac Med, GMX, Inst Ciencias Forenses, Galcia 15872, Spain; [Tarekegn, Ayele] Henry Stewart Grp, London WC1A 2HN, England; [Turdikulova, Shahlo] Acad Sci Uzbek, Inst Bioorgan Chem, Tashkent 100125, Uzbekistan; [Utevska, Olga] Kharkov Natl Univ, Dept Genet & Cytol, UA-61077 Kharkov, Ukraine; [Vasquez, Rene; Villena, Mercedes] Univ Mayor San Andres, Inst Boliviano Biol Altura, La Paz 5912, Bolivia; [Vasquez, Rene; Villena, Mercedes] Univ Autonoma Tomas Frias, Potosi, Bolivia; [Voevoda, Mikhail] Russian Acad Med Sci, Siberian Branch, Inst Internal Med, Novosibirsk 630089, Russia; [Voevoda, Mikhail] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Winkler, Cheryl A.] NCI, Basic Res Lab, NIH, Frederick Natl Lab,Leidos Biomed, Frederick, MD 21702 USA; [Zalloua, Pierre] Lebanese Amer Univ, Sch Med, Beirut 135053, Lebanon; [Zalloua, Pierre] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Zemunik, Tatijana] Univ Split, Sch Med, Dept Med Biol, Split 21000, Croatia; [Tishkoff, Sarah A.] Univ Penn, Dept Biol & Genet, Philadelphia, PA 19104 USA; [Singh, Lalji; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Villems, Richard] Estonian Acad Sci, EE-10130 Tallinn, Estonia; [Comas, David] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Inst Biol Evolut CSIC UPF, Barcelona 08003, Spain; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Krause, Johannes] Univ Tubingen, Senckenberg Ctr Human Evolut & Palaeoenvironm, D-72070 Tubingen, Germany; [Krause, Johannes] Max Planck Inst Geschichte & Nat Wissensch, D-07745 Jena, Germany	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Eberhard Karls University of Tubingen; Max Planck Society; Johannes Gutenberg University of Mainz; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Stockholm University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Adelaide; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Edinburgh; University of Edinburgh; University of Edinburgh; Sultan Qaboos University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Universidad Costa Rica; Universidad de Antioquia; Rambam Health Care Campus; University of Pecs; University of Pecs; Al Akhawayn University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; IRCCS Oasi Maria SS; Belgorod State University; University of Toronto; University of Buenos Aires; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Bern; Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; North-Eastern Federal University in Yakutsk; Yakut Science Centre of Complex Medical Problems; University of Chicago; University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Bergen; Illumina; Medical University Sofia; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; University of Arizona; University of Cambridge; Vilnius University; Estonian Biocentre; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; University College London; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Tartu; University of Oulu; Muhimbili University of Health & Allied Sciences; North-Eastern Federal University in Yakutsk; University of Palermo; Universidad de Tarapaca; Universidad de Chile; University of Edinburgh; Academy of Sciences of Uzbekistan; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; University of Helsinki; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Academy of Sciences of Uzbekistan; Sadykov Institute of Bioorganic Chemistry; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; Universidad Mayor de San Andres; Russian Academy of Medical Sciences; Russian Academy of Sciences; Novosibirsk State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Lebanese American University; Harvard University; Harvard T.H. Chan School of Public Health; University of Split; University of Pennsylvania; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Estonian Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; johannes.krause@uni-tuebingen.de	Metspalu, Mait/G-8671-2015; Krause, Johannes/E-6640-2015; Osipova, Ludmila P/O-6480-2014; Zemunik, Tatijana/D-8584-2017; Haak, Wolfgang/Z-4947-2019; Voevoda, Mikhail/N-6713-2015; Calì, Francesco/D-9178-2017; Churnosov, Mikhail/W-1313-2017; KUČINSKAS, Vaidutis/A-4798-2013; Thomas, Mark G/A-2219-2012; Karachanak-Yankova, Sena/AAL-2721-2021; Starikovskaya, Elena/N-5636-2015; Sajantila, Antti/AAY-9084-2021; Krause, Johannes/AFP-2642-2022; Fedorova, Sardana/K-5445-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Damba, Larissa/AAR-6776-2021; Sukernik, Rem I/N-6990-2015; Haak, Wolfgang/C-2362-2014; Gubina, Marina/AAD-9163-2019; Comas, David/D-5382-2014; Salas, Antonio/E-3977-2012; Posth, Cosimo/AAL-6219-2021; Kivisild, Toomas/P-5889-2017; Rudan, Igor/I-1467-2012; Ruiz-Linares, Andres/AAR-1104-2021; Li, Heng/D-9344-2011; Khusainova, Rita/E-6061-2014; Dryomov, Stanislav/N-5476-2015; Platonov, Fedor/K-8010-2017; Litvinov, Sergey/L-1738-2013; Salas, Antonio/U-2029-2019; Kelso, Janet/N-1812-2019; Posukh, Olga L/Q-6065-2016; Turdikulova, Shahlo/R-7669-2016; Scavuzzo, Cataldo/D-5048-2017; Castellano, Sergi/A-7437-2016; Busby, George/K-9024-2014	Metspalu, Mait/0000-0003-3099-9161; Krause, Johannes/0000-0001-5475-4690; Osipova, Ludmila P/0000-0001-7602-1156; Zemunik, Tatijana/0000-0001-8120-2891; Haak, Wolfgang/0000-0003-2475-2007; Voevoda, Mikhail/0000-0001-9425-413X; Calì, Francesco/0000-0001-8667-8223; Churnosov, Mikhail/0000-0003-1254-6134; Thomas, Mark G/0000-0002-2452-981X; Karachanak-Yankova, Sena/0000-0001-6441-629X; Krause, Johannes/0000-0001-9144-3920; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Haak, Wolfgang/0000-0003-2475-2007; Comas, David/0000-0002-5075-0956; Salas, Antonio/0000-0002-2336-702X; Kivisild, Toomas/0000-0002-6297-7808; Rudan, Igor/0000-0001-6993-6884; Ruiz-Linares, Andres/0000-0001-8372-1011; Li, Heng/0000-0003-4874-2874; Khusainova, Rita/0000-0002-8643-850X; Salas, Antonio/0000-0002-2336-702X; Kelso, Janet/0000-0002-3618-322X; Posukh, Olga L/0000-0003-1352-3591; Turdikulova, Shahlo/0000-0003-0764-2332; Fedorova, Sardana/0000-0002-6952-3868; Sawyer, Susanna/0000-0002-8477-6089; Sudmant, Peter/0000-0002-9573-8248; zalloua, pierre/0000-0002-8494-5081; Scavuzzo, Cataldo/0000-0002-3905-4191; Romano, Valentino/0000-0003-3238-5702; Cooper, Alan/0000-0002-7738-7851; Capelli, Cristian/0000-0001-9348-9084; Sahakyan, Hovhannes/0000-0003-1596-2838; Utevska, Olga/0000-0002-5787-0467; Nakkalajarvi, Klemetti/0000-0002-8128-4206; Sajantila, Antti/0000-0003-4117-5248; Gallego Romero, Irene/0000-0003-1613-8998; Castellano, Sergi/0000-0002-5819-4210; Nesheva, Desislava/0000-0002-8574-8477; Jha, Aashish/0000-0003-3227-1086; Renaud, Gabriel/0000-0002-0630-027X; Thangaraj, Kumarasamy/0000-0002-0075-0106; Busby, George/0000-0003-4148-6222; van Driem, George/0000-0002-7185-0657; Bos, Kirsten/0000-0003-2937-3006; Brisighelli, Francesca/0000-0001-5469-4413; Toncheva, Draga/0000-0002-7451-6363	DFG [KR 4015/1-1]; Carl-Zeiss Foundation; Baden Wurttemberg Foundation; Max Planck Society; NSERC; NSF [OCI-1053575]; RFBR [13-06-00670, 13-04-01711, 13-04-90420]; Molecular and Cell Biology Program of the Presidium, Russian Academy of Sciences; OTKA [73430, 103983]; Finnish Professorpool (Paulo Foundation) Grant; LITGEN project - European Social Fund under Global Grant Measure [VP1-3.1-SMM-07-K-01-013]; Ukrainian SFFS grant [F53.4/071]; NIH [8DP1ES022577-04, GM40282, HG004120, HG002385, GM100233]; NSF HOMINID [BCS-0827436, BCS-1032255]; Indian CSIR Network Project [BSC0121]; Indian CSIR Bhatnagar Fellowship; European Union Regional Development Fund through Centre of Excellence in Genomics; University of Tartu; Estonian Basic Research grant [SF0270177As08]; Estonian Science Foundation [8973]; National Cancer Institute, National Institutes of Health [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research;  [SAF2011-26983];  [EM2012/045]; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399, P01HG004120, R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233, R01GM040282] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Carl-Zeiss Foundation; Baden Wurttemberg Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); RFBR(Russian Foundation for Basic Research (RFBR)); Molecular and Cell Biology Program of the Presidium, Russian Academy of Sciences; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Finnish Professorpool (Paulo Foundation) Grant; LITGEN project - European Social Fund under Global Grant Measure; Ukrainian SFFS grant(State Fund for Fundamental Research (SFFR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF HOMINID; Indian CSIR Network Project; Indian CSIR Bhatnagar Fellowship; European Union Regional Development Fund through Centre of Excellence in Genomics; University of Tartu; Estonian Basic Research grant; Estonian Science Foundation; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the 1,615 volunteers from 147 diverse populations who donated DNA samples and whose genetic data are newly reported in this study. We are grateful to C. Beall, N. Bradman, A. Gebremedhin, D. Labuda, M. Nelis and A. Di Rienzo for sharing DNA samples; to D. Weigel, C. Lanz, V. Schunemann, P. Bauer and O. Riess for support and access to DNA sequencing facilities; to P. Johnson for advice on contamination estimation; to G. Hellenthal for help with the ChromoPainter software; and to P. Skoglund for sharing graphics software. We thank K. Nordtvedt for alerting us to newly discovered Y-chromosome SNPs. We downloaded the POPRES data from dbGaP at (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000145.v4.p2) through dbGaP accession number phs000145.v1.p2. We thank all the volunteers who donated DNA. We thank the staff of the Unita Operativa Complessa di Medicina Trasfusionale, Azienda Ospedaliera Umberto I, Siracusa, Italy for assistance in sample collection; and The National Laboratory for the Genetics of Israeli Populations for facilitating access to DNA. We thank colleagues at the Applied Genomics at the Children's Hospital of Philadelphia, especially H. Hakonarson, C. Kim, K. Thomas, and C. Hou, for genotyping samples on the Human Origins array. J.Kr., A. M. and C. P. are grateful for support from DFG grant number KR 4015/1-1, the Carl-Zeiss Foundation and the Baden Wurttemberg Foundation. S. P., G. R., Q. F., C. F., K. P., S. C. and J.Ke. acknowledge support from the Presidential Innovation Fund of the Max Planck Society. G. R. was supported by an NSERC fellowship. J.G.S. acknowledges use of the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by NSF grant number OCI-1053575. E. B. and O. B. were supported by RFBR grants 13-06-00670, 13-04-01711, 13-04-90420 and by the Molecular and Cell Biology Program of the Presidium, Russian Academy of Sciences. B. M. was supported by grants OTKA 73430 and 103983. A.Saj. was supported by a Finnish Professorpool (Paulo Foundation) Grant. The Lithuanian sampling was supported by the LITGEN project (VP1-3.1-SMM-07-K-01-013), funded by the European Social Fund under the Global Grant Measure. A. S. was supported by Spanish grants SAF2011-26983 and EM2012/045. O. U. was supported by Ukrainian SFFS grant F53.4/071. S. A. T. was supported by NIH Pioneer Award 8DP1ES022577-04 and NSF HOMINID award BCS-0827436. K. T. was supported by an Indian CSIR Network Project (GENESIS: BSC0121). L. S. was supported by an Indian CSIR Bhatnagar Fellowship. R. V., M. M., J.P. and E. M. were supported by the European Union Regional Development Fund through the Centre of Excellence in Genomics to the Estonian Biocentre and University of Tartu and by an Estonian Basic Research grant SF0270177As08. M. M. was additionally supported by Estonian Science Foundation grant number 8973. J.G.S. and M. S. were supported by NIH grant GM40282. P. H. S. and E. E. E. were supported by NIH grants HG004120 and HG002385. D. R. and N.P. were supported by NSF HOMINID award BCS-1032255 and NIH grant GM100233. D. R. and E. E. E. are Howard Hughes Medical Institute investigators. This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.; This Research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	*1000 GEN PROJ CON, 2010, NATURE, V468, P1053; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bar-Yosef O., 1998, CHRONOLOGY MIDDLE PA, P39; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Brace CL, 2006, P NATL ACAD SCI USA, V103, P242, DOI 10.1073/pnas.0509801102; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Delsate D., 2009, B SOC PREHIST LUXEMB, V31, P7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fu Q., NATURE IN PRESS; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lippold S., 2014, HUMAN PATERNAL MATER; Lipson M, 2013, MOL BIOL EVOL, V30, P1788, DOI 10.1093/molbev/mst099; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Stauble H., 2005, HAUSER ABSOLUTE DATI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	68	702	716	15	512	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					409	+		10.1038/nature13673	http://dx.doi.org/10.1038/nature13673			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AP1GD	25230663	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000341814900058
J	Hong, WZ; Kim, DW; Anderson, DJ				Hong, Weizhe; Kim, Dong-Wook; Anderson, David J.			Antagonistic Control of Social versus Repetitive Self-Grooming Behaviors by Separable Amygdala Neuronal Subsets	CELL			English	Article							SYRIAN-HAMSTER BRAIN; MEDIAL AMYGDALA; AGGRESSIVE-BEHAVIOR; MALE-RATS; VENTROMEDIAL HYPOTHALAMUS; AGONISTIC BEHAVIOR; SEXUAL-BEHAVIOR; MATING-BEHAVIOR; PREOPTIC AREA; FOS PROTEIN	Animals display a range of innate social behaviors that play essential roles in survival and reproduction. While the medial amygdala (MeA) has been implicated in prototypic social behaviors such as aggression, the circuit-level mechanisms controlling such behaviors are not well understood. Using cell-type-specific functional manipulations, we find that distinct neuronal populations in the MeA control different social and asocial behaviors. A GABAergic subpopulation promotes aggression and two other social behaviors, while neighboring glutamatergic neurons promote repetitive self-grooming, an asocial behavior. Moreover, this glutamatergic subpopulation inhibits social interactions independently of its effect to promote self-grooming, while the GABAergic subpopulation inhibits self-grooming, even in a nonsocial context. These data suggest that social versus repetitive asocial behaviors are controlled in an antagonistic manner by inhibitory versus excitatory amygdala subpopulations, respectively. These findings provide a framework for understanding circuit-level mechanisms underlying opponency between innate behaviors, with implications for their perturbation in psychiatric disorders.	[Hong, Weizhe; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Kim, Dong-Wook] CALTECH, Program Computat & Neural Syst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Core, Vector/CAF-4832-2022; Hong, Weizhe/E-3164-2010; Hong, Weizhe/AAD-7172-2020	Hong, Weizhe/0000-0003-1523-8575; Hong, Weizhe/0000-0003-1523-8575	NIH [MH085082, MH070053]; Gerald Fischbach; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070053, R01MH085082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald Fischbach; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank X. Wang, X. Da, M. McCardle, R. Robertson, and C. Park for technical assistance, T. Anthony for the ChR2 virus, the Caltech GEMS and animal facility for maintaining mice, M. Zelikowsky, H. Cai, and K. Asahina for commenting on the manuscript, and members of the D.J.A. laboratory for discussions. W.H. is a Helen Hey Whitney Fellow. D.J.A. is a Howard Hughes Medical Institute Investigator and a Paul G. Allen Distinguished Investigator. This work was supported in part by NIH grants MH085082 and MH070053, and a grant from Gerald Fischbach and the Simons Foundation.	Adams DB, 2006, NEUROSCI BIOBEHAV R, V30, P304, DOI 10.1016/j.neubiorev.2005.09.004; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Bergan JF, 2014, ELIFE, V3, DOI 10.7554/eLife.02743; Bian XL, 2008, J NEUROPHYSIOL, V99, P77, DOI 10.1152/jn.00902.2007; Birmingham E, 2011, SOC NEUROSCI-UK, V6, P420, DOI 10.1080/17470919.2011.561547; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BUSCH DE, 1974, PHYSIOL BEHAV, V12, P887, DOI 10.1016/0031-9384(74)90027-4; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Couture SM, 2010, PSYCHOL MED, V40, P569, DOI 10.1017/S003329170999078X; Dhungel S, 2011, NEUROSCIENCE, V199, P225, DOI 10.1016/j.neuroscience.2011.09.051; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; ERSKINE MS, 1993, BRAIN RES BULL, V32, P447, DOI 10.1016/0361-9230(93)90289-N; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; KEMBLE ED, 1984, PHYSIOL BEHAV, V32, P131, DOI 10.1016/0031-9384(84)90084-2; KOLLACK SS, 1992, NEUROSCI LETT, V143, P223, DOI 10.1016/0304-3940(92)90270-H; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; KONDO Y, 1992, PHYSIOL BEHAV, V51, P939, DOI 10.1016/0031-9384(92)90074-C; KONDO Y, 1995, PHYSIOL BEHAV, V57, P69, DOI 10.1016/0031-9384(94)00205-J; KRUK MR, 1991, NEUROSCI BIOBEHAV R, V15, P527, DOI 10.1016/S0149-7634(05)80144-7; Kruk MR, 1998, NEUROSCI BIOBEHAV R, V23, P163, DOI 10.1016/S0149-7634(98)00018-9; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; LEHMAN MN, 1980, SCIENCE, V210, P557, DOI 10.1126/science.7423209; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Niimi K, 2012, BRAIN RES, V1480, P41, DOI 10.1016/j.brainres.2012.08.050; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; ROSVOLD HE, 1954, J COMP PHYSIOL PSYCH, V47, P173, DOI 10.1037/h0058870; Sasson N, 2007, NEUROPSYCHOLOGIA, V45, P2580, DOI 10.1016/j.neuropsychologia.2007.03.009; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; TAKAHASHI LK, 1988, BEHAV NEUROSCI, V102, P268, DOI 10.1037/0735-7044.102.2.268; Tinbergen N, 1951, STUDY INSTINCT; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041; VOCHTELOO JD, 1987, PHYSIOL BEHAV, V41, P99, DOI 10.1016/0031-9384(87)90137-5; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wang Y, 2013, BEHAV BRAIN RES, V245, P42, DOI 10.1016/j.bbr.2013.02.002; Williams JHG, 2008, AUTISM RES, V1, P73, DOI 10.1002/aur.15; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zufall F, 2007, CURR OPIN NEUROBIOL, V17, P483, DOI 10.1016/j.conb.2007.07.012	59	213	215	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1348	1361		10.1016/j.cell.2014.07.049	http://dx.doi.org/10.1016/j.cell.2014.07.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215491	Green Accepted, Bronze			2022-12-28	WOS:000343094200016
J	Pasciuto, E; Bagni, C				Pasciuto, Emanuela; Bagni, Claudia			SnapShot: FMRP mRNA Targets and Diseases	CELL			English	Editorial Material							FRAGILE-X-SYNDROME		[Pasciuto, Emanuela; Bagni, Claudia] VIB Ctr Biol Dis, B-3000 Leuven, Belgium; [Pasciuto, Emanuela; Bagni, Claudia] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Pasciuto, Emanuela; Bagni, Claudia] Katholieke Univ Leuven, LIND, B-3000 Leuven, Belgium; [Bagni, Claudia] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Rome Tor Vergata	Pasciuto, E (corresponding author), VIB Ctr Biol Dis, B-3000 Leuven, Belgium.		Pasciuto, Emanuela/AAP-2982-2020	Bagni, Claudia/0000-0002-4419-210X; Pasciuto, Emanuela/0000-0002-5391-9585				Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Jacquemont S, 2007, LANCET NEUROL, V6, P45, DOI 10.1016/S1474-4422(06)70676-7; Luca R, 2013, EMBO MOL MED, V5, P1523, DOI 10.1002/emmm.201302847	6	42	43	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1446	+		10.1016/j.cell.2014.08.035	http://dx.doi.org/10.1016/j.cell.2014.08.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215498	Bronze			2022-12-28	WOS:000343094200024
J	Weirauch, MT; Yang, A; Albu, M; Cote, AG; Montenegro-Montero, A; Drewe, P; Najafabadi, HS; Lambert, SA; Mann, I; Cook, K; Zheng, H; Goity, A; van Bakel, H; Lozano, JC; Galli, M; Lewsey, MG; Huang, EY; Mukherjee, T; Chen, XT; Reece-Hoyes, JS; Govindarajan, S; Shaulsky, G; Walhout, AJM; Bouget, FY; Ratsch, G; Larrondo, LF; Ecker, JR; Hughes, TR				Weirauch, Matthew T.; Yang, Ally; Albu, Mihai; Cote, Atina G.; Montenegro-Montero, Alejandro; Drewe, Philipp; Najafabadi, Hamed S.; Lambert, Samuel A.; Mann, Ishminder; Cook, Kate; Zheng, Hong; Goity, Alejandra; van Bakel, Harm; Lozano, Jean-Claude; Galli, Mary; Lewsey, Mathew G.; Huang, Eryong; Mukherjee, Tuhin; Chen, Xiaoting; Reece-Hoyes, John S.; Govindarajan, Sridhar; Shaulsky, Gad; Walhout, Albertha J. M.; Bouget, Francois-Yves; Ratsch, Gunnar; Larrondo, Luis F.; Ecker, Joseph R.; Hughes, Timothy R.			Determination and Inference of Eukaryotic Transcription Factor Sequence Specificity	CELL			English	Article							DNA-BINDING SPECIFICITIES; GENOME-WIDE ASSOCIATION; NUCLEOSOME OCCUPANCY; RECOGNITION; DATABASE; MICROARRAY; PREDICTION; EVOLUTION; REVEALS; MODELS	Transcription factor (TF) DNA sequence preferences direct their regulatory activity, but are currently known for only similar to 1% of eukaryotic TFs. Broadly sampling DNA-binding domain (DBD) types from multiple eukaryotic clades, we determined DNA sequence preferences for >1,000 TFs encompassing 54 different DBD classes from 131 diverse eukaryotes. We find that closely related DBDs almost always have very similar DNA sequence preferences, enabling inference of motifs for similar to 34% of the similar to 170,000 known or predicted eukaryotic TFs. Sequences matching both measured and inferred motifs are enriched in chromatin immunoprecipitation sequencing (ChIP-seq) peaks and upstream of transcription start sites in diverse eukaryotic lineages. SNPs defining expression quantitative trait loci in Arabidopsis promoters are also enriched for predicted TF binding sites. Importantly, our motif "library" can be used to identify specific TFs whose binding may be altered by human disease risk alleles. These data present a powerful resource for mapping transcriptional networks across eukaryotes.	[Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.; Yang, Ally; Albu, Mihai; Cote, Atina G.; Najafabadi, Hamed S.; Mann, Ishminder; Zheng, Hong; van Bakel, Harm; Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Weirauch, Matthew T.; Yang, Ally; Albu, Mihai; Cote, Atina G.; Najafabadi, Hamed S.; Mann, Ishminder; Zheng, Hong; van Bakel, Harm; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Montenegro-Montero, Alejandro; Goity, Alejandra; Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Santiago 8331150, Chile; [Drewe, Philipp; Ratsch, Gunnar] Sloan Kettering Inst, Computat Biol Ctr, New York, NY 10065 USA; [Lambert, Samuel A.; Cook, Kate; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [van Bakel, Harm] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Lozano, Jean-Claude; Bouget, Francois-Yves] Univ Paris 06, Sorbonne Univ, CNRS, Lab Oceanog Microbienne,Observ Oceanol,UMR 7621, F-66650 Banyuls Sur Mer, France; [Galli, Mary; Lewsey, Mathew G.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Lewsey, Mathew G.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Huang, Eryong; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mukherjee, Tuhin; Chen, Xiaoting] Univ Cincinnati, Dept Elect & Comp Syst, Cincinnati, OH 45221 USA; [Reece-Hoyes, John S.; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01655 USA; [Govindarajan, Sridhar] DNA2 0 Inc, Menlo Pk, CA 94025 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Toronto; University of Toronto; Pontificia Universidad Catolica de Chile; Memorial Sloan Kettering Cancer Center; University of Toronto; Icahn School of Medicine at Mount Sinai; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Salk Institute; Salk Institute; Baylor College of Medicine; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Salk Institute	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	t.hughes@utoronto.ca	van Bakel, Harm/N-9561-2017; Montenegro-Montero, Alejandro/H-4863-2015; Lewsey, Mathew G/AAE-8530-2019; Rätsch, Gunnar/O-5914-2017; Ecker, Joseph R/B-9144-2008; Weirauch, Matthew/M-5459-2019; Lambert, Samuel/ABA-7732-2021; Larrondo, Luis/J-1086-2016	van Bakel, Harm/0000-0002-1376-6916; Montenegro-Montero, Alejandro/0000-0003-3780-4072; Rätsch, Gunnar/0000-0001-5486-8532; Ecker, Joseph R/0000-0001-5799-5895; Lambert, Samuel/0000-0001-8222-008X; Cook, Kate/0000-0002-0174-1113; Larrondo, Luis/0000-0002-8832-7109; Lewsey, Mathew/0000-0002-2631-4337; Walhout, Marian/0000-0001-5587-3608; Shaulsky, Gad/0000-0002-0532-0551; Reece-Hoyes, John/0000-0001-5251-5813; Najafabadi, Hamed/0000-0003-2735-4231; Boss, Philipp/0000-0002-5459-9771	Canadian Institutes of Health Research [MOP-77721, MOP-111007]; CIHR; Canadian Institute for Advanced Research (CIFAR) Junior Fellows Genetic Networks Program; NIH/NICHD [P01 HD39691]; NIH [GM082971]; EU Marie Curie International Outgoing Fellowship [252475]; National Science Foundation (NSF) [MCB-1024999]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF 3034]; Millennium Nucleus for Fungal Integrative and Synthetic Biology [NC120043]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1131030]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082971] Funding Source: NIH RePORTER; Direct For Biological Sciences [1024999] Funding Source: National Science Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research (CIFAR) Junior Fellows Genetic Networks Program(Canadian Institute for Advanced Research (CIFAR)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU Marie Curie International Outgoing Fellowship; National Science Foundation (NSF)(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Millennium Nucleus for Fungal Integrative and Synthetic Biology; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the following people for experimental and computational support on this project: Shaheynoor Talukder, Andrew Vorobyov, Anton van der Ven, Wilfred de Vega, Nicole Park, C. Alexander Valencia, Geanany Rasanathan, Yogesh Hooda, Sanie Mnaimneh, Kenneth Chu, Oliver Boright, Jerry Li, Agnieszka Janska, Esther Chan, Trevis Alleyne, Emily Stoakes, Oliver Stegle, Todd Riley, and Harmen Bussemaker. We are grateful to Martha Bulyk, Jussi Taipale, Raphael Kopan, Artem Barski, Ian Lewkowich, Brenda Andrews, and Charlie Boone for helpful conversations and advice, and the many investigators who generously contributed template DNA or RNA used in PCR cloning of DBDs (listed in Table S6). This work was supported by grants from the Canadian Institutes of Health Research to T.R.H. (MOP-77721 and MOP-111007). M.T.W. was supported by fellowships from CIHR and the Canadian Institute for Advanced Research (CIFAR) Junior Fellows Genetic Networks Program. T.R.H. is a CIFAR scholar. E.H. and G.S. were supported by a grant from the NIH/NICHD P01 HD39691. J.S.R.-H. and A.J.M.W. were funded by NIH GM082971. M.G.L. was supported by an EU Marie Curie International Outgoing Fellowship (project 252475). Research in the J.R.E. laboratory is supported by the National Science Foundation (NSF) (grant MCB-1024999), the Howard Hughes Medical Institute, and the Gordon and Betty Moore Foundation (GBMF 3034). J.R.E. is an HHMI-GBMF Investigator. A.M.M., A.G., and L.F.L. were supported by Millennium Nucleus for Fungal Integrative and Synthetic Biology (NC120043) and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1131030), both to L.F.L.	Aggarwal P, 2010, PLANT CELL, V22, P1174, DOI 10.1105/tpc.109.066647; Alleyne TM, 2009, BIOINFORMATICS, V25, P1012, DOI 10.1093/bioinformatics/btn645; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bernard B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042779; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Christensen RG, 2012, BIOINFORMATICS, V28, pI84, DOI 10.1093/bioinformatics/bts202; COOK WJ, 1994, J BIOL CHEM, V269, P9374; de Boer CG, 2014, GENOME RES, V24, P154, DOI 10.1101/gr.164327.113; de Boer CG, 2012, NUCLEIC ACIDS RES, V40, pD169, DOI 10.1093/nar/gkr993; De Masi F, 2011, NUCLEIC ACIDS RES, V39, P4553, DOI 10.1093/nar/gkr070; de Mendoza A, 2013, P NATL ACAD SCI USA, V110, pE4858, DOI 10.1073/pnas.1311818110; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; Eddy Sean R, 2009, Genome Inform, V23, P205; Enuameh MS, 2013, GENOME RES, V23, P928, DOI 10.1101/gr.151472.112; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2011, SUBCELL BIOCHEM, V52, P155, DOI 10.1007/978-90-481-9069-0_7; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; Maglich JM, 2001, GENOME BIOL, V2; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; Mathias JR, 2001, J BIOL CHEM, V276, P32696, DOI 10.1074/jbc.M103097200; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Megraw M, 2009, GENOME RES, V19, P644, DOI 10.1101/gr.085449.108; Mintseris J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-429; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Shelest E, 2008, FEMS MICROBIOL LETT, V286, P145, DOI 10.1111/j.1574-6968.2008.01293.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stubbs L, 2011, SUBCELL BIOCHEM, V52, P75, DOI 10.1007/978-90-481-9069-0_4; Tanaka E, 2011, BIOINFORMATICS, V27, P1603, DOI 10.1093/bioinformatics/btr257; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	63	816	823	4	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1431	1443		10.1016/j.cell.2014.08.009	http://dx.doi.org/10.1016/j.cell.2014.08.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215497	Green Accepted, Bronze			2022-12-28	WOS:000343094200022
J	Alleyne, G; Beaglehole, R; Bonita, R				Alleyne, George; Beaglehole, Robert; Bonita, Ruth			Quantifying targets for the SDG health goal	LANCET			English	Editorial Material									[Alleyne, George] Pan Amer Hlth Org, Washington, DC 20037 USA; [Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand	Pan American Health Organization; University of Auckland	Alleyne, G (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.	alleyned@paho.org						Fukada-Parr S., 2012, 217STESA2012DWP117 D; Global Thematic Consultation on Health, 2013, WORLD WE WANT HLTH P; Hulme D., 2010, 110 BROOKS WORLD POV; Hulme D., 2007, MAKING MILLENNIUM DE; Jahan S, 2012, DOES IT MAKE SENSE H; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Norheim OF, 2014, LANCET; Sustainable Development Platform, 2014, OUTC DOC OP WORK GRO; The Partnership for Maternal Newborn & Child health, 2014, NEWB CHILD HLTH; WHO, 2010, WOR HEALT REP, P1	10	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					208	209		10.1016/S0140-6736(14)61655-X	http://dx.doi.org/10.1016/S0140-6736(14)61655-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ2DL	25242036				2022-12-28	WOS:000348044800007
J	Appleby, J; Rutty, GN; Hainsworth, SV; Woosnam-Savage, RC; Morgan, B; Brough, A; Earp, RW; Robinson, C; King, TE; Morris, M; Buckley, R				Appleby, Jo; Rutty, Guy N.; Hainsworth, Sarah V.; Woosnam-Savage, Robert C.; Morgan, Bruno; Brough, Alison; Earp, Richard W.; Robinson, Claire; King, Turi E.; Morris, Mathew; Buckley, Richard			Perimortem trauma in King Richard III: a skeletal analysis	LANCET			English	Article							MARKS; BONE	Background Richard III was the last king of England to die in battle, but how he died is unknown. On Sept 4, 2012, a skeleton was excavated in Leicester that was identified as Richard. We investigated the trauma to the skeleton with modern forensic techniques, such as conventional CT and micro-CT scanning, to characterise the injuries and establish the probable cause of death. Methods We assessed age and sex through direct analysis of the skeleton and from CT images. All bones were examined under direct light and multi-spectral illumination. We then scanned the skeleton with whole-body post-mortem CT. We subsequently examined bones with identified injuries with micro-CT. We deemed that trauma was perimortem when we recorded no evidence of healing and when breakage characteristics were typical of fresh bone. We used previous data to identify the weapons responsible for the recorded injuries. Findings The skeleton was that of an adult man with a gracile build and severe scoliosis of the thoracic spine. Standard anthropological age estimation techniques based on dry bone analysis gave an age range between 20s and 30s. Standard post-mortem CT methods were used to assess rib end morphology, auricular surfaces, pubic symphyseal face, and cranial sutures, to produce a multifactorial narrower age range estimation of 30-34 years. We identified nine perimortem injuries to the skull and two to the postcranial skeleton. We identified no healed injuries. The injuries were consistent with those created by weapons from the later medieval period. We could not identify the specific order of the injuries, because they were all distinct, with no overlapping wounds. Three of the injuries-two to the inferior cranium and one to the pelvis-could have been fatal. Interpretation The wounds to the skull suggest that Richard was not wearing a helmet, although the absence of defensive wounds on his arms and hands suggests he was still otherwise armoured. Therefore, the potentially fatal pelvis injury was probably received post mortem, meaning that the most likely injuries to have caused his death are the two to the inferior cranium.	[Appleby, Jo; Morris, Mathew; Buckley, Richard] Univ Leicester, Sch Archaeol & Ancient Hist, Leicester LE1 7RH, Leics, England; [Rutty, Guy N.; Brough, Alison] Univ Leicester, East Midlands Forens Pathol Unit, Leicester LE1 7RH, Leics, England; [Hainsworth, Sarah V.; Earp, Richard W.] Univ Leicester, Dept Engn, Leicester LE1 7RH, Leics, England; [King, Turi E.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Woosnam-Savage, Robert C.] Royal Armouries Museum, Leeds, W Yorkshire, England; [Morgan, Bruno; Robinson, Claire] Univ Hosp Leicester, Leicester Royal Infirm, Dept Imaging, Leicester, Leics, England	University of Leicester; University of Leicester; University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester	Appleby, J (corresponding author), Univ Leicester, Sch Archaeol & Ancient Hist, Leicester LE1 7RH, Leics, England.	ja253@le.ac.uk	King, Turi/AAL-5716-2021	Morgan, Bruno/0000-0001-9708-675X; Hainsworth, Sarah/0000-0001-9907-1236; Robinson, Claire/0000-0002-8759-7457; King, Turi/0000-0003-3025-3829	University of Leicester	University of Leicester	The University of Leicester.	Appleby J, 2014, LANCET, V383, P1944, DOI 10.1016/S0140-6736(14)60762-5; Brooks S, 1990, J HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brough AL, 2014, FORENSIC SCI MED PAT; Buckberry JL, 2002, AM J PHYS ANTHROPOL, V119, P231, DOI 10.1002/ajpa.10130; Buckley R, 2013, ANTIQUITY, V87, P519, DOI 10.1017/S0003598X00049103; Buikstra J.E., 1994, STANDARDS DATA COLLE, V44; Cooper C., 2009, THESIS GUTENBERG U G; Cox John, 1986, CROWLAND CHRONICLE C; Doutrepont G, 1935, CHRONIQUES JEAN MOLI; Ellis H., 1844, 3 BOOKS POLYDORE VER; Froissart J, CHRONIQUES SIRE JEAN; Hudson John, 1994, LAW GOVT MEDIEVAL EN; Inglemark BE, 1939, ARMOUR BATTLE WISBY, V1361, P149; Larkin J. F., 1964, TUDOR ROYAL PROCLAMA, VI; Lewis JE, 2008, J ARCHAEOL SCI, V35, P2001, DOI 10.1016/j.jas.2008.01.016; McKinley Jacqueline., 2004, GUIDELINES STANDARDS, P14; Novak SA, 2007, BLOOD RED ROSES ARCH, V1461, P90; Quatrehomme G, 1999, J FORENSIC SCI, V44, P568; Richardson T, 2007, BLOOD RED ROSES ARCH, V1461, P137; Rimer G, 2007, BLOOD RED ROSES ARCH, V1461, P119; Rous John, 1745, JOANNIS ROSSI ANTIQU; Rutty GN, 2013, FORENSIC SCI INT, V225, P60, DOI 10.1016/j.forsciint.2012.10.030; Saville PA, 2007, INT J LEGAL MED, V121, P349, DOI 10.1007/s00414-006-0120-z; Steadman DW, 2008, AM J PHYS ANTHROPOL, V136, P51, DOI 10.1002/ajpa.20778; United Nations Educational Scientific and Cultural Organization, 2004, IST PROT MAN EFF INV; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Visser-Fuchs L, 1999, RICARDIAN, V9, P525; Woosnam-Savage R, 2001, BRASSEYS BOOK BODY A	28	36	36	1	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					253	259		10.1016/S0140-6736(14)60804-7	http://dx.doi.org/10.1016/S0140-6736(14)60804-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AZ2DL	25238931	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000348044800029
J	Bremner, R; Sage, J				Bremner, Rod; Sage, Julien			CANCER The origin of human retinoblastoma	NATURE			English	Editorial Material							TUMOR; CELL; E2F1; RB		[Bremner, Rod] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Stanford University; Stanford University	Bremner, R (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.		Bremner, Rod/I-6490-2012	Bremner, Rod/0000-0001-9184-7212	NCI NIH HHS [R01 CA114102] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA114102] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Chen D, 2013, CELL DEATH DIFFER, V20, P931, DOI 10.1038/cdd.2013.24; Conkrite K, 2012, J CLIN INVEST, V122, P1726, DOI 10.1172/JCI61403; Dyer MA, 2005, NAT REV CANCER, V5, P91, DOI 10.1038/nrc1545; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; KYRITSIS AP, 1984, NATURE, V307, P471, DOI 10.1038/307471a0; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Rootman DB, 2013, BRIT J OPHTHALMOL, V97, P59, DOI 10.1136/bjophthalmol-2012-302133; Sage J, 2012, GENE DEV, V26, P1409, DOI 10.1101/gad.193730.112; Sangwan M, 2012, ONCOGENE, V31, P5019, DOI 10.1038/onc.2011.654; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Xu XLL, 2014, NATURE, V514, P385, DOI 10.1038/nature13813; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051	13	16	19	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					312	313		10.1038/nature13748	http://dx.doi.org/10.1038/nature13748			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25252972	Green Accepted, Bronze			2022-12-28	WOS:000342988600038
J	Carvalhais, N; Forkel, M; Khomik, M; Bellarby, J; Jung, M; Migliavacca, M; Mu, MQ; Saatchi, S; Santoro, M; Thurner, M; Weber, U; Ahrens, B; Beer, C; Cescatti, A; Randerson, JT; Reichstein, M				Carvalhais, Nuno; Forkel, Matthias; Khomik, Myroslava; Bellarby, Jessica; Jung, Martin; Migliavacca, Mirco; Mu, Mingquan; Saatchi, Sassan; Santoro, Maurizio; Thurner, Martin; Weber, Ulrich; Ahrens, Bernhard; Beer, Christian; Cescatti, Alessandro; Randerson, James T.; Reichstein, Markus			Global covariation of carbon turnover times with climate in terrestrial ecosystems	NATURE			English	Article							SOIL ORGANIC-CARBON; RESPIRATION; PRODUCTIVITY; DYNAMICS; STORAGE; MATTER; STOCK; DECOMPOSITION; SENSITIVITY; BOREAL	The response of the terrestrial carbon cycle to climate change is among the largest uncertainties affecting future climate change projections(1,2). The feedback between the terrestrial carbon cycle and climate is partly determined by changes in the turnover time of carbon in land ecosystems, which in turn is an ecosystem property that emerges from the interplay between climate, soil and vegetation type(3-6). Here we present a global, spatially explicit and observation-based assessment of whole-ecosystem carbon turnover times that combines new estimates of vegetation and soil organic carbon stocks and fluxes. We find that the overall mean global carbon turnover time is 23(4)(+7) years (95 per cent confidence interval). Onaverage, carbon resides in the vegetation and soil near the Equator for a shorter time than at latitudes north of 75 degrees north (mean turnover times of 15 and 255 years, respectively). We identify a clear dependence of the turnover time on temperature, as expected from our present understanding of temperature controls on ecosystem dynamics. Surprisingly, our analysis also reveals a similarly strong association between turnover time and precipitation. Moreover, we find that the ecosystem carbon turnover times simulated by state-of-the-art coupled climate/carbon-cycle models vary widely and that numerical simulations, on average, tend to underestimate the global carbon turnover time by 36 per cent. The models show stronger spatial relationships with temperature than do observation-based estimates, but generally do not reproduce the strong relationships with precipitation and predict faster carbon turnover in many semiarid regions. Our findings suggest that future climate/carbon-cycle feedbacks may depend more strongly on changes in the hydrological cycle than is expected at present and is considered in Earth system models.	[Carvalhais, Nuno; Forkel, Matthias; Khomik, Myroslava; Jung, Martin; Migliavacca, Mirco; Thurner, Martin; Weber, Ulrich; Ahrens, Bernhard; Beer, Christian; Reichstein, Markus] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Carvalhais, Nuno] Univ Nova Lisboa, FCT, DCEA, P-2829516 Caparica, Portugal; [Khomik, Myroslava] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON L8S 4K1, Canada; [Bellarby, Jessica] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [Bellarby, Jessica] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Migliavacca, Mirco] Univ Milano Bicocca, DISAT, Remote Sensing Environm Dynam Lab, I-20126 Milan, Italy; [Mu, Mingquan; Randerson, James T.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Saatchi, Sassan] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Santoro, Maurizio] Gamma Remote Sensing, CH-3073 Gumlingen, Switzerland; [Beer, Christian] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Beer, Christian] Stockholm Univ, Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Cescatti, Alessandro] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Climate Risk Management Unit, I-21027 Ispra, Italy	Max Planck Society; Universidade Nova de Lisboa; McMaster University; University of Aberdeen; Lancaster University; University of Milano-Bicocca; University of California System; University of California Irvine; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); GAMMA Remote Sensing AG; Stockholm University; Stockholm University; European Commission Joint Research Centre; EC JRC ISPRA Site	Carvalhais, N (corresponding author), Max Planck Inst Biogeochem, Hans Knoll Str 10, D-07745 Jena, Germany.	nuno.carvalhais@bgc-jena.mpg.de	Thurner, Martin/K-4854-2017; Beer, Christian/D-2296-2013; Ahrens, Bernhard/P-1790-2018; Randerson, James/Y-2550-2019; Cescatti, Alessandro/ABE-6319-2020; Reichstein, Markus/A-7494-2011; Saatchi, Sassan/AAQ-2649-2021; Migliavacca, Mirco/J-9986-2019; Forkel, Matthias/O-5592-2019	Thurner, Martin/0000-0003-2362-5161; Beer, Christian/0000-0002-5377-3344; Randerson, James/0000-0001-6559-7387; Reichstein, Markus/0000-0001-5736-1112; Migliavacca, Mirco/0000-0003-3546-8407; Forkel, Matthias/0000-0003-0363-9697; Carvalhais, Nuno/0000-0003-0465-1436; Ahrens, Bernhard/0000-0001-7226-6682; Khomik, Myroslava/0000-0002-0377-8833	European Union (FP7) through the project GEOCARBON [283080]; ERC starting grant QUASOM [ERC-2007-StG-208516]; European Union (FP7) through the project CARBONES [242316]; European Union (FP7) through the project EMBRACE [283201]; Natural Environment Research Council [ceh010010] Funding Source: researchfish; Div Atmospheric & Geospace Sciences [1048890] Funding Source: National Science Foundation	European Union (FP7) through the project GEOCARBON; ERC starting grant QUASOM; European Union (FP7) through the project CARBONES; European Union (FP7) through the project EMBRACE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We would like to thank C. Jones for comments that improved the manuscript. We are grateful to A. Ito, D. Zaks and S. Del Grosso for sharing their NPP data sets with us. We thank S. Schott for figure editing. We acknowledge support by the European Union (FP7) through the projects GEOCARBON (283080), CARBONES (242316) and EMBRACE (283201) and an ERC starting grant QUASOM (ERC-2007-StG-208516).	Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Anav A, 2013, J CLIMATE, V26, P6801, DOI 10.1175/JCLI-D-12-00417.1; Beer C, 2014, J CLIMATE, V27, P4815, DOI 10.1175/JCLI-D-13-00543.1; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; Bird MI, 1996, NATURE, V381, P143, DOI 10.1038/381143a0; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; DiMiceli C. M., 2011, ANN GLOBAL AUTOAMATE; Fahey TJ, 2005, BIOGEOCHEMISTRY, V75, P109, DOI 10.1007/s10533-004-6321-y; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friend AD, 2014, P NATL ACAD SCI USA, V111, P3280, DOI 10.1073/pnas.1222477110; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Hugelius G, 2013, EARTH SYST SCI DATA, V5, P3, DOI 10.5194/essd-5-3-2013; Ito A, 2011, GLOBAL CHANGE BIOL, V17, P3161, DOI 10.1111/j.1365-2486.2011.02450.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Jenkinson D. S., 1988, Russell's soil conditions and plant growth. Eleventh edition, P564; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; JOFFRE R, 1993, ECOLOGY, V74, P570, DOI 10.2307/1939317; Jung M, 2006, REMOTE SENS ENVIRON, V101, P534, DOI 10.1016/j.rse.2006.01.020; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kauppi PE, 2003, SILVA FENN, V37, P451, DOI 10.14214/sf.484; King AW, 1997, CLIMATIC CHANGE, V35, P199, DOI 10.1023/A:1005317530770; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Koven C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040150; Krawchuk MA, 2011, ECOLOGY, V92, P121, DOI 10.1890/09-1843.1; Lieth H., 1975, PRIMARY PRODUCTIVITY, V14, P237, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Lieth H., 1972, PUB CLIMATOL, V25, P37; Lindeman R., 1980, INTRO BIVARIATE MULT; Malhi Y, 2009, GEOPHYS MONOGR SER, V186, P355, DOI 10.1029/2008GM000779; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; OADES JM, 1988, BIOGEOCHEMISTRY, V5, P35, DOI 10.1007/BF02180317; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Piani C, 2010, J HYDROL, V395, P199, DOI 10.1016/j.jhydrol.2010.10.024; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rhode H., 1992, GLOBAL BIOGEOCHEMICA, V50, P55, DOI 10.1016/S0074-6142(08)62687-X; Rodhe H., 1992, GLOBAL BIOGEOCHEMICA; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Santoro M., 2013, P ESA LIV PLAN S; Schlesinger W.H., 1995, SOILS GLOBAL CHANGE, V25, P9; Schrumpf M, 2011, BIOGEOSCIENCES, V8, P1193, DOI 10.5194/bg-8-1193-2011; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Sundquist ET., 1985, CARBON CYCLE ATMOSPH, P55, DOI DOI 10.1029/GM032P0005; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thonicke K, 2001, GLOBAL ECOL BIOGEOGR, V10, P661, DOI 10.1046/j.1466-822X.2001.00175.x; Thurner M, 2014, GLOBAL ECOL BIOGEOGR, V23, P297, DOI 10.1111/geb.12125; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Turetsky MR, 2012, NEW PHYTOL, V196, P49, DOI 10.1111/j.1469-8137.2012.04254.x; VETAAS OR, 1992, J VEG SCI, V3, P337, DOI 10.2307/3235758; Vonk JE, 2013, NAT GEOSCI, V6, P675, DOI 10.1038/ngeo1937; Webb R. W., 2000, GLOBAL SOIL TEXTURE; Weedon GP, 2011, J HYDROMETEOROL, V12, P823, DOI 10.1175/2011JHM1369.1; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Xia JY, 2013, GLOBAL CHANGE BIOL, V19, P2104, DOI 10.1111/gcb.12172; Zaks DPM, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002705; Zhang K., 2012, COMPUTING RES REPOS; Zobler L., 1986, 87802 NASA GODD I SP	71	455	475	81	805	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					213	+		10.1038/nature13731	http://dx.doi.org/10.1038/nature13731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25252980	Green Published			2022-12-28	WOS:000342663100039
J	Huang, RJ; Zhang, YL; Bozzetti, C; Ho, KF; Cao, JJ; Han, YM; Daellenbach, KR; Slowik, JG; Platt, SM; Canonaco, F; Zotter, P; Wolf, R; Pieber, SM; Bruns, EA; Crippa, M; Ciarelli, G; Piazzalunga, A; Schwikowski, M; Abbaszade, G; Schnelle-Kreis, J; Zimmermann, R; An, ZS; Szidat, S; Baltensperger, U; El Haddad, I; Prevot, ASH				Huang, Ru-Jin; Zhang, Yanlin; Bozzetti, Carlo; Ho, Kin-Fai; Cao, Jun-Ji; Han, Yongming; Daellenbach, Kaspar R.; Slowik, Jay G.; Platt, Stephen M.; Canonaco, Francesco; Zotter, Peter; Wolf, Robert; Pieber, Simone M.; Bruns, Emily A.; Crippa, Monica; Ciarelli, Giancarlo; Piazzalunga, Andrea; Schwikowski, Margit; Abbaszade, Guelcin; Schnelle-Kreis, Juergen; Zimmermann, Ralf; An, Zhisheng; Szidat, Soenke; Baltensperger, Urs; El Haddad, Imad; Prevot, Andre S. H.			High secondary aerosol contribution to particulate pollution during haze events in China	NATURE			English	Article							ORGANIC AEROSOLS; SOURCE APPORTIONMENT; PM2.5; EMISSIONS; FIELD	Rapid industrialization and urbanization in developing countries has led to an increase in air pollution, along a similar trajectory to that previously experienced by the developed nations(1). In China, particulate pollution is a serious environmental problem that is influencing air quality, regional and global climates, and human health(2,3). In response to the extremely severe and persistent haze pollution experienced by about 800 million people during the first quarter of 2013 (refs 4, 5), the Chinese State Council announced its aim to reduce concentrations of PM2.5 (particulate matter with an aerodynamic diameter less than 2.5 micrometres) by up to 25 per cent relative to 2012 levels by 2017 (ref. 6). Such efforts however require elucidation of the factors governing the abundance and composition of PM2.5, which remain poorly constrained in China(3,7,8). Here we combine a comprehensive set of novel and state-of-the-art offline analytical approaches and statistical techniques to investigate the chemical nature and sources of particulate matter at urban locations in Beijing, Shanghai, Guangzhou and Xi'an during January 2013. We find that the severe haze pollution event was driven to a large extent by secondary aerosol formation, which contributed 30-77 per cent and 44-71 per cent (average for all four cities) of PM2.5 and of organic aerosol, respectively. On average, the contribution of secondary organic aerosol (SOA) and secondary inorganic aerosol (SIA) are found to be of similar importance (SOA/SIA ratios range from 0.6 to 1.4). Our results suggest that, in addition to mitigating primary particulate emissions, reducing the emissions of secondary aerosol precursors from, for example, fossil fuel combustion and biomass burning is likely to be important for controlling China's PM2.5 levels and for reducing the environmental, economic and health impacts resulting from particulate pollution.	[Huang, Ru-Jin; Bozzetti, Carlo; Daellenbach, Kaspar R.; Slowik, Jay G.; Platt, Stephen M.; Canonaco, Francesco; Zotter, Peter; Wolf, Robert; Pieber, Simone M.; Bruns, Emily A.; Crippa, Monica; Ciarelli, Giancarlo; Baltensperger, Urs; El Haddad, Imad; Prevot, Andre S. H.] PSI, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Huang, Ru-Jin; Cao, Jun-Ji; Han, Yongming; An, Zhisheng] Chinese Acad Sci, Inst Earth Environm, SKLLQG, Xian 710075, Peoples R China; [Huang, Ru-Jin; Cao, Jun-Ji; Han, Yongming; An, Zhisheng] Chinese Acad Sci, Inst Earth Environm, Key Lab Aerosol Chem & Phys, Xian 710075, Peoples R China; [Zhang, Yanlin; Schwikowski, Margit; Szidat, Soenke] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Zhang, Yanlin; Schwikowski, Margit; Szidat, Soenke] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Zhang, Yanlin; Schwikowski, Margit] PSI, Lab Radiochem & Environm Chem, CH-5232 Villigen, Switzerland; [Ho, Kin-Fai] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Piazzalunga, Andrea] Univ Milano Bicocca, Dept Earth & Environm Sci, I-20126 Milan, Italy; [Abbaszade, Guelcin; Schnelle-Kreis, Juergen; Zimmermann, Ralf] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Joint Mass Spectrometry Ctr, Cooperat Grp Comprehens Mol Analyt, D-85764 Neuherberg, Germany; [Abbaszade, Guelcin; Schnelle-Kreis, Juergen; Zimmermann, Ralf] Helmholtz Virtual Inst Complex Mol Syst Environm, D-85764 Neuherberg, Germany; [Zimmermann, Ralf] Univ Rostock, Joint Mass Spectrometry Ctr, Inst Chem, D-18015 Rostock, Germany	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Chinese Academy of Sciences; Institute of Earth Environment, CAS; Chinese Academy of Sciences; Institute of Earth Environment, CAS; University of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Chinese University of Hong Kong; University of Milano-Bicocca; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Rostock	Cao, JJ (corresponding author), Chinese Acad Sci, Inst Earth Environm, SKLLQG, Xian 710075, Peoples R China.	jjcao@ieecas.cn; andre.prevot@psi.ch	Huang, Ru-Jin/K-5022-2018; Prevot, Andre S. H./C-6677-2008; Haddad, Imad El/B-8073-2011; Zhang, Yanlin/AAH-7770-2021; Slowik, Jay G/F-4894-2011; Francesco, Canonaco/GZN-0838-2022; Junji, Cao/D-3259-2014; bruns, emily/A-4558-2013; Platt, Stephen M/G-1678-2019; Dällenbach, Kaspar Rudolf/ABB-4630-2020; Szidat, Sönke/D-6706-2011; Zhang, Yan-Lin/I-3875-2012; Daellenbach, Kaspar/AAY-4521-2020; Ho, Kin Fai/E-6131-2011; Crippa, Monica/ABD-8045-2021; Schnelle-Kreis, Jürgen/M-9845-2014; AN, Zhisheng/F-8834-2012	Huang, Ru-Jin/0000-0002-4907-9616; Prevot, Andre S. H./0000-0002-9243-8194; Haddad, Imad El/0000-0002-2461-7238; Slowik, Jay G/0000-0001-5682-850X; Junji, Cao/0000-0003-1000-7241; Platt, Stephen M/0000-0002-8439-6633; Dällenbach, Kaspar Rudolf/0000-0003-1246-6396; Szidat, Sönke/0000-0002-1824-6207; Zhang, Yan-Lin/0000-0002-8722-8635; Ho, Kin Fai/0000-0001-7464-3437; Schnelle-Kreis, Jürgen/0000-0003-4846-2303; an, zhi sheng/0000-0002-9538-9826; Schwikowski, Margit/0000-0002-0856-5183; Pieber, Simone M./0000-0002-5674-6640	European Community [290605]; Swiss National Science Foundation (SAPMAV) [200021_13016]; Swiss National Science Foundation (WOOSHI) [200021L_140590]; Swiss National Science Foundation (Ambizione) [PZ00P2_131673]; Swiss Competence Center Environment and Sustainability; Swiss Competence Center Energy and Mobility under project OPTIWARES; National Science Foundation of China [40925009]; "Strategic Priority Research Program'' of the Chinese Academy of Sciences [XDA05100402]; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health - Aerosol and Health (HICE)	European Community(European Commission); Swiss National Science Foundation (SAPMAV)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (WOOSHI)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (Ambizione)(Swiss National Science Foundation (SNSF)); Swiss Competence Center Environment and Sustainability; Swiss Competence Center Energy and Mobility under project OPTIWARES; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program'' of the Chinese Academy of Sciences(Chinese Academy of Sciences); Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health - Aerosol and Health (HICE)	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 290605, the Swiss National Science Foundation (SAPMAV, no. 200021_13016, WOOSHI, no. 200021L_140590, and Ambizione, PZ00P2_131673), the Swiss Competence Centers Environment and Sustainability as well as Energy and Mobility under project OPTIWARES, the National Science Foundation of China (no. 40925009), the "Strategic Priority Research Program'' of the Chinese Academy of Sciences (XDA05100402), and the Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health - Aerosol and Health (HICE). The help of G. Salazar (University of Bern) during <SUP>14</SUP>C analysis is acknowledged.	[Anonymous], 1998, CMB8 APPL VALIDATION; Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; Canonaco F, 2013, ATMOS MEAS TECH, V6, P3649, DOI 10.5194/amt-6-3649-2013; Cao J., 2012, J EARTH ENV, V3, P1030; Cao JJ, 2013, J GEOPHYS RES-ATMOS, V118, P4834, DOI 10.1002/jgrd.50381; Chen RJ, 2013, AM J RESP CRIT CARE, V188, P1170, DOI 10.1164/rccm.201304-0678LE; China National Environmental Monitoring Centre, AIR QUAL REP 74 CHIN; Chinese State Council, ATM POLL PREV CONTR; DeCarlo PF, 2006, ANAL CHEM, V78, P8281, DOI 10.1021/ac061249n; Ervens B, 2011, ATMOS CHEM PHYS, V11, P11069, DOI 10.5194/acp-11-11069-2011; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Orasche J, 2011, ATMOS CHEM PHYS, V11, P8977, DOI 10.5194/acp-11-8977-2011; Pandis S. N., 2006, ATMOSPHERIC CHEM PHY; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; Saravanan R., 2014, NATURE COMMUN, P5; Seinfeld JH, 2004, AICHE J, V50, P1096, DOI 10.1002/aic.10102; Tiwari S, 2013, ATMOS RES, V125, P50, DOI 10.1016/j.atmosres.2013.01.011; UNEP, 2013, AFR ENV OUTL 3 OUR E; Wang GH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027624; Wang X, 2013, ATMOS CHEM PHYS, V13, P10919, DOI 10.5194/acp-13-10919-2013; Wang XF, 2012, ATMOS ENVIRON, V63, P68, DOI 10.1016/j.atmosenv.2012.09.029; Wang Y, 2013, ATMOS CHEM PHYS, V13, P2635, DOI 10.5194/acp-13-2635-2013; World Health Organization, 7 MILL PREM DEATHS A; Wuebbles DJ, 2007, ENVIRON POLLUT, V150, P65, DOI 10.1016/j.envpol.2007.06.066; Xing J, 2011, ATMOS CHEM PHYS, V11, P3119, DOI 10.5194/acp-11-3119-2011; Yang F, 2011, ATMOS CHEM PHYS, V11, P5207, DOI 10.5194/acp-11-5207-2011; Zhang Q, 2012, NATURE, V484, P161, DOI 10.1038/484161a; Zhang YL, 2012, ATMOS CHEM PHYS, V12, P10841, DOI 10.5194/acp-12-10841-2012; Zheng M, 2005, ATMOS ENVIRON, V39, P3967, DOI 10.1016/j.atmosenv.2005.03.036	30	2862	3205	304	4676	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					218	222		10.1038/nature13774	http://dx.doi.org/10.1038/nature13774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25231863	Green Accepted			2022-12-28	WOS:000342663100040
J	Robart, AR; Chan, RT; Peters, JK; Rajashankar, KR; Toor, N				Robart, Aaron R.; Chan, Russell T.; Peters, Jessica K.; Rajashankar, Kanagalaghatta R.; Toor, Navtej			Crystal structure of a eukaryotic group II intron lariat	NATURE			English	Article							RNA; SITE; CRYSTALLOGRAPHY; NUCLEOTIDES; RECOGNITION; REVEALS; STEPS	The formation of branched lariat RNA is an evolutionarily conserved feature of splicing reactions for both group II and spliceosomal introns. The lariat is important for the fidelity of 5' splice-site selection and consists of a 2'-5' phosphodiester bond between a bulged adenosine and the 5' end of the intron. To gain insight into this ubiquitous intramolecular linkage, we determined the crystal structure of a eukaryotic group IIB intron in the lariat form at 3.7 angstrom. This revealed that two tandem tetraloop-receptor interactions, eta-eta' and pi-pi', place domain VI in the core to position the lariat bond in the post-catalytic state. On the basis of structural and biochemical data, we propose that pi-pi' is a dynamic interaction that mediates the transition between the two steps of splicing, with pi-pi' serving an ancillary role. The structure also reveals a four-magnesium-ion cluster involved in both catalysis and positioning of the 5' end. Given the evolutionary relationship between group II and nuclear introns, it is likely that this active site configuration exists in the spliceosome as well.	[Robart, Aaron R.; Chan, Russell T.; Peters, Jessica K.; Toor, Navtej] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA	University of California System; University of California San Diego; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Toor, N (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ntoor@ucsd.edu		Toor, Navtej/0000-0002-6134-163X; Peters, Jessica/0000-0003-3541-7431; Robart, Aaron/0000-0002-0518-3972	Cell, Molecular, and Genetics Training Program - NIH predoctoral training grant [5T32GM007240]; UCSD Molecular Biophysics Training Program - NIH predoctoral training grant [5T32GM008326]; NIH grant [8P41GM103403-10]; US DOE [DE-AC02-06CH11357]; Hellman Foundation Fellowship; NIH [5R01GM102216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM102216, T32GM007240, T32GM008326] Funding Source: NIH RePORTER	Cell, Molecular, and Genetics Training Program - NIH predoctoral training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Molecular Biophysics Training Program - NIH predoctoral training grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US DOE(United States Department of Energy (DOE)); Hellman Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Banerjee and the staff of the NE-CAT beamlines at the Advanced Photon Source (APS) of Argonne National Laboratory. We thank P. Ghosh, S. Joseph, G. Ghosh, R. Doolittle, Y. Tor, D. Donoghue and T. Wiryaman for comments on the manuscript. We thank R. Das and F.-C. Chou for assistance with phenix.erasser for structure refinement and G. Bricogne for advice on Buster refinement. We also thank N. T. Schirle for preliminary biochemical characterization of the P.li.LSUI2 intron. R.T.C. was supported by the Cell, Molecular, and Genetics Training Program funded by NIH predoctoral training grant 5T32GM007240. J.K.P. was supported by the UCSD Molecular Biophysics Training Program funded by NIH predoctoral training grant 5T32GM008326. NE-CAT is supported by NIH grant 8P41GM103403-10 and APS is supported by the US DOE under contract number DE-AC02-06CH11357. This work was supported by a Hellman Foundation Fellowship and NIH grant 5R01GM102216 awarded to N.T.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Anokhina M, 2013, EMBO J, V32, P2804, DOI 10.1038/emboj.2013.198; Basu S, 1998, NAT STRUCT BIOL, V5, P986, DOI 10.1038/2960; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; CHANFREAU G, 1993, EMBO J, V12, P5173, DOI 10.1002/j.1460-2075.1993.tb06212.x; Chanfreau G, 1996, EMBO J, V15, P3466, DOI 10.1002/j.1460-2075.1996.tb00713.x; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; Costa M, 1997, J MOL BIOL, V274, P353, DOI 10.1006/jmbi.1997.1416; Di Leo Enza, 2004, Hum Mutat, V24, P440, DOI 10.1002/humu.9287; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova O, 2003, J MOL BIOL, V330, P197, DOI 10.1016/S0022-2836(03)00594-1; Fedorova O, 2008, RNA, V14, P1048, DOI 10.1261/rna.942308; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; GRABOWSKI PJ, 1984, CELL, V37, P415, DOI 10.1016/0092-8674(84)90372-6; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; Keating KS, 2012, ACTA CRYSTALLOGR D, V68, P985, DOI 10.1107/S0907444912018549; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; KONARSKA MM, 1985, NATURE, V313, P552, DOI 10.1038/313552a0; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; Li CF, 2011, EMBO J, V30, P3040, DOI 10.1038/emboj.2011.214; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADGETT RA, 1984, SCIENCE, V225, P898, DOI 10.1126/science.6206566; PARKER R, 1985, CELL, V41, P107, DOI 10.1016/0092-8674(85)90065-0; PARKER R, 1993, NATURE, V361, P660, DOI 10.1038/361660a0; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Rest JS, 2003, MOL BIOL EVOL, V20, P1134, DOI 10.1093/molbev/msg135; Roitzsch M, 2009, RNA, V15, P473, DOI 10.1261/rna.1392009; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toor N, 2006, NUCLEIC ACIDS RES, V34, P6461, DOI 10.1093/nar/gkl820; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0	46	90	90	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					193	+		10.1038/nature13790	http://dx.doi.org/10.1038/nature13790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25252982	Green Accepted			2022-12-28	WOS:000342663100034
J	Carrasco, LR; Larrosa, C; Milner-Gulland, EJ; Edwards, DP				Carrasco, L. R.; Larrosa, C.; Milner-Gulland, E. J.; Edwards, D. P.			A double-edged sword for tropical forests	SCIENCE			English	Editorial Material							OIL; GENOME; YIELD		[Carrasco, L. R.; Larrosa, C.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Larrosa, C.; Milner-Gulland, E. J.] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Edwards, D. P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	National University of Singapore; Imperial College London; University of Sheffield	Carrasco, LR (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsctlr@nus.edu.sg; david.edwards@sheffield.ac.uk	Carrasco, Luis R/H-8017-2012; Edwards, David/AAC-5091-2019	Carrasco, Luis R/0000-0002-2894-1473; Edwards, David/0000-0001-8562-3853				Corley RHV, 2009, ENVIRON SCI POLICY, V12, P134, DOI 10.1016/j.envsci.2008.10.011; Fox JL, 2013, NAT BIOTECHNOL, V31, P867, DOI 10.1038/nbt1013-867a; Hoekstra AY, 2014, SCIENCE, V344, P1114, DOI 10.1126/science.1248365; International Institute for Applied Systems Analysis, GAEZ V3 0 GLOBAL AGR; Khaidir A.M., 2014, NEW STRAITS TIMES; Ledford H, 2014, NATURE, V512, P357, DOI 10.1038/512357a; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; O'Rourke D, 2014, SCIENCE, V344, P1124, DOI 10.1126/science.1248526; Phalan B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0285; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Singh R, 2013, NATURE, V500, P340, DOI 10.1038/nature12356; Villoria NB, 2013, AM J AGR ECON, V95, P1301, DOI 10.1093/ajae/aat034; West PC, 2014, SCIENCE, V345, P325, DOI 10.1126/science.1246067; Wich SA, 2014, CURR BIOL, V24, P1659, DOI 10.1016/j.cub.2014.05.077	15	47	47	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					38	40		10.1126/science.1256685	http://dx.doi.org/10.1126/science.1256685			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278600				2022-12-28	WOS:000342446900025
J	Hwang, C; Chang, ETY				Hwang, Cheinway; Chang, Emmy T. Y.			Seafloor secrets revealed	SCIENCE			English	Editorial Material							MARINE GRAVITY; CRYOSAT-2; ALTIMETRY; FIELD		[Hwang, Cheinway] Natl Chiao Tung Univ, Dept Civil Engn, Hsinchu, Taiwan; [Chang, Emmy T. Y.] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University	Hwang, C (corresponding author), Natl Chiao Tung Univ, Dept Civil Engn, Hsinchu, Taiwan.	cheinway@mail.nctu.edu.tw; etychang@ntu.edu.tw		CHANG, Emmy/0000-0002-9886-7643				Andersen OB, 2010, J GEODESY, V84, P191, DOI 10.1007/s00190-009-0355-9; Chelton D. B., 2001, SATELLITE ALTIMETRY, P1, DOI DOI 10.1016/S0074-6142(01)80146-7; Clift PD, 2001, GEOL SOC SPEC PUBL, V187, P489, DOI 10.1144/GSL.SP.2001.187.01.24; Garcia ES, 2014, GEOPHYS J INT, V196, P1402, DOI 10.1093/gji/ggt469; Hwang CW, 2014, TECTONOPHYSICS, V611, P83, DOI 10.1016/j.tecto.2013.11.027; Hwang CW, 1996, GEOPHYS J INT, V125, P705, DOI 10.1111/j.1365-246X.1996.tb06018.x; McNutt MK, 1998, REV GEOPHYS, V36, P211, DOI 10.1029/98RG00255; Raney RK, 2011, COASTAL ALTIMETRY, P535, DOI 10.1007/978-3-642-12796-0_20; Sandwell DT, 2014, SCIENCE, V346, P65, DOI 10.1126/science.1258213; Sandwell DT., 2013, LEADING EDGE, V32, P892, DOI [DOI 10.1190/TLE32080892.1, 10.1190/tle32080892.1]; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Wingham DJ, 2006, ADV SPACE RES-SERIES, V37, P841, DOI 10.1016/j.asr.2005.07.027	12	32	35	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					32	33		10.1126/science.1260459	http://dx.doi.org/10.1126/science.1260459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278596				2022-12-28	WOS:000342446900021
J	Hinman, RS; McCrory, P; Pirotta, M; Relf, I; Forbes, A; Crossley, KM; Williamson, E; Kyriakides, M; Novy, K; Metcalf, BR; Harris, A; Reddy, P; Conaghan, PG; Bennell, KL				Hinman, Rana S.; McCrory, Paul; Pirotta, Marie; Relf, Ian; Forbes, Andrew; Crossley, Kay M.; Williamson, Elizabeth; Kyriakides, Mary; Novy, Kitty; Metcalf, Ben R.; Harris, Anthony; Reddy, Prasuna; Conaghan, Philip G.; Bennell, Kim L.			Acupuncture for Chronic Knee Pain A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OSTEOARTHRITIS; HIP; OUTCOMES; LASER; RECOMMENDATIONS; INTERVENTION; MANAGEMENT; THERAPY; WOMAC	IMPORTANCE There is debate about benefits of acupuncture for knee pain. OBJECTIVE To determine the efficacy of laser and needle acupuncture for chronic knee pain. DESIGN, SETTING, AND PARTICIPANTS Zelen-design clinical trial (randomization occurred before informed consent), in Victoria, Australia (February 2010-December 2012). Community volunteers (282 patients aged >= 50 years with chronic knee pain) were treated by family physician acupuncturists. INTERVENTIONS No acupuncture (control group, n = 71) and needle (n = 70), laser (n = 71), and sham laser (n = 70) acupuncture. Treatments were delivered for 12 weeks. Participants and acupuncturists were blinded to laser and sham laser acupuncture. Control participants were unaware of the trial. MAIN OUTCOMES AND MEASURES Primary outcomes were average knee pain (numeric rating scale, 0 [no pain] to 10 [worst pain possible]; minimal clinically important difference [MCID], 1.8 units) and physical function (Western Ontario and McMaster Universities Osteoarthritis Index, 0 [no difficulty] to 68 [extreme difficulty]; MCID, 6 units) at 12 weeks. Secondary outcomes included other pain and function measures, quality of life, global change, and 1-year follow-up. Analyses were by intention-to-treat using multiple imputation for missing outcome data. RESULTS At 12 weeks and 1 year, 26 (9%) and 50 (18%) participants were lost to follow-up, respectively. Analyses showed neither needle nor laser acupuncture significantly improved pain (mean difference; -0.4 units; 95% CI, -1.2 to 0.4, and -0.1; 95% CI, -0.9 to 0.7, respectively) or function (-1.7; 95% CI, -6.1 to 2.6, and 0.5; 95% CI, -3.4 to 4.4, respectively) compared with sham at 12 weeks. Compared with control, needle and laser acupuncture resulted in modest improvements in pain (-1.1; 95% CI, -1.8 to -0.4, and -0.8; 95% CI, -1.5 to -0.1, respectively) at 12 weeks, but not at 1 year. Needle acupuncture resulted in modest improvement in function compared with control at 12 weeks (-3.9; 95% CI, -7.7 to -0.2) but was not significantly different from sham (-1.7; 95% CI, -6.1 to 2.6) and was not maintained at 1 year. There were no differences for most secondary outcomes and no serious adverse events. CONCLUSIONS AND RELEVANCE In patients older than 50 years with moderate or severe chronic knee pain, neither laser nor needle acupuncture conferred benefit over sham for pain or function. Our findings do not support acupuncture for these patients. Copyright 2014 American Medical Association. All rights reserved.	[Hinman, Rana S.; McCrory, Paul; Metcalf, Ben R.; Bennell, Kim L.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Physiotherapy, Ctr Hlth Exercise & Sports Med,Sch Hlth Sci, Melbourne, Vic 3010, Australia; [McCrory, Paul] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Pirotta, Marie; Relf, Ian; Kyriakides, Mary; Novy, Kitty] Univ Melbourne, Fac Med Dent & Hlth Sci, Sch Med, Dept Gen Practice, Melbourne, Vic 3010, Australia; [Forbes, Andrew] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Crossley, Kay M.] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld, Australia; [Williamson, Elizabeth] Farr Inst Hlth Informat Res, London, England; [Williamson, Elizabeth] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Harris, Anthony] Monash Univ, Fac Business & Econ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia; [Reddy, Prasuna] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Conaghan, Philip G.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Conaghan, Philip G.] NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; Monash University; University of Newcastle; University of Leeds; Leeds Biomedical Research Centre	Hinman, RS (corresponding author), Univ Melbourne, Sch Hlth Sci, Dept Physiotherapy, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia.	ranash@unimelb.edu.au	McCrory, Paul/Q-8688-2019; Crossley, Kay M/G-4436-2010; Bennell, Kim/C-7022-2014	Harris, Anthony/0000-0003-1641-3320; Metcalf, Ben/0000-0002-4945-3217; Crossley, Kay/0000-0001-5892-129X; Forbes, Andrew/0000-0003-4269-914X; McCrory, Paul/0000-0003-4850-0568; Bennell, Kim/0000-0003-4982-5639; Reddy, Prasuna/0000-0002-0709-9352; Hinman, Rana/0000-0001-6368-9456; Conaghan, Philip/0000-0002-3478-5665; Relf, Ian/0000-0002-9708-5906	National Health and Medical Research Council [566783, 1026383, 1050830, 1004233]; Australian Research Council Future Fellowships [FT130100175, FT0991413]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowships(Australian Research Council)	This trial was funded by the National Health and Medical Research Council (project 566783). Drs Hinman and Bennell are both funded in part by Australian Research Council Future Fellowships (FT130100175 and FT0991413, respectively). Dr McCrory is funded in part by a National Health and Medical Research Council Practitioner Fellowship (1026383). Dr Pirotta is funded in part by a National Health and Medical Research Council Career Development Fellowship (1050830). Dr Williamson was funded in part by a National Health and Medical Research Council grant (1004233).	Abhishek A, 2013, OSTEOARTHR CARTILAGE, V21, P1229, DOI 10.1016/j.joca.2013.04.018; Adamson J, 2006, CONTEMP CLIN TRIALS, V27, P305, DOI 10.1016/j.cct.2005.11.003; American Academy of Orthopaedic Surgeons, TREATM OST KNEE EV B; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; [Anonymous], 1984, LANCET, V1, P1445; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Baxter GD, 2008, J ACUPUNCT MERIDIAN, V1, P65, DOI 10.1016/S2005-2901(09)60026-1; BELLAMY N, 1992, J RHEUMATOL, V19, P451; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bishop FL, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-102; CHANG RW, 1990, J BONE JOINT SURG AM, V72A, P1451, DOI 10.2106/00004623-199072100-00004; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; Hinman RS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-161; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Ilbuldu E, 2004, PHOTOMED LASER SURG, V22, P306; Irnich D, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq009; Jinks C, 2004, RHEUMATOLOGY, V43, P55, DOI 10.1093/rheumatology/keg438; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Lund Irene, 2006, Acupunct Med, V24, P13; MacPherson Hugh, 2010, J Evid Based Med, V3, P140, DOI 10.1111/j.1756-5391.2010.01086.x; MacPherson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077438; Mantyselka P, 2001, PAIN, V89, P175, DOI 10.1016/S0304-3959(00)00361-4; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Quilty B, 2003, J RHEUMATOL, V30, P1311; Relf I, 2008, EVID-BASED COMPL ALT, V5, P383, DOI 10.1093/ecam/nem085; Sherman KJ, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-114; Stuart E, 2008, PREV SCI, V9, P288, DOI 10.1007/s11121-008-0104-y; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Witt CM, 2013, COMPLEMENT THER MED, V21, P112, DOI 10.1016/j.ctim.2012.12.005; Yousefi-Nooraie R, 2007, COCHRANE DB SYST REV, V2; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015	38	150	189	7	94	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1313	1322		10.1001/jama.2014.12660	http://dx.doi.org/10.1001/jama.2014.12660			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268438	Green Published, Green Accepted			2022-12-28	WOS:000342345400017
J	Kicheva, A; Bollenbach, T; Ribeiro, A; Valle, HP; Lovell-Badge, R; Episkopou, V; Briscoe, J				Kicheva, Anna; Bollenbach, Tobias; Ribeiro, Ana; Valle, Helena Perez; Lovell-Badge, Robin; Episkopou, Vasso; Briscoe, James			Coordination of progenitor specification and growth in mouse and chick spinal cord	SCIENCE			English	Article							CYCLIN-DEPENDENT KINASES; PATTERN-FORMATION; SIZE REGULATION; NEURAL-TUBE; CELL; GRADIENT; EMBRYO; EXPRESSION; DIFFERENTIATION; ORIENTATION	Development requires tissue growth as well as cell diversification. To address how these processes are coordinated, we analyzed the development of molecularly distinct domains of neural progenitors in the mouse and chick neural tube. We show that during development, these domains undergo changes in size that do not scale with changes in overall tissue size. Our data show that domain proportions are first established by opposing morphogen gradients and subsequently controlled by domain-specific regulation of differentiation rate but not differences in proliferation rate. Regulation of differentiation rate is key to maintaining domain proportions while accommodating both intra- and interspecies variations in size. Thus, the sequential control of progenitor specification and differentiation elaborates pattern without requiring that signaling gradients grow as tissues expand.	[Kicheva, Anna; Ribeiro, Ana; Valle, Helena Perez; Lovell-Badge, Robin; Briscoe, James] Natl Inst Med Res, MRC, London NW7 1AA, England; [Bollenbach, Tobias] IST Austria, A-3400 Klosterneuburg, Austria; [Valle, Helena Perez] Univ London Imperial Coll Sci Technol & Med, London, England; [Lovell-Badge, Robin] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Lovell-Badge, Robin] UCL, Fac Life Sci, Div Biosci, London WC1E 6BT, England; [Episkopou, Vasso] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, London SW7 2AZ, England	MRC National Institute for Medical Research; Institute of Science & Technology - Austria; Imperial College London; University of Hong Kong; University of London; University College London; Imperial College London	Briscoe, J (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jbrisco@nimr.mrc.ac.uk	Bollenbach, Tobias/AAK-3206-2020	Bollenbach, Tobias/0000-0003-4398-476X; Lovell-Badge, Robin/0000-0001-9364-4179; Briscoe, James/0000-0002-1020-5240; Kicheva, Anna/0000-0003-4509-4998; Ribeiro, Ana/0000-0003-0132-9740	Medical Research Council (MRC) [U117560541]; Wellcome Trust [WT098326MA]; Federation of European Biochemical Societies; Marie-Curie fellowship; MRC fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016629] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G00577X/1, BB/G00577X/2] Funding Source: researchfish; Medical Research Council [MC_U117560541] Funding Source: researchfish; BBSRC [BB/G00577X/1, BB/G00577X/2] Funding Source: UKRI; MRC [MC_U117560541] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Federation of European Biochemical Societies; Marie-Curie fellowship(European Commission); MRC fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Simons, C. Tabin, A. Ugur, M. Gonzalez-Gaitan, N. Bushati, and M. Cohen for comments on the manuscript; B. Simons and G. Zhang for discussions and help with the clonal analysis; R. Perez and S. Loubery for discussions; S. Booth, C. Scott, C. Galichet, S. Malas, K. L. Lee, and A. Ekonomou for generating the Sox1<SUP>CreER</SUP> strain; X. Cao, T. Sauka-Spengler, E. Laufer, J. Chelly, T. Jessell, C. Tickle, O. Pourquie, and M. Gotz for providing reagents; and N. Mousavy for technical assistance. This work was funded by the Medical Research Council (MRC) (U117560541) and the Wellcome Trust (WT098326MA). A. K. was supported by Federation of European Biochemical Societies, Marie-Curie, and MRC fellowships. The supplementary materials contain additional data. Author contributions: A. K. performed the experiments. A. K. and J. B. conceived the work, analyzed the data, and wrote the manuscript. T. B. analyzed the gradient dynamics and helped with the quantitative analysis. A. R. analyzed the patterning dynamics. H. P. V. participated in the photoactivation and live imaging. V. E. and R.L.-B. contributed the Sox1<SUP>CroER</SUP> mouse.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Cheung D, 2014, DEVELOPMENT, V141, P124, DOI 10.1242/dev.098640; Das RM, 2014, SCIENCE, V343, P200, DOI 10.1126/science.1247521; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; Erhardt JA, 1998, J BIOL CHEM, V273, P23517, DOI 10.1074/jbc.273.36.23517; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; Forer A, 1998, CHROMOSOME RES, V6, P533, DOI 10.1023/A:1009224322399; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Huang P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002762; Inomata H, 2013, CELL, V153, P1296, DOI 10.1016/j.cell.2013.05.004; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; Januschke J, 2010, J CELL BIOL, V188, P693, DOI 10.1083/jcb.200905024; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kicheva A, 2012, SCIENCE, V338, P210, DOI 10.1126/science.1225182; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; LEWIS NE, 1982, J EMBRYOL EXP MORPH, V72, P169; Marklund U, 2010, DEVELOPMENT, V137, P437, DOI 10.1242/dev.036806; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Martynoga B, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008359; Megason SG, 2002, DEVELOPMENT, V129, P2087; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; RANDS GF, 1986, J EMBRYOL EXP MORPH, V98, P209; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Ribes V, 2010, GENE DEV, V24, P1186, DOI 10.1101/gad.559910; Saade M, 2013, CELL REP, V4, P492, DOI 10.1016/j.celrep.2013.06.038; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sasai N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001907; SMITH CL, 1962, NATURE, V193, P555, DOI 10.1038/193555a0; Southard J., 1977, MOUSE NEWS LETT, V56, P40; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Yamaguchi Y, 2011, J CELL BIOL, V195, P1047, DOI 10.1083/jcb.201104057	56	88	88	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1577	+	1254927	10.1126/science.1254927	http://dx.doi.org/10.1126/science.1254927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258086	Green Accepted			2022-12-28	WOS:000342164500032
J	Saeed, S; Quintin, J; Kerstens, HHD; Rao, NA; Aghajanirefah, A; Matarese, F; Cheng, SC; Ratter, J; Berentsen, K; van der Ent, MA; Sharifi, N; Janssen-Megens, EM; Ter Huurne, M; Mandoli, A; van Schaik, T; Ng, A; Burden, F; Downes, K; Frontini, M; Kumar, V; Giamarellos-Bourboulis, EJ; Ouwehand, WH; van der Meer, JWM; Joosten, LAB; Wijmenga, C; Martens, JHA; Xavier, RJ; Logie, C; Netea, MG; Stunnenberg, HG				Saeed, Sadia; Quintin, Jessica; Kerstens, Hindrik H. D.; Rao, Nagesha A.; Aghajanirefah, Ali; Matarese, Filomena; Cheng, Shih-Chin; Ratter, Jacqueline; Berentsen, Kim; van der Ent, Martijn A.; Sharifi, Nilofar; Janssen-Megens, Eva M.; Ter Huurne, Menno; Mandoli, Amit; van Schaik, Tom; Ng, Aylwin; Burden, Frances; Downes, Kate; Frontini, Mattia; Kumar, Vinod; Giamarellos-Bourboulis, Evangelos J.; Ouwehand, Willem H.; van der Meer, Jos W. M.; Joosten, Leo A. B.; Wijmenga, Cisca; Martens, Joost H. A.; Xavier, Ramnik J.; Logie, Colin; Netea, Mihai G.; Stunnenberg, Hendrik G.			Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity	SCIENCE			English	Article							LIVER X RECEPTOR; NF-KAPPA-B; GENE-EXPRESSION; DENDRITIC CELLS; HOST-DEFENSE; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; HUMAN GENOME; IRAK-M; INFLAMMATION	Monocyte differentiation into macrophages represents a cornerstone process for host defense. Concomitantly, immunological imprinting of either tolerance or trained immunity determines the functional fate of macrophages and susceptibility to secondary infections. We characterized the transcriptomes and epigenomes in four primary cell types: monocytes and in vitro-differentiated naive, tolerized, and trained macrophages. Inflammatory and metabolic pathways were modulated in macrophages, including decreased inflammasome activation, and we identified pathways functionally implicated in trained immunity. beta-glucan training elicits an exclusive epigenetic signature, revealing a complex network of enhancers and promoters. Analysis of transcription factor motifs in deoxyribonuclease I hypersensitive sites at cell-type-specific epigenetic loci unveiled differentiation and treatment-specific repertoires. Altogether, we provide a resource to understand the epigenetic changes that underlie innate immunity in humans.	[Saeed, Sadia; Kerstens, Hindrik H. D.; Rao, Nagesha A.; Aghajanirefah, Ali; Matarese, Filomena; Berentsen, Kim; van der Ent, Martijn A.; Sharifi, Nilofar; Janssen-Megens, Eva M.; Ter Huurne, Menno; Mandoli, Amit; van Schaik, Tom; Martens, Joost H. A.; Logie, Colin; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Saeed, Sadia; Kerstens, Hindrik H. D.; Rao, Nagesha A.; Aghajanirefah, Ali; Matarese, Filomena; Berentsen, Kim; van der Ent, Martijn A.; Sharifi, Nilofar; Janssen-Megens, Eva M.; Ter Huurne, Menno; Mandoli, Amit; van Schaik, Tom; Martens, Joost H. A.; Logie, Colin; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Med, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Quintin, Jessica; Cheng, Shih-Chin; Ratter, Jacqueline; van der Meer, Jos W. M.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA 02142 USA; [Burden, Frances; Downes, Kate; Frontini, Mattia; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Burden, Frances; Downes, Kate; Frontini, Mattia; Ouwehand, Willem H.] Blood & Transplant Cambridge Ctr, Natl Hlth Serv, Cambridge CB0 2PT, England; [Kumar, Vinod; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Giamarellos-Bourboulis, Evangelos J.] Univ Athens, Sch Med 1, Dept Internal Med 4, Athens 12462, Greece	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Groningen; National & Kapodistrian University of Athens	Stunnenberg, HG (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.	c.logie@ncmls.ru.nl; mihai.netea@radboudumc.nl; h.stunnenberg@ncmls.ru.nl	Logie, Colin/L-9833-2019; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; Martens, Joost/D-4966-2012; van der Meer, Jos W.M./C-8521-2013; Logie, Colin/A-1528-2010; Ratter-Rieck, Jacqueline M/G-6301-2016; Joosten, Leo AB/H-3138-2015; Kumar, Vinod/ABC-4866-2020; Schaik, Tom/ABD-5197-2020; Stunnenberg, Hendrik G./D-6875-2012; CHENG, SHIH-CHIN/M-3773-2019; Netea, Mihai/N-5155-2014; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Ng, Aylwin/AAQ-6478-2020	Logie, Colin/0000-0002-8534-6582; Martens, Joost/0000-0003-2008-6537; van der Meer, Jos W.M./0000-0001-5120-3690; Logie, Colin/0000-0002-8534-6582; Ratter-Rieck, Jacqueline M/0000-0002-3807-9442; Joosten, Leo AB/0000-0001-6166-9830; Kumar, Vinod/0000-0002-2775-6049; Schaik, Tom/0000-0001-7850-5074; Stunnenberg, Hendrik G./0000-0002-0066-1576; CHENG, SHIH-CHIN/0000-0003-1251-8774; Wijmenga, Cisca/0000-0002-5635-1614; Saeed, Sadia/0000-0002-6587-6543; Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911; Ouwehand, Willem/0000-0002-7744-1790	European Union [282510-BLUEPRINT]; Netherlands Organization for Scientific Research; ERC [310372]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10151, NF-SI-0510-10214, RP-PG-0310-1002] Funding Source: researchfish	European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors are grateful to J. Stamatoyannopoulos for help with DNaseI-seq. We thank S. van Heeringen for access to his databases and expertise. The research leading to the results described in this manuscript has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 282510-BLUEPRINT. M.G.N. was supported by a Vici grant of the Netherlands Organization for Scientific Research and an ERC Consolidator Grant (no. 310372) and J.H.A.M by a VIDI grant of the Netherlands Organization for Scientific Research. All the genome-wide data generated and analyzed in this study, as well as the sequencing details, can be accessed via GEO accession no. GSE58310.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dong CS, 2013, GENE, V519, P279, DOI 10.1016/j.gene.2013.02.015; Endo-Umeda K, 2014, J STEROID BIOCHEM, V140, P7, DOI 10.1016/j.jsbmb.2013.11.010; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gunthner R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/731023; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hotz B, 2010, J GASTROINTEST SURG, V14, P388, DOI 10.1007/s11605-009-1068-3; Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Khuu CH, 2007, MOL IMMUNOL, V44, P1598, DOI 10.1016/j.molimm.2006.08.006; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kohro T, 2000, J Atheroscler Thromb, V7, P145; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Li JN, 2007, J LEUKOCYTE BIOL, V81, P328, DOI 10.1189/jlb.0206124; Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shen M, 2001, EUR J CELL BIOL, V80, P329, DOI 10.1078/0171-9335-00167; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Turro E, 2014, BIOINFORMATICS, V30, P180, DOI 10.1093/bioinformatics/btt624; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Heeringen SJ, 2011, BIOINFORMATICS, V27, P270, DOI 10.1093/bioinformatics/btq636; WENGER GD, 1985, J IMMUNOL, V134, P1836; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	68	904	921	17	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1578	+	1251086	10.1126/science.1251086	http://dx.doi.org/10.1126/science.1251086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258085	Green Accepted			2022-12-28	WOS:000342164500033
J	Muller, FJ; Loring, JF				Mueller, Franz-Josef; Loring, Jeanne F.			A compass for stem-cell differentiation	NATURE			English	Editorial Material							DEFINED FACTORS; DIRECT CONVERSION; FIBROBLASTS		[Mueller, Franz-Josef] Univ Klinikum Schleswig Holstein, Zentrum Integrat Psychiat Kiel, D-24105 Kiel, Germany; [Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA	University of Kiel; Schleswig Holstein University Hospital; Scripps Research Institute	Muller, FJ (corresponding author), Univ Klinikum Schleswig Holstein, Zentrum Integrat Psychiat Kiel, D-24105 Kiel, Germany.	fj.mueller@zip-kiel.de; jloring@scripps.edu	Müller, Franz-Josef/E-3336-2010; Loring, Jeanne/A-1620-2011	Müller, Franz-Josef/0000-0001-9478-8430; Loring, Jeanne/0000-0001-6226-9767				Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Slack JMW, 2002, NAT REV GENET, V3, P889, DOI 10.1038/nrg933; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waddington C., 1957, STRATEGY GENES	9	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					498	499		10.1038/513498a	http://dx.doi.org/10.1038/513498a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254472				2022-12-28	WOS:000342075800029
J	Holmes, D				Holmes, David			Profile Mary Renfrew: researcher, reformer, midwife	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1089	1089		10.1016/S0140-6736(14)61664-0	http://dx.doi.org/10.1016/S0140-6736(14)61664-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PU	25241711				2022-12-28	WOS:000342630600018
J	Maruani, A; Boutron, I; Baron, G; Ravaud, P				Maruani, Annabel; Boutron, Isabelle; Baron, Gabriel; Ravaud, Philippe			Impact of sending email reminders of the legal requirement for posting results on ClinicalTrials.gov: cohort embedded pragmatic randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REDUCING WASTE; REGISTRATION; PUBLICATION; EDITORS; DRUGS	Objective To evaluate the impact of sending an email to responsible parties of completed trials that do not comply with the Food and Drug Administration Amendments Act 801 legislation, to remind them of the legal requirement to post results. Design Cohort embedded pragmatic randomized controlled trial. Setting Trials registered on ClinicalTrials.gov. Participants 190 out of 379 trials randomly selected by computer generated randomization list to receive the intervention (personalized emails structured as a survey and sent by one of us to responsible parties of the trials, indirectly reminding them of the legal requirement and potential penalties for non-compliance). Main outcome measures The primary outcome was the proportion of results posted on ClinicalTrials.gov at three months. The secondary outcome was the proportion posted at six months. In a second step, two assessors blinded to the intervention group collected the date of the first results being received on ClinicalTrials.gov. A post hoc sensitivity analysis excluding trials wrongly included was performed. Results Among 379 trials included, 190 were randomized to receive the email intervention. The rate of posting of results did not differ at three months between trials with or without the intervention: 36/190 (19%) v 24/189 (13%), respectively (relative risk 1.5, 95% confidence interval 0.9 to 2.4, P=0.096) but did at six months: 46/190 (24%) v 27/189 (14%), 1.7, 1.1 to 2.6, P=0.014. In the sensitivity analysis, which excluded 48/379 trials (13%), 26/190 (14%) and 22/189 (12%), respectively, results were significant at three months (relative risk 5.1, 1.1 to 22.9, P=0.02) and at six months (4.1, 1.3 to 10.6, P=0.001). Conclusions Sending email reminders about the FDA's legal requirement to post results at ClinicalTrials.gov improved significantly the posting rate at six months but not at three months.	[Maruani, Annabel; Boutron, Isabelle; Baron, Gabriel; Ravaud, Philippe] Univ Paris 05, Sorbonne Paris Cite, Hop Hotel Dieu, AP HP,Ctr Epidemiol Clin,INSERM,U1153, F-75181 Paris 04, France; [Ravaud, Philippe] French Cochrane Ctr, Paris, France; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Columbia University	Ravaud, P (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Hop Hotel Dieu, AP HP,Ctr Epidemiol Clin,INSERM,U1153, 1 Pl Parvis Notre Dame, F-75181 Paris 04, France.	philippe.ravaud@htd.aphp.fr	ravaud, philippe/C-1694-2009	Maruani, Annabel/0000-0003-3734-810X; Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241				Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Gill CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001186; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Gopal RK, 2012, CONTEMP CLIN TRIALS, V33, P486, DOI 10.1016/j.cct.2012.02.001; Holtz RL, 2012, WHAT YOU DONT KNOW D; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5905; Lehman R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8158; Lester M, 2011, J CLIN RES BEST PRAC, V7, P1; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; R Core Team, 2012, R LANG ENV STAT COMP; Relton C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1066; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Nguyen TAH, 2013, J CLIN ONCOL, V31, P2998, DOI 10.1200/JCO.2012.46.9577; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; Wadman M., 2012, NATURE NEWS, DOI [10.1038/nature.2012.10549, DOI 10.1038/NATURE.2012.10549]; Wager E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5248; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	19	14	14	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2014	349								g5579	10.1136/bmj.g5579	http://dx.doi.org/10.1136/bmj.g5579			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4PK	25239625	Green Published, hybrid			2022-12-28	WOS:000342060000007
J	Caldentey, CV				Caldentey, C. Vicens			In long-term benzodiazepine users, primary care-based, structured, tapering interventions reduced use	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Centro Salud Son Serra Vileta, Balearic Islands, Spain		Caldentey, CV (corresponding author), Centro Salud Son Serra Vileta, Balearic Islands, Spain.	caterina-vicens@gmail.com							0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC3	10.7326/0003-4819-161-6-201409160-02003	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222415				2022-12-28	WOS:000343894400002
J	Winkelmayer, WC				Winkelmayer, Wolfgang C.			Review: In CKD, novel oral anticoagulants do not differ from vitamin K antagonists for efficacy or bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Winkelmayer, WC (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.								0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC10	10.7326/0003-4819-161-6-201409160-02010	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222410				2022-12-28	WOS:000343894400009
J	Heath, B				Heath, Bob			The art of medicine "Hello it's me...why aren't you there?"	LANCET			English	Editorial Material												Bob.heath.therapy@gmail.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					948	949		10.1016/S0140-6736(14)61618-4	http://dx.doi.org/10.1016/S0140-6736(14)61618-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9ML	25225702				2022-12-28	WOS:000341679700013
J	Squiers, W				Squiers, William			Emergency preservation and resuscitation: a Lazarus trial?	LANCET			English	Editorial Material							EXSANGUINATION; ARREST		Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Squiers, W (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	w.squiers@princeton.edu						Acute Care Research, EM PRES RES CARD ARR; Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; [Anonymous], EM PRES RES EPR CARD; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Shaw D., 2014, LANCET; United States Department of Health and Human Services, 2013, GUID I REV BOARDS CL; Wu XR, 2008, J CEREBR BLOOD F MET, V28, P302, DOI 10.1038/sj.jcbfm.9600524	7	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					939	939		10.1016/S0140-6736(14)61410-0	http://dx.doi.org/10.1016/S0140-6736(14)61410-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9ML	25220961				2022-12-28	WOS:000341679700008
J	Topisirovic, I; Sonenberg, N				Topisirovic, Ivan; Sonenberg, Nahum			Distinctive tRNA Repertoires in Proliferating versus Differentiating Cells	CELL			English	Editorial Material							CANCER; EXPRESSION		[Topisirovic, Ivan] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Topisirovic, Ivan] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Topisirovic, I (corresponding author), McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	ivan.topisirovic@mcgill.ca; nahum.sonenberg@mcgill.ca	Topisirovic, Ivan/A-9426-2008	Topisirovic, Ivan/0000-0002-5510-9762				Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Marshall L, 2012, EMBO J, V31, P1916, DOI 10.1038/emboj.2012.33; Pavon-Eternod M, 2013, RNA, V19, P461, DOI 10.1261/rna.037507.112; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Yona AH, 2013, ELIFE, V2, DOI 10.7554/eLife.01339	10	10	11	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1238	1239		10.1016/j.cell.2014.08.031	http://dx.doi.org/10.1016/j.cell.2014.08.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215483	Bronze, Green Published			2022-12-28	WOS:000343094200006
J	Williams, GS				Williams, Gwyn Samuel			Irlen syndrome: expensive lenses for this ill defined syndrome exploit patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Singleton Hosp, ST6 Ophthalmol, Swansea SA2 8QA, W Glam, Wales	Singleton Hospital	Williams, GS (corresponding author), Singleton Hosp, ST6 Ophthalmol, Swansea SA2 8QA, W Glam, Wales.	gwynwilliams@doctors.org.uk						COTTON MM, 1990, AUST NZ J OPHTHALMOL, V18, P307, DOI 10.1111/j.1442-9071.1990.tb00625.x; Hyatt K. J., 2009, EDUC TREAT CHILD, V32, P313, DOI DOI 10.1353/ETC.0.0054; Kriss I, 2005, J RES READ, V28, P350, DOI 10.1111/j.1467-9817.2005.00274.x; Ritchie SJ, 2011, PEDIATRICS, V128, pE932, DOI 10.1542/peds.2011-0314; Robinson GL, 2001, PERCEPT MOTOR SKILL, V93, P486, DOI 10.2466/PMS.93.6.486-504; Vidal-Lopez J, 2011, PERCEPT MOTOR SKILL, V112, P770, DOI 10.2466/15.19.24.PMS.112.3.770-782	6	1	1	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4872	10.1136/bmj.g4872	http://dx.doi.org/10.1136/bmj.g4872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25239616				2022-12-28	WOS:000339906000011
J	Hamer, DH; Chen, LH				Hamer, Davidson H.; Chen, Lin H.			Chikungunya: Establishing a New Home in the Western Hemisphere	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; Mt Auburn Hosp, Cambridge, MA USA	Boston University; Harvard University; Mount Auburn Hospital	Hamer, DH (corresponding author), Ctr Global Hlth & Dev, 801 Massachusetts Ave,Crosstown Third Floor, Boston, MA 02118 USA.	dhamer@bu.edu	Hamer, Davidson Howes/J-2020-2019; Chen, Lin/ADS-6751-2022	Hamer, Davidson Howes/0000-0002-4700-1495; Chen, Lin/0000-0002-5684-8436				Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; Khan K., 2014, PLOS CURR, V6, DOI [10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5, DOI 10.1371/CURRENTS.OUTBREAKS.2134A0A7BF37FD8D388181539FEA2DA5]; Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268; Pan American Health Organization, 2014, CHIK; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]	10	21	21	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					827	U118		10.7326/M14-1958	http://dx.doi.org/10.7326/M14-1958			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UJ	25244354				2022-12-28	WOS:000347247200012
J	Zovkic, IB; Paulukaitis, BS; Day, JJ; Etikala, DM; Sweatt, JD				Zovkic, Iva B.; Paulukaitis, Brynna S.; Day, Jeremy J.; Etikala, Deepa M.; Sweatt, J. David			Histone H2A.Z subunit exchange controls consolidation of recent and remote memory	NATURE			English	Article							DNA METHYLATION; REGULATES MEMORY; GENE-EXPRESSION; TRANSCRIPTION; ACETYLATION; NUCLEOSOMES; PLASTICITY; PATHWAY; BRAIN	Memory formation is a multi-stage process that initially requires cellular consolidation in the hippocampus, after which memories are downloaded to the cortex for maintenance, in a process termed systems consolidation(1). Epigenetic mechanisms regulate both types of consolidation(2-7), but histone variant exchange, in which canonical histones are replaced with their variant counterparts, is an entire branch of epigenetics that has received limited attention in the brain(8-12) and has never, to our knowledge, been studied in relation to cognitive function. Here we show that histone H2A.Z, a variant of histone H2A, is actively exchanged in response to fear conditioning in the hippocampus and the cortex, where it mediates gene expression and restrains the formation of recent and remote memory. Our data provide evidence for H2A.Z involvement in cognitive function and specifically implicate H2A.Z as a negative regulator of hippocampal consolidation and systems consolidation, probably through downstream effects on gene expression. Moreover, alterations in H2A.Z binding at later stages of systems consolidation suggest that this histone has the capacity to mediate stable molecular modifications required for memory retention. Overall, our data introduce histone variant exchange as a novel mechanism contributing to the molecular basis of cognitive function and implicate H2A.Z as a potential therapeutic target for memory disorders.	[Zovkic, Iva B.; Paulukaitis, Brynna S.; Day, Jeremy J.; Etikala, Deepa M.; Sweatt, J. David] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Zovkic, Iva B.; Paulukaitis, Brynna S.; Day, Jeremy J.; Etikala, Deepa M.; Sweatt, J. David] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@uab.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399; Sweatt, J. David/0000-0003-3567-485X; Zovkic, Iva/0000-0002-4497-6334	DARPA [HR0011-12-1-0015]; NIH [MH091122, MH57014]; NSERC-PDF [PDF 387473-10]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014, R01MH091122] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC-PDF(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors' work is supported by DARPA grant HR0011-12-1-0015 and NIH grants MH091122, MH57014 (J.D.S.) and NSERC-PDF grant PDF 387473-10 (I.B.Z.). We would like to thank F. Sultan for providing RNA primers and K. Alison Margolies for providing the immunohistochemistry images.	Baptista T, 2013, ONCOTARGET, V4, P1673, DOI 10.18632/oncotarget.1237; Bargaje R, 2012, NUCLEIC ACIDS RES, V40, P8965, DOI 10.1093/nar/gks665; Bellucci L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054102; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; Chauhan S, 2012, NUCLEIC ACIDS RES, V40, P600, DOI 10.1093/nar/gkr725; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Michod D, 2012, NEURON, V74, P122, DOI 10.1016/j.neuron.2012.02.021; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Nock A, 2012, MOL CELL, V48, P837, DOI 10.1016/j.molcel.2012.10.009; PINA B, 1987, DEV BIOL, V123, P51, DOI 10.1016/0012-1606(87)90426-X; Santoro SW, 2012, ELIFE, V1, DOI 10.7554/eLife.00070; Schauer T, 2013, CELL REP, V5, P271, DOI 10.1016/j.celrep.2013.09.001; Smith AP, 2010, PLANT PHYSIOL, V152, P217, DOI 10.1104/pp.109.145532; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014	28	110	114	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					582	+		10.1038/nature13707	http://dx.doi.org/10.1038/nature13707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25219850	Green Accepted			2022-12-28	WOS:000346247600002
J	Kovatch, KJ				Kovatch, Kevin J.			Graduation Gift	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Kovatch, KJ (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	kovatch@upenn.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1301	1302		10.1001/jama.2014.10544	http://dx.doi.org/10.1001/jama.2014.10544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268435				2022-12-28	WOS:000342345400014
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Don't blame us	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTRATHECAL VINCRISTINE					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Gilbar Peter, 2012, J Oncol Pharm Pract, V18, P377, DOI 10.1177/1078155212453752; Gilbar Peter, 2012, J Oncol Pharm Pract, V18, P155, DOI 10.1177/1078155210396396; Reddy GK, 2011, CLIN NEUROL NEUROSUR, V113, P68, DOI 10.1016/j.clineuro.2010.08.008; SCHOCHE SS, 1968, J NEUROPATH EXP NEUR, V27, P645; The National Advisory Group on the Safety of Patients in England, 2013, PROMISE LEARN COMMIT; Toft B, 2001, EXT ENQ ADV INC OCC	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2014	349								g5884	10.1136/bmj.g5884	http://dx.doi.org/10.1136/bmj.g5884			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CA	25269697	Bronze, Green Published			2022-12-28	WOS:000342665100011
J	Sherman, MH; Yu, RT; Engle, DD; Ding, N; Atkins, AR; Tiriac, H; Collisson, EA; Connor, F; Van Dyke, T; Kozlov, S; Martin, P; Tseng, TW; Dawson, DW; Donahue, TR; Masamune, A; Shimosegawa, T; Apte, MV; Wilson, JS; Ng, B; Lau, SL; Gunton, JE; Wahl, GM; Hunter, T; Drebin, JA; O'Dwyer, PJ; Liddle, C; Tuveson, DA; Downes, M; Evans, RM				Sherman, Mara H.; Yu, Ruth T.; Engle, Dannielle D.; Ding, Ning; Atkins, Annette R.; Tiriac, Herve; Collisson, Eric A.; Connor, Frances; Van Dyke, Terry; Kozlov, Serguei; Martin, Philip; Tseng, Tiffany W.; Dawson, David W.; Donahue, Timothy R.; Masamune, Atsushi; Shimosegawa, Tooru; Apte, Minoti V.; Wilson, Jeremy S.; Ng, Beverly; Lau, Sue Lynn; Gunton, Jenny E.; Wahl, Geoffrey M.; Hunter, Tony; Drebin, Jeffrey A.; O'Dwyer, Peter J.; Liddle, Christopher; Tuveson, David A.; Downes, Michael; Evans, Ronald M.			Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy	CELL			English	Article							DUCTAL ADENOCARCINOMA; STELLATE CELLS; MOUSE MODEL; TUMOR-STROMA; MICE LACKING; IN-VIVO; PROGRESSION; GROWTH; FIBROBLASTS; GEMCITABINE	The poor clinical outcome in pancreatic ductal adenocarcinoma (PDA) is attributed to intrinsic chemoresistance and a growth-permissive tumor micro-environment. Conversion of quiescent to activated pancreatic stellate cells (PSCs) drives the severe stromal reaction that characterizes PDA. Here, we reveal that the vitamin D receptor (VDR) is expressed in stroma from human pancreatic tumors and that treatment with the VDR ligand calcipotriol markedly reduced markers of inflammation and fibrosis in pancreatitis and human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in induced stromal remodeling, increased intratumoral gemcitabine, reduced tumor volume, and a 57% increase in survival compared to chemotherapy alone. This work describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response and suggests vitamin D priming as an adjunct in PDA therapy.	[Sherman, Mara H.; Yu, Ruth T.; Ding, Ning; Atkins, Annette R.; Tseng, Tiffany W.; Wahl, Geoffrey M.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Engle, Dannielle D.; Tiriac, Herve; Tuveson, David A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Collisson, Eric A.] Univ Calif San Francisco, Dept Med Hematol & Oncol, San Francisco, CA 94143 USA; [Connor, Frances] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Van Dyke, Terry] NCI, Ctr Adv Preclin Res, Frederick, MD 21702 USA; [Kozlov, Serguei; Martin, Philip] Leidos Biomed Inc, Frederick Natl Lab Canc Res, Ctr Adv Preclin Res, Frederick, MD 21702 USA; [Dawson, David W.; Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Masamune, Atsushi; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808574, Japan; [Apte, Minoti V.; Wilson, Jeremy S.] Univ New S Wales, South Western Sydney Clin Sch, Fac Med, Pancreat Res Grp, Sydney, NSW 2052, Australia; [Ng, Beverly; Lau, Sue Lynn; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW 2010, Australia; [Ng, Beverly; Gunton, Jenny E.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Lau, Sue Lynn; Gunton, Jenny E.] Univ Sydney, Fac Med, Sydney, NSW 2052, Australia; [Lau, Sue Lynn; Gunton, Jenny E.] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW 2145, Australia; [Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Drebin, Jeffrey A.] Hosp Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [O'Dwyer, Peter J.] Hosp Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Cold Spring Harbor Laboratory; University of California System; University of California San Francisco; Cancer Research UK; CRUK Cambridge Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tohoku University; University of New South Wales Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; University of Sydney; Salk Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Howard Hughes Medical Institute; Salk Institute	Downes, M (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	Evans, Ronald/AAF-4001-2019; Gunton, Jenny E/AAH-7719-2021; Wilson, Jeremy S/I-4586-2013; Apte, Minoti/X-2864-2019	Evans, Ronald/0000-0002-9986-5965; Wilson, Jeremy S/0000-0003-2355-8632; Apte, Minoti/0000-0003-0194-8939; Engle, Dannielle/0000-0003-1876-7675; Ng, Beverly Cheok Kuan/0000-0002-0787-9770; Yu, Ruth/0000-0002-9527-9627; Masamune, Atsushi/0000-0001-7184-7282; Atkins, Annette/0000-0003-2558-7058; Tiriac, Herve/0000-0001-5039-6750	Ruth L. Kirchstein National Research Service [T32-CA009370]; NIH [HL105278, DK0577978, DK090962, CA014195, ES010337]; Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Stand Up to Cancer Dream Team Translational Cancer Research Grant; Program of the Entertainment Industry Foundation [SU2C-AACR-DT0509]; National Health and Medical Research Council of Australia [512354, 632886, 1043199]; Cancer Council of NSW; Japan Society for the Promotion of Science [23591008]; Lustgarten Foundation; NATIONAL CANCER INSTITUTE [P30CA014195, P30CA045508, T32CA148056, T32CA009370, P01CA163200] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, R24DK090962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	Ruth L. Kirchstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Stand Up to Cancer Dream Team Translational Cancer Research Grant; Program of the Entertainment Industry Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of NSW(Cancer Council New South Wales); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Lustgarten Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank E. Ong and C. Brondos for administrative support; M. Baran, T. Guerin, J. Schlomer, J. Kalen, L. Riffel, P. Mackin, S. Kaufman, J. Alvarez, and H. Juguilon for technical assistance; and D. von Hoff and T. Bapiro for discussion. We thank T. Guerin and J. Schlomer for efficacy studies done at the Center for Advanced Preclinical Research (CAPR), the Center for Cancer Research, the National Cancer Institute. M.H.S. was supported by a Ruth L. Kirchstein National Research Service Award (T32-CA009370). This work was funded by grants from the NIH (HL105278, DK0577978, DK090962, CA014195, and ES010337), the Helmsley Charitable Trust, and the Samuel Waxman Cancer Research Foundation. R.M.E. and M.D. are supported in part by a Stand Up to Cancer Dream Team Translational Cancer Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0509). C.L. and M.D. are funded by grants from the National Health and Medical Research Council of Australia Project Grants 512354, 632886 and 1043199. M.A. and J.W. are funded by grants from the Cancer Council of NSW. A.M. is supported by Grant-in-Aid from Japan Society for the Promotion of Science (23591008). R.M.E. is an investigator of the Howard Hughes Medical Institute and March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute and supported by a grant from The Lustgarten Foundation.	Aikawa T, 2006, MOL CANCER THER, V5, P1108, DOI 10.1158/1535-7163.MCT-05-0516; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bapiro TE, 2011, CANCER CHEMOTH PHARM, V68, P1243, DOI 10.1007/s00280-011-1613-0; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cantorna MT, 1998, J NUTR, V128, P68, DOI 10.1093/jn/128.1.68; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Dowell NG, 2007, MAGN RESON MED, V58, P622, DOI 10.1002/mrm.21368; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Heinemann V, 2012, CANCER TREAT REV, V38, P843, DOI 10.1016/j.ctrv.2011.12.004; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Ma YF, 2006, J CLIN INVEST, V116, P892, DOI 10.1172/JCI25901; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Mann S, 2003, CHEM BRIT, V39, P3; Mantoni TS, 2011, CANCER RES, V71, P3453, DOI 10.1158/0008-5472.CAN-10-1633; Masamune A, 2009, J GASTROENTEROL, V44, P249, DOI 10.1007/s00535-009-0013-2; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; NAVEHMANY T, 1993, ENDOCRINOLOGY, V133, P2724, DOI 10.1210/en.133.6.2724; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Persons KS, 2010, ANTICANCER RES, V30, P1875; Phillips PA, 2003, GUT, V52, P275, DOI 10.1136/gut.52.2.275; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Rhim A.D., 2014, CANCER CELL, V25, P725; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wehr AY, 2011, PANCREAS, V40, P557, DOI 10.1097/MPA.0b013e318214efaf; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wolpin BM, 2012, CANCER EPIDEM BIOMAR, V21, P82, DOI 10.1158/1055-9965.EPI-11-0836; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Yu WD, 2010, CELL CYCLE, V9, P3022, DOI 10.4161/cc.9.15.12381; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje	62	675	703	9	142	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					80	93		10.1016/j.cell.2014.08.007	http://dx.doi.org/10.1016/j.cell.2014.08.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259922	Green Accepted, Bronze			2022-12-28	WOS:000343095000011
J	Aikawa, K; Baier, S; Frisch, A; Mark, M; Ravensbergen, C; Ferlaino, F				Aikawa, K.; Baier, S.; Frisch, A.; Mark, M.; Ravensbergen, C.; Ferlaino, F.			Observation of Fermi surface deformation in a dipolar quantum gas	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION; PHYSICS; PHASES; LIQUID; ATOMS	In the presence of isotropic interactions, the Fermi surface of an ultracold Fermi gas is spherical. Introducing anisotropic interactions can deform the Fermi surface, but the effect is subtle and challenging to observe experimentally. Here, we report on the observation of a Fermi surface deformation in a degenerate dipolar Fermi gas of erbium atoms. The deformation is caused by the interplay between strong magnetic dipole-dipole interaction and the Pauli exclusion principle. We demonstrate the many-body nature of the effect and its tunability with the Fermi energy. Our observation provides a basis for future studies on anisotropic many-body phenomena in normal and superfluid phases.	[Aikawa, K.; Baier, S.; Frisch, A.; Mark, M.; Ravensbergen, C.; Ferlaino, F.] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Aikawa, K.; Baier, S.; Frisch, A.; Mark, M.; Ravensbergen, C.; Ferlaino, F.] Univ Innsbruck, Zentrum Quantenphys, A-6020 Innsbruck, Austria; [Ravensbergen, C.; Ferlaino, F.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; Austrian Academy of Sciences	Ferlaino, F (corresponding author), Univ Innsbruck, Inst Expt Phys, Tech Str 25, A-6020 Innsbruck, Austria.	francesca.ferlaino@uibk.ac.at	Baier, Simon/B-3559-2018; Ferlaino, Francesca/E-6726-2012; Aikawa, Kiyotaka/D-4896-2016; Baier, Simon/AAV-7185-2021	Baier, Simon/0000-0002-2840-5590; Ferlaino, Francesca/0000-0002-3020-6291; Baier, Simon/0000-0002-2840-5590; Ravensbergen, Cornelis/0000-0002-5492-4167	Austrian Ministry of Science and Research (BMWF); Austrian Science Fund (FWF) [Y479-N20]; European Research Council [259435]; Lise-Meitner program of FWF; Austrian Science Fund (FWF) [Y 479] Funding Source: researchfish	Austrian Ministry of Science and Research (BMWF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Lise-Meitner program of FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to A. Pelster, M. Ueda, M. Baranov, R. Grimm, T. Pfau, B. L. Lev, and E. Fradkin for fruitful discussions. This work is supported by the Austrian Ministry of Science and Research (BMWF) and the Austrian Science Fund (FWF) through a START grant under project Y479-N20 and by the European Research Council under project 259435. K. A. is supported within the Lise-Meitner program of the FWF.	Aikawa K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.010404; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Babadi M, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.063638; Baillie D, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.023605; Baranov MA, 2012, CHEM REV, V112, P5012, DOI 10.1021/cr2003568; Baranov MA, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.013606; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Chan CK, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.023602; Cheng CH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.070404; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Fregoso BM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.205301; Fregoso BM, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103003; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Griesmaier A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160401; Gurarie V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230403; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Landau L., 1980, STAT PHYS, Vthird; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; Lu MW, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215301; Lu ZK, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033625; Miyakawa T, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.061603; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; POMERANCHUK II, 1959, SOV PHYS JETP-USSR, V8, P361; Rosenthal EP, 2014, NAT PHYS, V10, P225, DOI [10.1038/NPHYS2870, 10.1038/nphys2870]; Sogo T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055017; You L, 1999, PHYS REV A, V60, P2324, DOI 10.1103/PhysRevA.60.2324	27	75	75	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1484	1487		10.1126/science.1255259	http://dx.doi.org/10.1126/science.1255259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237096	Green Submitted			2022-12-28	WOS:000341752900036
J	Dasgupta, P; Ramanathan, V				Dasgupta, Partha; Ramanathan, Veerabhadran			Pursuit of the common good Religious institutions may mobilize public opinion and action	SCIENCE			English	Editorial Material							CLIMATE		[Dasgupta, Partha] Univ Cambridge, Fac Econ, Cambridge CB3 9DD, England; [Ramanathan, Veerabhadran] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Ramanathan, Veerabhadran] TERI Univ, Delhi 110070, India	University of Cambridge; University of California System; University of California San Diego; Scripps Institution of Oceanography; TERI University	Ramanathan, V (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA.	vramanathan@ucsd.edu						Anant TCA, 2013, GREEN NATL ACCOUNTS; Anenberg SC, 2013, ENVIRON SCI TECHNOL, V47, P3944, DOI 10.1021/es304942e; [Anonymous], 2014, PONT AC WORKSH SUST; Bhagwati J., 2013, WHY GROWTH MATTERS E; Casillas CE, 2010, SCIENCE, V330, P1181, DOI 10.1126/science.1197412; Chakravarty S, 2009, P NATL ACAD SCI USA, V106, P11884, DOI 10.1073/pnas.0905232106; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Dasgupta P., 2003, EC NONCONVEX ECOSYST; Dasgupta PS, 2013, SCIENCE, V340, P324, DOI 10.1126/science.1224664; Dreze J., 2013, UNCERTAIN GLORY INDI, DOI 10.2307/j.ctt32bcbm; Food and Agricultural Organization of the United Nations, 2003, FOOD WAST FOOTPR IMP; McNutt M, 2014, SCIENCE, V345, P1429, DOI 10.1126/science.1259742; Perrings C, 2014, OUR UNCOMMON HERITAG; Ramanathan V., 2013, EMERGENCY SOCIALLY E; Revkin A. C., 2014, NY TIMES; STARRETT DA, 1972, J ECON THEORY, V4, P180, DOI 10.1016/0022-0531(72)90148-2	16	24	24	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1457	1458		10.1126/science.1259406	http://dx.doi.org/10.1126/science.1259406			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0LM	25237092				2022-12-28	WOS:000341752900026
J	Malissa, H; Kavand, M; Waters, DP; van Schooten, KJ; Burn, PL; Vardeny, ZV; Saam, B; Lupton, JM; Boehme, C				Malissa, H.; Kavand, M.; Waters, D. P.; van Schooten, K. J.; Burn, P. L.; Vardeny, Z. V.; Saam, B.; Lupton, J. M.; Boehme, C.			Room-temperature coupling between electrical current and nuclear spins in OLEDs	SCIENCE			English	Article							MAGNETORESISTANCE; STORAGE; DEVICES; MEMORY	The effects of external magnetic fields on the electrical conductivity of organic semiconductors have been attributed to hyperfine coupling of the spins of the charge carriers and hydrogen nuclei. We studied this coupling directly by implementation of pulsed electrically detected nuclear magnetic resonance spectroscopy in organic light-emitting diodes (OLEDs). The data revealed a fingerprint of the isotope (protium or deuterium) involved in the coherent spin precession observed in spin-echo envelope modulation. Furthermore, resonant control of the electric current by nuclear spin orientation was achieved with radiofrequency pulses in a double-resonance scheme, implying current control on energy scales one-millionth the magnitude of the thermal energy.	[Malissa, H.; Kavand, M.; Waters, D. P.; van Schooten, K. J.; Vardeny, Z. V.; Saam, B.; Lupton, J. M.; Boehme, C.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Burn, P. L.] Univ Queensland, Sch Chem & Mol Biosci, Ctr Organ Photon & Elect, Brisbane, Qld 4072, Australia; [Lupton, J. M.] Univ Regensburg, Inst Expt & Angew Phys, D-93053 Regensburg, Germany	Utah System of Higher Education; University of Utah; University of Queensland; University of Regensburg	Malissa, H (corresponding author), Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.	hmalissa@physics.utah.edu; john.lupton@ur.de; boehme@physics.utah.edu	Malissa, Hans/M-4772-2016; Burn, Paul/F-5347-2010	Malissa, Hans/0000-0002-5964-3225; Burn, Paul/0000-0003-3405-3517; Waters, David/0000-0002-8255-7464	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Material Sciences and Engineering [DESC0000909]; Utah NSF-Materials Research Science and Engineering Centers program [DMR 1121252]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Material Sciences and Engineering(United States Department of Energy (DOE)); Utah NSF-Materials Research Science and Engineering Centers program	This work was funded by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Material Sciences and Engineering under Award DESC0000909. We also acknowledge the Utah NSF-Materials Research Science and Engineering Centers program (DMR 1121252) supporting the acquisition and development of the experimental facilities. P.L.B. is a University of Queensland Vice-Chancellor's Senior Research Fellow. We thank J. Yu for preparing the deuterated MEH-PPV.	Baker WJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.267601; Boehme C, 2013, NAT NANOTECHNOL, V8, P612, DOI 10.1038/nnano.2013.177; Dikanov S. A., 1992, ELECT SPIN ECHO ENVE; Fehr M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.193202; Fursman CE, 2002, J PHYS CHEM B, V106, P9679, DOI 10.1021/jp0257202; Hoehne F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.187601; Huebl H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177602; Kersten SP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.197402; Lee SY, 2011, J AM CHEM SOC, V133, P2019, DOI 10.1021/ja108352d; Li G, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.165311; Mahato RN, 2013, SCIENCE, V341, P257, DOI 10.1126/science.1237242; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; McCamey DR, 2008, NAT MATER, V7, P723, DOI 10.1038/nmat2252; McCamey DR, 2010, SCIENCE, V330, P1652, DOI 10.1126/science.1197931; McCamey DR, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125206; McCamey DR, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.017601; MIMS WB, 1977, J CHEM PHYS, V66, P5536, DOI 10.1063/1.433875; Nguyen TD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166804; Nguyen TD, 2010, NAT MATER, V9, P345, DOI [10.1038/nmat2633, 10.1038/NMAT2633]; Reufer M, 2005, NAT MATER, V4, P340, DOI 10.1038/nmat1354; Schweiger A., 2001, PRINCIPLES PULSE ELE; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Wohlgenannt M, 2012, PHYS STATUS SOLIDI-R, V6, P229, DOI 10.1002/pssr.201206129	23	74	75	2	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1487	1490		10.1126/science.1255624	http://dx.doi.org/10.1126/science.1255624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237097				2022-12-28	WOS:000341752900037
J	Rey, PF; Coltice, N; Flament, N				Rey, Patrice F.; Coltice, Nicolas; Flament, Nicolas			Spreading continents kick-started plate tectonics	NATURE			English	Article							MANTLE CONVECTION; LITHOSPHERIC MANTLE; GREENSTONE-BELT; EVOLUTION; DEFORMATION; SUBDUCTION; STRENGTH; CRUST; EARTH; CONSTRAINTS	Stresses acting on cold, thick and negatively buoyant oceanic lithosphere are thought to be crucial to the initiation of subduction and the operation of plate tectonics(1,2), which characterizes the present-day geodynamics of the Earth. Because the Earth's interior was hotter in the Archaean eon, the oceanic crust may have been thicker, thereby making the oceanic lithosphere more buoyant than at present(3), and whether subduction and plate tectonics occurred during this time is ambiguous, both in the geological record and in geodynamic models(4). Here we show that because the oceanic crust was thick and buoyant(5), early continents may have produced intra-lithospheric gravitational stresses large enough to drive their gravitational spreading, to initiate subduction at their margins and to trigger episodes of subduction. Our model predicts the co-occurrence of deep to progressively shallower mafic volcanics and arc magmatism within continents in a self-consistent geodynamic framework, explaining the enigmatic multimodal volcanism and tectonic record of Archaean cratons(6). Moreover, our model predicts a petrological stratification and tectonic structure of the sub-continental lithospheric mantle, two predictions that are consistent with xenolith(5) and seismic studies, respectively, and consistent with the existence of amid-lithospheric seismic discontinuity(7). The slow gravitational collapse of early continents could have kick-started transient episodes of plate tectonics until, as the Earth's interior cooled and oceanic lithosphere became heavier, plate tectonics became self-sustaining.	[Rey, Patrice F.; Flament, Nicolas] Univ Sydney, Earthbyte Res Grp, Sch Geosci, Sydney, NSW 2006, Australia; [Coltice, Nicolas] Univ Lyon 1, Ecole Normale Super Lyon, UMR CNRS 5276, Lab Geol Lyon, F-69622 Villeurbanne, France; [Coltice, Nicolas] Inst Univ France, F-75005 Paris, France	University of Sydney; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France	Rey, PF (corresponding author), Univ Sydney, Earthbyte Res Grp, Sch Geosci, Sydney, NSW 2006, Australia.	patrice.rey@sydney.edu.au	Flament, Nicolas/I-5904-2019; Flament, Nicolas/N-8344-2013	Flament, Nicolas/0000-0002-3237-0757; Flament, Nicolas/0000-0002-3237-0757; Coltice, Nicolas/0000-0001-5444-414X; Rey, Patrice/0000-0002-1767-8593	Australian Government; Institut Universitaire de France; European Research Council (ERC) [617588]; Statoil ASA	Australian Government(Australian GovernmentCGIAR); Institut Universitaire de France; European Research Council (ERC)(European Research Council (ERC)); Statoil ASA	We thank W. L. Griffin for comments on the manuscript. P.F.R. acknowledges the assistance of resources provided at the NCI National Facility systems at the Australian National University through the National Computational Merit Allocation Scheme supported by the Australian Government. N.C. was supported by the Institut Universitaire de France, and the European Research Council (ERC) within the framework of the SP2-Ideas Program ERC-2013-CoG, under ERC grant agreement no. 617588. N.C. acknowledges discussions with B. Romanowicz and B. Tauzin. N. F. was supported by Statoil ASA.	Aoki I, 2004, PHYS EARTH PLANET IN, V143, P129, DOI 10.1016/j.pepi.2003.10.007; Arndt NT, 2009, LITHOS, V109, P61, DOI 10.1016/j.lithos.2008.10.019; Ayer J, 2002, PRECAMBRIAN RES, V115, P63, DOI 10.1016/S0301-9268(02)00006-2; Bailey RC, 1999, NATURE, V398, P413, DOI 10.1038/18866; Bateman R, 2001, PRECAMBRIAN RES, V108, P75, DOI 10.1016/S0301-9268(00)00148-0; Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; BOTT MHP, 1993, J GEOL SOC LONDON, V150, P941, DOI 10.1144/gsjgs.150.5.0941; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; BYERLEE JD, 1968, J GEOPHYS RES, V73, P4741, DOI 10.1029/JB073i014p04741; CAZENAVE A, 1989, NATURE, V340, P54, DOI 10.1038/340054a0; Demouchy S, 2013, PHYS EARTH PLANET IN, V220, P37, DOI 10.1016/j.pepi.2013.04.008; Escartin J, 1997, J GEOPHYS RES-SOL EA, V102, P2897, DOI 10.1029/96JB02792; Faccenna C, 1999, J GEOPHYS RES-SOL EA, V104, P2749, DOI 10.1029/1998JB900072; Fei HZ, 2013, NATURE, V498, P213, DOI 10.1038/nature12193; Flament N, 2008, EARTH PLANET SC LETT, V275, P326, DOI 10.1016/j.epsl.2008.08.029; Griffin WL, 2009, J PETROL, V50, P1185, DOI 10.1093/petrology/egn033; Harrison TM, 2005, SCIENCE, V310, P1947, DOI 10.1126/science.1117926; Herzberg C, 2009, NATURE, V458, P619, DOI 10.1038/nature07857; Hirth G., 2003, GEOPHYS MONOGR INSID, V138, P83, DOI DOI 10.1029/138GM06; HUPPERT HE, 1982, J FLUID MECH, V121, P43, DOI 10.1017/S0022112082001797; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; Kind R, 2012, TECTONOPHYSICS, V536, P25, DOI 10.1016/j.tecto.2012.03.005; Lenardic A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001859; Maaloe S, 2004, MINER PETROL, V81, P1, DOI 10.1007/s00710-004-0028-6; Martin H, 2005, LITHOS, V79, P1, DOI 10.1016/j.lithos.2004.04.048; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; Moresi L, 2003, J COMPUT PHYS, V184, P476, DOI 10.1016/S0021-9991(02)00031-1; Moresi L, 1998, GEOPHYS J INT, V133, P669, DOI 10.1046/j.1365-246X.1998.00521.x; Nikolaeva K, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006549; O'Neill C, 2006, COMPUT GEOSCI-UK, V32, P1769, DOI 10.1016/j.cageo.2006.04.006; ORD A, 1989, TECTONOPHYSICS, V158, P269, DOI 10.1016/0040-1951(89)90328-4; Polat A, 2002, CHEM GEOL, V184, P231, DOI 10.1016/S0009-2541(01)00363-1; Rey PF, 2008, GEOLOGY, V36, P635, DOI 10.1130/G25031A.1;; Rolf T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048677; SLEEP NH, 1982, J GEOL, V90, P363, DOI 10.1086/628691; Sproule RA, 2002, PRECAMBRIAN RES, V115, P153, DOI 10.1016/S0301-9268(02)00009-8; van Hunen J, 2008, LITHOS, V103, P217, DOI 10.1016/j.lithos.2007.09.016; van Hunen J, 2012, ANNU REV EARTH PL SC, V40, P195, DOI [10.1146/annurev-earth-842711-105255, 10.1146/annurev-earth-042711-105255]; van Thienen P, 2005, PHYS EARTH PLANET IN, V150, P287, DOI 10.1016/j.pepi.2004.11.010; Wang YF, 2012, EARTH PLANET SC LETT, V353, P99, DOI 10.1016/j.epsl.2012.08.004; Wyman DA, 2002, PRECAMBRIAN RES, V115, P37, DOI 10.1016/S0301-9268(02)00005-0; Yuan HY, 2010, NATURE, V466, P1063, DOI 10.1038/nature09332; Zhang C, 2013, PRECAMBRIAN RES, V231, P206, DOI 10.1016/j.precamres.2013.03.004; Zhong SJ, 2013, J GEOPHYS RES-SOL EA, V118, P6025, DOI 10.1002/2013JB010408	44	67	73	5	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					405	+		10.1038/nature13728	http://dx.doi.org/10.1038/nature13728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230662	Green Submitted			2022-12-28	WOS:000341814900057
J	Zhu, ZH; Hoffman, JE				Zhu, Zhihuai; Hoffman, Jennifer E.			CONDENSED-MATTER PHYSICS Catching relativistic electrons	NATURE			English	Editorial Material							TOPOLOGICAL DIRAC SEMIMETAL	Low-energy electrons have been found to mimic relativistic high-energy particles in cadmium arsenide. This defines the first stable '3D Dirac semimetal', which holds promise for fundamental-physics exploration and practical applications.	[Zhu, Zhihuai; Hoffman, Jennifer E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Zhu, ZH (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	zhzhu@physics.harvard.edu; jhoffman@physics.harvard.edu	Hoffman, Jennifer E/H-4334-2011	Hoffman, Jennifer E/0000-0003-2752-5379				Borisenko S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.027603; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Jeon S, 2014, NAT MATER, V13, P851, DOI 10.1038/nmat4023; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kharzeev DE, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115119; Liu ZK, 2014, NAT MATER, V13, P677, DOI [10.1038/NMAT3990, 10.1038/nmat3990]; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Neupane M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4786; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; ROSENBERG AJ, 1959, J APPL PHYS, V30, P1621, DOI 10.1063/1.1735019; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang ZJ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125427; Wang ZJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195320; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405	17	8	8	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					319	320		10.1038/513319a	http://dx.doi.org/10.1038/513319a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230648	Green Submitted			2022-12-28	WOS:000341814900040
J	Donia, MS; Cimermancic, P; Schulze, CJ; Brown, LCW; Martin, J; Mitreva, M; Clardy, J; Linington, RG; Fischbach, MA				Donia, Mohamed S.; Cimermancic, Peter; Schulze, Christopher J.; Brown, Laura C. Wieland; Martin, John; Mitreva, Makedonka; Clardy, Jon; Linington, Roger G.; Fischbach, Michael A.			A Systematic Analysis of Biosynthetic Gene Clusters in the Human Microbiome Reveals a Common Family of Antibiotics	CELL			English	Article							POLYSACCHARIDES; METABOLITES; DISCOVERY; BACTERIAL; PEPTIDE	In complex biological systems, small molecules often mediate microbe-microbe and microbe-host interactions. Using a systematic approach, we identified 3,118 small-molecule biosynthetic gene clusters (BGCs) in genomes of human-associated bacteria and studied their representation in 752 metagenomic samples from the NIH Human Microbiome Project. Remarkably, we discovered that BGCs for a class of antibiotics in clinical trials, thiopeptides, are widely distributed in genomes and metagenomes of the human microbiota. We purified and solved the structure of a thiopeptide antibiotic, lactocillin, from a prominent member of the vaginal microbiota. We demonstrate that lactocillin has potent antibacterial activity against a range of Gram-positive vaginal pathogens, and we show that lactocillin and other thiopeptide BGCs are expressed in vivo by analyzing human metatranscriptomic sequencing data. Our findings illustrate the widespread distribution of small-molecule-encoding BGCs in the human microbiome, and they demonstrate the bacterial production of drug-like molecules in humans.	[Donia, Mohamed S.; Cimermancic, Peter; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Donia, Mohamed S.; Cimermancic, Peter; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Schulze, Christopher J.; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Brown, Laura C. Wieland] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Martin, John; Mitreva, Makedonka] Washington Univ, Sch Med, Dept Med, Genome Inst, St Louis, MO 63108 USA; [Clardy, Jon] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Washington University (WUSTL)	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	fischbach@fischbachgroup.org	Linington, Roger/ABD-5582-2021	Linington, Roger/0000-0003-1818-4971; Mitreva, Makedonka/0000-0001-9572-3436; Fischbach, Michael/0000-0003-3079-8247	Howard Hughes Medical Institute Predoctoral Fellowship; NIH [TW006634, OD007290, AI101018, AI101722, GM081879]; Medical Research Program Grant from the W.M. Keck Foundation; Fellowship for Science and Engineering from the David and Lucile Packard Foundation; DARPA [HR0011-12-C-0067]; Program for Breakthrough Biomedical Research; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101722, R01AI101018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM067547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Predoctoral Fellowship(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Program Grant from the W.M. Keck Foundation; Fellowship for Science and Engineering from the David and Lucile Packard Foundation; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Program for Breakthrough Biomedical Research; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are indebted to Marnix Medema (Max Planck Institute for Marine Microbiology), Amrita Pati (JGI), and members of the Fischbach Group for helpful advice. We thank Krishna Parsawar and Chad Nelson (University of Utah) and Jeff Johnson (UCSF) for help with mass spectrometry experiments and Mark Kelly (UCSF) for help with NMR experiments. This work was supported by a Howard Hughes Medical Institute Predoctoral Fellowship (P.C.), NIH grant TW006634 (R.G.L.), a Medical Research Program Grant from the W.M. Keck Foundation (M.A.F.), a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.), DARPA award HR0011-12-C-0067 ( M. A. F.), Program for Breakthrough Biomedical Research (M.A.F.), and NIH grants OD007290, AI101018, AI101722, and GM081879 (M.A.F.). M.A.F. is on the scientific advisory boards of NGM Biopharmaceuticals and Warp Drive Bio.	An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; BAUMANN H, 1992, BIOCHEMISTRY-US, V31, P4081, DOI 10.1021/bi00131a026; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Brzuszkiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021581; CHIKINDAS ML, 1995, ANTIMICROB AGENTS CH, V39, P2656, DOI 10.1128/AAC.39.12.2656; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Davis C., 2013, J DATA MINING GENOMI, V4, P3; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P7093, DOI 10.1128/AEM.01442-10; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Gonzalez DJ, 2010, J BIOL CHEM, V285, P28220, DOI 10.1074/jbc.M110.118554; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Just-Baringo X, 2014, MAR DRUGS, V12, P317, DOI 10.3390/md12010317; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kwan JC, 2012, P NATL ACAD SCI USA, V109, P20655, DOI 10.1073/pnas.1213820109; Kwon HC, 2006, J AM CHEM SOC, V128, P1622, DOI 10.1021/ja0558948; LaMarche MJ, 2012, J MED CHEM, V55, P2376, DOI 10.1021/jm201685h; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lee JH, 2011, J BACTERIOL, V193, P5030, DOI 10.1128/JB.05640-11; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Leimena MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-530; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; Malcolmson SJ, 2013, P NATL ACAD SCI USA, V110, P8483, DOI 10.1073/pnas.1307111110; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MCINERNEY BV, 1991, J NAT PROD, V54, P774, DOI 10.1021/np50075a005; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zou Y, 2013, CHEMBIOCHEM, V14, P679, DOI 10.1002/cbic.201300068	45	401	416	7	141	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1402	1414		10.1016/j.cell.2014.08.032	http://dx.doi.org/10.1016/j.cell.2014.08.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215495	Bronze, Green Accepted			2022-12-28	WOS:000343094200020
J	Raal, FJ; Honarpour, N; Blom, DJ; Hovingh, GK; Xu, F; Scott, R; Wasserman, SM; Stein, EA; Investigators, T				Raal, Frederick J.; Honarpour, Narimon; Blom, Dirk J.; Hovingh, G. Kees; Xu, Feng; Scott, Rob; Wasserman, Scott M.; Stein, Evan A.; Investigators, T. E. S. L. A.			Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; MONOCLONAL-ANTIBODY; AMG 145; LDL-C; RECEPTOR GENE; OPEN-LABEL; EFFICACY; ATORVASTATIN; SIMVASTATIN; REDUCTION	Background Homozygous familial hypercholesterolaemia is a rare, serious disorder caused by very low or absent plasma clearance of LDL, substantially raised LDL cholesterol, and accelerated development of cardiovascular disease. Conventional lipid-lowering treatments are modestly effective. Evolocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), reduced LDL cholesterol by 16% in a pilot study. We now report results with evolocumab in a randomised, double-blind, placebo-controlled phase 3 trial. Methods This randomised, double-blind, placebo-controlled phase 3 trial was undertaken at 17 sites in ten countries in North America, Europe, the Middle East, and South Africa. 50 eligible patients (aged >= 12 years) with homozygous familial hypercholesterolaemia, on stable lipid-regulating therapy for at least 4 weeks, and not receiving lipoprotein apheresis, were randomly allocated by a computer-generated randomisation sequence in a 2:1 ratio to receive subcutaneous evolocumab 420 mg or placebo every 4 weeks for 12 weeks. Randomisation was stratified by LDL cholesterol at screening (<11 mmol/L or >= 11 mmol/L) and implemented by a computerised interactive voice-response system. Patients, study personnel, and the funder were masked to treatment and to the efficacy results by the central laboratory not returning LDL cholesterol or any lipid results to the clinical sites after the baseline visit. The primary endpoint was percentage change in ultracentrifugation LDL cholesterol from baseline at week 12 compared with placebo, analysed by intention-to-treat. This trial is registered with ClinicalTrials.gov, number NCT01588496. Findings Of the 50 eligible patients randomly assigned to the two treatment groups, 49 actually received the study drug and completed the study (16 in the placebo group and 33 in the evolocumab group). Compared with placebo, evolocumab significantly reduced ultracentrifugation LDL cholesterol at 12 weeks by 30.9% (95% CI-43.9% to 18.0%; p<0.0001). Treatment-emergent adverse events occurred in ten (63%) of 16 patients in the placebo group and 12 (36%) of 33 in the evolocumab group. No serious clinical or laboratory adverse events occurred, and no anti-evolocumab antibody development was detected during the study. Interpretation In patients with homozygous familial hypercholesterolaemia receiving stable background lipid-lowering treatment and not on apheresis, evolocumab 420 mg administered every 4 weeks was well tolerated and significantly reduced LDL cholesterol compared with placebo.	[Raal, Frederick J.] Univ Witwatersrand, Fac Hlth Sci, Carbohydrate & Lipid Metab Res Unit, Johannesburg, South Africa; [Honarpour, Narimon; Xu, Feng; Scott, Rob; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Blom, Dirk J.] Univ Cape Town, Fac Hlth Sci, Dept Med, Div Lipidol, ZA-7925 Cape Town, South Africa; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA	University of Witwatersrand; Amgen; University of Cape Town; University of Amsterdam; Academic Medical Center Amsterdam	Stein, EA (corresponding author), Metab & Atherosclerosis Res Ctr, Cincinnati, OH 45229 USA.	esteinmrl@aol.com	Raal, FJ/ABD-5111-2021; Xu, Feng/L-8097-2019	Raal, FJ/0000-0002-9170-7938; Xu, Feng/0000-0003-3212-6284; Bruckert, Eric/0000-0002-4527-9629; ABIFADEL, Marianne/0000-0001-7645-8323; Scott, Robert/0000-0001-8266-1061; Blom, Dirk/0000-0003-3965-5912	Amgen	Amgen(Amgen)	This study was funded by Amgen. We thank the patients, parents, and the investigators (see appendix) for their valuable contributions to enable completion of this trial, and Meera Kodukulla (of Amgen) and Laura Evans (on behalf of Amgen) for editorial support.	Bertolini S, 2013, ATHEROSCLEROSIS, V227, P342, DOI 10.1016/j.atherosclerosis.2013.01.007; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Cuchel M, 2014, EUR HEART J, V35, P2146, DOI 10.1093/eurheartj/ehu274; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Davidson MH, 1997, AM J CARDIOL, V79, P38, DOI 10.1016/S0002-9149(96)00742-4; Gagne C, 2002, CIRCULATION, V105, P2469, DOI 10.1161/01.CIR.0000018744.58460.62; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Koren MJ, 2014, J AM COLL CARDIOL, V63, P2531, DOI 10.1016/j.jacc.2014.03.018; Koren MJ, 2014, CIRCULATION, V129, P234, DOI 10.1161/CIRCULATIONAHA.113.007012; Kraft HG, 2000, ARTERIOSCL THROM VAS, V20, P522, DOI 10.1161/01.ATV.20.2.522; Marais AD, 2008, ATHEROSCLEROSIS, V197, P400, DOI 10.1016/j.atherosclerosis.2007.06.028; Pedro-Botet J, 2001, ATHEROSCLEROSIS, V158, P183, DOI 10.1016/S0021-9150(01)00410-5; Raal FJ, 1997, ATHEROSCLEROSIS, V135, P249, DOI 10.1016/S0021-9150(97)00168-8; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Raal FJ, 2014, J AM COLL CARDIOL, V63, P1278, DOI 10.1016/j.jacc.2014.01.006; Raal FJ, 2012, ATHEROSCLEROSIS, V223, P262, DOI 10.1016/j.atherosclerosis.2012.02.019; Raal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rader DJ, 2014, CIRCULATION, V129, P1022, DOI 10.1161/CIRCULATIONAHA.113.001292; Robinson JG, 2014, JAMA-J AM MED ASSOC, V311, P1870, DOI 10.1001/jama.2014.4030; SEED M, 1990, NEW ENGL J MED, V322, P1494, DOI 10.1056/NEJM199005243222104; Sjouke B, 2014, EUR HEART J; Stein EA, 2014, J AM COLL CARDIOL, V63; Stein EA, 2014, EUR HEART J, V35, P2249, DOI 10.1093/eurheartj/ehu085; Stein EA, 2013, CIRCULATION, V128, P2113, DOI 10.1161/CIRCULATIONAHA.113.004678; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; Thompson GR, 2008, ATHEROSCLEROSIS, V198, P247, DOI 10.1016/j.atherosclerosis.2008.02.009; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x	28	501	529	3	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					341	350		10.1016/S0140-6736(14)61374-X	http://dx.doi.org/10.1016/S0140-6736(14)61374-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25282520				2022-12-28	WOS:000348509000027
J	Brende, B; Hoie, B				Brende, Borge; Hoie, Bent			Towards evidence-based, quantitative Sustainable Development Goals for 2030	LANCET			English	Editorial Material									[Brende, Borge] Minist Foreign Affairs, N-0032 Oslo, Norway; [Hoie, Bent] Minist Hlth & Care Serv, Oslo, Norway		Brende, B (corresponding author), Minist Foreign Affairs, N-0032 Oslo, Norway.	vegard.holmelid@mfa.no						[Anonymous], 2013, MILL DEV GOALS REP 2; Furtwangler T, 2014, PATH BLOG       0827; Norheim OF, 2014, LANCET; Sustainable Development Platform, 2014, OUTC DOC OP WORK GRO	4	13	13	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					206	208		10.1016/S0140-6736(14)61654-8	http://dx.doi.org/10.1016/S0140-6736(14)61654-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ2DL	25242038	hybrid			2022-12-28	WOS:000348044800006
J	Norheim, OF; Jha, P; Admasu, K; Godal, T; Hum, RJ; Kruk, ME; Gomez-Dantes, O; Mathers, CD; Pan, H; Sepulveda, J; Suraweera, W; Verguet, S; Woldemariam, AT; Yamey, G; Jamison, DT; Peto, R				Norheim, Ole F.; Jha, Prabhat; Admasu, Kesetebirhan; Godal, Tore; Hum, Ryan J.; Kruk, Margaret E.; Gomez-Dantes, Octavio; Mathers, Colin D.; Pan, Hongchao; Sepulveda, Jaime; Suraweera, Wilson; Verguet, Stephane; Woldemariam, Addis T.; Yamey, Gavin; Jamison, Dean T.; Peto, Richard			Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN Sustainable Development Goal for health	LANCET			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISEASE; MEXICO; SURVIVAL; COVERAGE; MIDDLE; RISK	Background The UN will formulate ambitious Sustainable Development Goals for 2030, including one for health. Feasible goals with some quantifiable, measurable targets can influence governments. We propose, as a quatitative health target, "Avoid in each country 40% of premature deaths (under-70 deaths that would be seen in the 2030 population at 2010 death rates), and improve health care at all ages". Targeting overall mortality and improved health care ignores no modifiable cause of death, nor any cause of disability that is treatable (or also causes many deaths). 40% fewer premature deaths would be important in all countries, but implies very different priorities in different populations. Reinforcing this target for overall mortality in each country are four global subtargets for 2030: avoid two-thirds of child and maternal deaths; two-thirds of tuberculosis, HIV, and malaria deaths; a third of premature deaths from non-communicable diseases (NCDs); and a third of those from other causes (other communicable diseases, undernutrition, and injuries). These challenging subtargets would halve under-50 deaths, avoid a third of the (mainly NCD) deaths at ages 50-69 years, and so avoid 40% of under-70 deaths. To help assess feasibility, we review mortality rates and trends in the 25 most populous countries, in four country income groupings, and worldwide. Methods UN sources yielded overall 1970-2010 mortality trends. WHO sources yielded cause-specific 2000-10 trends, standardised to country-specific 2030 populations; decreases per decade of 42% or 18% would yield 20-year reductions of two-thirds or a third. Results Throughout the world, except in countries where the effects of HIV or political disturbances predominated, mortality decreased substantially from 1970-2010, particularly in childhood. From 2000-10, under-70 age-standardised mortality rates decreased 19% (with the low-income and lower-middle-income countries having the greatest absolute gains). The proportional decreases per decade (2000-10) were: 34% at ages 0-4 years; 17% at ages 5-49 years; 15% at ages 50-69 years; 30% for communicable, perinatal, maternal, or nutritional causes; 14% for NCDs; and 13% for injuries (accident, suicide, or homicide). Interpretation Moderate acceleration of the 2000-10 proportional decreases in mortality could be feasible, achieving the targeted 2030 disease-specific reductions of two-thirds or a third. If achieved, these reductions avoid about 10 million of the 20 million deaths at ages 0-49 years that would be seen in 2030 at 2010 death rates, and about 17 million of the 41 million such deaths at ages 0-69 years. Such changes could be achievable by 2030, or soon afterwards, at least in areas free of war, other major effects of political disruption, or a major new epidemic.	[Norheim, Ole F.] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway; [Jha, Prabhat; Suraweera, Wilson] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5S 1A1, Canada; [Admasu, Kesetebirhan; Woldemariam, Addis T.] Minist Hlth, Addis Ababa, Ethiopia; [Godal, Tore] Minist Foreign Affairs, Oslo, Norway; [Hum, Ryan J.] Univ Toronto, Ctr Global Engn, Toronto, ON M5S 1A1, Canada; [Kruk, Margaret E.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Gomez-Dantes, Octavio] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Mathers, Colin D.] WHO Mortal & Burden Dis Unit, Geneva, Switzerland; [Pan, Hongchao; Peto, Richard] Univ Oxford, Nuffield Dept Populat Hlth Clin Trial Serv Unit, Oxford, England; [Pan, Hongchao; Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Sepulveda, Jaime; Yamey, Gavin; Jamison, Dean T.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Verguet, Stephane] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Bergen; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Columbia University; Instituto Nacional de Salud Publica; University of Oxford; University of Oxford; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Norheim, OF (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, PB 7800, N-5020 Bergen, Norway.	Ole.norheim@igs.uib.no; RPeto@ctsu.ox.ac.uk	Suraweera, Wilson MG/O-8962-2014; Norheim, Ole Frithjof/AAC-8771-2020; Kruk, Margaret E/E-3058-2010	Norheim, Ole Frithjof/0000-0002-5748-5956; Kruk, Margaret E/0000-0002-9549-8432; Jha, Prabhat/0000-0001-7067-8341; Mathers, Colin/0000-0002-0617-6731; Suraweera, Wilson/0000-0001-9673-5746	UK Medical Research Council; Norwegian Agency for Development Cooperation; Centre for Global Health Research; Bill & Melinda Gates Foundation	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Norwegian Agency for Development Cooperation; Centre for Global Health Research; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	UK Medical Research Council, Norwegian Agency for Development Cooperation, Centre for Global Health Research, and Bill & Melinda Gates Foundation.	Acosta-Cazares B, 2010, AM HEART J, V160, P230, DOI 10.1016/j.ahj.2010.05.016; Astudillo O, 2014, LANCET DIABETES ENDO, V2, P15, DOI 10.1016/S2213-8587(13)70160-8; Barquera S, 2010, SALUD PUBLICA MEXICO, V52, pS63; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Boyle CF, ACHIEVING GRAND CONV; Child Trends, 2013, FAM LIF DIFF CENTR S; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Doll R, 1994, MORTALITY SMOKING DE; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jha P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-19; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lopez A, 2013, LANCET, V381, P1275, DOI 10.1016/S0140-6736(13)60838-7; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, 2014, LANCET; Open Working Group, 2014, OUTC DOC OP WORK GRO; Peto R, 2014, SCIENCE, V345, P1272, DOI 10.1126/science.1259971; Phillips DE, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-14; Requejo J, 2014, COUNTDOWN 2015 MATER; Roth GA, 2011, B WORLD HEALTH ORGAN, V89, P92, DOI 10.2471/BLT.10.079947; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Sepulveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Thornicroft G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5189; UN, 2010, RES AD GEN ASS; UNICEF, 2013, POST 2015 WORLD FIT; UNICEF D, 2014, MON SIT CHILDR WOM; United Nations, 2014, ACT AG SUST DEV; United Nations, 2014, REP SECR GEN HIGH LE; United Nations Global Compact, POST 2015 AG REL SUS; United Nations Sustainable Development Knowledge Platform, 2014, SUST DEV GOALS; UNPD, 2012, WORLD POP PROSP 2012; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; Victora CG, 2012, POSITION PAPER INT E; Wamala S, 2014, HDB GLOBAL HLTH POLI, P425; Wang H, 2014, LANCET; Waters HR, 2010, EC TOBACCO TOBACCO T; WHO/UNICEF Joint Water Supply and Sanitation Monitoring Programme, 2015, PROGR SAN DRINK WAT; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WHO. World Health Organisation, 2014, GLOB HLTH EST 2013; World Bank, 1993, INV IN HLTH; World Bank Group, 2012, WORLD BANK LIST EC; World Health Organization, 2011, GLOB STAT REP NONCOM; Yamey G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5295; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3	53	164	169	1	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					239	252		10.1016/S0140-6736(14)61591-9	http://dx.doi.org/10.1016/S0140-6736(14)61591-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25242039	Green Published, Green Submitted			2022-12-28	WOS:000348044800028
J	O'Connor, EA; Lin, JS; Burda, BU; Henderson, JT; Walsh, ES; Whitlock, EP				O'Connor, Elizabeth A.; Lin, Jennifer S.; Burda, Brittany U.; Henderson, Jillian T.; Walsh, Emily S.; Whitlock, Evelyn P.			Behavioral Sexual Risk-Reduction Counseling in Primary Care to Prevent Sexually Transmitted Infections: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; AFRICAN-AMERICAN WOMEN; HIV PREVENTION; BACTERIAL VAGINOSIS; RANDOMIZED-TRIAL; CONDOM USE; PARTNER VIOLENCE; ADOLESCENT GIRLS; DISEASE STD; INTERVENTION	Background: Sexually transmitted infections (STIs) are common and preventable. Purpose: To update a previous systematic review about the benefits and harms of sexual risk-reduction counseling to prevent STIs for the U.S. Preventive Services Task Force. Data Sources: Selected databases from January 2007 through October 2013, manual searches of references lists and gray literature, and studies from the previous review. Study Selection: English-language fair-or good-quality trials conducted in adolescents or adults. Data Extraction: One investigator abstracted data and a second checked the abstraction. Study quality was dual-reviewed. Data Synthesis: 31 trials were included: 16 (n = 56 110) were newly published and 15 (n = 14 214) were from the previous review. Most trials targeted persons at increased risk for STIs based on sociodemographic characteristics, risky sexual behavior, or history of an STI. High-intensity (>2 hours) interventions reduced STI incidence in adolescents (odds ratio, 0.38 [95% CI, 0.24 to 0.60]) and adults (odds ratio, 0.70 [CI, 0.56 to 0.87]). Lower-intensity interventions were generally not effective in adults, but some approaches were promising. Although moderate-intensity interventions may be effective in adolescents, data were very sparse. Reported behavioral outcomes were heterogeneous and most likely to show a benefit with high-intensity interventions at 6 months or less. No consistent evidence was found that sexual risk-reduction counseling was harmful. Limitations: Low-risk populations and male adolescents were underrepresented. Reliability of self-reported behavioral outcomes was unknown. Conclusion: High-intensity counseling on sexual risk reduction can reduce STIs in primary care and related settings, especially in sexually active adolescents and in adults at increased risk for STIs.	[O'Connor, Elizabeth A.; Lin, Jennifer S.; Burda, Brittany U.; Henderson, Jillian T.; Walsh, Emily S.; Whitlock, Evelyn P.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA	Kaiser Permanente					Kaiser Permanente Research Affiliates Evidence-based Practice Center [HHSA-290-2012-00151-I]	Kaiser Permanente Research Affiliates Evidence-based Practice Center	This review was conducted by the Kaiser Permanente Research Affiliates Evidence-based Practice Center under contract to AHRQ (contract HHSA-290-2012-00151-I).	Akers DD, 2008, MODEL PROGRAMS ADOLE, P375; [Anonymous], 2012, COCHRANE HDB SYSTEMA; Benner TA, 2008, MODEL PROGRAMS ADOLE, P253; Berenson AB, 2012, CONTRACEPTION, V86, P716, DOI 10.1016/j.contraception.2012.06.007; Berkman A, 2007, AIDS CARE, V19, P579, DOI 10.1080/09540120701213989; Boekeloo BO, 1999, PEDIATRICS, V103, P107, DOI 10.1542/peds.103.1.107; Bolu OO, 2004, SEX TRANSM DIS, V31, P469, DOI 10.1097/01.olq.0000135987.12346.f2; Boyer CB, 1997, AIDS, V11, P359, DOI 10.1097/00002030-199703110-00014; Carey MP, 2008, CONTEMP CLIN TRIALS, V29, P569, DOI 10.1016/j.cct.2008.02.001; Carey MP, 2010, AIDS BEHAV, V14, P504, DOI 10.1007/s10461-009-9587-1; Carey MP, 2004, J CONSULT CLIN PSYCH, V72, P252, DOI 10.1037/0022-006X.72.2.252; Centers for Disease Control and Prevention, 2013, INC PREV COST SEX TR; Centers for Disease Control and Prevention, 2013, COMP EV HIV BEH INT; Champion JD, 2007, INT J STD AIDS, V18, P748, DOI 10.1258/095646207782212180; Champion JD, 2012, INT J NURS STUD, V49, P138, DOI 10.1016/j.ijnurstu.2011.08.010; Charania MR, 2011, AIDS BEHAV, V15, P1283, DOI 10.1007/s10461-010-9812-y; Chesson HW, 2011, SEX TRANSM DIS, V38, P889, DOI 10.1097/OLQ.0b013e318223be77; Chin HB, 2012, AM J PREV MED, V42, P272, DOI 10.1016/j.amepre.2011.11.006; Cianelli R, 2012, HEALTH CARE WOMEN IN, V33, P321, DOI 10.1080/07399332.2012.655388; Cortes-Bordoy J, 2010, EUR J DERMATOL, V20, P339, DOI 10.1684/ejd.2010.0898; Crosby R, 2009, AM J PUBLIC HEALTH, V99, pS96, DOI 10.2105/AJPH.2007.123893; DANIELSON R, 1990, FAM PLANN PERSPECT, V22, P115, DOI 10.2307/2135642; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiClemente RJ, 2011, INT J STD AIDS, V22, P332, DOI 10.1258/ijsa.2011.010429; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Dworkin SL, 2007, ARCH SEX BEHAV, V36, P269, DOI 10.1007/s10508-006-9092-9; Ehrhardt A., 2002, AIDS BEHAV, V6, P1, DOI DOI 10.1023/A:1014534110868; Ehrhardt AA, 2002, AIDS CARE, V14, P147, DOI 10.1080/09540120220104677; Forhan SE, 2009, PEDIATRICS, V124, P1505, DOI 10.1542/peds.2009-0674; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; Guilamo-Ramos V, 2011, J ADOLESCENT HEALTH, V48, P159, DOI 10.1016/j.jadohealth.2010.06.007; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Hoffman S, 2003, AM J PUBLIC HEALTH, V93, P1897, DOI 10.2105/AJPH.93.11.1897; Holden AEC, 2008, SEX TRANSM DIS, V35, P898, DOI 10.1097/OLQ.0b013e31817d7a33; Javanbakht M, 2010, SEX TRANSM DIS, V37, P369, DOI 10.1097/OLQ.0b013e3181cbf77d; Jemmott JB, 2005, ARCH PEDIAT ADOL MED, V159, P440, DOI 10.1001/archpedi.159.5.440; Jemmott LS, 2007, AM J PUBLIC HEALTH, V97, P1034, DOI 10.2105/AJPH.2003.020271; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kershaw TS, 2009, AM J PUBLIC HEALTH, V99, P2079, DOI 10.2105/AJPH.2008.154476; Khalid M, HUM DEV REP 2013 RIS; Kirby D, 2005, EVIDENCE BASED OBSTE, V7, P74; Korte JE, 2004, SEX TRANSM DIS, V31, P166, DOI 10.1097/01.OLQ.0000115461.50698.55; Lang DL, 2009, PREV SCI, V10, P270, DOI 10.1007/s11121-009-0127-z; Lin JS, 2008, ANN INTERN MED, V149, P497, DOI 10.7326/0003-4819-149-7-200810070-00011; Marion LN, 2009, RES NURS HEALTH, V32, P274, DOI 10.1002/nur.20326; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; Marrazzo JM, 2011, SEX TRANSM INFECT, V87, P399, DOI 10.1136/sti.2011.049213; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P335, DOI 10.1097/OLQ.0b013e3181ca3cac; Melendez RM, 2003, ARCH SEX BEHAV, V32, P499, DOI 10.1023/A:1026081309709; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Meyers D, 2008, AM FAM PHYSICIAN, V77, P819; Milhausen RR, 2008, SEX ED, V8, P47, DOI DOI 10.1080/14681810701811803; Miller S, 2000, AIDS CARE, V12, P603, DOI 10.1080/095401200750003789; Mittal M, 2011, SEX TRANSM DIS, V38, P510, DOI 10.1097/OLQ.0b013e318207f59b; Neumann MS, 2011, SEX TRANSM DIS, V38, P133, DOI 10.1097/OLQ.0b013e3181f0c051; O'Connor EA, 2014, AHRQ PUBLICATION; O'Leary A, 2008, HEALTH PSYCHOL, V27, pS180, DOI 10.1037/0278-6133.27.2(Suppl.).S180; Peipert JF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.038; Peipert J, 2007, CONTEMP CLIN TRIALS, V28, P626, DOI 10.1016/j.cct.2007.01.012; Petersen R, 2007, PERSPECT SEX REPRO H, V39, P21, DOI 10.1363/3902107; Proude EM, 2004, FAM PRACT, V21, P537, DOI 10.1093/fampra/cmh510; Rhodes F, 2007, AIDS BEHAV, V11, P393, DOI 10.1007/s10461-007-9208-9; Sales JM, 2010, J WOMENS HEALTH, V19, P219, DOI 10.1089/jwh.2008.1326; Scholes D, 2003, AIDS, V17, P1547, DOI 10.1097/00002030-200307040-00016; Semaan S, 2010, DRUG ALCOHOL DEPEN, V106, P7, DOI 10.1016/j.drugalcdep.2009.07.015; Shain RN, 1999, NEW ENGL J MED, V340, P93, DOI 10.1056/NEJM199901143400203; Shain RN, 2004, SEX TRANSM DIS, V31, P401, DOI 10.1097/01.olq.0000135301.97350.84; Thurman AR, 2008, OBSTET GYNECOL, V111, P1417, DOI 10.1097/AOG.0b013e318177143a; Warner L, 2008, PLOS MED, V5, P919, DOI 10.1371/journal.pmed.0050135; WENGER NS, 1992, ANN INTERN MED, V117, P905, DOI 10.7326/0003-4819-117-11-905; Wingood GM, 2006, AM J PUBLIC HEALTH, V96, P1085, DOI 10.2105/AJPH.2004.053595; Wingood GM, 2013, JAIDS-J ACQ IMM DEF, V63, pS36, DOI 10.1097/QAI.0b013e3182920031	74	30	30	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					874	U70		10.7326/M14-0475	http://dx.doi.org/10.7326/M14-0475			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UW	25243895				2022-12-28	WOS:000347248400029
J	Yan, C; Liu, D; Li, L; Wempe, MF; Guin, S; Khanna, M; Meier, J; Hoffman, B; Owens, C; Wysoczynski, CL; Nitz, MD; Knabe, WE; Ahmed, M; Brautigan, DL; Paschal, BM; Schwartz, MA; Jones, DNM; Ross, D; Meroueh, SO; Theodorescu, D				Yan, Chao; Liu, Degang; Li, Liwei; Wempe, Michael F.; Guin, Sunny; Khanna, May; Meier, Jeremy; Hoffman, Brenton; Owens, Charles; Wysoczynski, Christina L.; Nitz, Matthew D.; Knabe, William E.; Ahmed, Mansoor; Brautigan, David L.; Paschal, Bryce M.; Schwartz, Martin A.; Jones, David N. M.; Ross, David; Meroueh, Samy O.; Theodorescu, Dan			Discovery and characterization of small molecules that target the GTPase Ral	NATURE			English	Article							ACTIVATION; PROTEIN; EFFECTORS; REVEALS; PATHWAY; BIND; RAIA; SEC5	The Ras-like GTPases RalA and RalB are important drivers of tumour growth and metastasis(1). Chemicals that block Ral function would be valuable as research tools and for cancer therapeutics. Here we used protein structure analysis and virtual screening to identify drug-like molecules that bind to a site on the GDP-bound form of Ral. The compounds RBC6, RBC8 and RBC10 inhibited the binding of Ral to its effector RALBP1, as well as inhibiting Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines. The binding of the RBC8 derivative BQU57 to RalB was confirmed by isothermal titration calorimetry, surface plasmon resonance and H-1-N-15 transverse relaxation-optimized spectroscopy (TROSY) NMR spectroscopy. RBC8 and BQU57 show selectivity for Ral relative to the GTPases Ras and RhoA and inhibit tumour xenograft growth to a similar extent to the depletion of Ral using RNA interference. Our results show the utility of structure-based discovery for the development of therapeutics for Ral-dependent cancers.	[Yan, Chao; Guin, Sunny; Owens, Charles; Theodorescu, Dan] Univ Colorado, Dept Surg, Aurora, CO 80045 USA; [Liu, Degang; Li, Liwei; Khanna, May; Knabe, William E.; Meroueh, Samy O.] Indiana Univ Sch Med, Dept Biochem, Indianapolis, IN 46202 USA; [Wempe, Michael F.; Ross, David] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Meier, Jeremy; Hoffman, Brenton; Schwartz, Martin A.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Wysoczynski, Christina L.; Jones, David N. M.; Theodorescu, Dan] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Nitz, Matthew D.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Ahmed, Mansoor] Yale Univ, Dept Cardiol, New Haven, CT 06511 USA; [Ahmed, Mansoor; Schwartz, Martin A.] Yale Univ, Dept Cell Biol, New Haven, CT 06511 USA; [Paschal, Bryce M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Meroueh, Samy O.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University Bloomington; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia; Yale University; Yale University; University of Virginia; Indiana University System; Indiana University-Purdue University Indianapolis; University of Colorado System; University of Colorado Anschutz Medical Campus	Theodorescu, D (corresponding author), Univ Colorado, Dept Surg, Aurora, CO 80045 USA.	dan.theodorescu@ucdenver.edu	Yan, Chao/B-1950-2015; Ahmed, Mansoor/K-6748-2019	Khanna, May/0000-0002-9989-6374; Yan, Chao/0000-0002-6029-224X	NIH [CA091846, CA075115, CA104106, GM47214]; IUPUI Research Scholar Grant Foundation; American Cancer Society; Colorado Clinical and Translational Sciences Institute from the National Center for Research Resources, NIH [UL1TR001082]; NATIONAL CANCER INSTITUTE [P01CA104106, R29CA075115, P50CA091846, R01CA075115, P30CA046934, R01CA143971, P30CA044579] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635, R01GM047214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IUPUI Research Scholar Grant Foundation; American Cancer Society(American Cancer Society); Colorado Clinical and Translational Sciences Institute from the National Center for Research Resources, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants CA091846, CA075115, CA104106 and GM47214 by the IUPUI Research Scholar Grant Foundation and by an American Cancer Society Research Scholar grant The researchers used the services of the Medicinal Chemistry Core (MCC) facility (M.F.W.) housed within the Department of Pharmaceutical Sciences, University of Colorado. In part, the MCC is funded by Colorado Clinical and Translational Sciences Institute grant UL1TR001082 from the National Center for Research Resources, NIH. We acknowledge D. S. Backos for assistance with computational modelling, A. Spencer for biochemical assays, B. Helfrich for assistance with lung cancer cell line culturing, and H. Mo and J. Harwood for assistance in the training and collection of NMR data in the early stages of the project.	Awasthi S, 2002, DRUG METAB DISPOS, V30, P1300, DOI 10.1124/dmd.30.12.1300; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang ZZ, 2013, ACS CHEM BIOL, V8, P58, DOI 10.1021/cb300663j; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Hinoi T, 1996, J BIOL CHEM, V271, P19710, DOI 10.1074/jbc.271.33.19710; Holbourn KP, 2005, P NATL ACAD SCI USA, V102, P5357, DOI 10.1073/pnas.0501525102; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Martin Timothy D, 2012, Small GTPases, V3, P126, DOI 10.4161/sgtp.19571; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Pautsch A, 2005, EMBO J, V24, P3670, DOI 10.1038/sj.emboj.7600813; Peschard P, 2012, CURR BIOL, V22, P2063, DOI 10.1016/j.cub.2012.09.013; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Smith SC, 2012, CANCER RES, V72, P3480, DOI 10.1158/0008-5472.CAN-11-3966; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Steggerda SM, 2000, J BIOL CHEM, V275, P23175, DOI 10.1074/jbc.C000252200; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Tsimberidou AM, 2010, EXPERT OPIN INV DRUG, V19, P1569, DOI 10.1517/13543784.2010.535516; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Zipfel PA, 2010, ONCOGENE, V29, P4859, DOI 10.1038/onc.2010.224	34	100	125	5	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					443	+		10.1038/nature13713	http://dx.doi.org/10.1038/nature13713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25219851	Green Accepted, Green Submitted			2022-12-28	WOS:000345770600053
J	Smolka, S; Wuester, W; Haupt, F; Faelt, S; Wegscheider, W; Imamoglu, A				Smolka, Stephan; Wuester, Wolf; Haupt, Florian; Faelt, Stefan; Wegscheider, Werner; Imamoglu, Atac			Cavity quantum electrodynamics with many-body states of a two-dimensional electron gas	SCIENCE			English	Article							SPIN POLARIZATION; SEMICONDUCTOR; TRANSITION; ENERGY; WELLS; GAAS	Light-matter interaction has played a central role in understanding as well as engineering new states of matter. Reversible coupling of excitons and photons enabled groundbreaking results in condensation and superfluidity of nonequilibrium quasiparticles with a photonic component. We investigated such cavity-polaritons in the presence of a high-mobility two-dimensional electron gas, exhibiting strongly correlated phases. When the cavity was on resonance with the Fermi level, we observed previously unknown many-body physics associated with a dynamical hole-scattering potential. In finite magnetic fields, polaritons show distinct signatures of integer and fractional quantum Hall ground states. Our results lay the groundwork for probing nonequilibrium dynamics of quantum Hall states and exploiting the electron density dependence of polariton splitting so as to obtain ultrastrong optical nonlinearities.	[Smolka, Stephan; Wuester, Wolf; Haupt, Florian; Faelt, Stefan; Imamoglu, Atac] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Wuester, Wolf; Faelt, Stefan; Wegscheider, Werner] ETH, Solid State Phys Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Imamoglu, A (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	imamoglu@phys.ethz.ch			Swiss National Center of Competence in Research Quantum Photonics (NCCR QP) of the Swiss National Science Foundation (SNSF)	Swiss National Center of Competence in Research Quantum Photonics (NCCR QP) of the Swiss National Science Foundation (SNSF)	The authors acknowledge insightful discussions with L. Glazman, M. Goldstein, A. Rosch, A. Srivastava, and J. von Delft. This work is supported by Swiss National Center of Competence in Research Quantum Photonics (NCCR QP), research instrument of the Swiss National Science Foundation (SNSF).	Aifer EH, 1996, PHYS REV LETT, V76, P680, DOI 10.1103/PhysRevLett.76.680; ANDERSON PW, 1967, PHYS REV LETT, V18, P1049, DOI 10.1103/PhysRevLett.18.1049; Averkiev NS, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045320; Bar-Joseph I, 2005, SEMICOND SCI TECH, V20, pR29, DOI 10.1088/0268-1242/20/6/R01; BENNETT BR, 1990, IEEE J QUANTUM ELECT, V26, P113, DOI 10.1109/3.44924; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; CHAKRABORTY T, 1990, SURF SCI, V229, P16, DOI 10.1016/0039-6028(90)90821-O; Das Sarma S., 1996, PERSPECTIVES QUANTUM; Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; EISENSTEIN JP, 1990, PHYS REV B, V41, P7910, DOI 10.1103/PhysRevB.41.7910; Gabbay A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157402; HALPERIN BI, 1983, HELV PHYS ACTA, V56, P75; Hayakawa J, 2013, NAT NANOTECHNOL, V8, P31, DOI [10.1038/nnano.2012.209, 10.1038/NNANO.2012.209]; HOUDRE R, 1994, PHYS REV LETT, V73, P2043, DOI 10.1103/PhysRevLett.73.2043; Kukushkin IV, 1999, PHYS REV LETT, V82, P3665, DOI 10.1103/PhysRevLett.82.3665; Kumada N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.116802; OHTAKA K, 1990, REV MOD PHYS, V62, P929, DOI 10.1103/RevModPhys.62.929; Perrin M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075340; Plochocka P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.126806; ROSCH A, 1995, PHYS REV LETT, V75, P1988, DOI 10.1103/PhysRevLett.75.1988; Sbierski B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.157402; SKOLNICK MS, 1987, PHYS REV LETT, V58, P2130, DOI 10.1103/PhysRevLett.58.2130; Smet JH, 2002, NATURE, V415, P281, DOI 10.1038/415281a; Tiemann L, 2012, SCIENCE, V335, P828, DOI 10.1126/science.1216697; Verdene B, 2007, NAT PHYS, V3, P392, DOI 10.1038/nphys588; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314	26	74	74	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					332	335		10.1126/science.1258595	http://dx.doi.org/10.1126/science.1258595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25278508				2022-12-28	WOS:000343041100039
J	Lu, Z; Chang, YC; Yin, QZ; Ng, CY; Jackson, WM				Lu, Zhou; Chang, Yih Chung; Yin, Qing-Zhu; Ng, C. Y.; Jackson, William M.			Evidence for direct molecular oxygen production in CO2 photodissociation	SCIENCE			English	Article							ABSORPTION-SPECTRUM; ATMOSPHERE; STATE; TEMPERATURE; LIMITS; ATOMS; PATH; HCO	Photodissociation of carbon dioxide (CO2) has long been assumed to proceed exclusively to carbon monoxide (CO) and oxygen atom (O) primary products. However, recent theoretical calculations suggested that an exit channel to produce C + O-2 should also be energetically accessible. Here we report the direct experimental evidence for the C + O2 channel in CO2 photodissociation near the energetic threshold of the C(P-3) + O2(X-3 Sigma(-)(g)) channel with a yield of 5 +/- 2% using vacuum ultraviolet laser pump-probe spectroscopy and velocity-map imaging detection of the C(P-3(J)) product between 101.5 and 107.2 nanometers. Our results may have implications for nonbiological oxygen production in CO2-heavy atmospheres.	[Lu, Zhou; Chang, Yih Chung; Ng, C. Y.; Jackson, William M.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Yin, Qing-Zhu] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Ng, CY (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	cyng@ucdavis.edu; wmjackson@ucdavis.edu	Jackson, William/G-6983-2017; Chang, Yih/H-7445-2013; Ng, Cheuk-Yiu/D-4529-2017; Yin, Qing-Zhu/B-8198-2009	Chang, Yih/0000-0002-3763-1864; Ng, Cheuk-Yiu/0000-0003-4425-5307; Yin, Qing-Zhu/0000-0002-4445-5096	NASA Origins of Solar Systems Program [NNX13AJ50G]; Institute of Geophysics and Planetary Physics-Los Alamos National Laboratory University of California; U.S. Department of Energy [DE-FG02-02ER15306]; NSF [CHE-1301501]	NASA Origins of Solar Systems Program(National Aeronautics & Space Administration (NASA)); Institute of Geophysics and Planetary Physics-Los Alamos National Laboratory University of California; U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This work was supported in part by NASA Origins of Solar Systems Program grant no. NNX13AJ50G and an Institute of Geophysics and Planetary Physics-Los Alamos National Laboratory University of California grant to Q.-Z.Y. and C.Y.N. Additionally, C.Y.N. was supported by U.S. Department of Energy contract no. DE-FG02-02ER15306. W.M.J. was supported NSF grant no. CHE-1301501. We thank S. Y. Grebenshchikov at the Technical University of Munich for discussions and G. Stark for providing the digitized CO<INF>2</INF> photoabsorption spectrum.	Adachi J, 1997, J CHEM PHYS, V107, P4919, DOI 10.1063/1.474855; Archer LE, 2013, J QUANT SPECTROSC RA, V117, P88, DOI 10.1016/j.jqsrt.2012.11.009; CHANDLER DW, 1987, J CHEM PHYS, V87, P1445, DOI 10.1063/1.453276; COSSARTMAGOS C, 1987, MOL PHYS, V61, P1077, DOI 10.1080/00268978700101671; Dibeler V. H., 1973, International Journal of Mass Spectrometry and Ion Physics, V11, P49, DOI 10.1016/0020-7381(73)80055-5; Gao H, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4807302; Gharaibeh MA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3360309; Grebenshchikov SY, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808369; Grubb MP, 2012, SCIENCE, V335, P1075, DOI 10.1126/science.1216911; Hartogh P, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015160; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Holland HD, 2009, GEOCHIM COSMOCHIM AC, V73, P5241, DOI 10.1016/j.gca.2009.05.070; Huestis DL, 2010, FARADAY DISCUSS, V147, P307, DOI 10.1039/c003456h; Hwang DY, 2000, CHEM PHYS, V256, P169, DOI 10.1016/S0301-0104(00)00108-7; KABLE SH, 1991, J PHYS CHEM-US, V95, P8013, DOI 10.1021/j100174a006; KASTING JF, 1979, J GEOPHYS RES-OCEANS, V84, P3097, DOI 10.1029/JC084iC06p03097; KASTING JF, 1984, J ATMOS CHEM, V1, P403, DOI 10.1007/BF00053803; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; Kuo CT, 2004, CHINESE J PHYS, V42, P65; LAWRENCE GM, 1972, J CHEM PHYS, V57, P5616, DOI 10.1063/1.1678271; Mahaffy PR, 2013, SCIENCE, V341, P263, DOI 10.1126/science.1237966; Riedel J, 2005, CHEM PHYS LETT, V414, P473, DOI 10.1016/j.cplett.2005.08.115; SCHOPF JW, 1975, ANNU REV EARTH PL SC, V3, P213, DOI 10.1146/annurev.ea.03.050175.001241; Suits AG, 2008, ACCOUNTS CHEM RES, V41, P873, DOI 10.1021/ar8000734; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; WERNER HJ, 1990, CHEM PHYS LETT, V175, P203, DOI 10.1016/0009-2614(90)85543-L	26	82	82	1	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					61	64		10.1126/science.1257156	http://dx.doi.org/10.1126/science.1257156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278605	Green Published			2022-12-28	WOS:000342446900049
J	Theurillat, JPP; Udeshi, ND; Errington, WJ; Svinkina, T; Baca, SC; Pop, M; Wild, PJ; Blattner, M; Groner, AC; Rubin, MA; Moch, H; Prive, GG; Carr, SA; Garraway, LA				Theurillat, Jean-Philippe P.; Udeshi, Namrata D.; Errington, Wesley J.; Svinkina, Tanya; Baca, Sylvan C.; Pop, Marius; Wild, Peter J.; Blattner, Mirjam; Groner, Anna C.; Rubin, Mark A.; Moch, Holger; Prive, Gilbert G.; Carr, Steven A.; Garraway, Levi A.			Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer	SCIENCE			English	Article							DEK ONCOGENE; LIGASE; MUTATIONS; DEGRADATION; ADAPTER; TUMORIGENESIS; RECEPTOR; GENES; CELLS	Cancer genome characterization has revealed driver mutations in genes that govern ubiquitylation; however, the mechanisms by which these alterations promote tumorigenesis remain incompletely characterized. Here, we analyzed changes in the ubiquitin landscape induced by prostate cancer-associated mutations of SPOP, an E3 ubiquitin ligase substrate-binding protein. SPOP mutants impaired ubiquitylation of a subset of proteins in a dominant-negative fashion. Of these, DEK and TRIM24 emerged as effector substrates consistently up-regulated by SPOP mutants. We highlight DEK as a SPOP substrate that exhibited decreases in ubiquitylation and proteasomal degradation resulting from heteromeric complexes of wild-type and mutant SPOP protein. DEK stabilization promoted prostate epithelial cell invasion, which implicated DEK as an oncogenic effector. More generally, these results provide a framework to decipher tumorigenic mechanisms linked to dysregulated ubiquitylation.	[Theurillat, Jean-Philippe P.; Udeshi, Namrata D.; Svinkina, Tanya; Pop, Marius; Carr, Steven A.; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Theurillat, Jean-Philippe P.; Baca, Sylvan C.; Pop, Marius; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Theurillat, Jean-Philippe P.; Baca, Sylvan C.; Pop, Marius; Groner, Anna C.; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Errington, Wesley J.; Prive, Gilbert G.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Errington, Wesley J.; Prive, Gilbert G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Wild, Peter J.; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Blattner, Mirjam; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Rubin, Mark A.] Weill Cornell & New York Presbyterian Hosp, Inst Precis Med, New York, NY 10065 USA; [Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Zurich; University Zurich Hospital; Cornell University; NewYork-Presbyterian Hospital; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Dana-Farber Cancer Institute	Garraway, LA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	levi_garraway@dfci.harvard.edu	Carr, Steven A./AAH-8366-2019	Rubin, Mark/0000-0002-8321-9950; Wild, Peter Johannes/0000-0002-1017-3744; Prive, Gilbert/0000-0002-0712-4319	Swiss Science foundation [SSMBS PASMP3_145764]; SystemX.ch grant (PhophoNet PPM), the Swiss initiative in systems biology; Novartis Foundation Medicine; Boehringer Ingelheim; Millennium/Takeda; NATIONAL CANCER INSTITUTE [P50CA090381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Swiss Science foundation(Swiss National Science Foundation (SNSF)); SystemX.ch grant (PhophoNet PPM), the Swiss initiative in systems biology; Novartis Foundation Medicine; Boehringer Ingelheim(Boehringer Ingelheim); Millennium/Takeda(Takeda Pharmaceutical Company Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Gaffney for illustrations and A. Fitsche and M. Storz for excellent technical assistance. J.-P.P.T. is funded by a fellowship from the Swiss Science foundation (SSMBS PASMP3_145764). P.J.W. is funded by a SystemX.ch grant (PhophoNet PPM), the Swiss initiative in systems biology. M. A. R. and Cornell University have filed a patent (WO 2012115789 A2) relating to the use of SPOP mutations as markers for human prostate cancer. L. A. G. is a paid consultant for the following pharmaceutical companies: Novartis Foundation Medicine, Boehringer Ingelheim, and Millennium/Takeda.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; An J, 2014, CELL REP, V6, P657, DOI 10.1016/j.celrep.2014.01.013; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Blattner M, 2014, NEOPLASIA, V16, P14, DOI 10.1593/neo.131704; Broxmeyer HE, 2012, STEM CELLS DEV, V21, P1449, DOI 10.1089/scd.2011.0451; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Li C, 2011, ONCOGENE, V30, P4350, DOI 10.1038/onc.2011.151; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Riveiro-Falkenbach E, 2010, CLIN CANCER RES, V16, P2932, DOI 10.1158/1078-0432.CCR-09-2330; van Geersdaele LK, 2013, ACTA CRYSTALLOGR D, V69, P1677, DOI 10.1107/S0907444913012687; Vinnedge LMP, 2011, ONCOGENE, V30, P2741, DOI 10.1038/onc.2011.2; Vinnedge LMP, 2013, CELL CYCLE, V12, P51, DOI 10.4161/cc.23121; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	23	150	157	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					85	89		10.1126/science.1250255	http://dx.doi.org/10.1126/science.1250255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278611	Green Accepted			2022-12-28	WOS:000342446900056
J	Griffith, CA				Griffith, Caitlin A.			SOLAR SYSTEM Not just a storm in a teacup	NATURE			English	Editorial Material							ATMOSPHERE; TITAN		Univ Arizona, Dept Planetary Sci, Tucson, AZ USA	University of Arizona	Griffith, CA (corresponding author), Univ Arizona, Dept Planetary Sci, Tucson, AZ USA.	griffith@lpl.arizona.edu						Clark RN, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003369; CRUIKSHANK DP, 1991, ICARUS, V94, P345, DOI 10.1016/0019-1035(91)90233-J; de Kok RJ, 2014, NATURE, V514, P65, DOI 10.1038/nature13789; Flasar FM, 2009, PHILOS T R SOC A, V367, P649, DOI 10.1098/rsta.2008.0242; Griffith CA, 2006, SCIENCE, V313, P1620, DOI 10.1126/science.1128245; Horst SM, 2012, ASTROBIOLOGY, V12, P809, DOI 10.1089/ast.2011.0623; Lavvas P, 2011, ICARUS, V215, P732, DOI 10.1016/j.icarus.2011.06.040; Le Mouelic S, 2012, PLANET SPACE SCI, V60, P86, DOI 10.1016/j.pss.2011.04.006; Rannou P, 2005, ADV SPACE RES-SERIES, V36, P2194, DOI 10.1016/j.asr.2005.09.041; Trainer MG, 2006, P NATL ACAD SCI USA, V103, P18035, DOI 10.1073/pnas.0608561103; Vinatier S., ICARUS UNPUB; West R. A., 2013, AAS DIVISION PLANETA, V45; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	13	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					40	41		10.1038/514040a	http://dx.doi.org/10.1038/514040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279913				2022-12-28	WOS:000342420800028
J	Paul, S; Isaacs, AJ; Treasure, T; Altorki, NK; Sedrakyan, A				Paul, Subroto; Isaacs, Abby J.; Treasure, Tom; Altorki, Nasser K.; Sedrakyan, Art			Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSISTED THORACIC-SURGERY; LYMPH-NODE DISSECTION; CELL LUNG-CANCER; SURGICAL RESECTION; ENGLAND; MORBIDITY; THORACOTOMY; RECURRENCE; EXPERIENCE; OPERATIONS	Objective To compare long term survival after minimally invasive lobectomy and thoracotomy lobectomy. Design Propensity matched analysis. Setting Surveillance, Epidemiology and End Results (SEER)-Medicare database. Participants All patients with lung cancer from 2007 to 2009 undergoing lobectomy. Main outcome measure Influence of less invasive thoracoscopic surgery on overall survival, disease-free survival, and cancer specific survival. Results From 2007 to 2009, 6008 patients undergoing lobectomy were identified (n=4715 (78%) thoracotomy). The median age of the entire cohort was 74 (interquartile range 70-78) years. The median length of follow-up for entire group was 40 months. In a matched analysis of 1195 patients in each treatment category, no statistical differences in three year overall survival, disease-free survival, or cancer specific survival were found between the groups (overall survival: 70.6% v 68.1%, P=0.55; disease-free survival: 86.2% v 85.4%, P=0.46; cancer specific survival: 92% v 89.5%, P=0.05). Conclusion This propensity matched analysis showed that patients undergoing thoracoscopic lobectomy had similar overall, cancer specific, and disease-free survival compared with patients undergoing thoracotomy lobectomy. Thoracoscopic techniques do not seem to compromise these measures of outcome after lobectomy.	[Paul, Subroto; Isaacs, Abby J.; Sedrakyan, Art] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Hlth Policy & Res, Patient Ctr Comparat Effectiveness Program, New York, NY 10065 USA; [Paul, Subroto; Altorki, Nasser K.; Sedrakyan, Art] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Cardiothorac Surg, New York, NY 10065 USA; [Treasure, Tom] UCL, Clin Operat Res Unit, London, England	Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; University of London; University College London	Paul, S (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Hlth Policy & Res, Patient Ctr Comparat Effectiveness Program, New York, NY 10065 USA.	pas2022@med.cornell.edu		Isaacs, Abby/0000-0003-4139-6964	US Food and Drug Administration (FDA)	US Food and Drug Administration (FDA)	AS received funding from the US Food and Drug Administration (FDA) for establishing the MDEpiNet Science and Infrastructure Centre. SP is a senior investigator within the Weill Cornell Medical College Patient Centered Comparative Effectiveness Program and the US FDA's Medical Device Epidemiology Network's (MDEpiNet) Science and Infrastructure Centre (director: AS).	Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; BELCHER JR, 1983, THORAX, V38, P428, DOI 10.1136/thx.38.6.428; Boffa DJ, 2012, ANN THORAC SURG, V94, P347, DOI 10.1016/j.athoracsur.2012.04.059; Cattaneo SM, 2008, ANN THORAC SURG, V85, P231, DOI 10.1016/j.athoracsur.2007.07.080; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Cooper MA, 2014, BMJ-BRIT MED J, V348, pg4198; Demmy TL, 1999, ANN THORAC SURG, V68, P194, DOI 10.1016/S0003-4975(99)00467-1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Flores RM, 2009, J THORAC CARDIOV SUR, V138, P11, DOI 10.1016/j.jtcvs.2009.03.030; Franklin JM, 2014, STAT MED, V33, P1685, DOI 10.1002/sim.6058; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Jin Linda X, 2011, J Healthc Qual, V33, P48, DOI 10.1111/j.1945-1474.2011.00148.x; Kuhry E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003432.pub2; Lardinois D, 2005, ANN THORAC SURG, V80, P268, DOI 10.1016/j.athoracsur.2005.02.005; Lardinois D, 2006, EUR J CARDIO-THORAC, V30, P787, DOI 10.1016/j.ejcts.2006.08.008; Lee PC, 2013, ANN THORAC SURG, V96, P951, DOI 10.1016/j.athoracsur.2013.04.104; Licht PB, 2013, ANN THORAC SURG, V96, P943, DOI 10.1016/j.athoracsur.2013.04.011; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; Lund JL, 2013, MED CARE, V51, pE27, DOI 10.1097/MLR.0b013e31823ab60f; McKenna RJ, 2006, ANN THORAC SURG, V81, P421, DOI 10.1016/j.athoracsur.2005.07.078; National Institute for Health and Clinical Excellence, 2011, LUNG CANC DIAGN TREA; National Institute for Health Research, 26 NIHR HTA CLIN EV; Nicastri DG, 2008, J THORAC CARDIOV SUR, V135, P642, DOI 10.1016/j.jtcvs.2007.09.014; Onaitis MW, 2006, ANN SURG, V244, P420, DOI 10.1097/01.sla.0000234892.79056.63; Paul S, 2013, EUR J CARDIO-THORAC, V43, P813, DOI 10.1093/ejcts/ezs428; Paul S, 2010, J THORAC CARDIOV SUR, V139, P366, DOI 10.1016/j.jtcvs.2009.08.026; Rassen J, 2013, USING PHARMCOEPI TOO; Riaz SP, 2012, THORAX, V67, P811, DOI 10.1136/thoraxjnl-2012-201768; Riaz SP, 2012, EUR J CANCER, V48, P54, DOI 10.1016/j.ejca.2011.07.012; Rich AL, 2011, THORAX, V66, P1078, DOI 10.1136/thx.2011.158972; Rich AL, 2011, LUNG CANCER, V72, P16, DOI 10.1016/j.lungcan.2010.07.002; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schipper PH, 2009, ANN THORAC SURG, V88, P1566, DOI 10.1016/j.athoracsur.2009.08.055; Shapiro M, 2012, EJSO-EUR J SURG ONC, V38, P516, DOI 10.1016/j.ejso.2011.12.018; Su S, 2014, J THORAC CARDIOVASC, V147, P52; Su S, 2014, J THORAC CARDIOV SUR, V147, P747, DOI 10.1016/j.jtcvs.2013.10.001; Tieu B, 2012, SEMIN THORAC CARDIOV, V24, P99, DOI 10.1053/j.semtcvs.2012.06.002; Treasure T, 2013, THORAX, V68, P187, DOI 10.1136/thoraxjnl-2012-202880; Treasure T, 2012, THORAX, V67, P759, DOI 10.1136/thoraxjnl-2012-202006; Wang HH, 2012, ANN CARDIOTHORAC SUR, V1, P27, DOI 10.3978/j.issn.2225-319X.2012.04.02; Warren JL, 2002, MED CARE, V40, P3	42	96	102	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2014	349								g5575	10.1136/bmj.g5575	http://dx.doi.org/10.1136/bmj.g5575			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CH	25277994	Green Published, hybrid			2022-12-28	WOS:000342665800001
J	Perkel, JM				Perkel, Jeffrey M.			TOOLBOX SCIENTIFIC WRITING: THE ONLINE COOPERATIVE	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	8	9	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					127	128		10.1038/514127a	http://dx.doi.org/10.1038/514127a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP9SS	25279924	Bronze			2022-12-28	WOS:000342420800050
J	Zu, C; Wang, WB; He, L; Zhang, WG; Dai, CY; Wang, F; Duan, LM				Zu, C.; Wang, W. -B.; He, L.; Zhang, W. -G.; Dai, C. -Y.; Wang, F.; Duan, L. -M.			Experimental realization of universal geometric quantum gates with solid-state spins	NATURE			English	Article							TRAPPED IONS; COMPUTATION; ENTANGLEMENT; DIAMOND; PHASES	Experimental realization of a universal set of quantum logic gates is the central requirement for the implementation of a quantum computer. In an 'all-geometric' approach to quantum computation(1,2), the quantum gates are implemented using Berry phases(3) and their non-Abelian extensions, holonomies(4), from geometric transformation of quantum states in the Hilbert space(5). Apart from its fundamental interest and rich mathematical structure, the geometric approach has some built-innoise-resilience features(1,2,6,7). On the experimental side, geometric phases and holonomies have been observed in thermal ensembles of liquid molecules using nuclear magnetic resonance(8,9); however, such systems are known to be non-scalable for the purposes of quantum computing(10). There are proposals to implement geometric quantum computation in scalable experimental platforms such as trapped ions(11), superconducting quantum bits(12) and quantum dots(13), and a recent experiment has realized geometric single-bit gates in a superconducting system(14). Here we report the experimental realization of a universal set of geometric quantum gates using the solid-state spins of diamond nitrogen-vacancy centres. These diamond defects provide a scalable experimental platform(15-17) with the potential for room-temperature quantum computing(16-19), which has attracted strong interest in recent years(20). Our experiment shows that all-geometric and potentially robust quantum computation can be realized with solid-state spin quantum bits, making use of recent advances in the coherent control of this system(15-20).	[Zu, C.; Wang, W. -B.; He, L.; Zhang, W. -G.; Dai, C. -Y.; Wang, F.; Duan, L. -M.] Tsinghua Univ, IIIS, Ctr Quantum Informat, Beijing 100084, Peoples R China; [Duan, L. -M.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	Tsinghua University; University of Michigan System; University of Michigan	Duan, LM (corresponding author), Tsinghua Univ, IIIS, Ctr Quantum Informat, Beijing 100084, Peoples R China.	lmduan@umich.edu			National Basic Research Program of China [2011CBA00302]; Ministry of Education of China; IARPA MUSIQC program; AFOSR; ARO MURI program	National Basic Research Program of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China); IARPA MUSIQC program; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ARO MURI program	We thank M. Lukin's group for discussions. This work was supported by the National Basic Research Program of China 2011CBA00302 and the quantum information project from the Ministry of Education of China. In addition, L.-M. D. acknowledges support from the IARPA MUSIQC program, the AFOSR and the ARO MURI program.	Abdumalikov AA, 2013, NATURE, V496, P482, DOI 10.1038/nature12010; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Doherty MW, 2013, PHYS REP, V528, P1, DOI 10.1016/j.physrep.2013.02.001; Dolde F, 2013, NAT PHYS, V9, P139, DOI 10.1038/nphys2545; Dolde F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4371; Duan LM, 2010, REV MOD PHYS, V82, P1209, DOI 10.1103/RevModPhys.82.1209; Duan LM, 2001, SCIENCE, V292, P1695, DOI 10.1126/science.1058835; Falci G, 2000, NATURE, V407, P355, DOI 10.1038/35030052; Feng GR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.190501; Jacques V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057403; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Jiang L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062323; Johansson M, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.062322; Jones JA, 2000, NATURE, V403, P869, DOI 10.1038/35002528; Lloyd S, 2001, SCIENCE, V292, P1669, DOI 10.1126/science.1062065; Loredo JC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.143603; Neumann P, 2010, NAT PHYS, V6, P249, DOI 10.1038/NPHYS1536; Nielsen, 2010, QUANTUM COMPUTATION; Pachos J, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.010305; Pachos J. K., 2012, INTRO TOPOLOGICAL QU; Shapere A., 1989, GEOMETRIC PHASES PHY; Sjoqvist E, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103035; Solinas P, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.062315; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; Yao NY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1788; Yao NY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040505; Zanardi P, 1999, PHYS LETT A, V264, P94, DOI 10.1016/S0375-9601(99)00803-8; Zhu SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.097902	30	239	241	8	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					72	+		10.1038/nature13729	http://dx.doi.org/10.1038/nature13729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279920	Green Submitted			2022-12-28	WOS:000342420800037
J	Rieux-Laucat, F; Casanova, JL				Rieux-Laucat, Frederic; Casanova, Jean-Laurent			Autoimmunity by haploinsufficiency	SCIENCE			English	Editorial Material							LYMPHOPROLIFERATIVE SYNDROME; MUTATIONS; HUMANS; CTLA-4		[Rieux-Laucat, Frederic] Necker Hosp Sick Children, INSERM, Lab Immunogenet Pediat Autoimmun, UMR 1163, Paris, France; [Rieux-Laucat, Frederic; Casanova, Jean-Laurent] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Lab Human Genet Infect Dis, INSERM, UMR 1163,Imagine Inst, Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Hematol & Immunol Unit, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Rieux-Laucat, F (corresponding author), Necker Hosp Sick Children, INSERM, Lab Immunogenet Pediat Autoimmun, UMR 1163, Paris, France.	jean-laurent.casanova@rockefeller.edu	Casanova, Jean-Laurent/I-3418-2017; Rieux-Laucat, Frédéric/A-7916-2017	Rieux-Laucat, Frédéric/0000-0001-7858-7866	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI095983] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ARIGA T, 1989, J CLIN INVEST, V83, P1888, DOI 10.1172/JCI114095; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2013, COLD SH Q B, V78, P157, DOI 10.1101/sqb.2013.78.019968; Cheng MH, 2012, ANNU REV IMMUNOL, V30, P393, DOI 10.1146/annurev-immunol-020711-074953; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; Krummel M. F., 1995, J EXP MED, V182, P495; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Magerus-Chatinet A, 2011, J CLIN INVEST, V121, P106, DOI 10.1172/JCI43752; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	15	47	47	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1560	1561		10.1126/science.1260791	http://dx.doi.org/10.1126/science.1260791			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258064				2022-12-28	WOS:000342164500020
J	Tervo, DGR; Proskurin, M; Manakov, M; Kabra, M; Vollmer, A; Branson, K; Karpova, AY				Tervo, Dougal G. R.; Proskurin, Mikhail; Manakov, Maxim; Kabra, Mayank; Vollmer, Alison; Branson, Kristin; Karpova, Alla Y.			Behavioral Variability through Stochastic Choice and Its Gating by Anterior Cingulate Cortex	CELL			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; HUMAN BRAIN; REINFORCEMENT; UNCERTAINTY; MODEL; GAME; ENVIRONMENT; MODULATION; SELECTION	Behavioral choices that ignore prior experience promote exploration and unpredictability but are seemingly at odds with the brain's tendency to use experience to optimize behavioral choice. Indeed, when faced with virtual competitors, primates resort to strategic counterprediction rather than to stochastic choice. Here, we show that rats also use history- and model-based strategies when faced with similar competitors but can switch to a "stochastic" mode when challenged with a competitor that they cannot defeat by counterprediction. In this mode, outcomes associated with an animal's actions are ignored, and normal engagement of anterior cingulate cortex (ACC) is suppressed. Using circuit perturbations in transgenic rats, we demonstrate that switching between strategic and stochastic behavioral modes is controlled by locus coeruleus input into ACC. Our findings suggest that, under conditions of uncertainty about environmental rules, changes in noradrenergic input alter ACC output and prevent erroneous beliefs from guiding decisions, thus enabling behavioral variation.	[Tervo, Dougal G. R.; Proskurin, Mikhail; Manakov, Maxim; Kabra, Mayank; Vollmer, Alison; Branson, Kristin; Karpova, Alla Y.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Karpova, AY (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	alla@janelia.hhmi.org	Proskurin, Mikhail/AAD-8552-2022	Proskurin, Mikhail/0000-0003-2548-9722	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We are grateful to K. Deisseroth for providing the TH-Cre rat transgenic line and to A. Hantman for providing the hM4-DREADD virus. We thank H. Hou (Janelia Summer Undergraduate Program) for help with the exploratory set of behavioral experiments and K. Morris, S. Lindo, and M. Copeland for technical assistance with surgeries and histology. W. Denk, S. Druckmann, T.J. Florence, V. Jayaraman, T. Jessell, M. Karlsson, A. Leonardo, N. Spruston, and C. Zuker offered useful discussions and comments on the manuscript. K. Ris-Vicari created the task illustration. This work was supported by the Howard Hughes Medical Institute.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bauer H, 2003, NEUROIMAGE, V20, P927, DOI 10.1016/S1053-8119(03)00363-X; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dong SY, 2010, MOL BIOSYST, V6, P1376, DOI 10.1039/c002568m; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fee MS, 2011, NEUROSCIENCE, V198, P152, DOI 10.1016/j.neuroscience.2011.09.069; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Green CS, 2010, P NATL ACAD SCI USA, V107, P16401, DOI 10.1073/pnas.1001709107; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Karlsson MP, 2012, SCIENCE, V338, P135, DOI 10.1126/science.1226518; Lee D, 2005, COGNITIVE BRAIN RES, V25, P416, DOI 10.1016/j.cogbrainres.2005.07.003; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, pE3660, DOI 10.1073/pnas.1305373110; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Padoa-Schioppa C, 2013, NEURON, V80, P1322, DOI 10.1016/j.neuron.2013.09.013; PAGE S, 1985, J EXP PSYCHOL-ANIM B, V11, P429, DOI 10.1037/0097-7403.11.3.429; Payzan-LeNestour E, 2013, NEURON, V79, P191, DOI 10.1016/j.neuron.2013.04.037; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Sutton R. S., 1998, REINFORCEMENT LEARNI, V1; SUTTON RS, 1990, P 7 INT C MACH LEARN, P216; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Xu ZQD, 1998, J COMP NEUROL, V392, P227, DOI 10.1002/(SICI)1096-9861(19980309)392:2<227::AID-CNE6>3.0.CO;2-4; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zhu LS, 2012, P NATL ACAD SCI USA, V109, P1419, DOI 10.1073/pnas.1116783109	46	134	134	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					21	32		10.1016/j.cell.2014.08.037	http://dx.doi.org/10.1016/j.cell.2014.08.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259917	Bronze			2022-12-28	WOS:000343095000006
J	McCartney, M				McCartney, Margaret			Margaret McCartney: For Scotland, the real winner is democracy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2014	349								g5773	10.1136/bmj.g5773	http://dx.doi.org/10.1136/bmj.g5773			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UL	25248669	Bronze, Green Published			2022-12-28	WOS:000342425700009
J	Geissler, PW; Okwaro, F				Geissler, P. Wenzel; Okwaro, Ferdinand			Discuss inequality	NATURE			English	Editorial Material									[Geissler, P. Wenzel] Univ Oslo, N-0316 Oslo, Norway; [Geissler, P. Wenzel] Univ Cambridge, Div Social Anthropol, Cambridge CB2 1TN, England; [Okwaro, Ferdinand] Univ Cambridge, Ctr African Studies, Cambridge CB2 1TN, England	University of Oslo; University of Cambridge; University of Cambridge	Geissler, PW (corresponding author), Univ Oslo, N-0316 Oslo, Norway.	p.w.geissler@sai.uio.no; fokwaro@gmail.com						Crane J, 2011, LANCET, V377, P1388, DOI 10.1016/S0140-6736(10)61920-4; Feierman S., 2011, EVIDENCE ETHOS EXPT; Geissler PW, 2013, AM ETHNOL, V40, P13, DOI 10.1111/amet.12002; Lachenal G., 2014, PARA STATES MED SCI; Prince Ruth, 2013, MAKING UNMAKING PUBL; Redfield P, 2012, CULT ANTHROPOL, V27, P358, DOI 10.1111/j.1548-1360.2012.01147.x	6	15	15	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					303	303		10.1038/513303a	http://dx.doi.org/10.1038/513303a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1GD	25230632	Bronze			2022-12-28	WOS:000341814900019
J	Marx, V				Marx, Vivien			WHEN DISEASE STRIKES FROM NOWHERE	NATURE			English	Editorial Material																		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Hu H, 2014, NAT BIOTECHNOL, V32, P663, DOI 10.1038/nbt.2895; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	6	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					445	447		10.1038/513445a	http://dx.doi.org/10.1038/513445a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1GD	25230666	Bronze			2022-12-28	WOS:000341814900068
J	Zhang, ZS; Ramstein, G; Schuster, M; Li, C; Contoux, C; Yan, Q				Zhang, Zhongshi; Ramstein, Gilles; Schuster, Mathieu; Li, Camille; Contoux, Camille; Yan, Qing			Aridification of the Sahara desert caused by Tethys Sea shrinkage during the Late Miocene	NATURE			English	Article							CLIMATE-CHANGE; AFRICAN; EVOLUTION; MONSOON; SIMULATIONS; FEEDBACKS; PLATEAU; UPLIFT; MODEL; AGE	It is widely believed that the Sahara desert is no more than similar to 2-3-million years (Myr) old(1), with geological evidence showing a remarkable aridification of north Africa at the onset of the Quaternary ice ages(2-4). Before that time, north African aridity was mainly controlled by the African summer monsoon (ASM)(5-8), which oscillated with Earth's orbital precession cycles. Afterwards, the Northern Hemisphere glaciation added an ice volume forcing on the ASM, which additionally oscillated with glacial-interglacial cycles(2). These findings led to the idea that the Sahara desert came into existence when the Northern Hemisphere glaciated similar to 2-3 Myr ago. The later discovery, however, of aeolian dune deposits similar to 7 Myr old(9) suggested a much older age, although this interpretation is hotly challenged(1) and there is no clear mechanism for aridification around this time. Here we use climate model simulations to identify the Tortonian stage (similar to 7-11 Myr ago) of the Late Miocene epoch as the pivotal period for triggering north African aridity and creating the Sahara desert. Through a set of experiments with the Norwegian Earth System Model(10) and the Community Atmosphere Model(11), we demonstrate that the African summer monsoon was drastically weakened by the Tethys Sea shrinkage during the Tortonian, allowing arid, desert conditions to expand across north Africa. Not only did the Tethys shrinkage alter the mean climate of the region, it also enhanced the sensitivity of the African monsoon to orbital forcing, which subsequently became the major driver of Sahara extent fluctuations. These important climatic changes probably caused the shifts in Asian and African flora and fauna observed during the same period(4,12-14), with possible links to the emergence of early hominins in north Africa(15,16).	[Zhang, Zhongshi; Contoux, Camille] Uni Res Climate, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Zhang, Zhongshi; Yan, Qing] Chinese Acad Sci, Inst Atmospher Phys, Nansen Zhu Int Res Ctr, Beijing 100029, Peoples R China; [Ramstein, Gilles] CE Saclay, CEA CNRS UVSQ, Lab Sci Climat & Environm IPSL, UMR8212, F-91191 Gif Sur Yvette, France; [Schuster, Mathieu] CNRS, Ecole & Observ Sci Terre, Inst Phys Globe Strasbourg UMR 7516, F-67084 Strasbourg, France; [Schuster, Mathieu] Univ Strasbourg, F-67084 Strasbourg, France; [Li, Camille] Univ Bergen, Inst Geophys, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway	Bjerknes Centre for Climate Research; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Bjerknes Centre for Climate Research; University of Bergen	Zhang, ZS (corresponding author), Uni Res Climate, Bjerknes Ctr Climate Res, Allegaten 70, N-5007 Bergen, Norway.	zhongshi.zhang@uni.no	Yan, Qing/K-4625-2019; Zhang, zs/GXN-3521-2022; Li, Camille/G-5802-2011; Zhang, Zhongshi/L-2891-2013; Yan, Qing/C-5413-2013; Ramstein, Gilles/L-3328-2014	Yan, Qing/0000-0001-5299-7824; Li, Camille/0000-0002-5439-2973; Zhang, Zhongshi/0000-0002-2354-1622; Yan, Qing/0000-0001-5299-7824; Ramstein, Gilles/0000-0002-1522-917X; Schuster, Mathieu/0000-0002-4412-8685; contoux, camille/0000-0001-8487-9275	Chinese Academy of Sciences [XDA05080803]; National 973 Program of China [2010CB950102]; Earth System Modelling (ESM) project - Statoil, Norway; Dynamics of Past Warm Climates (DYNAWARM) project - Centre for Climate Dynamics (SKD) at the Bjerknes Centre; Aurora mobility program France-Norway - Research Council of Norway	Chinese Academy of Sciences(Chinese Academy of Sciences); National 973 Program of China(National Basic Research Program of China); Earth System Modelling (ESM) project - Statoil, Norway; Dynamics of Past Warm Climates (DYNAWARM) project - Centre for Climate Dynamics (SKD) at the Bjerknes Centre; Aurora mobility program France-Norway - Research Council of Norway	We thank N. Caud for her help in preparing the paper, and F. Guy for discussions on hominin emergence and evolution. This study was jointly supported by the Strategic and Special Frontier Project of Science and Technology of the Chinese Academy of Sciences (grant no. XDA05080803); the National 973 Program of China (grant no. 2010CB950102); the Earth System Modelling (ESM) project financed by Statoil, Norway; the Dynamics of Past Warm Climates (DYNAWARM) project financed by the Centre for Climate Dynamics (SKD) at the Bjerknes Centre; and the Aurora mobility program France-Norway financed by the Research Council of Norway.	[Anonymous], 2010, DESCRIPTION NCAR COM; Barrier E., 2008, PALAEOTECTONIC MAPS; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Bentsen M, 2013, GEOSCI MODEL DEV, V6, P687, DOI 10.5194/gmd-6-687-2013; Bice K. L., 1998, TECTONIC BOUNDARY CO, P227; Boos WR, 2010, NATURE, V463, P218, DOI 10.1038/nature08707; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Chou C, 2003, J CLIMATE, V16, P406, DOI 10.1175/1520-0442(2003)016<0406:MLTNEO>2.0.CO;2; Claussen M, 2003, CLIMATIC CHANGE, V57, P99, DOI 10.1023/A:1022115604225; Cook KH, 2012, J CLIMATE, V25, P2609, DOI 10.1175/JCLI-D-11-00185.1; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Eaton B., 2010, USERS GUIDE COMMUNIT; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Feakins SJ, 2013, GEOLOGY, V41, P295, DOI 10.1130/G33845.1; Fluteau F, 1999, J GEOPHYS RES-ATMOS, V104, P11995, DOI 10.1029/1999JD900048; Francois L, 2006, PALAEOGEOGR PALAEOCL, V238, P302, DOI 10.1016/j.palaeo.2006.03.034; Gupta AK, 2004, GEOLOGY, V32, P753, DOI 10.1130/G20662.1; Huber M, 2012, J ASIAN EARTH SCI, V44, P3, DOI 10.1016/j.jseaes.2011.09.014; Karami MP, 2011, GLOBAL PLANET CHANGE, V79, P73, DOI 10.1016/j.gloplacha.2011.07.011; Kroepelin S, 2006, SCIENCE, V312, P1138; Kutzbach JE, 1997, SCIENCE, V278, P440, DOI 10.1126/science.278.5337.440; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Lin SJ, 1998, Q J ROY METEOR SOC, V124, P2531, DOI 10.1256/smsqj.55118; Lin SJ, 1996, MON WEATHER REV, V124, P2046, DOI 10.1175/1520-0493(1996)124<2046:MFFSLT>2.0.CO;2; Lunt DJ, 2008, EARTH PLANET SC LETT, V271, P53, DOI 10.1016/j.epsl.2008.03.035; Maslin MA, 2007, J HUM EVOL, V53, P443, DOI 10.1016/j.jhevol.2007.06.005; Micheels A, 2007, PALAEOGEOGR PALAEOCL, V253, P251, DOI 10.1016/j.palaeo.2007.03.042; Mishra SK, 2011, J CLIMATE, V24, P4037, DOI 10.1175/2011JCLI3860.1; Mouthereau F, 2011, GEOL MAG, V148, P726, DOI 10.1017/S0016756811000306; Neale RB, 2013, J CLIMATE, V26, P5150, DOI 10.1175/JCLI-D-12-00236.1; Partridge T.C, 1997, TECTONIC UPLIFT CLIM, P63, DOI DOI 10.1007/978-1-4615-5935-1; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pound MJ, 2011, PALAEOGEOGR PALAEOCL, V300, P29, DOI 10.1016/j.palaeo.2010.11.029; Ramstein G, 1997, NATURE, V386, P788, DOI 10.1038/386788a0; Rodriguez-Sanchez F., 2011, CLIMATE CHANGE ECOLO, P280; Rogl F, 1999, GEOL CARPATH, V50, P339; Ruddiman W., 1989, P OCEAN DRILLING PG, V108, P463, DOI DOI 10.2973/0DP.PR0C.SR.108.173.1989; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Schuster M, 2009, CR GEOSCI, V341, P603, DOI 10.1016/j.crte.2009.04.001; Scotese C.R., 2001, DIGITAL PALEOGEOGRAP; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Shields CA, 2012, J CLIMATE, V25, P3993, DOI 10.1175/JCLI-D-11-00260.1; Shultz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076750; Simmons A. J., 1981, 28 EUR CTR MED RANG; Steppuhn A, 2007, GLOBAL PLANET CHANGE, V57, P189, DOI 10.1016/j.gloplacha.2006.09.003; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Tierney JE, 2013, SCIENCE, V342, P843, DOI 10.1126/science.1240411; Wu GX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00404; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211; Zhang ZS, 2012, GEOSCI MODEL DEV, V5, P523, DOI 10.5194/gmd-5-523-2012; Zhang ZS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2521	53	155	165	10	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					401	+		10.1038/nature13705	http://dx.doi.org/10.1038/nature13705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230661				2022-12-28	WOS:000341814900056
J	Burland, L; Green, BL				Burland, Lydia; Green, Ben L.			A cutaneous manifestation of intra-abdominal disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUBCUTANEOUS FAT NECROSIS; ACUTE-PANCREATITIS; PANNICULITIS; MANAGEMENT; AMYLASE; LIPASE; SIGN		[Burland, Lydia] Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England; [Green, Ben L.] Leeds Teaching Hosp Trust, Leeds LS1 3EX, W Yorkshire, England	Bradford Royal Infirmary; University of Leeds	Green, BL (corresponding author), Leeds Teaching Hosp Trust, Leeds LS1 3EX, W Yorkshire, England.	blgreen@doctors.org.uk						Ayub K, 2004, COCHRANE DB SYST REV, V4; Banks PA, 2002, GASTROINTEST ENDOSC, V56, pS226, DOI 10.1067/mge.2002.129022; DHAWAN SS, 1990, AM J GASTROENTEROL, V85, P1025; El-Dhuwaib Y, 2012, ANN ROY COLL SURG, V94, P402, DOI 10.1308/003588412X13171221591934; FINE RM, 1983, INT J DERMATOL, V22, P575, DOI 10.1111/j.1365-4362.1983.tb02128.x; FORSTROM L, 1975, ARCH DERMATOL, V111, P497, DOI 10.1001/archderm.111.4.497; FOX JA, 1966, BRIT J SURG, V53, P193, DOI 10.1002/bjs.1800530310; Garcia-Romero D, 2008, DERMATOL CLIN, V26, P465, DOI 10.1016/j.det.2008.05.009; Goldacre MJ, 2004, BRIT MED J, V328, P1466, DOI 10.1136/bmj.328.7454.1466; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; LERCH MM, 1993, GASTROENTEROLOGY, V104, P853, DOI 10.1016/0016-5085(93)91022-A; Lightner AM, 2001, FRONT BIOSCI, V6, P66; MEYERS MA, 1989, GASTROINTEST RADIOL, V14, P31, DOI 10.1007/BF01889150; Requena L, 2001, J AM ACAD DERMATOL, V45, P325, DOI 10.1067/mjd.2001.114735; Requena L, 2001, J AM ACAD DERMATOL, V45, P163, DOI 10.1067/mjd.2001.114736; Sekimoto M, 2006, J HEPATO-BILIARY-PAN, V13, P10, DOI 10.1007/s00534-005-1047-3; SIBRACK LA, 1978, CUTIS, V21, P763; SIGMUND WJ, 1954, NEW ENGL J MED, V251, P851, DOI 10.1056/NEJM195411182512104; Treacy J, 2001, ANZ J SURG, V71, P577, DOI 10.1046/j.1445-2197.2001.02220.x; Walzel P., 1927, WIEN KLIN WOCHENSCHR, V40, P218; Zheng ZJ, 2011, ANN DERMATOL, V23, P225, DOI 10.5021/ad.2011.23.2.225	21	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2014	349								g5492	10.1136/bmj.g5492	http://dx.doi.org/10.1136/bmj.g5492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OW	25231052				2022-12-28	WOS:000342058300004
J	Bronfort, G; Hondras, MA; Schulz, CA; Evans, RL; Long, CR; Grimm, R				Bronfort, Gert; Hondras, Maria A.; Schulz, Craig A.; Evans, Roni L.; Long, Cynthia R.; Grimm, Richard			Spinal Manipulation and Home Exercise With Advice for Subacute and Chronic Back-Related Leg Pain A Trial With Adaptive Allocation	ANNALS OF INTERNAL MEDICINE			English	Article							LUMBAR-DISK HERNIATION; QUALITY-OF-LIFE; NECK PAIN; CONSERVATIVE TREATMENTS; NONOPERATIVE TREATMENT; EPIDURAL INJECTIONS; NATURAL-HISTORY; CLINICAL-TRIALS; MIXED-METHODS; HEALTH SURVEY	Background: Back-related leg pain (BRLP) is often disabling and costly, and there is a paucity of research to guide its management. Objective: To determine whether spinal manipulative therapy (SMT) plus home exercise and advice (HEA) compared with HEA alone reduces leg pain in the short and long term in adults with BRLP. Design: Controlled pragmatic trial with allocation by minimization conducted from 2007 to 2011. (ClinicalTrials.gov: NCT00494065) Setting: 2 research centers (Minnesota and Iowa). Patients: Persons aged 21 years or older with BRLP for least 4 weeks. Intervention: 12 weeks of SMT plus HEA or HEA alone. Measurements: The primary outcome was patient-rated BRLP at 12 and 52 weeks. Secondary outcomes were self-reported low back pain, disability, global improvement, satisfaction, medication use, and general health status at 12 and 52 weeks. Blinded objective tests were done at 12 weeks. Results: Of the 192 enrolled patients, 191 (99%) provided follow-up data at 12 weeks and 179 (93%) at 52 weeks. For leg pain, SMT plus HEA had a clinically important advantage over HEA (difference, 10 percentage points [95% CI, 2 to 19]; P = 0.008) at 12 weeks but not at 52 weeks (difference, 7 percentage points [CI, -2 to 15]; P = 0.146). Nearly all secondary outcomes improved more with SMT plus HEA at 12 weeks, but only global improvement, satisfaction, and medication use had sustained improvements at 52 weeks. No serious treatment-related adverse events or deaths occurred. Limitation: Patients and providers could not be blinded. Conclusion: For patients with BRLP, SMT plus HEA was more effective than HEA alone after 12 weeks, but the benefit was sustained only for some secondary outcomes at 52 weeks.	Univ Minnesota, Minneapolis, MN 55455 USA; Northwestern Hlth Sci Univ, Minneapolis, MN 55431 USA; Minneapolis Med Res Fdn Inc, Berman Ctr Outcomes & Clin Res, Minneapolis, MN 55404 USA; Palmer Ctr Chiropract Res, Davenport, IA 52803 USA	University of Minnesota System; University of Minnesota Twin Cities; Minneapolis Medical Research Foundation	Bronfort, G (corresponding author), Univ Minnesota, Ctr Spiritual & Healing, MMC 505,425 Delaware St Southeast, Minneapolis, MN 55455 USA.	bronf003@umn.edu	Hondras, Maria/AAW-1979-2021	Schulz, Craig/0000-0002-4019-1521	Health Resources and Services Administration, U.S. Department of Health and Human Services [R18HP07638]	Health Resources and Services Administration, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	By the Health Resources and Services Administration, U.S. Department of Health and Human Services (grant R18HP07638).	Albert HB, 2012, SPINE, V37, P531, DOI 10.1097/BRS.0b013e31821ace7f; Andersson Gunnar B. J., 1997, P93; [Anonymous], 1987, Spine (Phila Pa 1976), V12, pS1; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bombardier C, 2001, J RHEUMATOL, V28, P431; Bronfort G, 2000, J MANIP PHYSIOL THER, V23, P536, DOI 10.1067/mmt.2000.109678; Bronfort G, 2004, J MANIP PHYSIOL THER, V27, P503, DOI 10.1016/j.jmpt.2004.08.002; Bronfort G, 2012, ANN INTERN MED, V156, P1, DOI 10.7326/0003-4819-156-1-201201030-00002; Bronfort G, 2011, SPINE J, V11, P585, DOI 10.1016/j.spinee.2011.01.036; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Cherkin DC, 1996, SPINE, V21, P345, DOI 10.1097/00007632-199602010-00019; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Delitto A, 2012, J ORTHOP SPORT PHYS, V42, pA1, DOI 10.2519/jospt.2012.42.4.A1; Deshpande A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub3; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; Engers A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004057.pub3; Evans RL, 2003, J MANIP PHYSIOL THER, V26, P502, DOI 10.1016/S0161-4754(03)00107-6; Evans R, 2014, EUR SPINE J, V23, P888, DOI 10.1007/s00586-013-3149-y; Fritz JM, 2011, SPINE, V36, P1772, DOI 10.1097/BRS.0b013e318216337d; Fritz JM, 2009, SPINE, V34, P2803, DOI 10.1097/BRS.0b013e3181ae2bd4; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Hahne AJ, 2010, SPINE, V35, pE488, DOI 10.1097/BRS.0b013e3181cc3f56; Hill JC, 2011, SPINE, V36, P2168, DOI 10.1097/BRS.0b013e31820712bb; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; JAESCHKE R, 1990, CONTROL CLIN TRIALS, V11, P43, DOI 10.1016/0197-2456(90)90031-V; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kent PM, 2008, MANUAL THER, V13, P12, DOI 10.1016/j.math.2007.05.009; Kongsted A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-236; Konstantinou K, 2013, CLIN J PAIN, V29, P644, DOI 10.1097/AJP.0b013e31826f9a52; Lawrence DJ, 2008, J MANIP PHYSIOL THER, V31, P659, DOI 10.1016/j.jmpt.2008.10.007; Leininger B, 2011, PHYS MED REH CLIN N, V22, P105, DOI 10.1016/j.pmr.2010.11.002; Lequin MB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002534; Lin CWC, 2014, EUR J PAIN, V18, P455, DOI 10.1002/j.1532-2149.2013.00384.x; Luijsterburg PAJ, 2007, EUR SPINE J, V16, P881, DOI 10.1007/s00586-007-0367-1; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P199; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; McGill S, 2002, LOW BACK DISORDERS E, P205; McGill SM, 2002, LOW BACK DISORDERS E, P239; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mckenzie RA, 1990, TREAT YOUR OWN BACK, P37; McMorland G, 2010, J MANIP PHYSIOL THER, V33, P576, DOI 10.1016/j.jmpt.2010.08.013; National Health and Family Planning Commission of the People's Republic of China, 2010, PRACT GUID PREC ULTR, P1; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nyiendo J, 2001, J MANIP PHYSIOL THER, V24, P433, DOI 10.1016/S0161-4754(01)77689-0; hm A, 2012, PATIENT SAF SURG, V6, DOI 10.1186/1754-9493-6-2; Oliveira VC, 2012, ARTHRIT CARE RES, V64, P1739, DOI 10.1002/acr.21737; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Petersen T, 2011, SPINE, V36, P1999, DOI 10.1097/BRS.0b013e318201ee8e; Pickar JG, 2012, J ELECTROMYOGR KINES, V22, P785, DOI 10.1016/j.jelekin.2012.01.015; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564; Pinto RZ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e497; ROLAND M, 1983, SPINE, V8, P145, DOI 10.1097/00007632-198303000-00005; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Schulz CA, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-8; Seffinger MA, 2004, SPINE, V29, pE413, DOI 10.1097/01.brs.0000141178.98157.8e; Selim AJ, 1998, SPINE, V23, P470, DOI 10.1097/00007632-199802150-00013; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441	66	39	41	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					381	U38		10.7326/M14-0006	http://dx.doi.org/10.7326/M14-0006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222385				2022-12-28	WOS:000343894400013
J	Armstrong, S				Armstrong, Stephen			Video games on prescription	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						Brody E, 2013, GP               AUG; Dutta N., 2014, HEALTHSITE      0910; Gunning E, SHOULD PATIENTS BE A; Jee C, 2014, COMPUTERWORLD   0714; Kato PM, 2008, PEDIATRICS, V122, pE305, DOI 10.1542/peds.2007-3134; McGonigal J., 2011, WALL STREET J; Thompson BM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5211	7	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2014	349								g5615	10.1136/bmj.g5615	http://dx.doi.org/10.1136/bmj.g5615			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OJ	25224744				2022-12-28	WOS:000342056800003
J	Lawn, JE				Lawn, Joy E.			The child survival revolution: what next?	LANCET			English	Editorial Material							HEALTH; PROGRESS		London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Lawn, JE (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.	joy.lawn@lshtm.ac.uk	Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443				Adams AM, 2013, LANCET, V382, P2027, DOI 10.1016/S0140-6736(13)62060-7; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Kerber KJ, 2013, AIDS, V27, P2637, DOI 10.1097/01.aids.0000432987.53271.40; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; National Institute of Population Studies, 2013, PAK DEM HLTH SURV 20; Oestergaard MZ, 2013, INT J EPIDEMIOL, V42, P645, DOI 10.1093/ije/dyt059; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; UNICEF, 2017, LEVELS TRENDS CHILD; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9	13	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					931	933		10.1016/S0140-6736(14)61057-6	http://dx.doi.org/10.1016/S0140-6736(14)61057-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9ML	25220959				2022-12-28	WOS:000341679700004
J	Frishkoff, LO; Karp, DS; M'Gonigle, LK; Mendenhall, CD; Zook, J; Kremen, C; Hadly, EA; Daily, GC				Frishkoff, Luke O.; Karp, Daniel S.; M'Gonigle, Leithen K.; Mendenhall, Chase D.; Zook, Jim; Kremen, Claire; Hadly, Elizabeth A.; Daily, Gretchen C.			Loss of avian phylogenetic diversity in neotropical agricultural systems	SCIENCE			English	Article							ECOSYSTEM SERVICES; EXTINCTION; CONSERVATION; BIRDS; COMMUNITIES; DISTURBANCE; STABILITY; EVOLUTION; PATTERNS; CLIMATE	Habitat conversion is the primary driver of biodiversity loss, yet little is known about how it is restructuring the tree of life by favoring some lineages over others. We combined a complete avian phylogeny with 12 years of Costa Rican bird surveys (118,127 detections across 487 species) sampled in three land uses: forest reserves, diversified agricultural systems, and intensive monocultures. Diversified agricultural systems supported 600 million more years of evolutionary history than intensive monocultures but 300 million fewer years than forests. Compared with species with many extant relatives, evolutionarily distinct species were extirpated at higher rates in both diversified and intensive agricultural systems. Forests are therefore essential for maintaining diversity across the tree of life, but diversified agricultural systems may help buffer against extreme loss of phylogenetic diversity.	[Frishkoff, Luke O.; Mendenhall, Chase D.; Hadly, Elizabeth A.; Daily, Gretchen C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frishkoff, Luke O.; Mendenhall, Chase D.; Daily, Gretchen C.] Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA; [Karp, Daniel S.; M'Gonigle, Leithen K.; Kremen, Claire] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Karp, Daniel S.] Nature Conservancy, Berkeley, CA 94705 USA; [Zook, Jim] Union Ornitol Costa Rica, Naranjo De Alajuela, Costa Rica; [Daily, Gretchen C.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Daily, Gretchen C.] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere, SE-10405 Stockholm, Sweden; [Daily, Gretchen C.] Univ Stockholm, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden	Stanford University; Stanford University; University of California System; University of California Berkeley; Stanford University; Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; Stockholm University	Frishkoff, LO (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	frishkol@stanford.edu; dkarp@berkeley.edu	Frishkoff, Luke/H-8680-2019	Frishkoff, Luke/0000-0001-5738-2140	Ward Wilson Woods Jr. Environmental Studies Fund; NSF Doctoral Dissertation Improvement Grant; NatureNet fellowship from the Nature Conservancy; Natural Sciences and Engineering Research Council postdoctoral fellowship; Bing Ecology and Conservation Graduate Fellowship; Heinz foundation; Moore Family foundation; Winslow foundation; LuEsther T. Mertz trust; Pew Charitable trust	Ward Wilson Woods Jr. Environmental Studies Fund; NSF Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); NatureNet fellowship from the Nature Conservancy; Natural Sciences and Engineering Research Council postdoctoral fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bing Ecology and Conservation Graduate Fellowship; Heinz foundation; Moore Family foundation; Winslow foundation; LuEsther T. Mertz trust; Pew Charitable trust	We thank the Organization for Tropical Studies and Los Cusingos Bird Sanctuary for facilitating collection of field data and P. Ehrlich for comments on this manuscript. This work was supported by the Ward Wilson Woods Jr. Environmental Studies Fund and an NSF Doctoral Dissertation Improvement Grant to L.O.F., a NatureNet fellowship from the Nature Conservancy to D.S.K., an Natural Sciences and Engineering Research Council postdoctoral fellowship to L.K.M., and a Bing Ecology and Conservation Graduate Fellowship to C.D.M. Data collection was made possible by donors to the Center for Conservation Biology and grants to G.C.D. from the Heinz, Moore Family, and Winslow foundations and the LuEsther T. Mertz and the Pew Charitable trusts. Original data are available at Dryad (10.5061/dryad.fv921).	Arregoitia LDV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1092; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cadotte MW, 2013, P NATL ACAD SCI USA, V110, P8996, DOI 10.1073/pnas.1301685110; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Dinnage R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007071; Driese SG, 2007, PALAEOGEOGR PALAEOCL, V248, P1, DOI 10.1016/j.palaeo.2006.11.013; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gaston KJ, 1997, EVOL ECOL, V11, P557, DOI 10.1007/s10682-997-1511-4; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Irestedt M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-268; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; Karp DS, 2011, P NATL ACAD SCI USA, V108, P21134, DOI 10.1073/pnas.1118276108; Kremen C, 2012, ECOL SOC, V17, DOI 10.5751/ES-05035-170440; Luck GW, 2012, J ANIM ECOL, V81, P1065, DOI 10.1111/j.1365-2656.2012.01974.x; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perfecto I., 2009, NATURES MATRIX LINKI; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015	27	149	155	3	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1343	1346		10.1126/science.1254610	http://dx.doi.org/10.1126/science.1254610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214627	Green Published			2022-12-28	WOS:000341483800064
J	Niemeier, D; Gombachika, H; Richards-Kortum, R				Niemeier, Deb; Gombachika, Harry; Richards-Kortum, Rebecca			How to transform the practice of engineering to meet global health needs	SCIENCE			English	Editorial Material							IMMUNIZATION	More of the world's population has access to cell phones than to basic sanitation facilities, a gap that can only be closed if the engineering and international aid communities adopt new approaches to design for scarcity and scalability.	[Niemeier, Deb] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Gombachika, Harry] Univ Malawi, Dept Elect Engn, Malawi Polytech, Blantyre, Malawi; [Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	University of California System; University of California Davis; University of Malawi; Rice University	Richards-Kortum, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467				Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; amfAR, 2018, ZIMB DAT PEPFAR MON; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Baldinger P, 2008, POWERING HLTH OPTION; Chakma J, 2014, NEW ENGL J MED, V370, P3, DOI 10.1056/NEJMp1311068; Freschi L., 2010, AIDWATCH; Frost LJ, 2008, ACCESS GOOD HLTH TEC; Habyarimana J, 2011, J PUBLIC ECON, V95, P1438, DOI 10.1016/j.jpubeco.2011.06.008; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P814; Lancet, 2014, LANCET, V383, P1359; Lloyd JS, 1999, B WORLD HEALTH ORGAN, V77, P1001; Matthews P., 2012, ENG AFRICA IDENTIFYI; PATH, 2005, UN DEV; Polis CB, 2014, CONTRACEPTION, V89, P385, DOI 10.1016/j.contraception.2013.11.008; Richards-Kortum R, 2012, SCIENCE, V336, P430, DOI 10.1126/science.1213947; Stuart K, 2011, J ROY SOC MED, V104, P401, DOI 10.1258/jrsm.2011.100394; Sutanto A, 1999, B WORLD HEALTH ORGAN, V77, P119; Tchobanoglous L., 2011, DIRECT POTABLE REUSE; Thier A, 2001, J URBAN HEALTH, V78, P372, DOI 10.1093/jurban/78.2.372; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382	22	20	20	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1287	1290		10.1126/science.1257085	http://dx.doi.org/10.1126/science.1257085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214615				2022-12-28	WOS:000341483800047
J	Gingold, H; Tehler, D; Christoffersen, NR; Nielsen, MM; Asmar, F; Kooistra, SM; Christophersen, NS; Christensen, LL; Borre, M; Sorensen, KD; Andersen, LD; Andersen, CL; Hulleman, E; Wurdinger, T; Ralfkiaer, E; Helin, K; Gronbaek, K; Omtoft, T; Waszak, SM; Dahan, O; Pedersen, JS; Lund, AH; Pilpel, Y				Gingold, Hila; Tehler, Disa; Christoffersen, Nanna R.; Nielsen, Morten M.; Asmar, Fazila; Kooistra, Susanne M.; Christophersen, Nicolaj S.; Christensen, Lise Lotte; Borre, Michael; Sorensen, Karina D.; Andersen, Lars D.; Andersen, Claus L.; Hulleman, Esther; Wurdinger, Tom; Ralfkiaer, Elisabeth; Helin, Kristian; Gronbaek, Kirsten; Omtoft, Torben; Waszak, Sebastian M.; Dahan, Orna; Pedersen, Jakob Skou; Lund, Anders H.; Pilpel, Yitzhak			A Dual Program for Translation Regulation in Cellular Proliferation and Differentiation	CELL			English	Article							TRANSFER-RNA GENES; NONOPTIMAL CODON USAGE; POLYMERASE-II; CELLS REVEALS; POL II; EXPRESSION; EFFICIENCY; CANCER; INITIATION; BIAS	A dichotomous choice for metazoan cells is between proliferation and differentiation. Measuring tRNA pools in various cell types, we found two distinct subsets, one that is induced in proliferating cells, and repressed otherwise, and another with the opposite signature. Correspondingly, we found that genes serving cell-autonomous functions and genes involved in multicellularity obey distinct codon usage. Proliferation-induced and differentiation-induced tRNAs often carry anticodons that correspond to the codons enriched among the cell-autonomous and the multicellularity genes, respectively. Because mRNAs of cell-autonomous genes are induced in proliferation and cancer in particular, the concomitant induction of their codon-enriched tRNAs suggests coordination between transcription and translation. Histone modifications indeed change similarly in the vicinity of cell-autonomous genes and their corresponding tRNAs, and in multicellularity genes and their tRNAs, suggesting the existence of transcriptional programs coordinating tRNA supply and demand. Hence, we describe the existence of two distinct translation programs that operate during proliferation and differentiation.	[Gingold, Hila; Dahan, Orna; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Tehler, Disa; Christoffersen, Nanna R.; Kooistra, Susanne M.; Christophersen, Nicolaj S.; Helin, Kristian; Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr Danstem, DK-2200 Copenhagen, Denmark; [Nielsen, Morten M.; Sorensen, Karina D.; Andersen, Lars D.; Andersen, Claus L.; Omtoft, Torben; Pedersen, Jakob Skou] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Borre, Michael] Aarhus Univ Hosp, Dept Urol, DK-8000 Aarhus, Denmark; [Andersen, Claus L.] Aarhus Univ Hosp, Dept Surg, DK-8000 Aarhus, Denmark; [Pedersen, Jakob Skou] Aarhus Univ Hosp, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark; [Asmar, Fazila; Gronbaek, Kirsten] Univ Copenhagen, Rigshosp, Dept Hematol, DK-2100 Copenhagen, Denmark; [Ralfkiaer, Elisabeth] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Hulleman, Esther] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Dept Pediat Oncol, NL-1007 MB Amsterdam, Netherlands; [Wurdinger, Tom] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Dept Neurosurg,Neurooncol Res Grp, NL-1007 MB Amsterdam, Netherlands; [Wurdinger, Tom] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Wurdinger, Tom] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Waszak, Sebastian M.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland	Weizmann Institute of Science; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lund, AH (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark.	anders.lund@bric.ku.dk; pilpel@weizmann.ac.il	Helin, Kristian/HDM-8306-2022; Pedersen, Jakob/G-3382-2012; Waszak, Sebastian M./D-7828-2015; Helin, Kristian/K-2526-2019; Hulleman, Esther/AAD-7073-2021; Andersen, Claus L/C-1477-2017; Lund, Anders H./F-4786-2014; Andersen, Claus Lindbjerg/A-9217-2012	Helin, Kristian/0000-0003-1975-6097; Pedersen, Jakob/0000-0002-7236-4001; Waszak, Sebastian M./0000-0003-3042-9521; Lund, Anders H./0000-0002-7407-3398; Hulleman, Esther/0000-0001-9256-947X; Nielsen, Morten/0000-0002-8972-7577; Borre, Michael/0000-0002-1519-9185; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Sorensen, Karina Dalsgaard/0000-0002-4902-5490; Dyrskjot, Lars/0000-0001-7061-9851; Gronbaek, Kirsten/0000-0002-1535-9601; Tehler, Disa Elisabet/0000-0003-3233-5369	European Research Council (ERC) grant; Danish National Advanced Technology Foundation; Danish Council for Strategic Research; Danish Council for Independent Research; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society; Netherlands Organisation for scientific research (NWO); Danish National Research Foundation [DNRF82]; Novo Nordisk Fonden [NNF13OC0003435] Funding Source: researchfish; The Danish Cancer Society [R72-A4591] Funding Source: researchfish	European Research Council (ERC) grant(European Research Council (ERC)); Danish National Advanced Technology Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Netherlands Organisation for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	Work in the authors' laboratory is supported by a European Research Council (ERC) grant (Y.P.) and by the Danish National Advanced Technology Foundation, the Danish Council for Strategic Research, the Danish Council for Independent Research, the Novo Nordisk Foundation, the Lundbeck Foundation, and the Danish Cancer Society (A.H.L.). Y.P. is an incumbent of the Ben-May Professorial Chair. S.M.K. was supported by a postdoctoral fellowship from the Netherlands Organisation for scientific research (NWO). The Centre for Epigenetics is supported by the Danish National Research Foundation (DNRF82). We thank Simon Kasif and Erez Dekel for stimulating discussions.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Bert SA, 2013, CANCER CELL, V23, P9, DOI 10.1016/j.ccr.2012.11.006; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Dahan O, 2011, TRENDS GENET, V27, P316, DOI 10.1016/j.tig.2011.05.008; Almondes KGD, 2010, REV ASSOC MED BRAS, V56, P484, DOI 10.1590/S0104-42302010000400025; Doherty A, 2013, MOL BIOL EVOL, V30, P2263, DOI 10.1093/molbev/mst128; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dutkowski J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002180; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gingold H, 2012, NUCLEIC ACIDS RES, V40, P10053, DOI 10.1093/nar/gks772; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Klochendler A, 2012, DEV CELL, V23, P681, DOI 10.1016/j.devcel.2012.08.009; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Kutter C, 2011, NAT GENET, V43, P948, DOI 10.1038/ng.906; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Navon S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r12; Nielsen MM, 2014, RNA, V20, P236, DOI 10.1261/rna.038927.113; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Pavon-Eternod M, 2013, RNA, V19, P461, DOI 10.1261/rna.037507.112; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P3836, DOI 10.1093/nar/24.19.3836; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Subramaniam AR, 2013, P NATL ACAD SCI USA, V110, P2419, DOI 10.1073/pnas.1211077110; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Xu Y, 2013, NATURE, V495, P116, DOI 10.1038/nature11942; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	48	262	268	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1281	1292		10.1016/j.cell.2014.08.011	http://dx.doi.org/10.1016/j.cell.2014.08.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215487	Bronze			2022-12-28	WOS:000343094200011
J	Basnet, H; Su, XB; Tan, YL; Meisenhelders, J; Merkurjev, D; Ohgi, KA; Hunters, T; Pillus, L; Rosenfeld, MG				Basnet, Harihar; Su, Xue B.; Tan, Yuliang; Meisenhelders, Jill; Merkurjev, Dana; Ohgi, Kenneth A.; Hunters, Tony; Pillus, Lorraine; Rosenfeld, Michael G.			Tyrosine phosphorylation of histone H2A by CK2 regulates transcriptional elongation	NATURE			English	Article							PROTEIN-KINASE CK2; RNA-POLYMERASE-II; YEAST; UBIQUITYLATION; METHYLATION; MUTANTS; HETEROCHROMATIN; UBIQUITINATION; TRANSITION; EXPRESSION	Post-translational histone modifications have a critical role in regulating transcription, the cell cycle, DNA replication and DNA damage repair(1). The identification of new histone modifications critical for transcriptional regulation at initiation, elongation or termination is of particular interest. Here we report a new layer of regulation in transcriptional elongation that is conserved from yeast to mammals. This regulation is based on the phosphorylation of a highly conserved tyrosine residue, Tyr 57, in histone H2A and is mediated by the unsuspected tyrosine kinase activity of casein kinase 2 (CK2). Mutation of Tyr 57 in H2A in yeast or inhibition of CK2 activity impairs transcriptional elongation in yeast as well as in mammalian cells. Genome-wide binding analysis reveals that CK2 alpha, the catalytic subunit of CK2, binds across RNA-polymerase-II-transcribed coding genes and active enhancers. Mutation of Tyr 57 causes a loss of H2B mono-ubiquitination as well as H3K4me3 and H3K79me3, histone marks associated with active transcription. Mechanistically, both CK2 inhibition and the H2A(Y57F) mutation enhance H2B deubiquitination activity of the Spt-Ada-Gcn5 acetyltransferase (SAGA) complex, suggesting a critical role of this phosphorylation in coordinating the activity of the SAGA complex during transcription. Together, these results identify a new component of regulation in transcriptional elongation based on CK2-dependent tyrosine phosphorylation of the globular domain of H2A.	[Basnet, Harihar; Tan, Yuliang; Merkurjev, Dana; Ohgi, Kenneth A.; Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Basnet, Harihar] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Su, Xue B.; Pillus, Lorraine] Univ Calif San Diego, UCSD Moores Canc Ctr, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Merkurjev, Dana] Univ Calif San Diego, Dept Bioengn, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Meisenhelders, Jill; Hunters, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA.	lpillus@ucsd.edu; mrosenfeld@ucsd.edu			NIH [NS034934, DK039949, DK018477, HL065445, CA173903, GM033279]; UC-CRCC; NCI [CA82683]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA173903, R01CA082683] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018477, R37DK039949, T32DK007541, R01DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC-CRCC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge M. Ghassemian for assistance in mass spectrometry analysis. We also acknowledge K. Arndt for providing the UBP8 null yeast strain. CK2 constructs were provided by D. Litchfield. We acknowledge J. Hightower for assistance in figure preparation. We acknowledge K. Tumaneng and I. Bassets for critical reading of the manuscript and D. J. Forbes for discussion. This work was supported by grants NS034934, DK039949, DK018477, HL065445 and CA173903 from NIH to M.G.R., UC-CRCC to L.P., NIH-GM033279 support for X.B.S. and NCI CA82683 grant to T.H.M. G.R. is an Investigator with the HHMI. T.H. is a Frank and Else Schilling American Cancer Society Professor and holds the Renato Dulbecco Chair in Cancer Research.	Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Ferguson SB, 2005, GENETICS, V169, P1203, DOI 10.1534/genetics.104.034256; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vilk G, 2008, CELL SIGNAL, V20, P1942, DOI 10.1016/j.cellsig.2008.07.002; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	29	80	83	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					267	+		10.1038/nature13736	http://dx.doi.org/10.1038/nature13736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25252977	Green Submitted, Green Accepted			2022-12-28	WOS:000346383500050
J	Nadj-Perge, S; Drozdov, IK; Li, J; Chen, H; Jeon, S; Seo, J; MacDonald, AH; Bernevig, BA; Yazdani, A				Nadj-Perge, Stevan; Drozdov, Ilya K.; Li, Jian; Chen, Hua; Jeon, Sangjun; Seo, Jungpil; MacDonald, Allan H.; Bernevig, B. Andrei; Yazdani, Ali			Observation of Majorana fermions in ferromagnetic atomic chains on a superconductor	SCIENCE			English	Article							QUANTUM COMPUTATION; ANYONS; STATES	Majorana fermions are predicted to localize at the edge of a topological superconductor, a state of matter that can form when a ferromagnetic system is placed in proximity to a conventional superconductor with strong spin-orbit interaction. With the goal of realizing a one-dimensional topological superconductor, we have fabricated ferromagnetic iron (Fe) atomic chains on the surface of superconducting lead (Pb). Using high-resolution spectroscopic imaging techniques, we show that the onset of superconductivity, which gaps the electronic density of states in the bulk of the Fe chains, is accompanied by the appearance of zero-energy end-states. This spatially resolved signature provides strong evidence, corroborated by other observations, for the formation of a topological phase and edge-bound Majorana fermions in our atomic chains.	[Nadj-Perge, Stevan; Drozdov, Ilya K.; Li, Jian; Jeon, Sangjun; Seo, Jungpil; Bernevig, B. Andrei; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Nadj-Perge, Stevan; Drozdov, Ilya K.; Li, Jian; Jeon, Sangjun; Seo, Jungpil; Bernevig, B. Andrei; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Chen, Hua; MacDonald, Allan H.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	Princeton University; Princeton University; University of Texas System; University of Texas Austin	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	yazdani@princeton.edu	MacDonald, Allan/M-9883-2019; Drozdov, Ilya K./AAL-7402-2021; MacDonald, Allan/GPF-8212-2022; LI, RUIJIAN/GYJ-0470-2022; Nadj-Perge, Stevan/G-4115-2013; Li, Jian/B-8398-2011; Chen, Hua/H-3092-2013	Drozdov, Ilya K./0000-0002-8185-1194; MacDonald, Allan/0000-0003-3561-3379; Nadj-Perge, Stevan/0000-0002-2916-360X; Li, Jian/0000-0003-0297-6528; Chen, Hua/0000-0003-0676-3079; Yazdani, Ali/0000-0003-4996-8904; Nadj-Perge, Stevan/0000-0002-2394-9070; Seo, Jungpil/0000-0002-0442-288X	Majorana Basic Research Challenge grant [ONR-N00014-14-1-0330, ONR-N00014-11-1-0635, ONR-N00014-13-10661]; NSF-Materials Research Science and Engineering Center programs through the Princeton Center for Complex Materials [DMR-0819860]; NSF CAREER [DMR-095242]; Welch Foundation [TBF1473]; ARO-MURI [W911NF-12-1-0461]; U.S. Department of Energy Office of Basic Energy Sciences; DARPA-SPWAR [N6601-11-1-4110]; Laboratory for Physical Sciences; W. Keck Foundation; European Union Marie Curie program [IOF 302937]; Swiss National Science Foundation; NSF [PHYS-1066293];  [NSF-DMR-1104612];  [ARO-W911NF-1-0262];  [ARO-W911NF-1-0606]; Direct For Mathematical & Physical Scien [1104612] Funding Source: National Science Foundation	Majorana Basic Research Challenge grant; NSF-Materials Research Science and Engineering Center programs through the Princeton Center for Complex Materials(National Science Foundation (NSF)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Welch Foundation(The Welch Foundation); ARO-MURI(MURI); U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); DARPA-SPWAR; Laboratory for Physical Sciences; W. Keck Foundation(W.M. Keck Foundation); European Union Marie Curie program(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSF(National Science Foundation (NSF)); ; ; ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank F. von Oppen, L. Glazman, D. Loss, A. Stern, J. Alicea, M. Franz, R. Lutchyn, C.-K. Shih, B. Feldman, M. Randeria, P. Lee, and N. P. Ong for helpful discussions. The work at Princeton University has been primarily supported by Majorana Basic Research Challenge grant through ONR-N00014-14-1-0330, ONR-N00014-11-1-0635, ONR-N00014-13-10661, NSF-Materials Research Science and Engineering Center programs through the Princeton Center for Complex Materials DMR-0819860, and NSF CAREER DMR-095242. Work at the University of Texas at Austin was supported by ONR-N00014-14-1-0330 and the Welch Foundation grant TBF1473. This project was also made possible using the facilities at Princeton Nanoscale Microscopy Laboratory supported by grants through NSF-DMR-1104612, ARO-W911NF-1-0262, ARO-MURI program W911NF-12-1-0461, U.S. Department of Energy Office of Basic Energy Sciences, DARPA-SPWAR Meso program N6601-11-1-4110, Laboratory for Physical Sciences and ARO-W911NF-1-0606, and the W. Keck Foundation. A.Y., B. A. B., and Princeton University have filed a provisional patent related to this work. S. N.-P. acknowledges support of the European Union Marie Curie program (IOF 302937); J. L. acknowledges support of the Swiss National Science Foundation; and A.Y. acknowledges the hospitality of the Aspen Center for Physics, supported under NSF grant PHYS-1066293.	Alicea J, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076501; Balatsky AV, 2006, REV MOD PHYS, V78, P373, DOI 10.1103/RevModPhys.78.373; Beenakker CWJ, 2013, ANNU REV CONDEN MA P, V4, P113, DOI 10.1146/annurev-conmatphys-030212-184337; Bode M, 1998, PHYS REV LETT, V81, P4256, DOI 10.1103/PhysRevLett.81.4256; Braunecker B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.147202; Chung SB, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.060510; Churchill HOH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241401; Das A, 2012, NAT PHYS, V8, P887, DOI [10.1038/NPHYS2479, 10.1038/nphys2479]; Deng MT, 2012, NANO LETT, V12, P6414, DOI 10.1021/nl303758w; Duckheim M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054513; Fang C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.106401; Finck ADK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.126406; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; FULDE P, 1964, PHYS REV, V135, pA550, DOI 10.1103/PhysRev.135.A550; Ivanov DA, 2001, PHYS REV LETT, V86, P268, DOI 10.1103/PhysRevLett.86.268; Kells G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.100503; Kim Y, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.060401; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Klinovaja J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.186805; LARKIN AI, 1965, SOV PHYS JETP-USSR, V20, P762; Law KT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237001; Lee EJH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186802; Liu J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.267002; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Majorana E., 1937, NUOVO CIMENTO, V5, P171, DOI [10.1007/BF02961314, DOI 10.1007/BF02961314]; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Moser J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.056601; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.020407; Nakosai S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.180503; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Pientka F, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.155420; Pietzsch O, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.057202; Pikulin DI, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/125011; Potter AC, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094516; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; RUSINOV AI, 1969, SOV PHYS JETP-USSR, V29, P1101; SALOMAA MM, 1988, PHYS REV B, V37, P9298, DOI 10.1103/PhysRevB.37.9298; SHIBA H, 1968, PROG THEOR PHYS, V40, P435, DOI 10.1143/PTP.40.435; Vazifeh MM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.206802; Wark D, 2014, NATURE, V510, P224, DOI 10.1038/nature13501; Wilczek F, 2009, NAT PHYS, V5, P614, DOI 10.1038/nphys1380; Yazdani A, 1997, SCIENCE, V275, P1767, DOI 10.1126/science.275.5307.1767; Yazdani A., 2014, NOB S NEW FORM MATT; Yu L., 1965, ACTA PHYS SINICA, V21, P75, DOI DOI 10.7498/APS.21.75; Zhou BB, 2013, NAT PHYS, V9, P474, DOI [10.1038/nphys2672, 10.1038/NPHYS2672]; Zyuzin AA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.056802	49	1370	1382	21	472	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		602	607		10.1126/science.1259327	http://dx.doi.org/10.1126/science.1259327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25278507	Green Accepted, Green Submitted			2022-12-28	WOS:000343799700041
J	Bommer, M; Kunze, C; Fesseler, J; Schubert, T; Diekert, G; Dobbek, H				Bommer, Martin; Kunze, Cindy; Fesseler, Jochen; Schubert, Torsten; Diekert, Gabriele; Dobbek, Holger			Structural basis for organohalide respiration	SCIENCE			English	Article							TETRACHLOROETHENE REDUCTIVE DEHALOGENASE; DEHALOSPIRILLUM MULTIVORANS; DECHLORINATION; B-12	Organohalide-respiring microorganisms can use a variety of persistent pollutants, including trichloroethene (TCE), as terminal electron acceptors. The final two-electron transfer step in organohalide respiration is catalyzed by reductive dehalogenases. Here we report the x-ray crystal structure of PceA, an archetypal dehalogenase from Sulfurospirillum multivorans, as well as structures of PceA in complex with TCE and product analogs. The active site harbors a deeply buried norpseudo-B-12 cofactor within a nitroreductase fold, also found in a mammalian B-12 chaperone. The structures of PceA reveal how a cobalamin supports a reductive haloelimination exploiting a conserved B-12-binding scaffold capped by a highly variable substrate-capturing region.	[Bommer, Martin; Fesseler, Jochen; Dobbek, Holger] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Kunze, Cindy; Schubert, Torsten; Diekert, Gabriele] Univ Jena, Inst Mikrobiol, Lehrstuhl Angew & Okol Mikrobiol, D-07743 Jena, Germany	Humboldt University of Berlin; Friedrich Schiller University of Jena	Diekert, G (corresponding author), Univ Jena, Inst Mikrobiol, Lehrstuhl Angew & Okol Mikrobiol, Philosophenweg 12, D-07743 Jena, Germany.	gabriele.diekert@uni-jena.de; holger.dobbek@biologie.hu-berlin.de	Schubert, Torsten/N-2457-2016; Schubert, Torsten/ABG-5468-2020	Schubert, Torsten/0000-0002-6569-1194; Schubert, Torsten/0000-0002-6569-1194	Cluster of Excellence "Unifying Concepts in Catalysis (UniCat)"; Deutsche Forschungsgemeinschaft (DFG) [Research Unit FOR 1530]; DFG [SFB 1078-A5]; Ernst Abbe Foundation	Cluster of Excellence "Unifying Concepts in Catalysis (UniCat)"(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Ernst Abbe Foundation	H.D. acknowledges support by the Cluster of Excellence "Unifying Concepts in Catalysis (UniCat)." G.D. and T.S. were supported by the Deutsche Forschungsgemeinschaft (DFG) (Research Unit FOR 1530). M.B. was funded by the DFG through grant SFB 1078-A5. We are grateful for the funding of C.K. by the Ernst Abbe Foundation; in addition, we thank the staff at the Helmholtz-Zentrum Berlin (HZB) MX beamlines and DESY PETRA III beamline P11 for their assistance. We acknowledge access to beamlines of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory. The authors thank O. Einsle for critical reading of the manuscript. Structure factors and models have been deposited in the Protein Data Bank under accession numbers 4UQU (empty), 4UR0 (TCE bound), 4UR1 (cis-DBE bound), 4UR2 (iodide bound), and 4UR3 (P2<INF>1</INF> crystal form).	DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Glod G, 1997, ENVIRON SCI TECHNOL, V31, P253, DOI 10.1021/es9603867; Goris T, 2014, ENVIRON MICROBIOL, V16, P3562, DOI 10.1111/1462-2920.12589; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Hug LA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0322; John M, 2006, ARCH MICROBIOL, V186, P99, DOI 10.1007/s00203-006-0125-5; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Krautler B, 2003, HELV CHIM ACTA, V86, P3698, DOI 10.1002/hlca.200390313; Mac Nelly A, 2014, APPL ENVIRON MICROB, V80, P4313, DOI 10.1128/AEM.00881-14; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; McCauley KM, 2005, J AM CHEM SOC, V127, P1126, DOI 10.1021/ja048573p; Miller E, 1996, ARCH MICROBIOL, V166, P379, DOI 10.1007/BF01682983; Neumann A, 1996, J BIOL CHEM, V271, P16515, DOI 10.1074/jbc.271.28.16515; Schmitz RPH, 2007, ENVIRON SCI TECHNOL, V41, P7370, DOI 10.1021/es071026u; SCHOLZMURAMATSU H, 1995, ARCH MICROBIOL, V163, P48, DOI 10.1007/BF00262203; Schumacher W, 1997, FEBS LETT, V409, P421, DOI 10.1016/S0014-5793(97)00520-6; Shey J, 2000, J AM CHEM SOC, V122, P12403, DOI 10.1021/ja0055965; Svetlitchnaia T, 2006, P NATL ACAD SCI USA, V103, P14331, DOI 10.1073/pnas.0601420103; Ye LD, 2010, ENVIRON MICROBIOL, V12, P501, DOI 10.1111/j.1462-2920.2009.02093.x	21	151	152	19	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					455	458		10.1126/science.1258118	http://dx.doi.org/10.1126/science.1258118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25278505				2022-12-28	WOS:000343822900039
J	Seo, H; Cai, XY; Donahue, CH; Lee, D				Seo, Hyojung; Cai, Xinying; Donahue, Christopher H.; Lee, Daeyeol			Neural correlates of strategic reasoning during competitive games	SCIENCE			English	Article							DECISION-MAKING; PREFRONTAL CORTEX; REINFORCEMENT; SIGNALS; REPRESENTATIONS; COMPUTATIONS	Although human and animal behaviors are largely shaped by reinforcement and punishment, choices in social settings are also influenced by information about the knowledge and experience of other decision-makers. During competitive games, monkeys increased their payoffs by systematically deviating from a simple heuristic learning algorithm and thereby countering the predictable exploitation by their computer opponent. Neurons in the dorsomedial prefrontal cortex (dmPFC) signaled the animal's recent choice and reward history that reflected the computer's exploitative strategy. The strength of switching signals in the dmPFC also correlated with the animal's tendency to deviate from the heuristic learning algorithm. Therefore, the dmPFC might provide control signals for overriding simple heuristic learning algorithms based on the inferred strategies of the opponent.	[Seo, Hyojung; Cai, Xinying; Donahue, Christopher H.; Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Lee, Daeyeol] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Lee, Daeyeol] Yale Univ, Dept Psychol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Seo, H (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	hyojung.seo@yale.edu; daeyeol.lee@yale.edu	Donahue, Christopher/T-1778-2019; Lee, Daeyeol/A-6794-2008	Donahue, Christopher/0000-0003-1574-1162; Lee, Daeyeol/0000-0003-3474-019X	National Institutes of Health [R01 MH 073246, R01 DA 029330, T32 NS007224]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the grants from the National Institutes of Health (R01 MH 073246, R01 DA 029330, and T32 NS007224). All primary behavioral and neurophysiological data are archived in the Department of Neurobiology at Yale University School of Medicine.	Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Botvinick MM, 2012, CURR OPIN NEUROBIOL, V22, P956, DOI 10.1016/j.conb.2012.05.008; Camerer C, 2003, BEHAV GAME THEORY; Donahue CH, 2013, NEURON, V80, P223, DOI 10.1016/j.neuron.2013.07.040; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Genovesio A, 2006, J NEUROSCI, V26, P7305, DOI 10.1523/JNEUROSCI.0699-06.2006; Gigerenzer G, 2009, TOP COGN SCI, V1, P107, DOI 10.1111/j.1756-8765.2008.01006.x; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Ito M, 2011, CURR OPIN NEUROBIOL, V21, P368, DOI 10.1016/j.conb.2011.04.001; Kim H, 2013, J NEUROSCI, V33, P52, DOI 10.1523/JNEUROSCI.2422-12.2013; Lee D, 2013, NEURON, V78, P233, DOI 10.1016/j.neuron.2013.04.008; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; Lee SW, 2014, NEURON, V81, P687, DOI 10.1016/j.neuron.2013.11.028; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Suzuki S, 2012, NEURON, V74, P1125, DOI 10.1016/j.neuron.2012.04.030; Tsujimoto S, 2010, NAT NEUROSCI, V13, P120, DOI 10.1038/nn.2453; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; Zhu LS, 2012, P NATL ACAD SCI USA, V109, P1419, DOI 10.1073/pnas.1116783109	30	61	61	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					340	343		10.1126/science.1256254	http://dx.doi.org/10.1126/science.1256254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25236468	Green Accepted			2022-12-28	WOS:000343041100041
J	Schloss, PD				Schloss, Patrick D.			MICROBIOLOGY An integrated view of the skin microbiome	NATURE			English	Editorial Material							DIVERSITY		Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schloss, PD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	pschloss@umich.edu		Schloss, Patrick/0000-0002-6935-4275	NHGRI NIH HHS [R01 HG005975] Funding Source: Medline; NIGMS NIH HHS [R01 GM099514] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259	6	22	27	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					44	45		10.1038/514044a	http://dx.doi.org/10.1038/514044a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279916				2022-12-28	WOS:000342420800031
J	Ma, XC; Zhou, ZQ; Yi, HM; Pang, XP; Shi, YJ; Chen, QY; Meltzer, ME; le Cessie, S; He, MG; Rozelle, S; Liu, YZ; Congdon, N				Ma, Xiaochen; Zhou, Zhongqiang; Yi, Hongmei; Pang, Xiaopeng; Shi, Yaojiang; Chen, Qianyun; Meltzer, Mirjam E.; le Cessie, Saskia; He, Mingguang; Rozelle, Scott; Liu, Yizhi; Congdon, Nathan			Effect of providing free glasses on children's educational outcomes in China: cluster randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PEDIATRIC-REFRACTIVE-ERROR; VISUAL IMPAIRMENT; SCHOOL-CHILDREN; RURAL CHINA; SOUTHERN CHINA; SEE-WELL; MYOPIA; PREVALENCE; VISION	Objective To assess the effect of provision of free glasses on academic performance in rural Chinese children with myopia. Design Cluster randomized, investigator masked, controlled trial. Setting 252 primary schools in two prefectures in western China, 2012-13. Participants 3177 of 19 934 children in fourth and fifth grades (mean age 10.5 years) with visual acuity <6/12 in either eye without glasses correctable to >6/12 with glasses. 3052 (96.0%) completed the study. Interventions Children were randomized by school (84 schools per arm) to one of three interventions at the beginning of the school year: prescription for glasses only (control group), vouchers for free glasses at a local facility, or free glasses provided in class. Main outcome measures Spectacle wear at endline examination and end of year score on a specially designed mathematics test, adjusted for baseline score and expressed in standard deviations. Results Among 3177 eligible children, 1036 (32.6%) were randomized to control, 988 (31.1%) to vouchers, and 1153 (36.3%) to free glasses in class. All eligible children would benefit from glasses, but only 15% wore them at baseline. At closeout glasses wear was 41% (observed) and 68% (self reported) in the free glasses group, and 26% (observed) and 37% (self reported) in the controls. Effect on test score was 0.11 SD (95% confidence interval 0.01 to 0.21) when the free glasses group was compared with the control group. The adjusted effect of providing free glasses (0.10, 0.002 to 0.19) was greater than parental education (0.03, -0.04 to 0.09) or family wealth (0.01, -0.06 to 0.08). This difference between groups was significant, but was smaller than the prespecified 0.20 SD difference that the study was powered to detect. Conclusions The provision of free glasses to Chinese children with myopia improves children's performance on mathematics testing to a statistically significant degree, despite imperfect compliance, although the observed difference between groups was smaller than the study was originally designed to detect. Myopia is common and rarely corrected in this setting.	[Ma, Xiaochen] Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; [Ma, Xiaochen] Stanford Univ, Stanford Ctr Int Dev, Stanford, CA 94305 USA; [Zhou, Zhongqiang; Chen, Qianyun; Meltzer, Mirjam E.; He, Mingguang; Liu, Yizhi; Congdon, Nathan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Zhongqiang; Chen, Qianyun; Meltzer, Mirjam E.; He, Mingguang; Liu, Yizhi; Congdon, Nathan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Div Prevent Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Yi, Hongmei] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Ctr Chinese Agr Policy, Beijing, Peoples R China; [Pang, Xiaopeng] Renmin Univ China, Sch Agr Econ & Rural Dev, Beijing, Peoples R China; [Shi, Yaojiang] Xibei Univ, Sch Econ Management, Xian, Peoples R China; [le Cessie, Saskia] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Rozelle, Scott] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Congdon, Nathan] ORBIS Int, New York, NY USA	University of California System; University of California Davis; Stanford University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Renmin University of China; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Stanford University	Congdon, N (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	ncongdon1@gmail.com	liu, yi/GXE-9662-2022; He, Mingguang/AAY-5239-2020; le+Cessie, Saskia/HGC-8966-2022; PANG, XIAOPENG/AAW-4461-2021	He, Mingguang/0000-0002-6912-2810; Yi, Hongmei/0000-0002-6934-0498; le Cessie, Saskia/0000-0003-2154-4923	OneSight (Mason, OH); Luxottica-China (Shanghai); Essilor-China(Shanghai); CLSA (Asia Pacific Markets); CLSA (Hong Kong); Charity Aid Foundation (Sydney); Chinese government	OneSight (Mason, OH); Luxottica-China (Shanghai); Essilor-China(Shanghai); CLSA (Asia Pacific Markets); CLSA (Hong Kong); Charity Aid Foundation (Sydney); Chinese government	This study was funded by OneSight (Mason, OH), Luxottica-China (Shanghai), Essilor-China(Shanghai), CLSA (Asia Pacific Markets; Hong Kong), Charity Aid Foundation (Sydney), and an anonymous donor (Hong Kong). NC is supported by a Thousand Man Plan grant from the Chinese government. The study sponsors had no role in study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication.	[Anonymous], 2011, OPTIMAL DESIGN SOFTW; [Anonymous], 2013, ART YUL; [Anonymous], 2014, SURVEY CHINA SHOWS W; [Anonymous], 2013, DIMENSION DISABILITY; [Anonymous], 2013, ART TIANSH; Atkinson Janette, 2002, Strabismus, V10, P187, DOI 10.1076/stra.10.3.187.8125; Congdon N, 2008, ARCH OPHTHALMOL-CHIC, V126, P1717, DOI 10.1001/archopht.126.12.1717; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Congdon N, 2011, OPHTHALMOLOGY, V118, P2343, DOI 10.1016/j.ophtha.2011.06.016; Congdon NG, 2008, BRIT J OPHTHALMOL, V92, P13, DOI 10.1136/bjo.2007.122028; Dirani M, 2010, OPHTHAL EPIDEMIOL, V17, P18, DOI 10.3109/09286580903450320; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Hill CJ, 2014, MDRC WORKING PAPERS; Johnson R, 1996, J BEHAV OPTOM, V7, P39; Krumholtz I, 2000, Optometry, V71, P426; Li LP, 2010, ARCH OPHTHALMOL-CHIC, V128, P759, DOI 10.1001/archophthalmol.2010.73; Liang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040850; Mathers M, 2010, CHILD CARE HLTH DEV, V36, P756, DOI 10.1111/j.1365-2214.2010.01109.x; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Roch-Levecq AC, 2008, ARCH OPHTHALMOL-CHIC, V126, P252, DOI 10.1001/archophthalmol.2007.36; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sharma A, 2012, SURV OPHTHALMOL, V57, P272, DOI 10.1016/j.survophthal.2011.11.002; Williams WR, 2005, ARCH DIS CHILD, V90, P150, DOI 10.1136/adc.2003.046755; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Zhang MZ, 2009, INVEST OPHTH VIS SCI, V50, P2011, DOI 10.1167/iovs.08-2849; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	30	116	121	2	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2014	349								g5740	10.1136/bmj.g5740	http://dx.doi.org/10.1136/bmj.g5740			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UL	25249453	Green Published, hybrid			2022-12-28	WOS:000342425700006
J	Green, DR; Galluzzi, L; Kroemer, G				Green, Douglas R.; Galluzzi, Lorenzo; Kroemer, Guido			Metabolic control of cell death	SCIENCE			English	Review							STRESS-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL FISSION; ATP SYNTHASE; ER-STRESS; BCL-XL; SPHINGOLIPID METABOLISM; PROFILING REVEALS; TUMOR SUPPRESSION	Beyond their contribution to basic metabolism, the major cellular organelles, in particular mitochondria, can determine whether cells respond to stress in an adaptive or suicidal manner. Thus, mitochondria can continuously adapt their shape to changing bioenergetic demands as they are subjected to quality control by autophagy, or they can undergo a lethal permeabilization process that initiates apoptosis. Along similar lines, multiple proteins involved in metabolic circuitries, including oxidative phosphorylation and transport of metabolites across membranes, may participate in the regulated or catastrophic dismantling of organelles. Many factors that were initially characterized as cell death regulators are now known to physically or functionally interact with metabolic enzymes. Thus, several metabolic cues regulate the propensity of cells to activate self-destructive programs, in part by acting on nutrient sensors. This suggests the existence of "metabolic checkpoints" that dictate cell fate in response to metabolic fluctuations. Here, we discuss recent insights into the intersection between metabolism and cell death regulation that have major implications for the comprehension and manipulation of unwarranted cell loss.	[Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Galluzzi, Lorenzo; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, F-75006 Paris, France; [Galluzzi, Lorenzo; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75005 Paris, France; [Galluzzi, Lorenzo; Kroemer, Guido] INSERM, U1138, F-94805 Villejuif, France; [Kroemer, Guido] Gustave Roussy, Metab & Cell Biol Platforms, F-94805 Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France	St Jude Children's Research Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org; kroemer@orange.fr	Galluzzi, Lorenzo/AAH-3286-2021; KROEMER, Guido/B-4263-2013; Green, Douglas R/N-8083-2018; Galluzzi, Lorenzo/AAG-6432-2019; Galluzzi, Lorenzo/AAG-6294-2019; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; Green, Douglas R/0000-0002-7332-1417; 	NCI NIH HHS [R01 CA169291] Funding Source: Medline; NIAID NIH HHS [R01 AI044828, R01 AI040646, R01 AI047891] Funding Source: Medline; NIGMS NIH HHS [R01 GM096208] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, R01AI044828, R01AI047891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096208] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Breckenridge DG, 2002, P NATL ACAD SCI USA, V99, P4331, DOI 10.1073/pnas.072088099; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dutta C, 2012, CANCER RES, V72, P4193, DOI 10.1158/0008-5472.CAN-11-4204; Echeverry N, 2013, CELL DEATH DIFFER, V20, P785, DOI 10.1038/cdd.2013.10; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2007, NAT CELL BIOL, V9, P487, DOI 10.1038/ncb0507-487; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Garcia-Garcia C, 2010, BIOCHEM PHARMACOL, V79, P853, DOI 10.1016/j.bcp.2009.10.022; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Green DR, 2012, TRENDS CELL BIOL, V22, P555, DOI 10.1016/j.tcb.2012.08.008; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gu HT, 2008, MOL CANCER THER, V7, P2298, DOI 10.1158/1535-7163.MCT-08-0186; Gump JM, 2014, NAT CELL BIOL, V16, P47, DOI 10.1038/ncb2886; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P109, DOI 10.1097/MPG.0b013e31820e82a1; Ibrahim SH, 2011, J HEPATOL, V54, P765, DOI 10.1016/j.jhep.2010.09.039; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Johnson ES, 2013, J BIOL CHEM, V288, P14463, DOI 10.1074/jbc.M112.437210; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lartigue L, 2009, MOL BIOL CELL, V20, P4871, DOI 10.1091/mbc.E09-07-0649; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Long JS, 2013, MOL CELL, V50, P394, DOI 10.1016/j.molcel.2013.03.016; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mccoy F, 2013, MOL CELL, V52, P325, DOI 10.1016/j.molcel.2013.08.043; Meynet O, 2013, BLOOD, V122, P2402, DOI 10.1182/blood-2013-01-478651; Michels J, 2014, ONCOGENE, V33, P3894, DOI 10.1038/onc.2013.352; Monserrate JP, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-63; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Namba T, 2013, CELL REP, V5, P331, DOI 10.1016/j.celrep.2013.09.020; Nieminen AI, 2013, P NATL ACAD SCI USA, V110, pE1839, DOI 10.1073/pnas.1208530110; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Obeng EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/jbc.M502685200; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Paradis S, 2013, CARDIOVASC RES, V98, P420, DOI 10.1093/cvr/cvt079; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Perera MN, 2012, BIOCHEM J, V445, P81, DOI 10.1042/BJ20112103; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; Ren H, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-146; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Willems L, 2013, BLOOD, V122, P3521, DOI 10.1182/blood-2013-03-493163; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	154	446	469	20	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1466	+	1250256	10.1126/science.1250256	http://dx.doi.org/10.1126/science.1250256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237106	Green Accepted			2022-12-28	WOS:000341752900032
J	Neuner, J; Carnahan, J				Neuner, Joan; Carnahan, Jennifer			Dual X-ray Absorptiometry for Diagnosis of Osteoporosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FRACTURE RISK		[Neuner, Joan] Med Coll Wisconsin, Div Gen Internal Med, Milwaukee, WI 53226 USA; [Neuner, Joan] Med Coll Wisconsin, Ctr Patient Care & Outcomes Res, Milwaukee, WI 53226 USA; [Carnahan, Jennifer] Med Coll Wisconsin, Clement J Jablocki VA Med Ctr, Dept Internal Med, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Neuner, J (corresponding author), Med Coll Wisconsin, Div Gen Internal Med, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jneuner@mcw.edu			American Cancer Society (ACS)	American Cancer Society (ACS)(American Cancer Society)	Dr Neuner reports receipt of funding from the American Cancer Society (ACS).	Bolland MJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8669; Crandall CJ, 2012, COMP EFFECTIVENESS R; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Leslie WD, 2011, OSTEOPOROSIS INT, V22, P839, DOI 10.1007/s00198-010-1461-5; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; World Health Organization Collaborating Centre for Metabolic Bone Diseases, WHO FRACT RISK ASS T	10	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1147	1148		10.1001/jama.2014.1402	http://dx.doi.org/10.1001/jama.2014.1402			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226481				2022-12-28	WOS:000341624700025
J	[Anonymous]				[Anonymous]			Geriatrics-The Care of the Aged (Reprinted from JAMA vol 109, pg 2143-2144, 1937)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Giese C. L., 1932, COLORADO MED, V29, P159; HORN WS, 1937, TEX STATE J MED, V33, P448; Pepper O. H., 1936, M CLIN N AM, V20, P127; WORCESTER A, 1935, CARE AGED DYING DEAD; 1937, JAMA, V109, P2143	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1159	1159		10.1001/jama.2014.10855	http://dx.doi.org/10.1001/jama.2014.10855			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226491				2022-12-28	WOS:000341624700034
J	Vickers, AJ; Edwards, K; Cooperberg, MR; Mushlin, AI				Vickers, Andrew J.; Edwards, Kelly; Cooperberg, Matthew R.; Mushlin, Alvin I.			A Simple Schema for Informed Decision Making About Prostate Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; Weill Cornell Med Ctr, New York, NY 10065 USA; Univ Washington, Sch Med, Seattle, WA 98195 USA; UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA	Memorial Sloan Kettering Cancer Center; Cornell University; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Vickers, AJ (corresponding author), Mem Sloan Kettering Canc Ctr, 307 East 63rd St,2nd Floor,Box 44, New York, NY 10065 USA.	VickersA@mskcc.org	Cooperberg, Matthew R/G-6249-2017	Cooperberg, Matthew R/0000-0003-4339-6685; Vickers, Andrew/0000-0003-1525-6503	NATIONAL CANCER INSTITUTE [P30CA008748, R01CA160816, R01CA175491, P50CA092629] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000050] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, R01CA160816, P50 CA092629, P50-CA92629, R01 CA160816, R01 CA175491] Funding Source: Medline; NCRR NIH HHS [UL1 RR024996] Funding Source: Medline; NCCDPHP CDC HHS [1-U48-DP-000050, U48 DP000050] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCCDPHP CDC HHS		Carlsson S, 2012, J CLIN ONCOL, V30, P2581, DOI 10.1200/JCO.2011.40.4327; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Chou R, 2011, JAMA-J AM MED ASSOC, V306, P2721, DOI 10.1001/jama.2011.1891; Feng B, 2013, ANN FAM MED, V11, P315, DOI 10.1370/afm.1509; Gaster B, 2010, ANN INTERN MED, V153, P661, DOI 10.7326/0003-4819-153-10-201011160-00010; Giguere A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-72; National Cancer Institute, 2012, PROST SPEC ANT PSA T; Qaseem A, 2013, ANN INTERN MED, V158, P761, DOI 10.7326/0003-4819-158-10-201305210-00633	8	23	24	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					441	U101		10.7326/M14-0151	http://dx.doi.org/10.7326/M14-0151			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222389	Green Submitted, Green Accepted			2022-12-28	WOS:000343894400019
J	Swerdlow, DI; Preiss, D; Kuchenbaecker, KB; Holmes, MV; Engmann, JEL; Shah, T; Sofat, R; Stender, S; Johnson, PCD; Scott, RA; Leusink, M; Verweij, N; Sharp, SJ; Guo, YR; Giambartolomei, C; Chung, C; Peasey, A; Amuzu, A; Li, K; Palmen, J; Howard, P; Cooper, JA; Drenos, F; Li, YR; Lowe, G; Gallacher, J; Stewart, MCW; Tzoulaki, I; Buxbaum, SG; Daphne, LV; Forouhi, NG; Onland-Moret, NC; van der Schouw, YT; Schnabel, RB; Hubacek, JA; Kubinova, R; Baceviciene, M; Tamosiunas, A; Pajak, A; Topor-Madry, R; Stepaniak, U; Malyutina, SA; Baldassarre, D; Sennblad, B; Tremoli, E; de Faire, U; Veglia, F; Ford, I; Jukema, JW; Westendorp, RGJ; de Borst, GJ; de Jong, PA; Algra, A; Spiering, W; Maitland-van der Zee, AH; Klungel, OH; de Boer, A; Doevendans, PA; Eaton, CB; Robinson, JG; Duggan, D; Kjekshus, J; Downs, JR; Gotto, AM; Keech, AC; Marchioli, R; Tognoni, G; Sever, PS; Poulter, NR; Waters, DD; Pedersen, TR; Amarenco, P; Nakamura, H; McMurray, JJV; Lewsey, JD; Chasman, DI; Ridker, PM; Maggioni, AP; Tavazzi, L; Ray, KK; Seshasai, SRK; Manson, JE; Price, JF; Whincup, PH; Morris, RW; Lawlor, DA; Smith, GD; Ben-Shlomo, Y; Schreiner, PJ; Fornage, M; Siscovick, DS; Cushman, M; Kumari, M; Wareham, NJ; Verschuren, WMM; Redline, S; Patel, SR; Whittaker, JC; Hamsten, A; Delaney, JA; Dale, C; Gaunt, TR; Wong, A; Kuh, D; Hardy, R; Kathiresan, S; Castillo, BA; van der Harst, P; Brunner, EJ; Tybjaerg-Hansen, A; Marmot, MG; Krauss, RM; Tsai, M; Coresh, J; Hoogeveen, RC; Psaty, BM; Lange, LA; Hakonarson, H; Dudbridge, F; Humphries, SE; Talmud, PJ; Kivimaki, M; Timpson, NJ; Langenberg, C; Asselbergs, FW; Voevoda, M; Bobak, M; Pikhart, H; Wilson, JG; Reiner, AP; Keating, BJ; Hingorani, AD; Sattar, N				Swerdlow, Daniel I.; Preiss, David; Kuchenbaecker, Karoline B.; Holmes, Michael V.; Engmann, Jorgen E. L.; Shah, Tina; Sofat, Reecha; Stender, Stefan; Johnson, Paul C. D.; Scott, Robert A.; Leusink, Maarten; Verweij, Niek; Sharp, Stephen J.; Guo, Yiran; Giambartolomei, Claudia; Chung, Christina; Peasey, Anne; Amuzu, Antoinette; Li, Kawah; Palmen, Jutta; Howard, Philip; Cooper, Jackie A.; Drenos, Fotios; Li, Yun R.; Lowe, Gordon; Gallacher, John; Stewart, Marlene C. W.; Tzoulaki, Ioanna; Buxbaum, Sarah G.; Daphne, L. van der A.; Forouhi, Nita G.; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Schnabel, Renate B.; Hubacek, Jaroslav A.; Kubinova, Ruzena; Baceviciene, Migle; Tamosiunas, Abdonas; Pajak, Andrzej; Topor-Madry, Roman; Stepaniak, Urszula; Malyutina, Sofi A.; Baldassarre, Damiano; Sennblad, Bengt; Tremoli, Elena; de Faire, Ulf; Veglia, Fabrizio; Ford, Ian; Jukema, J. Wouter; Westendorp, Rudi G. J.; de Borst, Gert Jan; de Jong, Pim A.; Algra, Ale; Spiering, Wilko; Maitland-van der Zee, Anke H.; Klungel, Olaf H.; de Boer, Anthonius; Doevendans, Pieter A.; Eaton, Charles B.; Robinson, Jennifer G.; Duggan, David; Kjekshus, John; Downs, John R.; Gotto, Antonio M.; Keech, Anthony C.; Marchioli, Roberto; Tognoni, Gianni; Sever, Peter S.; Poulter, Neil R.; Waters, David D.; Pedersen, Terje R.; Amarenco, Pierre; Nakamura, Haruo; McMurray, John J. V.; Lewsey, James D.; Chasman, Daniel I.; Ridker, Paul M.; Maggioni, Aldo P.; Tavazzi, Luigi; Ray, Kausik K.; Seshasai, Sreenivasa Rao Kondapally; Manson, Joann E.; Price, Jackie F.; Whincup, Peter H.; Morris, Richard W.; Lawlor, Debbie A.; Smith, George Davey; Ben-Shlomo, Yoav; Schreiner, Pamela J.; Fornage, Myriam; Siscovick, David S.; Cushman, Mary; Kumari, Meena; Wareham, Nick J.; Verschuren, W. M. Monique; Redline, Susan; Patel, Sanjay R.; Whittaker, John C.; Hamsten, Anders; Delaney, Joseph A.; Dale, Caroline; Gaunt, Tom R.; Wong, Andrew; Kuh, Diana; Hardy, Rebecca; Kathiresan, Sekar; Castillo, Berta A.; van der Harst, Pim; Brunner, Eric J.; Tybjaerg-Hansen, Anne; Marmot, Michael G.; Krauss, Ronald M.; Tsai, Michael; Coresh, Josef; Hoogeveen, Ronald C.; Psaty, Bruce M.; Lange, Leslie A.; Hakonarson, Hakon; Dudbridge, Frank; Humphries, Steve E.; Talmud, Philippa J.; Kivimaeki, Mika; Timpson, Nicholas J.; Langenberg, Claudia; Asselbergs, Folkert W.; Voevoda, Mikhail; Bobak, Martin; Pikhart, Hynek; Wilson, James G.; Reiner, Alex P.; Keating, Brendan J.; Hingorani, Aroon D.; Sattar, Naveed		DIAGRAM Consortium; MAGIC Consortium; InterAct Consortium	HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials	LANCET			English	Article							HIGH-DOSE ATORVASTATIN; BODY-MASS INDEX; STATIN THERAPY; MENDELIAN RANDOMIZATION; ASSOCIATION ANALYSES; LDL CHOLESTEROL; METAANALYSIS; RISK; PREVENTION; DISEASE	Background Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the intended drug target. Methods We used single nucleotide polymorphisms in the HMGCR gene, rs17238484 (for the main analysis) and rs12916 (for a subsidiary analysis) as proxies for HMGCR inhibition by statins. We examined associations of these variants with plasma lipid, glucose, and insulin concentrations; bodyweight; waist circumference; and prevalent and incident type 2 diabetes. Study-specific effect estimates per copy of each LDL-lowering allele were pooled by meta-analysis. These findings were compared with a meta-analysis of new-onset type 2 diabetes and bodyweight change data from randomised trials of statin drugs. The effects of statins in each randomised trial were assessed using meta-analysis. Findings Data were available for up to 223 463 individuals from 43 genetic studies. Each additional rs17238484-G allele was associated with a mean 0.06 mmol/L (95% CI 0.05-0.07) lower LDL cholesterol and higher body weight (0.30 kg, 0.18-0.43), waist circumference (0.32 cm, 0.16-0.47), plasma insulin concentration (1.62%, 0.53-2.72), and plasma glucose concentration (0.23%, 0.02-0.44). The rs12916 SNP had similar effects on LDL cholesterol, bodyweight, and waist circumference. The rs17238484-G allele seemed to be associated with higher risk of type 2 diabetes (odds ratio [OR] per allele 1.02, 95% CI 1.00-1.05); the rs12916-T allele association was consistent (1.06, 1.03-1.09). In 129 170 individuals in randomised trials, statins lowered LDL cholesterol by 0.92 mmol/L (95% CI 0.18-1.67) at 1-year of follow-up, increased bodyweight by 0.24 kg (95% CI 0.10-0.38 in all trials; 0.33 kg, 95% CI 0.24-0.42 in placebo or standard care controlled trials and 0.15 kg, 95% CI 0.39 to 0.08 in intensive-dose vs moderate-dose trials) at a mean of 4. 2 years (range 1.9-6.7) of follow-up, and increased the odds of new-onset type 2 diabetes (OR 1.12, 95% CI 1.06-1.18 in all trials; 1.11, 95% CI 1.03-1. 20 in placebo or standard care controlled trials and 1.12, 95% CI 1.04-1. 22 in intensive-dose vs moderate dose trials). Interpretation The increased risk of type 2 diabetes noted with statins is at least partially explained by HMGCR inhibition.	[Swerdlow, Daniel I.; Holmes, Michael V.; Engmann, Jorgen E. L.; Shah, Tina; Asselbergs, Folkert W.; Hingorani, Aroon D.] UCL, UCL Inst Cardiovasc Sci & Farr Inst, London, England; [Sofat, Reecha] UCL, UCL Dept Med, London, England; [Chung, Christina; Peasey, Anne; Kumari, Meena; Brunner, Eric J.; Marmot, Michael G.; Kivimaeki, Mika; Bobak, Martin; Pikhart, Hynek] UCL, UCL Res Dept Epidemiol & Publ Hlth, London, England; [Giambartolomei, Claudia] UCL, UCL Genet Inst, London, England; [Morris, Richard W.] UCL, UCL Dept Primary Care & Populat Hlth, London, England; [Li, Kawah; Palmen, Jutta; Howard, Philip; Cooper, Jackie A.; Drenos, Fotios; Humphries, Steve E.; Talmud, Philippa J.] UCL, Ctr Cardiovasc Genet, London, England; [Wong, Andrew; Kuh, Diana; Hardy, Rebecca] UCL, MRCUnit Lifelong Hlth & Ageing, Inst Epidemiol & Hlth Care, London, England; [Preiss, David; McMurray, John J. V.; Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovascular Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Johnson, Paul C. D.; Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Lowe, Gordon] Univ Glasgow, Inst Cardiovasc & Med, Glasgow, Lanark, Scotland; [Lewsey, James D.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Kuchenbaecker, Karoline B.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Kuchenbaecker, Karoline B.] Univ Penn, Dept Surg, Div Transplantat, Ctr Clin Epidemiol & Biostat,Perelman Sch Med, Philadelphia, PA 19104 USA; [Kuchenbaecker, Karoline B.] Univ Penn, Clin Epidemiol Unit, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stender, Stefan; Tybjaerg-Hansen, Anne] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Scott, Robert A.; Sharp, Stephen J.; Forouhi, Nita G.; Wareham, Nick J.; Langenberg, Claudia] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Leusink, Maarten; Maitland-van der Zee, Anke H.; Klungel, Olaf H.; de Boer, Anthonius] Univ Utrecht, Fac Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Guo, Yiran; Li, Yun R.; Castillo, Berta A.; Hakonarson, Hakon; Keating, Brendan J.] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Dale, Caroline] Dept Noncommunicable Dis Epidemiol, London WC1, England; [Amuzu, Antoinette; Dudbridge, Frank] London Sch Hyg & Trop Med, London WC1, England; [Gallacher, John] Cardiff Univ, Sch Med, Dept Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Stewart, Marlene C. W.; Price, Jackie F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Tzoulaki, Ioanna] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Sever, Peter S.; Poulter, Neil R.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Buxbaum, Sarah G.] Jackson State Univ, Jackson, MS USA; [Daphne, L. van der A.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Borst, Gert Jan] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [Doevendans, Pieter A.; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Schnabel, Renate B.] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Hubacek, Jaroslav A.] Ctr Med Expt, Inst Clin & Expt Med, Prague, Czech Republic; [Kubinova, Ruzena] Natl Inst Publ Hlth, Prague, Czech Republic; [Tamosiunas, Abdonas] Inst Cardiol, Kaunas, Lithuania; [Baceviciene, Migle] Lithuanian Univ Hlth Sci, Kaunas, Lithuania; [Pajak, Andrzej; Topor-Madry, Roman; Stepaniak, Urszula] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Epidemiol & Populat Studies,Inst Publ Hlth, Krakow, Poland; [Malyutina, Sofi A.; Voevoda, Mikhail] Russian Acad Med Sci, Inst Internal & Prevent Med, Siberian Branch, Novosibirsk, Russia; [Voevoda, Mikhail] Russian Acad Med Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia; [Baldassarre, Damiano; Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Sennblad, Bengt] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Veglia, Fabrizio] IRCCS, Biostat Unit, Milan, Italy; [Baldassarre, Damiano; Tremoli, Elena] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Eaton, Charles B.] Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA; [Robinson, Jennifer G.] Univ Iowa, Iowa City, IA 52242 USA; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Kjekshus, John] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway; [Pedersen, Terje R.] Univ Oslo, Rikshosp, Ctr Preventat Med, N-0027 Oslo, Norway; [Downs, John R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Downs, John R.] VERDICT, South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Gotto, Antonio M.] Weill Cornell Med Coll, New York, NY USA; [Keech, Anthony C.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Marchioli, Roberto] Quintiles, Hematol & Oncol Therapeut Delivery Unit, Milan, Italy; [Tognoni, Gianni] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Chieti, Italy; [Waters, David D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Amarenco, Pierre] Denis Diderot Univ, Paris, France; [Nakamura, Haruo] Mitsukoshi Hlth & Welf Fdn, Tokyo, Japan; [Chasman, Daniel I.; Ridker, Paul M.; Manson, Joann E.] Harvard Univ, Div Prevent Med, Sch Med, Boston, MA USA; [Patel, Sanjay R.] Harvard Univ, Div Sleep Med, Sch Med, Boston, MA USA; [Redline, Susan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Maggioni, Aldo P.] ANMCO Res Ctr, Florence, Italy; [Tavazzi, Luigi] Maria Cecilia Hosp, GVM Care & Res, ES Hlth Sci Fdn, Cotignola, RA, Italy; [Ray, Kausik K.; Seshasai, Sreenivasa Rao Kondapally] Cardiac & Cell Sci Res Inst, London, England; [Whincup, Peter H.] St Georges Univ, London, England; [Lawlor, Debbie A.; Smith, George Davey; Gaunt, Tom R.; Timpson, Nicholas J.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Debbie A.; Smith, George Davey; Ben-Shlomo, Yoav; Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Tsai, Michael] Univ Minnesota, Minneapolis, MN USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Med, Dept Epidemiol, Cardiovascular Hlth Res Unit, Seattle, WA USA; [Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Delaney, Joseph A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Cushman, Mary] Univ Vermont, Dept Med, Colchester, VT USA; [Cushman, Mary] Univ Vermont, Dept Pathol, Colchester, VT USA; [Whittaker, John C.] GlaxoSmithKline, Stevenage, Herts, England; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Broad Inst, Program Med & Populat Gent, Cambridge, MA USA; [Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Hoogeveen, Ronald C.] Baylor Coll Med, Dept Med, Div Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Lange, Leslie A.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Asselbergs, Folkert W.] Durrer Ctr Cardiogenet Res, ICIN Netherlands Heart Inst, Utrecht, Netherlands; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Rigshospitalet; University of Copenhagen; University of Cambridge; Utrecht University; University of Groningen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; London School of Hygiene & Tropical Medicine; Cardiff University; University of Edinburgh; Imperial College London; Imperial College London; Jackson State University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institute for Clinical & Experimental Medicine (IKEM); National Institute of Public Health (SZU) - Czech Republic; Lithuanian University of Health Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University; Russian Academy of Medical Sciences; Russian Academy of Sciences; Russian Academy of Medical Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Milan; Karolinska Institutet; Karolinska Institutet; IRCCS Centro Cardiologico Monzino; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Iowa; Translational Genomics Research Institute; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Cornell University; University of Sydney; IQVIA; Consorzio Mario Negri Sud; University of California System; University of California San Francisco; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Maria Cecilia Hospital; St Georges University London; University of Bristol; University of Bristol; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont; University of Vermont; GlaxoSmithKline; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Mississippi; University of Mississippi Medical Center; Fred Hutchinson Cancer Center	Preiss, D (corresponding author), Univ Glasgow, BHF Glasgow Cardiovascular Res Ctr, Glasgow G12 8TA, Lanark, Scotland.	d.swerdlow@ucl.ac.uk; david.preiss@glasgow.ac.uk	Verweij, Niek/A-4499-2017; Pikhart, Hynek/E-3074-2010; Davey Smith, George/A-7407-2013; Wong, Andrew/M-8899-2016; Buxbaum, Sarah G./E-1970-2013; van der Schouw, Yvonne T./F-8327-2014; mcmurray, John/B-2467-2013; de Jong, Pim A/G-7220-2014; Verweij, Niek/ABC-6249-2021; Schnabel, Renate B/ABE-6668-2021; Gaunt, Tom R/O-3918-2014; , Jennifer/AAD-8336-2019; Asselbergs, Folkert W./ABD-6752-2021; Whittaker, John C/B-8609-2012; Ray, Kausik/Z-2055-2019; Voevoda, Mikhail/N-6713-2015; Tavazzi, Luigi/ABD-5119-2020; Stepaniak, Urszula/U-2387-2018; Jukema, J. Wouter/ABD-6503-2021; Baldassarre, Damiano/J-3295-2016; Kivimaki, Mika/B-3607-2012; Ford, Ian/ABE-6145-2020; Tamosiunas, Abdonas/AAD-4274-2021; Hubacek, Jaroslav Alois/AAN-6134-2021; Attrill, Lauren/V-1688-2018; Guo, Yiran/H-4120-2011; Timpson, Nicholas John/O-7548-2015; Tzoulaki, Ioanna/ABE-6269-2020; Malyutina, Sofia/J-1651-2018; Kuh, Diana/L-6019-2014; Hardy, Rebecca/AFR-1989-2022; Onland-Moret, N. Charlotte/G-9185-2011; Ben-Shlomo, Yoav/ABD-2004-2021; Stender, Stefan/AAC-8258-2019; Wong, Andrew/AAE-6995-2019; Brunner, Eric/H-2114-2011; Topor-Madry, Roman/ABF-5449-2020; Langenberg, Claudia/ABG-9067-2021; Swerdlow, Daniel/A-3497-2009; Cushman, Mary/K-1157-2019; Delaney, Joseph A/J-8204-2019; Baceviciene, Migle/AAG-1246-2020; Maggioni, Aldo Pietro/AAL-5334-2020; Marmot, M G/Y-3920-2019; Fox, Laura J/C-6249-2016; TREMOLI, ELENA/I-8126-2018; Johnson, Paul/O-9695-2014; Maitland-van der Zee, Anke/I-9572-2016	Pikhart, Hynek/0000-0001-5277-4049; Davey Smith, George/0000-0002-1407-8314; Wong, Andrew/0000-0003-2079-4779; Buxbaum, Sarah G./0000-0002-4886-3564; van der Schouw, Yvonne T./0000-0002-4605-435X; mcmurray, John/0000-0002-6317-3975; de Jong, Pim A/0000-0003-4840-6854; Verweij, Niek/0000-0002-4303-7685; Schnabel, Renate B/0000-0001-7170-9509; Gaunt, Tom R/0000-0003-0924-3247; Asselbergs, Folkert W./0000-0002-1692-8669; Whittaker, John C/0000-0002-3529-2379; Voevoda, Mikhail/0000-0001-9425-413X; Tavazzi, Luigi/0000-0003-0336-8356; Stepaniak, Urszula/0000-0002-1904-4674; Jukema, J. Wouter/0000-0002-3246-8359; Baldassarre, Damiano/0000-0002-2766-8882; Kivimaki, Mika/0000-0002-4699-5627; Hubacek, Jaroslav Alois/0000-0001-6537-1353; Timpson, Nicholas John/0000-0002-7141-9189; Tzoulaki, Ioanna/0000-0002-4275-9328; Malyutina, Sofia/0000-0001-6539-0466; Kuh, Diana/0000-0001-7386-2857; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Ben-Shlomo, Yoav/0000-0001-6648-3007; Stender, Stefan/0000-0003-0281-5900; Wong, Andrew/0000-0003-2079-4779; Brunner, Eric/0000-0002-0595-4474; Langenberg, Claudia/0000-0002-5017-7344; Swerdlow, Daniel/0000-0002-7946-3459; Cushman, Mary/0000-0002-7871-6143; Delaney, Joseph A/0000-0003-1771-1776; Baceviciene, Migle/0000-0002-9819-2316; Maggioni, Aldo Pietro/0000-0003-2764-6779; Marmot, M G/0000-0002-2431-6419; Forouhi, Nita/0000-0002-5041-248X; TREMOLI, ELENA/0000-0002-0929-6106; Bobak, Martin/0000-0002-2633-6851; Peasey, Anne/0000-0001-7434-2079; Schreiner, Pamela/0000-0002-9920-6257; Humphries, Stephen E/0000-0002-8221-6547; Stewart, Marlene/0000-0001-7939-7001; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hingorani, Aroon/0000-0001-8365-0081; Masasabi, John/0000-0003-4130-7837; Li, Yun Rose/0000-0002-8077-4975; Tsai, Michael/0000-0001-7553-3408; Johnson, Paul/0000-0001-6663-7520; Preiss, David/0000-0003-3139-1836; Hardy, Rebecca/0000-0001-9949-0799; Whincup, Peter/0000-0002-5589-4107; TAVAZZI, LUIGI/0000-0003-4448-5209; Engmann, Jorgen/0000-0001-7015-7773; Drenos, Fotios/0000-0003-2469-5516; Maitland-van der Zee, Anke/0000-0002-0414-3442; Price, Jackie/0000-0003-3251-3970; s, hema/0000-0002-3440-9475; Hoogeveen, Ron/0000-0003-2399-4653; Sofat, Reecha/0000-0002-0242-6115; Lawlor, Debbie A/0000-0002-6793-2262; Patel, Sanjay/0000-0002-9142-5172; Dale, Caroline/0000-0002-3889-8974; Morris, Richard/0000-0001-7240-4563; Eaton, Charles/0000-0002-7723-9461; Talmud, Philippa/0000-0002-5560-1933; Kumari, Meena/0000-0001-9716-1035	Medical Research Council (MRC) Doctoral Training Award; Rosetrees Trust; MRC Population Health Scientist Fellowship [G0802432]; National Institutes of Health (NIH); British Heart Foundation (Schillingford) Clinical Training Fellowship [FS/07/011]; Danish MRC [10-083788]; Research Fund at Rigshospitalet; Copenhagen University Hospital; Chief Physician Johan Boserup and Lise Boserup's Fund; Wellcome Trust [064947/Z/01/Z, 081081/Z/06/Z]; National Institute on Aging [1R01 AG23522-01, AG034454]; MacArthur Foundation; National Institute on Minority Health; Health Disparities of the NIH [P20MD006899]; MRC [K013351, G0600705]; Ministry of Health, Czech Republic [00023001]; Magnus Bergvall Foundation; Foundation for Old Servants; National Institute for Healthy Ageing [05060810]; British Heart Foundation; Chest, Heart and Stroke Scotland; Wellcome Trust; British Heart Foundation [RG/13/2/30098]; MooDFOOD Collaborative Project (FP7) [613598]; NIH [NIH U19 HL065797, NHLBI 33014]; British Heart Foundation (BHF) [RG 08/008, PG/07/133/24260]; EMIF [115372]; National Heart, Lung and Blood Institute [HL036310]; Academy of Finland; Netherlands Organisation for Health Research and Development (ZonMw grant) [90700342]; University College London NIHR Biomedical Research Centre; Diabetes UK; British Heart Foundation [RG/08/008/25291, PG/13/66/30442, RG/07/008/23674, RG/08/013/25942, RG/13/16/30528, RG/10/12/28456] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G0500877, G0601647, MC_UU_12015/5, MR/K006215/1, G0100222, MC_UU_12015/1, MC_PC_13048, MC_UU_12013/3, MC_UP_A100_1003, G8802774, MC_UU_12013/5, G0902037, MC_UU_12013/1, G1000616, MC_U106179471, MC_UU_12019/1, G19/35, MC_PC_13046, G0600705, G0701830, MR/K006584/1, MC_UU_12013/8, MR/K013351/1, G0802432] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10059, NF-SI-0512-10135] Funding Source: researchfish; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G1000616, MC_UU_12013/1, MC_UU_12015/5, MC_UU_12013/5, G0902037, MR/K013351/1, MC_UU_12013/8, MC_UP_A100_1003, G0802432, MC_UU_12015/1, G0701830, G0500877, MC_UU_12013/3, MC_UU_12019/1, MR/K006215/1, G0601647] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG023522] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	Medical Research Council (MRC) Doctoral Training Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); MRC Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation (Schillingford) Clinical Training Fellowship; Danish MRC(Danish Medical Research Council); Research Fund at Rigshospitalet; Copenhagen University Hospital; Chief Physician Johan Boserup and Lise Boserup's Fund; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation; National Institute on Minority Health; Health Disparities of the NIH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); Magnus Bergvall Foundation; Foundation for Old Servants; National Institute for Healthy Ageing; British Heart Foundation(British Heart Foundation); Chest, Heart and Stroke Scotland; Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MooDFOOD Collaborative Project (FP7); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation (BHF)(British Heart Foundation); EMIF; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Academy of Finland(Academy of Finland); Netherlands Organisation for Health Research and Development (ZonMw grant); University College London NIHR Biomedical Research Centre; Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	DIS is supported by a Medical Research Council (MRC) Doctoral Training Award and a grant from the Rosetrees Trust. MVH is supported by a MRC Population Health Scientist Fellowship (G0802432). JELL is supported by grants from the National Institutes of Health (NIH) and the MRC. RS has been supported by a British Heart Foundation (Schillingford) Clinical Training Fellowship (FS/07/011). SS is supported by the Danish MRC (grant no. 10-083788), the Research Fund at Rigshospitalet, Copenhagen University Hospital, and Chief Physician Johan Boserup and Lise Boserup's Fund. CC and APe are supported by grants from the Wellcome Trust (064947/Z/01/Z and 081081/Z/06/Z), a grant from the National Institute on Aging (1R01 AG23522-01), and a grant from MacArthur Foundation. SGB was supported by an award from the National Institute on Minority Health and Health Disparities of the NIH (award number P20MD006899). NGF is supported by a grant from the MRC. JAH is supported by the project (Ministry of Health, Czech Republic) for the development of research organisation 00023001 (IKEM, Prague, Czech Republic). APa is supported by grants from the Wellcome Trust (064947/Z/01/Z and 081081/Z/06/Z) and National Institute on Aging (1R01 AG23522-01). BS is supported by the Magnus Bergvall Foundation and the Foundation for Old Servants. RGJW is supported by the National Institute for Healthy Ageing (Grant 05060810). JFP is supported by the British Heart Foundation; Chest, Heart and Stroke Scotland; the Wellcome Trust; and the MRC. DAL, GDS, and NJT work in a unit that receives funding from the MRC and University of Bristol. EJB's research is supported by a British Heart Foundation programme grant (RG/13/2/30098) and the MooDFOOD Collaborative Project (FP7 grant 613598). RMK is supported by the NIH (grant NIH U19 HL065797). SEH and PJT are supported by the British Heart Foundation (BHF RG 08/008, PG/07/133/24260), MRC, and NIH (grant NHLBI 33014). MKi is supported by the National Institute on Aging (AG034454); the M RC (K013351); the National Heart, Lung and Blood Institute (HL036310); and the Academy of Finland. NJT is supported by the MRC (grant G0600705). FWA is supported by a clinical fellowship from the Netherlands Organisation for Health Research and Development (ZonMw grant 90700342). ADH is supported by University College London NIHR Biomedical Research Centre. NS's research is supported by the British Heart Foundation, Diabetes UK, and the EU/EF PIA Innovative Medicines Initiative Joint Undertaking (EMIF grant 115372). We thank Merck and Novartis for contributing data to the statin trials analysis. Details of grants or other support for included studies are provided in the appendix.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Axsom K, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0299-z; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baker WL, 2010, DIABETES RES CLIN PR, V87, P98, DOI 10.1016/j.diabres.2009.10.008; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Danaei G, 2013, DIABETES CARE, V36, P1236, DOI 10.2337/dc12-1756; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; FDA Drug Safety Communication, 2012, IMP SAF LAB CHANG CH; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Holman RR, 2009, DIABETOLOGIA, V52, P50, DOI 10.1007/s00125-008-1179-5; Holmes MV, 2014, AM J HUM GENET, V94, P198, DOI 10.1016/j.ajhg.2013.12.014; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; O'Regan C, 2008, AM J MED, V121, P24, DOI 10.1016/j.amjmed.2007.06.033; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Sabatine MS, 2004, CIRCULATION, V110, P834; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	40	433	441	1	115	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					351	361		10.1016/S0140-6736(14)61183-1	http://dx.doi.org/10.1016/S0140-6736(14)61183-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25262344	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000348509000028
J	Foresti, O; Rodriguez-Vaello, V; Funaya, C; Carvalho, P				Foresti, Ombretta; Rodriguez-Vaello, Victoria; Funaya, Charlotta; Carvalho, Pedro			Quality control of inner nuclear membrane proteins by the Asi complex	SCIENCE			English	Article							ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; UBIQUITIN LIGASE; GENES	Misfolded proteins in the endoplasmic reticulum (ER) are eliminated by a quality control system called ER-associated protein degradation (ERAD). However, it is unknown how misfolded proteins in the inner nuclear membrane (INM), a specialized ER subdomain, are degraded. We used a quantitative proteomics approach to reveal an ERAD branch required for INM protein quality control in yeast. This branch involved the integral membrane proteins Asi1, Asi2, and Asi3, which assembled into an Asi complex. Besides INM misfolded proteins, the Asi complex promoted the degradation of functional regulators of sterol biosynthesis. Asi-mediated ERAD was required for ER homeostasis, which suggests that spatial segregation of protein quality control systems contributes to ER function.	[Foresti, Ombretta; Rodriguez-Vaello, Victoria; Carvalho, Pedro] CRG, Cell & Dev Biol Programme, Barcelona 08003, Spain; [Foresti, Ombretta; Rodriguez-Vaello, Victoria; Carvalho, Pedro] Univ Pompeu Fabra, Barcelona 08003, Spain; [Funaya, Charlotta] European Mol Biol Lab, Electron Microscopy Core Facil, D-69117 Heidelberg, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; European Molecular Biology Laboratory (EMBL)	Carvalho, P (corresponding author), CRG, Cell & Dev Biol Programme, Carrer Doctor Aiguader 88, Barcelona 08003, Spain.	pedro.carvalho@crg.eu	Foresti, Ombretta/M-3930-2019; Foresti, Ombretta/J-8165-2015; Carvalho, Pedro/HHN-1424-2022	Foresti, Ombretta/0000-0002-6878-0395; Foresti, Ombretta/0000-0002-6878-0395; Fredriksson Funaya, Charlotta/0000-0003-1375-1287; Carvalho, Pedro/0000-0002-9691-5277	CRG; International Early Career Award from the HHMI; EMBO Young Investigator Program; Spanish MCCIN; ERC	CRG; International Early Career Award from the HHMI; EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Spanish MCCIN; ERC(European Research Council (ERC)European Commission)	Mass spectrometric measurements and data analysis were performed in the CRG/UPF Proteomics Unit (part of the ProteoRed, Instituto de Salud Carlos III). We thank M. Hochstrasser, M. Mendoza, and L. Veenhoff for reagents; C. Chiva and E. Sabido for help with the SILAC; R. Oliete for Erg11 and Nsg1 plasmids; and V. Goder, A. Ruggiano, and J. Valcarcel for critical reading of the manuscript. This work was supported by CRG, an International Early Career Award from the HHMI, the EMBO Young Investigator Program, grants from the Spanish MCCIN and ERC (P. C.), and a fellowship from the Spanish MCCIN (V.R.-V.).	Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Forsberg H, 2001, GENETICS, V158, P973; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Katta SS, 2014, TRENDS CELL BIOL, V24, P221, DOI 10.1016/j.tcb.2013.10.006; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Ndoja A, 2014, MOL CELL, V53, P893, DOI 10.1016/j.molcel.2014.02.002; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Stolz A, 2013, P NATL ACAD SCI USA, V110, P15271, DOI 10.1073/pnas.1304928110; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Zargari A, 2007, J BIOL CHEM, V282, P594, DOI 10.1074/jbc.M609201200	18	123	125	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					751	755		10.1126/science.1255638	http://dx.doi.org/10.1126/science.1255638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25236469				2022-12-28	WOS:000344690100042
J	Batey, RT				Batey, Robert T.			STRUCTURAL BIOLOGY Lariat lessons	NATURE			English	Editorial Material							GROUP-II INTRON; MESSENGER-RNA; CRYSTAL-STRUCTURE; SPLICEOSOME		Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625				Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Cech TR, 2009, COLD SH Q B, V74, P11, DOI 10.1101/sqb.2009.74.024; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Podar M, 1998, NATURE, V391, P915, DOI 10.1038/36142; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Robart AR, 2014, NATURE, V514, P193, DOI 10.1038/nature13790; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803	13	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					173	174		10.1038/nature13754	http://dx.doi.org/10.1038/nature13754			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25252981				2022-12-28	WOS:000342663100027
J	Caspeta, L; Chen, Y; Ghiaci, P; Feizi, A; Buskov, S; Hallstrom, BM; Petranovic, D; Nielsen, J				Caspeta, Luis; Chen, Yun; Ghiaci, Payam; Feizi, Amir; Buskov, Steen; Hallstrom, Bjorn M.; Petranovic, Dina; Nielsen, Jens			Altered sterol composition renders yeast thermotolerant	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOCHROME DEFICIENCY; ENZYMATIC-HYDROLYSIS; ETHANOL-PRODUCTION; PROTEIN; RAFTS	Ethanol production for use as a biofuel is mainly achieved through simultaneous saccharification and fermentation by yeast. Operating at >= 40 degrees C would be beneficial in terms of increasing efficiency of the process and reducing costs, but yeast does not grow efficiently at those temperatures. We used adaptive laboratory evolution to select yeast strains with improved growth and ethanol production at >= 40 degrees C. Sequencing of the whole genome, genome-wide gene expression, and metabolic-flux analyses revealed a change in sterol composition, from ergosterol to fecosterol, caused by mutations in the C-5 sterol desaturase gene, and increased expression of genes involved in sterol biosynthesis. Additionally, large chromosome III rearrangements and mutations in genes associated with DNA damage and respiration were found, but contributed less to the thermotolerant phenotype.	[Caspeta, Luis; Chen, Yun; Feizi, Amir; Petranovic, Dina; Nielsen, Jens] Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, SE-41296 Gothenburg, Sweden; [Ghiaci, Payam; Petranovic, Dina; Nielsen, Jens] Chalmers Unvers Technol, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden; [Buskov, Steen] Novozymes, Analyt Sci, DK-4400 Kalundborg, Denmark; [Hallstrom, Bjorn M.] Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden; [Nielsen, Jens] Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark	Chalmers University of Technology; Technical University of Denmark; Chalmers University of Technology; Novozymes; Royal Institute of Technology; Technical University of Denmark	Nielsen, J (corresponding author), Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, SE-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Chen, Yun/G-6645-2017; Nielsen, Jens/Q-1347-2017	Chen, Yun/0000-0002-2146-6008; Petranovic, Dina/0000-0001-8724-3942; Nielsen, Jens/0000-0002-9955-6003; Caspeta, Luis/0000-0003-4622-5179	Novo Nordisk Foundation; European Research Council [247013]; Vetenskapsradet; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); Vetenskapsradet(Swedish Research Council); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was funded by the Novo Nordisk Foundation, the European Research Council (grant no. 247013), and Vetenskapsradet. We acknowledge the Science for Life Laboratory, the National Genomics Infrastructure, and Uppmax for providing assistance in massive parallel sequencing and computational infrastructure. Data are provided in the supplementary materials.	Abdel-Banat BMA, 2010, APPL MICROBIOL BIOT, V85, P861, DOI 10.1007/s00253-009-2248-5; Abreu-Cavalheiro A, 2013, BRAZ J MICROBIOL, V44, P665, DOI 10.1590/S1517-83822013000300001; Amorim HV, 2010, ACS SYM SER, V1058, P73; Caspeta L, 2014, APPL ENERG, V113, P277, DOI 10.1016/j.apenergy.2013.07.036; Caspeta L, 2013, NAT BIOTECHNOL, V31, P789, DOI 10.1038/nbt.2683; Caspeta L, 2013, ENERG ENVIRON SCI, V6, P1077, DOI 10.1039/c3ee24403b; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; LINDQUIST S, 1981, NATURE, V293, P311, DOI 10.1038/293311a0; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Moy TI, 2002, MICROBIOL-SGM, V148, P1081, DOI 10.1099/00221287-148-4-1081; Nielsen J, 2013, CURR OPIN BIOTECH, V24, P398, DOI 10.1016/j.copbio.2013.03.023; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; PIPER PW, 1993, FEMS MICROBIOL REV, V11, P339, DOI 10.1016/0168-6445(93)90005-T; Piper PW, 1997, CELL STRESS CHAPERON, V2, P12, DOI 10.1379/1466-1268(1997)002<0012:HTIPMH>2.3.CO;2; Sabina J, 2009, J BIOL CHEM, V284, P29635, DOI 10.1074/jbc.M109.032102; SHERMAN F, 1956, EXP CELL RES, V11, P659, DOI 10.1016/0014-4827(56)90180-X; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; THOMPSON ED, 1974, J BACTERIOL, V120, P779, DOI 10.1128/JB.120.2.779-784.1974; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; WATSON K, 1978, J BACTERIOL, V136, P815, DOI 10.1128/JB.136.2.815-817.1978; YCAS M, 1956, EXP CELL RES, V10, P746, DOI 10.1016/0014-4827(56)90055-6; Yona AH, 2012, P NATL ACAD SCI USA, V109, P21010, DOI 10.1073/pnas.1211150109; [No title captured], DOI DOI 10.1155/2012/789652	29	262	281	16	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					75	78		10.1126/science.1258137	http://dx.doi.org/10.1126/science.1258137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278608				2022-12-28	WOS:000342446900053
J	Adams, MA; Parikh, PD; Miller, K; Rubenstein, JH				Adams, Megan A.; Parikh, Parul Divya; Miller, Kwon; Rubenstein, Joel H.			Medical Professional Liability Claims Related to Esophageal Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SURVEILLANCE; DISEASE		[Adams, Megan A.] Univ Michigan, Div Gastroenterol, Sch Med, Ann Arbor, MI 48109 USA; [Parikh, Parul Divya; Miller, Kwon] PIAA, Rockville, MD USA; [Rubenstein, Joel H.] Ann Arbor Vet Affairs Med Ctr, Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Adams, MA (corresponding author), Univ Michigan, Div Gastroenterol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	meganada@med.umich.edu	Adams, Megan A./V-1654-2019	Adams, Megan A./0000-0002-3878-7684	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062708] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK062708] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ben-Menachem T, 2012, GASTROINTEST ENDOSC, V76, P707, DOI 10.1016/j.gie.2012.03.252; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Rubenstein JH, 2008, AM J GASTROENTEROL, V103, P842, DOI 10.1111/j.1572-0241.2007.01689.x; Shaheen NJ, 2012, ANN INTERN MED, V157, P808, DOI 10.7326/0003-4819-157-11-201212040-00008; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x	6	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1348	1349		10.1001/jama.2014.7960	http://dx.doi.org/10.1001/jama.2014.7960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268443	Bronze			2022-12-28	WOS:000342345400022
J	Bernstein, R				Bernstein, Rachel			Faculty Searches Get a Facelift	CELL			English	Editorial Material																			0	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					5	8		10.1016/j.cell.2014.09.006	http://dx.doi.org/10.1016/j.cell.2014.09.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259912	Bronze			2022-12-28	WOS:000343095000001
J	Aaron, SD				Aaron, Shawn D.			Management and prevention of exacerbations of COPD	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; N-ACETYLCYSTEINE; DOUBLE-BLIND; SALMETEROL/FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE/SALMETEROL; NONINVASIVE VENTILATION; INHALED CORTICOSTEROIDS; INFLAMMATORY MARKERS; ANTIBIOTIC-THERAPY	Patients with chronic obstructive pulmonary disease (COPD) are prone to acute respiratory exacerbations, which can develop suddenly or subacutely over the course of several days. Exacerbations have a detrimental effect on patients' health status and increase the burden on the healthcare system. Initial treatment is unsuccessful in 24-27% of patients, who have a relapse or a second exacerbation within 30 days of the initial event. No obvious benefit has been seen in recent clinical trials of anti-tumour necrosis factor therapy, anti-leukotriene therapy, intensive chest physiotherapy, or early inpatient pulmonary rehabilitation for treatment of exacerbations. By contrast, clinical trials of prevention rather than acute treatment have shown promising results. Long acting 8 agonist (LABA) or long acting anti-muscarinic (LAMA) bronchodilators and inhaled corticosteroid-LABA combinations prevent exacerbations in patients at risk, with relative risk reductions averaging 14-27% for each of these drugs relative to placebo. Triple therapy with inhaled corticosteroid-LABA plus LAMA may provide additional benefit, although study results to date are heterogeneous and more studies are needed. Pneumonia is an important complication of treatment with inhaled corticosteroid-LABA products, and the risk of pneumonia seems to be doubled in patients with COPD who use fluticasone. The addition of azithromycin to usual COPD therapy prevents exacerbations, although it may prolong the Q-T interval and increase the risk of death from cardiovascular disease in patients prone to arrhythmia. New potential drugs-including mitogen activated protein kinase inhibitors, phosphodiesterase 3 inhibitors, and monoclonal antibodies to the interleukin 1 receptor-offer additional hope for treatments that may prevent exacerbations in the future.	Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute	Aaron, SD (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada.	saaron@ohri.ca		Aaron, Shawn/0000-0002-4762-3542	Boerhinger-Ingelheim; Astra-Zeneca; Novartis	Boerhinger-Ingelheim; Astra-Zeneca(AstraZeneca); Novartis(Novartis)	I have read and understood BMJ policy on declaration of interests and declare the following interests: I have served on advisory boards for Boerhinger-Ingelheim, Astra-Zeneca, and Novartis and have been paid about $10 000 (6000; pound (sic)7530) for these activities in the past 24 months.	Aaron SD, 2008, THORAX, V63, P122, DOI 10.1136/thx.2007.082636; Aaron SD, 2003, NEW ENGL J MED, V348, P2618, DOI 10.1056/NEJMoa023161; Aaron SD, 2002, CHEST, V121, P688, DOI 10.1378/chest.121.3.688; Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Aaron SD, 2013, THORAX, V68, P142, DOI 10.1136/thoraxjnl-2012-202432; Aaron SD, 2012, THORAX, V67, P238, DOI 10.1136/thoraxjnl-2011-200768; Agusti A, 2014, EUR RESPIR J, V43, P763, DOI 10.1183/09031936.00054213; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; [Anonymous], 2013, READMISSIONS US HOSP; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2012, INT J CHRONIC OBSTR, V7, P375, DOI 10.2147/COPD.S31100; Cazzola M, 2014, LANCET RESP MED, V2, P166, DOI 10.1016/S2213-2600(13)70294-7; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Chandra D, 2012, AM J RESP CRIT CARE, V185, P152, DOI 10.1164/rccm.201106-1094OC; Compton C, 2013, PULM PHARMACOL THER, V26, P562, DOI 10.1016/j.pupt.2013.05.009; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; D'Urzo A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-156; Daniels JMA, 2010, AM J RESP CRIT CARE, V181, P150, DOI 10.1164/rccm.200906-0837OC; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Decramer ML, 2013, LANCET RESP MED, V1, P524, DOI 10.1016/S2213-2600(13)70158-9; Donaldson GC, 2005, CHEST, V128, P1995, DOI 10.1378/chest.128.4.1995; Donath E, 2013, RESP MED, V107, P1385, DOI 10.1016/j.rmed.2013.05.004; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Franciosi LG, 2013, LANCET RESP MED, V1, P714, DOI 10.1016/S2213-2600(13)70187-5; *GOLD, 2004, GLOB STRAT DIAGN MAN; Greening NJ, 2014, BMJ-BRIT MED J, V349, pg4315; Gross NJ, 2013, COPD, V10, P625, DOI 10.3109/15412555.2013.832093; Han Meilan K, 2011, Proc Am Thorac Soc, V8, P356, DOI 10.1513/pats.201102-016RM; Tse HN, 2013, CHEST, V144, P106, DOI 10.1378/chest.12-2357; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Nannini LJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003794.pub4; Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Jones PW, 2009, COPD, V6, P59, DOI 10.1080/15412550802587943; Karner C, 2012, COCHRANE DB SYST REV, V7; Kerwin E, 2012, EUR RESPIR J, V40, P1106, DOI 10.1183/09031936.00040712; Kew K, 2013, COCHRANE DB SYST REV, V3; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Leuppi JD, 2013, JAMA-J AM MED ASSOC, V309, P2223, DOI 10.1001/jama.2013.5023; Llor C, 2012, AM J RESP CRIT CARE, V186, P716, DOI 10.1164/rccm.201206-0996OC; Mackay AJ, 2012, AM J RESP CRIT CARE, V185, P1218, DOI 10.1164/rccm.201110-1843OC; Marzoratti L, 2013, THER ADV RESPIR DIS, V7, P225, DOI 10.1177/1753465813480550; Mercer Becky A, 2006, Int J Chron Obstruct Pulmon Dis, V1, P137, DOI 10.2147/copd.2006.1.2.137; Molyneaux PL, 2013, AM J RESP CRIT CARE, V188, P1224, DOI 10.1164/rccm.201302-0341OC; Mosholder AD, 2013, NEW ENGL J MED, V368, P1665, DOI 10.1056/NEJMp1302726; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Myou S, 1999, AM J RESP CRIT CARE, V160, P817, DOI 10.1164/ajrccm.160.3.9812065; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nouira S, 2001, LANCET, V358, P2020, DOI 10.1016/S0140-6736(01)07097-0; O'Donnell DE, 2006, THORAX, V61, P354, DOI 10.1136/thx.2005.041830; O'Donnell DE, 2007, CAN RESPIR J, V14, p5B, DOI 10.1155/2007/830570; Osadnik CR, 2014, THORAX, V69, P137, DOI 10.1136/thoraxjnl-2013-203425; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Parker CM, 2005, EUR RESPIR J, V26, P420, DOI 10.1183/09031936.05.00136304; Piquet J, 2013, EUR RESPIR J, V42, P946, DOI 10.1183/09031936.00180312; Poole PJ, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002733.PUB2; Prieto-Centurion Valentin, 2014, Ann Am Thorac Soc, V11, P417, DOI 10.1513/AnnalsATS.201308-254OC; Ramsay M, 2013, CURR OPIN PULM MED, V19, P626, DOI 10.1097/MCP.0b013e3283659e4c; Rennard S, 2013, COPD, V10, P393, DOI 10.3109/15412555.2013.795423; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sethi S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-10; Sin DD, 2009, LANCET, V374, P712, DOI 10.1016/S0140-6736(09)61250-2; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Walters JA, 2010, COCHRANE DB SYST REV, V11; Walters JA., 2010, COCHRANE DB SYST REV, V5; Wang MT, 2013, AM J MED, V126, P598, DOI 10.1016/j.amjmed.2013.01.036; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2013, LANCET RESP MED, V1, P199, DOI 10.1016/S2213-2600(13)70052-3; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Wilson R, 2013, J INFECTION, V67, P497, DOI 10.1016/j.jinf.2013.08.010; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342; Woodcock A, 2013, CHEST, V144, P1222, DOI 10.1378/chest.13-0178; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; Woodruff PG, 2011, COPD, V8, P21, DOI 10.3109/15412555.2010.540273; Xu W, 2010, EUR RESPIR J, V35, P1022, DOI 10.1183/09031936.00079409; Zheng JP, 2014, LANCET RESP MED, V2, P187, DOI 10.1016/S2213-2600(13)70286-8	99	57	60	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2014	349								g5237	10.1136/bmj.g5237	http://dx.doi.org/10.1136/bmj.g5237			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UG	25245156				2022-12-28	WOS:000342425100001
J	Fernyhough, C				Fernyhough, Charles			The art of medicine Hearing the voice	LANCET			English	Editorial Material									[Fernyhough, Charles] Univ Durham, Sch Educ, Durham DH1 1SZ, England; [Fernyhough, Charles] Univ Durham, Dept Psychol, Durham DH1 3HP, England	Durham University; Durham University	Fernyhough, C (corresponding author), Univ Durham, Sch Educ, Durham DH1 1SZ, England.	c.p.fernyhough@durham.ac.uk	Fernyhough, Charles/A-1057-2010	Fernyhough, Charles/0000-0002-3822-710X	Wellcome Trust [098455] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1090	1091		10.1016/S0140-6736(14)61665-2	http://dx.doi.org/10.1016/S0140-6736(14)61665-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	25247222				2022-12-28	WOS:000342630600019
J	Zhang, Y; Sontheimer, EJ				Zhang, Yan; Sontheimer, Erik J.			Cascading into focus	SCIENCE			English	Editorial Material							CRISPR-CAS SYSTEMS; IMMUNE-SYSTEM; RNA; DNA; INTERFERENCE; PROKARYOTES; DEGRADATION		[Zhang, Yan; Sontheimer, Erik J.] Univ Massachusetts, RNA Therapeut Inst, Program Mol Med, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zhang, Y (corresponding author), Univ Massachusetts, RNA Therapeut Inst, Program Mol Med, Sch Med, Worcester, MA 01605 USA.	erik.sontheimer@umassmed.edu		Sontheimer, Erik/0000-0002-0881-0310				Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	12	1	1	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1452	1453		10.1126/science.1260026	http://dx.doi.org/10.1126/science.1260026			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237089				2022-12-28	WOS:000341752900023
J	Lissauer, JJ; Dawson, RI; Tremaine, S				Lissauer, Jack J.; Dawson, Rebekah I.; Tremaine, Scott			Advances in exoplanet science from Kepler	NATURE			English	Review							EARTH-SIZED PLANET; IN-SITU FORMATION; R-CIRCLE-PLUS; SOLAR-TYPE; RADIUS DISTRIBUTION; STELLAR SPIN; II. ANALYSIS; HOST STARS; CANDIDATES; MASS	Numerous telescopes and techniques have been used to find and study extrasolar planets, but none has been more successful than NASA's Kepler space telescope. Kepler has discovered most of the known exoplanets, the smallest planets to orbit normal stars and the planets most likely to be similar to Earth. Most importantly, Kepler has provided us with our first look at the typical characteristics of planets and planetary systems for planets with sizes as small as, and orbits as large as, those of Earth.	[Lissauer, Jack J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Dawson, Rebekah I.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Tremaine, Scott] Inst Adv Study, Princeton, NJ 08540 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley; Institute for Advanced Study - USA	Lissauer, JJ (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	jack.lissauer@nasa.gov	Tremaine, Scott D/M-4281-2015	Tremaine, Scott D/0000-0002-0278-7180	Miller Institute for Basic Research in Science at the University of California, Berkeley	Miller Institute for Basic Research in Science at the University of California, Berkeley(University of California System)	This research has made use of the Exoplanet Orbit Database at http://exoplanets.org and the Extrasolar Planets Encyclopedia at http://exoplanets.eu. We are grateful to the Kepler Science Team for their extensive efforts in producing the high-quality data set that has made possible the results reviewed here. We thank W. Borucki, E. Chiang, S. Dong, E. Lee, E. Lopez, L. Rogers, J. Rowe, A. Youdin and K. Zahnle for helpful discussions and comments on the manuscript. R.I.D. and S.T. gratefully acknowledge funding from the Miller Institute for Basic Research in Science at the University of California, Berkeley.	Albrecht S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/18; Angerhausen D., 2014, PREPRINT; Ballard S, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/200; Barclay T, 2013, NATURE, V494, P452, DOI 10.1038/nature11914; Baruteau C., 2013, PREPRINT; Batalha NM, 2014, P NATL ACAD SCI USA, V111, P12647, DOI 10.1073/pnas.1304196111; Batalha NM, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/24; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Batalha NM, 2010, ASTROPHYS J LETT, V713, pL103, DOI 10.1088/2041-8205/713/2/L103; Batygin K, 2012, NATURE, V491, P418, DOI 10.1038/nature11560; Borucki W. J., 2007, TRANS EXTR PLAN WORK; Borucki WJ, 2013, SCIENCE, V340, P587, DOI 10.1126/science.1234702; Borucki WJ, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/120; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Burke CJ, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/19; Chaplin WJ, 2013, ANNU REV ASTRON ASTR, V51, P353, DOI 10.1146/annurev-astro-082812-140938; Chiang E, 2013, MON NOT R ASTRON SOC, V431, P3444, DOI 10.1093/mnras/stt424; Christensen-Dalsgaard J, 2013, EAS PUBLICATIONS, V63, P91, DOI 10.1051/eas/1363011; Christiansen JL, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/35; Dawson RI, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/89; Dawson RI, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/2/L24; Dawson RI, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/122; Deck KM, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/1/L21; Demory BO, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L20; Dong SB, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L3; Dong SB, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/53; Dreizler S., 2014, KEPLER 9 REVISITED 6; Dressing CD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/95; Eggenberger A, 2010, EAS PUBLICATIONS, V42, P19, DOI 10.1051/eas/1042002; Evans NW, 2002, MON NOT R ASTRON SOC, V333, pL1, DOI 10.1046/j.1365-8711.2002.05579.x; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Fabrycky DC, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/146; Fang JL, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/115; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Fischer DA, 2012, MON NOT R ASTRON SOC, V419, P2900, DOI 10.1111/j.1365-2966.2011.19932.x; Foreman-Mackey D., 2014, PREPRINT; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Fressin F, 2012, NATURE, V482, P195, DOI 10.1038/nature10780; Gilliland RL, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/6; GLADMAN B, 1993, ICARUS, V106, P247, DOI 10.1006/icar.1993.1169; Hadden S, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/80; Hansen BMS, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/53; HELLER CH, 1993, ASTROPHYS J, V408, P337, DOI 10.1086/172591; Hirano T, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/9; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; Holman MJ, 1999, ASTRON J, V117, P621, DOI 10.1086/300695; Holman MJ, 1997, NATURE, V387, P785, DOI 10.1038/42890; Howard AW, 2013, NATURE, V503, P381, DOI 10.1038/nature12767; Howard AW, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/15; IDA S, 1990, ICARUS, V88, P129, DOI 10.1016/0019-1035(90)90182-9; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Jontof-Hutter D, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/15; Kipping DM, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/101; Kipping DM, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/115; Kipping DM, 2014, MON NOT R ASTRON SOC, V440, P2164, DOI 10.1093/mnras/stu318; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Latham DW, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/2/L24; Lissauer JJ, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/44; Lissauer JJ, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/131; Lissauer JJ, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/112; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Lithwick Y, 2012, ASTROPHYS J LETT, V756, DOI 10.1088/2041-8205/756/1/L11; Lopez ED, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/1; Lopez ED, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/2; Lopez ED, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/59; Marcy GW, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/20; Moorhead AV, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/1; Morton TD, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/10; Morton TD, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/6; Morton TD, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/170; Muirhead PS, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/144; Nesvorny D, 2012, SCIENCE, V336, P1133, DOI 10.1126/science.1221141; Orosz JA, 2012, SCIENCE, V337, P1511, DOI 10.1126/science.1228380; PEALE SJ, 1976, ANNU REV ASTRON ASTR, V14, P215, DOI 10.1146/annurev.aa.14.090176.001243; Pepe F, 2013, NATURE, V503, P377, DOI 10.1038/nature12768; Petigura EA, 2013, P NATL ACAD SCI USA, V110, P19273, DOI 10.1073/pnas.1319909110; Petigura EA, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/69; Petigura EA, 2012, PUBL ASTRON SOC PAC, V124, P1073, DOI 10.1086/668291; Petrovich C, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/101; Petrovich C, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/24; Plavchan P, 2014, PUBL ASTRON SOC PAC, V126, P34, DOI 10.1086/674819; Prsa A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/83; Rafikov RR, 2010, ASTRON J, V139, P565, DOI 10.1088/0004-6256/139/2/565; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Rappaport S, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/1; Rein H, 2012, MON NOT R ASTRON SOC, V427, pL21, DOI 10.1111/j.1745-3933.2012.01337.x; Ricker George R., 2014, Journal of the American Association of Variable Star Observers, V42; Rogers L., 2014, PREPRINT; Rogers LA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/59; Sanchis-Ojeda R, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/47; Sanchis-Ojeda R, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/54; Sanchis-Ojeda R, 2012, NATURE, V487, P449, DOI 10.1038/nature11301; Santerne A, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219608; Santos NC, 2001, ASTRON ASTROPHYS, V373, P1019, DOI 10.1051/0004-6361:20010648; Smith AW, 2009, ICARUS, V201, P381, DOI 10.1016/j.icarus.2008.12.027; Smith JC, 2012, PUBL ASTRON SOC PAC, V124, P1000, DOI 10.1086/667697; Steffen JH, 2012, P NATL ACAD SCI USA, V109, P7982, DOI 10.1073/pnas.1120970109; Stumpe MC, 2012, PUBL ASTRON SOC PAC, V124, P985, DOI 10.1086/667698; Swift JJ, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/105; Tabachnik S, 2002, MON NOT R ASTRON SOC, V335, P151, DOI 10.1046/j.1365-8711.2002.05610.x; Tamuz O, 2008, ASTRON ASTROPHYS, V480, pL33, DOI 10.1051/0004-6361:20078737; Tenenbaum P, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/1/24; Torres G, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/24; TREMAINE S, 1991, ICARUS, V89, P85, DOI 10.1016/0019-1035(91)90089-C; Tremaine S, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/4/94; WANG J., PREPRINT; Wang J, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/111; Weiss LM, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L6; Winn JN, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/1/L1; Wright JT, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/160; Wright JT, 2011, PUBL ASTRON SOC PAC, V123, P412, DOI 10.1086/659427; Wu YQ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/74; Youdin AN, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/38; Zakamska NL, 2011, MON NOT R ASTRON SOC, V410, P1895, DOI 10.1111/j.1365-2966.2010.17570.x	128	61	64	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					336	344		10.1038/nature13781	http://dx.doi.org/10.1038/nature13781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230655	Green Submitted			2022-12-28	WOS:000341814900046
J	Gershon, AS; Campitelli, MA; Croxford, R; Stanbrook, MB; To, T; Upshur, R; Stephenson, AL; Stukel, TA				Gershon, Andrea S.; Campitelli, Michael A.; Croxford, Ruth; Stanbrook, Matthew B.; To, Teresa; Upshur, Ross; Stephenson, Anne L.; Stukel, Therese A.			Combination Long-Acting beta-Agonists and Inhaled Corticosteroids Compared With Long-Acting beta-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK; HEALTH; COPD; ASTHMA; INDIVIDUALS; FLUTICASONE; SALMETEROL	IMPORTANCE Chronic obstructive pulmonary disease (COPD), a manageable respiratory condition, is the third leading cause of death worldwide. Knowing which prescription medications are the most effective in improving health outcomes for people with COPD is essential to maximizing health outcomes. OBJECTIVE To estimate the long-term benefits of combination long-acting beta-agonists (LABAs) and inhaled corticosteroids compared with LABAs alone in a real-world setting. DESIGN, SETTING, AND PATIENTS Population-based, longitudinal cohort study conducted in Ontario, Canada, from 2003 to 2011. All individuals aged 66 years or older who met a validated case definition of COPD on the basis of health administrative data were included. After propensity score matching, there were 8712 new users of LABA-inhaled corticosteroid combination therapy and 3160 new users of LABAs alone who were followed up for median times of 2.7 years and 2.5 years, respectively. EXPOSURES Newly prescribed combination LABAs and inhaled corticosteroids or LABAs alone. MAIN OUTCOMES AND MEASURES Composite outcome of death and COPD hospitalization. RESULTS The main outcome was observed among 5594 new users of LABAs and inhaled corticosteroids (3174 deaths [36.4%]; 2420 COPD hospitalizations [27.8%]) and 2129 new users of LABAs alone (1179 deaths [37.3%]; 950 COPD hospitalizations [30.1%]). New use of LABAs and inhaled corticosteroids was associated with a modestly reduced risk of death or COPD hospitalization compared with new use of LABAs alone (difference in composite outcome at 5 years, -3.7%; 95% CI, -5.7% to -1.7%; hazard ratio [HR], 0.92; 95% CI, 0.88-0.96). The greatest difference was among COPD patients with a codiagnosis of asthma (difference in composite at 5 years, -6.5%; 95% CI, -10.3% to -2.7%; HR, 0.84; 95% CI, 0.77-0.91) and those who were not receiving inhaled long-acting anticholinergic medication (difference in composite at 5 years, -8.4%; 95% CI, -11.9% to -4.9%; HR, 0.79; 95% CI, 0.73-0.86). CONCLUSIONS AND RELEVANCE Among older adults with COPD, particularly those with asthma and those not receiving a long-acting anticholinergic medication, newly prescribed LABA and inhaled corticosteroid combination therapy, compared with newly prescribed LABAs alone, was associated with a significantly lower risk of the composite outcome of death or COPD hospitalization. Copyright 2014 American Medical Association. All rights reserved.	[Gershon, Andrea S.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Gershon, Andrea S.; Campitelli, Michael A.; Croxford, Ruth; Stanbrook, Matthew B.; To, Teresa; Upshur, Ross; Stukel, Therese A.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Gershon, Andrea S.; Stanbrook, Matthew B.; To, Teresa; Upshur, Ross; Stephenson, Anne L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Gershon, Andrea S.; To, Teresa] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Gershon, Andrea S.; Stukel, Therese A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Stanbrook, Matthew B.] Univ Hlth Network, Toronto, ON, Canada; [Stephenson, Anne L.] St Michaels Hosp, Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Gershon, AS (corresponding author), Inst Clin Evaluat Sci, G1 06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	andrea.gershon@ices.on.ca		Stukel, Therese/0000-0002-2951-1360	Physicians' Services Incorporated Foundation, Toronto, Ontario; New Investigator Award - Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes [OTG-88591]; University of Toronto, Toronto, Ontario, Canada; Government of Ontario; Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care	Physicians' Services Incorporated Foundation, Toronto, Ontario; New Investigator Award - Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes(Canadian Institutes of Health Research (CIHR)); University of Toronto, Toronto, Ontario, Canada(University of Toronto); Government of Ontario; Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	Dr Gershon is supported by a Fellowship for Translational Health Research from the Physicians' Services Incorporated Foundation, Toronto, Ontario, and was supported by a New Investigator Award funded by team grant OTG-88591 from the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes while working on this study. Dr To is supported by the Dales Award in Medical Research from the University of Toronto, Toronto, Ontario, Canada. Funding for this project was made available through a Drug Innovation Fund Grant from the Government of Ontario. This study was also supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care.	Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Bourbeau J, 2008, THORAX, V63, P831, DOI 10.1136/thx.2007.086041; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dore DD, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-47; Finkelstein MM, 2004, CAN J PUBLIC HEALTH, V95, P90, DOI 10.1007/BF03405773; Frois C, 2009, CLIN THER, V31, P2779, DOI 10.1016/j.clinthera.2009.12.021; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon A, 2013, JAMA INTERN MED, V173, P1175, DOI 10.1001/jamainternmed.2013.1016; Gershon A, 2011, ANN INTERN MED, V154, P583, DOI 10.7326/0003-4819-154-9-201105030-00003; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Global Initiative for Asthma, GLOB IN CHRON OBSTR; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Iron K, 2008, LIVING DYING ONTARIO; Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2; Karner C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008532.pub2; Lee TA, 2008, ANN INTERN MED, V149, P380, DOI 10.7326/0003-4819-149-6-200809160-00004; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Loke YK, 2011, THORAX, V66, P699, DOI 10.1136/thx.2011.160028; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu SE, 2002, BIOMETRICS, V58, P764, DOI 10.1111/j.0006-341X.2002.00764.x; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Reid RJ, 2001, MED CARE, V39, P86, DOI 10.1097/00005650-200101000-00010; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Thomas Steven, 2009, Health Rep, V20, P53; Zhang X, 2011, STAT MED, V30, P1933, DOI 10.1002/sim.4264	32	101	110	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1114	1121		10.1001/jama.2014.11432	http://dx.doi.org/10.1001/jama.2014.11432			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226477	Bronze			2022-12-28	WOS:000341624700021
J	Laxminarayan, R				Laxminarayan, Ramanan			Antibiotic effectiveness: Balancing conservation against innovation	SCIENCE			English	Editorial Material							RESISTANCE; AZITHROMYCIN; VACCINE; PART	Antibiotic effectiveness is a natural societal resource that is diminished by antibiotic use. As with other such assets, keeping it available requires both conservation and innovation. Conservation encompasses making the best use of current antibiotic effectiveness by reducing demand through vaccination, infection control, diagnostics, public education, incentives for clinicians to prescribe fewer antibiotics, and restrictions on access to newer, last-resort antibiotics. Innovation includes improving the efficacy of current drugs and replenishing effectiveness by developing new drugs. In this paper, I assess the relative benefits and costs of these two approaches to maintaining our ability to treat infections.	[Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA; [Laxminarayan, Ramanan] Princeton Environm Inst, Princeton, NJ USA; [Laxminarayan, Ramanan] Publ Hlth Fdn India, New Delhi, India	Princeton University; Public Health Foundation of India	Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA.	ramanan@cddep.org	Laxminarayan, Ramanan/ABD-5050-2021					[Anonymous], 2007, EXTENDING CURE POLIC; Bennett D, 2008, COMPETING DOCTORS AN; Boucher HW, 2014, NEW ENGL J MED, V370, P2169, DOI 10.1056/NEJMoa1310480; Buchman TG, 2008, J AM COLL SURGEONS, V207, P265, DOI 10.1016/j.jamcollsurg.2008.02.035; Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86; Capita R, 2014, APPL ENVIRON MICROB, V80, P1268, DOI 10.1128/AEM.02283-13; Corey GR, 2014, NEW ENGL J MED, V370, P2180, DOI 10.1056/NEJMoa1310422; Dong HJ, 1999, HEALTH POLICY, V48, P29, DOI 10.1016/S0168-8510(99)00026-3; Fantin B, 2009, J INFECT DIS, V200, P390, DOI 10.1086/600122; Fowler VG, 2013, JAMA-J AM MED ASSOC, V309, P1368, DOI 10.1001/jama.2013.3010; Frana TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053738; Garonzik SM, 2011, ANTIMICROB AGENTS CH, V55, P3284, DOI 10.1128/AAC.01733-10; Goossens H, 2008, EURO SURVEILL, V13; Hewitt Jeff, 2011, SHADOW DROUGHT NEED; Holmes D, 2014, NAT MED, V20, P320, DOI 10.1038/nm0414-320; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Laxminarayan R, 2001, J ENVIRON ECON MANAG, V42, P183, DOI 10.1006/jeem.2000.1156; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Laxminarayan R, 2012, SCIENCE, V338, P615, DOI 10.1126/science.1231010; Mereckiene J, 2008, EURO SURVEILL, V13; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Okeke IN, 2005, LANCET INFECT DIS, V5, P568, DOI 10.1016/S1473-3099(05)70217-6; Outterson K, 2013, J LAW MED ETHICS, V41, P688, DOI 10.1111/jlme.12079; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Seidman JC, 2014, INT J EPIDEMIOL, V43, P1105, DOI 10.1093/ije/dyu062; Sweidan M., 2005, P 2 NAT WORKSH RAT U, P1; Theuretzbacher U, 2009, INT J ANTIMICROB AG, V34, P15, DOI 10.1016/j.ijantimicag.2009.02.005; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; WHO, 2013, BAS REP GLOB SEX TRA	35	114	114	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1299	1301		10.1126/science.1254163	http://dx.doi.org/10.1126/science.1254163			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214620				2022-12-28	WOS:000341483800052
J	Guglani, S				Guglani, Samir			The art of medicine Medicine's human voices	LANCET			English	Editorial Material									Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.	sam@medicineunboxed.org						Auden W. H., 2009, SELECTED POEMS; Carson A, 2009, GRIEF LESSONS 4 PLAY; Carver R, 1996, ALL US; Darling Julia, 2005, POETRY CURE; Eliot T. S., 1963, COLLECTED POEMS 1909; Frame J, 1992, POCKET MIRROR; Grosz S., 2013, EXAMINED LIFE; Hitchens Christopher, 2012, MORTALITY; MACNEICE L, 1988, SELECTED POEMS; Milosz Czeslaw., 2005, NEW COLLECTED POEMS	10	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					848	849		10.1016/S0140-6736(14)61478-1	http://dx.doi.org/10.1016/S0140-6736(14)61478-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DK	25215392	Bronze			2022-12-28	WOS:000341362200015
J	Serruys, PW; Chevalier, B; Dudek, D; Cequier, A; Carrie, D; Iniguez, A; Dominici, M; van der Schaaf, RJ; Haude, M; Wasungu, L; Veldhof, S; Peng, L; Staehr, P; Grundeken, MJ; Ishibashi, Y; Garcia-Garcia, HM; Onuma, Y				Serruys, Patrick W.; Chevalier, Bernard; Dudek, Dariusz; Cequier, Angel; Carrie, Didier; Iniguez, Andres; Dominici, Marcello; van der Schaaf, Rene J.; Haude, Michael; Wasungu, Luc; Veldhof, Susan; Peng, Lei; Staehr, Peter; Grundeken, Maik J.; Ishibashi, Yuki; Garcia-Garcia, Hector M.; Onuma, Yoshinobu			A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial	LANCET			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ASSOCIATION TASK-FORCE; SHEAR-STRESS PATTERNS; VIVO ACUTE STENT; VASCULAR SCAFFOLD; MYOCARDIAL-INFARCTION; AMERICAN-COLLEGE; IMPLANTATION; GUIDELINES; 2ND-GENERATION	Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for treatment for coronary artery disease, no data from comparisons with its metallic stent counterpart are available. In a randomised controlled trial we aimed to compare an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent. Here we report secondary clinical and procedural outcomes after 1 year of follow-up. Methods In a single-blind, multicentre, randomised trial, we enrolled eligible patients aged 18-85 years with evidence of myocardial ischaemia and one or two de-novo native lesions in different epicardial vessels. We randomly assigned patients in a 2: 1 ratio to receive treatment with an everolimus-eluting bioresorbable scaffold (Absorb, Abbott Vascular, Santa Clara, CA, USA) or treatment with an everolimus-eluting metallic stent (Xience, Abbott Vascular, Santa Clara, CA, USA). Randomisation was stratified by diabetes status and number of planned target lesions. The co-primary endpoints of this study are vasomotion (change in mean lumen diameter before and after nitrate administration at 3 years) and difference between minimum lumen diameter (after nitrate administration) after the index procedure and at 3 years. Secondary endpoints were procedural performance assessed by quantitative angiography and intravascular ultrasound; composite clinical endpoints based on death, myocardial infarction, and coronary revascularisation; device and procedural success; and angina status assessed by the Seattle Angina Questionnaire and exercise testing at 6 and 12 months. Cumulative angina rate based on adverse event reporting was analysed post hoc. This trial is registered at ClinicalTrials.gov, number NCT01425281. Findings Between Nov 28, 2011, and June 4, 2013, we enrolled 501 patients and randomly assigned them to the bioresorbable scaffold group (335 patients, 364 lesions) or the metallic stent group (166 patients, 182 lesions). Dilatation pressure and balloon diameter at the highest pressure during implantation or postdilatation were higher and larger in the metallic stent group, whereas the acute recoil post implantation was similar (0.19 mm for both, p=0.85). Acute lumen gain was lower for the bioresorbable scaffold by quantitative coronary angiography (1.15 mm vs 1.46 mm, p<0.0001) and quantitative intravascular ultrasound (2.85 mm(2) vs 3.60 mm(2), p<0.0001), resulting in a smaller lumen diameter or area post procedure. At 1 year, however, cumulative rates of first new or worsening angina from adverse event reporting were lower (72 patients [22%] in the bioresorbable scaffold group vs 50 [30%] in the metallic stent group, p=0.04), whereas performance during maximum exercise and angina status by SAQ were similar. The 1-year composite device orientated endpoint was similar between the bioresorbable scaffold and metallic stent groups (16 patients [5%] vs five patients [3%], p=0.35). Three patients in the bioresorbable scaffold group had definite or probable scaffold thromboses (one definite acute, one definite sub-acute, and one probable late), compared with no patients in the metallic stent group. There were 17 (5%) major cardiac adverse events in the bioresorbable scaffold group compared with five (3%) events in the metallic stent group, with the most common adverse events being myocardial infarction (15 cases [4%] vs two cases [1%], respectively) and clinically indicated target-lesion revascularisation (four cases [1%] vs three cases [2%], respectively).	[Serruys, Patrick W.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Cardiovasc Hlth, London, England; [Chevalier, Bernard] Inst Jacques Cartier, Massy, France; [Dudek, Dariusz] Jagiellonian Univ, Dept Cardiol, Krakow, Poland; [Dudek, Dariusz] Univ Hosp, Cardio Vasc Intervent, Krakow, Poland; [Cequier, Angel] Bellvitge Univ Hosp, Barcelona, Spain; [Carrie, Didier] Hop Rangueil, Toulouse, France; [Iniguez, Andres] Hosp Meixoeiro, Vigo, Spain; [Dominici, Marcello] S Maria Univ Hosp, Terni, Italy; [van der Schaaf, Rene J.] OLVG, Amsterdam, Netherlands; [Haude, Michael] Stadt Kliniken Neuss Lukaskrankenhaus GmbH, Neuss, Germany; [Wasungu, Luc; Veldhof, Susan] Abbott Vasc, Diegem, Belgium; [Peng, Lei; Staehr, Peter] Abbott Vasc, Santa Clara, CA USA; [Grundeken, Maik J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Ishibashi, Yuki; Garcia-Garcia, Hector M.; Onuma, Yoshinobu] Erasmus MC, Rotterdam, Netherlands; [Garcia-Garcia, Hector M.; Onuma, Yoshinobu] Cardialysis BV, Rotterdam, Netherlands	Imperial College London; Jacques Cartier Private Hospital; Jagiellonian University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CHU de Toulouse; Complexo Hospitalario Universitario de Vigo; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Cardialysis	Serruys, PW (corresponding author), Thorax Ctr Rotterdam, Ba-583,S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	patrick.w.j.c.serruys@gmail.com	Onuma, Yoshinobu/AHB-6273-2022; Garcia-Garcia, Hector Manuel/AAG-7471-2020; Chevalier, Bernard/AAU-2855-2021	Onuma, Yoshinobu/0000-0001-7702-0649; Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; CARRIE, didier/0000-0003-2479-8144; Wasungu, Luc/0000-0003-1416-5220	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	Abbott Vascular.	Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bourantas CV, 2014, JACC-CARDIOVASC INTE, V7, P315, DOI 10.1016/j.jcin.2013.05.034; Bourantas CV, 2014, INT J CARDIOVAS IMAG, V30, P485, DOI 10.1007/s10554-014-0374-3; Brown AJ, 2014, CATHETER CARDIO INTE, V84, P37, DOI 10.1002/ccd.25378; Brugaletta S, 2012, CIRC J, V76, P1616, DOI 10.1253/circj.CJ-11-1416; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Diletti R, 2012, AM HEART J, V164, P654, DOI 10.1016/j.ahj.2012.08.010; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Gomez-Lara J, 2011, JACC-CARDIOVASC INTE, V4, P789, DOI 10.1016/j.jcin.2011.04.009; Gomez-Lara J, 2010, JACC-CARDIOVASC INTE, V3, P1190, DOI 10.1016/j.jcin.2010.07.016; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; Lane JP, 2014, JACC-CARDIOVASC INTE, V7, P688, DOI 10.1016/j.jcin.2013.11.024; Lindsey JB, 2009, JACC-CARDIOVASC INTE, V2, P1074, DOI 10.1016/j.jcin.2009.09.002; Mattesini A, 2014, MINERVA CARDIOANGIOL, V62, P71; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; O'Brien CC, 2013, J CONTROL RELEASE, V168, P115, DOI 10.1016/j.jconrel.2013.03.014; Onuma Y, 2011, CATHETER CARDIO INTE, V78, P3, DOI 10.1002/ccd.22864; Onuma Y, 2010, CIRCULATION, V122, P2288, DOI 10.1161/CIRCULATIONAHA.109.921528; Onuma Y, 2010, EUROINTERVENTION, V6, P447, DOI 10.4244/EIJ30V6I4A76; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Ormiston JA, 2012, CIRC-CARDIOVASC INTE, V5, P620, DOI 10.1161/CIRCINTERVENTIONS.112.971549; Ormiston JA, 2011, CIRC-CARDIOVASC INTE, V4, P535, DOI 10.1161/CIRCINTERVENTIONS.111.963710; Park DW, 2014, AM J CARDIOL, V113, P1105, DOI 10.1016/j.amjcard.2013.12.016; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; Serruys PW, 2014, EUROINTERVENTION, V9, P1271, DOI 10.4244/EIJV9I11A217; Serruys PW, 2012, EUR HEART J, V33, P16, DOI 10.1093/eurheartj/ehr384; Serruys PW, 2011, J AM COLL CARDIOL, V58, P1578, DOI 10.1016/j.jacc.2011.05.050; Serruys PW, 2010, CIRCULATION, V122, P2301, DOI 10.1161/CIRCULATIONAHA.110.970772; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; SERRUYS PW, 1988, CIRCULATION, V77, P361, DOI 10.1161/01.CIR.77.2.361; Skalidis EI, 2006, EUR HEART J, V27, P2606, DOI 10.1093/eurheartj/ehl257; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Tanimoto S, 2007, CATHETER CARDIO INTE, V70, P515, DOI 10.1002/ccd.21136; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184	36	481	503	6	116	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					43	54		10.1016/S0140-6736(14)61455-0	http://dx.doi.org/10.1016/S0140-6736(14)61455-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25230593				2022-12-28	WOS:000347154200027
J	Morain, SR; Flexner, C; Kass, NE; Sugarman, J				Morain, Stephanie R.; Flexner, Charles; Kass, Nancy E.; Sugarman, Jeremy			Forecast for the Physician Payment Sunshine Act: Partly to Mostly Cloudy?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Berman Inst Bioeth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Johns Hopkins Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Morain, SR (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA.	smorain1@jhu.edu		Sugarman, Jeremy/0000-0001-7022-8332; Morain, Stephanie/0000-0001-7278-7517	NIAID NIH HHS [P30 AI094189, 1P30AI094189] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agrawal S, 2013, NEW ENGL J MED, V368, P2054, DOI 10.1056/NEJMp1303523; Centers for Medicare & Medicaid Services, 2014, OP PAYM OFF WEBS OP; Centers for Medicare & Medicaid Services (CMS), 2013, FED REGISTER, V78, P9457; Gorlach I, 2013, J LAW MED ETHICS, V41, P315, DOI 10.1111/jlme.12022; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Kantarjian HM, 2013, J CLIN ONCOL, V31, P3600, DOI 10.1200/JCO.2013.49.1845; Kirschner NM, 2014, ANN INTERN MED, V161, P519, DOI 10.7326/M14-1303	7	19	19	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					915	U110		10.7326/M14-1683	http://dx.doi.org/10.7326/M14-1683			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25265454	Green Accepted			2022-12-28	WOS:000347248400035
J	Lukens, JR; Gurung, P; Vogel, P; Johnson, GR; Carter, RA; McGoldrick, DJ; Bandi, SR; Calabrese, CR; Vande Walle, L; Lamkanfi, M; Kanneganti, TD				Lukens, John R.; Gurung, Prajwal; Vogel, Peter; Johnson, Gordon R.; Carter, Robert A.; McGoldrick, Daniel J.; Bandi, Srinivasa Rao; Calabrese, Christopher R.; Vande Walle, Lieselotte; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			Dietary modulation of the microbiome affects autoinflammatory disease	NATURE			English	Article							IL-1-BETA; CASPASE-8; MICE; CELL; INFLAMMASOME; PROTEINASE-3; HOMEOSTASIS; ACTIVATION; DEFICIENT; RECEPTORS	The incidences of chronic inflammatory disorders have increased considerably over the past three decades(1). Recent shifts in dietary consumption may have contributed importantly to this surge, but how dietary consumption modulates inflammatory disease is poorly defined. Pstpip2(cmo) mice, which express a homozygous Leu98Pro missense mutation in the Pombe Cdc15 homology family protein PSTPIP2 (proline-serine-threonine phosphatase interacting protein 2), spontaneously develop osteomyelitis that resembles chronic recurrent multifocal osteomyelitis in humans(2-4). Recent reports demonstrated a crucial role for interleukin-1 beta (IL-1 beta) in osteomyelitis, but deletion of the inflammasome components caspase-1 and NLRP3 failed to rescue Pstpip2(cmo) mice from inflammatory bone disease(5,6). Thus, the upstream mechanisms controlling IL-1 beta production in Pstpip2(cmo) mice remain to be identified. In addition, the environmental factors driving IL-1 beta-dependent inflammatory bone erosion are unknown. Here we show that the intestinal microbiota of diseased Pstpip2(cmo) mice was characterized by an outgrowth of Prevotella. Notably, Pstpip2(cmo) mice that were fed a diet rich in fat and cholesterol maintained a normal body weight, but were markedly protected against inflammatory bone disease and bone erosion. Diet-induced protection against osteomyelitis was accompanied by marked reductions in intestinal Prevotella levels and significantly reduced pro-IL-1 beta expression in distant neutrophils. Furthermore, pro-IL-1 beta expression was also decreased in Pstpip2(cmo) mice treated with antibiotics, and in wild-type mice that were kept under germ-free conditions. We further demonstrate that combined deletion of caspases 1 and 8 was required for protection against IL-1 beta-dependent inflammatory bone disease, whereas the deletion of either caspase alone or of elastase or neutrophil proteinase 3 failed to prevent inflammatory disease. Collectively, this work reveals diet-associated changes in the intestinal microbiome as a crucial factor regulating inflammasome- and caspase-8-mediated maturation of IL-1 beta and osteomyelitis in Pstpip2cmo mice.	[Lukens, John R.; Gurung, Prajwal; Johnson, Gordon R.; Bandi, Srinivasa Rao; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Carter, Robert A.; McGoldrick, Daniel J.] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Calabrese, Christopher R.] St Jude Childrens Res Hosp, Small Anim Imaging Core, Memphis, TN 38105 USA; [Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Vogel, Peter/N-2490-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vogel, Peter/0000-0002-7535-0545; Gurung, Prajwal/0000-0002-7451-9433; Bandi, Srinivasa/0000-0001-9320-5248; Lukens, John/0000-0002-6795-0866	Ghent University [BOF 01N02313, 01J11113]; European Research Council [281600]; National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health [AR056296]; National Cancer Institute, part of the National Institutes of Health [CA163507]; National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health [AI101935]; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	Ghent University(Ghent University); European Research Council(European Research Council (ERC)European Commission); National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health; National Cancer Institute, part of the National Institutes of Health; National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Chaplin, V. Dixit, R. Flavell, D. Green and C. Pham for the supply of mutant mice. We thank J. Kim for helping to acquire and analyse the micro-computed tomography data. We thank S. Olsen, D. Roeber and the Genome Sequencing Facility in the Hartwell Center at St Jude Children's Research Hospital for performing metagenomics sequencing of 16S rRNA. M.L. is supported by grants from Ghent University (BOF 01N02313 and 01J11113) and the European Research Council (Grant 281600). L.V.W. is a postdoctoral fellow of the Fund for Scientific Research-Flanders. This work was supported by: the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Number AR056296 (T.-D.K.); the National Cancer Institute, part of the National Institutes of Health, under Award Number CA163507 (T.-D.K.); the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, under Award Number AI101935 (T.-D.K.); and ALSAC.	Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Cassel SL, 2014, P NATL ACAD SCI USA, V111, P1072, DOI 10.1073/pnas.1318685111; Chitu V, 2009, BLOOD, V114, P2497, DOI 10.1182/blood-2009-02-204925; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Ferguson PJ, 2006, BONE, V38, P41, DOI 10.1016/j.bone.2005.07.009; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	29	194	200	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					246	+		10.1038/nature13788	http://dx.doi.org/10.1038/nature13788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25274309	Green Accepted			2022-12-28	WOS:000346383500045
J	Thomassen, MJ; Kavuru, MS				Thomassen, Mary Jane; Kavuru, Mani S.			LUNG DISEASE Treatment by cell transplant	NATURE			English	Editorial Material							PULMONARY ALVEOLAR PROTEINOSIS; COLONY-STIMULATING FACTOR; ACTIVATED RECEPTOR-GAMMA; CSF-DEFICIENT MICE; RITUXIMAB THERAPY; KNOCKOUT MICE; PPAR-GAMMA; MACROPHAGES; HOMEOSTASIS; EXPRESSION		[Thomassen, Mary Jane] E Carolina Univ, Div Pulm Crit Care & Sleep Med, Greenville, NC 27834 USA; [Kavuru, Mani S.] Thomas Jefferson Univ & Hosp, Div Pulm & Crit Care Med, Philadelphia, PA 19107 USA	University of North Carolina; East Carolina University; Jefferson University	Thomassen, MJ (corresponding author), E Carolina Univ, Div Pulm Crit Care & Sleep Med, Greenville, NC 27834 USA.	thomassenm@ecu.edu; mani.kavuru@jefferson.edu						Bonfield TL, 2003, AM J RESP CELL MOL, V29, P677, DOI 10.1165/rcmb.2003-0148OC; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; Kavuru MS, 2011, EUR RESPIR J, V38, P1361, DOI 10.1183/09031936.00197710; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; Malur A, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-46; Malur A, 2011, AM J PHYSIOL-LUNG C, V300, pL73, DOI 10.1152/ajplung.00128.2010; Reed JA, 1999, AM J PHYSIOL-LUNG C, V276, pL556, DOI 10.1152/ajplung.1999.276.4.L556; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Thomassen MJ, 2007, J LIPID RES, V48, P2762, DOI 10.1194/jlr.P700022-JLR200; Thomassen MJ, 2000, CLIN IMMUNOL, V95, P85, DOI 10.1006/clim.2000.4859; Yoshida M, 2001, AM J PHYSIOL-LUNG C, V280, pL379, DOI 10.1152/ajplung.2001.280.3.L379	20	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					438	440		10.1038/nature13758	http://dx.doi.org/10.1038/nature13758			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25274303				2022-12-28	WOS:000343775900026
J	Holst, LB; Haase, N; Wetterslev, J; Wernerman, J; Guttormsen, AB; Karlsson, S; Johansson, PI; Aneman, A; Vang, ML; Winding, R; Nebrich, L; Nibro, HL; Rasmussen, BS; Lauridsen, JRM; Nielsen, JS; Oldner, A; Pettila, V; Cronhjort, MB; Andersen, LH; Pedersen, UG; Reiter, N; Wiis, J; White, JO; Russell, L; Thornberg, KJ; Hjortrup, PB; Muller, RG; Moller, MH; Steensen, M; Tjader, I; Kilsand, K; Odeberg-Wernerman, S; Sjobo, B; Bundgaard, H; Thyo, MA; Lodahl, D; Maerkedahl, R; Albeck, C; Illum, D; Kruse, M; Winkel, P; Perner, A				Holst, Lars B.; Haase, Nicolai; Wetterslev, Jorn; Wernerman, Jan; Guttormsen, Anne B.; Karlsson, Sari; Johansson, Par I.; Aneman, Anders; Vang, Marianne L.; Winding, Robert; Nebrich, Lars; Nibro, Helle L.; Rasmussen, Bodil S.; Lauridsen, Johnny R. M.; Nielsen, Jane S.; Oldner, Anders; Pettila, Ville; Cronhjort, Maria B.; Andersen, Lasse H.; Pedersen, Ulf G.; Reiter, Nanna; Wiis, Jorgen; White, Jonathan O.; Russell, Lene; Thornberg, Klaus J.; Hjortrup, Peter B.; Muller, Rasmus G.; Moller, Morten H.; Steensen, Morten; Tjader, Inga; Kilsand, Kristina; Odeberg-Wernerman, Suzanne; Sjobo, Brit; Bundgaard, Helle; Thyo, Maria A.; Lodahl, David; Maerkedahl, Rikke; Albeck, Carsten; Illum, Dorte; Kruse, Mary; Winkel, Per; Perner, Anders		TRISS Trial Grp; Scandinavian Critical Care Trials	Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-CELL TRANSFUSION; SEVERE SEPSIS; CLINICAL CHARACTERISTICS; HYDROXYETHYL STARCH; UNSELECTED PATIENTS; CRITICALLY-ILL; MORTALITY; MULTICENTER; RISK; REQUIREMENTS	BACKGROUND Blood transfusions are frequently given to patients with septic shock. However, the benefits and harms of different hemoglobin thresholds for transfusion have not been established. METHODS In this multicenter, parallel-group trial, we randomly assigned patients in the intensive care unit (ICU) who had septic shock and a hemoglobin concentration of 9 g per deciliter or less to receive 1 unit of leukoreduced red cells when the hemoglobin level was 7 g per deciliter or less (lower threshold) or when the level was 9 g per deciliter or less (higher threshold) during the ICU stay. The primary outcome measure was death by 90 days after randomization. RESULTS We analyzed data from 998 of 1005 patients (99.3%) who underwent randomization. The two intervention groups had similar baseline characteristics. In the ICU, the lower-threshold group received a median of 1 unit of blood (interquartile range, 0 to 3) and the higher-threshold group received a median of 4 units (interquartile range, 2 to 7). At 90 days after randomization, 216 of 502 patients (43.0%) assigned to the lower-threshold group, as compared with 223 of 496 (45.0%) assigned to the higher-threshold group, had died (relative risk, 0.94; 95% confidence interval, 0.78 to 1.09; P = 0.44). The results were similar in analyses adjusted for risk factors at baseline and in analyses of the per-protocol populations. The numbers of patients who had ischemic events, who had severe adverse reactions, and who required life support were similar in the two intervention groups. CONCLUSIONS Among patients with septic shock, mortality at 90 days and rates of ischemic events and use of life support were similar among those assigned to blood transfusion at a higher hemoglobin threshold and those assigned to blood transfusion at a lower threshold; the latter group received fewer transfusions.	[Holst, Lars B.; Haase, Nicolai; Andersen, Lasse H.; Pedersen, Ulf G.; Reiter, Nanna; Wiis, Jorgen; White, Jonathan O.; Russell, Lene; Thornberg, Klaus J.; Hjortrup, Peter B.; Muller, Rasmus G.; Moller, Morten H.; Steensen, Morten; Perner, Anders] Rigshosp, Dept Intens Care, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Wetterslev, Jorn; Winkel, Per] Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2100 Copenhagen, Denmark; [Johansson, Par I.] Rigshosp, Transfus Med Sect, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Copenhagen, Denmark; [Vang, Marianne L.; Bundgaard, Helle; Thyo, Maria A.] Randers Cent Hosp, Randers, Denmark; [Winding, Robert; Lodahl, David; Maerkedahl, Rikke] Herning Hosp, Herning, Denmark; [Nebrich, Lars; Albeck, Carsten] Univ Copenhagen, Hvidovre Hosp, DK-2650 Hvidovre, Denmark; [Nibro, Helle L.; Illum, Dorte] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Rasmussen, Bodil S.] Aalborg Univ Hosp, Aalborg, Denmark; [Lauridsen, Johnny R. M.] Holbaek Cent Hosp, Holbaek, Denmark; [Nielsen, Jane S.] Kolding Cty Hosp, Kolding, Denmark; [Kruse, Mary] Hjorring Hosp, Hjorring, Denmark; [Wernerman, Jan; Tjader, Inga; Kilsand, Kristina; Odeberg-Wernerman, Suzanne] Karolinska Univ Hosp, Stockholm, Sweden; [Oldner, Anders] Karolinska Univ Hosp, Solna, Sweden; [Cronhjort, Maria B.] Soder Sjukhuset, S-10064 Stockholm, Sweden; [Guttormsen, Anne B.; Sjobo, Brit] Haukeland Hosp, N-5021 Bergen, Norway; [Guttormsen, Anne B.; Sjobo, Brit] Univ Bergen, Bergen, Norway; [Karlsson, Sari] Tampere Univ Hosp, Tampere, Finland; [Pettila, Ville] Univ Helsinki Hosp, Helsinki, Finland; [Pettila, Ville] Univ Helsinki, Helsinki, Finland; [Aneman, Anders] Liverpool Hosp, Sydney, NSW, Australia	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; University of Copenhagen; Aarhus University; Aalborg University; Aalborg University Hospital; Holbaek Hospital; Kolding Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital; University of Bergen; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Liverpool Hospital	Perner, A (corresponding author), Rigshosp, Dept Intens Care, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	anders.perner@regionh.dk	Møller, Morten Hylander/AAQ-6891-2020; Krammel, Vera/N-4826-2014; Johansson, Pär I/P-9283-2015; Cronhjort, Maria/AAH-8819-2021; Reiter, Nanna/AAW-8322-2021; Oldner, Anders/Q-4353-2018; Wetterslev, Jørn/ABF-1251-2020; Johansson, Pär/GQB-1032-2022; Thorsen-Meyer, Hans-Christian/ABA-6959-2021; Russell, Lene/I-8743-2019	Møller, Morten Hylander/0000-0002-6378-9673; Krammel, Vera/0000-0002-8273-8396; Johansson, Pär I/0000-0001-9778-5964; Oldner, Anders/0000-0003-1600-9221; Wetterslev, Jørn/0000-0001-7778-1771; Johansson, Pär/0000-0001-9778-5964; Thorsen-Meyer, Hans-Christian/0000-0001-7002-3089; Russell, Lene/0000-0001-7352-8728; Rowan, Kathryn/0000-0001-8217-5602; Perner, Anders/0000-0002-4668-0123; Buhl Hjortrup, Peter/0000-0002-3847-3247; Aneman, Anders/0000-0003-2096-5304; Cronhjort, Maria/0000-0002-0444-8553; Dyrskog, Stig/0000-0002-1903-1742; Poulsen, Lone Musaeus/0000-0002-7030-3395; Rasmussen, Bodil Steen/0000-0003-2190-145X	Danish Strategic Research Council	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	Funded by the Danish Strategic Research Council and others; TRISS ClinicalTrials.gov number, NCT01485315.	Asfar P, 2014, NEW ENGL J MED, V370, P1583, DOI 10.1056/NEJMoa1312173; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Carlsen S, 2011, ACTA ANAESTH SCAND, V55, P394, DOI 10.1111/j.1399-6576.2011.02399.x; Carson Jeffrey L, 2012, Cochrane Database Syst Rev, pCD002042, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Chatterjee S, 2013, JAMA INTERN MED, V173, P132, DOI 10.1001/2013.jamainternmed.1001; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Fergusson D, 2004, CAN J ANAESTH, V51, P417, DOI 10.1007/BF03018302; Haase N, 2013, INTENS CARE MED, V39, P2126, DOI 10.1007/s00134-013-3111-9; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Heyland DK, 2011, CRIT CARE, V15, DOI 10.1186/cc10110; Holst LB, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-150; ICH Steering Committee, 1998, ICH HARM TRIP GUID S; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Labelle A, 2012, CRIT CARE MED, V40, P2016, DOI 10.1097/CCM.0b013e318250aa72; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Park DW, 2012, CRIT CARE MED, V40, P3140, DOI 10.1097/CCM.0b013e3182657b75; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Reade MC, 2010, EMERG MED J, V27, P110, DOI 10.1136/emj.2008.070912; Reinikainen M, 2010, INTENS CARE MED, V36, P673, DOI 10.1007/s00134-009-1688-9; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Rosland RG, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-14; Smith SH, 2012, CRIT CARE, V16, DOI 10.1186/cc11333; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Vincent JL, 2008, ANESTHESIOLOGY, V108, P31, DOI 10.1097/01.anes.0000296070.75956.40; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Walsh TS, 2013, CRIT CARE MED, V41, P2354, DOI 10.1097/CCM.0b013e318291cce4; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Zarychanski R, 2008, CRIT CARE MED, V36, P2973, DOI 10.1097/CCM.0b013e31818b8c6b; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	32	535	555	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1381	1391		10.1056/NEJMoa1406617	http://dx.doi.org/10.1056/NEJMoa1406617			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25270275	Bronze			2022-12-28	WOS:000342674800007
J	Williams, TM; Wolfe, L; Davis, T; Kendall, T; Richter, B; Wang, Y; Bryce, C; Elkaim, GH; Wilmers, CC				Williams, Terrie M.; Wolfe, Lisa; Davis, Tracy; Kendall, Traci; Richter, Beau; Wang, Yiwei; Bryce, Caleb; Elkaim, Gabriel Hugh; Wilmers, Christopher C.			Instantaneous energetics of puma kills reveal advantage of felid sneak attacks	SCIENCE			English	Article							BODY-SIZE; COST; WILD; LOCOMOTION; REQUIREMENTS; ACCELERATION; CONSUMPTION	Pumas (Puma concolor) live in diverse, often rugged, complex habitats. The energy they expend for hunting must account for this complexity but is difficult to measure for this and other large, cryptic carnivores. We developed and deployed a physiological SMART (species movement, acceleration, and radio tracking) collar that used accelerometry to continuously monitor energetics, movements, and behavior of free-ranging pumas. This felid species displayed marked individuality in predatory activities, ranging from low-cost sit-and-wait behaviors to constant movements with energetic costs averaging 2.3 times those predicted for running mammals. Pumas reduce these costs by remaining cryptic and precisely matching maximum pouncing force (overall dynamic body acceleration = 5.3 to 16.1g) to prey size. Such instantaneous energetics help to explain why most felids stalk and pounce, and their analysis represents a powerful approach for accurately forecasting resource demands required for survival by large, mobile predators.	[Williams, Terrie M.; Kendall, Traci; Richter, Beau; Bryce, Caleb] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; [Wolfe, Lisa; Davis, Tracy] Colorado Pk & Wildlife, Wildlife Hlth Program, Ft Collins, CO 80521 USA; [Wang, Yiwei; Wilmers, Christopher C.] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Elkaim, Gabriel Hugh] Univ Calif Santa Cruz, Dept Comp Engn, Autonomous Syst Lab, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Williams, TM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA.	williams@biology.ucsc.edu	Bryce, Caleb/AAZ-3337-2020; Bryce, Caleb/ABI-5943-2020	Bryce, Caleb/0000-0002-6789-9538; 	NSF [DBI-0963022, 1255913]; Direct For Biological Sciences [0963022] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by NSF grants DBI-0963022 and 1255913 (T. M. W., C. C. W., and G. H. E.) with in-kind support from the California Department of Fish and Wildlife. We thank P. Houghtaling, Y. Shakeri, C. Wylie, and D. Tichenor for assistance in catching wild pumas and finding kill sites, and J. A. Estes and the anonymous referees for critical review of this manuscript. Animal procedures were approved by the UCSC IACUC. Statistical data are tabulated in the supplementary materials, with electronic versions available upon request from the senior author through the UCSC Mammal Physiology Project database.	Bidder OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050556; CHASSIN PS, 1976, PHYSIOL ZOOL, V49, P1; CORTS KE, 1984, J WILDLIFE MANAGE, V48, P1456, DOI 10.2307/3801820; Girard I, 2001, PHYSIOL BIOCHEM ZOOL, V74, P191, DOI 10.1086/319668; GONYEA WJ, 1976, ACTA ANAT, V96, P81; Gorman ML, 1998, NATURE, V391, P479, DOI 10.1038/35131; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; Laundre JW, 2005, J WILDLIFE MANAGE, V69, P723, DOI 10.2193/0022-541X(2005)069[0723:PEAR]2.0.CO;2; Laundre JW, 2003, J ARID ENVIRON, V55, P675, DOI 10.1016/S0140-1963(02)00316-6; Macdonald David W., 2010, P3; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; Miller CS, 2014, BIOL CONSERV, V170, P120, DOI 10.1016/j.biocon.2013.12.012; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Schaller G. B., 1972, SERENGETI LION; Stephens D.W., 1986, pi; Sunquist M.E., 1989, P283; TAYLOR CR, 1981, RESP PHYSIOL, V44, P25, DOI 10.1016/0034-5687(81)90075-X; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1104, DOI 10.1152/ajplegacy.1970.219.4.1104; TAYLOR CR, 1982, J EXP BIOL, V97, P1; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Williams JB, 2002, PHYSIOL BIOCHEM ZOOL, V75, P479, DOI 10.1086/344490; Williams TM, 2002, COMP BIOCHEM PHYS A, V133, P203, DOI 10.1016/S1095-6433(02)00136-8; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson JW, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0620; Wilson RP, 2013, ECOL LETT, V16, P1145, DOI 10.1111/ele.12149; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x	29	132	132	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					81	85		10.1126/science.1254885	http://dx.doi.org/10.1126/science.1254885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278610				2022-12-28	WOS:000342446900055
J	DeLoughery, TG				DeLoughery, Thomas G.			Microcytic Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONHEME-IRON-ABSORPTION; INTRAVENOUS IRON; DEFICIENCY ANEMIA; CONTROLLED-TRIAL; CHRONIC DISEASE; WOMEN; SUPPLEMENTATION; DIAGNOSIS; FERRITIN; THERAPY	THE MICROCYTIC ANEMIAS ARE THOSE CHARACTERIZED BY THE PRODUCTION of red cells that are smaller than normal. The small size of these cells is due to decreased production of hemoglobin, the predominant constituent of red cells (Fig. 1). The causes of microcytic anemia are a lack of globin product (thalassemia), restricted iron delivery to the heme group of hemoglobin (anemia of inflammation), a lack of iron delivery to the heme group (iron-deficiency anemia), and defects in the synthesis of the heme group (sideroblastic anemias). This review highlights new aspects of the most common microcytic anemias: thalassemia, anemia of inflammation, and iron-deficiency anemia.	[DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Hematol Sect, Knight Canc Inst, Portland, OR 97239 USA; [DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97239 USA; [DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	DeLoughery, TG (corresponding author), Oregon Hlth & Sci Univ, Div Hematol Med Oncol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	delought@ohsu.edu			Alexion	Alexion	Dr. DeLoughery reports receiving grant support from Alexion. No other potential conflict of interest relevant to this article was reported.	An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028; [Anonymous], 2008, PHARM LETT PRESCRIBE; Auerbach M, 2011, AM J HEMATOL, V86, P860, DOI 10.1002/ajh.22153; Chertow GM, 2006, NEPHROL DIAL TRANSPL, V21, P378, DOI 10.1093/ndt/gfi253; COOK JD, 1976, AM J CLIN NUTR, V29, P859, DOI 10.1093/ajcn/29.8.859; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; GUYATT GH, 1992, J GEN INTERN MED, V7, P145, DOI 10.1007/BF02598003; Guyatt GH, 1992, J GEN INTERN MED, V7, P423; Hunt JR, 2009, AM J CLIN NUTR, V89, P1792, DOI 10.3945/ajcn.2009.27439; Hurrell RF, 1999, BRIT J NUTR, V81, P289, DOI 10.1017/S0007114599000537; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Krayenbuehl PA, 2011, BLOOD, V118, P3222, DOI 10.1182/blood-2011-04-346304; Love AL, 2008, AM J HEMATOL, V83, P403, DOI 10.1002/ajh.21106; Lu M, 2010, AM J HEMATOL, V85, P315, DOI 10.1002/ajh.21656; Mei ZG, 2005, J NUTR, V135, P1974, DOI 10.1093/jn/135.8.1974; Okam MM, 2012, AM J HEMATOL, V87, pE123, DOI 10.1002/ajh.23322; ONEILCUTTING MA, 1987, ARCH INTERN MED, V147, P489, DOI 10.1001/archinte.147.3.489; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Pasricha SR, 2014, J NUTR, V144, P906, DOI 10.3945/jn.113.189589; Passarello C, 2012, HAEMATOL-HEMATOL J, V97, P472, DOI 10.3324/haematol.2011.052357; Pavord S, 2012, BRIT J HAEMATOL, V156, P588, DOI 10.1111/j.1365-2141.2011.09012.x; Payen E, 2012, HEMATOL-AM SOC HEMAT, P276, DOI 10.1182/asheducation-2012.1.276; Peeling P, 2008, EUR J APPL PHYSIOL, V103, P381, DOI 10.1007/s00421-008-0726-6; Rimon E, 2005, AM J MED, V118, P1142, DOI 10.1016/j.amjmed.2005.01.065; ROBERTSON JD, 1987, BRIT MED J, V295, P303, DOI 10.1136/bmj.295.6593.303; Ruz M, 2012, AM J CLIN NUTR, V96, P810, DOI 10.3945/ajcn.112.039255; Ryan K, 2010, BRIT J HAEMATOL, V149, P35, DOI 10.1111/j.1365-2141.2009.08054.x; SCOTT DE, 1967, J AMER MED ASSOC, V199, P897, DOI 10.1001/jama.199.12.897; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Vaucher P, 2012, CAN MED ASSOC J, V184, P1247, DOI 10.1503/cmaj.110950; Verdon F, 2003, BRIT MED J, V326, P1124, DOI 10.1136/bmj.326.7399.1124; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zhou SJ, 2009, EUR J CLIN NUTR, V63, P183, DOI 10.1038/sj.ejcn.1602926; Zhu A, 2010, DIGEST DIS SCI, V55, P548, DOI 10.1007/s10620-009-1108-6; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	35	85	92	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1324	1331		10.1056/NEJMra1215361	http://dx.doi.org/10.1056/NEJMra1215361			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25271605				2022-12-28	WOS:000342429800009
J	Sun, T; Wang, KL; Iinuma, T; Hino, R; He, JH; Fujimoto, H; Kido, M; Osada, Y; Miura, S; Ohta, Y; Hu, Y				Sun, Tianhaozhe; Wang, Kelin; Iinuma, Takeshi; Hino, Ryota; He, Jiangheng; Fujimoto, Hiromi; Kido, Motoyuki; Osada, Yukihito; Miura, Satoshi; Ohta, Yusaku; Hu, Yan			Prevalence of viscoelastic relaxation after the 2011 Tohoku-oki earthquake	NATURE			English	Article							LITHOSPHERE-ASTHENOSPHERE BOUNDARY; POSTSEISMIC DEFORMATION; ARC; DISPLACEMENT; FRICTION; SUMATRA; ZONE; MELT	After a large subduction earthquake, crustal deformation continues to occur, with a complex pattern of evolution(1). This postseismic deformation is due primarily to viscoelastic relaxation of stresses induced by the earthquake rupture and continuing slip (afterslip) or relocking of different parts of the fault(2-6). When postseismic geodetic observations are used to study Earth's rheology and fault behaviour, it is commonly assumed that short-term (a few years) deformation near the rupture zone is caused mainly by afterslip, and that viscoelasticity is important only for longer-term deformation(6,7). However, it is difficult to test the validity of this assumption against conventional geodetic data. Here we show that new seafloor GPS(Global Positioning System) observations immediately after the great Tohoku-oki earthquake provide unambiguous evidence for the dominant role of viscoelastic relaxation in short-term postseismic deformation. These data reveal fast landward motion of the trench area, opposing the seaward motion of GPS siteson land. Using numerical models of transient viscoelastic mantle rheology, we demonstrate that the landward motion is a consequence of relaxation of stresses induced by the asymmetric rupture of the thrust earthquake, a process previously unknown because of the lack of near-field observations. Our findings indicate that previous models assuming an elastic Earth will have substantially overestimated afterslip downdip of the rupture zone, and underestimated afterslip updip of the rupture zone; our knowledge of fault friction based on these estimates therefore needs to be revised.	[Sun, Tianhaozhe; Wang, Kelin] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8P 5C2, Canada; [Sun, Tianhaozhe; He, Jiangheng] Nat Resources Canada, Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada; [Iinuma, Takeshi; Fujimoto, Hiromi; Kido, Motoyuki; Osada, Yukihito] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 9800845, Japan; [Miura, Satoshi; Ohta, Yusaku] Tohoku Univ, Grad Sch Sci, Res Ctr Predict Earthquakes & Volcan Erupt, Sendai, Miyagi 9808578, Japan; [Hu, Yan] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Hu, Yan] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of Victoria; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Tohoku University; Tohoku University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wang, KL (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8P 5C2, Canada.	kwang@nrcan.gc.ca	Hu, Yan/N-9570-2014; Kido, Motoyuki/AAC-3862-2019; Ohta, Yusaku/G-4457-2010; Miura, Satoshi/GSN-5361-2022; Iinuma, Takeshi/J-6994-2012	Hu, Yan/0000-0002-5704-4827; Ohta, Yusaku/0000-0003-4818-477X; Miura, Satoshi/0000-0003-1151-5862; Iinuma, Takeshi/0000-0003-0386-2055; Fujimoto, Hiromi/0000-0002-3501-6219; Kido, Motoyuki/0000-0002-7240-8203	Geological Survey of Canada; Natural Sciences and Engineering Research Council of Canada through University of Victoria; University of Victoria; Howard E. Petch Scholarship; Ministry of Education, Culture, Sports, Science and Technology of Japan under Earthquake and Volcano Hazards Observation and Research Program; Grants-in-Aid for Scientific Research [23253003] Funding Source: KAKEN	Geological Survey of Canada(Natural Resources Canada); Natural Sciences and Engineering Research Council of Canada through University of Victoria; University of Victoria; Howard E. Petch Scholarship; Ministry of Education, Culture, Sports, Science and Technology of Japan under Earthquake and Volcano Hazards Observation and Research Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Japan Coast Guard for making available digital values of published data. Comments from M. Sato improved the manuscript. K. W. was supported by Geological Survey of Canada core funding and a Natural Sciences and Engineering Research Council of Canada Discovery Grant through the University of Victoria. T. S. was supported by a University of Victoria PhD Fellowship and a Howard E. Petch Scholarship. The Tohoku University seafloor observation study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan under its Earthquake and Volcano Hazards Observation and Research Program. This is Geological Survey of Canada contribution 20140167.	DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Fischer KM, 2010, ANNU REV EARTH PL SC, V38, P551, DOI 10.1146/annurev-earth-040809-152438; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Fujimoto H., 2014, MONOGR ENV EARTH PLA, V2, P23, DOI DOI 10.5047/MEEP.2014.00202.0023; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Hsu YJ, 2006, SCIENCE, V312, P1921, DOI 10.1126/science.1126960; Hu Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003163; Hu Y, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-106; Hu Y, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009153; Iinuma T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009186; Japan Coast Guard & Tohoku University, 2013, REP COORD COMM EARTH, V90, P3; Karato SI, 2012, EARTH PLANET SC LETT, V321, P95, DOI 10.1016/j.epsl.2012.01.001; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Kido M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050057; Kido M, 2008, EARTH PLANETS SPACE, V60, P229, DOI 10.1186/BF03352785; Kido M, 2006, EARTH PLANETS SPACE, V58, P911, DOI 10.1186/BF03351996; Kita S, 2010, EARTH PLANET SC LETT, V290, P415, DOI 10.1016/j.epsl.2009.12.038; Kogan MG, 2013, J GEOPHYS RES-SOL EA, V118, P3691, DOI 10.1002/jgrb.50245; Kubota T., 2012, SOURCE MODELS M 7 CL; MELOSH HJ, 1981, B SEISMOL SOC AM, V71, P1391; Nakajima J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026773; Noda H, 2012, J STRUCT GEOL, V38, P234, DOI 10.1016/j.jsg.2011.08.012; Obana K, 2013, EARTH PLANET SC LETT, V382, P111, DOI 10.1016/j.epsl.2013.09.007; Osada Y., 2012, SEAFLOOR CRUSTAL MOV; Ozawa S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009120; Ozawa S, 2011, NATURE, V475, P373, DOI 10.1038/nature10227; PELTIER WR, 1974, REV GEOPHYS, V12, P649, DOI 10.1029/RG012i004p00649; Pollitz FF, 2006, GEOPHYS J INT, V167, P397, DOI 10.1111/j.1365-246X.2006.03018.x; Pritchard ME, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004258; Rychert CA, 2009, SCIENCE, V324, P495, DOI 10.1126/science.1169754; Sakamaki T, 2013, NAT GEOSCI, V6, P1041, DOI [10.1038/NGEO1982, 10.1038/ngeo1982]; Sato M, 2013, J GEOPHYS RES-SOL EA, V118, P3860, DOI 10.1002/jgrb.50275; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Schmerr N, 2012, SCIENCE, V335, P1480, DOI 10.1126/science.1215433; Shao G., 2012, INC RES I SEISM WORK; SPIESS FN, 1985, IEEE T GEOSCI REMOTE, V23, P502, DOI 10.1109/TGRS.1985.289441; Suito H, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005954; Sun T., 2013, VISCOELASTIC LANDWAR; Tajima F, 2013, TECTONOPHYSICS, V586, P15, DOI 10.1016/j.tecto.2012.09.014; Wada I, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047705; Wada I, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002570; Wang KL, 2012, NATURE, V484, P327, DOI 10.1038/nature11032; Watanabe S., 2011, GEOPHYS RES IN PRESS; Yamamoto Y, 2011, J GEOPHYS RES-SOL EA, V116, DOI [10.1029/2011JB008470, 10.1029/2010JB008470]; Yuen D. A., 1981, GEODYNAMICS SERIES, V4, P59; Zhao DP, 2009, TECTONOPHYSICS, V467, P89, DOI 10.1016/j.tecto.2008.12.017	46	177	183	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					84	+		10.1038/nature13778	http://dx.doi.org/10.1038/nature13778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25231864				2022-12-28	WOS:000342420800040
J	Touraine, M; Grohe, H; Coffi, RG; Sathasivam, S; Juan, M; Louardi, EH; Seck, AC				Touraine, Marisol; Groehe, Hermann; Coffi, Raymonde Goudou; Sathasivam, Subramaniam; Juan, Mercedes; Louardi, El Houssaine; Seck, Awa Call			Universal health coverage and the post-2015 agenda	LANCET			English	Editorial Material									[Touraine, Marisol] Minist Hlth, Paris, France; [Groehe, Hermann] Minist Hlth, Bonn, Germany; [Coffi, Raymonde Goudou] Minist Hlth, Abidjan, Cote Ivoire; [Juan, Mercedes] Minist Hlth, Mexico City, DF, Mexico; [Louardi, El Houssaine] Minist Hlth, Rabat, Morocco; [Seck, Awa Call] Minist Hlth, Dakar, Senegal		Touraine, M (corresponding author), Minist Hlth, Paris, France.	marcosl@who.int						[Anonymous], 2013, MILL DEV GOALS REP 2; UNAIDS, 2013, UNAIDS 2013 AIDS NUM; WHO, 2010, WORLD MALARIA REPORT 2010, P1; You D, 2011, UN INTER AGENCY GROU; Zere E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-252	5	9	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1161	1162		10.1016/S0140-6736(14)61419-7	http://dx.doi.org/10.1016/S0140-6736(14)61419-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	25242037				2022-12-28	WOS:000343002600004
J	Mullen, GM; Mullins, CB				Mullen, Gregory M.; Mullins, C. Buddie			Water's place in Au catalysis	SCIENCE			English	Editorial Material							TEMPERATURE CO OXIDATION; CARBON-MONOXIDE		[Mullen, Gregory M.; Mullins, C. Buddie] Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA; [Mullins, C. Buddie] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Mullen, GM (corresponding author), Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA.	mullins@che.utexas.edu	Mullen, Gregory/O-7163-2016					Bond GC, 2000, GOLD BULL, V33, P41, DOI 10.1007/BF03216579; Bongiorno A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.106102; Costello CK, 2003, APPL CATAL A-GEN, V243, P15, DOI 10.1016/S0926-860X(02)00533-1; Date M, 2004, ANGEW CHEM INT EDIT, V43, P2129, DOI 10.1002/anie.200453796; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Ketchie WC, 2007, J CATAL, V250, P94, DOI 10.1016/j.jcat.2007.06.001; Kung HH, 2003, J CATAL, V216, P425, DOI 10.1016/S0021-9517(02)00111-2; Mullen GM, 2013, TOP CATAL, V56, P1499, DOI 10.1007/s11244-013-0143-x; Ojeda M, 2012, J CATAL, V285, P92, DOI 10.1016/j.jcat.2011.09.015; Ojifinni RA, 2008, J AM CHEM SOC, V130, P6801, DOI 10.1021/ja800351j; Saavedra J, 2014, SCIENCE, V345, P1599, DOI 10.1126/science.1256018; Schubert MM, 2004, J CATAL, V222, P32, DOI 10.1016/j.jcat.2003.08.015	12	9	9	0	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1564	1565		10.1126/science.1259527	http://dx.doi.org/10.1126/science.1259527			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258066				2022-12-28	WOS:000342164500022
J	Schippers, KJ; Nichols, SA				Schippers, Klaske J.; Nichols, Scott A.			Deep, Dark Secrets of Melatonin in Animal Evolution	CELL			English	Editorial Material							SLEEP		[Schippers, Klaske J.; Nichols, Scott A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA	University of Denver	Nichols, SA (corresponding author), Univ Denver, Dept Biol Sci, Denver, CO 80208 USA.	scott.nichols@du.edu		Schippers, Klaske/0000-0002-1605-3372				DOLLINS AB, 1994, P NATL ACAD SCI USA, V91, P1824, DOI 10.1073/pnas.91.5.1824; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Randel N, 2014, ELIFE, V3, DOI 10.7554/eLife.02730; Tan DX, 1993, ENDOCR J, V1, P57; Tosches MA, 2014, CELL, V159, P46, DOI 10.1016/j.cell.2014.07.042; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	8	19	20	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					9	10		10.1016/j.cell.2014.09.004	http://dx.doi.org/10.1016/j.cell.2014.09.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259913	Bronze			2022-12-28	WOS:000343095000002
J	Freeman, RB; Huang, W				Freeman, Richard B.; Huang, Wei			Strength in diversity	NATURE			English	Editorial Material									[Freeman, Richard B.] Natl Bur Econ Res, Sci & Engn Workforce Project, Cambridge, MA 02138 USA; [Freeman, Richard B.; Huang, Wei] Harvard Univ, Cambridge, MA 02138 USA	National Bureau of Economic Research; Harvard University	Freeman, RB (corresponding author), Natl Bur Econ Res, Sci & Engn Workforce Project, Cambridge, MA 02138 USA.	freeman@nber.org	Huang, Wei/R-7886-2016	Huang, Wei/0000-0003-4454-1485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI027763] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams J, 2013, NATURE, V497, P557, DOI 10.1038/497557a; Apfelbaum EP, 2014, PERSPECT PSYCHOL SCI, V9, P235, DOI 10.1177/1745691614527466; Freeman R. B., J LABOR EC IN PRESS; Kerr WR, 2008, REV ECON STAT, V90, P518, DOI 10.1162/rest.90.3.518; Samovar L.A., 2009, COMMUNICATION CULTUR	5	134	134	4	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					305	305		10.1038/513305a	http://dx.doi.org/10.1038/513305a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1GD	25230634	Bronze			2022-12-28	WOS:000341814900021
J	Wood, LN; Anger, JT				Wood, Lauren N.; Anger, Jennifer T.			Urinary incontinence in women	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OVERACTIVE BLADDER SYMPTOMS; QUALITY-OF-LIFE; MIDURETHRAL SLINGS; RISK-FACTORS; URGE INCONTINENCE; NERVE-STIMULATION; ADVERSE EVENTS; DOUBLE-BLIND; STRESS; PREVALENCE	Urinary incontinence affects women of all ages. History, physical examination, and certain tests can guide specialists in diagnosing stress urinary incontinence, urgency urinary incontinence, and mixed urinary incontinence. First line management includes lifestyle and behavior modification, as well as pelvic floor strength and bladder training. Drug therapy is helpful in the treatment of urgency incontinence that does not respond to conservative measures. In addition, sacral neuromodulation, intravesical onabotulinumtoxinA injections, and posterior tibial nerve stimulation can be used in select patient populations with drug refractory urgency incontinence. Midurethral synthetic slings, including retropubic and transobturator approaches, are safe and efficacious surgical options for stress urinary incontinence and have replaced more invasive bladder neck slings that use autologous or cadaveric fascia. Despite controversy surrounding vaginal mesh for prolapse, synthetic slings for the treatment of stress urinary incontinence are considered safe and minimally invasive.	[Wood, Lauren N.; Anger, Jennifer T.] Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA 90211 USA	Cedars Sinai Medical Center	Anger, JT (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA 90211 USA.	jennifer.anger@cshs.org						Abdel-Fattah M, 2011, EUR UROL, V60, P468, DOI 10.1016/j.eururo.2011.05.003; Abrams P, 2000, LANCET, V355, P2153; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Albo ME, 2007, NEW ENGL J MED, V356, P2143, DOI 10.1056/NEJMoa070416; Anger JT, 2013, NEUROUROL URODYNAM, V32, P1058, DOI 10.1002/nau.22353; Anger JT, 2011, NEUROUROL URODYNAM, V30, P1295, DOI 10.1002/nau.21004; Anger JT, 2010, J UROLOGY, V183, P2258, DOI 10.1016/j.juro.2010.02.009; Anger JT, 2006, J UROLOGY, V176, P247, DOI 10.1016/S0022-5347(06)00588-X; Anger JT, 2006, J UROLOGY, V176; Avery KNL, 2007, J UROLOGY, V177, P39, DOI 10.1016/j.juro.2006.08.075; BENVENUTI F, 1987, AM J PHYS MED REHAB, V66, P155; Bortolotti A, 2000, EUR UROL, V37, P30, DOI 10.1159/000020096; BRANCH LG, 1994, J AM GERIATR SOC, V42, P1257, DOI 10.1111/j.1532-5415.1994.tb06507.x; Brazzelli M, 2006, J UROLOGY, V175, P835, DOI 10.1016/S0022-5347(05)00326-5; Brostrom S, 2009, EUR J CLIN PHARMACOL, V65, P309, DOI 10.1007/s00228-008-0600-9; Brown JS, 2000, LANCET, V356, P535, DOI 10.1016/S0140-6736(00)02577-0; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Brubaker L, 2012, J UROLOGY, V187, P1324, DOI 10.1016/j.juro.2011.11.087; Brubaker L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.011; BUMP RC, 1992, AM J OBSTET GYNECOL, V167, P1213, DOI 10.1016/S0002-9378(11)91691-3; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Buser N, 2012, EUR UROL, V62, P1040, DOI 10.1016/j.eururo.2012.08.060; Cameron AP, 2011, J UROLOGY, V185, P970, DOI 10.1016/j.juro.2010.10.060; Chancellor MB, 2013, TOXICON, V67, P129, DOI 10.1016/j.toxicon.2013.01.020; Chancellor MB, 2012, DRUG AGING, V29, P259, DOI 10.2165/11597530-000000000-00000; Chapple C, 2013, EUR UROL, V64, P249, DOI 10.1016/j.eururo.2013.04.001; Chapple CR, 2014, NEUROUROL URODYNAM, V33, P17, DOI 10.1002/nau.22505; Cheater FM, 2000, BEST PRACT RES CL OB, V14, P183, DOI 10.1053/beog.1999.0071; Cruz F, 2011, EUR UROL, V60, P742, DOI 10.1016/j.eururo.2011.07.002; DELANCEY JOL, 1994, AM J OBSTET GYNECOL, V170, P1713, DOI 10.1016/S0002-9378(12)91840-2; Dmochowski RR, 2010, J UROLOGY, V183, P1906, DOI 10.1016/j.juro.2010.02.2369; Dumoulin C, 2010, COCHRANE DB SYST REV, V1; Erdem N, 2006, AM J MED, V119, P29, DOI 10.1016/j.amjmed.2005.12.014; Fonda D, 1998, NEUROUROL URODYNAM, V17, P273, DOI 10.1002/(SICI)1520-6777(1998)17:3<273::AID-NAU12>3.0.CO;2-L; Fuganti PE, 2011, INT BRAZ J UROL, V37, P528, DOI 10.1590/S1677-55382011000400013; Ganz ML, 2010, UROLOGY, V75, P533, DOI [10.1016/j.urology.2009.06.096, 10.1016/j.urology.2009.08.003]; Gleason JL, 2013, INT UROGYNECOL J, V24, P295, DOI 10.1007/s00192-012-1829-5; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; Hahnestad YS, 2004, BRIT MED J, V329, P889, DOI 10.1136/bmj.329.7471.889; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; HAYLEN BT, 1989, BRIT J UROL, V64, P147, DOI 10.1111/j.1464-410X.1989.tb05975.x; HUNSKAAR S, 1991, J AM GERIATR SOC, V39, P378, DOI 10.1111/j.1532-5415.1991.tb02903.x; Hunskaar S, 1999, INCONTINENCE, P197; Kato K, 2005, BJU INT, V95, P98, DOI 10.1111/j.1464-410X.2004.05259.x; Keegan PE, 2007, COCHRANE DB SYST REV, V3; Khan IJ, 2004, CLIN GERIATR MED, V20, P499, DOI 10.1016/j.cger.2004.04.001; Kinnunen O, 1991, Aging (Milano), V3, P161; Latthe PM, 2007, BJOG-INT J OBSTET GY, V114, P522, DOI 10.1111/j.1471-0528.2007.01268.x; Lee HN, 2010, INT UROGYNECOL J, V21, P1479, DOI 10.1007/s00192-010-1224-z; Levin PJ, 2012, INT UROGYNECOL J, V23, P1591, DOI 10.1007/s00192-012-1712-4; Levy R, 2006, ADV THER, V23, P556, DOI 10.1007/BF02850045; Li JH, 2013, INT UROL NEPHROL, V45, P679, DOI 10.1007/s11255-013-0410-6; MacDiarmid SA, 2010, J UROLOGY, V183, P234, DOI 10.1016/j.juro.2009.08.160; Madhuvrata P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005429.pub2; Maher CF, 2005, BJOG-INT J OBSTET GY, V112, P797, DOI 10.1111/j.1471-0528.2005.00547.x; Melville JL, 2005, OBSTET GYNECOL, V106, P585, DOI 10.1097/01.AOG.0000173985.39533.37; Min LC, 2011, J AM GERIATR SOC, V59, P1435, DOI 10.1111/j.1532-5415.2011.03517.x; Nager CW, 2012, NEW ENGL J MED, V366, P1987, DOI 10.1056/NEJMoa1113595; National Institute for Health & Care Excellence, 2013, UR INC MAN UR INC WO; Nilsson CG, 2008, INT UROGYNECOL J, V19, P1043, DOI 10.1007/s00192-008-0666-z; Nitti VW, 2013, J UROLOGY, V189, P2186, DOI 10.1016/j.juro.2012.12.022; Nitti VW, 2013, J UROLOGY, V189, P1388, DOI 10.1016/j.juro.2012.10.017; Norton P, 2006, LANCET, V367, P57, DOI 10.1016/S0140-6736(06)67925-7; Novara G, 2007, EUR UROL, V52, P663, DOI 10.1016/j.eururo.2007.06.018; Nygaard I, 2003, OBSTET GYNECOL, V101, P149, DOI 10.1016/S0029-7844(02)02519-X; Nygaard IE, 2004, OBSTET GYNECOL, V104, P607, DOI 10.1097/01.AOG.0000137874.84862.94; Ogah J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006375.pub2; Parazzini F, 2003, BJOG-INT J OBSTET GY, V110, P927, DOI 10.1111/j.1471-0528.2003.02343.x; Peters KM, 2009, J UROLOGY, V182, P1055, DOI 10.1016/j.juro.2009.05.045; Petros PEP, 1990, ACTA OBSTET GYN SCAN, V69, P7, DOI 10.1111/j.1600-0412.1990.tb08027.x; Peyrat L, 2002, BJU INT, V89, P61, DOI 10.1046/j.1464-4096.2001.01813.x; Richter HE, 2010, NEW ENGL J MED, V362, P2066, DOI 10.1056/NEJMoa0912658; Richter HE, 2010, OBSTET GYNECOL, V115, P609, DOI 10.1097/AOG.0b013e3181d055d4; Riesenhuber A, 2006, AMINO ACIDS, V31, P81, DOI 10.1007/s00726-006-0363-5; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Sampselle CM, 2002, OBSTET GYNECOL, V100, P1230, DOI 10.1016/S0029-7844(02)02241-X; Samuelsson E, 2000, ACTA OBSTET GYN SCAN, V79, P208, DOI 10.1034/j.1600-0412.2000.079003208.x; Schimpf MO, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.01.030; Sexton CC, 2011, INT J CLIN PRACT, V65, P567, DOI 10.1111/j.1742-1241.2010.02626.x; Starkman JS, 2007, NEUROUROL URODYNAM, V26, P29, DOI 10.1002/nau.20360; Staskin David R, 2004, Curr Urol Rep, V5, P423, DOI 10.1007/s11934-004-0064-0; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Thom D, 1998, J AM GERIATR SOC, V46, P473, DOI 10.1111/j.1532-5415.1998.tb02469.x; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; Todorova A, 2001, J CLIN PHARMACOL, V41, P636, DOI 10.1177/00912700122010528; UEBERSAX JS, 1995, NEUROUROL URODYNAM, V14, P131, DOI 10.1002/nau.1930140206; Valtin H, 2002, AM J PHYSIOL-REG I, V283, pR993, DOI 10.1152/ajpregu.00365.2002; van Leijsen SAL, 2013, OBSTET GYNECOL, V121, P999, DOI 10.1097/AOG.0b013e31828c68e3; Van Oyen H, 2002, ACTA CLIN BELG, V57, P207, DOI 10.1179/acb.2002.043; Wein AJ, 2012, CAMPBELL WALSH UROLO, V10th, P1871; Wilson L, 2001, OBSTET GYNECOL, V98, P398, DOI 10.1016/S0029-7844(01)01464-8; Wing RR, 2010, J UROLOGY, V184, P1005, DOI 10.1016/j.juro.2010.05.031; Wyman JF, 2009, INT J CLIN PRACT, V63, P1177, DOI 10.1111/j.1742-1241.2009.02078.x; Zargham Mahtab, 2013, Adv Biomed Res, V2, P22, DOI 10.4103/2277-9175.108010	94	115	127	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2014	349								g4531	10.1136/bmj.g4531	http://dx.doi.org/10.1136/bmj.g4531			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OJ	25225003				2022-12-28	WOS:000342056800001
J	Sattar, N; Forrest, E; Preiss, D				Sattar, Naveed; Forrest, Ewan; Preiss, David			Non-alcoholic fatty liver disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CARDIOVASCULAR-DISEASE; ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE; OBESE-PATIENTS; RISK; STEATOHEPATITIS; FIBROSIS; ADULTS; MEN; INTERVENTIONS		[Sattar, Naveed; Preiss, David] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Forrest, Ewan] Glasgow Royal Infirm, Dept Gastroenterol, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; University of Glasgow	Sattar, N (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland.	naveed.sattar@glasgow.ac.uk		Preiss, David/0000-0003-3139-1836				Almeida AD, 2008, WORLD J GASTROENTERO, V14, P1415, DOI 10.3748/wjg.14.1415; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Athyros VG, 2010, LANCET, V376, P1916, DOI 10.1016/S0140-6736(10)61272-X; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chatterton H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4624; Clark JM, 2001, GASTROENTEROLOGY, V120, pA65; Eslami L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008623.pub2; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Hart CL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1240; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Lilford RJ, 2013, HEALTH TECHNOL ASSES, V17, pi; Loomba R, 2012, HEPATOLOGY, V56, P943, DOI 10.1002/hep.25772; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; McPherson S, 2014, J HEPATOL, V60, P1055, DOI 10.1016/j.jhep.2014.01.010; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Merriman RB, 2006, HEPATOLOGY, V44, P874, DOI 10.1002/hep.21346; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Ryan CK, 2002, LIVER TRANSPLANT, V8, P1114, DOI 10.1053/jlts.2002.36740; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Shyangdan D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15380; Sorbi D, 1999, AM J GASTROENTEROL, V94, P1018; Sung KC, 2012, DIABETES CARE, V35, P717, DOI 10.2337/dc11-1853; Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010; Utzschneider KM, 2014, J DIABETES COMPLICAT, V28, P177, DOI 10.1016/j.jdiacomp.2013.11.007; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; Wong VWS, 2006, ALIMENT PHARM THER, V24, P1215, DOI 10.1111/j.1365-2036.2006.03112.x; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO	34	161	168	4	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4596	10.1136/bmj.g4596	http://dx.doi.org/10.1136/bmj.g4596			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25239614	Green Published			2022-12-28	WOS:000339906000003
J	Bove, T; Zangrillo, A; Guarracino, F; Alvaro, G; Persi, B; Maglioni, E; Galdieri, N; Comis, M; Caramelli, F; Pasero, DC; Pala, G; Renzini, M; Conte, M; Paternoster, G; Martinez, B; Pinelli, F; Frontini, M; Zucchetti, MC; Pappalardo, F; Amantea, B; Camata, A; Pisano, A; Verdecchia, C; Dal Checco, E; Cariello, C; Faita, L; Baldassarri, R; Scandroglio, AM; Saleh, O; Lembo, R; Calabro, MG; Bellomo, R; Landoni, G				Bove, Tiziana; Zangrillo, Alberto; Guarracino, Fabio; Alvaro, Gabriele; Persi, Bruno; Maglioni, Enivarco; Galdieri, Nicola; Comis, Marco; Caramelli, Fabio; Pasero, Daniela C.; Pala, Giovanni; Renzini, Massimo; Conte, Massimiliano; Paternoster, Gianluca; Martinez, Blanca; Pinelli, Fulvio; Frontini, Mario; Zucchetti, Maria C.; Pappalardo, Federico; Amantea, Bruno; Camata, Annamaria; Pisano, Antonio; Verdecchia, Claudio; Dal Checco, Erika; Cariello, Claudia; Faita, Luana; Baldassarri, Rubia; Scandroglio, Anna M.; Saleh, Omar; Lembo, Rosalba; Calabro, Maria G.; Bellomo, Rinaldo; Landoni, Giovanni			Effect of Fenoldopam on Use of Renal Replacement Therapy Among Patients With Acute Kidney Injury After Cardiac Surgery A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; DOUBLE-BLIND; FAILURE; RISK; MORTALITY; PROTECTION; INFUSION; DIALYSIS; NEED	IMPORTANCE No effective pharmaceutical agents have yet been identified to treat acute kidney injury after cardiac surgery. OBJECTIVE To determine whether fenoldopam reduces the need for renal replacement therapy in critically ill cardiac surgery patients with acute kidney injury. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, double-blind, placebo-controlled, parallel-group study from March 2008 to April 2013 in 19 cardiovascular intensive care units in Italy. We randomly assigned 667 patients admitted to intensive care units after cardiac surgery with early acute kidney injury (>= 50% increase of serum creatinine level from baseline or oliguria for >= 6 hours) to receive fenoldopam (338 patients) or placebo (329 patients). We used a computer-generated permuted block randomization sequence for treatment allocation. All patients completed their follow-up 30 days after surgery, and data were analyzed according to the intention-to-treat principle. INTERVENTIONS Continuous infusion of fenoldopam or placebo for up to 4 days with a starting dose of 0.1 mu g/kg/min (range, 0.025-0.3 mu g/kg/min). MAIN OUTCOMES AND MEASURES The primary end point was the rate of renal replacement therapy. Secondary end points included mortality (intensive care unit and 30-day mortality) and the rate of hypotension during study drug infusion. RESULTS The study was stopped for futility as recommended by the safety committee after a planned interim analysis. Sixty-nine of 338 patients (20%) allocated to the fenoldopam group and 60 of 329 patients (18%) allocated to the placebo group received renal replacement therapy (P = .47). Mortality at 30 days was 78 of 338 (23%) in the fenoldopam group and 74 of 329 (22%) in the placebo group (P = .86). Hypotension occurred in 85 (26%) patients in the fenoldopam group and in 49 (15%) patients in the placebo group (P = .001). CONCLUSIONS AND RELEVANCE Among patients with acute kidney injury after cardiac surgery, fenoldopam infusion, compared with placebo, did not reduce the need for renal replacement therapy or risk of 30-day mortality but was associated with an increased rate of hypotension.	[Bove, Tiziana; Zangrillo, Alberto; Pappalardo, Federico; Scandroglio, Anna M.; Saleh, Omar; Lembo, Rosalba; Calabro, Maria G.; Landoni, Giovanni] IRCCS San Raffaele Sci Inst, I-20132 Milan, Italy; [Guarracino, Fabio; Cariello, Claudia; Baldassarri, Rubia] Univ Hosp Pisa, Pisa, Italy; [Alvaro, Gabriele; Amantea, Bruno; Faita, Luana] Mater Domini Hosp, Catanzaro, Italy; [Persi, Bruno; Camata, Annamaria] Osped Civile Ca Foncello Treviso, Treviso, Italy; [Maglioni, Enivarco] Siena Hosp, Siena, Italy; [Galdieri, Nicola; Pisano, Antonio] Monaldi Hosp, AORN Dei Colli, Naples, Italy; [Comis, Marco; Verdecchia, Claudio] Molinette Mauriziano Hosp, Turin, Italy; [Caramelli, Fabio; Dal Checco, Erika] S Orsola Malpighi Univ Hosp, Bologna, Italy; [Pasero, Daniela C.] Univ Turin, Citta Salute & Sci Hosp, Turin, Italy; [Pala, Giovanni] Osped Civile SS Annunziata, Sassari, Italy; [Renzini, Massimo] Osped Santa Maria Misericordia, Perugia, Italy; [Conte, Massimiliano] Cotignola & Citta Lecce Hosp, Maria Cecilia Hosp GVM Care & Res, Lecce, Italy; [Paternoster, Gianluca] AO Reg San Carlo, Potenza, Italy; [Martinez, Blanca] Santa Maria Misericordia Univ Hosp Udine, Udine, Italy; [Pinelli, Fulvio] Careggi Univ Hosp, Florence, Italy; [Frontini, Mario] AO Spedali Civili Brescia, Brescia, Italy; [Zucchetti, Maria C.] AO Osped Riuniti Papardo Piemonte, Messina, Italy; [Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Zangrillo, Alberto; Landoni, Giovanni] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pisa; Azienda Ospedaliero Universitaria Pisana; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Azienda Ospedaliero-Universitaria di Bologna; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Hospital Santa Maria della Misericordia; Maria Cecilia Hospital; Hospital Santa Maria della Misericordia; University of Florence; Azienda Ospedaliero Universitaria Careggi; Hospital Spedali Civili Brescia; Monash University; Vita-Salute San Raffaele University	Landoni, G (corresponding author), IRCCS San Raffaele Sci Inst, Via Olgettina 60, I-20132 Milan, Italy.	landoni.giovanni@hsr.it	Renzini, Massimo/AAL-6507-2020; Bove, Tiziana/AAC-2109-2022; Giovanni, Landoni/AAH-1881-2019; Pinelli, Fulvio/AAV-4729-2021; Zangrillo, Alberto/AAH-2037-2019; Pisano, Antonio/AAG-1028-2020; pasero, daniela cristina/ABF-4731-2021	Giovanni, Landoni/0000-0002-8594-5980; Zangrillo, Alberto/0000-0002-7687-7648; Pisano, Antonio/0000-0002-5118-444X; Guarracino, Fabio/0000-0002-2562-0199; Calabro, Maria Grazia/0000-0003-1843-3165; Bellomo, Rinaldo/0000-0002-1650-8939; BOVE, Tiziana/0000-0002-5489-2898; Saleh, Omar/0000-0003-2704-3759; Pappalardo, Federico/0000-0001-9129-833X	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by a grant from the Italian Ministry of Health.	[Anonymous], 2001, J Postgrad Med, V47, P264; Aravindan N, 2006, KIDNEY BLOOD PRESS R, V29, P165, DOI 10.1159/000095350; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2006, CRIT CARE, V10, DOI 10.1186/cc5045; Bove T, 2013, HEART LUNG VESSEL, V5, P55; Bove T, 2009, HEART LUNG VESSEL, V1, P13; Caimmi PP, 2003, J CARDIOTHOR VASC AN, V17, P491, DOI 10.1016/S1053-0770(03)00155-1; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 1997, CIRCULATION, V95, P878; Cogliati AA, 2007, J CARDIOTHOR VASC AN, V21, P847, DOI 10.1053/j.jvca.2007.02.022; Garg AX, 2014, JAMA-J AM MED ASSOC, V311, P2191, DOI 10.1001/jama.2014.4952; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Halpenny M, 2001, ANAESTHESIA, V56, P953, DOI 10.1046/j.1365-2044.2001.02220.x; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Landoni G, 2010, HEART LUNG VESSEL, V2, P111; Landoni G, 2011, ACTA ANAESTH SCAND, V55, P259, DOI 10.1111/j.1399-6576.2010.02381.x; Landoni G, 2008, J CARDIOTHOR VASC AN, V22, P27, DOI 10.1053/j.jvca.2007.07.015; Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.2006.10.013; Landoni G, 2013, J CARDIOTHOR VASC AN, V27, P1384, DOI 10.1053/j.jvca.2013.06.028; Mao H, 2013, CARDIORENAL MED, V3, P178, DOI 10.1159/000353134; Mathur VS, 1999, CRIT CARE MED, V27, P1832, DOI 10.1097/00003246-199909000-00021; Meco M, 2011, J CARDIOTHOR VASC AN, V25, P642, DOI 10.1053/j.jvca.2010.09.020; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; O'Hara JF, 2013, UROLOGY, V81, P340, DOI 10.1016/j.urology.2012.09.041; Ranucci M, 2010, MINERVA ANESTESIOL, V76, P249; Reboussin DM, 1992, 60 U WISC DEP BIOST; Ricci Z, 2011, CRIT CARE, V15, DOI 10.1186/cc10295; Schetz M, 2008, INT J ARTIF ORGANS, V31, P179, DOI 10.1177/039139880803100211; Singer I, 1998, AM J KIDNEY DIS, V31, P743, DOI 10.1016/S0272-6386(98)70043-5; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Tumlin JA, 2005, AM J KIDNEY DIS, V46, P26, DOI 10.1053/j.ajkd.2005.04.002; Tumlin JA, 2009, CURR OPIN CRIT CARE, V15, P514, DOI 10.1097/MCC.0b013e328332f6f9; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wijeysundera DN, 2007, JAMA-J AM MED ASSOC, V297, P1801, DOI 10.1001/jama.297.16.1801; Yi X, 2013, TRANSPL P, V45, P517, DOI 10.1016/j.transproceed.2012.02.051	35	97	100	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2244	2253		10.1001/jama.2014.13573	http://dx.doi.org/10.1001/jama.2014.13573			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25265449	Bronze			2022-12-28	WOS:000345684800019
J	Mitman, G				Mitman, Gregg			HISTORY OF MEDICINE Ebola in a Stew of Fear	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mitman, Gregg] Univ Wisconsin, Dept Med Hist & Bioeth, Madison, WI 53706 USA; [Mitman, Gregg] Univ Wisconsin, Dept Hist Sci, Madison, WI 53706 USA; [Mitman, Gregg] Univ Wisconsin, Dept Hist, Madison, WI 53706 USA; [Mitman, Gregg] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mitman, G (corresponding author), Univ Wisconsin, Dept Med Hist & Bioeth, Madison, WI 53706 USA.				Divn Of Social and Economic Sciences [1331078] Funding Source: National Science Foundation	Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		[Anonymous], 1931, COMMUNICATION; Financial Tracking Service, EB VIR 3 OUTBR W AFR; Loring Whitman Collection, 1926, LOR WHITM DIAR, P91	3	31	32	0	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1763	1765		10.1056/NEJMp1411244	http://dx.doi.org/10.1056/NEJMp1411244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS3IH	25229794	Bronze			2022-12-28	WOS:000344170300003
J	De Vos, M; Smitz, J; Woodruff, TK				De Vos, Michel; Smitz, Johan; Woodruff, Teresa K.			Fertility preservation in women with cancer	LANCET			English	Article							CRYOPRESERVED OVARIAN TISSUE; IN-VITRO MATURATION; PROTECTS MOUSE OOCYTES; BREAST-CANCER; ADJUVANT CHEMOTHERAPY; YOUNG-WOMEN; DEVELOPMENTAL COMPETENCE; ANALOG TRIPTORELIN; EMBRYO DEVELOPMENT; ARSENIC TRIOXIDE	Enhanced long-term survival rates of young women with cancer and advances in reproductive medicine and cryobiology have culminated in an increased interest in fertility preservation methods in girls and young women with cancer. Present data suggest that young patients with cancer should be referred for fertility preservation counselling quickly to help with their coping process. Although the clinical application of novel developments, including oocyte vitrification and oocyte maturation in vitro, has resulted in reasonable success rates in assisted reproduction programmes, experience with these techniques in the setting of fertility preservation is in its infancy. It is hoped that these and other approaches, some of which are still regarded as experimental (eg, ovarian tissue cryopreservation, pharmacological protection against gonadotoxic agents, in-vitro follicle growth, and follicle transplantation) will be optimised and become established within the next decade. Unravelling the complex mechanisms of activation and suppression of follicle growth will not only expand the care of thousands of women diagnosed with cancer, but also inform the care of millions of women confronted with reduced reproductive fitness because of ageing.	[De Vos, Michel] UZ Brussel, Ctr Reprod Med, B-1090 Brussels, Belgium; [Smitz, Johan] UZ Brussel, Lab Clin Chem & Radioimmunol, B-1090 Brussels, Belgium; [Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University Hospital Brussels; University Hospital Brussels; Northwestern University; Feinberg School of Medicine	De Vos, M (corresponding author), UZ Brussel, Ctr Reprod Med, B-1090 Brussels, Belgium.	mdevos@uzbrussel.be	De Vos, Michel/AAG-3014-2020	De Vos, Michel/0000-0001-5019-5924	Research Foundation-Flanders [G.0343.13]; Flemish Agency for Innovation by Science and Technology [IWT/TBM/110680]; Belgian Foundation against Cancer (HOPE) [C69]; NIH/NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD076188, P50HD076188] Funding Source: NIH RePORTER	Research Foundation-Flanders(FWO); Flemish Agency for Innovation by Science and Technology; Belgian Foundation against Cancer (HOPE); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Fertility preservation research at UZ Brussel is supported by grants from the Research Foundation-Flanders (G.0343.13 to JS), the Flemish Agency for Innovation by Science and Technology (IWT/TBM/110680 to JS), and the Belgian Foundation against Cancer (Project HOPE, C69 to JS). Fertility preservation research at Northwestern University is supported by NIH/NICHD U54 grant to TKW. We thank Shuo Xiao for contributing the table to this article and Stacey Tobin for editorial support, and acknowledge the many important contributions to the entire specialty, but because of editorial restrictions, a maximum of 100 references were allowed.	Ahn RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058491; Ahn RW, 2010, CLIN CANCER RES, V16, P3607, DOI 10.1158/1078-0432.CCR-10-0068; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; Amorim CA, 2011, REPROD BIOMED ONLINE, V23, P160, DOI 10.1016/j.rbmo.2011.04.005; Amorim CA, 2011, FERTIL STERIL, V95, P1094, DOI 10.1016/j.fertnstert.2010.11.046; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; Anderson RA, 2008, HUM REPROD, V23, P2246, DOI 10.1093/humrep/den252; Anderson RA, 2011, J CLIN ENDOCR METAB, V96, P1336, DOI 10.1210/jc.2010-2582; Azim AA, 2008, J CLIN ONCOL, V26, P2630, DOI 10.1200/JCO.2007.14.8700; Baerwald AR, 2003, BIOL REPROD, V69, P1023, DOI 10.1095/biolreprod.103.017772; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Blumenfeld Z, 2007, ONCOLOGIST, V12, P1044, DOI 10.1634/theoncologist.12-9-1044; Brambillasca F, 2013, J ASSIST REPROD GEN, V30, P1531, DOI 10.1007/s10815-013-0112-0; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Brougham MFH, 2012, J CLIN ENDOCR METAB, V97, P2059, DOI 10.1210/jc.2011-3180; BRUNING PF, 1990, BRIT J CANCER, V61, P308, DOI 10.1038/bjc.1990.58; Cakmak H, 2013, FERTIL STERIL, V100, P1673, DOI 10.1016/j.fertnstert.2013.07.1992; Camats N, 2009, MUTAT RES-FUND MOL M, V669, P67, DOI 10.1016/j.mrfmmm.2009.05.002; Carter J, 2005, GYNECOL ONCOL, V97, P90, DOI 10.1016/j.ygyno.2004.12.019; Chen HM, 2006, J AM CHEM SOC, V128, P13348, DOI 10.1021/ja064864h; Chen H, 2009, ANGEW CHEM INT EDIT, V48, P9295, DOI 10.1002/anie.200903655; Chen H, 2009, MOL CANCER THER, V8, P1955, DOI 10.1158/1535-7163.MCT-09-0045; Colleoni M, 2000, J CLIN ONCOL, V18, P584, DOI 10.1200/JCO.2000.18.3.584; Corney RH, 2014, PSYCHO-ONCOLOGY, V23, P20, DOI 10.1002/pon.3365; Decanter C, 2010, REPROD BIOMED ONLINE, V20, P280, DOI 10.1016/j.rbmo.2009.11.010; Del Mastro L, 2011, JAMA-J AM MED ASSOC, V306, P269, DOI 10.1001/jama.2011.991; Dolmans MM, 2013, J ASSIST REPROD GEN, V30, P305, DOI 10.1007/s10815-013-9952-x; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Dunlop CE, 2013, MATURITAS, V76, P279, DOI 10.1016/j.maturitas.2013.04.017; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; Escriba MJ, 2012, J ASSIST REPROD GEN, V29, P1261, DOI 10.1007/s10815-012-9860-5; Fasano G, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-150; Fleming R, 2012, FERTIL STERIL, V98, P1097, DOI 10.1016/j.fertnstert.2012.07.1114; Forman EJ, 2010, FERTIL STERIL, V94, P1652, DOI 10.1016/j.fertnstert.2009.10.008; Fujino Y, 2013, FERTIL STERIL, V100, pS171, DOI 10.1016/j.fertnstert.2013.07.1473; Garcia-Velasco JA, 2013, FERTIL STERIL, V99, P1994, DOI 10.1016/j.fertnstert.2013.02.004; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; Gremeau AS, 2012, FERTIL STERIL, V98, P355, DOI 10.1016/j.fertnstert.2012.04.046; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Herraiz S, 2014, FERTIL STERIL, V101, P775, DOI 10.1016/j.fertnstert.2013.11.016; Howlader N, 2011, SEER CANC STAT REV 1; Jadoul P, 2007, ATLAS OPERATIVE LAPA, P349; Jain KK, 2005, TECHNOL CANCER RES T, V4, P407, DOI 10.1177/153303460500400408; Jeanes H, 2007, EXPERT OPIN PHARMACO, V8, P279, DOI 10.1517/14656566.8.3.279; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; KALECHMAN Y, 1993, RADIAT RES, V136, P197, DOI 10.2307/3578611; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Keros V, 2009, HUM REPROD, V24, P1670, DOI 10.1093/humrep/dep079; Kim MK, 2011, J ASSIST REPROD GEN, V28, P1167, DOI 10.1007/s10815-011-9681-y; Kim SY, 2013, CELL DEATH DIFFER, V20, P987, DOI 10.1038/cdd.2013.31; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Labied S, 2013, TRANSPLANTATION, V95, P426, DOI 10.1097/TP.0b013e318279965c; Letourneau JM, 2012, CANCER-AM CANCER SOC, V118, P1933, DOI 10.1002/cncr.26403; Letourneau JM, 2012, CANCER-AM CANCER SOC, V118, P1710, DOI 10.1002/cncr.26459; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Mersereau JE, 2013, CANCER-AM CANCER SOC, V119, P4044, DOI 10.1002/cncr.28317; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Nogueira D, 2006, BIOL REPROD, V74, P177, DOI 10.1095/biolreprod.105.040485; Pfeifer S, 2013, FERTIL STERIL, V100, P1214, DOI 10.1016/j.fertnstert.2013.08.012; Prasath EB, 2014, HUM REPROD, V29, P276, DOI 10.1093/humrep/det420; Recchia F, 2006, CANCER-AM CANCER SOC, V106, P514, DOI 10.1002/cncr.21646; Revel A, 2009, FERTIL STERIL, V92, P458, DOI 10.1016/j.fertnstert.2008.07.013; Rienzi L, 2010, HUM REPROD, V25, P66, DOI 10.1093/humrep/dep346; Riggs R, 2010, FERTIL STERIL, V93, P109, DOI 10.1016/j.fertnstert.2008.09.084; Rosendahl M, 2006, HUM REPROD, V21, P2006, DOI 10.1093/humrep/del140; Rosendahl M, 2013, J ASSIST REPROD GEN, V30, P11, DOI 10.1007/s10815-012-9912-x; Schmidt KT, 2013, REPROD BIOMED ONLINE, V26, P272, DOI 10.1016/j.rbmo.2012.12.001; Schroder CP, 2004, HUM REPROD, V19, P1069, DOI 10.1093/humrep/deh244; Shapiro BS, 2010, FERTIL STERIL, V93, P319, DOI 10.1016/j.fertnstert.2009.07.966; Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.TEA.2011.0204, 10.1089/ten.tea.2011.0204]; Smitz J, 2010, HUM REPROD UPDATE, V16, P395, DOI 10.1093/humupd/dmp056; Sonmezer M, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.030; Stern CJ, 2013, HUM REPROD, V28, P2996, DOI 10.1093/humrep/det360; Stern CJ, 2011, AUST NZ J OBSTET GYN, V51, DOI 10.1111/j.1479-828X.2011.01289.x; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Telfer EE, 2012, NAT MED, V18, P353, DOI 10.1038/nm.2699; Tingen CM, 2011, REPRODUCTION, V141, P809, DOI 10.1530/REP-10-0483; Turan V, 2013, FERTIL STERIL, V100, P1681, DOI 10.1016/j.fertnstert.2013.08.030; Turner NH, 2013, ANN ONCOL, V24, P2224, DOI 10.1093/annonc/mdt196; Van Eyck AS, 2010, FERTIL STERIL, V93, P1676, DOI 10.1016/j.fertnstert.2009.04.048; Vigone G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-380; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Xu M, 2009, HUM REPROD, V24, P2531, DOI 10.1093/humrep/dep228; Yeo CX, 2008, HUM REPROD, V23, P67, DOI 10.1093/humrep/dem140; Yu KD, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-240; Zamah AM, 2010, HUM REPROD, V25, P2569, DOI 10.1093/humrep/deq212; Zelinski MB, 2011, FERTIL STERIL, V95, P1440, DOI 10.1016/j.fertnstert.2011.01.012; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	99	187	192	0	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1302	1310		10.1016/S0140-6736(14)60834-5	http://dx.doi.org/10.1016/S0140-6736(14)60834-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	25283571	Green Accepted			2022-12-28	WOS:000343003400034
J	Spatzal, T; Perez, KA; Einsle, O; Howard, JB; Rees, DC				Spatzal, Thomas; Perez, Kathryn A.; Einsle, Oliver; Howard, James B.; Rees, Douglas C.			Ligand binding to the FeMo-cofactor: Structures of CO-bound and reactivated nitrogenase	SCIENCE			English	Article							MOLYBDENUM-IRON PROTEIN; KLEBSIELLA-PNEUMONIAE NITROGENASE; MOFE-PROTEIN; AZOTOBACTER-VINELANDII; CRYSTALLOGRAPHIC STRUCTURE; INFRARED-SPECTROSCOPY; CARBON-MONOXIDE; ALPHA-SUBUNIT; MECHANISM; SUBSTRATE	The mechanism of nitrogenase remains enigmatic, with a major unresolved issue concerning how inhibitors and substrates bind to the active site. We report a crystal structure of carbon monoxide (CO)-inhibited nitrogenase molybdenum-iron (MoFe)-protein at 1.50 angstrom resolution, which reveals a CO molecule bridging Fe2 and Fe6 of the FeMo-cofactor. The mu(2) binding geometry is achieved by replacing a belt-sulfur atom (S2B) and highlights the generation of a reactive iron species uncovered by the displacement of sulfur. The CO inhibition is fully reversible as established by regain of enzyme activity and reappearance of S2B in the 1.43 angstrom resolution structure of the reactivated enzyme. The substantial and reversible reorganization of the FeMo-cofactor accompanying CO binding was unanticipated and provides insights into a catalytically competent state of nitrogenase.	[Spatzal, Thomas; Perez, Kathryn A.; Howard, James B.; Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Spatzal, Thomas; Perez, Kathryn A.; Howard, James B.; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Einsle, Oliver] Univ Freiburg, Inst Biochem, D-79104 Freiburg, Germany; [Einsle, Oliver] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Howard, James B.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Freiburg; University of Freiburg; University of Minnesota System; University of Minnesota Twin Cities	Spatzal, T (corresponding author), CALTECH, Howard Hughes Med Inst, MailCode 114-96, Pasadena, CA 91125 USA.	spatzal@caltech.edu; dcrees@caltech.edu		Einsle, Oliver/0000-0001-8722-2893	NIH [GM45162]; Deutsche Forschungsgemeinschaft [EI-520/7, RTG 1976]; European Research Council N-ABLE project; Gordon and Betty Moore Foundation; Beckman Institute; Sanofi-Aventis Bioengineering Research Program at Caltech; U.S. Department of Energy, Office of Biological and Environmental Research; NIH: National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; Center for Environmental Microbial Interactions; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162, P41GM103393, R37GM045162] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council N-ABLE project; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Sanofi-Aventis Bioengineering Research Program at Caltech; U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH: National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Environmental Microbial Interactions; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Peters, L. Zhang, J. Rittle, C. Morrison, B. Wenke, and K. Dorner for informative discussions. This work was supported by NIH grant GM45162 (D.C.R.), Deutsche Forschungsgemeinschaft grants EI-520/7 and RTG 1976, and the European Research Council N-ABLE project (O.E.). We gratefully acknowledge the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program at Caltech for their generous support of the Molecular Observatory at Caltech and the staff at Beamline 12-2, Stanford Synchrotron Radiation Lightsource (SSRL), for their assistance with data collection. SSRL is operated for the U.S. Department of Energy and supported by its Office of Biological and Environmental Research and by the NIH: National Institute of General Medical Sciences (P41GM103393) and the National Center for Research Resources (P41RR001209). We thank the Center for Environmental Microbial Interactions for its support of microbiology research at Caltech. Coordinates and structure factors have been deposited in the Protein Data Bank of the Research Collaboratory for Structural Bioinformatics, with IDs 4TKV (Av1-CO) and 4TKU (Av1 reactivated).	Benton PMC, 2003, BIOCHEMISTRY-US, V42, P9102, DOI 10.1021/bi034595x; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Cameron LM, 1998, BIOCHEMISTRY-US, V37, P9449, DOI 10.1021/bi972667c; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; Christiansen J, 2000, J BIOL CHEM, V275, P11459, DOI 10.1074/jbc.275.15.11459; Dance I, 2007, CHEM-ASIAN J, V2, P936, DOI 10.1002/asia.200700131; DAVIS LC, 1979, BIOCHEMISTRY-US, V18, P4860, DOI 10.1021/bi00589a014; Dos Santos PC, 2007, J INORG BIOCHEM, V101, P1642, DOI 10.1016/j.jinorgbio.2007.05.007; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; George SJ, 1997, J AM CHEM SOC, V119, P6450, DOI 10.1021/ja971088s; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Hu YL, 2011, SCIENCE, V333, P753, DOI 10.1126/science.1206883; Hu YL, 2011, COORDIN CHEM REV, V255, P1218, DOI 10.1016/j.ccr.2010.11.018; HWANG JC, 1973, BIOCHIM BIOPHYS ACTA, V292, P256, DOI 10.1016/0005-2728(73)90270-3; KIM CH, 1995, BIOCHEMISTRY-US, V34, P2798, DOI 10.1021/bi00009a008; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Lee CC, 2010, SCIENCE, V329, P642, DOI 10.1126/science.1191455; Lee HI, 1997, J AM CHEM SOC, V119, P10121, DOI 10.1021/ja9715096; LOWE DJ, 1984, BIOCHEM J, V224, P895, DOI 10.1042/bj2240895; LOWE DJ, 1993, BIOCHEM J, V292, P93, DOI 10.1042/bj2920093; Maskos Z, 2003, J INORG BIOCHEM, V93, P11, DOI 10.1016/S0162-0134(02)00480-4; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; PETERS JW, 1995, J BIOL CHEM, V270, P27007, DOI 10.1074/jbc.270.45.27007; POLLOCK RC, 1995, J AM CHEM SOC, V117, P8686, DOI 10.1021/ja00138a033; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rittle J, 2013, P NATL ACAD SCI USA, V110, P15898, DOI 10.1073/pnas.1310153110; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; SCOTT DJ, 1990, NATURE, V343, P188, DOI 10.1038/343188a0; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; THORNELEY RNF, 1983, BIOCHEM J, V215, P393, DOI 10.1042/bj2150393; Yan LF, 2011, EUR J INORG CHEM, P2064, DOI 10.1002/ejic.201100029	34	266	268	14	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1620	1623		10.1126/science.1256679	http://dx.doi.org/10.1126/science.1256679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258081	Green Accepted			2022-12-28	WOS:000342164500048
J	Garces, F; Sok, D; Kong, L; McBride, R; Kim, HJ; Saye-Francisco, KF; Julien, JP; Hua, YZ; Cupo, A; Moore, JP; Paulson, JC; Ward, AB; Burton, DR; Wilson, IA				Garces, Fernando; Sok, Devin; Kong, Leopold; McBride, Ryan; Kim, Helen J.; Saye-Francisco, Karen F.; Julien, Jean-Philippe; Hua, Yuanzi; Cupo, Albert; Moore, John P.; Paulson, James C.; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.			Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies	CELL			English	Article							BROAD; DEGLYCOSYLATION; GLYCOSYLATION; COMPLEX; CLONES; DOMAIN; GP120	The HIV envelope glycoprotein (Env) is densely covered with self-glycans that should help shield it from recognition by the human immune system. Here, we examine how a particularly potent family of broadly neutralizing antibodies (Abs) has evolved common and distinct structural features to counter the glycan shield and interact with both glycan and protein components of HIV Env. The inferred germline antibody already harbors potential binding pockets for a glycan and a short protein segment. Affinity maturation then leads to divergent evolutionary branches that either focus on a single glycan and protein segment (e.g., Ab PGT124) or engage multiple glycans (e.g., Abs PGT121-123). Furthermore, other surrounding glycans are avoided by selecting an appropriate initial antibody shape that prevents steric hindrance. Such molecular recognition lessons are important for engineering proteins that can recognize or accommodate glycans.	[Garces, Fernando; Kong, Leopold; Kim, Helen J.; Julien, Jean-Philippe; Hua, Yuanzi; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Garces, Fernando; Sok, Devin; Kong, Leopold; Saye-Francisco, Karen F.; Julien, Jean-Philippe; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Garces, Fernando; Sok, Devin; Kong, Leopold; Saye-Francisco, Karen F.; Julien, Jean-Philippe; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA; [Sok, Devin; Saye-Francisco, Karen F.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cupo, Albert; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Burton, Dennis R.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Burton, Dennis R.] Harvard Univ, Cambridge, MA 02139 USA; [Sok, Devin] Int AIDS Vaccine Initiat, New York, NY 10038 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; International AIDS Vaccine Initiative	Burton, DR (corresponding author), Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.	burton@scripps.edu; wilson@scripps.edu	Ward, Andrew B/F-9203-2014; Paulson, James/AAG-3565-2019; Ward, Andrew/ABD-7728-2021; McBride, Ryan/E-6812-2011	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Kong, Leopold/0000-0001-7456-1773; Kim, Helen/0000-0003-0096-7740; Julien, Jean-Philippe/0000-0001-7602-3995	DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences (NIGMS); US National Institutes of Health (NIH) through the National Center for Research Resources' P41 program [RR017573]; International AIDS Vaccine Initiative Neutralizing Antibody Center; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [CHAVI-ID UM1 AI00663]; HIV Vaccine Research and Design (HIVRAD) program [P01 AI832362, R37 AI36082]; NIH [R01 AI084817, R01 AI332932]; Joint Center of Structural Genomics (JCSG) - NIH NIGMS Protein Structure Initiative [U54 GM094586]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R56AI084817, R01AI033292, P01AI082362, R37AI036082, R01AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, U54GM094586, R01GM046192] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH's National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health (NIH) through the National Center for Research Resources' P41 program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative Neutralizing Antibody Center; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; HIV Vaccine Research and Design (HIVRAD) program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center of Structural Genomics (JCSG) - NIH NIGMS Protein Structure Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to N. Laursen and X. Dai for assistance with data processing; A. Irimia and A. Sarkar for assistance with glycan refinement; N. Laursen and R. Stanfield for helpful discussions; M. Elsliger for computer support; M. Deller and H. Tien for crystallization screening; C. Corbaci for help with preparing figures; and J.P. Verenini for manuscript formatting. X-ray data sets were collected at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the National Institute of General Medical Sciences (NIGMS). Electron microscopy data were collected at the National Resource for Automated Molecular Microscopy (NRAMM) at the Scripps Research Institute, which is supported by US National Institutes of Health (NIH) through the National Center for Research Resources' P41 program (RR017573). This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Center; by the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID UM1 AI00663) (A.B.W., D.R.B., and I.A.W.), by the HIV Vaccine Research and Design (HIVRAD) program (P01 AI832362 and R37 AI36082) (J.P.M., A.B.W., and I.A.W.), by NIH R01 AI084817 (I.A.W.), by NIH R01 AI332932 (D.R.B.), and by the Joint Center of Structural Genomics (JCSG) funded by the NIH NIGMS Protein Structure Initiative (U54 GM094586) (I.A.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Binley JM, 1998, AIDS RES HUM RETROV, V14, P191, DOI 10.1089/aid.1998.14.191; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Dam TK, 2000, J BIOL CHEM, V275, P14223, DOI 10.1074/jbc.275.19.14223; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746	35	137	159	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					69	79		10.1016/j.cell.2014.09.009	http://dx.doi.org/10.1016/j.cell.2014.09.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259921	Green Accepted, Bronze			2022-12-28	WOS:000343095000010
J	Gasparini, NM				Gasparini, Nicole M.			A fresh look at river flow	NATURE			English	Editorial Material									Tulane Univ, Dept Earth & Environm Sci, New Orleans, LA 70118 USA	Tulane University	Gasparini, NM (corresponding author), Tulane Univ, Dept Earth & Environm Sci, New Orleans, LA 70118 USA.	ngaspari@tulane.edu						Gilbert G.K., 1877, GEOLOGY HENRY MOUNTA, DOI 10.5962/bhl.title.51652; MacVicar BJ, 2012, WATER RESOUR RES, V48, DOI 10.1029/2010WR009374; Rantz S. E., 1982, 2175 USGS; Venditti JG, 2014, NATURE, V513, P534, DOI 10.1038/nature13779; von Karman T., 1930, NACHR GES WISS GOTT, V5, P58	5	1	1	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					490	491		10.1038/513490a	http://dx.doi.org/10.1038/513490a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254468				2022-12-28	WOS:000342075800023
J	Cole, TB				Cole, Thomas B.			Bingham Mine Jonas Lie	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1080	1081		10.1001/jama.2013.279727	http://dx.doi.org/10.1001/jama.2013.279727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226460				2022-12-28	WOS:000341624700001
J	Bewley, S; Rose, L; Gotzsche, P; Blennerhassett, M; Colquhoun, D; Pryke, M; Tindall, G; Braillon, A; Richmond, C; Illman, J; May, J				Bewley, Susan; Rose, Les; Gotzsche, Peter; Blennerhassett, Mitzi; Colquhoun, David; Pryke, Miriam; Tindall, Gillian; Braillon, Alain; Richmond, Caroline; Illman, John; May, James			BREAST CANCER SCREENING TRIAL Time to halt an out of control trial with ineffective oversight	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									[Bewley, Susan] St Thomas Hosp, Womens Hlth Acad Ctr, London SE1 7EH, England; [Gotzsche, Peter] Nord Cochrane Ctr, Copenhagen, Denmark; [Colquhoun, David] UCL, London, England; [Pryke, Miriam] Kings Coll London, London WC2R 2LS, England; [Braillon, Alain] Univ Hosp, Alcohol Treatment Unit, Amiens, France	Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; University of London; King's College London; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Bewley, S (corresponding author), St Thomas Hosp, Womens Hlth Acad Ctr, 10th Floor, London SE1 7EH, England.	susan.bewley@kcl.ac.uk	Colquhoun, David/C-1664-2008	Colquhoun, David/0000-0002-4263-017X				[Anonymous], 2009, PROTOCOL; Blennerhassett MAJ, 2012, RAPID RESPONSES INDE; Health Watch, 2014, CONC AG EXT TRIAL MA; Independent UK Panel on Breast Cancer Screening, 2012, IND BREAST SCREEN RE, V70; McCartney M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5105	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2014	349								g5601	10.1136/bmj.g5601	http://dx.doi.org/10.1136/bmj.g5601			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OP	25232068				2022-12-28	WOS:000342057500008
J	Mahalwar, P; Walderich, B; Singh, AP; Nusslein-Volhard, C				Mahalwar, Prateek; Walderich, Brigitte; Singh, Ajeet Pratap; Nuesslein-Volhard, Christiane			Local reorganization of xanthophores fine-tunes and colors the striped pattern of zebrafish	SCIENCE			English	Article							ADULT PIGMENT PATTERN; NEURAL CREST; CELLS; MELANOPHORES; IRIDOPHORES; SUGGESTS; FMS	The pattern of alternating blue and golden stripes displayed by adult zebrafish is composed of three kinds of pigment cells: black melanophores, yellow xanthophores, and silvery-blue iridophores. We analyzed the dynamics of xanthophores during stripe morphogenesis in vivo with long-term time-lapse imaging. Larval xanthophores start to proliferate at the onset of metamorphosis and give rise to adult xanthophores covering the flank before the arrival of stem-cell-derived iridophores and melanophores. Xanthophores compact to densely cover the iridophores forming the interstripe, and they acquire a loose stellate shape over the melanophores in the stripes. Thus, xanthophores, attracted by iridophores and repelling melanophores, sharpen and color the pattern. Variations on these cell behaviors may contribute to the generation of color pattern diversity in fish.	[Mahalwar, Prateek; Walderich, Brigitte; Singh, Ajeet Pratap; Nuesslein-Volhard, Christiane] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Max Planck Society	Singh, AP (corresponding author), Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany.	ajeet.singh@tuebingen.mpg.de; christiane.nuesslein-volhard@tuebingen.mpg.de		Singh, Ajeet/0000-0002-3819-5136	Max-Planck Society; European Molecular Biology Organization	Max-Planck Society(Max Planck Society); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank A. Mongera and S. Alsheimer for providing transgenic lines before publication; U. Irion, C. Sollner, and P. Muller for comments on the manuscript; and S. Perathoner, H.-G. Frohnhofer, A. Fadeev, U. Schach, H. Heth, and our fish facility, as well as C. Liebig and our light microscopy facility, for support. This work was funded by the Max-Planck Society. A.P.S. received a postdoctoral fellowship (EMBO-LTF) from the European Molecular Biology Organization.	Budi EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002044; Dooley CM, 2013, DEVELOPMENT, V140, P1003, DOI 10.1242/dev.087007; Frohnhofer HG, 2013, DEVELOPMENT, V140, P2997, DOI 10.1242/dev.096719; Gray C, 2011, THROMB HAEMOSTASIS, V105, P811, DOI 10.1160/TH10-08-0525; Hirata M, 2005, DEV DYNAM, V234, P293, DOI 10.1002/dvdy.20513; Hirata M, 2003, DEV DYNAM, V227, P497, DOI 10.1002/dvdy.10334; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; Mongera A, 2013, DEVELOPMENT, V140, P916, DOI 10.1242/dev.091066; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; Rodrigues FSLM, 2012, GENESIS, V50, P750, DOI 10.1002/dvg.22033; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; Takahashi G, 2008, PIGM CELL MELANOMA R, V21, P677, DOI 10.1111/j.1755-148X.2008.00504.x; Woolley TE, 2014, PIGM CELL MELANOMA R, V27, P686, DOI 10.1111/pcmr.12276; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Yamanaka H, 2014, P NATL ACAD SCI USA, V111, P1867, DOI 10.1073/pnas.1315416111	20	79	80	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1362	1364		10.1126/science.1254837	http://dx.doi.org/10.1126/science.1254837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214630				2022-12-28	WOS:000341483800069
J	Rebesco, M; Domack, E; Zgur, F; Lavoie, C; Leventer, A; Brachfeld, S; Willmott, V; Halverson, G; Truffer, M; Scambos, T; Smith, J; Pettit, E				Rebesco, M.; Domack, E.; Zgur, F.; Lavoie, C.; Leventer, A.; Brachfeld, S.; Willmott, V.; Halverson, G.; Truffer, M.; Scambos, T.; Smith, J.; Pettit, E.			Boundary condition of grounding lines prior to collapse, Larsen-B Ice Shelf, Antarctica	SCIENCE			English	Article							GLACIAL MORPHOLOGY; PALMER DEEP; SEA; DISINTEGRATION; STABILITY; BENEATH; SHEET; PENINSULA; RETREAT; SYSTEM	Grounding zones, where ice sheets transition between resting on bedrock to full floatation, help regulate ice flow. Exposure of the sea floor by the 2002 Larsen-B Ice Shelf collapse allowed detailed morphologic mapping and sampling of the embayment sea floor. Marine geophysical data collected in 2006 reveal a large, arcuate, complex grounding zone sediment system at the front of Crane Fjord. Radiocarbon-constrained chronologies from marine sediment cores indicate loss of ice contact with the bed at this site about 12,000 years ago. Previous studies and morphologic mapping of the fjord suggest that the Crane Glacier grounding zone was well within the fjord before 2002 and did not retreat further until after the ice shelf collapse. This implies that the 2002 Larsen-B Ice Shelf collapse likely was a response to surface warming rather than to grounding zone instability, strengthening the idea that surface processes controlled the disintegration of the Larsen Ice Shelf.	[Rebesco, M.; Zgur, F.; Lavoie, C.] Ist Nazl Oceanog & Geofis Sperimentale OGS, I-34010 Sgonico, TS, Italy; [Domack, E.] Hamilton Coll, Dept Geosci, Clinton, NY 13323 USA; [Domack, E.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Lavoie, C.] Univ Aveiro, Dept Geosci, Ctr Environm & Marine Studies, P-3810193 Aveiro, Portugal; [Leventer, A.] Colgate Univ, Dept Geol, Hamilton, NY 13346 USA; [Brachfeld, S.] Montclair State Univ, Dept Earth & Environm Studies, Montclair, NJ 07043 USA; [Willmott, V.] Alfred Wegener Inst Helmholtz Zentrum Polar & Mee, Int Cooperat, D-27570 Bremerhaven, Germany; [Halverson, G.] McGill Univ, Montreal, PQ H3A 2A7, Canada; [Truffer, M.] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Scambos, T.] Univ Colorado, Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; [Smith, J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Pettit, E.] Univ Alaska Fairbanks, Dept Geosci, Fairbanks, AK 99775 USA	Istituto Nazionale di Oceanografia e di Geofisica Sperimentale; Hamilton College; State University System of Florida; University of South Florida; Universidade de Aveiro; Colgate University; Montclair State University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; McGill University; University of Alaska System; University of Alaska Fairbanks; University of Colorado System; University of Colorado Boulder; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Alaska System; University of Alaska Fairbanks	Domack, E (corresponding author), Hamilton Coll, Dept Geosci, Clinton, NY 13323 USA.	edomack@usf.edu	Willmott Puig, Veronica/AGN-3478-2022; Rebesco, Michele/B-7462-2014	Rebesco, Michele/0000-0002-9492-4081; Brachfeld, Stefanie/0000-0003-4612-2866; Leventer, Amy/0000-0001-9401-0987; Zgur, Fabrizio/0000-0002-7761-4110; Pettit, Erin/0000-0002-6765-9841; Halverson, Galen/0000-0003-3061-7928	NSF-Office of Polar Programs [0732467, 0732625, 0732605]; Italian Programma Nazionale di Ricerche in Antartide project ULISSE; Natural Environment Research Council [bas0100027] Funding Source: researchfish	NSF-Office of Polar Programs(National Science Foundation (NSF)); Italian Programma Nazionale di Ricerche in Antartide project ULISSE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the shipboard participants, captain, and crew of cruises NBP0603 and LMG0502 and the staff at the Antarctic Marine Geology Research Facility, Florida State University. This project was supported by grants from the NSF-Office of Polar Programs (0732467 to E. D.; 0732625 to A. L.; 0732605 to S. B.) and from Italian Programma Nazionale di Ricerche in Antartide project ULISSE. The data reported in this paper are tabulated in the supplementary materials. M. R. collected and interpreted seismic reflection data aboard cruise NBP0603 and assisted with writing major portions of the manuscript. E. D. supervised collection of field data and sedimentologic core data for cruises LMG0502 and NBP0603, wrote major portions of the paper, and drafted Figs. 2 and 3. F.Z. collected, processed, and interpreted seismic reflection data aboard cruise NBP0603 and wrote sections of the paper dealing with interpretation of the reflection data. C. L. processed multibeam data, drafted Fig. 1, and wrote sections of the paper dealing with multibeam data. A. L. helped collect data aboard LMG0502 and NBP0603, analyzed diatom abundance data, and wrote sections of the paper dealing with diatom abundance and interpretation. S. B. helped collect data aboard NBP0603, collected and analyzed magnetic susceptibility data, and wrote sections of the paper dealing with physical properties of sediment cores. V. W. assisted in collecting sediment cores during LMG0502, collected color images of sediment cores during this cruise, and helped to draft portions of Fig. 2. G. H. assisted in collecting sediment cores during NBP0603, provided color images of sediment cores collected in this cruise, and helped with editing the manuscript. M.T. imported air geophysical data for interpretation of longitudinal profile of the Crane Glacier and provided editing of the manuscript. T.S. imported remote sensing data and interpretation of grounding line fluctuation before and after ice shelf collapse and assisted in writing and editing the paper. J.S. participated in collecting sediment cores and other data during LMG0502 and assisted in writing and editing the paper. E.P. was instrumental in the extensive discussion related to supplemental material dealing with ice terraces and morainal debris.	Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Anandakrishnan S, 2007, SCIENCE, V315, P1835, DOI 10.1126/science.1138393; Anderson JB, 1991, GEOLOGY ANTARCTICA, P285; Anderson JB, 2007, SCIENCE, V315, P1803, DOI 10.1126/science.1140766; Camerlenghi A, 2001, MAR GEOPHYS RES, V22, P417, DOI 10.1023/A:1016399616365; Canals M, 2000, GEOLOGY, V28, P31, DOI 10.1130/0091-7613(2000)028<0031:DSFEOP>2.3.CO;2; Domack E, 2005, NATURE, V436, P681, DOI 10.1038/nature03908; Domack E, 2006, GEOMORPHOLOGY, V75, P125, DOI 10.1016/j.geomorph.2004.06.013; DOMACK EW, 1993, GEOL SOC AM BULL, V105, P1175, DOI 10.1130/0016-7606(1993)105<1175:OAPCOM>2.3.CO;2; Domack EW, 1999, GEOL SOC AM BULL, V111, P1517, DOI 10.1130/0016-7606(1999)111<1517:LPHROT>2.3.CO;2; Evans J, 2005, NAT HIST, V114, P24; Hulbe CL, 2008, GLOBAL PLANET CHANGE, V63, P1, DOI 10.1016/j.gloplacha.2008.04.001; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; King EC, 2009, NAT GEOSCI, V2, P585, DOI 10.1038/NGEO581; McMullen K, 2006, PALAEOGEOGR PALAEOCL, V231, P169, DOI 10.1016/j.palaeo.2005.08.004; Oppenheimer M, 1998, NATURE, V393, P325, DOI 10.1038/30661; Post AL, 2007, MAR ECOL PROG SER, V344, P29, DOI 10.3354/meps06966; Rack W, 2004, ANN GLACIOL-SER, V39, P505, DOI 10.3189/172756404781814005; Rebesco M, 1998, MAR GEOL, V151, P89, DOI 10.1016/S0025-3227(98)00057-7; Rebesco M, 2011, MAR GEOL, V279, P141, DOI 10.1016/j.margeo.2010.10.018; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2006, PHILOS T R SOC A, V364, P1637, DOI 10.1098/rsta.2006.1793; Sane E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052632; Scambos T, 2003, ANTARCT RES SER, V79, P79; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Scambos TA, 2011, ANN GLACIOL, V52, P74, DOI 10.3189/172756411799096204; Skvarca P, 2004, ANN GLACIOL-SER, V39, P557, DOI 10.3189/172756404781814573; Sugden D. E., 1976, GLACIERS LANDSCAPE G	28	31	33	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1354	1358		10.1126/science.1256697	http://dx.doi.org/10.1126/science.1256697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214629	Green Accepted			2022-12-28	WOS:000341483800067
J	Brown, A; Amunts, A; Bai, XC; Sugimoto, Y; Edwards, PC; Murshudov, G; Scheres, SHW; Ramakrishnan, V				Brown, Alan; Amunts, Alexey; Bai, Xiao-chen; Sugimoto, Yoichiro; Edwards, Patricia C.; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.			Structure of the large ribosomal subunit from human mitochondria	SCIENCE			English	Article							ELONGATION-FACTOR-G; CRYO-EM STRUCTURE; TRANSFER-RNA; TRANSLATION; SNAPSHOTS; REVEALS; SEARCH; GENES; STALK; L11	Human mitochondrial ribosomes are highly divergent from all other known ribosomes and are specialized to exclusively translate membrane proteins. They are linked with hereditary mitochondrial diseases and are often the unintended targets of various clinically useful antibiotics. Using single-particle cryogenic electron microscopy, we have determined the structure of its large subunit to 3.4 angstrom resolution, revealing 48 proteins, 21 of which are specific to mitochondria. The structure unveils an adaptation of the exit tunnel for hydrophobic nascent peptides, extensive remodeling of the central protuberance, including recruitment of mitochondrial valine transfer RNA (tRNA(Val)) to play an integral structural role, and changes in the tRNA binding sites related to the unusual characteristics of mitochondrial tRNAs.	[Brown, Alan; Amunts, Alexey; Bai, Xiao-chen; Sugimoto, Yoichiro; Edwards, Patricia C.; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Scheres, Sjors H.W./AAY-2265-2021; Amunts, A./AAZ-2279-2020; Brown, Alan/I-1473-2019; Bai, Xiao-chen/HGV-1244-2022	Scheres, Sjors H.W./0000-0002-0462-6540; Amunts, A./0000-0002-5302-1740; Brown, Alan/0000-0002-0021-0476; Bai, Xiao-chen/0000-0002-4234-5686; Sugimoto, Yoichiro/0000-0003-1646-7679; Ramakrishnan, V/0000-0002-4699-2194	UK Medical Research Council [MC_U105184332, MC_UP_A025_1013]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; Human Frontiers Science Program; EU FP7 Marie Curie; MRC [MC_U105184332, MC_UP_A025_1012, MC_UP_A025_1013] Funding Source: UKRI; Medical Research Council [MC_U105184332, MC_UP_A025_1013, MC_UP_A025_1012] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; Human Frontiers Science Program(Human Frontier Science Program); EU FP7 Marie Curie(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Y. Gordiyenko for help with rRNA purification; S. Peak-Chew and M. Skehel for mass spectrometry; G. McMullan, S. Chen, and C. Savva for help with data collection; J. Grimmett and T. Darling for help with computing; and I. S. Fernandez and J. L. Llacer for stimulating discussions. This work was funded by grants from the UK Medical Research Council (MC_U105184332 to V. R. and MC_UP_A025_1013 to S. H. W. S.); a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute and the Jeantet Foundation (V. R.); fellowships from Human Frontiers Science Program (A. A.), and EU FP7 Marie Curie (X. B.). Cryo-EM density maps have been deposited with the Electron Microscopy Data Bank (accession number EMD-2762), and coordinates have been deposited with the Protein Data Bank (PDB) (entry code 3J7Y).	Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011; CHUNG HKJ, 1990, J BIOL CHEM, V265, P21000; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Lehmann J, 2013, NUCLEIC ACIDS RES, V41, P5494, DOI 10.1093/nar/gkt219; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Lightowlers RN, 2014, FEBS LETT, V588, P2496, DOI 10.1016/j.febslet.2014.05.054; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; Noeske J, 2012, CURR OPIN STRUC BIOL, V22, P743, DOI 10.1016/j.sbi.2012.07.011; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; Rhodin MHJ, 2011, MOL GENET GENOMICS, V285, P505, DOI 10.1007/s00438-011-0623-2; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Singh R, 2014, MITOCHONDRION, V16, P50, DOI 10.1016/j.mito.2013.10.005; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577	30	193	232	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					718	722		10.1126/science.1258026	http://dx.doi.org/10.1126/science.1258026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25278503	Green Accepted			2022-12-28	WOS:000344690100032
J	Anderson, DA				Anderson, David A.			A detour for love	SCIENCE			English	Editorial Material									Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Anderson, DA (corresponding author), Washington Univ, St Louis, MO 63130 USA.								0	0	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					134	134		10.1126/science.346.6205.134	http://dx.doi.org/10.1126/science.346.6205.134			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0BR	25278613	Bronze			2022-12-28	WOS:000342446900063
J	Bisognano, M; Schummers, D				Bisognano, Maureen; Schummers, Dan			ESSAY Flipping healthcare: an essay by Maureen Bisognano and Dan Schummers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bisognano, Maureen; Schummers, Dan] Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Bisognano, M (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	mbisognano@ihi.org	Bisognano, Maureen/AAR-9724-2020					Asch DA, 2012, NEW ENGL J MED, V367, P1, DOI 10.1056/NEJMp1203869; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; De Blok J, 2013, JOURNAL; IHI Open School, 2013, TREV PERKS DIAB; Kenney C.C., 2008, PUBLIC AFFAIRS; Kretzmann J, 1996, NATL CIVIC REV, V85, P23, DOI [10.1002/ncr.4100850405, DOI 10.1002/NCR.4100850405]; Rosenberg Tina, 2013, NY TIMES; Sheehan A, 2014, HLTH CARE WHOLE PERS	8	18	18	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	2014	349								g5852	10.1136/bmj.g5852	http://dx.doi.org/10.1136/bmj.g5852			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CI	25280777				2022-12-28	WOS:000342665900003
J	Andrews, LC; Catania, GA; Hoffman, MJ; Gulley, JD; Luthi, MP; Ryser, C; Hawley, RL; Neumann, TA				Andrews, Lauren C.; Catania, Ginny A.; Hoffman, Matthew J.; Gulley, Jason D.; Luethi, Martin P.; Ryser, Claudia; Hawley, Robert L.; Neumann, Thomas A.			Direct observations of evolving subglacial drainage beneath the Greenland Ice Sheet	NATURE			English	Article							HAUT GLACIER DAROLLA; WATER-PRESSURE; BASAL MOTION; ABLATION ZONE; SURFACE; FLOW; SYSTEM; MELT; ACCELERATION; EVOLUTION	Seasonal acceleration of the Greenland Ice Sheet is influenced by the dynamic response of the subglacial hydrologic system to variability in meltwater delivery to the bed(1,2) via crevasses and moulins (vertical conduits connecting supraglacial water to the bed of the ice sheet). As the melt season progresses, the subglacial hydrologic system drains supraglacial meltwater more efficiently(1-4), decreasing basal water pressure(4) and moderating the ice velocity response to surface melting(1,2). However, limited direct observations of subglacial water pressure(4-7) mean that the spatiotemporal evolution of the subglacial hydrologic system remains poorly understood. Here we show that ice velocity is well correlated with moulin hydraulic head but is out of phase with that of nearby (0.3-2 kilometres away) boreholes, indicating that moulins connect to an efficient, channelized component of the subglacial hydrologic system, which exerts the primary control on diurnal and multi-day changes in ice velocity. Our simultaneous measurements of moulin and borehole hydraulic head and ice velocity in the Paakitsoq region of western Greenland show that decreasing trends in ice velocity during the latter part of the melt season cannot be explained by changes in the ability of moulin-connected channels to convey supraglacial melt. Instead, these observations suggest that decreasing late-season ice velocity may be caused by changes in connectivity in unchannelized regions of the subglacial hydrologic system. Understanding this spatiotemporal variability in subglacial pressures is increasingly important because melt-season dynamics affect ice velocity beyond the conclusion of the melt season(8-10).	[Andrews, Lauren C.; Catania, Ginny A.; Gulley, Jason D.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Andrews, Lauren C.; Catania, Ginny A.; Ryser, Claudia] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78758 USA; [Hoffman, Matthew J.] Los Alamos Natl Lab, Fluid Dynam & Solid Mech Grp, Los Alamos, NM 87545 USA; [Hoffman, Matthew J.; Neumann, Thomas A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Gulley, Jason D.] Michigan Technol Univ, Dept Geol & Mining Engn & Sci, Houghton, MI 49931 USA; [Luethi, Martin P.] Univ Zurich, Dept Geog, Glaciol & Geomorphodynam Grp, Phys Geog Div, CH-8057 Zurich, Switzerland; [Luethi, Martin P.; Ryser, Claudia] Swiss Fed Inst Technol, Lab Hydraul Hydrol & Glaciol, CH-8093 Zurich, Switzerland; [Hawley, Robert L.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Michigan Technological University; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Dartmouth College	Andrews, LC (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	landrews@ig.utexas.edu	Lüthi, Martin/AAA-3668-2021; Catania, Ginny/B-9787-2008; Andrews, Lauren C/D-8274-2017; Neumann, Thomas/D-5264-2012	Lüthi, Martin/0000-0003-4419-8496; Catania, Ginny/0000-0002-7561-5902; Andrews, Lauren C/0000-0003-3727-4737; Hawley, Robert/0000-0001-8466-0839; Hoffman, Matthew/0000-0001-5076-0540	United States National Science Foundation [OPP-0908156, OPP-0909454, ANT-0424589]; Swiss National Science Foundation [200021_127197]; National Geographic Society [9067-12]; UTIG; NASA Cryospheric Sciences and Climate Modeling Programs within US Department of Energy, Office of Science; NSF [EAR-0946767]; NSF; NASA [EAR-0735156]; NSF OPP [ANT-1043681]	United States National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Geographic Society(National Geographic Society); UTIG; NASA Cryospheric Sciences and Climate Modeling Programs within US Department of Energy, Office of Science(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NSF OPP(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was supported by United States National Science Foundation grants OPP-0908156, OPP-0909454 and ANT-0424589 (to CReSIS), Swiss National Science Foundation grant 200021_127197, and National Geographic Society grant 9067-12. L. C. A. was also supported by UTIG Ewing-Worzel and Gale White Graduate Student Fellowships. M.J.H. was also supported by NASA Cryospheric Sciences and Climate Modeling Programs within the US Department of Energy, Office of Science. J.D.G. was also supported by an NSF Postdoctoral Fellowship (EAR-0946767). Logistical support was provided by CH2MHill Polar Services. The GPS base station and several on-ice GPS units were provided by the UNAVCO facility with support from the NSF and NASA under cooperative agreement EAR-0735156. The University of Minnesota Polar Geospatial Center, funded under NSF OPP collaborative agreement ANT-1043681, provided WorldView imagery. We thank K. M. Schild, J. A. MacGregor, J. D. Nowinski, B. F. Morriss and others for assistance in the field.	Anderson RS, 2004, J GEOPHYS RES-EARTH, V109, DOI 10.1029/2004JF000120; Bartholomaus TC, 2008, NAT GEOSCI, V1, P33, DOI 10.1038/ngeo.2007.52; Bartholomew I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002220; Bartholomew I, 2010, NAT GEOSCI, V3, P408, DOI 10.1038/NGEO863; Catania GA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041108; Catania GA, 2008, J GLACIOL, V54, P567, DOI 10.3189/002214308786570854; Chandler DM, 2013, NAT GEOSCI, V6, P195, DOI 10.1038/ngeo1737; Chen G., 1998, THESIS MIT; Covington MD, 2012, J HYDROL, V414, P59, DOI 10.1016/j.jhydrol.2011.10.027; Cowton T, 2013, J GEOPHYS RES-EARTH, V118, P29, DOI 10.1029/2012JF002540; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Dow CF, 2013, ANN GLACIOL, V54, P135, DOI 10.3189/2013AoG64A032; Doyle SH, 2014, GEOPHYS RES LETT, V41, P899, DOI 10.1002/2013GL058933; Gogineni P., 2012, CRESIS RADAR DEPTH S; Gordon S, 1998, HYDROL PROCESS, V12, P105, DOI 10.1002/(SICI)1099-1085(199801)12:1<105::AID-HYP566>3.3.CO;2-R; Gulley JD, 2012, J GLACIOL, V58, P926, DOI 10.3189/2012JoG11J189; Harper JT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030233; Harrison W. D., 1988, P 3 INT WORKSH IC DR, P123; Hewitt IJ, 2013, EARTH PLANET SC LETT, V371, P16, DOI 10.1016/j.epsl.2013.04.022; Hoffman MJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001934; Hoffman M, 2014, J GEOPHYS RES-EARTH, V119, P414, DOI 10.1002/2013JF002943; HOLMLUND P, 1983, GEOGR ANN A, V65, P19, DOI 10.2307/520717; Howat IM, 2014, CRYOSPHERE, V8, P1509, DOI 10.5194/tc-8-1509-2014; Howat IM, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000925; HUBBARD BP, 1995, J GLACIOL, V41, P572, DOI 10.3189/S0022143000034894; HUMPHREY N, 1990, J GLACIOL, V36, P287, DOI 10.3189/002214390793701354; Iken A, 1997, J GLACIOL, V43, P328, DOI 10.3189/S0022143000003282; Iken A., 1972, J GLACIOL, V11, P53, DOI [10.3189/S0022143000022486, DOI 10.3189/S0022143000022486]; Joughin I, 2013, CRYOSPHERE, V7, P1185, DOI 10.5194/tc-7-1185-2013; LI VC, 1984, PURE APPL GEOPHYS, V122, P545, DOI 10.1007/BF00874616; Luthi M, 2002, J GLACIOL, V48, P369, DOI 10.3189/172756502781831322; Mair D, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000514; Mair D, 2003, J GLACIOL, V49, P555, DOI 10.3189/172756503781830467; Mair DWF, 2002, J GLACIOL, V48, P208, DOI 10.3189/172756502781831502; McGrath D, 2011, J GLACIOL, V57, P954, DOI 10.3189/002214311798043735; Meierbachtol T, 2013, SCIENCE, V341, P777, DOI 10.1126/science.1235905; MURRAY T, 1995, J GEOPHYS RES-SOL EA, V100, P10231, DOI 10.1029/95JB00671; Paterson W. S. B., 1994, PHYS GLACIERS, P60; Ryser C, 2014, J GLACIOL, V60, P647, DOI 10.3189/2014JoG13J196; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618; Sole A, 2013, GEOPHYS RES LETT, V40, P3940, DOI 10.1002/grl.50764; Sugiyama S, 2004, J GLACIOL, V50, P353, DOI 10.3189/172756504781829846; Sundal AV, 2011, NATURE, V469, P522, DOI 10.1038/nature09740; Tedstone AJ, 2013, P NATL ACAD SCI USA, V110, P19719, DOI 10.1073/pnas.1315843110; Vieli A, 2004, J GLACIOL, V50, P389, DOI 10.3189/172756504781829963; Walter F, 2014, GEOLOGY, V42, P487, DOI 10.1130/G35492.1; Werder MA, 2009, J GLACIOL, V55, P889, DOI 10.3189/002214309790152447	47	186	186	5	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					80	+		10.1038/nature13796	http://dx.doi.org/10.1038/nature13796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279921				2022-12-28	WOS:000342420800039
J	Tosches, MA; Bucher, D; Vopalensky, P; Arendt, D				Tosches, Maria Antonietta; Bucher, Daniel; Vopalensky, Pavel; Arendt, Detlev			Melatonin Signaling Controls Circadian Swimming Behavior in Marine Zooplankton	CELL			English	Article							REAL-TIME PCR; VERTICAL MIGRATION; CILIARY PHOTORECEPTORS; PLATYNEREIS LARVAE; SLEEP; EVOLUTION; NEURONS; OPSIN; RADIATION; REVEALS	Melatonin, the "hormone of darkness," is a key regulator of vertebrate circadian physiology and behavior. Despite its ubiquitous presence in Metazoa, the function of melatonin signaling outside vertebrates is poorly understood. Here, we investigate the effect of melatonin signaling on circadian swimming behavior in a zooplankton model, the marine annelid Platynereis dumerilii. We find that melatonin is produced in brain photoreceptors with a vertebrate-type opsin-based phototransduction cascade and a light-entrained clock. Melatonin released at night induces rhythmic burst firing of cholinergic neurons that innervate locomotor-ciliated cells. This establishes a nocturnal behavioral state by modulating the length and the frequency of ciliary arrests. Based on our findings, we propose that melatonin signaling plays a role in the circadian control of ciliary swimming to adjust the vertical position of zooplankton in response to ambient light.	[Tosches, Maria Antonietta; Bucher, Daniel; Vopalensky, Pavel; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Bucher, Daniel; Arendt, Detlev] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Tosches, MA (corresponding author), European Mol Biol Lab, Dev Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	tosches@embl.de; arendt@embl.de		Vopalensky, Pavel/0000-0002-6171-1557	European Molecular Biology Laboratory; European Research Council [EAAdG-2011-294810_BrainEvoDevo]; Deutsche Forschungsgemeinschaft [AR 387/2-1, SFB488-A14]	European Molecular Biology Laboratory; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the European Molecular Biology Laboratory (to M.A.T., D.B., P.V., and D.A.), by a European Research Council grant (EAAdG-2011-294810_BrainEvoDevo) (to D.A., M.A.T., and P.V.), and by Deutsche Forschungsgemeinschaft grants (AR 387/2-1 to D.A; SFB488-A14 to D.A. and D.B.). We thank the EMBL Advanced Light Microscopy Facility and Genomic Core Facility, with special thanks to P. Collier and V. Benes for the Fluidigm experiments, H. Bading for generous access to the resources of the Department of Neurobiology, IZN, Heidelberg, C.P. Bengtson for assistance during electrophysiology experiments, G. Jekely for the initial analysis of MTNR and CNGA alpha expression and critical feedback, K. Tessmar-Raible for insightful discussions, H. Martinez-Vergara for producing the GCaMP6s mRNA, R. Tomer for averaging gene expression patterns for PrImR, H. Roebert for the initial efforts to clone the hiomt gene, and the Arendt lab for constructive feedback.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; ALLDREDGE AL, 1980, J EXP MAR BIOL ECOL, V44, P133, DOI 10.1016/0022-0981(80)90150-1; ANCTIL M, 1991, J COMP PHYSIOL B, V161, P569, DOI 10.1007/BF00260746; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; BALZER I, 1991, SCIENCE, V253, P795, DOI 10.1126/science.1876838; Bentkowski P, 2010, HYDROBIOLOGIA, V643, P43, DOI 10.1007/s10750-010-0134-x; CALKINS J, 1980, NATURE, V283, P563, DOI 10.1038/283563a0; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; DOLLINS AB, 1994, P NATL ACAD SCI USA, V91, P1824, DOI 10.1073/pnas.91.5.1824; Douglas CL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-42; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Falcon J, 2010, BIOLOGICAL CLOCK IN FISH, P9, DOI 10.1201/b10170-3; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; HARDELAND R, 1995, J PINEAL RES, V18, P104, DOI 10.1111/j.1600-079X.1995.tb00147.x; Hardeland R, 2003, J PINEAL RES, V34, P233, DOI 10.1034/j.1600-079X.2003.00040.x; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; JIANG ZG, 1995, BRAIN RES, V687, P125, DOI 10.1016/0006-8993(95)00478-9; LACALLI TC, 1990, PHILOS T R SOC B, V330, P391, DOI 10.1098/rstb.1990.0207; LACALLI TC, 1990, PHILOS T R SOC B, V330, P371, DOI 10.1098/rstb.1990.0206; Lamb TD, 2013, PROG RETIN EYE RES, V36, P52, DOI 10.1016/j.preteyeres.2013.06.001; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Marlow H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-7; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; Nilsson DE, 2013, VISUAL NEUROSCI, V30, P5, DOI 10.1017/S0952523813000035; NOWAK JZ, 1993, J PINEAL RES, V15, P35, DOI 10.1111/j.1600-079X.1993.tb00507.x; Ochoa-Sanchez R, 2011, J NEUROSCI, V31, P18439, DOI 10.1523/JNEUROSCI.2676-11.2011; Ooka S, 2010, DEV GROWTH DIFFER, V52, P195, DOI 10.1111/j.1440-169X.2009.01154.x; Passamaneck YJ, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-6; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Randel N, 2014, ELIFE, V3, DOI 10.7554/eLife.02730; Randel N, 2013, INTEGR COMP BIOL, V53, P7, DOI 10.1093/icb/ict046; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; Rivera AS, 2012, J EXP BIOL, V215, P1278, DOI 10.1242/jeb.067140; Roopin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052266; RUDJAKOV JA, 1970, MAR BIOL, V6, P98, DOI 10.1007/BF00347238; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tanaka D, 2007, NEUROPHARMACOLOGY, V53, P157, DOI 10.1016/j.neuropharm.2007.04.017; Tilden AR, 2003, BRAIN RES, V992, P252, DOI 10.1016/j.brainres.2003.08.053; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Tosches MA, 2013, CURR OPIN NEUROBIOL, V23, P1080, DOI 10.1016/j.conb.2013.09.005; Yang XF, 2011, NEUROSCIENCE, V173, P19, DOI 10.1016/j.neuroscience.2010.11.028; Zantke J, 2014, GENETICS, V197, P19, DOI 10.1534/genetics.112.148254; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	49	75	77	0	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					46	57		10.1016/j.cell.2014.07.042	http://dx.doi.org/10.1016/j.cell.2014.07.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259919	Green Published, hybrid			2022-12-28	WOS:000343095000008
J	Mayor, M; Lovis, C; Santos, NC				Mayor, Michel; Lovis, Christophe; Santos, Nuno C.			Doppler spectroscopy as a path to the detection of Earth-like planets	NATURE			English	Review							EXTRA-SOLAR PLANETS; NEPTUNE-MASS PLANET; IN SUPER-EARTHS; BRIGHT K-STAR; M-CIRCLE-PLUS; HARPS SEARCH; HOT JUPITERS; 51 PEGASI; LITHIUM DEPLETION; ORBITAL MIGRATION	Doppler spectroscopy was the first technique used to reveal the existence of extrasolar planetary systems hosted by solar-type stars. Radial-velocity surveys led to the detection of a rich population of super-Earths and Neptune-type planets. The numerous detected systems revealed a remarkable diversity. Combining Doppler measurements with photometric observations of planets transiting their host stars further provides access to the planet bulk density, a first step towards comparative exoplanetology. The development of new high-precision spectrographs and space-based facilities will ultimately lead us to characterize rocky planets in the habitable zone of our close stellar neighbours.	[Mayor, Michel; Lovis, Christophe] Univ Geneva, Geneva Observ, CH-1290 Versoix, Switzerland; [Santos, Nuno C.] Univ Porto, Fac Ciencias, Ctr Astrofis, P-4150762 Oporto, Portugal; [Santos, Nuno C.] Univ Porto, Fac Ciencias, Dept Fis & Astron, P-4150762 Oporto, Portugal; [Santos, Nuno C.] Univ Porto, Ctr Astrofis, Inst Astrofis & Ciencias Espaco, P-4150762 Oporto, Portugal	University of Geneva; Universidade do Porto; Universidade do Porto; Universidade do Porto	Mayor, M (corresponding author), Univ Geneva, Geneva Observ, 51 Chemin Maillettes, CH-1290 Versoix, Switzerland.	michel.mayor@unige.ch	Santos, Nuno C/E-9957-2011	Santos, Nuno C/0000-0003-4422-2919	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [IF/00169/2012]; POPH/FSE (EC) by FEDER through the program Programa Operacional de Factores de Competitividade-COMPETE; European Research Council/European Community [239953]; Swiss National Science Foundation	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); POPH/FSE (EC) by FEDER through the program Programa Operacional de Factores de Competitividade-COMPETE; European Research Council/European Community(European CommissionEuropean Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank A. Triaud for his help in preparing Fig. 2. N.C.S. was supported by Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through the Investigador FCT contract reference IF/00169/2012 and POPH/FSE (EC) by FEDER funding through the program Programa Operacional de Factores de Competitividade-COMPETE. N.C.S. further acknowledges the support from the European Research Council/European Community under FP7 through Starting Grant agreement number 239953. M.M and C.L. acknowledge the support of the Swiss National Science Foundation.	Adibekyan VZ, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322551; Adibekyan VZ, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219564; Aigrain S, 2012, MON NOT R ASTRON SOC, V419, P3147, DOI 10.1111/j.1365-2966.2011.19960.x; Bakos G, 2004, PUBL ASTRON SOC PAC, V116, P266, DOI 10.1086/382735; Bakos GA, 2010, ASTROPHYS J, V710, P1724, DOI 10.1088/0004-637X/710/2/1724; Baranne A, 1996, ASTRON ASTROPHYS SUP, V119, P373, DOI 10.1051/aas:1996251; Batygin K, 2010, ASTROPHYS J LETT, V714, pL238, DOI 10.1088/2041-8205/714/2/L238; Baumann P, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/201015137; Belorizky D, 1938, ASTRONOMIE, V52, P359; Bodenheimer P, 2001, ASTROPHYS J, V548, P466, DOI 10.1086/318667; Boisse I, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219115; Bonfils X, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201014704; Bonfils X, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219623; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; BOSS AP, 1995, SCIENCE, V267, P360, DOI 10.1126/science.267.5196.360; Bouchy F, 2005, ASTRON ASTROPHYS, V444, pL15, DOI 10.1051/0004-6361:200500201; Brogi M, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/27; Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Burrows A, 2007, ASTROPHYS J, V661, P502, DOI 10.1086/514326; Butler RP, 1996, PUBL ASTRON SOC PAC, V108, P500, DOI 10.1086/133755; Butler RP, 2004, ASTROPHYS J, V617, P580, DOI 10.1086/425173; Butler RP, 1997, ASTROPHYS J, V474, pL115, DOI 10.1086/310444; Butler RP, 1999, ASTROPHYS J, V526, P916, DOI 10.1086/308035; CAMPBELL B, 1988, ASTROPHYS J, V331, P902, DOI 10.1086/166608; Campbell B., 1985, STELLAR RADIAL VELOC, P5; Chabrier G, 2007, ASTROPHYS J, V661, pL81, DOI 10.1086/518473; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Chiang E, 2013, MON NOT R ASTRON SOC, V431, P3444, DOI 10.1093/mnras/stt424; Cochran W. D., 1999, IAU C, P113; Correia ACM, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200912700; Correia ACM, 2009, ASTRON ASTROPHYS, V496, P521, DOI 10.1051/0004-6361:200810774; Crida A., ASTRON ASTR IN PRESS; Cumming A, 2008, PUBL ASTRON SOC PAC, V120, P531, DOI 10.1086/588487; Dawson RI, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/2/L24; Dawson RI, 2010, ASTROPHYS J, V722, P937, DOI 10.1088/0004-637X/722/1/937; Delfosse X, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201219013; Demory BO, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117178; Dick S. J., 1991, BIOASTRONOMY SEARCH, P356; Dragomir D, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/1/L2; Dumusque X, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117148; Dumusque X, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015877; Dumusque X, 2012, NATURE, V491, P207, DOI 10.1038/nature11572; Endl M, 2000, ASTRON ASTROPHYS, V362, P585; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Ford EB, 2008, ASTROPHYS J, V686, P621, DOI 10.1086/590926; Gillon M, 2007, ASTRON ASTROPHYS, V472, pL13, DOI 10.1051/0004-6361:20077799; Hernandez JIG, 2010, ASTROPHYS J, V720, P1592, DOI 10.1088/0004-637X/720/2/1592; Guillot T, 2006, ASTRON ASTROPHYS, V453, pL21, DOI 10.1051/0004-6361:20065476; Guillot T, 2002, ASTRON ASTROPHYS, V385, P156, DOI 10.1051/0004-6361:20011624; Hebrard G, 2008, ASTRON ASTROPHYS, V488, P763, DOI 10.1051/0004-6361:200810056; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; Holman M, 1997, NATURE, V386, P254, DOI 10.1038/386254a0; Howard AW, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/10; Howard AW, 2010, SCIENCE, V330, P653, DOI 10.1126/science.1194854; Israelian G, 2001, NATURE, V411, P163, DOI 10.1038/35075512; Israelian G, 2009, NATURE, V462, P189, DOI 10.1038/nature08483; Jeans J., 1919, PROBLEMS COSMOGONY S, P290; LATHAM DW, 1989, NATURE, V339, P38, DOI 10.1038/339038a0; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lovis C, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015577; Lovis C, 2009, IAU SYMP P SERIES, P502, DOI 10.1017/S1743921308027051; Marcy G. W., 1994, BOTTOM MAIN SEQUENCE, P98; Marcy GW, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/20; MARCY GW, 1992, PUBL ASTRON SOC PAC, V104, P270, DOI 10.1086/132989; Mayor M, 2009, ASTRON ASTROPHYS, V507, P487, DOI 10.1051/0004-6361/200912172; Mayor M, 2009, ASTRON ASTROPHYS, V493, P639, DOI 10.1051/0004-6361:200810451; Mayor M., 2011, HARPS SEARCH SO EXTR; Mayor M., 2003, MESSENGER, V114, P20; Mazeh T, 2000, ASTROPHYS J, V532, pL55, DOI 10.1086/312558; McArthur BE, 2004, ASTROPHYS J, V614, pL81, DOI 10.1086/425561; Meunier N, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201219917; Mordasini C, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201117350; Moutou C, 2009, ASTRON ASTROPHYS, V498, pL5, DOI 10.1051/0004-6361/200911954; Naef D, 2001, ASTRON ASTROPHYS, V375, pL27, DOI 10.1051/0004-6361:20010853; Pepe F, 2007, ASTRON ASTROPHYS, V462, P769, DOI 10.1051/0004-6361:20066194; Pepe F, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117055; Pollacco DL, 2006, PUBL ASTRON SOC PAC, V118, P1407, DOI 10.1086/508556; Queloz D, 2000, ASTRON ASTROPHYS, V354, P99; Queloz D, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014768; Ramirez I, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201014456; Rasio FA, 1996, SCIENCE, V274, P954, DOI 10.1126/science.274.5289.954; Reddy BE, 2002, MON NOT R ASTRON SOC, V335, P1005, DOI 10.1046/j.1365-8711.2002.05682.x; Reuyl D, 1943, ASTROPHYS J, V97, P41, DOI 10.1086/144489; Rivera EJ, 2010, ASTROPHYS J, V719, P890, DOI 10.1088/0004-637X/719/1/890; Santos NC, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321286; Santos NC, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015494; Santos NC, 2004, ASTRON ASTROPHYS, V426, pL19, DOI 10.1051/0004-6361:200400076; Sato B, 2005, ASTROPHYS J, V633, P465, DOI 10.1086/449306; Selsis F, 2007, ASTRON ASTROPHYS, V476, P1373, DOI 10.1051/0004-6361:20078091; Strand K, 1943, PASP, V55, P29, DOI [DOI 10.1086/125484, 10.1086/125484]; Struve O., 1952, OBSERVATORY, V72, P199; Takeda G, 2005, ASTROPHYS J, V627, P1001, DOI 10.1086/430467; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Tinney CG, 2001, ASTROPHYS J, V551, P507, DOI 10.1086/320097; Torres G, 2008, ASTROPHYS J, V677, P1324, DOI 10.1086/529429; Triaud AHMJ, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014525; Triaud AHMJ, 2009, ASTRON ASTROPHYS, V506, P377, DOI 10.1051/0004-6361/200911897; Tuomi M, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220268; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; WALKER GAH, 1995, ICARUS, V116, P359, DOI 10.1006/icar.1995.1130; Winn JN, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/1/L18; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145; Wright JT, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/160; Wright JT, 2009, ASTROPHYS J, V693, P1084, DOI 10.1088/0004-637X/693/2/1084; Zeng L, 2013, PUBL ASTRON SOC PAC, V125, P227, DOI 10.1086/669163	117	52	52	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					328	335		10.1038/nature13780	http://dx.doi.org/10.1038/nature13780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230654				2022-12-28	WOS:000341814900045
J	Stafford-Smith, M				Stafford-Smith, Mark			UN sustainability goals need quantified targets	NATURE			English	Editorial Material									[Stafford-Smith, Mark] Sci Comm Future Earth, Paris, France; [Stafford-Smith, Mark] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Stafford-Smith, M (corresponding author), Sci Comm Future Earth, Paris, France.	mark.staffordsmith@csiro.au	Smith, Mark Stafford/G-1680-2010	Smith, Mark Stafford/0000-0002-1333-3651					0	22	24	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					281	281		10.1038/513281a	http://dx.doi.org/10.1038/513281a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1GD	25230610	Bronze			2022-12-28	WOS:000341814900007
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: We lack the tools to help patients decide about statins	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADHERENCE; MORTALITY					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				CANNER PL, 1980, NEW ENGL J MED, V303, P1038; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Curtis JR, 2011, MED CARE, V49, P427, DOI 10.1097/MLR.0b013e318207ed9e; Hinchliffe A, 2011, PATIENT ADHERENCE TO; McPherson K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4130; National Institute for Health and Care Excellence, 2014, LIPID MODIFICATION C	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2014	349								g5688	10.1136/bmj.g5688	http://dx.doi.org/10.1136/bmj.g5688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OP	25227927	Green Published, Bronze			2022-12-28	WOS:000342057500017
J	Garcia, P; Armstrong, R; Zaman, MH				Garcia, Patricia; Armstrong, Robert; Zaman, Muhammad H.			Models of education in medicine, public health, and engineering	SCIENCE			English	Editorial Material								Discussion on global health in both the academic and the public domain has focused largely on research, capacity building, and service delivery. Although these efforts along with financial commitments from public and private partners have contributed to a broader appreciation and understanding of global health challenges, the reflection of global health in academic training has largely been lacking. However, integrative models are beginning to appear.	[Garcia, Patricia] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Armstrong, Robert] Aga Khan Univ, Dept Paediat, Coll Med, Nairobi, Kenya; [Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA	Universidad Peruana Cayetano Heredia; Aga Khan University; Boston University; Howard Hughes Medical Institute	Garcia, P (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru.			Armstrong, Robert/0000-0001-9319-3961				Crisp N., 2010, TUMING WORLD UPSIDE; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Garcia PJ, 2009, J PUBLIC HEALTH POL, V30, P250, DOI 10.1057/jphp.2009.6; Medical Education Partnership Initiative Principal Investigators, 2014, ACAD MED S8, V89, pS1; Oden M, 2010, ANN BIOMED ENG, V38, P3031, DOI 10.1007/s10439-010-0036-0	5	6	7	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1281	1283		10.1126/science.1258782	http://dx.doi.org/10.1126/science.1258782			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214613				2022-12-28	WOS:000341483800045
J	Baker, NE; Jenny, A				Baker, Nicholas E.; Jenny, Andreas			Metabolism and the Other Fat: A Protocadherin in Mitochondria	CELL			English	Editorial Material							CADHERINS		[Baker, Nicholas E.; Jenny, Andreas] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Baker, Nicholas E.; Jenny, Andreas] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	nicholas.baker@einstein.yu.edu; andreas.jenny@einstein.yu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104213, R01GM088202] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM088202, R01 GM104213, GM088202, GM104213] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bossuyt W, 2014, ONCOGENE, V33, P1218, DOI 10.1038/onc.2013.82; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Morris LGT, 2013, CELL CYCLE, V12, P1011, DOI 10.4161/cc.24305; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Sharma P, 2013, PROG MOL BIOL TRANSL, V116, P215, DOI 10.1016/B978-0-12-394311-8.00010-8; Sing A, 2014, CELL, V158, P1293, DOI 10.1016/j.cell.2014.07.036; Thomas C, 2012, DEV DYNAM, V241, P27, DOI 10.1002/dvdy.22736; Zhao X., 2013, PLOS ONE, V8	8	0	0	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1240	1241		10.1016/j.cell.2014.08.039	http://dx.doi.org/10.1016/j.cell.2014.08.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215484	Bronze			2022-12-28	WOS:000343094200007
J	Sing, A; Tsatskis, Y; Fabian, L; Hester, I; Rosenfeld, R; Serricchio, M; Yau, N; Bietenhader, M; Shanbhag, R; Jurisicova, A; Brill, JA; McQuibban, GA; McNeill, H				Sing, Anson; Tsatskis, Yonit; Fabian, Lacramioara; Hester, Ian; Rosenfeld, Robyn; Serricchio, Mauro; Yau, Norman; Bietenhader, Mailis; Shanbhag, Riya; Jurisicova, Andrea; Brill, Julie A.; McQuibban, G. Angus; McNeill, Helen			The Atypical Cadherin Fat Directly Regulates Mitochondrial Function and Metabolic State	CELL			English	Article							RESPIRATORY COMPLEX-I; PLANAR CELL POLARITY; DROSOPHILA-MELANOGASTER; HIPPO PATHWAY; LIFE-SPAN; MUTATIONS; PROTOCADHERINS; PROLIFERATION; MORPHOGENESIS; RECEPTOR	Fat (Ft) cadherins are enormous cell adhesion molecules that function at the cell surface to regulate the tumor-suppressive Hippo signaling pathway and planar cell polarity (PCP) tissue organization. Mutations in Ft cadherins are found in a variety of tumors, and it is presumed that this is due to defects in either Hippo signaling or PCP. Here, we show Drosophila Ft functions in mitochondria to directly regulate mitochondrial electron transport chain integrity and promote oxidative phosphorylation. Proteolytic cleavage releases a soluble 68 kDa fragment (Ft(mito)) that is imported into mitochondria. Ft(mito) binds directly to NADH dehydrogenase ubiquinone flavoprotein 2 (Ndufv2), a core component of complex I, stabilizing the holoenzyme. Loss of Ft leads to loss of complex I activity, increases in reactive oxygen species, and a switch to aerobic glycolysis. Defects in mitochondrial activity in ft mutants are independent of Hippo and PCP signaling and are reminiscent of the Warburg effect.	[Sing, Anson; Tsatskis, Yonit; Hester, Ian; Rosenfeld, Robyn; Yau, Norman; Jurisicova, Andrea] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Sing, Anson; Rosenfeld, Robyn; Yau, Norman; Brill, Julie A.; McNeill, Helen] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Fabian, Lacramioara; Brill, Julie A.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G OA4, Canada; [Serricchio, Mauro; Bietenhader, Mailis; Shanbhag, Riya; McQuibban, G. Angus] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	McQuibban, GA (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	angus.mcquibban@utoronto.ca; mcneill@lunenfeld.ca	McNeill, Helen/E-4579-2013; Jurisicova, Andrea/E-4580-2013; Brill, Julie A/A-1044-2008	McNeill, Helen/0000-0003-1126-5154; Brill, Julie A/0000-0002-5925-9901; Tsatskis, Yonit/0000-0003-2580-0728; Serricchio, Mauro/0000-0002-7094-9807; Fabian, Lacramioara/0000-0001-7124-5556	Swiss National Science Foundation [PBBEP3_146277]; CIHR [MOP-130437, MOP-79408, MOP-102656, MOP-97933]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CIHR(Canadian Institutes of Health Research (CIHR))	We thank G. Halder, U. Banerjee, S. Blair, D. Bohmann, K. Irvine, M. Simon, Y. Heng, D. Holmyard, K. Conway, K. Hales, and D. Walker for flies, advice, imaging, antibodies, and other critical reagents. M.S. was supported by PBBEP3_146277 from the Swiss National Science Foundation. This work was supported by funding from the CIHR to J.A.B. (MOP-130437), G.A.M. (MOP-79408), and H.M. (MOP-102656 and MOP-97933).	Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Bossuyt W, 2014, ONCOGENE, V33, P1218, DOI 10.1038/onc.2013.82; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Cappello S, 2013, NAT GENET, V45, P1300, DOI 10.1038/ng.2765; CASAL J, 1990, EUR J CELL BIOL, V51, P38; Cho J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050644; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Fabian L, 2010, MOL BIOL CELL, V21, P1546, DOI 10.1091/mbc.E09-07-0582; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Feng YQ, 2009, P NATL ACAD SCI USA, V106, P11989, DOI 10.1073/pnas.0811540106; Fuller Margaret T., 1993, P71; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Matakatsu H, 2012, DEVELOPMENT, V139, P1498, DOI 10.1242/dev.070367; McNeill H., 2010, COLD SPRING HARB PER, V2; Morris LGT, 2013, CELL CYCLE, V12, P1011, DOI 10.4161/cc.24305; Nagaraj R, 2012, GENE DEV, V26, P2027, DOI 10.1101/gad.183061.111; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Owusu-Ansah E., 2008, PROTOC EXCH; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pan GH, 2013, DEVELOPMENT, V140, P831, DOI 10.1242/dev.088534; REGAN CL, 1990, GENETICS, V125, P77; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Saburi S, 2012, DEVELOPMENT, V139, P1806, DOI 10.1242/dev.077461; Sambrook J., 2006, CSH PROTOC; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Thomas C, 2012, DEV DYNAM, V241, P27, DOI 10.1002/dvdy.22736; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zhao XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062998	42	47	50	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1293	1308		10.1016/j.cell.2014.07.036	http://dx.doi.org/10.1016/j.cell.2014.07.036			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215488	Green Submitted, Bronze			2022-12-28	WOS:000343094200012
J	O'Connell, MR; Oakes, BL; Sternberg, SH; East-Seletsky, A; Kaplan, M; Doudna, JA				O'Connell, Mitchell R.; Oakes, Benjamin L.; Sternberg, Samuel H.; East-Seletsky, Alexandra; Kaplan, Matias; Doudna, Jennifer A.			Programmable RNA recognition and cleavage by CRISPR/Cas9	NATURE			English	Article							SINGLE-STRANDED RNA; DNA; COMPLEX; BINDING; ENDONUCLEASE; MECHANISM; SELECTION; PROTEINS; SYSTEMS; CAS9	The CRISPR-associated protein Cas9 is an RNA-guided DNA endo-nuclease that uses RNA-DNA complementarity to identify target sites for sequence-specific double-stranded DNA (dsDNA) cleavage(1-5). In its native context, Cas9 acts on DNA substrates exclusively because both binding and catalysis require recognition of a short DNA sequence, known as the protospacer adjacent motif (PAM), next to and on the strand opposite the twenty-nucleotide target site in dsDNA(4-7). Cas9 has proven to be a versatile tool for genome engineering and gene regulation in a large range of prokaryotic and eukaryotic cell types, and in whole organisms(8), but it has been thought to be incapable of targeting RNA(5). Here we show that Cas9 binds with high affinity to single-stranded RNA(ssRNA) targets matching the Cas9-associated guide RNA sequence when the PAM is presented in trans as a separate DNA oligonucleotide. Furthermore, PAM-presenting oligonucleotides (PAMmers) stimulate site-specific endonucleolytic cleavage of ssRNA targets, similar to PAM-mediated stimulation of Cas9-catalysed DNA cleavage(7). Using specially designed PAMmers, Cas9 can be specifically directed to bind or cut RNA targets while avoiding corresponding DNA sequences, and we demonstrate that this strategy enables the isolation of a specific endogenous messenger RNA from cells. These results reveal a fundamental connection between PAM binding and substrate selection by Cas9, and highlight the utility of Cas9 for programmable transcript recognition without the need for tags.	[O'Connell, Mitchell R.; Oakes, Benjamin L.; East-Seletsky, Alexandra; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; [Sternberg, Samuel H.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kaplan, Matias; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Kaplan, Matias/0000-0003-3062-7026; Seletsky, Alexandra/0000-0001-6673-5817; O'Connell, Mitchell/0000-0002-8642-3973; Sternberg, Samuel/0000-0001-8240-9114	National Science Foundation; National Defense Science & Engineering Graduate Research Fellowship programs; NIH NRSA; NIH [P50GM102706-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, T32GM007232, P50GM102706] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Defense Science & Engineering Graduate Research Fellowship programs; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Staahl and K. Zhou for technical assistance, A. Iavarone for assistance with mass spectrometry measurements, Integrated DNA Technologies for the synthesis of DNA and RNA oligonucleotides, and members of the Doudna laboratory and J. Cate for discussions and critical reading of the manuscript. S.H.S. acknowledges support from the National Science Foundation and National Defense Science & Engineering Graduate Research Fellowship programs. A.E.-S. and B.L.O. acknowledge support from NIH NRSA trainee grants. Funding was provided by the NIH-funded Center for RNA Systems Biology (P50GM102706-03). J.A.D. is an Investigator of the Howard Hughes Medical Institute.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Filipovska A, 2011, RNA BIOL, V8, P978, DOI 10.4161/rna.8.6.17907; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hsia KC, 2004, STRUCTURE, V12, P205, DOI 10.1016/j.str.2004.01.004; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim DH, 2008, BIOTECHNIQUES, V44, P613, DOI 10.2144/000112792; Lee HY, 2013, P NATL ACAD SCI USA, V110, P5416, DOI 10.1073/pnas.1302807110; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pommer AJ, 2001, J MOL BIOL, V314, P735, DOI 10.1006/jmbi.2001.5189; Sampson TR, 2014, BIOESSAYS, V36, P34, DOI 10.1002/bies.201300135; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003; Wang Y, 2013, FEBS J, V280, P3755, DOI 10.1111/febs.12367; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Yagi Y, 2014, PLANT J, V78, P772, DOI 10.1111/tpj.12377; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651	34	395	475	12	254	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					263	+		10.1038/nature13769	http://dx.doi.org/10.1038/nature13769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25274302	Green Submitted, Green Accepted			2022-12-28	WOS:000346383500049
J	Decker, BK; Sevransky, JE; Barrett, K; Davey, RT; Chertow, DS				Decker, Brooke K.; Sevransky, Jonathan E.; Barrett, Kevin; Davey, Richard T.; Chertow, Daniel S.			Preparing for Critical Care Services to Patients With Ebola	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS TRANSMISSION		NIH, Bethesda, MD 20892 USA; Emory Univ Hosp, Med Intens Care Unit, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; Emory University	Decker, BK (corresponding author), NIH, Ctr Clin, 10 Ctr Dr,Room 2C145, Bethesda, MD 20892 USA.	brooke.decker@nih.gov		Decker M.D., Brooke K/0000-0002-3404-9115				Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Centers for Disease Control and Prevention, 2014, INF PREV CONTR REC H; Eckmanns T, 2006, INFECT CONT HOSP EP, V27, P931, DOI 10.1086/507294; Fischer WA, 2014, ANN INTERN MED, V161, P753, DOI 10.7326/M14-1953; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320; Klompas M, 2014, ANN INTERN MED, V161, P751, DOI 10.7326/M14-1918	7	24	24	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					831	U124		10.7326/M14-2141	http://dx.doi.org/10.7326/M14-2141			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UJ	25244048				2022-12-28	WOS:000347247200014
J	Sandwell, DT; Muller, RD; Smith, WHF; Garcia, E; Francis, R				Sandwell, David T.; Mueller, R. Dietmar; Smith, Walter H. F.; Garcia, Emmanuel; Francis, Richard			New global marine gravity model from CryoSat-2 and Jason-1 reveals buried tectonic structure	SCIENCE			English	Article							SOUTH-ATLANTIC; RECONSTRUCTIONS; MARGIN; BASIN; FIELD	Gravity models are powerful tools for mapping tectonic structures, especially in the deep ocean basins where the topography remains unmapped by ships or is buried by thick sediment. We combined new radar altimeter measurements from satellites CryoSat-2 and Jason-1 with existing data to construct a global marine gravity model that is two times more accurate than previous models. We found an extinct spreading ridge in the Gulf of Mexico, a major propagating rift in the South Atlantic Ocean, abyssal hill fabric on slow-spreading ridges, and thousands of previously uncharted seamounts. These discoveries allow us to understand regional tectonic processes and highlight the importance of satellite-derived gravity models as one of the primary tools for the investigation of remote ocean basins.	[Sandwell, David T.; Garcia, Emmanuel] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Mueller, R. Dietmar] Univ Sydney, Sch Geosci, EarthByte Grp, Sydney, NSW 2006, Australia; [Smith, Walter H. F.] NOAA, Lab Satellite Altimetry, College Pk, MD 20740 USA; [Francis, Richard] European Space Agcy, European Space Res & Technol Ctr, NL-2201 AZ Noordwijk, Netherlands	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Sydney; National Oceanic Atmospheric Admin (NOAA) - USA; European Space Agency	Sandwell, DT (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	dsandwell@ucsd.edu	Krammel, Vera/N-4826-2014; Smith, Walter H.F./F-5627-2010; Müller, Dietmar/L-1200-2019; Smith, Walter H F/AAM-6681-2020	Krammel, Vera/0000-0002-8273-8396; Smith, Walter H.F./0000-0002-8814-015X; Müller, Dietmar/0000-0002-3334-5764; Smith, Walter H F/0000-0002-8814-015X; Sandwell, David/0000-0001-5657-8707; Garcia, Emmanuel Soliman/0000-0002-3917-517X	NSF [OCE-1128801]; Office of Naval Research [N00014-12-1-0111]; National Geospatial Intelligence Agency [HM0177-13-1-0008]; Australian Research Council [FL099224]; ConocoPhillips; Directorate For Geosciences [1128801] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); National Geospatial Intelligence Agency; Australian Research Council(Australian Research Council); ConocoPhillips; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The CryoSat-2 data were provided by the European Space Agency, and NASA/Centre National d'Etudes Spatiales provided data from the Jason-1 altimeter. This research was supported by NSF (grant OCE-1128801), the Office of Naval Research (grant N00014-12-1-0111), the National Geospatial Intelligence Agency (grant HM0177-13-1-0008), the Australian Research Council (grant FL099224), and ConocoPhillips. Version 23 of global grids of the gravity anomalies and VGG can be downloaded from the supplementary materials and also at the following FTP site: ftp://topex.ucsd.edu/pub/global_grav_1min. The manuscript contents are the opinions of the authors, and the participation of W. H. F. S. should not be construed as indicating that the contents of the paper are a statement of official policy, decision, or position on behalf of NOAA or the U.S. government.	CANDE SC, 1988, J GEOPHYS RES-SOLID, V93, P13479, DOI 10.1029/JB093iB11p13479; GOFF JA, 2004, OCEANOGRAPHY, V17, P24, DOI DOI 10.5670/OCEANOG.2004.64; Granot R, 2012, NAT GEOSCI, V5, P220, DOI [10.1038/ngeo1404, 10.1038/NGEO1404]; Heine C, 2013, SOLID EARTH, V4, P215, DOI 10.5194/se-4-215-2013; Lawver LA, 1998, MEMOIRS NATL I POLAR, V53, P214; LIU CS, 1982, J GEOPHYS RES, V87, P7673, DOI 10.1029/JB087iB09p07673; Matthew K., 2011, J GEOPHYS RES, V116, P1; Mohriak WU, 2010, PETROL GEOSCI, V16, P231, DOI 10.1144/1354-079309-910; Mohriak WU, 2012, GEOL SOC SPEC PUBL, V363, P131, DOI 10.1144/SP363.7; Muller RD, 1998, NATURE, V396, P455, DOI 10.1038/24850; O'Neill C, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000784; Pavlis NK, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008916; Pindell JL, 2009, GEOL SOC SPEC PUBL, V328, P1, DOI 10.1144/SP328.1; Scotchman IC, 2010, PETROL GEOL CONF P, P855, DOI 10.1144/0070855; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; STECKLER MS, 1978, EARTH PLANET SC LETT, V41, P1, DOI 10.1016/0012-821X(78)90036-5; WILSON JT, 1965, NATURE, V207, P343, DOI 10.1038/207343a0	18	808	884	15	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					65	67		10.1126/science.1258213	http://dx.doi.org/10.1126/science.1258213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278606				2022-12-28	WOS:000342446900050
J	Perry, JRB; Day, F; Elks, CE; Sulem, P; Thompson, DJ; Ferreira, T; He, CY; Chasman, DI; Esko, T; Thorleifsson, G; Albrecht, E; Ang, WQ; Corre, T; Cousminer, DL; Feenstra, B; Franceschini, N; Ganna, A; Johnson, AD; Kjellqvist, S; Lunetta, KL; McMahon, G; Nolte, IM; Paternoster, L; Porcu, E; Smith, AV; Stolk, L; Teumer, A; Tsernikova, N; Tikkanen, E; Ulivi, S; Wagner, EK; Amin, N; Bierut, LJ; Byrne, EM; Hottenga, JJ; Koller, DL; Mangino, M; Pers, TH; Yerges-Armstrong, LM; Zhao, JH; Andrulis, IL; Anton-Culver, H; Atsma, F; Bandinelli, S; Beckmann, MW; Benitez, J; Blomqvist, C; Bojesen, SE; Bolla, MK; Bonanni, B; Brauch, H; Brenner, H; Buring, JE; Chang-Claude, J; Chanock, S; Chen, JH; Chenevix-Trench, G; Collee, JM; Couch, FJ; Couper, D; Coviello, AD; Cox, A; Czene, K; D'adamo, AP; Smith, GD; De Vivo, I; Demerath, EW; Dennis, J; Devilee, P; Dieffenbach, AK; Dunning, AM; Eiriksdottir, G; Eriksson, JG; Fasching, PA; Ferrucci, L; Flesch-Janys, D; Flyger, H; Foroud, T; Franke, L; Garcia, ME; Garcia-Closas, M; Geller, F; de Geus, EEJ; Giles, GG; Gudbjartsson, DF; Gudnason, V; Guenel, P; Guo, SQ; Hall, P; Hamann, U; Haring, R; Hartman, CA; Heath, A; Hofman, A; Hooning, MJ; Hopper, JL; Hu, FB; Hunter, DJ; Karasik, D; Kiel, DP; Knight, JA; Kosma, VM; Kutalik, Z; Lai, S; Lambrechts, D; Lindblom, A; Magi, R; Magnusson, PK; Mannermaa, A; Martin, NG; Masson, G; McArdle, PF; McArdle, WL; Melbye, M; Michailidou, K; Mihailov, E; Milani, L; Milne, RL; Nevanlinna, H; Neven, P; Nohr, EA; Oldehinkel, AJ; Oostra, BA; Palotie, A; Peacock, M; Pedersen, NL; Peterlongo, P; Peto, J; Pharoah, PDP; Postma, DS; Pouta, A; Pylkas, K; Radice, P; Ring, S; Rivadeneira, F; Robino, A; Rose, LM; Rudolph, A; Salomaa, V; Sanna, S; Schlessinger, D; Schmidt, MK; Southey, MC; Sovio, U; Stampfer, MJ; Stockl, D; Storniolo, AM; Timpson, NJ; Tyrer, J; Visser, JA; Vollenweider, P; Volzke, H; Waeber, G; Waldenberger, M; Wallaschofski, H; Wang, Q; Willemsen, G; Winqvist, R; Wolffenbuttel, BHR; Wright, MJ; Boomsma, DI; Econs, MJ; Khaw, KT; Loos, RJF; McCarthy, MI; Montgomery, GW; Rice, JP; Streeten, EA; Thorsteinsdottir, U; van Duijn, CM; Alizadeh, BZ; Bergmann, S; Boerwinkle, E; Boyd, HA; Crisponi, L; Gasparini, P; Gieger, C; Harris, TB; Ingelsson, E; Jarvelin, MR; Kraft, P; Lawlor, D; Metspalu, A; Pennell, CE; Ridker, PM; Snieder, H; Sorensen, TIA; Spector, TD; Strachan, DP; Uitterlinden, AG; Wareham, NJ; Widen, E; Zygmunt, M; Murray, A; Easton, DF; Stefansson, K; Murabito, JM; Ong, KK				Perry, John R. B.; Day, Felix; Elks, Cathy E.; Sulem, Patrick; Thompson, Deborah J.; Ferreira, Teresa; He, Chunyan; Chasman, Daniel I.; Esko, Toenu; Thorleifsson, Gudmar; Albrecht, Eva; Ang, Wei Q.; Corre, Tanguy; Cousminer, Diana L.; Feenstra, Bjarke; Franceschini, Nora; Ganna, Andrea; Johnson, Andrew D.; Kjellqvist, Sanela; Lunetta, Kathryn L.; McMahon, George; Nolte, Ilja M.; Paternoster, Lavinia; Porcu, Eleonora; Smith, Albert V.; Stolk, Lisette; Teumer, Alexander; Tsernikova, Natalia; Tikkanen, Emmi; Ulivi, Sheila; Wagner, Erin K.; Amin, Najaf; Bierut, Laura J.; Byrne, Enda M.; Hottenga, Jouke-Jan; Koller, Daniel L.; Mangino, Massimo; Pers, Tune H.; Yerges-Armstrong, Laura M.; Zhao, Jing Hua; Andrulis, Irene L.; Anton-Culver, Hoda; Atsma, Femke; Bandinelli, Stefania; Beckmann, Matthias W.; Benitez, Javier; Blomqvist, Carl; Bojesen, Stig E.; Bolla, Manjeet K.; Bonanni, Bernardo; Brauch, Hiltrud; Brenner, Hermann; Buring, Julie E.; Chang-Claude, Jenny; Chanock, Stephen; Chen, Jinhui; Chenevix-Trench, Georgia; Collee, J. Margriet; Couch, Fergus J.; Couper, David; Coviello, Andrea D.; Cox, Angela; Czene, Kamila; D'adamo, Adamo Pio; Smith, George Davey; De Vivo, Immaculata; Demerath, Ellen W.; Dennis, Joe; Devilee, Peter; Dieffenbach, Aida K.; Dunning, Alison M.; Eiriksdottir, Gudny; Eriksson, Johan G.; Fasching, Peter A.; Ferrucci, Luigi; Flesch-Janys, Dieter; Flyger, Henrik; Foroud, Tatiana; Franke, Lude; Garcia, Melissa E.; Garcia-Closas, Montserrat; Geller, Frank; de Geus, Eco E. J.; Giles, Graham G.; Gudbjartsson, Daniel F.; Gudnason, Vilmundur; Guenel, Pascal; Guo, Suiqun; Hall, Per; Hamann, Ute; Haring, Robin; Hartman, Catharina A.; Heath, AndrewC.; Hofman, Albert; Hooning, Maartje J.; Hopper, John L.; Hu, Frank B.; Hunter, David J.; Karasik, David; Kiel, Douglas P.; Knight, Julia A.; Kosma, Veli-Matti; Kutalik, Zoltan; Lai, Sandra; Lambrechts, Diether; Lindblom, Annika; Maegi, Reedik; Magnusson, Patrik K.; Mannermaa, Arto; Martin, Nicholas G.; Masson, Gisli; McArdle, Patrick F.; McArdle, Wendy L.; Melbye, Mads; Michailidou, Kyriaki; Mihailov, Evelin; Milani, Lili; Milne, Roger L.; Nevanlinna, Heli; Neven, Patrick; Nohr, Ellen A.; Oldehinkel, Albertine J.; Oostra, Ben A.; Palotie, Aarno; Peacock, Munro; Pedersen, Nancy L.; Peterlongo, Paolo; Peto, Julian; Pharoah, Paul D. P.; Postma, Dirkje S.; Pouta, Anneli; Pylkaes, Katri; Radice, Paolo; Ring, Susan; Rivadeneira, Fernando; Robino, Antonietta; Rose, Lynda M.; Rudolph, Anja; Salomaa, Veikko; Sanna, Serena; Schlessinger, David; Schmidt, Marjanka K.; Southey, Mellissa C.; Sovio, Ulla; Stampfer, Meir J.; Stoeckl, Doris; Storniolo, Anna M.; Timpson, Nicholas J.; Tyrer, Jonathan; Visser, Jenny A.; Vollenweider, Peter; Voelzke, Henry; Waeber, Gerard; Waldenberger, Melanie; Wallaschofski, Henri; Wang, Qin; Willemsen, Gonneke; Winqvist, Robert; Wolffenbuttel, Bruce H. R.; Wright, Margaret J.; Boomsma, Dorret I.; Econs, Michael J.; Khaw, Kay-Tee; Loos, Ruth J. F.; McCarthy, Mark I.; Montgomery, Grant W.; Rice, John P.; Streeten, Elizabeth A.; Thorsteinsdottir, Unnur; van Duijn, Cornelia M.; Alizadeh, Behrooz Z.; Bergmann, Sven; Boerwinkle, Eric; Boyd, Heather A.; Crisponi, Laura; Gasparini, Paolo; Gieger, Christian; Harris, Tamara B.; Ingelsson, Erik; Jaervelin, Marjo-Riitta; Kraft, Peter; Lawlor, Debbie; Metspalu, Andres; Pennell, Craig E.; Ridker, Paul M.; Snieder, Harold; Sorensen, Thorkild I. A.; Spector, Tim D.; Strachan, David P.; Uitterlinden, Andre G.; Wareham, Nicholas J.; Widen, Elisabeth; Zygmunt, Marek; Murray, Anna; Easton, Douglas F.; Stefansson, Kari; Murabito, Joanne M.; Ong, Ken K.		Australian Ovarian Canc Study; GENICA Network; kConFabt LifeLines Cohort Study; InterAct Consortium; Early Growth Genetics EGG Consorti	Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche	NATURE			English	Article							CENTRAL PRECOCIOUS PUBERTY; GENE-EXPRESSION; WIDE ASSOCIATION; METAANALYSIS; VARIANTS; RISK; REVEALS; CELLS; TRANSCRIPTION; MUTATIONS	Age at menarche is a marker of timing of puberty in females. It varies widely between individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-causemortality(1). Studies of rare human disorders of puberty and animal models point to a complex hypothalamic-pituitary-hormonal regulation(2,3), but the mechanisms that determine pubertal timing and underlie its links to disease risk remain unclear. Here, using genome-wide and custom-genotyping arrays in up to 182,416 women of European descent from 57 studies, we found robust evidence (P < 5 x 10(-8)) for 123 signals at 106 genomic loci associated with age at menarche. Many loci were associated with other pubertal traits in both sexes, and there was substantial overlap with genes implicated in body mass index and various diseases, including rare disorders of puberty. Menarche signals were enriched in imprinted regions, with three loci (DLK1-WDR25, MKRN3-MAGEL2 and KCNK9) demonstrating parent-of-origin-specific associations concordant with known parental expression patterns. Pathway analyses implicated nuclear hormone receptors, particularly retinoic acid and gamma-aminobutyric acid-B2 receptor signalling, among novel mechanisms that regulate pubertal timing in humans. Our findings suggest a genetic architecture involving at least hundreds of common variants in the coordinated timing of the pubertal transition.	[Perry, John R. B.; Day, Felix; Elks, Cathy E.; Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.; Ong, Ken K.] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Inst Metab Sci, Box 285 Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Perry, John R. B.; Murray, Anna] Univ Exeter, Sch Med, Exeter EX1 2LU, Devon, England; [Perry, John R. B.; Ferreira, Teresa; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr forHuman Genet, Oxford OX3 7BN, England; [Perry, John R. B.; Mangino, Massimo; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Sulem, Patrick; Thorleifsson, Gudmar; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Thompson, Deborah J.; Bolla, Manjeet K.; Dennis, Joe; Gudbjartsson, Daniel F.; Michailidou, Kyriaki; Wang, Qin; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [He, Chunyan; Wagner, Erin K.] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46202 USA; [He, Chunyan; Wagner, Erin K.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; [Chasman, Daniel I.; Buring, Julie E.; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Chasman, Daniel I.; Buring, Julie E.; Karasik, David; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Esko, Toenu; Tsernikova, Natalia; Maegi, Reedik; Mihailov, Evelin; Milani, Lili; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Tartu 51010, Estonia; [Esko, Toenu; Pers, Tune H.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Esko, Toenu; Pers, Tune H.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Esko, Toenu; Pers, Tune H.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Esko, Toenu; Pers, Tune H.; Hunter, David J.] MIT, Board Inst, Cambridge, MA 02142 USA; [Esko, Toenu; Pers, Tune H.; Hunter, David J.] Harvard Univ, Cambridge, MA 02142 USA; [Esko, Toenu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Albrecht, Eva; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Ang, Wei Q.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Nedlands, WA 6009, Australia; [Corre, Tanguy; Kutalik, Zoltan; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Corre, Tanguy; Kutalik, Zoltan; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Cousminer, Diana L.; Tikkanen, Emmi; Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, FI-00014 Helsinki, Finland; [Feenstra, Bjarke; Geller, Frank; Melbye, Mads; Boyd, Heather A.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Ganna, Andrea; Czene, Kamila; Hall, Per; Magnusson, Patrik K.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Johnson, Andrew D.; Lunetta, Kathryn L.; Murabito, Joanne M.] NHLBI, Framingham, MA 01702 USA; [Johnson, Andrew D.; Lunetta, Kathryn L.; Murabito, Joanne M.] Boston Univ Framingham Heart Study, Framingham, MA 01702 USA; [Kjellqvist, Sanela] Karolinska Inst, Sci Life Lab, S-17121 Solna, Sweden; [Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [McMahon, George; Paternoster, Lavinia; Smith, George Davey; Ring, Susan; Timpson, Nicholas J.; Lawlor, Debbie] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [McMahon, George; Smith, George Davey; McArdle, Wendy L.; Ring, Susan; Timpson, Nicholas J.; Lawlor, Debbie] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Nolte, Ilja M.; Alizadeh, Behrooz Z.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Porcu, Eleonora; Lai, Sandra; Sanna, Serena; Crisponi, Laura] CNR, Inst Genet & Biomed Res, I-09042 Cagliari, Sardinia, Italy; [Porcu, Eleonora] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Smith, Albert V.; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, IS-101 Reykjavik, Iceland; [Stolk, Lisette; Rivadeneira, Fernando; Visser, Jenny A.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Stolk, Lisette; Rivadeneira, Fernando; van Duijn, Cornelia M.; Uitterlinden, Andre G.] Netherlands Consortium Hlth Aging, NL-2300 RC Leiden, Netherlands; [Stolk, Lisette; Rivadeneira, Fernando; van Duijn, Cornelia M.; Uitterlinden, Andre G.] Natl Genom Initiat, NL-2300 RC Leiden, Netherlands; [Teumer, Alexander] Univ Med Greifswald, Interfac Inst Genet & Funct Gen, D-17475 Greifswald, Germany; [Tsernikova, Natalia; Mihailov, Evelin; Metspalu, Andres] Univ Tartu, Dept Biotechnol, EE-51010 Tartu, Estonia; [Tikkanen, Emmi] Univ Helsinki, Hjelt Inst, FI-00014 Helsinki, Finland; [Ulivi, Sheila; D'adamo, Adamo Pio; Robino, Antonietta; Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy; [Amin, Najaf; Oostra, Ben A.; van Duijn, Cornelia M.] Eramus MC, Dept Epidemiol, Genet Epidemiol Unit, NL-3015 GE Rotterdam, Netherlands; [Bierut, Laura J.; Rice, John P.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Byrne, Enda M.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia; [Byrne, Enda M.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Hottenga, Jouke-Jan; de Geus, Eco E. J.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Koller, Daniel L.; Foroud, Tatiana; Econs, Michael J.] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Pers, Tune H.] Board Inst, Cambridge, MA 02142 USA; [Pers, Tune H.] Tech 142 Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Yerges-Armstrong, Laura M.; McArdle, Patrick F.; Streeten, Elizabeth A.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Yerges-Armstrong, Laura M.; McArdle, Patrick F.; Streeten, Elizabeth A.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ontario Canc Genet Network, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA; [Atsma, Femke] Sanquin Res, NL-6525 GA Nijmegen, Netherlands; [Bandinelli, Stefania] Tuscany Reg Hlth Agcy, Florence, Italy; [Bandinelli, Stefania] Univ Florence, Dept Med & Surg Crit Care, I-50134 Florence, Italy; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, I-50122 Florence, Italy; [Beckmann, Matthias W.; Fasching, Peter A.] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen EMN, Univ Hosp Erlangen, Univ Breast Ctr Franconia,Dept Gynecol & Obstet, D-91054 Erlangen, Germany; [Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genet Grp, E-28029 Madrid, Spain; [Benitez, Javier] Ctr Invest Red Enfermed Raras CIBERER, E-46010 Valencia, Spain; [Blomqvist, Carl] Univ Helsinki, Dept Oncol, FI-00100 Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, FI-00100 Helsinki, Finland; [Bojesen, Stig E.] Univ Copenhagen, Univ Copenhagen Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2100 Copenhagen, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Bonanni, Bernardo] Ist Europeo Oncol IEO, Div Canc Prevent & Genet, I-20139 Milan, Italy; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, D-72074 Tubingen, Germany; [Brenner, Hermann; Dieffenbach, Aida K.] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida K.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chen, Jinhui] Indiana Univ, Sch Med, Dept Anat, Indianapolis, IN 46202 USA; [Chen, Jinhui] Indiana Univ, Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Chen, Jinhui] Indiana Univ, Sch Med, Stark Neurosci Res Ctr, Indianapolis, IN 46202 USA; [Chenevix-Trench, Georgia; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld 4006, Australia; [Collee, J. Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Couper, David] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Coviello, Andrea D.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA; [Coviello, Andrea D.] Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA; [Cox, Angela] Univ Sheffield, Dept Oncol, Sheffield Canc Res Ctr, Sheffield S10 2RX, S Yorkshire, England; [D'adamo, Adamo Pio; Robino, Antonietta; Gasparini, Paolo] Univ Trieste, Dept Clin Med Sci Surg & Hlth, I-34149 Trieste, Italy; [De Vivo, Immaculata; Hu, Frank B.; Hunter, David J.; Stampfer, Meir J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [De Vivo, Immaculata; Hu, Frank B.; Hunter, David J.; Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [De Vivo, Immaculata; Hu, Frank B.; Hunter, David J.; Stampfer, Meir J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Demerath, Ellen W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Dunning, Alison M.; Pharoah, Paul D. P.; Tyrer, Jonathan] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge CB2 1TN, England; [Eriksson, Johan G.; Pouta, Anneli; Salomaa, Veikko] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FI-00014 Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, FI-00029 Hus Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, FI-00290 Helsinki, Finland; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Gerontol Res Ctr, Bethesda, MD 20892 USA; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, D-20246 Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, D-20246 Hamburg, Germany; [Flyger, Henrik] Univ Copenhagen Hosp, Herlev Hosp, Dept Breast Surg, DK-2100 Copenhagen, Denmark; [Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 AB Groningen, Netherlands; [Garcia, Melissa E.; Harris, Tamara B.] NIA, NIH, Bethesda, MD 20892 USA; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Garcia-Closas, Montserrat] Inst Canc Res, Div Breast Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [de Geus, Eco E. J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 BI Amsterdam, Netherlands; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3004, Australia; [Giles, Graham G.; Hopper, John L.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Gudbjartsson, Daniel F.; Guenel, Pascal] INSERM Natl Inst Hlth & Med Res, CESP Ctr Res Epidemiol & Populat Hlth, U1018, F-94807 Villejuif, France; [Guenel, Pascal] Univ Paris Sud, UMRS 1018, F-94807 Villejuif, France; [Guo, Suiqun] Southern Med Univ, Dept Obstet & Gynecol, Guangzhou 510515, Guangdong, Peoples R China; [Hamann, Ute] Deutsch Krebsforsch Zentrum DKFZ, D-69120 Heidelberg, Germany; [Haring, Robin; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem, D-17475 Greifswald, Germany; [Haring, Robin; Wallaschofski, Henri] Univ Med Greifswald, Lab Med, D-17475 Greifswald, Germany; [Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 AB Groningen, Netherlands; [Heath, AndrewC.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Hooning, Maartje J.] Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands; [Hu, Frank B.; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Karasik, David; Kiel, Douglas P.] Hebrew Senior Life Inst Aging Res, Boston, MA 02131 USA; [Kiel, Douglas P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Kiel, Douglas P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5T 3M7, Canada; [Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Sch Med, FI-70211 Kuopio, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, FI-70029 Kuopio, Finland; [Lambrechts, Diether] VIB, Vesalius Res Ctr VRC, B-3000 Louvain, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Louvain, Belgium; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Melbye, Mads] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, FI-00029 Hus Helsinki, Finland; [Nevanlinna, Heli] Univ Helsinki, Cent Hosp, FI-00029 Hus Helsinki, Finland; [Neven, Patrick] KULeuven Univ Leuven, Dept Oncol, Multidisciplinary Breast Ctr, Univ Hosp Leuven, B-3000 Louvain, Belgium; [Nohr, Ellen A.] Univ Southern Denmark, Inst Clin Res, Res Unit Obstet & Gynecol, DK-5000 Odense C, Denmark; [Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, NL-9700 RB Groningen, Netherlands; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Palotie, Aarno] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Peacock, Munro; Storniolo, Anna M.; Econs, Michael J.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Peterlongo, Paolo] Fdn Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; [Peto, Julian] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Dept, London WC1E 7HT, England; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, GRIAC Res Inst, NL-9700 RB Groningen, Netherlands; [Pouta, Anneli] Oulu Univ Hosp, Dept Obstet & Gynecol, FI-90029 Oys Oulu, Finland; [Pylkaes, Katri; Winqvist, Robert] Univ Oulu, Oulu Univ Hosp, NordLab Oulu, Lab Canc Genet & Tumor Biol,Dept Clin Chem, FI-90014 Oulu, Finland; [Pylkaes, Katri; Winqvist, Robert] Univ Oulu, Oulu Univ Hosp, NordLab Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; [Radice, Paolo] Fdn IRCCS Ist Nazl Tumori INT, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, I-20133 Milan, Italy; [Schlessinger, David] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1006 BE Amsterdam, Netherlands; [Southey, Mellissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Sovio, Ulla; Jaervelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ctr Environm & Hlth, MRC Hlth Protect Agcy HPA,Dept Epidemiol & Biosta, London W2 1PG, England; [Sovio, Ulla] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 0SW, England; [Stoeckl, Doris] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, D-8576 Neuherberg, Germany; [Stoeckl, Doris] Univ Munich, Dept Obstet & Gynaecol, D-81377 Munich, Germany; [Vollenweider, Peter; Waeber, Gerard] Univ Lausanne Hosp, Dept Internal Med, CH-1015 Lausanne, Switzerland; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Voelzke, Henry; Wallaschofski, Henri] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, D-17475 Greifswald, Germany; [Waldenberger, Melanie] Helmholtz Zentrum Munchen German Res Ctr Environm, Res Unit Mol Epidemiol, D-8576 Neuherberg, Germany; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 AB Groningen, Netherlands; [Wright, Margaret J.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0QQ, England; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, Mindich Child Hlth & Dev Inst, Dept Prevent Med,Genet Obes & Related Metab Trait, New York, NY 10029 USA; [McCarthy, Mark I.] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Streeten, Elizabeth A.] Geriatr Res & Educ Clin Ctr GRECC, Vet Adm Med Ctr, Baltimore, MD 21201 USA; [van Duijn, Cornelia M.] Ctr Med Syst Biol, NL-2300 RC Leiden, Netherlands; [Boerwinkle, Eric] Univ Houston, Human Genet Ctr & Divof Epidemiol, Houston, TX 77025 USA; [Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, S-75105 Uppsala, Sweden; [Jaervelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, FI-90014 Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; [Jaervelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, FI-90101 Oulu, Finland; [Jaervelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, FI-90220 Oulu, Finland; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Capital Reg, Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, DK-2000 Frederiksberg, Denmark; [Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England; [Zygmunt, Marek] Univ Med Greifswald, Dept Obstet & Gynecol, D-17475 Greifswald, Germany; [Murabito, Joanne M.] Boston Univ, Sch Med, Dept Med, Gen Internal Med Sect, Boston, MA 02118 USA; [Ong, Ken K.] Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England	University of Cambridge; University of Exeter; University of Oxford; Wellcome Centre for Human Genetics; University of London; King's College London; University of Cambridge; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Western Australia; University of Lausanne; Swiss Institute of Bioinformatics; University of Helsinki; Statens Serum Institut; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Karolinska Institutet; Boston University; University of Bristol; University of Bristol; University of Groningen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; Icelandic Heart Association; University of Iceland; Erasmus University Rotterdam; Erasmus MC; Greifswald Medical School; University of Tartu; University of Helsinki; IRCCS Burlo Garofolo; Washington University (WUSTL); University of Queensland; QIMR Berghofer Medical Research Institute; Vrije Universiteit Amsterdam; Indiana University System; Indiana University-Purdue University Indianapolis; Technical University of Denmark; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; University of Toronto; University of California System; University of California Irvine; University of Florence; Azienda Sanitaria di Firenze; University of Erlangen Nuremberg; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; IRCCS European Institute of Oncology (IEO); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; QIMR Berghofer Medical Research Institute; Erasmus University Rotterdam; Erasmus MC; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill; Boston University; Boston University; University of Sheffield; University of Trieste; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Copenhagen; Herlev & Gentofte Hospital; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Vrije Universiteit Amsterdam; Cancer Council Victoria; University of Melbourne; University of Iceland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Southern Medical University - China; Helmholtz Association; German Cancer Research Center (DKFZ); Greifswald Medical School; Greifswald Medical School; University of Groningen; Washington University (WUSTL); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Flanders Institute for Biotechnology (VIB); KU Leuven; Karolinska Institutet; Stanford University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; KU Leuven; University Hospital Leuven; University of Southern Denmark; University of Groningen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; IFOM - FIRC Institute of Molecular Oncology; University of London; London School of Hygiene & Tropical Medicine; University of Groningen; University of Oulu; University of Oulu; University of Oulu; Fondazione IRCCS Istituto Nazionale Tumori Milan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Netherlands Cancer Institute; University of Melbourne; Imperial College London; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Greifswald Medical School; German Centre for Cardiovascular Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Groningen; QIMR Berghofer Medical Research Institute; University of Cambridge; Icahn School of Medicine at Mount Sinai; University of Oxford; University of Oxford; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Houston System; University of Houston; Uppsala University; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Harvard University; Harvard T.H. Chan School of Public Health; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of London; Greifswald Medical School; Boston University; University of Cambridge	Perry, JRB (corresponding author), Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Inst Metab Sci, Box 285 Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	john.perry@mrc-epid.cam.ac.uk; Murabito@bu.edu	Attrill, Lauren/V-1688-2018; Bowtell, David/H-1007-2016; Fox, Laura J/C-6249-2016; Stöckl, Doris/B-5352-2014; Garcia-Closas, Montserrat/AAZ-6930-2021; Rivadeneira, Fernando/O-5385-2015; DEVILEE, PETER/ABR-2140-2022; Smith, Albert Vernon/K-5150-2015; Schmidt, Marjanka K/G-9058-2011; Magnusson, Patrik KE/C-4458-2017; Sovio, Ulla/H-8532-2019; Chenevix-Trench, Georgia/AAV-2014-2020; Middeldorp, Christel M/L-7728-2017; d'Adamo, Adamo Pio/G-4064-2011; Ormel, Johan/C-6094-2013; Knight, Julia/R-5617-2019; Devilee, Peter/GXV-8005-2022; Radice, Paolo/O-3119-2013; Lambrechts, Diether/AAJ-3167-2020; Teumer, Alexander/S-7438-2019; Colaus, PsyColaus/K-6607-2013; Waldenberger, Melanie/B-5355-2014; Knight, Julia/A-6843-2012; Brenner, Hermann/ABE-6383-2020; Montgomery, Grant W/B-7148-2008; Loos, Ruth/GON-5877-2022; Flyger, Henrik/AAM-6494-2021; Pahkala, Katja/GPX-7471-2022; Guenel, Pascal/H-3728-2018; Franke, Lude/P-7036-2016; Visser, Jenny A./F-8156-2011; Milani, Lili/N-1097-2019; Loos, Ruth J F/Q-2862-2016; Grioni, Sara/K-5320-2016; Kutalik, Zoltan/HHZ-5697-2022; Hypponen, Elina/B-2596-2014; Mägi, Reedik/AAJ-9679-2021; Michailidou, Kyriaki/ABD-5122-2020; Gasparini, Paolo/B-6173-2014; Boomsma, Dorret I/AAX-4470-2020; Martin, Nicholas/R-9235-2019; Timpson, Nicholas John/O-7548-2015; de Geus, Eco J.C./M-9318-2015; bandinelli, stefania/AAL-4570-2020; Crisponi, Laura/AAC-2642-2019; Gudnason, Vilmundur/K-6885-2015; Bierut, Laura Jean/W-6806-2019; Johnson, Andrew D/G-6520-2013; Pennell, Craig/ABD-6902-2020; Mangino, Massimo/F-5134-2011; Fasching, Peter A/ABH-9912-2020; Davey Smith, George/A-7407-2013; Atsma, F./L-4178-2015; Deloukas, Panos/B-2922-2013; Gudnason, Vilmundur/AAE-7126-2019; Pahkala, Katja/D-7449-2013; Lai, Sandra/AAY-4176-2020; Wijmenga, Cisca/D-2173-2009; Pharoah, Paul/V-6658-2019; Peterlongo, Paolo/Q-4717-2018; Bonanni, Bernardo/AAM-7928-2020; Garcia-Closas, Montserrat/F-3871-2015; Khaw, Kay-Tee/AAZ-3209-2021; Ripatti, Samuli/H-9446-2014; Guenel, Pascal/AAS-7688-2021; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Brenner, Hermann/B-4627-2017; Alizadeh, Behrooz Z Ziad/J-2921-2017; Langenberg, Claudia/ABG-9067-2021; Stefansson, Kari/AAE-7187-2019; Wright, Margaret Jane/A-4560-2016; McCarthy, Mark/M-3763-2015; Paternoster, Lavinia/C-1292-2015; Byrne, Enda/J-6068-2014; Robino, Antonietta/K-9398-2016; Wilkening, Robin/J-5535-2018	Bowtell, David/0000-0001-9089-7525; Garcia-Closas, Montserrat/0000-0003-1033-2650; Rivadeneira, Fernando/0000-0001-9435-9441; Smith, Albert Vernon/0000-0003-1942-5845; Schmidt, Marjanka K/0000-0002-2228-429X; Magnusson, Patrik KE/0000-0002-7315-7899; Sovio, Ulla/0000-0002-0799-1105; Chenevix-Trench, Georgia/0000-0002-1878-2587; Middeldorp, Christel M/0000-0002-6218-0428; d'Adamo, Adamo Pio/0000-0001-9367-4909; Knight, Julia/0000-0002-7610-7635; Radice, Paolo/0000-0001-6298-4111; Lambrechts, Diether/0000-0002-3429-302X; Teumer, Alexander/0000-0002-8309-094X; Waldenberger, Melanie/0000-0003-0583-5093; Brenner, Hermann/0000-0002-6129-1572; Montgomery, Grant W/0000-0002-4140-8139; Guenel, Pascal/0000-0002-8359-518X; Franke, Lude/0000-0002-5159-8802; Milani, Lili/0000-0002-5323-3102; Loos, Ruth J F/0000-0002-8532-5087; Grioni, Sara/0000-0002-5891-8426; Kutalik, Zoltan/0000-0001-8285-7523; Hypponen, Elina/0000-0003-3670-9399; Michailidou, Kyriaki/0000-0001-7065-1237; Martin, Nicholas/0000-0003-4069-8020; Timpson, Nicholas John/0000-0002-7141-9189; de Geus, Eco J.C./0000-0001-6022-2666; Crisponi, Laura/0000-0001-9128-8537; Gudnason, Vilmundur/0000-0001-5696-0084; Bierut, Laura Jean/0000-0002-9952-4810; Johnson, Andrew D/0000-0001-6369-5178; Pennell, Craig/0000-0002-0937-6165; Mangino, Massimo/0000-0002-2167-7470; Fasching, Peter A/0000-0003-4885-8471; Davey Smith, George/0000-0002-1407-8314; Deloukas, Panos/0000-0001-9251-070X; Gudnason, Vilmundur/0000-0001-5696-0084; Pahkala, Katja/0000-0001-9338-4397; Pharoah, Paul/0000-0001-8494-732X; Peterlongo, Paolo/0000-0001-6951-6855; Garcia-Closas, Montserrat/0000-0003-1033-2650; Ripatti, Samuli/0000-0002-0504-1202; Guenel, Pascal/0000-0002-8359-518X; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Brenner, Hermann/0000-0002-6129-1572; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Langenberg, Claudia/0000-0002-5017-7344; Wright, Margaret Jane/0000-0001-7133-4970; Niinikoski, Harri/0000-0002-7071-918X; McCarthy, Mark/0000-0002-4393-0510; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; s, hema/0000-0002-3440-9475; Czene, Kamila/0000-0002-3233-5695; Ganna, Andrea/0000-0002-8147-240X; Murray, Anna/0000-0002-2351-2522; Geller, Frank/0000-0002-9238-3269; Amin, Najaf/0000-0002-8944-1771; Kerrison, Nicola/0000-0002-1471-953X; Nevanlinna, Heli/0000-0002-0916-2976; Day, Felix/0000-0003-3789-7651; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Winqvist, Robert/0000-0003-0932-9104; Lawlor, Debbie A/0000-0002-6793-2262; Franks, Paul/0000-0002-0520-7604; Blomqvist, Carl/0000-0003-3041-1938; LAI, SANDRA/0000-0003-4198-9989; Karasik, David/0000-0002-8826-0530; melbye, mads/0000-0001-8264-6785; Navarro, Carmen/0000-0001-8896-7483; Southey, Melissa/0000-0002-6313-9005; Esko, Tonu/0000-0003-1982-6569; Brauch, Hiltrud/0000-0001-7531-2736; Waeber, Gerard/0000-0003-4193-788X; Bojesen, Stig/0000-0002-4061-4133; Willemsen, Gonneke/0000-0003-3755-0236; Pylkas, Katri/0000-0002-2449-0521; Cox, Angela/0000-0002-5138-1099; Paternoster, Lavinia/0000-0003-2514-0889; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Dobrovic, Alexander/0000-0003-3414-112X; Boyd, Heather/0000-0001-6849-9985; Bergmann, Sven/0000-0002-6785-9034; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Demerath, Ellen/0000-0002-4585-4064; Eriksson, Johan/0000-0002-2516-2060; Kiel, Douglas/0000-0001-8474-0310; Van Duijn, Cornelia/0000-0002-2374-9204; Giles, Graham/0000-0003-4946-9099; Magi, Reedik/0000-0002-2964-6011; Bandinelli, Stefania/0000-0002-6491-0850; Feenstra, Bjarke/0000-0003-1478-649X; Overvad, Kim/0000-0001-6429-7921; Dunning, Alison Margaret/0000-0001-6651-7166; Lunetta, Kathryn/0000-0002-9268-810X; Lotz, Anne/0000-0002-8715-0743; Thorne, Heather/0000-0003-3610-2511; Zeggini, Eleftheria/0000-0003-4238-659X; De Vivo, Immaculata/0000-0002-7185-7402; Sacerdote, Carlotta/0000-0002-8008-5096; Devilee, Peter/0000-0002-8023-2009; Forouhi, Nita/0000-0002-5041-248X; Couper, David/0000-0002-4313-9235; Palotie, Aarno/0000-0002-2527-5874; Byrne, Enda/0000-0002-9491-7797; Gasparini, Paolo/0000-0002-0859-0856; Gieger, Christian/0000-0001-6986-9554; Pers, Tune/0000-0003-0207-4831; Robino, Antonietta/0000-0003-2152-2353; Wilkening, Robin/0000-0002-8332-5016	Cancer Research UK [10124, 11022, 10118] Funding Source: Medline; Medical Research Council [G9815508, MC_PC_15018, MC_UU_12013/1, MC_U106179471, MC_UU_12015/1, MC_UU_12013/3, G1000143, MR/J012165/1, G0401527, MC_UU_12015/2, G0701863, MC_U106179472] Funding Source: Medline; NCATS NIH HHS [UL1 TR001108] Funding Source: Medline; NCI NIH HHS [P50 CA116201] Funding Source: Medline; NIA NIH HHS [R01 AG041517, U01 AG049505] Funding Source: Medline; NINDS NIH HHS [R01 NS017950] Funding Source: Medline; Wellcome Trust [098381, 102215] Funding Source: Medline; MRC [MC_UU_12015/2, MC_U106179472, MR/J012165/1, MC_UU_12013/1, MC_UU_12015/1, G0701863, MC_UU_12013/3] Funding Source: UKRI; Cancer Research UK [16561, 16563, 16565] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; Cancer Foundation Finland sr [110135] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA116201] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041517, U01AG049505] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Foundation Finland sr; The Francis Crick Institute; National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 2011, DIABETOLOGIA, V54, P2272, DOI DOI 10.1007/s00125-011-2182-9; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Cho S, 2001, MOL BRAIN RES, V87, P214, DOI 10.1016/S0169-328X(01)00020-1; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Constantin S, 2012, ENDOCRINOLOGY, V153, P3758, DOI 10.1210/en.2012-1126; Cousminer D. L., 2014, HUM MOL GENET; Cusanovich DA, 2012, HUM MOL GENET, V21, P2111, DOI 10.1093/hmg/dds021; D'Aloisio AA, 2013, EPIDEMIOLOGY, V24, P277, DOI 10.1097/EDE.0b013e31828062b7; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Grinspon RP, 2011, INT J ANDROL, V34, pE487, DOI 10.1111/j.1365-2605.2011.01210.x; Grundberg E, 2013, AM J HUM GENET, V93, P1158, DOI 10.1016/j.ajhg.2013.11.003; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hindorff LA, CATALOG PUBLISHED GE; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Kabakchiev B, 2013, GASTROENTEROLOGY, V144, P1488, DOI 10.1053/j.gastro.2013.03.001; Kompass KS, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-6; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Lomniczi A, 2013, NAT NEUROSCI, V16, P281, DOI 10.1038/nn.3319; Maeda T, 2011, AGING MALE, V14, P21, DOI 10.3109/13685538.2010.502270; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Nagl F, 2009, AM J PHYSIOL-CELL PH, V297, pC1146, DOI 10.1152/ajpcell.00034.2009; Parker SE, 2014, J CLIN ENDOCR METAB, V99, P594, DOI 10.1210/jc.2013-2954; Partsch CJ, 2002, J PEDIATR-US, V141, P441, DOI 10.1067/mpd.2002.127280; Prentice P, 2013, INT J OBESITY, V37, P1036, DOI 10.1038/ijo.2012.177; Rantalainen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027338; Ruf N, 2007, HUM MOL GENET, V16, P2591, DOI 10.1093/hmg/ddm216; Sasayama D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054967; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schroder A, 2013, PHARMACOGENOMICS J, V13, P12, DOI 10.1038/tpj.2011.44; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Silveira LFG, 2013, J CLIN ENDOCR METAB, V98, P1781, DOI 10.1210/jc.2012-3550; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stelzer Y, 2014, NAT GENET, V46, P551, DOI 10.1038/ng.2968; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sulzbacher S, 2009, STEM CELL REV REP, V5, P159, DOI 10.1007/s12015-009-9061-5; Temple IK, 2007, J MED GENET, V44, P637, DOI 10.1136/jmg.2007.050807; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zadik Z, 2004, CLIN ENDOCRINOL, V60, P682, DOI 10.1111/j.1365-2265.2004.02034.x; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	77	343	351	0	149	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					92	+		10.1038/nature13545	http://dx.doi.org/10.1038/nature13545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25231870	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000342420800042
J	Cho, NW; Dilley, RL; Lampson, MA; Greenberg, RA				Cho, Nam Woo; Dilley, Robert L.; Lampson, Michael A.; Greenberg, Roger A.			Interchromosomal Homology Searches Drive Directional ALT Telomere Movement and Synapsis	CELL			English	Article							DOUBLE-STRAND BREAKS; PROMYELOCYTIC LEUKEMIA BODIES; DNA-DAMAGE RESPONSE; HUMAN-CELLS; MEIOTIC RECOMBINATION; CHROMATIN MOBILITY; HOP2-MND1 COMPLEX; END RESECTION; HOP2 PROTEIN; PML BODY	Telomere length maintenance is a requisite feature of cellular immortalization and a hallmark of human cancer. While most human cancers express telomerase activity, similar to 10%-15% employ a recombination-dependent telomere maintenance pathway known as alternative lengthening of telomeres (ALT) that is characterized by multitelomere clusters and associated promyelocytic leukemia protein bodies. Here, we show that a DNA double-strand break (DSB) response at ALT telomeres triggers long-range movement and clustering between chromosome termini, resulting in homology-directed telomere synthesis. Damaged telomeres initiate increased random surveillance of nuclear space before displaying rapid directional movement and association with recipient telomeres over micron-range distances. This phenomenon required Rad51 and the Hop2-Mnd1 heterodimer, which are essential for homologous chromosome synapsis during meiosis. These findings implicate a specialized homology searching mechanism in ALT-dependent telomere maintenance and provide a molecular basis underlying the preference for recombination between nonsister telomeres during ALT.	[Cho, Nam Woo; Dilley, Robert L.; Greenberg, Roger A.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Basser Res Ctr BRCA, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Greenberg, RA (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu		Dilley, Robert/0000-0001-7358-9088	NIH [GM101149, CA138835, CA17494]; DOD Breast Cancer Idea Award; Harrington Discovery Institute Scholar-Innovator Award; Pennsylvania Breast Cancer Coalition grant; Abramson Family Cancer Research Institute; Basser Research Center for BRCA; HHMI International Student Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA174904, R01CA138835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988, R01GM101149, T32GM007170] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Breast Cancer Idea Award(United States Department of Defense); Harrington Discovery Institute Scholar-Innovator Award; Pennsylvania Breast Cancer Coalition grant; Abramson Family Cancer Research Institute; Basser Research Center for BRCA; HHMI International Student Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Jiang, G. Yuan, F.B. Johnson, R. Marmorstein, and D. Roth for critical discussion, and F.B. Johnson, R. Reddel, A. Sfeir, and T. de Lange for sharing cell lines. We thank L. Kang and C. Yu for critical discussion of mobility data. This work was supported by NIH grants GM101149, CA138835, and CA17494, (to R.A.G.) who is also supported by a DOD Breast Cancer Idea Award, a Harrington Discovery Institute Scholar-Innovator Award, a Pennsylvania Breast Cancer Coalition grant, and funds from the Abramson Family Cancer Research Institute and the Basser Research Center for BRCA. N.W.C. is supported by a HHMI International Student Research Fellowship.	Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bechter OE, 2003, EMBO REP, V4, P1138, DOI 10.1038/sj.embor.7400027; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bugreev DV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5198; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; Cesare AJ, 2012, CURR OPIN CELL BIOL, V24, P731, DOI 10.1016/j.ceb.2012.08.007; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Chung I, 2011, J CELL SCI, V124, P3603, DOI 10.1242/jcs.084681; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Draskovic I, 2009, P NATL ACAD SCI USA, V106, P15726, DOI 10.1073/pnas.0907689106; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fasching CL, 2007, CANCER RES, V67, P7072, DOI 10.1158/0008-5472.CAN-07-1556; Guigas G, 2008, BIOPHYS J, V94, P90, DOI 10.1529/biophysj.107.117044; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jegou T, 2009, MOL BIOL CELL, V20, P2070, DOI 10.1091/mbc.E08-02-0108; Jiang WQ, 2007, ONCOGENE, V26, P4635, DOI 10.1038/sj.onc.1210260; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Lesterlin C, 2014, NATURE, V506, P249, DOI 10.1038/nature12868; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Levi V, 2005, BIOPHYS J, V89, P4275, DOI 10.1529/biophysj.105.066670; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pezza RJ, 2010, BIOPHYS J, V99, P3763, DOI 10.1016/j.bpj.2010.10.028; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Robertson RB, 2009, P NATL ACAD SCI USA, V106, P12688, DOI 10.1073/pnas.0811465106; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Saxton MJ, 2007, BIOPHYS J, V92, P1178, DOI 10.1529/biophysj.106.092619; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wu GK, 2003, CANCER RES, V63, P2589; Yeager TR, 1999, CANCER RES, V59, P4175; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	60	211	213	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					108	121		10.1016/j.cell.2014.08.030	http://dx.doi.org/10.1016/j.cell.2014.08.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259924	Bronze, Green Accepted			2022-12-28	WOS:000343095000013
J	Fraine, J; Deming, D; Benneke, B; Knutson, H; Jordan, A; Espinoza, N; Madhusudhan, N; Wilkins, A; Todorov, K				Fraine, Jonathan; Deming, Drake; Benneke, Bjorn; Knutson, Heather; Jordan, Andres; Espinoza, Nestor; Madhusudhan, Nikku; Wilkins, Ashlee; Todorov, Kamen			Water vapour absorption in the clear atmosphere of a Neptune-sized exoplanet	NATURE			English	Article							TRANSMISSION SPECTROSCOPY; SUPER-EARTHS; C/O RATIO; TRANSITS; SEARCH; KEPLER; FRAMEWORK; SPECTRUM; CURVES; ORBITS	Transmission spectroscopy has so far detected atomic and molecular absorption in Jupiter-sized exoplanets, but intense efforts to measure molecular absorption in the atmospheres of smaller (Neptune-sized) planets during transits have revealed only featureless spectra(1-4). From this it was concluded that the majority of small, warm planets evolve to sustain atmospheres with high mean molecular weights (little hydrogen), opaque clouds or scattering hazes, reducing our ability to observe the composition of these atmospheres(1-5). Here we report observations of the transmission spectrum of the exoplanet HAT-P-11b (which has a radius about four times that of Earth) from the optical wavelength range to the infrared. We detected water vapour absorption at a wavelength of 1.4 micrometres. The amplitude of the water absorption (approximately 250 parts per million) indicates that the planetary atmosphere is predominantly clear down to an altitude corresponding to about 1 millibar, and sufficiently rich in hydrogen to have a large scale height (over which the atmospheric pressure varies by a factor of e). The spectrum is indicative of a planetary atmosphere in which the abundance of heavy elements is no greater than about 700 times the solar value. This is in good agreement with the core-accretion theory of planet formation, in which a gas giant planet acquires its atmosphere by accreting hydrogen-rich gas directly from the protoplanetary nebula onto a large rocky or icy core(6).	[Fraine, Jonathan; Deming, Drake; Wilkins, Ashlee] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Fraine, Jonathan; Jordan, Andres; Espinoza, Nestor] Pontificia Univ Catolica Chile, Inst Astrofis, Santiago 7820436, Chile; [Fraine, Jonathan; Benneke, Bjorn; Knutson, Heather] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Deming, Drake] NASA, Astrobiol Inst Virtual Planetary Lab, Seattle, WA 98195 USA; [Madhusudhan, Nikku] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Todorov, Kamen] Swiss Fed Inst Technol, Dept Phys, CH-8049 Zurich, Switzerland	University System of Maryland; University of Maryland College Park; Pontificia Universidad Catolica de Chile; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fraine, J (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	jfraine@astro.umd.edu	Fraine, Jonathan/D-8385-2019	Fraine, Jonathan/0000-0003-0910-5805; Todorov, Kamen/0000-0002-9276-8118; Jordan, Andres/0000-0002-5389-3944	'Millennium Institute of Astrophysics (MAS)' of the Millennium Science Initiative, Chilean Ministry of Economy [IC120009]; FONDECYT [1130857]; BASAL CATA [PFB-06]; CONICYT-PCHA/Doctorado Nacional	'Millennium Institute of Astrophysics (MAS)' of the Millennium Science Initiative, Chilean Ministry of Economy; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); BASAL CATA(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); CONICYT-PCHA/Doctorado Nacional	J.F., A.J. and N.E. acknowledge support from project IC120009 'Millennium Institute of Astrophysics (MAS)' of the Millennium Science Initiative, Chilean Ministry of Economy; FONDECYT project 1130857; and BASAL CATA PFB-06. N.E. is supported by CONICYT-PCHA/Doctorado Nacional. We thank P. McCullough for his assistance in the planning and execution of our observations. We are grateful to I. Crossfield, L. Kreidberg and E. Agol for providing their open-source, Python code banks on their individual websites. We are also grateful for discussions with M. Line, J. Fortney and J. Moses about the nature of photochemistry and interior structures. We thank the ATLAS and PHOENIX teams for providing stellar models. We also thank the SciPy and NumPy associations for providing extensive and rigorous numerical routines for an assortment of mathematical and computational techniques.	Bakos GA, 2010, ASTROPHYS J, V710, P1724, DOI 10.1088/0004-637X/710/2/1724; Ballard S, 2010, PUBL ASTRON SOC PAC, V122, P1341, DOI 10.1086/657159; Benneke B, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/153; Benneke B, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/100; Bernath PF, 2002, IAU SYMP, V12, P70; Berta ZK, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/12; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Carter JA, 2009, ASTROPHYS J, V704, P51, DOI 10.1088/0004-637X/704/1/51; Castelli F., 2004, NEW GRIDS ATLAS9 MOD; Chiang E, 2013, MON NOT R ASTRON SOC, V431, P3444, DOI 10.1093/mnras/stt424; Claret A, 2000, ASTRON ASTROPHYS, V363, P1081; DAngelo G., 2010, EXOPLANETS, P319; Deming D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/95; Deming D, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/33; Ehrenreich D., 2014, PREPRINT; Ford EB, 2005, ASTRON J, V129, P1706, DOI 10.1086/427962; Fortney JJ, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/80; Fraine JD, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/127; Hu RY, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/63; Husser TO, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201219058; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Knutson H., 2014, PREPRINT; Knutson HA, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/126; Knutson HA, 2014, NATURE, V505, P66, DOI 10.1038/nature12887; Knutson HA, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/22; Knutson HA, 2010, ASTROPHYS J, V720, P1569, DOI 10.1088/0004-637X/720/2/1569; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888; Lewis NK, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/95; Madhusudhan N, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/36; Madhusudhan N, 2011, NATURE, V469, P64, DOI 10.1038/nature09602; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; McCullough P. M., 2012, WFC320128 SPAC TEL S; Moses JI, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/34; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Patil A, 2010, J STAT SOFTW, V35, P1; Rajan A., 2011, WFC3 DATA HDB 2011; Rogers LA, 2010, ASTROPHYS J, V712, P974, DOI 10.1088/0004-637X/712/2/974; Sanchis-Ojeda R, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/61; Sing DK, 2011, MON NOT R ASTRON SOC, V416, P1443, DOI 10.1111/j.1365-2966.2011.19142.x; Todorov KO, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/111; Wilkins AN, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/113	46	157	157	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					526	+		10.1038/nature13785	http://dx.doi.org/10.1038/nature13785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254473	Green Accepted, Green Submitted			2022-12-28	WOS:000342075800035
J	Karo, JM; Schatz, DG; Sun, JC				Karo, Jenny M.; Schatz, David G.; Sun, Joseph C.			The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer Cells	CELL			English	Article							DOUBLE-STRAND BREAKS; COMMON LYMPHOID PROGENITORS; V(D)J RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; NK CELLS; HUMAN CYTOMEGALOVIRUS; SCID MUTATION; CUTTING EDGE; ACTIVE-SITE; SERINE 139	The emergence of recombination-activating genes (RAGs) in jawed vertebrates endowed adaptive immune cells with the ability to assemble a diverse set of antigen receptor genes. In contrast, innate lymphocytes, such as natural killer (NK) cells, are not believed to require RAGs. Here, we report that NK cells unable to express RAGs or RAG endonuclease activity during ontogeny exhibit a cell-intrinsic hyperresponsiveness but a diminished capacity to survive following virus-driven proliferation, a reduced expression of DNA damage response mediators, and defects in the repair of DNA breaks. Evidence for this novel function of RAG has also been observed in T cells and innate lymphoid cells (ILCs), revealing an unexpected role for RAG proteins beyond V(D)J recombination. We propose that DNA cleavage events mediated by RAG endow developing adaptive and innate lymphocytes with a cellular "fitness" that safeguards their persistence later in life during episodes of rapid proliferation or cellular stress.	[Karo, Jenny M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Karo, Jenny M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Schatz, David G.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yale University; Howard Hughes Medical Institute; Yale University	Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	sunj@mskcc.org			Geoffrey Beene fellowship; Cancer Research Institute (CRI); NIH [R37 AI32524, AI100874]; Searle Scholars Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100874, R37AI032524] Funding Source: NIH RePORTER	Geoffrey Beene fellowship; Cancer Research Institute (CRI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the J.C.S. lab for technical support and experimental assistance; members of the Memorial Sloan Kettering Cancer Center NK club; L. Lanier, A. Rudensky, J. Chaudhuri, J. Petrini, S. Josefowicz, and A. Beaulieu for insightful discussions and critical reading of the manuscript; and P. Kincade, G. Teng, P. Fink, and M. Bevan for providing mice and reagents critical to this study. J.M.K. was supported by a Geoffrey Beene fellowship and a Cancer Research Institute (CRI) STaRT grant. D.G.S. is an investigator of the Howard Hughes Medical Institute and is supported by NIH grant R37 AI32524. J.C.S. is supported by the Searle Scholars Program, by the CRI, and by NIH Grant AI100874.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Andrews DM, 2010, IMMUNOL CELL BIOL, V88, P107, DOI 10.1038/icb.2009.94; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Fronkova E, 2005, J IMMUNOL, V175, P2495, DOI 10.4049/jimmunol.175.4.2495; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Helmink BA, 2012, ANNU REV IMMUNOL, V30, P175, DOI 10.1146/annurev-immunol-030409-101320; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii M, 2010, IMMUNOL REV, V237, P10, DOI 10.1111/j.1600-065X.2010.00933.x; Igarashi H, 2001, BLOOD, V97, P2680, DOI 10.1182/blood.V97.9.2680; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kuwata N, 1999, J IMMUNOL, V163, P6355; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; LANIER LL, 1992, J IMMUNOL, V149, P1876; Larsen BD, 2010, CELL CYCLE, V9, P2940, DOI 10.4161/cc.9.15.12335; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039	56	113	115	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					94	107		10.1016/j.cell.2014.08.026	http://dx.doi.org/10.1016/j.cell.2014.08.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259923	Green Accepted, Bronze			2022-12-28	WOS:000343095000012
J	Kuppermann, M; Pena, S; Bishop, JT; Nakagawa, S; Gregorich, SE; Sit, A; Vargas, J; Caughey, AB; Sykes, S; Pierce, L; Norton, ME				Kuppermann, Miriam; Pena, Sherri; Bishop, Judith T.; Nakagawa, Sanae; Gregorich, Steven E.; Sit, Anita; Vargas, Juan; Caughey, Aaron B.; Sykes, Susan; Pierce, Lasha; Norton, Mary E.			Effect of Enhanced Information, Values Clarification, and Removal of Financial Barriers on Use of Prenatal Genetic Testing A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOWN-SYNDROME; AMNIOCENTESIS; VALIDATION; DIAGNOSIS	IMPORTANCE Prenatal genetic testing guidelines recommend providing patients with detailed information to allow informed, preference-based screening and diagnostic testing decisions. The effect of implementing these guidelines is not well understood. OBJECTIVE To analyze the effect of a decision-support guide and elimination of financial barriers to testing on use of prenatal genetic testing and decision making among pregnant women of varying literacy and numeracy levels. DESIGN, SETTING, AND PARTICIPANTS Randomized trial conducted from 2010-2013 at prenatal clinics at 3 county hospitals, 1 community clinic, 1 academic center, and 3 medical centers of an integrated health care delivery system in the San Francisco Bay area. Participants were English-or Spanish-speaking women who had not yet undergone screening or diagnostic testing and remained pregnant at 11 weeks' gestation (n = 710). INTERVENTIONS A computerized, interactive decision-support guide and access to prenatal testing with no out-of-pocket expense (n = 357) or usual care as per current guidelines (n = 353). MAIN OUTCOMES AND MEASURES The primary outcomewas invasive diagnostic test use, obtained via medical record review. Secondary outcomes included testing strategy undergone, and knowledge about testing, risk comprehension, and decisional conflict and regret at 24 to 36 weeks' gestation. RESULTS Women randomized to the intervention group, compared with those randomized to the control group, were less likely to have invasive diagnostic testing (5.9% vs 12.3%; odds ratio [OR], 0.45 [95% CI, 0.25-0.80]) and more likely to forgo testing altogether (25.6% vs 20.4%; OR, 3.30 [95% CI, 1.43-7.64], reference group screening followed by invasive testing). Women randomized to the intervention group also had higher knowledge scores (9.4 vs 8.6 on a 15-point scale; mean group difference, 0.82 [95% CI, 0.34-1.31]) and were more likely to correctly estimate the amniocentesis-related miscarriage risk (73.8% vs 59.0%; OR, 1.95 [95% CI, 1.39-2.75]) and their estimated age-adjusted chance of carrying a fetus with trisomy 21 (58.7% vs 46.1%; OR, 1.66 [95% CI, 1.22-2.28]). Significant differences did not emerge in decisional conflict or regret. CONCLUSIONS AND RELEVANCE Full implementation of prenatal testing guidelines using a computerized, interactive decision-support guide in the absence of financial barriers to testing resulted in less test use and more informed choices. If validated in additional populations, this approach may result in more informed and preference-based prenatal testing decision making and fewer women undergoing testing.	[Kuppermann, Miriam; Pena, Sherri; Bishop, Judith T.; Nakagawa, Sanae; Vargas, Juan; Norton, Mary E.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Kuppermann, Miriam] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kuppermann, Miriam; Gregorich, Steven E.] Univ Calif San Francisco, Med Effectiveness Res Ctr Diverse Populat, San Francisco, CA 94143 USA; [Gregorich, Steven E.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Sit, Anita] Santa Clara Valley Med Ctr, Dept Obstet Gynecol, San Jose, CA 95128 USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Sykes, Susan] La Clin Raza, Oakland, CA USA; [Pierce, Lasha] Alameda Cty Hlth Syst, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Santa Clara Valley Medical Center; Oregon Health & Science University	Kuppermann, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 3333 Calif St,Ste 335, San Francisco, CA 94143 USA.	kuppermannm@obgyn.ucsf.edu			National Institutes of Health [R01HD049686]; March of Dimes Foundation [12-FY09-213]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by grants from the National Institutes of Health (R01HD049686) and the March of Dimes Foundation (Social and Behavioral Sciences Research Grant 12-FY09-213).	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459; American College of Obstetricians and Gynecologists Committee on Genetics, 2013, Obstet Gynecol, V122, P1374, DOI 10.1097/01.AOG.0000438962.16108.d1; American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Bass PF, 2003, J GEN INTERN MED, V18, P1036, DOI 10.1111/j.1525-1497.2003.10651.x; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; Driscoll DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.027; Goel V, 1996, PRENATAL DIAG, V16, P425, DOI 10.1002/(SICI)1097-0223(199605)16:5<425::AID-PD874>3.3.CO;2-U; Grobman WA, 2002, PRENATAL DIAG, V22, P1195, DOI 10.1002/pd.494; HADDOW JE, 1994, NEW ENGL J MED, V330, P1114, DOI 10.1056/NEJM199404213301603; Jaques AM, 2010, PRENATAL DIAG, V30, P522, DOI 10.1002/pd.2509; Kuppermann M, 2000, OBSTET GYNECOL, V96, P511, DOI 10.1016/S0029-7844(00)00969-8; Kuppermann M, 2009, OBSTET GYNECOL, V113, P53, DOI 10.1097/AOG.0b013e31818e7ec4; LI KH, 1991, STAT SINICA, V1, P65; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; NADLER HL, 1971, OBSTET GYNECOL, V38, P789; National Institute of Child Health and Human Development, 1979, NIH CONSENSUS STATE, V2, P11; Norton ME, 2013, OBSTET GYNECOL, V121, P265, DOI 10.1097/AOG.0b013e31827e5c85; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Press N, 1997, SOC SCI MED, V45, P979, DOI 10.1016/S0277-9536(97)00011-7; Roter DL, 2009, PATIENT EDUC COUNS, V75, P392, DOI 10.1016/j.pec.2009.01.005; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; van den Heuvel A, 2010, PATIENT EDUC COUNS, V78, P24, DOI 10.1016/j.pec.2009.05.014	24	79	79	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1210	1217		10.1001/jama.2014.11479	http://dx.doi.org/10.1001/jama.2014.11479			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP3QA	25247517	Bronze, Green Accepted			2022-12-28	WOS:000341990600021
J	Puhan, MA; Schunemann, HJ; Murad, MH; Li, TJ; Brignardello-Petersen, R; Singh, JA; Kessels, AG; Guyatt, GH				Puhan, Milo A.; Schuenemann, Holger J.; Murad, Mohammad Hassan; Li, Tianjing; Brignardello-Petersen, Romina; Singh, Jasvinder A.; Kessels, Alfons G.; Guyatt, Gordon H.		GRADE Working Grp	A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE DECISION-MAKING; ISPOR TASK-FORCE; INCONSISTENCY; CONSISTENCY; DISEASE		[Puhan, Milo A.] Epidemiol Biostat & Prevent Inst Epidemiol, CH-8001 Zurich, Switzerland; [Schuenemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Murad, Mohammad Hassan] Mayo Clin Prevent Med, Rochester, MN 55905 USA; [Li, Tianjing] Johns Hopkins Bloomberg Sch Publ Hlth Epidemiol, Baltimore, MD USA; [Brignardello-Petersen, Romina] Univ Toronto Clin Epidemiol & Hlth Care Res, Toronto, ON, Canada; [Singh, Jasvinder A.] Univ Alabama Clin Immunol & Rheumatol, Birmingham, AL USA; [Kessels, Alfons G.] Univ Maastricht, Maastricht, Netherlands	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Maastricht University	Puhan, MA (corresponding author), Epidemiol Biostat & Prevent Inst Epidemiol, Hirschengraben 84, CH-8001 Zurich, Switzerland.	miloalan.puhan@uzh.ch	Puhan, Milo/ABE-6298-2020; Singh, Jasvinder/R-6172-2019; Murad, M. Hassan/AAW-4367-2020	Puhan, Milo/0000-0003-4721-1879; Singh, Jasvinder/0000-0003-3485-0006; Murad, Mohammad Hassan/0000-0001-5502-5975; Li, Tianjing/0000-0001-5371-4558; Schunemann, Holger/0000-0003-3211-8479				Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P671, DOI 10.1177/0272989X13487257; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hawkins N, 2009, MED DECIS MAKING, V29, P273, DOI 10.1177/0272989X08330120; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Kessels A, 2013, OA EPIDEMIOLOGY, V1, P7, DOI DOI 10.13172/2053-079X-1-1-690; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; Mustafa RA, 2013, J CLIN EPIDEMIOL, V66, P736, DOI 10.1016/j.jclinepi.2013.02.004; Palmerini T, 2013, AM HEART J, V165, P910, DOI 10.1016/j.ahj.2013.03.011; Pandor A, 2013, HEART, V99, P1717, DOI 10.1136/heartjnl-2013-303811; Puhan MA, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-2; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Tan SH, 2014, J CLIN EPIDEMIOL, V67, P672, DOI 10.1016/j.jclinepi.2013.11.006; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859	37	848	854	2	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2014	349								g5630	10.1136/bmj.g5630	http://dx.doi.org/10.1136/bmj.g5630			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UP	25252733	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000342426100002
J	Adams, BD; Benger, J				Adams, Bruce D.; Benger, Jonathan			Should we take patients to hospital in cardiac arrest?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PREDICTION RULE; LIFE-SUPPORT TERMINATION; CARDIOPULMONARY-RESUSCITATION; SURVIVAL; IMPLEMENTATION; GUIDELINES; DERIVATION		[Adams, Bruce D.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Benger, Jonathan] Univ W England, Bristol BS16 1QY, Avon, England; [Benger, Jonathan] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England	University of Texas System; University of Texas Health San Antonio; University of West England; University of Bristol	Adams, BD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, 7703 Floyd Curl Dr,Mail Code 7736, San Antonio, TX 78229 USA.	adamsb@uthscsa.edu; Jonathan.Benger@uwe.ac.uk						Arlt M, 2011, RESUSCITATION, V82, P1243, DOI 10.1016/j.resuscitation.2011.03.022; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; BONNIN MJ, 1993, JAMA-J AM MED ASSOC, V270, P1457, DOI 10.1001/jama.270.12.1457; Chiang WC, 2015, EMERG MED J, V32, P318, DOI 10.1136/emermed-2013-203289; Eckstein M, 2005, ANN EMERG MED, V45, P504, DOI 10.1016/j.annemergmed.2004.11.024; Edbrooke DL, 2011, CRIT CARE, V15, DOI 10.1186/cc10029; Gilbert M, 2000, LANCET, V355, P375, DOI 10.1016/S0140-6736(00)01021-7; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Herlitz J, 2008, RESUSCITATION, V76, P31, DOI 10.1016/j.resuscitation.2007.06.027; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Kajino K, 2013, RESUSCITATION, V84, P54, DOI 10.1016/j.resuscitation.2012.05.027; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1433, DOI 10.1001/jama.270.12.1433; Millin MG, 2011, PREHOSP EMERG CARE, V15, P547, DOI 10.3109/10903127.2011.608872; Morrison LJ, 2007, RESUSCITATION, V74, P266, DOI 10.1016/j.resuscitation.2007.01.009; Morrison LJ, 2007, RESUSCITATION, V74, P150, DOI 10.1016/j.resuscitation.2006.10.030; Morrison LJ, 2006, NEW ENGL J MED, V355, P478, DOI 10.1056/NEJMoa052620; Morrison LJ, 2014, RESUSCITATION, V85, P486, DOI 10.1016/j.resuscitation.2013.12.013; Morrison LJ, 2009, RESUSCITATION, V80, P324, DOI 10.1016/j.resuscitation.2008.11.014; Muller T, 2013, RESUSCITATION, V84, P1463, DOI 10.1016/j.resuscitation.2013.08.004; Naess AC, 2004, RESUSCITATION, V60, P57, DOI 10.1016/S0300-9572(03)00262-4; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2010, CIRCULATION, V122, pE439, DOI 10.1161/CIR.0b013e3181efa990; Nolan JP, 2010, RESUSCITATION, V81, pE1, DOI 10.1016/j.resuscitation.2010.08.002; Ong MEH, 2007, RESUSCITATION, V75, P244, DOI 10.1016/j.resuscitation.2007.04.013; Orioles A, 2013, CRIT CARE MED, V41, P2794, DOI 10.1097/CCM.0b013e31829a7202; Perkins GD, 2012, EMERG MED J, V29, P3, DOI 10.1136/emermed-2011-200758; Sherbino J, 2010, J EMERG MED, V38, P80, DOI 10.1016/j.jemermed.2009.08.002; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Suchard JR, 1999, J EMERG MED, V17, P801, DOI 10.1016/S0736-4679(99)00086-4; Tagami T, 2012, CIRCULATION, V126, P589, DOI 10.1161/CIRCULATIONAHA.111.086173; Verbeek PR, 2002, ACAD EMERG MED, V9, P671, DOI 10.1197/aemj.9.7.671; ZOLL PM, 1956, NEW ENGL J MED, V254, P727, DOI 10.1056/NEJM195604192541601	32	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2014	349								g5659	10.1136/bmj.g5659	http://dx.doi.org/10.1136/bmj.g5659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UL	25249357	Green Published			2022-12-28	WOS:000342425700004
J	Even, J; Yakushev, A; Dullmann, CE; Haba, H; Asai, M; Sato, TK; Brand, H; Di Nitto, A; Eichler, R; Fan, FL; Hartmann, W; Huang, M; Jager, E; Kaji, D; Kanaya, J; Kaneya, Y; Khuyagbaatar, J; Kindler, B; Kratz, JV; Krier, J; Kudou, Y; Kurz, N; Lommel, B; Miyashita, S; Morimoto, K; Morita, K; Murakami, M; Nagame, Y; Nitsche, H; Ooe, K; Qin, Z; Schadel, M; Steiner, J; Sumita, T; Takeyama, M; Tanaka, K; Toyoshima, A; Tsukada, K; Turler, A; Usoltsev, I; Wakabayashi, Y; Wang, Y; Wiehl, N; Yamaki, S				Even, J.; Yakushev, A.; Duellmann, Ch E.; Haba, H.; Asai, M.; Sato, T. K.; Brand, H.; Di Nitto, A.; Eichler, R.; Fan, F. L.; Hartmann, W.; Huang, M.; Jaeger, E.; Kaji, D.; Kanaya, J.; Kaneya, Y.; Khuyagbaatar, J.; Kindler, B.; Kratz, J. V.; Krier, J.; Kudou, Y.; Kurz, N.; Lommel, B.; Miyashita, S.; Morimoto, K.; Morita, K.; Murakami, M.; Nagame, Y.; Nitsche, H.; Ooe, K.; Qin, Z.; Schaedel, M.; Steiner, J.; Sumita, T.; Takeyama, M.; Tanaka, K.; Toyoshima, A.; Tsukada, K.; Tuerler, A.; Usoltsev, I.; Wakabayashi, Y.; Wang, Y.; Wiehl, N.; Yamaki, S.			Synthesis and detection of a seaborgium carbonyl complex	SCIENCE			English	Article							TRANSITION-METAL; SG(CO)(6); CHEMISTRY; ELEMENTS	Experimental investigations of transactinoide elements provide benchmark results for chemical theory and probe the predictive power of trends in the periodic table. So far, in gas-phase chemical reactions, simple inorganic compounds with the transactinoide in its highest oxidation state have been synthesized. Single-atom production rates, short half-lives, and harsh experimental conditions limited the number of experimentally accessible compounds. We applied a gas-phase carbonylation technique previously tested on short-lived molybdenum (Mo) and tungsten (W) isotopes to the preparation of a carbonyl complex of seaborgium, the 106th element. The volatile seaborgium complex showed the same volatility and reactivity with a silicon dioxide surface as those of the hexacarbonyl complexes of the lighter homologs Mo and W. Comparison of the product's adsorption enthalpy with theoretical predictions and data for the lighter congeners supported a Sg(CO)(6) formulation.	[Even, J.; Duellmann, Ch E.; Khuyagbaatar, J.; Wiehl, N.] Helmholtz Inst Mainz, D-55099 Mainz, Germany; [Yakushev, A.; Duellmann, Ch E.; Brand, H.; Hartmann, W.; Jaeger, E.; Kindler, B.; Krier, J.; Kurz, N.; Lommel, B.; Steiner, J.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Duellmann, Ch E.; Di Nitto, A.; Kratz, J. V.; Wiehl, N.] Johannes Gutenberg Univ Mainz, Inst Kernchem, D-55099 Mainz, Germany; [Haba, H.; Huang, M.; Kaji, D.; Kanaya, J.; Kudou, Y.; Morimoto, K.; Morita, K.; Murakami, M.; Sumita, T.; Takeyama, M.; Tanaka, K.; Wakabayashi, Y.; Yamaki, S.] RIKEN, Wako, Saitama 3510198, Japan; [Asai, M.; Sato, T. K.; Kaneya, Y.; Miyashita, S.; Nagame, Y.; Schaedel, M.; Toyoshima, A.; Tsukada, K.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Eichler, R.; Tuerler, A.; Usoltsev, I.] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Eichler, R.; Tuerler, A.; Usoltsev, I.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Fan, F. L.; Qin, Z.; Wang, Y.] Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Peoples R China; [Miyashita, S.] Hiroshima Univ, Dept Chem, Higashihiroshima 7398526, Japan; [Morita, K.] Kyushu Univ, Dept Phys, Higashi Ku, Fukuoka 8128581, Japan; [Murakami, M.; Ooe, K.] Niigata Univ, Dept Chem, Niigata 9502181, Japan; [Nitsche, H.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Nitsche, H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Yamaki, S.] Saitama Univ, Dept Phys, Saitama 3388570, Japan	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Johannes Gutenberg University of Mainz; RIKEN; Japan Atomic Energy Agency; University of Bern; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Hiroshima University; Kyushu University; Niigata University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Saitama University	Dullmann, CE (corresponding author), Helmholtz Inst Mainz, D-55099 Mainz, Germany.	duellman@uni-mainz.de	Di+Nitto, Antonio/AAK-4033-2021; Eichler, Robert/G-5130-2011; Di Nitto, Antonio/Q-8071-2019; Türler, Andreas/D-3913-2014; Fan, Fang/GRO-2696-2022; Morimoto, Kouji/D-1773-2016; fan, fang/GQY-9173-2022; Morita, Kosuke/S-5663-2019; Sato, Tetsuya K/T-9755-2018; Düllmann, Christoph E/L-3401-2017; Even, Julia/K-1186-2016	Eichler, Robert/0000-0002-6690-7284; Di Nitto, Antonio/0000-0002-9319-366X; Türler, Andreas/0000-0002-4274-1056; Morimoto, Kouji/0000-0002-7312-9046; Sato, Tetsuya K/0000-0002-5490-9178; Düllmann, Christoph E/0000-0002-1194-0423; Jadambaa, Khuyagbaatar/0000-0003-1371-2384; Takeyama, Mirei/0000-0001-7003-321X; Even, Julia/0000-0002-6314-9094	Reimei Research Program (Japan Atomic Energy Agency); German Federal Ministry for Education and Research [06MZ7164]; Helmholtz association [VH-NG-723]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [19002005, 23750072]; Swiss National Science Foundation [200020_144511]; Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Heavy Element Chemistry Program of the U.S. Department of Energy at Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; National Natural Science Foundation of China [11079006]	Reimei Research Program (Japan Atomic Energy Agency)(Japan Atomic Energy Agency); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz association(Helmholtz Association); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Heavy Element Chemistry Program of the U.S. Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was performed at the RI Beam Factory operated by RIKEN Nishina Center and the Center for Nuclear Study, University of Tokyo. We thank the ion source and accelerator staff at the RIKEN Nishina Center for accelerator-based research for providing intense and stable ion beams and V. Pershina for interesting discussions. The present work is partially supported by the Reimei Research Program (Japan Atomic Energy Agency); the German Federal Ministry for Education and Research contract 06MZ7164; the Helmholtz association contract VH-NG-723; the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Grant-in-Aids 19002005 and 23750072; the Swiss National Science Foundation contract 200020_144511; the Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Heavy Element Chemistry Program of the U.S. Department of Energy at Lawrence Berkeley National Laboratory under contract DE-AC02-05CH11231; and the National Natural Science Foundation of China (grant 11079006).	Dullmann CE, 2005, NUCL INSTRUM METH A, V551, P528, DOI 10.1016/j.nima.2005.05.077; Even J, 2014, RADIOCHIM ACTA, V102, P1093, DOI 10.1515/ract-2013-2198; Even J, 2012, INORG CHEM, V51, P6431, DOI 10.1021/ic300305m; Frenking G, 2000, CHEM REV, V100, P717, DOI 10.1021/cr980401l; Haba H, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.024611; Haba H., 2007, J NUCL RADIOCHEM SCI, V8, P55; Katz JJ, 1951, CHEM URANIUM; Mond L., 1890, J CHEM SOC, V57, P749, DOI DOI 10.1039/CT8905700749; MORITA K, 1992, NUCL INSTRUM METH B, V70, P220, DOI 10.1016/0168-583X(92)95935-K; NASH CS, 1995, NEW J CHEM, V19, P669; Nash CS, 1999, J AM CHEM SOC, V121, P10830, DOI 10.1021/ja9928273; Pershina V, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4802765; PYYKKO P, 1979, ACCOUNTS CHEM RES, V12, P276, DOI 10.1021/ar50140a002; Schadel M., 2013, CHEM SUPERHEAVY ELEM; SCHMIDT KH, 1984, Z PHYS A-HADRON NUCL, V316, P19, DOI 10.1007/BF01415656; SLATER JL, 1971, J CHEM PHYS, V55, P5129, DOI 10.1063/1.1675634; Turler A, 2013, CHEM REV, V113, P1237, DOI 10.1021/cr3002438; WERNER H, 1990, ANGEW CHEM INT EDIT, V29, P1077, DOI 10.1002/anie.199010773; Yakushev A, 2014, INORG CHEM, V53, P1624, DOI 10.1021/ic4026766; Zvara I., 1985, RADIOCHIM ACTA, V38, P95, DOI DOI 10.1524/RACT.1985.38.2.95; Zvara I., 2008, INORGANIC RADIOCHEMI	21	59	60	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1491	1493		10.1126/science.1255720	http://dx.doi.org/10.1126/science.1255720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237098				2022-12-28	WOS:000341752900038
J	Pepe, F; Ehrenreich, D; Meyer, MR				Pepe, Francesco; Ehrenreich, David; Meyer, Michael R.			Instrumentation for the detection and characterization of exoplanets	NATURE			English	Review							INFRARED TRANSMISSION SPECTROSCOPY; TELESCOPE IMAGING SPECTROGRAPH; RADIAL-VELOCITY CONFIRMATION; TIME-SERIES PHOTOMETRY; LASER FREQUENCY COMB; EXTRA-SOLAR PLANETS; FIELD CAMERA 3; HIGH-RESOLUTION; HD 189733B; ORBITAL MOTION	In no other field of astrophysics has the impact of new instrumentation been as substantial as in the domain of exoplanets. Before 1995 our knowledge of exoplanets was mainly based on philosophical and theoretical considerations. The years that followed have been marked, instead, by surprising discoveries made possible by high-precision instruments. Over the past decade, the availability of new techniques has moved the focus of research from the detection to the characterization of exoplanets. Next-generation facilities will produce even more complementary data that will lead to a comprehensive view of exoplanet characteristics and, by comparison with theoretical models, to a better understanding of planet formation.	[Pepe, Francesco; Ehrenreich, David] Univ Geneva, Astron Observ, CH-1290 Versoix, Switzerland; [Meyer, Michael R.] Swiss Fed Inst Technol, Inst Astron, CH-8093 Zurich, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pepe, F (corresponding author), Univ Geneva, Astron Observ, 51 Chemin Maillettes, CH-1290 Versoix, Switzerland.	Francesco.Pepe@unige.ch		Ehrenreich, David/0000-0001-9704-5405; Pepe, Francesco/0000-0002-9815-773X	Swiss National Science Foundation (SNSF); SNSF	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF))	D.E. would like to dedicate this article to the memory of STIS Principal Investigator Bruce Woodgate who passed away in April 2014. This work has been carried out within the frame of the National Centre for Competence in Research 'PlanetS' supported by the Swiss National Science Foundation (SNSF). The authors acknowledge the financial support of the SNSF.	Aceituno J, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220361; Alonso R, 2004, ASTROPHYS J, V613, pL153, DOI 10.1086/425256; Amara A, 2012, MON NOT R ASTRON SOC, V427, P948, DOI 10.1111/j.1365-2966.2012.21918.x; Avila G, 2008, P SOC PHOTO-OPT INS, V7018, pW184, DOI 10.1117/12.789509; Avila G, 1998, P SOC PHOTO-OPT INS, V3355, P900, DOI 10.1117/12.316747; Bailey V., 2014, P IAU, V8, P26; Bakos GA, 2007, ASTROPHYS J, V656, P552, DOI 10.1086/509874; Baranne A, 1996, ASTRON ASTROPHYS SUP, V119, P373, DOI 10.1051/aas:1996251; Baranne A., 1979, Vistas in Astronomy, V23, P279, DOI 10.1016/0083-6656(79)90016-3; BARDEN SC, 1981, PUBL ASTRON SOC PAC, V93, P154, DOI 10.1086/130795; Barge P., 2006, COROT MISSION PRELAU; Barnes JR, 2014, MON NOT R ASTRON SOC, V439, P3094, DOI 10.1093/mnras/stu172; Barnes JR, 2011, MON NOT R ASTRON SOC, V412, P1599, DOI 10.1111/j.1365-2966.2010.17979.x; Bastien FA, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/2/29; Bean JL, 2010, NATURE, V468, P669, DOI 10.1038/nature09596; Beaulieu JP, 2008, ASTROPHYS J, V677, P1343, DOI 10.1086/527045; Bernstein RA, 2003, P SOC PHOTO-OPT INS, V4841, P1694, DOI 10.1117/12.461502; Berta ZK, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/35; Boisse I, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201014354; Borucki W, 2009, IAU SYMP P SERIES, P289, DOI 10.1017/S1743921308026513; Bouchy F, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201219979; Bouchy F, 2001, ASTRON ASTROPHYS, V374, P733, DOI 10.1051/0004-6361:20010730; Bouchy F., 2006, P C 10 ANN 51 PEG B, P319; Bourrier V, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220533; Bramall DG, 2012, PROC SPIE, V8446, DOI 10.1117/12.925935; Broeg C, 2013, EPJ WEB CONF, V47, DOI 10.1051/epjconf/20134703005; Brogi M, 2012, NATURE, V486, P502, DOI 10.1038/nature11161; Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; BROWN TM, 1994, PUBL ASTRON SOC PAC, V106, P1285, DOI 10.1086/133506; Butler RP, 1996, PUBL ASTRON SOC PAC, V108, P500, DOI 10.1086/133755; Cameron AC, 2007, MON NOT R ASTRON SOC, V375, P951, DOI 10.1111/j.1365-2966.2006.11350.x; CAMPBELL B, 1979, PUBL ASTRON SOC PAC, V91, P540, DOI 10.1086/130535; Cegla HM, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/104; Cegla HM, 2012, MON NOT R ASTRON SOC, V421, pL54, DOI 10.1111/j.1745-3933.2011.01205.x; Chabrier G., 2014, GIANT PLANET BROWN D; Chakraborty A., 2010, P SOC PHOTO-OPT INS, V7735; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Charbonneau D., 2008, BAAS, V40, P242; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Chauvin G, 2004, ASTRON ASTROPHYS, V425, pL29, DOI 10.1051/0004-6361:200400056; Chazelas B., 2010, STUDY OPTICAL FIBER; Chazelas B, 2012, PROC SPIE, V8450, DOI 10.1117/12.926188; CHEOPS Study Team, 2013, CHEOPS DEF STUD REP; Close L., 2013, P 3 AO4ELT C; Codona JL, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/100; Colon KD, 2013, REV MEX AST ASTR, V42, P1; Cosentino R, 2012, PROC SPIE, V8446, DOI 10.1117/12.925738; Crane JD, 2010, PROC SPIE, V7735, DOI 10.1117/12.857792; Crepp JR, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/132; Croll B, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/78; Crossfield IJM, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/132; Davies R, 2012, ANNU REV ASTRON ASTR, V50, P305, DOI 10.1146/annurev-astro-081811-125447; Dekker H, 2000, P SOC PHOTO-OPT INS, V4008, P534, DOI 10.1117/12.395512; Delfosse X., 2013, P ANN M FRENCH SOC A, P497; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/95; Demory BO, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117178; des Etangs AL, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219363; Desert JM, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/2/L40; Desert JM, 2009, ASTROPHYS J, V699, P478, DOI 10.1088/0004-637X/699/1/478; Desort M, 2007, ASTRON ASTROPHYS, V473, P983, DOI 10.1051/0004-6361:20078144; DUMUSQUE X, 2011, IAU SYMP P SERIES, V276, P527; Dumusque X, 2012, NATURE, V491, P207, DOI 10.1038/nature11572; Dumusque X, 2011, IAU SYMP P SERIES, P530, DOI 10.1017/S1743921311021090; Ehrenreich D, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219981; Ehrenreich D., 2014, NEAR INFRARED TRANSM; Ehrenreich D, 2007, ASTROPHYS J, V668, pL179, DOI 10.1086/522792; Evans TM, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/2/L16; Fossati L, 2010, ASTROPHYS J LETT, V714, pL222, DOI 10.1088/2041-8205/714/2/L222; Fusco T., 2013, P 3 AO4ELT C; Ge J., 2012, P SOC PHOTO-OPT INS, V8446; Ge J, 2012, PROC SPIE, V8446, DOI 10.1117/12.925795; Gettel S., 2013, CORRECTING ASTROPHYS; Gibson NP, 2012, MON NOT R ASTRON SOC, V422, P753, DOI 10.1111/j.1365-2966.2012.20655.x; Gibson NP, 2011, MON NOT R ASTRON SOC, V411, P2199, DOI 10.1111/j.1365-2966.2010.17837.x; Green JC, 2001, P SOC PHOTO-OPT INS, V4498, P229, DOI 10.1117/12.450058; GRIFFIN RF, 1967, ASTROPHYS J, V148, P465, DOI 10.1086/149168; Grillmair CJ, 2007, ASTROPHYS J, V658, pL115, DOI 10.1086/513741; Grillmair CJ, 2008, NATURE, V456, P767, DOI 10.1038/nature07574; Guyon O, 2003, ASTRON ASTROPHYS, V404, P379, DOI 10.1051/0004-6361:20030457; Halverson S, 2014, PUBL ASTRON SOC PAC, V126, P445, DOI 10.1086/676649; Heacox W. D., 1988, FIBER OPTICS ASTRONO, P204; HEACOX WD, 1992, ASTRON ASTROPHYS REV, V3, P169, DOI 10.1007/BF00872526; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; Horton A, 2012, PROC SPIE, V8446, DOI 10.1117/12.924945; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; Howell S. B., 2014, PUBL ASTRON SOC PACI; HUBBARD EN, 1979, ASTROPHYS J, V229, P1074, DOI 10.1086/157041; Huelamo N, 2008, ASTRON ASTROPHYS, V489, pL9, DOI 10.1051/0004-6361:200810596; HUNTER TR, 1992, PUBL ASTRON SOC PAC, V104, P1244, DOI 10.1086/133115; Ireland MJ, 2013, MON NOT R ASTRON SOC, V433, P1718, DOI 10.1093/mnras/stt859; Johnson AR, 2014, OPT EXPRESS, V22, P1394, DOI 10.1364/OE.22.001394; Kalas P., 2014, P IAU, V8, P204; Kalas P, 2008, SCIENCE, V322, P1345, DOI 10.1126/science.1166609; Kaufer A., 1999, MESSENGER, V95, P8; Kaufl HU, 2004, P SOC PHOTO-OPT INS, V5492, P1218, DOI 10.1117/12.551480; Kenworthy MA, 2007, ASTROPHYS J, V660, P762, DOI 10.1086/513596; Kimble RA, 2008, PROC SPIE, V7010, DOI 10.1117/12.789581; Knutson H. A., 2014, HUBBLE SPACE TELESCO; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2014, NATURE, V505, P66, DOI 10.1038/nature12887; Konacki M, 2003, NATURE, V421, P507, DOI 10.1038/nature01379; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888; Kulow JR, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/132; Lagrange AM, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016354; Lagrange AM, 2009, ASTRON ASTROPHYS, V506, P927, DOI 10.1051/0004-6361/200912098; Lagrange AM, 2009, ASTRON ASTROPHYS, V493, pL21, DOI 10.1051/0004-6361:200811325; LATHAM DW, 1989, NATURE, V339, P38, DOI 10.1038/339038a0; Li CH, 2008, NATURE, V452, P610, DOI 10.1038/nature06854; Linsky JL, 2010, ASTROPHYS J, V717, P1291, DOI 10.1088/0004-637X/717/2/1291; Lovis C, 2008, ASTR SOC P, V398, P455; Macintosh B., 2014, P NATL ACAD SCI US; Mahadevan S, 2012, PROC SPIE, V8446, DOI 10.1117/12.926102; Mahadevan S, 2009, ASTROPHYS J, V692, P1590, DOI 10.1088/0004-637X/692/2/1590; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; Martinez-Arnaiz R, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/200913725; Mawet D, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201321315; Mawet D, 2012, PROC SPIE, V8442, DOI 10.1117/12.927245; Mayor M, 2000, ASTR SOC P, V219, P441; Mayor M., 2003, MESSENGER, V114, P20; McCarthy D. W. J., 1984, B AM ASTRON SOC, V16, P965; Milli J, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321881; Moutou C, 2013, ICARUS, V226, P1625, DOI 10.1016/j.icarus.2013.03.022; Narayan R, 2005, ASTROPHYS J, V620, P1002, DOI 10.1086/426380; Narita N, 2005, PUBL ASTRON SOC JPN, V57, P471, DOI 10.1093/pasj/57.3.471; Nielsen EL, 2010, ASTROPHYS J, V717, P878, DOI 10.1088/0004-637X/717/2/878; Noguchi K, 2002, PUBL ASTRON SOC JPN, V54, P855, DOI 10.1093/pasj/54.6.855; Oliva E, 2012, PROC SPIE, V8446, DOI 10.1117/12.925274; Osterman S, 2007, PROC SPIE, V6693, DOI 10.1117/12.734193; Pasquini Luca, 2010, Messenger, P20; Pepe F, 2004, IAU SYMP, P103; Pepe F, 2014, ASTRON NACHR, V335, P8, DOI 10.1002/asna.201312004; Pepe F., 2002, MESSENGER, V110, P9; Pepe FA, 2008, PHYS SCRIPTA, VT130, DOI 10.1088/0031-8949/2008/T130/014007; Perruchot S, 2011, PROC SPIE, V8151, DOI 10.1117/12.892466; Phillips D. F., 2012, P SOC PHOTO-OPT INS, V8446; Plavchan PP, 2013, PROC SPIE, V8864, DOI 10.1117/12.2023696; Pont F, 2007, ASTRON ASTROPHYS, V476, P1347, DOI 10.1051/0004-6361:20078269; Quanz S. P., 2014, INT J ASTROBIOL; Quanz S. P., 2011, MESSENGER, V146, P25; Quanz SP, 2010, ASTROPHYS J LETT, V722, pL49, DOI 10.1088/2041-8205/722/1/L49; Quirrenbach A, 2012, PROC SPIE, V8446, DOI 10.1117/12.925164; Ranjan S, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/148; Rauer H., 2013, EXP ASTRON; Reiners A, 2010, ASTROPHYS J, V710, P432, DOI 10.1088/0004-637X/710/1/432; Reiners A, 2009, ASTRON ASTROPHYS, V498, P853, DOI 10.1051/0004-6361/200810257; Richardson LJ, 2006, ASTROPHYS J, V649, P1043, DOI 10.1086/506503; Ricker G., 2009, BAAS, V41, P193; Saar SH, 2000, ASTROPHYS J, V534, pL105, DOI 10.1086/312648; Sahlmann J., 2012, P SOC PHOTO-OPT INS, V8445; Santos NC, 2000, ASTRON ASTROPHYS, V361, P265; Santos NC, 2004, ASTRON ASTROPHYS, V426, pL19, DOI 10.1051/0004-6361:200400076; Schafer S, 2012, PROC SPIE, V8446, DOI 10.1117/12.926232; Schettino G, 2010, PROC SPIE, V7808, DOI 10.1117/12.863828; Schneider J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116713; Schwab C., 2012, IAU P; Schwab C., 2014, STABILIZING FABRY PE; Schwab C., 2010, P SPIE, V7735, DOI [10.1117/12.856709, DOI 10.1117/12.856709]; Sing DK, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015579; Sing DK, 2009, ASTRON ASTROPHYS, V505, P891, DOI 10.1051/0004-6361/200912776; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Snellen I., 2012, P SOC PHOTO-OPT INS, V8444; Snellen IAG, 2008, ASTRON ASTROPHYS, V487, P357, DOI 10.1051/0004-6361:200809762; Snellen IAG, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/182; Snellen IAG, 2014, NATURE, V509, P63, DOI 10.1038/nature13253; Sozzetti A, 2014, MON NOT R ASTRON SOC, V437, P497, DOI 10.1093/mnras/stt1899; Steinmetz T, 2008, SCIENCE, V321, P1335, DOI 10.1126/science.1161030; Strassmeier KG, 2008, PROC SPIE, V7014, DOI 10.1117/12.787376; Swain MR, 2008, NATURE, V452, P329, DOI 10.1038/nature06823; Szentgyorgyi A, 2012, PROC SPIE, V8446, DOI 10.1117/12.924957; Tamura M, 2012, PROC SPIE, V8446, DOI 10.1117/12.925885; THOMPSON RI, 1994, P SOC PHOTO-OPT INS, V2198, P1202, DOI 10.1117/12.176808; Tull RG, 1998, P SOC PHOTO-OPT INS, V3355, P387, DOI 10.1117/12.316774; TULL RG, 1995, PUBL ASTRON SOC PAC, V107, P251, DOI 10.1086/133548; Udalski A, 2002, ACTA ASTRONOM, V52, P115; Van Grootel V, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/2; VANDEKAMP P, 1969, ASTRON J, V74, P238, DOI 10.1086/110799; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Vogt S. S., 2014, PUBL ASTRON SOC PACI; VOGT SS, 1987, PUBL ASTRON SOC PAC, V99, P1214, DOI 10.1086/132107; WALKER GAH, 1992, ASTR SOC P, V32, P67; Wildi F, 2011, PROC SPIE, V8151, DOI 10.1117/12.901550; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; Woodgate BE, 1998, PUBL ASTRON SOC PAC, V110, P1183, DOI 10.1086/316243; Wright JT, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/160; Wright JT, 2005, PUBL ASTRON SOC PAC, V117, P657, DOI 10.1086/430369	199	64	66	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					358	366		10.1038/nature13784	http://dx.doi.org/10.1038/nature13784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230658	Green Submitted			2022-12-28	WOS:000341814900049
J	Gan, F; Zhang, SY; Rockwell, NC; Martin, SS; Lagarias, JC; Bryant, DA				Gan, Fei; Zhang, Shuyi; Rockwell, Nathan C.; Martin, Shelley S.; Lagarias, J. Clark; Bryant, Donald A.			Extensive remodeling of a cyanobacterial photosynthetic apparatus in far-red light	SCIENCE			English	Article							PHOTOSYSTEM-II; CHLOROPHYLL D; EXPRESSION; COMPLEX; PHYCOBILISOMES; TRANSCRIPTION; BIOSYNTHESIS; CHROMOPHORES; ACCLIMATION; PENETRATION	Cyanobacteria are unique among bacteria in performing oxygenic photosynthesis, often together with nitrogen fixation and, thus, are major primary producers in many ecosystems. The cyanobacterium, Leptolyngbya sp. strain JSC-1, exhibits an extensive photoacclimative response to growth in far-red light that includes the synthesis of chlorophylls d and f. During far-red acclimation, transcript levels increase more than twofold for similar to 900 genes and decrease by more than half for similar to 2000 genes. Core subunits of photosystem I, photosystem II, and phycobilisomes are replaced by proteins encoded in a 21-gene cluster that includes a knotless red/far-red phytochrome and two response regulators. This acclimative response enhances light harvesting for wavelengths complementary to the growth light (lambda = 700 to 750 nanometers) and enhances oxygen evolution in far-red light.	[Gan, Fei; Zhang, Shuyi; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Rockwell, Nathan C.; Martin, Shelley S.; Lagarias, J. Clark] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	dab14@psu.edu	Lagarias, John Clark/L-3139-2013; Gan, Fei/I-8599-2017	Lagarias, John Clark/0000-0002-2093-0403; Zhang, Shuyi/0000-0001-8500-5836; Gan, Fei/0000-0003-1670-5251	NSF [MCB-1021725]; U.S. Department of Energy's Office of Science, Biological, and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory [DE-AC02-05CH11231, DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [DOE DE-FG02-09ER16117]; Div Of Molecular and Cellular Bioscience [1021725] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Energy's Office of Science, Biological, and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory(University of California System); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by grant MCB-1021725 from the NSF to D.A.B. The genome sequence of Leptolyngbya sp. strain JSC-1 was determined under the auspices of the U.S. Department of Energy's Office of Science, Biological, and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. Spectroscopic characterization of RfpA and NpR4776-PCM was funded by a grant from the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (DOE DE-FG02-09ER16117 to J.C.L.) The authors thank J. R. Miller for assistance in performing mass analyses on Chls d and f; B. Stanley and A. Stanley for advice and technical assistance in performing the tryptic peptide mass fingerprinting; and C. Praul and C. Price for assistance in performing RNA-seq profiling. The authors thank J. Lecomte, W. Schluchter, J. Golbeck, and A. Glazer for reading the manuscript and helpful suggestions. This whole-genome shotgun project for Leptolyngbya sp. strain JSC-1 (alternative name, Marsacia ferruginose; IMG taxon ID 2022827000; GOLD ID = Gi02032) has been deposited at DDBJ/EMBL/GenBank under the accession JMKF00000000; the version described in this paper is version JMKF01000000. RNA-seq data were deposited in the NCBI Sequence Read Archive (SRA) under accession number SRP041154.	Allen JF, 2007, NATURE, V445, P610, DOI 10.1038/445610a; Alvey RM, 2011, BIOCHEMISTRY-US, V50, P4890, DOI 10.1021/bi200307s; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; BLISS D, 1985, PLANT CELL ENVIRON, V8, P475, DOI 10.1111/j.1365-3040.1985.tb01683.x; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Brown II, 2010, APPL ENVIRON MICROB, V76, P6664, DOI 10.1128/AEM.00662-10; Bryant D. A., 1994, ADV PHOTOSYNTHESIS R, V1; BRYANT DA, 1981, EUR J BIOCHEM, V119, P415, DOI 10.1111/j.1432-1033.1981.tb05624.x; BRYANT DA, 1981, EUR J BIOCHEM, V119, P425, DOI 10.1111/j.1432-1033.1981.tb05625.x; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Bryant DA, 2013, ADV BOT RES, V66, P99, DOI 10.1016/B978-0-12-397923-0.00004-7; Chen M, 2012, FEBS LETT, V586, P3249, DOI 10.1016/j.febslet.2012.06.045; Chen M, 2011, TRENDS PLANT SCI, V16, P427, DOI 10.1016/j.tplants.2011.03.011; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; Christman HD, 2011, J BACTERIOL, V193, P6874, DOI 10.1128/JB.05999-11; Dong CX, 2009, BBA-BIOENERGETICS, V1787, P1122, DOI 10.1016/j.bbabio.2009.04.007; Ducret A, 1998, J MOL BIOL, V278, P369, DOI 10.1006/jmbi.1998.1678; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fujita Y., 1994, MOL BIOL CYANOBACTER, P677; Gaiducov N., 1902, ABH PREUSS AKAD WISS, V5, P1; Gaidukov N., 1903, BER DEUT BOT GES, V21, P517; Garcia-Pichel F., 2003, ALGOLOGICAL STUDIES, V109, P213, DOI DOI 10.1127/1864-1318/2003/0109-0213; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1975, ARCH MICROBIOL, V104, P15, DOI 10.1007/BF00447294; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Grotjohann I, 2005, PHOTOSYNTH RES, V85, P51, DOI 10.1007/s11120-005-1440-4; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; Kirilovsky D, 2013, PHOTOCH PHOTOBIO SCI, V12, P1135, DOI 10.1039/c3pp25406b; Kiss E, 2012, BBA-BIOENERGETICS, V1817, P1083, DOI 10.1016/j.bbabio.2012.04.010; Li YQ, 2013, J PHYS CHEM B, V117, P11309, DOI 10.1021/jp402413d; Li YQ, 2012, BBA-BIOENERGETICS, V1817, P1292, DOI 10.1016/j.bbabio.2012.02.026; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Maresca JA, 2008, PHOTOSYNTH RES, V97, P121, DOI 10.1007/s11120-008-9312-3; Mulo P, 2012, BBA-BIOENERGETICS, V1817, P247, DOI 10.1016/j.bbabio.2011.04.011; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Sousa FL, 2013, GENOME BIOL EVOL, V5, P200, DOI 10.1093/gbe/evs127; TESTER M, 1987, PLANT CELL ENVIRON, V10, P281, DOI 10.1111/j.1365-3040.1987.tb01607.x; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913	47	234	240	1	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1312	1317		10.1126/science.1256963	http://dx.doi.org/10.1126/science.1256963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214622	Green Submitted			2022-12-28	WOS:000341483800056
J	Levine, B; Kroemer, G				Levine, Beth; Kroemer, Guido			SnapShot: Macroautophagy	CELL			English	Editorial Material							AUTOPHAGOSOME FORMATION; MOLECULAR-MECHANISMS; MACHINERY; PATHWAY; YEAST		[Levine, Beth] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Kroemer, Guido] Inst Gustave Roussy, INSERM, Villejuif, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.		KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; 	NCI NIH HHS [R01 CA084254, R01 CA109618] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; LEVINE B, 2008, CELL; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	14	16	16	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					162	U14						3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	25221369				2022-12-28	WOS:000253427600024
J	Pellegrino, MW; Nargund, AM; Kirienko, NV; Gillis, R; Fiorese, CJ; Haynes, CM				Pellegrino, Mark W.; Nargund, Amrita M.; Kirienko, Natalia V.; Gillis, Reba; Fiorese, Christopher J.; Haynes, Cole M.			Mitochondrial UPR-regulated innate immunity provides resistance to pathogen infection	NATURE			English	Article							CAENORHABDITIS-ELEGANS; TRANSLATIONAL INHIBITION; GENES; PATHWAYS; IMPORT; KINASE	Metazoans identify and eliminate bacterial pathogens in microbe-rich environments such as the intestinal lumen; however, the mechanisms are unclear. Host cells could potentially use intracellular surveillance or stress response programs to detect pathogens that target monitored cellular activities and then initiate innate immune responses(1-3). Mitochondrial function is evaluated by monitoring mitochondrial protein import efficiency of the transcription factor ATFS-1, which mediates the mitochondrial unfolded protein response (UPRmt). During mitochondrial stress, mitochondrial import is impaired(4), allowing ATFS-1 to traffic to the nucleus where it mediates a transcriptional response to re-establish mitochondrial homeostasis(5). Here we examined the role of ATFS-1 in Caenorhabditis elegans during pathogen exposure, because during mitochondrial stress ATFS-1 induced not only mitochondrial protective genes but also innate immune genes that included a secreted lysozyme and anti-microbial peptides. Exposure to the pathogen Pseudomonas aeruginosa caused mitochondrial dysfunction and activation of the UPRmt. C. elegans lacking atfs-1 were susceptible to P. aeruginosa, whereas hyper-activation of ATFS-1 and the UPRmt improved clearance of P. aeruginosa from the intestine and prolonged C. elegans survival in a manner mainly independent of known innate immune pathways(6,7). We propose that ATFS-1 import efficiency and the UPRmt is a means to detect pathogens that target mitochondria and initiate a protective innate immune response.	[Pellegrino, Mark W.; Nargund, Amrita M.; Gillis, Reba; Haynes, Cole M.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Kirienko, Natalia V.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Kirienko, Natalia V.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Fiorese, Christopher J.; Haynes, Cole M.] Weill Cornell Med Coll, BCMB Allied Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University	Haynes, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10065 USA.	haynesc@mskcc.org		Fiorese, Christopher/0000-0002-7521-7103; Kirienko, Natalia/0000-0002-1537-4967	Ellison Medical Foundation; Lucille Castori Center for Microbes, Inflammation and Cancer at MSKCC; National Institutes of Health [R01AG040061, F32AI100501, R01AI085581]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI100501, R01AI085581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040061] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Lucille Castori Center for Microbes, Inflammation and Cancer at MSKCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Troemel, M. Pilon, S. Mitani of the National Bioresource Project, and the Caenorhabditis Genetics Center for providing C. elegans strains. We thank D. Kim and J. Xavier for providing P. aeruginosa strains, and T. Langer and S. Troeder for mammalian reagents. This work was supported by the Ellison Medical Foundation, the Lucille Castori Center for Microbes, Inflammation and Cancer at MSKCC and the National Institutes of Health (R01AG040061) to C.M.H., (F32AI100501) to N.V.K. and (R01AI085581) to F. Ausubel.	Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Kato Y, 2002, BIOCHEM J, V361, P221, DOI 10.1042/0264-6021:3610221; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kirienko NV, 2013, CELL HOST MICROBE, V13, P406, DOI 10.1016/j.chom.2013.03.003; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; O'Malley YQ, 2003, AM J PHYSIOL-LUNG C, V284, pL420, DOI 10.1152/ajplung.00316.2002; Pukkila-Worley R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002733; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Runkel ED, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003346; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Twumasi-Boateng K, 2012, AGING CELL, V11, P659, DOI 10.1111/j.1474-9726.2012.00829.x; Walter L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001084; Wright G, 2001, EXP CELL RES, V263, P107, DOI 10.1006/excr.2000.5096; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	36	194	198	6	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					414	+		10.1038/nature13818	http://dx.doi.org/10.1038/nature13818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25274306	Green Accepted, Green Submitted			2022-12-28	WOS:000346484800051
J	Manka, R; Binter, C; Kozerke, S				Manka, Robert; Binter, Christian; Kozerke, Sebastian			Hurricane aorta	LANCET			English	Editorial Material									[Manka, Robert] Univ Zurich Hosp, Clin Cardiol, CH-8091 Zurich, Switzerland; [Manka, Robert] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Manka, Robert; Binter, Christian; Kozerke, Sebastian] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Manka, Robert; Binter, Christian; Kozerke, Sebastian] ETH, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Manka, R (corresponding author), Univ Zurich Hosp, Clin Cardiol, CH-8091 Zurich, Switzerland.	robert.manka@usz.ch	Kozerke, Sebastian/J-3209-2015	Kozerke, Sebastian/0000-0003-3725-8884					0	3	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2141	2141		10.1016/S0140-6736(14)60752-2	http://dx.doi.org/10.1016/S0140-6736(14)60752-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25242035				2022-12-28	WOS:000346354300030
J	Gu, LC; Li, C; Aach, J; Hill, DE; Vidal, M; Church, GM				Gu, Liangcai; Li, Chao; Aach, John; Hill, David E.; Vidal, Marc; Church, George M.			Multiplex single-molecule interaction profiling of DNA-barcoded proteins	NATURE			English	Article							COUPLED RECEPTOR; POLYMERASE COLONIES; IN-VITRO; DISCOVERY; BINDING; AMPLIFICATION; GENOME; ASSAYS; IDENTIFICATION; TRANSDUCTION	In contrast with advances in massively parallel DNA sequencing(1), high-throughput protein analyses(2-4) are often limited by ensemble measurements, individual analyte purification and hence compromised quality and cost-effectiveness. Single-molecule protein detection using optical methods(5) is limited by the number of spectrally non-overlapping chromophores. Here we introduce a single-molecular-interaction sequencing (SMI-seq) technology for parallel protein interaction profiling leveraging single-molecule advantages. DNA barcodes are attached to proteins collectively via ribosome display(6) or individually via enzymatic conjugation. Barcoded proteins are assayed en masse in aqueous solution and subsequently immobilized in a polyacrylamide thin film to construct a random single-molecule array, where barcoding DNAs are amplified into in situ polymerase colonies (polonies)(7) and analysed by DNA sequencing. This method allows precise quantification of various proteins with a theoretical maximum array density of over one million polonies per square millimetre. Furthermore, protein interactions can be measured on the basis of the statistics of colocalized polonies arising from barcoding DNAs of interacting proteins. Two demanding applications, G-protein coupled receptor and antibody-binding profiling, are demonstrated. SMI-seq enables 'library versus library' screening in a one-pot assay, simultaneously interrogating molecular binding affinity and specificity.	[Gu, Liangcai; Aach, John; Hill, David E.; Vidal, Marc; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Li, Chao; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Hill, David E.; Vidal, Marc] Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA; [Hill, David E.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Gu, LC (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	liangcaigu@gmail.com; gchurch@genetics.med.harvard.edu	Gu, Liangcai/U-6908-2019	church, george/0000-0001-6232-9969	US Department of Energy [DE-FG02-02ER63445]; NIH NHGRI [HG001715]; Jane Coffin Childs Fund for Medical Research; Harvard Origins of Life Initiative; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG001715, U01HG001715] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Jane Coffin Childs Fund for Medical Research; Harvard Origins of Life Initiative; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant from the US Department of Energy (DE-FG02-02ER63445) to G.M.C. and a grant from the NIH NHGRI (HG001715) to M.V. and D.E.H.L.G. was supported by a postdoctoral fellowship from the Jane Coffin Childs Fund for Medical Research and a grant from Harvard Origins of Life Initiative. We thank W. Harper, L. Pontano Vaites, S. Elledge and J. Zhu for providing plasmids, F. Vigneault for comments on the manuscript, J. Lai and D. Breslau for assistance on imaging setup, and members of the Church and Vidal groups for constructive discussions.	Aach J, 2004, J THEOR BIOL, V228, P31, DOI 10.1016/j.jtbi.2003.12.003; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Darmanis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025583; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fujimori Shigeo, 2012, Sci Rep, V2, P691, DOI 10.1038/srep00691; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Hammond M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040405; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; JOHN J, 1988, J BIOL CHEM, V263, P11792; Kiel C, 2009, J BIOL CHEM, V284, P31893, DOI 10.1074/jbc.M109.031153; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Lewis JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-8; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lowman HB, 1997, ANNU REV BIOPH BIOM, V26, P401, DOI 10.1146/annurev.biophys.26.1.401; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Luttrell LM, 2002, J CELL SCI, V115, P455; MacBeath G, 2000, SCIENCE, V289, P1760; McGregor LM, 2014, J AM CHEM SOC, V136, P3264, DOI 10.1021/ja412934t; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Mitra N, 2013, ACS CHEM BIOL, V8, P617, DOI 10.1021/cb300466n; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Nishihara T, 2000, J HEALTH SCI, V46, P282; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PARKER EM, 1991, J BIOL CHEM, V266, P519; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Young K, 1998, NAT BIOTECHNOL, V16, P946, DOI 10.1038/nbt1098-946; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173; Zhu J, 2013, NAT BIOTECHNOL, V31, P331, DOI 10.1038/nbt.2539	50	54	62	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					554	+		10.1038/nature13761	http://dx.doi.org/10.1038/nature13761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25252978	Green Accepted			2022-12-28	WOS:000346247600001
J	Shaw, AT; Ou, SHI; Bang, YJ; Camidge, DR; Solomon, BJ; Salgia, R; Riely, GJ; Varella-Garcia, M; Shapiro, GI; Costa, DB; Doebele, RC; Le, LP; Zheng, ZL; Tan, WW; Stephenson, P; Shreeve, SM; Tye, LM; Christensen, JG; Wilner, KD; Clark, JW; Iafrate, AJ				Shaw, Alice T.; Ou, Sai-Hong I.; Bang, Yung-Jue; Camidge, D. Ross; Solomon, Benjamin J.; Salgia, Ravi; Riely, Gregory J.; Varella-Garcia, Marileila; Shapiro, Geoffrey I.; Costa, Daniel B.; Doebele, Robert C.; Long Phi Le; Zheng, Zongli; Tan, Weiwei; Stephenson, Patricia; Shreeve, S. Martin; Tye, Lesley M.; Christensen, James G.; Wilner, Keith D.; Clark, Jeffrey W.; Iafrate, A. John			Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANAPLASTIC LYMPHOMA KINASE; ROS GENE; INHIBITORS; RESISTANT; PROTEINS; FUSIONS; SAFETY; TUMORS	Background Chromosomal rearrangements of the gene encoding ROS1 proto-oncogene receptor tyrosine kinase (ROS1) define a distinct molecular subgroup of non-small-cell lung cancers (NSCLCs) that may be susceptible to therapeutic ROS1 kinase inhibition. Crizotinib is a small-molecule tyrosine kinase inhibitor of anaplastic lymphoma kinase (ALK), ROS1, and another proto-oncogene receptor tyrosine kinase, MET. Methods We enrolled 50 patients with advanced NSCLC who tested positive for ROS1 rearrangement in an expansion cohort of the phase 1 study of crizotinib. Patients were treated with crizotinib at the standard oral dose of 250 mg twice daily and assessed for safety, pharmacokinetics, and response to therapy. ROS1 fusion partners were identified with the use of next-generation sequencing or reverse-transcriptase-polymerase-chain-reaction assays. Results The objective response rate was 72% (95% confidence interval [CI], 58 to 84), with 3 complete responses and 33 partial responses. The median duration of response was 17.6 months (95% CI, 14.5 to not reached). Median progression-free survival was 19.2 months (95% CI, 14.4 to not reached), with 25 patients (50%) still in follow-up for progression. Among 30 tumors that were tested, we identified 7 ROS1 fusion partners: 5 known and 2 novel partner genes. No correlation was observed between the type of ROS1 rearrangement and the clinical response to crizotinib. The safety profile of crizotinib was similar to that seen in patients with ALK-rearranged NSCLC. Conclusions In this study, crizotinib showed marked antitumor activity in patients with advanced ROS1-rearranged NSCLC. ROS1 rearrangement defines a second molecular subgroup of NSCLC for which crizotinib is highly active.	[Shaw, Alice T.; Long Phi Le; Zheng, Zongli; Clark, Jeffrey W.; Iafrate, A. John] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Shapiro, Geoffrey I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Costa, Daniel B.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Ou, Sai-Hong I.] Univ Calif Irvine, Irvine, CA USA; [Tan, Weiwei; Shreeve, S. Martin; Tye, Lesley M.; Christensen, James G.; Wilner, Keith D.] Pfizer Oncol, La Jolla, CA USA; [Bang, Yung-Jue] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Camidge, D. Ross; Varella-Garcia, Marileila; Doebele, Robert C.] Univ Colorado, Aurora, CO USA; [Solomon, Benjamin J.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Salgia, Ravi] Univ Chicago, Chicago, IL 60637 USA; [Riely, Gregory J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Zheng, Zongli] Karolinska Inst, Stockholm, Sweden; [Stephenson, Patricia] Rho, Chapel Hill, NC USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Irvine; Pfizer; Seoul National University (SNU); Seoul National University Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Peter Maccallum Cancer Center; University of Chicago; Memorial Sloan Kettering Cancer Center; Karolinska Institutet; Rho	Shaw, AT (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Yawkey 7B,32 Fruit St, Boston, MA 02114 USA.	ashaw1@mgh.harvard.edu	zheng, zongli/C-7309-2008; Riely, Gregory/AAF-4300-2019; Bang, Yung Jue/J-2759-2012; zheng, zongli/B-2917-2011; Ou, Sai-Hong/AAA-3389-2020; Camidge, David Ross/AAG-9144-2019; Doebele, Robert C./I-8230-2019	Bang, Yung Jue/0000-0001-6000-4597; zheng, zongli/0000-0003-4849-4903; Doebele, Robert C./0000-0001-6728-6857; Costa, Daniel/0000-0002-0689-395X; Solomon, Benjamin/0000-0003-3059-5730	Pfizer; National Cancer Institute [R21CA161590, K12CA086913, P50CA058187, P30CA046934]; Uniting against Lung Cancer; Swedish Research Council [350-2012-368]; Be a Piece of the Solution; NATIONAL CANCER INSTITUTE [P30CA008748, R21CA161590, P50CA058187, K12CA086913, P30CA046934] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Uniting against Lung Cancer; Swedish Research Council(Swedish Research CouncilEuropean Commission); Be a Piece of the Solution; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Pfizer, by grants from the National Cancer Institute (R21CA161590, to Dr. Iafrate; K12CA086913, to Dr. Doebele; P50CA058187, to Drs. Doebele and Camidge; and P30CA046934, to Dr. Varella-Garcia), by a research grant from Uniting against Lung Cancer (to Dr. Shaw), by the Swedish Research Council (postdoctoral fellowship 350-2012-368, to Dr. Zheng), and by Be a Piece of the Solution.	Awad MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMoa1215530; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Birch AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028250; BIRCHMEIER C, 1986, MOL CELL BIOL, V6, P3109, DOI 10.1128/MCB.6.9.3109; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Davies KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082236; Davies KD, 2013, CLIN CANCER RES, V19, P4040, DOI 10.1158/1078-0432.CCR-12-2851; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Gainor JF, 2013, ONCOLOGIST, V18, P865, DOI 10.1634/theoncologist.2013-0095; Gettinger SN, 2014, ANN M AM SOC CLIN ON; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Huang QH, 2014, J MED CHEM, V57, P1170, DOI 10.1021/jm401805h; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kwak EL, 2009, J CLIN ONCOL, V27; Kwak EL, 2011, NEW ENGL J MED, V364, P588; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Lee J, 2013, CANCER-AM CANCER SOC, V119, P1627, DOI 10.1002/cncr.27967; Marsilje TH, 2013, J MED CHEM, V56, P5675, DOI 10.1021/jm400402q; MATSUSHIME H, 1986, MOL CELL BIOL, V6, P3000, DOI 10.1128/MCB.6.8.3000; Maul RS, 1999, ONCOGENE, V18, P7838, DOI 10.1038/sj.onc.1203206; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; NAGARAJAN L, 1986, P NATL ACAD SCI USA, V83, P6568, DOI 10.1073/pnas.83.17.6568; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2012, ANN M AM SOC CLIN ON; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Yasuda H, 2012, J THORAC ONCOL, V7, P1086, DOI 10.1097/JTO.0b013e3182570919; Yoshida A, 2013, AM J SURG PATHOL, V37, P554, DOI 10.1097/PAS.0b013e3182758fe6; Zheng Z, NAT MED IN PRESS	35	1286	1359	6	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1963	1971		10.1056/NEJMoa1406766	http://dx.doi.org/10.1056/NEJMoa1406766			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25264305	Green Accepted, Bronze			2022-12-28	WOS:000345002900005
J	Aylward, B; Barboza, P; Bawo, L; Bertherat, E; Bilivogui, P; Blake, I; Brennan, R; Briand, S; Chakauya, JM; Chitala, K; Conteh, RM; Cori, A; Croisier, A; Dangou, JM; Diallo, B; Donnelly, CA; Dye, C; Eckmanns, T; Ferguson, NM; Formenty, P; Fuhrer, C; Fukuda, K; Garske, T; Gasasira, A; Gbanyan, S; Graaff, P; Heleze, E; Jambai, A; Jombart, T; Kasolo, F; Kadiobo, AM; Keita, S; Kertesz, D; Kone, M; Lane, C; Markoff, J; Massaquoi, M; Mills, H; Mulba, JM; Musa, E; Myhre, J; Nasidi, A; Nilles, E; Nouvellet, P; Nshimirimana, D; Nuttall, I; Nyenswah, T; Olu, O; Pendergast, S; Perea, W; Polonsky, J; Riley, S; Ronveaux, O; Sakoba, K; Krishnan, RSG; Senga, M; Shuaib, F; Van Kerkhove, MD; Vaz, R; Kannangarage, NW; Yoti, Z				Aylward, Bruce; Barboza, Philippe; Bawo, Luke; Bertherat, Eric; Bilivogui, Pepe; Blake, Isobel; Brennan, Rick; Briand, Sylvie; Chakauya, Jethro Magwati; Chitala, Kennedy; Conteh, Roland M.; Cori, Anne; Croisier, Alice; Dangou, Jean-Marie; Diallo, Boubacar; Donnelly, Christl A.; Dye, Christopher; Eckmanns, Tim; Ferguson, Neil M.; Formenty, Pierre; Fuhrer, Caroline; Fukuda, Keiji; Garske, Tini; Gasasira, Alex; Gbanyan, Stephen; Graaff, Peter; Heleze, Emmanuel; Jambai, Amara; Jombart, Thibaut; Kasolo, Francis; Kadiobo, Albert Mbule; Keita, Sakoba; Kertesz, Daniel; Kone, Moussa; Lane, Chris; Markoff, Jered; Massaquoi, Moses; Mills, Harriet; Mulba, John Mike; Musa, Emmanuel; Myhre, Joel; Nasidi, Abdusalam; Nilles, Eric; Nouvellet, Pierre; Nshimirimana, Deo; Nuttall, Isabelle; Nyenswah, Tolbert; Olu, Olushayo; Pendergast, Scott; Perea, William; Polonsky, Jonathan; Riley, Steven; Ronveaux, Olivier; Sakoba, Keita; Krishnan, Ravi Santhana Gopala; Senga, Mikiko; Shuaib, Faisal; Van Kerkhove, Maria D.; Vaz, Rui; Kannangarage, Niluka Wijekoon; Yoti, Zabulon		WHO Ebola Response Team	Ebola Virus Disease in West Africa - The First 9 Months of the Epidemic and Forward Projections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMORRHAGIC-FEVER; CLINICAL-OBSERVATIONS; CONGO; KIKWIT; TRANSMISSION	BACKGROUND On March 23, 2014, the World Health Organization (WHO) was notified of an outbreak of Ebola virus disease (EVD) in Guinea. On August 8, the WHO declared the epidemic to be a "public health emergency of international concern." METHODS By September 14, 2014, a total of 4507 probable and confirmed cases, including 2296 deaths from EVD (Zaire species) had been reported from five countries in West Africa - Guinea, Liberia, Nigeria, Senegal, and Sierra Leone. We analyzed a detailed subset of data on 3343 confirmed and 667 probable Ebola cases collected in Guinea, Liberia, Nigeria, and Sierra Leone as of September 14. RESULTS The majority of patients are 15 to 44 years of age (49.9% male), and we estimate that the case fatality rate is 70.8% (95% confidence interval [CI], 69 to 73) among persons with known clinical outcome of infection. The course of infection, including signs and symptoms, incubation period (11.4 days), and serial interval (15.3 days), is similar to that reported in previous outbreaks of EVD. On the basis of the initial periods of exponential growth, the estimated basic reproduction numbers (R-0) are 1.71 (95% CI, 1.44 to 2.01) for Guinea, 1.83 (95% CI, 1.72 to 1.94) for Liberia, and 2.02 (95% CI, 1.79 to 2.26) for Sierra Leone. The estimated current reproduction numbers (R) are 1.81 (95% CI, 1.60 to 2.03) for Guinea, 1.51 (95% CI, 1.41 to 1.60) for Liberia, and 1.38 (95% CI, 1.27 to 1.51) for Sierra Leone; the corresponding doubling times are 15.7 days (95% CI, 12.9 to 20.3) for Guinea, 23.6 days (95% CI, 20.2 to 28.2) for Liberia, and 30.2 days (95% CI, 23.6 to 42.3) for Sierra Leone. Assuming no change in the control measures for this epidemic, by November 2, 2014, the cumulative reported numbers of confirmed and probable cases are predicted to be 5740 in Guinea, 9890 in Liberia, and 5000 in Sierra Leone, exceeding 20,000 in total. CONCLUSIONS These data indicate that without drastic improvements in control measures, the numbers of cases of and deaths from EVD are expected to continue increasing from hundreds to thousands per week in the coming months.	[Aylward, Bruce; Barboza, Philippe; Bertherat, Eric; Brennan, Rick; Briand, Sylvie; Chakauya, Jethro Magwati; Chitala, Kennedy; Croisier, Alice; Dangou, Jean-Marie; Dye, Christopher; Eckmanns, Tim; Formenty, Pierre; Fuhrer, Caroline; Fukuda, Keiji; Gasasira, Alex; Graaff, Peter; Kasolo, Francis; Kadiobo, Albert Mbule; Kertesz, Daniel; Kone, Moussa; Markoff, Jered; Musa, Emmanuel; Myhre, Joel; Nilles, Eric; Nshimirimana, Deo; Nuttall, Isabelle; Olu, Olushayo; Pendergast, Scott; Perea, William; Polonsky, Jonathan; Ronveaux, Olivier; Krishnan, Ravi Santhana Gopala; Senga, Mikiko; Vaz, Rui; Kannangarage, Niluka Wijekoon; Yoti, Zabulon] WHO, Geneva, Switzerland; [Bawo, Luke; Gbanyan, Stephen; Keita, Sakoba; Kone, Moussa; Massaquoi, Moses; Mulba, John Mike; Nyenswah, Tolbert] Minist Hlth, Monrovia, Liberia; [Nasidi, Abdusalam; Shuaib, Faisal] Minist Hlth, Abuja, Nigeria; [Conteh, Roland M.; Jambai, Amara] Minist Hlth, Freetown, Sierra Leone; [Blake, Isobel; Cori, Anne; Donnelly, Christl A.; Garske, Tini; Mills, Harriet; Nouvellet, Pierre; Riley, Steven; Van Kerkhove, Maria D.] Univ London Imperial Coll Sci Technol & Med, WHO Collaborating Ctr Infect Dis Modelling, Dept Infect Dis Epidemiol, Med Res Council,Ctr Outbreak Anal & Modelling, London, England; [Lane, Chris] Publ Hlth England, London, England	World Health Organization; Ministry of Health & Sanitation Sierra Leone; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Public Health England	Donnelly, CA (corresponding author), Univ London Imperial Coll Sci Technol & Med, WHO Collaborating Ctr Infect Dis Modelling, Dept Infect Dis Epidemiol, Med Res Council,Ctr Outbreak Anal & Modelling, London, England.	c.donnelly@imperial.ac.uk; dyec@who.int	Nilles, Eric/ABA-4757-2021; Ferguson, Neil/B-8578-2008; Olu, Olushayo Oluseun/S-9167-2019; Dye, Christopher/AIC-4659-2022; Olu, Olushayo Oluseun/AHD-3365-2022; Cori, Anne/AFL-1641-2022	Nilles, Eric/0000-0001-7044-5257; Ferguson, Neil/0000-0002-1154-8093; Olu, Olushayo Oluseun/0000-0001-6832-873X; Cori, Anne/0000-0002-8443-9162; Donnelly, Christl/0000-0002-0195-2463; Jean-Marie, Dangou/0000-0003-2117-0714; Fukuda, Keiji/0000-0002-9598-9565; Riley, Steven/0000-0001-7904-4804; nouvellet, pierre/0000-0002-6094-5722; Polonsky, Jonathan/0000-0002-8634-4255; Blake, Isobel/0000-0002-3977-1318	Medical Research Council; Bill and Melinda Gates Foundation; Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences (National Institutes of Health); Health Protection Research Units of the National Institute for Health Research; European Union PREDEMICS consortium; Wellcome Trust; Fogarty International Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10252, NF-SI-0513-10125, HPRU-2012-10080] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences (National Institutes of Health); Health Protection Research Units of the National Institute for Health Research; European Union PREDEMICS consortium; Wellcome Trust(Wellcome Trust); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Medical Research Council, the Bill and Melinda Gates Foundation, the Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences (National Institutes of Health), the Health Protection Research Units of the National Institute for Health Research, European Union PREDEMICS consortium, Wellcome Trust, and Fogarty International Center.	Althaus CL, 2014, PLOS CURRENTS OUTBRE, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P25; [Anonymous], 2014, MORB MORTAL WKLY REP; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; Bray M, 2003, J INFECT DIS, V188, P1613, DOI 10.1086/379727; Breman JG, 1978, EBOLA VIRUS HAEMORRH, V85-97; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Centers for Disease Control and Prevention, 2014, EB OUTBR 2000 2014; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Fisman D, 2014, PLOS CURRENTS OUTBRE; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; MUYEMBE T, 1995, LANCET, V345, P1448; Ndambi R, 1999, J INFECT DIS, V179, pS8, DOI 10.1086/514297; Nishiura H, 2014, EURO SURVEILL, V19; Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x; Parkes-Ratanshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100333; Raabe VN, 2010, T ROY SOC TROP MED H, V104, P48, DOI 10.1016/j.trstmh.2009.07.011; Roddy P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052986; SUREAU PH, 1989, REV INFECT DIS, V11, pS790; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wamala JF, 2010, EMERG INFECT DIS, V16, P1087, DOI 10.3201/eid1607.091525; World Health Organization, CAS DEF REC EB MARB; World Health Organization, EB VIR DIS CUB MED T	31	1010	1034	13	616	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1481	1495		10.1056/NEJMoa1411100	http://dx.doi.org/10.1056/NEJMoa1411100			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25244186	Green Accepted, Green Published			2022-12-28	WOS:000342994700005
J	Pruitt, JN; Goodnight, CJ				Pruitt, Jonathan N.; Goodnight, Charles J.			Site-specific group selection drives locally adapted group compositions	NATURE			English	Article							SPIDER ANELOSIMUS-STUDIOSUS; SOCIALLY POLYMORPHIC SPIDER; HARVESTER ANT COLONIES; MULTILEVEL SELECTION; FITNESS CONSEQUENCES; KIN SELECTION; LIFE-HISTORY; POPULATION; ADAPTATION; EVOLUTION	Group selection may be defined as selection caused by the differential extinction or proliferation of groups(1,2). The socially polymorphic spider Anelosimus studiosus exhibits a behavioural polymorphism in which females exhibit either a 'docile' or 'aggressive' behavioural phenotype(3,4). Natural colonies are composed of a mixture of related docile and aggressive individuals, and populations differ in colonies' characteristic docile: aggressive ratios(5,6). Using experimentally constructed colonies of known composition, here we demonstrate that population-level divergence in docile: aggressive ratios is driven by site-specific selection at the group level-certain ratios yield high survivorship at some sites but not others. Our data also indicate that colonies responded to the risk of extinction: perturbed colonies tended to adjust their composition over two generations to match the ratio characteristic of their native site, thus promoting their long-term survival in their natal habitat. However, colonies of displaced individuals continued to shift their compositions towards mixtures that would have promoted their survival had they remained at their home sites, regardless of their contemporary environment. Thus, the regulatory mechanisms that colonies use to adjust their composition appear to be locally adapted. Our data provide experimental evidence of group selection driving collective traits in wild populations.	[Pruitt, Jonathan N.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Goodnight, Charles J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Vermont	Pruitt, JN (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	pruittj@pitt.edu	Goodnight, Charles/K-3208-2019	Pruitt, Jonathan/0000-0003-0326-6755	National Science Foundation [1352705]	National Science Foundation(National Science Foundation (NSF))	We are indebted to S. E. Riechert for her assistance with the design and implementation of this experiment, and to J. Troupe and J. Taylor for their assistance with establishing and censusing colonies. J. E. Strassmann and W. P. Carson were invaluable in aiding in the submission of this paper. We thank M. Rebeiz for recommending that we compare colonies composed of native versus foreign individuals. S. M. Bertram, E. M. Jakob, C. N. Keiser, C. M. Wright, N. Pinter-Wollman, J. M. Jandt and A. P. Modlmeier provided helpful comments on this paper. Funding for this work was provided by a National Science Foundation grant to J.N.P. (IOS #1352705).	AVILES L, 1993, AM NAT, V142, P320, DOI 10.1086/285540; Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; COLWELL RK, 1981, NATURE, V290, P401, DOI 10.1038/290401a0; Duncan SI, 2010, MOL ECOL, V19, P810, DOI 10.1111/j.1365-294X.2010.04523.x; Eldakar OT, 2009, SCIENCE, V326, P816, DOI 10.1126/science.1180183; Gardner A, 2011, J EVOLUTION BIOL, V24, P1020, DOI 10.1111/j.1420-9101.2011.02236.x; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Goodnight C, 2013, EVOLUTION, V67, P1539, DOI 10.1111/j.1558-5646.2012.01821.x; Gordon DM, 2013, NATURE, V498, P91, DOI 10.1038/nature12137; Ingram KK, 2013, J ANIM ECOL, V82, P540, DOI 10.1111/1365-2656.12036; Muir WM, 1996, POULTRY SCI, V75, P447, DOI 10.3382/ps.0750447; Pruitt JN, 2008, ANIM BEHAV, V76, P871, DOI 10.1016/j.anbehav.2008.05.009; Pruitt JN, 2013, ECOL LETT, V16, P879, DOI 10.1111/ele.12123; Pruitt JN, 2012, ECOL LETT, V15, P1026, DOI 10.1111/j.1461-0248.2012.01825.x; Pruitt JN, 2012, FUNCT ECOL, V26, P29, DOI 10.1111/j.1365-2435.2011.01922.x; Pruitt JN, 2009, EVOLUTION, V63, P2966, DOI 10.1111/j.1558-5646.2009.00771.x; Pruitt JN, 2009, ANIM BEHAV, V78, P175, DOI 10.1016/j.anbehav.2009.04.016; Riechert SE, 2008, ANIM BEHAV, V75, P1893, DOI 10.1016/j.anbehav.2007.10.033; SMITH JM, 1976, Q REV BIOL, V51, P277, DOI 10.1086/409311; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Wade MJ, 2010, EVOL APPL, V3, P453, DOI 10.1111/j.1752-4571.2010.00147.x; WADE MJ, 1978, Q REV BIOL, V53, P101, DOI 10.1086/410450; WADE MJ, 1977, EVOLUTION, V31, P134, DOI 10.1111/j.1558-5646.1977.tb00991.x; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2008, J EVOLUTION BIOL, V21, P374, DOI 10.1111/j.1420-9101.2007.01458.x; Williams George C., 1972, ADAPTATION NATURAL S; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; WILSON DS, 1983, ANNU REV ECOL SYST, V14, P159, DOI 10.1146/annurev.es.14.110183.001111; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	29	78	81	0	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					359	+		10.1038/nature13811	http://dx.doi.org/10.1038/nature13811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25274310				2022-12-28	WOS:000342988600050
J	Feehley, T; Nagler, CR				Feehley, Taylor; Nagler, Cathryn R.			HEALTH The weighty costs of non-caloric sweeteners	NATURE			English	Editorial Material							DIET-INDUCED OBESITY; GUT MICROBIOME; ASSOCIATION; METAGENOME; ECOLOGY		[Feehley, Taylor; Nagler, Cathryn R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Feehley, T (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	cnagler@bsd.uchicago.edu			NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106302] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009547] Funding Source: Medline; NIAID NIH HHS [R01 AI106302] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Gardner C, 2012, DIABETES CARE, V35, P1798, DOI 10.2337/dc12-9002; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540	13	11	11	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					176	177		10.1038/nature13752	http://dx.doi.org/10.1038/nature13752			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3BG	25231865	Green Accepted			2022-12-28	WOS:000342663100029
J	de Kok, RJ; Teanby, NA; Maltagliati, L; Irwin, PGJ; Vinatier, S				de Kok, Remco J.; Teanby, Nicholas A.; Maltagliati, Luca; Irwin, Patrick G. J.; Vinatier, Sandrine			HCN ice in Titan's high-altitude southern polar cloud	NATURE			English	Article							OPTICAL-CONSTANTS; STRATOSPHERIC AEROSOLS; ATMOSPHERE; CONDENSATION	Titan's middle atmosphere is currently experiencing a rapid change of season after northern spring arrived in 2009 (refs 1, 2). A large cloud was observed(3) for the first time above Titan's southern pole in May 2012, at an altitude of 300 kilometres. A temperature maximum was previously observed there, and condensation was not expected for any of Titan's atmospheric gases. Here we report that this cloud is composed of micrometre-sized particles of frozen hydrogen cyanide (HCN ice). The presence of HCN particles at this altitude, together with temperature determinations from mid-infrared observations, indicate a dramatic cooling of Titan's atmosphere inside the winter polar vortex in early 2012. Such cooling is in contrast to previously measured high-altitude warming in the polar vortex(1), and temperatures are a hundred degrees colder than predicted by circulation models(4). These results show that post-equinox cooling at the winter pole of Titan is much more efficient than previously thought.	[de Kok, Remco J.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [de Kok, Remco J.] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Teanby, Nicholas A.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Maltagliati, Luca; Vinatier, Sandrine] Univ Paris Diderot, Univ Paris 06, CNRS, LESIA Observ Paris, F-92195 Meudon, France; [Irwin, Patrick G. J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	Leiden University; Leiden University - Excl LUMC; University of Bristol; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Oxford	de Kok, RJ (corresponding author), Leiden Univ, Leiden Observ, Postbus 9513, NL-2300 RA Leiden, Netherlands.	R.J.de.Kok@sron.nl	Vinatier, Sandrine/AAB-8763-2019; de Kok, Remco/U-5637-2019	Vinatier, Sandrine/0000-0001-5541-2502; de Kok, Remco/0000-0001-6906-2662; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Teanby, Nicholas/0000-0003-3108-5775	PEPSci programme of the Netherlands Organisation for Scientific Research (NWO); UK Science and Technology Facilities Council; Agence Nationale de la Recherche for support (ANR Project "APOSTIC", France) [11BS56002, 968]; Science and Technology Facilities Council [ST/K00106X/1, ST/I001948/1, ST/F007957/2] Funding Source: researchfish; STFC [ST/I001948/1, ST/F007957/2, ST/K00106X/1] Funding Source: UKRI	PEPSci programme of the Netherlands Organisation for Scientific Research (NWO); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Agence Nationale de la Recherche for support (ANR Project "APOSTIC", France)(French National Research Agency (ANR)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	R.J.d.K. thanks the PEPSci programme of the Netherlands Organisation for Scientific Research (NWO) for support. N.A.T. and P.G.J.I. were supported by the UK Science and Technology Facilities Council. L. M. thanks the Agence Nationale de la Recherche for support (ANR Project "APOSTIC" no. 11BS56002, 968 France). We thank B. Bezard, T. M. Ansty, C. Nixon and M. Lopez-Puertas for discussions; we also thank the VIMS and CIRS operation and calibration teams.	Achterberg RK, 2011, ICARUS, V211, P686, DOI 10.1016/j.icarus.2010.08.009; Anderson CM, 2010, ICARUS, V207, P914, DOI 10.1016/j.icarus.2009.12.024; Anderson CM, 2011, ICARUS, V212, P762, DOI 10.1016/j.icarus.2011.01.024; Bellucci A, 2009, ICARUS, V201, P198, DOI 10.1016/j.icarus.2008.12.024; Clark RN, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003369; Coustenis A, 1999, PLANET SPACE SCI, V47, P1305, DOI 10.1016/S0032-0633(99)00053-7; de Kok R, 2008, ICARUS, V197, P572, DOI 10.1016/j.icarus.2008.05.024; de Kok R, 2007, ICARUS, V191, P223, DOI 10.1016/j.icarus.2007.04.003; Griffith CA, 2006, SCIENCE, V313, P1620, DOI 10.1126/science.1128245; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Irwin PGJ, 2008, J QUANT SPECTROSC RA, V109, P1136, DOI 10.1016/j.jqsrt.2007.11.006; Jennings DE, 2012, ASTROPHYS J LETT, V761, DOI 10.1088/2041-8205/761/1/L15; Lavvas P, 2011, ICARUS, V215, P732, DOI 10.1016/j.icarus.2011.06.040; Lebonnois S, 2012, ICARUS, V218, P707, DOI 10.1016/j.icarus.2011.11.032; Maltagliati L., 2014, ICARUS UNPUB; Rannou P, 2005, ADV SPACE RES-SERIES, V36, P2194, DOI 10.1016/j.asr.2005.09.041; Samuelson RE, 1997, PLANET SPACE SCI, V45, P941, DOI 10.1016/S0032-0633(97)00088-3; Samuelson RE, 2007, ICARUS, V189, P63, DOI 10.1016/j.icarus.2007.02.005; Teanby NA, 2010, ASTROPHYS J LETT, V724, pL84, DOI 10.1088/2041-8205/724/1/L84; Teanby NA, 2012, NATURE, V491, P732, DOI 10.1038/nature11611; Tomasko MG, 2008, PLANET SPACE SCI, V56, P648, DOI 10.1016/j.pss.2007.10.012; Vinatier S., ICARUS UNPUB; Vinatier S, 2012, ICARUS, V219, P5, DOI 10.1016/j.icarus.2012.02.009; WARREN SG, 1986, APPL OPTICS, V25, P2650, DOI 10.1364/AO.25.002650; Warren SG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009744; West R. A., 2013, ASS DIV PLAN SCI M A, V45	28	44	45	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					65	+		10.1038/nature13789	http://dx.doi.org/10.1038/nature13789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279918	Green Submitted			2022-12-28	WOS:000342420800035
J	Rosen, MR				Rosen, Michael R.			Gene Therapy and Biological Pacing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS		Columbia Univ, Dept Pharmacol, New York, NY 10027 USA	Columbia University	Rosen, MR (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10027 USA.							Bakker ML, 2012, CARDIOVASC RES, V94, P439, DOI 10.1093/cvr/cvs120; Boink GJJ, 2013, J AM COLL CARDIOL, V61, P1192, DOI 10.1016/j.jacc.2012.12.031; Hu YF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008681; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Rosen MR, 2011, NAT REV CARDIOL, V8, P656, DOI 10.1038/nrcardio.2011.120	5	36	37	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1158	1159		10.1056/NEJMcibr1408897	http://dx.doi.org/10.1056/NEJMcibr1408897			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25229921				2022-12-28	WOS:000341687300015
J	Ford, ES; Maynard, LM; Li, CY				Ford, Earl S.; Maynard, Leah M.; Li, Chaoyang			Trends in Mean Waist Circumference and Abdominal Obesity Among US Adults, 1999-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							UNITED-STATES		[Ford, Earl S.; Maynard, Leah M.; Li, Chaoyang] US Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Ford, ES (corresponding author), US Ctr Dis Control & Prevent, 4770 Buford Hwy, Atlanta, GA 30341 USA.	eford@cdc.gov	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Elobeid MA, 2007, OBESITY, V15, P2380, DOI 10.1038/oby.2007.282; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; Lean MJ, 2002, AM J CLIN NUTR, V76, P699, DOI 10.1093/ajcn/76.4.699; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732	6	125	130	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1151	1153		10.1001/jama.2014.8362	http://dx.doi.org/10.1001/jama.2014.8362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226482	Bronze, Green Accepted			2022-12-28	WOS:000341624700026
J	Gire, SK; Goba, A; Andersen, KG; Sealfon, RSG; Park, DJ; Kanneh, L; Jalloh, S; Momoh, M; Fullah, M; Dudas, G; Wohl, S; Moses, LM; Yozwiak, NL; Winnicki, S; Matranga, CB; Malboeuf, CM; Qu, J; Gladden, AD; Schaffner, SF; Yang, X; Jiang, PP; Nekoui, M; Colubri, A; Coomber, MR; Fonnie, M; Moigboi, A; Gbakie, M; Kamara, FK; Tucker, V; Konuwa, E; Saffa, S; Sellu, J; Jalloh, AA; Kovoma, A; Koninga, J; Mustapha, I; Kargbo, K; Foday, M; Yillah, M; Kanneh, F; Robert, W; Massally, JLB; Chapman, SB; Bochicchio, J; Murphy, C; Nusbaum, C; Young, S; Birren, B; Grant, DS; Scheiffelin, JS; Lander, ES; Happi, C; Gevao, SM; Gnirke, A; Rambaut, A; Garry, RF; Khan, SH; Sabeti, PC				Gire, Stephen K.; Goba, Augustine; Andersen, Kristian G.; Sealfon, Rachel S. G.; Park, Daniel J.; Kanneh, Lansana; Jalloh, Simbirie; Momoh, Mambu; Fullah, Mohamed; Dudas, Gytis; Wohl, Shirlee; Moses, Lina M.; Yozwiak, Nathan L.; Winnicki, Sarah; Matranga, Christian B.; Malboeuf, Christine M.; Qu, James; Gladden, Adrianne D.; Schaffner, Stephen F.; Yang, Xiao; Jiang, Pan-Pan; Nekoui, Mahan; Colubri, Andres; Coomber, Moinya Ruth; Fonnie, Mbalu; Moigboi, Alex; Gbakie, Michael; Kamara, Fatima K.; Tucker, Veronica; Konuwa, Edwin; Saffa, Sidiki; Sellu, Josephine; Jalloh, Abdul Azziz; Kovoma, Alice; Koninga, James; Mustapha, Ibrahim; Kargbo, Kandeh; Foday, Momoh; Yillah, Mohamed; Kanneh, Franklyn; Robert, Willie; Massally, James L. B.; Chapman, Sinead B.; Bochicchio, James; Murphy, Cheryl; Nusbaum, Chad; Young, Sarah; Birren, BruceW.; Grant, Donald S.; Scheiffelin, John S.; Lander, Eric S.; Happi, Christian; Gevao, Sahr M.; Gnirke, Andreas; Rambaut, Andrew; Garry, Robert F.; Khan, S. Humarr; Sabeti, Pardis C.			Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak	SCIENCE			English	Article							PURIFYING SELECTION; HEMORRHAGIC-FEVER; POLYMERASE; RNA	In its largest outbreak, Ebola virus disease is spreading through Guinea, Liberia, Sierra Leone, and Nigeria. We sequenced 99 Ebola virus genomes from 78 patients in Sierra Leone to similar to 2000x coverage. We observed a rapid accumulation of interhost and intrahost genetic variation, allowing us to characterize patterns of viral transmission over the initial weeks of the epidemic. This West African variant likely diverged from central African lineages around 2004, crossed from Guinea to Sierra Leone in May 2014, and has exhibited sustained human-to-human transmission subsequently, with no evidence of additional zoonotic sources. Because many of the mutations alter protein sequences and other biologically meaningful targets, they should be monitored for impact on diagnostics, vaccines, and therapies critical to outbreak response.	[Gire, Stephen K.; Andersen, Kristian G.; Wohl, Shirlee; Yozwiak, Nathan L.; Winnicki, Sarah; Schaffner, Stephen F.; Jiang, Pan-Pan; Nekoui, Mahan; Colubri, Andres; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Gire, Stephen K.; Andersen, Kristian G.; Sealfon, Rachel S. G.; Park, Daniel J.; Wohl, Shirlee; Yozwiak, Nathan L.; Winnicki, Sarah; Matranga, Christian B.; Malboeuf, Christine M.; Qu, James; Gladden, Adrianne D.; Schaffner, Stephen F.; Yang, Xiao; Jiang, Pan-Pan; Nekoui, Mahan; Chapman, Sinead B.; Bochicchio, James; Murphy, Cheryl; Nusbaum, Chad; Young, Sarah; Birren, BruceW.; Lander, Eric S.; Gnirke, Andreas; Sabeti, Pardis C.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gire, Stephen K.; Kanneh, Lansana; Jalloh, Simbirie; Momoh, Mambu; Fullah, Mohamed; Coomber, Moinya Ruth; Fonnie, Mbalu; Moigboi, Alex; Gbakie, Michael; Kamara, Fatima K.; Tucker, Veronica; Konuwa, Edwin; Saffa, Sidiki; Sellu, Josephine; Jalloh, Abdul Azziz; Kovoma, Alice; Koninga, James; Mustapha, Ibrahim; Kargbo, Kandeh; Foday, Momoh; Yillah, Mohamed; Kanneh, Franklyn; Robert, Willie; Massally, James L. B.; Grant, Donald S.; Khan, S. Humarr] Kenema Govt Hosp, Kenema, Sierra Leone; [Sealfon, Rachel S. G.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Momoh, Mambu; Fullah, Mohamed] Eastern Polytech Coll, Kenema, Sierra Leone; [Dudas, Gytis; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Wohl, Shirlee; Lander, Eric S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Moses, Lina M.; Scheiffelin, John S.; Garry, Robert F.] Tulane Univ, Med Ctr, New Orleans, LA 70112 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Happi, Christian] Redeemers Univ, Redemption, Ogun State, Nigeria; [Gevao, Sahr M.] Univ Sierra Leone, Freetown, Sierra Leone; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Rambaut, Andrew] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Kenema Government Hospital; Massachusetts Institute of Technology (MIT); University of Edinburgh; Harvard University; Harvard Medical School; Tulane University; Massachusetts Institute of Technology (MIT); Redeemers University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Edinburgh	Goba, A (corresponding author), Kenema Govt Hosp, Kenema, Sierra Leone.	augstgoba@yahoo.com; andersen@broadinstitute.org; psabeti@oeb.harvard.edu	Sabeti, Pardis/GQH-8610-2022; Dudas, Gytis/H-5968-2019; Schaffner, Stephen F/D-1189-2011; Rambaut, Andrew/B-2481-2009; Fahmy, Alaa/A-9950-2015	Dudas, Gytis/0000-0002-0227-4158; Rambaut, Andrew/0000-0003-4337-3707; Fahmy, Alaa/0000-0002-9060-0135; Schaffner, Stephen/0000-0001-6699-3568; Murphy, Cheryl/0000-0003-2285-8107; Garry, Robert/0000-0002-5683-3250; Nekoui, Mahan/0000-0001-7466-4801; Matranga, Christian/0000-0002-9037-5468; Wohl, Shirlee/0000-0002-0311-3348; Moses, Lina/0000-0003-4292-647X; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Happi, Christian/0000-0002-3056-6705	NSF Graduate Research Fellowship Program; NIH grant [GM080177, 1DP2OD006514-01]; NIH [1U01HG007480-01]; World Bank; European Union [FP7/2007-2013 278433-PREDEMICS]; European Research Council [260864]; Natural Environment Research Council grant [D76739X]; National Institute of Allergy and Infectious Diseases grant [HHSN272200900049C]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818, U19AI115589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER; Natural Environment Research Council [1086074] Funding Source: researchfish	NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Bank(The World Bank India); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Institute of Allergy and Infectious Diseases grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Office of the President of Sierra Leone (President E. Koroma, M. Jones, S. Blyden), the Sierra Leone Ministry of Health and Sanitation (Minister M. Kargbo, B. Kargbo, M. A. Vandi, A. Jambai), the Kenema District Health Management Team, and the Lassa fever program for their efforts in outbreak response. We thank P. Cingolani, Y.-C. Wu, M. Lipsitch, S. Gunther, S. Baize, N. Wauquier, J. Bangura, V. Lungay, L. Hensley, J. Johnson, M. Voorhees, A. O'Hearn, R. Schoepp, L. Gaffney, J. Kuhn, S. C. Sealfon, J. B. Shapiro, C. Edwards, and Sabeti lab members for technical support and feedback. Supported by the NSF Graduate Research Fellowship Program (R. S. G. S.), NIH grant GM080177 (S. Wohl), NIH grant 1U01HG007480-01 and the World Bank (C. H.), European Union grant FP7/2007-2013 278433-PREDEMICS and European Research Council grant 260864 (A. R.), Natural Environment Research Council grant D76739X (G. D.), NIH grant 1DP2OD006514-01, and National Institute of Allergy and Infectious Diseases grant HHSN272200900049C. Sequence data are available at NCBI (NCBI BioGroup: PRJNA257197). Sharing of RNA samples used in this study requires approval from the Sierra Leone Ministry of Health and Sanitation.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Dudas G., 2014, PLOS CURR, DOI [10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d, DOI 10.1371/CURRENTS.OUTBREAKS.84EEFE5CE43EC9DC0BF0670F7B8B417D]; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Kuhn JH, 2011, BIOSECUR BIOTERROR, V9, P361, DOI 10.1089/bsp.2011.0051; Kuhn JH, 2008, FILOVIRUSES COMPENDI; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Reynard O, 2014, M S-MED SCI, V30, P671, DOI 10.1051/medsci/20143006018; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Wertheim JO, 2011, MOL BIOL EVOL, V28, P3355, DOI 10.1093/molbev/msr170	16	775	826	4	682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1369	1372		10.1126/science.1259657	http://dx.doi.org/10.1126/science.1259657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214632	Green Accepted, Green Submitted			2022-12-28	WOS:000341483800071
J	van Meerbeeck, JP; Ball, D				van Meerbeeck, Jan P.; Ball, David			Small-cell lung cancer: local therapy for a systemic disease?	LANCET			English	Editorial Material									[van Meerbeeck, Jan P.] Ghent & Antwerp Univ, B-2610 Antwerp, Belgium; [Ball, David] Univ Melbourne, Sir Peter MacCallum Dept Clin Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; University of Melbourne	van Meerbeeck, JP (corresponding author), Ghent & Antwerp Univ, B-2610 Antwerp, Belgium.	jan.van.meerbeeck@uza.be	van Meerbeeck, Jan/ABA-5109-2020	van Meerbeeck, Jan/0000-0001-7872-8622				De Ruysscher D, 2006, J CLIN ONCOL, V24, P1057, DOI 10.1200/JCO.2005.02.9793; Fruh M, 2013, ANN ONCOL, V24, P99, DOI 10.1093/annonc/mdt178; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; Prophylactic Cranial Irradiation Overview Collaborative Group, 2000, COCHRANE DB SYST REV, V4; Radiation Therapy Oncology Group, RAD THER TREAT PAT E; Siva S, 2010, J THORAC ONCOL, V5, P1091, DOI 10.1097/JTO.0b013e3181de7143; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Slotman BJ, 2014, LANCET; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Weickhardt AJ, 2012, J THORAC ONCOL, V7, P1807, DOI 10.1097/JTO.0b013e3182745948	11	7	7	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					9	10		10.1016/S0140-6736(14)61252-6	http://dx.doi.org/10.1016/S0140-6736(14)61252-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25230596				2022-12-28	WOS:000347154200009
J	Xu, XLL; Singh, HP; Wang, L; Qi, DL; Poulos, BK; Abramson, DH; Jhanwar, SC; Cobrinik, D				Xu, Xiaoliang L.; Singh, Hardeep P.; Wang, Lu; Qi, Dong-Lai; Poulos, Bradford K.; Abramson, David H.; Jhanwar, Suresh C.; Cobrinik, David			Rb suppresses human cone-precursor-derived retinoblastoma tumours	NATURE			English	Article							GENOMIC INSTABILITY; EXPRESSION; CELLS; GENE; IDENTIFICATION; PROTEINS; RETINA	Retinoblastoma is a childhood retinal tumour that initiates in response to biallelic RB1 inactivation and loss of functional retinoblastoma (Rb) protein. Although Rb has diverse tumour-suppressor functions and is inactivated in many cancers(1-5), germline RB1 mutations predispose to retinoblastoma far more strongly than to other malignancies(6). This tropism suggests that retinal cell-type-specific circuitry sensitizes to Rb loss, yet the nature of the circuitry and the cell type in which it operates have beenunclear(7,8). Here we show that post-mitotic human cone precursors are uniquely sensitive to Rb depletion. Rb knockdown induced cone precursor proliferation in prospectively isolated populations and in intact retina. Proliferation followed the induction of E2F-regulated genes, and depended on factors having strong expression in maturing cone precursors and crucial roles in retinoblastoma cell proliferation, including MYCN and MDM2. Proliferation of Rb-depleted cones and retinoblastoma cells also depended on the Rb-related protein p107, SKP2, and a p27 downregulation associated with cone precursor maturation. Moreover, Rb-depleted cone precursors formed tumours in orthotopic xenografts with histological features and protein expression typical of human retinoblastoma. These findings provide a compelling molecular rationale for a cone precursor origin of retinoblastoma. More generally, they demonstrate that cell-type-specific circuitry can collaborate with an initiating oncogenic mutation to enable tumorigenesis.	[Xu, Xiaoliang L.; Wang, Lu; Jhanwar, Suresh C.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Xu, Xiaoliang L.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, New York, NY 10021 USA; [Singh, Hardeep P.; Qi, Dong-Lai; Cobrinik, David] Childrens Hosp Los Angeles, Div Ophthalmol, Dept Surg, Vis Ctr, Los Angeles, CA 90027 USA; [Singh, Hardeep P.; Qi, Dong-Lai; Cobrinik, David] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Poulos, Bradford K.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Jhanwar, Suresh C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Cobrinik, David] Univ So Calif, Keck Sch Med, Dept Ophthalmol, USC Eye Inst, Los Angeles, CA 90033 USA; [Cobrinik, David] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Children's Hospital Los Angeles; Children's Hospital Los Angeles; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Southern California; University of Southern California	Jhanwar, SC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	jhanwars@mskcc.org; dcobrinik@chla.usc.edu	Wang, Lu/N-8128-2018	Wang, Lu/0000-0002-0073-0666; Singh, Hardeep/0000-0002-9586-8544	Gerber Foundation; Fund for Ophthalmic Knowledge; Research and Development Funds of the MSKCC Department of Pathology; Larry & Celia Moh Foundation; National Institutes of Health [1R01CA137124]; NATIONAL CANCER INSTITUTE [R01CA137124] Funding Source: NIH RePORTER	Gerber Foundation; Fund for Ophthalmic Knowledge; Research and Development Funds of the MSKCC Department of Pathology; Larry & Celia Moh Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. MacLeish, D. Forrest, C. Craft, G. Chader, C. Gregory-Evans, R. Molday, P. Hargrave, Y. Imanishi, K. Palczewsk, E. Weiss, A. Swaroop, T. Li, R. Lee and J. Saari for antibodies. We thank T. Baumgartner and P. Byrne for FACS assistance, N. Lampen for electron microscopy assistance, N. Zhou, T. Patel and J. Wang for technical assistance, S. Puranik and Z. Li for DNA constructs, and J. Aparicio for critical reading of the manuscript. Funding was received from The Gerber Foundation (X. L. X.), The Fund for Ophthalmic Knowledge (D. H. A.), the Research and Development Funds of the MSKCC Department of Pathology (S. C. J.), The Larry & Celia Moh Foundation (D. C.), and National Institutes of Health grant 1R01CA137124 (D.C.).	ALBERT DM, 1974, T OPHTHAL SOC UK, V94, P909; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D., 2013, ANIMAL MODELS BRAIN, P141; Cobrinik D, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-72; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; DiCiommo DP, 2004, INVEST OPHTH VIS SCI, V45, P3320, DOI 10.1167/iovs.04-0140; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Gombos DS, 2012, SEMIN FETAL NEONAT M, V17, P239, DOI 10.1016/j.siny.2012.04.003; Gordon GM, 2011, PROTEIN CELL, V2, P864, DOI 10.1007/s13238-011-1117-z; Hauck SM, 2008, MOL CELL PROTEOMICS, V7, P1349, DOI 10.1074/mcp.M700456-MCP200; Kapatai G, 2013, BRIT J CANCER, V109, P512, DOI 10.1038/bjc.2013.283; Kleinerman RA, 2005, J CLIN ONCOL, V23, P2272, DOI 10.1200/JCO.2005.05.054; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Lee TC, 2006, INVEST OPHTH VIS SCI, V47, P5590, DOI 10.1167/iovs.06-0063; Li AM, 2002, INVEST OPHTH VIS SCI, V43, P1375; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; POPOFF NA, 1971, LAB INVEST, V25, P389; Priya K, 2009, CANCER BIOL THER, V8, P714, DOI 10.4161/cbt.8.8.7921; Sangwan M, 2012, ONCOGENE, V31, P5019, DOI 10.1038/onc.2011.654; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x; Ts'o M O, 1970, Am J Ophthalmol, V69, P339; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wikler KC, 1997, J COMP NEUROL, V377, P500; Xu XL, 2010, AM J PATHOL, V177, P424, DOI 10.2353/ajpath.2010.090512; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	32	127	138	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					385	+		10.1038/nature13813	http://dx.doi.org/10.1038/nature13813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25252974	Green Accepted			2022-12-28	WOS:000342988600056
J	Ransohoff, RM				Ransohoff, Richard M.			Good barriers make good neighbors	SCIENCE			English	Editorial Material							CEREBROSPINAL-FLUID; CHOROID-PLEXUS		Cleveland Clin, Lerner Coll Med, Neuroinflammat Res Ctr, Mellen Ctr MS Treatment & Res, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Ransohoff, RM (corresponding author), Cleveland Clin, Lerner Coll Med, Neuroinflammat Res Ctr, Mellen Ctr MS Treatment & Res, 9500 Euclid Ave, Cleveland, OH 44195 USA.	rransohof@gmail.com						Asensio VC, 2001, J VIROL, V75, P7067, DOI 10.1128/JVI.75.15.7067-7077.2001; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Bueno D, 2014, CROAT MED J, V55, P306, DOI 10.3325/cmj.2014.55.306; DOHRMANN GJ, 1970, BRAIN RES, V18, P197, DOI 10.1016/0006-8993(70)90324-0; Gato A, 2014, CROAT MED J, V55, P299, DOI 10.3325/cmj.2014.55.299; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Lehtinen MK, 2013, J NEUROSCI, V33, P17553, DOI 10.1523/JNEUROSCI.3258-13.2013	10	4	5	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					36	37		10.1126/science.1260705	http://dx.doi.org/10.1126/science.1260705			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278599				2022-12-28	WOS:000342446900024
J	Holland, TL; Arnold, C; Fowler, VG				Holland, Thomas L.; Arnold, Christopher; Fowler, Vance G., Jr.			Clinical Management of Staphylococcus aureus Bacteremia A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INFECTIOUS-DISEASES CONSULTATION; BLOOD-STREAM INFECTION; MINIMUM INHIBITORY CONCENTRATION; GRAM-POSITIVE INFECTIONS; INTRAVENOUS-DRUG-USERS; SOFT-TISSUE INFECTIONS; HIGH-DOSE DAPTOMYCIN; METHICILLIN-RESISTANT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; STANDARD THERAPY	IMPORTANCE Several management strategies may improve outcomes in patients with Staphylococcus aureus bacteremia. OBJECTIVES To review evidence of management strategies for S aureus bacteremia to determine whether transesophageal echocardiography is necessary in all adult cases and what is the optimal antibiotic therapy for methicillin-resistant S aureus (MRSA) bacteremia. EVIDENCE REVIEW A PubMed search from inception through May 2014 was performed to identify studies addressing the role of transesophageal echocardiography in S aureus bacteremia. A second search of PubMed, EMBASE, and the Cochrane Library from January 1990 through May 2014 was performed to find studies addressing antibiotic treatment for MRSA bacteremia. Studies reporting outcomes from antibiotic therapy for MRSA bacteremia were included. All searches, which were limited to English and focused on adults, were augmented by review of bibliographic references from included studies. The quality of evidence was assessed using the Grades of Recommendation, Assessment, Development and Evaluation system with consensus of independent evaluations by at least 2 of the authors. FINDINGS In 9 studies with a total of 4050 patients, use of transesophageal echocardiography was associated with higher rates of a diagnosis of endocarditis (14%-28%) compared with transthoracic echocardiography (2%-15%). In 4 studies, clinical or transthoracic echocardiography findings did not predict subsequent transesophageal echocardiography findings of endocarditis. Five studies identified clinical or transthoracic echocardiography characteristics associated with low risk of endocarditis (negative predictive values from 93% to 100%). Characteristics associated with a low risk of endocarditis include absence of a permanent intracardiac device, sterile follow-up blood cultures within 4 days after the initial set, no hemodialysis dependence, nosocomial acquisition of S aureus bacteremia, absence of secondary foci of infection, and no clinical signs of infective endocarditis. Of 81 studies of antibiotic therapy for MRSA bacteremia, only 1 high-quality trial was identified. In that study of 246 patients with S aureus bacteremia, daptomycin was not inferior to vancomycin or an antistaphylococcal penicillin, each in combination with low-dose, short-course gentamicin (clinical success rate, 44.2%[53/120] vs 41.7%[48/115]; absolute difference, 2.4%[95% CI, -10.2% to 15.1%]). CONCLUSIONS AND RELEVANCE All adult patients with S aureus bacteremia should undergo echocardiography. Characteristics of low-risk patients with S aureus bacteremia for whom transesophageal echocardiography can be safely avoided have been identified. Vancomycin and daptomycin are the first-line antibiotic choices for MRSA bacteremia. Well-designed studies to address the management of S aureus bacteremia are needed. Copyright 2014 American Medical Association. All rights reserved.	[Holland, Thomas L.; Arnold, Christopher; Fowler, Vance G., Jr.] Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA; [Holland, Thomas L.; Fowler, Vance G., Jr.] Duke Univ, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University	Fowler, VG (corresponding author), Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, POB 102359, Durham, NC 27710 USA.	vance.fowler@duke.edu	Fowler, Vance/AAW-2017-2021; Holland, Thomas/AAA-6096-2022	Holland, Thomas/0000-0001-7745-9010	National Institute of Allergy and Infectious Diseases [UM1-AI104681]; National Institutes of Health [K24-AI093969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI093969, UM1AI104681] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this article was supported by award UM1-AI104681 from the National Institute of Allergy and Infectious Diseases. Dr Fowler was supported by grant K24-AI093969 from the National Institutes of Health.	Bernstein IL, 2008, ANN ALLERG ASTHMA IM, V100, pS1, DOI 10.1016/S1081-1206(10)60305-5; Birmingham MC, 2003, CLIN INFECT DIS, V36, P159, DOI 10.1086/345744; Carugati M, 2013, ANTIMICROB AGENTS CH, V57, P6213, DOI 10.1128/AAC.01563-13; Casapao AM, 2014, ANTIMICROB AGENTS CH, V58, P2541, DOI 10.1128/AAC.02371-13; Casella F, 2009, ECHOCARDIOGR-J CARD, V26, P900, DOI 10.1111/j.1540-8175.2009.00906.x; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09; Cheng CW, 2013, INT J ANTIMICROB AG, V41, P293, DOI 10.1016/j.ijantimicag.2012.10.019; Choi SH, 2011, J INFECTION, V62, P181, DOI 10.1016/j.jinf.2010.12.002; Chong YP, 2013, ANTIMICROB AGENTS CH, V57, P1150, DOI 10.1128/AAC.01021-12; ClinicalTrials.gov website, TREATM ALG RED US VA; Cosgrove SE, 2009, CLIN INFECT DIS, V48, P713, DOI 10.1086/597031; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Deresinski S, 2007, CLIN INFECT DIS, V44, P1543, DOI 10.1086/518452; Dhand A, 2011, CLIN INFECT DIS, V53, P158, DOI 10.1093/cid/cir340; Dilworth TJ, 2014, ANTIMICROB AGENTS CH, V58, P102, DOI 10.1128/AAC.01204-13; Dodek P, 1999, CLIN INFECT DIS, V29, P1251, DOI 10.1086/313435; Drew RH, 2000, J ANTIMICROB CHEMOTH, V46, P775, DOI 10.1093/jac/46.5.775; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; DWORKIN RJ, 1989, LANCET, V2, P1071; El Atrouni WI, 2009, CLIN INFECT DIS, V49, pE130, DOI 10.1086/648442; Falcone M, 2012, INT J ANTIMICROB AG, V39, P64, DOI 10.1016/j.ijantimicag.2011.09.011; Food and Drug Administration, 2007, INF HEALTHC PROF LIN; Food Drug Administration, FDA DRUG SAF COMM FD; Forsblom E, 2013, CLIN INFECT DIS, V56, P527, DOI 10.1093/cid/cis889; Forstner C, 2013, CLIN MICROBIOL INFEC, V19, pE291, DOI 10.1111/1469-0691.12169; Fowler V. G. Jr., 1999, Clinical Infectious Diseases, V28, P106, DOI 10.1086/515076; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 1997, J AM COLL CARDIOL, V30, P1072, DOI 10.1016/S0735-1097(97)00250-7; Fries BL, 2014, CLIN INFECT DIS, V58, P598, DOI 10.1093/cid/cit730; Gardiner D, 2010, CLIN INFECT DIS, V50, P229, DOI 10.1086/648720; Goldberg E, 2010, J ANTIMICROB CHEMOTH, V65, P1779, DOI 10.1093/jac/dkq179; Gomez J, 2007, EUR J CLIN MICROBIOL, V26, P239, DOI 10.1007/s10096-007-0272-x; Gould FK, 2009, J ANTIMICROB CHEMOTH, V63, P849, DOI 10.1093/jac/dkp065; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hall RG, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-104; Heldman AW, 1996, AM J MED, V101, P68, DOI 10.1016/S0002-9343(96)00070-8; Holden E, 2014, J ANTIMICROB CHEMOTH, V69, P1960, DOI 10.1093/jac/dku082; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Incani A, 2013, EUR J CLIN MICROBIOL, V32, P1003, DOI 10.1007/s10096-013-1838-4; Isobe M, 2012, J INFECT CHEMOTHER, V18, P841, DOI 10.1007/s10156-012-0423-6; Jang HC, 2009, CLIN INFECT DIS, V49, P395, DOI 10.1086/600295; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; JERNIGAN JA, 1993, ANN INTERN MED, V119, P304, DOI 10.7326/0003-4819-119-4-199308150-00010; Joseph JP, 2013, J ANTIMICROB CHEMOTH, V68, P444, DOI 10.1093/jac/dks408; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Kaasch AJ, 2011, CLIN INFECT DIS, V53, P1, DOI 10.1093/cid/cir320; KHANDHERIA BK, 1994, MAYO CLIN PROC, V69, P856, DOI 10.1016/S0025-6196(12)61788-1; Khatib R, 2006, EUR J CLIN MICROBIOL, V25, P181, DOI 10.1007/s10096-006-0096-0; Khatib R, 2013, MEDICINE, V92, P182, DOI 10.1097/MD.0b013e318294a710; Kim SH, 2008, ANTIMICROB AGENTS CH, V52, P192, DOI 10.1128/AAC.00700-07; KORZENIOWSKI O, 1982, ANN INTERN MED, V97, P496, DOI 10.7326/0003-4819-97-4-496; Kullar R, 2011, PHARMACOTHERAPY, V31, P527, DOI 10.1592/phco.31.6.527; Kullar R, 2011, CLIN INFECT DIS, V52, P975, DOI 10.1093/cid/cir124; Lahey T, 2009, MEDICINE, V88, P263, DOI 10.1097/MD.0b013e3181b8fccb; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Lemonovich TL, 2011, INFECTION, V39, P549, DOI 10.1007/s15010-011-0189-2; LEVINE DP, 1991, ANN INTERN MED, V115, P674, DOI 10.7326/0003-4819-115-9-674; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3731, DOI 10.1128/AAC.00101-07; MARKOWITZ N, 1992, ANN INTERN MED, V117, P390, DOI 10.7326/0003-4819-117-5-390; McConeghy KW, 2013, CLIN INFECT DIS, V57, P1760, DOI 10.1093/cid/cit560; MENICHETTI F, 1994, ANTIMICROB AGENTS CH, V38, P2041, DOI 10.1128/AAC.38.9.2041; Mermel LA, 2010, CLIN INFECT DIS, V50, P1079, DOI 10.1086/651933; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Moore CL, 2012, CLIN INFECT DIS, V54, P51, DOI 10.1093/cid/cir764; Moore CL, 2011, ANTIMICROB AGENTS CH, V55, P4581, DOI 10.1128/AAC.00115-11; Murray KP, 2013, CLIN INFECT DIS, V56, P1562, DOI 10.1093/cid/cit112; Nagao M, 2010, CLIN MICROBIOL INFEC, V16, P1783, DOI 10.1111/j.1469-0691.2010.03156.x; NOLAN CM, 1976, AM J MED, V60, P495, DOI 10.1016/0002-9343(76)90715-4; Park HJ, 2012, J INFECTION, V65, P505, DOI 10.1016/j.jinf.2012.08.007; Pastagia M, 2012, EMERG INFECT DIS, V18, P1072, DOI 10.3201/eid1807.101371; Pragman Alexa A, 2012, Infect Dis Clin Pract (Baltim Md), V20, P261; Raad I, 2005, CLIN INFECT DIS, V40, P374, DOI 10.1086/427283; Rasmussen RV, 2011, EUR J ECHOCARDIOGR, V12, P414, DOI 10.1093/ejechocard/jer023; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Robinson JO, 2012, EUR J CLIN MICROBIOL, V31, P2421, DOI 10.1007/s10096-012-1585-y; Rosen AB, 1999, ANN INTERN MED, V130, P810, DOI 10.7326/0003-4819-130-10-199905180-00004; Rubinstein E, 2011, CLIN INFECT DIS, V52, P31, DOI 10.1093/cid/ciq031; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Schweizer ML, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-279; Shorr AF, 2005, J ANTIMICROB CHEMOTH, V56, P923, DOI 10.1093/jac/dki355; Soriano A, 2011, CLIN INFECT DIS, V53, P10, DOI 10.1093/cid/cir305; Stryjewski ME, 2007, CLIN INFECT DIS, V44, P190, DOI 10.1086/510386; Stryjewski ME, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-289; Stryjewski ME, 2013, INT J ANTIMICROB AG, V42, P367, DOI 10.1016/j.ijantimicag.2013.06.003; Stryjewski ME, 2005, CLIN INFECT DIS, V40, P1601, DOI 10.1086/429914; Sullenberger AL, 2005, J HEART VALVE DIS, V14, P23; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Tissot F, 2014, J INFECTION, V69, P226, DOI 10.1016/j.jinf.2014.05.004; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; van Hal SJ, 2013, CLIN INFECT DIS, V56, P1779, DOI 10.1093/cid/cit178; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Van Hal SJ, 2005, J INFECTION, V51, P218, DOI 10.1016/j.jinf.2005.01.011; Weston A, 2014, CLIN INFECT DIS, V58, P1533, DOI 10.1093/cid/ciu165; Wilcox MH, 2009, CLIN INFECT DIS, V48, P203, DOI 10.1086/595686; Yoon YK, 2014, ANTIMICROB AGENTS CH, V58, P317, DOI 10.1128/AAC.00520-13	99	271	286	8	94	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1330	1341		10.1001/jama.2014.9743	http://dx.doi.org/10.1001/jama.2014.9743			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268440	Green Accepted			2022-12-28	WOS:000342345400019
J	Cleeves, LI; Bergin, EA; Alexander, CMO; Du, FJ; Graninger, D; Oberg, KI; Harries, TJ				Cleeves, L. Ilsedore; Bergin, Edwin A.; Alexander, Conel M. O'D.; Du, Fujun; Graninger, Dawn; Oeberg, Karin I.; Harries, Tim J.			The ancient heritage of water ice in the solar system	SCIENCE			English	Article							LOW-MASS PROTOSTARS; PROTOPLANETARY DISKS; DEUTERIUM FRACTIONATION; DEUTERATED WATER; D/H RATIO; NEBULA; ORIGIN; ABUNDANCES; CHEMISTRY; ASTEROIDS	Identifying the source of Earth's water is central to understanding the origins of life-fostering environments and to assessing the prevalence of such environments in space. Water throughout the solar system exhibits deuterium-to-hydrogen enrichments, a fossil relic of low-temperature, ion-derived chemistry within either (i) the parent molecular cloud or (ii) the solar nebula protoplanetary disk. Using a comprehensive treatment of disk ionization, we find that ion-driven deuterium pathways are inefficient, which curtails the disk's deuterated water formation and its viability as the sole source for the solar system's water. This finding implies that, if the solar system's formation was typical, abundant interstellar ices are available to all nascent planetary systems.	[Cleeves, L. Ilsedore; Bergin, Edwin A.; Du, Fujun] Univ Michigan, Dept Astron, 311 West Hall,1085 South Univ Ave, Ann Arbor, MI 48109 USA; [Alexander, Conel M. O'D.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Graninger, Dawn; Oeberg, Karin I.] Harvard Univ, Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Harries, Tim J.] Univ Exeter, Dept Phys & Astron, Exeter EX4 4QL, Devon, England	University of Michigan System; University of Michigan; Carnegie Institution for Science; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Exeter	Cleeves, LI (corresponding author), Univ Michigan, Dept Astron, 311 West Hall,1085 South Univ Ave, Ann Arbor, MI 48109 USA.	cleeves@umich.edu	Alexander, Conel M. O'D./N-7533-2013	Alexander, Conel M. O'D./0000-0002-8558-1427; Du, Fujun/0000-0002-7489-0179; Harries, Timothy/0000-0001-8228-9503; Cleeves, L. Ilsedore/0000-0003-2076-8001; Graninger, Dawn/0000-0003-1582-0581	NSF [AST-1008800]; NASA [NNA09DA81A, NNX11AG67G, NNX12A193G]; U.K. Science and Technology Facilities Council [ST/J001627/1]; Direct For Mathematical & Physical Scien [1008800] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); U.K. Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	L.I.C. and E.A.B. acknowledge support by NSF grant AST-1008800. C.M.O'D.A. was partially supported by NASA Astrobiology grant NNA09DA81A and by NASA Cosmochemistry grant NNX11AG67G. F. D. was supported by NASA grant NNX12A193G. T.J.H. was supported by U.K. Science and Technology Facilities Council grant ST/J001627/1.	Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Albertsson T, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/39; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Barnes JJ, 2014, EARTH PLANET SC LETT, V390, P244, DOI 10.1016/j.epsl.2014.01.015; BERGIN EA, 1995, ASTROPHYS J, V441, P222, DOI 10.1086/175351; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; Ceccarelli C, 2014, PROTOSTARS PLANETS, P859, DOI [10.2458/azu_uapress_9780816531240-ch037, DOI 10.2458/AZU_UAPRESS_9780816531240-CH037]; Chapillon E, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117354; Ciesla FJ, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L1; Cleeves LI, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/5; Coutens A, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201117627; Dartois E, 2003, ASTRON ASTROPHYS, V399, P1009, DOI 10.1051/0004-6361:20021558; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; Encrenaz T, 2008, ANNU REV ASTRON ASTR, V46, P57, DOI 10.1146/annurev.astro.46.060407.145229; Furuya K, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/11; Geiss J, 2003, SPACE SCI REV, V106, P3, DOI 10.1023/A:1024651232758; Lawrence DJ, 2013, SCIENCE, V339, P292, DOI 10.1126/science.1229953; Minamidani T, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/73; Persson MV, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322845; Persson MV, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201117917; Robert F, 2000, SPACE SCI REV, V92, P201, DOI 10.1023/A:1005291127595; Umebayashi T, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/104; Usui T, 2012, EARTH PLANET SC LETT, V357, P119, DOI 10.1016/j.epsl.2012.09.008; van Dishoeck E. F., 2014, PROTOSTARS PLANETS, VVI, P835, DOI DOI 10.2458/AZU_UAPRESS_9780816531240-CH036; Visser R, 2009, ASTRON ASTROPHYS, V495, P881, DOI 10.1051/0004-6361/200810846; Willacy K, 2009, ASTROPHYS J, V703, P479, DOI 10.1088/0004-637X/703/1/479; Yang L, 2013, ICARUS, V226, P256, DOI 10.1016/j.icarus.2013.05.027	28	161	162	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1590	1593		10.1126/science.1258055	http://dx.doi.org/10.1126/science.1258055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258075	Green Submitted			2022-12-28	WOS:000342164500039
J	Agudelo, LZ; Femenia, T; Orhan, F; Porsmyr-Palmertz, M; Goiny, M; Martinez-Redondo, V; Correia, JC; Izadi, M; Bhat, M; Schuppe-Koistinen, I; Pettersson, AT; Ferreira, DMS; Krook, A; Barres, R; Zierath, JR; Erhardt, S; Lindskog, M; Ruas, JL				Agudelo, Leandro Z.; Femenia, Teresa; Orhan, Funda; Porsmyr-Palmertz, Margareta; Goiny, Michel; Martinez-Redondo, Vicente; Correia, Jorge C.; Izadi, Manizheh; Bhat, Maria; Schuppe-Koistinen, Ina; Pettersson, Amanda T.; Ferreira, Duarte M. S.; Krook, Anna; Barres, Romain; Zierath, Juleen R.; Erhardt, Sophie; Lindskog, Maria; Ruas, Jorge L.			Skeletal Muscle PGC-1 alpha 1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression	CELL			English	Article							PGC-1 COACTIVATORS; PHYSICAL-EXERCISE; MAJOR DEPRESSION; EXPRESSION; ADAPTATIONS; BRAIN; HYPOTHESIS; RESISTANCE; PLASTICITY; ANXIETY	Depression is a debilitating condition with a profound impact on quality of life for millions of people worldwide. Physical exercise is used as a treatment strategy for many patients, but the mechanisms that underlie its beneficial effects remain unknown. Here, we describe a mechanism by which skeletal muscle PGC-1 alpha 1 induced by exercise training changes kynurenine metabolism and protects from stress-induced depression. Activation of the PGC1 alpha 1-PPAR alpha/delta pathway increases skeletal muscle expression of kynurenine aminotransferases, thus enhancing the conversion of kynurenine into kynurenic acid, a metabolite unable to cross the blood-brain barrier. Reducing plasma kynurenine protects the brain from stress-induced changes associated with depression and renders skeletal muscle-specific PGC-1 alpha 1 transgenic mice resistant to depression induced by chronic mild stress or direct kynurenine administration. This study opens therapeutic avenues for the treatment of depression by targeting the PGC-1 alpha 1-PPAR axis in skeletal muscle, without the need to cross the blood-brain barrier.	[Agudelo, Leandro Z.; Femenia, Teresa; Porsmyr-Palmertz, Margareta; Martinez-Redondo, Vicente; Correia, Jorge C.; Izadi, Manizheh; Pettersson, Amanda T.; Ferreira, Duarte M. S.; Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol Mol & Cellular Exercise, S-17177 Stockholm, Sweden; [Femenia, Teresa; Lindskog, Maria] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Orhan, Funda; Goiny, Michel; Krook, Anna; Barres, Romain; Zierath, Juleen R.; Erhardt, Sophie] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Bhat, Maria; Schuppe-Koistinen, Ina] AstraZeneca R&D, Innovat Med, Personalized Healthcare & Biomarkers, Translat Sci Ctr,Sci Life Lab, S-17165 Solna, Sweden; [Bhat, Maria; Schuppe-Koistinen, Ina] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; AstraZeneca; Karolinska Institutet; Karolinska Institutet	Lindskog, M (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	mia.lindskog@ki.se; jorge.ruas@ki.se	Krook, Anna/K-1192-2015; Erhardt, Sophie/F-5596-2011; BARRES, Romain/N-2501-2016; Lindskog, Maria/F-1729-2011; Ruas, Jorge/AAE-6094-2019; Ferreira, Duarte M Sacramento/E-4270-2012	Krook, Anna/0000-0002-0891-0258; Erhardt, Sophie/0000-0001-7359-5250; BARRES, Romain/0000-0002-0158-519X; Lindskog, Maria/0000-0002-4178-2825; Ruas, Jorge/0000-0002-1110-2606; Ferreira, Duarte M Sacramento/0000-0001-5940-7102; Zierath, Juleen/0000-0001-6891-7497; Correia, Jorge/0000-0002-6377-9053; Schuppe-Koistinen, Ina/0000-0002-1423-3089; FEMENIA CANTO, TERESA/0000-0003-0455-752X; Klein, Amanda/0000-0003-3998-920X	AstraZeneca-Karolinska Institutet Joint Research Program in Translational Science; Novo Nordisk Foundation (Denmark); Petrus and Augusta Hedlund's Foundation; Stockholm County Council; Strategic Research Programme in Diabetes at Karolinska Institutet; Swedish Brain Foundation; Swedish Diabetes Association; Swedish Foundation for Strategic Research; Swedish Research Council; Knut and Alice Wallenberg Foundation; Ahlen Foundation; Ake Wiberg Foundation; Karolinska Institutet doctoral fellowship; Fundacao para a Ciencia e Tecnologia (FCT, Portugal); Wenner-Gren Foundations (Sweden); Swedish Society for Medical Research (SSMF); Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish	AstraZeneca-Karolinska Institutet Joint Research Program in Translational Science; Novo Nordisk Foundation (Denmark)(Novo Nordisk Foundation); Petrus and Augusta Hedlund's Foundation; Stockholm County Council(Stockholm County Council); Strategic Research Programme in Diabetes at Karolinska Institutet; Swedish Brain Foundation; Swedish Diabetes Association; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ahlen Foundation; Ake Wiberg Foundation; Karolinska Institutet doctoral fellowship; Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Wenner-Gren Foundations (Sweden); Swedish Society for Medical Research (SSMF); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors would like to thank Karin Pernold for expert help with animal experiments. This project was supported by grants from the AstraZeneca-Karolinska Institutet Joint Research Program in Translational Science, Novo Nordisk Foundation (Denmark), Petrus and Augusta Hedlund's Foundation, Stockholm County Council, Strategic Research Programme in Diabetes at Karolinska Institutet, Swedish Brain Foundation, Swedish Diabetes Association, Swedish Foundation for Strategic Research, Swedish Research Council, Knut and Alice Wallenberg Foundation, Ahlen Foundation, and Ake Wiberg Foundation. F.O. is supported by a Karolinska Institutet doctoral fellowship. J.C.C. was supported in part by a PhD fellowship from the Fundacao para a Ciencia e Tecnologia (FCT, Portugal), V.M.R. and D.M.S.F. by postdoctoral fellowships from the Wenner-Gren Foundations (Sweden), and A.T.P. by a postdoctoral fellowship from the Swedish Society for Medical Research (SSMF).	Anisman H, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003579; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bajramovic JJ, 2000, J NEUROIMMUNOL, V106, P14, DOI 10.1016/S0165-5728(99)00260-X; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bechtholt-Gompf AJ, 2010, NEUROPSYCHOPHARMACOL, V35, P2049, DOI 10.1038/npp.2010.74; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; Brene S, 2007, PHYSIOL BEHAV, V92, P136, DOI 10.1016/j.physbeh.2007.05.015; Castren E, 2013, JAMA PSYCHIAT, V70, P983, DOI 10.1001/jamapsychiatry.2013.1; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Claes S, 2011, PSYCHIAT RES, V188, P355, DOI 10.1016/j.psychres.2011.03.012; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Czepluch FS, 2011, THROMB HAEMOSTASIS, V105, P122, DOI 10.1160/TH10-06-0363; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deussing JM, 2005, CR BIOL, V328, P199, DOI 10.1016/j.crvi.2005.01.001; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Eyre H, 2012, BRAIN BEHAV IMMUN, V26, P251, DOI 10.1016/j.bbi.2011.09.015; Femenia T, 2012, BRAIN RES, V1476, P58, DOI 10.1016/j.brainres.2012.03.053; FOY MR, 1987, BEHAV NEURAL BIOL, V48, P138, DOI 10.1016/S0163-1047(87)90664-9; Froger N, 2004, J NEUROSCI, V24, P2787, DOI 10.1523/JNEUROSCI.4132-03.2004; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; GAL EM, 1980, NEUROCHEM RES, V5, P223, DOI 10.1007/BF00964611; Gibb J, 2011, BRAIN BEHAV IMMUN, V25, P468, DOI 10.1016/j.bbi.2010.11.008; Gomez-Galan M, 2013, MOL PSYCHIATR, V18, P582, DOI 10.1038/mp.2012.10; Han QA, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-19; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P4; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu WN, 2013, BEHAV BRAIN RES, V242, P110, DOI 10.1016/j.bbr.2012.12.041; Lloyd RB, 2011, CURR TOP MED CHEM, V11, P609; McClintock SM, 2011, J CLIN PSYCHOPHARM, V31, P180, DOI 10.1097/JCP.0b013e31820ebd2c; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006; Myint AM, 2014, PROG NEURO-PSYCHOPH, V48, P304, DOI 10.1016/j.pnpbp.2013.08.008; Oxenkrug G, 2013, MOL NEUROBIOL, V48, P294, DOI 10.1007/s12035-013-8497-4; Pittenger Christopher, 2013, Dialogues Clin Neurosci, V15, P455; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Schmitt B, 2003, PHYSIOL GENOMICS, V15, P148, DOI 10.1152/physiolgenomics.00089.2003; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu HQ, 2014, SCHIZOPHRENIA BULL, V40, pS152, DOI 10.1093/schbul/sbt157; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033	61	411	426	3	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					33	45		10.1016/j.cell.2014.07.051	http://dx.doi.org/10.1016/j.cell.2014.07.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259918	Bronze			2022-12-28	WOS:000343095000007
J	Brooke, M				Brooke, Michael			The Courtship Habits of the Great Crested Grebe	NATURE			English	Editorial Material									Univ Museum Zool, Cambridge, England	University of Cambridge	Brooke, M (corresponding author), Univ Museum Zool, Cambridge, England.	m.brooke@zoo.cam.ac.uk							0	2	2	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					484	485		10.1038/513484a	http://dx.doi.org/10.1038/513484a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254461	Bronze			2022-12-28	WOS:000342075800016
J	Licht, A; van Cappelle, M; Abels, HA; Ladant, JB; Trabucho-Alexandre, J; France-Lanord, C; Donnadieu, Y; Vandenberghe, J; Rigaudier, T; Lecuyer, C; Terry, D; Adriaens, R; Boura, A; Guo, Z; Soe, AN; Quade, J; Dupont-Nivet, G; Jaeger, JJ				Licht, A.; van Cappelle, M.; Abels, H. A.; Ladant, J. -B.; Trabucho-Alexandre, J.; France-Lanord, C.; Donnadieu, Y.; Vandenberghe, J.; Rigaudier, T.; Lecuyer, C.; Terry, D., Jr.; Adriaens, R.; Boura, A.; Guo, Z.; Soe, Aung Naing; Quade, J.; Dupont-Nivet, G.; Jaeger, J. -J.			Asian monsoons in a late Eocene greenhouse world	NATURE			English	Article							LATE MIDDLE EOCENE; GRAIN-SIZE; ISOTOPE COMPOSITIONS; PONDAUNG FORMATION; STABLE-ISOTOPES; CLIMATE; OXYGEN; CHINA; RECONSTRUCTIONS; SENSITIVITY	The strong present-day Asian monsoons are thought to have originated between 25 and 22 million years (Myr) ago, driven by Tibetan-Himalayan uplift. However, the existence of older Asian monsoons and their response to enhanced greenhouse conditions such as those in the Eocene period (55-34Myrago) are unknown because of the paucity of well-dated records. Here we show late Eocene climate records revealing marked monsoon-like patterns in rainfall and wind south and north of the Tibetan-Himalayan orogen. This is indicated by low oxygen isotope values with strong seasonality in gastropod shells and mammal teeth from Myanmar, and by aeolian dust deposition in northwest China. Our climate simulations support modern-like Eocene monsoonal rainfall and show that a reinforced hydrological cycle responding to enhanced greenhouse conditions counterbalanced the negative effect of lower Tibetan relief on precipitation. These strong monsoons later weakened with the global shift to icehouse conditions 34 Myr ago.	[Licht, A.; Jaeger, J. -J.] Univ Poitiers, CNRS, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, UMR 7262, F-86000 Poitiers, France; [Licht, A.; France-Lanord, C.; Rigaudier, T.] Univ Lorraine, CNRS, Ctr Rech Petrograph & Geochim, UMR 7358, F-54501 Vandoeuvre Les Nancy, France; [Licht, A.; Quade, J.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [van Cappelle, M.; Abels, H. A.; Dupont-Nivet, G.] Univ Utrecht, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; [van Cappelle, M.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Abels, H. A.; Adriaens, R.] Katholieke Univ Leuven, Dept Earth & Environm Sci, B-3001 Louvain, Belgium; [Ladant, J. -B.; Donnadieu, Y.] CNRS, Lab Sci Climat & Environm, UMR 8212, F-91198 Gif Sur Yvette, France; [Trabucho-Alexandre, J.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Vandenberghe, J.] Vrije Univ, Dept Earth Sci, NL-1081 HV Amsterdam, Netherlands; [Lecuyer, C.] Univ Lyon, CNRS, Inst Univ France, Lab Geol Lyon,UMR 5276, F-69622 Lyon, France; [Terry, D., Jr.] Temple Univ, Dept Earth & Environm Sci, Philadelphia, PA 19122 USA; [Boura, A.] UPMC, MNHN, CNRS, Ctr Rech Paleodiversite & Paleoenvironm, F-75005 Paris, France; [Guo, Z.; Dupont-Nivet, G.] Peking Univ, Key Lab Orogen Belts & Crustal Evolut, Beijing 100871, Peoples R China; [Soe, Aung Naing] Def Serv Acad, Dept Geol, Pyin Oo Lwin, Myanmar; [Dupont-Nivet, G.] Univ Rennes, CNRS, UMR 6118, F-35042 Rennes, France; [Dupont-Nivet, G.] Univ Potsdam, Inst Earth & Environm Sci, D-14476 Potsdam, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of Arizona; Utrecht University; Imperial College London; KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; Durham University; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); Institut Universitaire de France; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Peking University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; University of Potsdam	Licht, A (corresponding author), Univ Poitiers, CNRS, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, UMR 7262, F-86000 Poitiers, France.	alicht@email.arizona.edu	France-Lanord, Christian/F-8848-2010; Anaïs, Boura/ABB-7025-2021; Donnadieu, Yannick/G-7546-2016; Licht, Alexis/P-4284-2018; Rigaudier, Thomas/GRF-4581-2022; Lecuyer, Christophe/AAO-8154-2021; Vandenberghe, Jef/H-5846-2019; DUPONT-NIVET, Guillaume/HII-9066-2022; Alexandre, João P. Trabucho/AAT-5878-2020	France-Lanord, Christian/0000-0002-4873-5546; Anaïs, Boura/0000-0002-3144-8217; Donnadieu, Yannick/0000-0002-7315-2684; Licht, Alexis/0000-0002-5267-7545; Rigaudier, Thomas/0000-0003-4947-3784; Vandenberghe, Jef/0000-0001-9910-1319; Alexandre, João P. Trabucho/0000-0003-1997-027X; Lecuyer, Christophe/0000-0001-9513-2492; Dupont-Nivet, Guillaume/0000-0001-9905-9739; Abels, Hemmo/0000-0001-7648-3369; van Cappelle, Marijn/0000-0003-2129-7870	University of Poitiers; Netherlands Organisation for Scientific Research (NWO-ALW); Marie Curie CIG [294282]; Ministry of Culture of the Republic of the Union of Myanmar; French ministry of Foreign Affairs; French ministry of Higher Education and Research; Alexander von Humboldt Foundation; Chinese Ministry of Education; National Natural Science Foundation of China (NSFC); Fyssen Foundation;  [ANR-09-BLAN-0238-02]	University of Poitiers; Netherlands Organisation for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Marie Curie CIG; Ministry of Culture of the Republic of the Union of Myanmar; French ministry of Foreign Affairs; French ministry of Higher Education and Research; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fyssen Foundation; 	We thank the Commissariat a l'Energie Atomique/Centre de Calcul Recherche et Technologie for access to computing facilities; V. Barbin for cathodoluminescence microscopy; C. Fontaine for X-ray diffraction; R. Amiot, T. Bouten, M. Konert, M. Lebbink and T. Zalm for laboratory assistance; the many colleagues of the Franco-Burmese palaeontological team for field assistance; and D. Dettman and F. Fluteau for discussions. This work was supported by the ANR-09-BLAN-0238-02 Program, the University of Poitiers, the Netherlands Organisation for Scientific Research (NWO-ALW) with funding to H. A. and G.D.-N., the Marie Curie CIG 294282, the Ministry of Culture of the Republic of the Union of Myanmar, the French ministries of Foreign Affairs and of Higher Education and Research, the Alexander von Humboldt Foundation, the Chinese Ministry of Education and the National Natural Science Foundation of China (NSFC). A. L. was also funded by a Fyssen Foundation study grant.	Abels HA, 2011, PALAEOGEOGR PALAEOCL, V299, P399, DOI 10.1016/j.palaeo.2010.11.028; Alonso-Zarza AM, 2009, SEDIMENT GEOL, V222, P42, DOI 10.1016/j.sedgeo.2009.03.010; Araguas-Araguas L, 1998, J GEOPHYS RES-ATMOS, V103, P28721, DOI 10.1029/98JD02582; Boos WR, 2010, NATURE, V463, P218, DOI 10.1038/nature08707; Bosboom RE, 2011, PALAEOGEOGR PALAEOCL, V299, P385, DOI 10.1016/j.palaeo.2010.11.019; Breitenbach SFM, 2010, EARTH PLANET SC LETT, V292, P212, DOI 10.1016/j.epsl.2010.01.038; Clift PD, 2008, NAT GEOSCI, V1, P875, DOI 10.1038/ngeo351; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; Dettman DL, 2001, GEOLOGY, V29, P31, DOI 10.1130/0091-7613(2001)029<0031:SSIEFA>2.0.CO;2; Dupont-Nivet G, 2008, GEOLOGY, V36, P987, DOI 10.1130/G25063A.1; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; Fluteau F, 1999, J GEOPHYS RES-ATMOS, V104, P11995, DOI 10.1029/1999JD900048; Gajurel AP, 2006, CHEM GEOL, V233, P156, DOI 10.1016/j.chemgeo.2006.03.002; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall R, 2012, TECTONOPHYSICS, V570, P1, DOI 10.1016/j.tecto.2012.04.021; Hourdin F, 2006, CLIM DYNAM, V27, P787, DOI 10.1007/s00382-006-0158-0; Huber M, 2012, J ASIAN EARTH SCI, V44, P3, DOI 10.1016/j.jseaes.2011.09.014; Jaeger JJ, 2004, CR PALEVOL, V3, P243, DOI 10.1016/j.crpv.2004.05.003; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P3889, DOI 10.1016/0016-7037(96)00248-7; Krinsley D. H., 2011, ATLAS QUARTZ SAND SU; Lefebvre V, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002345; Licht A, 2013, J GEOL SOC LONDON, V170, P929, DOI 10.1144/jgs2012-126; Licht A, 2014, REV PALAEOBOT PALYNO, V202, P29, DOI 10.1016/j.revpalbo.2013.12.002; Licht A, 2014, SEDIMENTOLOGY, V61, P362, DOI 10.1111/sed.12059; Lu HY, 2001, J QUATERNARY SCI, V16, P89, DOI 10.1002/1099-1417(200101)16:1<89::AID-JQS578>3.0.CO;2-8; Martin C, 2011, PALAEOGEOGR PALAEOCL, V311, P19, DOI 10.1016/j.palaeo.2011.07.010; Molnar P, 2010, ANNU REV EARTH PL SC, V38, P77, DOI 10.1146/annurev-earth-040809-152456; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; Qiang XK, 2011, SCI CHINA EARTH SCI, V54, P136, DOI 10.1007/s11430-010-4126-5; Quan C, 2012, PALAEOGEOGR PALAEOCL, V365, P302, DOI 10.1016/j.palaeo.2012.09.035; Ramstein G, 1997, NATURE, V386, P788, DOI 10.1038/386788a0; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Sharma S, 2004, QUATERNARY RES, V62, P19, DOI 10.1016/j.yqres.2004.03.003; Sun DH, 2008, PALAEOGEOGR PALAEOCL, V264, P39, DOI 10.1016/j.palaeo.2008.03.011; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Tindall J, 2010, EARTH PLANET SC LETT, V292, P265, DOI 10.1016/j.epsl.2009.12.049; Vandenberghe J, 2013, EARTH-SCI REV, V121, P18, DOI 10.1016/j.earscirev.2013.03.001; Vuille M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006022; Wang DH, 2013, J ASIAN EARTH SCI, V62, P776, DOI 10.1016/j.jseaes.2012.11.032; Wilson DS, 2012, PALAEOGEOGR PALAEOCL, V335, P24, DOI 10.1016/j.palaeo.2011.05.028; Xu M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007337; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang SP, 2008, INT J CLIMATOL, V28, P1563, DOI 10.1002/joc.1659; Zhang ZS, 2007, EARTH PLANET SC LETT, V257, P622, DOI 10.1016/j.epsl.2007.03.024; Zhang ZS, 2012, J ASIAN EARTH SCI, V44, P24, DOI 10.1016/j.jseaes.2011.05.013	49	281	304	20	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					501	+		10.1038/nature13704	http://dx.doi.org/10.1038/nature13704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25219854				2022-12-28	WOS:000342075800030
J	Lionetti, D; Agapie, T				Lionetti, Davide; Agapie, Theodor			How calcium affects oxygen formation	NATURE			English	Editorial Material							REDOX-INACTIVE METALS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; PHOTOSYSTEM-II; COMPLEXES; CLUSTERS		[Lionetti, Davide; Agapie, Theodor] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Lionetti, D (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	agapie@caltech.edu			NIGMS NIH HHS [R01 GM102687] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102687] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bang S., 2014, NATURE CHEM; Fukuzumi S, 2010, NAT CHEM, V2, P756, DOI [10.1038/NCHEM.731, 10.1038/nchem.731]; Herbert DE, 2013, J AM CHEM SOC, V135, P19075, DOI 10.1021/ja4104974; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Lee YM, 2013, CHEM SCI, V4, P3917, DOI 10.1039/c3sc51864g; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Li FF, 2013, J AM CHEM SOC, V135, P10198, DOI 10.1021/ja402645y; Park YJ, 2013, CHEM SCI, V4, P717, DOI 10.1039/c2sc21400h; Tsui EY, 2013, NAT CHEM, V5, P293, DOI [10.1038/NCHEM.1578, 10.1038/nchem.1578]; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yoon H, 2013, J AM CHEM SOC, V135, P9186, DOI 10.1021/ja403965h	11	13	13	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					495	496		10.1038/nature13753	http://dx.doi.org/10.1038/nature13753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25231867	Green Accepted			2022-12-28	WOS:000342075800027
J	Price, GD; Howitt, SM				Price, G. Dean; Howitt, Susan M.			Towards turbocharged photosynthesis	NATURE			English	Editorial Material							CO2 FIXATION		[Price, G. Dean; Howitt, Susan M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia	Australian National University	Price, GD (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	dean.price@anu.edu.au; susan.howitt@anu.edu.au	Howitt, Susan M/C-9308-2009; Price, G Dean/C-9505-2009	Howitt, Susan M/0000-0002-2192-2317; Price, G Dean/0000-0001-5906-4912				Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Lin MT, 2014, PLANT J, V79, P1, DOI 10.1111/tpj.12536; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; McGrath JM, 2014, PLANT PHYSIOL, V164, P2247, DOI 10.1104/pp.113.232611; Price GD, 2013, J EXP BOT, V64, P753, DOI 10.1093/jxb/ers257; Rae BD, 2013, MICROBIOL MOL BIOL R, V77, P357, DOI 10.1128/MMBR.00061-12; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103	8	13	13	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					497	498		10.1038/nature13749	http://dx.doi.org/10.1038/nature13749			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25231859				2022-12-28	WOS:000342075800028
J	Yamamoto, S; Jaiswal, M; Charng, WL; Gambin, T; Karaca, E; Mirzaa, G; Wiszniewski, W; Sandoval, H; Haelterman, NA; Xiong, B; Zhang, K; Bayat, V; David, G; Li, TC; Chen, KC; Gala, U; Harel, T; Pehlivan, D; Penney, S; Vissers, LELM; de Ligt, J; Jhangiani, SN; Xie, YJ; Tsang, SH; Parman, Y; Sivaci, M; Battaloglu, E; Muzny, D; Wan, YW; Liu, ZD; Lin-Moore, AT; Clark, RD; Curry, CJ; Link, N; Schulze, KL; Boerwinkle, E; Dobyns, WB; Allikmets, R; Gibbs, RA; Chen, R; Lupski, JR; Wangler, MF; Bellen, HJ				Yamamoto, Shinya; Jaiswal, Manish; Charng, Wu-Lin; Gambin, Tomasz; Karaca, Ender; Mirzaa, Ghayda; Wiszniewski, Wojciech; Sandoval, Hector; Haelterman, Nele A.; Xiong, Bo; Zhang, Ke; Bayat, Vafa; David, Gabriela; Li, Tongchao; Chen, Kuchuan; Gala, Upasana; Harel, Tamar; Pehlivan, Davut; Penney, Samantha; Vissers, Lisenka E. L. M.; de Ligt, Joep; Jhangiani, Shalini N.; Xie, Yajing; Tsang, Stephen H.; Parman, Yesim; Sivaci, Merve; Battaloglu, Esra; Muzny, Donna; Wan, Ying-Wooi; Liu, Zhandong; Lin-Moore, Alexander T.; Clark, Robin D.; Curry, Cynthia J.; Link, Nichole; Schulze, Karen L.; Boerwinkle, Eric; Dobyns, William B.; Allikmets, Rando; Gibbs, Richard A.; Chen, Rui; Lupski, James R.; Wangler, Michael F.; Bellen, Hugo J.			A Drosophila Genetic Resource of Mutants to Study Mechanisms Underlying Human Genetic Diseases	CELL			English	Article							HUMAN NEURODEGENERATIVE DISEASES; X-CHROMOSOME; IN-VIVO; MELANOGASTER; RNAI; MUTATIONS; SCREEN; SYSTEM; COLLECTION; GENOMICS	Invertebrate model systems are powerful tools for studying human disease owing to their genetic tractability and ease of screening. We conducted a mosaic genetic screen of lethal mutations on the Drosophila X chromosome to identify genes required for the development, function, and maintenance of the nervous system. We identified 165 genes, most of whose function has not been studied in vivo. In parallel, we investigated rare variant alleles in 1,929 human exomes from families with unsolved Mendelian disease. Genes that are essential in flies and have multiple human homologs were found to be likely to be associated with human diseases. Merging the human data sets with the fly genes allowed us to identify disease-associated mutations in six families and to provide insights into microcephaly associated with brain dysgenesis. This bidirectional synergism between fly genetics and human genomics facilitates the functional annotation of evolutionarily conserved genes involved in human health.	[Yamamoto, Shinya; Charng, Wu-Lin; Haelterman, Nele A.; Xiong, Bo; Bayat, Vafa; David, Gabriela; Li, Tongchao; Chen, Kuchuan; Gala, Upasana; Chen, Rui; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Yamamoto, Shinya; Jaiswal, Manish; Charng, Wu-Lin; Gambin, Tomasz; Karaca, Ender; Wiszniewski, Wojciech; Sandoval, Hector; Harel, Tamar; Pehlivan, Davut; Penney, Samantha; Muzny, Donna; Lin-Moore, Alexander T.; Link, Nichole; Schulze, Karen L.; Gibbs, Richard A.; Chen, Rui; Lupski, James R.; Wangler, Michael F.; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yamamoto, Shinya; Wan, Ying-Wooi; Liu, Zhandong; Bellen, Hugo J.] Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Jaiswal, Manish; Schulze, Karen L.; Bellen, Hugo J.] Howard Hughes Med Inst, Houston, TX 77030 USA; [Gambin, Tomasz] Warsaw Univ Technol, Inst Comp Sci, PL-00661 Warsaw, Poland; [Mirzaa, Ghayda; Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mirzaa, Ghayda; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Wiszniewski, Wojciech; Harel, Tamar; Penney, Samantha; Lupski, James R.; Wangler, Michael F.] Texas Childrens Hosp, Houston, TX 77030 USA; [Zhang, Ke; Bellen, Hugo J.] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Vissers, Lisenka E. L. M.; de Ligt, Joep] Radboudumc, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Jhangiani, Shalini N.; Muzny, Donna; Boerwinkle, Eric; Gibbs, Richard A.; Chen, Rui; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Xie, Yajing; Tsang, Stephen H.; Allikmets, Rando] Columbia Univ, Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA; [Tsang, Stephen H.; Allikmets, Rando] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Parman, Yesim] Istanbul Univ, Sch Med, Dept Neurol, TR-34390 Istanbul, Turkey; [Parman, Yesim] Istanbul Univ, Sch Med, Neuropathol Lab, TR-34390 Istanbul, Turkey; [Sivaci, Merve; Battaloglu, Esra] Bogazici Univ, Dept Mol Biol & Genet, TR-34342 Istanbul, Turkey; [Wan, Ying-Wooi] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Liu, Zhandong] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Clark, Robin D.] Loma Linda Univ, Med Ctr, Dept Pediat, Div Med Genet, Loma Linda, CA 92354 USA; [Curry, Cynthia J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Curry, Cynthia J.] Genet Med Cent Calif, Fresno, CA 93701 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Warsaw University of Technology; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Baylor College of Medicine; Baylor College of Medicine; Radboud University Nijmegen; Baylor College of Medicine; Columbia University; Columbia University; Istanbul University; Istanbul University; Bogazici University; Baylor College of Medicine; Baylor College of Medicine; Loma Linda University; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; Baylor College of Medicine	Wangler, MF (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	michael.wangler@bcm.edu; hbellen@bcm.edu	Gambin, Tomasz/HDN-5840-2022; Dobyns, William/AAI-2768-2020; Allikmets, Rando/ABD-4533-2021; Battaloğlu, Esra/AAF-1559-2020; Yamamoto, Shinya/ABB-2837-2021; Wangler, Michael/H-6368-2019; Bayat, Vafa/ABG-2774-2021; Zhang, Ke/B-8598-2018; Vissers, Lisenka ELM/A-2598-2015; Pehlivan, Davut/I-3235-2019; Xiong, Bo/M-3605-2014; Dobyns, William Brian/ABC-6525-2021	Gambin, Tomasz/0000-0002-0941-4571; Dobyns, William/0000-0002-7681-2844; Yamamoto, Shinya/0000-0003-2172-8036; Wangler, Michael/0000-0001-5245-5910; Zhang, Ke/0000-0002-4794-8355; Vissers, Lisenka ELM/0000-0001-6470-5497; Liu, Zhandong/0000-0002-7608-0831; Sandoval, Hector/0000-0002-9186-7384; Xiong, Bo/0000-0002-2695-9100; de Ligt, Joep/0000-0002-0348-419X; Jaiswal, Manish/0000-0001-8360-8289; Bellen, Hugo/0000-0001-5992-5989	National Institutes of Health (NIH) [1RC4GM096355-01, U54HG006542, R01NBS058529, 5P30HD024064, K23NS078056, 5R01GM067858, T32 NS043124-11, 5K12GM084897, K08NS076547, EY021163, EY019861, EY019007]; Nakajima Foundation; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital National Science Centre Poland [DEC-2012/06/M/NZ2/00101]; Burroughs Wellcome Fund [1008200]; NSF DMS [1263932]; Bogazici University Research Foundation [09B101P]; Research to Prevent Blindness to the Department of Ophthalmology, Columbia University; Robert and Renee Belfer Family Foundation; Huffington Foundation; Target ALS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092, P30HD024064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY019861, P30EY019007, R01EY018213, R01EY021163] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096355, R01GM067858, K12GM084897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS078056, R01NS058529, K08NS076547, T32NS043124] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nakajima Foundation; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital National Science Centre Poland; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF DMS(National Science Foundation (NSF)); Bogazici University Research Foundation(Bogazici University); Research to Prevent Blindness to the Department of Ophthalmology, Columbia University(Research to Prevent Blindness (RPB)); Robert and Renee Belfer Family Foundation; Huffington Foundation; Target ALS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Chen, C. Benitez, X. Shi, S. Gibbs, A. Jawaid, H. Wang, Y.Q. Lin, D. Bei, L. Wang, Y. He, and H. Pan for technical support; Y- N. Jan, T. Kaufman, C. Doe, U. Banergee, J. Olson, K. Cook, and D. Bilder for reagents; and J. Shulman, J. Zallen, E. Seto, and H.Y. Zoghbi for critical reading of this manuscript. This study was supported by the National Institutes of Health (NIH) 1RC4GM096355-01 (H.J.B. and R. Chen), U54HG006542 (BHCMG), R01NBS058529 (J.R.L.), 5P30HD024064 (Confocal microscopy at the Intellectual and Developmental Disabilities Research Center), K23NS078056 (W.W.) 5R01GM067858 (H.S.), T32 NS043124-11(H.S.), and 5K12GM084897 (H.S.), K08NS076547(M.F.W.), EY021163 (R.A.), EY019861 (R.A.), and EY019007 (R.A. and S.H.T.). Additional support: Nakajima Foundation and the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital (S.Y.) National Science Centre Poland (DEC-2012/06/M/NZ2/00101) (W.W.), Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund (Grant No. 1008200) (B.X.), NSF DMS# 1263932 (Z.L.), Bogazici University Research Foundation (09B101P) (E. Battaloglu), Research to Prevent Blindness to the Department of Ophthalmology, Columbia University (R.A., S.H.T.). H.J.B. is a Howard Hughes Medical Institute Investigator and received funds from the Robert and Renee Belfer Family Foundation, the Huffington Foundation, and Target ALS.	Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Bamshad MJ, 2012, AM J MED GENET A, V158A, P1523, DOI 10.1002/ajmg.a.35470; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Benos PV, 2001, GENOME RES, V11, P710, DOI 10.1101/gr.173801; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boekel Christian, 2008, V420, P119, DOI 10.1007/978-1-59745-583-1_7; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Charng WL, 2014, CURR OPIN NEUROBIOL, V27, P158, DOI 10.1016/j.conb.2014.03.001; Cook RK, 2010, GENETICS, V186, P1095, DOI 10.1534/genetics.110.123265; Cullen CF, 2005, J CELL BIOL, V171, P593, DOI 10.1083/jcb.200508127; Emoto K, 2012, CURR OPIN NEUROBIOL, V22, P805, DOI 10.1016/j.conb.2012.04.005; Gonzaga-Jauregui C, 2013, JAMA NEUROL, V70, P1491, DOI 10.1001/jamaneurol.2013.4598; Green EW, 2014, NAT METHODS, V11, P222, DOI 10.1038/nmeth.2856; Haelterman NA, 2014, GENOME RES, V24, P1707, DOI 10.1101/gr.174615.114; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Jaiswal M, 2012, ANNU REV GENET, V46, P371, DOI 10.1146/annurev-genet-110711-155456; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Liao TSV, 2006, GENETICS, V174, P525, DOI 10.1534/genetics.106.061705; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lu BW, 2009, ANNU REV PATHOL-MECH, V4, P315, DOI 10.1146/annurev.pathol.3.121806.151529; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Mohr SE, 2014, METHODS, V68, P82, DOI 10.1016/j.ymeth.2014.02.018; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Newsome TP, 2000, DEVELOPMENT, V127, P851; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oortveld MAW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003911; Pastor-Pareja JC, 2013, ANNU REV GENET, V47, P51, DOI 10.1146/annurev-genet-110711-155414; Rujano MA, 2013, NAT CELL BIOL, V15, P1294, DOI 10.1038/ncb2858; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2010, GENETICS, V186, P1111, DOI 10.1534/genetics.110.121285; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Yamamoto S, 2014, EXP ANIM TOKYO, V63, P107, DOI 10.1538/expanim.63.107	47	231	232	14	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					200	214		10.1016/j.cell.2014.09.002	http://dx.doi.org/10.1016/j.cell.2014.09.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259927	Green Accepted, Bronze			2022-12-28	WOS:000343095000020
J	Yamashita, A; Morioka, M; Kishi, H; Kimura, T; Yahara, Y; Okada, M; Fujita, K; Sawai, H; Ikegawa, S; Tsumaki, N				Yamashita, Akihiro; Morioka, Miho; Kishi, Hiromi; Kimura, Takeshi; Yahara, Yasuhito; Okada, Minoru; Fujita, Kaori; Sawai, Hideaki; Ikegawa, Shiro; Tsumaki, Noriyuki			Statin treatment rescues FGFR3 skeletal dysplasia phenotypes	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-3; ACHONDROPLASIA; MUTATIONS; APOPTOSIS; MICE; ACTIVATION; EXPRESSION; CARTILAGE; DWARFISM; PEPTIDE	Gain-of-function mutations in the fibroblast growth factor receptor 3 gene (FGFR3) result in skeletal dysplasias, such as thanatophoric dysplasia and achondroplasia (ACH). The lack of disease models using human cells has hampered the identification of a clinically effective treatment for these diseases. Here we show that statin treatment can rescue patient-specific induced pluripotent stem cell (iPSC) models and a mouse model of FGFR3 skeletal dysplasia. We converted fibroblasts from thanatophoric dysplasia type I (TD1) and ACH patients into iPSCs. The chondrogenic differentiation of TD1 iPSCs and ACH iPSCs resulted in the formation of degraded cartilage. We found that statins could correct the degraded cartilage in both chondrogenically differentiated TD1 and ACH iPSCs. Treatment of ACH model mice with statin led to a significant recovery of bone growth. These results suggest that statins could represent a medical treatment for infants and children with TD1 and ACH.	[Yamashita, Akihiro; Morioka, Miho; Kishi, Hiromi; Kimura, Takeshi; Yahara, Yasuhito; Okada, Minoru; Fujita, Kaori; Tsumaki, Noriyuki] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Cell Induct & Regulat Field, Kyoto 6068507, Japan; [Kimura, Takeshi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Sawai, Hideaki] Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo 6638501, Japan; [Ikegawa, Shiro] RIKEN, Ctr Integrated Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Tsumaki, Noriyuki] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	Kyoto University; Osaka University; Hyogo College of Medicine; RIKEN; Japan Science & Technology Agency (JST)	Tsumaki, N (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Cell Induct & Regulat Field, Kyoto 6068507, Japan.	ntsumaki@cira.kyoto-u.ac.jp	Ikegawa, Shiro/N-6895-2015; Yahara, Yasuhito/AAO-7487-2020; Sawai, Hideaki/S-4602-2019	Ikegawa, Shiro/0000-0003-0316-2147; Sawai, Hideaki/0000-0002-8997-464X; Tsumaki, Noriyuki/0000-0002-0520-3654; Kimura, Takeshi/0000-0003-1179-8903	Japan Science Technology Agency (JST), CREST; Research Center Network for Realization of Regenerative Medicine; MEXT [24890101, 26861716, 24390354]	Japan Science Technology Agency (JST), CREST; Research Center Network for Realization of Regenerative Medicine; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank H. Ohashi, J. Murotsuki, T. Yamada and K. Ozono for preparation of the dermal fibroblasts from a patient and discussion. We thank D. Ornitz and A. Yasoda for the Fgfr3<SUP>Ach</SUP> mice. We thank K. Okita and S. Yamanaka for providing the hiPSC line 409B2, and A. Hotta for transducing the piggyBac vectors. We thank A. Motomura, X. Chen, Y. Minegishi, M. Nishino, T. Kobayashi, N. Oda, E. Ikeda and Y. Makita for their assistance. This study was supported in part by the Japan Science Technology Agency (JST), CREST (to N. T.) and Research Center Network for Realization of Regenerative Medicine (to N. T.), and Scientific Research Grant No. 24890101 (to A. Y.) and 26861716 (to A. Y.) and No. 24390354 (to N. T.) from MEXT.	Baker JF, 2012, J ORTHOP TRAUMATOL, V13, P119, DOI 10.1007/s10195-012-0200-4; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garcia S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006247; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Guo CS, 2008, CELL SIGNAL, V20, P1471, DOI 10.1016/j.cellsig.2008.04.001; Harada D, 2007, BONE, V41, P273, DOI 10.1016/j.bone.2006.11.030; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Ikegami D, 2011, OSTEOARTHR CARTILAGE, V19, P233, DOI 10.1016/j.joca.2010.11.007; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jin M, 2012, HUM MOL GENET, V21, P5443, DOI 10.1093/hmg/dds390; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Krejci P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003961; Laederich MB, 2010, CURR OPIN PEDIATR, V22, P516, DOI 10.1097/MOP.0b013e32833b7a69; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Millar PJ, 2014, CLIN SCI, V126, P401, DOI 10.1042/CS20130332; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Naski MC, 1998, DEVELOPMENT, V125, P4977; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Olivieri F, 2012, CURR VASC PHARMACOL, V10, P216, DOI 10.2174/157016112799305076; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Simopoulou T, 2010, J ORTHOP RES, V28, P110, DOI 10.1002/jor.20953; Takeo T, 2009, CRYOBIOLOGY, V58, P196, DOI 10.1016/j.cryobiol.2008.12.011; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wolfe SM, 2004, LANCET, V363, P2189, DOI 10.1016/S0140-6736(04)16513-6; Xie YL, 2012, HUM MOL GENET, V21, P3941, DOI 10.1093/hmg/dds181; Yamanaka Y, 2003, J BONE MINER RES, V18, P1395, DOI 10.1359/jbmr.2003.18.8.1395; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676; Yudoh K, 2010, AGING-US, V2, P990, DOI 10.18632/aging.100213; Zhang J, 2013, INT J BIOCHEM CELL B, V45, P745, DOI 10.1016/j.biocel.2012.11.001	35	145	156	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					507	+		10.1038/nature13775	http://dx.doi.org/10.1038/nature13775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25231866				2022-12-28	WOS:000342075800031
J	Arnaoutov, A; Dasso, M				Arnaoutov, Alexei; Dasso, Mary			IRBIT is a novel regulator of ribonucleotide reductase in higher eukaryotes	SCIENCE			English	Article							ALLOSTERIC REGULATION; INDUCED OLIGOMERIZATION; COMPREHENSIVE MODEL; STRUCTURAL BASIS; BINDING; CONSEQUENCES; INHIBITOR; RECEPTOR; SML1	Ribonucleotide reductase (RNR) supplies the balanced pools of deoxynucleotide triphosphates (dNTPs) necessary for DNA replication and maintenance of genomic integrity. RNR is subject to allosteric regulatory mechanisms in all eukaryotes, as well as to control by small protein inhibitors Sml1p and Spd1p in budding and fission yeast, respectively. Here, we show that the metazoan protein IRBIT forms a deoxyadenosine triphosphate (dATP)-dependent complex with RNR, which stabilizes dATP in the activity site of RNR and thus inhibits the enzyme. Formation of the RNR-IRBIT complex is regulated through phosphorylation of IRBIT, and ablation of IRBIT expression in HeLa cells causes imbalanced dNTP pools and altered cell cycle progression. We demonstrate a mechanism for RNR regulation in higher eukaryotes that acts by enhancing allosteric RNR inhibition by dATP.	[Arnaoutov, Alexei; Dasso, Mary] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Arnaoutov, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	arnaouta@mail.nih.gov		Arnaoutov, Alexei/0000-0001-7647-7217; Dasso, Mary/0000-0002-5410-1371	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008954] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HD008954-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahluwalia D, 2013, P NATL ACAD SCI USA, V110, P18596, DOI 10.1073/pnas.1310849110; Ahmad MF, 2013, PROG MOL BIOL TRANSL, V117, P389, DOI 10.1016/B978-0-12-386931-9.00014-3; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Chabes A, 1999, J BIOL CHEM, V274, P36679, DOI 10.1074/jbc.274.51.36679; Cooper BJ, 2006, J BIOL CHEM, V281, P22471, DOI 10.1074/jbc.M602520200; Danielsson J, 2008, BIOCHEMISTRY-US, V47, P13428, DOI 10.1021/bi801040b; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Kiefer H, 2009, J BIOL CHEM, V284, P10694, DOI 10.1074/jbc.M807136200; ORMO M, 1990, ANAL BIOCHEM, V189, P138, DOI 10.1016/0003-2697(90)90059-I; Reichard P, 2000, J BIOL CHEM, V275, P33021, DOI 10.1074/jbc.M005337200; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wash R, 2012, J GEN VIROL, V93, P2118, DOI 10.1099/vir.0.043406-0; Wijerathna SR, 2011, PHARMACEUTICALS, V4, P1328, DOI 10.3390/ph4101328; Yang DK, 2009, J CLIN INVEST, V119, P193, DOI 10.1172/JCI36983	19	35	39	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1512	1515		10.1126/science.1251550	http://dx.doi.org/10.1126/science.1251550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237103	Green Accepted			2022-12-28	WOS:000341752900044
J	Corbett, EC				Corbett, Eugene C., Jr.			In newly diagnosed type 2 diabetes, a Mediterranean diet (vs a low-fat diet) delayed start of glucose-lowering drugs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Virginia, Charlottesville, VA 22903 USA	University of Virginia	Corbett, EC (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.							Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	1	0	0	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC4	10.7326/0003-4819-161-6-201409160-02004	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222416				2022-12-28	WOS:000343894400003
J	Pathak, N; Dodds, J; Zamora, J; Khan, K				Pathak, Neha; Dodds, Julie; Zamora, Javier; Khan, Khalid			Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIAGNOSTIC-TEST ACCURACY; REAL-TIME PCR; DNA DETECTION; PAIRED URINE; SCREENING TOOL; SAMPLES; CANCER; GRADE; WOMEN; PERFORMANCE	Objective To determine the accuracy of testing for human papillomavirus (HPV) DNA in urine in detecting cervical HPV in sexually active women. Design Systematic review and meta-analysis. Data sources Searches of electronic databases from inception until December 2013, checks of reference lists, manual searches of recent issues of relevant journals, and contact with experts. Eligibility criteria Test accuracy studies in sexually active women that compared detection of urine HPV DNA with detection of cervical HPV DNA. Data extraction and synthesis Data relating to patient characteristics, study context, risk of bias, and test accuracy. 2x2 tables were constructed and synthesised by bivariate mixed effects meta-analysis. Results 16 articles reporting on 14 studies (1443 women) were eligible for meta-analysis. Most used commercial polymerase chain reaction methods on first void urine samples. Urine detection of any HPV had a pooled sensitivity of 87% (95% confidence interval 78% to 92%) and specificity of 94% (95% confidence interval 82% to 98%). Urine detection of high risk HPV had a pooled sensitivity of 77% (68% to 84%) and specificity of 88% (58% to 97%). Urine detection of HPV 16 and 18 had a pooled sensitivity of 73% (56% to 86%) and specificity of 98% (91% to 100%). Metaregression revealed an increase in sensitivity when urine samples were collected as first void compared with random or midstream (P=0.004). Limitations The major limitations of this review are the lack of a strictly uniform method for the detection of HPV in urine and the variation in accuracy between individual studies. Conclusions Testing urine for HPV seems to have good accuracy for the detection of cervical HPV, and testing first void urine samples is more accurate than random or midstream sampling. When cervical HPV detection is considered difficult in particular subgroups, urine testing should be regarded as an acceptable alternative.	[Pathak, Neha; Dodds, Julie; Zamora, Javier; Khan, Khalid] Barts & London Queen Marys Sch Med & Dent, Womens Hlth Res Unit, Ctr Primary Care & Publ Hlth, Blizard Inst, London E1 2AB, England; [Zamora, Javier] Hosp Ramon & Cajal IRYCIS, Clin Biostat Unit, Madrid, Spain; [Zamora, Javier] CIBER Epidemiol & Salud Publ, Madrid, Spain	University of London; Queen Mary University London; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Zamora, J (corresponding author), Barts & London Queen Marys Sch Med & Dent, Womens Hlth Res Unit, Ctr Primary Care & Publ Hlth, Blizard Inst, London E1 2AB, England.	javier.zamora@hrc.es	Zamora, Javier/B-1722-2009; Khan, Khalid S/AAT-8824-2020; Zamora, Javier/AEO-0608-2022	Zamora, Javier/0000-0003-4901-588X; Khan, Khalid S/0000-0001-5084-7312; Zamora, Javier/0000-0003-4901-588X; Pathak, Neha/0000-0002-1077-5358	MRC [G0901608] Funding Source: UKRI; Medical Research Council [G0901608] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alameda Francesc, 2007, J Low Genit Tract Dis, V11, P5, DOI 10.1097/01.lgt.0000230204.65742.e4; Bissett SL, 2011, J MED VIROL, V83, P1744, DOI 10.1002/jmv.22167; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Brinkman JA, 2002, J CLIN MICROBIOL, V40, P3155, DOI 10.1128/JCM.40.9.3155-3161.2002; Chien PFW, 2012, BJOG-INT J OBSTET GY, V119, P903, DOI 10.1111/j.1471-0528.2011.03242.x; Collaboration C, 2014, HDB DTA REV; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Cuschieri K, 2011, J MED VIROL, V83, P1983, DOI 10.1002/jmv.22183; Daponte A, 2008, CLIN MICROBIOL INFEC, V14, P619, DOI 10.1111/j.1469-0691.2008.01974.x; Daponte A, 2006, J CLIN VIROL, V36, P189, DOI 10.1016/j.jcv.2006.03.009; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Enerly E, 2013, CLIN EPIDEMIOL, V5, P371; Farnbrini M, 2008, GYNECOL ONCOL, V109, P59, DOI 10.1016/j.ygyno.2007.12.032; FORSLUND O, 1993, J CLIN MICROBIOL, V31, P1975, DOI 10.1128/JCM.31.8.1975-1979.1993; Gupta A, 2006, J CLIN VIROL, V37, P190, DOI 10.1016/j.jcv.2006.07.007; Jacobson DL, 2000, PEDIATR INFECT DIS J, V19, P722, DOI 10.1097/00006454-200008000-00010; Johnson DJ, 2007, J FORENSIC SCI, V52, P110, DOI 10.1111/j.1556-4029.2006.00329.x; Jong EE, 2008, J CLIN VIROL, V41, P111, DOI 10.1016/j.jcv.2007.10.007; Kitchener HC, 2011, EUR J CANCER, V47, P864, DOI 10.1016/j.ejca.2011.01.008; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Mendez K, 2014, INT J GYNECOL OBSTET, V124, P151, DOI 10.1016/j.ijgo.2013.07.036; Mendez K, 2013, P R HEALTH SCI J, V32, P3; Munoz M, 2013, PLOS ONE, V8, P7; Munoz M, 2013, J CLIN MICROBIOL, V51, P3688, DOI 10.1128/JCM.01302-13; National Cancer Intelligence Network, 2014, CERV CANC INC SCREEN; Payan C, 2007, J CLIN MICROBIOL, V45, P897, DOI 10.1128/JCM.02022-06; Pieralli A, 2010, GYNECOL ONCOL, V116, P586, DOI 10.1016/j.ygyno.2009.11.010; Prusty BK, 2005, INT J GYNECOL OBSTET, V90, P223, DOI 10.1016/j.ijgo.2005.06.004; Registry Trent Cancer, 2012, PROF CERV CANC ENGL; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Sahasrabuddhe VV, 2014, J CLIN MICROBIOL, V52, P187, DOI 10.1128/JCM.01623-13; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Sehgal A, 2009, J OBSTET GYNAECOL, V29, P583, DOI 10.1080/01443610903061736; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Song ES, 2007, J KOREAN MED SCI, V22, P99, DOI 10.3346/jkms.2007.22.1.99; Stanczuk GA, 2003, J MED VIROL, V71, P110, DOI 10.1002/jmv.10456; Strauss S, 1999, EUR J EPIDEMIOL, V15, P537, DOI 10.1023/A:1007574231879; Tanzi E, 2013, J MED VIROL, V85, P91, DOI 10.1002/jmv.23434; Vorsters A, 2012, EUR J CLIN MICROBIOL, V31, P627, DOI 10.1007/s10096-011-1358-z; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	47	79	83	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2014	349								g5264	10.1136/bmj.g5264	http://dx.doi.org/10.1136/bmj.g5264			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OP	25232064	Green Published, hybrid			2022-12-28	WOS:000342057500001
J	Sureka, K; Choi, PH; Precit, M; Delince, M; Pensinger, DA; Huynh, TN; Jurado, AR; Goo, YA; Sadilek, M; Iavarone, AT; Sauer, JD; Tong, L; Woodward, JJ				Sureka, Kamakshi; Choi, Philip H.; Precit, Mimi; Delince, Matthieu; Pensinger, Daniel A.; Tuanh Ngoc Huynh; Jurado, Ashley R.; Goo, Young Ah; Sadilek, Martin; Iavarone, Anthony T.; Sauer, John-Demian; Tong, Liang; Woodward, Joshua J.			The Cyclic Dinucleotide c-di-AMP Is an Allosteric Regulator of Metabolic Enzyme Function	CELL			English	Article							AUREUS PYRUVATE-CARBOXYLASE; LISTERIA-MONOCYTOGENES; DNA INTEGRITY; CRYSTAL-STRUCTURES; MEMBRANE-PROTEIN; STRUCTURAL BASIS; PRFA ACTIVITY; GMP; REVEALS; GLUTAMATE	Cyclic di-adenosine monophosphate (c-di-AMP) is a broadly conserved second messenger required for bacterial growth and infection. However, the molecular mechanisms of c-di-AMP signaling are still poorly understood. Using a chemical proteomics screen for c-di-AMP-interacting proteins in the pathogen Listeria monocytogenes, we identified several broadly conserved protein receptors, including the central metabolic enzyme pyruvate carboxylase (LmPC). Biochemical and crystallographic studies of the LmPC-c-di-AMP interaction revealed a previously unrecognized allosteric regulatory site 25 angstrom from the active site. Mutations in this site disrupted c-di-AMP binding and affected catalytic activity of LmPC as well as PC from pathogenic Enterococcus faecalis. C-di-AMP depletion resulted in altered metabolic activity in L. monocytogenes. Correction of this metabolic imbalance rescued bacterial growth, reduced bacterial lysis, and resulted in enhanced bacterial burdens during infection. These findings greatly expand the c-di-AMP signaling repertoire and reveal a central metabolic regulatory role for a cyclic dinucleotide.	[Sureka, Kamakshi; Precit, Mimi; Tuanh Ngoc Huynh; Woodward, Joshua J.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Choi, Philip H.; Jurado, Ashley R.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Delince, Matthieu] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pensinger, Daniel A.; Sauer, John-Demian] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Goo, Young Ah] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil, QB3, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; Columbia University; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu; jjwoodwa@uw.edu	Sureka, Kamakshi/ABE-4125-2021; Sauer, John-Demian/AAV-8538-2020	Sureka, Kamakshi/0000-0003-3093-5299; Sauer, John-Demian/0000-0001-9367-794X; Tong, Liang/0000-0002-0563-6468; Pensinger, Daniel/0000-0002-6742-5527	NIH [OD012208, U54AI057141, R01DK067238]; NIH Medical Scientist Training Program [GM007367]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, T32GM095421, T32GM007367] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Dan Portnoy (UC Berkeley) for generous support and reagents, Brad Cookson and Dan Stetson (University of Washington) for murine bone marrow, Jason Smith and Sam Miller (University of Washington) for instrument access, Jake McKinlay (University of Indiana) for <SUP>13</SUP>C-enrichement protocols, Nicholas Olivarez for technical support, and Joseph Mougous (University of Washington) for feedback on the preparation of the manuscript. We thank Linda Yu for earlier studies on PC expression and purification; Neil Whalen, Rick Jackimowicz and Howard Robinson for access to the X29A beamline at the NSLS. The in-house instrument for X-ray diffraction screening was purchased with an NIH grant to LT (OD012208). P.H.C. was also supported by an NIH Medical Scientist Training Program (GM007367). This work was supported by NIH grants U54AI057141 ( to J.J.W.) and R01DK067238 (to L.T.).	Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BOOTH IR, 1990, FEMS MICROBIOL LETT, V75, P239, DOI 10.1016/0378-1097(90)90534-W; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Cotter PD, 2005, APPL ENVIRON MICROB, V71, P2832, DOI 10.1128/AEM.71.6.2832-2839.2005; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kim HJ, 2006, J BACTERIOL, V188, P179, DOI 10.1128/JB.188.1.179-190.2006; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Liu SQ, 2006, APPL ENVIRON MICROB, V72, P3955, DOI 10.1128/AEM.02607-05; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Sun Y, 2010, INFECT IMMUN, V78, P4667, DOI 10.1128/IAI.00546-10; Sundriyal A, 2014, J BIOL CHEM, V289, P6978, DOI 10.1074/jbc.M113.516195; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yan DL, 1996, P NATL ACAD SCI USA, V93, P6527, DOI 10.1073/pnas.93.13.6527; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008; Zhang L, 2013, J BIOL CHEM, V288, P22426, DOI 10.1074/jbc.M113.464883; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110	52	136	141	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1389	1401		10.1016/j.cell.2014.07.046	http://dx.doi.org/10.1016/j.cell.2014.07.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215494	Bronze, Green Accepted			2022-12-28	WOS:000343094200019
J	Zoghbi, HY				Zoghbi, Huda Y.			From Anatomy to Electrophysiology: Clinical Lasker Goes Deep	CELL			English	Editorial Material							ADVANCED PARKINSONS-DISEASE; SUBTHALAMIC NUCLEUS; BRAIN-STIMULATION; BASAL GANGLIA; ORGANIZATION		[Zoghbi, Huda Y.] Texas Childrens Hosp, Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Zoghbi, HY (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; DELONG MR, 1984, CIBA F SYMP, V107, P64; Isaias IU, 2009, ARCH NEUROL-CHICAGO, V66, P465, DOI 10.1001/archneurol.2009.20; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Miller W.C., 1987, ADV BEHAV BIOL, P415; Riva-Posse P, 2014, BIOL PSYCHIAT; Smith GS, 2012, ARCH NEUROL-CHICAGO, V69, P1141, DOI 10.1001/archneurol.2012.590	14	1	1	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1225	1229		10.1016/j.cell.2014.08.021	http://dx.doi.org/10.1016/j.cell.2014.08.021			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215480	Bronze			2022-12-28	WOS:000343094200002
J	Watts, G				Watts, Geoff			David Robert Hadden Obituary	LANCET			English	Biographical-Item																		HADDEN DR, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					850	850		10.1016/S0140-6736(14)61479-3	http://dx.doi.org/10.1016/S0140-6736(14)61479-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	25215393				2022-12-28	WOS:000341362200016
J	Liu, L; Oza, S; Hogan, D; Perin, J; Rudan, I; Lawn, JE; Cousens, S; Mathers, C; Black, RE				Liu, Li; Oza, Shefali; Hogan, Daniel; Perin, Jamie; Rudan, Igor; Lawn, Joy E.; Cousens, Simon; Mathers, Colin; Black, Robert E.			Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis	LANCET			English	Article							NEONATAL-MORTALITY; UNDER-5 MORTALITY; INCOME COUNTRIES; NEWBORN BABIES; TIME TRENDS; DEATHS; INTERVENTIONS; PRETERM; HEALTH; PROGRESS	Background Trend data for causes of child death are crucial to inform priorities for improving child survival by and beyond 2015. We report child mortality by cause estimates in 2000-13, and cause-specific mortality scenarios to 2030 and 2035. Methods We estimated the distributions of causes of child mortality separately for neonates and children aged 1-59 months. To generate cause-specific mortality fractions, we included new vital registration and verbal autopsy data. We used vital registration data in countries with adequate registration systems. We applied vital registration-based multicause models for countries with low under-5 mortality but inadequate vital registration, and updated verbal autopsy-based multicause models for high mortality countries. We used updated numbers of child deaths to derive numbers of deaths by causes. We applied two scenarios to derive cause-specific mortality in 2030 and 2035. Findings Of the 6.3 million children who died before age 5 years in 2013, 51.8% (3.257 million) died of infectious causes and 44% (2.761 million) died in the neonatal period. The three leading causes are preterm birth complications (0.965 million [15.4%, uncertainty range (UR) 9.8-24.5]; UR 0.615-1.537 million), pneumonia (0.935 million [14.9%, 13.0-16.8]; 0.817-1.057 million), and intrapartum-related complications (0.662 million [10.5%, 6.7-16.8]; 0.421-1.054 million). Reductions in pneumonia, diarrhoea, and measles collectively were responsible for half of the 3.6 million fewer deaths recorded in 2013 versus 2000. Causes with the slowest progress were congenital, preterm, neonatal sepsis, injury, and other causes. If present trends continue, 4.4 million children younger than 5 years will still die in 2030. Furthermore, sub-Saharan Africa will have 33% of the births and 60% of the deaths in 2030, compared with 25% and 50% in 2013, respectively. Interpretation Our projection results provide concrete examples of how the distribution of child causes of deaths could look in 15-20 years to inform priority setting in the post-2015 era. More evidence is needed about shifts in timing, causes, and places of under-5 deaths to inform child survival agendas by and beyond 2015, to end preventable child deaths in a generation, and to count and account for every newborn and every child.	[Liu, Li; Perin, Jamie; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Oza, Shefali; Lawn, Joy E.; Cousens, Simon] London Sch Hyg & Trop Med, MARCH Ctr, London WC1, England; [Hogan, Daniel; Mathers, Colin] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Rudan, Igor] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Edinburgh	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	rblack1@jhu.edu	Lawn, Joy/ABE-6382-2020; liu, li/HGC-0900-2022; Rudan, Igor/I-1467-2012	Lawn, Joy/0000-0002-4573-1443; Rudan, Igor/0000-0001-6993-6884; Mathers, Colin/0000-0002-0617-6731; Oza, Shefali/0000-0001-5872-486X	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Bill & Melinda Gates Foundation.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; [Anonymous], 2013, MILL DEV GOALS REP 2; [Anonymous], MAL VACC RAINB TABL; Bassat Q, 2013, LANCET GLOB HEALTH, V1, pE125, DOI 10.1016/S2214-109X(13)70037-8; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Bryce J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-225; Child Trends, 2013, FAM LIF DIFF CENTR S; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Debes AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S19; Division of Policy and Strategy UNICEF, 2013, COMM CHILD SURV PROM; Efron B, 2003, STAT SCI, V18, P135, DOI 10.1214/ss/1063994968; El Arifeen S, 2012, LANCET, V379, P1022, DOI 10.1016/S0140-6736(11)61848-5; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Glass RI, 2012, JAMA-J AM MED ASSOC, V308, P141, DOI 10.1001/jama.2012.7357; Grantham-McGregor SM, 2014, ANN NY ACAD SCI, V1308, P11, DOI 10.1111/nyas.12284; Haider BA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub3; Independent Expert Review Group for the Commission on Information and Accountability for Women's and Children's Health, 2013, EV WOM EV CHILD STRE; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Johnson HL, 2010, INT J EPIDEMIOL, V39, P1103, DOI 10.1093/ije/dyq074; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Lake A, 2011, LANCET, V378, P1277, DOI 10.1016/S0140-6736(11)61450-5; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-27; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Population Division of the United Nations Department of Economic and Social Affairs, 2013, WORLD POP PROSP 2012; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Requejo JH, 2014, LANCET; Ronsmans C, 2009, FOOD NUTR BULL, V30, pS547, DOI 10.1177/15648265090304S409; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Soofi S, 2012, LANCET, V379, P1029, DOI 10.1016/S0140-6736(11)61877-1; Sutherland WJ, 2013, NATURE, V503, P167, DOI 10.1038/503167a; Thayyil S, 2013, LANCET, V382, P223, DOI 10.1016/S0140-6736(13)60134-8; The Partnership for Maternal Neonatal and Child Health, PLAC HLTH WOM CHILDR; UNICEF, 2013, AIDS FREE GEN CHILDR; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; West KP, 2013, FASEB J, V27; WHO, 2014, WORLD HLTH ASS CLOS; Wolfe I, 2013, LANCET, V381, P1224, DOI 10.1016/S0140-6736(12)62085-6; World Bank Group WHO, 2014, GLOB CIV REG VIT STA	62	1798	1892	5	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					430	440		10.1016/S0140-6736(14)61698-6	http://dx.doi.org/10.1016/S0140-6736(14)61698-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25280870				2022-12-28	WOS:000348509900030
J	Pickard, JM; Maurice, CF; Kinnebrew, MA; Abt, MC; Schenten, D; Golovkina, TV; Bogatyrev, SR; Ismagilov, RF; Pamer, EG; Turnbaugh, PJ; Chervonsky, AV				Pickard, Joseph M.; Maurice, Corinne F.; Kinnebrew, Melissa A.; Abt, Michael C.; Schenten, Dominik; Golovkina, Tatyana V.; Bogatyrev, Said R.; Ismagilov, Rustem F.; Pamer, Eric G.; Turnbaugh, Peter J.; Chervonsky, Alexander V.			Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness	NATURE			English	Article							CHAIN FATTY-ACIDS; DIFFERENTIAL EXPRESSION; GAS-CHROMATOGRAPHY; ESCHERICHIA-COLI; GENE-EXPRESSION; GUT MICROBIOTA; FUCOSE; MICE; INFECTION; ANOREXIA	Systemic infection induces conserved physiological responses that include both resistance and 'tolerance of infection' mechanisms(1). Temporary anorexia associated with an infection is often beneficial(2,3), reallocating energy from food foraging towards resistance to infection(4) or depriving pathogens of nutrients(5). However, it imposes a stress on intestinal commensals, as they also experience reduced substrate availability; this affects host fitness owing to the loss of caloric intake and colonization resistance (protection from additional infections)(6). We hypothesized that the host might utilize internal resources to support the gut microbiota during the acute phase of the disease. Here we show that systemic exposure to Toll-like receptor (TLR) ligands causes rapid alpha(1,2)-fucosylation of small intestine epithelial cells (IECs) in mice, which requires the sensing of TLR agonists, as well as the production of interleukin(IL)-23 by dendritic cells, activation of innate lymphoid cells and expression of fucosyltransferase 2 (Fut2) by IL-22-stimulated IECs. Fucosylated proteins are shed into the lumen and fucose is liberated and metabolized by the gut microbiota, as shown by reporter bacteria and community-wide analysis of microbial gene expression. Fucose affects the expression of microbial metabolic pathways and reduces the expression of bacterial virulence genes. It also improves host tolerance of the mild pathogen Citrobacter rodentium. Thus, rapid IEC fucosylation appears to be a protective mechanism that utilizes the host's resources to maintain host-microbial interactions during pathogen-induced stress.	[Pickard, Joseph M.; Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Pickard, Joseph M.; Chervonsky, Alexander V.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Maurice, Corinne F.; Turnbaugh, Peter J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Kinnebrew, Melissa A.; Abt, Michael C.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Schenten, Dominik] Univ Arizona, Tucson, AZ 85721 USA; [Golovkina, Tatyana V.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Bogatyrev, Said R.; Ismagilov, Rustem F.] CALTECH, Pasadena, CA 91125 USA	University of Chicago; University of Chicago; Harvard University; Memorial Sloan Kettering Cancer Center; University of Arizona; University of Chicago; California Institute of Technology	Chervonsky, AV (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achervon@bsd.uchicago.edu	Bogatyrev, Said/AAS-2121-2020	Chervonsky, Alexander/0000-0001-7547-871X; Maurice, Corinne/0000-0001-7187-3472; Abt, Michael/0000-0002-7351-2061; Turnbaugh, Peter/0000-0002-0888-2875	National Institutes of Health [P50 GM068763, AI96706, AI42135, T32 AI065382]; Harvard Bauer Fellows Program; National Science Foundation [EFRI-1137089]; Digestive Disease Research Core Center [DK42086]; Kenneth Rainin Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007090, R01AI090084, R01AI095706, R01AI042135, R41AI096706, T32AI065382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Bauer Fellows Program; National Science Foundation(National Science Foundation (NSF)); Digestive Disease Research Core Center; Kenneth Rainin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Reardon and C. Daly for sequencing support, H. Ye for help with metabolic cage analysis, N. F. Dalleska for assistance and use of GC-MS instrumentation in the Environmental Analysis Center at the California Institute of Technology, and G. Nunez for luciferase-expressing C. rodentium. This work was supported by grants from the National Institutes of Health (P50 GM068763 to P.J.T., AI96706 and AI42135 to E. G. P., T32 AI065382 to J.M.P.), the Harvard Bauer Fellows Program, National Science Foundation grant EFRI-1137089 to R. F. I. and A. V. C., Digestive Disease Research Core Center grant DK42086 and a Kenneth Rainin Foundation grant to A.V.C.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BOCCI V, 1969, AM J PHYSIOL, V216, P1337, DOI 10.1152/ajplegacy.1969.216.6.1337; BORONAT A, 1979, J BACTERIOL, V140, P320, DOI 10.1128/JB.140.2.320-326.1979; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARK MA, 1993, J HISTOCHEM CYTOCHEM, V41, P1679, DOI 10.1177/41.11.7691933; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Domino SE, 2001, MOL CELL BIOL, V21, P8336, DOI 10.1128/MCB.21.24.8336-8345.2001; Domino SE, 2001, J BIOL CHEM, V276, P23748, DOI 10.1074/jbc.M100735200; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; FLEMING SE, 1987, LIPIDS, V22, P195, DOI 10.1007/BF02537302; Holmen JM, 2002, GLYCOCONJUGATE J, V19, P67, DOI 10.1023/A:1022589015687; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; MALICK LE, 1975, STAIN TECHNOL, V50, P265, DOI 10.3109/10520297509117069; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Morrow AL, 2011, J PEDIATR-US, V158, P745, DOI 10.1016/j.jpeds.2010.10.043; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakamoto M, 2011, MICROBIOL-SGM, V157, P3388, DOI 10.1099/mic.0.052332-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Tangerman A, 1996, ANAL BIOCHEM, V236, P1, DOI 10.1006/abio.1996.0123; Thomsson KA, 2002, BIOCHEM J, V367, P609, DOI 10.1042/BJ20020371; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; UMESAKI Y, 1981, J BIOCHEM-TOKYO, V90, P559, DOI 10.1093/oxfordjournals.jbchem.a133506; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang ZG, 2010, J BACTERIOL, V192, P2013, DOI 10.1128/JB.01085-09; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580	54	338	350	6	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					638	+		10.1038/nature13823	http://dx.doi.org/10.1038/nature13823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25274297	Green Accepted			2022-12-28	WOS:000343801500051
J	Peake, SL; Delaney, A; Bailey, M; Bellomo, R; Cameron, PA; Cooper, DJ; Higgins, AM; Holdgate, A; Howe, BD; Webb, SAR; Williams, P				Peake, Sandra L.; Delaney, Anthony; Bailey, Michael; Bellomo, Rinaldo; Cameron, Peter A.; Cooper, D. James; Higgins, Alisa M.; Holdgate, Anna; Howe, Belinda D.; Webb, Steven A. R.; Williams, Patricia		ARISE Investigators; ANZICS Clinical Trials Grp	Goal-Directed Resuscitation for Patients with Early Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURVIVING SEPSIS CAMPAIGN; AUSTRALASIAN RESUSCITATION; EVALUATION ARISE; GUIDELINES; THERAPY; CARE; EPIDEMIOLOGY; MULTICENTER; MORTALITY	BACKGROUND Early goal-directed therapy (EGDT) has been endorsed in the guidelines of the Surviving Sepsis Campaign as a key strategy to decrease mortality among patients presenting to the emergency department with septic shock. However, its effectiveness is uncertain. METHODS In this trial conducted at 51 centers (mostly in Australia or New Zealand), we randomly assigned patients presenting to the emergency department with early septic shock to receive either EGDT or usual care. The primary outcome was all-cause mortality within 90 days after randomization. RESULTS Of the 1600 enrolled patients, 796 were assigned to the EGDT group and 804 to the usual-care group. Primary outcome data were available for more than 99% of the patients. Patients in the EGDT group received a larger mean (+/- SD) volume of intravenous fluids in the first 6 hours after randomization than did those in the usual-care group (1964 +/- 1415 ml vs. 1713 +/- 1401 ml) and were more likely to receive vasopressor infusions (66.6% vs. 57.8%), red-cell transfusions (13.6% vs. 7.0%), and dobutamine (15.4% vs. 2.6%) (P<0.001 for all comparisons). At 90 days after randomization, 147 deaths had occurred in the EGDT group and 150 had occurred in the usual-care group, for rates of death of 18.6% and 18.8%, respectively (absolute risk difference with EGDT vs. usual care, -0.3 percentage points; 95% confidence interval, -4.1 to 3.6; P=0.90). There was no significant difference in survival time, in-hospital mortality, duration of organ support, or length of hospital stay. CONCLUSIONS In critically ill patients presenting to the emergency department with early septic shock, EGDT did not reduce all-cause mortality at 90 days. (Funded by the National Health and Medical Research Council of Australia and the Alfred Foundation; ARISE ClinicalTrials.gov number, NCT00975793.)	[Peake, Sandra L.; Delaney, Anthony; Bailey, Michael; Bellomo, Rinaldo; Cooper, D. James; Higgins, Alisa M.; Howe, Belinda D.; Webb, Steven A. R.; Williams, Patricia] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Cameron, Peter A.] Monash Univ, Sch Publ Hlth, Melbourne, Vic 3004, Australia; [Peake, Sandra L.; Williams, Patricia] Univ Adelaide, Adelaide, SA, Australia; [Peake, Sandra L.; Williams, Patricia] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Delaney, Anthony] Royal N Shore Hosp, Sydney, NSW, Australia; [Delaney, Anthony] Univ Sydney, Sydney, NSW 2006, Australia; [Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic 3084, Australia; [Cameron, Peter A.; Cooper, D. James] Alfred Hosp, Melbourne, Vic, Australia; [Holdgate, Anna] Liverpool Hosp, Sydney, NSW, Australia; [Holdgate, Anna] Univ New S Wales, Sydney, NSW, Australia; [Webb, Steven A. R.] Royal Perth Hosp, Perth, WA 6001, Australia; [Webb, Steven A. R.] Univ Western Australia, Perth, WA 6009, Australia; [Cameron, Peter A.] Hamad Med, Doha, Qatar	Monash University; Monash University; University of Adelaide; Royal North Shore Hospital; University of Sydney; University of Sydney; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Liverpool Hospital; University of New South Wales Sydney; Royal Perth Hospital; University of Western Australia; University of Western Australia; Hamad Medical Corporation	Howe, BD (corresponding author), Australian & New Zealand Intens Care Res Ctr, Alfred Ctr, Level 6 Lobby B,99 Commercial Rd, Melbourne, Vic 3004, Australia.	anzicrc@monash.edu	Williams, Patricia/AAH-6571-2019; Lam, Sin Man/ACC-8966-2022; Higgins, Alisa/AAM-8088-2020; Cooper, D. James/G-7961-2013; Delaney, Anthony/AAE-3365-2019; Bailey, Michael J/A-4499-2012; Graham, Colin A/B-4535-2013	Lam, Sin Man/0000-0002-1766-4271; Higgins, Alisa/0000-0001-8295-7559; Cooper, D. James/0000-0002-5872-9051; Bailey, Michael J/0000-0002-5551-1401; Graham, Colin A/0000-0002-4381-7470; Micallef, Sharon/0000-0002-8496-2324; SHEHABI, Yahya/0000-0003-4707-7462; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Cameron, Peter/0000-0002-1443-557X; Furyk, Jeremy/0000-0002-9503-0928; Nichol, Alistair/0000-0002-4689-1238; Emberson, Jonathan/0000-0001-7792-9422; Bellomo, Rinaldo/0000-0002-1650-8939; Delaney, Anthony/0000-0002-1015-7146; Wilkman, Erika/0000-0003-4250-7523	National Health and Medical Research Council of Australia; Alfred Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Alfred Foundation	Funded by the National Health and Medical Research Council of Australia and the Alfred Foundation; ARISE ClinicalTrials.gov number, NCT00975793.	Angus DC, 2004, CRIT CARE MED, V32, P2199, DOI 10.1097/01.CCM.0000145228.62451.F6; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; [Anonymous], CRIT CARE MED; [Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; ARISE, 2007, Crit Care Resusc, V9, P8; Barochia AV, 2010, CRIT CARE MED, V38, P668, DOI 10.1097/CCM.0b013e3181cb0ddf; Bellomo R, 2009, CRIT CARE MED, V37, P3114, DOI 10.1097/CCM.0b013e3181bc7bd5; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Delaney AP, 2013, CRIT CARE RESUSC, V15, P162; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Huang DT, 2013, INTENS CARE MED, V39, P1760, DOI 10.1007/s00134-013-3024-7; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Jawad Issrah, 2012, J Glob Health, V2, P010404, DOI 10.7189/jogh.02.010404; Jones AE, 2007, CHEST, V132, P425, DOI 10.1378/chest.07-0234; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kjaergard LL, 2008, ANN INTERN MED, V149, P219, DOI 10.7326/0003-4819-149-3-200808050-00023; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kortgen A, 2006, CRIT CARE MED, V34, P943, DOI 10.1097/01.CCM.0000206112.32673.D4; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Peake S, 2007, CRIT CARE MED, V35, P994, DOI 10.1097/01.CCM.0000257481.37623.3B; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Perel A, 2008, CRIT CARE, V12, DOI 10.1186/cc6979; Quenot JP, 2013, CRIT CARE, V17, DOI 10.1186/cc12598; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Zhang ZH, 2013, CRIT CARE, V17, DOI 10.1186/cc11919	33	1233	1318	4	97	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1496	1506		10.1056/NEJMoa1404380	http://dx.doi.org/10.1056/NEJMoa1404380			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25272316	Green Published			2022-12-28	WOS:000342994700006
J	Gostin, LO; Reeve, BH; Ashe, M				Gostin, Lawrence O.; Reeve, Belinda H.; Ashe, Marice			The Historic Role of Boards of Health in Local Innovation New York City's Soda Portion Case	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OBESITY		[Gostin, Lawrence O.; Reeve, Belinda H.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Ashe, Marice] ChangeLab Solut, Oakland, CA USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044; Reeve, Belinda/0000-0002-0376-5717				[Anonymous], PROT PUBL HLTH NEW Y; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Gostin LO, 2014, NATURE, V511, P147, DOI 10.1038/511147a; Grynbaum MM, 2012, NY TIMES; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pomeranz JL, 2011, AM J PUBLIC HEALTH, V101, P1192, DOI 10.2105/AJPH.2010.300023	6	11	11	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1511	1512		10.1001/jama.2014.12498	http://dx.doi.org/10.1001/jama.2014.12498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25222190				2022-12-28	WOS:000342983200011
J	Sayer, C; Lee, TH				Sayer, Caroline; Lee, Thomas H.			Time after Time - Health Policy Implications of a Three-Generation Case Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sayer, Caroline] Camden Clin Commissioning Grp, Camden, England; [Lee, Thomas H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Press Ganey Associates, Boston, MA 02115 USA; [Lee, Thomas H.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Sayer, C (corresponding author), Camden Clin Commissioning Grp, Camden, England.								0	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1273	1276		10.1056/NEJMp1407153	http://dx.doi.org/10.1056/NEJMp1407153			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP9VS	25271599				2022-12-28	WOS:000342429800002
J	Hamann, T				Hamann, Thomas			Perovskites take lead in solar hydrogen race	SCIENCE			English	Editorial Material							WATER; PHOTOANODES; CELLS; TIO2		Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Hamann, T (corresponding author), Michigan State Univ, Dept Chem, 578 South Shaw Lane,Room 411, E Lansing, MI 48824 USA.	hamann@chemistry.msu.edu		Hamann, Thomas/0000-0001-6917-7494				Barber J, 2007, PHILOS T R SOC A, V365, P1007, DOI 10.1098/rsta.2006.1962; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Hu S, 2014, SCIENCE, V344, P1005, DOI 10.1126/science.1251428; Hu S, 2013, ENERG ENVIRON SCI, V6, P2984, DOI 10.1039/c3ee40453f; Kenney MJ, 2013, SCIENCE, V342, P836, DOI 10.1126/science.1241327; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Leijtens T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3885; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Luo JS, 2014, SCIENCE, V345, P1593, DOI 10.1126/science.1258307; McKone JR, 2014, CHEM MATER, V26, P407, DOI 10.1021/cm4021518; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816	14	31	31	2	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1566	1567		10.1126/science.1260051	http://dx.doi.org/10.1126/science.1260051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258068				2022-12-28	WOS:000342164500024
J	Baell, J; Walters, MA				Baell, Jonathan; Walters, Michael A.			Chemical con artists foil drug discovery	NATURE			English	Editorial Material							COMPOUND; PAINS		[Baell, Jonathan] Monash Univ, Melbourne, Vic 3004, Australia; [Walters, Michael A.] Univ Minnesota, Minneapolis, MN USA	Monash University; University of Minnesota System; University of Minnesota Twin Cities	Baell, J (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.	jonathan.baell@monash.edu; mwalters@umn.edu	Baell, Jonathan/E-5844-2017	Baell, Jonathan/0000-0003-2114-8242; Walters, Michael/0000-0001-5650-9277				Baell JB, 2013, AUST J CHEM, V66, P1483, DOI 10.1071/CH13551; Baell JB, 2011, DRUG DISCOV TODAY, V16, P840, DOI 10.1016/j.drudis.2011.06.011; Baell JB, 2010, FUTURE MED CHEM, V2, P1529, DOI [10.4155/fmc.10.237, 10.4155/FMC.10.237]; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Dahlin JL, 2014, FUTURE MED CHEM, V6, P1265, DOI [10.4155/FMC.14.60, 10.4155/fmc.14.60]; Hu Y, 2013, AAPS J, V15, P808, DOI 10.1208/s12248-013-9488-0; Ingolfsson HI, 2014, ACS CHEM BIOL, V9, P1788, DOI 10.1021/cb500086e; Priyadarsini KI, 2013, CURR PHARM DESIGN, V19, P2093; Ramesh C, 2010, J MED CHEM, V53, P1004, DOI 10.1021/jm9011802; Voss ME, 2003, BIOORG MED CHEM LETT, V13, P533, DOI 10.1016/S0960-894X(02)00941-1	10	703	708	6	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					481	483		10.1038/513481a	http://dx.doi.org/10.1038/513481a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254460	Bronze			2022-12-28	WOS:000342075800015
J	Helmus, MR; Mahler, DL; Losos, JB				Helmus, Matthew R.; Mahler, D. Luke; Losos, Jonathan B.			Island biogeography of the Anthropocene	NATURE			English	Article							SCALE; MODEL; COMMUNITIES; SPECIATION; EVOLUTION; DYNAMICS; PLANTS; COULD	For centuries, biogeographers have examined the factors that produce patterns of biodiversity across regions. The study of islands has proved particularly fruitful and has led to the theory that geographic area and isolation influence species colonization, extinction and speciation such that larger islands have more species and isolated islands have fewer species (that is, positive species-area and negative species-isolation relationships)(1-4). However, experimental tests of this theory have been limited, owing to the difficulty in experimental manipulation of islands at the scales at which speciation and long-distance colonization are relevant(5). Here we have used the human-aided transport of exotic anole lizards among Caribbean islands as such a test at an appropriate scale. In accord with theory, as anole colonizations have increased, islands impoverished in native species have gained the most exotic species, the past influence of speciation on island biogeography has been obscured, and the species-area relationship has strengthened while the species-isolation relationship has weakened. Moreover, anole biogeography increasingly reflects anthropogenic rather than geographic processes. Unlike the island biogeography of the past that was determined by geographic area and isolation, in the Anthropocene-an epoch proposed for the present time interval-island biogeography is dominated by the economic isolation of-human populations.	[Helmus, Matthew R.] Vrije Univ Amsterdam, Dept Anim Ecol, Amsterdam Global Change Inst, NL-1081 HV Amsterdam, Netherlands; [Mahler, D. Luke] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Vrije Universiteit Amsterdam; University of California System; University of California Davis; Harvard University; Harvard University	Helmus, MR (corresponding author), Vrije Univ Amsterdam, Dept Anim Ecol, Amsterdam Global Change Inst, NL-1081 HV Amsterdam, Netherlands.	mrhelmus@gmail.com	Helmus, Matthew R./C-4998-2015	Helmus, Matthew R./0000-0003-3977-0507	Netherlands Organisation for Scientific Research [858.14.040]; US National Science Foundation [DBI 0906011]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); US National Science Foundation(National Science Foundation (NSF))	We thank J. Behm, J. Ellers, A. Ives, C. Pfister, J. Vermaat and T. Wootton for critical feedback; S. Buckner, S. Charles, A. Fields, M. Lopez Darias, G. Perry, R. Platenberg, R. Powell, G. Reynolds, A. Sanchez, G. van Buurt and G. Wever for information on anole introductions; and A. Reglain for access to the RAC/REMPEITC-Caribe UNEP shipping traffic data set. M. R. H. was supported by the Netherlands Organisation for Scientific Research (858.14.040) and the US National Science Foundation (DBI 0906011).	Bhagwati J., 1988, PROTECTIONISM; Blackburn TM, 2008, GLOBAL ECOL BIOGEOGR, V17, P246, DOI 10.1111/j.1466-8238.2007.00361.x; Essl F, 2012, NATURE, V487, P39, DOI 10.1038/487039b; Gillespie RG, 2008, MOL ECOL, V17, P45, DOI 10.1111/j.1365-294X.2007.03466.x; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Helmus MR, 2012, ECOLOGY, V93, pS31, DOI 10.1890/11-0435.1; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Kessler AGO, 2010, HERPETOL CONSERV BIO, V5, P223; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P1; MAC ARTHUR ROBERT H., 1967; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Moriniere V., 2012, DEV GIS BASED DATABA; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Poe S, 2014, AM NAT, V184, P132, DOI 10.1086/676523; Powell Robert, 2012, Bulletin of the Florida Museum of Natural History, V51, P85; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Rosindell J, 2011, ECOL LETT, V14, P552, DOI 10.1111/j.1461-0248.2011.01617.x; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schoener TW, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P52; SCHOENER TW, 1983, NATURE, V302, P332, DOI 10.1038/302332a0; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; Thomas CD, 2013, NATURE, V502, P7, DOI 10.1038/502007a; Wagner CE, 2014, ECOL LETT, V17, P583, DOI 10.1111/ele.12260; Whittaker RJ, 2000, J BIOGEOGR, V27, P1049, DOI 10.1046/j.1365-2699.2000.00487.x; WILSON EO, 1969, ECOLOGY, V50, P267, DOI 10.2307/1934855	32	157	163	7	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					543	+		10.1038/nature13739	http://dx.doi.org/10.1038/nature13739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25254475				2022-12-28	WOS:000342075800039
J	Downing, CP; Woc-Colburn, L; Tyring, SK				Downing, Christopher P.; Woc-Colburn, Laila; Tyring, Stephen K.			Nasal Erythema and Crusting After a Trip to the Venezuelan Rainforest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CUTANEOUS LEISHMANIASIS; MUCOSAL LEISHMANIASIS; DIAGNOSIS		[Downing, Christopher P.; Tyring, Stephen K.] Ctr Clin Studies, Houston, TX 77030 USA; [Woc-Colburn, Laila] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA; [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Downing, CP (corresponding author), Ctr Clin Studies, Houston, TX 77030 USA.		Woc-Colburn, Laila/U-7357-2019	Woc-Colburn, Laila/0000-0003-2888-7806				Daneshbod Y, 2011, ARCH PATHOL LAB MED, V135, P478, DOI 10.1043/2010-0069-OA.1; MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9; McGwire BS, 2014, QJM-INT J MED, V107, P7, DOI 10.1093/qjmed/hct116; NAVIN TR, 1990, AM J TROP MED HYG, V42, P36, DOI 10.4269/ajtmh.1990.42.36; Oliveira JGS, 2005, ACTA TROP, V94, P55, DOI 10.1016/j.actatropica.2004.12.003; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Rodriguez EM, 2013, EPIDEMICS-NETH, V5, P11, DOI 10.1016/j.epidem.2012.10.002; Scope A, 2003, J AM ACAD DERMATOL, V49, P672, DOI 10.1067/S0190-9622(03)01576-7; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489	9	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1250	1251		10.1001/jama.2014.3610	http://dx.doi.org/10.1001/jama.2014.3610			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25247522				2022-12-28	WOS:000341990600026
J	Doyle, LW; Anderson, PJ; Haslam, R; Lee, KJ; Crowther, C				Doyle, Lex W.; Anderson, Peter J.; Haslam, Ross; Lee, Katherine J.; Crowther, Caroline		Australasian Collaborative Trial	School-age Outcomes of Very Preterm Infants After Antenatal Treatment With Magnesium Sulfate vs Placebo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEEKS GESTATIONAL-AGE; TEST-SCORES; CHILDREN; BIRTH; WEIGHT; HEALTH; BORN; NEUROPROTECTION; QUESTIONNAIRE; RELIABILITY	IMPORTANCE Antenatal magnesium sulfate given to pregnant women at imminent risk of very preterm delivery reduces the risk of cerebral palsy in early childhood, although its effects into school age have not been reported from randomized trials. OBJECTIVE To determine the association between exposure to antenatal magnesium sulfate and neurological, cognitive, academic, and behavioral outcomes at school age. DESIGN, SETTING, AND PARTICIPANTS The ACTOMgSO4 was a randomized clinical trial conducted in 16 centers in Australia and New Zealand, comparing magnesium sulfate with placebo given to pregnant women (n = 535 magnesium; n = 527 placebo) for whom imminent birth was planned or expected before 30 weeks' gestation. Children who survived from the 14 centers who participated in the school-age follow-up (n = 443 magnesium; n = 424 placebo) were invited for an assessment at 6 to 11 years of age between 2005 and 2011. MAIN OUTCOMES AND MEASURES Mortality, cerebral palsy, motor function, IQ, basic academic skills, attention and executive function, behavior, growth, and functional outcomes. Main analyses were imputed for missing data. RESULTS There were 1255 fetuses known to be alive at randomization. Of 867 survivors available for follow-up, outcomes at school age (corrected age 6-11 years) were determined for 669 (77%). There was little difference between groups on any of the cognitive, behavioral, growth, or functional outcomes. [GRAPHICS] CONCLUSIONS AND RELEVANCE Magnesium sulfate given to pregnant women at imminent risk of birth before 30 weeks' gestation was not associated with neurological, cognitive, behavioral, growth, or functional outcomes in their children at school age, although a mortality advantage cannot be excluded. The lack of long-term benefit requires confirmation in additional studies. Copyright 2014 American Medical Association. All rights reserved.	[Doyle, Lex W.; Anderson, Peter J.] Univ Melbourne, Dept Obstet, Melbourne, Vic, Australia; [Doyle, Lex W.; Anderson, Peter J.] Univ Melbourne, Dept Gynaecol, Melbourne, Vic, Australia; [Doyle, Lex W.; Anderson, Peter J.; Lee, Katherine J.] Univ Melbourne, Melbourne, Vic, Australia; [Doyle, Lex W.] Royal Womens Hosp, Melbourne, Vic, Australia; [Doyle, Lex W.; Anderson, Peter J.; Lee, Katherine J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Haslam, Ross] Womens & Childrens Hosp, Adelaide, SA, Australia; [Haslam, Ross] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Crowther, Caroline] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Crowther, Caroline] Univ Adelaide, Robinson Res Inst, Australian Res Ctr forWomen & Babies, Adelaide, SA, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Womens & Childrens Hospital Australia; University of Adelaide; University of Auckland; Robinson Research Institute; University of Adelaide	Doyle, LW (corresponding author), Royal Womens Hosp, Seventh Floor,20 Flemington Rd, Parkville, Vic 3052, Australia.	lwd@unimelb.edu.au	Anderson, Peter John/O-5302-2019; Doyle, Lex/AAJ-5205-2021; Colditz, Paul B/F-6772-2010; Anderson, Peter J/B-6839-2015; McKinlay, Christopher JD/E-6263-2018; Lee, Katherine J/A-2519-2016; Pritchard, Margo A/G-5188-2010; Harding, Jane E/J-5853-2015	Anderson, Peter John/0000-0001-7430-868X; Doyle, Lex/0000-0002-7667-7312; Colditz, Paul B/0000-0002-6408-8238; Anderson, Peter J/0000-0001-7430-868X; McKinlay, Christopher JD/0000-0003-1088-9467; Pritchard, Margo A/0000-0002-1058-9117; Harding, Jane E/0000-0003-2697-1422	National Health and Medical Research Council Australia [350326]; Victorian Government	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This study was funded by a project grant (350326) from the National Health and Medical Research Council Australia and the Victorian Government's Operational Infrastructure Support Program.	Anderson PJ, 2011, DEV NEUROPSYCHOL, V36, P57, DOI 10.1080/87565641.2011.540538; Bayley N, 1993, BAYLEY SCALES INFANT; Callanan C, 2001, J PAEDIATR CHILD H, V37, P152, DOI 10.1046/j.1440-1754.2001.00621.x; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Conners C.K., 1997, CONNERS TEACHER RATI; Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; Crowther CA, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001060; Crowther CA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-239; Doyle LW, 2010, J PEDIATR-US, V156, P49, DOI 10.1016/j.jpeds.2009.07.013; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Henderson SE SD, 1988, MOVEMENT ASSESSMENT; Magee L, 2011, J OBSTET GYNAECOL CA, V33, P516, DOI 10.1016/S1701-2163(16)34886-1; Manly T., 1999, TEST EVERYDAY ATTENT; Marret S, 2007, SEMIN FETAL NEONAT M, V12, P311, DOI 10.1016/j.siny.2007.04.001; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; NELSON KB, 1995, PEDIATRICS, V95, P263; Osterrieth P, 1993, CLIN NEUROPSYCHOL, V7, P3; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Rey A, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI DOI 10.1080/13854049308401883; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RICKARDS AL, 1989, AUST PAEDIATR J, V25, P127; Roberts G, 2010, ARCH DIS CHILD-FETAL, V95, pF90, DOI 10.1136/adc.2009.165480; Roberts G, 2009, J PEDIATR-US, V154, P829, DOI 10.1016/j.jpeds.2008.12.036; SAIGAL S, 1994, J PEDIATR-US, V125, P411, DOI 10.1016/S0022-3476(05)83288-3; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Waters E, 2000, AUST NZ J PUBL HEAL, V24, P207, DOI 10.1111/j.1467-842X.2000.tb00145.x; Wechsler D, 2003, WISC 4 ADM SCORING M; Wilkinson G.S., 1993, WRAT 3 WIDE RANGE AC; Wilson-Ching M, 2014, J PAEDIATR CHILD H, V50, P182, DOI 10.1111/jpc.12475	34	57	60	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1105	1113		10.1001/jama.2014.11189	http://dx.doi.org/10.1001/jama.2014.11189			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226476	Bronze			2022-12-28	WOS:000341624700020
J	Larkin, J; Ascierto, PA; Dreno, B; Atkinson, V; Liszkay, G; Maio, M; Mandala, M; Demidov, L; Stroyakovskiy, D; Thomas, L; de la Cruz-Merino, L; Dutriaux, C; Garbe, C; Sovak, MA; Chang, I; Choong, N; Hack, SP; McArthur, GA; Ribas, A				Larkin, James; Ascierto, Paolo A.; Dreno, Brigitte; Atkinson, Victoria; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Dutriaux, Caroline; Garbe, Claus; Sovak, Mika A.; Chang, Ilsung; Choong, Nicholas; Hack, Stephen P.; McArthur, Grant A.; Ribas, Antoni			Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC MELANOMA; IMPROVED SURVIVAL; MEK INHIBITION; RAS MUTATIONS; OPEN-LABEL; RESISTANCE; CANCER; SAFETY; MULTICENTER; ANTI-PD-1	BACKGROUND The combined inhibition of BRAF and MEK is hypothesized to improve clinical outcomes in patients with melanoma by preventing or delaying the onset of resistance observed with BRAF inhibitors alone. This randomized phase 3 study evaluated the combination of the BRAF inhibitor vemurafenib and the MEK inhibitor cobimetinib. METHODS We randomly assigned 495 patients with previously untreated unresectable locally advanced or metastatic BRAF V600 mutation-positive melanoma to receive vemurafenib and cobimetinib (combination group) or vemurafenib and placebo (control group). The primary end point was investigator-assessed progression-free survival. RESULTS The median progression-free survival was 9.9 months in the combination group and 6.2 months in the control group (hazard ratio for death or disease progression, 0.51; 95% confidence interval [CI], 0.39 to 0.68; P<0.001). The rate of complete or partial response in the combination group was 68%, as compared with 45% in the control group (P<0.001), including rates of complete response of 10% in the combination group and 4% in the control group. Progression-free survival as assessed by independent review was similar to investigator-assessed progression-free survival. Interim analyses of overall survival showed 9-month survival rates of 81% (95% CI, 75 to 87) in the combination group and 73% (95% CI, 65 to 80) in the control group. Vemurafenib and cobimetinib was associated with a nonsignificantly higher incidence of adverse events of grade 3 or higher, as compared with vemurafenib and placebo (65% vs. 59%), and there was no significant difference in the rate of study-drug discontinuation. The number of secondary cutaneous cancers decreased with the combination therapy. CONCLUSIONS The addition of cobimetinib to vemurafenib was associated with a significant improvement in progression-free survival among patients with BRAF V600-mutated metastatic melanoma, at the cost of some increase in toxicity.	[Larkin, James] Royal Marsden Hosp, London, England; [Ascierto, Paolo A.] Fdn G Pascale, Ist Nazl Tumori, Naples, Italy; [Maio, Michele] Azienda Osped Univ Senese, Siena, Italy; [Mandala, Mario] Papa Giovanni XXIII Hosp, Bergamo, Italy; [Dreno, Brigitte] Hotel Dieu Pl Alexis Ricordeau, Nantes, France; [Thomas, Luc] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France; [Dutriaux, Caroline] Hop St Andre, Bordeaux, France; [Atkinson, Victoria] Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [McArthur, Grant A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Liszkay, Gabriella] Natl Inst Oncol, Budapest, Hungary; [Demidov, Lev] NN Blokhin Russian Canc Res Ctr, Moscow, Russia; [Stroyakovskiy, Daniil] Moscow City Oncol Hosp 62, Krasnogorsk, Russia; [de la Cruz-Merino, Luis] Hosp Univ Virgen Macarena, Seville, Spain; [Garbe, Claus] Univ Tubingen, Tubingen, Germany; [Sovak, Mika A.; Chang, Ilsung; Choong, Nicholas; Hack, Stephen P.] Genentech Inc, San Francisco, CA 94080 USA; [Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	Royal Marsden NHS Foundation Trust; IRCCS Fondazione Pascale; University of Siena; University Hospital of Siena; ASST Papa Giovanni XXIII; Nantes Universite; CHU de Nantes; CHU Lyon; CHU Bordeaux; Peter Maccallum Cancer Center; National Institute of Oncology Hungary; N.N. Blokhin Russian Cancer Research Center; Hospital Universitario Virgen Macarena; Eberhard Karls University of Tubingen; Roche Holding; Genentech; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Ribas, A (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Jonsson Comprehens Canc Ctr, 11-934 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	aribas@mednet.ucla.edu	Ascierto, Paolo A/J-9106-2016; Atkinson, Victoria G/G-2507-2015; de la Cruz-Merino, Luis/K-8633-2017; Garbe, Claus/ABH-2128-2021; mandala, mario/AAB-8637-2022; Mandala', Mario/AAA-4258-2019	Ascierto, Paolo A/0000-0002-8322-475X; de la Cruz-Merino, Luis/0000-0002-5333-0535; Garbe, Claus/0000-0001-8530-780X; Maio, Michele/0000-0002-0323-6321; coral, sandra/0000-0002-1308-3082; McArthur, Grant/0000-0001-8908-6071; Stroyakovskiy, Daniil/0000-0003-1973-1092; Melucci, Maria Teresa/0000-0002-1677-3345; Larkin, James/0000-0001-5569-9523; Thomas, Luc/0000-0003-1995-2434	F. Hoffmann-La Roche/Genentech	F. Hoffmann-La Roche/Genentech(Hoffmann-La RocheRoche HoldingGenentech)	Supported by F. Hoffmann-La Roche/Genentech. Cobimetinib is being developed by F. Hoffmann-La Roche/Genentech, under a collaboration with Exelixis.	Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Larkin J, 2014, LANCET ONCOL, V15, P436, DOI 10.1016/S1470-2045(14)70051-8; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; McCannel TA, 2014, JAMA OPHTHALMOL, V132, P1005, DOI 10.1001/jamaophthalmol.2014.976; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; SCHOUTEN HJA, 1980, BIOMETR J, V22, P241; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shi HB, 2014, CANCER DISCOV, V4, P69, DOI 10.1158/2159-8290.CD-13-0279; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Urner-Bloch U, 2014, ANN ONCOL, V25, P1437, DOI 10.1093/annonc/mdu169; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	26	1371	1409	3	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1867	1876		10.1056/NEJMoa1408868	http://dx.doi.org/10.1056/NEJMoa1408868			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25265494	Green Published			2022-12-28	WOS:000344709800004
J	Doty, MM; Blumenthal, D; Collins, SR				Doty, Michelle M.; Blumenthal, David; Collins, Sara R.			The Affordable Care Act and Health Insurance for Latinos	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Doty, Michelle M.; Blumenthal, David; Collins, Sara R.] Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Doty, MM (corresponding author), Commonwealth Fund, 1 E 75th St, New York, NY 10021 USA.	mmd@cmwf.org						[Anonymous], 2013, RANK LAT POP STAT; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Collins SR, 2014, NEW FEDERAL SURVEYS; Doty M M R P, 2014, CATCHING COVERAGE OP; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275	5	20	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1735	1736		10.1001/jama.2014.13841	http://dx.doi.org/10.1001/jama.2014.13841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25255294				2022-12-28	WOS:000344194500007
J	Zoungas, S; Chalmers, J; Neal, B; Billot, L; Li, Q; Hirakawa, Y; Arima, H; Monaghan, H; Joshi, R; Colagiuri, S; Cooper, ME; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Lisheng, L; Mancia, G; Marre, M; Matthews, DR; Mogensen, CE; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; MacMahon, S; Patel, A; Woodward, M				Zoungas, S.; Chalmers, J.; Neal, B.; Billot, L.; Li, Q.; Hirakawa, Y.; Arima, H.; Monaghan, H.; Joshi, R.; Colagiuri, S.; Cooper, M. E.; Glasziou, P.; Grobbee, D.; Hamet, P.; Harrap, S.; Heller, S.; Lisheng, L.; Mancia, G.; Marre, M.; Matthews, D. R.; Mogensen, C. E.; Perkovic, V.; Poulter, N.; Rodgers, A.; Williams, B.; MacMahon, S.; Patel, A.; Woodward, M.		ADV-On Collaborative Grp	Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOMES; END; DISEASE; TRIALS	BACKGROUND In the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) factorial trial, the combination of perindopril and indapamide reduced mortality among patients with type 2 diabetes, but intensive glucose control, targeting a glycated hemoglobin level of less than 6.5%, did not. We now report results of the 6-year post-trial follow-up. METHODS We invited surviving participants, who had previously been assigned to perindopril-indapamide or placebo and to intensive or standard glucose control (with the glucose-control comparison extending for an additional 6 months), to participate in a post-trial follow-up evaluation. The primary end points were death from any cause and major macrovascular events. RESULTS The baseline characteristics were similar among the 11,140 patients who originally underwent randomization and the 8494 patients who participated in the post-trial follow-up for a median of 5.9 years (blood-pressure-lowering comparison) or 5.4 years (glucose-control comparison). Between-group differences in blood pressure and glycated hemoglobin levels during the trial were no longer evident by the first post-trial visit. The reductions in the risk of death from any cause and of death from cardiovascular causes that had been observed in the group receiving active blood-pressure-lowering treatment during the trial were attenuated but significant at the end of the post-trial follow-up; the hazard ratios were 0.91 (95% confidence interval [CI], 0.84 to 0.99; P = 0.03) and 0.88 (95% CI, 0.77 to 0.99; P = 0.04), respectively. No differences were observed during follow-up in the risk of death from any cause or major macrovascular events between the intensive-glucose-control group and the standard-glucose-control group; the hazard ratios were 1.00 (95% CI, 0.92 to 1.08) and 1.00 (95% CI, 0.92 to 1.08), respectively. CONCLUSIONS The benefits with respect to mortality that had been observed among patients originally assigned to blood-pressure-lowering therapy were attenuated but still evident at the end of follow-up. There was no evidence that intensive glucose control during the trial led to long-term benefits with respect to mortality or macrovascular events.	[Zoungas, S.; Chalmers, J.; Neal, B.; Billot, L.; Li, Q.; Hirakawa, Y.; Arima, H.; Monaghan, H.; Joshi, R.; Perkovic, V.; Rodgers, A.; MacMahon, S.; Patel, A.; Woodward, M.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Colagiuri, S.] Univ Sydney, Boden Inst, Sydney, NSW 2006, Australia; [Zoungas, S.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Cooper, M. E.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Harrap, S.] Univ Melbourne, Melbourne, Vic, Australia; [Harrap, S.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Glasziou, P.] Bond Univ, Robina, Qld, Australia; [Grobbee, D.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Grobbee, D.] Julius Clin Res, Utrecht, Netherlands; [Hamet, P.] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada; [Heller, S.] Univ Sheffield, Sheffield, S Yorkshire, England; [Heller, S.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Matthews, D. R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [MacMahon, S.; Woodward, M.] Univ Oxford, George Inst Global Hlth, Oxford, England; [Poulter, N.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Williams, B.] UCL, London, England; [Williams, B.] UCL Hosp Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Lisheng, L.] Chinese Hypertens League Inst, Beijing, Peoples R China; [Mancia, G.] Univ Milano Bicocca, Milan, Italy; [Mancia, G.] Ist Auxol Italiano, Milan, Italy; [Marre, M.] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Marre, M.] Univ Paris 07, Paris, France; [Mogensen, C. E.] Aarhus Sygehus, Med Dept M, Aarhus, Denmark; [Woodward, M.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	George Institute for Global Health; University of Sydney; University of Sydney; Monash University; Baker Heart and Diabetes Institute; University of Melbourne; Royal Melbourne Hospital; Bond University; Utrecht University; Utrecht University Medical Center; Universite de Montreal; University of Sheffield; University of Sheffield; University of Oxford; University of Oxford; Imperial College London; University of London; University College London; University of London; University College London; Chinese Hypertension League; University of Milano-Bicocca; IRCCS Istituto Auxologico Italiano; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Aarhus University; Johns Hopkins University	Zoungas, S (corresponding author), George Inst Global Hlth, POB M201,Missenden Rd, Camperdown, NSW 2050, Australia.		Stanton, Alice V/F-4697-2012; Glasziou, Paul/A-7832-2008; Perkovic, Vlado/AAY-1933-2021; Prabhakaran, Dorairaj/B-4147-2011; Sviryaev, Yurii/ABF-9859-2020; Saravanan, P/M-6142-2016; Woodward, Mark/D-8492-2015; Woodward, Mark/L-6817-2017; Billot, Laurent/Y-1241-2019; Cooper, Mark/AAC-5326-2020; Nolan, Christopher J/B-2026-2008; McManus, Ruth/G-3938-2011	Glasziou, Paul/0000-0001-7564-073X; Prabhakaran, Dorairaj/0000-0002-3172-834X; Sviryaev, Yurii/0000-0002-3170-0451; Saravanan, P/0000-0002-9566-2626; Billot, Laurent/0000-0002-4975-9793; Nolan, Christopher J/0000-0002-6964-3819; Joshi, Rohina/0000-0002-3374-401X; MacMahon, Stephen/0000-0003-2064-7699; Marre, Michel/0000-0002-3071-1837; Neal, Bruce/0000-0002-0490-7465; Zoungas, Sophia/0000-0003-2672-0949; Williams, Bryan/0000-0002-8094-1841; Rodgers, Anthony/0000-0003-1282-1896; Colagiuri, Stephen/0000-0002-2398-4781; Bompoint, Severine/0000-0001-5226-4321; Patel, Anushka/0000-0003-3825-4092; Harrap, Stephen/0000-0003-2907-6714; Monaghan, Helen/0000-0001-5369-178X; Perkovic, Vlado/0000-0002-4257-7620; Heller, Simon/0000-0002-2425-9565; Stanton, Alice/0000-0002-4961-165X; Li, Qiang/0000-0002-4384-8226; Chalmers, John/0000-0002-9931-0580; Woodward, Mark/0000-0001-9800-5296	National Health and Medical Research Council of Australia; MRC [MC_PC_13090] Funding Source: UKRI; British Heart Foundation [SP/10/6/28562] Funding Source: researchfish; Medical Research Council [MC_PC_13090] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10248] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Health and Medical Research Council of Australia and others; ADVANCE-ON ClinicalTrials.gov number, NCT00949286.)	Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Beckett N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7541; Brouwers FP, 2011, AM HEART J, V161, P1171, DOI 10.1016/j.ahj.2011.03.028; Chalmers J, 2001, DIABETOLOGIA, V44, P1118; Hata J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055807; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Kostis WJ, 2014, AM J CARDIOL, V113, P676, DOI 10.1016/j.amjcard.2013.11.013; Kostis WJ, 2010, HYPERTENSION, V56, P1060, DOI 10.1161/HYPERTENSIONAHA.110.160291; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6	14	393	427	3	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1392	1406		10.1056/NEJMoa1407963	http://dx.doi.org/10.1056/NEJMoa1407963			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25234206	Green Published			2022-12-28	WOS:000342674800008
J	Savitski, MM; Reinhard, FBM; Franken, H; Werner, T; Savitski, MF; Eberhard, D; Molina, DM; Jafari, R; Dovega, RB; Klaeger, S; Kuster, B; Nordlund, P; Bantscheff, M; Drewes, G				Savitski, Mikhail M.; Reinhard, Friedrich B. M.; Franken, Holger; Werner, Thilo; Savitski, Maria Faelth; Eberhard, Dirk; Molina, Daniel Martinez; Jafari, Rozbeh; Dovega, Rebecca Bakszt; Klaeger, Susan; Kuster, Bernhard; Nordlund, Paer; Bantscheff, Marcus; Drewes, Gerard			Tracking cancer drugs in living cells by thermal profiling of the proteome	SCIENCE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; KINASE INHIBITORS; TARGET ENGAGEMENT; SYSTEMS; KINOME; QUANTIFICATION; IDENTIFICATION; IMATINIB; PHOTOSENSITIVITY; RESISTANCE	The thermal stability of proteins can be used to assess ligand binding in living cells. We have generalized this concept by determining the thermal profiles of more than 7000 proteins in human cells by means of mass spectrometry. Monitoring the effects of small-molecule ligands on the profiles delineated more than 50 targets for the kinase inhibitor staurosporine. We identified the heme biosynthesis enzyme ferrochelatase as a target of kinase inhibitors and suggest that its inhibition causes the phototoxicity observed with vemurafenib and alectinib. Thermal shifts were also observed for downstream effectors of drug treatment. In live cells, dasatinib induced shifts in BCR-ABL pathway proteins, including CRK/CRKL. Thermal proteome profiling provides an unbiasedmeasure of drug-target engagement and facilitates identification of markers for drug efficacy and toxicity.	[Savitski, Mikhail M.; Reinhard, Friedrich B. M.; Franken, Holger; Werner, Thilo; Savitski, Maria Faelth; Eberhard, Dirk; Bantscheff, Marcus; Drewes, Gerard] GlaxoSmithKline, Mol Discovery Res, Cellzome GmbH, Heidelberg, Germany; [Molina, Daniel Martinez; Jafari, Rozbeh; Dovega, Rebecca Bakszt; Nordlund, Paer] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, Stockholm, Sweden; [Klaeger, Susan; Kuster, Bernhard] Tech Univ Munich, Dept Prote & Bioanalyt, Freising Weihenstephan, Germany; [Klaeger, Susan; Kuster, Bernhard] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Nordlund, Paer] Nanyang Technol Univ, Ctr Biomed Struct Biol, Singapore 639798, Singapore	GlaxoSmithKline; Cellzome GmbH; Karolinska Institutet; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Savitski, MM (corresponding author), GlaxoSmithKline, Mol Discovery Res, Cellzome GmbH, Meyerhofstr 1, Heidelberg, Germany.	mikhail.m.savitski@gsk.com; marcus.x.bantscheff@gsk.com; gerard.c.drewes@gsk.com	Bantscheff, Marcus/AAQ-2903-2021; Kuster, Bernhard/Q-6031-2016	Bantscheff, Marcus/0000-0002-8343-8977; Kuster, Bernhard/0000-0002-9094-1677; Klaeger, Susan/0000-0002-0074-5163; Reinhard, Friedrich/0000-0002-9164-6127; Drewes, Gerard/0000-0003-0575-6766; Jafari, Rozbeh/0000-0002-3396-4709	Karolinska Institute (DPA); Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden)	Karolinska Institute (DPA); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society)	We thank D. Thomson for the synthesis of GSK3182571; J. Stuhlfauth for cell culture; M. Jundt, K. Kammerer, M. Klos-Hudak, M. Paulmann, I. Togel, and T. Rudi for expert technical assistance; and F. Weisbrodt for help with the figures. We are grateful to M. Hann and G. Neubauer for discussions and support. P.N. acknowledges funding from Karolinska Institute (DPA), the Swedish Research Council (Vetenskapsradet), and the Swedish Cancer Society (Cancerfonden). M. M. S., F. B. M. R., M. B., P.N., and G. D. conceived the project; M. M. S., F. B. M. R., T. W., D. E., D. M. M., R.J, M. B., and G. D. designed the experiments; F. B. M. R., T. W., D. E., R. B. D., R.J., and D. M. M. conducted and supervised experiments; M. M. S., F. B. M. R., H. F., T. W., M. F. S., and M. B. analyzed proteomics data; M. M. S., F. B. M. R., S. K., B. K., M. B., and P.N. contributed to the manuscript; and G. D. wrote the manuscript. P.N. and D. M. M. are cofounders and shareholders of Pelago Bioscience. B. K. is a cofounder and shareholder of OmicScouts GmbH. P.N. is the inventor of a patent (approved in the UK and pending in other districts) controlled by Pelago Biosciences AB and Evitra Proteoma AB covering the basic CETSA method. R. H. and D. M. also have associations to Pelago Bioscience AB. Mass spectrometry data are available for download at ProteomicsDB (www.proteomicsdb.org; data set identifier PRDB004185).	Asial I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3901; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Becher I, 2013, ACS CHEM BIOL, V8, P599, DOI 10.1021/cb3005879; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dailey HA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011676; Deguchi Y, 2008, LEUKEMIA RES, V32, P980, DOI 10.1016/j.leukres.2007.11.008; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Ebbinghaus S, 2010, NAT METHODS, V7, P319, DOI [10.1038/NMETH.1435, 10.1038/nmeth.1435]; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fraser JA, 2010, J BIOL CHEM, V285, P37773, DOI 10.1074/jbc.M110.143107; Frei AP, 2012, NAT BIOTECHNOL, V30, P997, DOI 10.1038/nbt.2354; Gelot Pauline, 2013, Exp Dermatol, V22, P297, DOI 10.1111/exd.12119; Hamilton A, 2006, LEUKEMIA, V20, P1035, DOI 10.1038/sj.leu.2404189; Kruse U, 2011, LEUKEMIA, V25, P89, DOI 10.1038/leu.2010.233; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; ODA T, 1994, J BIOL CHEM, V269, P22925; Ou S., 2013, PAPER PRESENTED AT T; PACE CN, 1980, J BIOL CHEM, V255, P3862; Perez CA, 2014, LUNG CANCER, V84, P110, DOI 10.1016/j.lungcan.2014.02.001; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Savitski MM, 2011, ANAL CHEM, V83, P8959, DOI 10.1021/ac201760x; Savitski MM, 2010, J AM SOC MASS SPECTR, V21, P1668, DOI 10.1016/j.jasms.2010.01.012; SCHELLMAN JA, 1994, BIOPOLYMERS, V34, P1015, DOI 10.1002/bip.360340805; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wahlin S, 2010, J INVEST DERMATOL, V130, P631, DOI 10.1038/jid.2009.246; Werner T, 2014, ANAL CHEM, V86, P3594, DOI 10.1021/ac500140s; Werner T, 2012, ANAL CHEM, V84, P7188, DOI 10.1021/ac301553x; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Winter GE, 2012, NAT CHEM BIOL, V8, P905, DOI [10.1038/NCHEMBIO.1085, 10.1038/nchembio.1085]; Zhang LX, 2013, J PROTEOME RES, V12, P3104, DOI 10.1021/pr3008495; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	42	534	558	28	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					55	+	1255784	10.1126/science.1255784	http://dx.doi.org/10.1126/science.1255784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278616				2022-12-28	WOS:000342446900047
J	Fraser, B				Fraser, Barbara			EXTREME LIVING	NATURE			English	News Item							ADAPTATIONS; AMERICA											Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2012, QUATERNARY RES, V77, P418, DOI 10.1016/j.yqres.2012.02.003; Flegenheimer N, 2003, QUATERN INT, V109, P49, DOI 10.1016/S1040-6182(02)00202-1; Mendez Cesar, 2010, CURRENT RES PLEISTOC, V27, P19; Rademaker K, 2013, GEOLOGY, V41, P779, DOI 10.1130/G34313.1; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; 2012, NATURE, V485, P30	7	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					24	26		10.1038/514024a	http://dx.doi.org/10.1038/514024a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279901	Bronze			2022-12-28	WOS:000342420800016
J	Symington, LS				Symington, Lorraine S.			DNA REPAIR Making the cut	NATURE			English	Editorial Material							DOUBLE-STRAND BREAKS; END-RESECTION; SACCHAROMYCES-CEREVISIAE; ENDONUCLEASE; MRE11; SAE2; EXO1; MRE11-RAD50-XRS2; RECOMBINATION; STIMULATION		Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University	Symington, LS (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	lss5@columbia.edu						ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Makharashvili N, 2014, MOL CELL, V54, P1022, DOI 10.1016/j.molcel.2014.04.011; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Wang HL, 2014, MOL CELL, V54, P1012, DOI 10.1016/j.molcel.2014.04.012; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	15	9	10	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					39	40		10.1038/nature13751	http://dx.doi.org/10.1038/nature13751			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25231858				2022-12-28	WOS:000342420800027
J	Liu, F; Beames, JM; Petit, AS; McCoy, AB; Lester, MI				Liu, Fang; Beames, Joseph M.; Petit, Andrew S.; McCoy, Anne B.; Lester, Marsha I.			Infrared-driven unimolecular reaction of CH3CHOO Criegee intermediates to OH radical products	SCIENCE			English	Article							TORCH CAMPAIGN; TROPOSPHERE; OZONOLYSIS; CHEMISTRY	Ozonolysis of alkenes, an important nonphotolytic source of hydroxyl (OH) radicals in the troposphere, proceeds through energized Criegee intermediates that undergo unimolecular decay to produce OH radicals. Here, we used infrared (IR) activation of cold CH3CHOO Criegee intermediates to drive hydrogen transfer from the methyl group to the terminal oxygen, followed by dissociation to OH radicals. State-selective excitation of CH3CHOO in the CH stretch overtone region combined with sensitive OH detection revealed the IR spectrum of CH3CHOO, effective barrier height for the critical hydrogen transfer step, and rapid decay dynamics to OH products. Complementary theory provides insights on the IR overtone spectrum, as well as vibrational excitations, structural changes, and energy required to move from the minimum-energy configuration of CH3CHOO to the transition state for the hydrogen transfer reaction.	[Liu, Fang; Beames, Joseph M.; Petit, Andrew S.; Lester, Marsha I.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [McCoy, Anne B.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University of Pennsylvania; University System of Ohio; Ohio State University	Lester, MI (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	milester@sas.upenn.edu	Liu, Fang/I-2216-2015	Liu, Fang/0000-0002-1467-8328	NSF [CHE-1112016, CHE-1362835, CHE-1213347]; Dreyfus Postdoctoral Program in Environmental Chemistry [EP-12-025]; American Chemical Society Petroleum Research Fund [ACS PRF 53320-ND6]; U.S. Air Force Office of Scientific Research (USAFOSR) PECASE award under AFOSR [FA9950-13-1-0157]; Division Of Chemistry [1362835] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Dreyfus Postdoctoral Program in Environmental Chemistry; American Chemical Society Petroleum Research Fund(American Chemical Society); U.S. Air Force Office of Scientific Research (USAFOSR) PECASE award under AFOSR; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Additional details of the experiments and calculations are presented in the supplementary materials. This research was supported, in part, through NSF grants CHE-1112016 (M. I. L.), CHE-1362835 (M. I. L.), and CHE-1213347 (A. B. M.). J.M.B. acknowledges support through the Dreyfus Postdoctoral Program in Environmental Chemistry (EP-12-025). Acknowledgment is made to the Donors of the American Chemical Society Petroleum Research Fund for partial support of this research (ACS PRF 53320-ND6). A. S. P. acknowledges support from the U.S. Air Force Office of Scientific Research (USAFOSR) PECASE award under AFOSR grant FA9950-13-1-0157.	Anglada JM, 1996, J AM CHEM SOC, V118, P4636, DOI 10.1021/ja953858a; Beames JM, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4810865; Donahue NM, 2011, PHYS CHEM CHEM PHYS, V13, P10848, DOI 10.1039/c0cp02564j; Emmerson KM, 2007, ATMOS CHEM PHYS, V7, P167, DOI 10.5194/acp-7-167-2007; Emmerson KM, 2009, ATMOS ENVIRON, V43, P3220, DOI 10.1016/j.atmosenv.2009.03.042; Fenske JD, 2000, J PHYS CHEM A, V104, P7821, DOI 10.1021/jp001100u; Harrison RM, 2006, SCI TOTAL ENVIRON, V360, P5, DOI 10.1016/j.scitotenv.2005.08.053; Hasson AS, 2003, J PHYS CHEM A, V107, P6176, DOI 10.1021/jp0346007; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Kuwata KT, 2010, J PHYS CHEM A, V114, P9192, DOI 10.1021/jp105358v; Liu F, 2014, J PHYS CHEM A, V118, P2298, DOI 10.1021/jp412726z; Nakajima M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4861494; Novelli A, 2014, PHYS CHEM CHEM PHYS, V16, P19941, DOI 10.1039/c4cp02719a; Pitts Jr J. N., 2000, CHEM UPPER LOWER ATM; Stone D, 2012, CHEM SOC REV, V41, P6348, DOI 10.1039/c2cs35140d; Taatjes CA, 2013, SCIENCE, V340, P177, DOI 10.1126/science.1234689; Vereecken L, 2012, CHEM SOC REV, V41, P6259, DOI 10.1039/c2cs35070j	17	107	108	7	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1596	1598		10.1126/science.1257158	http://dx.doi.org/10.1126/science.1257158			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258077				2022-12-28	WOS:000342164500041
J	Pasciuto, E; Bagni, C				Pasciuto, Emanuela; Bagni, Claudia			SnapShot: FMRP Interacting Proteins	CELL			English	Editorial Material							TRANSLATION; RNA		[Pasciuto, Emanuela; Bagni, Claudia] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Pasciuto, Emanuela; Bagni, Claudia] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Pasciuto, Emanuela; Bagni, Claudia] Katholieke Univ Leuven, Leuven Inst Neurodegenerat Dis, B-3000 Louvain, Belgium; [Bagni, Claudia] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Rome Tor Vergata	Pasciuto, E (corresponding author), VIB Ctr Biol Dis, B-3000 Louvain, Belgium.		Pasciuto, Emanuela/AAP-2982-2020	Bagni, Claudia/0000-0002-4419-210X; Pasciuto, Emanuela/0000-0002-5391-9585				Alpatov R, 2014, CELL, V157, P869, DOI 10.1016/j.cell.2014.03.040; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008	7	28	28	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					218	+		10.1016/j.cell.2014.08.036	http://dx.doi.org/10.1016/j.cell.2014.08.036			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259928	Bronze, Green Published			2022-12-28	WOS:000343095000023
J	Arimura, S; Okada, T; Tezuka, T; Chiyo, T; Kasahara, Y; Yoshimura, T; Motomura, M; Yoshida, N; Beeson, D; Takeda, S; Yamanashi, Y				Arimura, Sumimasa; Okada, Takashi; Tezuka, Tohru; Chiyo, Tomoko; Kasahara, Yuko; Yoshimura, Toshiro; Motomura, Masakatsu; Yoshida, Nobuaki; Beeson, David; Takeda, Shin'ichi; Yamanashi, Yuji			DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL MUSCULAR-ATROPHY; HEMOPHILIA-B; FACTOR-IX; MUSCLE; EXPRESSION; MICE; MYASTHENIA; MUTATIONS; MUSK	The neuromuscular junction (NMJ) is the synapse between a motor neuron and skeletal muscle. Defects in NMJ transmission cause muscle weakness, termed myasthenia. The muscle protein Dok-7 is essential for activation of the receptor kinase MuSK, which governs NMJ formation, and DOK7 mutations underlie familial limb-girdle myasthenia (DOK7 myasthenia), a neuromuscular disease characterized by small NMJs. Here, we show in a mouse model of DOK7 myasthenia that therapeutic administration of an adeno-associated virus (AAV) vector encoding the human DOK7 gene resulted in an enlargement of NMJs and substantial increases in muscle strength and life span. When applied to model mice of another neuromuscular disorder, autosomal dominant Emery-Dreifuss muscular dystrophy, DOK7 gene therapy likewise resulted in enlargement of NMJs as well as positive effects on motor activity and life span. These results suggest that therapies aimed at enlarging the NMJ may be useful for a range of neuromuscular disorders.	[Arimura, Sumimasa; Tezuka, Tohru; Yamanashi, Yuji] Univ Tokyo, Inst Med Sci, Div Genet, Tokyo, Japan; [Okada, Takashi; Chiyo, Tomoko; Kasahara, Yuko; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan; [Yoshimura, Toshiro] Nagasaki Univ, Sch Hlth Sci, Dept Occupat Therapy, Nagasaki 852, Japan; [Motomura, Masakatsu] Nagasaki Inst Appl Sci, Dept Elect & Elect Engn, Fac Engn, Nagasaki, Japan; [Yoshida, Nobuaki] Univ Tokyo, Inst Med Sci, Lab Dev Genet, Tokyo, Japan; [Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Neurosci Grp, Oxford, England	University of Tokyo; National Center for Neurology & Psychiatry - Japan; Nagasaki University; Nagasaki Institute of Applied Science; University of Tokyo; University of Oxford	Yamanashi, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Genet, Tokyo, Japan.	yyamanas@ims.u-tokyo.ac.jp		Okada, Takashi/0000-0002-2910-3797	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23249013] Funding Source: KAKEN; Medical Research Council [MR/M006824/1] Funding Source: researchfish; MRC [MR/M006824/1] Funding Source: UKRI	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to C. L. Stewart and Y. Hayashi for the Lmna knock-out (KO) mice (AD-EDMD mice) and to J. M. Wilson for the helper plasmid pRep2Cap9. We thank R. F. Whittier and S. Miyoshi for critical reading of the manuscript. This work was supported by Grants-in-Aid of Scientific Research and of the Translational Research Network Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Y. Y. is an inventor on a patent (Japan patent P5339246 and U.S. patent 8222383) that covers the use of human DOK7 cDNA for commercial purposes. University of Pennsylvania holds a patent (Japan patent P5054975 and U.S. patent 7906111) that covers the use of AAV9 for commercial purposes.	Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Bruneteau G, 2013, BRAIN, V136, P2359, DOI 10.1093/brain/awt164; Buchlis G, 2012, BLOOD, V119, P3038, DOI 10.1182/blood-2011-09-382317; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Cavalcante P, 2012, CURR OPIN NEUROL, V25, P621, DOI 10.1097/WCO.0b013e328357a829; Celesia GG, 2001, CLIN NEUROPHYSIOL, V112, P2, DOI 10.1016/S1388-2457(00)00496-X; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Ghedini PC, 2008, MUSCLE NERVE, V38, P1585, DOI 10.1002/mus.21183; Gumerson JD, 2013, HUM MOL GENET, V22, P757, DOI 10.1093/hmg/dds483; Hagstrom JN, 2000, BLOOD, V95, P2536; Hamuro J, 2008, J BIOL CHEM, V283, P5518, DOI 10.1074/jbc.M708607200; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; Jang YC, 2011, EXP GERONTOL, V46, P193, DOI 10.1016/j.exger.2010.08.029; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Muller JS, 2007, BRAIN, V130, P1497, DOI 10.1093/brain/awm068; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nonnenmacher M, 2012, GENE THER, V19, P649, DOI 10.1038/gt.2012.6; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Palace J, 2007, BRAIN, V130, P1507, DOI 10.1093/brain/awm072; Perez-Garcia MJ, 2012, CELL REPORTS, V2, P497, DOI 10.1016/j.celrep.2012.08.004; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Saito F, 2007, J NEUROCHEM, V101, P1712, DOI 10.1111/j.1471-4159.2007.04462.x; Selcen D, 2008, ANN NEUROL, V64, P71, DOI 10.1002/ana.21408; Slater CR, 2006, BRAIN, V129, P2061, DOI 10.1093/brain/awl200; Slater Clarke R, 2008, Handb Clin Neurol, V91, P27, DOI 10.1016/S0072-9752(07)01502-3; Srour M, 2010, NEUROMUSCULAR DISORD, V20, P453, DOI 10.1016/j.nmd.2010.05.007; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Yamanashi Y, 2012, J BIOCHEM, V151, P353, DOI 10.1093/jb/mvs013; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	38	51	51	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1505	1508		10.1126/science.1250744	http://dx.doi.org/10.1126/science.1250744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237101				2022-12-28	WOS:000341752900042
J	Smith-Bindman, R; Aubin, C; Bailitz, J; Bengiamin, RN; Camargo, CA; Corbo, J; Dean, AJ; Goldstein, RB; Griffey, RT; Jay, GD; Kang, TL; Kriesel, DR; Ma, OJ; Mallin, M; Manson, W; Melnikow, J; Miglioretti, DL; Miller, SK; Mills, LD; Miner, JR; Moghadassi, M; Noble, VE; Press, GM; Stoller, ML; Valencia, VE; Wang, J; Wang, RC; Cummings, SR				Smith-Bindman, R.; Aubin, C.; Bailitz, J.; Bengiamin, R. N.; Camargo, C. A., Jr.; Corbo, J.; Dean, A. J.; Goldstein, R. B.; Griffey, R. T.; Jay, G. D.; Kang, T. L.; Kriesel, D. R.; Ma, O. J.; Mallin, M.; Manson, W.; Melnikow, J.; Miglioretti, D. L.; Miller, S. K.; Mills, L. D.; Miner, J. R.; Moghadassi, M.; Noble, V. E.; Press, G. M.; Stoller, M. L.; Valencia, V. E.; Wang, J.; Wang, R. C.; Cummings, S. R.			Ultrasonography versus Computed Tomography for Suspected Nephrolithiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADIATION-EXPOSURE; UROLITHIASIS; CHILDHOOD; DIAGNOSIS; SCANS; RISK; PAIN	BACKGROUND There is a lack of consensus about whether the initial imaging method for patients with suspected nephrolithiasis should be computed tomography (CT) or ultrasonography. METHODS In this multicenter, pragmatic, comparative effectiveness trial, we randomly assigned patients 18 to 76 years of age who presented to the emergency department with suspected nephrolithiasis to undergo initial diagnostic ultrasonography performed by an emergency physician (point-of-care ultrasonography), ultrasonography performed by a radiologist (radiology ultrasonography), or abdominal CT. Subsequent management, including additional imaging, was at the discretion of the physician. We compared the three groups with respect to the 30-day incidence of high-risk diagnoses with complications that could be related to missed or delayed diagnosis and the 6-month cumulative radiation exposure. Secondary outcomes were serious adverse events, related serious adverse events (deemed attributable to study participation), pain (assessed on an 11-point visual-analogue scale, with higher scores indicating more severe pain), return emergency department visits, hospitalizations, and diagnostic accuracy. RESULTS A total of 2759 patients underwent randomization: 908 to point-of-care ultrasonography, 893 to radiology ultrasonography, and 958 to CT. The incidence of high-risk diagnoses with complications in the first 30 days was low (0.4%) and did not vary according to imaging method. The mean 6-month cumulative radiation exposure was significantly lower in the ultrasonography groups than in the CT group (P<0.001). Serious adverse events occurred in 12.4% of the patients assigned to point-of-care ultrasonography, 10.8% of those assigned to radiology ultrasonography, and 11.2% of those assigned to CT (P = 0.50). Related adverse events were infrequent (incidence, 0.4%) and similar across groups. By 7 days, the average pain score was 2.0 in each group (P = 0.84). Return emergency department visits, hospitalizations, and diagnostic accuracy did not differ significantly among the groups. CONCLUSIONS Initial ultrasonography was associated with lower cumulative radiation exposure than initial CT, without significant differences in high-risk diagnoses with complications, serious adverse events, pain scores, return emergency department visits, or hospitalizations.	[Smith-Bindman, R.; Goldstein, R. B.; Moghadassi, M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Smith-Bindman, R.; Stoller, M. L.; Valencia, V. E.; Wang, R. C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Smith-Bindman, R.; Stoller, M. L.; Valencia, V. E.; Wang, R. C.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Kriesel, D. R.; Cummings, S. R.] Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA; [Bengiamin, R. N.] UCSF, Dept Emergency Med, Fresno, CA USA; [Kang, T. L.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Melnikow, J.] Univ Calif Davis, Ctr Healthcare Policy & Res, Davis, CA 95616 USA; [Miglioretti, D. L.] Univ Calif Davis, Div Biostat, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Mills, L. D.] Univ Calif Davis, Dept Emergency Med, Davis, CA 95616 USA; [Aubin, C.; Griffey, R. T.] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO 63130 USA; [Bailitz, J.] Rush Univ, Med Ctr, Dept Emergency Med, Jr Hosp Cook Cty, Chicago, IL 60612 USA; [Bailitz, J.] Rush Univ, Med Ctr, Dept Emergency Med, Chicago, IL 60612 USA; [Camargo, C. A., Jr.; Noble, V. E.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Camargo, C. A., Jr.; Noble, V. E.] Harvard Univ, Sch Med, Boston, MA USA; [Corbo, J.; Wang, J.] Jacobi Med Ctr, Dept Emergency Med, Bronx, NY USA; [Dean, A. J.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Jay, G. D.] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA; [Jay, G. D.] Brown Univ, Dept Emergency Med, Providence, RI 02912 USA; [Ma, O. J.] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Miglioretti, D. L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Mallin, M.] Univ Utah, Salt Lake City, UT USA; [Manson, W.] Emory Univ, Sch Med, Atlanta, GA USA; [Miller, S. K.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Press, G. M.] Univ Texas Houston, Houston Med Sch, Houston, TX USA; [Miner, J. R.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of Southern California; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Washington University (WUSTL); Rush University; Rush University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Jacobi Medical Center; University of Pennsylvania; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Oregon Health & Science University; Group Health Cooperative; Utah System of Higher Education; University of Utah; Emory University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Hennepin County Medical Center	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	rebecca.smith-bindman@ucsf.edu	Griffey, Richard/I-5256-2015; Miner, James/AAI-4801-2020; Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; Jay, Gregory/0000-0003-1517-8488; Valencia, Victoria/0000-0001-5250-5359; Wang, Ralph/0000-0001-5382-9486; Griffey, Richard/0000-0002-6279-7380	Agency for Healthcare Research and Quality through its Clinical and Health Outcomes Initiative in Comparative Effectiveness [R01HS019312]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS019312] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality through its Clinical and Health Outcomes Initiative in Comparative Effectiveness; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant (R01HS019312) from the Agency for Healthcare Research and Quality through its Clinical and Health Outcomes Initiative in Comparative Effectiveness.	Chi T, 2012, TRANSL ANDROL UROL, V1, P66, DOI 10.3978/j.issn.2223-4683.2011.12.06; Coursey CA, 2012, ULTRASOUND Q, V28, P227, DOI 10.1097/RUQ.0b013e3182625974; Dalziel PJ, 2013, EMERG MED J, V30, P3, DOI 10.1136/emermed-2012-201375; Edmonds ML, 2010, CAN J EMERG MED, V12, P201; Food and Drug Administration, 2014, WHAT IS SER ADV EV; Fwu CW, 2013, KIDNEY INT, V83, P479, DOI 10.1038/ki.2012.419; Huda W, 2008, RADIOLOGY, V248, P995, DOI 10.1148/radiol.2483071964; Lumbreras B, 2010, BRIT J RADIOL, V83, P276, DOI 10.1259/bjr/98067945; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mills AM, 2010, CAN J EMERG MED, V12, P485; National Research Council, 2006, HLTH RISKS EXP LOW L, P141; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Thompson RJ, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/624847; Westphalen AC, 2011, ACAD EMERG MED, V18, P700, DOI 10.1111/j.1553-2712.2011.01103.x; Worster A, 2002, ANN EMERG MED, V40, P280, DOI 10.1067/mem.2002.126170	18	343	345	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1100	1110		10.1056/NEJMoa1404446	http://dx.doi.org/10.1056/NEJMoa1404446			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25229916	Green Published			2022-12-28	WOS:000341687300005
J	Wilson, ML; Boesch, C; Fruth, B; Furuichi, T; Gilby, IC; Hashimoto, C; Hobaiter, CL; Hohmann, G; Itoh, N; Koops, K; Lloyd, JN; Matsuzawa, T; Mitani, JC; Mjungu, DC; Morgan, D; Muller, MN; Mundry, R; Nakamura, M; Pruetz, J; Pusey, AE; Riedel, J; Sanz, C; Schel, AM; Simmons, N; Waller, M; Watts, DP; White, F; Wittig, RM; Zuberbuhler, K; Wrangham, RW				Wilson, Michael L.; Boesch, Christophe; Fruth, Barbara; Furuichi, Takeshi; Gilby, Ian C.; Hashimoto, Chie; Hobaiter, Catherine L.; Hohmann, Gottfried; Itoh, Noriko; Koops, Kathelijne; Lloyd, Julia N.; Matsuzawa, Tetsuro; Mitani, John C.; Mjungu, Deus C.; Morgan, David; Muller, Martin N.; Mundry, Roger; Nakamura, Michio; Pruetz, Jill; Pusey, Anne E.; Riedel, Julia; Sanz, Crickette; Schel, Anne M.; Simmons, Nicole; Waller, Michel; Watts, David P.; White, Frances; Wittig, Roman M.; Zuberbuehler, Klaus; Wrangham, Richard W.			Lethal aggression in Pan is better explained by adaptive strategies than human impacts	NATURE			English	Article							KIBALE-NATIONAL-PARK; MALE CHIMPANZEES; INTRAGROUP INFANTICIDE; INTERGROUP AGGRESSION; WILD CHIMPANZEES; CANNIBALISM; VIOLENCE; NGOGO; EVOLUTION; DEATH	Observations of chimpanzees (Pan troglodytes) and bonobos (Pan paniscus) provide valuable comparative data for understanding the significance of conspecific killing. Two kinds of hypothesis have been proposed. Lethal violence is sometimes concluded to be the result of adaptive strategies, such that killers ultimately gain fitness benefits by increasing their access to resources such as food or mates(1-5). Alternatively, it could be a non-adaptive result of human impacts, such as habitat change or food provisioning(6-9). To discriminate between these hypotheses we compiled information from 18 chimpanzee communities and 4 bonobo communities studied over five decades. Our data include 152 killings (n = 58 observed, 41 inferred, and 53 suspected killings) by chimpanzees in 15 communities and one suspected killing by bonobos. We found that males were the most frequent attackers (92% of participants) and victims (73%); most killings (66%) involved intercommunity attacks; and attackers greatly outnumbered their victims (median 8:1 ratio). Variation in killing rates was unrelated to measures of human impacts. Our results are compatible with previously proposed adaptive explanations for killing by chimpanzees, whereas the human impact hypothesis is not supported.	[Wilson, Michael L.] Univ Minnesota, Dept Anthropol, Humphrey Ctr 395, Minneapolis, MN 55455 USA; [Wilson, Michael L.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Boesch, Christophe; Hohmann, Gottfried; Riedel, Julia; Wittig, Roman M.] Max Planck Inst Evolutionare Anthropol, Dept Primatol, D-04103 Leipzig, Germany; [Fruth, Barbara] Univ Munich, Div Neurobiol, D-81377 Munich, Germany; [Fruth, Barbara] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Furuichi, Takeshi; Hashimoto, Chie; Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Gilby, Ian C.; Pusey, Anne E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Gilby, Ian C.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Hobaiter, Catherine L.; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9JP, Fife, Scotland; [Itoh, Noriko; Nakamura, Michio] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto, Japan; [Koops, Kathelijne] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge CB2 1QH, England; [Lloyd, Julia N.; Simmons, Nicole] Makerere Univ, Dept Zool, Kampala, Uganda; [Matsuzawa, Tetsuro] Japan Monkey Ctr, Inuyama, Aichi 4840081, Japan; [Mitani, John C.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Mjungu, Deus C.] Jane Goodall Inst Tanzania, Gombe Stream Res Ctr, Kigoma, Tanzania; [Morgan, David] Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Muller, Martin N.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Mundry, Roger] Max Planck Inst Evolutionare Anthropol, D-04103 Leipzig, Germany; [Pruetz, Jill] Iowa State Univ, Dept Anthropol, Ames, IA 50011 USA; [Sanz, Crickette] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Schel, Anne M.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Waller, Michel; White, Frances] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Watts, David P.] Yale Univ, Dept Anthropol, New Haven, CT 06511 USA; [Zuberbuehler, Klaus] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Wrangham, Richard W.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society; University of Munich; Kyoto University; Duke University; Arizona State University; Arizona State University-Tempe; University of St Andrews; Kyoto University; University of Cambridge; Makerere University; Kyoto University; University of Michigan System; University of Michigan; University of New Mexico; Max Planck Society; Iowa State University; Washington University (WUSTL); University of York - UK; University of Oregon; Yale University; University of Neuchatel; Harvard University	Wilson, ML (corresponding author), Univ Minnesota, Dept Anthropol, Humphrey Ctr 395, 301 19th Ave South, Minneapolis, MN 55455 USA.	wilso198@umn.edu	Matsuzawa, Tetsuro/ABE-9654-2021; Zuberbühler, Klaus/A-9053-2011; Wilson, Michael Lawrence/AAC-9154-2020	Matsuzawa, Tetsuro/0000-0002-8147-2725; Zuberbühler, Klaus/0000-0001-8378-088X; Wilson, Michael Lawrence/0000-0003-3073-4518; Hobaiter, Cat/0000-0002-3893-0524; Pusey, Anne/0000-0002-2280-8954	National Science Foundation [BCS-0648481, LTREB-1052693]; National Institutes of Health [R01 AI 058715]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058715] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Science Foundation grants BCS-0648481 and LTREB-1052693 and National Institutes of Health grant R01 AI 058715. Numerous additional sources of funding have supported the long-term studies that contributed data to this study. We thank J. H. Jones for statistical advice; L. Pintea for preparing the map for Extended Data Fig. 1b; I. Lipende and R. Lawrence for providing details on recent cases at Gombe and Kanyantale; S. Amsler for helping to calculate the range of the Kanyantale community, and the many field assistants who collected data.	[Anonymous], 2013, R LANGUAGE ENV STAT; Arcadi AC, 1999, PRIMATES, V40, P337, DOI 10.1007/BF02557557; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BARTLETT TQ, 1993, AM ANTHROPOL, V95, P958, DOI 10.1525/aa.1993.95.4.02a00090; Bates D., 2013, LME4 LINEAR MIXED EF; Bishop N., 1981, International Journal of Primatology, V2, P153, DOI 10.1007/BF02693446; Boesch C., 2002, BEHAVIORAL DIVERSITY; Boesch C, 2000, THE CHIMPANZEES OF T; Boesch C., 2009, THE REAL CHIMPANZEE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Bolker B, 2012, GETTING STARTED WITH; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; BYGOTT JD, 1972, NATURE, V238, P410, DOI 10.1038/238410a0; Fawcett K, 2000, AM J PRIMATOL, V51, P243, DOI 10.1002/1098-2345(200008)51:4<243::AID-AJP3>3.0.CO;2-P; Ferguson RB, 2011, DEV PRIMATOL-PROG PR, P249, DOI 10.1007/978-1-4419-9520-9_14; Field A., 2005, DISCOVERING STATISTI; GOODALL J, 1977, FOLIA PRIMATOL, V28, P259, DOI 10.1159/000155817; Goodall J, 1986, THE CHIMPANZEES OF G; HAMAI M, 1992, PRIMATES, V33, P151, DOI 10.1007/BF02382746; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hashimoto C., 2005, PAN AFR NEWS, V12, P3, DOI [10.5134/143451, DOI 10.5134/143451]; Hiraiwa-Hasegawa M., 1984, DEMOGRAPHIC STUDY LA, V25, P401, DOI DOI 10.1007/BF02381663; Hobaiter C., 2010, THESIS; Hohmann G., 2011, AMONG AFRICAN APES S; Hosaka Kazuhiko, 2000, Primate Research, V16, P1; Inoue E, 2008, AM J PHYS ANTHROPOL, V137, P256, DOI 10.1002/ajpa.20865; Kaburu SSK, 2013, AM J PRIMATOL, V75, P789, DOI 10.1002/ajp.22135; Kawanaka K., 1981, AFR STUDY MONOGR, V1, P69; Kutsukake N, 2002, AM J PRIMATOL, V58, P175, DOI 10.1002/ajp.10058; Mitani JC, 2006, PRIMATES, V47, P6, DOI 10.1007/s10329-005-0139-7; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Mitani JC, 2009, EVOL ANTHROPOL, V18, P215, DOI 10.1002/evan.20229; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; Murray CM, 2007, INT J PRIMATOL, V28, P23, DOI 10.1007/s10764-006-9111-7; Newton-Fisher NE, 1999, FOLIA PRIMATOL, V70, P167, DOI 10.1159/000021690; NISHIDA T, 1985, Primates, V26, P274, DOI 10.1007/BF02382402; NISHIDA T, 1979, Primates, V20, P1, DOI 10.1007/BF02373826; NISHIDA T, 1985, Z TIERPSYCHOL, V67, P284; Nishida T., 2012, CHIMPANZEES OF THE L; NORIKOSHI K, 1982, Primates, V23, P66, DOI 10.1007/BF02381438; Potts KB, 2011, INT J PRIMATOL, V32, P669, DOI 10.1007/s10764-011-9494-y; Power M., 1991, THE EGALITARIANS HUM; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Pusey A, 2008, INT J PRIMATOL, V29, P949, DOI 10.1007/s10764-008-9281-6; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Sherrow HM, 2007, INT J PRIMATOL, V28, P9, DOI 10.1007/s10764-006-9112-6; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Sussman RW., 2013, WAR PEACE HUMAN NATU, P97, DOI [10.1093/acprof:oso/9780199858996.003.0006, DOI 10.1093/ACPROF:OSO/9780199858996.003.0006]; TAKAHATA Y, 1985, FOLIA PRIMATOL, V44, P161, DOI 10.1159/000156210; Thompson ME, 2009, HORM BEHAV, V55, P299, DOI 10.1016/j.yhbeh.2008.11.005; Townsend SW, 2007, CURR BIOL, V17, pR355, DOI 10.1016/j.cub.2007.03.020; Watts DP, 2006, AM J PRIMATOL, V68, P161, DOI 10.1002/ajp.20214; Watts DP, 2000, PRIMATES, V41, P357, DOI 10.1007/BF02557646; Watts DP, 2002, PRIMATES, V43, P263, DOI 10.1007/BF02629601; Watts DP, 2004, INT J PRIMATOL, V25, P507, DOI 10.1023/B:IJOP.0000023573.56625.59; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Williams JM, 2004, ANIM BEHAV, V68, P523, DOI 10.1016/j.anbehav.2003.09.015; Wilson ML, 2012, ANIM BEHAV, V83, P277, DOI 10.1016/j.anbehav.2011.11.004; Wilson ML, 2004, INT J PRIMATOL, V25, P523, DOI 10.1023/B:IJOP.0000023574.38219.92; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wrangham R. W., 1975, THESIS; Wrangham RW, 2006, PRIMATES, V47, P14, DOI 10.1007/s10329-005-0140-1; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1	64	241	243	4	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					414	+		10.1038/nature13727	http://dx.doi.org/10.1038/nature13727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230664	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000341814900059
J	Castellucci, LA; Cameron, C; Le Gal, G; Rodger, MA; Coyle, D; Wells, PS; Clifford, T; Gandara, E; Wells, G; Carrier, M				Castellucci, Lana A.; Cameron, Chris; Le Gal, Gregoire; Rodger, Marc A.; Coyle, Doug; Wells, Philip S.; Clifford, Tammy; Gandara, Esteban; Wells, George; Carrier, Marc			Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOLECULAR-WEIGHT HEPARIN; INTRAVENOUS UNFRACTIONATED HEPARIN; LONG-TERM TREATMENT; DEEP-VEIN THROMBOSIS; ORAL ANTICOAGULANT-THERAPY; CASE-FATALITY RATES; PULMONARY-EMBOLISM; INITIAL TREATMENT; STANDARD HEPARIN; ENOXAPARIN	IMPORTANCE Many anticoagulant strategies are available for the treatment of acute venous thromboembolism, yet little guidance exists regarding which drug is most effective and safe. OBJECTIVE To summarize and compare the efficacy and safety outcomes associated with 8 anticoagulation options (unfractionated heparin [UFH], low-molecular-weight heparin [LMWH], or fondaparinux in combination with vitamin K antagonists); LMWH with dabigatran or edoxaban; rivaroxaban; apixaban; and LMWH alone) for treatment of venous thromboembolism. DATA SOURCES A systematic literature search was conducted using MEDLINE, EMBASE, and the evidence-based medicine reviews from inception through February 28, 2014. STUDY SELECTION Eligible studies were randomized trials reporting rates of recurrent venous thromboembolism and major bleeding in patients with acute venous thromboembolism. Of the 1197 studies identified, 45 trials including 44 989 patients were included in the analyses. DATA EXTRACTION AND SYNTHESIS Two reviewers independently extracted trial-level data including number of patients, duration of follow-up, and outcomes. The data were pooled using network meta-analysis. MAIN OUTCOMES AND MEASURES The primary clinical and safety outcomes were recurrent venous thromboembolism and major bleeding, respectively. RESULTS Compared with the LMWH-vitamin K antagonist combination, a treatment strategy using the UFH-vitamin K antagonist combination was associated with an increased risk of recurrent venous thromboembolism (hazard ratio [HR], 1.42; 95% credible interval [CrI], 1.15-1.79). The proportion of patients experiencing recurrent venous thromboembolism during 3 months of treatment were 1.84%(95% CrI, 1.33%-2.51%) for the UFH-vitamin K antagonist combination and 1.30% (95% CrI, 1.02%-1.62%) for the LMWH-vitamin K antagonist combination. Rivaroxaban (HR, 0.55; 95% CrI, 0.35-0.89) and apixaban (HR, 0.31; 95% CrI, 0.15-0.62) were associated with a lower risk of bleeding than was the LMWH-vitamin K antagonist combination, with a lower proportion of patients experiencing a major bleeding event during 3 months of anticoagulation: 0.49% (95% CrI, 0.29%-0.85%) for rivaroxaban, 0.28%(95% CrI, 0.14%-0.50%) for apixaban, and 0.89%(95% CrI, 0.66%-1.16%) for the LMWH-vitamin K antagonist combination. CONCLUSIONS AND RELEVANCE Usingmeta-analytic pooling, there were no statistically significant differences for efficacy and safety associated with most treatment strategies used to treat acute venous thromboembolism compared with the LMWH-vitamin K antagonist combination. However, findings suggest that the UFH-vitamin K antagonist combination is associated with the least effective strategy and that rivaroxaban and apixaban may be associated with the lowest risk for bleeding. Copyright 2014 American Medical Association. All rights reserved.	[Castellucci, Lana A.; Le Gal, Gregoire; Rodger, Marc A.; Wells, Philip S.; Gandara, Esteban; Carrier, Marc] Univ Ottawa, Dept Med, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Cameron, Chris; Coyle, Doug] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Clifford, Tammy] Canadian Agcy Drugs & Technol Hlth, Ottawa, ON, Canada; [Wells, George] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa Heart Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Carrier, M (corresponding author), Ottawa Hosp Gen Campus, Dept Med, 501 Smyth Rd,Box 201A, Ottawa, ON K1H 8L6, Canada.	mcarrier@ottawahospital.on.ca	Gandara, Esteban/H-3336-2019	Gandara, Esteban/0000-0003-0313-9174; Coyle, Doug/0000-0003-3492-2268; Rodger, Marc/0000-0001-8166-3487	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research; Canadian Network and Centre for Trials Internationally (CANNeCTIN); CIHR Drug Safety and Effectiveness Network [116573]; Heart and Stroke Foundation of Ontario;  [CGV 121171]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally (CANNeCTIN); CIHR Drug Safety and Effectiveness Network(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); 	Dr Carrier is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada and holds a T2 Research Chair in Cancer and Thrombosis form the University of Ottawa. Dr Cameron is a recipient of grant CGV 121171. a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research and has received funding from Canadian Network and Centre for Trials Internationally (CANNeCTIN). He is also a trainee on Network Meta-analysis Team grant (116573) through the CIHR Drug Safety and Effectiveness Network. Dr Rodger is the recipient of a Career Scientist Award from the Heart and Stroke Foundation of Ontario. Dr Philip S. Wells is a recipient of a Canada Research Chair in Venous Thromboembolism.	Ageno W, 2006, J THROMB HAEMOST, V4, P1914, DOI 10.1111/j.1538-7836.2006.02132.x; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; BARRITT DW, 1960, LANCET, V1, P1309; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Beckman JA, 2003, THROMB HAEMOSTASIS, V89, P953, DOI 10.1055/s-0037-1613395; Belcaro G, 1999, ANGIOLOGY, V50, P781; BRATT G, 1990, THROMB HAEMOSTASIS, V64, P506; Breddin HK, 2001, NEW ENGL J MED, V344, P626, DOI 10.1056/NEJM200103013440902; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Chong BH, 2005, J THROMB THROMBOLYS, V19, P173, DOI 10.1007/s11239-005-1848-x; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Das SK, 1996, WORLD J SURG, V20, P521, DOI 10.1007/s002689900081; Daskalopoulos ME, 2005, EUR J VASC ENDOVASC, V29, P638, DOI 10.1016/j.ejvs.2004.02.029; de Llano LAP, 2003, ARCH BRONCONEUMOL, V39, P341; Dias S, 2011, 2 NICE DSU; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; DUROUX P, 1991, THROMB HAEMOSTASIS, V65, P251; Fiessinger JN, 1996, THROMB HAEMOSTASIS, V76, P195; Findik S, 2002, RESPIRATION, V69, P440, DOI 10.1159/000064023; Fleurence RL, 2007, PHARMACOECONOMICS, V25, P3, DOI 10.2165/00019053-200725010-00002; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Girolami A, 2004, ARCH INTERN MED, V164, P1077; Gonzalez-Fajardo JA, 1999, J VASC SURG, V30, P283, DOI 10.1016/S0741-5214(99)70139-4; Guyatt GH, 2012, CHEST, V141, pE185S, DOI 10.1378/chest.11-2289; Hansen D, 2010, ANAL SOCIAL MEDIA NE; Harenberg J, 2000, THROMB HAEMOSTASIS, V83, P652; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Higgins J., 2009, COCHRANE HDB SYSTEMA; Hull RD, 2000, ARCH INTERN MED, V160, P229, DOI 10.1001/archinte.160.2.229; HULL RD, 1992, NEW ENGL J MED, V326, P975, DOI 10.1056/NEJM199204093261502; Hull RD, 2007, AM J MED, V120, P72, DOI 10.1016/j.amjmed.2006.03.030; Kakkar VV, 2003, THROMB HAEMOSTASIS, V89, P674; Kearon C, 2006, JAMA-J AM MED ASSOC, V296, P935, DOI 10.1001/jama.296.8.935; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Kirchmaier CM, 1998, INT ANGIOL, V17, P135; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Leizorovicz A, 2011, THROMB RES, V128, P27, DOI 10.1016/j.thromres.2011.03.002; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LINDMARKER P, 1994, THROMB HAEMOSTASIS, V72, P186; LOPACIUK S, 1992, THROMB HAEMOSTASIS, V68, P14; Lopaciuk S, 1999, THROMB HAEMOSTASIS, V81, P26; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Merli G, 2001, ANN INTERN MED, V134, P191, DOI 10.7326/0003-4819-134-3-200102060-00009; Meyer G, 1995, THROMB HAEMOSTASIS, V74, P1432; PINI M, 1994, THROMB HAEMOSTASIS, V72, P191; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; Prins MH, 2002, THROMB HAEMOSTASIS, V87, P1; Ramacciotti E, 2004, THROMB RES, V114, P149, DOI 10.1016/j.thromres.2004.05.009; Riess H, 2003, THROMB HAEMOSTASIS, V90, P252, DOI 10.1160/TH02-09-0061; Romera A, 2009, EUR J VASC ENDOVASC, V37, P349, DOI 10.1016/j.ejvs.2008.11.030; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2014, CIRCULATION, V129, P764, DOI 10.1161/CIRCULATIONAHA.113.004450; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; SIMONNEAU G, 1993, ARCH INTERN MED, V153, P1541, DOI 10.1001/archinte.153.13.1541; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Thorlund K, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-2; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485; Veiga F, 2000, THROMB HAEMOSTASIS, V84, P559; White RH, 2003, CIRCULATION, V107, P14, DOI [DOI 10.1161/01.C1R.0000078468.11849.66, 10.1161/01.CIR.0000078468.11849.66, DOI 10.1161/01.CIR.0000078468.11849.66, 10.1161/01.cir.0000078468.11849.66]	71	101	110	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1122	1135		10.1001/jama.2014.10538	http://dx.doi.org/10.1001/jama.2014.10538			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226478	Bronze			2022-12-28	WOS:000341624700022
J	Ager, A; Burnham, G; Checchi, F; Gayer, M; Grais, RF; Henkens, M; Massaquoi, MBF; Nandy, R; Navarro-Colorado, C; Spiegel, P				Ager, A.; Burnham, G.; Checchi, F.; Gayer, M.; Grais, R. F.; Henkens, M.; Massaquoi, M. B. F.; Nandy, R.; Navarro-Colorado, C.; Spiegel, P.			Strengthening the evidence base for health programming in humanitarian crises	SCIENCE			English	Editorial Material							EMERGENCIES		[Ager, A.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Burnham, G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Checchi, F.] Save Children UK, London EC1M 4AR, England; [Gayer, M.] WHO, CH-1211 Geneva 27, Switzerland; [Grais, R. F.] Epicentre, F-75012 Paris, France; [Henkens, M.] Med Sans Frontieres Int, B-1090 Brussels, Belgium; [Massaquoi, M. B. F.] Clinton Hlth Access Initiat, Monrovia, Liberia; [Nandy, R.] UNICEF, Jakarta 12920, Indonesia; [Navarro-Colorado, C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA 30333 USA; [Spiegel, P.] UNHCR, CH-1211 Geneva 2, Switzerland	Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Save the Children; World Health Organization; Centers for Disease Control & Prevention - USA	Grais, RF (corresponding author), Epicentre, 55 Rue Crozatier, F-75012 Paris, France.	rebecca.grais@epicentre.msf.org	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661; Checchi, Francesco/0000-0001-9030-5382; Navarro Colorado, Carlos/0000-0002-2185-0157; Ager, Alastair/0000-0002-9474-3563; Freeman Grais, Rebecca/0000-0002-5037-8218	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ager A., 2011, INTER AGENCY GUIDE T; Ager Alastair, 2012, WORLD DISASTERS REPO, P80; [Anonymous], 2013, R2HC IS A PROGRAM MA; Black R, 2003, DISASTERS, V27, P95, DOI 10.1111/1467-7717.00222; Blanchett K., 2013, AN EVIDENCE REVIEW O; Burkle FM, 2012, LANCET, V379, P2223, DOI 10.1016/S0140-6736(11)60979-3; Curry D. R., 2013, AN ETHICAL FRAMEWORK; Evidence Aid Priority Setting Group E A P S G, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.c9c4f4db9887633409182d2864b20c31; Grais Rebecca F, 2011, Confl Health, V5, P21, DOI 10.1186/1752-1505-5-21; International Initiative on Impact Evaluation (3ie), 2014, IMPACT EVALUATIONS O; Lautze S, 2004, LANCET, V364, P2134, DOI 10.1016/S0140-6736(04)17555-7; Leaning J, 2001, LANCET, V357, P1432, DOI 10.1016/S0140-6736(00)04572-4; Leaning Jennifer, 2011, Confl Health, V5, P6, DOI 10.1186/1752-1505-5-6; Minetti A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001544; Sphere Project, 2011, THE SPHERE HANDBOOK; UNHCR, 2014, UNHCR GLOBAL TRENDS; Zachariah R, 2009, LANCET INFECT DIS, V9, P711, DOI 10.1016/S1473-3099(09)70229-4	17	42	42	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1290	1292		10.1126/science.1254164	http://dx.doi.org/10.1126/science.1254164			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214616				2022-12-28	WOS:000341483800048
J	Ye, CJ; Feng, T; Kwon, HK; Raj, T; Wilson, M; Asinovski, N; McCabe, C; Lee, MH; Frohlich, I; Paik, HI; Zaitlen, N; Hacohen, N; Stranger, B; De Jager, P; Mathis, D; Regev, A; Benoist, C				Ye, Chun Jimmie; Feng, Ting; Kwon, Ho-Keun; Raj, Towfique; Wilson, Michael; Asinovski, Natasha; McCabe, Cristin; Lee, Michelle H.; Frohlich, Irene; Paik, Hyun-il; Zaitlen, Noah; Hacohen, Nir; Stranger, Barbara; De Jager, Philip; Mathis, Diane; Regev, Aviv; Benoist, Christophe			Intersection of population variation and autoimmunity genetics in human T cell activation	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; RISK; DIFFERENTIATION; ARCHITECTURE; METAANALYSIS; ENGAGEMENT; MECHANISM; VARIANTS	T lymphocyte activation by antigen conditions adaptive immune responses and immunopathologies, but we know little about its variation in humans and its genetic or environmental roots. We analyzed gene expression in CD4(+) T cells during unbiased activation or in T helper 17 (T(H)17) conditions from 348 healthy participants representing European, Asian, and African ancestries. We observed interindividual variability, most marked for cytokine transcripts, with clear biases on the basis of ancestry, and following patterns more complex than simple T(H)1/2/17 partitions. We identified 39 genetic loci specifically associated in cis with activated gene expression. We further fine-mapped and validated a single-base variant that modulates YY1 binding and the activity of an enhancer element controlling the autoimmune-associated IL2RA gene, affecting its activity in activated but not regulatory T cells. Thus, interindividual variability affects the fundamental immunologic process of T helper activation, with important connections to autoimmune disease.	[Ye, Chun Jimmie; Raj, Towfique; McCabe, Cristin; De Jager, Philip; Mathis, Diane; Regev, Aviv; Benoist, Christophe] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Feng, Ting; Kwon, Ho-Keun; Wilson, Michael; Asinovski, Natasha; Paik, Hyun-il; Hacohen, Nir; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Raj, Towfique; McCabe, Cristin; Lee, Michelle H.; Frohlich, Irene; De Jager, Philip] Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Raj, Towfique; McCabe, Cristin; Lee, Michelle H.; Frohlich, Irene; De Jager, Philip] Brigham & Womens Hosp, Dept Psychiat, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Zaitlen, Noah] Univ Calif San Francisco, Lung Biol Ctr, Dept Med, San Francisco, CA 94158 USA; [Stranger, Barbara] Univ Chicago, Med Genet Sect, Chicago, IL 60637 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; University of Chicago; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; cbdm@hms.harvard.edu	Raj, Towfique/ABD-7620-2021; Ye, Chun/AAK-4868-2021	Ye, Chun/0000-0001-6560-3783; Stranger, Barbara/0000-0001-9021-7331; KWON, HOKEUN/0000-0003-3175-0376	U.S. National Institute of General Medical Sciences [RC2 GM093080]; NIH [F32 AG043267]; National Multiple Sclerosis Society [JF2138A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG043267] Funding Source: NIH RePORTER	U.S. National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to study participants in the PhenoGenetic project for their contribution. We thank the ImmVar participants, V. Kuchroo and D. Hafler for valuable discussions, K. Rothamel for processing of the microarray samples, and C. Laplace for graphics. This work was supported by U.S. National Institute of General Medical Sciences grant RC2 GM093080 (C.B.). T.R. was supported by an NIH F32 Fellowship (F32 AG043267). P.D.J. is a Harry Weaver Neuroscience Scholar Award Recipient of the National Multiple Sclerosis Society (JF2138A1). The gene expression data have been deposited at the Gene Expression Omnibus under accession no. 60236.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cerosaletti K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083811; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Delmastro MM, 2012, DIABETES, V61, P1760, DOI 10.2337/db11-1591; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Donner Y, 2012, NAT METHODS, V9, P1120, DOI [10.1038/NMETH.2207, 10.1038/nmeth.2207]; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Falconer DS, 1996, INTRO QUANTITATIVE G; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hess K, 2004, INT IMMUNOL, V16, P1711, DOI 10.1093/intimm/dxh172; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Li L, 2013, J IMMUNOL, V191, P3694, DOI 10.4049/jimmunol.1300408; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Siminovitch KA, 2004, NAT GENET, V36, P1248, DOI 10.1038/ng1204-1248; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; ZINKERNAGEL RM, 1994, IMMUNOL TODAY, V15, P262, DOI 10.1016/0167-5699(94)90005-1	46	151	154	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1311	+	1254665	10.1126/science.1254665	http://dx.doi.org/10.1126/science.1254665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6YZ	25214635	Green Submitted, Green Accepted			2022-12-28	WOS:000349774300002
J	Reid, DW; Chen, Q; Tay, ASL; Shenolikar, S; Nicchitta, CV				Reid, David W.; Chen, Qiang; Tay, Angeline S. -L.; Shenolikar, Shirish; Nicchitta, Christopher V.			The Unfolded Protein Response Triggers Selective mRNA Release from the Endoplasmic Reticulum	CELL			English	Article							MAMMALIAN-CELLS; GENE-EXPRESSION; BOUND RIBOSOMES; MEMBRANE; STRESS; TRANSLATION; IDENTIFICATION; TRANSLOCATION; LOCALIZATION; POLYPEPTIDES	The unfolded protein response (UPR) is a stress response program that reprograms cellular translation and gene expression in response to proteotoxic stress in the endoplasmic reticulum (ER). One of the primary means by which the UPR alleviates this stress is by reducing protein flux into the ER via a general suppression of protein synthesis and ER-specific mRNA degradation. We report here an additional UPR-induced mechanism for the reduction of protein flux into the ER, where mRNAs that encode signal sequences are released from the ER to the cytosol. By removing mRNAs from the site of translocation, this mechanism may serve as a potent means to transiently reduce ER protein folding load and restore proteostasis. These findings identify the dynamic subcellular localization of mRNAs and translation as a selective and rapid regulatory feature of the cellular response to protein folding stress.	[Reid, David W.; Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Chen, Qiang; Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Tay, Angeline S. -L.; Shenolikar, Shirish] Duke Natl Univ Singapore, Grad Sch Med, Program Cardiovasc & Metab Disorders, Singapore 169857, Singapore; [Shenolikar, Shirish] Duke Natl Univ Singapore, Grad Sch Med, Program Neurosci & Behav Disorders, Singapore 169857, Singapore	Duke University; Duke University; National University of Singapore; National University of Singapore	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	christopher.nicchitta@duke.edu			NIH [GM101533]; Duke/Duke-NUS Research Collaboration project; Singapore Ministry of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke/Duke-NUS Research Collaboration project; Singapore Ministry of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Nicchitta lab members for very helpful discussions, the Duke Genome Sequencing & Analysis Core Resource for technical support, and Nico Katsanis and Jason Willer for advice and instrument support for qRT-PCR experiments. This work was funded by a grant from the NIH (GM101533, C.V.N.) and by a Duke/Duke-NUS Research Collaboration Project funded by the Singapore Ministry of Health (to C.V.N. and S.S.).	ADESNIK M, 1976, J CELL BIOL, V71, P307, DOI 10.1083/jcb.71.1.307; BORGESE D, 1973, J MOL BIOL, V74, P415, DOI 10.1016/0022-2836(73)90037-5; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chen Q, 2011, MOL BIOL CELL, V22, P2646, DOI 10.1091/mbc.E11-03-0239; Cui XYA, 2014, WIRES RNA, V5, P481, DOI 10.1002/wrna.1225; DANG CV, 1983, J CELL BIOL, V96, P1138, DOI 10.1083/jcb.96.4.1138; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HORTSCH M, 1986, J CELL BIOL, V103, P241, DOI 10.1083/jcb.103.1.241; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; MUECKLER MM, 1981, J CELL BIOL, V90, P495, DOI 10.1083/jcb.90.2.495; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PALADE GEORGE E., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P85, DOI 10.1083/jcb.2.4.85; Potter MD, 2000, J BIOL CHEM, V275, P33828, DOI 10.1074/jbc.M005294200; PROSTKO CR, 1993, MOL CELL BIOCHEM, V128, P255, DOI 10.1007/BF01076776; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwechheimer C, 2013, J BACTERIOL, V195, P4161, DOI 10.1128/JB.02192-12; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Teng FYH, 2001, GENOME BIOL, V2; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131	44	80	80	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1362	1374		10.1016/j.cell.2014.08.012	http://dx.doi.org/10.1016/j.cell.2014.08.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215492	Green Accepted, Bronze			2022-12-28	WOS:000343094200017
J	Slotman, BJ; van Tinteren, H; Praag, JO; Knegjens, JL; El Sharouni, SY; Hatton, M; Keijser, A; Faivre-Finn, C; Senan, S				Slotman, Ben J.; van Tinteren, Harm; Praag, John O.; Knegjens, Joost L.; El Sharouni, Sherif Y.; Hatton, Matthew; Keijser, Astrid; Faivre-Finn, Corinne; Senan, Suresh			Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial	LANCET			English	Article							RADIATION-THERAPY	Background Most patients with extensive stage small-cell lung cancer (ES-SCLC) who undergo chemotherapy, and prophylactic cranial irradiation, have persistent intra thoracic disease. We assessed thoracic radiotherapy for treatment of this patient group. Methods We did this phase 3 randomised controlled trial at 42 hospitals: 16 in Netherlands, 22 in the UK, three in Norway, and one in Belgium. We enrolled patients with WHO performance score 0-2 and confirmed ES-SCLC who responded to chemotherapy. They were randomly assigned (1: 1) to receive either thoracic radiotherapy (30 Gy in ten fractions) or no thoracic radiotherapy. All underwent prophylactic cranial irradiation. The primary endpoint was overall survival at 1 year in the intention-to-treat population. Secondary endpoints included progression-free survival. This study is registered with the Nederlands Trial Register, number NTR1527. Findings We randomly assigned 498 patients between Feb 18, 2009, and Dec 21, 2012. Three withdrew informed consent, leaving 247 patients in the thoracic radiotherapy group and 248 in the control group. Mean interval between diagnosis and randomisation was 17 weeks. Median follow-up was 24 months. Overall survival at 1 year was not significantly different between groups: 33% (95% CI 27-39) for the thoracic radiotherapy group versus 28% (95% CI 22-34) for the control group (hazard ratio [HR] 0.84, 95% CI 0.69-1.01; p=0.066). However, in a secondary analysis, 2-year overall survival was 13% (95% CI 9-19) versus 3% (95% CI 2-8; p=0.004). Progression was less likely in the thoracic radiotherapy group than in the control group (HR 0.73, 95% CI 0.61-0.87; p=0.001). At 6 months, progression-free survival was 24% (95% CI 19-30) versus 7% (95% CI 4-11; p=0.001). We recorded no severe toxic effects. The most common grade 3 or higher toxic effects were fatigue (11 vs 9) and dyspnoea (three vs four). Interpretation Thoracic radiotheraphy in addition to prophylactic cranial irradiation should be considered for all patients with ES-SCLC who respond to chemotherapy.	[Slotman, Ben J.; Senan, Suresh] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, NL-1081 HV Amsterdam, Netherlands; [van Tinteren, Harm] Netherlands Canc Inst, Dept Stat, Amsterdam, Netherlands; [Knegjens, Joost L.] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands; [Praag, John O.] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands; [El Sharouni, Sherif Y.] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands; [Hatton, Matthew] Weston Pk Hosp, Dept Clin Oncol, Sheffield, S Yorkshire, England; [Keijser, Astrid] IKNL Clin Res Dept, Amsterdam, Netherlands; [Faivre-Finn, Corinne] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England	Vrije Universiteit Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Weston Park Hospital; University of Manchester	Slotman, BJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	bj.slotman@vumc.nl	Senan, Suresh/P-5790-2019	Senan, Suresh/0000-0003-3995-2204; Faivre-Finn, Corinne/0000-0001-5617-9781; van Tinteren, Harm/0000-0002-4626-8702	Dutch Cancer Society (CKTO); Dutch Lung Cancer Research Group; Cancer Research UK; Manchester Academic Health Science Centre Trials Coordination Unit; UK National Cancer Research Network; Cancer Research UK [12339, 20465] Funding Source: researchfish	Dutch Cancer Society (CKTO); Dutch Lung Cancer Research Group; Cancer Research UK(Cancer Research UK); Manchester Academic Health Science Centre Trials Coordination Unit; UK National Cancer Research Network; Cancer Research UK(Cancer Research UK)	Dutch Cancer Society (CKTO), Dutch Lung Cancer Research Group, Cancer Research UK, Manchester Academic Health Science Centre Trials Coordination Unit, and the UK National Cancer Research Network.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Bayman N, 2009, CLIN ONCOL-UK, V21, P78, DOI 10.1016/j.clon.2008.11.004; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Froeschl S, 2008, J THORAC ONCOL, V3, P163, DOI 10.1097/JTO.0b013e318160c0cb; Fruh M, 2013, ANN ONCOL, V24, P99, DOI 10.1093/annonc/mdt178; Giuliani ME, 2011, CLIN LUNG CANCER, V12, P375, DOI 10.1016/j.cllc.2011.03.028; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hanna N, 2006, J CLIN ONCOL, V24, P2038, DOI 10.1200/JCO.2005.04.8595; Jeremic B, 1999, J CLIN ONCOL, V17, P2092, DOI 10.1200/JCO.1999.17.7.2092; Jett JR, 2013, CHEST, V143, pE400, DOI 10.1378/chest.12-2363; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Riess JW, 2014, CLIN LUNG CANCER, V15, P93, DOI 10.1016/j.cllc.2013.12.010; Rodrigues G, 2012, CLIN LUNG CANCER, V13, P1, DOI 10.1016/j.cllc.2011.04.004; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Slotman BJ, 2011, INT J RADIAT ONCOL, V79, P998, DOI 10.1016/j.ijrobp.2010.10.039; Socinski MA, 2009, J CLIN ONCOL, V27, P4787, DOI 10.1200/JCO.2009.23.1548; Yee D, 2012, RADIOTHER ONCOL, V102, P234, DOI 10.1016/j.radonc.2011.08.042; Zatloukal P, 2010, ANN ONCOL, V21, P1810, DOI 10.1093/annonc/mdq036; ZELEN M, 1973, CANCER CHEMOTH REP 3, V4, P31; Zhu H, 2011, CANCER-AM CANCER SOC, V117, P5423, DOI 10.1002/cncr.26206	23	309	334	2	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					36	42		10.1016/S0140-6736(14)61085-0	http://dx.doi.org/10.1016/S0140-6736(14)61085-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25230595	Green Published, hybrid			2022-12-28	WOS:000347154200026
J	Young, LA; Buse, JB				Young, Laura A.; Buse, John B.			GLP-1 receptor agonists and basal insulin in type 2 diabetes	LANCET			English	Editorial Material							GLUCAGON-LIKE PEPTIDE-1; EXENATIDE		[Young, Laura A.; Buse, John B.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Buse, JB (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA.	jbuse@med.unc.edu	Buse, John Bernard/J-9742-2019	Buse, John Bernard/0000-0002-9723-3876				Buse JB, 2014, DIABETES CARE, V37, P2926, DOI 10.2337/dc14-0785; Buse JB, 2011, ANN INTERN MED, V154, P103, DOI 10.7326/0003-4819-154-2-201101180-00300; Dunning BE, 2005, DIABETOLOGIA, V48, P1700, DOI 10.1007/s00125-005-1878-0; Eng C, 2014, LANCET; ENG J, 1992, MT SINAI J MED, V59, P147; Gough SC, 2014, LANCET DIABETES ENDO; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Jendle J, 2014, DIABETES, V63, pA246; Kolterman OG, 2003, J CLIN ENDOCR METAB, V88, P3082, DOI 10.1210/jc.2002-021545	9	5	7	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2180	2181		10.1016/S0140-6736(14)61409-4	http://dx.doi.org/10.1016/S0140-6736(14)61409-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25220193				2022-12-28	WOS:000346655700009
J	Wolfe, BM; Belle, SH				Wolfe, Bruce M.; Belle, Steven H.			Long-term Risks and Benefits of Bariatric Surgery A Research Challenge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERVENTION	Long-term Outcomes of Bariatric Surgery: A National Institutes of Health Symposium Anita P. Courcoulas, MD, MPH; Susan Z. Yanovski, MD; Denise Bonds, MD, MPH; Thomas L. Eggerman, MD; Mary Horlick, MD; Myrlene A. Staten, MD; David E. Arterburn, MD, MPH IMPORTANCE The clinical evidence base demonstrating bariatric surgery's health benefits is much larger than it was when the National Institutes of Health last held a consensus panel in 1991. Still, it remains unclear whether ongoing studies will address critical questions about long-term complication rates and the sustainability of weight loss and comorbidity control. OBJECTIVE To summarize findings from a multidisciplinary workshop convened in May 2013 by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Heart, Lung, and Blood Institute. The workshop aimed to summarize the current state of knowledge of bariatric surgery, review research findings on the long-term outcomes of bariatric surgery, and establish priorities for future research directions. EVIDENCE REVIEW The evidence presented at the workshop was selected by the planning committee for both its quality and duration of follow-up. The data review emphasized randomized clinical trials and large observational studies with long-term follow-up, with or without a control group. FINDINGS Several small randomized clinical trials showed greater weight loss and type 2 diabetes mellitus remission compared with nonsurgical treatments within the first 2 years of follow-up after bariatric surgery. Large, long-term observational studies have shown durable (>5 years) weight loss, diabetes, and lipid improvements with bariatric surgery. Still unclear are predictors of outcomes, long-term complications, long-term survival, microvascular and macrovascular events, mental health outcomes, and costs. The studies needed to address these knowledge gaps would be expensive and logistically difficult to perform. CONCLUSIONS AND RELEVANCE High-quality evidence shows that bariatric surgical procedures result in greater weight loss than nonsurgical treatments and are more effective at inducing initial type 2 diabetes mellitus remission in obese patients. More information is needed about the long-term durability of comorbidity control and complications after bariatric procedures and this evidence will most likely come from carefully designed observational studies.	[Wolfe, Bruce M.] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,BTE223, Portland, OR 97239 USA; [Belle, Steven H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wolfe, BM (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,BTE223, Portland, OR 97239 USA.	wolfeb@ohsu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066557] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Arterburn DE, 2013, OBES SURG, V23, P93, DOI 10.1007/s11695-012-0802-1; Courcoulas AP, 2014, JAMA SURG, V149, P1323, DOI 10.1001/jamasurg.2014.2440; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; Flum David R, 2006, Surg Obes Relat Dis, V2, P78, DOI 10.1016/j.soard.2006.02.008; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Munoz DJ, 2007, OBES SURG, V17, P1487, DOI 10.1007/s11695-008-9427-9; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	9	23	23	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1792	+		10.1001/jama.2014.12966	http://dx.doi.org/10.1001/jama.2014.12966			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25272252				2022-12-28	WOS:000344194500017
J	Faria, NR; Rambaut, A; Suchard, MA; Baele, G; Bedford, T; Ward, MJ; Tatem, AJ; Sousa, JD; Arinaminpathy, N; Pepin, J; Posada, D; Peeters, M; Pybus, OG; Lemey, P				Faria, Nuno R.; Rambaut, Andrew; Suchard, Marc A.; Baele, Guy; Bedford, Trevor; Ward, Melissa J.; Tatem, Andrew J.; Sousa, Joao D.; Arinaminpathy, Nimalan; Pepin, Jacques; Posada, David; Peeters, Martine; Pybus, Oliver G.; Lemey, Philippe			The early spread and epidemic ignition of HIV-1 in human populations	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE-DEFICIENCY-SYNDROME; GENETIC DIVERSITY; NONPANDEMIC HIV-1; CONGO SUGGESTS; SYNDROME AIDS; GROUP-O; TYPE-1; ORIGIN; STRAINS	Thirty years after the discovery of HIV-1, the early transmission, dissemination, and establishment of the virus in human populations remain unclear. Using statistical approaches applied to HIV-1 sequence data from central Africa, we show that from the 1920s Kinshasa (in what is now the Democratic Republic of Congo) was the focus of early transmission and the source of pre-1960 pandemic viruses elsewhere. Location and dating estimates were validated using the earliest HIV-1 archival sample, also from Kinshasa. The epidemic histories of HIV-1 group M and nonpandemic group O were similar until similar to 1960, after which group M underwent an epidemiological transition and outpaced regional population growth. Our results reconstruct the early dynamics of HIV-1 and emphasize the role of social changes and transport networks in the establishment of this virus in human populations.	[Faria, Nuno R.; Arinaminpathy, Nimalan; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Faria, Nuno R.; Baele, Guy; Sousa, Joao D.; Lemey, Philippe] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, B-3000 Leuven, Belgium; [Rambaut, Andrew; Ward, Melissa J.] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; [Rambaut, Andrew; Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Rambaut, Andrew] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England; [Sousa, Joao D.] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, P-1349008 Lisbon, Portugal; [Sousa, Joao D.] Univ Nova Lisboa, Unidade Microbiol, Inst Higiene & Med Trop, P-1349008 Lisbon, Portugal; [Pepin, Jacques] Univ Sherbrooke, Dept Microbiol & Infect Dis, CHUS, Sherbrooke, PQ J1H 5N4, Canada; [Posada, David] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Peeters, Martine] Inst Rech Dev, Retrovirus Lab, UMI233, F-34032 Montpellier, France; [Peeters, Martine] Univ Montpellier, F-34032 Montpellier, France	University of Oxford; KU Leuven; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Edinburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; University of Southampton; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Sherbrooke; Universidade de Vigo; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	oliver.pybus@zoo.ox.ac.uk; philippe.lemey@rega.kuleuven.be	Pybus, Oliver G/B-2640-2012; Lemey, Philippe/C-3755-2018; Faria, Nuno R/I-2975-2012; Baele, Guy/R-8157-2017; Rambaut, Andrew/B-2481-2009; Posada, David/C-4502-2008	Pybus, Oliver G/0000-0002-8797-2667; Lemey, Philippe/0000-0003-2826-5353; Faria, Nuno R/0000-0001-8839-2798; Baele, Guy/0000-0002-1915-7732; Rambaut, Andrew/0000-0003-4337-3707; Posada, David/0000-0003-1407-3406; Tatem, Andrew/0000-0002-7270-941X; Bedford, Trevor/0000-0002-4039-5794; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Rodrigues Faria, Nuno/0000-0002-9747-8822; Sousa, Joao/0000-0002-7604-3109	European Union [278433-PREDEMICS]; European Research Council [260864]; "Onderzoeksfonds KU Leuven/Research Fund KU Leuven"; NSF [DMS 1264153, EF-0423641]; NIH [R01 HG006139]; National Evolutionary Synthesis Center (NESCent); Wellcome Trust [092807]; Royal Society; Fonds voor Wetenschappelijk Onderzoek Flanders [G.0692.14]; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050529, R01AI050529] Funding Source: NIH RePORTER	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); "Onderzoeksfonds KU Leuven/Research Fund KU Leuven"(KU Leuven); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Fonds voor Wetenschappelijk Onderzoek Flanders(FWO); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the researchers whose publicly available data made this work possible and A. M. Vandamme, M. L. Kalish, M. Worobey, and G. Leonard for helpful discussions. The research leading to these results has received funding from the European Union Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 278433-PREDEMICS and European Research Council grant agreement no. 260864. P. L. was partly supported by the "Onderzoeksfonds KU Leuven/Research Fund KU Leuven." M. A. S. is partly supported by NSF grant DMS 1264153 and NIH grant R01 HG006139. Collaboration between M. A. S., A. R., and P. L. was supported by the National Evolutionary Synthesis Center (NESCent) and NSF grant EF-0423641. This work was supported by the Wellcome Trust (grant 092807) to A. R. T. B. was supported by the Royal Society. J.D.S. is partly supported by the Fonds voor Wetenschappelijk Onderzoek Flanders grant G.0692.14. The data reported in this paper are deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.nn952). Author contributions: P. L., O.G.P., A. R., M. A. S., M. P., and N.R.F. conceived the experiments and designed the study. N.R.F. and P. L. conducted the phylodynamic analyses. D. P. performed the recombination analysis and G. B. the model selection analysis. M. A. S. and T. B. contributed methodology. T. B., M.J.W., and N.A. assisted the sequence analysis. J.P., A.J.T., and J.D.S. contributed historical and spatial data. M. P. provided sequence data. N.R.F., P. L., O.G.P., and A. R. wrote the paper. All authors discussed the results and approved the final manuscript. We declare no competing financial interests.	Ayouba A, 2000, AIDS, V14, P2623, DOI 10.1097/00002030-200011100-00033; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BEHEYT P, 1953, Ann Soc Belg Med Trop (1920), V33, P297; Bikandou B, 2004, AIDS RES HUM RETROV, V20, P1005, DOI 10.1089/aid.2004.20.1005; Bonacci G., 2008, CAHIERS DETUDES AFRI, V192, P895; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; Centers for Disease Control (CDC), 1981, MMWR-MORBID MORTAL W, V30, P250; Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548; de Saint-Moulin L., 2010, VILLES ET ORGANISATI; de Sousa JD, 2012, VIRUSES-BASEL, V4, P1950, DOI 10.3390/v4101950; de Sousa JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009936; Duke-Sylvester SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0194; Flouriot J., 1994, INTRODUCTION A LA GE; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Hance W. A., 1970, POPULATION MIGRATION; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Huybrechts A., 1970, TRANSPORTS ET STRUCT; Iles JC, 2013, INFECT GENET EVOL, V19, P386, DOI 10.1016/j.meegid.2013.01.021; Institut National de la Statistique, 1969, ETUDE SOCIO DEMOGRAP; JOCHELSON K, 1991, INT J HEALTH SERV, V21, P157, DOI 10.2190/11UE-L88J-46HN-HR0K; Kalish ML, 2004, EMERG INFECT DIS, V10, P1227; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kita K, 2004, AIDS RES HUM RETROV, V20, P1352, DOI 10.1089/aid.2004.20.1352; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kuyu C., 2006, LES HAITIENS AU CONG; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lemey P, 2006, AIDS REV, V8, P125; Magiorkinis G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002876; Mulanga-Kabeya C, 1998, AIDS, V12, P905, DOI 10.1097/00002030-199808000-00013; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Ngimbi M., 1982, KINSHASA 1881 1981 1; Niama FR, 2006, INFECT GENET EVOL, V6, P337, DOI 10.1016/j.meegid.2005.12.001; NZILAMBI N, 1988, NEW ENGL J MED, V318, P276, DOI 10.1056/NEJM198802043180503; Pandrea I, 2002, AIDS RES HUM RETROV, V18, P1103, DOI 10.1089/088922202320567842; Peeters M, 1997, AIDS, V11, P493, DOI 10.1097/00002030-199704000-00013; Pepin J., 2011, THE ORIGINS OF AIDS; Pepin J, 2012, SEX TRANSM INFECT, V88, P307, DOI 10.1136/sextrans-2011-050277; PIOT P, 1984, LANCET, V2, P65; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schierup M. H., 2003, PROCEEDINGS OF THE C, V187, P231; Schierup MH, 2000, GENETICS, V156, P879; Sharp PM, 2008, NATURE, V455, P605, DOI 10.1038/455605a; UNAIDS, 2013, GLOBAL REPORTS UNAID; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018; VANDEPERRE P, 1984, LANCET, V2, P62; Vangroenweghe D, 2001, PHILOS T ROY SOC B, V356, P923, DOI 10.1098/rstb.2001.0876; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Ward MJ, 2013, J VIROL, V87, P1967, DOI 10.1128/JVI.02478-12; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yusim K, 2001, PHILOS T R SOC B, V356, P855, DOI 10.1098/rstb.2001.0859; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	63	364	380	5	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					56	61		10.1126/science.1256739	http://dx.doi.org/10.1126/science.1256739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278604	Green Accepted			2022-12-28	WOS:000342446900048
J	Guarente, L				Guarente, Leonard			Aging Research-Where Do We Stand and Where Are We Going?	CELL			English	Article							LIFE-SPAN; CALORIC RESTRICTION; CIRCADIAN CONTROL; METABOLISM; SIRT1; GENE; LONGEVITY; PROTEINS; SIRTUINS; PATHWAY	The 40 th anniversary of Cell coincides with that of the National Institute on Aging (NIA). Indeed, Cell papers on NIA-funded research helped move the field into a genetic and molecular era. Now is a fair time to ask whether we are far down a trail leading to a deep understanding of aging or whether we are still tiptoeing cautiously at the trailhead.	[Guarente, Leonard] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Paul F Glenn Labs Sci Aging, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu			NIH; Jain Foundation; Glenn Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jain Foundation; Glenn Foundation	I want to thank lab members and Mark Collins for comments and the NIH, The Jain Foundation, and Glenn Foundation for Medical Research for funding. I apologize to those whose work I did not describe or cite due to space limitations. L. G. consults for GSK, Chronos, and Segterra and is a founder and shareholder in Elysium Health.	Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244; Guarente L, 2000, GENE DEV, V14, P1021; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Johnson TE, 2013, EXP GERONTOL, V48, P640, DOI 10.1016/j.exger.2013.02.023; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mattison JA, 2014, CELL METAB, V20, P183, DOI 10.1016/j.cmet.2014.04.018; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mercken E.M., 2014, AGING CELL; Milman S, 2013, CURR VASC PHARM; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Redman LM, 2011, J CLIN ENDOCR METAB, V96, pE312, DOI 10.1210/jc.2010-1971; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Sinclair DA, 2014, ANNU REV PHARMACOL, V54, P363, DOI 10.1146/annurev-pharmtox-010611-134657; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Stumpferl SW, 2012, GENOME RES, V22, P1963, DOI 10.1101/gr.136549.111; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	40	48	51	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					15	19		10.1016/j.cell.2014.08.041	http://dx.doi.org/10.1016/j.cell.2014.08.041			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259916	Bronze			2022-12-28	WOS:000343095000005
J	Oliver, D				Oliver, David			Preventing hospital admission: we need evidence based policy rather than "policy based evidence"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Oliver, David] Dept Hlth, New Delhi, India		Oliver, D (corresponding author), City Univ London, Sch Hlth Sci, London EC1V OHB, England.	David.Oliver@royalberkshire.nhs.uk						*AUD COMM, 2000, WAY GO HOM REH REM S; Ayling M, 2012, HLTH SERVICE S 1129; Bardsley M, 2013, NUFFIELD TRUST; Department of Health, 2011, WHOL SYST DEM PROGR; Easton J, 2012, HLTH SERVICE J; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; Ham C., 2011, INTEGRATED CARE WHAT; Health Foundation, 2013, UNBL HOSP GRIDL S WA; Hutt R, 2004, CASE MANAGING LONG T; NHS Confederation, 2010, DEAL DOWNT US EV; NHS England, 2019, NHS INT PEOPL PLAN; *PERS SOC SERV RES, 2010, NAT EV PARTN OLD PEO; Purdy S, 2012, INTERVENTIONS REDUCE; Rand Europe, 2012, EV UK INT CAR PIL; Singh D, 2005, TRANSFORMING CHRONIC; Steventon A, 2012, BMJ-BRIT MED J, V344, pe374; Steventon A, 2011, PARTNERSHIPS OLDER P; West D, 2014, HLTH SERVICE J, V26	18	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2014	349								g5538	10.1136/bmj.g5538	http://dx.doi.org/10.1136/bmj.g5538			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UL	25249450				2022-12-28	WOS:000342425700002
J	Halloran, ME; Longini, IM				Halloran, M. Elizabeth; Longini, Ira M., Jr.			Emerging, evolving, and established infectious diseases and interventions	SCIENCE			English	Editorial Material							WILD POLIOVIRUS; VACCINE; TRANSMISSION; CHOLERA; EPIDEMIOLOGY; PERTUSSIS; IMMUNITY; ISRAEL	Planning, implementing, and evaluating interventions against infectious diseases depend on the nature of the infectious disease; the availability of intervention measures; and logistical, economic, and political constraints. Infectious diseases and vaccine-or drug-based interventions can be loosely categorized by the degree to which the infectious disease and the intervention are well established. Pertussis, polio, and measles are three examples of long-known infectious diseases for which global vaccination has dramatically reduced the public health burden. Pertussis vaccination was introduced in the 1940s, polio vaccination in the 1950s, and measles vaccination in the 1960s, nearly eliminating these diseases in many places.	[Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Ctr Stat & Quantitat Infect Dis, Seattle, WA 98109 USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98105 USA; [Longini, Ira M., Jr.] Univ Florida, Dept Biostat, Ctr Stat & Quantitat Infect Dis, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Longini, Ira M., Jr.] Univ Florida, Coll Med, Gainesville, FL 32611 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Halloran, ME (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Ctr Stat & Quantitat Infect Dis, 1100 Fairview Ave North, Seattle, WA 98109 USA.	betz@u.washington.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER; NIAID NIH HHS [R37-AI032042, R37 AI032042] Funding Source: Medline; NIGMS NIH HHS [U01 GM070749, U01-GM070749] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Anis E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.38.20586; Azman AS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001901; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chao DL, 2011, P NATL ACAD SCI USA, V108, P7081, DOI 10.1073/pnas.1102149108; HALLORAN ME, 1994, AM J EPIDEMIOL, V140, P81, DOI 10.1093/oxfordjournals.aje.a117238; Halloran ME., 2010, DESIGN ANAL VACCINE; Jackson DW, 2014, EPIDEMIOL INFECT, V142, P672, DOI 10.1017/S0950268812003093; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509; Panozzo CA, 2014, AM J EPIDEMIOL, V179, P895, DOI 10.1093/aje/kwu001; Pawloski LC, 2014, CLIN VACCINE IMMUNOL, V21, P119, DOI 10.1128/CVI.00717-13; Shulman LM, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.7.20709; Struchiner CJ, 2007, EPIDEMIOL INFECT, V135, P181, DOI 10.1017/S0950268806006716; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; WHO, 2005, VACC INTR GUID ADD V	20	8	8	6	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1292	1294		10.1126/science.1254166	http://dx.doi.org/10.1126/science.1254166			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214617	Green Accepted			2022-12-28	WOS:000341483800049
J	Maka, V; Harish, K				Maka, Vinayak; Harish, Krishnamachar			Multiple chest wall swellings in adult Burkitt's lymphoma	LANCET			English	Editorial Material									[Maka, Vinayak] MS Ramaiah Med Coll, Dept Med Oncol, Bangalore 560054, Karnataka, India; [Harish, Krishnamachar] MS Ramaiah Med Coll, Dept Surg Oncol, Bangalore 560054, Karnataka, India		Maka, V (corresponding author), MS Ramaiah Med Coll, Dept Med Oncol, Bangalore 560054, Karnataka, India.	vinayakvmaka@gmail.com		Krishnamachar, Harish/0000-0003-0751-5296; Maka, Vinayak/0000-0001-6356-3861					0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2244	2244		10.1016/S0140-6736(14)61608-1	http://dx.doi.org/10.1016/S0140-6736(14)61608-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25263574				2022-12-28	WOS:000346655700027
J	Hamnvik, OPR; Saldana, F; Levy, BD; Loscalzo, J				Hamnvik, Ole-Petter Riksfjord; Saldana, Fidencio; Levy, Bruce D.; Loscalzo, Joseph			Against the Grain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELIAC-DISEASE; RISK	A 42-year-old man with a history of coronary artery disease and dyslipidemia presented to the emergency department with abdominal and chest discomfort. Two days earlier, he had had a sudden onset of abdominal pain in the left upper quadrant, which radiated to his back and in a bandlike pattern across the subcostal margin. The abdominal pain was associated with nausea and early satiety and worsened with movement. During the next 2 days, the abdominal discomfort increased from an intensity of 3 to 6 on a 10-point scale. In addition, he reported substernal chest pressure, which had developed the day before presentation and was consistent with his usual angina but was unresponsive to self-administration of one sublingual nitroglycerin tablet. The pain diminished with three sublingual nitroglycerin tablets administered in the emergency department but resolved only after he had been given intravenous morphine, ketorolac, and a chewable aspirin. The patient reported no abdominal trauma, emesis, rectal bleeding, or black stools. He had not consumed any meals outside his home recently. He reported having had chronic diarrhea since undergoing coronary-artery bypass surgery more than 10 years before presentation, but with increasing volume and frequency (four loose stools a day) after the dose of his cholesterol-lowering medication was increased 6 months earlier. He noted that the diarrhea would worsen with food intake. Over this period of time, he had a 16-kg (35-lb) unintentional weight loss with intermittent early satiety. He also noted daily headaches and frequent nocturia, and he reported feeling warm at night, without night sweats or fevers. A colonoscopy performed 4 months before the current presentation was unremarkable.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med Bldg, Boston, MA 02115 USA.	blevy@partners.org	McKinnon, Ross Allan/B-9340-2009; Hamnvik, Ole-Petter/D-1719-2011; Loscalzo, Joseph/ABD-8980-2021	McKinnon, Ross Allan/0000-0002-3725-793X; 				Casella G, 2013, LIVER INT, V33, P1128, DOI 10.1111/liv.12178; Catassi C, 2005, GASTROENTEROLOGY, V128, pS79, DOI 10.1053/j.gastro.2005.02.027; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hopper AD, 2007, BRIT MED J, V335, P558, DOI 10.1136/bmj.39316.442338.AD; Lebwohl B, 2012, GASTROINTEST ENDOSC, V76, P779, DOI 10.1016/j.gie.2012.05.011; Lucey BC, 2005, RADIOGRAPHICS, V25, P351, DOI 10.1148/rg.252045108; Ludvigsson JF, 2007, CLIN GASTROENTEROL H, V5, P1347, DOI 10.1016/j.cgh.2007.06.002; Ludvigsson JF, 2011, CIRCULATION, V123, P483, DOI 10.1161/CIRCULATIONAHA.110.965624; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79	12	2	2	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1333	1338		10.1056/NEJMcps1301321	http://dx.doi.org/10.1056/NEJMcps1301321			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25271607				2022-12-28	WOS:000342429800011
J	Victor, DG; Kennel, CF				Victor, David G.; Kennel, Charles F.			Ditch the 2 degrees C warming goal	NATURE			English	Editorial Material									[Victor, David G.] Univ Calif San Diego, Sch Int Relat & Pacif Studies, La Jolla, CA 92093 USA; [Kennel, Charles F.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Victor, DG (corresponding author), Univ Calif San Diego, Sch Int Relat & Pacif Studies, La Jolla, CA 92093 USA.	david.victor@ucsd.edu		Kennel, Charles/0000-0001-5997-7201				Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Bourguignon F., 2010, EQUITY GROWTH GLOBAL, P17; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Hansen J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/011006; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Levy Marc, 1993, I EARTH SOURCES EFFE, P75; Randalls S, 2010, WIRES CLIM CHANGE, V1, P598, DOI 10.1002/wcc.62; Victor D, 2011, GLOBAL WARMING GRIDL; Victor DG, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P111	10	82	82	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					30	31		10.1038/514030a	http://dx.doi.org/10.1038/514030a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP9SS	25279903	Bronze			2022-12-28	WOS:000342420800018
J	Chiang, YTP; Chikwe, J; Moskowitz, AJ; Itagaki, S; Adams, DH; Egorova, NN				Chiang, Yuting P.; Chikwe, Joanna; Moskowitz, Alan J.; Itagaki, Shinobu; Adams, David H.; Egorova, Natalia N.			Survival and Long-term Outcomes Following Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients Aged 50 to 69 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREFERRED OPTION; TISSUE VALVE; HEART-VALVE; MANAGEMENT; PROSTHESES; SELECTION; RISK	IMPORTANCE The choice between bioprosthetic and mechanical aortic valve replacement in younger patients is controversial because long-term survival and major morbidity are poorly characterized. OBJECTIVE To quantify survival and major morbidity in patients aged 50 to 69 years undergoing aortic valve replacement. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort analysis of 4253 patients aged 50 to 69 years who underwent primary isolated aortic valve replacement using bioprosthetic vs mechanical valves in New York State from 1997 through 2004, identified using the Statewide Planning and Research Cooperative System. Median follow-up time was 10.8 years (range, 0 to 16.9 years); the last follow-up date for mortality was November 30, 2013. Propensity matching yielded 1001 patient pairs. MAIN OUTCOMES AND MEASURES Primary outcome was all-cause mortality; secondary outcomes were stroke, reoperation, and major bleeding. RESULTS No differences in survival or stroke rates were observed in patients with bioprosthetic compared with mechanical valves. Actuarial 15-year survival was 60.6%(95% CI, 56.3%-64.9%) in the bioprosthesis group compared with 62.1%(95% CI, 58.2%-66.0%) in the mechanical prosthesis group (hazard ratio, 0.97 [95% CI, 0.83-1.14]). The 15-year cumulative incidence of stroke was 7.7%(95% CI, 5.7%-9.7%) in the bioprosthesis group and 8.6%(95% CI, 6.2%-11.0%) in the mechanical prosthesis group (hazard ratio, 1.04 [95% CI, 0.75-1.43). The 15-year cumulative incidence of reoperation was higher in the bioprosthesis group (12.1% [95% CI, 8.8%-15.4%] vs 6.9%[95% CI, 4.2%-9.6%]; hazard ratio, 0.52 [95% CI, 0.36-0.75]). The 15-year cumulative incidence of major bleeding was higher in the mechanical prosthesis group (13.0%[95% CI, 9.9%-16.1%] vs 6.6%[95% CI, 4.8%-8.4%]; hazard ratio, 1.75 [95% CI, 1.27-2.43]). The 30-day mortality rate was 18.7% after stroke, 9.0% after reoperation, and 13.2% after major bleeding. CONCLUSIONS AND RELEVANCE Among propensity-matched patients aged 50 to 69 years who underwent aortic valve replacement with bioprosthetic compared with mechanical valves, there was no significant difference in 15-year survival or stroke. Patients in the bioprosthetic valve group had a greater likelihood of reoperation but a lower likelihood of major bleeding. These findings suggest that bioprosthetic valves may be a reasonable choice in patients aged 50 to 69 years. Copyright 2014 American Medical Association. All rights reserved.	[Chiang, Yuting P.; Chikwe, Joanna; Itagaki, Shinobu; Adams, David H.] Mt Sinai Med Ctr, Dept Cardiovasc Surg, New York, NY 10029 USA; [Moskowitz, Alan J.; Egorova, Natalia N.] Icahn Sch Med Mt Sinai, Dept Hlth Evidence & Policy, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chikwe, J (corresponding author), Mt Sinai Med Ctr, Dept Cardiovasc Surg, 1190 Fifth Ave, New York, NY 10029 USA.	joanna.chikwe@mountsinai.org		Moskowitz, Alan/0000-0002-4412-9450	Icahn School of Medicine at Mount Sinai Patient Oriented Research Training and Leadership (PORTAL) Program; Edwards Lifesciences; Medtronic	Icahn School of Medicine at Mount Sinai Patient Oriented Research Training and Leadership (PORTAL) Program; Edwards Lifesciences; Medtronic(Medtronic)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Mr Chiang reported receiving a research stipend from the Icahn School of Medicine at Mount Sinai Patient Oriented Research Training and Leadership (PORTAL) Program. Dr Adams reported that the Icahn School of Medicine at Mount Sinai receives royalties payments from Edwards Lifesciences and Medtronic for intellectual property related to his involvement in the development of 2 mitral valve repair rings and 1 tricuspid valve repair ring and that he is National Co-Principal Investigator of the CoreValve United States Pivotal Trial, which was supported by Medtronic. No other authors reported disclosures.	Breglio A, 2013, ANN THORAC SURG, V95, P1603, DOI 10.1016/j.athoracsur.2013.01.073; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Brown ML, 2008, J THORAC CARDIOV SUR, V135, P878, DOI 10.1016/j.jtcvs.2007.10.065; Buie VC., 2010, VITAL HLTH STAT, V13, P1; Chikwe J, 2010, NAT REV CARDIOL, V7, P711, DOI 10.1038/nrcardio.2010.164; Davierwala PM, 2006, J THORAC CARDIOV SUR, V131, P329, DOI 10.1016/j.jtcvs.2005.09.022; Dvir D, 2012, CIRCULATION, V126, P2335, DOI 10.1161/CIRCULATIONAHA.112.104505; Grunkemeier G L, 2000, Curr Probl Cardiol, V25, P73; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; Hering D, 2005, CHEST, V127, P53, DOI 10.1378/chest.127.1.53; Kaneko T, 2013, CIRCULATION, V128, P1365, DOI 10.1161/CIRCULATIONAHA.113.002584; Koertke H, 2010, ANN THORAC SURG, V90, P1487, DOI 10.1016/j.athoracsur.2010.06.069; Kulik A, 2006, EUR J CARDIO-THORAC, V30, P485, DOI 10.1016/j.ejcts.2006.06.013; McClure RS, J THORAC CARDIOVASC, DOI [10.1016/jtcvs.2013.12.042, DOI 10.1016/JTCVS.2013.12.042]; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Oxenham H, 2003, HEART, V89, P715, DOI 10.1136/heart.89.7.715; Potter DD, 2005, J THORAC CARDIOV SUR, V129, P94, DOI 10.1016/j.jtcvs.2004.08.023; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ruel M, 2005, EUR J CARDIO-THORAC, V27, P425, DOI 10.1016/j.ejcts.2004.12.002; Ruel M, 2004, ANN THORAC SURG, V78, P77, DOI 10.1016/j.athoracsur.2003.12.058; Stassano P, 2009, J AM COLL CARDIOL, V54, P1862, DOI 10.1016/j.jacc.2009.07.032; Suri RM, 2013, CIRCULATION, V128, P1372, DOI 10.1161/CIRCULATIONAHA.113.001681; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109	23	172	178	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1323	1329		10.1001/jama.2014.12679	http://dx.doi.org/10.1001/jama.2014.12679			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268439	Bronze, Green Published			2022-12-28	WOS:000342345400018
J	Smith, JM				Smith, Jeanette M.			Forest of Fontainebleau, Autumn Narcisse Virgile Diaz de la Pena	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1280	1281		10.1001/jama.2013.279755	http://dx.doi.org/10.1001/jama.2013.279755			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268424				2022-12-28	WOS:000342345400001
J	Tricco, AC; Ashoor, HM; Antony, J; Beyene, J; Veroniki, AA; Isaranuwatchai, W; Harrington, A; Wilson, C; Tsouros, S; Soobiah, C; Yu, CH; Hutton, B; Hoch, JS; Hemmelgarn, BR; Moher, D; Majumdar, SR; Straus, SE				Tricco, Andrea C.; Ashoor, Huda M.; Antony, Jesmin; Beyene, Joseph; Veroniki, Areti Angeliki; Isaranuwatchai, Wanrudee; Harrington, Alana; Wilson, Charlotte; Tsouros, Sophia; Soobiah, Charlene; Yu, Catherine H.; Hutton, Brian; Hoch, Jeffrey S.; Hemmelgarn, Brenda R.; Moher, David; Majumdar, Sumit R.; Straus, Sharon E.			Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BASAL-BOLUS REGIMEN; NEUTRAL PROTAMINE HAGEDORN; FASTING BLOOD-GLUCOSE; NPH HUMAN INSULIN; GLARGINE HOE 901; GLYCEMIC CONTROL; NOCTURNAL HYPOGLYCEMIA; MEALTIME INSULIN; PARALLEL-GROUP; WEIGHT-GAIN	Objective To examine the safety, effectiveness, and cost effectiveness of long acting insulin for type 1 diabetes. Design Systematic review and network meta-analysis. Data sources Medline, Cochrane Central Register of Controlled Trials, Embase, and grey literature were searched through January 2013. Study selection Randomized controlled trials or non-randomized studies of long acting (glargine, detemir) and intermediate acting (neutral protamine Hagedorn (NPH), lente) insulin for adults with type 1 diabetes were included. Results 39 studies (27 randomized controlled trials including 7496 patients) were included after screening of 6501 titles/abstracts and 190 full text articles. Glargine once daily, detemir once daily, and detemir once/twice daily significantly reduced hemoglobin A(1c) compared with NPH once daily in network meta-analysis (26 randomized controlled trials, mean difference -0.39%, 95% confidence interval -0.59% to -0.19%; -0.26%, -0.48% to -0.03%; and -0.36%, -0.65% to -0.08%; respectively). Differences in network meta-analysis were observed between long acting and intermediate acting insulin for severe hypoglycemia (16 randomized controlled trials; detemir once/twice daily versus NPH once/twice daily: odds ratio 0.62, 95% confidence interval 0.42 to 0.91) and weight gain (13 randomized controlled trials; detemir once daily versus NPH once/twice daily: mean difference 4.04 kg, 3.06 to 5.02 kg; detemir once/twice daily versus NPH once daily: -5.51 kg, -6.56 to -4.46 kg; glargine once daily versus NPH once daily: -5.14 kg, -6.07 to -4.21). Compared with NPH, detemir was less costly and more effective in 3/14 cost effectiveness analyses and glargine was less costly and more effective in 2/8 cost effectiveness analyses. The remaining cost effectiveness analyses found that detemir and glargine were more costly but more effective than NPH. Glargine was not cost effective compared with detemir in 2/2 cost effectiveness analyses. Conclusions Long acting insulin analogs are probably superior to intermediate acting insulin analogs, although the difference is small for hemoglobin A(1c). Patients and their physicians should tailor their choice of insulin according to preference, cost, and accessibility.	[Tricco, Andrea C.; Ashoor, Huda M.; Antony, Jesmin; Veroniki, Areti Angeliki; Isaranuwatchai, Wanrudee; Harrington, Alana; Wilson, Charlotte; Tsouros, Sophia; Soobiah, Charlene; Yu, Catherine H.; Hoch, Jeffrey S.; Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada; [Beyene, Joseph] McMaster Univ, Hamilton, ON L8S 4K1, Canada; [Hutton, Brian; Moher, David] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON K1H 8L6, Canada; [Hutton, Brian; Moher, David] Univ Ottawa, Fac Med, Ottawa, ON K1H 8L6, Canada; [Hemmelgarn, Brenda R.] Univ Calgary, Dept Med Sci, Calgary, AB T2N 4Z6, Canada; [Hemmelgarn, Brenda R.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada; [Majumdar, Sumit R.] Univ Alberta, Dept Med, Edmonton, AB T6G 2R3, Canada; [Straus, Sharon E.] Univ Toronto, Dept Geriatr Med, Toronto, ON M5S 1A1, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Calgary; University of Calgary; University of Alberta; University of Toronto	Straus, SE (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada.	sharon.straus@utoronto.ca	Tricco, Andrea/B-9920-2011; Hoch, Jeffrey/O-3406-2017; Moher, David/I-3408-2019	Tricco, Andrea/0000-0002-4114-8971; Hoch, Jeffrey/0000-0002-4880-4281; Moher, David/0000-0003-2434-4206; /0000-0001-6388-4825; Hutton, Brian/0000-0001-5662-8647	Canadian Institutes for Health Research/Drug Safety and Effectiveness Network (CIHR/DSEN); CIHR/DSEN new investigator awards in knowledge synthesis; University of Ottawa Research chair; Faculty of Medicine and Dentistry; Faculty of Pharmacy and Pharmaceutical Sciences; Alberta Heritage Foundation for Medical Research; Alberta Innovates - Health Solutions; tier 1 Canada research chair in knowledge translation	Canadian Institutes for Health Research/Drug Safety and Effectiveness Network (CIHR/DSEN)(Canadian Institutes of Health Research (CIHR)); CIHR/DSEN new investigator awards in knowledge synthesis; University of Ottawa Research chair; Faculty of Medicine and Dentistry; Faculty of Pharmacy and Pharmaceutical Sciences; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Alberta Innovates - Health Solutions; tier 1 Canada research chair in knowledge translation	This systematic review was funded by the Canadian Institutes for Health Research/Drug Safety and Effectiveness Network (CIHR/DSEN). The study funder had no role in the design, conduct, analysis, and decision to submit for publication. ACT and BH are funded by CIHR/DSEN new investigator awards in knowledge synthesis. JB holds the John D Cameron endowed chair in the genetic determinants of chronic diseases, Department of Clinical Epidemiology and Biostatistics, McMaster University. DM is funded by a University of Ottawa Research chair. SRM is the endowed chair in patient health management (supported by the Faculties of Medicine and Dentistry and Pharmacy and Pharmaceutical Sciences) and holds a health scholar salary award (supported by Alberta Heritage Foundation for Medical Research and Alberta Innovates - Health Solutions). SES is funded by a tier 1 Canada research chair in knowledge translation.	Ashwell SG, 2006, DIABETIC MED, V23, P879, DOI 10.1111/j.1464-5491.2006.01913.x; Bartley PC, 2008, DIABETIC MED, V25, P442, DOI 10.1111/j.1464-5491.2007.02407.x; Bolli GB, 2009, NUTR METAB CARDIOVAS, V19, P571, DOI 10.1016/j.numecd.2008.05.003; Cameron CG, 2009, CAN MED ASSOC J, V180, P400, DOI 10.1503/cmaj.081180; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chatterjee S, 2007, DIABETES RES CLIN PR, V77, P215, DOI 10.1016/j.diabres.2006.11.002; Sanches ACC, 2011, DIABETES RES CLIN PR, V94, P333, DOI 10.1016/j.diabres.2011.09.001; Currie CJ, 2007, CURR MED RES OPIN, V23, pS33, DOI 10.1185/030079907X167534; De Leeuw I, 2005, DIABETES OBES METAB, V7, P73, DOI 10.1111/j.1463-1326.2004.00363.x; Drummond MF, 2005, METHODS EC HLTH EVAL; Fulcher GR, 2005, INTERN MED J, V35, P536, DOI 10.1111/j.1445-5994.2005.00902.x; Greiner RA, 2009, 69 AM DIAB ASS ADA S; Grima DT, 2007, PHARMACOECONOMICS, V25, P253, DOI 10.2165/00019053-200725030-00007; Gschwend Manuela Helena, 2009, J Med Econ, V12, P114, DOI 10.3111/13696990903080344; Heller S, 2009, CLIN THER, V31, P2086, DOI 10.1016/j.clinthera.2009.10.006; Hershon Kenneth S, 2004, Endocr Pract, V10, P10; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Home P, 2004, DIABETES CARE, V27, P1081, DOI 10.2337/diacare.27.5.1081; Kobayashi Masashi, 2007, Journal of the Japan Diabetes Society, V50, P649; Kolendorf K, 2006, DIABETIC MED, V23, P729, DOI 10.1111/j.1464-5491.2006.01862.x; Le Floch JP, 2009, DIABETES CARE, V32, P32, DOI 10.2337/dc08-0332; Mathiesen ER, 2012, DIABETES CARE, V35, P2012, DOI 10.2337/dc11-2264; McEwan P, 2007, CURR MED RES OPIN, V23, pS7, DOI 10.1185/030079907X167561; Moher D, 2011, 9 COCHR C MADR SPAIN; Monami M, 2009, DIABETES OBES METAB, V11, P372, DOI 10.1111/j.1463-1326.2008.00976.x; OANDA, 2013, HIST EXCH RAT; Pesic Milica, 2007, Vojnosanit Pregl, V64, P247, DOI 10.2298/VSP0704247P; Pfohl Martin, 2012, J Med Econ, V15 Suppl 2, P14, DOI 10.3111/13696998.2012.713879; Philippo H, 2007, EFFICACY SAFETY INSU; Pieber TR, 2007, DIABETIC MED, V24, P635, DOI 10.1111/j.1464-5491.2007.02113.x; Pieber TR, 2005, DIABETIC MED, V22, P850, DOI 10.1111/j.1464-5491.2005.01545.x; Pieber TR, 2000, DIABETES CARE, V23, P157, DOI 10.2337/diacare.23.2.157; Porcellati F, 2004, DIABETIC MED, V21, P1213, DOI 10.1111/j.1464-5491.2004.01323.x; Radman M, 2007, ANN SAUDI MED, V27, P166, DOI 10.5144/0256-4947.2007.166; Raskin P, 2000, DIABETES CARE, V23, P1666, DOI 10.2337/diacare.23.11.1666; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Raudenbush S.W., 2009, HDB RES SYNTHESIS ME, P295; Renard E, 2011, DIABETES TECHNOL THE, V13, P1213, DOI 10.1089/dia.2011.0063; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rosenstock J, 2000, DIABETES CARE, V23, P1137, DOI 10.2337/diacare.23.8.1137; Rossetti P, 2003, DIABETES CARE, V26, P1490, DOI 10.2337/diacare.26.5.1490; Russell-Jones D, 2004, CLIN THER, V26, P724, DOI 10.1016/S0149-2918(04)90072-0; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Santaguida P, 2008, MCMASTER QUALITY ASS; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Standl Eberhard, 2004, Diabetes Technol Ther, V6, P579, DOI 10.1089/dia.2004.6.579; Tran K, 2007, 92 CAN AG DRUGS TECH; Tricco A, 2013, SAFETY EFFECTIVENESS; Tricco AC, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-73; Tunis SL, 2009, CURR MED RES OPIN, V25, P1273, DOI [10.1185/03007990902869169, 10.1185/03007990902869169 ]; U.S. Department of Labor, 2013, CONS PRIC IND; Vague P, 2003, DIABETES CARE, V26, P590, DOI 10.2337/diacare.26.3.590; Valensi P, 2005, DIABETES METAB, V31, pS34; Valentine WJ, 2012, DIABETIC MED, V29, P303, DOI 10.1111/j.1464-5491.2011.03461.x; Valentine WJ, 2006, ADV THER, V23, P191, DOI 10.1007/BF02850126; Valentine WJ, 2011, SCAND J PUBLIC HEALT, V39, P79, DOI 10.1177/1403494810379290; Vardi M, 2008, COCHRANE DB SYST REV, V3; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wells G., NEWCASTLE OTTAWA SCA; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206; Zachariah S, 2011, DIABETES CARE, V34, P1487, DOI 10.2337/dc11-0098	64	60	60	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2014	349								g5459	10.1136/bmj.g5459	http://dx.doi.org/10.1136/bmj.g5459			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CF	25274009	hybrid, Green Published			2022-12-28	WOS:000342665600001
J	Adler, DS; Wilkinson, KN; Blockley, S; Mark, DF; Pinhasi, R; Schmidt-Magee, BA; Nahapetyan, S; Mallol, C; Berna, F; Glauberman, PJ; Raczynski-Henk, Y; Wales, N; Frahm, E; Joris, O; MacLeod, A; Smith, VC; Cullen, VL; Gasparian, B				Adler, D. S.; Wilkinson, K. N.; Blockley, S.; Mark, D. F.; Pinhasi, R.; Schmidt-Magee, B. A.; Nahapetyan, S.; Mallol, C.; Berna, F.; Glauberman, P. J.; Raczynski-Henk, Y.; Wales, N.; Frahm, E.; Joeris, O.; MacLeod, A.; Smith, V. C.; Cullen, V. L.; Gasparian, B.			Early Levallois technology and the Lower to Middle Paleolithic transition in the Southern Caucasus	SCIENCE			English	Article							LESSER CAUCASUS; GEGHAMA HIGHLAND; CORE TECHNOLOGY; MODERN HUMANS; QESEM CAVE; GEOCHRONOLOGY; VARIABILITY; CYCLES; ORIGIN; SITES	The Lower to Middle Paleolithic transition (similar to 400,000 to 200,000 years ago) is marked by technical, behavioral, and anatomical changes among hominin populations throughout Africa and Eurasia. The replacement of bifacial stone tools, such as handaxes, by tools made on flakes detached from Levallois cores documents the most important conceptual shift in stone tool production strategies since the advent of bifacial technology more than one million years earlier and has been argued to result from the expansion of archaic Homo sapiens out of Africa. Our data from Nor Geghi 1, Armenia, record the earliest synchronic use of bifacial and Levallois technology outside Africa and are consistent with the hypothesis that this transition occurred independently within geographically dispersed, technologically precocious hominin populations with a shared technological ancestry.	[Adler, D. S.; Schmidt-Magee, B. A.; Glauberman, P. J.; Wales, N.] Univ Connecticut, Dept Anthropol, 354 Mansfield Rd,Unit 1176, Storrs, CT 06269 USA; [Wilkinson, K. N.] Univ Winchester, Dept Archaeol, Winchester SO22 4NR, Hants, England; [Blockley, S.; MacLeod, A.] Univ London, Dept Geog, Egham TW20 0EX, Surrey, England; [Mark, D. F.] Scottish Univ Environm Res Ctr, Nat Environm Res Council, Argon Isotope Facil, E Kilbride G75 0QF, Lanark, Scotland; [Pinhasi, R.] Univ Coll Dublin, Sch Archaeol, Dublin 4, Ireland; [Nahapetyan, S.] Yerevan State Univ, Dept Cartog & Geomorphol, Yerevan 0025, Armenia; [Mallol, C.] Univ La Laguna, Dept Geog & Hist, Tenerife, Spain; [Berna, F.] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Raczynski-Henk, Y.] Ex Situ Silex, Leiden, Netherlands; [Wales, N.] Univ Copenhagen, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Frahm, E.] Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England; [Joeris, O.] MONREPOS Archaeol Res Ctr, D-56567 Schloss Monrepos, Neuwied, Germany; [Joeris, O.] Romisch German Zent Museum Mainz, Museum Human Behav Evolut, D-56567 Schloss Monrepos, Neuwied, Germany; [Smith, V. C.; Cullen, V. L.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; [Gasparian, B.] Natl Acad Sci Republ Armenia, Inst Archaeol & Ethnol, Yerevan 0025, Armenia	University of Connecticut; University of Winchester; University of London; Royal Holloway University London; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University College Dublin; Yerevan State University; Universidad de la Laguna; Simon Fraser University; University of Copenhagen; University of Sheffield; University of Oxford; National Academy of Sciences of Armenia; Institute of Archaeology & Ethnography - NAS RA	Adler, DS (corresponding author), Univ Connecticut, Dept Anthropol, 354 Mansfield Rd,Unit 1176, Storrs, CT 06269 USA.	daniel.adler@uconn.edu	Nahapetyan, Samvel/HDM-8050-2022; Smith, Victoria C/P-6317-2016; Wales, Nathan/B-4263-2015; Smith, Victoria/AAA-4152-2021; Pinhasi, Ron/AAT-1531-2020	Smith, Victoria C/0000-0003-0878-5060; Wales, Nathan/0000-0003-0359-8450; Smith, Victoria/0000-0003-0878-5060; Pinhasi, Ron/0000-0003-1629-8131; Glauberman, Phil/0000-0002-2970-2247; Berna, Francesco/0000-0002-3839-4012; Joris, Olaf/0000-0002-6360-5096; Blockley, Simon/0000-0003-0712-2118; Raczynski-Henk, Yannick/0000-0002-6032-9751	University of Connecticut [Norian Armenian Programs Committee, College of Liberal Arts and Sciences (CLAS), Office of Global Affairs, Study Abroad]; University of Connecticut [CLAS Book Committee]; UK Natural Environment Research Council [IP-1186-0510]; Leakey Foundation; Irish Research Council; University of Winchester; Natural Environment Research Council [1204874] Funding Source: researchfish	University of Connecticut [Norian Armenian Programs Committee, College of Liberal Arts and Sciences (CLAS), Office of Global Affairs, Study Abroad]; University of Connecticut [CLAS Book Committee]; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leakey Foundation; Irish Research Council(Irish Research Council for Science, Engineering and Technology); University of Winchester; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Data discussed in this paper can be found in the supplementary materials. All artifacts are stored at the Institute of Archeology and Ethnography, Yerevan, Armenia. We thank the following organizations for their financial support: the University of Connecticut [2008-2014: Norian Armenian Programs Committee, College of Liberal Arts and Sciences (CLAS), Office of Global Affairs, Study Abroad; and CLAS Book Committee]; the UK Natural Environment Research Council (grant IP-1186-0510), the L. S. B. Leakey Foundation (2010 and 2011), the Irish Research Council (2008 and 2009), and the University of Winchester. We also thank P. Avetisyan and B. Yeritsyan, Institute of Archeology and Ethnography, Republic of Armenia, for their collaboration.	Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Arutyunyan EV, 2007, DOKL EARTH SCI, V416, P1042, DOI 10.1134/S1028334X07070136; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Badalian R, 2001, RADIAT MEAS, V34, P373, DOI 10.1016/S1350-4487(01)00189-5; Barkal R, 2003, NATURE, V423, P977, DOI 10.1038/nature01718; Boeda E., 1994, CONCEPT LEVALLOIS VA; Brantingham PJ, 2001, J ARCHAEOL SCI, V28, P747, DOI 10.1006/jasc.2000.0594; Clark G., 1969, WORLD PREHISTORY NEW, DOI DOI 10.1016/j.jhevol.2018.01.003; Dibble E., 1995, DEFINITION INTERPRET, P41; Doronichev V.B., 2008, PALEOANTHROPOLOGY, V2008, P107; Eren MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029273; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Fontana F, 2013, J ANTHROPOL ARCHAEOL, V32, P478, DOI 10.1016/j.jaa.2013.08.003; Frahm E, 2014, J ARCHAEOL SCI, V41, P333, DOI 10.1016/j.jas.2013.08.012; Herries Andy I R, 2011, Int J Evol Biol, V2011, P961401, DOI 10.4061/2011/961401; Hopkinson Terry, 2013, Paleoanthropology, P61; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; JELINEK AJ, 1982, SCIENCE, V216, P1369, DOI 10.1126/science.216.4553.1369; Joannin S, 2010, EARTH PLANET SC LETT, V291, P149, DOI 10.1016/j.epsl.2010.01.007; Kuhn SL, 2013, CURR ANTHROPOL, V54, pS255, DOI 10.1086/673529; Lebedev VA, 2013, J VOLCANOL SEISMOL+, V7, P204, DOI 10.1134/S0742046313030044; Lycett SJ, 2007, J ANTHROPOL ARCHAEOL, V26, P541, DOI 10.1016/j.jaa.2007.07.003; Lycett SJ, 2013, WORLD ARCHAEOL, V45, P519, DOI 10.1080/00438243.2013.821670; Lycett SJ, 2013, J ARCHAEOL SCI, V40, P2384, DOI 10.1016/j.jas.2013.01.016; McBrearty S, 2013, J ANTHROPOL RES, V69, P7, DOI 10.3998/jar.0521004.0069.102; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mercier N, 2007, J ARCHAEOL SCI, V34, P1064, DOI 10.1016/j.jas.2006.09.021; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Ollivier V, 2010, QUATERN INT, V223, P312, DOI 10.1016/j.quaint.2010.02.008; Petraglia MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049840; Picin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076182; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Shea JJ, 2011, CURR ANTHROPOL, V52, P1, DOI 10.1086/658067; Shimelmitz R, 2011, J HUM EVOL, V61, P458, DOI 10.1016/j.jhevol.2011.06.003; STOCKLI R., 2005, BLUE MARBLE NEXT GEN; Tryon CA, 2013, CURR ANTHROPOL, V54, pS234, DOI 10.1086/673752; Valladas H, 2013, J HUM EVOL, V65, P585, DOI 10.1016/j.jhevol.2013.07.005; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653	39	137	139	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1609	1613		10.1126/science.1256484	http://dx.doi.org/10.1126/science.1256484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AP6CG	25258079				2022-12-28	WOS:000342164500045
J	Mace, GM				Mace, Georgina M.			Whose conservation?	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIODIVERSITY; FRAMEWORK		UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Mace, GM (corresponding author), UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, Mortimer St, London WC1E 6BT, England.	g.mace@ucl.ac.uk	Mace, Georgina M/I-3072-2016	Mace, Georgina M/0000-0001-8965-5211				Adams W.M., 2004, EXTINCTION STORY CON, DOI 10.4324/9781849770415; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2010, UN CONV BIOL DIV STR; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Hutton J, 2005, FORUM DEV STUD, V32, P341, DOI 10.1080/08039410.2005.9666319; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; McCauley DJ, 2006, NATURE, V443, P27, DOI 10.1038/443027a; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Redford KH, 2013, CONSERV BIOL, V27, P437, DOI 10.1111/cobi.12071; Redford KH, 2009, CONSERV BIOL, V23, P785, DOI 10.1111/j.1523-1739.2009.01271.x; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Soule M, 2014, CONSERV BIOL, V28, P637, DOI 10.1111/cobi.12293; Turner RK, 2008, ENVIRON RESOUR ECON, V39, P25, DOI 10.1007/s10640-007-9176-6	20	536	548	16	331	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1558	1560		10.1126/science.1254704	http://dx.doi.org/10.1126/science.1254704			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258063				2022-12-28	WOS:000342164500019
J	Zhang, XO; Wang, HB; Zhang, Y; Lu, XH; Chen, LL; Yang, L				Zhang, Xiao-Ou; Wang, Hai-Bin; Zhang, Yang; Lu, Xuhua; Chen, Ling-Ling; Yang, Li			Complementary Sequence-Mediated Exon Circularization	CELL			English	Article							RNA; IDENTIFICATION; ALGORITHM; FUSION; SRY	Exon circularization has been identified from many loci in mammals, but the detailed mechanism of its biogenesis has remained elusive. By using genome-wide approaches and circular RNA recapitulation, we demonstrate that exon circularization is dependent on flanking intronic complementary sequences. Such sequences and their distribution exhibit rapid evolutionary changes, showing that exon circularization is evolutionarily dynamic. Strikingly, exon circularization efficiency can be regulated by competition between RNA pairing across flanking introns or within individual introns. Importantly, alternative formation of inverted repeated Alu pairs and the competition between them can lead to alternative circularization, resulting in multiple circular RNA transcripts produced from a single gene. Collectively, exon circularization mediated by complementary sequences in human introns and the potential to generate alternative circularization products extend the complexity of mammalian posttranscriptional regulation.	[Zhang, Xiao-Ou; Yang, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Wang, Hai-Bin; Zhang, Yang; Chen, Ling-Ling] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Shanghai 200031, Peoples R China; [Wang, Hai-Bin; Lu, Xuhua] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Surg, Shanghai 200003, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Naval Medical University	Chen, LL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Shanghai 200031, Peoples R China.	linglingchen@sibcb.ac.cn; liyang@picb.ac.cn	Zhang, Yang/AFV-8861-2022; Chen, Ling-Ling/AAY-3547-2021; Zhang, Xiao-Ou/J-6229-2014	Zhang, Xiao-Ou/0000-0002-2027-1313; yang, li/0000-0001-8833-7473; chen, ling ling/0000-0001-9501-0305	CAS [XDA01010206, 2012OHTP08]; MOST [2014CB964800, 2014CB910600, 2011CBA01105]; NSFC [31322018, 31271376]; SIBS [2012SSTP01]	CAS(Chinese Academy of Sciences); MOST; NSFC(National Natural Science Foundation of China (NSFC)); SIBS	We are grateful to Gordon Carmichael for critical reading of the manuscript and Qing-Fei Yin and Hua-Hong Fang for technical support. H9 cells were obtained from the WiCell Research Institute. RNA-seq was performed at CAS-MPG Partner Institute for Computational Biology Omics Core, Shanghai, China. This work was supported by grants XDA01010206 and 2012OHTP08 from CAS; 2014CB964800, 2014CB910600, and 2011CBA01105 from MOST; 31322018 and 31271376 from NSFC; and 2012SSTP01 from SIBS.	Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Chen LL, 2008, CELL CYCLE, V7, P3294, DOI 10.4161/cc.7.21.6927; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; COCQUERELLE C, 1992, EMBO J, V11, P1095, DOI 10.1002/j.1460-2075.1992.tb05148.x; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Dubin RA, 1995, GENE, V167, P245, DOI 10.1016/0378-1119(95)00639-7; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hoffmann S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r34; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; KOS A, 1986, NATURE, V323, P558, DOI 10.1038/323558a0; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mukaka MM, 2012, MALAWI MED J, V24, P69; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Pasman Z, 1996, RNA, V2, P603; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Zhang XO, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-287; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017	31	1172	1267	9	168	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					134	147		10.1016/j.cell.2014.09.001	http://dx.doi.org/10.1016/j.cell.2014.09.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25242744	Bronze			2022-12-28	WOS:000343095000015
J	Lu, K				Lu, K.			Making strong nanomaterials ductile with gradients	SCIENCE			English	Editorial Material							COPPER; STRENGTH; STEEL; LAYER		[Lu, K.] Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China; [Lu, K.] Nanjing Univ Sci & Technol, Herbert Gleiter Inst Nanosci, Nanjing 210094, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Metal Research, CAS; Nanjing University of Science & Technology	Lu, K (corresponding author), Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China.	lu@imr.ac.cn						Fang TH, 2014, SCRIPTA MATER, V77, P17, DOI 10.1016/j.scriptamat.2014.01.006; Fang TH, 2011, SCIENCE, V331, P1587, DOI 10.1126/science.1200177; Huang HW, 2013, MATER SCI TECH-LOND, V29, P1200, DOI 10.1179/1743284712Y.0000000192; Hughes DA, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.135504; Kou HN, 2014, ADV MATER, V26, P5518, DOI 10.1002/adma.201401595; Li JJ, 2012, MODEL SIMUL MATER SC, V20, DOI 10.1088/0965-0393/20/8/085002; Li YS, 2008, SCRIPTA MATER, V59, P475, DOI 10.1016/j.scriptamat.2008.04.043; Wei YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4580; Wu XL, 2014, P NATL ACAD SCI USA, V111, P7197, DOI 10.1073/pnas.1324069111	9	655	685	70	912	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1455	1456		10.1126/science.1255940	http://dx.doi.org/10.1126/science.1255940			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237091				2022-12-28	WOS:000341752900025
J	Vohra, P				Vohra, Pankaj			PERSONAL VIEW Make Indian parents better aware of growth charts to prevent obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BODY-MASS INDEX; CHILDHOOD; INFANCY		Max Super Special Hosp, Delhi 110021, India		Vohra, P (corresponding author), Max Super Special Hosp, Press Enclave Marg, Delhi 110021, India.	pankajvohramd@yahoo.com						Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bhave Sheila, 2004, Indian Pediatr, V41, P559; Centers for Disease Control and Prevention, CDC GROWTH CHARTS; Fisberg M, 2004, J PEDIATR GASTR NUTR, V39, pS678, DOI 10.1097/00005176-200406002-00015; Kaur Harsohena, 2003, Treat Endocrinol, V2, P375, DOI 10.2165/00024677-200302060-00002; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Quak HS, 2008, J PEDIAT GASTROENTER, V47, P254; Singhal A, 2010, J PEDIATR GASTR NUTR, V51, pS119, DOI 10.1097/MPG.0b013e3181efd077	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2014	349								g5546	10.1136/bmj.g5546	http://dx.doi.org/10.1136/bmj.g5546			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OP	25228330				2022-12-28	WOS:000342057500006
J	Lauri, A; Brunet, T; Handberg-Thorsager, M; Fischer, AHL; Simakov, O; Steinmetz, PRH; Tomer, R; Keller, PJ; Arendt, D				Lauri, Antonella; Brunet, Thibaut; Handberg-Thorsager, Mette; Fischer, Antje H. L.; Simakov, Oleg; Steinmetz, Patrick R. H.; Tomer, Raju; Keller, Philipp J.; Arendt, Detlev			Development of the annelid axochord: Insights into notochord evolution	SCIENCE			English	Article							CAPITELLA SP I; DORSOVENTRAL AXIS; EXPRESSION; LARVAL; ORIGIN; FOREBRAIN; INVERSION; BILATERIA; MESODERM; FEATURES	The origin of chordates has been debated for more than a century, with one key issue being the emergence of the notochord. In vertebrates, the notochord develops by convergence and extension of the chordamesoderm, a population of midline cells of unique molecular identity. We identify a population of mesodermal cells in a developing invertebrate, the marine annelid Platynereis dumerilii, that converges and extends toward the midline and expresses a notochord-specific combination of genes. These cells differentiate into a longitudinal muscle, the axochord, that is positioned between central nervous system and axial blood vessel and secretes a strong collagenous extracellular matrix. Ancestral state reconstruction suggests that contractile mesodermal midline cells existed in bilaterian ancestors. We propose that these cells, via vacuolization and stiffening, gave rise to the chordate notochord.	[Lauri, Antonella; Brunet, Thibaut; Handberg-Thorsager, Mette; Fischer, Antje H. L.; Simakov, Oleg; Steinmetz, Patrick R. H.; Tomer, Raju; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Handberg-Thorsager, Mette; Tomer, Raju; Keller, Philipp J.] Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Arendt, Detlev] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Howard Hughes Medical Institute; Ruprecht Karls University Heidelberg	Arendt, D (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	detlev.arendt@embl.de	Brunet, Thibaut/AAJ-9370-2021; Lauri, Antonella/AAA-6542-2019; Simakov, Oleg/G-4572-2015; Steinmetz, Patrick/AAD-4093-2022; Simakov, Oleg/AAV-2494-2020	Simakov, Oleg/0000-0002-3585-4511; Simakov, Oleg/0000-0002-3585-4511; Steinmetz, Patrick/0000-0002-3705-2774; Brunet, Thibaut/0000-0002-1843-1613; Keller, Philipp/0000-0003-2896-4920	European Union's Seventh Framework Programme project "Evolution of gene regulatory networks in animal development (EVONET)" [215781-2]; Zoonet EU-Marie Curie early training network [005624]; European Molecular Biology Laboratory; EMBL International Ph.D. Programme; Boehringer Ingelheim Foundation; Howard Hughes Medical Institute; Visiting Scientist Program at the Janelia Farm Research Campus	European Union's Seventh Framework Programme project "Evolution of gene regulatory networks in animal development (EVONET)"; Zoonet EU-Marie Curie early training network; European Molecular Biology Laboratory; EMBL International Ph.D. Programme; Boehringer Ingelheim Foundation(Boehringer Ingelheim); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Visiting Scientist Program at the Janelia Farm Research Campus	We thank A. Miyawaki for kikGR, R. Renkawitz-Pohl for the antibody against beta-tubulin; P. McCrea for the antibody against beta-catenin, A. Altenburger for brachiopod data; S. Kaul-Strehlow, G. Mayer, M. V. Sorensen, and K. Worsaae for insightful discussions; I. Hausser-Siller at the Electron Microscopy Core Facility (EMCF) (BioQuant, Heidelberg University); and the EMBL EMCF. The work was supported by the European Union's Seventh Framework Programme project "Evolution of gene regulatory networks in animal development (EVONET)" [215781-2] (A.L.), the Zoonet EU-Marie Curie early training network [005624] (A. F. and R. T.), the European Molecular Biology Laboratory (A.L., T.B., M.T.H., A.H.L.F., O.S., P.R.H.S., and R.T.), the EMBL International Ph.D. Programme (A. L., T. B., A. H. L. F., P. R. H. S., R. T.), the Boehringer Ingelheim Foundation (O.S.), the Howard Hughes Medical Institute (P.J.K.), and the Visiting Scientist Program at the Janelia Farm Research Campus (M.H.T., R.T., D.A., and P.J.K.). A. L. and T. B. designed, performed, and documented most of the experiments; developed protocols; and wrote the manuscript. R. T. initiated and, together with M. H. T. and P.J.K., developed the Platynereis SiMView live imaging assay, and M. H. T. acquired the SiMView data. A. H. L. F. investigated musculature development and gene expression in Platynereis. M. H. T. contributed to the expression analysis. O.S. did transmission electron microscopy with T. B. and A. L. P. R. H. S. cloned and characterized twist. R.T. developed the injection protocol with N. Kegel and B. Backfisch. D.A. coordinated the study, wrote the manuscript, and drew the summary figure. The plasmid encoding the kikGR construct is covered by a material transfer agreement provided by the RIKEN Brain Science Institute. Alignments used for tree building are deposited on Dryad (10.5061/dryad.1ct82).	Altenburger A, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-3; Arendt D, 1997, MECH DEVELOP, V61, P7, DOI 10.1016/S0925-4773(96)00620-X; ARENDT D, 1994, NATURE, V371, P26, DOI 10.1038/371026a0; Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075; BASKIN DG, 1971, TISSUE CELL, V3, P579, DOI 10.1016/S0040-8166(71)80005-8; Belo JA, 1998, MECH DEVELOP, V72, P15, DOI 10.1016/S0925-4773(97)00204-9; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; Catala M, 1996, DEVELOPMENT, V122, P2599; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Dill KK, 2007, DEV GENES EVOL, V217, P435, DOI 10.1007/s00427-007-0153-4; Filippova A, 2005, ZOOMORPHOLOGY, V124, P1, DOI 10.1007/s00435-004-0106-7; Fischer AHL, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-31; Gerhart J, 2005, CURR OPIN GENET DEV, V15, P461, DOI 10.1016/j.gde.2005.06.004; Gerhart J, 2006, J CELL PHYSIOL, V209, P677, DOI 10.1002/jcp.20803; Hill SD, 2001, BIOL BULL, V201, P257, DOI 10.2307/1543353; Leung AWL, 2010, DEV DYNAM, V239, P2319, DOI 10.1002/dvdy.22366; Marletaz F, 2006, CURR BIOL, V16, pR577, DOI 10.1016/j.cub.2006.07.016; Marletaz F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r94; Miyamoto N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3713; Nubler-Jung K, 1999, J ZOOL SYST EVOL RES, V37, P93; Pera EM, 1997, DEVELOPMENT, V124, P4153; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Reintsch WE, 2005, J CELL BIOL, V170, P675, DOI 10.1083/jcb.200503009; Satoh N, 2012, EVOL DEV, V14, P56, DOI 10.1111/j.1525-142X.2011.00522.x; Scherholz M, 2013, CURR BIOL, V23, P2130, DOI 10.1016/j.cub.2013.08.056; Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Suzuki MM, 2000, DEV BIOL, V224, P168, DOI 10.1006/dbio.2000.9796; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; WEBB JE, 1973, J ZOOL, V170, P325, DOI 10.1111/j.1469-7998.1973.tb01381.x; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080	35	66	66	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1365	1368		10.1126/science.1253396	http://dx.doi.org/10.1126/science.1253396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214631				2022-12-28	WOS:000341483800070
J	Di Mario, C; Caiazzo, G				Di Mario, Carlo; Caiazzo, Gianluca			Biodegradable stents: the golden future of angioplasty?	LANCET			English	Editorial Material							ELUTING STENTS; METAL STENTS; IMPLANTATION; MULTICENTER; SCAFFOLD; ABSORB; TRIAL; SYSTEM		[Di Mario, Carlo; Caiazzo, Gianluca] Royal Brompton & Harefield NHS Fdn Trust, Cardiovasc Natl Inst, Hlth Res Biomed Res Unit, London SW3 6NP, England; [Caiazzo, Gianluca] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Div Cardiol, Catanzaro, Italy	Royal Brompton & Harefield NHS Foundation Trust; Magna Graecia University of Catanzaro	Di Mario, C (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, Cardiovasc Natl Inst, Hlth Res Biomed Res Unit, London SW3 6NP, England.	c.dimario@rbht.nhs.uk	Di Mario, Carlo/K-5185-2018	Di Mario, Carlo/0000-0002-4461-2055; Caiazzo, Gianluca/0000-0002-1215-8273				Brown AJ, 2014, CATHETER CARDIO INTE, V84, P37, DOI 10.1002/ccd.25378; Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11; Costopoulos C, 2015, CATHETER CARDIO INTE, V85, pE10, DOI 10.1002/ccd.25569; Doi H, 2009, JACC-CARDIOVASC INTE, V2, P1269, DOI 10.1016/j.jcin.2009.10.005; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066; Gori T, 2014, EUROINTERVENTION, V9, P36, DOI [10.4244/EIJV9I9A176, 10.4244/EIJV919A176]; Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6; Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570; Kocka V, 2014, EUR HEART J, V35, P787, DOI 10.1093/eurheartj/eht545; Kraak RP, 2015, EUROINTERVENTION, V10, P1160, DOI 10.4244/EIJY14M08_08; Mattesini A, 2014, JACC-CARDIOVASC INTE, V7, P741, DOI 10.1016/j.jcin.2014.01.165; Onuma Y, 2013, JACC-CARDIOVASC INTE, V6, P999, DOI 10.1016/j.jcin.2013.05.017; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Serruys P W, 2014, Lancet; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; van Geuns RJ, EUROPCR2014	17	19	19	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					10	12		10.1016/S0140-6736(14)61636-6	http://dx.doi.org/10.1016/S0140-6736(14)61636-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25230592				2022-12-28	WOS:000347154200010
J	Pham, HH; Cohen, M; Conway, PH				Pham, Hoangmai H.; Cohen, Melissa; Conway, Patrick H.			The Pioneer Accountable Care Organization Model Improving Quality and Lowering Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pham, Hoangmai H.; Cohen, Melissa; Conway, Patrick H.] Ctr Medicare Serv, Ctr Medicare & Medicaid Innovat, Baltimore, MD 21244 USA; [Pham, Hoangmai H.; Cohen, Melissa; Conway, Patrick H.] Ctr Medicaid Serv, Ctr Medicare & Medicaid Innovat, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Conway, PH (corresponding author), Ctr Medicare Serv, 7500 Secur Blvd,Mail Stop S3-02-01, Baltimore, MD 21244 USA.	patrick.conway@cms.hhs.gov						Kranker K., 2022, EVALUATION MEDICARE; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073	2	43	43	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1635	1636		10.1001/jama.2014.13109	http://dx.doi.org/10.1001/jama.2014.13109			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25229477	Bronze			2022-12-28	WOS:000343301400017
J	Ceschia, A				Ceschia, Audrey			The Institut Pasteur network: a crucial partner against Ebola	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Ceschia, A (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2014, LANCET, V384, P637; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; World Health Organization (WHO), 2014, EB RESP ROADM UPD	4	1	1	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1239	1240		10.1016/S0140-6736(14)61694-9	http://dx.doi.org/10.1016/S0140-6736(14)61694-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7NB	25283561				2022-12-28	WOS:000343003400006
J	Brennan, A; Meng, Y; Holmes, J; Hill-McManus, D; Meier, PS				Brennan, Alan; Meng, Yang; Holmes, John; Hill-McManus, Daniel; Meier, Petra S.			Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; POLICIES; TAX	Objective To evaluate the potential impact of two alcohol control policies under consideration in England: banning below cost selling of alcohol and minimum unit pricing. Design Modelling study using the Sheffield Alcohol Policy Model version 2.5. Setting England 2014-15. Population Adults and young people aged 16 or more, including subgroups of moderate, hazardous, and harmful drinkers. Interventions Policy to ban below cost selling, which means that the selling price to consumers could not be lower than tax payable on the product, compared with policies of minimum unit pricing at 0.40 pound ((sic)0.57; $0.75), 45p, and 50p per unit (7.9 g/10 mL) of pure alcohol. Main outcome measures Changes in mean consumption in terms of units of alcohol, drinkers' expenditure, and reductions in deaths, illnesses, admissions to hospital, and quality adjusted life years. Results The proportion of the market affected is a key driver of impact, with just 0.7% of all units estimated to be sold below the duty plus value added tax threshold implied by a ban on below cost selling, compared with 23.2% of units for a 45p minimum unit price. Below cost selling is estimated to reduce harmful drinkers' mean annual consumption by just 0.08%, around 3 units per year, compared with 3.7% or 137 units per year for a 45p minimum unit price (an approximately 45 times greater effect). The ban on below cost selling has a small effect on population health-saving an estimated 14 deaths and 500 admissions to hospital per annum. In contrast, a 45p minimum unit price is estimated to save 624 deaths and 23 700 hospital admissions. Most of the harm reductions (for example, 89% of estimated deaths saved per annum) are estimated to occur in the 5.3% of people who are harmful drinkers. Conclusions The ban on below cost selling, implemented in the England in May 2014, is estimated to have small effects on consumption and health harm. The previously announced policy of a minimum unit price, if set at expected levels between 40p and 50p per unit, is estimated to have an approximately 40-50 times greater effect.	[Brennan, Alan; Meng, Yang; Holmes, John; Hill-McManus, Daniel; Meier, Petra S.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield	Brennan, A (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England.	a.brennan@sheffield.ac.uk	Meier, Petra S/L-7387-2017; Meier, Petra/P-7504-2019; Hill-McManus, Daniel/AAA-9305-2022	Meier, Petra S/0000-0001-5354-1933; Meier, Petra/0000-0001-5354-1933; Brennan, Alan/0000-0002-1025-312X; Holmes, John/0000-0001-9283-2151; Hill-McManus, Daniel/0000-0002-1936-3907	University of Sheffield from the Medical Research Council; Economic and Social Research Council, UK [G1000043]; Medical Research Council [MR/K023195/1, MR/K023195/1B, G1000043] Funding Source: researchfish; MRC [G1000043] Funding Source: UKRI	University of Sheffield from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded from a grant secured by the University of Sheffield from the Medical Research Council and Economic and Social Research Council, UK (No G1000043). The analysis was independently designed and undertaken by the School of Health and Related Research and collaborators. The study funder has no input into the design, analysis, or interpretation of data.	Ally AK, 2014, ADDICTION; [Anonymous], 2013, IPSW SUP STRENGTH AL; [Anonymous], 2013, PUBLICANS MORNING AD; GUNNINGSCHEPERS L, 1989, HEALTH POLICY, V12, P1; Hill-MacManus D, 2012, MODEL BASED APPRAISA; Hill-McManus D, 2014, DRUG ALCOHOL DEPEN, V134, P136, DOI 10.1016/j.drugalcdep.2013.09.022; HM Government, 2012, CM8336, V8336; HM Government, 2010, COAL OUR PROGR GOV; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; Holmes J, 2012, DRUG ALCOHOL DEPEN, V123, P7, DOI 10.1016/j.drugalcdep.2011.12.005; Home Office, 2013, NEXT STEPS FOLL CONS; Jones L., 2008, ALCOHOL ATTRIBUTABLE; Meier PS, 2013, ALCOHOL ALCOHOLISM, V48, P241, DOI 10.1093/alcalc/agt001; Meng Y, 2012, MODEL BASED APPRAISA; Meng Y, 2013, MODELLED INCOME GROU; Meng Y, 2014, J HEALTH ECON, V34, P96, DOI 10.1016/j.jhealeco.2013.12.006; National Institute for Health and Care Excellence, 2010, ALC US DIS PREV HARM, V24; Purshouse R, 2009, MODELLING ASSESS EFF; Purshouse RC, 2013, ALCOHOL ALCOHOLISM, V48, P180, DOI 10.1093/alcalc/ags103; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Stockwell T, 2013, AM J PUBLIC HEALTH, V103, P2014, DOI 10.2105/AJPH.2013.301289; Stockwell T, 2012, ADDICTION, V107, P912, DOI 10.1111/j.1360-0443.2011.03763.x; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	27	36	36	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2014	349								g5452	10.1136/bmj.g5452	http://dx.doi.org/10.1136/bmj.g5452			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ3CA	25270743	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000342665100002
J	Laliberte, E; Zemunik, G; Turner, BL				Laliberte, Etienne; Zemunik, Graham; Turner, Benjamin L.			Environmental filtering explains variation in plant diversity along resource gradients	SCIENCE			English	Article							SPECIES RICHNESS; PHOSPHORUS; BIODIVERSITY; LIMITATION; DOMINANCE; PATTERNS; HISTORY; NICHES	The mechanisms that shape plant diversity along resource gradients remain unresolved because competing theories have been evaluated in isolation. By testing multiple theories simultaneously across a >2-million-year dune chronosequence in an Australian biodiversity hotspot, we show that variation in plant diversity is not explained by local resource heterogeneity, resource partitioning, nutrient stoichiometry, or soil fertility along this strong resource gradient. Rather, our results suggest that diversity is determined by environmental filtering from the regional flora, driven by soil acidification during long-term pedogenesis. This finding challenges the prevailing view that resource competition controls local plant diversity along resource gradients, and instead reflects processes shaping species pools over evolutionary time scales.	[Laliberte, Etienne; Zemunik, Graham] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia; [Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	University of Western Australia; Smithsonian Institution; Smithsonian Tropical Research Institute	Laliberte, E (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia.	etienne.laliberte@uwa.edu.au	Laliberté, Etienne/B-6855-2008; Turner, Benjamin/AAZ-1465-2021; Turner, Benjamin L/E-5940-2011	Laliberté, Etienne/0000-0002-3167-2622; Turner, Benjamin/0000-0002-6585-0722; Turner, Benjamin L/0000-0002-6585-0722	Australian Research Council [DE120100352]; University of Western Australia; Paul Hasluck Bequest	Australian Research Council(Australian Research Council); University of Western Australia; Paul Hasluck Bequest	We thank the Western Australia Department of Parks and Wildlife for access to field sites and facilities. This research was supported by a Discovery Early Career Research Award (DE120100352) from the Australian Research Council and research grants from the University of Western Australia to E. L. and a Ph.D. scholarship to G.Z. from the Paul Hasluck Bequest, administered by the Kwongan Foundation. We thank P. Hayes for collection of leaf nutrient data and J. Grace and H. Lambers for providing comments on the manuscript. The vegetation and soil data are available on Dryad (www.datadryad.org).	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Chiarucci A, 2003, DIVERS DISTRIB, V9, P283, DOI 10.1046/j.1472-4642.2003.00027.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GOUGH L, 1994, OIKOS, V70, P271, DOI 10.2307/3545638; Grace JB, 2011, ECOLOGY, V92, P108, DOI 10.1890/09-2137.1; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harrison S, 2006, ECOL MONOGR, V76, P41, DOI 10.1890/05-0910; Hayes P, 2014, J ECOL, V102, P396, DOI 10.1111/1365-2745.12196; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Laliberte E, 2013, TRENDS ECOL EVOL, V28, P331, DOI 10.1016/j.tree.2013.02.008; Laliberte E, 2012, J ECOL, V100, P631, DOI 10.1111/j.1365-2745.2012.01962.x; Lambers H., 2008, PLANT PHYSL ECOLOGY; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Partel M, 2002, ECOLOGY, V83, P2361, DOI 10.1890/0012-9658(2002)083[2361:LPDPAE]2.0.CO;2; Partel M, 1999, ECOGRAPHY, V22, P153, DOI 10.1111/j.1600-0587.1999.tb00463.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; TILMAN D, 1988; Tilman David, 1993, P13; Turner BL, 2008, J ECOL, V96, P698, DOI 10.1111/j.1365-2745.2008.01384.x; Venterink HO, 2011, PLANT SOIL, V345, P1, DOI 10.1007/s11104-011-0796-9; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	31	186	191	11	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1602	1605		10.1126/science.1256330	http://dx.doi.org/10.1126/science.1256330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258078				2022-12-28	WOS:000342164500043
J	Engreitz, JM; Sirokman, K; McDonel, P; Shishkin, AA; Surka, C; Russell, P; Grossman, SR; Chow, AY; Guttman, M; Lander, ES				Engreitz, Jesse M.; Sirokman, Klara; McDonel, Patrick; Shishkin, Alexander A.; Surka, Christine; Russell, Pamela; Grossman, Sharon R.; Chow, Amy Y.; Guttman, Mitchell; Lander, Eric S.			RNA-RNA Interactions Enable Specific Targeting of Noncoding RNAs to Nascent Pre-mRNAs and Chromatin Sites	CELL			English	Article							NUCLEAR SPECKLES; CROSS-LINKING; U1 SNRNP; REVEALS; MALAT1; BINDING; MOUSE; DIFFERENTIATION; POLYADENYLATION; INITIATION	Intermolecular RNA-RNA interactions are used by many noncoding RNAs (ncRNAs) to achieve their diverse functions. To identify these contacts, we developed a method based on RNA antisense purification to systematically map RNA-RNA interactions (RAP-RNA) and applied it to investigate two ncRNAs implicated in RNA processing: U1 small nuclear RNA, a component of the spliceosome, and Malat1, a large ncRNA that localizes to nuclear speckles. U1 and Malat1 interact with nascent transcripts through distinct targeting mechanisms. Using differential crosslinking, we confirmed that U1 directly hybridizes to 5' splice sites and 5' splice site motifs throughout introns and found that Malat1 interacts with pre-mRNAs indirectly through protein intermediates. Interactions with nascent pre-mRNAs cause U1 and Malat1 to localize proximally to chromatin at active genes, demonstrating that ncRNAs can use RNA-RNA interactions to target specific pre-mRNAs and genomic sites. RAP-RNA is sensitive to lower abundance RNAs as well, making it generally applicable for investigating ncRNAs.	[Engreitz, Jesse M.; Sirokman, Klara; McDonel, Patrick; Grossman, Sharon R.; Lander, Eric S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Engreitz, Jesse M.; Grossman, Sharon R.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Shishkin, Alexander A.; Surka, Christine; Russell, Pamela; Chow, Amy Y.; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Grossman, Sharon R.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); California Institute of Technology; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu; lander@broadinstitute.org		Russell, Pamela/0000-0003-2997-6392; Grossman, Sharon/0000-0001-6422-1134	Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate Fellowship; NIH Director's Early Independence Award [DP5OD012190]; Edward Mallincrodt Jr. Foundation; Searle Scholars program; Broad Institute of MIT and Harvard; California Institute of Technology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012190] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate Fellowship; NIH Director's Early Independence Award; Edward Mallincrodt Jr. Foundation; Searle Scholars program; Broad Institute of MIT and Harvard; California Institute of Technology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Amy Pandya-Jones for chromatin fractionation protocols; Xuebing Wu for assistance with scoring 5'ss motif matches; Tarjei Mikkelsen for assistance with oligonucleotide synthesis; Phil Sharp, Jason West, and Chris Davis for helpful discussions; and Leslie Gaffney for assistance with figures. This work was supported by the Fannie and John Hertz Foundation (J.M.E.), National Defense Science and Engineering Graduate Fellowship (J.M.E.), NIH Director's Early Independence Award DP5OD012190 (M.G.), Edward Mallincrodt Jr. Foundation (M.G.), Searle Scholars program (M.G.), the Broad Institute of MIT and Harvard (E.S.L. and M.G.), and the California Institute of Technology (M.G.). J.M.E., E.S.L., and M.G. are inventors on a patent application from the Broad Institute that covers the selective purification of RNA-bound molecular complexes in cells.	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; CALVET JP, 1979, P NATL ACAD SCI USA, V76, P755, DOI 10.1073/pnas.76.2.755; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dieterich C, 2013, WIRES RNA, V4, P107, DOI 10.1002/wrna.1147; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; MOUNT SM, 1983, CELL, V33, P509, DOI 10.1016/0092-8674(83)90432-4; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; O'Gorman W, 2005, J BIOL CHEM, V280, P36920, DOI 10.1074/jbc.M505791200; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Soruco MML, 2013, GENE DEV, V27, P1551, DOI 10.1101/gad.214585.113; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	45	308	315	2	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					188	199		10.1016/j.cell.2014.08.018	http://dx.doi.org/10.1016/j.cell.2014.08.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259926	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-28	WOS:000343095000019
J	Lin, MT; Occhialini, A; Andralojc, PJ; Parry, MAJ; Hanson, MR				Lin, Myat T.; Occhialini, Alessandro; Andralojc, P. John; Parry, Martin A. J.; Hanson, Maureen R.			A faster Rubisco with potential to increase photosynthesis in crops	NATURE			English	Article							SYNECHOCOCCUS PCC7942 REVEALS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CCMM PROTEIN; EXPRESSION; TOBACCO; PLANTS; CHLOROPLASTS; CARBOXYSOMES; SUBUNIT; ALGAE	In photosynthetic organisms, D-ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is the major enzyme assimilating atmospheric CO2 into the biosphere(1). Owing to the wasteful oxygenase activity and slow turnover of Rubisco, the enzyme is among the most important targets for improving the photosynthetic efficiency of vascular plants(2,3). It has been anticipated that introducing the CO2-concentrating mechanism (CCM) from cyanobacteria into plants could enhance crop yield(4-6). However, the complex nature of Rubisco's assembly has made manipulation of the enzyme extremely challenging, and attempts to replace it in plants with the enzymes from cyanobacteria and red algae have not been successful(7,8). Here we report two transplastomic tobacco lines with functional Rubisco from the cyanobacterium Synechococcus elongatus PCC7942 (Se7942). We knocked out the native tobacco gene encoding the large subunit of Rubisco by inserting the large and small subunit genes of the Se7942 enzyme, in combination with either the corresponding Se7942 assembly chaperone, RbcX, or an internal carboxysomal protein, CcmM35, which incorporates three small subunit-like domains(9,10). Se7942 Rubisco and CcmM35 formed macromolecular complexes within the chloroplast stroma, mirroring an early step in the biogenesis of cyanobacterial beta-carboxysomes(11,12). Both transformed lines were photosynthetically competent, supporting autotrophic growth, and their respective forms of Rubisco had higher rates of CO2 fixation per unit of enzyme than the tobacco control. These transplastomic tobacco lines represent an important step towards improved photosynthesis in plants and will be valuable hosts for future addition of the remaining components of the cyanobacterial CCM, such as inorganic carbon transporters and the beta-carboxysome shell proteins(4-6).	[Lin, Myat T.; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Occhialini, Alessandro; Andralojc, P. John; Parry, Martin A. J.] Rothamsted Res, Plant Biol & Crop Sci, Harpenden AL5 2JQ, Herts, England	Cornell University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Hanson, MR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	mrh5@cornell.edu	Hanson, Maureen R/D-3879-2009	Hanson, Maureen R/0000-0001-8141-3058; Parry, Martin/0000-0002-4477-672X; occhialini, alessandro/0000-0002-1162-798X	National Science Foundation [EF-1105584]; Biotechnology and Biological Sciences Research Council [BB/I024488/1]; National Institute of General Medical Sciences of the National Institutes of Health [F32GM103019]; 20:20 Wheat Institute Strategic Program [BBSRC BB/J/00426X/1]; Emerging Frontiers [1105584] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103019] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005202] Funding Source: researchfish; BBSRC [BBS/E/C/00005202, BB/I024488/1] Funding Source: UKRI	National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); 20:20 Wheat Institute Strategic Program; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank C. Kerfeld (Michigan State University) for helpful discussion and providing us with the Se7942 genomic DNA and purified His-tagged CcmM protein, W. Li (Cornell University) for technical assistance in generating, selecting and analysing the tobacco chloroplast transformants and M. Waqar Hameed (Cornell University) for the codon-optimized cyanobacterial Rubisco genes. This material is based upon work supported by the National Science Foundation under grant number EF-1105584 to M. R. H., Biotechnology and Biological Sciences Research Council under grant number BB/I024488/1 to M.A.J.P. and the National Institute of General Medical Sciences of the National Institutes of Health under award number F32GM103019 to M. T. L. P.J.A. and M.A.J.P. also acknowledge support from the 20:20 Wheat Institute Strategic Program (BBSRC BB/J/00426X/1).	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; BAINBRIDGE G, 1995, J EXP BOT, V46, P1269, DOI 10.1093/jxb/46.special_issue.1269; Cameron JC, 2013, CELL, V155, P1131, DOI 10.1016/j.cell.2013.10.044; Chen AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076127; Dhingra A, 2004, P NATL ACAD SCI USA, V101, P6315, DOI 10.1073/pnas.0400981101; Drechsel O, 2011, NUCLEIC ACIDS RES, V39, P1427, DOI 10.1093/nar/gkq978; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Gray BN, 2011, PLANT MOL BIOL, V76, P345, DOI 10.1007/s11103-011-9743-7; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Lin MT, 2014, PLANT J, V79, P1, DOI 10.1111/tpj.12536; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Long BM, 2011, PHOTOSYNTH RES, V109, P33, DOI 10.1007/s11120-011-9659-8; Long BM, 2010, PLANT PHYSIOL, V153, P285, DOI 10.1104/pp.110.154948; Maliga P, 2014, METHODS MOL BIOL, V1132, P147, DOI 10.1007/978-1-62703-995-6_8; McGrath JM, 2014, PLANT PHYSIOL, V164, P2247, DOI 10.1104/pp.113.232611; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Price GD, 2013, J EXP BOT, V64, P753, DOI 10.1093/jxb/ers257; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Whitney SM, 2001, P NATL ACAD SCI USA, V98, P14738, DOI 10.1073/pnas.261417298; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; YOKOTA A, 1985, PLANT PHYSIOL, V77, P735, DOI 10.1104/pp.77.3.735; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294; Zhou F, 2007, PLANT J, V52, P961, DOI 10.1111/j.1365-313X.2007.03261.x; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	30	273	286	20	414	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					547	+		10.1038/nature13776	http://dx.doi.org/10.1038/nature13776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25231869	Green Accepted, Green Published			2022-12-28	WOS:000342075800040
J	Taylor, WD				Taylor, Warren D.			Depression in the Elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LATE-LIFE DEPRESSION; TRANSCRANIAL MAGNETIC STIMULATION; PROBLEM-SOLVING THERAPY; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIALS; PLACEBO-CONTROLLED TRIAL; MAJOR DEPRESSION; OLDER-ADULTS; DOUBLE-BLIND; EXECUTIVE DYSFUNCTION	A 74-year-old woman with hypertension that is well controlled with hydrochlorothiazide is brought by her daughter for an evaluation. The daughter states that her mother is withdrawn, often tearful, and at times appears to have memory problems but has no history of psychiatric illness. The patient is a retired teacher who is widowed and has lived independently for several years. During the last few months, she has stopped going to church and visiting friends. The patient's symptoms include irritability, anhedonia, fatigue, a 4.5-kg (10-lb) weight loss over a period of 3 months, and difficulty sleeping. She feels like a burden to her family. How should she be treated?	[Taylor, Warren D.] Vanderbilt Univ, Geriatr Res Educ & Clin Ctr, Vet Affairs Med Ctr, Tennessee Valley Healthcare Syst,Med Ctr, Nashville, TN 37212 USA; [Taylor, Warren D.] Vanderbilt Univ, Ctr Cognit Med, Dept Psychiat, Med Ctr, Nashville, TN 37212 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University	Taylor, WD (corresponding author), Vanderbilt Univ, 1601 23rd Ave S, Nashville, TN 37212 USA.	warren.d.taylor@vanderbilt.edu	Taylor, Warren D/J-3687-2014					Alexopoulos GS, 2011, ARCH GEN PSYCHIAT, V68, P33, DOI 10.1001/archgenpsychiatry.2010.177; ALEXOPOULOS GS, 1993, BIOL PSYCHIAT, V34, P141, DOI 10.1016/0006-3223(93)90383-O; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Alexopoulos GS, 2005, BIOL PSYCHIAT, V58, P204, DOI 10.1016/j.biopsych.2005.04.024; [Anonymous], 2010, PRACTICE GUIDELINE T; AREAN PA, 1993, J CONSULT CLIN PSYCH, V61, P1003, DOI 10.1037/0022-006X.61.6.1003; Arean PA, 2010, AM J PSYCHIAT, V167, P1391, DOI 10.1176/appi.ajp.2010.09091327; Blazer DG, 2003, J GERONTOL A-BIOL, V58, P249; Bose A, 2008, AM J GERIAT PSYCHIAT, V16, P14, DOI 10.1097/JGP.0b013e3181591c09; Bridle C, 2012, BRIT J PSYCHIAT, V201, P180, DOI 10.1192/bjp.bp.111.095174; Conwell Y, 2008, PSYCHIAT CLIN N AM, V31, P333, DOI 10.1016/j.psc.2008.01.004; Crabb RM, 2012, BRIT J CLIN PSYCHOL, V51, P459, DOI 10.1111/j.2044-8260.2012.02038.x; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; Gerhard T, 2014, J CLIN PSYCHIAT, V75, P490, DOI 10.4088/JCP.13m08675; Gould RL, 2012, J AM GERIATR SOC, V60, P1817, DOI 10.1111/j.1532-5415.2012.04166.x; Hardy SE, 2009, AM J GERIATR PHARMAC, V7, P34, DOI 10.1016/j.amjopharm.2009.02.006; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Kasper S, 2005, AM J GERIAT PSYCHIAT, V13, P884, DOI 10.1176/appi.ajgp.13.10.884; Kiosses DN, 2011, PSYCHIAT CLIN N AM, V34, P377, DOI 10.1016/j.psc.2011.03.001; Lisanby SH, 2009, NEUROPSYCHOPHARMACOL, V34, P522, DOI 10.1038/npp.2008.118; Lyness JM, 1999, J GEN INTERN MED, V14, P249, DOI 10.1046/j.1525-1497.1999.00326.x; Mojtabai R, 2014, NEW ENGL J MED, V370, P1180, DOI 10.1056/NEJMp1311047; Mossey JM, 1996, J GERONTOL A-BIOL, V51, pM172, DOI 10.1093/gerona/51A.4.M172; Oslin DW, 2003, J CLIN PSYCHIAT, V64, P875, DOI 10.4088/JCP.v64n0804; Pallanti S, 2012, CNS SPECTRUMS, V17, P24, DOI 10.1017/S1092852912000417; Pinquart M, 2007, AGING MENT HEALTH, V11, P645, DOI 10.1080/13607860701529635; Prudic J, 2004, BIOL PSYCHIAT, V55, P301, DOI 10.1016/j.biopsych.2003.09.015; Prudic J, 2013, J ECT, V29, P3, DOI 10.1097/YCT.0b013e31826ea8c4; Rapaport MH, 2003, J CLIN PSYCHIAT, V64, P1065, DOI 10.4088/JCP.v64n0912; Raskin J, 2007, AM J PSYCHIAT, V164, P900, DOI 10.1176/appi.ajp.164.6.900; Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619; Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39; Reynolds CF, 2011, ARCH GEN PSYCHIAT, V68, P51, DOI 10.1001/archgenpsychiatry.2010.184; Roose SP, 2003, CURR MED RES OPIN, V19, P737, DOI 10.1185/030079903125002441; Roose SP, 2004, AM J PSYCHIAT, V161, P2050, DOI 10.1176/appi.ajp.161.11.2050; Rosenberg C, 2007, PSYCHOPHARMACOL BULL, V40, P63; Rutherford B, 2007, INT J GERIATR PSYCH, V22, P986, DOI 10.1002/gps.1775; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Schatzberg A, 2006, AM J GERIAT PSYCHIAT, V14, P361, DOI 10.1097/01.JGP.0000194645.70869.3b; Schneider LS, 2003, AM J PSYCHIAT, V160, P1277, DOI 10.1176/appi.ajp.160.7.1277; Sheffrin M, 2009, J CLIN PSYCHIAT, V70, P208, DOI 10.4088/JCP.07m03805; Sheikh JI, 2004, J AM GERIATR SOC, V52, P86, DOI 10.1111/j.1532-5415.2004.52015.x; Sheline YI, 2010, ARCH GEN PSYCHIAT, V67, P277, DOI 10.1001/archgenpsychiatry.2009.204; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Steffens DC, 2011, INT J GERIATR PSYCH, V26, P564, DOI 10.1002/gps.2564; Taylor WD, 2013, MOL PSYCHIATR, V18, P963, DOI 10.1038/mp.2013.20; Tollefson G D, 1995, Int Psychogeriatr, V7, P89, DOI 10.1017/S1041610295001888; Weihs KL, 2000, J CLIN PSYCHIAT, V61, P196, DOI 10.4088/JCP.v61n0309	51	169	182	3	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1228	1236		10.1056/NEJMcp1402180	http://dx.doi.org/10.1056/NEJMcp1402180			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25251617				2022-12-28	WOS:000342079700010
J	Davis, AM; Cifu, AS				Davis, Andrew M.; Cifu, Adam S.			Lung Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOSE COMPUTED-TOMOGRAPHY; HARMS		[Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Davis, AM (corresponding author), Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC3051, Chicago, IL 60637 USA.	amd@uchicago.edu						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Boiselle PM, 2013, JAMA-J AM MED ASSOC, V309, P1163, DOI 10.1001/jama.2012.216988; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Menezes R, 2014, J THORAC ONCOL, V9, P912, DOI 10.1097/JTO.0000000000000258; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Tammemagi MC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2253; Wiener RS, 2014, ANN INTERN MED	8	13	13	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1248	1249		10.1001/jama.2014.12272	http://dx.doi.org/10.1001/jama.2014.12272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25247521				2022-12-28	WOS:000341990600025
J	Watts, G				Watts, Geoff			Eric Dewailly Obituary	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1092	1092		10.1016/S0140-6736(14)61666-4	http://dx.doi.org/10.1016/S0140-6736(14)61666-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PU	25247223				2022-12-28	WOS:000342630600020
J	Meng, FK; McGrath, KP; Hoveyda, AH				Meng, Fanke; McGrath, Kevin P.; Hoveyda, Amir H.			Multifunctional organoboron compounds for scalable natural product synthesis	NATURE			English	Article							CARBON STEREOGENIC CENTERS; CU-CATALYZED HYDROBORATION; ENANTIOSELECTIVE SYNTHESIS; CONJUGATE ADDITIONS; NHC LIGANDS; EFFICIENT; ARYL; METATHESIS; NAFUREDIN; REAGENTS	Efficient catalytic reactions that can generate C-C bonds enantioselectively, and ones that can produce trisubstituted alkenes diastereoselectively, are central to research in organic chemistry. Transformations that accomplish these two tasks simultaneously are in high demand, particularly if the catalysts, substrates and reagents are inexpensive and if the reaction conditions are mild. Here we report a facile multicomponent catalytic process that begins with a chemoselective, site-selective and diastereoselective copper-boron addition to a monosubstituted allene; the resulting boron-substituted organocopper intermediates then participate in a similarly selective allylic substitution. The products, which contain a stereogenic carbon centre, a monosubstituted alkene and an easily functionalizable Z-trisubstituted alkenylboron group, are obtained in up to 89 per cent yield, with more than 98 per cent branch-selectivity and stereoselectivity and an enantiomeric ratio greater than 99: 1. The copper-based catalyst is derived from a robust heterocyclic salt that can be prepared in multigram quantities from inexpensive starting materials and without costly purification procedures. The utility of the approach is demonstrated through enantioselective synthesis of gram quantities of two natural products, namely rottnestol and herboxidiene (also known as GEX1A).	[Meng, Fanke; McGrath, Kevin P.; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu			National Institutes of Health, Institute of General Medical Sciences [GM-47480]; National Science Foundation [CHE-1111074, CHE-1362763]; LaMattina graduate fellowship in organic synthesis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047480, R29GM047480, R01GM057212, R01GM047480] Funding Source: NIH RePORTER	National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); LaMattina graduate fellowship in organic synthesis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Institutes of Health, Institute of General Medical Sciences (GM-47480) and the National Science Foundation (CHE-1111074 and CHE-1362763). F.M. acknowledges a LaMattina graduate fellowship in organic synthesis. We thank M. J. Koh, D. L. Silverio and F. Haeffner for discussions, Boston College for access to computational facilities and Frontier Scientific, Inc., for gifts of B<INF>2</INF>(pin)<INF>2</INF>.	Bower JF, 2009, ANGEW CHEM INT EDIT, V48, P34, DOI 10.1002/anie.200802938; Clavier H, 2005, J ORGANOMET CHEM, V690, P5237, DOI 10.1016/j.jorganchem.2005.04.027; Czuba IR, 2003, ORG BIOMOL CHEM, V1, P2044, DOI 10.1039/b302460a; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; deVries AHM, 1996, ANGEW CHEM INT EDIT, V35, P2374, DOI 10.1002/anie.199623741; Diez-Gonzalez S, 2007, COORDIN CHEM REV, V251, P874, DOI 10.1016/j.ccr.2006.10.004; ERICKSON KL, 1995, TETRAHEDRON, V51, P11953, DOI 10.1016/0040-4020(95)00761-V; Furstner A, 2007, J AM CHEM SOC, V129, P9150, DOI 10.1021/ja072334v; Gao F, 2014, J AM CHEM SOC, V136, P2149, DOI 10.1021/ja4126565; Gao F, 2010, ANGEW CHEM INT EDIT, V49, P8370, DOI 10.1002/anie.201005124; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Guzman-Martinez A, 2010, J AM CHEM SOC, V132, P10634, DOI 10.1021/ja104254d; Hamilton JY, 2014, J AM CHEM SOC, V136, P3006, DOI 10.1021/ja412962w; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Hassan A, 2011, ORG PROCESS RES DEV, V15, P1236, DOI 10.1021/op200195m; Hornillos V, 2013, J AM CHEM SOC, V135, P2140, DOI 10.1021/ja312487r; Ireland RE, 1996, J ORG CHEM, V61, P6856, DOI 10.1021/jo951646q; Jang H, 2011, J AM CHEM SOC, V133, P7859, DOI 10.1021/ja2007643; JONES TK, 1990, J AM CHEM SOC, V112, P2998, DOI 10.1021/ja00164a023; Jung B, 2012, J AM CHEM SOC, V134, P1490, DOI 10.1021/ja211269w; Kotha S, 2002, TETRAHEDRON, V58, P9633, DOI 10.1016/S0040-4020(02)01188-2; Lee KS, 2009, J ORG CHEM, V74, P4455, DOI 10.1021/jo900589x; Lee YM, 2009, J AM CHEM SOC, V131, P3160, DOI 10.1021/ja809382c; Maji B, 2011, ANGEW CHEM INT EDIT, V50, P6915, DOI 10.1002/anie.201102435; May TL, 2008, ANGEW CHEM INT EDIT, V47, P7358, DOI 10.1002/anie.200802910; Meng FK, 2014, J AM CHEM SOC, V136, P11304, DOI 10.1021/ja5071202; Meng FK, 2013, ANGEW CHEM INT EDIT, V52, P5046, DOI 10.1002/anie.201301018; Meng FK, 2013, ORG LETT, V15, P1414, DOI 10.1021/ol4004178; Morrill C, 2003, J ORG CHEM, V68, P6031, DOI 10.1021/jo0345345; Murray TJ, 2008, ORG LETT, V10, P3429, DOI 10.1021/ol800902g; NAKATSUKA M, 1990, J AM CHEM SOC, V112, P5583, DOI 10.1021/ja00170a024; Ngai MY, 2007, J AM CHEM SOC, V129, P12644, DOI 10.1021/ja075438e; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Park JK, 2011, J AM CHEM SOC, V133, P2410, DOI 10.1021/ja1112518; Pellicena M, 2011, ORG LETT, V13, P5350, DOI 10.1021/ol202210k; Ramon DJ, 2005, ANGEW CHEM INT EDIT, V44, P1602, DOI 10.1002/anie.200460548; Ruijter E, 2011, ANGEW CHEM INT EDIT, V50, P6234, DOI 10.1002/anie.201006515; Sasaki Y, 2011, ANGEW CHEM INT EDIT, V50, P2778, DOI 10.1002/anie.201007182; Sasaki Y, 2010, J AM CHEM SOC, V132, P1226, DOI 10.1021/ja909640b; SCHOW SR, 1986, J AM CHEM SOC, V108, P2662, DOI 10.1021/ja00270a027; SHOOP WL, 1995, VET PARASITOL, V59, P139, DOI 10.1016/0304-4017(94)00743-V; Takano D, 2001, ORG LETT, V3, P2289, DOI 10.1021/ol010089t; Takano D, 2001, TETRAHEDRON LETT, V42, P3017, DOI 10.1016/S0040-4039(01)00355-0; TANAKA H, 1987, J AM CHEM SOC, V109, P5031, DOI 10.1021/ja00250a050; Van Veldhuizen JJ, 2005, J AM CHEM SOC, V127, P6877, DOI 10.1021/ja050179j; Xu SQ, 2011, ADV SYNTH CATAL, V353, P2981, DOI 10.1002/adsc.201100420; Yoshikai N, 2012, CHEM REV, V112, P2339, DOI 10.1021/cr200241f; Zhang P, 2011, J AM CHEM SOC, V133, P9716, DOI 10.1021/ja2039248	48	158	161	1	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					367	374		10.1038/nature13735	http://dx.doi.org/10.1038/nature13735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230659	Green Accepted			2022-12-28	WOS:000341814900050
J	Akl, EA; Guyatt, GH				Akl, Elie A.; Guyatt, Gordon H.			In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Akl, Elie A.] Amer Univ Beirut, Beirut, Lebanon; [Guyatt, Gordon H.] McMaster Univ, Hamilton, ON, Canada	American University of Beirut; McMaster University	Akl, EA (corresponding author), Amer Univ Beirut, Beirut, Lebanon.		Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Akl, Elie A/0000-0002-3444-8618; 				Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC8	10.7326/0003-4819-161-6-201409160-02008	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222420				2022-12-28	WOS:000343894400007
J	Aung, K				Aung, KoKo			Review: In postmenopausal women and older men, vitamin D plus calcium reduces some fractures	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SERVICES TASK-FORCE; SUPPLEMENTATION		Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Aung, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.		Aung, KoKo/I-1236-2019	Aung, KoKo/0000-0002-3152-0610				Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Mouyis M, 2008, RHEUMATOLOGY, V47, P1348, DOI 10.1093/rheumatology/ken203; Moyer Virginia A, 2013, Ann Intern Med, V158, P691, DOI 10.7326/0003-4819-158-9-201305070-00603	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC5	10.7326/0003-4819-161-6-201409160-02005	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222417				2022-12-28	WOS:000343894400004
J	DeLoughery, TG				DeLoughery, Thomas G.			Review: Restrictive RBC transfusion strategies reduce nosocomial infections compared with liberal strategies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97207 USA	Oregon Health & Science University	DeLoughery, TG (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97207 USA.							Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Salpeter SR, 2014, AM J MED, V127, P124, DOI 10.1016/j.amjmed.2013.09.017	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC11	10.7326/0003-4819-161-6-201409160-02011	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222411				2022-12-28	WOS:000343894400010
J	Kempston, E				Kempston, Elizabeth			Patient commentary: Moving goalposts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2014	349								g5548	10.1136/bmj.g5548	http://dx.doi.org/10.1136/bmj.g5548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OP	25227124				2022-12-28	WOS:000342057500007
J	Graham, WJ; Witter, S				Graham, Wendy J.; Witter, Sophie			Counting what counts for maternal mortality	LANCET			English	Editorial Material									[Graham, Wendy J.; Witter, Sophie] Univ Aberdeen, Sch Med & Dent, Aberdeen AB9 2ZD, Scotland	University of Aberdeen	Graham, WJ (corresponding author), Univ Aberdeen, Sch Med & Dent, Foresterhill, Aberdeen AB9 2ZD, Scotland.	w.graham@abdn.ac.uk		Graham, Wendy/0000-0003-1473-5342				BAIRD D, 1952, NEW ENGL J MED, V246, P561, DOI 10.1056/NEJM195204102461501; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Fathalla MF, 2000, B WORLD HEALTH ORGAN, V78, P677; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Graham W., 1987, Health Policy and Planning, V2, P323, DOI 10.1093/heapol/2.4.323; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Langer A, 2013, LANCET, V381, P601, DOI 10.1016/S0140-6736(13)60259-7; Loudon I., 1992, DEATH CHILDBIRTH INT; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; United Nations Secretary General, 2013, LIF DIGN ALL ACC PRO; Witter S, 2014, COST IMPACT POLICIES	16	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					933	935		10.1016/S0140-6736(14)61604-4	http://dx.doi.org/10.1016/S0140-6736(14)61604-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9ML	25220960				2022-12-28	WOS:000341679700005
J	Mehl, G; Labrique, A				Mehl, Garrett; Labrique, Alain			Prioritizing integrated mHealth strategies for universal health coverage	SCIENCE			English	Editorial Material							CARE	As countries strive toward universal health coverage, mobile wireless technologies-mHealth tools-in support of enumeration, registration, unique identification, and maintenance of health records will facilitate improved health system performance. Electronic forms and registry systems will enable routine monitoring of the coverage of essential interventions for individuals within relevant target populations. A cascading model is presented for prioritizing and operationalizing the role of integrated mHealth strategies.	[Mehl, Garrett] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Labrique, Alain] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mehl, G (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	mehlg@who.int		Labrique, Alain/0000-0003-2502-7819	Wellcome Trust Funding Source: Medline; World Health Organization [001] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization(World Health Organization)		[Anonymous], WORLD 2013 ICT FACTS; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Chang LW, 2011, AIDS BEHAV, V15, P1776, DOI 10.1007/s10461-011-9995-x; Corby N., 2012, USING MOBILE FINANCE; Department of Health Western Cape Government, 2013, W CAP GOV PAT COMPL; Derenzi B., 2008, WORLD, V2012, P753; Labrique A, 2013, INT J MED INFORM, V82, P467, DOI 10.1016/j.ijmedinf.2012.11.016; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Mwanahamuntu MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001032; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Sachs JD, 2012, LANCET, V380, P944, DOI 10.1016/S0140-6736(12)61149-0; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; The UN General Assembly, 2012, 67 81 GLOB HLTH FOR; United Nations Children's Fund, 2013, REACH UN HLTH COV DI; Vega J, 2013, LANCET, V381, P179, DOI 10.1016/S0140-6736(13)60062-8; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	19	80	81	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1284	1287		10.1126/science.1258926	http://dx.doi.org/10.1126/science.1258926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214614				2022-12-28	WOS:000341483800046
J	Wang, YH; Israelsen, WJ; Lee, DJ; Yu, VWC; Jeanson, NT; Clish, CB; Cantley, LC; Heiden, MGV; Scadden, DT				Wang, Ying-Hua; Israelsen, William J.; Lee, Dongjun; Yu, Vionnie W. C.; Jeanson, Nathaniel T.; Clish, Clary B.; Cantley, Lewis C.; Heiden, Matthew G. Vander; Scadden, David T.			Cell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis	CELL			English	Article							PYRUVATE-KINASE M2; STEM-CELLS; TUMOR-GROWTH; BONE-MARROW; LACTATE-DEHYDROGENASE; OXIDATIVE STRESS; MYELOID-LEUKEMIA; HYPOXIC NICHE; ISOFORM; PKM2	The balance between oxidative and nonoxidative glucose metabolism is essential for a number of pathophysiological processes. By deleting enzymes that affect aerobic glycolysis with different potencies, we examine how modulating glucose metabolism specifically affects hematopoietic and leukemic cell populations. We find that a deficiency in the M2 pyruvate kinase isoform (PKM2) reduces the levels of metabolic intermediates important for biosynthesis and impairs progenitor function without perturbing hematopoietic stem cells (HSCs), whereas lactate dehydrogenase A (LDHA) deletion significantly inhibits the function of both HSCs and progenitors during hematopoiesis. In contrast, leukemia initiation by transforming alleles putatively affecting either HSCs or progenitors is inhibited in the absence of either PKM2 or LDHA, indicating that the cell-state-specific responses to metabolic manipulation in hematopoiesis do not apply to the setting of leukemia. This finding suggests that fine-tuning the level of glycolysis may be explored therapeutically for treating leukemia while preserving HSC function.	[Wang, Ying-Hua; Lee, Dongjun; Yu, Vionnie W. C.; Jeanson, Nathaniel T.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Wang, Ying-Hua; Lee, Dongjun; Yu, Vionnie W. C.; Jeanson, Nathaniel T.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Wang, Ying-Hua; Lee, Dongjun; Yu, Vionnie W. C.; Jeanson, Nathaniel T.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02114 USA; [Wang, Ying-Hua; Lee, Dongjun; Yu, Vionnie W. C.; Jeanson, Nathaniel T.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Israelsen, William J.; Heiden, Matthew G. Vander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Heiden, Matthew G. Vander] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Clish, Clary B.] Broad Inst & Harvard, Metabolite Profiling Platform, Cambridge, MA 02142 USA; [Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	david_scadden@harvard.edu	Cantley, Lewis C/D-1800-2014; Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021; Lee, Dongjun/ABF-4381-2021	Cantley, Lewis C/0000-0002-1298-7653; Clish, Clary B/0000-0001-8259-9245; Israelsen, William/0000-0002-3653-9353; Lee, Dongjun/0000-0001-6828-401X; Yu, Vionnie W. C./0000-0002-6658-0285	NIH-HSCI Training Grant [5T32HL87735-4]; American Cancer Society; MGH Fund; MGH Federal Share of the Program Income [C06 CA059267]; Proton Therapy Research and Treatment Center; BD Biosciences stem cell grant; Bullock-Wellman Fellowship; NIH [P30CA147882, R01CA168653, DK050234, HL044851, CA148180]; Burroughs Wellcome Fund; Ludwig Foundation; Damon Runyon Cancer Research Foundation; Tosteson Fund; NATIONAL CANCER INSTITUTE [P30CA147882, R01CA168653, C06CA059267, U54CA163191] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, T32HL087735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NIH-HSCI Training Grant; American Cancer Society(American Cancer Society); MGH Fund; MGH Federal Share of the Program Income; Proton Therapy Research and Treatment Center; BD Biosciences stem cell grant; Bullock-Wellman Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ludwig Foundation; Damon Runyon Cancer Research Foundation; Tosteson Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Borja Saez, Rushdia Yusuf, Dongsu Park, Stephen Sykes, Demetrios Kalaitzidis, and Ninib Baryawno for technical help and valuable suggestions; the MGH CRM Flow Core for help with flow cytometry; and Min Wu and the laboratory of Marcia Haigis at HMS for help with the Seahorse Analyzer. Y.H.W. was supported by NIH-HSCI Training Grant 5T32HL87735-4 and by the American Cancer Society. D.L. was supported by the MGH Fund for Medical Discovery. V.W.C.Y. was supported by an MGH Federal Share of the Program Income under C06 CA059267, by the Proton Therapy Research and Treatment Center, by a BD Biosciences stem cell grant, by a Bullock-Wellman Fellowship, and by a Tosteson Fund for Medical Discovery fellowship. M.V.H. was supported by NIH grants P30CA147882 and R01CA168653 as well as by the Smith family, the Stern family, the Burroughs Wellcome Fund, the Ludwig Foundation, and the Damon Runyon Cancer Research Foundation. M.V.H. is a consultant and scientific advisory board member for Agios Pharmaceuticals. D.T.S. is supported by NIH grants DK050234, HL044851, and CA148180.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Behringer B, 2003, ANN HEMATOL, V82, P381, DOI 10.1007/s00277-003-0650-0; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; DIMOPOULOS MA, 1991, ANN INTERN MED, V115, P931, DOI 10.7326/0003-4819-115-12-931; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Granchi C, 2011, J MED CHEM, V54, P1599, DOI 10.1021/jm101007q; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; IMAMURA K, 1972, J BIOCHEM-TOKYO, V71, P1043, DOI 10.1093/oxfordjournals.jbchem.a129852; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Parnell KM, 2013, MOL CANCER THER, V12, P1453, DOI 10.1158/1535-7163.MCT-13-0026; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Takahashi N, 1998, BLOOD, V92, P4758, DOI 10.1182/blood.V92.12.4758; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	38	217	227	3	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1309	1323		10.1016/j.cell.2014.07.048	http://dx.doi.org/10.1016/j.cell.2014.07.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215489	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000343094200013
J	Greber, BJ; Boehringer, D; Leibundgut, M; Bieri, P; Leitner, A; Schmitz, N; Aebersold, R; Ban, N				Greber, Basil J.; Boehringer, Daniel; Leibundgut, Marc; Bieri, Philipp; Leitner, Alexander; Schmitz, Nikolaus; Aebersold, Ruedi; Ban, Nenad			The complete structure of the large subunit of the mammalian mitochondrial ribosome	NATURE			English	Article							PEPTIDYL TRANSFERASE CENTER; TRANSFER-RNA; SYSTEM; IDENTIFICATION; VISUALIZATION; ANTIBIOTICS; INITIATION; EVOLUTION; SOFTWARE; PROTEINS	Mitochondrial ribosomes (mitoribosomes) are extensively modified ribosomes of bacterial descent specialized for the synthesis and insertion of membrane proteins that are critical for energy conversion and ATP production inside mitochondria(1). Mammalian mitoribosomes, which comprise 39S and 28S subunits(2), have diverged markedly from the bacterial ribosomes from which they are derived, rendering them unique compared to bacterial, eukaryotic cytosolic and fungal mitochondrial ribosomes(3-5). We have previously determined at 4.9 angstrom resolution the architecture of the porcine (Sus scrofa) 39S subunit(6), which is highly homologous to the human mitoribosomal large subunit. Here we present the complete atomic structure of the porcine 39S large mitoribosomal subunit determined in the context of a stalled translating mitoribosome at 3.4 angstrom resolution by cryo-electron microscopy and chemical crosslinking/mass spectrometry. The structure reveals the locations and the detailed folds of 50 mitoribosomal proteins, shows the highly conserved mitoribosomal peptidyl transferase active site in complex with its substrate transfer RNAs, and defines the path of the nascent chain in mammalian mitoribosomes along their idiosyncratic exit tunnel. Furthermore, we present evidence that a mitochondrial tRNA has become an integral component of the central protuberance of the 39S subunit where it architecturally substitutes for the absence of the 5S ribosomal RNA, a ubiquitous component of all cytoplasmic ribosomes.	[Greber, Basil J.; Boehringer, Daniel; Leibundgut, Marc; Bieri, Philipp; Schmitz, Nikolaus; Ban, Nenad] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland; [Leitner, Alexander; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Ban, N (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Leitner, Alexander/U-1601-2019	Leitner, Alexander/0000-0003-4126-0725; Bieri, Philipp/0000-0001-9031-2945; Dietz, Nikolaus/0000-0001-7300-4342; Greber, Basil/0000-0001-9379-7159	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) Structural Biology program of the Swiss National Science Foundation (SNSF); European Research Council (ERC) under the European Community [250071]; Commission of the European Communities through the PROSPECTS consortium (EU FP7 projects) [201648, 233226]; European Research Council [ERC-2008-AdG 233226]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) Structural Biology program of the Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Research Council (ERC) under the European Community(European Research Council (ERC)); Commission of the European Communities through the PROSPECTS consortium (EU FP7 projects); European Research Council(European Research Council (ERC)European Commission)	Cryo-EM data were collected at the electron microscopy facility of ETH Zurich (ScopeM). We thank P. Tittmann (ScopeM) for support. We thank J. Yu and C. Ciaudo for discussions. This work was supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology program of the Swiss National Science Foundation (SNSF), European Research Council (ERC) grant 250071 under the European Community's Seventh Framework Programme (to N.B.), the Commission of the European Communities through the PROSPECTS consortium (EU FP7 projects 201648, 233226) (R.A.), and the European Research Council (ERC-2008-AdG 233226) (R.A.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Boehringer D, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P405; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Davydov II, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2373; Desmond E, 2011, RES MICROBIOL, V162, P53, DOI 10.1016/j.resmic.2010.10.004; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabre B., 2014, EUPROT, V4, P82, DOI DOI 10.1016/J.EUPROT.2014.06.001; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Jones TA, 2004, ACTA CRYSTALLOGR D, V60, P2115, DOI 10.1107/S0907444904023509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Koskinen VR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003822; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Leitner A, 2014, P NATL ACAD SCI USA, V111, P9455, DOI 10.1073/pnas.1320298111; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; OBRIEN TW, 1971, J BIOL CHEM, V246, P3409; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Saller MJ, 2012, BIOL CHEM, V393, P1279, DOI 10.1515/hsz-2012-0199; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Urzhumtseva L, 2009, ACTA CRYSTALLOGR D, V65, P297, DOI 10.1107/S0907444908044296; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Zhang L, 2005, FEBS LETT, V579, P6423, DOI 10.1016/j.febslet.2005.09.103	58	175	178	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					283	U326		10.1038/nature13895	http://dx.doi.org/10.1038/nature13895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25271403	Green Submitted			2022-12-28	WOS:000344631400054
J	Jones, CM; Lurie, P; Woodcock, J				Jones, Christopher M.; Lurie, Peter; Woodcock, Janet			Addressing Prescription Opioid Overdose Data Support a Comprehensive Policy Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; DEATHS		[Jones, Christopher M.; Lurie, Peter] US FDA, Off Commissioner, Silver Spring, MD 20993 USA; [Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Jones, CM (corresponding author), US FDA, Off Commissioner, 10903 New Hampshire Ave,WO32 RM4220, Silver Spring, MD 20993 USA.	Christopher.M.Jones@fda.hhs.gov						Authority OH, OREGON PRESCRIPTION; Centers for Disease Control and Prevention (CDC), 2013, ADD PRESCR DRUG AB U; Dhalla IA, 2011, CAN FAM PHYSICIAN, V57, pE92; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; IMS Health, 2014, NATL PRESCR AUD; Johnson H, 2014, MMWR-MORBID MORTAL W, V63, P569; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Rosenblum A, 2007, DRUG ALCOHOL DEPEN, V90, P64, DOI 10.1016/j.drugalcdep.2007.02.012; US Food and Drug Administration (FDA), GUID IND AB IN PRESS; US Food and Drug Administration (FDA), 2012, AN AN DRUG PROD ADV	10	28	28	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1733	1734		10.1001/jama.2014.13480	http://dx.doi.org/10.1001/jama.2014.13480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25275855				2022-12-28	WOS:000344194500006
J	Harvey, SE; Parrott, F; Harrison, DA; Bear, DE; Segaran, E; Beale, R; Bellingan, G; Leonard, R; Mythen, MG; Rowan, KM				Harvey, Sheila E.; Parrott, Francesca; Harrison, David A.; Bear, Danielle E.; Segaran, Ella; Beale, Richard; Bellingan, Geoff; Leonard, Richard; Mythen, Michael G.; Rowan, Kathryn M.		CALORIES Trial Investigators	Trial of the Route of Early Nutritional Support in Critically Ill Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE-NATIONAL-AUDIT; PARENTERAL-NUTRITION; ENTERAL NUTRITION; PATIENT; GUIDELINES; PROVISION; PROGRAM; DISEASE; MODEL; UNITS	BACKGROUND Uncertainty exists about the most effective route for delivery of early nutritional support in critically ill adults. We hypothesized that delivery through the parenteral route is superior to that through the enteral route. METHODS We conducted a pragmatic, randomized trial involving adults with an unplanned admission to one of 33 English intensive care units. We randomly assigned patients who could be fed through either the parenteral or the enteral route to a delivery route, with nutritional support initiated within 36 hours after admission and continued for up to 5 days. The primary outcome was all-cause mortality at 30 days. RESULTS We enrolled 2400 patients; 2388 (99.5%) were included in the analysis (1191 in the parenteral group and 1197 in the enteral group). By 30 days, 393 of 1188 patients (33.1%) in the parenteral group and 409 of 1195 patients (34.2%) in the enteral group had died (relative risk in parenteral group, 0.97; 95% confidence interval, 0.86 to 1.08; P = 0.57). There were significant reductions in the parenteral group, as compared with the enteral group, in rates of hypoglycemia (44 patients [3.7%] vs. 74 patients [6.2%]; P = 0.006) and vomiting (100 patients [8.4%] vs. 194 patients [16.2%]; P<0.001). There were no significant differences between the parenteral group and the enteral group in the mean number of treated infectious complications (0.22 vs. 0.21; P = 0.72), 90-day mortality (442 of 1184 patients [37.3%] vs. 464 of 1188 patients [39.1%], P = 0.40), in rates of 14 other secondary outcomes, or in rates of adverse events. Caloric intake was similar in the two groups, with the target intake not achieved in most patients. CONCLUSIONS We found no significant difference in 30-day mortality associated with the route of delivery of early nutritional support in critically ill adults.	[Harvey, Sheila E.; Parrott, Francesca; Harrison, David A.; Rowan, Kathryn M.] Intens Care Natl Audit & Res Ctr, Clin Trials Unit, London WC1V 6AZ, England; [Bear, Danielle E.] Guys & St Thomas NHS Fdn Trust, Dept Nutr & Dietet, London, England; [Bear, Danielle E.; Beale, Richard] Guys & St Thomas NHS Fdn Trust, Dept Adult Crit Care, London, England; [Segaran, Ella; Leonard, Richard] Imperial Coll Healthcare NHS Trust, Dept Intens Care, London, England; [Beale, Richard] Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Bellingan, Geoff; Mythen, Michael G.] Univ Coll London Hosp NHS Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr, London, England; [Bellingan, Geoff; Mythen, Michael G.] UCL, London WC1E 6BT, England; [Leonard, Richard] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England	Intensive Care National Audit & Research Centre; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; University of London; King's College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Imperial College London	Rowan, KM (corresponding author), Intens Care Natl Audit & Res Ctr, Napier House,24 High Holborn, London WC1V 6AZ, England.	kathy.rowan@icnarc.org	Harrison, David/O-4355-2018; Montgomery, Hugh/C-2592-2008; Preller, Jacobus/AAD-4334-2022	Harrison, David/0000-0002-9002-9098; Brealey, David/0000-0002-1982-3379; Forbes, Alastair/0000-0001-7416-9843; Grieve, Richard/0000-0001-8899-1301; Montgomery, Hugh/0000-0001-8797-5019; Preller, Jacobus/0000-0001-5706-816X; Terblanche MBE, Ella/0000-0002-1761-8996; Bercades, Georgia/0000-0002-5961-3149; Harvey, Sheila/0000-0001-7604-8607; Rowan, Kathryn/0000-0001-8217-5602	Health Technology Assessment Program of the United Kingdom National Institute for Health Research [07/52/03]; Nutricia; Nestle Nutrition; Corpak MedSystems UK; Fresenius Kabi; Nestle Nutrition (through the European Society of Intensive Care Medicine); Baxter; National Institute for Health Research [07/52/03] Funding Source: researchfish	Health Technology Assessment Program of the United Kingdom National Institute for Health Research; Nutricia(Danone Nutricia); Nestle Nutrition(Nestle SA); Corpak MedSystems UK; Fresenius Kabi; Nestle Nutrition (through the European Society of Intensive Care Medicine)(Nestle SA); Baxter; National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a grant from the Health Technology Assessment Program of the United Kingdom National Institute for Health Research (project no. 07/52/03).; Ms. Bear reports receiving consulting fees from Nutricia, lecture fees from Nestle Nutrition, travel support from Nutricia and Baxter, and grant support through her institution from Corpak MedSystems UK; Ms. Segaran, receiving travel support from Abbott Nutrition; Dr. Beale, receiving consulting and lecture fees from Nestle Nutrition and grant support from Fresenius Kabi (all through his institution), and negotiating an unrestricted research grant from Nestle Nutrition (through the European Society of Intensive Care Medicine); and Dr. Mythen, receiving lecture fees from Fresenius Kabi and Baxter and grant support from Fresenius Kabi and holding a patent related to methods and apparatus for guiding medical care based on detected gastric function through Medical Defence Technologies. No other potential conflict of interest relevant to this article was reported.	Bion J, 2013, BMJ QUAL SAF, V22, P110, DOI 10.1136/bmjqs-2012-001325; Boitano M, 2010, NUTR CLIN PRACT, V25, P663, DOI 10.1177/0884533610385349; Casaer MP, 2013, AM J RESP CRIT CARE, V187, P247, DOI 10.1164/rccm.201206-0999OC; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; De Jonghe B, 2001, CRIT CARE MED, V29, P8, DOI 10.1097/00003246-200101000-00002; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Doig GS, 2013, JAMA-J AM MED ASSOC, V309, P2130, DOI 10.1001/jama.2013.5124; Engel JM, 2003, CLIN NUTR, V22, P187, DOI 10.1054/clnu.2002.0622; Fischer K, 2011, BIOSTATISTICS, V12, P247, DOI 10.1093/biostatistics/kxq053; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; Grant AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; National Patient Safety Agency, 2005, RED HARM CAUS MISPL; Naylor CJ, 2004, JPEN-PARENTER ENTER, V28, P251, DOI 10.1177/0148607104028004251; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; [No title captured]; [No title captured]; [No title captured]	31	325	360	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1673	1684		10.1056/NEJMoa1409860	http://dx.doi.org/10.1056/NEJMoa1409860			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25271389	Green Accepted, Green Published			2022-12-28	WOS:000343768500005
J	Whiten, A				Whiten, Andrew			ANIMAL BEHAVIOUR Incipient tradition in wild chimpanzees	NATURE			English	Editorial Material							CULTURAL TRANSMISSION		Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland	University of St Andrews	Whiten, A (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland.	a.whiten@st-andrews.ac.uk		Whiten, Andrew/0000-0003-2426-5890				Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Boesch C, 2012, WILD CULTURES: A COMPARISON BETWEEN CHIMPANZEE AND HUMAN CULTURES, P1, DOI 10.1017/CBO9781139178532; Haun D. B. M., 2014, ANIM COGN; HOBAITER, PLOS BIOL; Hobaiter C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001960; Hoppitt W., 2013, SOCIAL LEARNING INTR, DOI DOI 10.23943/PRINCETON/9780691150703.001.0001/UPSO-9780691150703; Luncz LV, 2014, AM J PRIMATOL, V76, P649, DOI 10.1002/ajp.22259; Nishida T., 2010, CHIMPANZEE BEHAV WIL; O'Malley RC, 2012, CURR ANTHROPOL, V53, P650, DOI 10.1086/666943; van de Waal E, 2013, SCIENCE, V340, P483, DOI 10.1126/science.1232769; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134	12	5	5	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					178	179		10.1038/nature13759	http://dx.doi.org/10.1038/nature13759			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25274304				2022-12-28	WOS:000342663100031
J	Pourquie, O				Pourquie, Olivier			Managing patterns and proportions over time	SCIENCE			English	Editorial Material									[Pourquie, Olivier] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Pourquie, Olivier] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Pourquie, Olivier] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM, CNRS,UMR 7104,U964, F-64700 Illkirch Graffenstaden, France	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pourquie, O (corresponding author), Harvard Univ, Dept Genet, Sch Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	pourquie@genetics.med.harvard.edu	Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227				Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Kicheva A, 2014, SCIENCE, V345, P1577, DOI 10.1126/science.1254927; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037	5	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1565	1566		10.1126/science.1260025	http://dx.doi.org/10.1126/science.1260025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP6CG	25258067				2022-12-28	WOS:000342164500023
J	Becker, S				Becker, Sandy			Rhubarb pie and science	SCIENCE			English	Editorial Material									Wesleyan Univ, Middletown, CT 06459 USA	Wesleyan University	Becker, S (corresponding author), Wesleyan Univ, Middletown, CT 06459 USA.								0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1534	1534		10.1126/science.345.6203.1534	http://dx.doi.org/10.1126/science.345.6203.1534			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0LM	25237105				2022-12-28	WOS:000341752900046
J	Kabrhel, C; Rempell, JS; Avery, LL; Dudzinski, DM; Weinberg, I				Kabrhel, Christopher; Rempell, Joshua S.; Avery, Laura L.; Dudzinski, David M.; Weinberg, Ido			Case 29-2014: A 60-Year-Old Woman with Syncope	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC VENOUS THROMBOEMBOLISM; MASSIVE PULMONARY-EMBOLISM; SURGICAL-TREATMENT; RISK; ECHOCARDIOGRAPHY; METAANALYSIS; MANAGEMENT; DIAGNOSIS; HEPARIN; CANCER		[Kabrhel, Christopher] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Avery, Laura L.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Dudzinski, David M.] Massachusetts Gen Hosp, Dept Echocardiog, Boston, MA 02114 USA; [Dudzinski, David M.; Weinberg, Ido] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Rempell, Joshua S.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Kabrhel, Christopher] Harvard Univ, Sch Med, Dept Emergency Med, Boston, MA USA; [Avery, Laura L.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Dudzinski, David M.] Harvard Univ, Sch Med, Dept Echocardiog, Boston, MA USA; [Dudzinski, David M.; Weinberg, Ido] Harvard Univ, Sch Med, Dept Cardiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kabrhel, C (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.			Kabrhel, Christopher/0000-0002-8699-7176	Diagnostica Stago; Siemens Healthcare; Sanofi; Advantage Health Care; VIVA Physicians	Diagnostica Stago; Siemens Healthcare(Siemens AG); Sanofi; Advantage Health Care; VIVA Physicians	Dr. Kabrhel reports receiving consulting fees from Diagnostica Stago and grant support to his institution from Diagnostica Stago and Siemens Healthcare; Dr. Dudzinski, consulting fees from Sanofi and Advantage Health Care; and Dr. Weinberg, consulting fees from VIVA Physicians. No other potential conflict of interest relevant to this article was reported.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Chong LY, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3979; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Dresden S, 2014, ANN EMERG MED, V63, P16, DOI 10.1016/j.annemergmed.2013.08.016; Eichinger S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000467; Hockberger RS, 2001, ANN EMERG MED, V37, P745, DOI 10.1067/mem.2001.115495; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kuo WT, 2009, J VASC INTERV RADIOL, V20, P1431, DOI 10.1016/j.jvir.2009.08.002; Labovitz AJ, 2010, J AM SOC ECHOCARDIOG, V23, P1225, DOI 10.1016/j.echo.2010.10.005; Leacche M, 2005, J THORAC CARDIOV SUR, V129, P1018, DOI 10.1016/j.jtcvs.2004.10.023; Lee AYY, 2005, J CLIN ONCOL, V23, P2123, DOI 10.1200/JCO.2005.03.133; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Rose PS, 2002, CHEST, V121, P806, DOI 10.1378/chest.121.3.806; Takahashi H, 2012, ANN THORAC SURG, V94, P785, DOI 10.1016/j.athoracsur.2012.03.101; Torbicki A, 2003, J AM COLL CARDIOL, V41, P2245, DOI 10.1016/S0735-1097(03)00479-0; van Doormaal FF, 2011, J THROMB HAEMOST, V9, P79, DOI 10.1111/j.1538-7836.2010.04101.x; Wan S, 2004, CIRCULATION, V110, P744, DOI 10.1161/01.CIR.0000137826.09715.9C; Watson HG, 2005, BLOOD REV, V19, P235, DOI 10.1016/j.blre.2004.08.001	22	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1143	1150		10.1056/NEJMcpc1403307	http://dx.doi.org/10.1056/NEJMcpc1403307			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25229919				2022-12-28	WOS:000341687300011
J	Shulman, GI				Shulman, Gerald I.			Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROTEIN-KINASE-C; MAGNETIC-RESONANCE-SPECTROSCOPY; MUSCLE GLYCOGEN-SYNTHESIS; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; GLUCOSE-TRANSPORT-PHOSPHORYLATION; INDUCED HEPATIC STEATOSIS; TYPE-2 DIABETIC PARENTS; SKELETAL-MUSCLE; LIVER-DISEASE; MITOCHONDRIAL DYSFUNCTION		[Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Amaro A, 2010, GASTROENTEROLOGY, V139, P149, DOI 10.1053/j.gastro.2010.03.039; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Ferreira LDMCB, 2001, DIABETES, V50, P1064, DOI 10.2337/diabetes.50.5.1064; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; International Diabetes Federation, 2014, IDF DIABETES ATLAS, V6th; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Itani SI, 2001, METABOLISM, V50, P553, DOI 10.1053/meta.2001.22512; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Krssak M, 1999, DIABETOLOGIA, V42, P386; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Peter A, 2012, INT J OBESITY, V36, P774, DOI 10.1038/ijo.2011.154; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Petersen KF, 1998, DIABETES, V47, P381, DOI 10.2337/diabetes.47.3.381; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Petersen KF, 2012, P NATL ACAD SCI USA, V109, P8236, DOI 10.1073/pnas.1205675109; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160; Rabol R, 2011, P NATL ACAD SCI USA, V108, P13705, DOI 10.1073/pnas.1110105108; Raddatz K, 2011, DIABETOLOGIA, V54, P1447, DOI 10.1007/s00125-011-2073-0; RANDLE PJ, 1963, LANCET, V1, P785; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; ROTHMAN DL, 1995, P NATL ACAD SCI USA, V92, P983, DOI 10.1073/pnas.92.4.983; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Sleigh A, 2011, J CLIN INVEST, V121, P2457, DOI 10.1172/JCI46405; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	73	553	561	6	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1131	1141		10.1056/NEJMra1011035	http://dx.doi.org/10.1056/NEJMra1011035			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25229917				2022-12-28	WOS:000341687300008
J	Armstrong, S				Armstrong, Stephen			HEALTH AND TECHNOLOGY Games for doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						de Freitas S, 2008, LEARN MEDIA TECHNOL, V33, P11, DOI 10.1080/17439880701868796; Egenfeldt-Nielsen S., 2007, J ED MULTIMED HYPERM, V16, P263; Giannotti D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057372; Rosser JC, 2012, JSLS-J SOC LAPAROEND, V16, P3, DOI 10.4293/108680812X13291597715664	4	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2014	349								g5642	10.1136/bmj.g5642	http://dx.doi.org/10.1136/bmj.g5642			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OP	25227507				2022-12-28	WOS:000342057500011
J	Giri, J				Giri, J.			Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Hosp Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Giri, J (corresponding author), Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.	giri.jay@gmail.com	Akl, Elie A/R-2079-2016	Akl, Elie A/0000-0002-3444-8618					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC9	10.7326/0003-4819-161-6-201409160-02009	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222421				2022-12-28	WOS:000343894400008
J	Dupas, P				Dupas, Pascaline			Getting essential health products to their end users: Subsidize, but how much?	SCIENCE			English	Editorial Material							CARE; QUALITY	Although coverage rates and health outcomes are improving, many poor people around the world still do not benefit from essential health products. An estimated two-thirds of child deaths could be prevented with increased coverage of products such as vaccines, point-of-use water treatment, iron fortification, and insecticide-treated bednets. What limits the flow of products from the producer's laboratory bench to the end users, and what can be done about it? Recent empirical research suggests a crucial role for heavy subsidies.	Stanford Univ, Dept Econ, Stanford, CA 94305 USA	Stanford University	Dupas, P (corresponding author), Stanford Univ, Dept Econ, Stanford, CA 94305 USA.	pdupas@stanford.edu		Dupas, Pascaline/0000-0003-0140-9417	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD061315] Funding Source: NIH RePORTER; NICHD NIH HHS [P01HD061315-01, P01 HD061315] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2014, ENCY HLTH EC, DOI DOI 10.1016/B978-0-12-375678-7.00126-7; Ashraf N, 2010, AM ECON REV, V100, P2383, DOI 10.1257/aer.100.5.2383; Attanasio O., 2014, SHOULD CASH TRANSFER; Banerjee AV, 2008, J EUR ECON ASSOC, V6, P487, DOI 10.1162/JEEA.2008.6.2-3.487; Banerjee AV, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2220; Barber SL, 2010, J DEV EFFECT, V2, P51, DOI 10.1080/19439341003592630; Barham T, 2011, J DEV ECON, V94, P74, DOI 10.1016/j.jdeveco.2010.01.003; Berry J., 2012, ELICITING UTILIZING; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; Cohen J, 2014, PRICE SUBSIDIES DIAG; Cohen J, 2010, Q J ECON, V125, P1, DOI 10.1162/qjec.2010.125.1.1; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; Das J, 2014, ANNU REV ECON, V6, P525, DOI 10.1146/annurev-economics-080213-041350; Dizon-Ross R., 2013, GOVERNANCE EFFECTIVE; Dupas P, 2014, ECONOMETRICA, V82, P197, DOI 10.3982/ECTA9508; Dupas P, 2009, AM ECON REV, V99, P224, DOI 10.1257/aer.99.2.224; Goldstein M, 2013, AM ECON J-APPL ECON, V5, P58, DOI 10.1257/app.5.2.58; Hoffmann V, 2009, AM ECON REV, V99, P236, DOI 10.1257/aer.99.2.236; JPAL, 2011, JPAL B; Kremer M, 2007, Q J ECON, V122, P1007, DOI 10.1162/qjec.122.3.1007; Meredith J, 2013, J DEV ECON, V105, P196, DOI 10.1016/j.jdeveco.2013.08.003; Olken B, 2013, SHOULD AID REWARD PE; Tarozzi A, 2014, AM ECON REV, V104, P1909, DOI 10.1257/aer.104.7.1909	23	38	38	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1279	1281		10.1126/science.1256973	http://dx.doi.org/10.1126/science.1256973			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214612	Green Accepted			2022-12-28	WOS:000341483800044
J	Bordenstein, SR				Bordenstein, Seth R.			Genomic and Cellular Complexity from Symbiotic Simplicity	CELL			English	Editorial Material									[Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci & Pathol, Dept Microbiol, Nashville, TN 37235 USA; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Immunol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Bordenstein, SR (corresponding author), Vanderbilt Univ, Dept Biol Sci & Pathol, Dept Microbiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	s.bordenstein@vanderbilt.edu			NIGMS NIH HHS [R01 GM085163] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085163] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Pallen MJ, 2011, TRENDS MICROBIOL, V19, P58, DOI 10.1016/j.tim.2010.11.001; Rosenberg E., 2013, HOLOGENOME CONCEPT H; TREATCLEMMONS LG, 1983, CURR GENET, V7, P489, DOI 10.1007/BF00377615; Van Leuven JT, 2014, CELL, V158, P1270, DOI 10.1016/j.cell.2014.07.047	10	2	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1236	1237		10.1016/j.cell.2014.08.022	http://dx.doi.org/10.1016/j.cell.2014.08.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215482	Bronze, Green Accepted			2022-12-28	WOS:000343094200005
J	Bournazos, S; Klein, F; Pietzsch, J; Seaman, MS; Nussenzweig, MC; Ravetch, JV				Bournazos, Stylianos; Klein, Florian; Pietzsch, John; Seaman, Michael S.; Nussenzweig, Michel C.; Ravetch, Jeffrey V.			Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity	CELL			English	Article							MONOCLONAL-ANTIBODY; BINDING-SITE; MOUSE MODEL; GAMMA-RI; HIV; POTENT; RECEPTOR; PROTECTION; SUBCLASS; VARIANTS	Broadly neutralizing antibodies (bNAbs) against HIV-1 provide both effective pre-exposure prophylaxis and treatment of HIV-1 infection in murine and nonhuman primate models, suggesting their potential use in humans. Although much is known about the role of variable domains in the neutralization breadth and potency of these bNAbs, the contribution of Fc domains to their activities is, by contrast, poorly characterized. Assessment of the in vivo activity of several bNAbs revealed that Fc gamma R-mediated effector function contributes substantially to their capacity to block viral entry, suppress viremia, and confer therapeutic activity. Enhanced in vivo potency of anti-HIV-1 bNAbs was associated with preferential engagement of activating, but not inhibitory Fc gamma Rs, and Fc domain-engineered bNAb variants with selective binding capacity for activating Fc gamma Rs displayed augmented protective activity. These findings reveal key roles for Fc effector function in the in vivo activity of anti-HIV-1 bNAbs and provide strategies for generating bNAbs with improved efficacy.	[Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Klein, Florian; Pietzsch, John; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA.	ravetch@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Ravetch, Jeffrey/Z-1596-2019; Bournazos, Stylianos/ABH-1578-2021	Ravetch, Jeffrey/0000-0003-2024-9041; 	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [AI081677, AI100148]; CTSA [UL1TR000043]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [AI100663]; Bill & Melinda Gates Foundation [OPP1033115, CA-VIMC1032144]; NBC Career Development Award [U54AI057158]; American Heart Association (AHA) postdoctoral fellowship [13POST14100003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, P01AI100148, P01AI081677, UM1AI100663] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NBC Career Development Award; American Heart Association (AHA) postdoctoral fellowship(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank all members of the Laboratory of Molecular Genetics and Immunology (Rockefeller University) for the helpful discussions and technical help. We also thank B. Donovan and A. Ploss (Laboratory of Virology and Infectious disease, Rockefeller University) for providing the hCD4/hCCR5 adenovirus; L. Nogueira, A. Halper-Stromberg, J. Horwitz, and H. Gruell (Laboratory of Molecular Immunology, Rockefeller University) for technical help and advice; J. Scheid and H. Mouquet (Rockefeller University) for providing the antibody plasmids; and L. Stamatatos (Seattle Biomedical Research Institute) for providing the gp140<SUP>SF162</SUP>. Research reported in this publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers AI081677 and AI100148 (to J.V.R. and M.C.N.), by the CTSA grant UL1TR000043 to Rockefeller University, and by Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery AI100663 (to M.C.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Research support was also provided by the Bill & Melinda Gates Foundation grant OPP1033115 to J.V.R. and M.C.N and CA-VIMC1032144 to M.S.S. S.B. was supported by an NBC Career Development Award (U54AI057158) and an American Heart Association (AHA) postdoctoral fellowship (13POST14100003).	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Ackerman ME, 2013, J VIROL, V87, P5468, DOI 10.1128/JVI.03403-12; Akiyoshi DE, 2010, INFECT IMMUN, V78, P1376, DOI 10.1128/IAI.00867-09; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bournazos S, 2014, J CLIN INVEST, V124, P725, DOI 10.1172/JCI72676; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dugast AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097229; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Forthal DN, 2011, AIDS, V25, P2099, DOI 10.1097/QAD.0b013e32834b64bd; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Heider KH, 2011, BLOOD, V118, P4159, DOI 10.1182/blood-2011-04-351932; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Horton HM, 2010, BLOOD, V116, P3004, DOI 10.1182/blood-2010-01-265280; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Lai JI, 2014, J VIROL, V88, P2799, DOI 10.1128/JVI.03130-13; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Moldt B, 2012, J VIROL, V86, P6189, DOI 10.1128/JVI.00491-12; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nguyen DC, 2011, IMMUNOGENETICS, V63, P351, DOI 10.1007/s00251-011-0514-z; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn Falk, 2012, Cancer Immun, V12, P13; Nimmerjahn F, 2010, P NATL ACAD SCI USA, V107, P19396, DOI 10.1073/pnas.1014515107; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perez LG, 2013, J VIROL, V87, P5287, DOI 10.1128/JVI.00278-13; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907	47	336	343	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1243	1253		10.1016/j.cell.2014.08.023	http://dx.doi.org/10.1016/j.cell.2014.08.023			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215485	Green Accepted, Bronze			2022-12-28	WOS:000343094200008
J	Lake, A; Chan, M				Lake, Anthony; Chan, Margaret			Putting science into practice for early child development	LANCET			English	Editorial Material									[Lake, Anthony] UNICEF, New York, NY 10038 USA; [Chan, Margaret] WHO, CH-1211 Geneva 27, Switzerland	UNICEF; World Health Organization	Lake, A (corresponding author), UNICEF, New York, NY 10038 USA.	chanm@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Britto P.R., 2013, HDB EARLY CHILDHOOD; DeHaan M., 2009, HDB DEV SOCIAL NEURO; Gertler P, 2014, SCIENCE, V344, P998, DOI 10.1126/science.1251178; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; National Scientific Council on the Developing Child, WORKING PAPER 3; Shonkoff JP, 2013, HDB EARLY CHILDHOOD, P1; UN Inter-Agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; Wachs TD, 2014, ANN NY ACAD SCI, V1308, P89, DOI 10.1111/nyas.12314; World Health Organization, 2012, CAR CHILD DEV IMPR C	11	35	36	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1816	1817		10.1016/S0140-6736(14)61680-9	http://dx.doi.org/10.1016/S0140-6736(14)61680-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH6ZE	25245180				2022-12-28	WOS:000354184500010
J	Ejnes, YD				Ejnes, Yul D.			California's Proposition 46 and Mandatory Physician Drug Testing: A Cause for Concern	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ejnes, Yul D.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Ejnes, YD (corresponding author), Coastal Med Inc, 75 Sockanosset Crossroad,Suite 101, Cranston, RI 02920 USA.	yul_ejnes@brown.edu						[Anonymous], 2014, WHAT AR BALL PROP IN; [Anonymous], 2002, STAT IN GUID; [Anonymous], 2004, AMA COD ETH; Boisaubin EV, 2001, AM J MED SCI, V322, P31, DOI 10.1097/00000441-200107000-00006; LEMON SJ, 1992, ARCH INTERN MED, V152, P2238, DOI 10.1001/archinte.152.11.2238; Mello MM, 2010, 102 MED PAYM ADV COM, P12; Nagourney A, 2014, NY TIMES, pA1; Pham JC, 2013, JAMA-J AM MED ASSOC, V309, P2101, DOI 10.1001/jama.2013.4635	8	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					911	U104		10.7326/M14-1866	http://dx.doi.org/10.7326/M14-1866			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25265244				2022-12-28	WOS:000347248400033
J	Eba, PM				Eba, Patrick M.			Ebola and human rights in west Africa	LANCET			English	Editorial Material									UNAIDS, CH-1211 Geneva 27, Switzerland	UNAIDS	Eba, PM (corresponding author), UNAIDS, CH-1211 Geneva 27, Switzerland.	ebap@unaids.org						[Anonymous], 2014, REUTERS; Butty J., 2014, ASS PRESS       0823; Hildebrandt Amber, 2014, CBC NEWS; Human Rights Watch, 2014, W AFR RESP RIGHTS EB; IRIN, 2014, IRINNEWS        0611; London Leslie, 2008, Health Hum Rights, V10, P65; MANN JM, 1988, J ROY STAT SOC A STA, V151, P131, DOI 10.2307/2982189; McNeil D., 2014, NY TIMES; Nossiter Adam, 2014, NEW YORK TIMES; Reuters, 2014, REUTERS         0829; Roy-Macauley C., 2014, ASS PRESS       0823; UN Economic and Social Council UN Commission on Human Rights, 1984, ECN419854 UN EC SOC; WHO, 2014, EB RESP ROADM	13	25	25	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2091	2093		10.1016/S0140-6736(14)61412-4	http://dx.doi.org/10.1016/S0140-6736(14)61412-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW6BK	25245179				2022-12-28	WOS:000346354300009
J	Hsiao, A; Ahmed, AMS; Subramanian, S; Griffin, NW; Drewry, LL; Petri, WA; Haque, R; Ahmed, T; Gordon, JI				Hsiao, Ansel; Ahmed, A. M. Shamsir; Subramanian, Sathish; Griffin, Nicholas W.; Drewry, Lisa L.; Petri, William A., Jr.; Haque, Rashidul; Ahmed, Tahmeed; Gordon, Jeffrey I.			Members of the human gut microbiota involved in recovery from Vibrio cholerae infection	NATURE			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; COLONIZATION; AUTOINDUCER; TOXIN; O1; COMMUNICATION; SEQUENCE; DATABASE; HARVEYI	Given the global burden of diarrhoeal diseases(1), it is important to understand how members of the gut microbiota affect the risk for, course of, and recovery from disease in children and adults. The acute, voluminous diarrhoea caused by Vibrio cholerae represents a dramatic example of enteropathogen invasion and gut microbial community disruption. Here we conduct a detailed time-series metagenomic study of faecal microbiota collected during the acute diarrhoeal and recovery phases of cholera in a cohort of Bangladeshi adults living in an area with a high burden of disease(2). We find that recovery is characterized by a pattern of accumulation of bacterial taxa that shows similarities to the pattern of assembly/maturation of the gut microbiota in healthy Bangladeshi children(3). To define the underlying mechanisms, we introduce into gnotobiotic mice an artificial community composed of human gut bacterial species that directly correlate with recovery from cholera in adults and are indicative of normal microbiota maturation in healthy Bangladeshi children(3). One of the species, Ruminococcus obe urn, exhibits consistent increases in its relative abundance upon V. choleraeinfection of the mice. Follow-up analyses, including mono-and co-colonization studies, establish that R. obeum restricts V. cholerae colonization, that R. obewn luxS (autoinducer-2 (AI-2) synthase) expression and AI-2 production increase significantly with V. cholerae invasion, and that R. obeum AI-2 causes quorum-sensing-mediated repression of several V. cholerae colonization factors. Co-colonization with V. choleraemutants discloses that R. obeum AI-2 reduces Vibrio colonization/pathogenicity through a novel pathway that does not depend on the V. cholerae AI-2 sensor, LuxP. The approach described can be used to mine the gut microbiota of Bangladeshi or other populations for members that use autoinducers and/or other mechanisms to limit colonization with V. cholerae, or conceivably other enteropathogens.	[Hsiao, Ansel; Subramanian, Sathish; Griffin, Nicholas W.; Drewry, Lisa L.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Ahmed, A. M. Shamsir] Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia; [Ahmed, A. M. Shamsir; Haque, Rashidul; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Dhaka 1212, Bangladesh; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	Washington University (WUSTL); University of Queensland; International Centre for Diarrhoeal Disease Research (ICDDR); University of Virginia; University of Virginia; University of Virginia	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Petri, William/AAL-3642-2020; Petri, William A./D-3639-2019	Petri, William/0000-0002-7268-1218; Drewry, Lisa/0000-0003-2208-9010	Bill & Melinda Gates Foundation; National Institutes of Health [Al43596]; NIH [T32DK077653, T32Al007172]; Crohn's and Colitis Foundation of America; Australian Agency for International Development; Government of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596, T32AI007172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, T32DK077653] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Australian Agency for International Development; Government of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Wagoner, J. Hoisington-Lopez, M. Meier, J. Cheng, D. O'Donnell, and M. Karlsson for technical support, J. Zhu for providing strains of V. cholerae and Vibrio harveyi, and W.-L Ng for providing Delta luxP V. cholerae. This work was supported in part by a grant from the Bill & Melinda Gates Foundation. The singleton birth cohort of Bangladeshi children was supported by a grant from the National Institutes of Health (Al43596). The post-doctoral fellowship stipend of A.H. was funded in part by NIH training grants (T32DK077653, T32Al007172) and by the Crohn's and Colitis Foundation of America. The International Centre for Diarrhoeal Disease Research, Bangladesh, acknowledges the following donors, which provided unrestricted support: the Australian Agency for International Development, the Government of Bangladesh, the Canadian International Development Agency, the Swedish International Development Cooperation Agency, and the Department for International Development, UK.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chowdhury F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000999; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duan FP, 2010, P NATL ACAD SCI USA, V107, P11260, DOI 10.1073/pnas.1001294107; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faiz M. A., 2011, Regional Health Forum, V15, P1; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu Z, 2006, J BACTERIOL, V188, P2446, DOI 10.1128/JB.188.7.2446-2453.2006; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Liu Z, 2007, INFECT IMMUN, V75, P122, DOI 10.1128/IAI.01190-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; World Health Organization, 2014, Weekly Epidemiological Record, V89, P345; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	40	234	245	4	141	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					423	+		10.1038/nature13738	http://dx.doi.org/10.1038/nature13738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25231861	Green Accepted			2022-12-28	WOS:000345770600048
J	Sergio, F; Tanferna, A; De Stephanis, R; Jimenez, LL; Blas, J; Tavecchia, G; Preatoni, D; Hiraldo, F				Sergio, Fabrizio; Tanferna, Alessandro; De Stephanis, Renaud; Lopez Jimenez, Lidia; Blas, Julio; Tavecchia, Giacomo; Preatoni, Damiano; Hiraldo, Fernando			Individual improvements and selective mortality shape lifelong migratory performance	NATURE			English	Article							AGE; BIRD; FLEXIBILITY; RAPTOR; NDVI	Billions of organisms, from bacteria to humans, migrate each year(1) and research on their migration biology is expanding rapidly through ever more sophisticated remote sensing technologies(2-4). However, little is known about how migratory performance develops through life for any organism. To date, age variation has been almost systematically simplified into a dichotomous comparison between recently born juveniles at their first migration versus adults of unknown age(5-7). These comparisons have regularly highlighted better migratory performance by adults compared with juveniles', but it is unknown whether such variation is gradual or abrupt and whether it is driven by improvements within the individual, by selective mortality of poor performers, or both. Here we exploit the opportunity offered by long-term monitoring of individuals through Global Positioning System (GPS) satellite tracking to combine within-individual and cross-sectional data on 364 migration episodes from 92 individuals of a raptorial bird, aged 1-27 years old. We show that the development of migratory behaviour follows a consistent trajectory, more gradual and prolonged than previously appreciated, and that this is promoted by both individual improvements and selective mortality, mainly operating in early life and during the pre-breeding migration. Individuals of different age used different travelling tactics and varied in their ability to exploit tailwinds or to cope with wind drift. All individuals seemed aligned along a race with their contemporary peers, whose outcome was largely determined by the ability to depart early, affecting their subsequent recruitment, reproduction and survival. Understanding how climate change and human action can affect the migration of younger animals maybe the key to managing and forecasting the declines of many threatened migrants.	[Sergio, Fabrizio; Tanferna, Alessandro; De Stephanis, Renaud; Lopez Jimenez, Lidia; Blas, Julio; Hiraldo, Fernando] CSIC, Estn Biol Donana, Dept Conservat Biol, Seville 41092, Spain; [Tavecchia, Giacomo] CSIC UIB, Inst Mediterranean Studies IMEDEA, Populat Ecol Grp, Esporles 07190, Spain; [Preatoni, Damiano] Insubria Univ, Dept Theoret & Appl Sci, I-21100 Varese, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; University of Insubria	Sergio, F (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, Ave Amer Vespucio, Seville 41092, Spain.	fsergio@ebd.csic.es	Hiraldo, Fernando/AAA-8314-2019; de Stephanis, Renaud/AAA-5682-2019; López, Lidia/HGE-0751-2022; Blas, Julio/A-2487-2012; Preatoni, Damiano/A-8621-2010; Tavecchia, Giacomo/N-3961-2014; Sergio, Fabrizio/B-3952-2015; Tanferna, Alessandro/L-6648-2015	Blas, Julio/0000-0003-0589-3322; Preatoni, Damiano/0000-0001-8760-1316; Lopez-Jimenez, Lidia/0000-0002-4109-3034; de Stephanis, Renaud/0000-0003-2522-7933; Tavecchia, Giacomo/0000-0001-5435-2691; Sergio, Fabrizio/0000-0002-8024-1773; Tanferna, Alessandro/0000-0003-0799-301X	Natural Research Ltd; Spanish Ministry of Science and Innovation/Economy and Competitiveness [CGL2008-01781, CGL2011-28103, CGL2012-32544]; FEDER; Spanish Ministry of Agriculture, Food and the Environment (Autonomous Organism of National Parks) [511/2012]; Consejeria de Medio Ambiente de la Junta de Andalucia [JA-58]; Junta de Andalucia [RNM 1790, RNM 3822, RNM 7307]; Juan de la Cierva Programme; Severo Ochoa Programme for Centres of Excellence of the Spanish Ministry of Economy and Competitiveness [SEV-2012-0262]; Ramon y Cajal contract from CSIC	Natural Research Ltd; Spanish Ministry of Science and Innovation/Economy and Competitiveness; FEDER(European Commission); Spanish Ministry of Agriculture, Food and the Environment (Autonomous Organism of National Parks); Consejeria de Medio Ambiente de la Junta de Andalucia(Junta de Andalucia); Junta de Andalucia(Junta de Andalucia); Juan de la Cierva Programme; Severo Ochoa Programme for Centres of Excellence of the Spanish Ministry of Economy and Competitiveness; Ramon y Cajal contract from CSIC	We thank F. J. Chicano, F. G. Vilches, J. M. Giralt and M. Anjos for help in the field, I. Afen and D. Aragones for support with GIS analyses, the personnel of the Reserva Biologica de Donana for logistical help and accommodation, the LEM-EBD for molecular sexing, and Microwave Telemetry for technical support. Part of the study was funded by Natural Research Ltd and research projects CGL2008-01781, CGL2011-28103 and CGL2012-32544 of the Spanish Ministry of Science and Innovation/Economy and Competitiveness and FEDER funds, 511/2012 of the Spanish Ministry of Agriculture, Food and the Environment (Autonomous Organism of National Parks), JA-58 of the Consejeria de Medio Ambiente de la Junta de Andalucia and by the Excellence Projects RNM 1790, RNM 3822 and RNM 7307 of the Junta de Andalucia. R.D.S. was supported by the Juan de la Cierva Programme and by the Severo Ochoa Programme for Centres of Excellence of the Spanish Ministry of Economy and Competitiveness (SEV-2012-0262). J.B. was supported by a Ramon y Cajal contract from the CSIC.	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 2000, EXPTL BIOL REV, P105; Alerstam T, 1993, BIRD MIGRATION; [Anonymous], 2020, ECONOMIST 0326; Barry R.G., 2010, ATMOSPHERE WEATHER C, V9th; Batschelet E., 1981, CIRCULAR STAT BIOL; Berthold P, 2001, AUK, V2nd; Bildstein K. L., 2006, MIGRATING RAPTORS WO; Blas J, 2009, ECOGRAPHY, V32, P647, DOI 10.1111/j.1600-0587.2008.05700.x; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Crawley M.J., 2007, R BOOK; Despland E, 2004, ECOGRAPHY, V27, P381, DOI 10.1111/j.0906-7590.2004.03779.x; Dodge S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0195; Hake M, 2003, OIKOS, V103, P385, DOI 10.1034/j.1600-0706.2003.12145.x; Hedenstrom A, 2002, BEHAV ECOL SOCIOBIOL, V52, P308, DOI 10.1007/s00265-002-0504-0; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kerlinger P., 1989, FLIGHT STRATEGIES MI; Klaassen RHG, 2008, BEHAV ECOL SOCIOBIOL, V62, P1427, DOI 10.1007/s00265-008-0572-x; Klaassen RHG, 2011, P ROY SOC B-BIOL SCI, V278, P1339, DOI 10.1098/rspb.2010.2106; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; MilnerGulland EJ, 2011, ANIMAL MIGRATION: A SYNTHESIS, P1, DOI 10.1093/acprof:oso/9780199568994.001.0001; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; R Core Team, 2020, R LANG ENV STAT COMP; Rappole J., 2013, AVIAN MIGRANT BIOL B; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Safi K, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-4; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; SCHIFFERLI A, 1967, Ornithologische Beobachter, V64, P34; Sergio F, 2005, ECOLOGY, V86, P340, DOI 10.1890/04-0137; Sergio F, 2011, SCIENCE, V331, P327, DOI 10.1126/science.1199422; Sergio F, 2011, BASIC APPL ECOL, V12, P107, DOI 10.1016/j.baae.2010.11.004; Sergio F, 2009, OECOLOGIA, V160, P507, DOI 10.1007/s00442-009-1314-0; Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x; Shannon HD, 2002, BOUND-LAY METEOROL, V104, P167, DOI 10.1023/A:1016095804357; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Stull R.B., 1988, ATMOSPHERIC OCEANOGR; Tabachnick B., 2013, USING MULTIVARIATE S, V6th ed.; Tanferna A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049659; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Trierweiler C, 2013, J ANIM ECOL, V82, P107, DOI 10.1111/j.1365-2656.2012.02036.x; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; VINUELA J, 1992, AUK, V109, P748; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Zalles J.I., 2000, BIRDL CONSERV SER; Zuur Alain F., 2009, P1	51	203	208	11	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					410	+		10.1038/nature13696	http://dx.doi.org/10.1038/nature13696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25252973				2022-12-28	WOS:000345770600045
J	Lamontagne, F; Clement, C; Fletcher, T; Jacob, ST; Fischer, WA; Fowler, RA				Lamontagne, Francois; Clement, Christophe; Fletcher, Thomas; Jacob, Shevin T.; Fischer, William A., II; Fowler, Robert A.			Doing Today's Work Superbly Well - Treating Ebola with Current Tools	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lamontagne, Francois] Univ Sherbrooke, Ctr Rech Clin, Ctr Hosp, Sherbrooke, PQ, Canada; [Clement, Christophe] Polyclin Bordeaux Nord Aquitaine, Bordeaux, France; [Fletcher, Thomas] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Jacob, Shevin T.] Univ Washington, Seattle, WA 98195 USA; [Fischer, William A., II] Univ N Carolina, Chapel Hill, NC USA; [Fowler, Robert A.] Univ Toronto, Toronto, ON, Canada	University of Sherbrooke; Liverpool School of Tropical Medicine; University of Liverpool; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto	Lamontagne, F (corresponding author), Univ Sherbrooke, Ctr Rech Clin, Ctr Hosp, Sherbrooke, PQ, Canada.		Jacob, Shevin/CAF-0449-2022	Jacob, Shevin/0000-0003-2425-9394; Lamontagne, Francois/0000-0002-0360-3427; Fletcher, Tom/0000-0002-3712-415X	Wellcome Trust [100890] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	69	70	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1565	1566		10.1056/NEJMp1411310	http://dx.doi.org/10.1056/NEJMp1411310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25251518	Green Published, Green Accepted			2022-12-28	WOS:000343648500002
J	Ariotti, S; Hogenbirk, MA; Dijkgraaf, FE; Visser, LL; Hoekstra, ME; Song, JY; Jacobs, H; Haanen, JB; Schumacher, TN				Ariotti, Silvia; Hogenbirk, Marc A.; Dijkgraaf, Feline E.; Visser, Lindy L.; Hoekstra, Mirjam E.; Song, Ji-Ying; Jacobs, Heinz; Haanen, John B.; Schumacher, Ton N.			Skin-resident memory CD8(+) T cells trigger a state of tissue-wide pathogen alert	SCIENCE			English	Article							HERPES-SIMPLEX-VIRUS; ANTIGEN PRESENTATION; LOCAL IMMUNITY; RM CELLS; INFECTION; POPULATION; VACCINE; CD4(+)	After an infection, pathogen-specific tissue-resident memory T cells (T-RM cells) persist in nonlymphoid tissues to provide rapid control upon reinfection, and vaccination strategies that create T-RM cell pools at sites of pathogen entry are therefore attractive. However, it is not well understood how T-RM cells provide such pathogen protection. Here, we demonstrate that activated T-RM cells in mouse skin profoundly alter the local tissue environment by inducing a number of broadly active antiviral and antibacterial genes. This "pathogen alert" allows skin T-RM cells to protect against an antigenically unrelated virus. These data describe a mechanism by which tissue-resident memory CD8(+) T cells protect previously infected sites that is rapid, amplifies the activation of a small number of cells into an organ-wide response, and has the capacity to control escape variants.	[Ariotti, Silvia; Dijkgraaf, Feline E.; Visser, Lindy L.; Hoekstra, Mirjam E.; Haanen, John B.; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Hogenbirk, Marc A.; Jacobs, Heinz] Netherlands Canc Inst, Div Biol Stress Response, NL-1066 CX Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Schumacher, TN (corresponding author), Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl	Schumacher, Ton/Y-2432-2019; Haanen, John/AAD-8578-2022; Haanen, John/AAD-8534-2022	Schumacher, Ton/0000-0003-0517-8804; Haanen, John/0000-0001-5884-7704; Jacobs, Heinz/0000-0001-6227-9850; Hoekstra, Mirjam/0000-0003-4434-9813	Netherlands Organization for Scientific Research [912.10.066]; European Research Council; Dutch Cancer Society [NKI-2008-4112]; Netherlands Organization for Health Research and Development TOP grant [91213018]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Health Research and Development TOP grant	We thank members of the Netherlands Cancer Institute Flow Cytometry, Digital Microscopy, Deep Sequencing Core, and Animal Pathology Facilities for technical support; R. van Mierlo and M. Toebes for assistance; and members of the Schumacher laboratory for discussion. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Expression data were deposited under Gene Expression Omnibus accession number GSE60599. This work was supported by The Netherlands Organization for Scientific Research grant 912.10.066 and European Research Council grant Life-his-T to T.N.S., and Dutch Cancer Society grant NKI-2008-4112 and The Netherlands Organization for Health Research and Development TOP grant 91213018 to H.J.	Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Ariotti S, 2012, ADV IMMUNOL, V114, P203, DOI 10.1016/B978-0-12-396548-6.00008-1; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hofmann M, 2013, EUR J IMMUNOL, V43, P2295, DOI 10.1002/eji.201343519; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schiffer JT, 2013, ELIFE, V2, DOI 10.7554/eLife.00288; Schiffer JT, 2013, NAT MED, V19, P280, DOI 10.1038/nm.3103; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	22	343	348	6	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					101	105		10.1126/science.1254803	http://dx.doi.org/10.1126/science.1254803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278612				2022-12-28	WOS:000342446900060
J	Suits, AG; Parker, DH				Suits, Arthur G.; Parker, David H.			Hot molecules-off the beaten path	SCIENCE			English	Editorial Material							DYNAMICS; PHOTODISSOCIATION; OXYGEN; STATE		[Suits, Arthur G.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Suits, Arthur G.; Parker, David H.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands	Wayne State University; Radboud University Nijmegen	Suits, AG (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	asuits@wayne.edu	Parker, David H/F-9688-2015	Parker, David H/0000-0003-0297-168X				Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Ezra GS, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/20/205101; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Grubb MP, 2012, SCIENCE, V335, P1075, DOI 10.1126/science.1216911; Joalland B, 2014, J PHYS CHEM LETT, V5, P1467, DOI 10.1021/jz500352x; Klippenstein SJ, 2014, J AM CHEM SOC, V136, P528, DOI 10.1021/ja408723a; Li W, 2008, SCIENCE, V322, P1207, DOI 10.1126/science.1163077; Lu Z, 2014, SCIENCE, V346, P61, DOI 10.1126/science.1257156; Pomerantz AE, 2005, J AM CHEM SOC, V127, P16368, DOI 10.1021/ja055440a; Prozument K, 2014, PHYS CHEM CHEM PHYS, V16, P15739, DOI 10.1039/c3cp55352c; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; Zhang YW, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3456738	12	5	5	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					30	31		10.1126/science.1259119	http://dx.doi.org/10.1126/science.1259119			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278595				2022-12-28	WOS:000342446900020
J	Liddle, GG				Liddle, G. G.			Sit-In Terminology (Reprinted from JAMA, vol 209, pg 419-419, 1969)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1969, JAMA, V209, P419	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1356	1356		10.1001/jama.2013.279720	http://dx.doi.org/10.1001/jama.2013.279720			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268454				2022-12-28	WOS:000342345400030
J	Zhang, CL; Tobias, DK; Chavarro, JE; Bao, W; Wang, D; Ley, SH; Hu, FB				Zhang, Cuilin; Tobias, Deirdre K.; Chavarro, Jorge E.; Bao, Wei; Wang, Dong; Ley, Sylvia H.; Hu, Frank B.			Adherence to healthy lifestyle and risk of gestational diabetes mellitus: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY; INCREASING PREVALENCE; SEDENTARY BEHAVIORS; PREGNANT-WOMEN; DIETARY; OBESITY; QUESTIONNAIRE; WEIGHT	Objective To quantify the association between a combination of healthy lifestyle factors before pregnancy (healthy body weight, healthy diet, regular exercise, and not smoking) and the risk of gestational diabetes. Design Prospective cohort study. Setting Nurses' Health Study II, United States. Participants 20 136 singleton live births in 14 437 women without chronic disease. Main outcome measure Self reported incident gestational diabetes diagnosed by a physician, validated by medical records in a previous study. Results Incident first time gestational diabetes was reported in 823 pregnancies. Each lifestyle factor measured was independently and significantly associated with risk of gestational diabetes. The combination of three low risk factors (non-smoker, >= 150 minutes a week of moderate to vigorous physical activity, and healthy eating (top two fifths of Alternate Healthy Eating Index-2010 adherence score)) was associated with a 41% lower risk of gestational diabetes compared with all other pregnancies (relative risk 0.59, 95% confidence interval 0.48 to 0.71). Addition of body mass index (BMI) <25 before pregnancy (giving a combination of four low risk factors) was associated with a 52% lower risk of gestational diabetes compared with all other pregnancies (relative risk 0.48, 0.38 to 0.61). Compared with pregnancies in women who did not meet any of the low risk lifestyle factors, those meeting all four criteria had an 83% lower risk of gestational diabetes (relative risk 0.17, 0.12 to 0.25). The population attributable risk percentage of the four risk factors in combination (smoking, inactivity, overweight, and poor diet) was 47.5% (95% confidence interval 35.6% to 56.6%). A similar population attributable risk percentage (49.2%) was observed when the distributions of the four low risk factors from the US National Health and Nutrition Examination Survey (2007-10) data were applied to the calculation. Conclusions Adherence to a low risk lifestyle before pregnancy is associated with a low risk of gestational diabetes and could be an effective strategy for the prevention of gestational diabetes.	[Zhang, Cuilin] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Bethesda, MD 20852 USA; [Tobias, Deirdre K.; Chavarro, Jorge E.; Wang, Dong; Ley, Sylvia H.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Tobias, Deirdre K.; Chavarro, Jorge E.; Wang, Dong; Ley, Sylvia H.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chavarro, Jorge E.; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Chavarro, Jorge E.; Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Zhang, CL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Bethesda, MD 20852 USA.	zhangcu@mail.nih.gov	Wang, Dong D./AAU-2951-2021; Chavarro, Jorge E/AAE-5665-2021; Bao, Wei/AAG-2431-2019	Wang, Dong D./0000-0002-0897-3048; Chavarro, Jorge E/0000-0002-4436-9630; Bao, Wei/0000-0002-7301-5786; Zhang, Cuilin/0000-0002-8014-2708; Ley, Sylvia/0000-0003-0084-2630	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [HHSN275201000020C]; National Institutes of Health [DK58845, CA50385, P30 DK46200, UM1 CA176726]; American Diabetes Association [7-12-MN-34]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008889] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA050385, UM1CA176726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK058845] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (contract No HHSN275201000020C). The Nurses' Health Study II was funded by research grants DK58845, CA50385, P30 DK46200, and UM1 CA176726 from the National Institutes of Health and by an American Diabetes Association Award 7-12-MN-34.	American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Bao W, 2014, JAMA INTERN MED, V174, P1047, DOI 10.1001/jamainternmed.2014.1795; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bryson CL, 2003, AM J EPIDEMIOL, V158, P1148, DOI 10.1093/aje/kwg273; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; Egeland GM, 2000, BMJ-BRIT MED J, V321, P546, DOI 10.1136/bmj.321.7260.546; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gunderson EP, 2009, OBSTET GYN CLIN N AM, V36, P317, DOI 10.1016/j.ogc.2009.04.001; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hartling L, 2012, EVIDENCE REPORTS TEC, V210; Hedderson MM, 2013, DIABETES CARE, V36, P3930, DOI 10.2337/dc13-0389; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Kaaja RJ, 2005, JAMA-J AM MED ASSOC, V294, P2751, DOI 10.1001/jama.294.21.2751; KENNEDY ET, 1995, J AM DIET ASSOC, V95, P1103, DOI 10.1016/S0002-8223(95)00300-2; Korpi-Hyovalti E, 2012, PRIM CARE DIABETES, V6, P261, DOI 10.1016/j.pcd.2012.07.004; Korpi-Hyovalti E, 2012, BRIT J NUTR, V108, P910, DOI 10.1017/S0007114511006118; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Mitanchez D, 2010, DIABETES METAB, V36, P617, DOI 10.1016/j.diabet.2010.11.013; Physical Activity Guidelines Committee, 2008, PHYS ACT GUID ADV CO; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Solomon CG, 1996, DIABETES CARE, V19, P12, DOI 10.2337/diacare.19.1.12; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543; Zhang CL, 2011, AM J CLIN NUTR, V94, p1975S, DOI 10.3945/ajcn.110.001032; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x	38	106	108	6	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2014	349								g5450	10.1136/bmj.g5450	http://dx.doi.org/10.1136/bmj.g5450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CA	25269649	Green Published, hybrid			2022-12-28	WOS:000342665100001
J	Hunt, DP; Sahani, DV; Corey, KE; Masia, R				Hunt, Daniel P.; Sahani, Dushyant V.; Corey, Kathleen E.; Masia, Ricard			Case 30-2014: A 29-Year-Old Man with Diarrhea, Nausea, and Weight Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELEVATED SERUM FERRITIN; AUTOIMMUNE HEPATITIS; WILSONS-DISEASE; FEATURES; EXPERIENCE; DIAGNOSIS; LIVER; MANAGEMENT; CIRRHOSIS		[Hunt, Daniel P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sahani, Dushyant V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Corey, Kathleen E.] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA; [Masia, Ricard] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hunt, Daniel P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sahani, Dushyant V.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Corey, Kathleen E.] Harvard Univ, Sch Med, Boston, MA USA; [Masia, Ricard] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hunt, DP (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Hunt, Dan/AAL-3807-2021					Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; An IC, 2013, CASE REP GASTROINTES, V2013, DOI 10.1155/2013/872987; Camilleri M, 2004, CLIN GASTROENTEROL H, V2, P198, DOI 10.1016/S1542-3565(04)00003-5; Chowdry S, 2012, ANN HEPATOL, V11, P559, DOI 10.1016/S1665-2681(19)31473-5; Dhawan A, 2005, LIVER TRANSPLANT, V11, P441, DOI 10.1002/lt.20352; FAA G, 1995, J HEPATOL, V22, P303, DOI 10.1016/0168-8278(95)80283-5; Ferenci P, 2005, CLIN GASTROENTEROL H, V3, P811, DOI 10.1016/S1542-3565(05)00181-3; Granito A, 2005, ALIMENT PHARM THER, V21, P1273, DOI 10.1111/j.1365-2036.2005.02488.x; Gregorio GV, 1997, HEPATOLOGY, V25, P541, DOI 10.1002/hep.510250308; Huster D, 2010, BEST PRACT RES CL GA, V24, P531, DOI 10.1016/j.bpg.2010.07.014; Johncilla M, 2011, SEMIN LIVER DIS, V31, P239, DOI 10.1055/s-0031-1286055; Juckett G, 2011, AM FAM PHYSICIAN, V84, P1119; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; LEE MH, 1995, AM J MED, V98, P566, DOI 10.1016/S0002-9343(99)80015-1; Lefton HB, 2009, MED CLIN N AM, V93, P787, DOI 10.1016/j.mcna.2009.03.002; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Milkiewicz P, 2000, J GASTROEN HEPATOL, V15, P570, DOI 10.1046/j.1440-1746.2000.02158.x; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Song GJ, 2013, CHINESE MED J-PEKING, V126, P2430, DOI 10.3760/cma.j.issn.0366-6999.20130184; Terrier B, 2007, AM J GASTROENTEROL, V102, P1132, DOI 10.1111/j.1572-0241.2007.01180_9.x; Thomas PD, 2003, GUT, V52, P1; Wang QX, 2013, J DIGEST DIS, V14, P175, DOI 10.1111/1751-2980.12022; Weiss KH, 2013, CLIN GASTROENTEROL H, V11, P1028, DOI 10.1016/j.cgh.2013.03.012; Wong K, 2006, CAN J GASTROENTEROL, V20, P467, DOI 10.1155/2006/357340; Wong RJ, 2011, J CLIN GASTROENTEROL, V45, P267, DOI 10.1097/MCG.0b013e3181dffaa5; Yener S, 2004, J GASTROEN HEPATOL, V19, P114, DOI 10.1111/j.1440-1746.2004.03254.x	26	2	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1238	1247		10.1056/NEJMcpc1405218	http://dx.doi.org/10.1056/NEJMcpc1405218			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4WH	25251619				2022-12-28	WOS:000342079700012
J	Volk, RJ; Hawk, E; Bevers, TB				Volk, Robert J.; Hawk, Ernest; Bevers, Therese B.			Should CMS Cover Lung Cancer Screening for the Fully Informed Patient?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Volk, Robert J.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Houston, TX 77230 USA; [Hawk, Ernest; Bevers, Therese B.] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Houston, TX 77230 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Volk, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, POB 301402, Houston, TX 77230 USA.	bvolk@mdanderson.org		Volk, Robert/0000-0001-8811-5854	NCI NIH HHS [P30 CA016672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Centers for Medicare & Medicaid Services, MEDCAC M 4 30 2014 L; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Joseph-Williams N, 2014, MED DECIS MAKING, V34, P699, DOI 10.1177/0272989X13501721; Ma JM, 2013, CANCER-AM CANCER SOC, V119, P1381, DOI 10.1002/cncr.27813; Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Riggs KR, 2014, JAMA INTERN MED, V174, P849, DOI 10.1001/jamainternmed.2014.853; Stacey D, 2014, COCHRANE DATABASE SY, V1	10	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1193	1194		10.1001/jama.2014.12709	http://dx.doi.org/10.1001/jama.2014.12709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25247511	Green Accepted			2022-12-28	WOS:000341990600013
J	Fares, I; Chagraoui, J; Gareau, Y; Gingras, S; Ruel, R; Mayotte, N; Csaszar, E; Knapp, DJHF; Miller, P; Ngom, M; Imren, S; Roy, DC; Watts, KL; Kiem, HP; Herrington, R; Iscove, NN; Humphries, RK; Eaves, CJ; Cohen, S; Marinier, A; Zandstra, PW; Sauvageau, G				Fares, Iman; Chagraoui, Jalila; Gareau, Yves; Gingras, Stephane; Ruel, Rejean; Mayotte, Nadine; Csaszar, Elizabeth; Knapp, David J. H. F.; Miller, Paul; Ngom, Mor; Imren, Suzan; Roy, Denis-Claude; Watts, Kori L.; Kiem, Hans-Peter; Herrington, Robert; Iscove, Norman N.; Humphries, R. Keith; Eaves, Connie J.; Cohen, Sandra; Marinier, Anne; Zandstra, Peter W.; Sauvageau, Guy			Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal	SCIENCE			English	Article							HUMAN CORD BLOOD; ARYL-HYDROCARBON RECEPTOR; BONE-MARROW; EXPANSION; TRANSPLANTATION; PROGRAMS; LEUKEMIA	The small number of hematopoietic stem and progenitor cells in cord blood units limits their widespread use in human transplant protocols. We identified a family of chemically related small molecules that stimulates the expansion ex vivo of human cord blood cells capable of reconstituting human hematopoiesis for at least 6 months in immunocompromised mice. The potent activity of these newly identified compounds, UM171 being the prototype, is independent of suppression of the aryl hydrocarbon receptor, which targets cells with more-limited regenerative potential. The properties of UM171 make it a potential candidate for hematopoietic stem cell transplantation and gene therapy.	[Fares, Iman; Chagraoui, Jalila; Mayotte, Nadine; Sauvageau, Guy] Univ Montreal, IRIC, Mol Genet Stem Cells Lab, Montreal, PQ, Canada; [Gareau, Yves; Gingras, Stephane; Ruel, Rejean; Marinier, Anne] Univ Montreal, IRIC, Montreal, PQ, Canada; [Csaszar, Elizabeth; Zandstra, Peter W.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Knapp, David J. H. F.; Miller, Paul; Ngom, Mor; Imren, Suzan; Humphries, R. Keith; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Knapp, David J. H. F.; Miller, Paul; Ngom, Mor; Imren, Suzan; Humphries, R. Keith; Eaves, Connie J.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Roy, Denis-Claude; Cohen, Sandra; Sauvageau, Guy] Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ H1T 2M4, Canada; [Roy, Denis-Claude; Cohen, Sandra; Sauvageau, Guy] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada; [Watts, Kori L.; Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Watts, Kori L.; Kiem, Hans-Peter] Univ Washington, Seattle, WA 98195 USA; [Kiem, Hans-Peter] Univ Washington, Dept Pathol & Med, Seattle, WA 98195 USA; [Herrington, Robert; Iscove, Norman N.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Iscove, Norman N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	Universite de Montreal; Universite de Montreal; University of Toronto; British Columbia Cancer Agency; University of British Columbia; Universite de Montreal; Universite de Montreal; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Sauvageau, G (corresponding author), Univ Montreal, IRIC, Mol Genet Stem Cells Lab, Montreal, PQ, Canada.	guy.sauvageau@umontreal.ca		Sauvageau, Guy/0000-0002-4333-7266; Knapp, David JHF/0000-0002-2161-9959; Roy, Denis-Claude/0000-0002-5921-1692; Eaves, Connie/0000-0002-3452-1926; Humphries, Richard/0000-0003-0540-7005	Stem Cell Network of Canada; IRIC Commercialization of Research; Fonds de Recherche du Quebec Sante-TheCell; NIH [HL84345]; Vanier Scholarship, Canadian Institutes of Health Research; Banting and Best Studentship, Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084345] Funding Source: NIH RePORTER	Stem Cell Network of Canada; IRIC Commercialization of Research; Fonds de Recherche du Quebec Sante-TheCell; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanier Scholarship, Canadian Institutes of Health Research; Banting and Best Studentship, Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the help of M. Cooke and A. Boitano in setting up the assay for the primary screen, the expert help of J. Duchaine at IRIC for assistance with the chemical screen, D. Gagne (also at IRIC) for technical support with flow cytometry, M. Frechette and V. Blouin-Chagnon for assistance with mice experiments, J. Roy and J. Krosl for scientific support and for critical reading of the manuscript, Hema-Quebec and the Women's and Children's Hospital of British Columbia for providing cord blood, and Maisonneuve-Rosemont hospital cell therapy laboratory staff for mobilized peripheral blood. Financial support was from a grant to G. S. and collaborators from the Stem Cell Network of Canada and from IRIC Commercialization of Research. D.-C. R. is also supported through Fonds de Recherche du Quebec Sante-TheCell. H.-P. K. is also supported through NIH grant HL84345. D. J. H. F. K. held a Vanier Scholarship, and P. M. a Banting and Best Studentship, both from the Canadian Institutes of Health Research. G. S., Y.G., R. R., S. G., and I. F. are inventors on a patent application filed by the University of Montreal, Canada, that covers pyrimidoindoles and their use in expansion of HSCs and progenitor cells. P.W.Z. and E. C. are inventors on a patent application filed by the University of Toronto, Canada, that covers the fed-batch system. Compounds UM729 and/or UM171 can be obtained from the G. S. laboratory at compound. sauvageaulab@gmail.com under a material transfer agreement with the University of Montreal. We report no conflict of interest.	Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bouchez LC, 2011, CHEMBIOCHEM, V12, P854, DOI 10.1002/cbic.201000734; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Cheung AMS, 2013, BLOOD, V122, P3129, DOI 10.1182/blood-2013-06-508432; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Gragert L, 2014, NEW ENGL J MED, V371, P339, DOI 10.1056/NEJMsa1311707; Henry EC, 1999, MOL PHARMACOL, V55, P716; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Miller PH, 2013, CURR OPIN HEMATOL, V20, P257, DOI 10.1097/MOH.0b013e328360aaf6; Norkin M, 2013, BONE MARROW TRANSPL, V48, P884, DOI 10.1038/bmt.2012.163; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Sloma I, 2013, EXP HEMATOL, V41, P837, DOI 10.1016/j.exphem.2013.07.001; Sparfel L, 2010, TOXICOL SCI, V114, P247, DOI 10.1093/toxsci/kfq007	17	343	373	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1509	1512		10.1126/science.1256337	http://dx.doi.org/10.1126/science.1256337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237102	Green Accepted			2022-12-28	WOS:000341752900043
J	Reines, AE				Reines, Amy E.			ASTROPHYSICS Giant black hole in a stripped galaxy	NATURE			English	Editorial Material							FUNDAMENTAL PLANE	An oversized, supermassive black hole has been discovered at the centre of a densely packed conglomeration of stars. The finding suggests that the system is the stripped nucleus of a once-larger galaxy. See Letter p. 398	Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Reines, AE (corresponding author), Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA.	reines@umich.edu		Reines, Amy/0000-0001-7158-614X				Brodie JP, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/6/199; Gultekin K, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L22; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Reines AE, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/116; SCHWARZSCHILD M, 1979, ASTROPHYS J, V232, P236, DOI 10.1086/157282; Seth AC, 2014, NATURE, V513, P398, DOI 10.1038/nature13762; Strader J, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L6; van den Bosch RCE, 2010, MON NOT R ASTRON SOC, V401, P1770, DOI 10.1111/j.1365-2966.2009.15832.x; Volonteri M, 2010, ASTRON ASTROPHYS REV, V18, P279, DOI 10.1007/s00159-010-0029-x	10	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					322	323		10.1038/513322a	http://dx.doi.org/10.1038/513322a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230650				2022-12-28	WOS:000341814900042
J	Villaume, MT; Baran, PS				Villaume, Matthew T.; Baran, Phil S.			ORGANIC CHEMISTRY Reactivity tamed one bond at a time	NATURE			English	Editorial Material								A catalyst that couples together three reactants to form just one compound out of several possibilities, as a single mirror-image isomer, should simplify the synthesis of biologically relevant molecules. See Article p. 367	[Villaume, Matthew T.; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Villaume, MT (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	pbaran@scripps.edu						Czuba IR, 2003, ORG BIOMOL CHEM, V1, P2044, DOI 10.1039/b302460a; de Graaff C, 2012, CHEM SOC REV, V41, P3969, DOI 10.1039/c2cs15361k; Joule J.A., 2010, HETEROCYCLIC CHEM, V5th ed. (; Keasling JD, 2012, NATURE, V492, P188, DOI 10.1038/492188a; Kuttruff CA, 2014, NAT PROD REP, V31, P419, DOI 10.1039/c3np70090a; Meng FK, 2014, NATURE, V513, P367, DOI 10.1038/nature13735; Meng FK, 2013, ANGEW CHEM INT EDIT, V52, P5046, DOI 10.1002/anie.201301018; Noyori R., 1994, ASYMMETRIC CATALYSIS, P221	8	1	1	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					324	325		10.1038/513324a	http://dx.doi.org/10.1038/513324a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230652				2022-12-28	WOS:000341814900044
J	Crawford, MJ; MacLaren, T; Reilly, JG				Crawford, Mike J.; MacLaren, Tom; Reilly, Joe G.			UNCERTAINTIES PAGE Are mood stabilisers helpful in treatment of borderline personality disorder?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							18-MONTH FOLLOW-UP; PART II; MEDICATION; PEOPLE; BASE		[Crawford, Mike J.] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8LN, England; [MacLaren, Tom] Cent & North West London NHS Fdn Trust, London, England; [Reilly, Joe G.] Univ Durham, Sch Med Pharm & Hlth, Durham DH1 3HP, England	Imperial College London; Durham University	Crawford, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8LN, England.	m.crawford@imperial.ac.uk		Crawford, Mike/0000-0003-3137-5772	Department of Health [10/103/01] Funding Source: Medline; National Institute for Health Research [10/103/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; American Psychiatric Association Practice Guidelines, 2001, Am J Psychiatry, V158, P1; Coid J, 2006, BRIT J PSYCHIAT, V188, P423, DOI 10.1192/bjp.188.5.423; Crawford MJ, 2011, ACTA PSYCHIAT SCAND, V124, P396, DOI 10.1111/j.1600-0447.2011.01728.x; Crawford MJ, 2009, ACTA PSYCHIAT SCAND, V119, P304, DOI 10.1111/j.1600-0447.2008.01306.x; Henry C, 2001, J PSYCHIATR RES, V35, P307, DOI 10.1016/S0022-3956(01)00038-3; Leiberich P, 2008, J PSYCHOPHARMACOL, V22, P805, DOI 10.1177/0269881107084004; Lieb K, 2010, BRIT J PSYCHIAT, V196, P4, DOI 10.1192/bjp.bp.108.062984; Loew TH, 2008, J CLIN PSYCHOPHARM, V28, P355, DOI 10.1097/JCP.0b013e318173a8fb; McGlashan TH, 2000, ACTA PSYCHIAT SCAND, V102, P256, DOI 10.1034/j.1600-0447.2000.102004256.x; National Institute for Health and Clinical Excellence, 2009, BORDERLINE PERSONALI; Paris J, 2001, COMPR PSYCHIAT, V42, P482, DOI 10.1053/comp.2001.26271; Prescribing Observatory for Mental Health, 2012, TOP 12A BAS REP PRES; Rogers B, 2012, J PSYCHIATR MENT HLT, V19, P341, DOI 10.1111/j.1365-2850.2011.01800.x; Sjastad HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050930; Stoffers JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005652.pub2	16	8	8	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2014	349								g5378	10.1136/bmj.g5378	http://dx.doi.org/10.1136/bmj.g5378			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OP	25228296				2022-12-28	WOS:000342057500003
J	Goto, Y; Obata, T; Kunisawa, J; Sato, S; Ivanov, II; Lamichhane, A; Takeyama, N; Kamioka, M; Sakamoto, M; Matsuki, T; Setoyama, H; Imaoka, A; Uematsu, S; Akira, S; Domino, SE; Kulig, P; Becher, B; Renauld, JC; Sasakawa, C; Umesaki, Y; Benno, Y; Kiyono, H				Goto, Yoshiyuki; Obata, Takashi; Kunisawa, Jun; Sato, Shintaro; Ivanov, Ivaylo I.; Lamichhane, Aayam; Takeyama, Natsumi; Kamioka, Mariko; Sakamoto, Mitsuo; Matsuki, Takahiro; Setoyama, Hiromi; Imaoka, Akemi; Uematsu, Satoshi; Akira, Shizuo; Domino, Steven E.; Kulig, Paulina; Becher, Burkhard; Renauld, Jean-Christophe; Sasakawa, Chihiro; Umesaki, Yoshinori; Benno, Yoshimi; Kiyono, Hiroshi			Innate lymphoid cells regulate intestinal epithelial cell glycosylation	SCIENCE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; ROR-GAMMA-T; ENTERICA SEROTYPE TYPHIMURIUM; COMMENSAL MICROFLORA; HOST; FUT2; MICROBIOTA; DIFFERENTIATION; SUSCEPTIBILITY; PATHWAY	Fucosylation of intestinal epithelial cells, catalyzed by fucosyltransferase 2 (Fut2), is a major glycosylation mechanism of host-microbiota symbiosis. Commensal bacteria induce epithelial fucosylation, and epithelial fucose is used as a dietary carbohydrate by many of these bacteria. However, the molecular and cellular mechanisms that regulate the induction of epithelial fucosylation are unknown. Here, we show that type 3 innate lymphoid cells (ILC3) induced intestinal epithelial Fut2 expression and fucosylation in mice. This induction required the cytokines interleukin-22 and lymphotoxin in a commensal bacteria-dependent and -independent manner, respectively. Disruption of intestinal fucosylation led to increased susceptibility to infection by Salmonella typhimurium. Our data reveal a role for ILC3 in shaping the gut microenvironment through the regulation of epithelial glycosylation.	[Goto, Yoshiyuki; Obata, Takashi; Kunisawa, Jun; Sato, Shintaro; Lamichhane, Aayam; Takeyama, Natsumi; Kamioka, Mariko; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo 1088639, Japan; [Goto, Yoshiyuki; Sato, Shintaro; Kiyono, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Goto, Yoshiyuki; Obata, Takashi; Sakamoto, Mitsuo] RIKEN, BioResource Ctr, Microbe Div Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan; [Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Osaka 5670085, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Int Res & Dev Ctr Mucosal Vaccines, Tokyo 1088639, Japan; [Ivanov, Ivaylo I.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Takeyama, Natsumi; Sasakawa, Chihiro] Nippon Inst Biol Sci, Tokyo 1980024, Japan; [Matsuki, Takahiro; Setoyama, Hiromi; Imaoka, Akemi; Umesaki, Yoshinori] Yakult Cent Inst, Tokyo 1868650, Japan; [Uematsu, Satoshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Div Innate Immune Regulat, Tokyo 1088639, Japan; [Uematsu, Satoshi] Chiba Univ, Sch Med, Dept Mucosal Immunol, Chuou Ku, Chiba 2608670, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Osaka 5650871, Japan; [Domino, Steven E.] Univ Michigan, Med Ctr, Cellular & Mol Biol Program, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Kulig, Paulina; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Renauld, Jean-Christophe] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Renauld, Jean-Christophe] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Div Bacterial Infect, Tokyo 1088639, Japan; [Sasakawa, Chihiro] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan; [Benno, Yoshimi] RIKEN, Innovat Ctr, Benno Lab, Wako, Saitama 3510198, Japan	University of Tokyo; Japan Science & Technology Agency (JST); RIKEN; National Institute of Health Sciences - Japan; University of Tokyo; Columbia University; Yakult Honsha Company, Limited; University of Tokyo; Chiba University; Osaka University; University of Michigan System; University of Michigan; University of Zurich; Ludwig Institute for Cancer Research; Universite Catholique Louvain; University of Tokyo; Chiba University; RIKEN	Kiyono, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo 1088639, Japan.	kiyono@ims.u-tokyo.ac.jp	Becher, Burkhard/ABE-4225-2020; Goto, Yoshiyuki/H-9860-2017; Kiyono, Hiroshi/AAC-6735-2022; Akira, Shizuo/C-3134-2009; Sakamoto, Mitsuo/C-3612-2017; Renauld, Jean-Christophe/B-7268-2012	Becher, Burkhard/0000-0002-1541-7867; Goto, Yoshiyuki/0000-0001-8552-4839; Sakamoto, Mitsuo/0000-0002-3622-4642; Sato, Shintaro/0000-0001-5156-3354; Matsuki, Takahiro/0000-0001-7777-1602; Renauld, Jean-Christophe/0000-0003-1736-2131; Kamioka, Mariko/0000-0003-4377-4850	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [230000-12]; Global Center of Excellence (COE) Program "Center of Education and Research for Advanced Genome-based Medicine"; Ministry of Health, Labor and Welfare of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Institutes of Health [1R01DK098378]; Crohn's and Colitis Foundation of America [259540]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098378] Funding Source: NIH RePORTER	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence (COE) Program "Center of Education and Research for Advanced Genome-based Medicine"; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Shimaoka, G. Eberl, M. Pasparakis, K. Honda, C. A. Hunter, C. O. Elson, and J. R. Mora for their critical and helpful comments and advice on this research. Y. Yokota and M. Yamamoto kindly provided Id2-deficient mice and LT beta R-Ig, respectively. R. Curtis III and H. Matsui kindly provided several strains of Salmonella typhimurium. We thank Y. Akiyama for her technical support with the S. typhimurium infection model. S. Tanaka gave us helpful technical suggestions for performing flow cytometric analysis. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Sequences of the bacterial 16S rRNA genes obtained from duodenal and ileal mucus bacteria have been deposited in the International Nucleotide Sequence Database (accession nos. AB470733 to AB470815). This work was supported by grants from the following sources: the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (to H.K.); a Grant-in-Aid for Scientific Research on Priority Areas, Scientific Research (S) (to H.K.); Specially Promoted Research (230000-12 to C.S.); Scientific Research (B) (to J.K.); for the Leading-edge Research Infrastructure Program and the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation (to Y.G., J.K., and H.K.); for the Leading-edge Research Infrastructure Program (to J.K. and H.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Global Center of Excellence (COE) Program "Center of Education and Research for Advanced Genome-based Medicine" (to H.K.); the Ministry of Health, Labor and Welfare of Japan (to J.K. and H.K.); the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to J.K.); Mochida Memorial Foundation for Medical and Pharmaceutical Research (to J.K.); the National Institutes of Health (1R01DK098378 to I.I.); and by the Crohn's and Colitis Foundation of America (SRA#259540 to I.I.). The authors declare no conflicts of interest.	Awoniyi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037311; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chessa D, 2009, MOL MICROBIOL, V71, P864, DOI 10.1111/j.1365-2958.2008.06566.x; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; DAVIS CP, 1974, INFECT IMMUN, V10, P948, DOI 10.1128/IAI.10.4.948-956.1974; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Domino SE, 2001, MOL CELL BIOL, V21, P8336, DOI 10.1128/MCB.21.24.8336-8345.2001; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Goto Y, 2013, IMMUNOL CELL BIOL, V91, P204, DOI 10.1038/icb.2012.80; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hurd EA, 2004, INFECT IMMUN, V72, P4279, DOI 10.1128/IAI.72.7.4279-4281.2004; Imbert-Marcille BM, 2014, J INFECT DIS, V209, P1227, DOI 10.1093/infdis/jit655; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Kibe R, 2004, FEMS MICROBIOL LETT, V235, P139, DOI 10.1111/j.1574-6968.2004.tb09578.x; KOOPMAN JP, 1987, LAB ANIM-UK, V21, P48, DOI 10.1258/002367787780740743; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Ohta N, 2002, J IMMUNOL, V169, P460, DOI 10.4049/jimmunol.169.1.460; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Terahara K, 2011, BIOCHEM BIOPH RES CO, V404, P822, DOI 10.1016/j.bbrc.2010.12.067; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Yamamoto M, 2004, J IMMUNOL, V173, P762, DOI 10.4049/jimmunol.173.2.762; Yamamoto M, 1998, J IMMUNOL, V160, P2188; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	56	343	368	9	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1310	+	1254009	10.1126/science.1254009	http://dx.doi.org/10.1126/science.1254009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6YZ	25214634	Green Accepted			2022-12-28	WOS:000349774300001
J	Hellweger, FL; van Sebille, E; Fredrick, ND				Hellweger, Ferdi L.; van Sebille, Erik; Fredrick, Neil D.			Biogeographic patterns in ocean microbes emerge in a neutral agent-based model	SCIENCE			English	Article							GLOBAL OCEAN; DISTANCE; MICROORGANISMS; DIVERSITY; BACTERIA; SURFACE	A key question in ecology and evolution is the relative role of natural selection and neutral evolution in producing biogeographic patterns. We quantify the role of neutral processes by simulating division, mutation, and death of 100,000 individual marine bacteria cells with full 1 million-base-pair genomes in a global surface ocean circulation model. The model is run for up to 100,000 years and output is analyzed using BLAST (Basic Local Alignment Search Tool) alignment and metagenomics fragment recruitment. Simulations show the production and maintenance of biogeographic patterns, characterized by distinct provinces subject to mixing and periodic takeovers by neighbors (coalescence), after which neutral evolution reestablishes the province and the patterns reorganize. The emergent patterns are substantial (e. g., down to 99.5% DNA identity between North and Central Pacific provinces) and suggest that microbes evolve faster than ocean currents can disperse them. This approach can also be used to explore environmental selection.	[Hellweger, Ferdi L.; Fredrick, Neil D.] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [van Sebille, Erik] Univ New S Wales, ARC, Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [van Sebille, Erik] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia	Northeastern University; University of New South Wales Sydney; University of New South Wales Sydney	Hellweger, FL (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA.	ferdi@coe.neu.edu	van Sebille, Erik/F-6781-2010	van Sebille, Erik/0000-0003-2041-0704	NSF; National Oceanic and Atmospheric Administration Massachusetts Institute of Technology SeaGrant; ARC [DE130101336]	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration Massachusetts Institute of Technology SeaGrant; ARC(Australian Research Council)	We thank R. Stepanauskas for interesting discussion that inspired this research. Three anonymous reviewers provided constructive criticism. F.L.H. and N.D.F. are supported by grants from the NSF and National Oceanic and Atmospheric Administration Massachusetts Institute of Technology SeaGrant. E.v.S. is supported by ARC via grant DE130101336. The source code is available at www.coe.neu.edu/similar to ferdi/Code/.	Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Brown MV, 2014, MAR GENOM, V15, P17, DOI 10.1016/j.margen.2014.03.002; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; Clark JR, 2013, LIMNOL OCEANOGR, V58, P1008, DOI 10.4319/lo.2013.58.3.1008; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Drake JW, 1998, GENETICS, V148, P1667; Ducklow H., 2000, MICROBIAL ECOLOGY OC, P85, DOI DOI 10.1002/9780470281840; FALKOWSKI PG, 1981, MAR BIOL, V65, P69, DOI 10.1007/BF00397069; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Ghiglione JF, 2012, P NATL ACAD SCI USA, V109, P17633, DOI 10.1073/pnas.1208160109; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hellweger FL, 2009, ENVIRON MICROBIOL, V11, P1386, DOI 10.1111/j.1462-2920.2009.01866.x; Hellweger FL, 2009, ECOL MODEL, V220, P8, DOI 10.1016/j.ecolmodel.2008.09.004; Hubbell Stephen P., 2001, V32, pi; Kreft JU, 2013, P NATL ACAD SCI USA, V110, P18027, DOI 10.1073/pnas.1317472110; MAC ARTHUR ROBERT H., 1967; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Papke RT, 2004, FEMS MICROBIOL ECOL, V48, P293, DOI 10.1016/j.femsec.2004.03.013; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Vergin KL, 2007, ENVIRON MICROBIOL, V9, P2430, DOI 10.1111/j.1462-2920.2007.01361.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilkins D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3457	33	101	102	7	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1346	1349		10.1126/science.1254421	http://dx.doi.org/10.1126/science.1254421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214628				2022-12-28	WOS:000341483800065
J	Rhodes, G				Rhodes, Gale			The career I dreamed of ?	SCIENCE			English	Editorial Material									Univ So Maine, Portland, ME 04103 USA	University of Maine System; University of Southern Maine	Rhodes, G (corresponding author), Univ So Maine, Portland, ME 04103 USA.								0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1414	1414		10.1126/science.345.6202.1414	http://dx.doi.org/10.1126/science.345.6202.1414			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214633				2022-12-28	WOS:000341483800073
J	Guzman, MG; Harris, E				Guzman, Maria G.; Harris, Eva			Dengue	LANCET			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; ORIGINAL ANTIGENIC SIN; HEMORRHAGIC-FEVER; VIRUS-INFECTIONS; AEDES-AEGYPTI; VASCULAR LEAKAGE; PROTECTIVE EFFICACY; DENDRITIC CELLS; KAMPHAENG PHET; ADULT PATIENTS	Dengue viruses have spread rapidly within countries and across regions in the past few decades, resulting in an increased frequency of epidemics and severe dengue disease, hyperendemicity of multiple dengue virus serotypes in many tropical countries, and autochthonous transmission in Europe and the USA. Today, dengue is regarded as the most prevalent and rapidly spreading mosquito-borne viral disease of human beings. Importantly, the past decade has also seen an upsurge in research on dengue virology, pathogenesis, and immunology and in development of antivirals, vaccines, and new vector-control strategies that can positively impact dengue control and prevention.	[Guzman, Maria G.] Pedro Kour Trop Med Inst, Havana, Cuba; [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Guzman, MG (corresponding author), Pedro Kouri Trop Med Inst, Dept Virol, PAHO WHO Collaborating Ctr Study Dengue & Its Vec, Km 6,POB 601,Marianao 13, Havana, Cuba.	lupe@ipk.sld.cu; eharris@berkeley.edu						Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Lorono-Pino MA, 2013, AM J TROP MED HYG, V89, P385, DOI 10.4269/ajtmh.12-0772; Allonso D, 2013, AM J TROP MED HYG, V88, P506, DOI 10.4269/ajtmh.2012.12-0619; Alves MJ, 2013, EUROSURVEILLANCE, V18, P6; Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436; Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545; Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087; Wilke ABB, 2012, REV INST MED TROP SP, V54, P287, DOI 10.1590/S0036-46652012000500009; Castro JEZ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/370872; Castro M, 2012, T ROY SOC TROP MED H, V106, P315, DOI 10.1016/j.trstmh.2012.01.013; Centers for Disease Control and Prevention, DENG MAP; Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117; Colbert JA, 2007, PEDIATR INFECT DIS J, V26, P850, DOI 10.1097/INF.0b013e3180619692; Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x; de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13; Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493; Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Fragnoud R, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-60; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Gamble J, 2000, CLIN SCI, V98, P211, DOI 10.1042/CS19990296; Garcia G, 2011, HUM IMMUNOL, V72, P904, DOI 10.1016/j.humimm.2011.06.010; Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008; Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Guzman MG, 2012, INT J INFECT DIS, V16, pE198, DOI 10.1016/j.ijid.2011.09.026; Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Halstead Scott B., 2008, V5, P219; Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Horstick O, 2012, PATHOG GLOB HEALTH, V106, P94, DOI 10.1179/2047773212Y.0000000017; Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923; Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551; Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12; Kelley JF, 2012, VIROLOGY, V422, P326, DOI 10.1016/j.virol.2011.10.030; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11; Lanteri MC, 2012, TRANSFUSION, V52, P1634, DOI 10.1111/j.1537-2995.2012.03747.x; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Loke P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000710; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Moi ML, 2013, T ROY SOC TROP MED H, V107, P51, DOI 10.1093/trstmh/trs007; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357; Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670; Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262; Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470; Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273; Parameswaran P, 2012, J VIROL, V86, P8546, DOI 10.1128/JVI.00736-12; Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58; Peh Alister En Kai, 2011, Front Biosci (Schol Ed), V3, P806; Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Perez AB, 2010, HUM IMMUNOL, V71, P1135, DOI 10.1016/j.humimm.2010.08.004; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Programme for Research and Training in Tropical Diseases, 2009, Dengue: guidelines for diagnosis, treatment, prevention and control; Puerta-Guardo H, 2013, J VIROL, V87, P7486, DOI 10.1128/JVI.00085-13; Lima MDQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001147; Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001990; Rainwater-Lovett K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-233; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Salgado D, 2012, PEDIATR INFECT DIS J, V31, P771, DOI 10.1097/INF.0b013e3182575e6a; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Sariol CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019323; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Severson DW, 2012, ANNU REV ENTOMOL, V57, P143, DOI 10.1146/annurev-ento-120710-100651; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Sierra B, 2012, AM J TROP MED HYG, V87, P538, DOI 10.4269/ajtmh.2012.11-0531; Sierra B, 2010, CELL IMMUNOL, V262, P134, DOI 10.1016/j.cellimm.2010.02.005; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Simmons CP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001752; Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11; Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451; St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481; Standish K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000633; Stein DA, 2011, J VIROL, V85, P10154, DOI 10.1128/JVI.05298-11; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Sun W, 2013, J INFECT DIS, V207, P700, DOI 10.1093/infdis/jis744; Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655; Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Thomas SJ, 2011, CURR OPIN INFECT DIS, V24, P442, DOI 10.1097/QCO.0b013e32834a1b0b; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785; Trung DT, 2010, CURR TOP MICROBIOL, V338, P57, DOI 10.1007/978-3-642-02215-9_5; Tsai CY, 2013, J MICROBIOL IMMUNOL, V46, P271, DOI 10.1016/j.jmii.2012.07.005; van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vazquez S, 2007, INT J INFECT DIS, V11, P256, DOI 10.1016/j.ijid.2006.05.005; Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Whitehorn J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-203; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; WHO, INT TRAV HLTH INT MA; Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157; World Health Organization, 2012, GLOB STRAT DENG PREV; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730; Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568	142	663	716	10	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					453	465		10.1016/S0140-6736(14)60572-9	http://dx.doi.org/10.1016/S0140-6736(14)60572-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25230594				2022-12-28	WOS:000348509900033
J	Robinovitch, SN; Scott, V; Feldman, F				Robinovitch, Stephen N.; Scott, Vicky; Feldman, Fabio			Home-safety modifications to reduce injuries from falls	LANCET			English	Editorial Material									[Robinovitch, Stephen N.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Scott, Vicky] British Columbia Minist Hlth, Victoria, BC, Canada; [Feldman, Fabio] Fraser Hlth Author, Surrey, BC, Canada	Simon Fraser University	Robinovitch, SN (corresponding author), Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada.	stever@sfu.ca		Robinovitch, Stephen/0000-0003-3881-6227				Gillespie L. D., 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Keall MD, 2014, LANCET; Nikolaus T, 2003, J AM GERIATR SOC, V51, P300, DOI 10.1046/j.1532-5415.2003.51102.x; Public Health Agency of Canada, 2014, SEN FALLS CAN 2 REP; *SMARTRISK, 2009, EC BURD INJ CAN; Turner S AG, 2011, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003600.PUB3	6	3	3	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					205	206		10.1016/S0140-6736(14)61188-0	http://dx.doi.org/10.1016/S0140-6736(14)61188-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ2DL	25255695				2022-12-28	WOS:000348044800005
J	Athauda, D; Tan, GS				Athauda, Dilan; Tan, Garryck Shernshih			Evolving Infarction in the Anterior Circulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Athauda, Dilan; Tan, Garryck Shernshih] Darent Valley Hosp, Dartford, Kent, England		Athauda, D (corresponding author), Darent Valley Hosp, Dartford, Kent, England.	dilanathauda@doctors.org.uk							0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					E20	E20		10.1056/NEJMicm1313055	http://dx.doi.org/10.1056/NEJMicm1313055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25271620				2022-12-28	WOS:000342429800001
J	McGlothlin, AE; Lewis, RJ				McGlothlin, Anna E.; Lewis, Roger J.			Minimal Clinically Important Difference Defining What Really Matters to Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OSTEOARTHRITIS		[McGlothlin, Anna E.; Lewis, Roger J.] Berry Consultants, Austin, TX USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Lewis, Roger J.] Los Angeles Biomed Res Inst, Torrance, CA USA; [Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lewis, RJ (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, Bldg D9,1000 W Carson St, Torrance, CA 90509 USA.	roger@emedharbor.edu		McGlothlin, Anna/0000-0002-9079-6166				BELLAMY N, 1992, J RHEUMATOL, V19, P451; Hinman RS, 2014, JAMA-J AM MED ASSOC, V312, P1313, DOI 10.1001/jama.2014.12660; Ikramuddin S, 2014, JAMA-J AM MED ASSOC, V312, P915, DOI 10.1001/jama.2014.10540; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P706, DOI 10.1001/archsurg.2009.150; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; Turner D, 2010, J CLIN EPIDEMIOL, V63, P28, DOI 10.1016/j.jclinepi.2009.01.024	7	271	276	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1342	1343		10.1001/jama.2014.13128	http://dx.doi.org/10.1001/jama.2014.13128			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268441				2022-12-28	WOS:000342345400020
J	Leow, MKS; Hamijoyo, L; Liew, H; Thirugnanam, U; Cheng, MHW; Loke, KSH; Teo, MSK; Chuah, KL; Chng, HH				Leow, Melvin Khee-Shing; Hamijoyo, Laniyati; Liew, Huiling; Thirugnanam, Umapathi; Cheng, Mathew Hern Wang; Loke, Kelvin S. H.; Teo, Michael Song Kim; Chuah, Khoon Leong; Chng, Hiok Hee			Oncogenic osteomalacia presenting as a crippling illness in a young man	LANCET			English	Editorial Material							HYPOPHOSPHATEMIC OSTEOMALACIA		[Leow, Melvin Khee-Shing] Tan Tock Seng Hosp, Dept Endocrinol, Singapore 308433, Singapore; [Cheng, Mathew Hern Wang] Tan Tock Seng Hosp, Dept Orthopaed, Singapore 308433, Singapore; [Teo, Michael Song Kim] Tan Tock Seng Hosp, Dept Diagnost Radiol, Singapore 308433, Singapore; [Chuah, Khoon Leong] Tan Tock Seng Hosp, Dept Pathol & Lab Med, Singapore 308433, Singapore; [Chng, Hiok Hee] Tan Tock Seng Hosp, Dept Rheumatol Allergy & Immunol, Singapore 308433, Singapore; [Leow, Melvin Khee-Shing] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore; [Hamijoyo, Laniyati] Padjadjaran State Univ, Dept Med, Bandung, Indonesia; [Thirugnanam, Umapathi] Natl Inst Neurosci, Singapore, Singapore; [Loke, Kelvin S. H.] Singapore Gen Hosp, Dept Nucl Med & PET, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital; National University of Singapore; Universitas Padjadjaran; National Neuroscience Institute (NNI); Singapore General Hospital	Leow, MKS (corresponding author), Tan Tock Seng Hosp, Dept Endocrinol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	melvin_leow@ttsh.com.sg	Leow, Melvin/AAJ-1168-2020; Hamijoyo, L/AAD-8933-2019; Leow, Melvin/H-3129-2019	Hamijoyo, L/0000-0002-1310-674X; Leow, Melvin/0000-0002-2837-5889				Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Farrow Emily G, 2009, Expert Rev Endocrinol Metab, V4, P435, DOI 10.1586/eem.09.27; Jiang Y, 2012, J BONE MINER RES, V27, P1967, DOI 10.1002/jbmr.1642; MCCANCE RA, 1947, Q J MED, V16, P33; NAKAHAMA H, 1995, UROL INT, V55, P38, DOI 10.1159/000282746	5	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1236	1236		10.1016/S0140-6736(14)61186-7	http://dx.doi.org/10.1016/S0140-6736(14)61186-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7MT	25263679				2022-12-28	WOS:000343002600030
J	McKeown, AN; Bridgham, JT; Anderson, DW; Murphy, MN; Ortlund, EA; Thornton, JW				McKeown, Alesia N.; Bridgham, Jamie T.; Anderson, Dave W.; Murphy, Michael N.; Ortlund, Eric A.; Thornton, Joseph W.			Evolution of DNA Specificity in a Transcription Factor Family Produced a New Gene Regulatory Module	CELL			English	Article							STEROID-HORMONE RECEPTORS; GLUCOCORTICOID-RECEPTOR; BINDING DOMAIN; RESPONSE ELEMENTS; ALTERED SPECIFICITY; WILD-TYPE; PROTEIN; RECOGNITION; DETERMINANTS; DIVERGENCE	Complex gene regulatory networks require transcription factors (TFs) to bind distinct DNA sequences. To understand how novel TF specificity evolves, we combined phylogenetic, biochemical, and biophysical approaches to interrogate how DNA recognition diversified in the steroid hormone receptor (SR) family. After duplication of the ancestral SR, three mutations in one copy radically weakened binding to the ancestral estrogen response element (ERE) and improved binding to a new set of DNA sequences (steroid response elements, SREs). They did so by establishing unfavorable interactions with ERE and abolishing unfavorable interactions with SRE; also required were numerous permissive substitutions, which nonspecifically improved cooperativity and affinity of DNA binding. Our findings indicate that negative determinants of binding play key roles in TFs' DNA selectivity and-with our prior work on the evolution of SR ligand specificity during the same interval-show how a specific new gene regulatory module evolved without interfering with the integrity of the ancestral module.	[McKeown, Alesia N.; Bridgham, Jamie T.; Anderson, Dave W.; Thornton, Joseph W.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Thornton, Joseph W.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Murphy, Michael N.; Ortlund, Eric A.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA	University of Oregon; University of Chicago; University of Chicago; Emory University	Thornton, JW (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	joet1@uchicago.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019; Thornton, Joseph/GSN-4190-2022	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; 	NIH [R01-GM104397, 5-T32-GM7759-33]; Howard Hughes Medical Institute; AHA [11PRE7510085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, R01GM104397] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); AHA(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Geeta Eick for phylogenetic analysis and Mike Harms for extensive advice. We thank Vincent Lynch, Pete von Hippel, members of the Thornton lab, and Will Hudson for comments on the manuscript. The University of Oregon ACISS cluster provided computing resources. This work was supported by NIH R01-GM104397 (J.W.T. and J.T.B.), a Howard Hughes Medical Institute Early Career Scientist Award (J.W.T.), NIH training grant 5-T32-GM7759-33 (A.N.M.), and AHA award 11PRE7510085 (D.W.A.).	ALROY I, 1992, NUCLEIC ACIDS RES, V20, P1045, DOI 10.1093/nar/20.5.1045; Bain DL, 2012, J MOL BIOL, V422, P18, DOI 10.1016/j.jmb.2012.06.005; Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; Baker CR, 2011, P NATL ACAD SCI USA, V108, P7493, DOI 10.1073/pnas.1019177108; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Bentley P., 1998, COMP VERTEBRATE ENDO; Berglund H, 1997, BIOCHEMISTRY-US, V36, P11188, DOI 10.1021/bi970343i; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Brayer KJ, 2011, P NATL ACAD SCI USA, V108, pE414, DOI 10.1073/pnas.1100990108; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chusacultanachai S, 1999, J BIOL CHEM, V274, P23591, DOI 10.1074/jbc.274.33.23591; Cohen HM, 2004, PROTEIN ENG DES SEL, V17, P3, DOI 10.1093/protein/gzh001; Eick GN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003072; Eick GN, 2011, MOL CELL ENDOCRINOL, V334, P31, DOI 10.1016/j.mce.2010.09.003; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; HARD T, 1990, BIOCHEMISTRY-US, V29, P5358; Harms MJ, 2013, P NATL ACAD SCI USA, V110, P11475, DOI 10.1073/pnas.1303930110; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Helsen C, 2012, MOL CELL ENDOCRINOL, V348, P411, DOI 10.1016/j.mce.2011.07.025; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Li H, 2010, CURR BIOL, V20, pR746, DOI 10.1016/j.cub.2010.06.056; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; LUNDBACK T, 1993, BIOCHEMISTRY-US, V32, P5074, DOI 10.1021/bi00070a015; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Rockah-Shmuel L, 2012, NUCLEIC ACIDS RES, V40, P11627, DOI 10.1093/nar/gks944; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Sayou C, 2014, SCIENCE, V343, P645, DOI 10.1126/science.1248229; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SCHWABE JWR, 1991, TRENDS BIOCHEM SCI, V16, P291, DOI 10.1016/0968-0004(91)90121-B; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Welboren WJ, 2009, ENDOCR-RELAT CANCER, V16, P1073, DOI 10.1677/ERC-09-0086; Wikstrom A, 1999, J MOL BIOL, V289, P963, DOI 10.1006/jmbi.1999.2806; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; ZILLIACUS J, 1992, J BIOL CHEM, V267, P24941; ZILLIACUS J, 1991, J BIOL CHEM, V266, P3101	48	64	64	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					58	68		10.1016/j.cell.2014.09.003	http://dx.doi.org/10.1016/j.cell.2014.09.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259920	Green Accepted, Bronze			2022-12-28	WOS:000343095000009
J	Deppen, SA; Blume, JD; Kensinger, CD; Morgan, AM; Aldrich, MC; Massion, PP; Walker, RC; McPheeters, ML; Putnam, JB; Grogan, EL				Deppen, Stephen A.; Blume, Jeffrey D.; Kensinger, Clark D.; Morgan, Ashley M.; Aldrich, Melinda C.; Massion, Pierre P.; Walker, Ronald C.; McPheeters, Melissa L.; Putnam, Joe B., Jr.; Grogan, Eric L.			Accuracy of FDG-PET to Diagnose Lung Cancer in Areas With Infectious Lung Disease A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SOLITARY PULMONARY NODULES; STANDARDIZED UPTAKE VALUE; F-18-FDG PET; DIFFERENTIATING BENIGN; COMPUTED-TOMOGRAPHY; SYSTEMATIC REVIEWS; 3 CM; LESIONS; CT	IMPORTANCE Positron emission tomography (PET) combined with fludeoxyglucose F 18 (FDG) is recommended for the noninvasive diagnosis of pulmonary nodules suspicious for lung cancer. In populations with endemic infectious lung disease, FDG-PET may not accurately identify malignant lesions. OBJECTIVES To estimate the diagnostic accuracy of FDG-PET for pulmonary nodules suspicious for lung cancer in regions where infectious lung disease is endemic and compare the test accuracy in regions where infectious lung disease is rare. DATA SOURCES AND STUDY SELECTION Databases of MEDLINE, EMBASE, and the Web of Science were searched from October 1, 2000, through April 28, 2014. Articles reporting information sufficient to calculate sensitivity and specificity of FDG-PET to diagnose lung cancer were included. Only studies that enrolled more than 10 participants with benign and malignant lesions were included. Database searches yielded 1923 articles, of which 257 were assessed for eligibility. Seventy studies were included in the analysis. Studies reported on a total of 8511 nodules; 5105 (60%) were malignant. DATA EXTRACTION AND SYNTHESIS Abstracts meeting eligibility criteria were collected by a research librarian and reviewed by 2 independent reviewers. Hierarchical summary receiver operating characteristic curves were constructed. A random-effects logistic regression model was used to summarize and assess the effect of endemic infectious lung disease on test performance. MAIN OUTCOME AND MEASURES The sensitivity and specificity for FDG-PET test performance. RESULTS Heterogeneity for sensitivity (I-2 = 87%) and specificity (I2 = 82%) was observed across studies. The pooled (unadjusted) sensitivity was 89%(95% CI, 86%-91%) and specificity was 75%(95% CI, 71%-79%). There was a 16% lower average adjusted specificity in regions with endemic infectious lung disease (61% [95% CI, 49%-72%]) compared with nonendemic regions (77% [95% CI, 73%-80%]). Lower specificity was observed when the analysis was limited to rigorously conducted and well-controlled studies. In general, sensitivity did not change appreciably by endemic infection status, even after adjusting for relevant factors. CONCLUSIONS AND RELEVANCE The accuracy of FDG-PET for diagnosing lung nodules was extremely heterogeneous. Use of FDG-PET combined with computed tomography was less specific in diagnosing malignancy in populations with endemic infectious lung disease compared with nonendemic regions. These data do not support the use of FDG-PET to diagnose lung cancer in endemic regions unless an institution achieves test performance accuracy similar to that found in nonendemic regions.	[Deppen, Stephen A.; Massion, Pierre P.; Grogan, Eric L.] Vet Affairs Hosp, Tennessee Valley Healthcare Syst, Nashville, TN USA; [Deppen, Stephen A.; Aldrich, Melinda C.; Putnam, Joe B., Jr.; Grogan, Eric L.] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN 37232 USA; [Blume, Jeffrey D.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Kensinger, Clark D.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Morgan, Ashley M.] Vanderbilt Univ, Med Ctr, Sch Med, Nashville, TN 37232 USA; [Aldrich, Melinda C.; McPheeters, Melissa L.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN 37232 USA; [Massion, Pierre P.] Vanderbilt Univ, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Nashville, TN 37232 USA; [Walker, Ronald C.] Tennessee Valley Healthcare Syst Vet Affairs, Dept Med Imaging, Nashville, TN USA; [Walker, Ronald C.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [McPheeters, Melissa L.] Vanderbilt Univ, Med Ctr, Dept Med, Div Obstet & Gynecol, Nashville, TN 37232 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University	Grogan, EL (corresponding author), Vanderbilt Univ, Med Ctr, 1313 21st Ave S,609 Oxford House, Nashville, TN 37232 USA.	eric.grogan@vanderbilt.edu		Putnam, Joe/0000-0002-7504-2104; McPheeters, Melissa/0000-0002-4423-797X	Agency for Healthcare Research and Quality [R03HS021554-01]; Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service Career Development award [10-024]; National Institutes of Health [K07CA172294]; National Cancer Institute; National Center for Advancing Translational Sciences at the National Institutes of Health [UL1TR000011]; National Cancer Institute [CA90949]; Early Detection Research Network (an initiative of the National Cancer Institute) (Dr Massion) [U01CA152662]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS021554] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA172294, P50CA090949, U01CA152662] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445, ZIATR000011] Funding Source: NIH RePORTER; Veterans Affairs [IK2HX000758] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service Career Development award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences at the National Institutes of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Early Detection Research Network (an initiative of the National Cancer Institute) (Dr Massion); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grant R03HS021554-01 from the Agency for Healthcare Research and Quality (Dr Grogan). This work was also supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service Career Development award 10-024 (Dr Grogan), grant K07CA172294 from the National Institutes of Health and the National Cancer Institute (Dr Aldrich), Vanderbilt Institute for Clinical and Translational Research grant UL1TR000011 from the National Center for Advancing Translational Sciences at the National Institutes of Health (REDCap database), the lung SPORE grant CA90949 from the National Cancer Institute (Dr Massion), and grant U01CA152662 from the Early Detection Research Network (an initiative of the National Cancer Institute) (Dr Massion).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Acker MR, 2005, J NUCL MED TECHNOL, V33, P69; Alkhawaldeh K, 2008, EUR J NUCL MED MOL I, V35, P246, DOI 10.1007/s00259-007-0584-1; Ashraf H, 2011, THORAX, V66, P315, DOI 10.1136/thx.2010.136747; Aukema TS, 2009, J THORAC ONCOL, V4, P1226, DOI 10.1097/JTO.0b013e3181b2b782; Baram Daniel, 2008, Med Sci Monit, V14, pCR379; Barnett PG, 2010, CHEST, V137, P53, DOI 10.1378/chest.08-0529; Bastarrika G, 2005, AM J RESP CRIT CARE, V171, P1378, DOI 10.1164/rccm.200411-1479OC; BAYLIN SB, 1982, EXP LUNG RES, V3, P209, DOI 10.3109/01902148209069654; Beyer T, 2000, J NUCL MED, V41, P1369; Beyer T, 2004, J NUCL MED, V45, p25S; Bradsher RW, 1996, CLIN INFECT DIS, V22, pS102, DOI 10.1093/clinids/22.Supplement_2.S102; Bryant AS, 2006, ANN THORAC SURG, V82, P1016, DOI 10.1016/j.athoracsur.2006.03.095; Buck AK, 2005, EUR J NUCL MED MOL I, V32, P525, DOI 10.1007/s00259-004-1706-7; Chang CY, 2010, MOL IMAGING BIOL, V12, P204, DOI 10.1007/s11307-009-0241-0; Chhajed PN, 2005, CHEST, V128, P3558, DOI 10.1378/chest.128.5.3558; Christensen JA, 2006, AM J ROENTGENOL, V187, P1361, DOI 10.2214/AJR.05.1166; Chundru S, 2008, NUCL MED COMMUN, V29, P623, DOI 10.1097/MNM.0b013e3282fdc979; Croft DR, 2002, LUNG CANCER-J IASLC, V36, P297, DOI 10.1016/S0169-5002(02)00023-5; Cronin P, 2008, RADIOLOGY, V246, P772, DOI 10.1148/radiol.2463062148; Dalli A, 2013, J BUON, V18, P935; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Degirmenci B, 2008, NUCL MED COMMUN, V29, P614, DOI 10.1097/MNM.0b013e3282f9b5a0; Delbeke D, 2006, J NUCL MED, V47, P885; Demura Y, 2003, J NUCL MED, V44, P540; Deppen S, 2011, ANN THORAC SURG, V92, P428, DOI 10.1016/j.athoracsur.2011.02.052; Ding QY, 2005, CHINESE MED J-PEKING, V118, P1572; Dittmann H, 2003, EUR J NUCL MED MOL I, V30, P1407, DOI 10.1007/s00259-003-1257-3; Fiorelli A, 2012, EUR J CARDIO-THORAC, V41, P852, DOI 10.1093/ejcts/ezr117; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Vicente AMG, 2011, J NUCL MED TECHNOL, V39, P91, DOI 10.2967/jnmt.110.082719; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Gould MK, 2001, JAMA-J AM MED ASSOC, V285, P914, DOI 10.1001/jama.285.7.914; Gould MK, 2003, ANN INTERN MED, V139, P879, DOI 10.7326/0003-4819-139-11-200311180-00013; Grgic A, 2010, EUR J NUCL MED MOL I, V37, P1087, DOI 10.1007/s00259-010-1387-3; Halter G, 2000, THORAC CARDIOV SURG, V48, P97, DOI 10.1055/s-2000-9875; Harders SW, 2012, CANCER IMAGING, V12, P437, DOI 10.1102/1470-7330.2012.0035; Herder GJ, 2005, CHEST, V128, P2490, DOI 10.1378/chest.128.4.2490; Herder GJ, 2004, EUR J NUCL MED MOL I, V31, P1231, DOI 10.1007/s00259-004-1552-7; Higashi K, 2001, J NUCL MED, V42, P1489; Huang YE, 2010, NUCL MED COMMUN, V31, P945, DOI 10.1097/MNM.0b013e32833ed57d; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Imdahl A, 2001, EUR J CARDIO-THORAC, V20, P324, DOI 10.1016/S1010-7940(01)00800-4; Jeong SY, 2008, LUNG CANCER, V61, P186, DOI 10.1016/j.lungcan.2007.12.021; Kadaria D, 2013, AM J MED SCI, V346, P358, DOI 10.1097/MAJ.0b013e31827b9b6d; Kagna O, 2009, EUR J NUCL MED MOL I, V36, P997, DOI 10.1007/s00259-009-1061-9; Kahn D, 2004, CHEST, V125, P494, DOI 10.1378/chest.125.2.494; Keith CJ, 2002, EUR J NUCL MED MOL I, V29, P1016, DOI 10.1007/s00259-002-0833-2; Kim SK, 2007, J NUCL MED, V48, P214; Kim SC, 2008, ANN NUCL MED, V22, P165, DOI 10.1007/s12149-007-0112-1; Kim SC, 2010, ANN NUCL MED, V24, P231, DOI 10.1007/s12149-010-0351-4; Kubota K, 2011, ANN NUCL MED, V25, P787, DOI 10.1007/s12149-011-0528-5; Lan XL, 2008, CLIN RADIOL, V63, P756, DOI 10.1016/j.crad.2008.01.003; Lee J, 2001, CHEST, V120, P1791, DOI 10.1378/chest.120.6.1791; Li YL, 2011, ANN NUCL MED, V25, P804, DOI 10.1007/s12149-011-0530-y; MacDonald K, 2011, CLIN RADIOL, V66, P244, DOI 10.1016/j.crad.2010.10.008; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; Mason RJ, 2010, MURRAY NADELS TXB RE, V5th; Menda Y, 2002, SEMIN NUCL MED, V32, P92, DOI 10.1053/snuc.2002.31564; Menda Y, 2001, NUCL MED COMMUN, V22, P1077, DOI 10.1097/00006231-200110000-00004; Minamimoto R, 2014, ANTICANCER RES, V34, P183; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; National Comprehensive Cancer Network, NAT COMPR CANC NETW; Nguyen NC, 2011, ACTA ONCOL, V50, P670, DOI 10.3109/0284186X.2010.550933; Nomori H, 2005, ANN THORAC SURG, V79, P984, DOI 10.1016/j.athoracsur.2004.07.072; Nunez R, 2007, REV ESP MED NUCL, V26, P196; Ohba Y, 2009, ANN THORAC SURG, V87, P886, DOI 10.1016/j.athoracsur.2008.09.081; Ohno Y, 2008, J MAGN RESON IMAGING, V27, P1284, DOI 10.1002/jmri.21348; Ohno Y, 2013, AM J ROENTGENOL, V200, pW593, DOI 10.2214/AJR.12.9197; Ohno Y, 2011, RADIOLOGY, V258, P599, DOI 10.1148/radiol.10100245; Okereke IC, 2011, EUR J CARDIO-THORAC, V39, P560, DOI 10.1016/j.ejcts.2010.07.039; Orlacchio A, 2007, RADIOL MED, V112, P157, DOI 10.1007/s11547-007-0132-x; Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Patel VK, 2013, CHEST, V143, P840, DOI 10.1378/chest.12-1487; Pauls S, 2008, MOL IMAGING BIOL, V10, P121, DOI 10.1007/s11307-007-0129-9; Pegna AL, 2013, J THORAC ONCOL, V8, P866, DOI 10.1097/JTO.0b013e31828f68d6; Reid A, 2013, CHEST, V144, DOI 10.1378/chest.1662734; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sachs S, 2005, CHEST, V128, P698, DOI 10.1378/chest.128.2.698; Sasaki M, 2001, ANN NUCL MED, V15, P425, DOI 10.1007/BF02988346; Sathekge MM, 2010, SAMJ S AFR MED J, V100, P598, DOI 10.7196/SAMJ.4082; Schillaci O, 2009, RADIOL MED, V114, P890, DOI 10.1007/s11547-009-0400-z; Sebro R, 2013, ANN NUCL MED, V27, P400, DOI 10.1007/s12149-013-0695-7; Silvestri GA, 2007, CHEST, V132, p178S, DOI 10.1378/chest.07-1360; Skehan SJ, 2001, CAN ASSOC RADIOL J, V52, P259; Tsunezuka Y, 2007, WORLD J SURG, V31, P314, DOI 10.1007/s00268-006-0475-9; Uppot R N, 2001, Del Med J, V73, P381; van't Westeinde SC, 2011, J THORAC ONCOL, V6, P1704, DOI 10.1097/JTO.0b013e3182286d0b; Veronesi G, 2007, ANN THORAC SURG, V84, P959, DOI 10.1016/j.athoracsur.2007.04.058; Wang F, 2007, J NUCL MED, V48, P1442, DOI 10.2967/jnumed.107.040824; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Xu BX, 2011, EUR J NUCL MED MOL I, V38, P285, DOI 10.1007/s00259-010-1625-8; Yamamoto Y, 2008, J COMPUT ASSIST TOMO, V32, P432, DOI 10.1097/RCT.0b013e3180980db9; Yang SN, 2001, ANTICANCER RES, V21, P4153; Yang WF, 2012, EUR J NUCL MED MOL I, V39, P1289, DOI 10.1007/s00259-012-2126-8; Yi CA, 2006, J NUCL MED, V47, P443; Zhang J, 2014, INT J CANCER, V134, P606, DOI 10.1002/ijc.28394; Zhuang HM, 2001, J NUCL MED, V42, P1412	101	104	107	2	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1227	1236		10.1001/jama.2014.11488	http://dx.doi.org/10.1001/jama.2014.11488			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25247519	Green Accepted, Bronze			2022-12-28	WOS:000341990600023
J	Richards, T				Richards, Tessa			Listen to patients first	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Richards, T (corresponding author), BMJ, London, England.	trichards@bmj.com						[Anonymous], 2006, VOLKSKRANT      0425; Bloem BR, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1838; Davies P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4905; Dyer C, 2001, BRIT MED J, V323, P181, DOI 10.1136/bmj.323.7306.181; Engelen L, 2013, PATIENTS NON INCLUDE; Radboud UMC, CARD SURG RES	6	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2014	349								g5765	10.1136/bmj.g5765	http://dx.doi.org/10.1136/bmj.g5765			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9UL	25248964				2022-12-28	WOS:000342425700007
J	Shabel, SJ; Proulx, CD; Piriz, J; Malinow, R				Shabel, Steven J.; Proulx, Christophe D.; Piriz, Joaquin; Malinow, Roberto			GABA/glutamate co-release controls habenula output and is modified by antidepressant treatment	SCIENCE			English	Article							MOSSY FIBER SYNAPSES; VENTRAL TEGMENTAL AREA; LATERAL HABENULA; GABAERGIC NEURONS; CEREBRAL METABOLISM; DEPRESSION; GLUTAMATE; BEHAVIOR; GABA; REWARD	The lateral habenula (LHb), a key regulator of monoaminergic brain regions, is activated by negatively valenced events. Its hyperactivity is associated with depression. Although enhanced excitatory input to the LHb has been linked to depression, little is known about inhibitory transmission. We discovered that g-aminobutyric acid (GABA) is co-released with its functional opponent, glutamate, from long-range basal ganglia inputs (which signal negative events) to limit LHb activity in rodents. At this synapse, the balance of GABA/ glutamate signaling is shifted toward reduced GABA in a model of depression and increased GABA by antidepressant treatment. GABA and glutamate co-release therefore controls LHb activity, and regulation of this form of transmission may be important for determining the effect of negative life events on mood and behavior.	[Shabel, Steven J.; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, San Diego, CA 92103 USA; [Shabel, Steven J.; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Div Biol, Neurobiol Sect, San Diego, CA 92103 USA; [Piriz, Joaquin] Univ Buenos Aires, Fac Med, CONICET, Grp Neurociencia Sistemas,Inst Fisiol & Biofis Ho, Buenos Aires, DF, Argentina	University of California System; University of California San Diego; University of California System; University of California San Diego; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Shabel, SJ (corresponding author), Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, San Diego, CA 92103 USA.	sshabel@gmail.com		Piriz, Joaquin/0000-0002-4588-6568; Shabel, Steven/0000-0002-2746-5399; Proulx, Christophe/0000-0001-6484-9677	NIH [NS047101]; Instituts de Recherche en Sante du Canada; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituts de Recherche en Sante du Canada; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Monyer and O. Kiehn for transgenic mice, R. Edwards for Vglut2 antibodies and DNA, K. Deisseroth for ChR2 DNA, J. Lin and R. Tsien for oChiEf DNA, T. Meerloo for electron microscopy assistance, and V. Joseph for histology assistance. We thank N. Spitzer and J. Issaacson and the Malinow laboratory for helpful suggestions. This work was supported by an NIH grant to R. M. awarded to the University of California, San Diego (UCSD) Neuroscience Core (NS047101). C.D.P was supported by a postdoctoral award by the Instituts de Recherche en Sante du Canada. All primary electrophysiological and immunohistochemical data are archived in the Center for Neural Circuits and Behavior at UCSD.	Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Barroso-Chinea P, 2008, NEUROBIOL DIS, V31, P422, DOI 10.1016/j.nbd.2008.05.019; Beltran JQ, 2012, J PHYSIOL-LONDON, V590, P4789, DOI 10.1113/jphysiol.2012.236372; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brinschwitz K, 2010, NEUROSCIENCE, V168, P463, DOI 10.1016/j.neuroscience.2010.03.050; Cabezas C, 2012, J NEUROSCI, V32, P11835, DOI 10.1523/JNEUROSCI.5543-11.2012; Caiati MD, 2013, J NEUROSCI, V33, P1755, DOI 10.1523/JNEUROSCI.5019-12.2013; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; CALDECOTTHAZARD S, 1988, EXP NEUROL, V99, P73, DOI 10.1016/0014-4886(88)90128-8; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Freo U, 2000, BRAIN RES, V854, P35, DOI 10.1016/S0006-8993(99)02261-1; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; GOTTESFELD Z, 1977, BRAIN RES, V130, P184, DOI 10.1016/0006-8993(77)90856-3; Gutierrez R, 2005, TRENDS NEUROSCI, V28, P297, DOI 10.1016/j.tins.2005.04.005; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; HYTTEL J, 1982, PROG NEURO-PSYCHOPH, V6, P277, DOI 10.1016/S0278-5846(82)80179-6; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jarosik J, 2007, EXP NEUROL, V204, P20, DOI 10.1016/j.expneurol.2006.09.008; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Patton GC, 2003, PSYCHOL MED, V33, P1203, DOI 10.1017/S0033291703008626; Safiulina VF, 2006, J NEUROSCI, V26, P597, DOI 10.1523/JNEUROSCI.4493-05.2006; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; TOKUNO H, 1988, BRAIN RES, V474, P390, DOI 10.1016/0006-8993(88)90457-X; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Uchigashima M, 2007, J NEUROSCI, V27, P8088, DOI 10.1523/JNEUROSCI.0702-07.2007; Vollmayr B, 2004, BEHAV BRAIN RES, V150, P217, DOI 10.1016/S0166-4328(03)00259-6; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Winter C, 2011, BEHAV BRAIN RES, V216, P463, DOI 10.1016/j.bbr.2010.07.034	42	216	222	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1494	1498		10.1126/science.1250469	http://dx.doi.org/10.1126/science.1250469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25237099	Green Accepted			2022-12-28	WOS:000341752900039
J	Wu, YB; Williams, EG; Dubuis, S; Mottis, A; Jovaisaite, V; Houten, SM; Argmann, CA; Faridi, P; Wolski, W; Kutalik, Z; Zamboni, N; Auwerx, J; Aebersold, R				Wu, Yibo; Williams, Evan G.; Dubuis, Sebastien; Mottis, Adrienne; Jovaisaite, Virginija; Houten, Sander M.; Argmann, Carmen A.; Faridi, Pouya; Wolski, Witold; Kutalik, Zoltan; Zamboni, Nicola; Auwerx, Johan; Aebersold, Ruedi			Multilayered Genetic and Omics Dissection of Mitochondrial Activity in a Mouse Reference Population	CELL			English	Article							STRESS-RESPONSE; PROTEIN; EXPRESSION; DHTKD1; NORMALIZATION; METABOLISM; ABUNDANCE; MAP	The manner by which genotype and environment affect complex phenotypes is one of the fundamental questions in biology. In this study, we quantified the transcriptome-a subset of the metabolome-and, using targeted proteomics, quantified a subset of the liver proteome from 40 strains of the BXD mouse genetic reference population on two diverse diets. We discovered dozens of transcript, protein, and metabolite QTLs, several of which linked to metabolic phenotypes. Most prominently, Dhtkd1 was identified as a primary regulator of 2-aminoadipate, explaining variance in fasted glucose and diabetes status in both mice and humans. These integrated molecular profiles also allowed further characterization of complex pathways, particularly the mitochondrial unfolded protein response (UPRmt). UPRmt shows strikingly variant responses at the transcript and protein level that are remarkably conserved among C. elegans, mice, and humans. Overall, these examples demonstrate the value of an integrated multilayered omics approach to characterize complex metabolic phenotypes.	[Wu, Yibo; Dubuis, Sebastien; Faridi, Pouya; Wolski, Witold; Zamboni, Nicola; Aebersold, Ruedi] ETHZ, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Williams, Evan G.; Mottis, Adrienne; Jovaisaite, Virginija; Auwerx, Johan] Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Argmann, Carmen A.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Faridi, Pouya] Shiraz Univ Med Sci, Sch Pharm & Pharmaceut Sci, Dept Tradit Pharm, Shiraz 7134914693, Iran; [Kutalik, Zoltan] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1010 Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Shiraz University of Medical Science; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; University of Zurich	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch; aebersold@imsb.biol.ethz.ch	Wu, Yibo/AAW-7121-2020; Wu, Yibo/AAK-8294-2020; Williams, Evan/M-7539-2017; Kutalik, Zoltan/HHZ-5697-2022; Colaus, PsyColaus/K-6607-2013; Faridi, Pouya/B-4721-2010; Zamboni, Nicola/K-3042-2012; Houten, Sander/Y-3599-2019; Auwerx, Johan/ABE-9307-2021	Wu, Yibo/0000-0002-8256-3901; Wu, Yibo/0000-0002-8256-3901; Williams, Evan/0000-0002-9746-376X; Kutalik, Zoltan/0000-0001-8285-7523; Faridi, Pouya/0000-0002-2712-3356; Zamboni, Nicola/0000-0003-1271-1021; Houten, Sander/0000-0002-6167-9147; Auwerx, Johan/0000-0002-5065-5393	GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation (SNSF) [33CSCO-122661]; ERC (Proteomics v3.0) [AdG-233226]; Fondation Romande pour la Recherche sur le Diabete; EPFL; ETHZ; ERC [AdG-231138, AdG-233226)]; Velux Stiftung; LiverX; AgingX programs of the Swiss Initiative for Systems Biology [51RTP0-151019, 2013/153]; SNSF [31003A-140780, 31003A-143914, 3100A0-107679, CSRII3-136201]; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); ERC (Proteomics v3.0); Fondation Romande pour la Recherche sur le Diabete; EPFL; ETHZ(ETH Zurich); ERC(European Research Council (ERC)European Commission); Velux Stiftung; LiverX; AgingX programs of the Swiss Initiative for Systems Biology; SNSF(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. van Cruchten and W. Smit for the serum analysis of 2-AA. The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (SNSF; 33CSCO-122661). The authors thank P. Vollenweider, G. Waeber, V. Mooser, and D. Waterworth, co-principal investigators of the CoLaus study. We also thank L. Gillet, H. Rost, and P. Picotti for insightful discussions and R. Huttenhain, A. Maiolica, P. Kouvonen, T. Sajic, A. Leitner, and A. Bensimon for technical support. Special thanks to M. Bochud, Y. Barreau, M. Firmann, V. Mayor, A. Bastian, B. Ramic, M. Moranville, M. Baumer, M. Sagette, J. Ecoffey, and S. Mermoud for data collection. Y.W. was supported by the ERC (Proteomics v3.0; AdG-233226 to R.A.) and the LiverX program of SystemsX, the Swiss Initiative for Systems Biology and E.G.W. by a fellowship from the Fondation Romande pour la Recherche sur le Diabete. J.A. is the Nestle Chair in Energy Metabolism. Research was supported by the EPFL, ETHZ, ERC (Sirtuins; AdG-231138 and Proteomics v3.0; AdG-233226), Velux Stiftung, LiverX, and AgingX programs of the Swiss Initiative for Systems Biology (51RTP0-151019 and 2013/153), SNSF (31003A-140780, 31003A-143914, 3100A0-107679, and CSRII3-136201), and the NIH (R01AG043930).	Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Ding Lily, 2004, COPD, V1, P191, DOI 10.1081/COPD-120039810; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Ghazalpour A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20135004; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HAYMOND MW, 1978, J CLIN INVEST, V62, P398, DOI 10.1172/JCI109141; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Holdt LM, 2013, GENETICS, V193, P601, DOI 10.1534/genetics.112.143354; Houten SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-57; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738; Karpievitch YV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S5; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; KOEPP P, 1974, Z KINDERHEILKD, V116, P177, DOI 10.1007/BF00464456; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marx V, 2013, NAT METHODS, V10, P703, DOI 10.1038/nmeth.2570; Mitterberger MC, 2012, EXP CELL RES, V318, P877, DOI 10.1016/j.yexcr.2012.02.011; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Rueedi R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004132; Runkel ED, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003346; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Skvorak KJ, 2009, J INHERIT METAB DIS, V32, P229, DOI 10.1007/s10545-009-1086-z; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Wong N, 2013, DIABETOLOGIA, V56, P1569, DOI 10.1007/s00125-013-2908-y; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Xu WY, 2012, AM J HUM GENET, V91, P1088, DOI 10.1016/j.ajhg.2012.09.018; Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	54	160	163	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1415	1430		10.1016/j.cell.2014.07.039	http://dx.doi.org/10.1016/j.cell.2014.07.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25215496	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000343094200021
J	Zhan, S; Zhang, W; Niitepold, K; Hsu, J; Haeger, JF; Zalucki, MP; Altizer, S; de Roode, JC; Reppert, SM; Kronforst, MR				Zhan, Shuai; Zhang, Wei; Niitepold, Kristjan; Hsu, Jeremy; Fernandez Haeger, Juan; Zalucki, Myron P.; Altizer, Sonia; de Roode, Jacobus C.; Reppert, Steven M.; Kronforst, Marcus R.			The genetics of monarch butterfly migration and warning colouration	NATURE			English	Article							DANAUS-PLEXIPPUS L.; COL4A1 MUTATIONS; FLIGHT; LEPIDOPTERA; POPULATION; SEQUENCE; REVEALS; GENES; ORIENTATION; PHYLOGENIES	The monarch butterfly, Danaus plexippus, is famous for its spectacular annual migration across North America, recent worldwide dispersal, and orange warning colouration. Despite decades of study and broad public interest, we know little about the genetic basis of these hallmark traits. Here we uncover the history of the monarch's evolutionary origin and global dispersal, characterize the genes and pathways associated with migratory behaviour, and identify the discrete genetic basis of warning colouration by sequencing 101 Danaus genomes from around the globe. The results rewrite our understanding of this classic system, showing that D. plexippus was ancestrally migratory and dispersed out of North America to occupy its broad distribution. We find the strongest signatures of selection associated with migration centre on flight muscle function, resulting in greater flight efficiency among migratory monarchs, and that variation in monarch warning colouration is controlled by a single myosin gene not previously implicated in insect pigmentation.	[Zhan, Shuai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Zhan, Shuai; Zhang, Wei; Kronforst, Marcus R.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Zhan, Shuai; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Niitepold, Kristjan; Hsu, Jeremy] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Niitepold, Kristjan] Univ Helsinki, Dept Biosci, FI-00014 Helsinki, Finland; [Fernandez Haeger, Juan] Univ Cordoba, Dept Bot Ecol & Fisiol Vegetal, E-14071 Cordoba, Spain; [Zalucki, Myron P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Altizer, Sonia] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [de Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chicago; University of Massachusetts System; University of Massachusetts Worcester; Stanford University; University of Helsinki; Universidad de Cordoba; University of Queensland; University System of Georgia; University of Georgia; Emory University	Zhan, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	szhan@sibs.ac.cn; mkronforst@uchicago.edu	Zhang, Wei/AAV-6724-2021; Niitepold, Kristjan/I-2210-2019; Zhang, Wei/P-1532-2015; Zalucki, Myron P/G-7983-2012; zhang, tingting/K-6664-2018	Zhang, Wei/0000-0002-6644-7046; Zalucki, Myron P/0000-0001-9603-7577; 	National Institutes of Health [GM086794-02S1]; National Science Foundation [IOS-134367, DEB-0643831, DEB-1019746, DEB-1316037]; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences; University of Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086794] Funding Source: NIH RePORTER; Direct For Biological Sciences [1019746, 1343671] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); University of Chicago(University of Chicago); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank B. Ballister, S. Barribeau, R. Bartel, N. Chamberlain, R. Cook, A. Davis, D. Feary, D. Frey, M. Maudsley, G. Moreira, E. Osburn, R. Rarick, E. Rendon, D. Rodrigues, E. Sternberg and J. Stimson for assistance collecting or providing specimens. We also thank J. Jensen and D. Lohman for discussion. This work was supported by National Institutes of Health grant GM086794-02S1, National Science Foundation grants IOS-134367, DEB-0643831, DEB-1019746 and DEB-1316037, start-up funds from the Chinese Academy of Sciences and Shanghai Institutes for Biological Sciences, and Neubauer Funds from the University of Chicago.	Ackery PR, 1984, MILKWEED BUTTERFLIES; Altizer S, 2010, EVOLUTION, V64, P1018, DOI 10.1111/j.1558-5646.2010.00946.x; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brower Lincoln P., 2007, Antenna, V31, P12; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dingle H, 2005, BIOL J LINN SOC, V85, P491, DOI 10.1111/j.1095-8312.2005.00512.x; Dockx C, 2007, BIOL J LINN SOC, V92, P605, DOI 10.1111/j.1095-8312.2007.00886.x; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Haeger JF, 2009, SHILAP-REV LEPIDOPT, V37, P421; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Gauthreaux SA, 1982, AVIAN BIOL, VVI, P93, DOI DOI 10.1016/B978-0-12-249406-2.50011-3; GIBO DL, 1979, CAN J ZOOL, V57, P1393, DOI 10.1139/z79-180; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Haber W.A., 1993, Natural History Museum of Los Angeles County Science Series, P201; Hakeda S, 2000, J CELL BIOL, V148, P101, DOI 10.1083/jcb.148.1.101; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUDSON RR, 1987, GENETICS, V116, P153; James D.G., 1993, Natural History Museum of Los Angeles County Science Series, P189; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Kelemen-Valkony I, 2012, MATRIX BIOL, V31, P29, DOI 10.1016/j.matbio.2011.09.004; Kitching I.J., 1993, Natural History Museum of Los Angeles County Science Series, P11; Knight A, 2009, J CHEM ECOL, V35, P816, DOI 10.1007/s10886-009-9655-z; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; Malcolm S. B., 1993, BIOL CONSERVATION MO; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Mitikka V, 2010, ANN ZOOL FENN, V47, P1; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Niitepold K, 2011, OECOLOGIA, V165, P847, DOI 10.1007/s00442-010-1886-8; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; Oberhauser KS, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P3; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peter BM, 2013, EVOLUTION, V67, P3274, DOI 10.1111/evo.12202; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Plaisier E, 2007, NEW ENGL J MED, V357, P2687, DOI 10.1056/NEJMoa071906; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REICHSTE.T, 1968, SCIENCE, V161, P861, DOI 10.1126/science.161.3844.861; Rendon-Salinas E., 2014, FOREST SURFACE OCCUP; Reppert SM, 2010, TRENDS NEUROSCI, V33, P399, DOI 10.1016/j.tins.2010.04.004; RITLAND DB, 1991, NATURE, V350, P497, DOI 10.1038/350497a0; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Smith DAS, 1997, OIKOS, V78, P127, DOI 10.2307/3545808; STIMSON J, 1984, Journal of Research on the Lepidoptera, V23, P153; Stimson John, 2000, Journal of the Lepidopterists' Society, V54, P29; TAJIMA F, 1989, GENETICS, V123, P585; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; URQUHART FA, 1976, NATL GEOGR, V150, P161; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; Vane-Wright R.I., 1993, Natural History Museum of Los Angeles County Science Series, P179; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zalucki MP, 2004, BIOL J LINN SOC, V82, P111, DOI 10.1111/j.1095-8312.2004.00322.x; Zhan S, 2013, NUCLEIC ACIDS RES, V41, pD758, DOI 10.1093/nar/gks1057; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345	83	159	166	8	405	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					317	+		10.1038/nature13812	http://dx.doi.org/10.1038/nature13812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25274300	Green Accepted			2022-12-28	WOS:000342988600041
J	Roehr, B				Roehr, Bob			FEATURE Creating the patient centered medical home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE					bobroehr@aol.com						Alliance for Health Reform, 2014, PAT CTR MED HOM PROM; Fiore K, 2014, MEDPAGE TODAY   0604; Kern LM, 2014, ANN INTERN MED, V160, P741, DOI 10.7326/M13-1798; Kush R, 2014, NEW ENGL J MED, V370, P2163, DOI 10.1056/NEJMp1401444; Psaty BM, 2014, NEW ENGL J MED, V370, P2165, DOI 10.1056/NEJMp1401664; Reid RJ, 2014, ANN INTERN MED, V160, P802, DOI 10.7326/M14-0863; Schneeweiss S, 2014, NEW ENGL J MED, V370, P2161, DOI 10.1056/NEJMp1401111	7	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	2014	349								g4916	10.1136/bmj.g4916	http://dx.doi.org/10.1136/bmj.g4916			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3CI	25280584				2022-12-28	WOS:000342665900001
J	Vriezinga, SL; Auricchio, R; Bravi, E; Castillejo, G; Chmielewska, A; Escobar, PC; Kolacek, S; Koletzko, S; Korponay-Szabo, IR; Mummert, E; Polanco, I; Putter, H; Ribes-Koninckx, C; Shamir, R; Szajewska, H; Werkstetter, K; Greco, L; Gyimesi, J; Hartman, C; Esch, CH; Hopman, E; Ivarsson, A; Koltai, T; Koning, F; Martinez-Ojinaga, E; te Marvelde, C; Pavic, AM; Romanos, J; Stoopman, E; Villanacci, V; Wijmenga, C; Troncone, R; Mearin, ML				Vriezinga, S. L.; Auricchio, R.; Bravi, E.; Castillejo, G.; Chmielewska, A.; Crespo Escobar, P.; Kolacek, S.; Koletzko, S.; Korponay-Szabo, I. R.; Mummert, E.; Polanco, I.; Putter, H.; Ribes-Koninckx, C.; Shamir, R.; Szajewska, H.; Werkstetter, K.; Greco, L.; Gyimesi, J.; Hartman, C.; Esch, C. Hogen; Hopman, E.; Ivarsson, A.; Koltai, T.; Koning, F.; Martinez-Ojinaga, E.; te Marvelde, C.; Pavic, A. Mocic; Romanos, J.; Stoopman, E.; Villanacci, V.; Wijmenga, C.; Troncone, R.; Mearin, M. L.			Randomized Feeding Intervention in Infants at High Risk for Celiac Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN; AUTOIMMUNITY; DIAGNOSIS; QUESTIONNAIRE; HETERODIMER; POPULATION; PREVENTION; NUTRITION; EPIDEMIC; HEALTH	BACKGROUND A window of opportunity has been suggested for reducing the risk of celiac disease by introducing gluten to infants at 4 to 6 months of age. METHODS We performed a multicenter, randomized, double-blind, placebo-controlled dietary-intervention study involving 944 children who were positive for HLA-DQ2 or HLA-DQ8 and had at least one first-degree relative with celiac disease. From 16 to 24 weeks of age, 475 participants received 100 mg of immunologically active gluten daily, and 469 received placebo. Anti-transglutaminase type 2 and antigliadin antibodies were periodically measured. The primary outcome was the frequency of biopsy-confirmed celiac disease at 3 years of age. RESULTS Celiac disease was confirmed by means of biopsies in 77 children. To avoid underestimation of the frequency of celiac disease, 3 additional children who received a diagnosis of celiac disease according to the 2012 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition diagnostic criteria (without having undergone biopsies) were included in the analyses (80 children; median age, 2.8 years; 59% were girls). The cumulative incidence of celiac disease among patients 3 years of age was 5.2% (95% confidence interval [CI], 3.6 to 6.8), with similar rates in the gluten group and the placebo group (5.9% [95% CI, 3.7 to 8.1] and 4.5% [95% CI, 2.5 to 6.5], respectively; hazard ratio in the gluten group, 1.23; 95% CI, 0.79 to 1.91). Rates of elevated levels of anti-transglutaminase type 2 and antigliadin antibodies were also similar in the two study groups (7.0% [95% CI, 4.7 to 9.4] in the gluten group and 5.7% [95% CI, 3.5 to 7.9] in the placebo group; hazard ratio, 1.14; 95% CI, 0.76 to 1.73). Breast-feeding, regardless of whether it was exclusive or whether it was ongoing during gluten introduction, did not significantly influence the development of celiac disease or the effect of the intervention. CONCLUSIONS As compared with placebo, the introduction of small quantities of gluten at 16 to 24 weeks of age did not reduce the risk of celiac disease by 3 years of age in this group of high-risk children. (Funded by the European Commission and others; PreventCD Current Controlled Trials number, ISRCTN74582487.)	[Vriezinga, S. L.; Esch, C. Hogen; Mearin, M. L.] Leiden Univ, Med Ctr, Dept Pediat, NL-2300 RC Leiden, Netherlands; [Putter, H.; te Marvelde, C.; Stoopman, E.] Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands; [Hopman, E.] Leiden Univ, Med Ctr, Dept Dietet, NL-2300 RC Leiden, Netherlands; [Koning, F.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; [Romanos, J.; Wijmenga, C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Auricchio, R.; Greco, L.; Troncone, R.] Univ Naples Federico II, Dept Med Translat Sci, Naples, Italy; [Auricchio, R.; Greco, L.; Troncone, R.] Univ Naples Federico II, European Lab Invest Food Induced Dis, Naples, Italy; [Bravi, E.] Eurospital, Trieste, Italy; [Villanacci, V.] Spedali Civil Brescia, Inst Pathol, I-25125 Brescia, Italy; [Castillejo, G.] Reus Univ Rovira & Virgili, Hosp Univ St Joan, Dept Pediat, Tarragona, Spain; [Crespo Escobar, P.] Inst Invest Sanitaria La Fe, Valencia, Spain; [Ribes-Koninckx, C.] La Fe Univ Hosp, Dept Pediat Gastroenterol & Hepatol, Valencia, Spain; [Polanco, I.; Martinez-Ojinaga, E.] La Paz Univ Hosp, Dept Pediat Gastroenterol & Nutr, Madrid, Spain; [Chmielewska, A.; Szajewska, H.] Med Univ Warsaw, Dept Pediat, Warsaw, Poland; [Kolacek, S.; Pavic, A. Mocic] Univ Childrens Hosp Zagreb, Referral Ctr Pediat Gastroenterol & Nutr, Zagreb, Croatia; [Koletzko, S.; Werkstetter, K.] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat Gastroenterol & Hepatol, Munich, Germany; [Mummert, E.] Thermo Fisher Sci, Freiburg, Germany; [Korponay-Szabo, I. R.; Gyimesi, J.] Heim Pal Childrens Hosp, Celiac Dis Ctr, Budapest, Hungary; [Shamir, R.; Hartman, C.] Tel Aviv Univ, Sackler Fac Med, Schneider Childrens Med Ctr, Inst Gastroenterol Nutr & Liver Dis, IL-69978 Tel Aviv, Israel; [Ivarsson, A.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Ivarsson, A.] Umea Univ, Dept Epidemiol, Umea, Sweden; [Ivarsson, A.] Umea Univ, Dept Global Hlth, Umea, Sweden; [Koltai, T.] Assoc European Coeliac Soc, Brussels, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Naples Federico II; University of Naples Federico II; Hospital Spedali Civili Brescia; Universitat Rovira i Virgili; Hospital Universitario La Paz; Medical University of Warsaw; University of Munich; Thermo Fisher Scientific; Tel Aviv University; Sackler Faculty of Medicine; Umea University; Umea University; Umea University	Mearin, ML (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, POB 9600, NL-2300 RC Leiden, Netherlands.	m.l.mearin_manrique@lumc.nl	Korponay-Szabó, Ilma/AAF-9048-2022; Szajewska, Hania/M-4141-2018; AURICCHIO, RENATA/AAC-7718-2022; Wijmenga, Cisca/D-2173-2009; Ribes-Koninckx, Maria Carmen/ABH-5577-2020; Wijmenga, Cisca/AAE-7719-2019; Putter, Hein/C-2244-2018; Korponay-Szabó, Ilma/AFK-1690-2022; Hojsak, Iva/AAI-8937-2020; Mocic Pavic, Ana/GZA-9443-2022	Szajewska, Hania/0000-0002-4596-2874; Wijmenga, Cisca/0000-0002-5635-1614; Putter, Hein/0000-0001-5395-1422; Hojsak, Iva/0000-0003-3262-5964; Koning, Frits/0000-0002-4007-5715; Ivarsson, Anneli/0000-0001-8944-2558	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	Funded by the European Commission and others; PreventCD Current Controlled Trials number, ISRCTN74582487.	Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Akobeng AK, 2006, ARCH DIS CHILD, V91, P39, DOI 10.1136/adc.2005.082016; Ascher H, 1996, SCAND J GASTROENTERO, V31, P61, DOI 10.3109/00365529609031628; Auricchio S, 1988, GASTROENTEROL INT, V1, P25; Babron MC, 2003, EUR J HUM GENET, V11, P828, DOI 10.1038/sj.ejhg.5201051; Biagi F, 2010, NAT REV GASTRO HEPAT, V7, P158, DOI 10.1038/nrgastro.2010.2; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; CATASSI C, 1993, GUT, V34, P1515, DOI 10.1136/gut.34.11.1515; Collin P, 2008, DIGEST LIVER DIS, V40, P101, DOI 10.1016/j.dld.2007.10.017; Esch CEH, 2010, ALIMENT PHARM THER, V31, P760, DOI 10.1111/j.1365-2036.2009.04226.x; Esch CEH, 2010, EUR J GASTROEN HEPAT, V22, P1424, DOI 10.1097/MEG.0b013e32833fe9ae; Goldberg DJ, 2012, J COSMET LASER THER, V14, P161, DOI 10.3109/14764172.2012.707100; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hopman EG, 2007, CLIN NUTR, V26, P264, DOI 10.1016/j.clnu.2006.12.003; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Ivarsson A, 2010, ACTA PAEDIATR, V99, P1429, DOI 10.1111/j.1651-2227.2010.01832.x; Ivarsson A, 2013, PEDIATRICS, V131, pE687, DOI 10.1542/peds.2012-1015; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Lagerqvist C, 2008, J PEDIATR GASTR NUTR, V47, P428, DOI 10.1097/MPG.0b013e31817d80f4; Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mearin M Luisa, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P86, DOI 10.1016/j.cppeds.2007.01.001; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Phares V, 2005, J PEDIATR PSYCHOL, V30, P631, DOI 10.1093/jpepsy/jsi050; Shamir R, 2006, MED DECIS MAKING, V26, P282, DOI 10.1177/0272989X06289012; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Stordal K, 2013, PEDIATRICS, V132, pE1202, DOI 10.1542/peds.2013-1752; Szajewska H, 2012, ALIMENT PHARM THER, V36, P607, DOI 10.1111/apt.12023; Troncone R, 2008, CURR OPIN CLIN NUTR, V11, P329, DOI 10.1097/MCO.0b013e3282f795f8; van Doorn RK, 2008, J PEDIATR GASTR NUTR, V47, P147, DOI 10.1097/MPG.0b013e31815ef87d; van Koppen EJ, 2009, PEDIATRICS, V123, pE582, DOI 10.1542/peds.2008-2221; Villanacci V, 2011, DIGEST LIVER DIS, V43, pS385, DOI 10.1016/S1590-8658(11)60594-X; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	40	292	311	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1304	1315		10.1056/NEJMoa1404172	http://dx.doi.org/10.1056/NEJMoa1404172			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25271603	Bronze			2022-12-28	WOS:000342429800007
J	Chokshi, DA; Chang, JE				Chokshi, Dave A.; Chang, Ji Eun			Preventing Early Readmissions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-FAILURE; RATES		[Chokshi, Dave A.; Chang, Ji Eun] NYU, Langone Med Ctr, Dept Populat Hlth, New York, NY 10016 USA; [Chokshi, Dave A.; Chang, Ji Eun] NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA; [Chokshi, Dave A.; Chang, Ji Eun] NYU, Wagner Sch Publ Serv, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University	Chokshi, DA (corresponding author), NYU, Langone Med Ctr, 227 E 30th St,Rm 647, New York, NY 10016 USA.	dave.chokshi@nyumc.org		Chokshi, Dave/0000-0001-7467-4591				[Anonymous], ARM BIGG FIN MED PUN; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Detsky AS, 2014, JAMA-J AM MED ASSOC, V311, P2169, DOI 10.1001/jama.2014.3695; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118	9	9	9	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1344	+		10.1001/jama.2014.9473	http://dx.doi.org/10.1001/jama.2014.9473			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25268442				2022-12-28	WOS:000342345400021
J	Hogbom, M				Hogbom, Martin			A dynamic tool for nitrogen reduction	SCIENCE			English	Editorial Material							MOLYBDENUM-IRON PROTEIN; COFACTOR; CARBON		Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Hogbom, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	hogbom@dbb.su.se		Hogbom, Martin/0000-0001-5574-9383				Blomberg MRA, 2014, CHEM REV, V114, P3601, DOI 10.1021/cr400388t; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Lundin D, 2012, J BIOL CHEM, V287, P20565, DOI 10.1074/jbc.M112.367458; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Smil V., 2004, ENRICHING EARTH FRIT; Spatzal T, 2014, SCIENCE, V345, P1620, DOI 10.1126/science.1256679; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Tinberg CE, 2011, ACCOUNTS CHEM RES, V44, P280, DOI 10.1021/ar1001473	12	3	3	0	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1568	1568		10.1126/science.1260021	http://dx.doi.org/10.1126/science.1260021			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258069	Green Published			2022-12-28	WOS:000342164500025
J	Arnoult, N; Karlseder, J				Arnoult, Nausica; Karlseder, Jan			ALT Telomeres Borrow from Meiosis to Get Moving	CELL			English	Editorial Material							MUTATIONS; DNA		[Arnoult, Nausica; Karlseder, Jan] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Karlseder, J (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	karlseder@salk.edu		Arnoult, Nausica/0000-0003-2633-0270	NATIONAL CANCER INSTITUTE [R01CA174942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087476] Funding Source: NIH RePORTER; NCI NIH HHS [CA174942, R01 CA174942] Funding Source: Medline; NIGMS NIH HHS [GM087476, R01 GM087476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bugreev DV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5198; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Draskovic I, 2009, P NATL ACAD SCI USA, V106, P15726, DOI 10.1073/pnas.0907689106; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]	8	6	6	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					11	12		10.1016/j.cell.2014.09.013	http://dx.doi.org/10.1016/j.cell.2014.09.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259914	Bronze, Green Accepted			2022-12-28	WOS:000343095000003
J	Smith, JM				Smith, Jeanette M.			Pavilion Street, Mount Adams Frances Farrand Dodge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1180	1181		10.1001/jama.2013.279741	http://dx.doi.org/10.1001/jama.2013.279741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25247498				2022-12-28	WOS:000341990600001
J	Sacks, HS				Sacks, Henry S.			Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6							JC12	10.7326/0003-4819-161-6-201409160-02012	http://dx.doi.org/10.7326/0003-4819-161-6-201409160-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222412				2022-12-28	WOS:000343894400011
J	Ghansah, A; Amenga-Etego, L; Amambua-Ngwa, A; Andagalu, B; Apinjoh, T; Bouyou-Akotet, M; Cornelius, V; Golassa, L; Andrianaranjaka, VH; Ishengoma, D; Johnson, K; Kamau, E; Maiga-Ascofare, O; Mumba, D; Tindana, P; Tshefu-Kitoto, A; Randrianarivelojosia, M; William, Y; Kwiatkowski, DP; Djimde, AA				Ghansah, Anita; Amenga-Etego, Lucas; Amambua-Ngwa, Alfred; Andagalu, Ben; Apinjoh, Tobias; Bouyou-Akotet, Marielle; Cornelius, Victoria; Golassa, Lemu; Andrianaranjaka, Voahangy Hanitriniaina; Ishengoma, Deus; Johnson, Kimberly; Kamau, Edwin; Maiga-Ascofare, Oumou; Mumba, Dieudonne; Tindana, Paulina; Tshefu-Kitoto, Antoinette; Randrianarivelojosia, Milijaona; William, Yavo; Kwiatkowski, Dominic P.; Djimde, Abdoulaye A.			Monitoring parasite diversity for malaria elimination in sub-Saharan Africa	SCIENCE			English	Editorial Material							ARTEMISININ RESISTANCE	The African continent continues to bear the greatest burden of malaria and the greatest diversity of parasites, mosquito vectors, and human victims. The evolutionary plasticity of malaria parasites and their vectors is a major obstacle to eliminating the disease. Of current concern is the recently reported emergence of resistance to the front-line drug, artemisinin, in South-East Asia in Plasmodium falciparum, which calls for preemptive surveillance of the African parasite population for genetic markers of emerging drug resistance. Here we describe the Plasmodium Diversity Network Africa (PDNA), which has been established across 11 countries in sub-Saharan Africa to ensure that African scientists are enabled to work together and to play a key role in the global effort for tracking and responding to this public health threat.	[Ghansah, Anita] Noguchi Mem Inst Med Res, Accra, Ghana; [Amenga-Etego, Lucas; Tindana, Paulina] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Amambua-Ngwa, Alfred] MRC, Gambia Unit, Banjul, Gambia; [Andagalu, Ben; Kamau, Edwin] KEMRI US Army Med Res Unit Kenya, Nairobi, Kenya; [Apinjoh, Tobias] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon; [Bouyou-Akotet, Marielle] Univ Sci Sante, Fac Med, Dept Parasitol Mycol, Libreville, Gabon; [Cornelius, Victoria; Johnson, Kimberly; Kwiatkowski, Dominic P.] Univ Oxford, MRC Ctr Genom & Global Hlth, Oxford, England; [Golassa, Lemu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Golassa, Lemu] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Andrianaranjaka, Voahangy Hanitriniaina; Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Malaria Res Unit, Antananarivo, Madagascar; [Ishengoma, Deus] Natl Inst Med Res, Tanga, Tanzania; [Mumba, Dieudonne; Tshefu-Kitoto, Antoinette] Univ Kinshasa, Fac Med, Ecole Sante Publ, Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Maiga-Ascofare, Oumou; Djimde, Abdoulaye A.] Univ Sci Tech & Technol Bamako, Fac Pharm, Dept Epidemiol Parasit Dis, MRTC, Bamako, Mali; [Maiga-Ascofare, Oumou] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [William, Yavo] Natl Inst Publ Hlth, Malaria Res & Control Ctr, Abidjan, Cote Ivoire; [Kwiatkowski, Dominic P.; Djimde, Abdoulaye A.] Wellcome Trust Sanger Inst, Hinxton, Herts, England	University of Ghana; Navrongo Health Research Center; University of London; London School of Hygiene & Tropical Medicine; Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Directorate Kenya (USAMRU-K); University of Oxford; Addis Ababa University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Institute Nacional de Recherche Biomedical; Universite de Kinshasa; University of Science & Technology of Bamako; Bernhard Nocht Institut fur Tropenmedizin; Wellcome Trust Sanger Institute	Djimde, AA (corresponding author), Univ Sci Tech & Technol Bamako, Fac Pharm, Dept Epidemiol Parasit Dis, MRTC, Bamako, Mali.	adjimde@icermali.org	Amambua-Ngwa, Alfred/ABA-7305-2020; Amambua-Ngwa, Alfred/HGU-8062-2022; Ishengoma, Deus/J-9484-2019; Golassa, Lemu/AAJ-2204-2021; Amambua-Ngwa, Alfred/AHD-7882-2022	Amambua-Ngwa, Alfred/0000-0003-4478-3601; Ishengoma, Deus/0000-0003-2040-3416; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Maiga Ascofare, Oumou/0000-0003-2947-5651; Randrianarivelojosia, Milijaona/0000-0003-2767-0349; Johnson, Kimberly J/0000-0002-6365-906X; Kwiatkowski, Dominic/0000-0002-5023-0176; Apinjoh, Tobias/0000-0001-9889-7271; Tindana, Paulina/0000-0002-9171-2083	MRC [G0600718, MC_EX_MR/K02440X/1] Funding Source: UKRI; Medical Research Council [G0600718, MC_EX_MR/K02440X/1] Funding Source: Medline; Wellcome Trust [090532, 090770] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fairhurst RM, 2012, AM J TROP MED HYG, V87, P231, DOI 10.4269/ajtmh.2012.12-0025; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; WHO, 2013, WORLD MALARIA REPORT 2013, P1	7	30	31	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1297	1298		10.1126/science.1259423	http://dx.doi.org/10.1126/science.1259423			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214619	Green Accepted			2022-12-28	WOS:000341483800051
J	Sepulveda, J; Murray, C				Sepulveda, Jaime; Murray, Christopher			The state of global health in 2014	SCIENCE			English	Editorial Material							SYSTEMATIC ANALYSIS; DISEASE; COUNTRIES; BURDEN	The global health landscape looks more promising than ever, although progress has been uneven. Here, we describe the current global burden of disease throughout the life cycle, highlighting regional differences in the unfinished agenda of communicable diseases and reproductive, maternal, and child health and the additive burden of emerging noncommunicable diseases and injuries. Understanding this changing landscape is an essential starting point for effective allocation of both domestic and international resources for health.	[Sepulveda, Jaime] Univ Calif UC San Francisco, San Francisco, CA 94132 USA; [Murray, Christopher] Univ Washington, IHME, Seattle, WA 98195 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Sepulveda, J (corresponding author), Univ Calif UC San Francisco, San Francisco, CA 94132 USA.	sepulvedaj@globalhealth.ucsf.edu						Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Kassebaum NJ, 2014, LANCET, DOI [10.1016/S0140-6736(14)60696-6, DOI 10.1016/S0140-6736(14)60696-6]; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Murray CJL, 2013, LANCET, V382, P491, DOI 10.1016/S0140-6736(13)61692-X; Murray CJL, 2013, LANCET, V382, P9, DOI 10.1016/S0140-6736(13)60225-1; National Institute on Aging, 2007, US DEP STAT PUBL, V07-6134; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ortblad KF, 2013, LANCET, V381, P105; United Nations, 2013, MILL DEV GOALS REP; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X	14	56	60	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1275	1278		10.1126/science.1257099	http://dx.doi.org/10.1126/science.1257099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214611				2022-12-28	WOS:000341483800043
J	Santos, RD; Watts, GF				Santos, Raul D.; Watts, Gerald F.			Familial hypercholesterolaemia: PCSK9 inhibitors are coming	LANCET			English	Editorial Material							DENSITY-LIPOPROTEIN CHOLESTEROL; PLACEBO-CONTROLLED TRIAL; MONOCLONAL-ANTIBODY; LDL CHOLESTEROL; HEART-DISEASE; AMG 145; EFFICACY; GUIDANCE; SAFETY		[Santos, Raul D.] Univ Sao Paulo, Med Sch Hosp, Heart Inst inCor, Lipid Clin, BR-05403 Sao Paulo, Brazil; [Santos, Raul D.] Univ Sao Paulo, Prevent Med Ctr, BR-05403 Sao Paulo, Brazil; [Santos, Raul D.] Univ Sao Paulo, Hosp Israelita Albert Einstein, Cardiol Program, BR-05403 Sao Paulo, Brazil; [Watts, Gerald F.] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp, Lipid Disorders Clin, Perth, WA 6009, Australia	Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Royal Perth Hospital; University of Western Australia	Santos, RD (corresponding author), Univ Sao Paulo, Med Sch Hosp, Heart Inst inCor, Lipid Clin, BR-05403 Sao Paulo, Brazil.	raul.santos@incor.usp.br	Santos, Raul/A-1170-2010	Santos, Raul/0000-0002-9860-6582; Watts, Gerald/0000-0003-2276-1524				Alonso R, 2014, J AM COLL CARDIOL, V63, P1983, DOI 10.1016/j.jacc.2014.01.063; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Raal FJ, 2014, LANCET; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Raal FJ, 2012, ATHEROSCLEROSIS, V223, P262, DOI 10.1016/j.atherosclerosis.2012.02.019; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; RADER DJ, 1994, J CLIN INVEST, V93, P2758, DOI 10.1172/JCI117292; Ridker PM, 2014, LANCET, V384, P607, DOI 10.1016/S0140-6736(14)61009-6; Santos RD, 2013, LANCET, V381, P1182, DOI 10.1016/S0140-6736(13)60797-7; Seed M, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012011; Sjouke B, 2015, EUR HEART J, V36, P560, DOI 10.1093/eurheartj/ehu058; Stein EA, 2013, CIRCULATION, V128, P2113, DOI 10.1161/CIRCULATIONAHA.113.004678; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; Varbo A, 2013, CIRCULATION, V128, P1298, DOI 10.1161/CIRCULATIONAHA.113.003008; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Watts GF, 2014, INT J CARDIOL, V171, P309, DOI 10.1016/j.ijcard.2013.11.025	22	28	29	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					307	310		10.1016/S0140-6736(14)61702-5	http://dx.doi.org/10.1016/S0140-6736(14)61702-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25282517				2022-12-28	WOS:000348509000005
J	Muppidi, JR; Schmitz, R; Green, JA; Xiao, WM; Larsens, AB; Braun, SE; An, JP; Xu, Y; Rosenwald, A; Ott, G; Gascoyne, RD; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Vaidehi, N; Staudt, LM; Cyster, JG				Muppidi, Jagan R.; Schmitz, Roland; Green, Jesse A.; Xiao, Wenming; Larsens, Adrien B.; Braun, Sterling E.; An, Jinping; Xu, Ying; Rosenwald, Andreas; Ott, German; Gascoyne, Randy D.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.; Weisenburger, Dennis D.; Chan, Wing C.; Vaidehi, Nagarajan; Staudt, Louis M.; Cyster, Jason G.			Loss of signalling via G alpha 13 in germinal centre B-cell-derived lymphoma	NATURE			English	Article							SOMATIC MUTATIONS; PATHOGENESIS; EZH2; EXPRESSION; PHYSIOLOGY; DEFINES; TARGETS; GENOME; PTEN	Germinal centre B-cell-like diffuse large B-cell lymphoma(GCB-DLBCL) is a common malignancy, yet the signalling pathways that are deregulated and the factors leading to its systemic dissemination are poorly defined(1,2). Work in mice showed that sphingosine-1-phosphate receptor-2 (S1PR2), a G alpha 12 and G alpha 13 coupled receptor, promotes growth regulation and local confinement of germinal centre B cells(3,4). Recent deep sequencing studies of GCB-DLBCL have revealed mutations in many genes in this cancer, including in GNA13 (encoding G alpha 13) and S1PR2 (refs 5-7). Here we show, using in vitro and in vivo assays, that GCB-DLBCL-associated mutations occurring in S1PR2 frequently disrupt the receptor's Akt and migration inhibitory functions. G alpha 13-deficient mouse germinal centre B cells and human GCB-DLBCL cells were unable to suppress pAkt and migration in response to S1P, and G alpha 13-deficient mice developed germinal centre B-cell-derived lymphoma. Germinal centre B cells, unlike most lymphocytes, are tightly confined in lymphoid organs and do not recirculate. Remarkably, deficiency in G alpha 13, but not S1PR2, led to germinal centre B-cell dissemination into lymph and blood. GCB-DLBCL cell lines frequently carried mutations in the G alpha 13 effector ARHGEF1, and Arhgef1 deficiency also led to germinal centre B-cell dissemination. The incomplete phenocopy of G alpha 13- and S1PR2 deficiency led us to discover that P2RY8, an orphan receptor that is mutated in GCB-DLBCL and another germinal centre B-cell-derived malignancy, Burkitt's lymphoma, also represses germinal centre B-cell growth and promotes confinement via G alpha 13. These findings identify a G alpha 13-dependent pathway that exerts dual actions in suppressing growth and blocking dissemination of germinal centre B cells that is frequently disrupted in germinal centre B-cell-derived lymphoma.	[Muppidi, Jagan R.; Green, Jesse A.; Braun, Sterling E.; An, Jinping; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Muppidi, Jagan R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Muppidi, Jagan R.; Green, Jesse A.; Braun, Sterling E.; An, Jinping; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Schmitz, Roland; Xiao, Wenming; Staudt, Louis M.] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Larsens, Adrien B.; Vaidehi, Nagarajan] City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA; [Rosenwald, Andreas] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.] British Columbia Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Delabie, Jan] Univ Hosp, Rikshosp, Pathol Clin, N-0372 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Univ Hosp, Rikshosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, N-0310 Oslo, Norway; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, J. R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Weisenburger, Dennis D.] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA; [Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City of Hope; Beckman Research Institute of City of Hope; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Oregon Health & Science University; Cleveland Clinic Foundation; City of Hope; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lstaudt@mail.nih.gov; jason.cyster@ucsf.edu	Smeland, Erlend/AAO-3214-2020; Campo, elias/O-7192-2016; Braun, Sterling/AAO-2622-2021; Campo, Elias/AAC-5593-2019; Staudt, Louis/AAC-5324-2019; Jaffe, Elaine/G-8981-2014; Braun, Sterling/AAN-8900-2021	Campo, elias/0000-0001-9850-9793; Braun, Sterling/0000-0002-5684-3432; Campo, Elias/0000-0001-9850-9793; Muppidi, Jagan/0000-0002-2639-4226; Delabie, Jan/0000-0001-5023-0689	Leukemia & Lymphoma Society; National Institutes of Health (NIH) [T32 DK007636, T32 CA1285835]; Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe); NIH [GM097261, AI45073]; Lymphoma/Leukemia Molecular Profiling Project; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [T32CA128583, R01CA012858, ZIABC011008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097261] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe)(Deutsche Krebshilfe); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma/Leukemia Molecular Profiling Project; NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Coughlin for Gna13f/f and Arhgef1<SUP>-/-</SUP> mice and R. Proia for S1pr2<SUP>-/-</SUP> mice. We thank X. Geng and G. Doitsch for assistance with processing of human tonsil, A. Reboldi for discussion, and T. Arnon and O. Bannard for reading the manuscript. J.R.M. is supported by a Fellow Award from the Leukemia & Lymphoma Society and by National Institutes of Health (NIH) institutional training grants (T32 DK007636 and T32 CA1285835); R.S. is supported by the Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe). N.V. was supported by NIH grant GM097261 for the modelling work. J.G.C. is an Investigator of the Howard Hughes Medical Institute. The human lymphoma samples were studied under the auspices of the Lymphoma/Leukemia Molecular Profiling Project. The work was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and NIH grant AI45073.	Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Cattoretti G, 2009, CANCER RES, V69, P8686, DOI 10.1158/0008-5472.CAN-09-1110; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Francis SA, 2006, BLOOD, V107, P1627, DOI 10.1182/blood-2005-03-1164; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Iqbal J, 2004, AM J PATHOL, V165, P159, DOI 10.1016/S0002-9440(10)63284-1; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rohde M., 2014, GENES CHROMOSOMES CA; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schuetz JM, 2012, LEUKEMIA, V26, P1383, DOI 10.1038/leu.2011.378; Sehn LH, 2011, J CLIN ONCOL, V29, P1452, DOI 10.1200/JCO.2010.33.3419; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	37	197	205	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					254	+		10.1038/nature13765	http://dx.doi.org/10.1038/nature13765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25274307	Green Accepted			2022-12-28	WOS:000346383500047
J	Nathan, C; Cars, O				Nathan, Carl; Cars, Otto			Antibiotic Resistance - Problems, Progress, and Prospects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nathan, Carl] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Cars, Otto] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Cornell University; Uppsala University	Nathan, C (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.							Cars O, 2014, UPSALA J MED SCI, V119, P209, DOI 10.3109/03009734.2014.912700; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Nathan C, 2007, NAT MED, V13, P304, DOI 10.1038/nm0307-304; So AD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1782	4	269	278	5	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1761	1763		10.1056/NEJMp1408040	http://dx.doi.org/10.1056/NEJMp1408040			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS3IH	25271470				2022-12-28	WOS:000344170300002
J	McAuley, DF; Laffey, JG; O'Kane, CM; Perkins, GD; Mullan, B; Trinder, TJ; Johnston, P; Hopkins, PA; Johnston, AJ; McDowell, C; McNally, C				McAuley, Daniel F.; Laffey, John G.; O'Kane, Cecilia M.; Perkins, Gavin D.; Mullan, Brian; Trinder, T. John; Johnston, Paul; Hopkins, Philip A.; Johnston, Andrew J.; McDowell, Cliona; McNally, Christine		HARP-2 Investigators; Irish Critical Care Trials Grp	Simvastatin in the Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LUNG INJURY; REDUCTASE INHIBITION; CLINICAL-TRIAL; INFLAMMATION; MORTALITY; STATINS; SEPSIS	BACKGROUND Studies in animals and in vitro and phase 2 studies in humans suggest that statins may be beneficial in the treatment of the acute respiratory distress syndrome (ARDS). This study tested the hypothesis that treatment with simvastatin would improve clinical outcomes in patients with ARDS. METHODS In this multicenter, double-blind clinical trial, we randomly assigned (in a 1: 1 ratio) patients with an onset of ARDS within the previous 48 hours to receive enteral simvastatin at a dose of 80 mg or placebo once daily for a maximum of 28 days. The primary outcome was the number of ventilator-free days to day 28. Secondary outcomes included the number of days free of nonpulmonary organ failure to day 28, mortality at 28 days, and safety. RESULTS The study recruited 540 patients, with 259 patients assigned to simvastatin and 281 to placebo. The groups were well matched with respect to demographic and baseline physiological variables. There was no significant difference between the study groups in the mean (+/- SD) number of ventilator-free days (12.6 +/- 9.9 with simvastatin and 11.5 +/- 10.4 with placebo, P = 0.21) or days free of nonpulmonary organ failure (19.4 +/- 11.1 and 17.8 +/- 11.7, respectively; P = 0.11) or in mortality at 28 days (22.0% and 26.8%, respectively; P = 0.23). There was no significant difference between the two groups in the incidence of serious adverse events related to the study drug. CONCLUSIONS Simvastatin therapy, although safe and associated with minimal adverse effects, did not improve clinical outcomes in patients with ARDS.	[McAuley, Daniel F.; O'Kane, Cecilia M.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 7AE, Antrim, North Ireland; [McAuley, Daniel F.; Mullan, Brian] Royal Victoria Hosp, Reg Intens Care Unit, Belfast BT12 6BA, Antrim, North Ireland; [McAuley, Daniel F.; McDowell, Cliona; McNally, Christine] Royal Victoria Hosp, Northern Ireland Clin Trials Unit, Belfast BT12 6BA, Antrim, North Ireland; [Trinder, T. John] Ulster Hosp, Intens Care Unit, Belfast, Antrim, North Ireland; [Perkins, Gavin D.] Heart England Natl Hlth Serv NHS Fdn Trust, Birmingham, W Midlands, England; [Perkins, Gavin D.] Univ Warwick, Warwick Med Sch Clin Trials Unit, Warwick, England; [Johnston, Paul] Antrim Area Hosp, Intens Care Unit, Belfast, Antrim, North Ireland; [Hopkins, Philip A.] Kings Coll Hosp London, Crit Care Units, Kings Hlth Partners, London, England; [Johnston, Andrew J.] Cambridge Univ Hosp NHS Fdn Trust, John Farman Intens Care Unit, Cambridge, England; [Laffey, John G.] Natl Univ Ireland, Dept Anaesthesia, Hlth Res Board Galway Clin Res Facil, Sch Med,Clin Sci Inst, Galway, Ireland; [Laffey, John G.] Univ Toronto, St Michaels Hosp, Dept Anesthesia, Ctr Crit Care Res,Keenan Res Ctr Biomed Sci, Toronto, ON, Canada	Queens University Belfast; Heart of England NHS Foundation Trust; University of Warwick; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Cambridge; Ollscoil na Gaillimhe-University of Galway; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	McAuley, DF (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, Hlth Sci Bldg,97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	d.f.mcauley@qub.ac.uk	Cecconi, Maurizio/A-6241-2012; Mellinghoff, Johannes/V-4844-2019; Perkins, Gavin/E-7613-2010; Camporota, Luigi/G-2390-2017	Cecconi, Maurizio/0000-0002-4376-6538; Mellinghoff, Johannes/0000-0002-5455-8953; Laffey, John/0000-0002-1246-9573; Camporota, Luigi/0000-0001-5600-1676; Perkins, Gavin/0000-0003-3027-7548; Breen, Dorothy/0000-0001-5010-4017; Danbury, Chris/0000-0001-7807-0541; McInerney, Veronica/0000-0003-4586-4091; Nichol, Alistair/0000-0002-4689-1238; Agarwal, Banwari/0000-0001-5508-2590; McAuley, Daniel/0000-0002-3283-1947; O'Kane, Cecilia/0000-0002-7138-5396	U.K. Efficacy and Mechanism Evaluation (EME) Programme; MRC [08/99/08]; NIHR [08/99/08]; Health Research Board (HRB), Dublin [HRA_POR-2010-131]; HSC Research and Development Division, Public Health Agency for Northern Ireland; Intensive Care Society of Ireland; Revive; GlaxoSmithKline; Peptinnovate; MRC [MC_G1002460] Funding Source: UKRI; Medical Research Council [MC_G1002460] Funding Source: researchfish; Public Health Agency [COM/4700/12, EAT/3456/06] Funding Source: researchfish	U.K. Efficacy and Mechanism Evaluation (EME) Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Health Research Board (HRB), Dublin; HSC Research and Development Division, Public Health Agency for Northern Ireland; Intensive Care Society of Ireland; Revive; GlaxoSmithKline(GlaxoSmithKline); Peptinnovate; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency	Supported by the U.K. Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership (08/99/08). The EME Programme is funded by the MRC and NIHR, with contributions from the Chief Scientist Office in Scotland, the National Institute for Social Care and Health Research in Wales, and the Health and Social Care (HSC) Research and Development Division, Public Health Agency for Northern Ireland; by a Health Research Award (HRA_POR-2010-131) from the Health Research Board (HRB), Dublin; and by additional funding from the HSC Research and Development Division, Public Health Agency for Northern Ireland, the Intensive Care Society of Ireland, and Revive.; Dr. McAuley reports receiving fees from GlaxoSmithKline for serving on advisory boards, consulting fees from GlaxoSmithKline and Peptinnovate, and clinical-trial support from GlaxoSmithKline paid to his institution; he is also a named inventor on a pending, unlicensed patent for the use of a pharmacotherapy (not a statin) for the treatment of the acute respiratory distress syndrome. Dr. O'Kane reports receiving clinical trial support from GlaxoSmithKline paid to her institution and travel support from AstraZeneca. Dr. Perkins reports receiving fees from GlaxoSmithKline for consulting and for serving on advisory boards. No other potential conflict of interest relevant to this article was reported.	Al Harbi Shmeylan A, 2011, BMC Clin Pharmacol, V11, P12, DOI 10.1186/1472-6904-11-12; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Chiarla C, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.08.006; Craig TR, 2011, AM J RESP CRIT CARE, V183, P620, DOI 10.1164/rccm.201003-0423OC; DRAGE SM, 2009, J INTENSIVE CARE SOC, V10, P61; Felton Tim W, 2009, BMC Res Notes, V2, P77, DOI 10.1186/1756-0500-2-77; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Jaswal DS, 2014, CRIT CARE MED; McAuley DF, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-170; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Shah AI, 2008, CRIT CARE MED, V36, pA15; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806	19	277	291	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1695	1703		10.1056/NEJMoa1403285	http://dx.doi.org/10.1056/NEJMoa1403285			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25268516	Green Published, Bronze			2022-12-28	WOS:000343768500007
J	Suzuki, T; Arumugam, P; Sakagami, T; Lachmann, N; Chalk, C; Sallese, A; Abe, S; Trapnell, C; Carey, B; Moritz, T; Malik, P; Lutzko, C; Wood, RE; Trapnell, BC				Suzuki, Takuji; Arumugam, Paritha; Sakagami, Takuro; Lachmann, Nico; Chalk, Claudia; Sallese, Anthony; Abe, Shuichi; Trapnell, Cole; Carey, Brenna; Moritz, Thomas; Malik, Punam; Lutzko, Carolyn; Wood, Robert E.; Trapnell, Bruce C.			Pulmonary macrophage transplantation therapy	NATURE			English	Article							COLONY-STIMULATING FACTOR; BONE-MARROW-TRANSPLANTATION; RECEPTOR-DEFICIENT MICE; ALVEOLAR PROTEINOSIS; GM-CSF; TISSUE MACROPHAGES; GENE-THERAPY; MOUSE MODEL; STEM-CELLS; LUNG	Bone-marrow transplantation is an effective cell therapy but requires myeloablation, which increases infection risk and mortality. Recent lineage-tracing studies documenting that resident macrophage populations self-maintain independently of haematological progenitors prompted us to consider organ-targeted, cell-specific therapy. Here, using granulocytemacrophage colony-stimulating factor (GM-CSF) receptor-beta-deficient (Csf2rb(-/-)) mice that develop a myeloid cell disorder identical to hereditary pulmonary alveolar proteinosis (hPAP) in children with CSF2RA or CSF2RB mutations, we show that pulmonary macrophage transplantation (PMT) of either wild-type or Csf2rb-gene-corrected macrophages without myeloablation was safe and well-tolerated and that one administration corrected the lung disease, secondary systemic manifestations and normalized disease-related biomarkers, and prevented disease-specific mortality. PMT-derived alveolar macrophages persisted for at least one year as did therapeutic effects. Our findings identify mechanisms regulating alveolar macrophage population size in health and disease, indicate that GM-CSF is required for phenotypic determination of alveolar macrophages, and support translation of PMT as the first specific therapy for children with hPAP.	[Suzuki, Takuji; Sakagami, Takuro; Chalk, Claudia; Sallese, Anthony; Abe, Shuichi; Carey, Brenna; Trapnell, Bruce C.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Pulm Biol, Cincinnati, OH 45229 USA; [Arumugam, Paritha; Malik, Punam; Lutzko, Carolyn] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; [Lachmann, Nico; Moritz, Thomas] Hannover Med Sch, Inst Expt Hematol, RG Reprograming & Gene Therapy, D-30625 Hannover, Germany; [Trapnell, Cole] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Trapnell, Cole] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA 02138 USA; [Wood, Robert E.; Trapnell, Bruce C.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; [Trapnell, Bruce C.] Univ Cincinnati, Med Ctr, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Hannover Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Trapnell, BC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Takuji.Suzuki@cchmc.org; Bruce.Trapnell@cchmc.org	Lachmann, Nico/H-6219-2017	Lachmann, Nico/0000-0002-4245-1497; Malik, Punam/0000-0002-8942-2108	NIH [R01 HL085453, R21 HL106134, R01HL118342, 8UL1TR000077-05, AR-47363, DK78392, DK90971]; American Thoracic Society Foundation Unrestricted Research Grant; CCHMC Foundation Trustee Grant; Deutsche Forschungsgemeinschaft (DFG) [Exc 62/1]; Else Kroner-Fresenius Stiftung; Eva-Luise Koehler Research Prize for Rare Diseases; Pulmonary Biology Division, CCHMC; Grants-in-Aid for Scientific Research [26461498] Funding Source: KAKEN; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118342, R01HL069549, R01HL085453, U54HL127672, R21HL106134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971, P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society Foundation Unrestricted Research Grant; CCHMC Foundation Trustee Grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung; Eva-Luise Koehler Research Prize for Rare Diseases; Pulmonary Biology Division, CCHMC; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (R01 HL085453, R21 HL106134, R01HL118342, 8UL1TR000077-05, AR-47363, DK78392, DK90971), American Thoracic Society Foundation Unrestricted Research Grant, CCHMC Foundation Trustee Grant, Deutsche Forschungsgemeinschaft (DFG; Cluster of Excellence Rebirth; Exc 62/1), the Else Kroner-Fresenius Stiftung, the Eva-Luise Koehler Research Prize for Rare Diseases 2013, and by the Pulmonary Biology Division, CCHMC. Flow cytometric data were acquired within the Research Flow Cytometry Core in the Division of Rheumatology, CCHMC. We thank our hPAP patients and their family members in the United States and internationally for their collaboration; J. Whitsett (CCHMC) and F. McCormack (UCMC) for critical reading of the manuscript; J. Krischer (University of South Florida) and Y. Maeda (CCHMC) for helpful discussions; S. Wert for help with lung histology; and D. Black, K. Link and C. Fox (CCHMC), and S. Brennig and H. Kempf (Hannover Medical School) for their technical help.	Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Arumugam PI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006995; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Bonfield TL, 2003, AM J RESP CELL MOL, V29, P677, DOI 10.1165/rcmb.2003-0148OC; Bonfield TL, 2003, AM J PHYSIOL-LUNG C, V285, pL1132, DOI 10.1152/ajplung.00216.2003; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Faust N, 2000, BLOOD, V96, P719; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GODLESKI JJ, 1972, J EXP MED, V136, P630, DOI 10.1084/jem.136.3.630; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hawgood S, 2001, ANNU REV PHYSIOL, V63, P495, DOI 10.1146/annurev.physiol.63.1.495; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Iyonaga K, 1999, EUR RESPIR J, V14, P383, DOI 10.1034/j.1399-3003.1999.14b24.x; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; Kleff V, 2008, MOL THER, V16, P757, DOI 10.1038/mt.2008.7; Lachmann N, 2014, AM J RESP CRIT CARE, V189, P167, DOI 10.1164/rccm.201306-1012OC; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; Matute-Bello G, 2004, J IMMUNOL METHODS, V292, P25, DOI 10.1016/j.jim.2004.05.010; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nishinakamura R, 1996, J EXP MED, V183, P2657, DOI 10.1084/jem.183.6.2657; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Perumbeti A, 2009, BLOOD, V114, P1174, DOI 10.1182/blood-2009-01-201863; Richard E, 2001, MOL THER, V4, P331, DOI 10.1006/mthe.2001.0467; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Sakagami T, 2010, AM J RESP CRIT CARE, V182, P49, DOI 10.1164/rccm.201001-0008OC; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; STRADLING JR, 1981, THORAX, V36, P321, DOI 10.1136/thx.36.5.321; Suzuki T, 2011, EUR RESPIR J, V37, P201, DOI 10.1183/09031936.00090610; Suzuki T, 2014, AM J RESP CRIT CARE, V189, P183, DOI 10.1164/rccm.201306-1039OC; Suzuki T, 2010, AM J RESP CRIT CARE, V182, P1292, DOI 10.1164/rccm.201002-0271OC; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Tanaka T, 2011, J MED GENET, V48, P205, DOI 10.1136/jmg.2010.082586; Thomassen MJ, 2007, J LIPID RES, V48, P2762, DOI 10.1194/jlr.P700022-JLR200; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Walters DM, 2001, AM J RESP CRIT CARE, V164, P1438, DOI 10.1164/ajrccm.164.8.2007121; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Wu M, 2001, P NATL ACAD SCI USA, V98, P14589, DOI 10.1073/pnas.251451498; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoshida M, 2001, AM J PHYSIOL-LUNG C, V280, pL379, DOI 10.1152/ajplung.2001.280.3.L379; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	54	191	199	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					450	+		10.1038/nature13807	http://dx.doi.org/10.1038/nature13807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25274301	Green Submitted, Green Accepted			2022-12-28	WOS:000343775900031
J	Collen, B; Nicholson, E				Collen, Ben; Nicholson, Emily			Taking the measure of change	SCIENCE			English	Editorial Material							INDICATORS		[Collen, Ben] UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England; [Nicholson, Emily] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	University of London; University College London; University of Melbourne	Collen, B (corresponding author), UCL, Ctr Biodivers & Environm Res, Mortimer St, London WC1E 6BT, England.	b.collen@ucl.ac.uk	Nicholson, Emily/H-9001-2013; Collen, Ben/F-2543-2016	Nicholson, Emily/0000-0003-2199-3446; Collen, Ben/0000-0003-2564-4243				Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Buckland S. T., 2011, Ecosphere, V2, part100, DOI 10.1890/ES11-00186.1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Kelly LT, 2015, CONSERV BIOL, V29, P473, DOI 10.1111/cobi.12384; Link JS, 2010, ICES J MAR SCI, V67, P787, DOI 10.1093/icesjms/fsp258; Mace GM, 2005, BIODIVERSITY MILLENN; Mccarthy MA, 2014, CONSERV BIOL, V28, P1575, DOI 10.1111/cobi.12308; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; Nicholson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041128; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Secretariat of the Convention on Biological Diversity, 2010, GLOBAL BIODIVERSITY, P3; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484	14	50	52	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					166	167		10.1126/science.1255772	http://dx.doi.org/10.1126/science.1255772			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25278506				2022-12-28	WOS:000342721500021
J	Howes, PD; Chandrawati, R; Stevens, MM				Howes, Philip D.; Chandrawati, Rona; Stevens, Molly M.			Colloidal nanoparticles as advanced biological sensors	SCIENCE			English	Review							RESONANCE ENERGY-TRANSFER; SEMICONDUCTOR QUANTUM DOTS; ENHANCED RAMAN-SCATTERING; MESSENGER-RNA DETECTION; NANO-BIO INTERFACE; SYNCHROTRON X-RAY; GOLD NANOPARTICLES; NANOCRYSTAL GROWTH; LIVE CELLS; POLYMER NANOPARTICLES	Colloidal nanoparticle biosensors have received intense scientific attention and offer promising applications in both research and medicine. We review the state of the art in nanoparticle development, surface chemistry, and biosensing mechanisms, discussing how a range of technologies are contributing toward commercial and clinical translation. Recent examples of success include the ultrasensitive detection of cancer biomarkers in human serum and in vivo sensing of methyl mercury. We identify five key materials challenges, including the development of robust mass-scale nanoparticle synthesis methods, and five broader challenges, including the use of simulations and bioinformatics-driven experimental approaches for predictive modeling of biosensor performance. The resultant generation of nanoparticle biosensors will form the basis of high-performance analytical assays, effective multiplexed intracellular sensors, and sophisticated in vivo probes.	[Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, Dept Bioengn, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England	Imperial College London; Imperial College London	Stevens, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Dept Bioengn, London SW7 2AZ, England.	m.stevens@imperial.ac.uk	Chandrawati, Rona/F-3336-2013; Howes, Philip D./U-8901-2017	Chandrawati, Rona/0000-0002-9780-8844; Howes, Philip D./0000-0002-1862-8395	Medical Research Council (MRC); Engineering and Physical Sciences Research Council (EPSRC); Marie Curie International Incoming Fellowship within 7th European Community Framework Programme [PIIF-GA-2011-299936]; EPSRC through Interdisciplinary Research Centre (IRC) [EP/K031953/1, EP/K020641/1]; EPSRC [EP/K020641/1, EP/K031953/1] Funding Source: UKRI; MRC [MC_PC_12015, MC_PC_13064] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K031953/1, EP/K020641/1] Funding Source: researchfish; Medical Research Council [MC_PC_13064, MC_PC_12015] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Curie International Incoming Fellowship within 7th European Community Framework Programme; EPSRC through Interdisciplinary Research Centre (IRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Gattinoni, J. Levitt, D. Howes, M. Thomas, R. Bain, M. Green, B. Pierce, F. Stellacci, A. J. de Mello, L. M. Liz-Marzan, and I. Yarovsky for useful discussions and feedback. P. H. acknowledges support from the Medical Research Council (MRC) and the Engineering and Physical Sciences Research Council (EPSRC). R. C. acknowledges the support of Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme (PIIF-GA-2011-299936). M. M. S. acknowledges support from EPSRC through the Interdisciplinary Research Centre (IRC) "Early-Warning Sensing Systems for Infectious Diseases" (EP/K031953/1) and research grant "Bio-functionalised Nanomaterials for Ultrasensitive Biosensing" (EP/K020641/1).	Aldeek F, 2013, ACS NANO, V7, P10197, DOI 10.1021/nn404479h; Algar WR, 2014, COORDIN CHEM REV, V263, P65, DOI 10.1016/j.ccr.2013.07.015; Algar WR, 2012, J AM CHEM SOC, V134, P1876, DOI 10.1021/ja210162f; Alhasan AH, 2012, ANAL CHEM, V84, P4153, DOI 10.1021/ac3004055; Barnard AS, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/8/086502; Barnard AS, 2013, CRYST GROWTH DES, V13, P5433, DOI 10.1021/cg401397y; Boeneman K, 2013, ACS NANO, V7, P3778, DOI 10.1021/nn400702r; Bremholm M, 2009, ANGEW CHEM INT EDIT, V48, P4788, DOI 10.1002/anie.200901048; Chan EM, 2010, NANO LETT, V10, P1874, DOI 10.1021/nl100669s; Chandrawati R, 2014, CHEM COMMUN, V50, P5431, DOI 10.1039/c4cc00572d; Charbonniere LJ, 2008, EUR J INORG CHEM, P3241, DOI 10.1002/ejic.200800332; Chen Q, 2013, NANO LETT, V13, P4556, DOI 10.1021/nl402694n; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Cortie MB, 2011, CHEM REV, V111, P3713, DOI 10.1021/cr1002529; Cutler JI, 2012, J AM CHEM SOC, V134, P1376, DOI 10.1021/ja209351u; Degliangeli F, 2014, J AM CHEM SOC, V136, P2264, DOI 10.1021/ja412152x; Delehanty JB, 2012, ANAL CHIM ACTA, V750, P63, DOI 10.1016/j.aca.2012.05.032; DeSantis CJ, 2013, J PHYS CHEM LETT, V4, P3072, DOI 10.1021/jz4011866; Ding CQ, 2014, ACCOUNTS CHEM RES, V47, P20, DOI 10.1021/ar400023s; Duan HW, 2010, CHEM MATER, V22, P4372, DOI 10.1021/cm100442x; Elvira KS, 2013, NAT CHEM, V5, P905, DOI [10.1038/NCHEM.1753, 10.1038/nchem.1753]; Feng S, 2014, ACS NANO, V8, P3069, DOI 10.1021/nn500614k; Feng W, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.63; Fischler M, 2008, CHEM COMMUN, P169, DOI 10.1039/b715602b; Gagner JE, 2012, J PHYS CHEM LETT, V3, P3149, DOI 10.1021/jz301253s; Garcia KP, 2014, SMALL, V10, P2516, DOI 10.1002/smll.201303540; Geissler D, 2013, J AM CHEM SOC, V135, P1102, DOI 10.1021/ja310317n; Gemmill KB, 2013, ANAL BIOANAL CHEM, V405, P6145, DOI 10.1007/s00216-013-6982-2; Ghadiali JE, 2011, ANGEW CHEM INT EDIT, V50, P3417, DOI 10.1002/anie.201008263; Giri S, 2011, ACS NANO, V5, P1580, DOI 10.1021/nn102873w; Gole A, 2008, LANGMUIR, V24, P266, DOI 10.1021/la7026303; Gomez-Grana S, 2013, J PHYS CHEM LETT, V4, P2209, DOI 10.1021/jz401269w; Gravel E, 2013, CHEM SCI, V4, P411, DOI 10.1039/c2sc21113k; Grzelczak M, 2013, LANGMUIR, V29, P4652, DOI 10.1021/la4001544; Gupta S, 2010, SMALL, V6, P1509, DOI 10.1002/smll.201000099; Hakkinen H, 2012, NAT CHEM, V4, P443, DOI [10.1038/NCHEM.1352, 10.1038/nchem.1352]; Han HS, 2010, J AM CHEM SOC, V132, P7838, DOI 10.1021/ja101677r; Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258; Howes P, 2010, J AM CHEM SOC, V132, P3989, DOI 10.1021/ja1002179; Howes PD, 2014, CHEM SOC REV, V43, P3835, DOI 10.1039/c3cs60346f; Hung A, 2013, CHEM SCI, V4, P928, DOI 10.1039/c2sc21639f; Jin ZW, 2012, TRENDS BIOTECHNOL, V30, P394, DOI 10.1016/j.tibtech.2012.04.005; Kang T, 2010, NANO LETT, V10, P1189, DOI 10.1021/nl1000086; Kim D, 2009, ANAL CHEM, V81, P9183, DOI 10.1021/ac9018389; Kuo CH, 2011, ADV FUNCT MATER, V21, P792, DOI 10.1002/adfm.201002108; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Laromaine A, 2007, J AM CHEM SOC, V129, P4156, DOI 10.1021/ja0706504; Liao HG, 2013, CHEM COMMUN, V49, P11720, DOI 10.1039/c3cc47473a; Liao HG, 2013, J AM CHEM SOC, V135, P5038, DOI 10.1021/ja310612p; Lignos I, 2014, CHEM MATER, V26, P2975, DOI 10.1021/cm500774p; Liu WH, 2010, J AM CHEM SOC, V132, P472, DOI 10.1021/ja908137d; Liu Y, 2013, J AM CHEM SOC, V135, P9869, DOI 10.1021/ja403798m; Lowe SB, 2012, ACS NANO, V6, P851, DOI 10.1021/nn204361s; Makarucha AJ, 2011, EUR BIOPHYS J BIOPHY, V40, P103, DOI 10.1007/s00249-010-0651-6; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; Medintz IL, 2006, NAT MATER, V5, P581, DOI 10.1038/nmat1676; Medintz IL, 2010, NAT MATER, V9, P676, DOI [10.1038/NMAT2811, 10.1038/nmat2811]; Meena SK, 2013, LANGMUIR, V29, P14954, DOI 10.1021/la403843n; Mei BC, 2009, NAT PROTOC, V4, P412, DOI 10.1038/nprot.2008.243; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Ock K, 2012, ANAL CHEM, V84, P2172, DOI 10.1021/ac2024188; Oh E, 2013, PART PART SYST CHAR, V30, P453, DOI 10.1002/ppsc.201200140; Pan W, 2013, ANAL CHEM, V85, P10581, DOI 10.1021/ac402700s; Peng F, 2014, ACCOUNTS CHEM RES, V47, P612, DOI 10.1021/ar400221g; Peng S, 2012, J PHYS CHEM C, V116, P11842, DOI 10.1021/jp304557p; Petershans A, 2011, CHEM COMMUN, V47, P10671, DOI 10.1039/c1cc12874d; Petryayeva E, 2014, ANAL CHEM, V86, P3195, DOI 10.1021/ac500131r; Prigodich AE, 2012, ANAL CHEM, V84, P2062, DOI 10.1021/ac202648w; Pu KY, 2014, NAT NANOTECHNOL, V9, P233, DOI [10.1038/NNANO.2013.302, 10.1038/nnano.2013.302]; Rodriguez-Lorenzo L, 2012, NAT MATER, V11, P604, DOI [10.1038/NMAT3337, 10.1038/nmat3337]; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Samal AK, 2013, LANGMUIR, V29, P15076, DOI 10.1021/la403707j; Sanles-Sobrido M, 2009, NANOSCALE, V1, P153, DOI 10.1039/b9nr00059c; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Sun YG, 2013, PART PART SYST CHAR, V30, P399, DOI 10.1002/ppsc.201300033; Susumu K, 2011, J AM CHEM SOC, V133, P9480, DOI 10.1021/ja201919s; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Tomczak N, 2013, NANOSCALE, V5, P12018, DOI 10.1039/c3nr03949h; Tonga GY, 2014, ADV MATER, V26, P359, DOI 10.1002/adma.201303001; Treuel L, 2014, ACS NANO, V8, P503, DOI 10.1021/nn405019v; Tyrakowski CM, 2014, PHYS CHEM CHEM PHYS, V16, P837, DOI 10.1039/c3cp53502a; Valencia PM, 2012, NAT NANOTECHNOL, V7, P623, DOI 10.1038/nnano.2012.168; Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q; Wang XH, 2010, BIOSENS BIOELECTRON, V26, P404, DOI 10.1016/j.bios.2010.07.121; Wegner KD, 2013, ACS NANO, V7, P7411, DOI 10.1021/nn403253y; Woehl TJ, 2014, NANO LETT, V14, P373, DOI 10.1021/nl4043328; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zamaleeva AI, 2014, NANO LETT, V14, P2994, DOI 10.1021/nl500733g; Zhan NQ, 2013, J AM CHEM SOC, V135, P13786, DOI 10.1021/ja405010v; Zhan NQ, 2013, ACS APPL MATER INTER, V5, P2861, DOI 10.1021/am302788q; Zhang M, 2013, ANALYST, V138, P4812, DOI 10.1039/c3an00666b; Zhang PF, 2012, J AM CHEM SOC, V134, P8388, DOI 10.1021/ja302367s; Zhang Y, 2006, ANGEW CHEM INT EDIT, V45, P4936, DOI 10.1002/anie.200601197; Zhang Y, 2012, ANAL CHEM, V84, P224, DOI 10.1021/ac202405q; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104; Zhong HZ, 2012, J PHYS CHEM LETT, V3, P3167, DOI 10.1021/jz301345x; Zhou WZ, 2014, ANALYST, V139, P2627, DOI 10.1039/c4an00132j	104	723	728	55	1902	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					53	+	1247390	10.1126/science.1247390	http://dx.doi.org/10.1126/science.1247390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278614	Green Submitted			2022-12-28	WOS:000342446900045
J	Krueger, AB; Stone, AA				Krueger, Alan B.; Stone, Arthur A.			Progress in measuring subjective well-being	SCIENCE			English	Editorial Material							STRESSORS; HEALTH; LIFE; PAIN		[Krueger, Alan B.] Princeton Univ, Princeton, NJ 08540 USA; [Krueger, Alan B.] NBER, Cambridge, MA 02138 USA; [Stone, Arthur A.] Univ So Calif, Los Angeles, CA 90089 USA	Princeton University; National Bureau of Economic Research; University of Southern California	Krueger, AB (corresponding author), Princeton Univ, Princeton, NJ 08540 USA.	akrueger@princeton.edu	Stone, Arthur A./AAC-3610-2019		NATIONAL INSTITUTE ON AGING [R01AG040629, P30AG024928, P01AG005842, R01AG042407] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG042407, P30AG024928, P01AG05842, R01AG042407, P01 AG005842, R01AG0406629, P30 AG024928, R01 AG040629] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bartoshuk L, 2014, PERSPECT PSYCHOL SCI, V9, P91, DOI 10.1177/1745691613512660; Benjamin DJ, 2014, AM ECON REV, V104, P2698, DOI 10.1257/aer.104.9.2698; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Cohen S, 2003, BRAIN BEHAV IMMUN, V17, P407, DOI 10.1016/S0889-1591(03)00110-7; Diener E, 2013, PERSPECT PSYCHOL SCI, V8, P663, DOI 10.1177/1745691613507583; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Kapteyn A, 2007, AM ECON REV, V97, P461, DOI 10.1257/aer.97.1.461; Krueger A. B., 2009, MEASURING SUBJECTIVE; Ludwig J, 2013, AM ECON REV, V103, P226, DOI 10.1257/aer.103.3.226; Luhmann M, 2012, J PERS SOC PSYCHOL, V102, P592, DOI 10.1037/a0025948; O'Donnel G., 2013, WELLBEING POLICY; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stone AA, 2014, SUBJECTIVE WELL BEIN; Ubel PA, 2010, QUAL LIFE RES, V19, P465, DOI 10.1007/s11136-010-9592-x	16	51	51	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					42	43		10.1126/science.1256392	http://dx.doi.org/10.1126/science.1256392			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ0BR	25278602	Green Accepted			2022-12-28	WOS:000342446900027
J	Lam, FH; Ghaderi, A; Fink, GR; Stephanopoulos, G				Lam, Felix H.; Ghaderi, Adel; Fink, Gerald R.; Stephanopoulos, Gregory			Engineering alcohol tolerance in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ETHANOL TOLERANCE; GENES; PH; IDENTIFICATION; MEMBRANE; BILAYER; STRESS	Ethanol toxicity in the yeast Saccharomyces cerevisiae limits titer and productivity in the industrial production of transportation bioethanol. We show that strengthening the opposing potassium and proton electrochemical membrane gradients is a mechanism that enhances general resistance to multiple alcohols. The elevation of extracellular potassium and pH physically bolsters these gradients, increasing tolerance to higher alcohols and ethanol fermentation in commercial and laboratory strains (including a xylose-fermenting strain) under industrial-like conditions. Production per cell remains largely unchanged, with improvements deriving from heightened population viability. Likewise, up-regulation of the potassium and proton pumps in the laboratory strain enhances performance to levels exceeding those of industrial strains. Although genetically complex, alcohol tolerance can thus be dominated by a single cellular process, one controlled by a major physicochemical component but amenable to biological augmentation.	[Lam, Felix H.; Ghaderi, Adel; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Lam, Felix H.; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; gregstep@mit.edu		Lam, Felix/0000-0001-6585-3360	MIT Energy Initiative; U.S. Department of Energy [DE-SC0008744]; National Institutes of Health [R01-GM035010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010] Funding Source: NIH RePORTER	MIT Energy Initiative; U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to present and former members of the Fink and Stephanopoulos labs for intellectual and technical guidance. Additionally, we thank V. Vyas and D. Pincus for critical commentary on the manuscript and Phibro for the gift of Lesaffre Ethanol Red. Support was provided by the MIT Energy Initiative and U.S. Department of Energy grant DE-SC0008744 to G. S. and National Institutes of Health grant R01-GM035010 to G. R. F. No competing financial interests impinged on this study. F. H. L., G. R. F., and G. S. are listed as co-inventors on a patent application filed by MIT and the Whitehead Institute. F. H. L., G. R. F., and G. S. designed all experiments and collaborated on the manuscript; A. G. conducted all bioreactor studies; and F. H. L. performed all other experiments, strain construction, and analysis of data. Supporting data are available in the supplementary materials.	Akao T, 2011, DNA RES, V18, P423, DOI 10.1093/dnares/dsr029; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Bai FW, 2004, J BIOTECHNOL, V110, P287, DOI 10.1016/j.jbiotec.2004.01.017; Cartwright C. P., 1986, MICROBIOLOGY, V132, P369; Chanda J, 2006, LANGMUIR, V22, P3775, DOI 10.1021/la053398r; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; Demain AL, 2009, J IND MICROBIOL BIOT, V36, P319, DOI 10.1007/s10295-008-0521-8; Dickey AN, 2007, BIOPHYS J, V92, P2366, DOI 10.1529/biophysj.106.097022; Horak J, 1997, BBA-REV BIOMEMBRANES, V1331, P41, DOI 10.1016/S0304-4157(96)00015-9; Katou T, 2009, J BIOSCI BIOENG, V107, P383, DOI 10.1016/j.jbiosc.2008.12.014; Lewis JA, 2010, GENETICS, V186, P1197, DOI 10.1534/genetics.110.121871; Madeira A, 2010, FEMS YEAST RES, V10, P252, DOI 10.1111/j.1567-1364.2010.00607.x; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Orij R, 2011, BBA-GEN SUBJECTS, V1810, P933, DOI 10.1016/j.bbagen.2011.03.011; Pais TM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003548; Reisser C., 2013, G3; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920; Zhou H, 2012, METAB ENG, V14, P611, DOI 10.1016/j.ymben.2012.07.011	25	125	134	7	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					71	75		10.1126/science.1257859	http://dx.doi.org/10.1126/science.1257859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25278607	Green Accepted, Green Submitted			2022-12-28	WOS:000342446900052
J	Behforouz, HL; Drain, PK; Rhatigan, JJ				Behforouz, Heidi L.; Drain, Paul K.; Rhatigan, Joseph J.			BECOMING A PHYSICIAN Rethinking the Social History	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Behforouz, Heidi L.; Rhatigan, Joseph J.] Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, Boston, MA 02115 USA; [Drain, Paul K.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Drain, Paul K.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Behforouz, Heidi L.; Drain, Paul K.; Rhatigan, Joseph J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Behforouz, HL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.							DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Haist SA, 2013, JAMA-J AM MED ASSOC, V310, P2245, DOI 10.1001/jama.2013.282328; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; Wilkinson RG, 2003, SOCIAL DETERMINANTS	5	67	68	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1277	1279		10.1056/NEJMp1404846	http://dx.doi.org/10.1056/NEJMp1404846			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP9VS	25271600				2022-12-28	WOS:000342429800003
J	Mortlock, D				Mortlock, Daniel			ASTRONOMY The age of the quasars	NATURE			English	Editorial Material							DIGITAL-SKY-SURVEY; 3C 273; LUMINOSITY		[Mortlock, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Mortlock, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England	Imperial College London; Imperial College London	Mortlock, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England.	d.mortlock@imperial.ac.uk			Science and Technology Facilities Council [ST/K001051/1] Funding Source: researchfish; STFC [ST/K001051/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Carilli CL, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/120; Casey CM, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/139; Fan XH, 2001, ASTRON J, V122, P2833, DOI 10.1086/324111; HAZARD C, 1963, NATURE, V197, P1037, DOI 10.1038/1971037a0; REES MJ, 1984, ANNU REV ASTRON ASTR, V22, P471, DOI 10.1146/annurev.aa.22.090184.002351; Richards GT, 2006, ASTRON J, V131, P2766, DOI 10.1086/503559; SCHMIDT M, 1963, NATURE, V197, P1040, DOI 10.1038/1971040a0; Vardanyan V, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/88	8	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					43	44		10.1038/514043a	http://dx.doi.org/10.1038/514043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25279915				2022-12-28	WOS:000342420800030
J	Attanasio, OP; Fernandez, C; Fitzsimons, EOA; Grantham-McGregor, SM; Meghir, C; Rubio-Codina, M				Attanasio, Orazio P.; Fernandez, Camila; Fitzsimons, Emla O. A.; Grantham-McGregor, Sally M.; Meghir, Costas; Rubio-Codina, Marta			Using the infrastructure of a conditional cash transfer program to deliver a scalable integrated early child development program in Colombia: cluster randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERELY MALNOURISHED CHILDREN; MIDDLE-INCOME COUNTRIES; PSYCHOSOCIAL STIMULATION; NUTRITIONAL SUPPLEMENTATION; JAMAICAN CHILDREN; INTERVENTION; GROWTH; ADULTS; TERM; MICRONUTRIENTS	Objective To assess the effectiveness of an integrated early child development intervention, combining stimulation and micronutrient supplementation and delivered on a large scale in Colombia, for children's development, growth, and hemoglobin levels. Design Cluster randomized controlled trial, using a 2x2 factorial design, with municipalities assigned to one of four groups: psychosocial stimulation, micronutrient supplementation, combined intervention, or control. Setting 96 municipalities in Colombia, located across eight of its 32 departments. Participants 1420 children aged 12-24 months and their primary carers. Intervention Psychosocial stimulation (weekly home visits with play demonstrations), micronutrient sprinkles given daily, and both combined. All delivered by female community leaders for 18 months. Main outcome measures Cognitive, receptive and expressive language, and fine and gross motor scores on the Bayley scales of infant development-III; height, weight, and hemoglobin levels measured at the baseline and end of intervention. Results Stimulation improved cognitive scores (adjusted for age, sex, testers, and baseline levels of outcomes) by 0.26 of a standard deviation (P = 0.002). Stimulation also increased receptive language by 0.22 of a standard deviation (P = 0.032). Micronutrient supplementation had no significant effect on any outcome and there was no interaction between the interventions. No intervention affected height, weight, or hemoglobin levels. Conclusions Using the infrastructure of a national welfare program we implemented the integrated early child development intervention on a large scale and showed its potential for improving children's cognitive development. We found no effect of supplementation on developmental or health outcomes. Moreover, supplementation did not interact with stimulation. The implementation model for delivering stimulation suggests that it may serve as a promising blueprint for future policy on early childhood development.	[Attanasio, Orazio P.] UCL, Dept Econ, London, England; [Fernandez, Camila] Math Policy Res, Princeton, NJ USA; [Fitzsimons, Emla O. A.] Inst Educ, London WC1H 0AL, England; [Grantham-McGregor, Sally M.] UCL Inst Child Hlth, London, England; [Meghir, Costas] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Rubio-Codina, Marta] Ctr Evaluat Dev Policy, Inst Fiscal Studies, London, England	University of London; University College London; Mathematica; University of London; University College London; University of London; University College London; Yale University; University of London; London School Economics & Political Science	Fitzsimons, EOA (corresponding author), Inst Educ, London WC1H 0AL, England.	e.fitzsimons@ioe.ac.uk			Economic and Social Research Council [RES-062-23-1548]; Inter-American Development Bank; World Bank; International Growth Center; ESRC [ES/H021221/1, ES/K010700/1] Funding Source: UKRI; Economic and Social Research Council [ES/G040923/1, ES/H021221/1, ES/K010700/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Inter-American Development Bank; World Bank(The World Bank India); International Growth Center; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by the Economic and Social Research Council (grant RES-062-23-1548), Inter-American Development Bank, World Bank, and International Growth Center.	Allen LH, 2009, J NUTR, V139, P1022, DOI 10.3945/jn.107.086199; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Attanasio O., 2013, ENRICHING HOME ENV L; Attanasio O, 2004, ECON HUM BIOL, V2, P411, DOI 10.1016/j.ehb.2004.10.005; Attanasio O, 2010, ECON DEV CULT CHANGE, V58, P181, DOI 10.1086/648188; AZEVEDO VIVIANE M. R, 2010, RAE, V25, P7; Bayley N., 2019, BAYLEY SCALES INFANT; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Cunha F, 2013, HDB DEV SYSTEMS THEO, P221; Cunha F, 2010, ECONOMETRICA, V78, P883, DOI 10.3982/ECTA6551; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Frongillo EA, UNICEF PSYCHOSOCIAL; Gardner JMM, 2005, AM J CLIN NUTR, V82, P399, DOI 10.1093/ajcn/82.2.399; Gertler P, 2014, SCIENCE, V344, P998, DOI 10.1126/science.1251178; Giovannini M, 2006, J PEDIATR GASTR NUTR, V42, P306, DOI 10.1097/01.mpg.0000189363.07040.4b; GONZALEZ VM, 1995, ARTHRITIS RHEUM-US, V38, P1429, DOI 10.1002/art.1780381010; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Grantham-McGregor SM, 2014, ANN NY ACAD SCI, V1308, P11, DOI 10.1111/nyas.12284; GRANTHAMMCGREGOR S, 1994, CHILD DEV, V65, P428; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Hamadani JD, 2006, J NUTR, V136, P2645, DOI 10.1093/jn/136.10.2645; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Instituto Colombiano de Bienestar Familiar, 2011, ENC NAC SIT NUTR ENS; Nahar B, 2012, EUR J CLIN NUTR, V66, P701, DOI 10.1038/ejcn.2012.13; POWELL C, 1989, Pediatrics, V84, P157; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Romano JP, 2005, ECONOMETRICA, V73, P1237, DOI 10.1111/j.1468-0262.2005.00615.x; Romano JR, 2005, J AM STAT ASSOC, V100, P94, DOI 10.1198/016214504000000539; Rubio-Codina M, 2014, J HUMAN RES IN PRESS; Schauer Claudia, 2003, Paediatr Child Health, V8, P87; Sharieff W, 2006, PUBLIC HEALTH NUTR, V9, P336, DOI 10.1079/PHN2006841; Tondeur WC, 2004, AM J CLIN NUTR, V80, P1436, DOI 10.1093/ajcn/80.5.1436; WABER DP, 1981, AM J CLIN NUTR, V34, P807, DOI 10.1093/ajcn/34.4.807; Walker SP, 2006, BRIT MED J, V333, P472, DOI 10.1136/bmj.38897.555208.2F; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Walker SP, 2011, PEDIATRICS, V127, P849, DOI 10.1542/peds.2010-2231; Walker SP, 2010, DEV MED CHILD NEUROL, V52, pe148, DOI 10.1111/j.1469-8749.2010.03637.x; Yousafzai AK, 2014, ANN NY ACAD SCI, V1308, P33, DOI 10.1111/nyas.12313; Zlotkin S, 2001, AM J CLIN NUTR, V74, P791; Zlotkin SH, 2005, PLOS MED, V2, P24, DOI 10.1371/journal.pmed.0020001	40	77	82	3	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2014	349								g5785	10.1136/bmj.g5785	http://dx.doi.org/10.1136/bmj.g5785			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ3BT	25266222	Green Published, hybrid			2022-12-28	WOS:000342664400002
J	Yagishita, S; Hayashi-Takagi, A; Ellis-Davies, GCR; Urakubo, H; Ishii, S; Kasai, H				Yagishita, Sho; Hayashi-Takagi, Akiko; Ellis-Davies, Graham C. R.; Urakubo, Hidetoshi; Ishii, Shin; Kasai, Haruo			A critical time window for dopamine actions on the structural plasticity of dendritic spines	SCIENCE			English	Article							LONG-TERM POTENTIATION; CELLULAR MECHANISM; NEURONS; ACTIVATION; EXPRESSION; PROTEINS; APLYSIA; CALCIUM; CAMKII	Animal behaviors are reinforced by subsequent rewards following within a narrow time window. Such reward signals are primarily coded by dopamine, which modulates the synaptic connections of medium spiny neurons in the striatum. The mechanisms of the narrow timing detection, however, remain unknown. Here, we optically stimulated dopaminergic and glutamatergic inputs separately and found that dopamine promoted spine enlargement only during a narrow time window (0.3 to 2 seconds) after the glutamatergic inputs. The temporal contingency was detected by rapid regulation of adenosine 3',5'-cyclic monophosphate in thin distal dendrites, in which protein-kinase A was activated only within the time window because of a high phosphodiesterase activity. Thus, we describe a molecular basis of reinforcement plasticity at the level of single dendritic spines.	[Yagishita, Sho; Hayashi-Takagi, Akiko; Kasai, Haruo] Univ Tokyo, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Yagishita, Sho; Hayashi-Takagi, Akiko; Kasai, Haruo] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Hayashi-Takagi, Akiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Ellis-Davies, Graham C. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Urakubo, Hidetoshi; Ishii, Shin] Kyoto Univ, Grad Sch Informat, Integrated Syst Biol Lab,Dept Syst Sci, Sakyo Ku, Kyoto 6068501, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Icahn School of Medicine at Mount Sinai; Kyoto University	Kasai, H (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Fac Med, Bunkyo Ku, Tokyo 1130033, Japan.	hkasai@m.u-tokyo.ac.jp	Yagishita, Sho/HII-4239-2022; Yagishita, Sho/Y-6908-2019	Yagishita, Sho/0000-0003-2854-773X; Yagishita, Sho/0000-0003-2854-773X; Urakubo, Hidetoshi/0000-0002-1816-0040; Ishii, Shin/0000-0001-9385-8230; Kasai, Haruo/0000-0003-2327-9027	Strategic Research Program for Brain Sciences ("Bioinformatics for Brain Sciences"), Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Education, Culture, Sports, Science, and Technology [2000009, 26221011]; National Institutes of Health [GM53395, DA035612, NS069720]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA035612] Funding Source: NIH RePORTER	Strategic Research Program for Brain Sciences ("Bioinformatics for Brain Sciences"), Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Kaibuchi, M. Mishina, T. Tanabe, K. Doya, J. Wickens, T. Toyoizumi, and K. Kasai for helpful discussion; K. Deisseroth for the channelrhodopsin-2 plasmids; M. Z. Lin for the Camuia-CR and AKAR2-CR plasmids; K. Iwamoto and S. Jinde for confocal microscopy; M. Ikeda for technical assistance; and M. Ogasawara and M. Tamura for laboratory facility. This work was supported by the Strategic Research Program for Brain Sciences ("Bioinformatics for Brain Sciences" to H. K. and S. I.) and Grants-in-Aid (2000009 and 26221011 to H. K.) from the Ministry of Education, Culture, Sports, Science, and Technology and by the National Institutes of Health GM53395, DA035612, and NS069720 (G.C.R.E.-D.). This work was also supported by the Human Frontier Science Program (H. K.). G.C.R.E.-D. has a patent in the United States for the synthesis of dinitroindolinyl-caged neurotransmitters.	BLACK J, 1985, BRAIN RES, V359, P113, DOI 10.1016/0006-8993(85)91418-0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Castro LRV, 2013, J PHYSIOL-LONDON, V591, P3197, DOI 10.1113/jphysiol.2013.252197; Cepeda Carlos, 2006, Sci STKE, V2006, ppe20, DOI 10.1126/stke.3332006pe20; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nakano Takashi, 2013, Front Comput Neurosci, V7, P119, DOI 10.3389/fncom.2013.00119; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; PAVLOV P, 1927, CONDITIONED REFLEXES; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Thorndike E. L., 1911, ANIMAL INTELLIGENCE; WILSON CJ, 1980, J COMP NEUROL, V194, P599, DOI 10.1002/cne.901940308; YOVELL Y, 1992, P NATL ACAD SCI USA, V89, P6526, DOI 10.1073/pnas.89.14.6526	30	300	302	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1616	1620		10.1126/science.1255514	http://dx.doi.org/10.1126/science.1255514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25258080	Green Accepted			2022-12-28	WOS:000342164500047
J	Clark, J				Clark, Jocalyn			Do the solutions for global health lie in healthcare?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNIVERSAL HEALTH; MEDICALIZATION; COVERAGE; DISEASES	Jocalyn Clark argues that the medicalisation of global health, like other aspects of human life and health, produces a narrow view of global health problems and will limit the success of solutions proposed to replace the millennium development goals Global health has risen in visibility over the past decade, leading to increased recognition of the world's gross inequalities in health and the disproportionate burden of poverty and disease borne by developing countries. A baby girl might expect to live to 83 years of age in Canada, but her life expectancy is closer to 55 years in some African countries. This is largely owing to high rates of child illness and infectious disease in poor countries but can also be attributed to the rising number of premature deaths from non-communicable causes. Underlying this disparity are inequalities in access to immunisation and clean water, income, education, and other factors important to health. Collective responsibility for improving global health-demonstrated by initiatives such as the Global Fund to Fight AIDS, Tuberculosis, and Malaria and the GAVI Alliance to increase access to immunisation in poor countries-has helped advance global health goals as part of a broader development agenda, which recognises that good health is conducive to economic growth and stability. As the millennium development goals programme reaches its end in 2015, a new global health agenda is emerging with mental health, non-communicable diseases (NCDs), and universal health coverage brought to the fore. This is to be welcomed but, as I argued in a recent series of articles in Global Health Action, the agenda has become too medicalised, which may limit its success.(1-4) How health problems and agendas are framed is important. It determines what gets included and excluded, and which priorities, strategies, resource commitments, and policies are made. The global health agenda-formed collectively by influential institutions such as the World Health Organization and other United Nations agencies, donors, research and advocacy organisations, industry, and journals-shapes public perceptions and expectations of how the global community will work to alleviate poverty, redress inequities, and save and improve lives.	[Clark, Jocalyn] Icddr B, Dhaka, Bangladesh; [Clark, Jocalyn] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); University of Toronto	Clark, J (corresponding author), Icddr B, Dhaka, Bangladesh.	j.clark@utoronto.ca		Clark, Jocalyn/0000-0002-8014-3989	Rockefeller Foundation	Rockefeller Foundation	I have read and understood BMJ policy on declaration of interests and declare the following interests: I am a former senior editor at PLOS Medicine and former assistant editor at The BMJ. I received a 2013 academic writing residency at the Bellagio Center from the Rockefeller Foundation in support of my work on the medicalisation of global health. This residency did not provide funding for research and the foundation had no influence over the work or decision to publish this article.	[Anonymous], 2011, DRUGS TREATING MENTA; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bell SE, 2012, SOC SCI MED, V75, P775, DOI 10.1016/j.socscimed.2012.04.002; Birn AE, 2011, GLOBAL HEALTH AND GLOBAL HEALTH ETHICS, P37; Bollyky TJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001485; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; BUNKER JP, 1994, MILBANK Q, V72, P225, DOI 10.2307/3350295; Clark J, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24002; Clark J, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24004; Clark J, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23998; Clark J, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24000; Clift C., 2013, IS UNIVERSAL HLTH CO; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; de Noronha JC, 2013, CAD SAUDE PUBLICA, V29, P847; Heath I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4239; Horton R, 2013, LANCET, V382, P1164, DOI 10.1016/S0140-6736(13)62024-3; Hunter D, 2010, BMJ-BRIT MED J, V340, pc684; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; IMS Institute for Healthcare Informatics, 2012, GLOB US MED OUTL 201; International Federation of Pharmaceutical Manufacturers and Associations, RES BAS PHARM IND CO; International Federation of Pharmaceutical Manufacturers and Associations, NON COMM DIS; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Marmot M, 2013, LANCET, V382, P1227, DOI 10.1016/S0140-6736(13)61791-2; McCoy D, 2004, LANCET, V364, P1630, DOI 10.1016/S0140-6736(04)17319-4; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Navarro Vicente, 2009, Glob Health Promot, V16, P5, DOI 10.1177/1757975908100746; Nettleton S, 2020, SOCIOL HEALTH ILL; O'Connell T, 2014, LANCET, V383, P277, DOI 10.1016/S0140-6736(13)60955-1; Petersen I, 2012, TRANSCULT PSYCHIATRY, V49, P418, DOI 10.1177/1363461512448375; Sadler JZ, 2009, THEOR MED BIOETH, V30, P411, DOI 10.1007/s11017-009-9122-4; Sangupta A, 2011, GLOBAL HLTH WATCH 3, P249; Sengupta, 2013, UNIVERSAL HLTH COVER; Stuckler D., 2011, SICK SOC RESPONDING, P87; Stuckler D, 2010, POLITICAL EC UNIVERS; Stuckler D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5336; Victora CG, 2012, HLTH POST 2015 DEV A; Wipfli H., 2013, PARTNERSHIPS PERIL K; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; World Health Organization (WHO), 2008, SCAL CAR MENT NEUR S	40	2	2	0	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2014	349								g5457	10.1136/bmj.g5457	http://dx.doi.org/10.1136/bmj.g5457			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP9UR	25258371				2022-12-28	WOS:000342426400002
J	Peng, M; Yin, N; Li, MO				Peng, Min; Yin, Na; Li, Ming O.			Sestrins Function as Guanine Nucleotide Dissociation Inhibitors for Rag GTPases to Control mTORC1 Signaling	CELL			English	Article							GTP-BINDING PROTEINS; AMINO-ACID LEVELS; TUMOR-SUPPRESSOR; GAP ACTIVITY; RHO GTPASES; COMPLEX; TARGET; RHEB; GEF; ACTIVATION	Mechanistic target of rapamycin complex 1 (mTORC1) integrates diverse environmental signals to control cellular growth and organismal homeostasis. In response to nutrients, Rag GTPases recruit mTORC1 to the lysosome to be activated, but how Rags are regulated remains incompletely understood. Here, we show that Sestrins bind to the heterodimeric RagA/B-RagC/D GTPases, and function as guanine nucleotide dissociation inhibitors (GDIs) for RagA/B. Sestrin overexpression inhibits amino-acid-induced Rag guanine nucleotide exchange and mTORC1 translocation to the lysosome. Mutation of the conserved GDI motif creates a dominant-negative form of Sestrin that renders mTORC1 activation insensitive to amino acid deprivation, whereas a cell-permeable peptide containing the GDI motif inhibits mTORC1 signaling. Mice deficient in all Sestrins exhibit reduced postnatal survival associated with defective mTORC1 inactivation in multiple organs during neonatal fasting. These findings reveal a nonredundant mechanism by which the Sestrin family of GDIs regulates the nutrient-sensing Rag GTPases to control mTORC1 signaling.	[Peng, Min; Yin, Na; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org	Peng, Min/O-3770-2017	Peng, Min/0000-0002-5885-0660; li, ming/0000-0002-1383-0535	National Institute of Allergy and Infectious Diseases [RO1 AI102888-01A1]; Starr Cancer Consortium [I3-A123]; Leukemia & Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102888] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Starr Cancer Consortium; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Laderoute and B. Viollet for SV40-immortalized AMPK alpha 1/alpha 2-deficient MEFs and D. Kwiatkowski for TSC2-deficient MEFs. We thank M. Huse and all members of the Li lab for helpful discussions. This work was supported by grants from the National Institute of Allergy and Infectious Diseases (RO1 AI102888-01A1 to M.O.L.), the Starr Cancer Consortium (I3-A123 to M.O.L.), and the Leukemia & Lymphoma Society (Scholar Award to M.O.L.).	Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bruning A, 2013, MOL ONCOL, V7, P1012, DOI 10.1016/j.molonc.2013.07.010; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; HOFFENBERG S, 1995, BIOCHEM BIOPH RES CO, V215, P241, DOI 10.1006/bbrc.1995.2459; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Lamming DW, 2013, J CLIN INVEST, V123, P980, DOI 10.1172/JCI64099; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Schmidt G, 1996, ONCOGENE, V12, P87; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008	46	151	179	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					122	133		10.1016/j.cell.2014.08.038	http://dx.doi.org/10.1016/j.cell.2014.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259925	Green Accepted, Bronze			2022-12-28	WOS:000343095000014
J	Vicens, Q; Westhof, E				Vicens, Quentin; Westhof, Eric			Biogenesis of Circular RNAs	CELL			English	Editorial Material									[Vicens, Quentin; Westhof, Eric] CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vicens, Q (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France.	q.vicens@ibmc-cnrs.unistra.fr; e.westhof@ibmc-cnrs.unistra.fr	Vicens, Quentin/N-6139-2019	Vicens, Quentin/0000-0003-3751-530X				Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Talhouarne GJS, 2014, RNA, V20, P1476, DOI 10.1261/rna.045781.114; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017	10	261	280	5	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					13	14		10.1016/j.cell.2014.09.005	http://dx.doi.org/10.1016/j.cell.2014.09.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25259915	Bronze			2022-12-28	WOS:000343095000004
J	Haines, A; Ebi, KL; Smith, KR; Woodward, A				Haines, Andy; Ebi, Kristie L.; Smith, Kirk R.; Woodward, Alistair			Health risks of climate change: act now or pay later	LANCET			English	Editorial Material									[Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res & Populat Hlth, London WC1H 9SH, England; [Ebi, Kristie L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Smith, Kirk R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of Auckland	Haines, A (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res & Populat Hlth, London WC1H 9SH, England.	andy.haines@lshtm.ac.uk		Woodward, Alistair/0000-0001-5425-6018; Haines, Andy/0000-0002-8053-4605				Dixon J, 2014, HLTH PEOPLE IN PRESS; Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; IPCC, 2013, CLIMATE CHANGE 2022; McMichael C, 2012, ENVIRON HEALTH PERSP, V120, P646, DOI 10.1289/ehp.1104375; O'Neill BC, 2012, LANCET, V380, P157, DOI 10.1016/S0140-6736(12)60958-1; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Stocker T., 2013, COMPUTATIONAL GEOMET, DOI 10.1017/ CBO9781107415324	10	27	27	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1073	1075		10.1016/S0140-6736(14)61659-7	http://dx.doi.org/10.1016/S0140-6736(14)61659-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	25241709				2022-12-28	WOS:000342630600008
J	Burchard, EG				Burchard, Esteban G.			Missing patients	NATURE			English	Editorial Material							ASTHMA; RACE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Burchard, EG (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	esteban.burchard@ucsf.edu						Aizer AA, 2014, CANCER-AM CANCER SOC, V120, P1532, DOI 10.1002/cncr.28617; Burchard EG, 1999, AM J RESP CRIT CARE, V160, P919, DOI 10.1164/ajrccm.160.3.9812024; Chen MS, 2014, CANCER-AM CANCER SOC, V120, P1091, DOI 10.1002/cncr.28575; Currie GP, 2006, DRUG SAFETY, V29, P647, DOI 10.2165/00002018-200629080-00002; Durazzo TS, 2013, JAMA SURG, V148, P617, DOI 10.1001/jamasurg.2013.1436; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Moorman JE, 2012, NATL SURVEILLANCE AS, P3; Naqvi M, 2007, J ASTHMA, V44, P639, DOI 10.1080/02770900701554441	8	29	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					301	302		10.1038/513301a	http://dx.doi.org/10.1038/513301a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1GD	25230631	Bronze			2022-12-28	WOS:000341814900018
J	Burrows, AS				Burrows, Adam S.			Highlights in the study of exoplanet atmospheres	NATURE			English	Review							EXTRASOLAR GIANT PLANETS; WATER-ABSORPTION; PHASE CURVES; HD 189733B; TRANSMISSION SPECTRUM; CARBON-MONOXIDE; ORBITAL MOTION; BROWN DWARFS; MASS-LOSS; CHEMISTRY	Exoplanets are now being discovered in profusion. To understand their character, however, we require spectral models and data. These elements of remote sensing can yield temperatures, compositions and even weather patterns, but only if significant improvements in both the parameter retrieval process and measurements are made. Despite heroic efforts to garner constraining data on exoplanet atmospheres and dynamics, reliable interpretation has frequently lagged behind ambition. I summarize the most productive, and at times novel, methods used to probe exoplanet atmospheres; highlight some of the most interesting results obtained; and suggest various broad theoretical topics in which further work could pay significant dividends.	Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Burrows, AS (corresponding author), Princeton Univ, 4 Ivy Lane, Princeton, NJ 08544 USA.	burrows@astro.princeton.edu			Hubble Space Telescope grants [HST-GO-12181.04-A, HST-GO-12314.03-A, HST-GO-12473.06-A, HST-GO-12550.02]; Jet Propulsion Laboratory/Spitzer [1417122, 1348668, 1371432, 1377197, 1439064]	Hubble Space Telescope grants; Jet Propulsion Laboratory/Spitzer	The author acknowledges support in part under Hubble Space Telescope grants HST-GO-12181.04-A, HST-GO-12314.03-A, HST-GO-12473.06-A, and HST-GO-12550.02 and Jet Propulsion Laboratory/Spitzer Agreements 1417122, 1348668, 1371432, 1377197 and 1439064.	Barman TS, 2005, ASTROPHYS J, V632, P1132, DOI 10.1086/444349; Beuzit JL, 2008, PROC SPIE, V7014, DOI 10.1117/12.790120; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Brogi M, 2012, NATURE, V486, P502, DOI 10.1038/nature11161; Brown TM, 2001, ASTROPHYS J, V553, P1006, DOI 10.1086/320950; Burrows A, 2008, ASTROPHYS J, V682, P1277, DOI 10.1086/589824; Burrows A, 1997, ASTROPHYS J, V491, P856, DOI 10.1086/305002; Burrows A, 2004, ASTROPHYS J, V609, P407, DOI 10.1086/420974; Burrows A, 2005, ASTROPHYS J, V625, pL135, DOI 10.1086/431242; Burrows A, 2005, NATURE, V433, P261, DOI 10.1038/nature03244; Burrows A, 2000, ASTROPHYS J, V531, P438, DOI 10.1086/308462; BURROWS A, 1995, NATURE, V378, P333, DOI 10.1038/378333a0; Burrows A, 2001, REV MOD PHYS, V73, P719, DOI 10.1103/RevModPhys.73.719; Burrows A, 1999, ASTROPHYS J, V512, P843, DOI 10.1086/306811; Burrows A., 2010, EXOPLANETS, P419; Burrows AS, 2014, P NATL ACAD SCI USA, V111, P12601, DOI 10.1073/pnas.1304208111; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Cowan NB, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/82; Crossfield IJM, 2014, NATURE, V505, P654, DOI 10.1038/nature12955; Crossfield IJM, 2010, ASTROPHYS J, V723, P1436, DOI 10.1088/0004-637X/723/2/1436; de Kok RJ, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321381; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2009, PUBL ASTRON SOC PAC, V121, P952, DOI 10.1086/605913; Deming D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/95; Ehrenreich D, 2006, ASTRON ASTROPHYS, V448, P379, DOI 10.1051/0004-6361:20053861; Ehrenreich D, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016356; Esteves LJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/51; Etangs ALD, 2008, ASTRON ASTROPHYS, V481, pL83, DOI 10.1051/0004-6361:200809388; Fletcher LN, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0064; Fortney JJ, 2003, ASTROPHYS J, V589, P615, DOI 10.1086/374387; Fossati L, 2010, ASTROPHYS J LETT, V714, pL222, DOI 10.1088/2041-8205/714/2/L222; Freedman RS, 2008, ASTROPHYS J SUPPL S, V174, P504, DOI 10.1086/521793; Grillmair CJ, 2008, NATURE, V456, P767, DOI 10.1038/nature07574; Guillot T, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/200913396; Hill C, 2013, ICARUS, V226, P1673, DOI 10.1016/j.icarus.2012.07.028; Howe AR, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/176; Kaltenegger L, 2007, ASTROPHYS J, V658, P598, DOI 10.1086/510996; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/22; Knutson HA, 2009, ASTROPHYS J, V703, P769, DOI 10.1088/0004-637X/703/1/769; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888; Kulow J. R., PREPRINT; Lagrange AM, 2009, ASTRON ASTROPHYS, V493, pL21, DOI 10.1051/0004-6361:200811325; Lecavelier Des Etangs A., 2010, ASTROPHYS ASTRON, V514, P10; Lewis NK, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/95; Linsky JL, 2010, ASTROPHYS J, V717, P1291, DOI 10.1088/0004-637X/717/2/1291; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lodders K, 2002, ICARUS, V155, P393, DOI 10.1006/icar.2001.6740; Lodders K., 1998, PLANETARY SCI COMPAN; Macintosh BA, 2008, PROC SPIE, V7015, DOI 10.1117/12.788083; Madhusudhan N., PREPRINT; Madhusudhan N, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/25; Madhusudhan N, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/34; Majeau C, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L20; Marley M. S., 2013, COMP CLIMATOLOGY TER, P367, DOI [10.2458/azuuapress9780816530595-ch15, DOI 10.2458/AZUUAPRESS9780816530595-CH15, DOI 10.2458/AZU_UAPRESS_9780816530595-CH15]; Marley MS, 1999, ASTROPHYS J, V513, P879, DOI 10.1086/306881; Moutou C, 2013, ICARUS, V226, P1625, DOI 10.1016/j.icarus.2013.03.022; Pont F, 2008, MON NOT R ASTRON SOC, V385, P109, DOI 10.1111/j.1365-2966.2008.12852.x; Pont F, 2013, MON NOT R ASTRON SOC, V432, P2917, DOI 10.1093/mnras/stt651; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Rowe JF, 2008, ASTROPHYS J, V689, P1345, DOI 10.1086/591835; Schaefer L, 2009, ASTROPHYS J LETT, V703, pL113, DOI 10.1088/0004-637X/703/2/L113; Seager S, 2000, ASTROPHYS J, V537, P916, DOI 10.1086/309088; Seager S, 2000, ASTROPHYS J, V540, P504, DOI 10.1086/309292; Sharp CM, 2007, ASTROPHYS J SUPPL S, V168, P140, DOI 10.1086/508708; Showman AP, 2009, ASTROPHYS J, V699, P564, DOI 10.1088/0004-637X/699/1/564; Sing D. K., 2011, ASTRON ASTROPHYS, V527, P10; Snellen IAG, 2014, NATURE, V509, P63, DOI 10.1038/nature13253; Spergel D. N., PREPRINT; Sudarsky D, 2000, ASTROPHYS J, V538, P885, DOI 10.1086/309160; Suzuki R, 2010, PROC SPIE, V7735, DOI 10.1117/12.857361; Tennyson J, 2015, EXP ASTRON, V40, P563, DOI 10.1007/s10686-014-9385-2; Tinetti G., 2011, P INT ASTR UN IAU S, V6, P359; Tinetti G., PREPRINT; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448	84	50	51	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					345	352		10.1038/nature13782	http://dx.doi.org/10.1038/nature13782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230656	Green Submitted			2022-12-28	WOS:000341814900047
J	Hatzes, AP				Hatzes, Artie P.			The role of space telescopes in the characterization of transiting exoplanets	NATURE			English	Review							EARTH-SIZED PLANET; EXTRASOLAR PLANET; SUPER-EARTH; GIANT PLANET; HD 189733B; ATMOSPHERE; COROT; MISSION; HUBBLE; PHOTOMETRY	Characterization studies now have a dominant role in the field of exoplanets. Such studies include the measurement of an exoplanet's bulk density, its brightness temperature and the chemical composition of its atmosphere. The use of space telescopes has played a key part in the characterization of transiting exoplanets. These facilities offer astronomers data of exquisite precision and temporal sampling as well as access to wavelength regions of the electromagnetic spectrum that are inaccessible from the ground. Space missions such as the Hubble Space Telescope, Microvariability and Oscillations of Stars (MOST), Spitzer Space Telescope, Convection, Rotation and Planetary Transits (CoRoT), and Kepler have rapidly advanced our knowledge of the physical properties of exoplanets and have blazed a trail for a series of future space missions that will help us to understand the observed diversity of exoplanets.	Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany		Hatzes, AP (corresponding author), Thuringer Landessternwarte Tautenburg, Sternwarte 5, D-07778 Tautenburg, Germany.	artie@tls-tautenburg.de						Alonso R, 2008, ASTRON ASTROPHYS, V482, pL21, DOI 10.1051/0004-6361:200809431; Baglin A, 2003, ADV SPACE RES, V31, P345, DOI 10.1016/S0273-1177(02)00624-5; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Ben-Jaffel L, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201221014; Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Csizmadia S, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201219888; Deeg HJ, 2010, NATURE, V464, P384, DOI 10.1038/nature08856; Deleuil M, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117681; Deleuil M, 2008, ASTRON ASTROPHYS, V491, P889, DOI 10.1051/0004-6361:200810625; Demory BO, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117178; Demory BO, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/2/L28; Demory BO, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/12; Gibson NP, 2011, MON NOT R ASTRON SOC, V411, P2199, DOI 10.1111/j.1365-2966.2010.17837.x; Hatzes AP, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/75; Howard AW, 2013, NATURE, V503, P381, DOI 10.1038/nature12767; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2014, NATURE, V505, P66, DOI 10.1038/nature12887; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888; Leger A., 2009, ASTRON ASTROPHYS, V586, P278; Pepe F, 2013, NATURE, V503, P377, DOI 10.1038/nature12768; Pont F, 2013, MON NOT R ASTRON SOC, V432, P2917, DOI 10.1093/mnras/stt651; Rauer H., 2014, EXP ASTRON UNPUB; Rowe JF, 2008, ASTROPHYS J, V689, P1345, DOI 10.1086/591835; Sanchis-Ojeda R, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/54; Snellen IAG, 2009, NATURE, V459, P543, DOI 10.1038/nature08045; Sudarsky D, 2003, ASTROPHYS J, V588, P1121, DOI 10.1086/374331; Swain MR, 2009, ASTROPHYS J, V704, P1616, DOI 10.1088/0004-637X/704/2/1616; Swain MR, 2008, NATURE, V452, P329, DOI 10.1038/nature06823; Vidal-Madjar A, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322234; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Walker GAH, 2008, ASTRON ASTROPHYS, V482, P691, DOI 10.1051/0004-6361:20078952; Winn JN, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/1/L18	33	4	5	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					353	357		10.1038/nature13783	http://dx.doi.org/10.1038/nature13783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25230657				2022-12-28	WOS:000341814900048
J	Harnden, A; Tulloh, R; Burgner, D				Harnden, Anthony; Tulloh, Robert; Burgner, David			Kawasaki disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-FEATURES; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; CHILDREN; UPDATE	This is one of a series of occasional articles highlighting conditions that may be more common than many doctors realise or may be missed at first presentation. The series advisers are Anthony Harnden, professor of primary care, Department of Primary Care Health Sciences, University of Oxford, and Richard Lehman, general practitioner, Banbury. To suggest a topic for this series, please email us at practice@bmj.com.	[Harnden, Anthony] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Tulloh, Robert] Univ Bristol, Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England; [Burgner, David] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Burgner, David] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia	University of Oxford; University of Bristol; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Harnden, A (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	anthony.harnden@phc.ox.ac.uk		Burgner, David/0000-0002-8304-4302; Tulloh, Robert/0000-0002-3180-6993				Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Eleftheriou D, 2014, ARCH DIS CHILD, V99, P74, DOI 10.1136/archdischild-2012-302841; Harnden A, 2009, PEDIATR INFECT DIS J, V28, P21, DOI 10.1097/INF.0b013e3181812ca4; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1514; Holman Robert C, 2010, Hawaii Med J, V69, P194; Kim GB, 2014, PEDIATR INFECT DIS J, V33, P24, DOI 10.1097/INF.0000000000000010; Lue HC, 2014, PEDIATR NEONATOL, V55, P92, DOI 10.1016/j.pedneo.2013.07.010; Moore A, 2014, BRIT J GEN PRACT, V64, pE477, DOI 10.3399/bjgp14X680953; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Saundankar J, 2014, PEDIATRICS, V133, pE1009, DOI 10.1542/peds.2013-2936; Tacke CE, 2012, EXPERT REV ANTI-INFE, V10, P1203, DOI [10.1586/ERI.12.101, 10.1586/eri.12.101]; Tacke CE, 2012, J PEDIATR-US, V161, P314, DOI 10.1016/j.jpeds.2012.01.071; Tsuda E, 2014, AM HEART J, V167, P249, DOI 10.1016/j.ahj.2013.10.025; Wood LE, 2009, HEART, V95, P787, DOI 10.1136/hrt.2008.143669; Yeom Jung Sook, 2013, Korean J Pediatr, V56, P377, DOI 10.3345/kjp.2013.56.9.377; Yim D, 2013, J PAEDIATR CHILD H, V49, P704, DOI 10.1111/jpc.12172; Yim D, 2013, J PAEDIATR CHILD H, V49, P614, DOI 10.1111/jpc.12221	19	11	12	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2014	349								g5336	10.1136/bmj.g5336	http://dx.doi.org/10.1136/bmj.g5336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4OW	25230954				2022-12-28	WOS:000342058300002
J	Ruetsch, C				Ruetsch, Charles			Treating Prescription Opioid Dependence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SAMPLE	IMPORTANCE Although abuse of prescription opioids (POs) is a significant public health problem, few experimental studies have investigated the treatment needs of this growing population. OBJECTIVE To evaluate, following brief stabilization with a combination of buprenorphine hydrochloride and naloxone hydrochloride dihydrate, the relative efficacy of 1-, 2-, and 4-week buprenorphine tapering regimens and subsequent naltrexone hydrochloride therapy in PO-dependent outpatients. DESIGN, SETTING, AND PARTICIPANTS A double-blind, 12-week randomized clinical trial was conducted in an outpatient research clinic. Following a brief period of buprenorphine stabilization, 70 PO-dependent adults were randomized to receive 1-, 2-, or 4-week tapers followed by naltrexone therapy. INTERVENTION During phase 1 (weeks 1-5 after randomization), participants visited the clinic daily; during phase 2 (weeks 6-12), visits were reduced to thrice weekly. Participants received behavioral therapy and urine toxicology testing throughout the trial. MAIN OUTCOMES AND MEASURES The percentage of participants negative for illicit opioid use, retention, naltrexone ingestion, and favorable treatment response (ie, retained in treatment, opioid abstinent, and receiving naltrexone at the end of the study). RESULTS Opioid abstinence at the end of phase 1was greater in the 4-week compared with the 2- and 1-week taper conditions (P = .02), with 63%(n = 14), 29% (n = 7), and 29% (n = 7) of participants abstinent in the 4-, 2-, and 1-week conditions, respectively. Abstinence at the end of phase 2 was also greater in the 4-week compared with the 2- and 1-week conditions (P = .03), with 50% (n = 11), 16%(n = 4), and 20%(n = 5) of participants abstinent in the 4-, 2-, and 1-week conditions, respectively. There were more treatment responders in the 4-week condition (P = .03), with 50% (n = 11), 17%(n = 4), and 21% (n = 5) of participants in the 4-, 2-, and 1-week groups considered responders at the end of treatment, respectively. Retention and naltrexone ingestion also were superior in the 4-week vs briefer tapers (both P = .04). Experimental condition (ie, taper duration) was the strongest predictor of treatment response, followed by buprenorphine stabilization dose. CONCLUSIONS AND RELEVANCE This study represents a rigorous experimental evaluation of outpatient buprenorphine stabilization, brief taper, and naltrexone maintenance for treatment of PO dependence. Results suggest that a meaningful subset of PO-dependent outpatients may respond positively to a 4-week taper plus naltrexone maintenance intervention.	Hlth Analyt, Sci, 9200 Rumsey Rd,Ste 215, Columbia, MD 21045 USA		Ruetsch, C (corresponding author), Hlth Analyt, Sci, 9200 Rumsey Rd,Ste 215, Columbia, MD 21045 USA.	charles.ruetsch@healthanalytic.com						Albright J, 2010, J ADDICT MED, V4, P197, DOI 10.1097/ADM.0b013e3181c816f3; [Anonymous], 2014, RESULTS FROM THE 199; Hillhouse M, 2011, AM J DRUG ALCOHOL AB, V37, P453, DOI 10.3109/00952990.2011.596974; McLellan AT, 2006, AM J ADDICTION, V15, P113, DOI 10.1080/10550490500528316; Olsen Y, 2014, JAMA-J AM MED ASSOC, V311, P1393, DOI 10.1001/jama.2014.2147; Ruetsch C, 2010, J SUBST ABUSE TREAT, V39, P307, DOI 10.1016/j.jsat.2010.07.003; Ruetsch C, 2010, J MANAGE CARE PHARM, V16, pS9; Sigmon SC, 2013, JAMA PSYCHIAT, V70, P1347, DOI 10.1001/jamapsychiatry.2013.2216; Westermeyer J, 2004, AM J ADDICTION, V13, P151, DOI 10.1080/10550490490435948	9	0	0	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1145	+		10.1001/jama.2014.4318	http://dx.doi.org/10.1001/jama.2014.4318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226480				2022-12-28	WOS:000341624700024
J	Strandberg, TE; Kolehmainen, L; Vuorio, A				Strandberg, Timo E.; Kolehmainen, Laura; Vuorio, Alpo			Evaluation and Treatment of Older Patients With Hypercholesterolemia A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONVERTING ENZYME-INHIBITORS; CORONARY-HEART-DISEASE; STATIN THERAPY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; ELDERLY-PATIENTS; MEDICATION USE; AGE-GROUPS; MORTALITY	IMPORTANCE Hypercholesterolemia is common among people older than 80 years. Substantial functional heterogeneity exists among older patients, and decision making for statin use differs in older patients relative to younger ones. OBJECTIVE To discuss the presentation, modifying factors, and treatment of hypercholesterolemia (usually with statins) among persons older than 80 years. EVIDENCE REVIEW MEDLINE and other sources were searched from January 1990 to June 2014. Personal libraries and a hand search of reference lists from guidelines and reviews from January 2000 to June 2014 were also used. FINDINGS Norandomized clinical trials (RCTs) of statin or any other hypocholesterolemic medication included persons older than 80 years at baseline. Findings from 75- to 80-year-old patients enrolled in RCTs and information from observational studies support statin treatment for secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and probably in patients with diabetes without ASCVD. Harms from statin drugs are not increased in older patients, so the use of these agents for primary prevention is possible. Because people older than 80 years are biologically heterogeneous with varying life expectancy, may have frailty or comorbid conditions, and may take multiple medications, the decision to treat with statins must be individualized. CONCLUSIONS AND RELEVANCE Ideally, treatment of hypercholesterolemia for patients at risk of ASCVD should start before they turn 80 years old. No RCT evidence exists to guide statin initiation after age 80 years. Decisions to use statins in older individuals are made individually and are not supported by high-quality evidence.	[Strandberg, Timo E.] Univ Helsinki, Dept Med, Geriatr Clin, FIN-00014 Helsinki, Finland; [Strandberg, Timo E.] Univ Oulu, Inst Hlth Sci Geriatr, Oulu, Finland; [Strandberg, Timo E.] Univ Hosp Oulu, Oulu, Finland; [Strandberg, Timo E.] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland; [Kolehmainen, Laura] North Karelia Cent Hosp, Unit Internal Med, Joensuu, Finland; [Vuorio, Alpo] Mehilainen Airport Hlth Ctr, Vantaa, Finland; [Vuorio, Alpo] Finnish Inst Occupat Hlth, Lappeenranta, Finland	University of Helsinki; University of Oulu; University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health	Strandberg, TE (corresponding author), Univ Helsinki, Dept Med, Geriatr Clin, Stenbackinkatu 9 A,POB 22, FIN-00014 Helsinki, Finland.	timo.strandberg@oulu.fi	Vuorio, Alpo/I-3116-2019	strandberg, timo/0000-0001-6299-925X	University Central Hospital of Helsinki; University Central Hospital of Oulu; Gustav V och Victoria Frimurarestiftelse	University Central Hospital of Helsinki; University Central Hospital of Oulu; Gustav V och Victoria Frimurarestiftelse	Dr Strandberg reported that his research, not directly applicable to this review, has been supported by the University Central Hospitals of Helsinki and Oulu and by the Gustav V och Victoria Frimurarestiftelse.	Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070; Agostini JV, 2007, J AM GERIATR SOC, V55, P420, DOI 10.1111/j.1532-5415.2007.01071.x; American Geriatrics Society (AGS), GUID DEM DIAGN TREAT; Andersen-Ranberg K, 2013, AGE AGEING, V42, P249, DOI 10.1093/ageing/afs108; Aronow WS, 2002, AM J CARDIOL, V89, P67, DOI 10.1016/S0002-9149(01)02167-1; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baumgartner S, 2011, CURR PHARM DESIGN, V17, P922, DOI 10.2174/138161211795428795; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Chokshi NP, 2012, AM J CARDIOL, V110, P1477, DOI 10.1016/j.amjcard.2012.06.058; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; Cooke CA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-198; Corti MC, 1997, ANN INTERN MED, V126, P753, DOI 10.7326/0003-4819-126-10-199705150-00001; Drewes YM, 2014, J AM GERIATR SOC, V62, P213, DOI 10.1111/jgs.12660; DuGoff EH, 2014, MED CARE, V52, P688, DOI 10.1097/MLR.0000000000000166; Eaton CB, 2002, J AM GERIATR SOC, V50, P1389, DOI 10.1046/j.1532-5415.2002.50360.x; ePrognosis, EST PROGN ELD; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fontana L, 2013, AGING CELL, V12, P459, DOI 10.1111/acel.12068; Foody JM, 2006, J AM GERIATR SOC, V54, P421, DOI 10.1111/j.1532-5415.2005.00635.x; Galindo-Ocana J, 2012, EUR J INTERN MED, V23, P179, DOI 10.1016/j.ejim.2011.06.004; Gill TM, 2012, JAMA-J AM MED ASSOC, V307, P199, DOI 10.1001/jama.2011.1992; Gnjidic D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002333; Gransbo K, 2010, J AM COLL CARDIOL, V55, P1362, DOI 10.1016/j.jacc.2010.01.013; Gray SL, 2012, J AM GERIATR SOC, V60, P2206, DOI 10.1111/jgs.12029; Gray SL, 2011, J AM GERIATR SOC, V59, P2226, DOI 10.1111/j.1532-5415.2011.03721.x; Holmes HM, 2008, J AM GERIATR SOC, V56, P1306, DOI 10.1111/j.1532-5415.2008.01741.x; Holmes HM, 2013, DRUG AGING, V30, P655, DOI 10.1007/s40266-013-0095-7; Iannuzzi JC, 2014, SURGERY, V155, P398, DOI 10.1016/j.surg.2013.11.008; Jacobs JM, 2013, J AM MED DIR ASSOC, V14, P883, DOI 10.1016/j.jamda.2013.08.012; Jukema JW, 2012, J AM COLL CARDIOL, V60, P875, DOI 10.1016/j.jacc.2012.07.007; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kozarov E, 2014, CARDIOVASC RES, V102, P362, DOI 10.1093/cvr/cvu058; LaCroix AZ, 2008, J GERONTOL A-BIOL, V63, P369, DOI 10.1093/gerona/63.4.369; Lee DSH, 2014, JAMA INTERN MED, V174, P1263, DOI 10.1001/jamainternmed.2014.2266; Lee SJ, 2013, JAMA-J AM MED ASSOC, V310, P2609, DOI 10.1001/jama.2013.282612; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lynch JE, 2012, AGE AGEING, V41, P260, DOI 10.1093/ageing/afr159; Macedo AF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-51; Marais AD, 2015, PHARMACOL THERAPEUT, V145, P58, DOI 10.1016/j.pharmthera.2014.07.004; Maycock CAA, 2002, J AM COLL CARDIOL, V40, P1777, DOI 10.1016/S0735-1097(02)02477-4; McGuinness B, 2013, INT J GERIATR PSYCH, V28, P119, DOI 10.1002/gps.3797; Morley JE, 2013, J AM MED DIR ASSOC, V14, P853, DOI 10.1016/j.jamda.2013.09.016; Muller M, 2014, HYPERTENSION, V63, P433, DOI 10.1161/HYPERTENSIONAHA.113.00911; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; OECD, OECD STATEXTRACTS; Olafsdottir E, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000132; Petersen LK, 2010, AGE AGEING, V39, P674, DOI 10.1093/ageing/afq129; Pilotto A, 2012, ARCH INTERN MED, V172, P594, DOI 10.1001/archinternmed.2011.1891; Savarese G, 2013, J AM COLL CARDIOL, V62, P2090, DOI 10.1016/j.jacc.2013.07.069; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Scuteri A, 2013, EXP GERONTOL, V48, P64, DOI 10.1016/j.exger.2012.02.009; Shah R, 2008, AM J CARDIOL, V101, P217, DOI 10.1016/j.amjcard.2007.08.050; Social Security Administration (SSA), ACT LIF TABL; Stein EA, 2014, BEST PRACT RES CL EN, V28, P309, DOI 10.1016/j.beem.2013.10.010; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Strandberg TE, 2013, ANN MED, V45, P265, DOI 10.3109/07853890.2012.727022; Szadkowska I, 2010, ARCH GERONTOL GERIAT, V50, P114, DOI 10.1016/j.archger.2008.12.012; Thomas JE, 2010, DRUG AGING, V27, P959, DOI 10.2165/11539550-000000000-00000; Tian JW, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-70; Tilvis RS, 2011, ANN MED, V43, P292, DOI 10.3109/07853890.2010.546363; Witham MD, 2014, AGE AGEING, V43, P661, DOI 10.1093/ageing/afu008; Yan YL, 2013, EUR J CLIN PHARMACOL, V69, P2001, DOI 10.1007/s00228-013-1570-0; Zhang HB, 2013, ANN INTERN MED, V159, P75, DOI 10.7326/0003-4819-159-1-201307020-00022	64	97	101	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1136	1144		10.1001/jama.2014.10924	http://dx.doi.org/10.1001/jama.2014.10924			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25226479				2022-12-28	WOS:000341624700023
J	Mark, DB; Knight, JD; Velazquez, EJ; Wasilewski, J; Howlett, JG; Smith, PK; Spertus, JA; Rajda, M; Yadav, R; Hamman, BL; Malinowski, M; Naik, A; Rankin, G; Harding, TM; Drew, LA; Desvigne-Nickens, P; Anstrom, KJ				Mark, Daniel B.; Knight, J. David; Velazquez, Eric J.; Wasilewski, Jaroslaw; Howlett, Jonathan G.; Smith, Peter K.; Spertus, John A.; Rajda, Miroslaw; Yadav, Rakesh; Hamman, Baron L.; Malinowski, Marcin; Naik, Ajay; Rankin, Gena; Harding, Tina M.; Drew, Laura A.; Desvigne-Nickens, Patrice; Anstrom, Kevin J.			Quality-of-Life Outcomes With Coronary Artery Bypass Graft Surgery in Ischemic Left Ventricular Dysfunction A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL STATUS; MEDICAL THERAPY; HEART-FAILURE; CARDIOMYOPATHY; QUESTIONNAIRE; GUIDELINES; DISEASE; ANGINA; DESIGN; MODELS	Background: The STICH (Surgical Treatment for Ischemic Heart Failure) trial compared a strategy of routine coronary artery bypass grafting (CABG) with guideline-based medical therapy for patients with ischemic left ventricular dysfunction. Objective: To describe treatment-related quality-of-life (QOL) outcomes, a major prespecified secondary end point in the STICH trial. Design: Randomized trial. (ClinicalTrials.gov: NCT00023595) Setting: 99 clinical sites in 22 countries. Patients: 1212 patients with a left ventricular ejection fraction of 0.35 or less and coronary artery disease. Intervention: Random assignment to medical therapy alone (602 patients) or medical therapy plus CABG (610 patients). Measurements: A battery of QOL instruments at baseline (98.9% complete) and 4, 12, 24, and 36 months after randomization (collection rates were 80% to 89% of those eligible). The principal prespecified QOL measure was the Kansas City Cardiomyopathy Questionnaire, which assesses the effect of heart failure on patients' symptoms, physical function, social limitations, and QOL. Results: The Kansas City Cardiomyopathy Questionnaire overall summary score was consistently higher (more favorable) in the CABG group than in the medical therapy group by 4.4 points (95% CI, 1.8 to 7.0 points) at 4 months, 5.8 points (CI, 3.1 to 8.6 points) at 12 months, 4.1 points (CI, 1.2 to 7.1 points) at 24 months, and 3.2 points (CI, 0.2 to 6.3 points) at 36 months. Sensitivity analyses to account for the effect of mortality on follow-up QOL measurement were consistent with the primary findings. Limitation: Therapy was not masked. Conclusion: In this cohort of symptomatic high-risk patients with ischemic left ventricular dysfunction and multivessel coronary artery disease, CABG plus medical therapy produced clinically important improvements in quality of life compared with medical therapy alone over 36 months.	Duke Univ, Med Ctr, Outcomes Res Grp, Duke Clin Res Inst, Durham, NC 27710 USA; Med Univ Silesia, PL-40635 Katowice, Poland; Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada; Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; All India Inst Med Sci, Delhi, India; Baylor Soltero Cardiovasc Res Ctr, Dallas, TX 75226 USA; SAL Hosp, Ahmadabad, Gujarat, India; NHLBI, Bethesda, MD 20892 USA	Duke University; Medical University Silesia; Dalhousie University; Queen Elizabeth II Health Sciences Centre; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; All India Institute of Medical Sciences (AIIMS) New Delhi; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mark, DB (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	daniel.mark@duke.edu	Spertus, John/ABD-3075-2021; Yadav, Rakesh/AAS-9629-2020; Howlett, Jonathan/T-2589-2019	Yadav, Rakesh/0000-0001-6733-7458; Howlett, Jonathan/0000-0002-0535-9771; Malinowski, Marcin/0000-0002-4526-2843; Mark, Daniel/0000-0001-6340-8087	National Heart, Lung, and Blood Institute; National Institutes of Health [U01 HL69011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069011] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the National Heart, Lung, and Blood Institute and the National Institutes of Health (grant U01 HL69011; Dr. Mark).	ALDERMAN EL, 1983, CIRCULATION, V68, P785, DOI 10.1161/01.CIR.68.4.785; Chiba Y, 2011, AM J EPIDEMIOL, V173, P745, DOI 10.1093/aje/kwq418; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; Efron B., 1994, MONOGRAPHS STAT APPL; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Hayden D, 2005, BIOMETRICS, V61, P305, DOI 10.1111/j.0006-341X.2005.030227.x; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Little RJ, 2012, STAT MED, V31, P3433, DOI 10.1002/sim.5519; Mark DB, 2008, NEW ENGL J MED, V359, P999, DOI 10.1056/NEJMoa0706719; O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3; Pauler DK, 2003, STAT MED, V22, P795, DOI 10.1002/sim.1397; PEDUZZI P, 1987, AM J CARDIOL, V59, P1017, DOI 10.1016/0002-9149(87)90841-1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROGERS WJ, 1990, CIRCULATION, V82, P1647, DOI 10.1161/01.CIR.82.5.1647; Rubin DB, 2006, STAT SCI, V21, P299, DOI 10.1214/088342306000000114; Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spertus JA, 2008, CIRCULATION, V118, P2103, DOI 10.1161/CIRCULATIONAHA.107.747568; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sullivan MD, 1998, PSYCHOSOM MED, V60, P473, DOI 10.1097/00006842-199807000-00014; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Velazquez EJ, 2007, J THORAC CARDIOV SUR, V134, P1540, DOI 10.1016/j.jtcvs.2007.05.069; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 1993, SF36 HLTH SURVEY MAN; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	27	40	41	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					392	U47		10.7326/M13-1380	http://dx.doi.org/10.7326/M13-1380			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25222386	Green Accepted			2022-12-28	WOS:000343894400014
J	Watts, G				Watts, Geoff			Judy Wasserheit: positively global	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					947	947		10.1016/S0140-6736(14)61617-2	http://dx.doi.org/10.1016/S0140-6736(14)61617-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9ML	25220963				2022-12-28	WOS:000341679700012
